PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Szmyd, R; Niska-Blakie, J; Diril, MK; Nunes, PR; Tzelepis, K; Lacroix, A; van Hul, N; Deng, LW; Matos, J; Dreesen, O; Bisteau, X; Kaldis, P				Szmyd, Radoslaw; Niska-Blakie, Joanna; Diril, M. Kasim; Nunes, Patricia Renck; Tzelepis, Konstantinos; Lacroix, Aurelie; van Hul, Noemi; Deng, Lih-Wen; Matos, Joao; Dreesen, Oliver; Bisteau, Xavier; Kaldis, Philipp			Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality	ONCOGENE			English	Article							CYCLIN-DEPENDENT KINASE; DNA-DAMAGE CHECKPOINT; HOLLIDAY JUNCTION RESOLUTION; INHIBITORY PHOSPHORYLATION; CELL-CYCLE; WEE1 KINASE; NUCLEAR ACCUMULATION; RE-REPLICATION; PROTEIN-KINASE; G2 CHECKPOINT	Cell cycle regulation, especially faithful DNA replication and mitosis, are crucial to maintain genome stability. Cyclin-dependent kinase (CDK)/cyclin complexes drive most processes in cellular proliferation. In response to DNA damage, cell cycle surveillance mechanisms enable normal cells to arrest and undergo repair processes. Perturbations in genomic stability can lead to tumor development and suggest that cell cycle regulators could be effective targets in anticancer therapy. However, many clinical trials ended in failure due to off-target effects of the inhibitors used. Here, we investigate in vivo the importance of WEE1- and MYT1-dependent inhibitory phosphorylation of mammalian CDK1. We generated Cdk1(AF) knockin mice, in which two inhibitory phosphorylation sites are replaced by the non-phosphorylatable amino acids T14A/Y15F. We uncovered that monoallelic expression of CDK1(AF) is early embryonic lethal in mice and induces S phase arrest accompanied by gamma H2AX and DNA damage checkpoint activation in mouse embryonic fibroblasts (MEFs). The chromosomal fragmentation in Cdk1(AF) MEFs does not rely on CDK2 and is partly caused by premature activation of MUS81-SLX4 structure-specific endonuclease complexes, as well as untimely onset of chromosome condensation followed by nuclear lamina disassembly. We provide evidence that tumor development in liver expressing CDK1(AF) is inhibited. Interestingly, the regulatory mechanisms that impede cell proliferation in CDK1(AF) expressing cells differ partially from the actions of the WEE1 inhibitor, MK-1775, with p53 expression determining the sensitivity of cells to the drug response. Thus, our work highlights the importance of improved therapeutic strategies for patients with various cancer types and may explain why some patients respond better to WEE1 inhibitors.	[Szmyd, Radoslaw; Niska-Blakie, Joanna; Diril, M. Kasim; Nunes, Patricia Renck; Tzelepis, Konstantinos; Lacroix, Aurelie; van Hul, Noemi; Bisteau, Xavier; Kaldis, Philipp] ASTAR, IMCB, 61 Biopolis Dr,Proteos 3-09, Singapore 138673, Singapore; [Szmyd, Radoslaw] NUS, NUS Grad Sch Integrat Sci & Engn, Singapore 117597, Singapore; [Niska-Blakie, Joanna] ASTAR, Bioinformat Inst BII, Singapore 138671, Singapore; [Deng, Lih-Wen; Kaldis, Philipp] NUS, Dept Biochem, Singapore 117597, Singapore; [Matos, Joao] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland; [Dreesen, Oliver] ASTAR, Inst Med Biol, Singapore 138648, Singapore; [Diril, M. Kasim] Dokuz Eylul Univ, Izmir Biomed & Genome Inst, TR-35340 Izmir, Turkey; [Nunes, Patricia Renck] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Tzelepis, Konstantinos] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Lacroix, Aurelie] McGill Univ, Dept Chem, 801 Sherbrooke St West, Montreal, PQ H3A 0B8, Canada; [Lacroix, Aurelie] McGill Univ, CSACS, 801 Sherbrooke St West, Montreal, PQ H3A 0B8, Canada	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; Swiss Federal Institutes of Technology Domain; ETH Zurich; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Dokuz Eylul University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Wellcome Trust Sanger Institute; McGill University; McGill University	Kaldis, P (corresponding author), ASTAR, IMCB, 61 Biopolis Dr,Proteos 3-09, Singapore 138673, Singapore.; Kaldis, P (corresponding author), NUS, Dept Biochem, Singapore 117597, Singapore.	kaldis@imcb.a-star.edu.sg	Nunes, Patricia Renck/W-8183-2019; Kaldis, Philipp/G-2714-2010; Bisteau, Xavier/Q-7239-2018; Dreesen, Oliver/AAJ-2132-2020; Diril, Kasim/GWZ-8547-2022; Diril, Kasim/Y-1632-2018; Van Hul, Noemi/AAB-7985-2020; Bisteau, Xavier/AAH-6744-2021; Matos, Joao/C-1488-2014	Kaldis, Philipp/0000-0002-7247-7591; Bisteau, Xavier/0000-0002-8896-5098; Van Hul, Noemi/0000-0003-1410-8808; Matos, Joao/0000-0002-3754-3709; Tzelepis, Konstantinos/0000-0002-4865-7648; Renck Nunes, Patricia/0000-0002-9680-0779; LACROIX, Aurelie/0000-0003-1801-1608	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore; National Medical Research Council Singapore, NMRC [NMRC/CBRG/0091/2015]	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council Singapore, NMRC(National Medical Research Council, Singapore)	We thank Zakiah Talib, June Wang, Vithya Anantaraja and Chloe Sim for animal care; and all past and current members of the Kaldis lab for support and discussions. We thank Jos Jonkers and Anton Berns for providing the Rosa26-CreERT2 mice, Andy McMahon for Esr1-Cre mice, T Jake Liang for Alb-Cre mice and Mark Lewandoski for the beta-actin-Cre/Flpe mice. We acknowledge the technical expertise provided by the Advanced Molecular Pathology Laboratory at IMCB. This work was supported by the Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore and in part by a grant from the National Medical Research Council Singapore, NMRC (NMRC/CBRG/0091/2015) to PK.	Aaltonen K, 2009, BRIT J CANCER, V100, P1055, DOI 10.1038/sj.bjc.6604874; Aarts M, 2012, CANCER DISCOV, V2, P524, DOI 10.1158/2159-8290.CD-11-0320; Abbas T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012914; Adhikari D, 2016, CELL RES, V26, P1212, DOI 10.1038/cr.2016.119; AJIRO K, 1983, J BIOL CHEM, V258, P4534; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Bayart E, 2004, CANCER RES, V64, P8954, DOI 10.1158/0008-5472.CAN-04-1613; Beck H, 2012, MOL CELL BIOL, V32, P4226, DOI 10.1128/MCB.00412-12; Bell JB, 2007, NAT PROTOC, V2, P3153, DOI 10.1038/nprot.2007.471; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Blasina A, 1997, MOL BIOL CELL, V8, P1013, DOI 10.1091/mbc.8.6.1013; Bonin A, 2000, METH MOL B, V158, P121; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen T, 2012, DRUG DISCOV TODAY, V17, P194, DOI 10.1016/j.drudis.2011.12.009; Chow JPH, 2013, ONCOGENE, V32, P4778, DOI 10.1038/onc.2012.504; Chow JPH, 2003, MOL BIOL CELL, V14, P3989, DOI 10.1091/mbc.E03-03-0168; Chow JPH, 2003, J BIOL CHEM, V278, P40815, DOI 10.1074/jbc.M306683200; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Coulonval K, 2011, MOL BIOL CELL, V22, P3971, DOI 10.1091/mbc.E11-02-0136; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109; Dominguez-Kelly R, 2011, J CELL BIOL, V194, P567, DOI 10.1083/jcb.201101047; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Duda H, 2016, DEV CELL, V39, P740, DOI 10.1016/j.devcel.2016.11.017; ENOCH T, 1991, J CELL BIOL, V112, P797, DOI 10.1083/jcb.112.5.797; FANG F, 1991, CELL, V66, P731, DOI 10.1016/0092-8674(91)90117-H; FUKUDA K, 1995, J BIOL CHEM, V270, P22527, DOI 10.1074/jbc.270.38.22527; Garcia TB, 2018, LEUKEMIA RES, V64, P30, DOI 10.1016/j.leukres.2017.11.004; Garner E, 2013, CELL REP, V5, P207, DOI 10.1016/j.celrep.2013.08.041; GAUTIER J, 1990, CELL, V60, P487, DOI 10.1016/0092-8674(90)90599-A; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Gupta M, 2007, J BIOL CHEM, V282, P4301, DOI 10.1074/jbc.M607910200; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; HARPER JW, 1993, CELL, V75, P805; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Heijink AM, 2015, P NATL ACAD SCI USA, V112, P15160, DOI 10.1073/pnas.1505283112; Hirai H, 2009, MOL CANCER THER, V8, P2992, DOI 10.1158/1535-7163.MCT-09-0463; Ho V, 2015, ONCOTARGET, V6, P27252, DOI 10.18632/oncotarget.4583; Hughes BT, 2013, P NATL ACAD SCI USA, V110, P8954, DOI 10.1073/pnas.1302927110; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Jin P, 1996, J CELL BIOL, V134, P963, DOI 10.1083/jcb.134.4.963; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Johnson N, 2009, MOL CELL, V35, P327, DOI 10.1016/j.molcel.2009.06.036; Kaldis P, 1999, CELL MOL LIFE SCI, V55, P284, DOI 10.1007/s000180050290; Kao H, 2001, J EXP MED, V194, P1313, DOI 10.1084/jem.194.9.1313; KELMAN Z, 1995, NUCLEIC ACIDS RES, V23, P3613, DOI 10.1093/nar/23.18.3613; Klotz-Noack K, 2012, J CELL SCI, V125, P2436, DOI 10.1242/jcs.100883; KORNBLUTH S, 1994, MOL BIOL CELL, V5, P273, DOI 10.1091/mbc.5.3.273; Krajewska M, 2013, ONCOGENE, V32, P3001, DOI 10.1038/onc.2012.296; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liu F, 1997, MOL CELL BIOL, V17, P571, DOI 10.1128/MCB.17.2.571; Lohka MJ, 1998, BIOL CELL, V90, P591, DOI 10.1016/S0248-4900(99)80017-3; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Matheson CJ, 2016, TRENDS PHARMACOL SCI, V37, P872, DOI 10.1016/j.tips.2016.06.006; Matos J, 2011, CELL, V147, P158, DOI 10.1016/j.cell.2011.08.032; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Minemoto Y, 2003, ARCH BIOCHEM BIOPHYS, V412, P13, DOI 10.1016/S0003-9861(03)00010-9; Monaco L, 2005, P NATL ACAD SCI USA, V102, P14244, DOI 10.1073/pnas.0506252102; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Moser R, 2014, CLIN CANCER RES, V20, P4274, DOI 10.1158/1078-0432.CCR-13-2858; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Nakajo N, 2000, GENE DEV, V14, P328; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; Padmakumar VC, 2009, MOL CELL BIOL, V29, P2582, DOI 10.1128/MCB.00952-08; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PAGANO M, 1993, J CELL BIOL, V121, P101, DOI 10.1083/jcb.121.1.101; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Pfander B, 2017, FEBS LETT, V591, P2048, DOI 10.1002/1873-3468.12727; Pfister SX, 2015, CANCER CELL, V28, P557, DOI 10.1016/j.ccell.2015.09.015; Pomerening JR, 2008, MOL BIOL CELL, V19, P3426, DOI 10.1091/mbc.E08-02-0172; Poon RYC, 1997, CANCER RES, V57, P5168; Poon RYC, 1996, J BIOL CHEM, V271, P13283, DOI 10.1074/jbc.271.22.13283; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rass U, 2010, GENE DEV, V24, P1559, DOI 10.1101/gad.585310; Ross KE, 2000, MOL BIOL CELL, V11, P1597, DOI 10.1091/mbc.11.5.1597; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Sarbajna S, 2014, GENE DEV, V28, P1124, DOI 10.1101/gad.238303.114; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Schuler M, 2004, GENESIS, V39, P167, DOI 10.1002/gene.20039; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tanaka S, 2010, CHROMOSOMA, V119, P565, DOI 10.1007/s00412-010-0291-8; Tominaga Y, 2006, INT J BIOL SCI, V2, P161; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vincent F, 1999, BIOL CELL, V91, P665; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Vriend LEM, 2013, BBA-REV CANCER, V1836, P227, DOI 10.1016/j.bbcan.2013.05.002; WALDMAN T, 1995, CANCER RES, V55, P5187; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; Wells NJ, 1999, J CELL SCI, V112, P3361; West SC, 2015, COLD SH Q B, V80, P103, DOI 10.1101/sqb.2015.80.027649; Wilkins BJ, 2014, SCIENCE, V343, P77, DOI 10.1126/science.1244508; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Wyatt HDM, 2013, MOL CELL, V52, P234, DOI 10.1016/j.molcel.2013.08.035; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Zhao H, 2012, MOL CELL BIOL, V32, P1421, DOI 10.1128/MCB.06721-11	121	34	34	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 14	2019	38	7					998	1018		10.1038/s41388-018-0464-0	http://dx.doi.org/10.1038/s41388-018-0464-0			21	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HL3OH	30190546	Green Published, hybrid			2022-12-26	WOS:000458624900006
J	Zhao, L; Zhang, DJ; Shen, Q; Jin, M; Lin, ZY; Ma, H; Huang, SY; Zhou, PF; Wu, G; Zhang, T				Zhao, Lei; Zhang, Dejun; Shen, Qiong; Jin, Min; Lin, Zhenyu; Ma, Hong; Huang, Shaoyi; Zhou, Pengfei; Wu, Gang; Zhang, Tao			KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway	ONCOGENE			English	Article							PROTEIN PHOSPHATASE 2A; PP2A INHIBITOR; POOR-PROGNOSIS; TUMOR INVASION; STATHMIN; OVEREXPRESSION; EXPRESSION; GROWTH; PHOSPHORYLATION; APOPTOSIS	Tumor metastasis is the main cause of death in advanced colorectal cancer. Our previous research showed that upregulation of KIAA1199 predicted poorer outcomes, and promoted cell motility and tumor metastasis in colorectal cancer, with the mechanisms not being fully elucidated. Here, we demonstrate that silencing of KIAA1199 results in reduced tumor metastasis in the orthotopic transplantation tumor model of colorectal cancer. Importantly, we find that KIAA1199 interacts with protein phosphatase 2A (PP2A) through the C-terminal domain and increases phosphatase activity of PP2A, which is essential for KIAA1199-mediated cell motility. Moreover, we identify stathmin, a microtubule-destabilizing protein, as a downstream of KIAA1199-PP2A complex. KIAA1199-induced dephosphorylation of stathmin results in microtubule destabilization and leads to enhanced cell motility. Furthermore, a microtubule-stabilizing drug paclitaxel could prevent KIAA1199-induced microtubule destabilization, and inhibit cell migration and invasion in vitro and tumor metastasis in vivo in colorectal cancer. Collectively, our study reveals that KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway, and suggests that KIAA1199 may be a promising target for preventing metastasis in colorectal cancer.	[Zhao, Lei; Zhang, Dejun; Jin, Min; Lin, Zhenyu; Ma, Hong; Wu, Gang; Zhang, Tao] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Wuhan 430022, Hubei, Peoples R China; [Shen, Qiong] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Surg, Wuhan 430030, Hubei, Peoples R China; [Huang, Shaoyi; Zhou, Pengfei] Wuhan YZY Med Sci & Technol Co Ltd, Wuhan 430075, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, T (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Wuhan 430022, Hubei, Peoples R China.	taozhangxh@hust.edu.cn			National Natural Science Foundation of China [81702392, 81874061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (81702392 to LZ and 81874061 to TZ). The authors acknowledge Liang Zeng, Jingjing Wu, and Yan Xue for technical assistance, and thank Dr. Shuangbing Xu for critical review of the paper. Data deposition The authors agree to submit the author's version of the accepted paper to public repositories.	Abe S, 2003, J HUM GENET, V48, P564, DOI 10.1007/s10038-003-0079-2; Ajay AK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-204; Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Boudreau RM, 2007, CELL SIGNAL, V19, P139, DOI 10.1016/j.cellsig.2006.05.030; Byrne FL, 2014, ONCOGENE, V33, P882, DOI 10.1038/onc.2013.11; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen J, 2013, ONCOGENE, V32, P1330, DOI 10.1038/onc.2012.141; Cortes J, 2012, BREAST CANCER RES TR, V133, P821, DOI 10.1007/s10549-011-1875-6; Cristobal I, 2012, HAEMATOL-HEMATOL J, V97, P543, DOI 10.3324/haematol.2011.050542; Duong FHT, 2014, CARCINOGENESIS, V35, P114, DOI 10.1093/carcin/bgt258; Etienne-Manneville S, 2013, ANNU REV CELL DEV BI, V29, P471, DOI 10.1146/annurev-cellbio-101011-155711; Evensen NA, 2013, JNCI-J NATL CANCER I, V105, P1402, DOI 10.1093/jnci/djt224; Fink SP, 2015, ONCOTARGET, V6, P30500, DOI 10.18632/oncotarget.5921; Jami MS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-194; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jia SQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175058; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kaverina I, 2011, SEMIN CELL DEV BIOL, V22, P968, DOI 10.1016/j.semcdb.2011.09.017; Knight LM, 2015, J VIROL, V89, P35, DOI 10.1128/JVI.02317-14; Koga A, 2017, PANCREATOLOGY, V17, P115, DOI 10.1016/j.pan.2016.12.007; Kuang XY, 2015, ONCOTARGET, V6, P22227, DOI 10.18632/oncotarget.4276; Lee E, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.2; Li N, 2011, P NATL ACAD SCI USA, V108, P12851, DOI 10.1073/pnas.1017372108; Li W, 2010, CANCER SCI, V101, P1226, DOI 10.1111/j.1349-7006.2010.01523.x; Liu CY, 2016, ONCOTARGET, V7, P9135, DOI 10.18632/oncotarget.7035; Liu P, 2013, ONCOL REP, V29, P419, DOI 10.3892/or.2012.2157; Lu J, 2010, J NEUROSURG, V113, P225, DOI 10.3171/2009.11.JNS091272; Lu J, 2009, P NATL ACAD SCI USA, V106, P11697, DOI 10.1073/pnas.0905930106; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; Matsuzaki S, 2009, ANN SURG ONCOL, V16, P2042, DOI 10.1245/s10434-009-0469-6; McDermott MSJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-157; Mistry SJ, 1998, BIOCHEM J, V334, P23, DOI 10.1042/bj3340023; Nemunaitis J, 2012, EXPERT OPIN THER TAR, V16, P631, DOI 10.1517/14728222.2012.696101; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Rong BX, 2016, ONCOTARGET, V7, P78980, DOI 10.18632/oncotarget.12982; Schweyer S, 2007, J PATHOL, V213, P72, DOI 10.1002/path.2203; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Shostak K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6232; Spano D, 2012, SEMIN CANCER BIOL, V22, P234, DOI 10.1016/j.semcancer.2012.03.006; Suh HN, 2016, SCI REP-UK, V6, DOI 10.1038/srep38273; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Xu J, 2015, INT J CLIN EXP PATHO, V8, P2909; Zhang DJ, 2017, INT J CANCER, V140, P2298, DOI 10.1002/ijc.30656; Zimmerman R, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.31	46	22	23	5	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 14	2019	38	7					935	949		10.1038/s41388-018-0493-8	http://dx.doi.org/10.1038/s41388-018-0493-8			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HL3OH	30202098				2022-12-26	WOS:000458624900002
J	Goto, H; Shimono, Y; Funakoshi, Y; Imamura, Y; Toyoda, M; Kiyota, N; Kono, S; Takao, S; Mukohara, T; Minami, H				Goto, Hideaki; Shimono, Yohei; Funakoshi, Yohei; Imamura, Yoshinori; Toyoda, Masanori; Kiyota, Naomi; Kono, Seishi; Takao, Shintaro; Mukohara, Toru; Minami, Hironobu			Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin	ONCOGENE			English	Article							COMPLEMENT FACTOR-D; MAMMARY-GLAND; IN-VIVO; OBESITY; TISSUE; PURIFICATION; ADIPONECTIN; OVERWEIGHT; RESISTANCE; SYSTEM	Tumor microenvironment plays a key role for tumor development and progression. Although adipose tissue is a predominant component of stroma in mammary tissues and secretes various cytokines, chemokines and growth factors, roles of adipocytes in breast cancers remain to be elucidated. In this study, we found that adipsin, an adipokine secreted from mammary adipose tissues, enhanced proliferation and cancer stem cell (CSC)-like properties of human breast cancer patient-derived xenograft (PDX) cells. Adipsin was predominantly expressed in both adipose tissues of the surgical specimens of breast cancer patients and adipose-derived stem cells (ADSCs) isolated from them, and its expression level was significantly higher in obese patients. ADSCs significantly enhanced the sphere-forming ability of breast cancer PDX cells derived from both estrogen receptor-positive and -negative breast cancer PDX cells. Suppression of adipsin-mediated signaling by a specific inhibitor or adipsin knockdown in ADSCs significantly decreased the sphere-forming ability and the expression of CSC markers in co-cultured breast cancer PDX cells. Growth of breast cancer PDX tumors was significantly enhanced by co-transplantation with ADSCs in vivo, and it was weakened when co-transplanted with the adipsin knocked-down ADSCs. These results suggest that adipsin is an important adipokine secreted from mammary adipose tissue that functions as a component of tumor microenvironment and a CSC niche in breast cancers.	[Goto, Hideaki; Shimono, Yohei; Funakoshi, Yohei; Imamura, Yoshinori; Toyoda, Masanori; Kiyota, Naomi; Mukohara, Toru; Minami, Hironobu] Kobe Univ, Div Med Oncol Hematol, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Shimono, Yohei] Kobe Univ, Div Mol & Cellular Biol, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Kiyota, Naomi; Mukohara, Toru; Minami, Hironobu] Kobe Univ Hosp, Ctr Canc, Kobe, Hyogo 6500017, Japan; [Kono, Seishi; Takao, Shintaro] Kobe Univ, Div Breast & Endocrine Surg, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Mukohara, Toru] Natl Canc Ctr Hosp East, Dept Breast & Med Oncol, Kashiwa, Chiba 2778577, Japan; [Shimono, Yohei] Fujita Hlth Univ, Dept Biochem, Toyoake, Aichi 4701192, Japan	Kobe University; Kobe University; Kobe University; Kobe University; National Cancer Center - Japan; Fujita Health University	Shimono, Y (corresponding author), Kobe Univ, Div Med Oncol Hematol, Grad Sch Med, Kobe, Hyogo 6500017, Japan.; Shimono, Y (corresponding author), Kobe Univ, Div Mol & Cellular Biol, Grad Sch Med, Kobe, Hyogo 6500017, Japan.; Shimono, Y (corresponding author), Fujita Hlth Univ, Dept Biochem, Toyoake, Aichi 4701192, Japan.	yshimono@med.kobe-u.ac.jp	Imamura, Yoshinori/ABD-4175-2021; Kiyota, Naomi/K-3226-2016	Kiyota, Naomi/0000-0001-8021-6116; Imamura, Yoshinori/0000-0002-5202-531X; Minami, Hironobu/0000-0001-8630-9145	Japan Society for the Promotion of Science (JSPS KAKENHI) [15K14381, 18K07231]; Japan-Belgium Research Cooperative Program from the Japan Society for the Promotion of Science; Japan Foundation for Applied Enzymology; Itoh-Chubei Foundation; Cancer Research Institute, Kanazawa University; Princess Takamatsu Cancer Research Fund	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan-Belgium Research Cooperative Program from the Japan Society for the Promotion of Science; Japan Foundation for Applied Enzymology; Itoh-Chubei Foundation; Cancer Research Institute, Kanazawa University; Princess Takamatsu Cancer Research Fund	This work was supported by: (1) grants-in-aid from the Japan Society for the Promotion of Science (JSPS KAKENHI) 15K14381 and 18K07231 (to YS); (2) Japan-Belgium Research Cooperative Program from the Japan Society for the Promotion of Science (to YS); (3) a grant from the Japan Foundation for Applied Enzymology (to YS); (4) a grant from the Itoh-Chubei Foundation (to YS); (5) an extramural collaborative research grant of Cancer Research Institute, Kanazawa University (to YS); (6) a grant from the Princess Takamatsu Cancer Research Fund (to YS). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Afshar-Kharghan V, 2017, J CLIN INVEST, V127, P780, DOI 10.1172/JCI90962; Agarwal A, 2015, CLIN OPHTHALMOL, V9, P1001, DOI [10.2147/OPTH.S59725, 10.2147/OPTH.S74959]; Ando S, 2012, NAT REV ENDOCRINOL, V8, P263, DOI 10.1038/nrendo.2011.184; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Booth A, 2016, HORM MOL BIOL CLIN I, V26, P25, DOI 10.1515/hmbci-2015-0073; Booth A, 2015, HORM MOL BIOL CLIN I, V21, P57, DOI 10.1515/hmbci-2014-0037; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Carmona-Fontaine C, 2011, DEV CELL, V21, P1026, DOI 10.1016/j.devcel.2011.10.012; Chedraui P, 2014, MATURITAS, V79, P86, DOI 10.1016/j.maturitas.2014.06.008; Cheng K.-H., 2011, GENOMIC MED BIOMARKE, V3, P53, DOI [10.1016/j.gmbhs.2011.08.003, DOI 10.1016/J.GMBHS.2011.08.003]; Cho MS, 2014, CELL REP, V6, P1085, DOI 10.1016/j.celrep.2014.02.014; Choi J, 2018, PROG LIPID RES, V69, P11, DOI 10.1016/j.plipres.2017.11.002; COOK KS, 1987, SCIENCE, V237, P402, DOI 10.1126/science.3299705; Couldrey C, 2002, DEV DYNAM, V223, P459, DOI 10.1002/dvdy.10065; Divella R, 2016, J CANCER, V7, P2346, DOI 10.7150/jca.16884; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Goodwin PJ, 2016, J CLIN ONCOL, V34, P4197, DOI 10.1200/JCO.2016.70.5327; Goodwin PJ, 2015, ANNU REV MED, V66, P281, DOI 10.1146/annurev-med-051613-012328; Hoy AJ, 2017, TRENDS MOL MED, V23, P381, DOI 10.1016/j.molmed.2017.02.009; Imamura Y, 2015, ONCOL REP, V33, P1837, DOI 10.3892/or.2015.3767; Isobe T, 2014, ELIFE, V3, DOI 10.7554/eLife.01977; Jiralerspong S, 2016, J CLIN ONCOL, V34, P4203, DOI 10.1200/JCO.2016.68.4480; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Lo JC, 2014, CELL, V158, P41, DOI 10.1016/j.cell.2014.06.005; Mantzoros C, 2004, J CLIN ENDOCR METAB, V89, P1102, DOI 10.1210/jc.2003-031804; Duong MN, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0569-0; Nabizadeh JA, 2016, J IMMUNOL, V196, P4783, DOI 10.4049/jimmunol.1600210; Neuhouser ML, 2015, JAMA ONCOL, V1, P611, DOI 10.1001/jamaoncol.2015.1546; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; Pattrick M, 2009, MOL IMMUNOL, V46, P755, DOI 10.1016/j.molimm.2008.09.013; Pierobon M, 2013, BREAST CANCER RES TR, V137, P307, DOI 10.1007/s10549-012-2339-3; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ratajczak MZ, 2006, EXP HEMATOL, V34, P986, DOI 10.1016/j.exphem.2006.03.015; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rutkowski MJ, 2010, MOL CANCER RES, V8, P1453, DOI 10.1158/1541-7786.MCR-10-0225; Schweizer R, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/120949; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Song NJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162228; Sprong T, 2006, BLOOD, V107, P4865, DOI 10.1182/blood-2005-07-2820; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Wang XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072962; WHITE RT, 1992, J BIOL CHEM, V267, P9210; Wysoczynski M, 2009, LEUKEMIA, V23, P1455, DOI 10.1038/leu.2009.73; Zimmerlin L, 2011, TISSUE ENG PT A, V17, P93, DOI [10.1089/ten.tea.2010.0248, 10.1089/ten.TEA.2010.0248]	51	66	68	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 7	2019	38	6					767	779		10.1038/s41388-018-0477-8	http://dx.doi.org/10.1038/s41388-018-0477-8			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HK5LC	30177835				2022-12-26	WOS:000458006300001
J	Chang, AN; Gao, N; Liu, ZN; Huang, J; Nairn, AC; Kamm, KE; Stull, JT				Chang, Audrey N.; Gao, Ning; Liu, Zhenan; Huang, Jian; Nairn, Angus C.; Kamm, Kristine E.; Stull, James T.			The dominant protein phosphatase PP1c isoform in smooth muscle cells, PP1c beta, is essential for smooth muscle contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein phosphorylation; smooth muscle; myosin; muscle physiology; protein phosphatase; contraction; MYPT1; PP1c	MYOSIN LIGHT-CHAIN; TARGETING SUBUNIT-1 PHOSPHORYLATION; CONSTITUTIVE PHOSPHORYLATION; KINASE ACTIVATION; CATALYTIC SUBUNIT; FORCE GENERATION; BINDING; MECHANISM; ROLES; DIPHOSPHORYLATION	Contractile force development of smooth muscle is controlled by balanced kinase and phosphatase activities toward the myosin regulatory light chain (RLC). Numerous biochemical and pharmacological studies have investigated the specificity and regulatory activity of smooth muscle myosin light-chain phosphatase (MLCP) bound to myosin filaments and comprised of the regulatory myosin phosphatase target subunit 1 (MYPT1) and catalytic protein phosphatase 1c (PP1c) subunits. Recent physiological and biochemical evidence obtained with smooth muscle tissues from a conditional MYPT1 knockout suggests that a soluble, MYPT1-unbound form of PP1c may additionally contribute to myosin RLC dephosphorylation and relaxation of smooth muscle. Using a combination of isoelectric focusing and isoform-specific immunoblotting, we found here that more than 90% of the total PP1c in mouse smooth muscles is the isoform. Moreover, conditional knockout of PP1c or PP1c in adult smooth muscles did not result in an apparent phenotype in mice up to 6 months of age and did not affect smooth muscle contractions ex vivo. In contrast, smooth muscle-specific conditional PP1c knockout decreased contractile force development in bladder, ileal, and aortic tissues and reduced mouse survival. Bladder smooth muscle tissue from WT mice was selectively permeabilized to remove soluble PP1c to measure contributions of total (-toxin treatment) and myosin-bound (Triton X-100 treatment) phosphatase activities toward phosphorylated RLC in myofilaments. Triton X-100 reduced PP1c content by 60% and the rate of RLC dephosphorylation by 2-fold. These results are consistent with the selective dephosphorylation of RLC by both MYPT1-bound and -unbound PP1c forms in smooth muscle.	[Chang, Audrey N.; Gao, Ning; Liu, Zhenan; Huang, Jian; Kamm, Kristine E.; Stull, James T.] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Chang, Audrey N.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University	Chang, AN (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.; Chang, AN (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	audreyn.chang@utsouthwestern.edu		Nairn, Angus/0000-0002-7075-0195	American Heart Association Scientist Development Grant; National Institutes of Health [DA10044, R01 HL112778, R01 HL080536]; Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080536, R01HL112778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by an American Heart Association Scientist Development Grant (to A. N. C.), National Institutes of Health Grants DA10044 (to A. C. N) and R01 HL112778 and R01 HL080536 (to J. T. S.), the Moss Heart Fund (to J. T. S.), and the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology (to J. T. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Brautigan DL, 2013, FEBS J, V280, P324, DOI 10.1111/j.1742-4658.2012.08609.x; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; CASSIDY P, 1979, J BIOL CHEM, V254, P1148; Chang AN, 2016, J MOL CELL CARDIOL, V101, P35, DOI 10.1016/j.yjmcc.2016.10.004; Chang AN, 2016, P NATL ACAD SCI USA, V113, pE3824, DOI 10.1073/pnas.1600633113; Chang AN, 2015, J BIOL CHEM, V290, P10703, DOI 10.1074/jbc.M115.642165; Chen CP, 2015, J PHYSIOL-LONDON, V593, P681, DOI 10.1113/jphysiol.2014.283853; Chen MJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag1796; CHEN YH, 1994, FEBS LETT, V356, P51, DOI 10.1016/0014-5793(94)01231-8; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Cohen PTW, 2002, J CELL SCI, V115, P241; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Dippold RP, 2014, AM J PHYSIOL-REG I, V307, pR256, DOI 10.1152/ajpregu.00145.2014; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Fisher SA, 2010, PHYSIOL GENOMICS, V42A, P169, DOI 10.1152/physiolgenomics.00111.2010; FUSSLE R, 1981, J CELL BIOL, V91, P83, DOI 10.1083/jcb.91.1.83; Gao N, 2017, J PHYSIOL-LONDON, V595, P6231, DOI 10.1113/JP274715; Gao N, 2016, J PHYSIOL-LONDON, V594, P3209, DOI 10.1113/JP271703; Gao N, 2013, J BIOL CHEM, V288, P7596, DOI 10.1074/jbc.M112.427112; GARDNER JP, 1989, PFLUG ARCH EUR J PHY, V414, P484, DOI 10.1007/BF00585061; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Hartshorne DJ, 1998, ACTA PHYSIOL SCAND, V164, P483; Hatch V, 2001, J CELL BIOL, V154, P611, DOI 10.1083/jcb.200105079; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; He WQ, 2013, GASTROENTEROLOGY, V144, P1456, DOI 10.1053/j.gastro.2013.02.045; He WQ, 2011, AM J PHYSIOL-HEART C, V301, pH584, DOI 10.1152/ajpheart.01212.2010; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Hong F, 2011, ARCH BIOCHEM BIOPHYS, V510, P135, DOI 10.1016/j.abb.2011.04.018; Huang J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193769; IIZUKA K, 1994, CELL CALCIUM, V16, P431, DOI 10.1016/0143-4160(94)90073-6; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; KAMM KE, 1989, J BIOL CHEM, V264, P21223; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Khasnis M, 2014, BIOCHEMISTRY-US, V53, P2701, DOI 10.1021/bi5001728; Kitazawa T, 1999, J PHYSIOL-LONDON, V520, P139, DOI 10.1111/j.1469-7793.1999.00139.x; Kuang SQ, 2012, CIRC RES, V110, P1411, DOI 10.1161/CIRCRESAHA.111.261743; Lin PJ, 1999, J BIOL CHEM, V274, P5987, DOI 10.1074/jbc.274.9.5987; Liu RJ, 2015, J MOL CELL CARDIOL, V87, P204, DOI 10.1016/j.yjmcc.2015.08.018; Mabuchi Y, 2010, BIOCHEMISTRY-US, V49, P2903, DOI 10.1021/bi901963e; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Milewicz DM, 2017, ARTERIOSCL THROM VAS, V37, P26, DOI 10.1161/ATVBAHA.116.303229; Mizuno Y, 2008, AM J PHYSIOL-CELL PH, V295, pC358, DOI 10.1152/ajpcell.90645.2007; Moffat LD, 2011, J BIOL CHEM, V286, P36978, DOI 10.1074/jbc.M111.257949; PATO MD, 1983, EUR J BIOCHEM, V132, P283, DOI 10.1111/j.1432-1033.1983.tb07360.x; PATO MD, 1983, J BIOL CHEM, V258, P7047; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Qiao YN, 2014, J BIOL CHEM, V289, P22512, DOI 10.1074/jbc.M113.525444; Scotto-Lavino E, 2010, J BIOL CHEM, V285, P6419, DOI 10.1074/jbc.M109.074773; SHIMIZU H, 1994, J BIOL CHEM, V269, P30407; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Smith L, 2000, FEBS LETT, V480, P298, DOI 10.1016/S0014-5793(00)01931-1; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Tsai MH, 2014, J PHYSIOL-LONDON, V592, P3031, DOI 10.1113/jphysiol.2014.273011; Tsai MH, 2012, J PHYSIOL-LONDON, V590, P5107, DOI 10.1113/jphysiol.2012.235424; Verbinnen I, 2017, BIOCHEM SOC T, V45, P89, DOI 10.1042/BST20160154; Walsh MP, 2011, IUBMB LIFE, V63, P987, DOI 10.1002/iub.527; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Watanabe T, 2003, METHOD ENZYMOL, V366, P321; Wilson DP, 2005, BIOCHEM J, V392, P641, DOI 10.1042/BJ20051173; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836; ZHANG ZJ, 1992, J BIOL CHEM, V267, P1484	66	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16677	16686		10.1074/jbc.RA118.003083	http://dx.doi.org/10.1074/jbc.RA118.003083			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30185619	Green Published, hybrid			2022-12-26	WOS:000448515100011
J	Kohno, M; Arakawa, T; Ota, H; Mori, T; Nishimoto, T; Fushinobu, S				Kohno, Masaki; Arakawa, Takatoshi; Ota, Hiromi; Mori, Tetsuya; Nishimoto, Tomoyuki; Fushinobu, Shinya			Structural features of a bacterial cyclic alpha-maltosyl-(1 -> 6)-maltose (CMM) hydrolase critical for CMM recognition and hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; crystal structure; X-ray crystallography; carbohydrate metabolism; oligosaccharide; amylase; carbohydrate degradation; cyclic oligosaccharides; cyclodextrins; neopullulanase; CMM catabolism; hydrolytic enzyme	VULGARIS R-47 ALPHA-AMYLASE-2; BACILLUS-GLOBISPORUS C-11; ARTHROBACTER-GLOBIFORMIS STRAIN; CYCLODEXTRIN-BINDING-PROTEIN; X-RAY STRUCTURE; THERMOACTINOMYCES-VULGARIS; ALPHA-AMYLASE; SUBSTRATE-BINDING; STEAROTHERMOPHILUS NEOPULLULANASE; ANGSTROM RESOLUTION	Cyclic -maltosyl-(16)-maltose (CMM, cyclo-{6)--d-Glcp-(14)--d-Glcp-(16)--d-Glcp-(14)--d-Glcp-(1})is a cyclic glucotetrasaccharide with alternating -1,4 and -1,6 linkages. CMM is composed of two maltose units and is one of the smallest cyclic glucooligosaccharides. Although CMM is resistant to usual amylases, it is efficiently hydrolyzed by CMM hydrolase (CMMase), belonging to subfamily 20 of glycoside hydrolase family 13 (GH13_20). Here, we determined the ligand-free crystal structure of CMMase from the soil-associated bacterium Arthrobacter globiformis and its structures in complex with maltose, panose, and CMM to elucidate the structural basis of substrate recognition by CMMase. The structures disclosed that although the monomer structure consists of three domains commonly adopted by GH13 and other -amylase-related enzymes, CMMase forms a unique wing-like dimer structure. The complex structure with CMM revealed four specific subsites, namely -3, -2, -1, and +1. We also observed that the bound CMM molecule adopts a low-energy conformer compared with the X-ray structure of a single CMM crystal, also determined here. Comparison of the CMMase active site with those in other enzymes of the GH13_20 family revealed that three regions forming the wall of the cleft, denoted PYF (Pro-203/Tyr-204/Phe-205), CS (Cys-163/Ser-164), and Y (Tyr-168), are present only in CMMase and are involved in CMM recognition. Combinations of multiple substitutions in these regions markedly decreased the activity toward CMM, indicating that the specificity for this cyclic tetrasaccharide is supported by the entire shape of the pocket. In summary, our work uncovers the mechanistic basis for the highly specific interactions of CMMase with its substrate CMM.	[Kohno, Masaki; Arakawa, Takatoshi; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Arakawa, Takatoshi; Fushinobu, Shinya] Univ Tokyo, Collaborat Res Inst Innovat Microbiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Kohno, Masaki; Mori, Tetsuya; Nishimoto, Tomoyuki] Hayashibara Co Ltd, R&D Div, Naka Ku, 675-1 Fujisaki, Okayama 7028006, Japan; [Ota, Hiromi] Okayama Univ, Adv Sci Res Ctr, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan	University of Tokyo; University of Tokyo; Okayama University	Fushinobu, S (corresponding author), Univ Tokyo, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Arakawa, Takatoshi/K-9739-2013; Ota, Hiromi/AAE-4359-2019; Fushinobu, Shinya/E-4987-2011	Arakawa, Takatoshi/0000-0001-6496-5440; Fushinobu, Shinya/0000-0003-1346-6435	Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED)	Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by the Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED). The authors declare that they have no conflicts of interest with the contents of this article.	Aga H, 2002, J BIOSCI BIOENG, V94, P336, DOI 10.1263/jbb.94.336; Aga H, 2002, BIOSCI BIOTECH BIOCH, V66, P1057, DOI 10.1271/bbb.66.1057; Biwer A, 2002, APPL MICROBIOL BIOT, V59, P609, DOI 10.1007/s00253-002-1057-x; Bradbrook GM, 2000, CARBOHYD RES, V329, P655, DOI 10.1016/S0008-6215(00)00212-3; Choi JH, 2009, BIOCHEM BIOPH RES CO, V378, P224, DOI 10.1016/j.bbrc.2008.11.020; COTE GL, 1994, EUR J BIOCHEM, V226, P641, DOI 10.1111/j.1432-1033.1994.tb20091.x; DOWD MK, 1994, BIOPOLYMERS, V34, P625, DOI 10.1002/bip.360340505; Dumbrepatil AB, 2010, PROTEINS, V78, P348, DOI 10.1002/prot.22548; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank M, 2007, NUCLEIC ACIDS RES, V35, pD287, DOI 10.1093/nar/gkl907; Guo JX, 2018, ACTA CRYSTALLOGR D, V74, P305, DOI 10.1107/S2059798318001754; Hashimoto Y, 2001, J BACTERIOL, V183, P5050, DOI 10.1128/JB.183.17.5050-5057.2001; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hondoh H, 2003, J MOL BIOL, V326, P177, DOI 10.1016/S0022-2836(02)01402-X; Huitema C., 2018, BIORXIV2018316588, DOI [10.1101/316588., DOI 10.1101/316588]; Ito K, 2007, BBA-PROTEINS PROTEOM, V1774, P443, DOI 10.1016/j.bbapap.2007.02.006; Janecek S, 1997, J MOL EVOL, V45, P322, DOI 10.1007/PL00006236; Jung TY, 2012, J BIOL CHEM, V287, P7979, DOI 10.1074/jbc.M111.304774; Kamasaka H, 2002, APPL ENVIRON MICROB, V68, P1658, DOI 10.1128/AEM.68.4.1658-1664.2002; Kamionka A, 2001, FEMS MICROBIOL LETT, V204, P55, DOI 10.1111/j.1574-6968.2001.tb10862.x; Kamitori S, 1999, J MOL BIOL, V287, P907, DOI 10.1006/jmbi.1999.2647; Kamitori S, 2002, J MOL BIOL, V318, P443, DOI 10.1016/S0022-2836(02)00111-0; Kim YK, 2004, CARBOHYD RES, V339, P1179, DOI 10.1016/j.carres.2004.02.008; Kondo S, 2001, J BIOCHEM, V129, P423, DOI 10.1093/oxfordjournals.jbchem.a002873; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee HS, 2002, J BIOL CHEM, V277, P21891, DOI 10.1074/jbc.M201623200; Light SH, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.202; Light SH, 2017, STRUCTURE, V25, P295, DOI 10.1016/j.str.2016.12.007; Lima HOS, 1998, APPL BIOCHEM BIOTECH, V70-2, P789, DOI 10.1007/BF02920189; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Machius M, 1998, STRUCTURE, V6, P281, DOI 10.1016/S0969-2126(98)00032-X; Mori T., 2009, Journal of Applied Glycoscience, V56, P127; Mori T., 2011, Journal of Applied Glycoscience, V58, P39, DOI 10.5458/jag.jag.JAG-2010_011; Mori T, 2008, BIOSCI BIOTECH BIOCH, V72, P1673, DOI 10.1271/bbb.70759; Mukai K, 2006, APPL ENVIRON MICROB, V72, P1065, DOI 10.1128/AEM.72.2.1065-1071.2006; Mukai K, 2005, CARBOHYD RES, V340, P1469, DOI 10.1016/j.carres.2005.03.010; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimoto T, 2002, BIOSCI BIOTECH BIOCH, V66, P1806, DOI 10.1271/bbb.66.1806; OGUMA T, 1993, BIOSCI BIOTECH BIOCH, V57, P1225, DOI 10.1271/bbb.57.1225; OGUMA T, 1994, FEBS LETT, V345, P135, DOI 10.1016/0014-5793(94)00418-8; Ohtaki A, 2004, J BIOL CHEM, V279, P31033, DOI 10.1074/jbc.M404311200; Ohtaki A, 2001, CARBOHYD RES, V334, P309, DOI 10.1016/S0008-6215(01)00190-2; Ohtaki A, 2006, CARBOHYD RES, V341, P1041, DOI 10.1016/j.carres.2006.01.029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pajatsch M, 1998, J BACTERIOL, V180, P2630, DOI 10.1128/JB.180.10.2630-2635.1998; PALOHEIMO M, 1992, APPL MICROBIOL BIOT, V36, P584; Park JT, 2013, BBA-PROTEINS PROTEOM, V1834, P380, DOI 10.1016/j.bbapap.2012.08.001; Schardinger F., 1903, NAHR U GENUSSM, V6, P865, DOI DOI 10.1007/BF02067497; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Tagami T, 2016, J BIOL CHEM, V291, P16438, DOI 10.1074/jbc.M116.727305; TAKATA H, 1992, J BIOL CHEM, V267, P18447; TONOZUKA T, 1995, BBA-PROTEIN STRUCT M, V1252, P35, DOI 10.1016/0167-4838(95)00101-Y; Uitdehaag JCM, 2001, PROTEINS, V43, P327, DOI 10.1002/prot.1044; Utsumi Y, 2009, J APPL GLYCOSCI, V56, P215, DOI [DOI 10.5458/JAG.56.215, 10.5458/jag.56.215]; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Watanabe H, 2006, CARBOHYD RES, V341, P957, DOI 10.1016/j.carres.2006.02.028; Watanabe H, 2006, BIOSCI BIOTECH BIOCH, V70, P2690, DOI 10.1271/bbb.60294; Watanabe H, 2006, BIOSCI BIOTECH BIOCH, V70, P1954, DOI 10.1271/bbb.60131; Yopi Tonozuka T., 2002, J APPL GLYCOSCI, V49, P107, DOI [10.5458/jag.49.107, DOI 10.5458/JAG.49.107]	59	4	4	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16874	16888		10.1074/jbc.RA118.004472	http://dx.doi.org/10.1074/jbc.RA118.004472			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30181215	Green Published, hybrid			2022-12-26	WOS:000448515100027
J	Shevket, SH; Gonzalez, D; Cartwright, JL; Kleanthous, C; Ferguson, SJ; Redfield, C; Mavridou, DAI				Shevket, Shevket H.; Gonzalez, Diego; Cartwright, Jared L.; Kleanthous, Colin; Ferguson, Stuart J.; Redfield, Christina; Mavridou, Despoina A. I.			The CcmC-CcmE interaction during cytochrome c maturation by System I is driven by protein-protein and not protein-heme contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome c; heme; post-translational modification (PTM); Gram-negative bacteria; nuclear magnetic resonance (NMR); CcmC; CcmE; cytochrome c maturation; protein-protein interactions; System I	BIOGENESIS SYSTEM; ESCHERICHIA-COLI; CHAPERONE CCME; APOCYTOCHROME-C; NMR-SPECTROSCOPY; LIGATION COMPLEX; BINDING SITE; TRAFFICKING; PATHWAY; BACTERIA	Cytochromes c are ubiquitous proteins, essential for life in most organisms. Their distinctive characteristic is the covalent attachment of heme to their polypeptide chain. This post-translational modification is performed by a dedicated protein system, which in many Gram-negative bacteria and plant mitochondria is a nine-protein apparatus (CcmA-I) called System I. Despite decades of study, mechanistic understanding of the protein-protein interactions in this highly complex maturation machinery is still lacking. Here, we focused on the interaction of CcmC, the protein that sources the heme cofactor, with CcmE, the pivotal component of System I responsible for the transfer of the heme to the apocytochrome. Using in silico analyses, we identified a putative interaction site between these two proteins (residues Asp(47), Gln(50), and Arg(55) on CcmC; Arg(73), Asp(101), and Glu(105) on CcmE), and we validated our findings by in vivo experiments in Escherichia coli. Moreover, employing NMR spectroscopy, we examined whether a heme-binding site on CcmE contributes to this interaction and found that CcmC and CcmE associate via protein-protein rather than protein-heme contacts. The combination of in vivo site-directed mutagenesis studies and high-resolution structural techniques enabled us to determine at the residue level the mechanism for the formation of one of the key protein complexes for cytochrome c maturation by System I.	[Mavridou, Despoina A. I.] Imperial Coll London, Dept Life Sci, MRC, Ctr Mol Bacteriol & Infect, London SW7 2DD, England; [Shevket, Shevket H.; Kleanthous, Colin; Ferguson, Stuart J.; Redfield, Christina] Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England; [Gonzalez, Diego] Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, Quartier UNIL Sorge, Lausanne, Switzerland; [Cartwright, Jared L.] Univ York, Dept Biol, Biosci Technol Facil, Wentworth Way, York YO10 5DD, N Yorkshire, England	Imperial College London; University of Oxford; University of Lausanne; University of York - UK	Mavridou, DAI (corresponding author), Imperial Coll London, Dept Life Sci, MRC, Ctr Mol Bacteriol & Infect, London SW7 2DD, England.; Ferguson, SJ; Redfield, C (corresponding author), Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England.	stuart.ferguson@bioch.ox.ac.uk; christina.redfield@bioch.ox.ac.uk; d.mavridou@imperial.ac.uk	Mavridou, Despoina/ABG-5940-2020	Mavridou, Despoina/0000-0002-7449-1151; Gonzalez, Diego/0000-0003-3414-1461; Redfield, Christina/0000-0001-7297-7708	Medical Research Council (MRC) [MR/M009505/1]; institutional MRC studentship; Swiss National Science Foundation [P2LAP3_155109, P300PA_167703]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/N006445/1]; BBSRC [BB/N006445/1] Funding Source: UKRI; MRC [MR/M009505/1] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); institutional MRC studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Medical Research Council (MRC) Career Development Award MR/M009505/1 (to D. A. I. M.), an institutional MRC studentship (to S. H. S), Swiss National Science Foundation Postdoc Mobility Fellowships P2LAP3_155109 and P300PA_167703 (to D. G.), and Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/N006445/1 (to S. J. F). The authors declare that they have no conflicts of interest with the contents of this article.	Allen JWA, 2011, FEBS J, V278, P4198, DOI 10.1111/j.1742-4658.2011.08231.x; Allen JWA, 2002, J BIOL CHEM, V277, P33559, DOI 10.1074/jbc.M204963200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMBLER RP, 1991, BIOCHIM BIOPHYS ACTA, V1058, P42, DOI 10.1016/S0005-2728(05)80266-X; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Babbitt SE, 2015, TRENDS BIOCHEM SCI, V40, P446, DOI 10.1016/j.tibs.2015.05.006; Barker PD, 1999, STRUCTURE, V7, pR281, DOI 10.1016/S0969-2126(00)88334-3; Bartsch R. G., 1971, METHODS ENZYMOL, V23, P344, DOI [10.1016/S0076-6879(71)23110-4, DOI 10.1016/S0076-6879(71)23110-4]; BECKMAN DL, 1992, GENE DEV, V6, P268, DOI 10.1101/gad.6.2.268; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; Christensen O, 2007, FEBS J, V274, P2322, DOI 10.1111/j.1742-4658.2007.05769.x; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P9703, DOI 10.1073/pnas.152120699; de Vitry C, 2011, FEBS J, V278, P4189, DOI 10.1111/j.1742-4658.2011.08373.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Matteo A, 2007, J BIOL CHEM, V282, P27012, DOI 10.1074/jbc.M702702200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Enggist E, 2003, J BACTERIOL, V185, P175, DOI 10.1128/JB.185.1.175-183.2003; Enggist E, 2002, STRUCTURE, V10, P1551, DOI 10.1016/S0969-2126(02)00885-7; Feissner RE, 2006, MOL MICROBIOL, V61, P219, DOI 10.1111/j.1365-2958.2006.05221.x; Garcia-Rubio I, 2007, BIOPHYS J, V92, P1361, DOI 10.1529/biophysj.106.098277; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; GOODHEW CF, 1986, BIOCHIM BIOPHYS ACTA, V852, P288, DOI 10.1016/0005-2728(86)90234-3; Han D, 2008, PROTEINS, V70, P900, DOI 10.1002/prot.21597; Harvat EM, 2009, BIOCHEMISTRY-US, V48, P1820, DOI 10.1021/bi801609a; HUSSAIN H, 1994, MOL MICROBIOL, V12, P153, DOI 10.1111/j.1365-2958.1994.tb01004.x; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; Mavridou DAI, 2007, J MOL BIOL, V370, P643, DOI 10.1016/j.jmb.2007.04.038; Mavridou DAI, 2013, BIOCHEMISTRY-US, V52, P7262, DOI 10.1021/bi400398t; Mavridou DAI, 2013, IUBMB LIFE, V65, P209, DOI 10.1002/iub.1123; Mavridou DAI, 2012, FEBS LETT, V586, P1702, DOI 10.1016/j.febslet.2012.04.055; Mavridou DAI, 2012, J BIOL CHEM, V287, P2342, DOI 10.1074/jbc.M111.313692; Moore G. R., 1990, CYTOCHROMES C EVOLUT; Ouyang N, 2006, PROTEINS, V65, P1021, DOI 10.1002/prot.21184; Ovchinnikov S, 2014, ELIFE, V3, DOI 10.7554/eLife.02030; Page MD, 1997, MOL MICROBIOL, V24, P977, DOI 10.1046/j.1365-2958.1997.4061775.x; PEARCE DA, 1995, J BIOL CHEM, V270, P20879, DOI 10.1074/jbc.270.36.20879; RAMSEIER TM, 1991, J BIOL CHEM, V266, P7793; Rayapuram N, 2008, J BIOL CHEM, V283, P25200, DOI 10.1074/jbc.M802621200; Ren Q, 2002, J BIOL CHEM, V277, P7657, DOI 10.1074/jbc.M110979200; Richard-Fogal C, 2010, J MOL BIOL, V401, P350, DOI 10.1016/j.jmb.2010.06.041; Richard-Fogal CL, 2008, J BACTERIOL, V190, P3489, DOI 10.1128/JB.00146-08; Richard-Fogal CL, 2009, EMBO J, V28, P2349, DOI 10.1038/emboj.2009.189; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; SAMBONGI Y, 1994, FEBS LETT, V340, P65, DOI 10.1016/0014-5793(94)80174-6; Sanders C, 2008, J BIOL CHEM, V283, P29715, DOI 10.1074/jbc.M805413200; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Schulz H, 1998, SCIENCE, V281, P1197, DOI 10.1126/science.281.5380.1197; Schulz H, 2000, MOL MICROBIOL, V37, P1379, DOI 10.1046/j.1365-2958.2000.02083.x; Shimizu H, 2001, BIOCHEMISTRY-US, V40, P13483, DOI 10.1021/bi011481h; Simon J, 2011, FEBS J, V278, P4179, DOI 10.1111/j.1742-4658.2011.08374.x; Stevens JM, 2003, J BIOL CHEM, V278, P20500, DOI 10.1074/jbc.M212925200; Stevens JM, 2011, FEBS J, V278, P4170, DOI 10.1111/j.1742-4658.2011.08376.x; Sutherland MC, 2018, J MOL BIOL, V430, P1065, DOI [10.1016/j.jmb.2018.02.021, 10.1016/j.jmb.2018.01.022]; Sutherland MC, 2016, BIOCHEMISTRY-US, V55, P3150, DOI 10.1021/acs.biochem.6b00427; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; THONYMEYER L, 1994, MOL MICROBIOL, V12, P1, DOI 10.1111/j.1365-2958.1994.tb00988.x; ThonyMeyer L, 1997, EUR J BIOCHEM, V246, P794, DOI 10.1111/j.1432-1033.1997.t01-1-00794.x; Uchida T, 2004, J BIOL CHEM, V279, P51981, DOI 10.1074/jbc.M408963200; Verissimo AF, 2017, J BIOL CHEM, V292, P13154, DOI 10.1074/jbc.M117.794586; Verissimo AF, 2014, BBA-BIOENERGETICS, V1837, P989, DOI 10.1016/j.bbabio.2014.03.003; Verissimo AF, 2011, J BIOL CHEM, V286, P40452, DOI 10.1074/jbc.M111.277764; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449	65	5	5	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16778	16790		10.1074/jbc.RA118.005024	http://dx.doi.org/10.1074/jbc.RA118.005024			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30206118	Green Published, hybrid			2022-12-26	WOS:000448515100019
J	Valach, M; Leveille-Kunst, A; Gray, MW; Burger, G				Valach, Matus; Leveille-Kunst, Alexandra; Gray, Michael W.; Burger, Gertraud			Respiratory chain Complex I of unparalleled divergence in diplonemids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electron transfer; mitochondrial respiratory chain complex; proteomics; protozoan; RNA editing; mitochondria; NADH-dehydrogenase; respirasome; supercomplex	ELECTRON-TRANSPORT CHAIN; MULTIPLE SEQUENCE ALIGNMENT; MEMBRANE-PROTEIN COMPLEXES; ARABIDOPSIS-THALIANA; SUBUNIT COMPOSITION; NATIVE ELECTROPHORESIS; TARGETING SEQUENCES; ACCESSORY SUBUNITS; TRYPANOSOMA-BRUCEI; MASS-SPECTROMETRY	Mitochondrial genes of Euglenozoa (Kinetoplastida, Diplonemea, and Euglenida) are notorious for being barely recognizable, raising the question of whether such divergent genes actually code for functional proteins. Here we demonstrate the translation and identify the function of five previously unassigned y genes encoded by mitochondrial DNA (mtDNA) of diplonemids. As is the rule in diplonemid mitochondria, y genes are fragmented, with gene pieces transcribed separately and then trans-spliced to form contiguous mRNAs. Further, y transcripts undergo massive RNA editing, including uridine insertions that generate up to 16-residue-long phenylalanine tracts, a feature otherwise absent from conserved mitochondrial proteins. By protein sequence analyses, MS, and enzymatic assays in Diplonema papillatum, we show that these y genes encode the subunits Nad2, -3, -4L, -6, and -9 of the respiratory chain Complex I (CI; NADH:ubiquinone oxidoreductase). The few conserved residues of these proteins are essentially those involved in proton pumping across the inner mitochondrial membrane and in coupling ubiquinone reduction to proton pumping (Nad2, -3, -4L, and -6) and in interactions with subunits containing electron-transporting Fe-S clusters (Nad9). Thus, in diplonemids, 10 CI subunits are mtDNA-encoded. Further, MS of D. papillatum CI allowed identification of 26 conventional and 15 putative diplonemid-specific nucleus-encoded components. Most conventional accessory subunits are well-conserved but unusually long, possibly compensating for the streamlined mtDNA-encoded components and for missing, otherwise widely distributed, conventional subunits. Finally, D. papillatum CI predominantly exists as a supercomplex I:III:IV that is exceptionally stable, making this protist an organism of choice for structural studies.	[Valach, Matus; Leveille-Kunst, Alexandra; Burger, Gertraud] Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada; [Valach, Matus; Leveille-Kunst, Alexandra; Burger, Gertraud] Univ Montreal, Robert Cedergren Ctr Bioinformat & Genom, Montreal, PQ H3T 1J4, Canada; [Gray, Michael W.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Gray, Michael W.] Dalhousie Univ, Ctr Comparat Genom & Evolutionary Bioinformat, Halifax, NS B3H 4R2, Canada	Universite de Montreal; Universite de Montreal; Dalhousie University; Dalhousie University	Valach, M; Burger, G (corresponding author), Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada.; Valach, M; Burger, G (corresponding author), Univ Montreal, Robert Cedergren Ctr Bioinformat & Genom, Montreal, PQ H3T 1J4, Canada.	matus.a.valach@gmail.com; gertraud.burger@umontreal.ca		Leveille-Kunst, Alexandra/0000-0003-2644-5334; Valach, Matus/0000-0001-8689-0080	Canadian Institute of Health Research (CIHR) Operating Grant [MOP-79309]; Gordon and Betty Moore Foundation Grant [GBMF-4983]; NSERC [RGPIN-2014-05286]	Canadian Institute of Health Research (CIHR) Operating Grant(Canadian Institutes of Health Research (CIHR)); Gordon and Betty Moore Foundation Grant; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institute of Health Research (CIHR) Operating Grant MOP-79309 (to G.B.), Gordon and Betty Moore Foundation Grant GBMF-4983 (to G.B.), and NSERC Grant RGPIN-2014-05286 (to G.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Acestor N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006908; Agip ANA, 2018, NAT STRUCT MOL BIOL, V25, P548, DOI 10.1038/s41594-018-0073-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angerer Heike, 2015, Biology-Basel, V4, P133, DOI 10.3390/biology4010133; Angerer H, 2014, P NATL ACAD SCI USA, V111, P5207, DOI 10.1073/pnas.1322438111; Angerer H, 2011, BIOCHEM J, V437, P279, DOI 10.1042/BJ20110359; Baeza-Delgado C, 2013, EUR BIOPHYS J BIOPHY, V42, P199, DOI 10.1007/s00249-012-0813-9; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Blaza JN, 2018, STRUCTURE, V26, P312, DOI 10.1016/j.str.2017.12.014; Bridges HR, 2010, MOL CELL PROTEOMICS, V9, P2318, DOI 10.1074/mcp.M110.001255; Burger G, 2003, NUCLEIC ACIDS RES, V31, P2353, DOI 10.1093/nar/gkg326; Burger G, 2016, TRENDS GENET, V32, P553, DOI 10.1016/j.tig.2016.06.005; Burger G, 2013, GENOME BIOL EVOL, V5, P418, DOI 10.1093/gbe/evt008; Cardol P, 2004, BBA-BIOENERGETICS, V1658, P212, DOI 10.1016/j.bbabio.2004.06.001; Cardol P, 2011, BBA-BIOENERGETICS, V1807, P1390, DOI 10.1016/j.bbabio.2011.06.015; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davies KM, 2018, P NATL ACAD SCI USA, V115, P3024, DOI 10.1073/pnas.1720702115; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Di Luca A, 2017, P NATL ACAD SCI USA, V114, pE6314, DOI 10.1073/pnas.1706278114; Duarte M, 2014, J BIOENERG BIOMEMBR, V46, P299, DOI 10.1007/s10863-014-9556-x; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellens KW, 2017, NUCLEIC ACIDS RES, V45, P11495, DOI 10.1093/nar/gkx937; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Faux NG, 2005, GENOME RES, V15, P537, DOI 10.1101/gr.3096505; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Formosa LE, 2018, SEMIN CELL DEV BIOL, V76, P154, DOI 10.1016/j.semcdb.2017.08.011; Fromm S, 2016, NEW PHYTOL, V211, P194, DOI 10.1111/nph.13886; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200; Gawryluk RMR, 2012, BBA-BIOENERGETICS, V1817, P2027, DOI 10.1016/j.bbabio.2012.06.005; Gawryluk RMR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-176; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Hirst Judy, 2011, Biochem J, V437, pe1, DOI 10.1042/BJ20110918; Hosler JP, 2006, ANNU REV BIOCHEM, V75, P165, DOI 10.1146/annurev.biochem.75.062003.101730; Junge W, 2015, ANNU REV BIOCHEM, V84, P631, DOI 10.1146/annurev-biochem-060614-034124; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kannan S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-455; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kiethega GN, 2013, RNA BIOL, V10, P301, DOI 10.4161/rna.23340; Kiethega GN, 2011, MOL BIOL EVOL, V28, P2425, DOI 10.1093/molbev/msr075; Klodmann J, 2010, PLANT CELL, V22, P797, DOI 10.1105/tpc.109.073726; Kumar AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166854; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Letts JA, 2017, NAT STRUCT MOL BIOL, V24, P800, DOI 10.1038/nsmb.3460; Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774; Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lukes J, 2015, CURR BIOL, V25, pR702, DOI 10.1016/j.cub.2015.04.052; Lukes J, 2011, IUBMB LIFE, V63, P528, DOI 10.1002/iub.489; Mach J, 2013, GENOME BIOL EVOL, V5, P860, DOI 10.1093/gbe/evt056; Marande W, 2005, EUKARYOT CELL, V4, P1137, DOI 10.1128/EC.4.6.1137-1146.2005; Marande W, 2007, SCIENCE, V318, P415, DOI 10.1126/science.1148033; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Meyer EH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00106; Meyer EH, 2011, J BIOL CHEM, V286, P26081, DOI 10.1074/jbc.M110.209601; Milenkovic D, 2017, CELL METAB, V25, P765, DOI 10.1016/j.cmet.2017.03.009; Moreira S, 2016, NUCLEIC ACIDS RES, V44, P4907, DOI 10.1093/nar/gkw188; Morgner N, 2008, BBA-BIOENERGETICS, V1777, P1384, DOI 10.1016/j.bbabio.2008.08.001; Opperdoes FR, 2008, TRENDS PARASITOL, V24, P310, DOI 10.1016/j.pt.2008.03.013; Cordoba JP, 2016, J EXP BOT, V67, P1589, DOI 10.1093/jxb/erv556; Perez E, 2014, MITOCHONDRION, V19, P338, DOI 10.1016/j.mito.2014.02.001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rich PR, 2017, BIOCHEM SOC T, V45, P813, DOI 10.1042/BST20160139; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Senkler J, 2017, PLANT J, V89, P1079, DOI 10.1111/tpj.13448; Smith DGS, 2007, J MOL BIOL, V374, P837, DOI 10.1016/j.jmb.2007.09.051; Soding J, 2011, CURR OPIN STRUC BIOL, V21, P404, DOI 10.1016/j.sbi.2011.03.005; Soo RM, 2017, SCIENCE, V355, P1436, DOI 10.1126/science.aal3794; Sorokina M, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-10; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754; Subrahmanian N, 2016, BBA-BIOENERGETICS, V1857, P1001, DOI 10.1016/j.bbabio.2016.01.009; Surve S, 2012, EUKARYOT CELL, V11, P183, DOI 10.1128/EC.05282-11; Suthammarak W, 2013, AGING CELL, V12, P1132, DOI 10.1111/acel.12144; Tashyreva D, 2018, PROTIST, V169, P158, DOI 10.1016/j.protis.2018.02.001; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Valach M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14286-z; Valach M, 2016, RNA BIOL, V13, P1204, DOI 10.1080/15476286.2016.1240143; Valach M, 2014, NUCLEIC ACIDS RES, V42, P2660, DOI 10.1093/nar/gkt1152; van der Sluis EO, 2015, GENOME BIOL EVOL, V7, P1235, DOI 10.1093/gbe/evv061; Verkhovskaya M, 2013, INT J BIOCHEM CELL B, V45, P491, DOI 10.1016/j.biocel.2012.08.024; White SH, 2008, ANNU REV BIOPHYS, V37, P23, DOI 10.1146/annurev.biophys.37.032807.125904; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012; Xia D, 2013, BBA-BIOENERGETICS, V1827, P1278, DOI 10.1016/j.bbabio.2012.11.008; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095	104	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16043	16056		10.1074/jbc.RA118.005326	http://dx.doi.org/10.1074/jbc.RA118.005326			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30166340	hybrid, Green Published			2022-12-26	WOS:000447256000024
J	Ayratova, D; Kisser, LV; Ziganshina, LE				Ayratova, Dina; Kisser, Lidiya Vacheslavovna; Ziganshina, Liliya Eugenevna			Assessing methodological quality of Russian clinical practice guidelines and introducing AGREE II instrument in Russia	PLOS ONE			English	Article								Background There are multiple organisations in Russia that publish clinical practice guidelines (CPGs). The demand for CPGs and appreciation of their role in healthcare provision has been steadily growing. However, quality and methodology of development of CPGs have not been systematically addressed. Aim To analyse the quality of Russian-produced CPGs for surgical treatment of hepatic-pancreatic-biliary diseases. Methods We searched Russian databases for CPGs, published between 2013 and 2017. We identified 6 relevant documents that met our inclusion criteria. We approached four experts in the field with written and verbal instructions on the use of the AGREE II questionnaire. Results All six CPGs received the highest domain scores for the domain Clarity of Presentation (46%-80%). The lowest domain scores were for the domain Editorial Independence (6%25%). Overall, the experts put the highest total sum scores to the CPG for treating chronic pancreatitis (70%), while the lowest total sum score was attributed to the CPG for treating acute cholangitis (22%). Conclusions The overall quality of CPGs, as assessed by the four experts with the AGREE II instrument, was low. The highest scoring, best organized and most comprehensive and straightforward CPG was the one for chronic pancreatitis. The AGREE II instrument should be considered for use in Russia by guideline developers to assess existing CPGs and inform the creation of new guidelines.	[Ayratova, Dina] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Kisser, Lidiya Vacheslavovna] Minist Hlth Kaliningrad Reg, Dept Org Providing Med & Med Devices, Kaliningrad, Russia; [Kisser, Lidiya Vacheslavovna; Ziganshina, Liliya Eugenevna] Cochrane Russia, Res & Educ Ctr Evidence Based Med, Cochrane, Russia; [Kisser, Lidiya Vacheslavovna; Ziganshina, Liliya Eugenevna] Kazan Fed Univ, Dept Basic & Clin Pharmacol, Kazan, Tatarstan, Russia	Arizona State University; Arizona State University-Tempe; Kazan Federal University	Ziganshina, LE (corresponding author), Cochrane Russia, Res & Educ Ctr Evidence Based Med, Cochrane, Russia.; Ziganshina, LE (corresponding author), Kazan Fed Univ, Dept Basic & Clin Pharmacol, Kazan, Tatarstan, Russia.	lezign@gmail.com	Ziganshina, Liliya Eugenevna/N-7251-2013	Ziganshina, Liliya Eugenevna/0000-0003-1999-0705; Kisar, Lidiya/0000-0003-3709-7224; Lienhard, Dina Ayratovna/0000-0003-1574-6350	Russian Government Program of Competitive Growth of Kazan Federal University; Susan and Marc Mulzet National Travel Award Program; AAAS Section L funding; Ministry of Health of Kaliningrad oblast; Kazan Federal University	Russian Government Program of Competitive Growth of Kazan Federal University; Susan and Marc Mulzet National Travel Award Program; AAAS Section L funding; Ministry of Health of Kaliningrad oblast; Kazan Federal University	The authors received no specific funding for this work. Liliya E. Ziganshina received partial salary from the Russian Government Program of Competitive Growth of Kazan Federal University (https://kpfu.ru/eng/strategy-5-top-100/roadmap-in-details) for development of Cochrane Russia. Another part of Liliya E. Ziganshinas salary came from the Kazan Federal University government budget for teaching pharmacology. The Kazan Federal University receives federal government budgeting through the Ministry of Education and Science of the Russian Federation (https://kpfu.ru/sveden; https://xn--80abucjiibhv9a.xn--p1ai/) based on the number of students taught. Dina Lienhard (Ziganshina) received an hourly wage from the Arizona State University for working as an Instructional Aide. She taught BIO181/182 (General Biology) and CHM237/238 (General Organic Chemistry) labs at the ASU Downtown Campus between Fall 2015 and Spring 2018. She also received a travel grant from Susan and Marc Mulzet National Travel Award Program to attend the American Association for the Advancement of Science (AAAS) meeting in Austin, TX in February of 2018, as well as AAAS Section L funding. There she presented her Honors Thesis research on the history of mammography guidelines in the United States. (https://www.cbs.asu.edu/news/biology-and-society-graduate-begins-her-phd-journey). Lidiya V. Kisser received her salary from the Ministry of Health of Kaliningrad oblast (https://www.infomed39.ru/; https://www.infomed39.ru/ministry/structures/) and PhD student stipend from the Kazan Federal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2017, NEW CLIN RECOMMENDAT; Banks Peter A, 2010, Gastroenterol Hepatol (N Y), V6, P1; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; HAYWARD RSA, 1995, JAMA-J AM MED ASSOC, V274, P570, DOI 10.1001/jama.274.7.570; Heuman DM, 2017, MEDSCAPE; Indar AA, 2002, BRIT MED J, V325, P639, DOI 10.1136/bmj.325.7365.639; Ivashkin VT, 2015, GALLSTONE DIS DIAGNO; Jarosova A D, 2014, CENT EUR J NURS MIDW, V5, P176, DOI [10.15452/CEJNM.2014.05.0014, DOI 10.15452/CEJNM.2014.05.0014]; Kabanov MY, 2014, CLIN RECOMMENDATIONS; Malakhanov V, 2016, SIBERIAN MED J, V8, P5; Mayo Clinic, 2017, CHOL SYMPT CAUS; Mosler Patrick, 2011, Curr Gastroenterol Rep, V13, P166, DOI 10.1007/s11894-010-0171-7; Natalsky AA, 2017, THESIS; Russian Ministry of Health Care, 2014, 2014 REP PUBL HLTH S; Russian Society of Surgeons, 2015, RUBR CLIN REC AC CHO; Russian Society of Surgeons, 2016, DRAFT NAT CLIN GUID; Russian Society of Surgeons Association of Hepatopancreatic Surgeons of CIS Countries, 2014, CLIN REC SURG TREATM; Russian Society of Surgeons Association of Hepatopancreatic Surgeons of CIS Countries Russian Society of Emergency Medicine, 2014, DIAGN TREATM AC PANC; Sackett DL, 1997, SEMIN PERINATOL, V21, P3, DOI 10.1016/S0146-0005(97)80013-4; Shevchenko R., 2017, MEDVESTNIK; Spirin A. V., 2015, THESIS; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yasar I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156483; Zakharova AV, 2013, PRACTICAL MED, V2, P156; Zhang ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053566	26	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203328	10.1371/journal.pone.0203328	http://dx.doi.org/10.1371/journal.pone.0203328			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204760	Green Published, Green Submitted, gold			2022-12-26	WOS:000444355500023
J	Siyoum, M; Astatkie, A; Mekonnen, S; Bekele, G; Taye, K; Tenaw, Z; Yohannes, Z; Kassaye, Z				Siyoum, Melese; Astatkie, Ayalew; Mekonnen, Shewangizaw; Bekele, Gezahegn; Taye, Kefyalew; Tenaw, Zelalem; Yohannes, Zemenu; Kassaye, Zerai			Home birth and its determinants among antenatal care-booked women in public hospitals in Wolayta Zone, southern Ethiopia	PLOS ONE			English	Article							DELIVERY; MORTALITY; PLACE	Introduction Antenatal care (ANC), health facility birth and postnatal care services are proved to reduce maternal and newborn morbidity and mortality. In Ethiopia, even though antenatal care coverage is good, still home birth is high. This study aimed to assess the prevalence and determinants of home birth among women who were booked for ANC in public hospitals in Wolaita zone, southern Ethiopia. Methods A cohort study was conducted from February to May 2017 among 554 third trimester pregnant mothers who visited public hospitals of Wolaita Zone, southern Ethiopia for ANC service. All women were interviewed twice: the first interview was done face-to-face in the health facility in which they were having ANC follow up to gather information about basic socio-demographic and obstetric characteristics; the second interview was done via telephone after they gave birth to get information about the place of birth. Epi-Data version 3.1 was used for data entry and the Statistical Package for the Social Sciences (SPSS) version 22 was used for data analysis. Results A total of 68 (13.5%; 95% Confidence Interval (CI): 10.5%-16.6%) women who were booked for ANC gave birth at home. Being uneducated (AOR = 2.46, 95% CI: [1.10-5.10]), starting ANC visit late (>16weeks) (AOR = 2.27, 95% CI: [1.14-4.50]), time taken to reach at health facility for ANC service (>30minutes) (AOR = 8.94, 95% CI: [4.50-17.72]), waiting time of greater than 30 minutes for ANC in health facilities (AOR = 1.18, 95% CI: [1.06-2.30]) and lack of knowledge about danger signs of pregnancy (AOR = 4.18, 95% CI: [1.80-9.70]) were significantly associated with home birth. Conclusions Home birth among ANC booked women is low compared to other studies. Yet, giving attention to women with no education and those coming from far areas while providing advice on birth preparedness and pregnancy danger signs may be useful to further reduce the rate of home birth. Advising mothers to start ANC early and trying to reduce ANC waiting time could also be of importance.	[Siyoum, Melese; Mekonnen, Shewangizaw; Bekele, Gezahegn; Tenaw, Zelalem; Yohannes, Zemenu] Hawassa Univ, Sch Nursing & Midwifery, Coll Med & Hlth Sci, Hawassa, Ethiopia; [Astatkie, Ayalew] Hawassa Univ, Sch Publ & Environm Hlth, Coll Med & Hlth Sci, Hawassa, Ethiopia; [Taye, Kefyalew; Kassaye, Zerai] Hawassa Univ, Sch Med, Coll Med & Hlth Sci, Hawassa, Ethiopia	Hawassa University; Hawassa University; Hawassa University	Siyoum, M (corresponding author), Hawassa Univ, Sch Nursing & Midwifery, Coll Med & Hlth Sci, Hawassa, Ethiopia.	melesesiyoum755@gmail.com	Astatkie, Ayalew/I-1167-2019	Astatkie, Ayalew/0000-0002-4840-9601; Dadi, Gezahegn Bekele/0000-0003-4119-3526; Siyoum, Melese/0000-0001-5451-5665	Save Newborn Life Phase-III Project of Save the Children Ethiopia, SNNPR branch	Save Newborn Life Phase-III Project of Save the Children Ethiopia, SNNPR branch	We extend our heartfelt gratitude to the Save Newborn Life Phase-III Project of Save the Children Ethiopia, SNNPR branch for financial support. The College of Medicine and Health Sciences of Hawassa University, Hawassa, Ethiopia also deserves thanks for initiating the collaboration with Save the Children Ethiopia. We are indebted to Professor Yemane Berhane for his comments and guidance in designing this study. We also remain thankful to Dr. Fitsum Woldegebriel (from Hawassa University), data collectors, study participants, and officials of Wolayta Zone Health Department and public hospitals in Wolayta zone who helped us one way or another in accomplishing this study.	Abebe Fantu, 2012, BMC Res Notes, V5, P653, DOI 10.1186/1756-0500-5-653; Abeje G, 2014, REPROD HLTH, V11, P1, DOI [10.1186/1742-4755-11-1, DOI 10.1186/1742-4755-11-1]; Amano A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-105; Bedilu Kucho, 2017, Journal of Public Health and Epidemiology, V9, P177, DOI 10.5897/JPHE2017.0921; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P69, DOI 10.4314/ejhs.v24i0.7S; Birmeta K, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-256; Carroli G, 2001, PAEDIATR PERINAT EP, V15, P1; Central Statistical Agency (CSA), 2012, ETH DEM HLTH SURV 20; Central Statistical Agency (CSA) [Ethiopia] ICF, 2016, ETHIOPIA DEMOGRAPHIC; Chinkhumba J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1014; CSA, 2014, ETH MIN DEM HLTH SUR; Desalegn E., 2014, J GYNECOLOGY OBSTET, V2, P1, DOI [DOI 10.11648/j.jgo.20140201.11, DOI 10.11648/J.JG0.20140201.11]; Ekele BA, 2007, ACTA OBSTET GYN SCAN, V86, P627, DOI 10.1080/00016340601134622; Faye A, 2010, REV EPIDEMIOL SANTE, V58, P323, DOI 10.1016/j.respe.2010.05.004; Fedral Minstry Of Health Ethiopia (FMOH), 2010, MAN PROT SEL OBST TO; Iyaniwura C, 2009, AFRICAN J REPROD HLT, V13; Karkee R, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-193; Kasaye HK, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1409-2; Mengesha ZB, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-130; Mills S, 2008, MATERN CHILD HLTH J, V12, P509, DOI 10.1007/s10995-007-0288-y; Montagu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017155; Nduka I., 2014, Journal of Medical Investigations and Practice, V9, P102; Shiferaw S, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-5; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Tadese F., 2014, CLIN MOTHER CHILD HL, V11, P164; Teferra AS, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-74; Tsegay R, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4159-1; Tsegay Y, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-30; UNFPA, 2012, TRENDS MAT HLTH ETH; Wagle Rajendra Raj, 2004, BMC Pregnancy Childbirth, V4, P8, DOI 10.1186/1471-2393-4-8; Workineh S., 2015, HLTH SCI J, V9, P1; Zegeye K, 2014, PRIMARY HLTH CARE, V4, P2167, DOI [10.4172/2167-1079.1000152, DOI 10.4172/2167-1079.1000152]	32	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203609	10.1371/journal.pone.0203609	http://dx.doi.org/10.1371/journal.pone.0203609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192861	gold, Green Submitted, Green Published			2022-12-26	WOS:000444093600117
J	Stauft, CB; Shen, SH; Song, YT; Gorbatsevych, O; Asare, E; Futcher, B; Mueller, S; Payne, A; Brecher, M; Kramer, L; Wimmer, E				Stauft, Charles B.; Shen, Sam H.; Song, Yutong; Gorbatsevych, Oleksandr; Asare, Emmanuel; Futcher, Bruce; Mueller, Steffen; Payne, Anne; Brecher, Matthew; Kramer, Laura; Wimmer, Eckard			Extensive recoding of dengue virus type 2 specifically reduces replication in primate cells without gain-of-function in Aedes aegypti mosquitoes	PLOS ONE			English	Article							CODON-PAIR BIAS; INFLUENZA-VIRUS; STRAIN 16681; ATTENUATION; POLIOVIRUS; GENOME; VACCINE; RNA; DEOPTIMIZATION; CDNA	Dengue virus (DENV), an arthropod-borne ("arbovirus") virus, causes a range of human maladies ranging from self-limiting dengue fever to the life-threatening dengue shock syndrome and proliferates well in two different taxa of the Animal Kingdom, mosquitoes and primates. Mosquitoes and primates show taxonomic group-specific intolerance to certain codon pairs when expressing their genes by translation. This is called "codon pair bias". By necessity, dengue viruses evolved to delicately balance this fundamental difference in their open reading frames (ORFs). We have undone the evolutionarily conserved genomic balance in the DENV2 ORF sequence and specifically shifted the encoding preference away from primates. However, this recoding of DENV2 raised concerns of 'gain-of-function,' namely whether recoding could inadvertently increase fitness for replication in the arthropod vector. Using mosquito cell lines and two strains of Aedes aegypti we did not observe any increase in fitness in DENV2 variants codon pair deoptimized for humans. This ability to disrupt and control DENV2' s host preference has great promise towards developing the next generation of synthetic vaccines not only for DENV but for other emerging arboviral pathogens such as chikungunya virus and Zika virus.	[Stauft, Charles B.; Shen, Sam H.; Song, Yutong; Gorbatsevych, Oleksandr; Asare, Emmanuel; Futcher, Bruce; Mueller, Steffen; Wimmer, Eckard] SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Stauft, Charles B.; Mueller, Steffen; Wimmer, Eckard] Codagenix Inc, Farmingdale, NY 11735 USA; [Payne, Anne; Brecher, Matthew; Kramer, Laura] New York State Dept Hlth, Wadsworth Ctr, Slingerlands, NY USA; [Kramer, Laura] SUNY Albany, Sch Publ Hlth, Albany, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Wimmer, E (corresponding author), SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.; Wimmer, E (corresponding author), Codagenix Inc, Farmingdale, NY 11735 USA.	eckard.wimmer@stonybrook.edu		Gorbatsevych, Oleksandr/0000-0002-2159-1490; Brecher, Matthew/0000-0003-1151-2290; Mueller, Steffen/0000-0003-2660-258X	National Institute of Health (NIH) [5R01AI110792, 5R21AI126048]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119175] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health (NIH) Research Project (R01) grant for project #5R01AI110792 entitled "Tailoring virulence of dengue virus in mammals and mosquitoes." Our work was also funded by another National Institute of Health (NIH) Exploratory/Developmental Grant (R21) for project #5R21AI126048.	Atkinson NJ, 2014, NUCLEIC ACIDS RES, V42, P4527, DOI 10.1093/nar/gku075; Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856; Broadbent AJ, 2016, VACCINE, V34, P563, DOI 10.1016/j.vaccine.2015.11.054; Buchan R, 2005, BMC BIOINFORMATICS, V6, pP4, DOI [10.1186/1471-2105-6-S3-P4, DOI 10.1186/1471-2105-6-S3-P4]; Burns CC, 2009, J VIROL, V83, P9957, DOI 10.1128/JVI.00508-09; Butrapet S, 2000, J VIROL, V74, P3011, DOI 10.1128/JVI.74.7.3011-3019.2000; Campbell A, 1999, P NATL ACAD SCI USA, V96, P9184, DOI 10.1073/pnas.96.16.9184; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chiu HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093305; Coffin JM, 2008, NEW ENGL J MED, V359, P2283, DOI 10.1056/NEJMcibr0805820; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386; DYER O, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5759; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Fields BN, 2013, FIELDS VIROLOGY; Futcher B, 2015, P NATL ACAD SCI USA, V112, pE3635, DOI 10.1073/pnas.1507710112; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094; Habjan M, 2008, J GEN VIROL, V89, P2157, DOI 10.1099/vir.0.2008/002097-0; Jin H, 2004, J VIROL, V78, P995, DOI 10.1128/JVI.78.2.995-998.2004; Khoo CCH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-130; Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500; Klitting R, 2018, BIORXIV, DOI [10.1101/256610, DOI 10.1101/256610]; KUNO G, 1982, INTERVIROLOGY, V18, P45, DOI 10.1159/000149303; Le Nouen C, 2017, P NATL ACAD SCI USA, V114, pE386, DOI 10.1073/pnas.1619242114; Le Nouen C, 2014, P NATL ACAD SCI USA, V111, P13169, DOI 10.1073/pnas.1411290111; Li PH, 2018, J VIROL, V92, DOI [10.1128/JVI.00701-18, 10.1128/jvi.00701-18]; Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; Mueller S, 2010, NAT BIOTECHNOL, V28, P723, DOI 10.1038/nbt.1636; Mueller S, 2009, CHEM BIOL, V16, P337, DOI 10.1016/j.chembiol.2009.03.002; National Academies of Sciences E Affairs P and G Committee on Science T Management C on DUR of CO for F, 2017, MAN DUAL US RES CONC; Nhan TX, 2015, CLIN MICROBIOL INFEC, V21, pE47, DOI 10.1016/j.cmi.2015.02.018; Ni YY, 2014, VIROLOGY, V450, P132, DOI 10.1016/j.virol.2013.12.009; Nougairede A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003172; Paul AV, 2000, VIROLOGY, V272, P72, DOI 10.1006/viro.2000.0354; Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003; Pryor MJ, 2001, AM J TROP MED HYG, V65, P427, DOI 10.4269/ajtmh.2001.65.427; Schaeffer E, 2015, J INVEST DERMATOL, V135, P1743, DOI 10.1038/jid.2014.525; Segundo FDS, 2016, J VIROL, V90, P1298, DOI 10.1128/JVI.02167-15; Shen SH, 2015, P NATL ACAD SCI USA, V112, P4749, DOI 10.1073/pnas.1502864112; Shen SH, 2006, REV CELL BIOL MOL ME, DOI [10.1002/3527600906.mcb.20120059/abstract, DOI 10.1002/3527600906.MCB.20120059/ABSTRACT]; Simmen MW, 2008, GENOMICS, V92, P33, DOI 10.1016/j.ygeno.2008.03.009; SINGH KRP, 1967, CURR SCI INDIA, V36, P506; Singh KRP, 1971, ARTHROPOD CELL CULTU, P127, DOI [10.1007/978-3-642-65224-0_20, DOI 10.1007/978-3-642-65224-0_20]; Song YT, 2017, P NATL ACAD SCI USA, V114, pE8731, DOI 10.1073/pnas.1714385114; Stauft CB, 2018, SYNTHETIC VIRUSES EL, DOI [10.1002/9780470015902.a0027771/abstract, DOI 10.1002/9780470015902.A0027771/ABSTRACT]; Stauft CB, 2017, SYNTHETIC VIRUSES EL; Takata MA, 2017, NATURE, V550, P124, DOI 10.1038/nature24039; Toyoda H, 2007, CANCER RES, V67, P2857, DOI 10.1158/0008-5472.CAN-06-3713; Toyoda H, 2011, INT J ONCOL, V38, P81, DOI 10.3892/ijo_00000826; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Wang BY, 2015, MBIO, V6, DOI 10.1128/mBio.00237-15; Wikan N, 2009, J VIROL METHODS, V157, P227, DOI 10.1016/j.jviromet.2008.12.019; Wimmer E, 2006, EMBO REP, V7, pS3, DOI 10.1038/sj.embor.7400728; Wimmer E, 2011, ANNU REV MICROBIOL, V65, P583, DOI 10.1146/annurev-micro-090110-102957; Wimmer E, 2009, NAT BIOTECHNOL, V27, P1163, DOI 10.1038/nbt.1593; Yang C, 2013, P NATL ACAD SCI USA, V110, P9481, DOI 10.1073/pnas.1307473110; Zhu YP, 2008, RNA BIOL, V5, P65, DOI 10.4161/rna.5.2.6044	60	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0198303	10.1371/journal.pone.0198303	http://dx.doi.org/10.1371/journal.pone.0198303			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192757	gold, Green Published, Green Submitted			2022-12-26	WOS:000444093600003
J	Young, DM; Parry, LE; Lee, D; Ray, S				Young, Dylan M.; Parry, Lauren E.; Lee, Duncan; Ray, Surajit			Spatial models with covariates improve estimates of peat depth in blanket peatlands	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; DECOMPOSITION; ACCUMULATION; RESTORATION; UNCERTAINTY; SENSITIVITY; SYSTEMS; STOCKS; BOG	Peatlands are spatially heterogeneous ecosystems that develop due to a complex set of autogenic physical and biogeochemical processes and allogenic factors such as the climate and topography. They are significant stocks of global soil carbon, and therefore predicting the depth of peatlands is an important part of establishing an accurate assessment of their magnitude. Yet there have been few attempts to account for both internal and external processes when predicting the depth of peatlands. Using blanket peatlands in Great Britain as a case study, we compare a linear and geostatistical (spatial) model and several sets of covariates applicable for peatlands around the world that have developed over hilly or undulating terrain. We hypothesized that the spatial model would act as a proxy for the autogenic processes in peatlands that can mediate the accumulation of peat on plateaus or shallow slopes. Our findings show that the spatial model performs better than the linear model in all cases-root mean square errors (RMSE) are lower, and 95% prediction intervals are narrower. In support of our hypothesis, the spatial model also better predicts the deeper areas of peat, and we show that its predictive performance in areas of deep peat is dependent on depth observations being spatially autocorrelated. Where they are not, the spatial model performs only slightly better than the linear model. As a result, we recommend that practitioners carrying out depth surveys fully account for the variation of topographic features in prediction locations, and that sampling approach adopted enables observations to be spatially autocorrelated.	[Young, Dylan M.] Univ Leeds, Sch Geog, Leeds, W Yorkshire, England; [Parry, Lauren E.] Univ Glasgow, Sch Interdisciplinary Studies, Glasgow, Lanark, Scotland; [Lee, Duncan; Ray, Surajit] Univ Glasgow, Sch Math & Stat, Glasgow, Lanark, Scotland	University of Leeds; University of Glasgow; University of Glasgow	Young, DM (corresponding author), Univ Leeds, Sch Geog, Leeds, W Yorkshire, England.	d.m.young@leeds.ac.uk		Lee, Duncan/0000-0002-6175-6800; Ray, S/0000-0003-3965-8136; Young, Dylan/0000-0002-6519-5473	EPSRC SECURE Feasibility Projects [EP/M008347/1]; EPSRC [EP/M008347/1] Funding Source: UKRI	EPSRC SECURE Feasibility Projects(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by EPSRC SECURE Feasibility Projects (EP/M008347/1) awarded to L E. Parry, D. Lee, and S. Ray.	Altdorff D, 2016, GEODERMA, V261, P178, DOI 10.1016/j.geoderma.2015.07.015; Baird AJ, 2012, ECOHYDROLOGY, V5, P242, DOI 10.1002/eco.230; Ballard CE, 2011, J HYDROL, V407, P81, DOI 10.1016/j.jhydrol.2011.07.005; Belyea LR, 2006, ECOL MONOGR, V76, P299, DOI 10.1890/0012-9615(2006)076[0299:BTLTPB]2.0.CO;2; Buffam I, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001034; Castaldi F, 2014, EUR J SOIL SCI, V65, P842, DOI 10.1111/ejss.12202; Chapman SJ, 2009, SOIL USE MANAGE, V25, P105, DOI 10.1111/j.1475-2743.2009.00219.x; Charman D., 2002, Peatlands and environmental change; Charman DJ, 2013, BIOGEOSCIENCES, V10, P929, DOI 10.5194/bg-10-929-2013; Chaudhary N, 2017, BIOGEOSCIENCES, V14, P4023, DOI 10.5194/bg-14-4023-2017; Cunliffe AM, 2013, WATER RESOUR RES, V49, P5342, DOI 10.1002/wrcr.20435; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Ding YL, 2014, INT J REMOTE SENS, V35, P7230, DOI 10.1080/01431161.2014.967889; Egoh BN, 2014, J APPL ECOL, V51, P899, DOI 10.1111/1365-2664.12251; Evans MR, 2012, PHILOS T R SOC B, V367, P163, DOI 10.1098/rstb.2011.0191; Frogbrook ZL, 2009, SOIL USE MANAGE, V25, P320, DOI 10.1111/j.1475-2743.2009.00232.x; Frolking S, 2010, EARTH SYST DYNAM, V1, P1, DOI 10.5194/esd-1-1-2010; Fyfe RM, 2014, SOIL USE MANAGE, V30, P23, DOI 10.1111/sum.12091; Gallego-Sala AV, 2013, NAT CLIM CHANGE, V3, P152, DOI [10.1038/NCLIMATE1672, 10.1038/nclimate1672]; GB National Outlines [SHAPE geospatial data], 2005, TIL GB; Ge YF, 2011, FRONT EARTH SCI-PRC, V5, P239, DOI 10.1007/s11707-011-0174-1; Graniero PA, 1999, CATENA, V36, P233, DOI 10.1016/S0341-8162(99)00008-9; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Holden NM, 2011, CATENA, V86, P75, DOI 10.1016/j.catena.2011.02.002; Ise T, 2008, NAT GEOSCI, V1, P763, DOI 10.1038/ngeo331; Keaney A, 2013, SPAT STAT-NETH, V5, P3, DOI 10.1016/j.spasta.2013.05.003; Kempen B, 2015, GEODERMA, V241, P313, DOI 10.1016/j.geoderma.2014.11.030; Keskin H, 2018, GEODERMA, V326, P22, DOI 10.1016/j.geoderma.2018.04.004; Kidd D., 2015, GEODERMA REG, V4, P1, DOI DOI 10.1016/J.GEODRS.2014.11.002; Lapen DR, 2005, HYDROL PROCESS, V19, P371, DOI 10.1002/hyp.1507; Lewis C, 2012, HYDROL PROCESS, V26, P1527, DOI 10.1002/hyp.8252; Lindsay R., 1988, FLOW COUNTRY PEATLAN; Loisel J, 2010, PALAEOGEOGR PALAEOCL, V291, P493, DOI 10.1016/j.palaeo.2010.03.020; Maltby E, 2010, CLIM RES, V45, P249, DOI 10.3354/cr00893; Martin-Ortega J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181686; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; Met Office, 2010, PRINC 1971 2000 AV; Minasny B, 2006, COMPUT GEOSCI-UK, V32, P1378, DOI 10.1016/j.cageo.2005.12.009; Minasny B, 2016, GEODERMA, V264, P301, DOI 10.1016/j.geoderma.2015.07.017; Morris PJ, 2015, GEOPHYS RES LETT, V42, P10788, DOI 10.1002/2015GL066824; Morris PJ, 2015, WATER RESOUR RES, V51, P5353, DOI 10.1002/2015WR017264; Parry LE, 2014, J GEOPHYS RES-BIOGEO, V119, P567, DOI 10.1002/2013JG002411; Parry LE, 2012, SOIL USE MANAGE, V28, P614, DOI 10.1111/j.1475-2743.2012.00447.x; Parry LE, 2014, J ENVIRON MANAGE, V133, P193, DOI 10.1016/j.jenvman.2013.11.033; Parry LE, 2013, GEODERMA, V211, P75, DOI 10.1016/j.geoderma.2013.07.006; Parsekian AD, 2012, SOIL SCI SOC AM J, V76, P1911, DOI 10.2136/sssaj2012.0040; R Core Team, 2021, R LANGUAGE ENV STAT; Rudiyanto, 2018, GEODERMA, V313, P25, DOI 10.1016/j.geoderma.2017.10.018; Rudiyanto, 2016, GEODERMA, V272, P20, DOI 10.1016/j.geoderma.2016.02.026; Siewert MB, 2018, BIOGEOSCIENCES, V15, P1663, DOI 10.5194/bg-15-1663-2018; Stumpf F, 2017, CATENA, V153, P30, DOI 10.1016/j.catena.2017.01.033; Swindles GT, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051500; TALLIS JH, 1985, J ECOL, V73, P283, DOI 10.2307/2259784; Tipping R, 2008, BIODIVERS CONSERV, V17, P2097, DOI 10.1007/s10531-007-9220-4; van Bellen S, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003877; Waddington JM, 2015, ECOHYDROLOGY, V8, P113, DOI 10.1002/eco.1493; Young DM, 2017, WATER RESOUR RES, V53, P6510, DOI 10.1002/2016WR019898; YU ZC, 2010, GEOPHYS RES LETT, V37, DOI DOI 10.1029/2010GL043584; Zhang GL, 2017, J INTEGR AGR, V16, P2871, DOI 10.1016/S2095-3119(17)61762-3	59	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202691	10.1371/journal.pone.0202691	http://dx.doi.org/10.1371/journal.pone.0202691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192790	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000444093600029
J	Halley, JM; Van Houtan, KS; Mantua, N				Halley, John M.; Van Houtan, Kyle S.; Mantua, Nate			How survival curves affect populations' vulnerability to climate change	PLOS ONE			English	Article							AGE-SPECIFIC SURVIVAL; LOGGERHEAD SEA-TURTLES; RECRUITMENT VARIABILITY; EXTINCTION RISK; LONG-TERM; DYNAMICS; MORTALITY; CONSERVATION; DEMOGRAPHY; FECUNDITY	Human activities are exposing organisms not only to direct threats (e.g. habitat loss) but also to indirect environmental pressures such as climate change, which involves not just directional global warming but also increasing climatic variability. Such changes will impact whole communities of organisms and the possible effects on population dynamics have raised concerns about increased extinction rates. Conservation-minded approaches to extinction risk vary from range shifts predicted by climate envelope models with no population dynamics to population viability analyses that ignore environmental variability altogether. Our modelling study shows that these extremes are modelling responses to a spectrum of environmental sensitivity that organisms may exhibit. We show how the survival curve plays a major role in how environmental variability leads to population fluctuations. While it is often supposed that low-fecundity organisms (those with high parental investment) will be the most vulnerable to climate change, it is those with high fecundity (low parental investment) that are likely to be more sensitive to such changes. We also find that abundance variations in high fecundity populations is driven primarily by fluctuations in the survival of early life stages, the more so if those environmental changes are autocorrelated in time. We show which types of conservation actions are most appropriate for a number of real populations. While the most effective conservation actions for organisms of low fecundity is to avoid killing them, for populations with high fecundity (and low parental investment), our study suggests conservation should focus more on protecting early life stages from hostile environments.	[Halley, John M.] Univ Ioannina, Sch Hlth Sci, Dept Biol Applicat & Technol, Ioannina, Greece; [Van Houtan, Kyle S.] Monterey Bay Aquarium, Monterey, CA USA; [Van Houtan, Kyle S.] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC USA; [Mantua, Nate] NOAA Fisheries, Southwest Fisheries Sci Ctr, Santa Cruz, CA USA	University of Ioannina; Monterey Bay Aquarium Research Institute; Duke University; National Oceanic Atmospheric Admin (NOAA) - USA	Halley, JM (corresponding author), Univ Ioannina, Sch Hlth Sci, Dept Biol Applicat & Technol, Ioannina, Greece.	jhalley@cc.uoi.gr	Van Houtan, Kyle Schuyler/A-4695-2008; Halley, John M/AAP-3004-2020; Van Houtan, Kyle S/GRY-0874-2022	Mantua, Nate/0000-0002-4562-4082; Van Houtan, Kyle/0000-0001-5725-1773	Presidential Early Career Award for Scientists and Engineers (PECASE)	Presidential Early Career Award for Scientists and Engineers (PECASE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A Presidential Early Career Award for Scientists and Engineers (PECASE) to KV supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; S. Pimm, D. Vokou, J. Nye, M. McClure, R. Griffis, R. Merrick and J. Hare improved early versions of this manuscript. A Presidential Early Career Award for Scientists and Engineers (PECASE) to KV supported this project. W. Morris and three anonymous reviewers provided helpful comments on an earlier version of this manuscript.	Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; APPELDOORN RS, 1988, B MAR SCI, V42, P159; Arendt MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081097; Ascani F, 2016, GLOBAL CHANGE BIOL, V22, P3529, DOI 10.1111/gcb.13331; Baker JD, 2012, MAR ECOL PROG SER, V469, P175, DOI 10.3354/meps09987; Beauplet G, 2006, OIKOS, V112, P430, DOI 10.1111/j.0030-1299.2006.14412.x; Bonet JA, 2012, FOREST ECOL MANAG, V265, P211, DOI 10.1016/j.foreco.2011.10.039; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Buller AHR, 1909, RES FUNGI, VI; Cabral JS, 2010, GLOBAL ECOL BIOGEOGR, V19, P85, DOI 10.1111/j.1466-8238.2009.00492.x; Chaloupka M, 2002, ECOL MODEL, V148, P79, DOI 10.1016/S0304-3800(01)00433-1; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; CROXALL JP, 1990, J ANIM ECOL, V59, P775, DOI 10.2307/4895; Cuddington KM, 1999, P ROY SOC B-BIOL SCI, V266, P969, DOI 10.1098/rspb.1999.0731; DEY WP, 1981, T AM FISH SOC, V110, P151, DOI 10.1577/1548-8659(1981)110<151:MAGOYS>2.0.CO;2; Edenhofer O., 2014, CONTRIBUTION WORKING; Egli S, 2006, BIOL CONSERV, V129, P271, DOI 10.1016/j.biocon.2005.10.042; ELLNER S, 1987, VEGETATIO, V69, P199, DOI 10.1007/BF00038701; Essington TE, 2017, ECOSYSTEMS, V20, P237, DOI 10.1007/s10021-016-0073-0; Essington TE, 2015, P NATL ACAD SCI USA, V112, P6648, DOI 10.1073/pnas.1422020112; FOGARTY MJ, 1991, TRENDS ECOL EVOL, V6, P241, DOI 10.1016/0169-5347(91)90069-A; Forero-Medina G, 2011, CONSERV BIOL, V25, P163, DOI 10.1111/j.1523-1739.2010.01572.x; Gaillard JM, 2003, ECOLOGY, V84, P3294, DOI 10.1890/02-0409; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Hagen CA, 2007, J WILDLIFE MANAGE, V71, P518, DOI 10.2193/2005-778; Halley JM, 1998, THEOR POPUL BIOL, V53, P1; Halley JM, 1996, J APPL ECOL, V33, P455, DOI 10.2307/2404977; Halley JM, 1996, J APPL ECOL, V33, P439, DOI 10.2307/2404976; Halley JM, 1999, THEOR POPUL BIOL, V56, P215, DOI 10.1006/tpbi.1999.1424; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hare JA, 2010, ECOL APPL, V20, P452, DOI 10.1890/08-1863.1; Hjort J, 1914, RAPPORTS PROCES VERB, V20, P3; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; Huntley B, 2010, ECOGRAPHY, V33, P621, DOI 10.1111/j.1600-0587.2009.06023.x; Hutchings JA, 2001, CAN J FISH AQUAT SCI, V58, P108, DOI 10.1139/cjfas-58-1-108; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Inchausti P, 2002, EVOL ECOL RES, V4, P1033; Jones TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045447; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Kell LT, 2005, ICES J MAR SCI, V62, P1483, DOI 10.1016/j.icesjms.2005.05.006; Koons DN, 2016, ECOL LETT, V19, P1023, DOI 10.1111/ele.12628; KOSLOW JA, 1992, CAN J FISH AQUAT SCI, V49, P210, DOI 10.1139/f92-025; Lande R., 2003, OXFORD SERIES ECOLOG; Lawson CR, 2015, ECOL LETT, V18, P724, DOI 10.1111/ele.12437; Loison A, 1999, ECOLOGY, V80, P2539, DOI 10.1890/0012-9658(1999)080[2539:ASSIFP]2.0.CO;2; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Martinez-Aguilar S, 2010, CIENC PESQ, V18, P32; Mcclure MM, 2013, CONSERV BIOL, V27, P1222, DOI 10.1111/cobi.12166; Mertz G, 1996, CAN J FISH AQUAT SCI, V53, P1618, DOI 10.1139/cjfas-53-7-1618; Midgley GF, 2010, ECOGRAPHY, V33, P612, DOI 10.1111/j.1600-0587.2009.06000.x; Morris W. F., 2002, QUANTITATIVE CONSERV; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; Olesiuk P.F, 2005, LIFE HIST POPULATION; Oli MK, 2020, ECOLOGY, V101, DOI 10.1002/ecy.2969; Pardo D, 2013, ECOLOGY, V94, P208, DOI 10.1890/12-0215.1; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearl R., 1928, RATE LIVING; PEPIN P, 1991, CAN J FISH AQUAT SCI, V48, P503, DOI 10.1139/f91-065; Pimm S, 2006, P NATL ACAD SCI USA, V103, P10941, DOI 10.1073/pnas.0604181103; Post, 2013, ECOLOGY CLIMATE CHAN; Ramsay MM, 1998, BOT J LINN SOC, V126, P173, DOI 10.1006/bojl.1997.0152; Reznick D, 2002, ECOLOGY, V83, P1509, DOI 10.2307/3071970; Rickman SJ, 2000, CAN J FISH AQUAT SCI, V57, P116, DOI 10.1139/cjfas-57-1-116; Rose KA, 2001, FISH FISH, V2, P293, DOI 10.1046/j.1467-2960.2001.00056.x; Sadovy Y, 2001, J FISH BIOL, V59, P90, DOI 10.1006/jfbi.2001.1760; Saether BE, 2004, ADV ECOL RES, V35, P185, DOI 10.1016/S0065-2504(04)35009-9; Saether BE, 2013, AM NAT, V182, P743, DOI 10.1086/673497; Sharov A, 2014, STRIPED BASS STOCK A; SMITH ML, 1992, NATURE, V356, P428, DOI 10.1038/356428a0; Tapilatu RF, 2009, LEATHERBACK TURTLE D; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; TINKLE DW, 1981, ECOLOGY, V62, P1426, DOI 10.2307/1941498; Towns DR, 2001, BIOL CONSERV, V98, P211, DOI 10.1016/S0006-3207(00)00156-7; Trites AW, 2007, FISH OCEANOGR, V16, P46, DOI 10.1111/j.1365-2419.2006.00408.x; Tuljapurkar S, 2009, PHILOS T R SOC B, V364, P1499, DOI 10.1098/rstb.2009.0021; Van Houtan KS, 2011, IR11024 PAC ISL SCI; Van Houtan KS, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0744; Van Houtan KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019043; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242	85	15	15	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203124	10.1371/journal.pone.0203124	http://dx.doi.org/10.1371/journal.pone.0203124			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188919	Green Published, Green Submitted, gold			2022-12-26	WOS:000444228700021
J	Leblond, A; Pezet, S; Trouvin, AP; Elhai, M; Gonzalez, V; Allanore, Y; Avouac, J				Leblond, Agathe; Pezet, Sonia; Trouvin, Anne Priscille; Elhai, Muriel; Gonzalez, Virginie; Allanore, Yannick; Avouac, Jerome			Linking systemic angiogenic markers to synovial vascularization in rheumatoid arthritis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; POWER DOPPLER ULTRASONOGRAPHY; ADHESION MOLECULES ICAM-1; DISEASE-ACTIVITY; E-SELECTIN; SE-SELECTIN; FACTOR VEGF; SVCAM-1; RISK; INFLAMMATION	Background Neoangiogenesis is a crucial event to promote the development of the hyperplasic proliferative pathologic synovium in Rheumatoid arthritis (RA). Ultrasound (US) is sensitive for detection of power Doppler (PD) vascularization. Objective To explore the associations between a set of complementary circulating angiogenic markers and a comprehensive US assessment in patients with RA. Patients and methods Serum levels of eight angiogenic markers were measured by quantitative ELISAs in a total of 125 patients with RA, who were all systematically assessed in parallel by PDUS, performed on 32 joints. Results Serum levels of soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) and Tie-2 were more likely to be increased in patients with synovial hyperemia detected on at least one joint (Power Doppler grade >= 1). sVCAM-1, Tie-2 and Angiostatin concentrations gradually increased together with the grade of the semiquantitative PDUS scale and concentrations of these three markers were markedly increased in patients with moderate to marked hyperemia (Power Doppler grade 2 and 3). Levels of sVCAM-1, Tie-2, and Angiostatin correlated with a global arthritis sum score, defined by the sum of the semiquantitative PDUS scores for all joints examined. Levels of Tie-2 and Placenta Growth Factor (PIGF) were associated with PDUS features indicating residual disease activity. Conclusion Our results support the relevance of measuring serum levels of vascular markers to evaluate the intensity and extent of synovial vascularization. Angiogenic markers, and particularly Tie-2, could be a valuable surrogate of active synovitis and their place in relation to PDUS in clinical practice deserve further investigation.	[Leblond, Agathe; Pezet, Sonia; Elhai, Muriel; Gonzalez, Virginie; Allanore, Yannick; Avouac, Jerome] Univ Paris 05, Sorbonne Paris Cite, INSERM U1016, Paris, France; [Leblond, Agathe; Pezet, Sonia; Elhai, Muriel; Gonzalez, Virginie; Allanore, Yannick; Avouac, Jerome] Inst Cochin, CNRS UMR8104, Paris, France; [Trouvin, Anne Priscille; Elhai, Muriel; Allanore, Yannick; Avouac, Jerome] Univ Paris 05, Sorbonne Paris Cite, Serv Rhumatol A, Hop Cochin, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Avouac, J (corresponding author), Univ Paris 05, Sorbonne Paris Cite, INSERM U1016, Paris, France.; Avouac, J (corresponding author), Inst Cochin, CNRS UMR8104, Paris, France.; Avouac, J (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Serv Rhumatol A, Hop Cochin, Paris, France.	jerome.avouac@cch.aphp.fr	Trouvin, Anne-Priscille/AGW-0981-2022; avouac, Jérôme/AAD-2101-2020	Trouvin, Anne-Priscille/0000-0002-3524-7455; Pezet, Sonia/0000-0003-3716-7229; Elhai, Muriel/0000-0001-8627-5758	Appel d'Offre Interne de l'Hopital Cochin - MERRI Performances des Etablissements de Sante dans la Promotion de la Recherche; Arthritis Foundation	Appel d'Offre Interne de l'Hopital Cochin - MERRI Performances des Etablissements de Sante dans la Promotion de la Recherche; Arthritis Foundation	Grant supports were supplied by: "Appel d'Offre Interne de l'Hopital Cochin - MERRI Performances des Etablissements de Sante dans la Promotion de la Recherche" and "Arthritis Foundation".	Almeida I, 2016, CLIN EXP RHEUMATOL, V34, pS37; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Arriens C, 2017, RHEUMATOLOGY, V56, P32, DOI 10.1093/rheumatology/kew407; Avouac J, 2014, J RHEUMATOL, V41, P248, DOI 10.3899/jrheum.130713; Bhasin S, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/325909; Chen Y, 2005, ARTHRITIS RHEUM-US, V52, P1585, DOI 10.1002/art.21016; Criscione LG, 2002, CURR OPIN RHEUMATOL, V14, P204, DOI 10.1097/00002281-200205000-00002; D'Agostino MA, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2016-000428; D'Agostino MA, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2015-000237; DeBusk LM, 2003, ARTHRITIS RHEUM-US, V48, P2461, DOI 10.1002/art.11213; Dunne JV, 2013, RHEUMATOL INT, V33, P475, DOI 10.1007/s00296-012-2378-4; Firestein GS, 1999, J CLIN INVEST, V103, P3, DOI 10.1172/JCI5929; Gok M, 2013, RHEUMATOL INT, V33, P879, DOI 10.1007/s00296-012-2452-y; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Howe HS, 2012, INT J RHEUM DIS, V15, P13, DOI 10.1111/j.1756-185X.2012.01720.x; Huang TL, 2017, J BONE MINER RES, V32, P407, DOI 10.1002/jbmr.2993; Kawashiri SY, 2011, RHEUMATOLOGY, V50, P962, DOI 10.1093/rheumatology/keq415; Kelly S, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0567-8; Klimiuk P, 2007, SCAND J RHEUMATOL, V36, P345, DOI 10.1080/03009740701406460; Klimiuk PA, 2002, ANN RHEUM DIS, V61, P804, DOI 10.1136/ard.61.9.804; KOCH AE, 1995, NATURE, V376, P517, DOI 10.1038/376517a0; Koch AE, 1998, ARTHRITIS RHEUM-US, V41, P951, DOI 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D; Kurosaka D, 2010, J RHEUMATOL, V37, P1121, DOI 10.3899/jrheum.090941; Kuryliszyn-Moskal A, 2005, CLIN RHEUMATOL, V24, P111, DOI 10.1007/s10067-004-0987-3; Leblond A, 2017, AUTOIMMUN REV, V16, P594, DOI 10.1016/j.autrev.2017.04.005; Littler AJ, 1997, BRIT J RHEUMATOL, V36, P164; Macias I, 2005, J RHEUMATOL, V32, P2102; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P253, DOI 10.1016/j.acvd.2010.03.007; Moritz F, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1304-2; Naredo E, 2005, ANN RHEUM DIS, V64, P375, DOI 10.1136/ard.2004.023929; Nordal HH, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1201-0; Oishi H, 2007, PATHOL INT, V57, P734, DOI 10.1111/j.1440-1827.2007.02165.x; Ramirez J, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4431; Robak E, 2007, EUR CYTOKINE NETW, V18, P181, DOI 10.1684/ecn.2007.0103; Saleem B, 2012, ANN RHEUM DIS, V71, P1316, DOI 10.1136/annrheumdis-2011-200548; Scire CA, 2009, RHEUMATOLOGY, V48, P1092, DOI 10.1093/rheumatology/kep171; Semerano L, 2011, JOINT BONE SPINE, V78, P118, DOI 10.1016/j.jbspin.2010.06.004; Shai I, 2006, OBESITY, V14, P2099, DOI 10.1038/oby.2006.245; Sokka T, 2009, J RHEUMATOL, V36, P1387, DOI 10.3899/jrheum.080770; Strunk J, 2004, RHEUMATOLOGY, V43, P1480, DOI 10.1093/rheumatology/keh380; Strunk J, 2013, JOINT BONE SPINE, V80, P270, DOI 10.1016/j.jbspin.2012.09.001; Szekanecz Z, 2010, JOINT BONE SPINE, V77, P13, DOI 10.1016/j.jbspin.2009.05.011; Taylor PC, 2004, ARTHRITIS RHEUM, V50, P1107, DOI 10.1002/art.20123; Terslev L, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2016-000427; van de Sande MGH, 2013, ARTHRITIS RHEUM-US, V65, P3073, DOI 10.1002/art.38128; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; Walsh SJ, 1999, J RHEUMATOL, V26, P2179; Wu TF, 2013, MOL CELL PROTEOMICS, V12, P1170, DOI 10.1074/mcp.M112.021667	49	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203607	10.1371/journal.pone.0203607	http://dx.doi.org/10.1371/journal.pone.0203607			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188942	Green Published, Green Submitted, gold			2022-12-26	WOS:000444228700047
J	Obiakara, MC; Fourcade, Y				Obiakara, Maxwell C.; Fourcade, Yoan			Climatic niche and potential distribution of Tithonia diversifolia (Hemsl.) A. Gray in Africa	PLOS ONE			English	Article							INVASIVE ALIEN PLANTS; SPECIES DISTRIBUTION; BIOLOGICAL INVASIONS; DISTRIBUTION MODELS; ECOSYSTEM SERVICES; MEXICAN SUNFLOWER; SAMPLING BIAS; SHIFTS; MAXENT; BIODIVERSITY	Mexican sunflower, Tithonia diversifolia (Asteraceae), is an invasive tropical plant species native to Central America. It has spread in more than 70 countries across Asia, Africa and Australia. In Africa, this species is known to disturb native crops and plant communities, but its negative impacts remain underestimated. Moreover, its potential invasion risk has not been investigated so far. A fundamental aspect in the identification and prediction of habitats susceptible to biological invasions lies in the ability of an organism to conserve or change its ecological niche as part of the invasion process. Here, we compared the realised climatic niche of T. diversifolia between its Central American and African ranges. In addition, reciprocal distribution models were calibrated on its native and invaded ranges. Models were combined and projected to current and future climatic conditions in Africa to estimate the potential distribution of this species. Niche overlap given by Schoner's D index was low (0.23), equivalency and similarity tests suggested that the climatic niche of T. diversifolia is not similar in both ranges. However the low expansion (U = 0.09) and very high stability (S = 0.92) indices support climatic niche conservatism for this species in Africa, although it has not filled its entire niche so far. Our combined reciprocal models highlight highly suitable areas for this species in humid regions throughout East, Central and West Africa, then in some parts of South Africa and Madagascar. Future projections indicated that the distribution of climatically suitable habitats will likely remain stable.	[Obiakara, Maxwell C.] Univ Ibadan, Dept Bot, Ecol Unit, Ibadan, Nigeria; [Fourcade, Yoan] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	University of Ibadan; Swedish University of Agricultural Sciences	Obiakara, MC (corresponding author), Univ Ibadan, Dept Bot, Ecol Unit, Ibadan, Nigeria.	mc.obiakara@gmail.com	Fourcade, Yoan/H-7253-2012; Obiakara, Maxwell C./L-2356-2019	Fourcade, Yoan/0000-0003-3820-946X; Obiakara, Maxwell C./0000-0002-0635-8068				Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132; Ajao AA, 2017, S AFR J BOT, V113, P396, DOI 10.1016/j.sajb.2017.09.017; Akobundu IO, 2016, AGYAKWA CWA HDB W AF; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Atwater DZ, 2018, NAT ECOL EVOL, V2, P34, DOI 10.1038/s41559-017-0396-z; Ayeni AO, 1997, WEED RES, V37, P443, DOI 10.1046/j.1365-3180.1997.d01-72.x; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Bosso L, 2016, HYSTRIX IT J MAMM, V27; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Braunisch V, 2013, ECOGRAPHY, V36, P971, DOI 10.1111/j.1600-0587.2013.00138.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Broennimann O, 2014, J BIOGEOGR, V41, P1126, DOI 10.1111/jbi.12274; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Butin E, 2005, EVOL ECOL RES, V7, P887; CABI (Centre for Agriculture and Bioscience International), 2021, INV SPEC COMP; Chapman D, 2017, GLOBAL ECOL BIOGEOGR, V26, P907, DOI 10.1111/geb.12599; Charles Heather, 2007, V193, P217; Chatterjee S., 2015, REGRESSION ANAL EXAM; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chukwuka K. S., 2007, Journal of Biological Sciences, V7, P771; Chukwuka K. S., 2007, Journal of Biological Sciences, V7, P709; Dellinger AS, 2016, NEW PHYTOL, V209, P1313, DOI 10.1111/nph.13694; Di Cola V, 2017, ECOGRAPHY, V40, P774, DOI 10.1111/ecog.02671; Early R, 2014, GLOBAL ECOL BIOGEOGR, V23, P1356, DOI 10.1111/geb.12208; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elton C.S., 2000, ECOLOGY INVASIONS AN; Suarez-Mota ME, 2016, POL J ECOL, V64, P369, DOI 10.3161/15052249PJE2016.64.3.007; Fernandez M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119891; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Goncalves E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111468; Gonzalez-Moreno P, 2015, GLOBAL ECOL BIOGEOGR, V24, P360, DOI 10.1111/geb.12271; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2014, TRENDS ECOL EVOL, V29, P260, DOI 10.1016/j.tree.2014.02.009; Henderson L, 2001, ALIEN WEEDS INVASIVE; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hernandez-Lambrano RE, 2017, AUSTRAL ECOL, V42, P577, DOI 10.1111/aec.12476; Hijmans R.J., 2017, CIRCLES, V9, P1, DOI DOI 10.1016/J.JHYDROL.2011.07.022; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jiang HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163718; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Kissling WD, 2018, BIOL REV, V93, P600, DOI 10.1111/brv.12359; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; LADUKE JC, 1982, RHODORA, V84, P453; Lee-Yaw JA, 2016, ECOL LETT, V19, P710, DOI 10.1111/ele.12604; Lenoir J, 2015, ECOGRAPHY, V38, P15, DOI 10.1111/ecog.00967; Lentz DL, 2008, INT J PLANT SCI, V169, P541, DOI 10.1086/528754; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Lima-Ribeiro MS, 2017, DIVERS DISTRIB, V23, P922, DOI 10.1111/ddi.12575; Lopez-Caamal A, 2013, PLANT SYST EVOL, V299, P1781, DOI 10.1007/s00606-013-0834-6; Mainali KP, 2015, GLOBAL CHANGE BIOL, V21, P4464, DOI 10.1111/gcb.13038; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Muoghalu JI, 2008, WEED RES, V48, P157, DOI 10.1111/j.1365-3180.2007.00613.x; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Naimi B, 2014, ECOGRAPHY, V37, P191, DOI 10.1111/j.1600-0587.2013.00205.x; Otusanya O., 2012, International Journal of Biology, V4, P97; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Petitpierre B, 2017, GLOBAL ECOL BIOGEOGR, V26, P275, DOI 10.1111/geb.12530; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2017, ECOGRAPHY, V40, P887, DOI 10.1111/ecog.03049; Powell KI, 2011, AM J BOT, V98, P539, DOI 10.3732/ajb.1000402; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Ray D, 2016, ECOL INFORM, V34, P153, DOI 10.1016/j.ecoinf.2016.06.003; Reside AE, 2017, BIOL CONSERV, V207, P9, DOI 10.1016/j.biocon.2017.01.004; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Roberts DR, 2017, ECOGRAPHY, V40, P913, DOI 10.1111/ecog.02881; Rodder D, 2011, GLOBAL ECOL BIOGEOGR, V20, P915, DOI 10.1111/j.1466-8238.2011.00659.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Team R.C, R LANG ENV STAT COMP; THUILLER W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI DOI 10.1111/J.1365-2486.2005.01018.X; Tiebre M. S., 2012, Journal of Asian Scientific Research, V2, P200; Tingley R, 2014, P NATL ACAD SCI USA, V111, P10233, DOI 10.1073/pnas.1405766111; Tongma S., 1997, Journal of Weed Science and Technology, V42, P373; Tovar-Sanchez E, 2012, PLANT SYST EVOL, V298, P1947, DOI 10.1007/s00606-012-0693-6; van Kleunen M, 2015, NATURE, V525, P100, DOI 10.1038/nature14910; van Wilgen BW, 2008, J ENVIRON MANAGE, V89, P336, DOI 10.1016/j.jenvman.2007.06.015; Verbruggen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068337; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Villero D, 2017, BIODIVERS CONSERV, V26, P251, DOI 10.1007/s10531-016-1243-2; Wang SH, 2004, ACTA ECOL SIN, V24, P444; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Bin W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141567; Werkowska W, 2017, ENVIRON REV, V25, P127, DOI 10.1139/er-2016-0045; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Yang J, 2012, WEED SCI, V60, P552, DOI 10.1614/WS-D-11-00175.1	96	11	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202421	10.1371/journal.pone.0202421	http://dx.doi.org/10.1371/journal.pone.0202421			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183733	gold, Green Submitted, Green Published			2022-12-26	WOS:000443789900027
J	Cui, R; Choi, SE; Kim, TH; Lee, HJ; Lee, SJ; Kang, Y; Jeon, JY; Kim, HJ; Lee, KW				Cui, Rihua; Choi, Sung-E; Kim, Tae Ho; Lee, Hwa Joung; Lee, Soo Jin; Kang, Yup; Jeon, Ja Young; Kim, Hae Jin; Lee, Kwan-Woo			Iron overload by transferrin receptor protein 1 regulation plays an important role in palmitate-induced insulin resistance in human skeletal muscle cells	FASEB JOURNAL			English	Article						free fatty acids; iron disturbances; calcium; iron-responsive element-binding proteins 2	CALCIUM-DEPENDENT INACTIVATION; HYPOXIA; GLUCOSE; MICE; CA2+; LIPOTOXICITY; PATHOGENESIS; INVOLVEMENT; SENSITIVITY; HOMEOSTASIS	Free fatty acid is considered to be one of the major pathogenic factors of inducing insulin resistance. The association between iron disturbances and insulin resistance has recently begun to receive a lot of attention. Although skeletal muscles are a major tissue for iron utilization and storage, the role of iron in palmitate (PA)-induced insulin resistance is unknown. We investigated the molecular mechanism underlying iron dysregulation in PA-induced insulin resistance. Interestingly, we found that PA simultaneously increased intracellular iron and induced insulin resistance. The iron chelator deferoxamine dramatically inhibited PA-induced insulin resistance, and iron donors impaired insulin sensitivity by activating JNK. PA up-regulated transferrin receptor 1 (tfR1), an iron uptake protein, which was modulated by iron-responsive element-binding proteins 2. Knockdown of tfR1 and iron-responsive element-binding proteins 2 prevented PA-induced iron uptake and insulin resistance. PA also translocated the tfR1 by stimulating calcium influx, but the calcium chelator, BAPTA-AM, dramatically reduced iron overload by inhibiting tfR1 translocation and ultimately increased insulin sensitivity. Iron overload may play a critical role in PA-induced insulin resistance. Blocking iron overload may thus be a useful strategy for preventing insulin resistance and diabetes.Cui, R., Choi, S.-E., Kim, T. H., Lee, H. J., Lee, S. J., Kang, Y., Jeon, J. Y., Kim, H. J., Lee, K.-W. Iron overload by transferrin receptor protein 1 regulation plays an important role in palmitate-induced insulin resistance in human skeletal muscle cells.	[Cui, Rihua; Lee, Hwa Joung; Jeon, Ja Young; Kim, Hae Jin; Lee, Kwan-Woo] Ajou Univ, Sch Med, Dept Endocrinol & Metab, Suwon, South Korea; [Choi, Sung-E; Lee, Soo Jin; Kang, Yup] Ajou Univ, Sch Med, Dept Physiol, Suwon, South Korea; [Kim, Tae Ho] Seoul Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea	Ajou University; Ajou University; Seoul Medical Center	Lee, KW (corresponding author), Ajou Univ, Sch Med, Dept Endocrinol & Metab, 206 Worldcup Ro, Suwon 16499, Gyeonggi Do, South Korea.	lkw65@ajou.ac.kr		Kim, Tae Ho/0000-0002-3720-8011; Jeon, Ja Young/0000-0002-3877-0479	National Research Foundation of Korea [NRF-2016-R1D1A1B03930214]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from the National Research Foundation of Korea (NRF-2016-R1D1A1B03930214 to K.-W.L.). The authors declare no conflicts of interest.	Adam J, 2017, CELL REP, V20, P3135, DOI 10.1016/j.celrep.2017.08.093; Adams BD, 2005, J INVEST DERMATOL, V125, P1200, DOI 10.1111/j.0022-202X.2005.23949.x; Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; Barrientos T, 2015, EBIOMEDICINE, V2, P1705, DOI 10.1016/j.ebiom.2015.09.041; Blatnik M, 2008, DIABETES, V57, P41, DOI 10.2337/db07-0838; Boden Guenther, 1998, Frontiers in Bioscience, V3, pD169; Brons C, 2009, J PHYSIOL-LONDON, V587, P3977, DOI 10.1113/jphysiol.2009.177758; Chen MQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109214; Chen Min, 2009, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V26, P1088; Ci WM, 2003, CELL CALCIUM, V33, P257, DOI 10.1016/S0143-4160(02)00240-3; Cooksey RC, 2010, AM J PHYSIOL-ENDOC M, V298, pE1236, DOI 10.1152/ajpendo.00022.2010; Corna G, 2016, J IMMUNOL, V197, P1914, DOI 10.4049/jimmunol.1501417; DeRuisseau KC, 2013, EXP GERONTOL, V48, P1294, DOI 10.1016/j.exger.2013.08.011; Dongiovanni P., 2015, PLOS ONE; Dongiovanni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116855; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Gabrielsen JS, 2012, J CLIN INVEST, V122, P3529, DOI 10.1172/JCI44421; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Gammella E, 2017, METALLOMICS, V9, P1367, DOI 10.1039/c7mt00143f; Gera S, 1999, J GEN PHYSIOL, V114, P535, DOI 10.1085/jgp.114.4.535; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; HAACK JA, 1994, BIOPHYS J, V66, P1051, DOI 10.1016/S0006-3495(94)80886-0; Hanson ES, 1999, J BIOL CHEM, V274, P5047, DOI 10.1074/jbc.274.8.5047; Hanson ES, 1998, J BIOL CHEM, V273, P7588, DOI 10.1074/jbc.273.13.7588; Huang JY, 2013, FASEB J, V27, P2845, DOI 10.1096/fj.12-216929; Huang JY, 2011, DIABETES, V60, P80, DOI 10.2337/db10-0593; Jaisson S, 2014, DIABETOLOGIA, V57, P1517, DOI 10.1007/s00125-014-3257-1; Jung IR, 2015, MOL CELL ENDOCRINOL, V407, P74, DOI 10.1016/j.mce.2015.03.007; Kerins MJ, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00079-17; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Lanner JT, 2006, DIABETES, V55, P2077, DOI 10.2337/db05-1613; Latunde-Dada GO, 2017, BBA-GEN SUBJECTS, V1861, P1893, DOI 10.1016/j.bbagen.2017.05.019; Lee MS, 2012, METABOLISM, V61, P1142, DOI 10.1016/j.metabol.2012.01.012; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Li XP, 2012, NEUROSIGNALS, V20, P223, DOI 10.1159/000332954; Ly LD, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2016.157; Moreno-Navarrete JM, 2014, DIABETOLOGIA, V57, P1957, DOI 10.1007/s00125-014-3298-5; Marsella M, 2014, HEMATOL ONCOL CLIN N, V28, P703, DOI 10.1016/j.hoc.2014.04.004; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Meli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066570; Moroishi T, 2011, CELL METAB, V14, P339, DOI 10.1016/j.cmet.2011.07.011; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Norouzirad R, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5350267; Owens J, 2013, IN VITRO CELL DEV-AN, V49, P695, DOI 10.1007/s11626-013-9655-8; Peter A, 2009, DIABETES, V58, P1757, DOI 10.2337/db09-0188; Ragheb R, 2009, BIOCHEM BIOPH RES CO, V389, P211, DOI 10.1016/j.bbrc.2009.08.106; Robach P, 2007, BLOOD, V109, P4724, DOI 10.1182/blood-2006-08-040006; Royle SJ, 2006, CELL MOL LIFE SCI, V63, P1823, DOI 10.1007/s00018-005-5587-0; Simcox JA, 2013, CELL METAB, V17, P329, DOI 10.1016/j.cmet.2013.02.007; Smith AG, 2005, INT J BIOCHEM CELL B, V37, P2047, DOI 10.1016/j.biocel.2005.03.002; Choi E, 2007, MOL CELL ENDOCRINOL, V272, P50, DOI 10.1016/j.mce.2007.04.004; Tarasov A, 2004, DIABETES, V53, pS113, DOI 10.2337/diabetes.53.suppl_3.S113; Tenopoulou M, 2007, BIOCHEM J, V403, P261, DOI 10.1042/BJ20061840; Widera A, 2003, ADV DRUG DELIVER REV, V55, P1439, DOI 10.1016/j.addr.2003.07.004; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Xu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.331; Ye Jianping, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P65	59	11	12	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1771	1786		10.1096/fj.201800448R	http://dx.doi.org/10.1096/fj.201800448R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30207798				2022-12-26	WOS:000457296600021
J	Matthiesen, J; Lender, C; Haferkorn, A; Fehling, H; Meyer, M; Matthies, T; Tannich, E; Roeder, T; Lotter, H; Bruchhaus, I				Matthiesen, Jenny; Lender, Corinna; Haferkorn, Anne; Fehling, Helena; Meyer, Martin; Matthies, Thorben; Tannich, Egbert; Roeder, Thomas; Lotter, Hannelore; Bruchhaus, Iris			Trigger-induced RNAi gene silencing to identify pathogenicity factors of Entamoeba histolytica	FASEB JOURNAL			English	Article						amoebic liver abscess; cysteine peptidase; eukaryotic transfection	AMEBIC LIVER-ABSCESS; CYSTEINE PROTEINASES; EXPRESSION; TRANSFECTION; VIRULENCE; IDENTIFICATION; PROTEASE-1; STRAINS	Recently, Entamoeba histolytica clones derived from isolate HM-1:IMSS that differ in their pathogenicity were identified. Whereas some clones induce amoebic liver abscesses (ALAs) in animal models of amoebiasis, others provoke only minimal liver lesions. Based on transcriptome studies of pathogenic and nonpathogenic clones, differentially expressed genes associated with reduced or increased liver pathology can be identified. Here, to analyze the influence of these genes on ALA formation in more detail, an RNA interference-trigger mediated silencing approach was used. Using newly identified trigger sequences, the expression of 15 genes was silenced. The respective transfectants were analyzed for their ability to induce liver destruction in the murine model for the disease. Silencing of EHI_180390 (encoding an AIG1 protein) increased liver pathology induced by a nonpathogenic parent clone, whereas silencing of EHI_127670 (encoding a hypothetical protein) decreased the pathogenicity of an initially pathogenic parent clone. Additional phenotypical in vitro analyses of EHI_127670 silencing as well as overexpression transfectants indicated that this molecule has an influence on size, growth, and cysteine peptidase activity of E. histolytica. This work describes an example of how the sole operational method for effective gene silencing in E. histolytica can be used for comprehensive analyses of putative pathogenicity factors.Matthiesen, J., Lender, C., Haferkorn, A., Fehling, H., Meyer, M., Matthies, T., Tannich, E., Roeder, T., Lotter, H., Bruchhaus, I. Trigger-induced RNAi gene silencing to identify pathogenicity factors of Entamoeba histolytica.	[Matthiesen, Jenny; Lender, Corinna; Haferkorn, Anne; Fehling, Helena; Meyer, Martin; Matthies, Thorben; Tannich, Egbert; Lotter, Hannelore; Bruchhaus, Iris] Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany; [Roeder, Thomas] Christian Albrechts Univ Kiel, Dept Mol Physiol, Inst Zool, Kiel, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Kiel	Lotter, H; Bruchhaus, I (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	lotter@bnitm.de; bruchhaus@bnitm.de	Roeder, Thomas/B-9016-2011	Roeder, Thomas/0000-0002-3489-3834; Fehling, Helena/0000-0003-1112-7608	Deutsche Forschungsgemeinschaft (DFG) [Br1744/11-2]; Jurgen Manchot Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Jurgen Manchot Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, Br1744/11-2) and Jurgen Manchot Stiftung. The authors declare no conflicts of interest.	Ankri S, 1999, INFECT IMMUN, V67, P421, DOI 10.1128/IAI.67.1.421-422.1999; Baumel-Alterzon S, 2013, CELL MICROBIOL, V15, P130, DOI 10.1111/cmi.12036; Baxt LA, 2010, EUKARYOT CELL, V9, P1283, DOI 10.1128/EC.00015-10; Biller L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-63; Biller L, 2009, PROTEOMICS, V9, P4107, DOI 10.1002/pmic.200900022; Blessmann J, 2003, J CLIN MICROBIOL, V41, P4745, DOI 10.1128/JCM.41.10.4745-4750.2003; Bracha R, 2003, EUKARYOT CELL, V2, P295, DOI 10.1128/EC.2.2.295-305.2003; Bracha Rivka, 2006, PLoS Pathog, V2, pe48, DOI 10.1371/journal.ppat.0020048; Davis PH, 2007, MOL BIOCHEM PARASIT, V151, P118, DOI 10.1016/j.molbiopara.2006.10.014; Davis PH, 2006, MOL MICROBIOL, V61, P1523, DOI 10.1111/j.1365-2958.2006.05344.x; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Ehrenkaufer GM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-216; Gilchrist CA, 2006, MOL BIOCHEM PARASIT, V147, P163, DOI 10.1016/j.molbiopara.2006.02.007; HAMANN L, 1995, P NATL ACAD SCI USA, V92, P8975, DOI 10.1073/pnas.92.19.8975; Hellberg A, 2000, MOL BIOCHEM PARASIT, V105, P305, DOI 10.1016/S0166-6851(99)00194-2; Hon CC, 2013, NUCLEIC ACIDS RES, V41, P1936, DOI 10.1093/nar/gks1271; Irmer H, 2009, MOL MICROBIOL, V72, P658, DOI 10.1111/j.1365-2958.2009.06672.x; Khalil MI, 2016, INT J PARASITOL, V46, P205, DOI 10.1016/j.ijpara.2015.11.004; Leippe M, 1995, PARASITOLOGY, V111, P569, DOI 10.1017/S0031182000077040; Lotter H, 2006, INFECT IMMUN, V74, P118, DOI 10.1128/IAI.74.1.118-124.2006; MacFarlane RC, 2006, INFECT IMMUN, V74, P340, DOI 10.1128/IAI.74.1.340-351.2006; Matthiesen J, 2013, MBIO, V4, DOI 10.1128/mBio.00072-13; Meyer M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005853; Mirelman D, 2008, IUBMB LIFE, V60, P598, DOI 10.1002/iub.96; Morf L, 2013, NUCLEIC ACIDS RES, V41, P9424, DOI 10.1093/nar/gkt717; NICKEL R, 1994, P NATL ACAD SCI USA, V91, P7095, DOI 10.1073/pnas.91.15.7095; Pearson RJ, 2013, J BIOL CHEM, V288, P4462, DOI 10.1074/jbc.M112.423467; Penuliar GM, 2012, J ANTIMICROB CHEMOTH, V67, P375, DOI 10.1093/jac/dkr484; Pompey JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106477; Rastew E, 2015, EXP PARASITOL, V154, P33, DOI 10.1016/j.exppara.2015.04.004; STANLEY SL, 1995, INFECT IMMUN, V63, P1587, DOI 10.1128/IAI.63.4.1587-1590.1995; Teixeira JE, 2012, INFECT IMMUN, V80, P2165, DOI 10.1128/IAI.06389-11; Tillack M, 2006, MOL BIOCHEM PARASIT, V149, P58, DOI 10.1016/j.molbiopara.2006.04.009; Weber C, 2016, SCI REP-UK, V6, DOI 10.1038/srep35852; Zhang HB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000219	35	5	5	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1658	1668		10.1096/fj.201801313R	http://dx.doi.org/10.1096/fj.201801313R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30169111	Bronze			2022-12-26	WOS:000457296600013
J	Pfeiler, S; Thakur, M; Grunauer, P; Megens, RTA; Joshi, U; Coletti, R; Samara, V; Muller-Stoy, G; Ishikawa-Ankerhold, H; Stark, K; Klingl, A; Frohlich, T; Arnold, GJ; Wormann, S; Bruns, CJ; Algul, H; Weber, C; Massberg, S; Engelmann, B				Pfeiler, Susanne; Thakur, Manovriti; Gruenauer, Petra; Megens, Remco T. A.; Joshi, Urjita; Coletti, Raffaele; Samara, Verena; Mueller-Stoy, Geraldine; Ishikawa-Ankerhold, Hellen; Stark, Konstantin; Klingl, Andreas; Froehlich, Thomas; Arnold, Georg J.; Woermann, Sonja; Bruns, Christiane J.; Alguel, Hana; Weber, Christian; Massberg, Steffen; Engelmann, Bernd			CD36-triggered cell invasion and persistent tissue colonization by tumor microvesicles during metastasis	FASEB JOURNAL			English	Article						super-resolution microscopy; microvesicle extravasation; Ly6C(-)macrophages	EXTRACELLULAR VESICLES; CANCER; MACROPHAGES; MICROPARTICLES; COMMUNICATION; MELANOMA; BIOLOGY	Tumor microvesicles are a peculiar type of extracellular vesicles that circulate in the blood of patients with metastatic cancer. The itineraries and immune cell interactions of tumor microvesicles during the intravascular and extravascular stages of metastasis are largely unknown. We found that the lipid receptor CD36 is a major mediator of the engulfment of pancreatic tumor microvesicles by myeloid immune cells in vitro and critically samples circulating tumor microvesicles by resident liver macrophages in mice in vivo. Direct nanoscopic imaging of individual tumor microvesicles shows that the microvesicles rapidly decay during engulfment whereby their cargo is targeted concomitantly to the plasma membrane and the cytoplasm excluding lysosomal compartments. CD36 also promotes internalization of blood cell (nontumor) microvesicles, which involves endolysosomal pathways. A portion of tumor microvesicles circulating in the liver microcirculation traverses the vessel wall in a CD36-dependent way. Extravasated microvesicles colonize distinct perivascular Ly6C(-) macrophages for at least 2 wk. Thus, the microvesicles are increasingly integrated into CD36-induced premetastatic cell clusters and enhance development of liver metastasis. Hence, promotion of metastasis by pancreatic tumor microvesicles is associated with CD36-regulated immune cell invasion and extravasation of microvesicles and persistent infiltration of specific tissue macrophages by microvesicle cargo.Pfeiler, S., Thakur, M., Grunauer, P., Megens, R. T. A., Joshi, U., Coletti, R., Samara, V., Muller-Stoy, G., Ishikawa-Ankerhold, H., Stark, K., Klingl, A., Frohlich, T., Arnold, G. J., Wormann, S., Bruns, C. J., Algul, H., Weber, C., Massberg, S., Engelmann, B. CD36-triggered cell invasion and persistent tissue colonization by tumor microvesicles during metastasis.	[Pfeiler, Susanne; Thakur, Manovriti; Gruenauer, Petra; Joshi, Urjita; Samara, Verena; Mueller-Stoy, Geraldine; Engelmann, Bernd] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Inst Lab Med, Munich, Germany; [Megens, Remco T. A.; Weber, Christian] Ludwig Maximilians Univ Munchen, Prophylaxe Kreislaufkrankheiten, Munich, Germany; [Coletti, Raffaele; Ishikawa-Ankerhold, Hellen; Stark, Konstantin; Massberg, Steffen] Ludwig Maximilians Univ Munchen, Med Klin 1, Munich, Germany; [Klingl, Andreas] Ludwig Maximilians Univ Munchen, Biol Bot 1, Munich, Germany; [Froehlich, Thomas; Arnold, Georg J.] Ludwig Maximilians Univ Munchen, Genzentrum, Munich, Germany; [Megens, Remco T. A.; Weber, Christian] Maastricht Univ, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Woermann, Sonja; Alguel, Hana] Tech Univ Munich, Klin & Poliklin Innere Med 2, Munich, Germany; [Bruns, Christiane J.] Univ Cologne, Chirurg Klin, Cologne, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich; Maastricht University; Technical University of Munich; University of Cologne	Engelmann, B (corresponding author), Ludwig Maximilians Univ Munchen, Inst Lab Med, Marchioninistr 15, D-81377 Munich, Germany.	Bernd.Engelmann@med.uni-muenchen.de	Fröhlich, Thomas/C-6735-2011; Klingl, Andreas/K-6675-2014; Weber, Christian/AAW-2153-2020; Massberg, Steffen/AAN-6054-2021; Stark, Konstantin/AAJ-2815-2020	Fröhlich, Thomas/0000-0002-4709-3211; Weber, Christian/0000-0003-4610-8714; Stark, Konstantin/0000-0002-5369-8399; Pfeiler, Susanne/0000-0002-8591-6186; megens, remco/0000-0001-9871-6696; Klingl, Andreas/0000-0001-8414-8317; Thakur, Manovriti/0000-0003-3825-4121	Deutsche Forschungsgemeinschaft [SFB1123, INST 409/150-1 FUGG]; Deutsche Krebshilfe; Wilhelm-Sander-Stiftung;  [SFB1321];  [SFB 914]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm-Sander-Stiftung; ; 	The authors thank Katja Reges (Institut fur Laboratoriumsmedizin, Klinikum der Universitat Munchen) for preparation of CFP-TF construct, and Kathrin Gartner (Helmholtz Zentrum Munchen) for help with nanoparticle tracking analysis. The work was supported by SFB1123 from Deutsche Forschungsgemeinschaft (Projects B06 to S.M. and B.E., A01 to C.W., and Z01 to R.T.A.M.; INST 409/150-1 FUGG to C.W., S.M., and R.T.A.M.), by SFB1321 (Project P10 to B.E. and S.M.), as well as by grants from Deutsche Krebshilfe and Wilhelm-Sander-Stiftung (to B.E.) and SFB 914 (Project Z01 to R.C., H.I.-A., and S.M.). S.P. and M.T. shared first authorship. The authors declare no conflicts of interest.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; Desrochers LM, 2016, DEV CELL, V37, P301, DOI 10.1016/j.devcel.2016.04.019; Ghosh A, 2008, J CLIN INVEST, V118, P1934, DOI 10.1172/JCI34904; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gopal SK, 2017, BIOCHEM J, V474, P21, DOI 10.1042/BCJ20160006; Grover SP, 2018, ARTERIOSCL THROM VAS, V38, P709, DOI 10.1161/ATVBAHA.117.309846; Kosaka N, 2016, J CLIN INVEST, V126, P1163, DOI 10.1172/JCI81130; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Lewis CE, 2016, CANCER CELL, V30, P18, DOI 10.1016/j.ccell.2016.05.017; Lima LG, 2009, CANCER LETT, V283, P168, DOI 10.1016/j.canlet.2009.03.041; Marcovecchio PM, 2017, ARTERIOSCL THROM VAS, V37, P2043, DOI 10.1161/ATVBAHA.117.309123; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Menck K, 2017, J EXTRACELL VESICLES, V6, P1, DOI 10.1080/20013078.2017.1340745; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Muller I, 2003, FASEB J, V17, P476, DOI 10.1096/fj.02-0574fje; Park YM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.38; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Prada I, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081296; Rautou PE, 2011, CIRC RES, V108, P335, DOI 10.1161/CIRCRESAHA.110.237420; Ruivo CF, 2017, CANCER RES, V77, P6480, DOI 10.1158/0008-5472.CAN-17-0994; Sansone P, 2017, CANCER RES, V77, P1927, DOI 10.1158/0008-5472.CAN-16-2129; Soung YH, 2017, CANCERS, V9, DOI 10.3390/cancers9010008; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Wang T, 2014, P NATL ACAD SCI USA, V111, pE3234, DOI 10.1073/pnas.1410041111	31	19	19	5	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1860	1872		10.1096/fj.201800985R	http://dx.doi.org/10.1096/fj.201800985R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30207797				2022-12-26	WOS:000457296600028
J	Park, JF; Yu, YP; Gong, N; Trinh, V; Luo, ZD				Park, John Francisco; Yu, Yanhui Peter; Gong, Nian; Trinh, Van Nancy; Luo, Z. David			The EGF-LIKE domain of thrombospondin-4 is a key determinant in the development of pain states due to increased excitatory synaptogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						thrombospondin; pain; synaptic plasticity; calcium channel; extracellular matrix protein; allodynia; neuropathic pain; pro-nociceptive domain; synaptogenesis; TSP4	CALCIUM-CHANNEL SUBUNIT; DORSAL-ROOT GANGLION; UP-REGULATION CONTRIBUTES; NEUROPATHIC PAIN; GABAPENTIN NEURONTIN; SYNAPSE FORMATION; HORN NEURONS; IN-VITRO; ALPHA(2)DELTA; SENSITIZATION	Up-regulation of thrombospondin-4 (TSP4) or voltage-gated calcium channel subunit (21) (Ca-v21) proteins in the spinal cord contributes to neuropathic pain development through an unidentified mechanism. We have previously shown that TSP4 interacts with Ca-v21 to promote excitatory synaptogenesis and the development of chronic pain states. However, the TSP4 determinants responsible for these changes are not known. Here, we tested the hypothesis that the Ca-v21-binding domains of TSP4 are synaptogenic and pronociceptive. We mapped the major Ca-v21-binding domains of TSP4 within the coiled-coil and epidermal growth factor (EGF)-like domains in vitro. Intrathecal injection of TSP4 fragment proteins containing the EGF-like domain (EGF-LIKE) into naive rodents was sufficient for inducing behavioral hypersensitivity similar to that produced by an equal molar dose of full-length TSP4. Gabapentin, a drug that binds to Ca-v21, blocked EGF-LIKE-induced behavioral hypersensitivity in a dose-dependent manner, supporting the notion that EGF-LIKE interacts with Ca-v21 and thereby mediates behavioral hypersensitivity. This notion was further supported by our findings that a peptide within EGF-LIKE (EGFD355-369) could block TSP4- or Ca-v21-induced behavioral hypersensitivity after intrathecal injections. Furthermore, only TSP4 proteins that contained EGF-LIKE could promote excitatory synaptogenesis between sensory and spinal cord neurons, which could be blocked by peptide EGFD355-369. Together, these findings indicate that EGF-LIKE is the molecular determinant that mediates aberrant excitatory synaptogenesis and chronic pain development. Blocking interactions between EGF-LIKE and Ca-v21 could be an alternative approach in designing target-specific pain medications.	[Park, John Francisco; Yu, Yanhui Peter; Luo, Z. David] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; [Gong, Nian; Trinh, Van Nancy; Luo, Z. David] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Gillespie Bldg,Rm 3113,837 Hlth Sci Rd, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Luo, ZD (corresponding author), Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Gillespie Bldg,Rm 3113,837 Hlth Sci Rd, Irvine, CA 92697 USA.	zluo@uci.edu			National Institutes of Health [DE021847, NS064341]; Pharmaceutical Research and Manufacturers of America Foundation [PRMAF-52427]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmaceutical Research and Manufacturers of America Foundation	This work supported in part by National Institutes of Health Grants DE021847 and NS064341 (to Z. D. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of Pre-Doctoral Fellowship in Pharmacology/Toxicology PRMAF-52427 from the Pharmaceutical Research and Manufacturers of America Foundation.	Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Albuquerque Cristovao, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5274; Albuquerque Cristovao, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5275; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Artru AA, 1999, SPINAL DRUG DELIVERY, P177; Bauer CS, 2009, J NEUROSCI, V29, P4076, DOI 10.1523/JNEUROSCI.0356-09.2009; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Burkey TH, 2004, METH MOLEC MED, P189; Chen JJ, 2018, CELL REP, V22, P2307, DOI 10.1016/j.celrep.2018.02.021; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; DELREE P, 1989, J NEUROSCI RES, V23, P198, DOI 10.1002/jnr.490230210; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gee NS, 1996, J BIOL CHEM, V271, P5768, DOI 10.1074/jbc.271.10.5768; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hendrich J, 2008, P NATL ACAD SCI USA, V105, P3628, DOI 10.1073/pnas.0708930105; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Joseph DJ, 2010, J NEUROSCI METH, V189, P197, DOI 10.1016/j.jneumeth.2010.04.002; Kim DS, 2012, J NEUROSCI, V32, P8977, DOI 10.1523/JNEUROSCI.6494-11.2012; Kim DS, 2009, PAIN, V143, P114, DOI 10.1016/j.pain.2009.02.006; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Lana B, 2016, SCI REP-UK, V6, DOI 10.1038/srep24531; Li CY, 2006, PAIN, V125, P20, DOI 10.1016/j.pain.2006.04.022; Li CY, 2004, J NEUROSCI, V24, P8494, DOI 10.1523/JNEUROSCI.2982-04.2004; Li KW, 2014, EUR J PAIN, V18, P489, DOI 10.1002/j.1532-2149.2013.00396.x; Li KW, 2014, J BIOL CHEM, V289, P7025, DOI 10.1074/jbc.M114.548990; Lin YX, 2004, J NEUROPHYSIOL, V92, P2820, DOI 10.1152/jn.00048.2004; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marais E, 2001, MOL PHARMACOL, V59, P1243, DOI 10.1124/mol.59.5.1243; Milligan ED, 2005, EUR J NEUROSCI, V21, P2136, DOI 10.1111/j.1460-9568.2005.04057.x; Narouz-Ott L, 2000, J BIOL CHEM, V275, P37110, DOI 10.1074/jbc.M007223200; Nguyen D, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-6; Ohshiro H, 2007, J NEUROSCI METH, V165, P49, DOI 10.1016/j.jneumeth.2007.05.018; Park J, 2016, J BIOL CHEM, V291, P13335, DOI 10.1074/jbc.M116.723478; RADULOVIC LL, 1995, DRUG METAB DISPOS, V23, P441; Ruthazer ES, 2006, J NEUROSCI, V26, P3594, DOI 10.1523/JNEUROSCI.0069-06.2006; Ruzza C, 2015, PEPTIDES, V69, P26, DOI 10.1016/j.peptides.2015.03.021; Seybold VS, 2004, METH MOLEC MED, P203; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Valder CR, 2003, J NEUROCHEM, V87, P560, DOI 10.1046/j.1471-4159.2003.02016.x; VARON S, 1971, BRAIN RES, V30, P83, DOI 10.1016/0006-8993(71)90007-2; VIDAL M, 1990, EMBO J, V9, P833, DOI 10.1002/j.1460-2075.1990.tb08180.x; Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X; Wang MH, 1999, BIOCHEM J, V342, P313, DOI 10.1042/0264-6021:3420313; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Yu YP, 2018, BRIT J PHARMACOL, V175, P2348, DOI 10.1111/bph.14149; Zeng J, 2013, EUR J PAIN, V17, P1458, DOI 10.1002/j.1532-2149.2013.00326.x; Zhou C, 2015, EUR J PAIN, V19, P1267, DOI 10.1002/ejp.656; Zhou C, 2014, EUR J PAIN, V18, P649, DOI 10.1002/j.1532-2149.2013.00416.x; Zurborg S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-66	56	8	9	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16453	16463		10.1074/jbc.RA118.003591	http://dx.doi.org/10.1074/jbc.RA118.003591			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30194282	hybrid, Green Published			2022-12-26	WOS:000447833600027
J	Pan, X; Wang, HIX				Pan, Xing; Wang, Huixiong			Resilience of and recovery strategies for weighted networks	PLOS ONE			English	Article							COMPLEX NETWORKS; SMALL-WORLD; CASCADING FAILURES; SYNCHRONIZATION; ROBUSTNESS; VERTEX	The robustness and resilience of complex networks have been widely studied and discussed in both research and industry because today, the diversity of system components and the complexity of the connection between units are increasingly influencing the reliability of complex systems. Previous studies have focused on node failure in networks, proposing several performance indicators. However, a single performance indicator cannot comprehensively measure all the performance aspects; thus, the selected performance indicators and recovery strategies lack consistency with respect to the targeted complex systems. This paper introduces a novel stress-strength-balanced weighted network model based on two network transmission hypotheses. Then, with respect to different concerns of the complex network, we propose two modified network performance measurement indicators and compare these indicators in terms of their trends in the attack process. In addition, we introduce several network recovery strategies and compare their efficiencies. Our findings are as follows: (1) The evaluation and judgment of the network performance depend on the performance measurement indicators we use. (2) Different recovery strategies exhibit distinct efficiencies in recovering different aspects of network performance, and no strategy exists that can improve all the network performance aspects simultaneously. (3) The timing of the recovery is proved to have a deep influence on the cost and efficiency of network recovery; thus, the optimal recovery strategy for a damaged network varies with the extent of the damage. From the results of the simulation of the attack-recovery process, we conclude that while defining and analyzing complex network models, we should adjust our network topology, weight assignment, and performance indicators in accordance with the focal characteristics of complex systems so that we can use the network model to build robust complex systems and efficient logistics and maintenance strategies.	[Pan, Xing; Wang, Huixiong] Beihang Univ, Sch Reliabil & Syst Engn, Beijing, Peoples R China	Beihang University	Wang, HIX (corresponding author), Beihang Univ, Sch Reliabil & Syst Engn, Beijing, Peoples R China.	wanghuixiong@buaa.edu.cn	Wang, Huixiong/M-3891-2019	Wang, Huixiong/0000-0002-8954-1967	National Natural Science Foundation of China [71171008, 71571004]; National Key Research and Development Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program	This study was supported by National Natural Science Foundation of China [grant numbers 71171008 and 71571004, http://www.nsfc.gov.cn/] and the National Key Research and Development Program [http://program.most.gov.cn/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Bao ZJ, 2009, PHYSICA A, V388, P4491, DOI 10.1016/j.physa.2009.07.017; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barker K, 2013, RELIAB ENG SYST SAFE, V117, P89, DOI 10.1016/j.ress.2013.03.012; Batty M, 2009, ENVIRON PLANN B, V36, P381, DOI 10.1068/b3603ed; Bellingeri M, 2018, PHYSICA A, V489, P47, DOI 10.1016/j.physa.2017.07.020; Bellingeri M, 2014, PHYSICA A, V414, P174, DOI 10.1016/j.physa.2014.06.079; Boas PRV, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/03/P03009; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Cats O, 2017, RELIAB ENG SYST SAFE, V167, P544, DOI 10.1016/j.ress.2017.07.009; Costa LD, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066127; da Cunha BR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142824; Di Muro MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep22834; Falck J, 2018, IEEE IND ELECTRON M, V12, P24, DOI 10.1109/MIE.2018.2825481; Fang QX, 2018, PHYSICA A, V490, P542, DOI 10.1016/j.physa.2017.08.050; Gao JX, 2016, NATURE, V530, P307, DOI 10.1038/nature16948; Gao J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.092002; Geng L, 2017, PHYSICA A, V482, P407, DOI 10.1016/j.physa.2017.04.025; Goh KI, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.018701; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Kabir MN, 2018, INT J CRIT INFR PROT, V20, P16, DOI 10.1016/j.ijcip.2017.11.002; Kinney R, 2005, EUR PHYS J B, V46, P101, DOI 10.1140/epjb/e2005-00237-9; La Rocca CE, 2018, PHYSICA A, V508, P577, DOI 10.1016/j.physa.2018.05.154; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Moore C, 2000, PHYS REV E, V62, P7059, DOI 10.1103/PhysRevE.62.7059; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Nogal M, 2016, RELIAB ENG SYST SAFE, V156, P84, DOI 10.1016/j.ress.2016.07.020; Ramirez-Marquez JE, 2018, RELIAB ENG SYST SAFE, V169, P466, DOI 10.1016/j.ress.2017.09.019; Shai S, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062805; Shekhtman LM, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/12/123007; STAUFFER D, 1994, INTRO PERCOLATION TH; Sterbenz J. P., 2011, TELECOMMUN SYST, P1, DOI [10.1007/s11235-011-9573-6, DOI 10.1007/S11235-011-9573-6]; Sun WM, 2017, EUR PHYS J B, V90, DOI 10.1140/epjb/e2016-70618-0; Vlacheas P, 2013, INT J CRIT INFR PROT, V6, P159, DOI 10.1016/j.ijcip.2013.08.004; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; West D.B., 1996, INTRO GRAPH THEORY, V2; Yang SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156764; Yang Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.258701; Zhang XG, 2018, RELIAB ENG SYST SAFE, V169, P364, DOI 10.1016/j.ress.2017.09.009	39	11	12	8	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203894	10.1371/journal.pone.0203894	http://dx.doi.org/10.1371/journal.pone.0203894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204786	Green Submitted, gold, Green Published			2022-12-26	WOS:000444355500055
J	Campos, R; Justo, AFO; Monica, FZ; Cogo, JC; Moreno, RA; de Souza, VB; Schenka, AA; De Nucci, G				Campos, Rafael; Oliveira Justo, Alberto Fernando; Monica, Fabiola Z.; Cogo, Jose Carlos; Moreno, Ronilson Agnaldo; de Souza, Valeria Barbosa; Schenka, Andre Almeida; De Nucci, Gilberto			Electrical field-induced contractions on Crotalus durissus terrificus and Bothrops jararaca aortae are caused by endothelium-derived catecholamine	PLOS ONE			English	Article							BREAST-CANCER; BETA-BLOCKERS; SURVIVAL	Endothelium is the main source of catecholamine release in the electrical-field stimulation (EFS)-induced aortic contractions of the non- venomous snake Panterophis guttatus. However, adrenergic vasomotor control in venomous snakes such as Crotalus durissus terrificus and Bothrops jararaca has not yet been investigated. Crotalus and Bothrops aortic rings were mounted in an organ bath system. EFS-induced aortae contractions were performed in the presence and absence of guanethidine (30 mu M), phentolamine (10 mu M) or tetrodotoxin (1 mu M). Frequency-induced contractions were also performed in aortae with endothelium removed. Immunohistochemical localization of both tyrosine hydroxylase (TH) and S-100 protein in snake aortic rings and brains, as well as in human tissue (paraganglioma tumour) were carried out. EFS (4 to 16 Hz) induced frequency-dependent aortic contractions in both Crotalus and Bothrops. The EFS-induced contractions were significantly reduced in the presence of either guanethidine or phentolamine in both snakes (p<0.05), whereas tetrodotoxin had no effect in either. Removal of the endothelium abolished the EFS-induced contractions in both snakes aortae (p<0.05). Immunohistochemistry revealed TH localization in endothelium of both snake aortae and human vessels. Nerve fibers were not observed in either snake aortae. In contrast, both TH and S100 protein were observed in snake brains and human tissue. Vascular endothelium is the main source of catecholamine release in EFS-induced contractions in Crotalus and Bothrops aortae. Human endothelial cells also expressed TH, indicating that endothelium- derived catecholamines possibly occur in mammalian vessels.	[Campos, Rafael; Oliveira Justo, Alberto Fernando; Monica, Fabiola Z.; Moreno, Ronilson Agnaldo; de Souza, Valeria Barbosa; Schenka, Andre Almeida; De Nucci, Gilberto] Univ Estadual Campinas, UNICAMP, Dept Pharmacol, Fac Med Sci, Campinas, SP, Brazil; [Cogo, Jose Carlos; De Nucci, Gilberto] Brazil Univ, Fac Biomed Engn, Itaquera, Brazil	Universidade Estadual de Campinas	Campos, R (corresponding author), Univ Estadual Campinas, UNICAMP, Dept Pharmacol, Fac Med Sci, Campinas, SP, Brazil.	rafaelcampos.vet@gmail.com	De Nucci, Gilberto/ABB-7380-2021; Monica, Fabiola Zakia/B-4191-2013; De Nucci, Gilberto/J-5990-2012; Justo, Alberto/AAI-1394-2021; Campos, Rafael/F-2471-2017	De Nucci, Gilberto/0000-0002-4346-7941; Monica, Fabiola Zakia/0000-0002-8449-6677; De Nucci, Gilberto/0000-0002-4346-7941; Oliveira Justo, Alberto Fernando/0000-0001-5531-0485; Campos, Rafael/0000-0002-9816-2061	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/11828-4]; Conselho Nacional de Desenvolvimento cientifico e tecnologico (CNPq) [140731/2013-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento cientifico e tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; 2011/11828-4) and by Conselho Nacional de Desenvolvimento cientifico e tecnologico (CNPq; 140731/2013-0). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; 2011/11828-4) and by Conselho Nacional de Desenvolvimento cientifico e tecnologico (CNPq; 140731/2013-0).	Barron TI, 2011, J CLIN ONCOL, V29, P2635, DOI 10.1200/JCO.2010.33.5422; Campos R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196123; Campos R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183766; De Giorgi V, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2017.2908; Jang Hye-In, 2017, Obstet Gynecol Sci, V60, P170, DOI 10.5468/ogs.2017.60.2.170; Lemeshow S, 2011, CANCER EPIDEM BIOMAR, V20, P2273, DOI 10.1158/1055-9965.EPI-11-0249; Melhem-Bertrandt A, 2011, J CLIN ONCOL, V29, P2645, DOI 10.1200/JCO.2010.33.4441; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Pasquier E, 2011, ONCOTARGET, V2, P797; SMYTHIES JR, 1971, NATURE, V231, P188, DOI 10.1038/231188a0; Sorriento D, 2012, HYPERTENSION, V60, P129, DOI 10.1161/HYPERTENSIONAHA.111.189605; Wang HM, 2013, ANN ONCOL, V24, P1312, DOI 10.1093/annonc/mds616	12	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2018	13	9							e0203573	10.1371/journal.pone.0203573	http://dx.doi.org/10.1371/journal.pone.0203573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7DK	30199552	Green Published, gold, Green Submitted			2022-12-26	WOS:000444681100016
J	McGuinness, KN; Pan, WL; Sheridan, RP; Murphy, G; Crespo, A				McGuinness, Kenneth N.; Pan, Weilan; Sheridan, Robert P.; Murphy, Grant; Crespo, Alejandro			Role of simple descriptors and applicability domain in predicting change in protein thermostability	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; STABILITY CHANGES; THERMAL-STABILITY; POINT MUTATIONS; TRAINING SET; QSAR MODELS; SIMILARITY; MUTANTS; DESIGN; TOOLS	The melting temperature (Tm) of a protein is the temperature at which half of the protein population is in a folded state. Therefore, Tm is a measure of the thermostability of a protein. Increasing the Tm of a protein is a critical goal in biotechnology and biomedicine. However, predicting the change in melting temperature (dTm) due to mutations at a single residue is difficult because it depends on an intricate balance of forces. Existing methods for predicting dTm have had similar levels of success using generally complex models. We find that training a machine learning model with a simple set of easy to calculate physicochemical descriptors describing the local environment of the mutation performed as well as more complicated machine learning models and is 2-6 orders of magnitude faster. Importantly, unlike in most previous publications, we perform a blind prospective test on our simple model by designing 96 variants of a protein not in the training set. Results from retrospective and prospective predictions reveal the limited applicability domain of each model. This study highlights the current deficiencies in the available dTm dataset and is a call to the community to systematically design a larger and more diverse experimental dataset of mutants to prospectively predict dTm with greater certainty.	[McGuinness, Kenneth N.; Sheridan, Robert P.; Crespo, Alejandro] Merck & Co Inc, Modeling & Informat, Kenilworth, NJ 07033 USA; [Pan, Weilan; Murphy, Grant] Merck & Co Inc, Biochem Engn & Struct, Rahway, NJ 07065 USA; [McGuinness, Kenneth N.] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ USA; [Crespo, Alejandro] EMD Serono Res & Dev Inst Inc, Drug Struct Predict & Design, Billerica, MA 01821 USA	Merck & Company; Merck & Company; Rutgers State University New Brunswick; Merck KGaA; EMD Serono Inc.	Crespo, A (corresponding author), Merck & Co Inc, Modeling & Informat, Kenilworth, NJ 07033 USA.; Crespo, A (corresponding author), EMD Serono Res & Dev Inst Inc, Drug Struct Predict & Design, Billerica, MA 01821 USA.	alejandro.crespo@emdserono.com		McGuinness, Kenneth/0000-0003-1898-1575	Merck Co.	Merck Co.(Merck & Company)	Merck & Co. provided support in the form of salaries for all authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contribution' section.	Araya CL, 2012, P NATL ACAD SCI USA, V109, P16858, DOI 10.1073/pnas.1209751109; BAGLEY SC, 1995, PROTEIN SCI, V4, P622; BEARD H, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0082849; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; BLAEN PJ, 2015, PLOS ONE, V10, DOI DOI 10.1371/J0URNAL.P0NE.0138022; Bommarius AS, 2013, CHEM SOC REV, V42, P6534, DOI 10.1039/c3cs60137d; Borgo B, 2012, P NATL ACAD SCI USA, V109, P1494, DOI 10.1073/pnas.1115172109; Brightman AO, 2000, BIOPOLYMERS, V54, P222; Broom A, 2017, J BIOL CHEM, V292, P14349, DOI 10.1074/jbc.M117.784165; Correa F, 2016, STRUCTURE, V24, P1918, DOI 10.1016/j.str.2016.08.014; Dadarlat VM, 2012, BIOPHYS J, V103, P1762, DOI 10.1016/j.bpj.2012.08.048; Davis SC, 2006, ENZYMATIC PROCESSES; Deller MC, 2016, INT UNION CRYSTALLOG, V72, P72, DOI [10.1107/S2053230X15024619, DOI 10.1107/S2053230X15024619]; Deng ZF, 2012, J MOL BIOL, V424, P150, DOI 10.1016/j.jmb.2012.09.014; Faber FA, 2017, J CHEM THEORY COMPUT, V13, P5255, DOI 10.1021/acs.jctc.7b00577; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; Ford MC, 2017, J CHEM INF MODEL, V57, P1276, DOI 10.1021/acs.jcim.7b00002; Gapsys V, 2016, ANGEW CHEM INT EDIT, V55, P7364, DOI 10.1002/anie.201510054; Geary RC, 1935, BIOMETRIKA, V27, P310, DOI 10.1093/biomet/27.3-4.310; Hanser T, 2016, SAR QSAR ENVIRON RES, V27, P865, DOI 10.1080/1062936X.2016.1250229; Horvath D, 2009, J CHEM INF MODEL, V49, P1762, DOI 10.1021/ci9000579; Jaworska J, 2005, ATLA-ALTERN LAB ANIM, V33, P445, DOI 10.1177/026119290503300508; Jazayeri A, 2015, J BIOL CHEM, V290, P19489, DOI 10.1074/jbc.R115.668251; Joo JC, 2010, J BIOTECHNOL, V146, P31, DOI 10.1016/j.jbiotec.2009.12.021; Kar S, 2018, METHODS MOL BIOL, V1800, P141, DOI 10.1007/978-1-4939-7899-1_6; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Khan S, 2016, J CHEM INF MODEL, V56, P2129, DOI 10.1021/acs.jcim.6b00305; Klesmith JR, 2017, P NATL ACAD SCI USA, V114, P2265, DOI 10.1073/pnas.1614437114; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lee CW, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0112751, DOI 10.1371/J0URNAL.P0NE.0112751]; Leuenberger P, 2017, SCIENCE, V355, DOI 10.1126/science.aai7825; Masso M, 2008, BIOINFORMATICS, V24, P2002, DOI 10.1093/bioinformatics/btn353; Masso M, 2010, PROTEIN ENG DES SEL, V23, P683, DOI 10.1093/protein/gzq042; Mathea M, 2016, MOL INFORM, V35, P160, DOI 10.1002/minf.201501019; Matsumurat M, 1989, BIOCHEMISTRY-US, V86, P6562, DOI [10.1073/pnas.86.17.6562, DOI 10.1073/PNAS.86.17.6562]; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; Modarres HP, 2016, RSC ADV, V6, P115252, DOI 10.1039/c6ra16992a; Modarres HP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191222; Moore EJ, 2017, P NATL ACAD SCI USA, V114, P12472, DOI 10.1073/pnas.1708907114; Mozo-Villarias A, 2003, PROTEIN ENG, V16, P279, DOI 10.1093/proeng/gzg033; Musil M, 2017, NUCLEIC ACIDS RES, V45, pW393, DOI 10.1093/nar/gkx285; Netzeva TI, 2005, ATLA-ALTERN LAB ANIM, V33, P155, DOI 10.1177/026119290503300209; NICHOLSON H, 1991, BIOCHEMISTRY-US, V30, P9816, DOI 10.1021/bi00105a002; NICHOLSON H, 1988, NATURE, V336, P651, DOI 10.1038/336651a0; Park H, 2016, J CHEM THEORY COMPUT, V12, P6201, DOI 10.1021/acs.jctc.6b00819; Piras P, 2018, J SEP SCI, V41, P1365, DOI 10.1002/jssc.201701334; Pucci F, 2017, CURR OPIN STRUC BIOL, V42, P117, DOI 10.1016/j.sbi.2016.12.007; Pucci F, 2016, J PHYS CHEM REF DATA, V45, DOI 10.1063/1.4947493; Pucci F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23257; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Rocklin GJ, 2017, SCIENCE, V357, P168, DOI 10.1126/science.aan0693; Saraboji K, 2006, BIOPOLYMERS, V82, P80, DOI 10.1002/bip.20462; Senn S, 2014, PROTEINS, V82, P648, DOI 10.1002/prot.24442; Sheridan RP, 2012, J CHEM INF MODEL, V52, P814, DOI 10.1021/ci300004n; Sheridan RP, 2009, J CHEM INF MODEL, V49, P1974, DOI 10.1021/ci900176y; Sheridan RP, 2004, J CHEM INF COMP SCI, V44, P1912, DOI 10.1021/ci049782w; Sheridan RP, 2001, J CHEM INF COMP SCI, V41, P1395, DOI 10.1021/ci0100144; Simpson Richard J, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.top79; Singh B, 2015, J PHYS CHEM B, V119, P392, DOI 10.1021/jp5079554; Spassov VZ, 2016, J COMPUT CHEM, V37, P2573, DOI 10.1002/jcc.24482; Steinbrecher T, 2017, J MOL BIOL, V429, P948, DOI 10.1016/j.jmb.2016.12.007; Sushko I, 2010, J CHEM INF MODEL, V50, P2094, DOI 10.1021/ci100253r; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Takahashi YT, 2006, BIOCHEMISTRY-US, V45, P11005, DOI 10.1021/bi061164g; Thornton AW, 2017, CHEM MATER, V29, P2844, DOI 10.1021/acs.chemmater.6b04933; Topham CM, 1997, PROTEIN ENG, V10, P7, DOI 10.1093/protein/10.1.7; van Dijk E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004277; Verras A, 2017, J CHEM INF MODEL, V57, P445, DOI 10.1021/acs.jcim.6b00572; Weiss WF, 2009, J PHARM SCI-US, V98, P1246, DOI 10.1002/jps.21521; Wunderlich M, 2006, PROTEIN ENG DES SEL, V19, P355, DOI 10.1093/protein/gzl019; Yang HQ, 2015, CHEMBIOENG REV, V2, P87, DOI 10.1002/cben.201400032; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; Yu H, 2017, SCI REP, V7, P1, DOI [10.1371/journal.pone.0112751, DOI 10.1038/SREP41212, DOI 10.1371/JOURNAL.PONE.0112751]; Zeiske T, 2016, J CHEM THEORY COMPUT, V12, P2489, DOI 10.1021/acs.jctc.6b00120	75	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203819	10.1371/journal.pone.0203819	http://dx.doi.org/10.1371/journal.pone.0203819			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192891	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600147
J	Redshaw, J; Leamy, T; Pincus, P; Suddendorf, T				Redshaw, Jonathan; Leamy, Talia; Pincus, Phoebe; Suddendorf, Thomas			Young children's capacity to imagine and prepare for certain and uncertain future outcomes	PLOS ONE			English	Article							MENTAL TIME-TRAVEL; EPISODIC FORESIGHT; 4-YEAR-OLD CHILDREN; THINKING; EVOLUTION; UNIQUE; MEMORY; SELF; APES	The current study used a minimalist paradigm to examine young children's capacity to imagine and prepare for certain and uncertain immediate future outcomes. In a counterbalanced order, 2.5-year-old children (N = 32) completed twelve trials each of two tasks: (1) the forked tube task, which assessed their ability to cover two possible tube exits to ensure they would catch a single target with an uncertain future trajectory, and (2) the double tube task, which assessed their ability to cover two separate tube exits to ensure they would catch two targets with certain future trajectories. Even though the optimal preparatory action was the same across both tasks, children were much more likely to spontaneously and consistently demonstrate this action in the double tube task than the forked tube task. Children's responses were unaffected by the number of targets seen in the demonstration phase, and instead appeared to be based on the particular contingencies of each apparatus. These results are consistent with the possibility that young children specifically struggle to imagine and prepare for mutually exclusive versions of uncertain future events.	[Redshaw, Jonathan; Leamy, Talia; Pincus, Phoebe; Suddendorf, Thomas] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia	University of Queensland	Redshaw, J (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	j.redshaw@uq.edu.au	Suddendorf, Thomas/A-1631-2017	Suddendorf, Thomas/0000-0003-3328-7442				Ambrose SH, 2010, CURR ANTHROPOL, V51, pS135, DOI 10.1086/650296; Atance CM, 2005, COGNITIVE DEV, V20, P341, DOI 10.1016/j.cogdev.2005.05.001; Atance CM, 2015, CHILD DEV PERSPECT, V9, P178, DOI 10.1111/cdep.12128; Atance CM, 2015, J EXP CHILD PSYCHOL, V129, P98, DOI 10.1016/j.jecp.2014.09.001; Baumeister RF., 2018, PSYCHOL CONSCIOUS, V5, P223, DOI [10.31234/osf.io/a3r7h, DOI 10.1037/CNS0000154, 10.1037/cns0000154]; Beck SR, 2006, CHILD DEV, V77, P413, DOI 10.1111/j.1467-8624.2006.00879.x; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Hoerl C., 2018, ROUTLEDGE HDB PHILOS, P56; Hudson JA, 2011, ADV CHILD DEV BEHAV, V40, P95; Jing HG, 2017, COGNITION, V169, P118, DOI 10.1016/j.cognition.2017.08.010; McCormack T, 2011, DEV REV, V31, P1, DOI 10.1016/j.dr.2011.02.002; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Payne G, 2015, MEMORY, V23, P675, DOI 10.1080/09658211.2014.921310; Perner J, 1991, UNDERSTANDING REPRES; PYLYSHYN ZW, 1978, BEHAV BRAIN SCI, V1, P592, DOI 10.1017/S0140525X00076895; Redshaw J, 2019, CHILD DEV, V90, P51, DOI 10.1111/cdev.13084; Redshaw J, 2016, CURR BIOL, V26, P1758, DOI 10.1016/j.cub.2016.04.062; Redshaw J, 2014, WIRES COGN SCI, V5, P519, DOI 10.1002/wcs.1308; Redshaw J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00404; Robinson EJ, 2006, CHILD DEV, V77, P1642, DOI 10.1111/j.1467-8624.2006.00964.x; Russell J, 2010, COGNITION, V114, P56, DOI 10.1016/j.cognition.2009.08.013; Scarf D, 2013, DEV PSYCHOBIOL, V55, P125, DOI 10.1002/dev.21004; Seed AM, 2016, CURR BIOL, V26, pR525, DOI 10.1016/j.cub.2016.05.022; Suddendorf T, 2006, SCIENCE, V312, P1006, DOI 10.1126/science.1129217; Suddendorf T., 1999, DESCENT MIND PSYCHOL, P218; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Suddendorf T, 2017, CHILD DEV PERSPECT, V11, P191, DOI 10.1111/cdep.12233; Suddendorf T, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0170; Suddendorf T, 2013, ANN NY ACAD SCI, V1296, P135, DOI 10.1111/nyas.12189; Suddendorf T, 2011, DEVELOPMENTAL SCI, V14, P26, DOI 10.1111/j.1467-7687.2010.00950.x; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5	31	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0202606	10.1371/journal.pone.0202606	http://dx.doi.org/10.1371/journal.pone.0202606			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT1IK	30180188	Green Published, Green Submitted, gold			2022-12-26	WOS:000444222400011
J	Stylianou, N; Lehman, ML; Wang, C; Fard, AT; Rockstroh, A; Fazli, L; Jovanovic, L; Ward, M; Sadowski, MC; Kashyap, AS; Buttyan, R; Gleave, ME; Westbrook, TF; Williams, ED; Gunter, JH; Nelson, CC; Hollier, BG				Stylianou, Nataly; Lehman, Melanie L.; Wang, Chenwei; Fard, Atefeh Taherian; Rockstroh, Anja; Fazli, Ladan; Jovanovic, Lidija; Ward, Micheal; Sadowski, Martin C.; Kashyap, Abhishek S.; Buttyan, Ralph; Gleave, Martin E.; Westbrook, Thomas F.; Williams, Elizabeth D.; Gunter, Jennifer H.; Nelson, Colleen C.; Hollier, Brett G.			A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome	ONCOGENE			English	Article							GENE-EXPRESSION SIGNATURE; ANDROGEN RECEPTOR; FREE SURVIVAL; CELL-CYCLE; TRANSITION; TUMOR; METASTASIS; PROGRESSION; REVEALS; EMT	The propensity of cancer cells to transition between epithelial and mesenchymal phenotypic states via the epithelial-mesenchymal transition (EMT) program can regulate metastatic processes, cancer progression, and treatment resistance. Transcriptional investigations using reversible models of EMT, revealed the mesenchymal-to-epithelial reverting transition (MErT) to be enriched in clinical samples of metastatic castrate resistant prostate cancer (mCRPC). From this enrichment, a metastasis-derived gene signature was identified that predicted more rapid cancer relapse and reduced survival across multiple human carcinoma types. Additionally, the transcriptional profile of MErT is not a simple mirror image of EMT as tumour cells retain a transcriptional "memory" following a reversible EMT. This memory was also enriched in mCRPC samples. Cumulatively, our studies reveal the transcriptional profile of epithelial-mesenchymal plasticity and highlight the unique transcriptional properties of MErT. Furthermore, our findings provide evidence to support the association of epithelial plasticity with poor clinical outcomes in multiple human carcinoma types.	[Stylianou, Nataly; Lehman, Melanie L.; Wang, Chenwei; Fard, Atefeh Taherian; Rockstroh, Anja; Jovanovic, Lidija; Sadowski, Martin C.; Williams, Elizabeth D.; Gunter, Jennifer H.; Nelson, Colleen C.; Hollier, Brett G.] Queensland Univ Technol, Australian Prostate Canc Res Ctr Queensland, Inst Hlth & Biomed Innovat, Fac Hlth,Sch Biomed Sci,Princess Alexandra Hosp,T, Brisbane, Qld, Australia; [Lehman, Melanie L.; Fazli, Ladan; Buttyan, Ralph; Gleave, Martin E.] Univ British Columbia, Dept Urol Sci, Vancouver Prostate Ctr, Vancouver, BC, Canada; [Ward, Micheal] Univ Queensland, Sch Med, Translat Res Inst, Glycat & Diabet Complicat Grp,Mater Res Inst, Brisbane, Qld, Australia; [Kashyap, Abhishek S.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Tissue Repair & Regenerat Program, Brisbane, Qld, Australia; [Westbrook, Thomas F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Queensland University of Technology (QUT); University of British Columbia; Mater Research; University of Queensland; Queensland University of Technology (QUT); Baylor College of Medicine	Hollier, BG (corresponding author), Queensland Univ Technol, Australian Prostate Canc Res Ctr Queensland, Inst Hlth & Biomed Innovat, Fac Hlth,Sch Biomed Sci,Princess Alexandra Hosp,T, Brisbane, Qld, Australia.	b.hollier@qut.edu.au	Fard, Ati/AAX-4092-2021; Williams, Elizabeth D/B-1538-2008; Gunter, Jennifer H/B-8960-2016; Stylianou, Nataly/GOP-1782-2022	Williams, Elizabeth D/0000-0002-3364-6655; Gunter, Jennifer H/0000-0003-2447-5732; Gleave, Martin/0000-0003-4235-0167; Sadowski, Martin/0000-0002-5267-1442; Taherian Fard, Atefeh/0000-0002-9126-4540; Stylianou, Nataly/0000-0002-8006-5730; Wang, Chenwei/0000-0002-2097-8634	Australian Government Department of Health; Queensland Government National and International Research Alliance Program; Movember Foundation; Prostate Cancer Foundation of Australia through a Movember Revolutionary Team Award; National Health and Medical Research Council of Australia [1100417]	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); Queensland Government National and International Research Alliance Program; Movember Foundation; Prostate Cancer Foundation of Australia through a Movember Revolutionary Team Award; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by funding from the Australian Government Department of Health, Queensland Government National and International Research Alliance Program funding to the Australian-Canadian Prostate Cancer Research Alliance as well as by the Movember Foundation and the Prostate Cancer Foundation of Australia through a Movember Revolutionary Team Award. This work was also supported by funding from the National Health and Medical Research Council of Australia (ID 1100417 to CC Nelson, BG Hollier, ML Lehman and ME Gleave).	Beltran H, 2014, CLIN CANCER RES, V20, P2846, DOI 10.1158/1078-0432.CCR-13-3309; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bishop JL, 2015, ENDOCR-RELAT CANCER, V22, pR165, DOI 10.1530/ERC-15-0137; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chikaish Y, 2011, ANTICANCER RES, V31, P4451; Colditz J, 2016, MOL CELL BIOCHEM, V421, P139, DOI 10.1007/s11010-016-2794-y; Cooperberg MR, 2013, J CLIN ONCOL, V31, P1428, DOI 10.1200/JCO.2012.46.4396; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; Du LT, 2016, CANCER MED-US, V5, P1962, DOI 10.1002/cam4.719; Dupuy F, 2015, CELL METAB, V22, P577, DOI 10.1016/j.cmet.2015.08.007; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hollier BG, 2013, CANCER RES, V73, P1981, DOI 10.1158/0008-5472.CAN-12-2962; Hoshino H, 2009, BIOCHEM BIOPH RES CO, V390, P1061, DOI 10.1016/j.bbrc.2009.10.117; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hugo HJ, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3580; Javaid S, 2013, CELL REP, V5, P1679, DOI 10.1016/j.celrep.2013.11.034; Kim RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035569; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; LaTulippe E, 2002, CANCER RES, V62, P4499; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Li HY, 2015, CELL SIGNAL, V27, P82, DOI 10.1016/j.cellsig.2014.09.018; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Ma ZF, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0042-9; Malek JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028561; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Miao L, 2017, CANCER RES, V77, P3101, DOI 10.1158/0008-5472.CAN-16-2169; Nouri M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00370; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Pereira L, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00013; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Roca H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076773; Rokavec M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04234-2; Sadowski MC, 2014, ONCOTARGET, V5, P9362, DOI 10.18632/oncotarget.2433; Schmidt JM, 2015, CELL REP, V10, P131, DOI 10.1016/j.celrep.2014.12.032; Sethi S, 2011, AM J TRANSL RES, V3, P90; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Shiota M, 2013, CANCER RES, V73, P3109, DOI 10.1158/0008-5472.CAN-12-3979; Sieh S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040217; Skrypek N, 2017, TRENDS GENET, V33, P943, DOI 10.1016/j.tig.2017.08.004; Sun YT, 2012, CANCER RES, V72, P527, DOI 10.1158/0008-5472.CAN-11-3004; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Tsuji T, 2008, CANCER RES, V68, P10377, DOI 10.1158/0008-5472.CAN-08-1444; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Ware KE, 2016, ONCOTARGET, V7, P50520, DOI 10.18632/oncotarget.10476; Yao RS, 2014, CANCER RES, V74, P5656, DOI 10.1158/0008-5472.CAN-14-0800; Ye X, 2017, NATURE, V547, pE1, DOI 10.1038/nature22816; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	69	49	50	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 14	2019	38	7					913	934		10.1038/s41388-018-0488-5	http://dx.doi.org/10.1038/s41388-018-0488-5			22	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HL3OH	30194451	hybrid, Green Published			2022-12-26	WOS:000458624900001
J	Yuki, R; Tatewaki, T; Yamaguchi, N; Aoyama, K; Honda, T; Kubota, S; Morii, M; Manabe, I; Kuga, T; Tomonaga, T; Yamaguchi, N				Yuki, Ryuzaburo; Tatewaki, Takashi; Yamaguchi, Noritaka; Aoyama, Kazumasa; Honda, Takuya; Kubota, Sho; Morii, Mariko; Manabe, Ichiro; Kuga, Takahisa; Tomonaga, Takeshi; Yamaguchi, Naoto			Desuppression of TGF-beta signaling via nuclear c-Abl-mediated phosphorylation of TIF1 gamma/TRIM33 at Tyr-524,-610, and-1048	ONCOGENE			English	Article							SRC-FAMILY KINASES; TYROSINE PHOSPHORYLATION; PROTEIN; CHROMATIN; ACTIVATION; TGF-BETA-1; MECHANISM; RECEPTOR; CANCER; SMAD4	Protein-tyrosine kinases regulate a broad range of intracellular processes occurring primarily just beneath the plasma membrane. With the greatest care to prevent dephosphorylation, we have shown that nuclear tyrosine phosphorylation regulates global chromatin structural states. However, the roles for tyrosine phosphorylation in the nucleus are poorly understood. Here we identify transcriptional intermediary factor 1-gamma (TIF1 gamma/TRIM33/Ectodermin), which suppresses transforming growth factor-beta (TGF-beta) signaling through the association with Smad2/3 transcription factor, as a new nuclear substrate of c-Abl tyrosine kinase. Replacement of the three tyrosine residues Tyr-524, -610, and -1048 with phenylalanine (3YF) inhibits c-Abl-mediated phosphorylation of TIF1. and enhances TIF1 gamma's association with Smad3. Importantly, knockdown-rescue experiments show that 3YF strengthens TIF1 gamma's ability to suppress TGF-beta signaling. Intriguingly, activation of c-Abl by epidermal growth factor (EGF) induces desuppression of TGF-beta signaling via enhancing the tyrosine phosphorylation level of TIF1 gamma. TGF-beta together with EGF synergistically provokes desuppressive responses of epithelial-tomesenchymal transition through tyrosine phosphorylation of TIF1 gamma. These results suggest that nuclear c-Abl-mediated tyrosine phosphorylation of TIF1 gamma has a desuppressive role in TGF-beta-Smad2/3 signaling.	[Yuki, Ryuzaburo; Tatewaki, Takashi; Yamaguchi, Noritaka; Aoyama, Kazumasa; Honda, Takuya; Kubota, Sho; Morii, Mariko; Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Mol Cell Biol, Chiba 2608675, Japan; [Yuki, Ryuzaburo; Manabe, Ichiro] Chiba Univ, Grad Sch Med, Lab Dis Biol & Mol Med, Chiba 2608670, Japan; [Kuga, Takahisa; Tomonaga, Takeshi] Natl Inst Biomed Innovat Hlth & Nutr, Lab Proteome Res, Osaka 5670085, Japan	Chiba University; Chiba University	Yamaguchi, N (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Lab Mol Cell Biol, Chiba 2608675, Japan.	nyama@faculty.chiba-u.jp	Kuga, Takahisa/AAX-9334-2020; Manabe, Ichiro/AAE-5105-2021	Honda, Takuya/0000-0002-7141-0088; Kubota, Sho/0000-0001-6119-1259	MEXT [15K07922, 16K08227]; Global COE Program from the MEXT; Program for Leading Graduate School (LGS) from the MEXT	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program from the MEXT; Program for Leading Graduate School (LGS) from the MEXT	We are grateful to Dr. Eli Canaani (Weizmann Institute of Science), Dr. Hiroyuki Miyoshi (RIKEN BRC, Tsukuba), Dr. Toshiki Tamura (National Institute of Infectious Diseases, Tokyo), and Dr. Masatoshi Tagawa (Chiba Cancer Center Research Institute, Chiba) for their materials. This work was supported in part by grantsin-aid for Scientific Research 15K07922 (to Naoto Y) and 16K08227 (to Noritaka Y), Global COE Program, and Program for Leading Graduate School (LGS) from the MEXT. KA and SK were G-COE Research Assistants. TH and M.M. were LGS Research Assistants. SK, TH, and MM are JSPS Research Fellows.	Agricola E, 2011, MOL CELL, V43, P85, DOI 10.1016/j.molcel.2011.05.020; Aoyama K, 2015, CELL BIOL INT, V39, P446, DOI 10.1002/cbin.10413; Aoyama K, 2013, EXP CELL RES, V319, P3251, DOI 10.1016/j.yexcr.2013.09.003; Aoyama K, 2011, EXP CELL RES, V317, P2874, DOI 10.1016/j.yexcr.2011.09.013; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Bergeron JJM, 2016, ANNU REV BIOCHEM, V85, P573, DOI 10.1146/annurev-biochem-060815-014659; Cans C, 2000, BIOCHEM PHARMACOL, V60, P1203, DOI 10.1016/S0006-2952(00)00434-2; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF1202, DOI 10.1152/ajprenal.00406.2005; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Fattet L, 2013, J CELL SCI, V126, P3713, DOI 10.1242/jcs.126748; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Grande M, 2002, J CELL SCI, V115, P4227, DOI 10.1242/jcs.00091; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Hasegawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116048; He JC, 2008, INVEST OPHTH VIS SCI, V49, P2936, DOI 10.1167/iovs.07-0900; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Herquel B, 2011, TRANSCR-AUSTIN, V2, P231, DOI 10.4161/trns.2.5.17725; Honda T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19599-1; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hunter T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020644; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Ishibashi K, 2013, J CELL SCI, V126, P625, DOI 10.1242/jcs.116277; Jia M., 2011, Experimental Oncology, V33, P170; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; Khatri A, 2016, J CELL SCI, V129, P9, DOI 10.1242/jcs.175521; Krainock M, 2016, J CLIN MED, V19, pE27; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kubota S, 2015, J BIOL CHEM, V290, P10891, DOI 10.1074/jbc.M115.643882; Kubota S, 2013, J BIOL CHEM, V288, P17871, DOI 10.1074/jbc.M112.437756; Kuki K, 2017, BIOCHEM BIOPH RES CO, V490, P1045, DOI 10.1016/j.bbrc.2017.06.163; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Morabito CJ, 2001, DEV BIOL, V234, P204, DOI 10.1006/dbio.2001.0254; Morii M, 2017, J BIOL CHEM, V292, P1648, DOI 10.1074/jbc.M116.753202; Morii M, 2015, CELL BIOL INT, V39, P923, DOI 10.1002/cbin.10460; Nasrollahi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18831; Obata Y, 2010, J CELL SCI, V123, P2649, DOI 10.1242/jcs.066266; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Quere R, 2014, P NATL ACAD SCI USA, V111, P10592, DOI 10.1073/pnas.1405546111; Saha Debabrata, 1999, Neoplasia (New York), V1, P508; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Schlessinger Joseph, 2014, Cold Spring Harb Perspect Biol, V6, DOI 10.1101/cshperspect.a008912; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Soeda S, 2013, EXP CELL RES, V319, P1382, DOI 10.1016/j.yexcr.2013.02.023; Sundqvist A, 2013, ONCOGENE, V32, P3606, DOI 10.1038/onc.2012.370; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Tamura T, 2000, INT IMMUNOL, V12, P1205, DOI 10.1093/intimm/12.8.1205; Uttamsingh S, 2008, ONCOGENE, V27, P2626, DOI 10.1038/sj.onc.1210915; Wang JYJ, 2014, MOL CELL BIOL, V34, P1188, DOI 10.1128/MCB.01454-13; Wang SN, 2010, AM J PHYSIOL-RENAL, V298, pF142, DOI 10.1152/ajprenal.00320.2009; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Yamaguchi N, 2001, J CELL SCI, V114, P1631; Yamaguchi N, 2017, J CELL BIOCHEM, V118, P1453, DOI 10.1002/jcb.25804; Yamaguchi N, 2015, BIOCHEM J, V471, P67, DOI 10.1042/BJ20150372; Yuki R, 2015, J CELL BIOCHEM, V116, P954, DOI 10.1002/jcb.25046	64	10	10	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 31	2019	38	5					637	655		10.1038/s41388-018-0481-z	http://dx.doi.org/10.1038/s41388-018-0481-z			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HJ6LI	30177833				2022-12-26	WOS:000457300300003
J	Lee, E; Ouzounova, M; Piranlioglu, R; Ma, MT; Guzel, M; Marasco, D; Chadli, A; Gestwicki, JE; Cowell, JK; Wicha, MS; Hassan, KA; Korkaya, H				Lee, Eunmi; Ouzounova, Maria; Piranlioglu, Raziye; Ma, Minh Thu; Guzel, Mustafa; Marasco, Daniela; Chadli, Ahmed; Gestwicki, Jason E.; Cowell, John K.; Wicha, Max S.; Hassan, Khaled A.; Korkaya, Hasan			The pleiotropic effects of TNF alpha in breast cancer subtypes is regulated by TNFAIP3/A20	ONCOGENE			English	Article							TUMOR-NECROSIS-FACTOR; ZINC-FINGER PROTEIN; NF-KAPPA-B; HSP70 PROTECTS; A20; CELLS; EXPRESSION; PROMOTES; BASAL; UBIQUITINATION	TNF alpha is a pleiotropic cytokine which fuels tumor cell growth, invasion, and metastasis in some malignancies, while in others it induces cytotoxic cell death. However, the molecular mechanism by which TNF alpha exerts its diverse effects on breast cancer subtypes remains elusive. Using in vitro assays and mouse xenografts, we show here that TNF alpha contributes to the aggressive properties of triple negative breast cancer (TNBC) cell lines via upregulation of TNFAIP3(A20). In a striking contrast, TNF alpha induces a potent cytotoxic cell death in luminal (ER+) breast cancer cell lines which fail to upregulate A20 expression. Overexpression of A20 not only protects luminal breast cancer cell lines from TNF alpha-induced cell death via inducing HSP70-mediated anti-apoptotic pathway but also promotes a robust EMT/CSC phenotype by activating the pStat3-mediated inflammatory signaling. Furthermore, A20 overexpression in luminal breast cancer cells induces aggressive metastatic properties in mouse xenografts via generating a permissive inflammatory microenvironment constituted by granulocytic-MDSCs. Collectively, our results reveal a mechanism by which A20 mediates pleiotropic effects of TNF alpha playing role in aggressive behaviors of TNBC subtype while its deficiency results in TNF alpha-induced apoptotic cell death in luminal breast cancer subtype.	[Lee, Eunmi; Ouzounova, Maria; Piranlioglu, Raziye; Ma, Minh Thu; Chadli, Ahmed; Cowell, John K.; Korkaya, Hasan] Augusta Univ, Dept Biochem & Mol Biol, Georgia Canc Ctr, Augusta, GA 30912 USA; [Guzel, Mustafa] Medipol Univ, Regenerat & Restorat Res Ctr REMER, Istanbul, Turkey; [Marasco, Daniela] Univ Naples Federico II, Dept Pharm, I-80134 Naples, Italy; [Gestwicki, Jason E.; Hassan, Khaled A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Wicha, Max S.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Ouzounova, Maria] CRCL, Dept Canc Cell Plast, Lyon, France	University System of Georgia; Augusta University; Istanbul Medipol University; University of Naples Federico II; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL)	Korkaya, H (corresponding author), Augusta Univ, Dept Biochem & Mol Biol, Georgia Canc Ctr, Augusta, GA 30912 USA.	hkorkaya@augusta.edu	Korkaya, Hasan/GRY-1016-2022; Ouzounova, Maria/B-7189-2014; Wicha, Max/AAE-7268-2019; Korkaya, Hasan/ABD-6282-2020	Ouzounova, Maria/0000-0001-8934-3461; Korkaya, Hasan/0000-0002-0719-5862; Piranlioglu, Raziye/0000-0003-2450-3887; Guzel, Prof. Mustafa/0000-0002-1423-0435	NCI NIH HHS [R35 CA197585] Funding Source: Medline; NINDS NIH HHS [R01 NS059690] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA197585] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bocchini Claire E, 2014, JAKSTAT, V3, pe970459, DOI 10.4161/21623988.2014.970459; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; da Silva CG, 2013, HEPATOLOGY, V57, P2014, DOI 10.1002/hep.26197; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Diao JJ, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0453-2; Gabai VL, 2016, CANCER RES, V76, P5926, DOI 10.1158/0008-5472.CAN-16-0800; Hadisaputri YE, 2017, INT J ONCOL, V50, P1002, DOI 10.3892/ijo.2017.3869; Hartman ZC, 2013, CANCER RES, V73, P3470, DOI 10.1158/0008-5472.CAN-12-4524-T; Hjelmeland AB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000319; JAATTELA M, 1992, EMBO J, V11, P3507, DOI 10.1002/j.1460-2075.1992.tb05433.x; Jia DY, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.319; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kim G, 2015, ONCOGENE, V34, P671, DOI 10.1038/onc.2014.4; Komander D, 2008, BIOCHEM J, V409, P77, DOI 10.1042/BJ20071399; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Korkaya H, 2011, CLIN CANCER RES, V17, P6125, DOI 10.1158/1078-0432.CCR-10-2743; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Kundrat L, 2010, J MOL BIOL, V395, P587, DOI 10.1016/j.jmb.2009.11.017; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee JH, 2017, NAT CELL BIOL, V19, P1260, DOI 10.1038/ncb3609; Mahat DB, 2016, MOL CELL, V62, P63, DOI 10.1016/j.molcel.2016.02.025; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Meng XZ, 2002, SHOCK, V17, P345, DOI 10.1097/00024382-200205000-00001; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; Ouzounova M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14979; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; Petrocca F, 2013, CANCER CELL, V24, P182, DOI 10.1016/j.ccr.2013.07.008; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Reeg S, 2016, FREE RADICAL BIO MED, V99, P153, DOI 10.1016/j.freeradbiomed.2016.08.002; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Van Molle W, 2002, IMMUNITY, V16, P685, DOI 10.1016/S1074-7613(02)00310-2; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wang YF, 2015, MOBILE SOCIAL NETWORKING AND COMPUTING: A MULTIDISCIPLINARY INTEGRATED PERSPECTIVE, P3; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; Zhong HH, 2016, CANCER RES, V76, P480, DOI 10.1158/0008-5472.CAN-15-0883	43	22	22	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 24	2019	38	4					469	482		10.1038/s41388-018-0472-0	http://dx.doi.org/10.1038/s41388-018-0472-0			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HI6UB	30166590	Green Accepted			2022-12-26	WOS:000456589800002
J	Howe, C; Ho, F; Nenninger, A; Raleiras, P; Stensjo, K				Howe, Christoph; Ho, Felix; Nenninger, Anja; Raleiras, Patricia; Stensjo, Karin			Differential biochemical properties of three canonical Dps proteins from the cyanobacterium Nostoc punctiforme suggest distinct cellular functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ferritin; DNA binding protein; iron; oxidative stress; reactive oxygen species (ROS); multifunctional protein; bacterial metabolism; cyanobacteria; metal homeostasis; DNA-binding proteins from starved cells	DNA-BINDING PROTEIN; SP PCC 7120; OXIDATIVE STRESS; MYCOBACTERIUM-SMEGMATIS; FERROXIDASE CENTER; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; GENE-EXPRESSION; METAL-BINDING	DNA-binding proteins from starved cells (Dps, EC: 1.16.3.1) have a variety of different biochemical activities such as DNA-binding, iron sequestration, and H2O2 detoxification. Most bacteria commonly feature one or two Dps enzymes, whereas the cyanobacterium Nostoc punctiforme displays an unusually high number of five Dps proteins (NpDps1-5). Our previous studies have indicated physiological differences, as well as cell-specific expression, among these five proteins. Three of the five NpDps proteins, NpDps1, -2, and -3, were classified as canonical Dps proteins. To further investigate their properties and possible importance for physiological function, here we characterized and compared them in vitro. Nondenaturing PAGE, gel filtration, and dynamic light-scattering experiments disclosed that the three NpDps proteins exist as multimeric protein species in the bacterial cell. We also demonstrate Dps-mediated iron oxidation catalysis in the presence of H2O2. However, no iron oxidation with O-2 as the electron acceptor was detected under our experimental conditions. In modeled structures of NpDps1, -2, and -3, protein channels were identified that could serve as the entrance for ferrous iron into the dodecameric structures. Furthermore, we could demonstrate pH-dependent DNA-binding properties for NpDps2 and -3. This study adds critical insights into the functions and stabilities of the three canonical Dps proteins from N. punctiforme and suggests that each of the Dps proteins within this bacterium has a specific biochemical property and function.	[Howe, Christoph; Ho, Felix; Nenninger, Anja; Raleiras, Patricia; Stensjo, Karin] Uppsala Univ, Dept Chem, Angstrom Lab, Mol Biomimet, SE-75120 Uppsala, Sweden; [Nenninger, Anja] Univ Exeter, Dept Biosci, Exeter, Devon, England; [Raleiras, Patricia] Medicago AB, Danmark Berga 13, SE-75598 Uppsala, Sweden	Uppsala University; University of Exeter	Stensjo, K (corresponding author), Uppsala Univ, Dept Chem, Angstrom Lab, Mol Biomimet, SE-75120 Uppsala, Sweden.	karin.stensjo@kemi.uu.se	Stensjo, Karin/E-3801-2017; Raleiras, Patrícia/A-2375-2016	Stensjo, Karin/0000-0001-6993-8476; Raleiras, Patrícia/0000-0001-7898-7827; Ho, Felix/0000-0001-7731-3396	NordForsk; NCoE Program [82845]; Swedish Energy Agency [11674-5]; Science for Life Laboratory, Mass Spectrometry Based Proteomics Facility in Uppsala	NordForsk; NCoE Program; Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Science for Life Laboratory, Mass Spectrometry Based Proteomics Facility in Uppsala	This work was supported by NordForsk, NCoE Program "NordAqua" project 82845, Swedish Energy Agency project 11674-5, and the Science for Life Laboratory, Mass Spectrometry Based Proteomics Facility in Uppsala. The authors declare that they have no conflicts of interest with the contents of this article.	Alaleona F, 2010, FEBS J, V277, P903, DOI 10.1111/j.1742-4658.2009.07532.x; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Ardini M, 2013, BBA-GEN SUBJECTS, V1830, P3745, DOI 10.1016/j.bbagen.2013.02.003; ARTISS JD, 1981, CLIN BIOCHEM, V14, P311, DOI 10.1016/S0009-9120(81)91065-1; BELKIN S, 1987, PLANT PHYSIOL, V84, P25, DOI 10.1104/pp.84.1.25; Bellapadrona G, 2009, J BIOL CHEM, V284, P19101, DOI 10.1074/jbc.M109.014670; Calhoun LN, 2011, J APPL MICROBIOL, V110, P375, DOI 10.1111/j.1365-2672.2010.04890.x; Campbell EL, 2007, J BACTERIOL, V189, P5247, DOI 10.1128/JB.00360-07; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Castruita M, 2006, APPL ENVIRON MICROB, V72, P2918, DOI 10.1128/AEM.72.4.2918-2924.2006; Ceci P, 2005, J BIOL CHEM, V280, P34776, DOI 10.1074/jbc.M502343200; Ceci P, 2004, NUCLEIC ACIDS RES, V32, P5935, DOI 10.1093/nar/gkh915; Ceci P, 2011, J BIOL INORG CHEM, V16, P869, DOI 10.1007/s00775-011-0784-9; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Chowdhury RP, 2008, BIOCHEMISTRY-US, V47, P11110, DOI 10.1021/bi801158e; Christman HD, 2011, J BACTERIOL, V193, P6874, DOI 10.1128/JB.05999-11; Cuypers MG, 2007, J MOL BIOL, V371, P787, DOI 10.1016/j.jmb.2006.11.032; de los Rios A, 2015, BIODIVERS CONSERV, V24, P841, DOI 10.1007/s10531-015-0907-7; Durham KA, 2002, J BASIC MICROB, V42, P367, DOI 10.1002/1521-4028(200212)42:6<367::AID-JOBM367>3.0.CO;2-T; Ekman M, 2014, ENVIRON MICROBIOL, V16, P829, DOI 10.1111/1462-2920.12233; FALKNER G, 1976, PLANT PHYSIOL, V58, P717, DOI 10.1104/pp.58.6.717; Fan RL, 2009, BIOCHEMISTRY-US, V48, P5623, DOI 10.1021/bi900387t; Franceschini S, 2006, FEBS J, V273, P4913, DOI 10.1111/j.1742-4658.2006.05490.x; Fujisawa T, 2017, NUCLEIC ACIDS RES, V45, pD551, DOI 10.1093/nar/gkw1131; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Gupta S, 2003, J BIOL CHEM, V278, P5235, DOI 10.1074/jbc.M208825200; Hahn A, 2015, ENVIRON MICROBIOL, V17, P767, DOI 10.1111/1462-2920.12516; Haikarainen T, 2010, CELL MOL LIFE SCI, V67, P341, DOI 10.1007/s00018-009-0168-2; HENNESSY DJ, 1984, CAN J CHEM, V62, P721, DOI 10.1139/v84-121; HINTERSTOISSER B, 1987, FEBS LETT, V217, P169, DOI 10.1016/0014-5793(87)80657-9; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Kauko A, 2006, J MOL BIOL, V364, P97, DOI 10.1016/j.jmb.2006.08.061; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Nguyen KH, 2012, BIOCHEMISTRY-US, V51, P6679, DOI 10.1021/bi300703x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li H, 2004, J BACTERIOL, V186, P3331, DOI 10.1128/JB.186.11.3331-3345.2004; Martinez A, 1997, J BACTERIOL, V179, P5188, DOI 10.1128/jb.179.16.5188-5194.1997; Meeks JC, 2002, ARCH MICROBIOL, V178, P395, DOI 10.1007/s00203-002-0476-5; Meeks JC, 2002, MICROBIOL MOL BIOL R, V66, P94, DOI 10.1128/MMBR.66.1.94-121.2002; Moparthi VK, 2016, BBA-BIOENERGETICS, V1857, P1766, DOI 10.1016/j.bbabio.2016.08.003; Morikawa K, 2006, GENES CELLS, V11, P409, DOI 10.1111/j.1365-2443.2006.00949.x; Oliveira Paulo, 2015, Life-Basel, V5, P130, DOI 10.3390/life5010130; Ow SY, 2009, J PROTEOME RES, V8, P187, DOI 10.1021/pr800285v; PENA MMO, 1995, ARCH MICROBIOL, V163, P337, DOI 10.1007/BF00404206; PENA MMO, 1995, J BIOL CHEM, V270, P22478, DOI 10.1074/jbc.270.38.22478; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Sato N, 2012, MICROBIOL-SGM, V158, P2527, DOI 10.1099/mic.0.060657-0; Schmidt R, 2009, MOL MICROBIOL, V72, P506, DOI 10.1111/j.1365-2958.2009.06666.x; Shcolnick S, 2009, PLANT PHYSIOL, V150, P2045, DOI 10.1104/pp.109.141853; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMITH FE, 1984, CLIN BIOCHEM, V17, P306, DOI 10.1016/S0009-9120(84)90613-1; Theoret JR, 2012, CLIN VACCINE IMMUNOL, V19, P1426, DOI 10.1128/CVI.00151-12; Yamamoto Y, 2002, J BACTERIOL, V184, P2931, DOI 10.1128/JB.184.11.2931-2939.2002; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	59	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16635	16646		10.1074/jbc.RA118.002425	http://dx.doi.org/10.1074/jbc.RA118.002425			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30171072	Green Published, hybrid			2022-12-26	WOS:000448515100008
J	Zheng, SQ; Chiu, H; Boudreau, J; Papanicolaou, T; Bendena, W; Ian, CS				Zheng, Shanqing; Chiu, Hilton; Boudreau, Jeffrey; Papanicolaou, Tony; Bendena, William; Ian Chin-Sang			A functional study of all 40 Caenorhabditis elegans insulin-like peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin; insulin-like growth factor (IGF); Caenorhabditis elegans (C; elegans); aging; cell division; C; elegans; dauer formation; fat accumulation; insulin like peptides; L1 arrest	C-ELEGANS; ENVIRONMENTAL CUES; RECEPTOR; PROTEINS; GROWTH; DISTINCT; ARREST; FAMILY; MEMBER; ACTS	The human genome encodes 10 insulin-like genes, whereas the Caenorhabditis elegans genome remarkably encodes 40 insulin-like genes. Knockout strategies to determine the roles of all the insulin/insulin-like peptide ligands (INS) in C. elegans has been challenging due to functional redundancy. Here, we individually overexpressed each of the 40 ins genes pan-neuronally, and monitored multiple phenotypes including: L1 arrest life span, neuroblast divisions under L1 arrest, dauer formation, and fat accumulation, as readouts to characterize the functions of each INS in vivo. Of the 40 INS peptides, we found functions for 35 INS peptides and functionally categorized each as agonists, antagonists, or of pleiotropic function. In particular, we found that 9 of 16 agonistic INS peptides shortened L1 arrest life span and promoted neuroblast divisions during L1 arrest. Our study revealed that a subset of -class INS peptides that contain a distinct F peptide sequence are agonists. Our work is the first to categorize the structures of INS peptides and relate these structures to the functions of all 40 INS peptides in vivo. Our findings will promote the study of insulin function on development, metabolism, and aging-related diseases.	[Zheng, Shanqing; Chiu, Hilton; Boudreau, Jeffrey; Papanicolaou, Tony; Bendena, William; Ian Chin-Sang] Queens Univ, Dept Biol, 116 Barrie St, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Ian, CS (corresponding author), Queens Univ, Dept Biol, 116 Barrie St, Kingston, ON K7L 3N6, Canada.	chinsang@queensu.ca		Zheng, Shanqing/0000-0002-5039-0196	Natural Sciences and Engineering Research Council of Canada [NSERC 249779]; Canadian Institutes of Health Research Grant [CIHR 130541]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant NSERC 249779 and Canadian Institutes of Health Research Grant CIHR 130541. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ailion M, 2003, GENETICS, V165, P127; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Anisimov VN, 2013, CRIT REV ONCOL HEMAT, V87, P201, DOI 10.1016/j.critrevonc.2013.01.005; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Armakolas A, 2015, MOL MED, V21, P167, DOI 10.2119/molmed.2014.00222; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Baugh LR, 2013, GENETICS, V194, P539, DOI 10.1534/genetics.113.150847; BRENNER S, 1974, GENETICS, V77, P71; Chen YT, 2014, DEV BIOL, V394, P314, DOI 10.1016/j.ydbio.2014.08.002; Chin-Sang ID, 1999, CELL, V99, P781, DOI 10.1016/S0092-8674(00)81675-X; Clark SG, 2003, DEVELOPMENT, V130, P3781, DOI 10.1242/dev.00571; Cornils A, 2011, DEVELOPMENT, V138, P1183, DOI 10.1242/dev.060905; de Abreu DAF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004225; Delaney CE, 2017, DEVELOPMENT, V144, P1273, DOI 10.1242/dev.145722; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Dlakic M, 2002, CURR BIOL, V12, pR155, DOI 10.1016/S0960-9822(02)00729-7; Duret L, 1998, GENOME RES, V8, P348, DOI 10.1101/gr.8.4.348; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Fukuyama M, 2015, CURR BIOL, V25, P1241, DOI 10.1016/j.cub.2015.03.016; Fukuyama M, 2012, BIOL OPEN, V1, P929, DOI 10.1242/bio.2012836; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Gonzalez JP, 2009, BIOSYSTEMS, V95, P7, DOI 10.1016/j.biosystems.2008.06.003; Horikawa M, 2010, MOL CELL ENDOCRINOL, V323, P183, DOI 10.1016/j.mce.2010.03.004; Hou NS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00143; Hua QX, 2003, GENE DEV, V17, P826, DOI 10.1101/gad.1058003; Hung WL, 2014, DEVELOPMENT, V141, P1767, DOI 10.1242/dev.103846; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Kaplan REW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005731; Kawano T, 2000, BIOCHEM BIOPH RES CO, V273, P431, DOI 10.1006/bbrc.2000.2971; Kodama E, 2006, GENE DEV, V20, P2955, DOI 10.1101/gad.1479906; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Matsunaga Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2168, DOI 10.1271/bbb.120540; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Murphy Coleen T, 2013, WormBook, P1, DOI 10.1895/wormbook.1.164.1; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007; Ritter AD, 2013, GENOME RES, V23, P954, DOI 10.1101/gr.150466.112; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Wahren J, 2000, AM J PHYSIOL-ENDOC M, V278, pE759, DOI 10.1152/ajpendo.2000.278.5.E759; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Zheng SQ, 2016, METHODS MOL BIOL, P307, DOI 10.1007/978-1-4939-3299-3_17	49	39	39	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16912	16922		10.1074/jbc.RA118.004542	http://dx.doi.org/10.1074/jbc.RA118.004542			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30206121	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000448515100030
J	Elkhadragy, L; Alsaran, H; Morel, M; Long, WW				Elkhadragy, Lobna; Alsaran, Hadel; Morel, Marion; Long, Weiwen			Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular signal-regulated kinase (ERK); cell migration; cell invasion; lung cancer; mitogen-activated protein kinase (MAPK); activation loop phosphorylation	PROTEIN-KINASES; EXPRESSION; MIGRATION; PATHWAY; SIGNAL; MICE; COACTIVATOR; PROGRESSION; CARCINOMA; MAPKS	ERK3 is an atypical mitogen-activated protein kinase (MAPK) that has recently gained interest for its role in promoting cancer cell migration and invasion. However, the molecular regulation of ERK3 functions in cancer cells is largely unknown. ERK3 has a single phospho-acceptor site (Ser(189)) in its activation motif rather than the TXY conserved in conventional MAPKs such as ERK1/2. Although dual phosphorylation of the TXY motif is known to be critical for the activation of conventional MAPKs, the role of Ser(189) phosphorylation in ERK3 activity and its function in cancer cells remain elusive. In this study, we revealed that activation loop phosphorylation is important for ERK3 in promoting cancer cell invasiveness, as the S189A mutation greatly decreased the ability of ERK3 to promote migration and invasion of lung cancer cells. Interestingly, a catalytically inactive ERK3 mutant was still capable of increasing migration and invasion, although to a lesser extent compared with WT ERK3, suggesting that ERK3 promotes cancer cell invasiveness by both kinase-dependent and kinase-independent mechanisms. To elucidate how the S189A mutation reduces the invasiveness-promoting ability of ERK3, we tested its effect on the kinase activity of ERK3 toward steroid receptor coactivator 3 (SRC3), a recently identified substrate of ERK3 critical for cancer cell invasiveness. Compared with ERK3, ERK3-S189A exhibited a dramatic decrease in kinase activity toward SRC3 and a concomitantly reduced ability to stimulate matrix metalloproteinase expression. Taken together, our study unravels the importance of Ser(189) phosphorylation for intramolecular regulation of ERK3 kinase activity and invasiveness-promoting ability in lung cancer cells.	[Elkhadragy, Lobna; Alsaran, Hadel; Morel, Marion; Long, Weiwen] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Long, WW (corresponding author), 112 Diggs Lab,3640 Colonel Glenn Hwy, Dayton, OH 45435 USA.	weiwen.long@wright.edu	Elkhadragy, Lobna/ABD-1314-2020; Morel, Marion/X-4104-2019	Elkhadragy, Lobna/0000-0001-8956-298X; Morel, Marion/0000-0002-1439-5360	Wright State University; NCI, National Institutes of Health [1R01CA193264-01]; Biomedical Sciences Ph.D. Program of Wright State University; NATIONAL CANCER INSTITUTE [R01CA193264] Funding Source: NIH RePORTER	Wright State University; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biomedical Sciences Ph.D. Program of Wright State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a start-up fund of Wright State University and NCI, National Institutes of Health grant 1R01CA193264-01 (to W. L.) and by the Biomedical Sciences Ph.D. Program of Wright State University (to L. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Mahdi R, 2015, CELL ADHES MIGR, V9, P483, DOI 10.1080/19336918.2015.1112485; Alsaran H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15135-9; Bian K, 2016, ONCOTARGET, V7, P6665, DOI 10.18632/oncotarget.6682; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cheng M, 1996, J BIOL CHEM, V271, P8951, DOI 10.1074/jbc.271.15.8951; Coulombe P, 2002, ANAL BIOCHEM, V310, P219, DOI 10.1016/S0003-2697(02)00319-6; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Crowe DL, 2004, INT J ONCOL, V24, P1159; De la Mota-Peynado A, 2011, J BIOL CHEM, V286, P13603, DOI 10.1074/jbc.M110.181743; Deleris P, 2008, J CELL PHYSIOL, V217, P778, DOI 10.1002/jcp.21560; Deleris P, 2011, J BIOL CHEM, V286, P6470, DOI 10.1074/jbc.M110.181529; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Julien C, 2003, J BIOL CHEM, V278, P42615, DOI 10.1074/jbc.M302724200; Klinger S, 2009, P NATL ACAD SCI USA, V106, P16710, DOI 10.1073/pnas.0900919106; Kostenko Sergiy, 2012, J Mol Signal, V7, P9, DOI 10.1186/1750-2187-7-9; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Liang B, 2005, WORLD J GASTROENTERO, V11, P623, DOI 10.3748/wjg.v11.i5.623; Ling SB, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0424-0; Long WW, 2012, J CLIN INVEST, V122, P1869, DOI 10.1172/JCI61492; Marquis M, 2014, MOL CELL BIOL, V34, P3374, DOI 10.1128/MCB.01701-13; Marquis M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086681; Perander M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43471; Rai R, 2004, ORAL ONCOL, V40, P705, DOI 10.1016/j.oraloncology.2004.01.010; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Wang W, 2014, J CELL PHYSIOL, V229, P1529, DOI 10.1002/jcp.24596; Xiang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111410; Yan J, 2006, ACTA PHARMACOL SIN, V27, P387, DOI 10.1111/j.1745-7254.2006.00315.x; Yan J, 2008, CANCER RES, V68, P5460, DOI 10.1158/0008-5472.CAN-08-0955	32	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16193	16205		10.1074/jbc.RA118.003699	http://dx.doi.org/10.1074/jbc.RA118.003699			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30166347	hybrid, Green Published			2022-12-26	WOS:000447833600008
J	Jeong, O; Kim, HG; Ryu, SY; Park, YK; Jung, MR				Jeong, Oh; Kim, Ho Goon; Ryu, Seong Yeob; Park, Young Kyu; Jung, Mi Ran			Adverse prognostic impact of splenectomy on survival in gastric carcinoma patients: Regression and propensity score matching analysis of 1074 patients	PLOS ONE			English	Article							TOTAL GASTRECTOMY; SPLEEN PRESERVATION; RADICAL SURGERY; LYMPH-NODE; CANCER; VETERANS; OUTCOMES; COHORT; TRIAL; RISK	Backgrounds Patients with proximal gastric carcinoma undergo total gastrectomy with concomitant splenectomy to ensure the complete removal of splenic hilar lymph nodes. However, the impact of splenectomy on survival remains uncertain. This study aimed to investigate the impact of splenectomy on survival among patients with gastric carcinoma. Methods Of 1074 patients who underwent total gastrectomy for proximal gastric carcinoma between 2006 and 2014, 229 patients underwent concomitant splenectomy or pancreaticosplenectomy during surgery. We investigated the prognostic impact of splenectomy using a regression and propensity score matched model. Results The splenectomy and non-splenectomy groups differed in many baseline characteristics, including tumor stage, and had respective crude 5-year survival rates of 55% and 81% (p<0.001). In a multivariate analysis adjusted for TNM stage and other prognostic factors, splenectomy was an independent poor prognostic factor for overall survival (hazard ratio [HR] = 1.67, 95% confidence interval [CI] = 1.11-2.51) and disease-free survival (HR = 1.61, 95% CI = 1.24-2.10). A survival evaluation stratified by TNM stage showed that splenectomy adversely affected survival among patients with stage III, but not stage I, II, and IV disease. In the propensity score-matched sample, splenectomy group also showed significantly worse overall survival (5-year, 65% vs. 79%, p = 0.010) and disease-free survival (5-year, 55% vs. 72%, p = 0.025) and was an independent poor prognostic factor in a multivariate analysis adjusting TNM stage and other prognostic factors. Conclusions Splenectomy adversely affects survival, particularly among patients with stage III gastric carcinoma, and should be avoided unless there is direct invasion to the splenic hilum.	[Jeong, Oh; Kim, Ho Goon; Ryu, Seong Yeob; Park, Young Kyu; Jung, Mi Ran] Chonnam Natl Univ, Dept Surg, Sch Med, Jeollanam Do, South Korea	Chonnam National University	Ryu, SY (corresponding author), Chonnam Natl Univ, Dept Surg, Sch Med, Jeollanam Do, South Korea.	surgeonjeong@gmail.com		Jeong, Oh/0000-0002-7076-6998				Aoyagi K, 2010, WORLD J HEPATOL, V2, P81, DOI 10.4254/wjh.v2.i2.81; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Cadili A, 2008, AM J MED, V121, P371, DOI 10.1016/j.amjmed.2008.02.014; Chen XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099650; Csendes A, 2002, SURGERY, V131, P401, DOI 10.1067/msy.2002.121891; Fatouros M, 2005, ANTICANCER RES, V25, P3023; GRIFFITH JP, 1995, GUT, V36, P684, DOI 10.1136/gut.36.5.684; HULL CC, 1988, ARCH SURG-CHICAGO, V123, P462; Ito H, 2013, ANTICANCER RES, V33, P277; Japanese Gastr Canc Assoc, 2021, GASTRIC CANCER, V24, P1, DOI [10.1007/s10120-020-01042-y, 10.1007/s10120-016-0622-4]; Karimi P, 2014, CANCER EPIDEM BIOMAR, V23, P700, DOI 10.1158/1055-9965.EPI-13-1057; Kristinsson SY, 2014, HAEMATOLOGICA, V99, P392, DOI 10.3324/haematol.2013.092460; Kwon SJ, 1997, WORLD J SURG, V21, P837, DOI 10.1007/s002689900314; Linet MS, 1996, AM J SURG, V172, P320, DOI 10.1016/S0002-9610(96)00196-1; MAEHARA Y, 1991, CANCER, V67, P3006, DOI 10.1002/1097-0142(19910615)67:12<3006::AID-CNCR2820671213>3.0.CO;2-V; MELLEMKJAER L, 1995, CANCER, V75, P577, DOI 10.1002/1097-0142(19950115)75:2<577::AID-CNCR2820750222>3.0.CO;2-K; OBRIEN PC, 1987, BIOMETRICS, V43, P169, DOI 10.2307/2531957; Oh SJ, 2009, J SURG ONCOL, V99, P275, DOI 10.1002/jso.21229; Otsuji E, 1999, BRIT J CANCER, V79, P1789, DOI 10.1038/sj.bjc.6690285; ROBINETTE CD, 1977, LANCET, V2, P127; Sano T, 2017, ANN SURG, V265, P277, DOI 10.1097/SLA.0000000000001814; Shin SH, 2009, ANN SURG ONCOL, V16, P1304, DOI 10.1245/s10434-009-0389-5; Sobin LH, 2011, TNM CLASSIFICATION M; Wanebo HJ, 1997, J AM COLL SURGEONS, V185, P177, DOI 10.1016/S1072-7515(01)00901-2; YAMAGISHI H, 1980, SURGERY, V87, P655; Yu W, 2006, BRIT J SURG, V93, P559, DOI 10.1002/bjs.5353; Zhang CH, 2007, ANN SURG ONCOL, V14, P1312, DOI 10.1245/s10434-006-9190-x	27	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203820	10.1371/journal.pone.0203820	http://dx.doi.org/10.1371/journal.pone.0203820			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204783	Green Published, gold, Green Submitted			2022-12-26	WOS:000444355500044
J	Kaur, N; Cooper, WR; Duringer, JM; Badillo-Vargas, IE; Esparza-Diaz, G; Rashed, A; Horton, DR				Kaur, Navneet; Cooper, William Rodney; Duringer, Jennifer M.; Badillo-Vargas, Ismael E.; Esparza-Diaz, Gabriela; Rashed, Arash; Horton, David R.			Survival and development of potato psyllid (Hemiptera: Triozidae) on Convolvulaceae: Effects of a plant-fungus symbiosis (Periglandula)	PLOS ONE			English	Article							BACTERICERA-COCKERELLI; ERGOT ALKALOIDS; 3 HAPLOTYPES; HOST-PLANT; UNITED-STATES; ENDOPHYTES; PSYLLOIDEA; GRASSES; INSECT; CLAVICIPITACEAE	Plant species in the family Solanaceae are the usual hosts of potato psyllid, Bactericera cockerelli (Sulc) (Hemiptera: Psylloidea: Triozidae). However, the psyllid has also been shown to develop on some species of Convolvulaceae (bindweeds and morning glories). Developmental success on Convolvulaceae is surprising given the rarity of psyllid species worldwide associated with this plant family. We assayed 14 species of Convolvulaceae across four genera (Convolvulus, Calystegia, Ipomoea, Turbina) to identify species that allow development of potato psyllid. Two populations of psyllids were assayed (Texas, Washington). The Texas population overlaps extensively with native Convolvulaceae, whereas Washington State is noticeably lacking in Convolvulaceae. Results of assays were overlain on a phylogenetic analysis of plant species to examine whether Convolvulaceae distantly related to the typical host (potato) were less likely to allow development than species of Convolvulaceae more closely related. Survival was independent of psyllid population and location of the plant species on our phylogenetic tree. We then examined whether presence of a fungal symbiont of Convolvulaceae (Periglandula spp.) affected psyllid survival. These fungi associate with Convolvulaceae and produce a class of mycotoxins (ergot alkaloids) that may confer protection against plant-feeding arthropods. Periglandula was found in 11 of our 14 species, including in two genera (Convolvulus, Calystegia) not previously known to host the symbiont. Of these 11 species, leaf tissues from five contained large quantities of two classes of ergot alkaloids (clavines, amides of lysergic acid) when evaluated by LC-MS/MS. All five species also harbored Periglandula. No ergot alkaloids were detected in species free of the fungal symbiont. Potato psyllid rapidly died on the five species that harbored Periglandula and contained ergot alkaloids, but survived to adulthood on seven of the nine species in which ergot alkaloids were not detected. These results support the hypothesis that a plant fungus symbiotic relationship affects the suitability of certain Convolvulaceae to potato psyllid.	[Kaur, Navneet; Rashed, Arash] Univ Idaho, Dept Entomol Plant Pathol & Nematol, Moscow, ID 83843 USA; [Kaur, Navneet; Cooper, William Rodney; Horton, David R.] USDA ARS, Temperate Tree Fruit & Vegetable Res Unit, Wapato, WA 98951, Australia; [Duringer, Jennifer M.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Badillo-Vargas, Ismael E.; Esparza-Diaz, Gabriela] Texas A&M AgriLife Res & Extens Ctr, Dept Entomol, Weslaco, TX USA; [Esparza-Diaz, Gabriela] AmerStem Inc, Camarillo, CA USA	Idaho; University of Idaho; Oregon State University; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Kaur, N (corresponding author), Univ Idaho, Dept Entomol Plant Pathol & Nematol, Moscow, ID 83843 USA.; Kaur, N (corresponding author), USDA ARS, Temperate Tree Fruit & Vegetable Res Unit, Wapato, WA 98951, Australia.	Navneet.kaur2@ars.usda.gov	Kaur, Navneet/J-4395-2019; Esparza-Diaz, Gabriela/AAA-1203-2020; Cooper, William/ABB-1389-2020; Díaz, Gabriela Esparza/E-2299-2012	Kaur, Navneet/0000-0001-5211-0437; Esparza-Diaz, Gabriela/0000-0002-0852-2570; Cooper, William/0000-0001-7983-3627; Craig, Morrie/0000-0001-8566-8875	ARS Federal-State Partnership Potato Research Grants program; Northwest Potato Research Consortium; USDA-NIFA-SCRI [2015-51181-24292]	ARS Federal-State Partnership Potato Research Grants program; Northwest Potato Research Consortium; USDA-NIFA-SCRI	This work was supported by the ARS Federal-State Partnership Potato Research Grants program, the Northwest Potato Research Consortium, and USDA-NIFA-SCRI (#2015-51181-24292) to DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor-Prats Diego, 1993, Chemoecology, V4, P55, DOI 10.1007/BF01245897; AMORPRATS D, 1993, BIOCHEM SYST ECOL, V21, P455, DOI 10.1016/0305-1978(93)90104-Y; AUSTIN D F, 1990, SIDA Contributions to Botany, V14, P273; Austin DF, 1996, TAXON, V45, P3, DOI 10.2307/1222581; Bacetty AA, 2009, PHYTOPATHOLOGY, V99, P1336, DOI 10.1094/PHYTO-99-12-1336; Beaulieu WT, 2015, MYCOLOGIA, V107, P667, DOI 10.3852/14-239; Beaulieu WT, 2013, J CHEM ECOL, V39, P919, DOI 10.1007/s10886-013-0314-z; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; Brem D, 2002, OIKOS, V96, P281, DOI 10.1034/j.1600-0706.2002.960210.x; Brown A.A., 2013, THESIS; BRUMMITT R K, 1980, Kew Bulletin, V35, P327, DOI 10.2307/4114579; Brummitt R. K., 2007, FLOWERING PLANT FAMI, P108; Brummitt R. K, 1963, THESIS; Brummitt RK, 2002, CALYSTEGIA SILVATICA; Burckhardt D, 2014, FLA ENTOMOL, V97, P242, DOI 10.1653/024.097.0132; Capinera JL., 2001, HDB VEGETABLE PESTS; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Cheplick GP, 2009, ECOLOGY EVOLUTION GR; CLAY K, 1989, J CHEM ECOL, V15, P169, DOI 10.1007/BF02027781; Clay K, 2002, AM NAT, V160, pS99, DOI 10.1086/342161; CLAY K, 1988, ECOLOGY, V69, P10, DOI 10.2307/1943155; Clay K, 2009, MYCOL SER, V27, P9; Cooper WR, 2015, ANN ENTOMOL SOC AM, V108, P137, DOI 10.1093/aesa/sau048; Eich E., 2008, SOLANACEAE CONVOLVUL, P33; Eserman LA, 2014, AM J BOT, V101, P92, DOI 10.3732/ajb.1300207; Faeth SH, 2002, OIKOS, V98, P25, DOI 10.1034/j.1600-0706.2002.980103.x; Florea S, 2017, PHYTOPATHOLOGY, V107, P504, DOI 10.1094/PHYTO-12-16-0435-RVW; Gallinger J, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00484; Horton DR, 2017, P ENTOMOL SOC WASH, V119, P191, DOI 10.4289/0013-8797.119.2.191; Horton David R., 2015, American Entomologist, V61, P234, DOI 10.1093/ae/tmv047; Horton David R., 2014, Journal of the Entomological Society of British Columbia, V111, P1; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Jensen A. S., 2012, P 12 ANN SCRI ZEBR C; Kartesz JT, 2011, N AM PLANT ATLAS; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KNOWLTON GEORGE F., 1934, JOUR ECON ENT, V27, P547, DOI 10.1093/jee/27.2.547; Kucht S, 2004, PLANTA, V219, P619, DOI 10.1007/s00425-004-1261-2; Leistner E, 2018, MYCOTA, P131; Liu D, 2007, ENTOMOL EXP APPL, V123, P35, DOI 10.1111/j.1570-7458.2007.00521.x; Malinowski DP, 2000, CROP SCI, V40, P923, DOI 10.2135/cropsci2000.404923x; Martin Nicholas A., 2008, Weta, V35, P12; McDonald J.A, 1995, HARVARD PAP BOT, V1, P97; Munyaneza JE, 2012, AM J POTATO RES, V89, P329, DOI 10.1007/s12230-012-9262-3; Mustafa T, 2015, ENVIRON ENTOMOL, V44, P593, DOI 10.1093/ee/nvv018; Mustafa T, 2015, ENVIRON ENTOMOL, V44, P300, DOI 10.1093/ee/nvu029; Ouvrard D., 2017, PSYLLIST WORLD PSYLL; Ouvrard D, 2015, SYST BIODIVERS, V13, P434, DOI 10.1080/14772000.2015.1046969; Panaccione DG, 2014, FUNCT ECOL, V28, P299, DOI 10.1111/1365-2435.12076; Percy DM, 2004, SYST BIOL, V53, P120, DOI 10.1080/10635150490264996; Percy DM, 2003, J NAT HIST, V37, P397, DOI [10.1080/00222930110096528, 10.1080/713834706]; Pletsch D. J, 1947, BULLETIN, V446; Potter DA, 2008, ENTOMOL EXP APPL, V126, P138, DOI 10.1111/j.1570-7458.2007.00650.x; Prager SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094047; Puketapu A, 2011, P AG SOC NZ, V41, P167; Rice C, 2012, ACSESS PUBL, P35, DOI 10.2134/2012.generalized-linear-mixed-models.c3; Richards B.L, 1928, PHYTOPATHOLOGY, V18, P140; Richards BL, 1933, J AGRIC RES, V46, P0189; ROMNEY V. E., 1939, JOUR ECON ENT, V32, P150, DOI 10.1093/jee/32.1.150; Saikkonen K, 2004, TRENDS PLANT SCI, V9, P275, DOI 10.1016/j.tplants.2004.04.005; Schardl CL, 2006, ALKALOIDS-CHEM BIOL, V63, P45, DOI 10.1016/S1099-4831(06)63002-2; Shymanovich T, 2015, J CHEM ECOL, V41, P93, DOI 10.1007/s10886-014-0534-x; Statistical Analysis Systems Institute, 2016, SAS VERS 9 4; Stefanovic S, 2003, SYST BOT, V28, P791; Steiner U, 2015, TOXINS, V7, P1355, DOI 10.3390/toxins7041355; Steiner U, 2011, MYCOLOGIA, V103, P1133, DOI 10.3852/11-031; Steiner U, 2008, PLANT SIGNAL BEHAV, V3, P704, DOI 10.4161/psb.3.9.6432; Sulyok M, 2007, ANAL BIOANAL CHEM, V389, P1505, DOI 10.1007/s00216-007-1542-2; Swisher KD, 2013, SOUTHWEST ENTOMOL, V38, P201, DOI 10.3958/059.038.0205; Swisher KD, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu023; Swisher KD, 2013, ENVIRON ENTOMOL, V42, P381, DOI 10.1603/EN12261; Swisher KD, 2012, ENVIRON ENTOMOL, V41, P1019, DOI 10.1603/EN12066; Teulon D. A. J., 2009, New Zealand Plant Protection, V62, P136; Thinakaran J, 2017, AM J POTATO RES, V94, P490, DOI 10.1007/s12230-017-9586-0; US Food and Drug Administration (USFDA), 2001, GUID IND BIOAN METH; Wallis R. L., 1955, USDA TECHNICAL B, V1107; White Jr JF, 2003, CLAVICIPITALEAN FUNG; Wood JRI, 2015, PHYTOKEYS, V51, P1, DOI 10.3897/phytokeys.51.7104; Yu J, 2011, J SYST EVOL, V49, P176, DOI 10.1111/j.1759-6831.2011.00134.x; Zhang YP, 1998, J VIROL METHODS, V71, P45, DOI 10.1016/S0166-0934(97)00190-0	79	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0201506	10.1371/journal.pone.0201506	http://dx.doi.org/10.1371/journal.pone.0201506			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204748	Green Submitted, gold, Green Published			2022-12-26	WOS:000444355500003
J	Sindhu, A; Janick-Buckner, D; Buckner, B; Gray, J; Zehr, U; Dilkes, BP; Johal, GS				Sindhu, Anoop; Janick-Buckner, Diane; Buckner, Brent; Gray, John; Zehr, Usha; Dilkes, Brian P.; Johal, Gurmukh S.			Propagation of cell death in dropdead1, a sorghum ortholog of the maize lls1 mutant	PLOS ONE			English	Article							DISEASE LESION MIMICS; CHLOROPHYLL BREAKDOWN; NEGATIVE REGULATOR; SINGLET OXYGEN; GENE; PHEOPHORBIDE; BIOSYNTHESIS; RESISTANCE; ACTIVATION; INITIATION	We describe dropdeadl-1 (ded1), an EMS-induced recessive lesion mimic mutant of sorghum. It is characterized by the formation of spreading necrotic lesions that share many attributes with those associated with the maize lethal leaf spot1 (lls1) and Arabidopsis accelerated cell death1 (acd1) mutation. We show that as in lls1, ded1 lesions are initiated by wounding and require light for continued propagation, and that loss of chloroplast integrity is responsible for ded1 cell death. Consistent with these parallels, we demonstrate that ded1 is an ortholog of lls1 and encodes pheophorbide a oxidase (PaO) with 93% identity at the protein level. The mutant ded1 allele resulted from a stop codon-inducing single base pair change in exon 6 of the sorghum ortholog of lls1. The ded1 transcript was rapidly and transiently induced after wounding and substantially elevated in leaves containing ded1 lesions. Given that PaO is a key enzyme of the chlorophyll degradation pathway, its dysfunction would result in the accumulation of pheophorbide, a potent photosensitizer that results in the production of singlet oxygen. Consistent with this, cell death associated with ded1 lesions is most likely caused by singlet oxygen as our results exclude superoxide and H2O2 from this role. We explore the signal responsible for the propagation of lesions affecting both ded1 and lls1 lesions and find that both developmental age and ethylene increase the rate of lesion expansion in both mutants.	[Sindhu, Anoop; Johal, Gurmukh S.] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Janick-Buckner, Diane; Buckner, Brent] Truman State Univ, Dept Biol, Kirksville, MO USA; [Gray, John] Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Zehr, Usha] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Dilkes, Brian P.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Dilkes, Brian P.; Johal, Gurmukh S.] Purdue Univ, Ctr Plant Biol, W Lafayette, IN 47907 USA; [Sindhu, Anoop] CHS Sunflower, Grandin, ND USA; [Zehr, Usha] MAHYCO Res Ctr, Dawalwadi, Maharashtra, India	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University System of Ohio; University of Toledo; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Johal, GS (corresponding author), Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA.; Johal, GS (corresponding author), Purdue Univ, Ctr Plant Biol, W Lafayette, IN 47907 USA.	gjohal@purdue.edu	Gray, John/O-7744-2018; Dilkes, Brian/C-9293-2012	Gray, John/0000-0003-1352-2900; Dilkes, Brian/0000-0003-2799-954X	National Science Foundation Plant Genome Research Program [1444503]; Agriculture Research Program at Purdue University	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Agriculture Research Program at Purdue University	The work presented was supported by grant number 1444503 from the National Science Foundation Plant Genome Research Program (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1444503) to GSJ and BPD and The Agriculture Research Program at Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G.N., 2005, PLANT PATHOL, P922, DOI DOI 10.1016/J.PLANTSCI.2005.02.019; Bonardi V, 2011, P NATL ACAD SCI USA, V108, P16463, DOI 10.1073/pnas.1113726108; Bruggeman Q, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00024; Buckner B, 1998, TRENDS PLANT SCI, V3, P218, DOI 10.1016/S1360-1385(98)01254-0; BUCKNER B, 1990, PLANT CELL, V2, P867, DOI 10.1105/tpc.2.9.867; Campbell MA, 2005, MOL PLANT PATHOL, V6, P11, DOI 10.1111/1468-0025.00206-i1; Dangl JL, 1996, PLANT CELL, V8, P1793, DOI 10.1105/tpc.8.10.1793; Danon A, 2005, PLANT J, V41, P68, DOI 10.1111/j.1365-313X.2004.02276.x; Dellaporta S., 1994, MAIZE HDB, P776, DOI [10.1007/978-1-4612-2694-9, DOI 10.1007/978-1-4612-2694-9]; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Ellis EA, 2011, PLANT J, V196, p3 ; Emerson RA, 1923, CORNELL U AGR EXP ST, V70, P3; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Gray J, 1997, CELL, V89, P25, DOI 10.1016/S0092-8674(00)80179-8; Gray J, 2002, PLANT PHYSIOL, V130, P1894, DOI 10.1104/pp.008441; Greenberg JT, 1996, P NATL ACAD SCI USA, V93, P12094, DOI 10.1073/pnas.93.22.12094; GREENBERG JT, 1993, PLANT J, V4, P327, DOI 10.1046/j.1365-313X.1993.04020327.x; Gutierrez J, 2011, PLANT SIGNAL BEHAV, V6, P1937, DOI 10.4161/psb.6.12.18264; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hoeberichts FA, 2003, BIOESSAYS, V25, P47, DOI 10.1002/bies.10175; Hortensteiner S, 2013, PLANT MOL BIOL, V82, P505, DOI 10.1007/s11103-012-9940-z; Hortensteiner S, 2011, BBA-BIOENERGETICS, V1807, P977, DOI 10.1016/j.bbabio.2010.12.007; Hortensteiner S, 1998, J BIOL CHEM, V273, P15335, DOI 10.1074/jbc.273.25.15335; Hu GS, 1996, PLANT CELL, V8, P1367, DOI 10.1105/tpc.8.8.1367; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; JOHAL GS, 1995, BIOESSAYS, V17, P685, DOI 10.1002/bies.950170805; Johal GS, 2007, APSNET FEATURES, DOI [10.1094/APSnetFeatures-2007-0707, DOI 10.1094/APSNETFEATURES-2007-0707]; Jung YH, 2005, PLANT PHYSIOL BIOCH, V43, P397, DOI 10.1016/j.plaphy.2005.03.002; Kim CH, 2008, EMBO REP, V9, P435, DOI 10.1038/embor.2008.57; Kim CH, 2013, PHOTOSYNTH RES, V116, P455, DOI 10.1007/s11120-013-9876-4; Kliebenstein DJ, 1999, MOL PLANT MICROBE IN, V12, P1022, DOI 10.1094/MPMI.1999.12.11.1022; Lee KP, 2007, P NATL ACAD SCI USA, V104, P10270, DOI 10.1073/pnas.0702061104; Li T, 2017, PLANT CELL, V29, P1316, DOI 10.1105/tpc.17.00349; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Mach JM, 2001, P NATL ACAD SCI USA, V98, P771, DOI 10.1073/pnas.021465298; Meskauskiene R, 2002, FEBS LETT, V532, P27, DOI 10.1016/S0014-5793(02)03617-7; Meskauskiene R, 2001, P NATL ACAD SCI USA, V98, P12826, DOI 10.1073/pnas.221252798; Mori M, 2007, PLANT MOL BIOL, V63, P847, DOI 10.1007/s11103-006-9130-y; NEUFFER MG, 1975, J HERED, V66, P265, DOI 10.1093/oxfordjournals.jhered.a108627; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Pruzinska A, 2003, P NATL ACAD SCI USA, V100, P15259, DOI 10.1073/pnas.2036571100; Sakuraba Y, 2012, PLANT CELL, V24, P507, DOI 10.1105/tpc.111.089474; Spassieva S, 2002, PLANT SCI, V162, P543, DOI 10.1016/S0168-9452(01)00595-7; Tanaka R, 2003, PLANT CELL PHYSIOL, V44, P1266, DOI 10.1093/pcp/pcg172; Tang CL, 2013, J EXP BOT, V64, P2955, DOI 10.1093/jxb/ert135; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tsujimoto Y, 2002, BIOSCIENCE REP, V22, P47, DOI 10.1023/A:1016061006256; Xie QJ, 2016, J GENET GENOMICS, V43, P145, DOI 10.1016/j.jgg.2015.09.012; Yamanouchi U, RICE SPOTTED LEAF GE; Yang ML, 2004, PLANT MOL BIOL, V54, P175, DOI 10.1023/B:PLAN.0000028789.51807.6a; Yao N, 2006, PLANT CELL, V18, P397, DOI 10.1105/tpc.105.036251; Zamyatnin AA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1701, DOI 10.1134/S0006297915130064; Zhang SR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0227; Zhu XY, 2015, PLANT J, V84, P597, DOI 10.1111/tpj.13030; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	56	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2018	13	9							e0201359	10.1371/journal.pone.0201359	http://dx.doi.org/10.1371/journal.pone.0201359			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7DK	30199528	Green Published, gold, Green Submitted			2022-12-26	WOS:000444681100002
J	Kawa, Y; Nagano, T; Yoshizaki, A; Dokuni, R; Katsurada, M; Terashita, T; Yasuda, Y; Umezawa, K; Yamamoto, M; Kamiryo, H; Kobayashi, K; Nishimura, Y				Kawa, Yoshitaka; Nagano, Tatsuya; Yoshizaki, Asuka; Dokuni, Ryota; Katsurada, Masahiro; Terashita, Tomomi; Yasuda, Yuichiro; Umezawa, Kanoko; Yamamoto, Masatsugu; Kamiryo, Hiroshi; Kobayashi, Kazuyuki; Nishimura, Yoshihiro			Role of S1P/S1PR3 axis in release of CCL20 from human bronchial epithelial cells	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE; AIRWAY INFLAMMATION; ASTHMA; LUNG; SPHINGOSINE-1-PHOSPHATE; BETA-1-ADRENOCEPTORS; POLYMORPHISMS; ACTIVATION; EXPRESSION; RECEPTORS	Background Sphingosine kinase phosphorylates sphingosine to generate sphingosine 1 phosphate (S1P) following stimulation of the five plasma membrane G-protein-coupled receptors. The objective of this study is to clarify the role of S1P and its receptors (S1PRs), especially S1PR3 in airway epithelial cells. Methods The effects of S1P on asthma-related genes expression were examined with the human bronchial epithelial cells BEAS-2B and Calu-3 using a transcriptome analysis and siRNA of S1PRs. To clarify the role of CCL20 in the airway inflammation, BALB/c mice were immunized with ovalbumin (OVA) and subsequently challenged with an OVA-containing aerosol to induce asthma with or without intraperitoneal administration of anti-CCL20. Finally, the anti-inflammatory effect of VPC 23019, S1PR1/3 antagonist, in the OVA-induced asthma was examined. Results S1P induced the expression of some asthma-related genes, such as ADRB2, PTGER4, and CCL20, in the bronchial epithelial cells. The knock-down of SIPR3 suppressed the expression of S1P-inducing CCL20. Anti-CCL20 antibody significantly attenuated the eosinophil numbers in the bronchoalveolar lavage fluid (P< 0.01). Upon OVA challenge, VPC23019 exhibited substantially attenuated eosinophilic inflammation. Conclusions S1P/S1PR3 pathways have a role in release of proinflammatory cytokines from bronchial epithelial cells. Our results suggest that S1P/S1PR3 may be a possible candidate for the treatment of bronchial asthma.	[Kawa, Yoshitaka; Nagano, Tatsuya; Yoshizaki, Asuka; Dokuni, Ryota; Katsurada, Masahiro; Terashita, Tomomi; Yasuda, Yuichiro; Umezawa, Kanoko; Yamamoto, Masatsugu; Kamiryo, Hiroshi; Kobayashi, Kazuyuki; Nishimura, Yoshihiro] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Resp Med,Chuo Ku, Kusunoki Cho, Kobe, Hyogo, Japan	Kobe University	Nagano, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Resp Med,Chuo Ku, Kusunoki Cho, Kobe, Hyogo, Japan.	tnagano@med.kobe-u.ac.jp	Yamamoto, Masatsugu/AAH-7093-2020	Yamamoto, Masatsugu/0000-0003-0596-555X; Katsurada, Masahiro/0000-0003-4655-3367	JSPS KAKENHI [16K19453, 23591119, 24591131]; GSK Japan Research Grant 2017	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); GSK Japan Research Grant 2017	This work was supported by JSPS KAKENHI 16K19453 and GSK Japan Research Grant 2017 to Masatsugu Yamamoto, JSPS KAKENHI 23591119 to Kazuyuki Kobayashi, and JSPS KAKENHI 24591131 to Yoshihiro Nishimura. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSTAD P, 1988, MOL CARCINOGEN, V1, P151, DOI 10.1002/mc.2940010303; D'Amato M, 1998, AM J RESP CRIT CARE, V158, P1968, DOI 10.1164/ajrccm.158.6.9804126; Dusaban SS, 2013, P NATL ACAD SCI USA, V110, P3609, DOI 10.1073/pnas.1217355110; Estrada R, 2008, J BIOL CHEM, V283, P30363, DOI 10.1074/jbc.M804392200; Hall IP, 2006, LANCET, V368, P771, DOI 10.1016/S0140-6736(06)69287-8; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hatakeyama Y, 2014, CANCER LETT, V343, P74, DOI 10.1016/j.canlet.2013.09.019; Hegde A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116458; HENRY PJ, 1990, BRIT J PHARMACOL, V99, P136, DOI 10.1111/j.1476-5381.1990.tb14667.x; HENRY PJ, 1990, BRIT J PHARMACOL, V99, P131, DOI 10.1111/j.1476-5381.1990.tb14666.x; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Hong GH, 2016, J IMMUNOL, V196, P2021, DOI 10.4049/jimmunol.1500747; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Kurz T, 2006, J ALLERGY CLIN IMMUN, V118, P396, DOI 10.1016/j.jaci.2006.04.036; Liggett SB, 2003, ASSAY DRUG DEV TECHN, V1, P317, DOI 10.1089/15406580360545134; LIJNEN HR, 1985, EUR J BIOCHEM, V150, P141, DOI 10.1111/j.1432-1033.1985.tb08999.x; Lin R, 2012, BRIT J PHARMACOL, V165, P2365, DOI 10.1111/j.1476-5381.2011.01725.x; Lin SZ, 2013, CANCER PREV RES, V6, P594, DOI 10.1158/1940-6207.CAPR-12-0379; Bin M, 2010, BIOORG MED CHEM LETT, V20, P2264, DOI 10.1016/j.bmcl.2010.02.006; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; MALEFYT RD, 1991, J EXP MED, V174, P1209; Matsuwaki Y, 2012, INT ARCH ALLERGY IMM, V158, P19, DOI 10.1159/000337756; MCWILLIAM AS, 1994, J EXP MED, V179, P1331, DOI 10.1084/jem.179.4.1331; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Nagano T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108373; Nguyen LP, 2017, P NATL ACAD SCI USA, V114, pE9163, DOI 10.1073/pnas.1710196114; Nishiuma T, 2008, AM J PHYSIOL-LUNG C, V294, pL1085, DOI 10.1152/ajplung.00445.2007; O'Sullivan MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095566; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rumzhum NN, 2016, AM J RESP CELL MOL, V54, P128, DOI 10.1165/rcmb.2014-0443OC; Szalai C, 2008, BRIT J PHARMACOL, V153, P1602, DOI 10.1038/bjp.2008.55; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Terashita T, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0465-x; van Rijt LS, 2004, J IMMUNOL METHODS, V288, P111, DOI 10.1016/j.jim.2004.03.004; Weckmann M, 2007, NAT MED, V13, P1308, DOI 10.1038/nm1660	36	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203211	10.1371/journal.pone.0203211	http://dx.doi.org/10.1371/journal.pone.0203211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192865	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600050
J	Liang, JS; Zhu, JS; Gong, L; Liu, XL; Wang, B				Liang, Jiansheng; Zhu, Junsheng; Gong, Lin; Liu, Xiaoli; Wang, Bin			Potentiometric titration for the high precision determination of active components in six types of chemical disinfectants	PLOS ONE			English	Article								Chemical disinfectants effectively kill pathogenic microorganisms, eliminating routes of transmission for infectious diseases. Accurate quantification of the active ingredients can help make a more effective use of disinfectants. In this study, the active ingredients in six different types of chemical disinfectants were systematically quantified with great precision and accuracy using potentiometric titration. The coefficient of variations fell in the range of 0.04%-0.46%. The recovery rates of samples were all above 95% and the extended uncertainty was 0.32g/L. This method can be broadly applied to the analysis of disinfectants in the future.	[Liang, Jiansheng; Zhu, Junsheng; Gong, Lin; Liu, Xiaoli; Wang, Bin] Wuhan Ctr Dis Prevent & Control, Dept Disinfect & Pest Control, Wuhan, Hubei, Peoples R China		Liang, JS (corresponding author), Wuhan Ctr Dis Prevent & Control, Dept Disinfect & Pest Control, Wuhan, Hubei, Peoples R China.	wh-ljs@sohu.com		Gong, Lin/0000-0001-5001-2825				Banach JL, 2015, INT J ENV RES PUB HE, V12, P8658, DOI 10.3390/ijerph120808658; Chen G, 2014, CHINESE J DISINFECTI, V31, P349; Chen X, 2015, MED RECAPITULATE, V21, P1061; FLEURETTE J, 1980, REV PRATICIEN, V30, P2167; Gao J, 2013, CHINESE J DISINFECTI, V30, P608; Granholm K, 2015, ANAL CHIM ACTA, V888, P36, DOI 10.1016/j.aca.2015.05.056; Hubei Bureau of Quality and Technical Supervision, 2012, 8012012 DBT HUB BUR; National Health and Family Planning Commission of the People's Republic of China Department of Oversight Division, 2002, DIS TECHN SPEC; The State Administration of Quality Supervision Inspection and Quarantine of the People's Republic of China Standardization Administration of China, 2008, 63531 ISO STAT ADM Q; Yun M, 2010, CHINESE J DISINFECTI, V27, P687; Zheng R, 2015, CHINESE J DISINFECTI, V32, P10	11	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203558	10.1371/journal.pone.0203558	http://dx.doi.org/10.1371/journal.pone.0203558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192844	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600101
J	Price, JT; Chi, BH; Phiri, WM; Ayles, H; Chintu, N; Chilengi, R; Stringer, JSA; Mutale, W				Price, Joan T.; Chi, Benjamin H.; Phiri, Winifreda M.; Ayles, Helen; Chintu, Namwinga; Chilengi, Roma; Stringer, Jeffrey S. A.; Mutale, Wilbroad			Associations between health systems capacity and mother-to-child HIV prevention program outcomes in Zambia	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; GLOBAL PLAN; TRANSMISSION; SERVICES; THINKING; WOMEN; BHOMA; INTERVENTION; CHALLENGES; ADHERENCE	Introduction Zambia has made substantial investments in health systems capacity, yet it remains unclear whether improved service quality improves outcomes. We investigated the association between health system capacity and use of prevention of mother-to-child HIV transmission (PMTCT) services in Zambia. Materials and methods We analyzed data from two studies conducted in rural and semi-urban Lusaka Province in 2014 +/- 2015. Health system capacity, our primary exposure, was measured with a validated balanced scorecard approach. Based on WHO building blocks for health systems strengthening, we derived overall and domain-specific facility scores (range: 0 +/- 100), with higher scores indicating greater capacity. Our outcome, community-level maternal antiretroviral drug use at 12 months postpartum, was measured via self-report in a large cohort study evaluating PMTCT program impact. Associations between health systems capacity and our outcome were analyzed via linear regression. Results Among 29 facilities, median overall facility score was 72 (IQR: 67 +/- 74). Median domain scores were: patient satisfaction 75 (IQR 71 +/- 78); human resources 85 (IQR: 63 +/- 87); finance 50 (IQR: 50 +/- 67); governance 82 (IQR: 74 +/- 91); service capacity 77 (IQR: 68 +/- 79); service provision 60 (IQR: 52 +/- 76). Our programmatic outcome was measured from 804 HIV-infected mothers. Median community-level antiretroviral use at 12 months was 81% (IQR: 69 +/- 89%). Patient satisfaction was the only domain score significantly associated with 12-month maternal antiretroviral use (beta: 0.22; p = 0.02). When we excluded the human resources and finance domains, we found a positive association between composite 4-domain facility score and 12-month maternal antiretroviral use in peri-urban but not rural facilities. Conclusions In these Zambian health facilities, patient satisfaction was positively associated with maternal antiretroviral 12 months postpartum. The association between overall health system capacity and maternal antiretroviral drug use was stronger in peri-urban versus rural facilities. Additional work is needed to guide strategic investments for improved outcomes in HIV and broader maternal-child health region-wide.	[Price, Joan T.; Chi, Benjamin H.; Stringer, Jeffrey S. A.] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC 27599 USA; [Phiri, Winifreda M.] UNC Global Projects Zambia, Lusaka, Zambia; [Ayles, Helen] Zambart, Lusaka, Zambia; [Chintu, Namwinga] Soc Family Hlth, Lusaka, Zambia; [Chilengi, Roma] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Mutale, Wilbroad] Univ Zambia, Sch Publ Hlth, Lusaka, Zambia	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Zambia	Price, JT (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC 27599 USA.	joan_price@med.unc.edu	Stringer, Jeffrey S. A./AAU-2342-2021	Stringer, Jeffrey/0000-0002-9590-7216; Ayles, Helen/0000-0003-4108-2842	Doris Duke Charitable Foundation; U.S. National Institutes of Health [R01 HD075131, K24 AI120796, K01 TW010857, T32 HD075731, P30 AI050410]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD075731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI120796, P30AI050410] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Doris Duke Charitable Foundation (www.ddcf.org) and the U.S. National Institutes of Health (www.nih.org) under the following grant numbers: R01 HD075131 (BHC), K24 AI120796 (BHC), K01 TW010857 (JTP), T32 HD075731 (BHC), P30 AI050410. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam T, 2012, HEALTH POLICY PLANN, V27, P1, DOI 10.1093/heapol/czs084; Aizire J, 2013, CURR HIV RES, V11, P144, DOI 10.2174/1570162X11311020007; Central Statistical Office Ministry of Health ICF International, 2014, ZAMB DEM HLTH SURV 2; Chi BH, 2018, PEDIATR INFECT DIS J, V37, P1137, DOI 10.1097/INF.0000000000001997; Chi BH, 2012, JAIDS-J ACQ IMM DEF, V60, pS78, DOI 10.1097/QAI.0b013e31825f3284; Chinkonde JR, 2009, REPROD HEALTH MATTER, V17, P143, DOI 10.1016/S0968-8080(09)33440-0; Colvin CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108150; Dang BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054729; Deressa W, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-328; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Ekouevi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029823; Ferguson L, 2012, TROP MED INT HEALTH, V17, P564, DOI 10.1111/j.1365-3156.2012.02958.x; Gourlay A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106325; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Hamilton E, 2017, JAIDS-J ACQ IMM DEF, V75, pS27, DOI 10.1097/QAI.0000000000001325; Hodgson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111421; Ishikawa N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090991; Loomba Foundation, 2015, GLOB WID REP 2015 GL; MacCarthy Sarah, 2015, J Int AIDS Soc, V18, P19395, DOI 10.7448/IAS.18.1.19395; McCoy SI, 2015, JAIDS-J ACQ IMM DEF, V69, pE74, DOI 10.1097/QAI.0000000000000597; Modi S, 2017, JAIDS-J ACQ IMM DEF, V75, pS76, DOI 10.1097/QAI.0000000000001336; Mounier-Jack S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-278; Mutale W, 2017, J EVAL CLIN PRACT, V23, P439, DOI 10.1111/jep.12354; Mutale W, 2016, J EVAL CLIN PRACT, V22, P112, DOI 10.1111/jep.12160; Mutale W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093977; Mutale W, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-34; Mutale W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058650; Mutale W, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-8; Nieuwkerk PT, 2005, JAIDS-J ACQ IMM DEF, V38, P445, DOI 10.1097/01.qai.0000147522.34369.12; Phillips T, 2017, AIDS BEHAV, V21, P450, DOI 10.1007/s10461-016-1448-0; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Sprague C, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-10; Stringer JSA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-S2-S7; Taylor M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002329; Theilgaard ZP, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-28; VanDeusen A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0859-2; Varga C, 2008, QUAL HEALTH RES, V18, P786, DOI 10.1177/1049732308318449; WHO, 2010, MONITORING BUILDING; WHO, 2016, CONGUID UANT DRU	39	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202889	10.1371/journal.pone.0202889	http://dx.doi.org/10.1371/journal.pone.0202889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192777	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600038
J	Yoon, RG; Kim, HS; Hong, GS; Park, JE; Jung, SC; Kim, SJ; Kim, JH				Yoon, Ra Gyoung; Kim, Ho Sung; Hong, Gil Sun; Park, Ji Eun; Jung, Seung Chai; Kim, Sang Joon; Kim, Jeong Hoon			Joint approach of diffusion-and perfusion-weighted MRI in intra-axial mass like lesions in clinical practice simulation	PLOS ONE			English	Article							HIGH-GRADE GLIOMAS; BRAIN-TUMORS; PERITUMORAL EDEMA; GLIOBLASTOMA-MULTIFORME; CT IMAGES; 3 T; COEFFICIENTS; COMBINATION; LYMPHOMA	Although advanced magnetic resonance imaging (MRI) techniques provide useful information for the differential diagnosis of intra-axial mass-like lesions, the specific diagnostic role of multimodal MRI over conventional magnetic resonance imaging (CMRI) alone in the differential diagnosis of mass-like lesions from a large heterogeneous cohort has not been studied. In this study, we aimed to determine the added value of a joint approach of diffusion-weighted imaging (DWI) and dynamic-susceptibility-contrast perfusion imaging (DSC-PWI) for diagnosis of intra-axial mass-like lesions, comparing them with CMRI alone. Furthermore, we performed these evaluations in a manner simulating clinical practice. Our institutional review board approved this retrospective study and waived the requirement for informed consent. A total of 1038 patients with intra-axial mass-like lesions were retrospectively recruited according to their histological and clinico-radiological diagnoses made between January 2005 and December 2014. All patients underwent CMRI, DWI and DSCPWI. The diagnostic accuracy and confidence in diagnosing each type of intra-axial mass-like lesions, and for differentiating the intra-axial brain tumors from non-neoplastic lesions, were compared according to the MRI protocols. The disease-specific sensitivity of joint approach differed according to specific disease entities in diagnosing each disease category. Joint approach provided the best diagnostic accuracy for discriminating intra-axial brain tumors from non-neoplastic lesions, with high diagnostic accuracy (95.3 +/- 96.7%), specificity (82 +/- 84.0%), positive-predictive-value (97.0 +/- 97.3%), and negative-predictivevalue (84.8 +/- 92.7%), with the reader's confidence values being significantly improved over those on CMRI alone (all p-values < 0.001). In conclusion, joint approach of DWI, DSC-PWI to CMRI helps to differentiate non-neoplastic lesions from intra-axial brain tumors, and improves diagnostic confidence compared with CMRI alone. The benefit from the combined imaging differs for each disease category; thus joint approach needs to be customized according to clinical suspicion.	[Yoon, Ra Gyoung] Eulji Univ, Coll Med, Eulji Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Ho Sung; Hong, Gil Sun; Park, Ji Eun; Jung, Seung Chai; Kim, Sang Joon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Ho Sung; Hong, Gil Sun; Park, Ji Eun; Jung, Seung Chai; Kim, Sang Joon] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea; [Kim, Jeong Hoon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurosurg, Seoul, South Korea	Eulji University; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, HS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.; Kim, HS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea.	radhskim@gmail.com		Kim, Ho Sung/0000-0002-9477-7421				Abdoli M, 2015, MULT SCLER RELAT DIS, V4, P555, DOI 10.1016/j.msard.2015.07.013; Al-Okaili RN, 2007, RADIOLOGY, V243, P539, DOI 10.1148/radiol.2432060493; Calli C, 2006, EUR J RADIOL, V58, P394, DOI 10.1016/j.ejrad.2005.12.032; Cha S, 2006, AM J NEURORADIOL, V27, P475; Chang SC, 2002, CLIN IMAG, V26, P227, DOI 10.1016/S0899-7071(02)00436-9; De Belder FE, 2012, J COMPUT ASSIST TOMO, V36, P577, DOI 10.1097/RCT.0b013e318261e913; Ferreri AJM, 2009, LANCET, V374, P1512, DOI 10.1016/S0140-6736(09)61416-1; Freedman MT, 2008, ACAD RADIOL, V15, P249, DOI 10.1016/j.acra.2007.07.010; Ge YL, 2005, AM J NEURORADIOL, V26, P1539; Hakyemez B, 2010, CLIN RADIOL, V65, P15, DOI 10.1016/j.crad.2009.09.005; Hakyemez B, 2006, J MAGN RESON IMAGING, V24, P817, DOI 10.1002/jmri.20707; Hatherill M, 2010, B WORLD HEALTH ORGAN, V88, P312, DOI 10.2471/BLT.09.062893; Kim HS, 2007, AM J NEURORADIOL, V28, P1693, DOI 10.3174/ajnr.A0674; Kim HS, 2014, RADIOLOGY, V273, P831, DOI 10.1148/radiol.14132868; Kremer S, 2002, J NEURORADIOLOGY, V29, P105; Lee H, 2011, MED PHYS, V38, P4667, DOI 10.1118/1.3611046; Liu X, 2011, NEURO-ONCOLOGY, V13, P447, DOI 10.1093/neuonc/noq197; Lu S, 2004, RADIOLOGY, V232, P221, DOI 10.1148/radiol.2321030653; Park SM, 2010, BRIT J RADIOL, V83, P466, DOI 10.1259/bjr/34304111; Prager AJ, 2015, AM J NEURORADIOL, V36, P877, DOI 10.3174/ajnr.A4218; Reiner Bruce I, 2007, J Am Coll Radiol, V4, P313, DOI 10.1016/j.jacr.2007.01.015; Senturk S, 2009, DIAGN INTERV RADIOL, V15, P3; Seo HS, 2008, AM J NEURORADIOL, V29, P458, DOI 10.3174/ajnr.A0842; Seong NJ, 2014, AM J ROENTGENOL, V203, P3, DOI 10.2214/AJR.13.11787; Server A, 2009, ACTA RADIOL, V50, P682, DOI 10.1080/02841850902933123; Stadnik TW, 2001, AM J NEURORADIOL, V22, P969; Thiel E, 2010, LANCET ONCOL, V11, P1036, DOI 10.1016/S1470-2045(10)70229-1; Toh CH, 2008, AM J NEURORADIOL, V29, P471, DOI 10.3174/ajnr.A0872; Tsougos I, 2012, CANCER IMAGING, V12, P423, DOI 10.1102/1470-7330.2012.0038; Wang S, 2011, AM J NEURORADIOL, V32, P507, DOI 10.3174/ajnr.A2333; Yamasaki F, 2005, RADIOLOGY, V235, P985, DOI 10.1148/radiol.2353031338	31	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202891	10.1371/journal.pone.0202891	http://dx.doi.org/10.1371/journal.pone.0202891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192785	gold, Green Published, Green Submitted			2022-12-26	WOS:000444093600039
J	Beom, JH; Kim, JH; Chung, HS; Kim, SM; Ko, DR; Cho, J				Beom, Jin Ho; Kim, Ji Hoon; Chung, Hyun Soo; Kim, Su Mi; Ko, Dong Ryul; Cho, Junho			Flipped-classroom training in advanced cardiopulmonary life support	PLOS ONE			English	Article							MEDICINE; PERFORMANCE; CLERKSHIP; MODEL	Background The effects of the flipped classroom have been demonstrated in various fields of education in recent years. Training in emergency medicine is also beginning to gradually implement the flipped classroom; however, its practical effect in emergency medicine contexts is not yet clear. Objective The present study investigates the effects of the flipped classroom on advanced cardiopulmonary life support (ACLS) training implemented among practicum students in emergency medicine. Methods The study randomly assigned into control and experimental conditions 108 fourth year students in the College of Medicine at Yonsei University, in Seoul, who were scheduled to take clinical practice in emergency medicine between March and July 2017. Students were taught about ACLS in either a traditional lecture-based classroom (control condition) or a flipped classroom (experimental condition); then, simulation training with ACLS scenarios was carried out. Finally, each student was rated on performance using a rating form developed in advance. Results ACLS simulation scores of the students in the flipped classroom were 70.9 +/- 10.9, which was higher than those of the students in the traditional classroom (67.1 +/- 11.3); however, this difference was not statistically significant (p = 0.339). In addition, the difference in student satisfaction as measured on a survey was statistically insignificant (p = 0.655). Conclusions Competency assessment after simulation-based training in ACLS undergone by senior medical students randomly assigned to flipped and traditional classrooms showed no statistical difference in competency between the two groups.	[Beom, Jin Ho; Kim, Ji Hoon; Chung, Hyun Soo; Ko, Dong Ryul; Cho, Junho] Yonsei Univ, Dept Emergency Med, Coll Med, Seoul, South Korea; [Kim, Su Mi] Yonsei Univ, Coll Med, Clin Simulat Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cho, J (corresponding author), Yonsei Univ, Dept Emergency Med, Coll Med, Seoul, South Korea.	emjh@yuhs.ac		Cho, Junho/0000-0003-2240-3989; Chung, Hyun Soo/0000-0001-6110-1495; Kim, Ji Hoon/0000-0002-0070-9568				Belfi LM, 2015, ACAD RADIOL, V22, P794, DOI 10.1016/j.acra.2014.11.003; Bliuc Ana-Maria, 2007, The Internet and Higher Education, V10, P231, DOI 10.1016/j.iheduc.2007.08.001; Boysen-Osborn M, 2016, J EDUC EVAL HEALTH P, V13, DOI 10.3352/jeehp.2016.13.11; Chen F, 2017, MED EDUC, V51, P585, DOI 10.1111/medu.13272; Cooper Avraham Z, 2017, J Grad Med Educ, V9, P392, DOI 10.4300/JGME-D-16-00827.1; Corrias A, 2015, IEEE ENG MED BIO, P3985, DOI 10.1109/EMBC.2015.7319267; DeRuisseau LR, 2016, ADV PHYSIOL EDUC, V40, P522, DOI 10.1152/advan.00033.2016; Fox J, 2017, SOUTH MED J, V110, P319, DOI 10.14423/SMJ.0000000000000649; Heitz C, 2015, WEST J EMERG MED, V16, P851, DOI 10.5811/westjem.2015.9.27256; Holmboe ES, 2010, MED TEACH, V32, P676, DOI 10.3109/0142159X.2010.500704; Khanova J, 2015, AM J PHARM EDUC, V79, DOI 10.5688/ajpe799140; Lew EK, 2016, INT J EMERG MED, V9, DOI 10.1186/s12245-016-0123-6; Liebert CA, 2016, AM J SURG, V211, P451, DOI 10.1016/j.amjsurg.2015.10.004; Lin Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174829; Makhdoom N, 2013, J TAIBAH UNIV MED SC, V8, P12, DOI 10.1016/j.jtumed.2013.01.002; McDonald K, 2013, J CONTIN EDUC NURS, V44, P437, DOI 10.3928/00220124-20130925-19; Mehta NB, 2013, ACAD MED, V88, P1418, DOI 10.1097/ACM.0b013e3182a36a07; MILLER GE, 1990, ACAD MED, V65, pS63, DOI 10.1097/00001888-199009000-00045; Morgan H, 2015, CLIN TEACH, V12, P155, DOI 10.1111/tct.12328; Ojennus DD, 2016, BIOCHEM MOL BIOL EDU, V44, P20, DOI 10.1002/bmb.20926; Park SE, 2015, J DENT EDUC, V79, P563; Rose E, 2016, J EMERG MED, V51, P284, DOI 10.1016/j.jemermed.2016.05.033; Tan E, 2015, EMERG MED AUSTRALAS, V27, P444, DOI 10.1111/1742-6723.12454; Whillier S, 2015, J CHIPROPR EDUC, V29, P127, DOI 10.7899/JCE-14-28; Zeng R, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-017-0881-8	25	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203114	10.1371/journal.pone.0203114	http://dx.doi.org/10.1371/journal.pone.0203114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183739	Green Submitted, Green Published, gold			2022-12-26	WOS:000443789900046
J	Naskalska, A; Dabrowska, A; Nowak, P; Szczepanski, A; Jasik, K; Milewska, A; Ochman, M; Zeglen, S; Rajfur, Z; Pyrc, K				Naskalska, Antonina; Dabrowska, Agnieszka; Nowak, Paulina; Szczepanski, Artur; Jasik, Krzysztof; Milewska, Aleksandra; Ochman, Marek; Zeglen, Slawomir; Rajfur, Zenon; Pyrc, Krzysztof			Novel coronavirus-like particles targeting cells lining the respiratory tract	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; SIZE-EXCLUSION CHROMATOGRAPHY; MEMBRANE-PROTEIN GENE; STRUCTURAL PROTEINS; SPIKE PROTEINS; SARS-COV; ADENOVIRUS DODECAHEDRON; EXPRESSION SYSTEM; SEQUENCE-ANALYSIS; PURIFICATION	Virus like particles (VLPs) produced by the expression of viral structural proteins can serve as versatile nanovectors or potential vaccine candidates. In this study we describe for the first time the generation of HCoV-NL63 VLPs using baculovirus system. Major structural proteins of HCoV-NL63 have been expressed in tagged or native form, and their assembly to form VLPs was evaluated. Additionally, a novel procedure for chromatography purification of HCoV-NL63 VLPs was developed. Interestingly, we show that these nanoparticles may deliver cargo and selectively transduce cells expressing the ACE2 protein such as ciliated cells of the respiratory tract. Production of a specific delivery vector is a major challenge for research concerning targeting molecules. The obtained results show that HCoV-NL63 VLPs may be efficiently produced, purified, modified and serve as a delivery platform. This study constitutes an important basis for further development of a promising viral vector displaying narrow tissue tropism.	[Naskalska, Antonina; Milewska, Aleksandra; Pyrc, Krzysztof] Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland; [Dabrowska, Agnieszka; Nowak, Paulina; Szczepanski, Artur; Milewska, Aleksandra; Pyrc, Krzysztof] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Microbiol Dept, Krakow, Poland; [Jasik, Krzysztof] Med Univ Silesia, Sch Pharm, Dept Skin Struct Studies, Div Lab Med, Sosnowiec, Poland; [Ochman, Marek; Zeglen, Slawomir] Silesian Ctr Heart Dis, Dept Cardiac Surg & Transplantol, Zabrze, Poland; [Rajfur, Zenon] Jagiellonian Univ, Inst Phys, Fac Phys Astron & Appl Comp Sci, Krakow, Poland	Jagiellonian University; Jagiellonian University; Medical University Silesia; Silesian Center for Heart Diseases; Jagiellonian University	Naskalska, A; Pyrc, K (corresponding author), Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland.; Pyrc, K (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Microbiol Dept, Krakow, Poland.	antonina.naskalska@uj.edu.pl; K.A.Pyrc@uj.edu.pl	JASIK, KRZYSZTOF PIOTR/F-9859-2018; Szczepański, Artur/AAP-1071-2020	JASIK, KRZYSZTOF PIOTR/0000-0003-3974-6507; Szczepański, Artur/0000-0003-0421-9520; Dabrowska, Agnieszka/0000-0003-1499-4950; Ochman, Marek/0000-0002-1410-5845; Naskalska, Antonina/0000-0002-5868-1000; ZEGLEN, SLAWOMIR/0000-0002-7708-4340; Pyrc, Krzysztof/0000-0002-3867-7688; Nowak, Paulina/0000-0001-5786-2339	National Science Center in Poland within the FUGA grant [UMO-2013/08/S/NZ6/00730]; National Science Center in Poland within the Sonata Bis grant [UMO-2012/07/E/NZ6/01712]; National Centre for Research and Development, Poland [Lider/27/55/L-2/10/2011]; European Union [POIG.02.01.00-12-064/08]; Ministry of Science and Higher Education of the Republic of Poland	National Science Center in Poland within the FUGA grant; National Science Center in Poland within the Sonata Bis grant; National Centre for Research and Development, Poland(National Centre for Research & Development, Poland); European Union(European Commission); Ministry of Science and Higher Education of the Republic of Poland(Ministry of Science and Higher Education, Poland)	This work was supported by the National Science Center in Poland within the FUGA grant (UMO-2013/08/S/NZ6/00730) and Sonata Bis grant (UMO-2012/07/E/NZ6/01712), https://www.ncn.gov.pl/. Part of the work was also supported by the National Centre for Research and Development, Poland (Lider/27/55/L-2/10/2011), http://www.ncbr.gov.pl/. The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union (grant No: POIG.02.01.00-12-064/08-"Molecular biotechnology for health"). Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a partner of the Leading National Research Center supported by the Ministry of Science and Higher Education of the Republic of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt AL, 2010, J VIROL, V84, P11418, DOI 10.1128/JVI.01131-10; Baudoux P, 1998, J VIROL, V72, P8636, DOI 10.1128/JVI.72.11.8636-8643.1998; Boscarino JA, 2008, J VIROL, V82, P2989, DOI 10.1128/JVI.01906-07; Bosch BJ, 2004, J VIROL, V78, P7369, DOI 10.1128/JVI.78.14.7369-7378.2004; Burden CS, 2012, J CHROMATOGR B, V880, P82, DOI 10.1016/j.jchromb.2011.10.044; CAVANAGH D, 1983, J GEN VIROL, V64, P1187, DOI 10.1099/0022-1317-64-5-1187; Chen SC, 2009, VIRUS GENES, V38, P365, DOI 10.1007/s11262-009-0341-6; Corse E, 2000, J VIROL, V74, P4319, DOI 10.1128/JVI.74.9.4319-4326.2000; Corse E, 2003, VIROLOGY, V312, P25, DOI 10.1016/S0042-6822(03)00175-2; de Haan CAM, 2000, J VIROL, V74, P4967, DOI 10.1128/JVI.74.11.4967-4978.2000; de Haan CAM, 1998, J VIROL, V72, P6838, DOI 10.1128/JVI.72.8.6838-6850.1998; Du P, 2017, J CHROMATOGR B, V1049, P16, DOI 10.1016/j.jchromb.2016.12.033; Effio CL, 2016, VACCINE, V34, P1259, DOI 10.1016/j.vaccine.2016.01.035; Fender P, 2003, J VIROL, V77, P4960, DOI 10.1128/JVI.77.8.4960-4964.2003; Fernandes F, 2013, EXPERT REV VACCINES, V12, P225, DOI [10.1586/erv.12.153, 10.1586/ERV.12.153]; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Gelhaus S, 2014, VIROLOGY, V464, P397, DOI 10.1016/j.virol.2014.07.035; Ho Y, 2004, BIOCHEM BIOPH RES CO, V318, P833, DOI 10.1016/j.bbrc.2004.04.111; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; HOGUE BG, 1990, ADV EXP MED BIOL, V276, P121; Hsieh PK, 2005, J VIROL, V79, P13848, DOI 10.1128/JVI.79.22.13848-13855.2005; Hsieh YC, 2008, J BIOMED SCI, V15, P707, DOI 10.1007/s11373-008-9278-3; Hu Yongwu, 2003, Genomics Proteomics & Bioinformatics, V1, P118; Huang Y, 2004, J VIROL, V78, P12557, DOI 10.1128/JVI.78.22.12557-12565.2004; JOUVENNE P, 1990, VIROLOGY, V174, P608, DOI 10.1016/0042-6822(90)90115-8; Kim HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035893; Kuo LL, 2016, VIROLOGY, V494, P100, DOI 10.1016/j.virol.2016.04.009; Kushnir N, 2012, VACCINE, V31, P58, DOI 10.1016/j.vaccine.2012.10.083; Lai ZW, 2011, BIOCHEMISTRY-US, V50, P5182, DOI 10.1021/bi200525y; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Lander GC, 2012, STRUCTURE, V20, P498, DOI 10.1016/j.str.2012.01.007; Lapps W, 1987, Adv Exp Med Biol, V218, P123; Lee YN, 2005, J VIROL METHODS, V129, P152, DOI 10.1016/j.jviromet.2005.05.022; Liu FX, 2013, PROTEIN EXPRES PURIF, V90, P104, DOI 10.1016/j.pep.2013.05.009; Liu GM, 2013, VACCINE, V31, P5524, DOI 10.1016/j.vaccine.2013.09.024; Liu JJ, 2016, YONSEI MED J, V57, P790, DOI 10.3349/ymj.2016.57.3.790; Lu BJ, 2010, IMMUNOLOGY, V130, P254, DOI 10.1111/j.1365-2567.2010.03231.x; Lu XY, 2007, IMMUNOLOGY, V122, P496, DOI 10.1111/j.1365-2567.2007.02676.x; Milewska A, 2014, J VIROL, V88, P13221, DOI 10.1128/JVI.02078-14; Milewska A, 2013, ANTIVIR RES, V97, P112, DOI 10.1016/j.antiviral.2012.11.006; Mortola E, 2004, FEBS LETT, V576, P174, DOI 10.1016/j.febslet.2004.09.009; MOUNIR S, 1992, J GEN VIROL, V73, P2731, DOI 10.1099/0022-1317-73-10-2731; Muller MA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-6; Nakauchi M, 2008, MICROBIOL IMMUNOL, V52, P625, DOI 10.1111/j.1348-0421.2008.00079.x; Narayanan K, 2000, J VIROL, V74, P8127, DOI 10.1128/JVI.74.17.8127-8134.2000; Nasimuzzaman M, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.71; Neuman BW, 2011, J STRUCT BIOL, V174, P11, DOI 10.1016/j.jsb.2010.11.021; NIEMANN H, 1984, EMBO J, V3, P665, DOI 10.1002/j.1460-2075.1984.tb01864.x; Pyrc K, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-7; RISCO C, 1995, J VIROL, V69, P5269, DOI 10.1128/JVI.69.9.5269-5277.1995; Ruch TR, 2012, VIRUSES-BASEL, V4, P363, DOI 10.3390/v4030363; Siu YL, 2008, J VIROL, V82, P11318, DOI 10.1128/JVI.01052-08; Steppert P, 2017, J CHROMATOGR A, V1487, P89, DOI 10.1016/j.chroma.2016.12.085; Szurgot I, 2015, MOL BIOTECHNOL, V57, P565, DOI 10.1007/s12033-015-9850-9; Thorp EB, 2006, J VIROL, V80, P1280, DOI 10.1128/JVI.80.3.1280-1289.2006; Tseng YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064013; Ujike M, 2015, VIRUSES-BASEL, V7, P1700, DOI 10.3390/v7041700; Urbas L, 2011, J CHROMATOGR A, V1218, P2451, DOI 10.1016/j.chroma.2011.01.032; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x; Wang C, 2017, ONCOTARGET, V8, P12686, DOI 10.18632/oncotarget.8475; Wang CL, 2017, VIRUS GENES, V53, P548, DOI 10.1007/s11262-017-1450-2; Xu PW, 2016, BIOTECHNOL LETT, V38, P299, DOI 10.1007/s10529-015-1973-3; Ye Y, 2007, J VIROL, V81, P3597, DOI 10.1128/JVI.01472-06; Yu YTC, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0234-7; Zaveckas M, 2015, J CHROMATOGR B, V991, P21, DOI 10.1016/j.jchromb.2015.04.004; Zeltins A, 2013, MOL BIOTECHNOL, V53, P92, DOI 10.1007/s12033-012-9598-4; Zheng Q, 2006, BIOCHEMISTRY-US, V45, P15205, DOI 10.1021/bi061686w	68	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203489	10.1371/journal.pone.0203489	http://dx.doi.org/10.1371/journal.pone.0203489			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183777	Green Published, Green Submitted, gold			2022-12-26	WOS:000443789900065
J	Vernelen, K; Barbe, B; Gillet, P; Van Esbroeck, M; China, B; Jacobs, J				Vernelen, Kris; Barbe, Barbara; Gillet, Philippe; Van Esbroeck, Marjan; China, Bernard; Jacobs, Jan			Photo-based External Quality Assessment of Malaria rapid diagnostic tests in a non-endemic setting	PLOS ONE			English	Article							TRAVELERS	Introduction In non-endemic settings, expertise in malaria microscopy is limited and rapid diagnostic tests (RDTs) are an adjunct to malaria diagnosis. Aim We performed an External Quality Assessment (EQA) on reading and interpretation of malaria RDTs in a non-endemic setting. Methods Participants were medical laboratories in Belgium and the Grand Duchy of Luxembourg using malaria RDTs; they received (i) 10 high-resolution photographs presenting test line combinations of RDTs with interpretations listed in a multiple choice format and (ii) a questionnaire about their practices of malaria diagnosis. Results Among 135 subscribing laboratories, 134 (99.3%) used 139 RDT products (11 different products from 8 brands). After exclusion of the results of one laboratory, analysis was done for 133 laboratories using 137 RDT products. Scores of 10/10, 9/10 and 8/10 were achieved for 58.4%, 13.1% and 8.0% of 137 RDT products respectively. For three-band P. falciparum-pan-Plasmodium RDTs (113 (82.5%) products, 6 brands), most frequent errors were (1) disregarding faint test lines (18.6%), (2) reporting invalid instead of P. falciparum (16.8%) and (3) reporting "Plasmodium spp., no further differentiation possible" without mentioning the presence or absence of P. falciparum (11.5%). For four-band RDTs (21 (15.3%) products, 1 brand), errors were (4) disregarding faint P. vivaxtest lines (47.6%) and (5) reporting "Plasmodium spp., no further differentiation possible" without mentioning the presence of P. falciparum and P. vivax (28.6%). Instructions for use (IFU) of only 4 out of 10 RDT products mentioned to interpret faint-intensity test lines as positive (conducive to errors 1 and 4) and IFU of 2 products displayed incorrect information (conducive to errors 2 and 5). Outside of office hours, 36.1% of participants relied on RDTs as the initial diagnostic test; 13.9% did not perform microscopic confirmation. Conclusion Reading and interpretation of malaria RDTs was satisfactory, but errors were embedded in the instructions for use of the products. Relying on RDTs alone for malaria diagnosis (about one third of participants) is not a recommended practice.	[Vernelen, Kris; China, Bernard] Sciensano, Qual Med Labs, Inst Publ Hlth, Brussels, Belgium; [Barbe, Barbara; Gillet, Philippe; Van Esbroeck, Marjan; Jacobs, Jan] Inst Trop Med, Antwerp, Belgium; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium	Sciensano; Institute of Tropical Medicine (ITM); KU Leuven	Vernelen, K (corresponding author), Sciensano, Qual Med Labs, Inst Publ Hlth, Brussels, Belgium.	Kris.Vernelen@sciensano.be	China, Bernard/AAJ-3243-2021; Jacobs, Jan/GRX-7316-2022; Vernelen, Kris/GSO-1844-2022	China, Bernard/0000-0001-5717-478X; gillet, philippe/0000-0001-5878-6446; Van Esbroeck, Marjan/0000-0002-7294-6319	budget of the Scientific Institute of Public Health	budget of the Scientific Institute of Public Health	This work was supported by the budget of the Scientific Institute of Public Health dedicated to external quality assessment in medical laboratories.	Abanyie FA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-340; [Anonymous], 2009, US RAP DIAGN TEST RD; Askling HH, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-328; Bailey JW, 2013, BRIT J HAEMATOL, V163, P573, DOI 10.1111/bjh.12572; Behrens RH, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0666-7; Bobenchik A, 2013, J CLIN MICROBIOL, V51, P379, DOI 10.1128/JCM.02509-12; Bronner U, 2011, APMIS, V119, P88, DOI 10.1111/j.1600-0463.2010.02696.x; Chilton D, 2006, J CLIN PATHOL, V59, P862, DOI 10.1136/jcp.2005.032904; DiMaio MA, 2012, J CLIN MICROBIOL, V50, P2877, DOI 10.1128/JCM.01013-12; Gillet P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-166; Gillet P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-359; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-271; Hanscheid T, 2003, CLIN MICROBIOL INFEC, V9, P497, DOI 10.1046/j.1469-0691.2003.00640.x; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Houze S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075486; Jacobs J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-505; Kurth F, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1673-z; Lalloo DG, 2016, J INFECTION, V72, P635, DOI 10.1016/j.jinf.2016.02.001; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P399, DOI 10.1111/1469-0691.12151; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P408, DOI 10.1111/1469-0691.12152; Millar SB, 2015, CLIN MICROBIOL INFEC, V21, P640, DOI 10.1016/j.cmi.2015.03.017; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Moulin F, 2009, ARCH PEDIATR, V19, P89; Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009; Mukadi P, 2015, MALARIA J, V14, P2637; Mukadi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071442; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Newman RD, 2004, ANN INTERN MED, V141, P547, DOI 10.7326/0003-4819-141-7-200410050-00012; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Rossi IA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-377; Santos L, 2015, J INFECT DEV COUNTR, V9, P321, DOI 10.3855/jidc.5454; WHO, 2016, WORLD MAL REP 2016	32	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0201622	10.1371/journal.pone.0201622	http://dx.doi.org/10.1371/journal.pone.0201622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169508	gold, Green Submitted, Green Published			2022-12-26	WOS:000443374400005
J	Giroux, M; Barra, J; Zrelli, IE; Barraud, PA; Cian, C; Guerraz, M				Giroux, Marion; Barra, Julien; Zrelli, Issam-Eddine; Barraud, Pierre-Alain; Cian, Corinne; Guerraz, Michel			The respective contributions of visual and proprioceptive afferents to the mirror illusion in virtual reality	PLOS ONE			English	Article							ONE ARM; INTEGRATION; POSITION; FEEDBACK; HAND; DISPLACEMENT; PERCEPTION; MOVEMENT; STIMULUS	The reflection of passive arm displacement in a mirror is a powerful means of inducing a kinaesthetic illusion in the static arm hidden behind the mirror. Our recent research findings suggest that this illusion is not solely visual in origin but results from the combination of visual and proprioceptive signals from the two arms. To determine the respective contributions of visual and proprioceptive signals to this illusion, we reproduced the mirror paradigm in virtual reality. As in the physical version of the mirror paradigm, one of the participant's arms (the left arm, in our study) could be flexed or extended passively. This movement was combined with displacements of the avatar's left and right forearms, as viewed in a first-person perspective through a virtual reality headset. In order to distinguish between visual and proprioceptive contributions, two unimodal conditions were applied separately: displacement of the avatar's forearms in the absence of physical displacement of the left arm (the visual condition), and displacement of the left forearm while the avatar's forearms were masked (the proprioceptive condition). Of the 34 female participants included in the study, 28 experienced a kinaesthetic mirror illusion in their static (right) arm. The strength of the illusion (expressed in terms of speed and duration) evoked by the bimodal condition was much higher than that observed in either of the two unimodal conditions. Our present results confirm that the involvement of visual signals in the mirror illusion-often considered as a prototypic visual illusion-has been overstated. The mirror illusion also involves non-visual signals (bilateral proprioceptive-somaesthetic signals, in fact) that interact with the visual signals and strengthen the kinaesthetic effect.	[Giroux, Marion; Barra, Julien; Zrelli, Issam-Eddine; Cian, Corinne; Guerraz, Michel] Univ Grenoble Alpes, Univ Savoie Mont Blanc, CNRS, LPNC, Grenoble, France; [Barraud, Pierre-Alain] Univ Grenoble Alpes, Univ Savoie Mont Blanc, CNRS, CHU Grenoble Aloes,Grenoble INP,TIMC IMAG, Grenoble, France; [Cian, Corinne] Inst Rech Biomed Armees, Bretigny Sur Orge, France	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite Gustave-Eiffel; CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel	Guerraz, M (corresponding author), Univ Grenoble Alpes, Univ Savoie Mont Blanc, CNRS, LPNC, Grenoble, France.	michel.guerraz@univ-smb.fr		GUERRAZ, Michel/0000-0002-4267-6995	University Savoie Mont Blanc (France)	University Savoie Mont Blanc (France)	This work was supported through funding from the University Savoie Mont Blanc (France).	Ambron E, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00067; Blanchard C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062475; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bresciani JP, 2008, SPRINGER TRAC ADV RO, V45, P61, DOI 10.1007/978-3-540-79035-8_5; Brun C, 2015, NEUROSCIENCE, V310, P268, DOI 10.1016/j.neuroscience.2015.09.052; Brun C, 2015, NEUROSCIENCE, V285, P343, DOI 10.1016/j.neuroscience.2014.11.036; Brunner I, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0186-z; Chancel M, 2016, J NEUROPHYSIOL, V116, P1522, DOI 10.1152/jn.00883.2015; Chancel M, 2017, NEUROSCIENCE, V362, P118, DOI 10.1016/j.neuroscience.2017.08.036; Chancel M, 2016, EXP BRAIN RES, V234, P1459, DOI 10.1007/s00221-015-4549-5; Cordo PJ, 2000, EXP BRAIN RES, V132, P1, DOI 10.1007/s002219900319; Deconinck FJA, 2015, NEUROREHAB NEURAL RE, V29, P349, DOI 10.1177/1545968314546134; Dichgans Johannes, 1978, PERCEPTION, P755, DOI DOI 10.1007/978-3-642-46354-9_25; Dietz V, 2015, CEREB CORTEX, V25, P948, DOI 10.1093/cercor/bht285; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dohle C, 2009, NEUROREHAB NEURAL RE, V23, P209, DOI 10.1177/1545968308324786; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Guerraz M, 2012, NEUROSCIENCE, V223, P258, DOI 10.1016/j.neuroscience.2012.07.059; Haggard P, 2000, PERCEPT PSYCHOPHYS, V62, P363, DOI 10.3758/BF03205556; Hakuta N, 2014, EXP BRAIN RES, V232, P2197, DOI 10.1007/s00221-014-3911-3; HAY JC, 1965, PSYCHON SCI, V2, P215, DOI 10.3758/BF03343413; Izumizaki M, 2010, J PHYSIOL-LONDON, V588, P2789, DOI 10.1113/jphysiol.2010.192336; Kuehn E, 2015, EXP BRAIN RES, V233, P1273, DOI 10.1007/s00221-015-4205-0; Laboissiere R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186431; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub2, 10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4]; Lee SH, 2018, ARCH PHYS MED REHAB, V99, P1447, DOI 10.1016/j.apmr.2018.01.030; Marasco PD, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6990; Metral M, 2015, EXP BRAIN RES, V233, P1463, DOI 10.1007/s00221-015-4220-1; Metral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080360; Ramachandran VS, 2009, BRAIN, V132, P1693, DOI 10.1093/brain/awp135; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Ridderikhoff A, 2006, NEUROSCI LETT, V399, P71, DOI 10.1016/j.neulet.2006.01.026; Seno T, 2012, SEEING PERCEIVING, V25, P631, DOI 10.1163/18784763-00002394; TARDYGERVET MF, 1984, BEHAV BRAIN RES, V11, P171, DOI 10.1016/0166-4328(84)90139-6; Touzalin-Chretien P, 2010, CEREB CORTEX, V20, P2007, DOI 10.1093/cercor/bhp271; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Wong JD, 2014, J NEUROPHYSIOL, V111, P1362, DOI 10.1152/jn.00537.2013; Zampini M, 2004, J NEUROL NEUROSUR PS, V75, P1626, DOI 10.1136/jnnp.2003.028589	39	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203086	10.1371/journal.pone.0203086	http://dx.doi.org/10.1371/journal.pone.0203086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161207	Green Submitted, Green Published, gold			2022-12-26	WOS:000443388900080
J	Xu, YF; Liu, ZL; Pan, C; Yang, XQ; Ning, SL; Liu, HD; Guo, S; Yu, JM; Zhang, ZL				Xu, Yun-Fei; Liu, Zeng-Li; Pan, Chang; Yang, Xiao-Qing; Ning, Shang-Lei; Liu, Hong-Da; Guo, Sen; Yu, Jin-Ming; Zhang, Zong-Li			HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium	ONCOGENE			English	Article							EXPRESSION; CONTRIBUTES; PROGRESSION; INJURY	Perihilar cholangiocarcinoma (PHCCA) is the most common type of cholangiocarcinoma with low resection rate and high morbidity. The study of PHCCA biomarkers made progresses slowly compared with intrahepatic cholangiocarcinoma because of surgical complexity and low possibility of radical surgery, which resulted in the difficulty of specimen obtainment. To screen and identify new biomarkers in PHCCA, we constructed a retrospective cohort with 121 PHCCA patients and a prospective cohort consisting of 64 PHCCA patients, and screened the candidate biomarkers by immunohistochemistry and quantified PCR. In our study, expression of high mobility group box 1 (HMGB1) was demonstrated to be significantly associated with microvascular density (MVD) and unfavorable prognosis of PHCCA in both retrospective and prospective study. Moreover, HMGB1 concentrations in bile and serum of PHCCA patients and healthy controls were detected and compared. Postoperative serum HMGB1 and reflux cholangitis indicated recurrence and unfavorable prognosis of PHCCA. With experiments in vitro and in vivo, we demonstrated that intracellular HMGB1 could be released from PHCCA cells and induce invasion and angiogenesis with LPS stimulation. VEGFR2 expression in vessel endothelial cells was upregulated by the released HMGB1 from PHCCA, resulting in the ectopic angiogenesis. In conclusion, intracellular HMGB1 could be released from PHCCA cells and promote angiogenesis via elevating VEGFR2 in vessel endothelial cells. High expression of HMGB1 was associated with MVD and poor prognosis in clinical analyzation. Postoperative serum HMGB1 and cholangitis could predict high recurrence and unfavorable prognosis.	[Xu, Yun-Fei; Liu, Zeng-Li; Ning, Shang-Lei; Guo, Sen; Zhang, Zong-Li] Shandong Univ, Dept Gen Surg, Qilu Hosp, Jinan, Shandong, Peoples R China; [Pan, Chang] Shandong Univ, Dept Emergency Med, Qilu Hosp, Jinan, Shandong, Peoples R China; [Pan, Chang] Shandong Univ, Chest Pain Ctr, Qilu Hosp, Jinan, Shandong, Peoples R China; [Yang, Xiao-Qing] Shandong Univ, Dept Pathol, Qianfoshan Hosp, Jinan, Shandong, Peoples R China; [Liu, Hong-Da] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Yu, Jin-Ming] Shandong Univ, Dept Radiat Oncol, Shandong Canc Hosp, Shandong Acad Med Sci, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Jinan	Zhang, ZL (corresponding author), Shandong Univ, Dept Gen Surg, Qilu Hosp, Jinan, Shandong, Peoples R China.; Yu, JM (corresponding author), Shandong Univ, Dept Radiat Oncol, Shandong Canc Hosp, Shandong Acad Med Sci, Jinan, Shandong, Peoples R China.	sdyujinming@163.com; zzlzzl1900@163.com	guo, sen/GWQ-3573-2022	Liu, Hongda/0000-0002-5977-9130	National Natural Science Foundation of China [81601668, 31701013]; Shandong Province Major Research and Design Program [2017GSF218059, 2016GSF201132]; Natural Science Foundation of Shandong [ZR2017BC032]; China Postdoctoral Science Foundation [2017M610167, 2017T100163]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Major Research and Design Program; Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The study was supported by National Natural Science Foundation of China (Grant Nos. 81601668 and 31701013), Shandong Province Major Research and Design Program (Grant Nos. 2017GSF218059 and 2016GSF201132), Natural Science Foundation of Shandong (Grant No. ZR2017BC032), and China Postdoctoral Science Foundation (Grant Nos. 2017M610167 and 2017T100163).	Avgousti DC, 2016, NATURE, V535, P173, DOI 10.1038/nature18317; DeOliveira ML, 2007, ANN SURG, V245, P755, DOI 10.1097/01.sla.0000251366.62632.d3; Dixelius J, 2006, CANCER RES, V66, P2089, DOI 10.1158/0008-5472.CAN-05-2217; Gnanasekar M, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/157103; Huebener P, 2015, J CLIN INVEST, V125, P539, DOI 10.1172/JCI76887; Kang R, 2017, CELL RES, V27, P916, DOI 10.1038/cr.2017.51; Kuniyasu H, 2005, AM J PATHOL, V166, P751, DOI 10.1016/S0002-9440(10)62296-1; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Lillemoe Keith D, 2003, Semin Gastrointest Dis, V14, P208; Poser I, 2003, MOL CELL BIOL, V23, P2991, DOI 10.1128/MCB.23.8.2991-2998.2003; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; Rizvi S, 2018, NAT REV CLIN ONCOL, V15, P95, DOI 10.1038/nrclinonc.2017.157; Rizvi S, 2013, GASTROENTEROLOGY, V145, P1215, DOI 10.1053/j.gastro.2013.10.013; Sia D, 2013, GASTROENTEROLOGY, V144, P829, DOI 10.1053/j.gastro.2013.01.001; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; van Beijnum JR, 2013, ONCOGENE, V32, P363, DOI 10.1038/onc.2012.49; Wu D, 2008, J PATHOL, V216, P167, DOI 10.1002/path.2391; Xu YF, 2015, WORLD J GASTROENTERO, V21, P3256, DOI 10.3748/wjg.v21.i11.3256; Xu YF, 2014, BIOCHEM BIOPH RES CO, V446, P54, DOI 10.1016/j.bbrc.2014.02.050; Yang H, 2015, MOL MED, V21, pS6, DOI 10.2119/molmed.2015.00087; Yang RK, 2009, AM J PHYSIOL-REG I, V297, pR362, DOI 10.1152/ajpregu.00184.2009; Yoshikawa D, 2008, BRIT J CANCER, V98, P418, DOI 10.1038/sj.bjc.6604129; Zhang QH, 2013, AUTOPHAGY, V9, P451, DOI 10.4161/auto.23691	24	49	49	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 7	2019	38	6					868	880		10.1038/s41388-018-0485-8	http://dx.doi.org/10.1038/s41388-018-0485-8			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HK5LC	30177842				2022-12-26	WOS:000458006300008
J	Swaroop, A; Oyer, JA; Will, CM; Huang, XX; Yu, WB; Troche, C; Bulic, M; Durham, BH; Wen, QJ; Crispino, JD; MacKerell, AD; Bennett, RL; Kelleher, NL; Licht, JD				Swaroop, Alok; Oyer, Jon A.; Will, Christine M.; Huang, Xiaoxiao; Yu, Wenbo; Troche, Catalina; Bulic, Marinka; Durham, Benjamin H.; Wen, Qiang Jeremy; Crispino, John D.; MacKerell, Alexander D., Jr.; Bennett, Richard L.; Kelleher, Neil L.; Licht, Jonathan D.			An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia	ONCOGENE			English	Article							MULTIPLE-MYELOMA; GENE-EXPRESSION; LYSINE 36; SOMATIC MUTATIONS; IN-VIVO; METHYLATION; MMSET; H3; EZH2; LANDSCAPE	NSD2, a histone methyltransferase specific for methylation of histone 3 lysine 36 (H3K36), exhibits a glutamic acid to lysine mutation at residue 1099 (E1099K) in childhood acute lymphocytic leukemia (ALL), and cells harboring this mutation can become the predominant clone in relapsing disease. We studied the effects of this mutant enzyme in silico, in vitro, and in vivo using gene edited cell lines. The E1099K mutation altered enzyme/substrate binding and enhanced the rate of H3K36 methylation. As a result, cell lines harboring E1099K exhibit increased H3K36 dimethylation and reduced H3K27 trimethylation, particularly on nucleosomes containing histone H3.1. Mutant NSD2 cells exhibit reduced apoptosis and enhanced proliferation, clonogenicity, adhesion, and migration. In mouse xenografts, mutant NSD2 cells are more lethal and brain invasive than wildtype cells. Transcriptional profiling demonstrates that mutant NSD2 aberrantly activates factors commonly associated with neural and stromal lineages in addition to signaling and adhesion genes. Identification of these pathways provides new avenues for therapeutic interventions in NSD2 dysregulated malignancies.	[Swaroop, Alok; Huang, Xiaoxiao; Troche, Catalina; Bennett, Richard L.; Licht, Jonathan D.] Univ Florida, Div Hematol Oncol, Hlth Canc Ctr, Gainesville, FL 32611 USA; [Swaroop, Alok; Oyer, Jon A.; Will, Christine M.; Huang, Xiaoxiao; Bulic, Marinka; Wen, Qiang Jeremy; Crispino, John D.; Licht, Jonathan D.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Chicago, IL 60611 USA; [Huang, Xiaoxiao; Kelleher, Neil L.] Northwestern Univ, Dept Chem, Chem Life Proc Inst, Evanston, IL USA; [Huang, Xiaoxiao] Northwestern Univ, Dept Mol Biosci, Chem Life Proc Inst, Evanston, IL USA; [Yu, Wenbo; MacKerell, Alexander D., Jr.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Comp Aided Drug Design Ctr, Baltimore, MD 21201 USA; [Durham, Benjamin H.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA	State University System of Florida; University of Florida; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Northwestern University; University System of Maryland; University of Maryland Baltimore; Memorial Sloan Kettering Cancer Center	Licht, JD (corresponding author), Univ Florida, Div Hematol Oncol, Hlth Canc Ctr, Gainesville, FL 32611 USA.; Licht, JD (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Chicago, IL 60611 USA.	jdlicht@ufl.edu	Bennett, Richard/ABF-9211-2021; Huang, Xiaoxiao/ABG-2564-2020; MacKerell, Alex/AAA-2560-2020; Licht, Jonathan/AAL-9184-2020	Huang, Xiaoxiao/0000-0002-4623-2005; Licht, Jonathan/0000-0002-3942-1369; Oyer, Jon/0000-0002-5479-3400; Bennett, Richard/0000-0002-0243-2443; Durham, Benjamin/0000-0001-8090-5448; Crispino, John/0000-0002-8182-8306; Swaroop, Alok/0000-0003-0317-6688; Yu, Wenbo/0000-0001-6962-5314	Leukemia and Lymphoma Society Specialized Center of Excellence grant; Samuel Waxman Cancer Research Foundation; Celgene [P41 GM108569, R01 GM067193]; Lauri Strauss Leukemia Foundation;  [T32 CA009560];  [F30 CA203292];  [R01 CA195732];  [R01 GM051501]; NATIONAL CANCER INSTITUTE [T32CA009560, R01CA195732, F30CA203292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051501, R01GM067193, T32GM008152, P41GM108569] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society Specialized Center of Excellence grant(Leukemia and Lymphoma Society); Samuel Waxman Cancer Research Foundation; Celgene(Bristol-Myers SquibbCelgene Corporation); Lauri Strauss Leukemia Foundation; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by T32 CA009560 (AS), F30 CA203292 (AS), R01 CA195732 (JDL), R01 GM051501 (ADM), a Leukemia and Lymphoma Society Specialized Center of Excellence grant (JDL), the Samuel Waxman Cancer Research Foundation (ADM and JDL) and Celgene (JDL), P41 GM108569 and R01 GM067193 (NLK) and the Lauri Strauss Leukemia Foundation (JAO, CT).	[Anonymous], 2016, CANC FACTS FIG 2016; Bea S, 2013, P NATL ACAD SCI USA, V110, P18250, DOI 10.1073/pnas.1314608110; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Brennan D, 2007, J CELL SCI, V120, P758, DOI 10.1242/jcs.03392; Brito JLR, 2009, HAEMATOL-HEMATOL J, V94, P78, DOI 10.3324/haematol.13426; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Broyl A, 2010, BLOOD, V116, P2543, DOI 10.1182/blood-2009-12-261032; Campos-Sanchez E, 2017, CELL REP, V19, P1586, DOI 10.1016/j.celrep.2017.04.069; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Damgaard T, 2009, LEUKEMIA LYMPHOMA, V50, P236, DOI 10.1080/10428190802699332; Ding LW, 2017, CANCER RES, V77, P390, DOI 10.1158/0008-5472.CAN-16-1303; Ezponda T, 2013, ONCOGENE, V32, P2882, DOI 10.1038/onc.2012.297; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Faderl SH, 2008, HEMATOL MALIG, P1, DOI 10.1007/978-3-540-72304-2; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Golub TR, 2007, NATURE, V446, P739, DOI 10.1038/446739a; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hart K, 2012, J CHEM THEORY COMPUT, V8, P348, DOI 10.1021/ct200723y; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; HOLM S, 1979, SCAND J STAT, V6, P65; Huang Z, 2013, CANCER RES, V73, P6277, DOI 10.1158/0008-5472.CAN-13-1000; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Keats JJ, 2005, BLOOD, V105, P4060, DOI 10.1182/blood-2004-09-3704; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kim SM, 2006, BIOCHEM BIOPH RES CO, V345, P318, DOI 10.1016/j.bbrc.2006.04.095; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; LaFave LM, 2013, NAT GENET, V45, P1269, DOI 10.1038/ng.2808; Lauring J, 2008, BLOOD, V111, P856, DOI 10.1182/blood-2007-05-088674; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee MS, 2002, J CHEM PHYS, V116, P10606, DOI 10.1063/1.1480013; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Loh ML, 2013, BLOOD, V122, P824; Lucio-Eterovic AK, 2010, P NATL ACAD SCI USA, V107, P16952, DOI 10.1073/pnas.1002653107; Ma XT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7604; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mueller F, 2012, METHODS MOL BIOL, V833, P153, DOI 10.1007/978-1-61779-477-3_11; Mullighan CG, 2013, BLOOD, V122, P3899, DOI 10.1182/blood-2013-08-460311; Oyer JA, 2014, LEUKEMIA, V28, P198, DOI 10.1038/leu.2013.204; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Popovic R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004566; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Ravandi F, 2002, LEUKEMIA RES, V26, P643, DOI 10.1016/S0145-2126(01)00188-6; Rotenberg M., 1970, METHODS COMPUTATIONA; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Society AC, 2014, CANC FACTS FIG 2014; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Tisi D, 2016, ACS CHEM BIOL, V11, P3093, DOI 10.1021/acschembio.6b00308; Van Rechem C, 2014, BBA-GENE REGUL MECH, V1839, P1463, DOI 10.1016/j.bbagrm.2014.05.014; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Wynn RF, 2010, ACUTE LYMPHOBLASTIC, P75; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zheng YP, 2014, PROTEOMICS, V14, P2190, DOI 10.1002/pmic.201400060; Zheng YP, 2012, P NATL ACAD SCI USA, V109, P13549, DOI 10.1073/pnas.1205707109; Zhu L, 2016, CANCER DISCOV, V6, P770, DOI 10.1158/2159-8290.CD-16-0058	70	23	24	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 31	2019	38	5					671	686		10.1038/s41388-018-0474-y	http://dx.doi.org/10.1038/s41388-018-0474-y			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HJ6LI	30171259	Green Accepted			2022-12-26	WOS:000457300300005
J	Wagstaff, BA; Rejzek, M; Field, RA				Wagstaff, Ben A.; Rejzek, Martin; Field, Robert A.			Identification of a Kdn biosynthesis pathway in the haptophyte Prymnesium parvum suggests widespread sialic acid biosynthesis among microalgae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						algae; sialic acid; carbohydrate biosynthesis; bioinformatics; carbohydrate processing; enzyme; glycobiology; KDN; Prymnesium parvum	IONIZATION-MASS-SPECTROMETRY; DEAMINATED NEURAMINIC ACID; JELLY COAT; 2-KETO-3-DEOXY-D-GLYCERO-D-GALACTO-NONONIC ACID; EMILIANIA-HUXLEYI; VIRUS; NUCLEOTIDE; CHAINS; SUGARS; POLYSIALOGLYCOPROTEIN	Sialic acids are a family of more than 50 structurally distinct acidic sugars on the surface of all vertebrate cells where they terminate glycan chains and are exposed to many interactions with the surrounding environment. In particular, sialic acids play important roles in cell-cell and host-pathogen interactions. The sialic acids or related nonulosonic acids have been observed in Deuterostome lineages, Eubacteria, and Archaea but are notably absent from plants. However, the structurally related C8 acidic sugar 3-deoxy-d-manno-2-octulosonic acid (Kdo) is present in Gram-negative bacteria and plants as a component of bacterial lipopolysaccharide and pectic rhamnogalacturonan II in the plant cell wall. Until recently, sialic acids were not thought to occur in algae, but as in plants, Kdo has been observed in algae. Here, we report the de novo biosynthesis of the deaminated sialic acid, 3-deoxy-d-glycero-d-galacto-2-nonulosonic acid (Kdn), in the toxin-producing microalga Prymnesium parvum. Using biochemical methods, we show that this alga contains CMP-Kdn and identified and recombinantly expressed the P. parvum genes encoding Kdn-9-P synthetase and CMP-Kdn synthetase enzymes that convert mannose-6-P to CMP-Kdn. Bioinformatics analysis revealed sequences related to those of the two P. parvum enzymes, suggesting that sialic acid biosynthesis is likely more widespread among microalgae than previously thought and that this acidic sugar may play a role in host-pathogen interactions involving microalgae. Our findings provide evidence that P. parvum has the biosynthetic machinery for de novo production of the deaminated sialic acid Kdn and that sialic acid biosynthesis may be common among microalgae.	[Wagstaff, Ben A.; Rejzek, Martin; Field, Robert A.] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Field, RA (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	rob.field@jic.ac.uk		Field, Rob/0000-0001-8574-0275; Rejzek, Martin/0000-0002-5091-544X	Research Councils UK [BB/j004561/1]; Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC Industrial CASE Ph. D. studentship - Environment Agency; BBSRC [BBS/E/J/000C0618] Funding Source: UKRI	Research Councils UK(UK Research & Innovation (UKRI)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Industrial CASE Ph. D. studentship - Environment Agency(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant BB/j004561/1 from the Research Councils UK and the Biotechnology and Biological Sciences Research Council (BBSRC) and by a BBSRC Industrial CASE Ph. D. studentship supported by the Environment Agency. The authors declare that they have no conflicts of interest with the contents of this article.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; BECKER D, 1990, PROTOPLASMA, V156, P103, DOI 10.1007/BF01666511; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Blix G, 1936, H-S Z PHYSIOL CHEM, V240, P43, DOI 10.1515/bchm2.1936.240.1-2.43; Crocker PR, 2001, TRENDS IMMUNOL, V22, P337, DOI 10.1016/S1471-4906(01)01930-5; Daughtry KD, 2013, BIOCHEMISTRY-US, V52, P5372, DOI 10.1021/bi400659k; Edvardsen B., 1998, NATO ASI SERIES G, V41, P192; Fulton JM, 2014, ENVIRON MICROBIOL, V16, P1137, DOI 10.1111/1462-2920.12358; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Graneli E, 2012, HARMFUL ALGAE, V14, P260, DOI 10.1016/j.hal.2011.10.024; Guo MX, 1996, J APPL PHYCOL, V8, P111, DOI 10.1007/BF02186313; Hao J, 2006, BIOCHEM J, V397, P195, DOI 10.1042/BJ20052034; Hao JJ, 2005, BIOCHEM BIOPH RES CO, V338, P1507, DOI 10.1016/j.bbrc.2005.10.113; HARA S, 1988, ANAL CHIM ACTA, V215, P267, DOI 10.1016/S0003-2670(00)85285-X; Hems ES, 2018, CARBOHYD RES, V463, P14, DOI 10.1016/j.carres.2018.04.008; Inoue S, 1996, J BIOL CHEM, V271, P24341, DOI 10.1074/jbc.271.40.24341; Inoue S, 1998, J BIOL CHEM, V273, P27199, DOI 10.1074/jbc.273.42.27199; IWASAKI M, 1990, J BIOL CHEM, V265, P2596; Janouskovec J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059001; KAARTVEDT S, 1991, CAN J FISH AQUAT SCI, V48, P2316, DOI 10.1139/f91-272; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keeling PJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001889; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Kenyon JJ, 2015, GLYCOBIOLOGY, V25, P644, DOI 10.1093/glycob/cwv007; KIMURA M, 1994, J BIOL CHEM, V269, P32138; Klein A, 1997, GLYCOBIOLOGY, V7, P421, DOI 10.1093/glycob/7.3.421; KNIREL YA, 1989, CARBOHYD RES, V188, P145, DOI 10.1016/0008-6215(89)84067-4; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; La Scola B, 2003, SCIENCE, V299, P2033; Leblanc K, 2009, BIOGEOSCIENCES, V6, P2155, DOI 10.5194/bg-6-2155-2009; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; NADANO D, 1986, J BIOL CHEM, V261, P1550; Pabst M, 2010, ANAL CHEM, V82, P9782, DOI 10.1021/ac101975k; PLANCKE Y, 1995, EUR J BIOCHEM, V231, P434, DOI 10.1111/j.1432-1033.1995.tb20716.x; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; Radaev S, 2000, J BIOL CHEM, V275, P9476, DOI 10.1074/jbc.275.13.9476; Rejzek M, 2017, METHOD ENZYMOL, V597, P209, DOI 10.1016/bs.mie.2017.06.005; Roelke DL, 2016, HYDROBIOLOGIA, V764, P29, DOI 10.1007/s10750-015-2273-6; Rose SL, 2014, ENVIRON MICROBIOL, V16, P1150, DOI 10.1111/1462-2920.12357; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schatz D, 2014, NEW PHYTOL, V204, P854, DOI 10.1111/nph.13008; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Schoemann V, 2005, J SEA RES, V53, P43, DOI 10.1016/j.seares.2004.01.008; Shashkov AS, 2002, CARBOHYD RES, V337, P2255, DOI 10.1016/S0008-6215(02)00188-X; Short SM, 2012, ENVIRON MICROBIOL, V14, P2253, DOI 10.1111/j.1462-2920.2012.02706.x; Southard GM, 2010, J AM WATER RESOUR AS, V46, P14, DOI 10.1111/j.1752-1688.2009.00387.x; Stencel-Baerenwald JE, 2014, NAT REV MICROBIOL, V12, P739, DOI 10.1038/nrmicro3346; STRECKER G, 1992, EUR J BIOCHEM, V207, P995, DOI 10.1111/j.1432-1033.1992.tb17135.x; STRECKER G, 1992, FEBS LETT, V298, P39, DOI 10.1016/0014-5793(92)80018-C; Sundaram AK, 2004, BIOCHEM J, V383, P83, DOI 10.1042/BJ20040218; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; TERADA T, 1993, J BIOL CHEM, V268, P2640; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; Varki A, 2017, ESSENTIALS GLYCOBIOL, V2015-2017; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Wagstaff B. A., 2017, VIRUSES, V9, pE40; Wagstaff BA, 2018, BIOCHEM SOC T, V46, P413, DOI [10.1042/BST20170393, 10.1042/bst20170393]; Wagstaff BA, 2015, CARBOHYD RES, V404, P17, DOI 10.1016/j.carres.2014.12.005; Wang LB, 2008, CHEM BIOL, V15, P893, DOI 10.1016/j.chembiol.2008.08.005; Wilhelm SW, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005752; Wilson WH, 2002, J MAR BIOL ASSOC UK, V82, P369, DOI 10.1017/S002531540200560X; YARIV J, 1961, J GEN MICROBIOL, V24, P165, DOI 10.1099/00221287-24-2-165	65	8	8	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16277	16290		10.1074/jbc.RA118.004921	http://dx.doi.org/10.1074/jbc.RA118.004921			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30171074	Green Published, hybrid			2022-12-26	WOS:000447833600014
J	Grinberg, IR; Lundin, D; Sahlin, M; Crona, M; Berggren, G; Hofer, A; Sjoberg, BM				Grinberg, Inna Rozman; Lundin, Daniel; Sahlin, Margareta; Crona, Mikael; Berggren, Gustav; Hofer, Anders; Sjoberg, Britt-Marie			A glutaredoxin domain fused to the radical-generating subunit of ribonucleotide reductase (RNR) functions as an efficient RNR reductant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribonucleotide reductase; allosteric regulation; oxidation-reduction (redox); radical; manganese; ATP-cone; dATP inhibition; dithiol-monothiol; glutaredoxin; tetramers	ESCHERICHIA-COLI; INTERESTING ENZYME; THIOREDOXIN; COFACTOR; PROTEIN; WORLD; GLUTATHIONE; MECHANISM; SYSTEMS; THIOL	Class I ribonucleotide reductase (RNR) consists of a catalytic subunit (NrdA) and a radical-generating subunit (NrdB) that together catalyze reduction of ribonucleotides to their corresponding deoxyribonucleotides. NrdB from the firmicute Facklamia ignava is a unique fusion protein with N-terminal addons of a glutaredoxin (Grx) domain followed by an ATP-binding domain, the ATP cone. Grx, usually encoded separately from the RNR operon, is a known RNR reductant. We show that the fused Grx domain functions as an efficient reductant of the F. ignava class I RNR via the common dithiol mechanism and, interestingly, also via a monothiol mechanism, although less efficiently. To our knowledge, a Grx that uses both of these two reaction mechanisms has not previously been observed with a native substrate. The ATP cone is in most RNRs an N-terminal domain of the catalytic subunit. It is an allosteric on/off switch promoting ribonucleotide reduction in the presence of ATP and inhibiting RNR activity in the presence of dATP. We found that dATP bound to the ATP cone of F. ignava NrdB promotes formation of tetramers that cannot form active complexes with NrdA. The ATP cone bound two dATP molecules but only one ATP molecule. F. ignava NrdB contains the recently identified radical-generating cofactor Mn-III/Mn-IV. We show that NrdA from F. ignava can form a catalytically competent RNR with the Mn-III/Mn-IV-containing NrdB from the flavobacterium Leeuwenhoekiella blandensis. In conclusion, F. ignava NrdB is fused with a Grx functioning as an RNR reductant and an ATP cone serving as an on/off switch.	[Grinberg, Inna Rozman; Lundin, Daniel; Sahlin, Margareta; Crona, Mikael; Sjoberg, Britt-Marie] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Crona, Mikael] Swedish Orphan Biovitrum AB, SE-11276 Stockholm, Sweden; [Berggren, Gustav] Uppsala Univ, Dept Chem, SE-75236 Uppsala, Sweden; [Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden	Stockholm University; Swedish Orphan Biovitrum; Uppsala University; Umea University	Sjoberg, BM (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	britt-marie.sjoberg@dbb.su.se	Berggren, Gustav/H-8659-2013	Berggren, Gustav/0000-0002-6717-6612; Hofer, Anders/0000-0003-2890-2957; Sjoberg, Britt-Marie/0000-0001-5953-3360	Swedish Cancer Society [CAN 2016/670]; Swedish Research Council [2016-01920, 621-2014-5670]; Wenner-Gren Foundations grant; Carl Trygger Foundation; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [213-2014-880]; European Research Council [714102]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Wenner-Gren Foundations grant; Carl Trygger Foundation; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); European Research Council(European Research Council (ERC)European Commission)	This work was supported by Swedish Cancer Society Grant CAN 2016/670 (to B.-M. S.), Swedish Research Council Grant 2016-01920 (to B.-M. S.), a Wenner-Gren Foundations grant (to B.-M. S.), and a Carl Trygger Foundation grant (to A. H.). Work in the laboratory of G. B. is supported by Swedish Research Council Grant 621-2014-5670; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning Grant 213-2014-880; and European Research Council Grant 714102. The authors declare that they have no conflicts of interest with the contents of this article.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Avval FZ, 2009, J BIOL CHEM, V284, P8233, DOI 10.1074/jbc.M809338200; Begas P, 2015, CHEM SCI, V6, P3788, DOI 10.1039/c5sc01051a; Berggren G, 2017, METALLOPROTEIN ACTIV, DOI [10.1002/9781119951438.eibc2480, DOI 10.1002/9781119951438.EIBC2480]; BERGLUND O, 1975, J BIOL CHEM, V250, P7450; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Collins MD, 1998, J CLIN MICROBIOL, V36, P2146, DOI 10.1128/JCM.36.7.2146-2148.1998; Collins MD, 1997, INT J SYST BACTERIOL, V47, P880, DOI 10.1099/00207713-47-3-880; Cotruvo JA, 2013, J AM CHEM SOC, V135, P4027, DOI 10.1021/ja312457t; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; Crona M., 2010, THESIS; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fahey RC, 2013, BBA-GEN SUBJECTS, V1830, P3182, DOI 10.1016/j.bbagen.2012.10.006; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; Grinberg IR, 2018, ELIFE, V7, DOI 10.7554/eLife.31529; Haft DH, 2018, NUCLEIC ACIDS RES, V46, pD851, DOI 10.1093/nar/gkx1068; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hogbom M, 2004, SCIENCE, V305, P245, DOI 10.1126/science.1098419; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Jiang W, 2007, SCIENCE, V316, P1188, DOI 10.1126/science.1141179; Jonna VR, 2015, J BIOL CHEM, V290, P17339, DOI 10.1074/jbc.M115.649624; Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044; Kaufman SL, 1996, ANAL CHEM, V68, P1895, DOI 10.1021/ac951128f; Kingry LC, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00035; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lillig CH, 2013, ANTIOXID REDOX SIGN, V18, P1654, DOI 10.1089/ars.2012.5007; Lundin Daniel, 2015, Life-Basel, V5, P604, DOI 10.3390/life5010604; Mashamaite LN, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140157; Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753; Mathews CK, 2018, FASEB J, V32, P4067, DOI 10.1096/fj.201800790R; Mathews CK, 2016, STRUCTURE, V24, P843, DOI 10.1016/j.str.2016.05.006; Rahmati E, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw272; Reichard P, 2010, BIOCHEM BIOPH RES CO, V396, P19, DOI 10.1016/j.bbrc.2010.02.108; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; Rose HR, 2018, BIOCHEMISTRY-US, V57, P2679, DOI 10.1021/acs.biochem.8b00247; Sengupta Rajib, 2014, World J Biol Chem, V5, P68, DOI 10.4331/wjbc.v5.i1.68; Srinivas V., 2018, BIORXIV; Stubbe J, 2000, CURR OPIN STRUC BIOL, V10, P731, DOI 10.1016/S0959-440X(00)00153-6; Torrents E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00052; Ukuwela AA, 2018, CHEM SCI, V9, P1173, DOI 10.1039/c7sc04416j; VlamisGardikas A, 1997, J BIOL CHEM, V272, P11236; ZHENG M, 1994, INORG CHEM, V33, P382, DOI 10.1021/ic00080a030	46	9	9	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15889	15900		10.1074/jbc.RA118.004991	http://dx.doi.org/10.1074/jbc.RA118.004991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30166338	Green Published, hybrid			2022-12-26	WOS:000447256000013
J	Gallay, J; Pothin, E; Mosha, D; Lutahakana, E; Mazuguni, F; Zuakulu, M; Decosterd, LA; Genton, B				Gallay, Joanna; Pothin, Emilie; Mosha, Dominic; Lutahakana, Erick; Mazuguni, Festo; Zuakulu, Martin; Decosterd, Laurent Arthur; Genton, Blaise			Predictors of residual antimalarial drugs in the blood in community surveys in Tanzania	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; POPULATION PHARMACOKINETICS; SULFADOXINE-PYRIMETHAMINE; CLINICAL PHARMACOKINETICS; MALARIA PARASITES; FEBRILE ILLNESS; CHILDREN; CHLOROQUINE; COMBINATION; METABOLITES	Background Understanding pattern of antimalarials use at large scale helps ensuring appropriate use of treatments and preventing the spread of resistant parasites. We estimated the proportion of individuals in community surveys with residual antimalarials in their blood and identified the factors associated with the presence of the most commonly detected drugs, lumefantrine and/or desbutyl-lumefantrine (LF/DLF) or sulfadoxine-pyrimethamine (SP). Methods A cross-sectional survey was conducted in 2015 in three regions of Tanzania with different levels of malaria endemicity. Interviews were conducted and blood samples collected through household surveys for further antimalarial measurements using liquid chromatography coupled to tandem mass spectrometry. In addition, diagnosis and treatment availability was investigated through outlet surveys. Multilevel mixed effects logistic regression models were used to estimate odds ratios for having LF/DLF or SP in the blood. Results Amongst 6391 participants, 12.4% (792/6391) had LF/DLF and 8.0% (510/6391) SP in the blood. Factors associated with higher odds of detecting LF/DLF in the blood included fever in the previous two weeks (OR = 2.6, p<0.001), living in districts of higher malaria prevalence (OR = 1.5, p<0.001) and living in a ward in which all visited drug stores had artemisinin-based combination therapies in stocks (OR = 2.7, p = 0.020). Participants in older age groups were less likely to have LF/DLF in the blood (OR = 0.9, p<0.001). Factors associated with higher odds of having SP in the blood included being pregnant (OR = 4.6, p<0.001), living in Mwanza (OR = 3.9, p<0.001 compared to Mbeya), fever in the previous two weeks (OR = 1.7, p<0.001) and belonging to older age groups (OR = 1.2, p<0.001). Conclusion The most significant predictors identified were expected. History of fever in the past two weeks and young age were significant predictors of LF/DLF in the blood, which is encouraging. Antimalarial drug pressure was high and hence the use of recommended first-line drugs in combination with malaria Rapid Diagnostics Tests should be promoted to ensure appropriate treatment.	[Gallay, Joanna; Pothin, Emilie; Genton, Blaise] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Gallay, Joanna; Pothin, Emilie; Genton, Blaise] Univ Basel, Basel, Switzerland; [Gallay, Joanna; Decosterd, Laurent Arthur] Univ Hosp, Serv & Lab Clin Pharmacol, Lausanne, Switzerland; [Mosha, Dominic; Lutahakana, Erick; Mazuguni, Festo; Zuakulu, Martin] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Genton, Blaise] Univ Hosp, Div Infect Dis, Lausanne, Switzerland; [Genton, Blaise] Univ Hosp, Dept Community Hlth, Lausanne, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Ifakara Health Institute; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Gallay, J (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.; Gallay, J (corresponding author), Univ Basel, Basel, Switzerland.; Gallay, J (corresponding author), Univ Hosp, Serv & Lab Clin Pharmacol, Lausanne, Switzerland.	Joanna.gallay@swisstph.ch	Decosterd, Laurent/E-8494-2019	Decosterd, Laurent/0000-0002-9840-1325; Mazuguni, Festo/0000-0002-0984-7529	Swiss National Science Foundation [320030_149597]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Financial support for this work was provided by grant No 320030_149597 from the Swiss National Science Foundation (http://www.snf.ch/fr/Pages/default.aspx). BG received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinan J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175446; [Anonymous], NAT MAL STRAT PLAN 2; [Anonymous], 2011, GLOB PLAN ART RES CO; [Anonymous], 2017, MAL CHILDR 5; [Anonymous], 2015, TANZANIA DEMOGRAPHIC; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Chipwaza B, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-252; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Ducharme J, 1996, CLIN PHARMACOKINET, V31, P257, DOI 10.2165/00003088-199631040-00003; Embrey M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164332; European Union (EU), 2012, POPULATION HOUSING C; Gallay J, 2018, J PHARM BIOMED ANAL; Gallay J, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2357-7; Gardella F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-124; Hastings I, 2011, TRENDS PARASITOL, V27, P67, DOI 10.1016/j.pt.2010.09.005; HELLGREN U, 1994, TROP MED PARASITOL, V45, P293; Hertz JT, 2013, TROP MED INT HEALTH, V18, P1406, DOI 10.1111/tmi.12191; Hodel EM, 2009, J CHROMATOGR B, V877, P867, DOI 10.1016/j.jchromb.2009.02.006; Hodel EM, 2010, J INFECT DIS, V202, P1088, DOI 10.1086/655779; Hodel EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008184; Jullien V, 2010, ANTIMICROB AGENTS CH, V54, P2611, DOI 10.1128/AAC.01496-09; Kavishe RA, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1387-2; Kay K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0810-4; Larson PS, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-526; Lussiana C, 2016, HEALTH POLICY PLANN, V31, P928, DOI 10.1093/heapol/czv028; Metta E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-249; Michael D, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1819-7; Mockenhaupt FP, 2000, ANTIMICROB AGENTS CH, V44, P835, DOI 10.1128/AAC.44.4.835-839.2000; Mugittu K, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-55; MUGITTU K, 2006, TANZANIA MALAR J, V5, DOI DOI 10.1186/1475-2875-5-126; Muller I, 1998, INT J EPIDEMIOL, V27, P878, DOI 10.1093/ije/27.5.878; Nadjm B, 2012, T ROY SOC TROP MED H, V106, P688, DOI 10.1016/j.trstmh.2012.08.006; Najnin N, 2011, J HEALTH POPUL NUTR, V29, P523, DOI 10.3329/jhpn.v29i5.8907; National Guidelines for Diagnosis and Treatment of Malaria, 2005, UN REP TANZ; National Malaria Control Program NMCP Ghana, 2013, EP PROF MAL ITS CONT; Njozi M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1097; Nwanyanwu OC, 1996, T ROY SOC TROP MED H, V90, P66, DOI 10.1016/S0035-9203(96)90482-4; Odongo CO, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0702-7; Orrell C, 2008, EUR J CLIN PHARMACOL, V64, P683, DOI 10.1007/s00228-007-0452-8; Reuter SE, 2015, J ANTIMICROB CHEMOTH, V70, P868, DOI 10.1093/jac/dku430; Ringsted FM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-238; Salman S, 2011, ANTIMICROB AGENTS CH, V55, P5306, DOI 10.1128/AAC.05136-11; Tekete MM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-275; Thomson R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095607; Verhoef H, 1999, AM J TROP MED HYG, V61, P770, DOI 10.4269/ajtmh.1999.61.770; WATSIERAH CA, 2010, KENYA MALAR J, V9, DOI DOI 10.1186/1475-2875-9-295; Watsierah CA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-99; White NJ, 1999, CLIN PHARMACOKINET, V37, P105, DOI 10.2165/00003088-199937020-00002; White NJ, 2003, P ROY SOC B-BIOL SCI, V270, P545, DOI 10.1098/rspb.2002.2241; World Health Organization, 2015, GUID TREATM MAL, Vthird	51	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202745	10.1371/journal.pone.0202745	http://dx.doi.org/10.1371/journal.pone.0202745			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192770	gold, Green Accepted, Green Published			2022-12-26	WOS:000444093600033
J	Ishiyama, H; Ishikawa, A; Kitazawa, H; Fujii, S; Matsubayashi, J; Yamada, S; Takakuwa, T				Ishiyama, Hana; Ishikawa, Aoi; Kitazawa, Haruka; Fujii, Sena; Matsubayashi, Jun; Yamada, Shigehito; Takakuwa, Tetsuya			Branching morphogenesis of the urinary collecting system in the human embryonic metanephros	PLOS ONE			English	Article							KIDNEY DEVELOPMENT; MOUSE KIDNEY; MICRODISSECTION; QUANTIFICATION; NEPHRONS; DISEASE; NUMBER	An elaborate system of ducts collects urine from all nephrons, and this structure is known as the urinary collecting system (UCS). This study focused on how the UCS is formed during human embryogenesis. Fifty human embryos between the Carnegie stage (CS) 14 and CS23 were selected from the Kyoto Collection at the Congenital Anomaly Research Center of Kyoto University, Japan. Metanephroses, including the UCS, were segmented on serial digital virtual histological sections. Three-dimensional images were computationally reconstructed for morphological and quantitative analyses. A CS timeline was plotted. It consisted of the 3-D structural morphogenesis of UCS and quantification of the total amount of end-branching, average and maximum numbers of generations, deviation in the metanephros, differentiation of the urothelial epithelium in the renal pelvis, and timing of the rapid expansion of the renal pelvis. The first UCS branching generation occurred by CS16. The average branching generation reached a maximum of 8.74 +/- 1.60 and was already the twelfth in CS23. The total end-branching number squared between the start and the end of the embryonic period. UCS would reach the fifteenth branching generation soon after CS23. The number of nephrons per UCS end-branch was low (0.21 +/- 0.14 at CS19, 1.34 +/- 0.49 at CS23), indicating that the bifid branching occurred rapidly and that the formation of nephrons followed after. The renal pelvis expanded mainly in CS23, which was earlier than that reported in a previous study. The number of nephrons connected to the UCS in the expanded group (246.0 +/- 13.2) was significantly larger than that of the pre-expanded group (130.8 +/- 80.1) (P < 0.05). The urothelial epithelium differentiated from the zeroth to the third generations at CS23. Differentiation may have continued up until the tenth generation to allow for renal pelvis expansion. The branching speed was not uniform. There were significantly more branching generations in the polar-than in the interpolar regions (P < 0.05). Branching speed reflects the growth orientation required to form the metanephros. Further study will be necessary to understand the renal pelvis expansion mechanism in CS23. Our CS-based timeline enabled us to map UCS formation and predict functional renal capacity after differentiation and growth.	[Ishiyama, Hana; Ishikawa, Aoi; Kitazawa, Haruka; Fujii, Sena; Matsubayashi, Jun; Yamada, Shigehito; Takakuwa, Tetsuya] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan; [Yamada, Shigehito] Kyoto Univ, Grad Sch Med, Congenital Anomaly Res Ctr, Kyoto, Japan	Kyoto University; Kyoto University	Takakuwa, T (corresponding author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan.	tez@hs.med.kyoto-u.ac.jp	Yamada, Shigehito/G-2061-2010	Yamada, Shigehito/0000-0002-8194-6927; Takakuwa, Tetsuya/0000-0002-9660-9384; Matsubayashi, Jun/0000-0003-4104-6833	Japan Society for the Promotion of Science [18K07876, 17H05294, 16K15535, 26220004]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science; Grant numbers: 18K07876, 17H05294, 16K15535, 26220004.	Airik R, 2007, KIDNEY INT, V72, P1459, DOI 10.1038/sj.ki.5002589; Al-Awqati Q, 1998, KIDNEY INT, V54, P1832, DOI 10.1046/j.1523-1755.1998.00196.x; BRACE RA, 1989, AM J OBSTET GYNECOL, V161, P382, DOI 10.1016/0002-9378(89)90527-9; Cebrian C, 2004, DEV DYNAM, V231, P601, DOI 10.1002/dvdy.20143; Clayton DB, 2018, CURR UROL REP, V19, DOI 10.1007/s11934-018-0760-9; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Furuichi K, 2018, ANAT REC HOBOKEN, V301; Lindstrom NO, 2018, J AM SOC NEPHROL, V29, P785, DOI 10.1681/ASN.2017080887; LUDWIG E, 1962, ACTA ANAT, V49, P168; Merlet-Benichou C, 1999, LAB INVEST, V79, P515; NEWMAN J, 1989, J ANAT, V166, P135; NISHIMURA H, 1968, TERATOLOGY, V1, P281, DOI 10.1002/tera.1420010306; O'Rahilly R., 1987, DEV STAGES HUMAN EMB, P1; Oliver J., 1968, NEPHRONS KIDNEYS QUA; ORAHILLY R, 1972, Z ANAT ENTWICKLUNGS, V138, P99, DOI 10.1007/BF00519927; OSATHANONDH V, 1963, ARCH PATHOL, V76, P277; OSATHANONDH V, 1963, ARCH PATHOL, V76, P290; Piscione TD, 2002, DIFFERENTIATION, V70, P227, DOI 10.1046/j.1432-0436.2002.700602.x; Potter EL, 1972, NORMAL ABNORMAL DEV; Puddu M, 2009, AM J NEPHROL, V30, P162, DOI 10.1159/000211324; Sampogna RV, 2015, J AM SOC NEPHROL, V26, P2414, DOI 10.1681/ASN.2014090886; Shah MM, 2004, DEVELOPMENT, V131, P1449, DOI 10.1242/dev.01089; SHIOTA K, 1991, Congenital Anomalies, V31, P67, DOI 10.1111/j.1741-4520.1991.tb00360.x; Shiota K., 1983, ATLAS HUMAN PRENATAL, P129; Short K, 2013, DEVELOPMENT, V140, P471, DOI 10.1242/dev.088500; Short KM, 2016, NAT REV NEPHROL, V12, P754, DOI 10.1038/nrneph.2016.157; Short KM, 2014, DEV CELL, V29, P188, DOI 10.1016/j.devcel.2014.02.017; SILVERMAN H, 1969, ACTA ANAT, V74, P36; STREETER GL, 1951, CONTRIB EMBRYOL, V34, P167	29	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203623	10.1371/journal.pone.0203623	http://dx.doi.org/10.1371/journal.pone.0203623			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192900	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600120
J	Rahman, M; Mukta, JA; Sabir, AA; Gupta, DR; Mohi-Ud-Din, M; Hasanuzzaman, M; Miah, MG; Rahman, M; Islam, MT				Rahman, Mosaddiqur; Mukta, Julakha Akter; Sabir, Abdullah As; Gupta, Dipali Rani; Mohi-Ud-Din, Mohammed; Hasanuzzaman, Mirza; Miah, Md. Giashuddin; Rahman, Mahfuzur; Islam, Md Tofazzal			Chitosan biopolymer promotes yield and stimulates accumulation of antioxidants in strawberry fruit	PLOS ONE			English	Article							GROWTH; HORTICULTURE; PHENOLICS; NUTRIENT; DISEASES; QUALITY	Strawberry is a well-known source of natural antioxidants with excellent free radical scavenging capacity. This study determined the effects of chitosan application in field condition on plant growth, fruit yield and antioxidant activities in strawberry fruit. Foliar applications of chitosan on strawberry significantly increased plant growth and fruit yield (up to 42% higher) compared to untreated control. Increased fruit yield was attributed to higher plant growth, individual fruit weight and total fruit weight/plant due to the chitosan application. Surprisingly, the fruit from plants sprayed with chitosan also had significantly higher contents (up to 2.6-fold) of carotenoids, anthocyanins, flavonoids and phenolics compared to untreated control. Total antioxidant activities in fruit of chitosan treated plants were also significantly higher (ca. 2-fold) (p<0.05) than untreated control. To the best of our knowledge, this is the first report of chitosan applied on field plants providing significant improvement of both yield and health benefiting biochemical contents in strawberry fruit. Further study on the elucidation of mechanisms involved with enhancement of growth, yield and biochemical contents by chitosan is needed to promote sustainable production of strawberry.	[Rahman, Mosaddiqur; Mukta, Julakha Akter; Sabir, Abdullah As; Gupta, Dipali Rani; Islam, Md Tofazzal] Bangabandhu Sheikh Mujibur Rahman Agr Univ, Dept Biotechnol, Gazipur, Bangladesh; [Mohi-Ud-Din, Mohammed] Bangabandhu Sheikh Mujibur Rahman Agr Univ, Dept Crop Bot, Gazipur, Bangladesh; [Hasanuzzaman, Mirza] Sher E Bangla Agr Univ, Dept Agron, Dhaka, Bangladesh; [Miah, Md. Giashuddin] Bangabandhu Sheikh Mujibur Rahman Agr Univ, Dept Agroforestry & Environm, Gazipur, Bangladesh; [Rahman, Mahfuzur] West Virginia Univ, Extens Serv, Morgantown, WV USA	Bangabandhu Sheikh Mujibur Rahman Agricultural University (BSMRAU); Bangabandhu Sheikh Mujibur Rahman Agricultural University (BSMRAU); Sher-e-Bangla Agricultural University (SAU); Bangabandhu Sheikh Mujibur Rahman Agricultural University (BSMRAU); West Virginia University	Islam, MT (corresponding author), Bangabandhu Sheikh Mujibur Rahman Agr Univ, Dept Biotechnol, Gazipur, Bangladesh.; Rahman, M (corresponding author), West Virginia Univ, Extens Serv, Morgantown, WV USA.	mm.rahman@mail.wvu.edu; tofazzalislam@yahoo.com	Islam, Tofazzal/F-2563-2010; Hasanuzzaman, Mirza/A-1665-2010	Islam, Tofazzal/0000-0002-7613-0261; Hasanuzzaman, Mirza/0000-0002-0461-8743; DIPALI, GUPTA/0000-0001-5150-0089; Mohi-Ud-Din, Mohammed/0000-0003-2294-8495	USDA Foreign Agriculture Service (FAS) [SR-CR-13-002]; West Virginia University; World Bank through HEQEP CP [2071]; U.S. Government	USDA Foreign Agriculture Service (FAS); West Virginia University; World Bank through HEQEP CP; U.S. Government	This research was mainly funded by a grant awarded to M. Rahman by USDA Foreign Agriculture Service (FAS) program contract Agr number SR-CR-13-002 and support from the West Virginia University research seed grant. A partial funding from the World Bank to this work through HEQEP CP # 2071 to MTI of Department of Biotechnology of BSMRAU, Bangladesh is also appreciated. The J. William Fulbright Visiting Scholar Fellowship from U.S. Government to MTI is also highly acknowledged. We also thank Mr. Abdul Wahed Mallik, Senior Farm Manager, Head and Staffs of Department of Agroforestry and Environment of BSMRAU for excellent support for field experiments.	Abdel-Mawgoud A.M.R., 2010, EUR J SCI RES, V39, P170; [Anonymous], J ECOLOGICAL ENG; Bautista-Banos S, 2006, CROP PROT, V25, P108, DOI 10.1016/j.cropro.2005.03.010; Benhamou N, 1998, PLANTA, V204, P153, DOI 10.1007/s004250050242; Brammer H., 1978, SOILS RICE, P35, DOI DOI 10.1186/S12284-015-0068-Z; DAS DK, 1994, METHOD ENZYMOL, V234, P410; Flores-Felix JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122281; Ekinci M, 2014, ACTA SCI POL-HORTORU, V13, P71; El-Miniawy S. M., 2013, Research Journal of Agriculture and Biological Sciences, V9, P366; El-Sawy NM, 2010, CARBOHYD POLYM, V79, P555, DOI 10.1016/j.carbpol.2009.09.002; ELGHAOUTH A, 1991, J FOOD SCI, V56, P1618, DOI 10.1111/j.1365-2621.1991.tb08655.x; Fernandes VC, 2012, ENVIRON SCI POLLUT R, V19, P4184, DOI 10.1007/s11356-012-0934-9; Giampieri F, 2017, ANN NY ACAD SCI, V1398, P62, DOI 10.1111/nyas.13373; Heinonen IM, 1998, J AGR FOOD CHEM, V46, P4107, DOI 10.1021/jf980181c; Hossain A, 2016, FOOD CHEM, V199, P648, DOI 10.1016/j.foodchem.2015.12.056; Hughes NM, 2007, AM J BOT, V94, P784, DOI 10.3732/ajb.94.5.784; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jitareerat P, 2007, NEW ZEAL J CROP HORT, V35, P211, DOI 10.1080/01140670709510187; Keutgen A, 2007, FOOD CHEM, V105, P1487, DOI 10.1016/j.foodchem.2007.05.033; Kliebenstein DJ, 2016, PHYSIOL MOL PLANT P, V95, P55, DOI 10.1016/j.pmpp.2016.02.004; Lachman J, 2003, PLANT SOIL ENVIRON, V49, P370, DOI 10.17221/4139-PSE; Landi L, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00235; Malerba M, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10020118; Mensor LL, 2001, PHYTOTHER RES, V15, P127, DOI 10.1002/ptr.687; Mondal M. M. A., 2012, Australian Journal of Crop Science, V6, P918; Mukta JA, 2017, BIOCATAL AGR BIOTECH, V11, P9, DOI 10.1016/j.bcab.2017.05.005; MURRAY JR, 1991, PLANT PHYSIOL, V97, P343, DOI 10.1104/pp.97.1.343; Pichyangkura R, 2015, SCI HORTIC-AMSTERDAM, V196, P49, DOI 10.1016/j.scienta.2015.09.031; Pirbalouti AG, 2017, SCI HORTIC-AMSTERDAM, V217, P114, DOI 10.1016/j.scienta.2017.01.031; Rahman MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093192; Rahman M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20235-1; Ramakrishna R, 2017, J FOOD SCI TECH MYS, V54, P3666, DOI 10.1007/s13197-017-2828-9; Romanazzi G, 2017, CRIT REV FOOD SCI, V57, P579, DOI 10.1080/10408398.2014.900474; Sakif T. I., 2016, Advances in Bioscience and Biotechnology, V7, P337, DOI 10.4236/abb.2016.78032; Sojka M., 2015, NFS Journal, V1, P31, DOI 10.1016/j.nfs.2015.09.001; Sun-Waterhouse D, 2011, INT J FOOD SCI TECH, V46, P899, DOI 10.1111/j.1365-2621.2010.02499.x; U. S. Department of Agriculture, 2014, STRAWB CONS CONT GRO; Wang H, 1996, J AGR FOOD CHEM, V44, P701, DOI 10.1021/jf950579y; Xoca-Orozco LA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00956; Zhang DL, 1997, POSTHARVEST BIOL TEC, V12, P195, DOI 10.1016/S0925-5214(97)00057-4; Zhang YJ, 2008, J AGR FOOD CHEM, V56, P670, DOI 10.1021/jf071989c	41	55	55	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203769	10.1371/journal.pone.0203769	http://dx.doi.org/10.1371/journal.pone.0203769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192877	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600141
J	Palacio, LPQ; Gonzalez, MN; Hernandez-Vasquez, Y; Perrone, AE; Parodi-Talice, A; Bua, J; Postan, M				Quebrada Palacio, Luz P.; Gonzalez, Mariela N.; Hernandez-Vasquez, Yolanda; Perrone, Alina E.; Parodi-Talice, Adriana; Bua, Jacqueline; Postan, Miriam			Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates	PLOS ONE			English	Article							IN-VITRO; CHAGAS-DISEASE; SUPEROXIDE-DISMUTASE; BENZNIDAZOLE; RESISTANCE; STRAINS; POPULATION; EXPRESSION; INFECTION; VIRULENCE	Trypanosoma cruzi is a genetically heterogeneous group of organisms that cause Chagas disease. It has been long suspected that the clinical outcome of the disease and response to therapeutic agents are, at least in part, related to the genetic characteristics of the parasite. Herein, we sought to validate the significance of the genotype of T. cruzi isolates recovered from patients with different clinical forms of Chagas disease living in Argentina on their biological behaviour and susceptibility to drugs. Genotype identification of the newly established isolates confirmed the reported predominance of TcV, with a minor frequency of TcI. Epimastigote sensitivity assays demonstrated marked dissimilar responses to benznidazole, nifurtimox, pentamidine and dihydroartemisinin in vitro. Two TcV isolates exhibiting divergent response to benznidazole in epimastigote assays were further tested for the expression of anti-oxidant proteins. Benznidazole-resistant BOL-FC10A epimastigotes had decreased expression of Old Yellow Enzyme and cytosolic superoxide dismutase, and overexpression of mitochondrial superoxide dismutase and tryparedoxin-1, compared to benznidazole-susceptible AR-SE23C parasites. Drug sensitivity assays on intracellular amastigotes and trypomastigotes reproduced the higher susceptibility of AR-SE23C over BOL-FC10A parasites to benznidazole observed in epimastigotes assays. However, the susceptibility/resistance profile of amastigotes and trypomastigotes to nifurtimox, pentamidine and dihydroartemisinin varied markedly with respect to that of epimastigotes. C3H/He mice infected with AR-SE23C trypomastigotes had higher levels of parasitemia and mortality rate during the acute phase of infection compared to mice infected with BOL-FC10A trypomastigotes. Treatment of infected mice with benznidazole or nifurtimox was efficient to reduce patent parasitemia induced by either isolate. Nevertheless, qPCR performed at 70 dpi revealed parasite DNA in the blood of mice infected with AR-SE23C but not in BOL-FC10A infected mice. These results demonstrate high level of intra-type diversity which may represent an important obstacle for the testing of chemotherapeutic agents.	[Quebrada Palacio, Luz P.; Bua, Jacqueline; Postan, Miriam] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Quebrada Palacio, Luz P.; Gonzalez, Mariela N.; Hernandez-Vasquez, Yolanda; Perrone, Alina E.; Bua, Jacqueline; Postan, Miriam] Inst Nacl Parasitol Dr Mario Fatala Chaben, Dept Invest, Buenos Aires, DF, Argentina; [Parodi-Talice, Adriana] Univ Republica, Unidad Biol Mol, Inst Pasteur Montevideo, Secc Genet,Fac Ciencias, Montevideo, Uruguay; [Gonzalez, Mariela N.] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Thymus Res, Rio De Janeiro, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay; Fundacao Oswaldo Cruz	Postan, M (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.; Postan, M (corresponding author), Inst Nacl Parasitol Dr Mario Fatala Chaben, Dept Invest, Buenos Aires, DF, Argentina.	miriampostan@yahoo.com		Postan, Miriam/0000-0002-1759-5819	Agencia Nacional de Promocion Cientifica y Tecnologica; Fondo para la Investigacion Cientifica y Tecnologica [PICT 2010 NE 2148, PICT 2013 NE 2828]; FOCANLIS	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fondo para la Investigacion Cientifica y Tecnologica; FOCANLIS	This work was supported by grants of Agencia Nacional de Promocion Cientifica y Tecnologica, Fondo para la Investigacion Cientifica y Tecnologica (PICT 2010 NE 2148, PICT 2013 NE 2828 to MP), and FOCANLIS 2010 to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade HM, 2008, J PROTEOME RES, V7, P2357, DOI 10.1021/pr700659m; [Anonymous], 2016, CHAG DIS; Apt W, 2015, PARASITOL RES, V114, P3007, DOI 10.1007/s00436-015-4503-2; Aquilino C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040901; BICE DE, 1970, J PARASITOL, V56, P663, DOI 10.2307/3277711; Brisse S, 2000, MOL BIOCHEM PARASIT, V111, P95, DOI 10.1016/S0166-6851(00)00302-9; Brisse S, 2001, INT J PARASITOL, V31, P1218, DOI 10.1016/S0020-7519(01)00238-7; Bua J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002476; Bua J, 2012, T ROY SOC TROP MED H, V106, P623, DOI 10.1016/j.trstmh.2012.03.015; Canavaci AMC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000740; CROFT S L, 1986, Parasitology Today, V2, P64, DOI 10.1016/0169-4758(86)90157-2; Cura CI, 2012, PARASITOLOGY, V139, P516, DOI 10.1017/S0031182011002186; del Puerto R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000687; Diaz MV, 2014, ACTA TROP, V134, P1, DOI 10.1016/j.actatropica.2014.02.012; Pineyro MD, 2011, J PROTEOMICS, V74, P1683, DOI 10.1016/j.jprot.2011.04.006; dos Santos DM, 2009, EXP PARASITOL, V121, P8, DOI 10.1016/j.exppara.2008.09.012; Duffy T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000419; FILARDI LS, 1987, T ROY SOC TROP MED H, V81, P755, DOI 10.1016/0035-9203(87)90020-4; Hall BS, 2011, J BIOL CHEM, V286, P13088, DOI 10.1074/jbc.M111.230847; Ho WE, 2014, PHARMACOL THERAPEUT, V142, P126, DOI 10.1016/j.pharmthera.2013.12.001; Kaiser A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140994; Katsuno K, 2015, NAT REV DRUG DISCOV, V14, P751, DOI 10.1038/nrd4683; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Kubata BK, 2002, J EXP MED, V196, P1241, DOI 10.1084/jem.20020885; LAMBRECHT FRANK L., 1965, REV INST MED TROP SAO PAULO, V7, P346; Lewis MD, 2009, AM J TROP MED HYG, V81, P1041, DOI 10.4269/ajtmh.2009.09-0305; Macedo Andra M, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004118; Maciejewska D, 2012, EUR J MED CHEM, V48, P164, DOI 10.1016/j.ejmech.2011.12.010; Mejia AM, 2012, J INFECT DIS, V206, P220, DOI 10.1093/infdis/jis331; Maya JD, 2007, COMP BIOCHEM PHYS A, V146, P601, DOI 10.1016/j.cbpa.2006.03.004; Messenger LA, 2015, EXPERT REV ANTI-INFE, V13, P995, DOI 10.1586/14787210.2015.1056158; Mishina YV, 2007, ANTIMICROB AGENTS CH, V51, P1852, DOI 10.1128/AAC.01544-06; Monje-Rumi MM, 2015, INFECT GENET EVOL, V29, P53, DOI 10.1016/j.meegid.2014.11.001; Monteiro WM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002069; Moraes CB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04703; Moreno M, 2010, MEM I OSWALDO CRUZ, V105, P918, DOI 10.1590/S0074-02762010000700014; Morillo CA, 2015, NEW ENGL J MED, V373, P1295, DOI 10.1056/NEJMoa1507574; NEAL RA, 1988, T ROY SOC TROP MED H, V82, P709, DOI 10.1016/0035-9203(88)90208-8; Nogueira FB, 2006, ACTA TROP, V100, P119, DOI 10.1016/j.actatropica.2006.10.004; Luna KP, 2009, BIOMEDICA, V29, P448; Zago MP, 2016, INFECT IMMUN, V84, P1842, DOI 10.1128/IAI.00193-16; Peloso EF, 2012, ARCH BIOCHEM BIOPHYS, V520, P117, DOI 10.1016/j.abb.2012.02.020; POSTAN M, 1983, AM J TROP MED HYG, V32, P497, DOI 10.4269/ajtmh.1983.32.497; Ragone PG, 2012, ACTA TROP, V123, P196, DOI 10.1016/j.actatropica.2012.05.003; READY PD, 1980, T ROY SOC TROP MED H, V74, P238, DOI 10.1016/0035-9203(80)90252-7; SCHLEMPER BR, 1977, J PROTOZOOL, V24, P544, DOI 10.1111/j.1550-7408.1977.tb01010.x; Temperton NJ, 1998, MOL BIOCHEM PARASIT, V96, P167, DOI 10.1016/S0166-6851(98)00127-3; Tibayrenc M, 2015, ACTA TROP, V151, P156, DOI 10.1016/j.actatropica.2015.05.006; Trochine A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002844; URDANETAMORALES S, 1983, ANN PARASIT HUM COMP, V58, P317, DOI 10.1051/parasite/1983584317; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; Yeo M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001049; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021; Zingales B, 2018, ACTA TROP, V184, P38, DOI 10.1016/j.actatropica.2017.09.017; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	55	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203462	10.1371/journal.pone.0203462	http://dx.doi.org/10.1371/journal.pone.0203462			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183775	gold, Green Published, Green Submitted			2022-12-26	WOS:000443789900067
J	Southard, SM; Kotipatruni, RP; Rust, WL				Southard, Sheryl M.; Kotipatruni, Rama P.; Rust, William L.			Generation and selection of pluripotent stem cells for robust differentiation to insulin-secreting cells capable of reversing diabetes in rodents	PLOS ONE			English	Article							IN-VITRO; BETA-CELLS; PANCREATIC PROGENITORS; ENCAPSULATION DEVICE; NICOTINAMIDE ANALOGS; ENDOCRINE-CELLS; HUMAN ES; ENDODERM; MICE; VIVO	Induced pluripotent stem cell (iPSC) technology enables the creation and selection of pluripotent cells with specific genetic traits. This report describes a pluripotent cell line created specifically to form replacement pancreatic cells as a therapy for insulin-dependent diabetes. Beginning with primary pancreatic tissue acquired through organ donation, cells were isolated, re-programmed using non-integrating vectors and exposed to a four day differentiation protocol to generate definitive endoderm, a developmental precursor to pancreas. The best performing iPSC lines were then subjected to a 12-day basic differentiation protocol to generate endocrine pancreas precursors. The line that most consistently generated highly pure populations was selected for further development. This approach created an iPSC-variant cell line, SR1423, with a genetic profile correlated with preferential differentiation toward endodermal lineage at the loss of mesodermal potential. This report further describes an improved differentiation protocol that, coupled with SR1423, generated populations of greater than 60% insulin-expressing cells that secrete insulin in response to glucose and are capable of reversing diabetes in rodents. Created and banked following cGMP guidelines, SR1423 is a candidate cell line for the production of insulin-producing cells useful for the treatment of diabetes.	[Southard, Sheryl M.; Kotipatruni, Rama P.; Rust, William L.] SERAXIS Inc, Germantown, MD 20876 USA		Rust, WL (corresponding author), SERAXIS Inc, Germantown, MD 20876 USA.	wrust@seraxis.com	K, R/F-5701-2011	K, R/0000-0001-9853-2686; Rust, William/0000-0001-6910-1916	Seraxis Inc	Seraxis Inc	The Research presented in this manuscript was funded exclusively by Seraxis Inc, a privately held biotechnology company. The funder provided support in the form of salaries for authors SS, RK and WR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agulnick AD, 2015, STEM CELL TRANSL MED, V4, P1214, DOI 10.5966/sctm.2015-0079; An D, 2018, P NATL ACAD SCI USA, V115, pE263, DOI 10.1073/pnas.1708806115; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Borowiak M, 2009, CURR OPIN CELL BIOL, V21, P727, DOI 10.1016/j.ceb.2009.08.006; Bruin JE, 2014, STEM CELL RES, V12, P194, DOI 10.1016/j.scr.2013.10.003; Chetty S, 2013, NAT METHODS, V10, P553, DOI [10.1038/NMETH.2442, 10.1038/nmeth.2442]; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Desai T, 2017, NAT REV DRUG DISCOV, V16, DOI 10.1038/nrd.2017.67; Dohrmann C, 2000, MECH DEVELOP, V92, P47, DOI 10.1016/S0925-4773(99)00324-X; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Fuerer C, 2014, J BIOL CHEM, V289, P17854, DOI 10.1074/jbc.M114.550301; Gong H, 2014, STEM CELLS, V32, P1759, DOI 10.1002/stem.1702; Horbelt D, 2015, J BIOL CHEM, V290, P3390, DOI 10.1074/jbc.M114.604397; Huang PX, 2014, CHEM REV, V114, P233, DOI 10.1021/cr400161b; Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; Jensen VS, 2016, AM J TRANSL RES, V8, P3574; King A, 2001, J BIOMED MATER RES, V57, P374, DOI 10.1002/1097-4636(20011205)57:3<374::AID-JBM1180>3.0.CO;2-L; Kirk K, 2014, STEM CELL RES, V12, P807, DOI 10.1016/j.scr.2014.03.003; Koyanagi-Aoi M, 2013, P NATL ACAD SCI USA, V110, P20569, DOI 10.1073/pnas.1319061110; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lee JY, 2017, NUCLEIC ACIDS RES, V45, P4696, DOI 10.1093/nar/gkx188; Lim H, 2014, J VIS EXP; Millman JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11463; Moody Sallly A., 2014, PRINCIPLES DEV GENET; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pagliuca FW, 2014, CELL; Reichenbach DK, 2013, AM J TRANSPLANT, V13, P580, DOI 10.1111/ajt.12056; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2013, STEM CELLS, V31, P2432, DOI 10.1002/stem.1489; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Russ HA, 2015, EMBO J, V34, P1759, DOI 10.15252/embj.201591058; SANCHEZPACHECO A, 1992, FEBS LETT, V312, P42, DOI 10.1016/0014-5793(92)81406-C; SANCHEZPACHECO A, 1993, MOL CELL ENDOCRINOL, V91, P127, DOI 10.1016/0303-7207(93)90264-K; Schimmack S, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-15; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Shapiro J, 2014, DIABETES METAB SYNDR, V211; Sherwood RI, 2011, MECH DEVELOP, V128, P387, DOI 10.1016/j.mod.2011.07.005; Shulman M., 2012, METHOD MOL BIOL, P287; Singec I, 2016, STEM CELL REP, V7, P527, DOI 10.1016/j.stemcr.2016.07.019; Sugimoto H, 2007, DIABETES, V56, P1825, DOI 10.2337/db06-1226; Szegedi SS, 2008, J BIOL CHEM, V283, P8939, DOI 10.1074/jbc.M710449200; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Uzan B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004734; Vegas AJ, 2016, NAT BIOTECHNOL, V34, P345, DOI 10.1038/nbt.3462; Vegas AJ, 2016, NAT MED, V22, P306, DOI 10.1038/nm.4030; Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]; Walkin L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-18; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28	54	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203126	10.1371/journal.pone.0203126	http://dx.doi.org/10.1371/journal.pone.0203126			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183752	Green Submitted, Green Published, gold			2022-12-26	WOS:000443789900047
J	von Castell, C; Hecht, H; Oberfeld, D				von Castell, Christoph; Hecht, Heiko; Oberfeld, Daniel			Bright paint makes interior-space surfaces appear farther away	PLOS ONE			English	Article							VIRTUAL ENVIRONMENTS; DISTANCE JUDGMENTS; OFFICE INTERIOR; PERCEPTION; PERFORMANCE; LIGHTNESS; COLORS; IMPACT; MOOD; SPACIOUSNESS	Previous studies have reported that bright ceilings appear higher than dark ceilings, irrespective of the other colorimetric properties of the ceiling color (hue, saturation) and irrespective of the luminance of the remaining room surfaces (walls, floor). In the present study, we expand these findings to width and depth estimates. We presented stereoscopic full-scale room simulations on a head-mounted display and varied the luminance of the side walls, rear wall, and ceiling independently of each other. Participants judged the width and depth of the simulated rooms. Our results show that the perceived spatial layout of a given room is significantly influenced by the luminance of the direct bounding surfaces (e.g., the side walls when judging perceived width) but less affected by the luminance of the other surfaces. In the discussion, we provide an overall picture of effects of surface luminance on the perceived layout of interior spaces and discuss the conclusions in the context of existing interior-design guidelines.	[von Castell, Christoph; Hecht, Heiko; Oberfeld, Daniel] Johannes Gutenberg Univ Mainz, Mainz, Germany	Johannes Gutenberg University of Mainz	von Castell, C (corresponding author), Johannes Gutenberg Univ Mainz, Mainz, Germany.	castell@uni-mainz.de	von Castell, Christoph/AAE-2501-2021; Hecht, Heiko/H-3106-2011; Oberfeld, Daniel/A-7997-2008	Hecht, Heiko/0000-0001-9418-862X; Oberfeld, Daniel/0000-0002-6710-3309; von Castell, Christoph/0000-0002-0677-1055	Deutsche Forschungsgemeinschaft (DFG): "Innenraumwahrnehmung" [HE 2122/10-2, OB 346/5-2]	Deutsche Forschungsgemeinschaft (DFG): "Innenraumwahrnehmung"(German Research Foundation (DFG))	This study was supported by a grant from Deutsche Forschungsgemeinschaft (DFG): "Innenraumwahrnehmung", HE 2122/10-2 (Heiko Hecht) and OB 346/5-2 (Daniel Oberfeld). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKING CA, 1972, ERGONOMICS, V15, P645, DOI 10.1080/00140137208924465; AINSWORTH RA, 1993, PERCEPT MOTOR SKILL, V76, P235, DOI 10.2466/pms.1993.76.1.235; AL-Ayash A, 2016, COLOR RES APPL, V41, P196, DOI 10.1002/col.21949; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Bennett R. R, 1998, CLIN VISUAL OPTICS; Boyce RB, 2014, HUMAN FACTORS LIGHTI; Cohen J.E., 1988, STAT POWER ANAL BEHA; Commission Internationale de I'Eclairage, 2006, COL CIE STAND COL 1; Commission Internationale de I'Eclairage, 2008, COL STAND ILL FORC 2; Dinobile K, 2017, USE PAINT COLORS CHA; Fairchild M. D., 2005, COLOR APPEARANCE MOD; Franz G, 2006, P 19 INT ASS PEOPL E; Geuss MN, 2012, J EXP PSYCHOL HUMAN, V38, P1242, DOI 10.1037/a0027524; Giessler JF, 1990, ENTWURF GESTALTUNG I; Gilchrist AL, 2007, CURR BIOL, V17, pR267, DOI 10.1016/j.cub.2007.01.040; Grechkin TY, 2010, ACM T APPL PERCEPT, V7, DOI 10.1145/1823738.1823744; Heuser KC, 1989, INNENARCHITEKTUR RAU, V1; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hoffman DM, 2008, J VISION, V8, DOI 10.1167/8.3.33; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Imamoglu V, 1986, METU J FACULTY ARCHI, V7; Inui M., 1973, LIGHTING RES TECHNOL, V5, P103, DOI [https://doi.org/10.1177/096032717300500205, DOI 10.1177/096032717300500205]; Kelly JW, 2017, ACM T APPL PERCEPT, V15, DOI 10.1145/3106155; Kelly JW, 2015, ATTEN PERCEPT PSYCHO, V77, P1848, DOI 10.3758/s13414-015-0948-8; Kelly JW, 2013, ATTEN PERCEPT PSYCHO, V75, P1473, DOI 10.3758/s13414-013-0503-4; Kuhl SA, 2009, ACM T APPL PERCEPT, V6, DOI 10.1145/1577755.1577762; Kuller R, 2006, ERGONOMICS, V49, P1496, DOI 10.1080/00140130600858142; Kuller R, 2009, COLOR RES APPL, V34, P141, DOI 10.1002/col.20476; KUNISHIMA M, 1985, ERGONOMICS, V28, P869, DOI 10.1080/00140138508963208; Kunz BR, 2009, ATTEN PERCEPT PSYCHO, V71, P1284, DOI 10.3758/APP.71.6.1284; Kwallek N, 1997, COLOR RES APPL, V22, P121, DOI 10.1002/(SICI)1520-6378(199704)22:2<121::AID-COL7>3.0.CO;2-V; Kwallek N, 1996, COLOR RES APPL, V21, P448, DOI 10.1002/(SICI)1520-6378(199612)21:6<448::AID-COL7>3.0.CO;2-W; Kwallek N., 2005, IMPLICATIONS, V5, P1; Leyrer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127000; Leyrer M, 2015, ACM T APPL PERCEPT, V12, P3, DOI 10.1145/2699254; Loyola M, 2017, VIRTUAL REALITY, P1; Marsden A. M., 1969, Lighting Research and Technology, V1, P171; Marsden AM., 1970, LIGHTING RES TECHNOL, V2, P10; Martyniuk O., 1973, ARCHITECTURAL PSYCHO, P51; Meerwein G, 2007, FARBE KOMMUNIKATION; Mohler BJ, 2010, PRESENCE-TELEOP VIRT, V19, P230, DOI 10.1162/pres.19.3.230; Muller W, 1976, ELEMENTE BAUENS BAND, V9; Neufert E, 2009, BAUENTWURFSLEHRE; Oberfeld D, 2011, HUM FACTORS, V53, P284, DOI 10.1177/0018720811407331; Oberfeld D, 2010, Q J EXP PSYCHOL, V63, P1999, DOI 10.1080/17470211003646161; Piryankova IV, 2013, DISPLAYS, V34, P153, DOI 10.1016/j.displa.2013.01.001; Renner RS, 2013, ACM COMPUT SURV, V46, DOI 10.1145/2543581.2543590; Shore C, 2012, TIPS PAINTING YOUR H; Siegel ZD, 2017, J EXP PSYCHOL HUMAN, V43, P1805, DOI 10.1037/xhp0000401; Stamps AE, 2007, DESIGN STUD, V28, P535, DOI 10.1016/j.destud.2007.01.001; Stamps AE, 2006, ENVIRON BEHAV, V38, P841, DOI 10.1177/0013916506288052; Stevens SS, 1975, PSYCHOPHYSICS INTRO; von Castell C, 2018, HUM FACTORS, V60, P1228, DOI 10.1177/0018720818789524; von Castell C, 2018, COLOR RES APPL, V43, P65, DOI 10.1002/col.22168; von Castell C, 2017, Q J EXP PSYCHOL, V70, P516, DOI 10.1080/17470218.2015.1136658; von Castell C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113267; WorldViz, 2016, VIZ 5 COMP SOFTW; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117; Yildirim K, 2015, INDOOR BUILT ENVIRON, V24, P607, DOI 10.1177/1420326X14526214	59	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0201976	10.1371/journal.pone.0201976	http://dx.doi.org/10.1371/journal.pone.0201976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS6HC	30183714	Green Published, gold, Green Submitted			2022-12-26	WOS:000443789900011
J	Knezevic, A; Stajic, M; Sofrenic, I; Stanojkovic, T; Milovanovic, I; Tesevic, V; Vukojevic, J				Knezevic, Aleksandar; Stajic, Mirjana; Sofrenic, Ivana; Stanojkovic, Tatjana; Milovanovic, Ivan; Tesevic, Vele; Vukojevic, Jelena			Antioxidative, antifungal, cytotoxic and antineurodegenerative activity of selected Trametes species from Serbia	PLOS ONE			English	Article							RAPID COLORIMETRIC ASSAY; IN-VITRO; GROWTH; MUSHROOM; EXTRACT; CELLS; LEUKEMIA; FUNGI	In a last few decades mushrooms are increasingly attracting attention as functional food and sources of biologically active compounds. Several Trametes species have been used for centuries in traditional medicine of East Asia cultures, but only T. versicolorwas studied sufficiently while there are less substantial data about medicinal properties of other species. Trametes versicolor, T. hirsuta and T. gibbosa were the species tested for biological activities. Antifungal potentials of extracts were assessed for clinical strains of selected Candida and Aspergillus species. ABTS and FRAP assays were used to evaluate antioxidant capacities of studied extracts. Cytotoxic activity was determined against human cervix and lung adenocarcinoma and colon carcinoma cell lines. Antineurodegenerative activity was assessed by determining the rate of acetylcholinesterase and tyrosinase activity. The presence of metabolites in extracts of mycelia and basidiocarps of studied Trametes species was analyzed by H-1 NMR spectroscopy. Studied extracts showed low antifungal potential in comparison with ketoconazole. Basidiocarp extracts were more effective ABTS(+) scavengers and Fe2+ reducers than mycelium ones but less effective in comparison with L-ascorbic acid. Results showed that mycelium extracts had stronger cytotoxic effects against three cancer cell lines than basidiocarp ones, and that cervix adenocarcinoma cells were the most sensitive to the extracts and commercial cytostatics. T. versicolor mycelium extract was the most effective inhibitor of acetylcholinesterase activity but double weaker than galantamine, and T. gibbosa mycelium extract was significantly better inhibitor of tyrosinase activity than kojic acid for 40.9%. Chemical analysis indicated strong synergistic action of triterpenes, sugars and polyphenols in applied assays. The results suggest that tested Trametes species have significant medicinal potentials which could be attributed to antioxidative and cytotoxic activity. Additionally both, basidiocarps and mycelia extracts can strongly inhibit activity of acetylcholinesterase and tyrosinase.	[Knezevic, Aleksandar; Stajic, Mirjana; Milovanovic, Ivan; Vukojevic, Jelena] Univ Belgrade, Fac Biol, Belgrade, Serbia; [Sofrenic, Ivana; Tesevic, Vele] Univ Belgrade, Fac Chem, Studentski Trg, Belgrade, Serbia; [Stanojkovic, Tatjana] Inst Oncol & Radiol Serbia, Belgrade, Serbia	University of Belgrade; University of Belgrade; Institute for Oncology & Radiology of Serbia (IORS)	Knezevic, A (corresponding author), Univ Belgrade, Fac Biol, Belgrade, Serbia.	knezevica@bio.bg.ac.rs	Sofrenić, Ivana/W-2421-2018; Stanojkovic, Tatjana/AHA-7955-2022; Tesevic, Vele/Q-6093-2016	Sofrenić, Ivana/0000-0002-9799-670X; Knezevic, Aleksandar/0000-0002-2776-9675; Tesevic, Vele/0000-0001-7060-9055; Milovanovic, Ivan/0000-0002-5772-4355	Ministry of Education, Science and Technological Development (Republic of Serbia) [173032, 172053]	Ministry of Education, Science and Technological Development (Republic of Serbia)	This work was supported by Ministry of Education, Science and Technological Development (Republic of Serbia), Grant No. 173032, AK, MS, IM, JV; Ministry of Education, Science and Technological Development (Republic of Serbia), Grant No. 172053, IS, VT.	Abd El Hady F., 2014, INT J PHARM SCI REV, V26, P338; Alves MJ, 2013, J APPL MICROBIOL, V115, P346, DOI 10.1111/jam.12196; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; [Anonymous], 1998, M38P NCCLS; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Brakhage AA, 2005, MED MYCOL, V43, pS75, DOI 10.1080/13693780400028967; Cheng K.F., 2008, CANC THER, V6, P117; Courtecuisse R, 1999, MUSHROOMS BRITAIN EU; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007; de Billerbeck VG, 2001, CAN J MICROBIOL, V47, P9, DOI 10.1139/cjm-47-1-9; El-Hady F.K.A., 2014, INT J PHARM SCI REV, V26, P301; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Ferreira ICFR, 2009, CURR MED CHEM, V16, P1543, DOI 10.2174/092986709787909587; Gan C. H., 2013, International Food Research Journal, V20, P1095; Harhaji L, 2008, FOOD CHEM TOXICOL, V46, P1825, DOI 10.1016/j.fct.2008.01.027; Hleba L., 2014, Scientific Papers: Animal Science and Biotechnologies, V47, P89; Hsieh TC, 2002, J ALTERN COMPLEM MED, V8, P591, DOI 10.1089/107555302320825101; Jamila N, 2015, J ENZYM INHIB MED CH, V30, P133, DOI 10.3109/14756366.2014.895720; Janjusevic L, 2018, NAT PROD RES, V32, P963, DOI 10.1080/14786419.2017.1366484; Janjusevic L, 2017, J ENZYM INHIB MED CH, V32, P355, DOI 10.1080/14756366.2016.1252759; Johnsy G., 2011, Journal of Pharmacy Research, V4, P3939; Karaman M, 2010, PHYTOTHER RES, V24, P1473, DOI 10.1002/ptr.2969; Kim Seong-Eun, 2012, Mycobiology, V40, P134, DOI 10.5941/MYCO.2012.40.2.134; Knezevic A, 2015, BOOK OF ABSTRACTS OF, P198; Knezevic Aleksandar, 2015, ScientificWorldJournal, V2015, P146378, DOI 10.1155/2015/146378; Lau CBS, 2004, LIFE SCI, V75, P797, DOI 10.1016/j.lfs.2004.04.001; Likhitwitayawuid K, 2001, J NAT PROD, V64, P1457, DOI 10.1021/np0101806; Lindequist U, 2005, EVID-BASED COMPL ALT, V2, P285, DOI 10.1093/ecam/neh107; Mau JL, 2002, J AGR FOOD CHEM, V50, P6072, DOI 10.1021/jf0201273; MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mossier DB, 1993, DERMATOLOGY GEN MED, P949; Ng TB, 1998, GEN PHARMACOL, V30, P1, DOI 10.1016/S0306-3623(97)00076-1; OHNO M, 1991, J IMMUNOL METHODS, V145, P199, DOI 10.1016/0022-1759(91)90327-C; Otsuka Y., 2013, INT J NUTR FOOD SCI, V2, P85, DOI DOI 10.11648/j.ijnfs.20130202.19; PACKER L, 2004, OXIDAT STRESS DIS, pR7; Palacios I, 2011, FOOD CHEM, V128, P674, DOI 10.1016/j.foodchem.2011.03.085; Park YK, 1997, ARQ BIOL TECNOL, V40, P97; Patoka J., 2012, MILIT MED SCI LETT, V81, P40; Phillips R, 1981, FOLIA GEOBOT; Picman AK, 1995, BIOCHEM SYST ECOL, V23, P683, DOI 10.1016/0305-1978(95)00081-X; Pop RM, 2018, NOT BOT HORTI AGROBO, V46, P343, DOI 10.15835/nbha46211132; Ren G, 2006, FITOTERAPIA, V77, P408, DOI 10.1016/j.fitote.2006.05.004; Samson R. A., 2010, CBS LAB MANUAL SERIE, V2; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Scarpari M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171412; Senol FS, 2010, FOOD CHEM, V120, P34, DOI 10.1016/j.foodchem.2009.09.066; Sheikh I.A., 2014, INT J PHARM PHARM SC, V6, P679; Shnyreva AV, 2018, INT J MED MUSHROOMS, V20, P1, DOI 10.1615/IntJMedMushrooms.2018025250; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Sivaprakasam E., 2011, International Journal of Pharmaceutical Sciences and Drug Research, V3, P219; Souza NAB, 2010, BRAZ J PHARM SCI, V46, P499, DOI 10.1590/S1984-82502010000300013; Stajic M, 2013, CURR TOP MED CHEM, V13, P2660, DOI 10.2174/15680266113136660192; TAKEUCHI T, 1969, J ANTIBIOT, V22, P215, DOI 10.7164/antibiotics.22.215; Wasser Solomon P, 2014, Biomed J, V37, P345, DOI 10.4103/2319-4170.138318; Wheeler M H, 1988, Curr Top Med Mycol, V2, P338; Yamac M, 2006, PHARM BIOL, V44, P660, DOI 10.1080/13880200601006897	58	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203064	10.1371/journal.pone.0203064	http://dx.doi.org/10.1371/journal.pone.0203064			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169542	Green Published, gold, Green Submitted			2022-12-26	WOS:000443374400019
J	Cox, RM; Toots, M; Yoon, JJ; Sourimant, J; Ludeke, B; Fearns, R; Bourque, E; Patti, J; Lee, E; Vernachio, J; Plemper, RK				Cox, Robert M.; Toots, Mart; Yoon, Jeong-Joong; Sourimant, Julien; Ludeke, Barbara; Fearns, Rachel; Bourque, Elyse; Patti, Joseph; Lee, Edward; Vernachio, John; Plemper, Richard K.			Development of an allosteric inhibitor class blocking RNA elongation by the respiratory syncytial virus polymerase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antiviral agent; viral polymerase; drug development; medicinal chemistry; animal virus; RdRp; respiratory disease; respiratory syncytial virus; RNA-dependent RNA polymerase	ENTRY INHIBITORS; INFLUENZA-VIRUS; DRUG DISCOVERY; YOUNG-CHILDREN; MESSENGER-RNA; L PROTEIN; REPLICATION; SOLUBILITY; METABOLISM; INFECTION	Respiratory syncytial virus (RSV) represents a significant health threat to infants and to elderly or immunocompromised individuals. There are currently no vaccines available to prevent RSV infections, and disease management is largely limited to supportive care, making the identification and development of effective antiviral therapeutics against RSV a priority. To identify effective chemical scaffolds for managing RSV disease, we conducted a high-throughput anti-RSV screen of a 57,000-compound library. We identified a hit compound that specifically blocked activity of the RSV RNA-dependent RNA polymerase (RdRp) complex, initially with moderate low-micromolar potency. Mechanistic characterization in an in vitro RSV RdRp assay indicated that representatives of this compound class block elongation of RSV RNA products after initial extension by up to three nucleotides. Synthetic hit-to-lead exploration yielded an informative 3D quantitative structure-activity relationship (3D-QSAR) model and resulted in analogs with more than 20-fold improved potency and selectivity indices (SIs) of >1,000. However, first-generation leads exhibited limited water solubility and poor metabolic stability. A second optimization strategy informed by the 3D-QSAR model combined with in silico pharmacokinetics (PK) predictions yielded an advanced lead, AVG-233, that demonstrated nanomolar activity against both laboratory-adapted RSV strains and clinical RSV isolates. This anti-RSV activity extended to infection of established cell lines and primary human airway cells. PK profiling in mice revealed 34% oral bioavailability of AVG-233 and sustained high drug levels in the circulation after a single oral dose of 20 mg/kg. This promising first-in-class lead warrants further development as an anti-RSV drug.	[Cox, Robert M.; Toots, Mart; Yoon, Jeong-Joong; Sourimant, Julien; Plemper, Richard K.] Georgia State Univ, Inst Biomed Sci, Atlanta, GA 30303 USA; [Ludeke, Barbara; Fearns, Rachel] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Patti, Joseph; Lee, Edward; Vernachio, John] Aviragen Therapeut, Alpharetta, GA 30009 USA	University System of Georgia; Georgia State University; Boston University	Plemper, RK (corresponding author), Georgia State Univ, Inst Biomed Sci, Atlanta, GA 30303 USA.	rplemper@gsu.edu		Fearns, Rachel/0000-0003-0783-7498; Sourimant, Julien/0000-0002-1660-1666	NIAID, National Institutes of Health (NIH) [AI071002]; NICHD, NIH [HD079327]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD079327] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071002] Funding Source: NIH RePORTER	NIAID, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by NIAID, National Institutes of Health (NIH), Grant AI071002 and NICHD, NIH, Grant HD079327 (to R. K. P.). J. P., E. L., J. V., and R. K. P. are co-inventors on a patent application covering the use of the AVG-233 compound class for antiviral therapy. This study could affect their personal financial status. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdolmaleki A, 2017, CURR DRUG TARGETS, V18, P556, DOI 10.2174/1389450117666160101120822; Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1; AHERNE W, 1970, J CLIN PATHOL, V23, P7, DOI 10.1136/jcp.23.1.7; Ali J, 2012, J CHEM INF MODEL, V52, P420, DOI 10.1021/ci200387c; ANDERSON LJ, 1990, J INFECT DIS, V161, P640, DOI 10.1093/infdis/161.4.640; Antoni D, 2015, INT J MOL SCI, V16, P5517, DOI 10.3390/ijms16035517; Asakawa N, 2012, INT J MED CHEM, V2012, DOI 10.1155/2012/498931; Baker KA, 1999, MOL CELL, V3, P309, DOI 10.1016/S1097-2765(00)80458-X; Cherkasov A, 2014, J MED CHEM, V57, P4977, DOI 10.1021/jm4004285; Cianci C, 2004, ANTIMICROB AGENTS CH, V48, P413, DOI 10.1128/AAC.48.2.413-422.2004; COLLINS PL, 1995, P NATL ACAD SCI USA, V92, P11563, DOI 10.1073/pnas.92.25.11563; Cox R, 2016, EXPERT OPIN DRUG DIS, V11, P543, DOI 10.1517/17460441.2016.1174212; Cox RM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602350; CRAMER RD, 1988, J AM CHEM SOC, V110, P5959, DOI 10.1021/ja00226a005; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; Dang NL, 2016, BIOINFORMATICS, V32, P3183, DOI 10.1093/bioinformatics/btw350; Delaney JS, 2004, J CHEM INF COMP SCI, V44, P1000, DOI 10.1021/ci034243x; DeVincenzo JP, 2014, NEW ENGL J MED, V371, P711, DOI 10.1056/NEJMoa1401184; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Dixon SL, 2006, J COMPUT AID MOL DES, V20, P647, DOI 10.1007/s10822-006-9087-6; Doak BC, 2014, CHEM BIOL, V21, P1115, DOI 10.1016/j.chembiol.2014.08.013; Domachowske JB, 1999, CLIN MICROBIOL REV, V12, P298, DOI 10.1128/CMR.12.2.298; Duprex WP, 1999, J VIROL, V73, P9568, DOI 10.1128/JVI.73.11.9568-9575.1999; Eglen R, 2011, ASSAY DRUG DEV TECHN, V9, P108, DOI 10.1089/adt.2010.0305; El Saleeby CM, 2011, J INFECT DIS, V204, P996, DOI 10.1093/infdis/jir494; GROOTHUIS JR, 1990, J PEDIATR-US, V117, P792, DOI 10.1016/S0022-3476(05)83347-5; GROSFELD H, 1995, J VIROL, V69, P5677, DOI 10.1128/JVI.69.9.5677-5686.1995; Heylen E, 2017, BIOCHEM PHARMACOL, V127, P1, DOI 10.1016/j.bcp.2016.09.014; Hotard AL, 2012, VIROLOGY, V434, P129, DOI 10.1016/j.virol.2012.09.022; Jacob RT, 2012, J BIOMOL SCREEN, V17, P1080, DOI 10.1177/1087057112450186; Jimenez-Somarribas A, 2017, J MED CHEM, V60, P2305, DOI 10.1021/acs.jmedchem.6b01568; Klebe G, 1999, J COMPUT AID MOL DES, V13, P1, DOI 10.1023/A:1008047919606; Krumm SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008517; Krumm SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020069; Lewis DFV, 2008, EXPERT OPIN DRUG MET, V4, P1181, DOI 10.1517/17425255.4.9.1181 ; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; LUGO RA, 1993, CLIN PHARMACY, V12, P95; Makhuri FR, 2015, EUR J PHARM SCI, V78, P151, DOI 10.1016/j.ejps.2015.07.011; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ndungu JM, 2012, J MED CHEM, V55, P4220, DOI 10.1021/jm201699w; Nie QD, 2018, CHEM BIOL DRUG DES, V92, P1750, DOI 10.1111/cbdd.13344; Noton SL, 2015, J VIROL, V89, P7786, DOI 10.1128/JVI.00530-15; Noton SL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002980; Peterson LA, 2013, CHEM RES TOXICOL, V26, P6, DOI 10.1021/tx3003824; Rydberg P, 2010, ACS MED CHEM LETT, V1, P96, DOI 10.1021/ml100016x; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Shiri F, 2019, ARAB J CHEM, V12, P2150, DOI 10.1016/j.arabjc.2014.11.063; Stokes KL, 2011, J VIROL, V85, P5782, DOI 10.1128/JVI.01693-10; Sun AM, 2011, ACS MED CHEM LETT, V2, P798, DOI 10.1021/ml200125r; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tiong-Yip CL, 2014, ANTIMICROB AGENTS CH, V58, P3867, DOI 10.1128/AAC.02540-14; Wang GY, 2015, J MED CHEM, V58, P1862, DOI 10.1021/jm5017279; Wang W, 2014, CURR PHARM BIOTECHNO, V15, P691, DOI 10.2174/138920101508140930153336; Wassermann AM, 2015, NAT CHEM BIOL, V11, P958, DOI 10.1038/nchembio.1936; Weisshaar M, 2016, J VIROL, V90, P7368, DOI 10.1128/JVI.00898-16; Xiong H, 2013, BIOORG MED CHEM LETT, V23, P6789, DOI 10.1016/j.bmcl.2013.10.018; Yan D, 2015, BIOCHEMISTRY-US, V54, P5589, DOI 10.1021/acs.biochem.5b00623; Yan D, 2014, P NATL ACAD SCI USA, V111, pE3441, DOI 10.1073/pnas.1405198111; Yan D, 2013, J VIROL, V87, P11076, DOI 10.1128/JVI.01425-13; Yang JJ, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0137-3; Yoon JJ, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00766-18;e00766-18; YU QZ, 1995, J VIROL, V69, P2412, DOI 10.1128/JVI.69.4.2412-2419.1995	63	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16761	16777		10.1074/jbc.RA118.004862	http://dx.doi.org/10.1074/jbc.RA118.004862			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30206124	Green Published, hybrid			2022-12-26	WOS:000448515100018
J	Park, AM; Tsunoda, I; Yoshie, O				Park, Ah-Mee; Tsunoda, Ikuo; Yoshie, Osamu			Heat shock protein 27 promotes cell cycle progression by down-regulating E2F transcription factor 4 and retinoblastoma family protein p130	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; E2F transcription factor; small heat shock protein (sHsp); cellular senescence; cell proliferation; transcription repressor; cyclin A2; cyclin B1; cyclin B2; HSPB1	SECRETORY PHENOTYPE; PROTEASOMAL DEGRADATION; INDUCED APOPTOSIS; GENE-EXPRESSION; IN-VITRO; SENESCENCE; HSP27; CANCER; ARREST; HEAT-SHOCK-PROTEIN-27	Heat shock protein 27 (HSP27) protects cells under stress. Here, we demonstrate that HSP27 also promotes cell cycle progression of MRC-5 human lung fibroblast cells. Serum starvation for 24 h induced G(1) arrest in these cells, and upon serum refeeding, the cells initiated cell cycle progression accompanied by an increase in HSP27 protein levels. HSP27 levels peaked at 12 h, and transcriptional up-regulation of six G(2)/M-related genes (CCNA2, CCNB1, CCNB2, CDC25C, CDCA3, and CDK1) peaked at 24-48 h. siRNA-mediated HSP27 silencing in proliferating MRC-5 cells induced G(2) arrest coinciding with down-regulation of these six genes. Of note, the promoters of all of these genes have the cell cycle-dependent element and/or the cell cycle gene-homology region. These promoter regions are known to be bound by the E2F family proteins (E2F-1 to E2F-8) and retinoblastoma (RB) family proteins (RB1, p107, and p130), among which E2F-4 and p130 were strongly up-regulated in HSP27-knockdown cells. E2F-4 or p130 knockdown concomitant with the HSP27 knockdown rescued MRC-5 cells from G(2) arrest and up-regulated the six cell cycle genes. Moreover, we observed cellular senescence in MRC-5 cells on day 3 after the HSP27 knockdown, as evidenced by increased senescence-associated beta-gal activity and up-regulated inflammatory cytokines. The cellular senescence was also suppressed by the concomitant knockdown of E2F-4/HSP27 or p130/HSP27. Our findings indicate that HSP27 promotes cell cycle progression of MRC-5 cells by suppressing expression of the transcriptional repressors E2F-4 and p130.	[Park, Ah-Mee; Tsunoda, Ikuo; Yoshie, Osamu] Kindai Univ, Fac Med, Dept Microbiol, 377-2 Ohnohigashi, Osaka 5898511, Japan; [Yoshie, Osamu] Hlth & Kampo Inst, 1-11-10 Murasakiyama, Sendai, Miyagi 9813205, Japan	Kindai University (Kinki University)	Park, AM (corresponding author), Kindai Univ, Fac Med, Dept Microbiol, 377-2 Ohnohigashi, Osaka 5898511, Japan.	ampk@med.kindai.ac.jp	Tsunoda, Ikuo/B-4722-2008; Park, Ah-Mee/AAS-2545-2020	Tsunoda, Ikuo/0000-0003-1798-714X; Park, Ah-Mee/0000-0001-8453-3872; Yoshie, Osamu/0000-0003-4353-5809	Japan Science and Technology Agency (CREST Program); Novartis Pharma Research Grants 2017; NIGMS, National Institutes of Health, COBRE Grant [P30-GM110703];  [JP15K08975]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110703] Funding Source: NIH RePORTER	Japan Science and Technology Agency (CREST Program)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Novartis Pharma Research Grants 2017; NIGMS, National Institutes of Health, COBRE Grant; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by Grant-in-Aid for Scientific Research C JP15K08975 (B) (to A. M. P.), a grant from the Japan Science and Technology Agency (CREST Program) (to O. Y.), Novartis Pharma Research Grants 2017 (to A. M. P. and I. T.), and NIGMS, National Institutes of Health, COBRE Grant P30-GM110703 (to I. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acunzo J, 2014, CURR DRUG TARGETS, V15, P423, DOI 10.2174/13894501113146660230; Arrigo AP, 2017, CELL STRESS CHAPERON, V22, P517, DOI 10.1007/s12192-017-0765-1; Blagosklonny MV, 2014, CELL CYCLE, V13, P3628, DOI 10.4161/15384101.2014.985507; Bukrinsky M, 2004, DNA CELL BIOL, V23, P223, DOI 10.1089/104454904773819806; Burban A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01171-y; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Christians ES, 2012, INT J BIOCHEM CELL B, V44, P1632, DOI 10.1016/j.biocel.2012.06.006; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Deng WJ, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0283-8; Friedman MJ, 2009, J BIOL CHEM, V284, P27944, DOI 10.1074/jbc.M109.037937; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Georgakilas AG, 2017, TRENDS MOL MED, V23, P310, DOI 10.1016/j.molmed.2017.02.001; Gire V, 2015, CELL CYCLE, V14, P297, DOI 10.1080/15384101.2014.1000134; Gudkov AV, 2005, BIOCHEM BIOPH RES CO, V331, P726, DOI 10.1016/j.bbrc.2005.03.153; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hayashi N, 2012, CELL DEATH DIFFER, V19, P990, DOI 10.1038/cdd.2011.184; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Horman S, 1999, INT J CANCER, V82, P574, DOI 10.1002/(SICI)1097-0215(19990812)82:4<574::AID-IJC17>3.0.CO;2-L; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Leontieva OV, 2012, CELL CYCLE, V11, P4642, DOI 10.4161/cc.22937; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Liu XW, 2004, AM J PHYSIOL-HEART C, V286, pH933, DOI 10.1152/ajpheart.00759.2003; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; O'Callaghan-Sunol C, 2007, CANCER RES, V67, P11779, DOI 10.1158/0008-5472.CAN-07-2441; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Parcellier A, 2006, FASEB J, V20, P1179, DOI 10.1096/fj.05-4184fje; Park AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148998; Plesca D, 2007, CELL CYCLE, V6, P1147, DOI 10.4161/cc.6.10.4259; Rocchi P, 2006, BJU INT, V98, P1082, DOI 10.1111/j.1464-410X.2006.06425.x; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Shin JS, 2008, INT J ONCOL, V32, P435; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Terzi MY, 2016, MOL BIOL REP, V43, P1213, DOI 10.1007/s11033-016-4065-0; Thurlings I, 2016, METHODS MOL BIOL, V1342, P71, DOI 10.1007/978-1-4939-2957-3_4; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Wettstein G, 2012, INT J BIOCHEM CELL B, V44, P1680, DOI 10.1016/j.biocel.2012.05.024; Williams GH, 2012, J PATHOL, V226, P352, DOI 10.1002/path.3022; Wu JM, 2017, TRENDS PHARMACOL SCI, V38, P226, DOI 10.1016/j.tips.2016.11.009; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhou XM, 2006, MECH AGEING DEV, V127, P779, DOI 10.1016/j.mad.2006.07.003; Zhu ZK, 2010, MOL PHARMACEUT, V7, P1283, DOI 10.1021/mp100073s	53	7	8	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15815	15826		10.1074/jbc.RA118.003310	http://dx.doi.org/10.1074/jbc.RA118.003310			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30166342	Green Published, hybrid			2022-12-26	WOS:000447256000006
J	Koehler-McNicholas, SR; Nickel, EA; Barrons, K; Blaharski, KE; Dellamano, CA; Ray, SF; Schnall, BL; Hendershot, BD; Hansen, AH				Koehler-McNicholas, Sara R.; Nickel, Eric A.; Barrons, Kyle; Blaharski, Kathryn E.; Dellamano, Clifford A.; Ray, Samuel F.; Schnall, Barri L.; Hendershot, Brad D.; Hansen, Andrew H.			Mechanical and dynamic characterization of prosthetic feet for high activity users during weighted and unweighted walking	PLOS ONE			English	Article							FOOT FOREFOOT FLEXIBILITY; CARRYING MILITARY LOADS; BELOW-KNEE AMPUTEES; GAIT; CARRIAGE; BACKPACK; SHAPE; KINEMATICS; AMPUTATION	Many Service members and Veterans with lower-limb amputations have the potential for high function and the desire to resume physically demanding occupations that require them to carry heavy loads (e.g., military service, firefighters, farmers, ranchers, construction workers). However, it is currently unclear which prosthetic feet best accommodate heavy load carriage while also providing good overall function and mobility during unweighted activities. The main objective of this study was to investigate the ability of currently available prosthetic ankle-foot systems to accommodate weighted walking by examining the mechanical characteristics (i.e., forefoot stiffness) and dynamic function (i.e., rocker radius, effective foot length ratio, and late-stance energy return) of prosthetic feet designed for high activity users. Load versus deflection curves were obtained for nine prosthetic ankle-foot systems using a servohydraulic test frame and load cell. Effective roll-over shape characteristics and late-stance energy return measures were then obtained using quantitative gait analysis for three users with unilateral, transtibial amputation. Results from mechanical and dynamic testing showed that although forefoot stiffness varied across the nine feet investigated in this study, changes measured in roll-over shape radius and effective foot length ratio were relatively small in response to weighted walking. At the same time, prosthetic feet with more compliant forefoot keel structures appeared to provide more late-stance energy return compared to feet with stiffer forefoot keel structures. These results suggest that prosthetic ankle-foot systems with compliant forefoot keel structures may better accommodate weighted walking by reducing the metabolic cost of physically demanding activities. However, to more fully understand the biomechanical and functional implications of these results, other factors, such as the residual-limb strength of the user and the overall stiffness profile of the prosthetic foot, should also be considered.	[Koehler-McNicholas, Sara R.; Nickel, Eric A.; Barrons, Kyle; Blaharski, Kathryn E.; Dellamano, Clifford A.; Hansen, Andrew H.] Minneapolis Dept Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA; [Dellamano, Clifford A.] Univ Minnesota, Coll Engn, Dept Biomed Engn, Minneapolis, MN USA; [Ray, Samuel F.; Schnall, Barri L.; Hendershot, Brad D.] Walter Reed Natl Mil Med Ctr, Dept Rehabil, Bethesda, MD USA; [Hendershot, Brad D.] Dept Def Vet Affairs, Extrem Trauma & Amputat Ctr Excellence, Bethesda, MD USA; [Hendershot, Brad D.] Uniformed Serv Univ Hlth Sci, Dept Rehabil Med, Bethesda, MD 20814 USA; [Hansen, Andrew H.] Univ Minnesota, Dept Rehabil Med, Program Rehabil Sci, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA; University of Minnesota System; University of Minnesota Twin Cities	Koehler-McNicholas, SR (corresponding author), Minneapolis Dept Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA.	sara.koehler@va.gov	Hendershot, Brad/AAG-7046-2020	Koehler-McNicholas, Sara/0000-0002-7201-3607	BADER Consortium via the Congressionally Designated Medical Research Program [W81XWH-11-2-0222]	BADER Consortium via the Congressionally Designated Medical Research Program	Support for this project was provided by the BADER Consortium via the Congressionally Designated Medical Research Program (Award # W81XWH-11-2-0222, Barri L. Schnall). The views expressed herein are those of the authors, and do not necessarily reflect the official policy or position of the Departments of the Army, Navy, Defense, the Department of Veterans Affairs, nor the United States Government.	Adamczyk PG, 2013, J EXP BIOL, V216, P2722, DOI 10.1242/jeb.082347; Attwells RL, 2006, ERGONOMICS, V49, P1527, DOI 10.1080/00140130600757237; Birrell SA, 2009, ERGONOMICS, V52, P1298, DOI 10.1080/00140130903003115; Doyle SS, 2014, CLIN BIOMECH, V29, P149, DOI 10.1016/j.clinbiomech.2013.11.019; Fey NP, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007824; Fey NP, 2011, CLIN BIOMECH, V26, P1025, DOI 10.1016/j.clinbiomech.2011.06.007; Hansen A.H., 2004, JPO, V16, P41; Hansen AH, 2005, J REHABIL RES DEV, V42, P381, DOI 10.1682/JRRD.2004.04.0048; Hansen AH, 2003, PROSTHET ORTHOT INT, V27, P89, DOI 10.1080/03093640308726664; Hansen AH, 2006, PROSTHET ORTHOT INT, V30, P286, DOI 10.1080/03093640600816982; Hofstad Cheriel J, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD003978.PUB2]; Klodd E, 2010, J REHABIL RES DEV, V47, P899, DOI 10.1682/JRRD.2009.10.0166; Klodd E, 2010, J REHABIL RES DEV, V47, P543, DOI 10.1682/JRRD.2010.01.0003; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; Majumdar D, 2010, ERGONOMICS, V53, P782, DOI 10.1080/00140131003672015; Quesada PM, 2000, ERGONOMICS, V43, P293, DOI 10.1080/001401300184413; Sanderson DJ, 1997, GAIT POSTURE, V6, P126, DOI 10.1016/S0966-6362(97)01112-0; Schnall BL, 2014, J REHABIL RES DEV, V51, P1505, DOI 10.1682/JRRD.2014.01.0022; Schnall BL, 2012, J REHABIL RES DEV, V49, P535, DOI 10.1682/JRRD.2011.04.0075; Sinitski EH, 2016, APPL ERGON, V52, P169, DOI 10.1016/j.apergo.2015.07.014; Takahashi KZ, 2012, J BIOMECH, V45, P2662, DOI 10.1016/j.jbiomech.2012.08.017; van der Linde H, 2004, J REHABIL RES DEV, V41, P555, DOI 10.1682/JRRD.2003.06.0102	22	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2018	13	9							e0202884	10.1371/journal.pone.0202884	http://dx.doi.org/10.1371/journal.pone.0202884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT7EB	30208040	Green Published, gold, Green Submitted			2022-12-26	WOS:000444683000041
J	Alemu, YM; Habtewold, TD; Alemu, SM				Alemu, Yihun Mulugeta; Habtewold, Tesfa Dejenie; Alemu, Sisay Mulugeta			Mother's knowledge on prevention of mother-to-child transmission of HIV, Ethiopia: A cross sectional study	PLOS ONE			English	Article							PREGNANT-WOMEN; TESTING SERVICES; TANZANIA; PROGRAM	Objective To identify proportion of and factors for comprehensive knowledge on prevention of mother-to-child transmission of HIV in pregnant women attending antenatal care in Northern Ethiopia. Methods A total of 416 pregnant women were interviewed between October 2012 and May 2013. Logistic regression analysis was used to identify factors for comprehensive knowledge on prevention of mother-to-child transmission of HIV. Results The proportion of pregnant women, who have comprehensive knowledge on prevention of mother-to-child transmission of HIV, was 52%. The odds of having comprehensive knowledge on prevention of mother-to-child transmission of HIV were higher among pregnant women who were younger (16 to 24 years old) (Adjusted Odds Ratio (AOR) = 2.95; 95%Cl: 1.20, 7.26), urban residents (AOR = 2.45; 95%CI: 1.39, 4.32), attending secondary education and above (AOR = 4.43; 95%CI: 2.40, 8.20), employed (AOR = 4.99;95%CI: 2.45, 10.16), have five children or more (AOR = 9.34; 95%CI:3.78, 23.07), have favored attitude towards HIV positive living (AOR = 2.53; 95%CI: 1.43, 4.44) and have perceived susceptibility to HIV (AOR = 10.72; 95%CI: 3.90, 29.39). Conclusion The proportion of women who have comprehensive knowledge on prevention of mother-to-child transmission of HIV in this study setting was low. Measures which will escalate mother's knowledge on prevention of mother-to-child transmission of HIV should be emphasized. Efforts to improve mother's knowledge on prevention of mother-to-child transmission of HIV should target women who were older age (> = 35years), rural residents, unemployed, not 16 attending formal education, primigravids, have no favored attitude towards HIV positive living and have not perceived susceptibility to HIV.	[Alemu, Yihun Mulugeta] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia; [Habtewold, Tesfa Dejenie] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Alemu, Sisay Mulugeta] Int Med Corps, Mental Hlth & Psychosocial Support Program, Ado Refugee Camp, Dollo Ado, Ethiopia	Bahir Dar University; University of Groningen	Alemu, YM (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia.	yihun.mulugeta@yahoo.com		Alemu, Yihun Mulugeta/0000-0003-3145-3494; Habtewold, Tesfa Dejenie/0000-0003-4476-518X; Alemu, Sisay Mulugeta/0000-0002-9270-9281				Abiodun MO, 2007, J NATL MED ASSOC, V99, P758; Abtew S, 2016, HIV AIDS-RES PALLIAT, V8, P101, DOI 10.2147/HIV.S100301; Adams MB, 2015, J MED SYST, V39, DOI 10.1007/s10916-014-0157-3; Alemu YM, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1389-2; Amoran OE, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-13; Anigilaje EA, 2016, PATIENT PREFER ADHER, V10, P57, DOI 10.2147/PPA.S87228; Ashimi A O, 2014, West Afr J Med, V33, P68; Baiden F, 2005, AIDS CARE, V17, P648, DOI 10.1080/09540120412331319688; Bajunirwe Francis, 2005, AIDS Res Ther, V2, P10, DOI 10.1186/1742-6405-2-10; Calvo-Armengol A, 2004, AM ECON REV, V94, P426, DOI 10.1257/0002828041464542; Central Statistical Agency, 2014, HIV AIDS EST PROJ ET; Creek T, 2009, AIDS BEHAV, V13, P356, DOI 10.1007/s10461-007-9322-8; Falnes EF, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-36; Federal Ministry of Health Ethiopia, 2011, GUID PREV MOTH CHILD; Haffejee F, 2016, HEALTH SA GESONDHEID, V21, DOI 10.1016/j.hsag.2016.02.001; Haile ZT, 2016, AIDS CARE, V28, P70, DOI 10.1080/09540121.2015.1062465; Hasan ATMH, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-174; Kinuthia J, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-61; Kipp W, 2001, AIDS EDUC PREV, V13, P279, DOI 10.1521/aeap.13.3.279.19743; Kominami M, 2007, PEDIATR INT, V49, P286, DOI 10.1111/j.1442-200X.2007.02355.x; Mahmoud MM, 2007, J MED VIROL, V79, P469, DOI 10.1002/jmv.20850; Malaju MT, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-73; Mpairwe H, 2005, JAIDS-J ACQ IMM DEF, V39, P354, DOI 10.1097/01.qai.0000148081.38331.92; Murithi LK, 2015, AIDS BEHAV, V19, P645, DOI 10.1007/s10461-014-0939-0; Nubed CK, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3516-9; Omwega A M, 2006, East Afr Med J, V83, P610; Orne-Gliemann J, 2006, TROP MED INT HEALTH, V11, P341, DOI 10.1111/j.1365-3156.2006.01563.x; Qu Bo, 2008, Int J Biomed Sci, V4, P192; Sama CB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172102; UNICEF, 2014, SURV HLTH ETH HAS LA, P2104; USAID, 2013, REP GLOB AIDS EP; USAID, 2016, REP GLOB AIDS EP; Vajargah K. F., 2015, INDIAN J FUNDAM APPL, V5, P1432; Veloso Valdiléa G, 2008, Rev. Saúde Pública, V42, P859, DOI 10.1590/S0034-89102008000500011; Ventola C Lee, 2014, P T, V39, P491; Woldesenbet S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132425; World Health Organization, 2017, GLOB GUID CRIT PROC, V2nd	37	12	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203043	10.1371/journal.pone.0203043	http://dx.doi.org/10.1371/journal.pone.0203043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT2UM	30204752	Green Submitted, Green Published, gold			2022-12-26	WOS:000444355500016
J	de Oliveira, SM; Altmayer, S; Zanon, M; Sidney, LA; Moreira, ALS; Dalcin, PD; Garcez, A; Hochhegger, B; Moreira, JD; Watte, G				de Oliveira, Samanta Madeira; Altmayer, Stephan; Zanon, Matheus; Sidney-Filho, Luzielio Alves; Schneider Moreira, Ana Luiza; Dalcin, Paulo de Tarso; Garcez, Anderson; Hochhegger, Bruno; Moreira, Jose da Silva; Watte, Guilherme			Predictors of noncompliance to pulmonary tuberculosis treatment: An insight from South America	PLOS ONE			English	Article							PATIENT ADHERENCE; UNITED-STATES; CONSEQUENCES; NONADHERENCE; PAKISTAN; VIETNAM; BRAZIL; WOMEN; CITY	Purpose To investigate the factors associated with a higher risk of noncompliance to tuberculosis (TB) treatment in Porto Alegre, Brazil. Methods We identified 478 adult patients for this case-control study undergoing treatment for confirmed pulmonary TB. Cases (noncompliance) were defined as patients who stopped treatment for more than 30 consecutive days (n = 118). Controls were defined as all patients who completed treatment and were cured (n = 360). Factors associated with noncompliance were calculated with unadjusted and adjusted odds ratio (OR). Results The rate of noncompliance in our study was 25%. The factors of noncompliance after adjustments in the overall population were, in order of magnitude, living in an area of lower income (OR = 4.35, 95%CI: 2.50-7.58), abuse of drugs (OR = 2.73, 95%CI: 1.47-5.09), nonadherence to a previous treatment regimen (OR = 2.1, 95%CI: 1.28-3.45), and history of smoking (OR = 1.72, 95%CI: 1.00-3.00). Age, race, gender, level of education, HIV infection or diabetes status were not associated with a higher risk of noncompliance. In the subgroup of re-treatment cases, poverty (OR = 2.65; 95%CI = 1.06-6.66), smoking history (OR = 2.94; 95%CI = 1.09-7.92), male gender (OR = 3.25; 95%CI = 1.32-8.0), and younger age (OR = 4.3; 95%CI = 1.15-16.07) were also associated with a higher risk of dropout. Conclusion Predictors of poor compliance to TB treatment were low income, abuse of drugs, re-treatment cases and history of smoking.	[de Oliveira, Samanta Madeira; Dalcin, Paulo de Tarso] Univ Fed Rio Grande do Sul, Postgrad Program Resp Med, Porto Alegre, RS, Brazil; [Altmayer, Stephan; Zanon, Matheus; Hochhegger, Bruno] Univ Fed Ciencias Saude Porto Alegre, Dept Radiol, Porto Alegre, RS, Brazil; [Sidney-Filho, Luzielio Alves] Univ Fed Espirito Santo, Dept Surg, Vitoria, ES, Brazil; [Schneider Moreira, Ana Luiza; Moreira, Jose da Silva; Watte, Guilherme] Irmandade Santa Casa Misericordia Porto Alegre, Dept Resp Med, Porto Alegre, RS, Brazil; [Garcez, Anderson] Univ Vale Rio dos Sinos, Dept Publ Hlth, Sao Leopoldo, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade Federal do Espirito Santo; Universidade do Vale do Rio dos Sinos (Unisinos)	Altmayer, S (corresponding author), Univ Fed Ciencias Saude Porto Alegre, Dept Radiol, Porto Alegre, RS, Brazil.	stephanaltmayer@gmail.com	Zanon, Matheus/AAP-3630-2020; Hochhegger, Bruno/AAH-9945-2019; Garcez, Anderson/AAH-5877-2021; Watte, G./ABC-7864-2020	Watte, G./0000-0002-6948-3982; Zanon, Matheus/0000-0001-7851-5125; Hochhegger, Bruno/0000-0003-1984-4636; Altmayer, Stephan/0000-0001-9214-1916				Acosta Lisiane Morelia Weide, 2014, Rev. bras. epidemiol., V17, P88, DOI 10.1590/1809-4503201400060008; ADDINGTON WW, 1979, CHEST, V76, P741, DOI 10.1378/chest.76.6_Supplement.741; Herrero MB, 2015, CAD SAUDE PUBLICA, V31, P1983, DOI 10.1590/0102-311X00024314; Campani STA, 2011, J BRAS PNEUMOL, V37, P776, DOI 10.1590/S1806-37132011000600011; Departamento de Vigila A ncia Epidemiolo A gica Ministe A rio da Sau A de, 2011, MAN REC CONTR TUB BR; Glaziou P, 2013, SEMIN RESP CRIT CARE, V34, P3, DOI 10.1055/s-0032-1333467; Johansson E, 1999, INT J TUBERC LUNG D, V3, P862; Kent PT, 1985, PUBLIC HLTH MYCOBACT, P159; Khan MA, 2005, HEALTH POLICY PLANN, V20, P354, DOI 10.1093/heapol/czi047; Lewin S, 2001, COCHRANE DATABASE SY; Liefooghe R, 1995, SOC SCI MED, V41, P1685, DOI 10.1016/0277-9536(95)00129-U; Long NH, 1999, INT J TUBERC LUNG D, V3, P388; Moro RN, 2016, CLIN INFECT DIS, V62, P1390, DOI 10.1093/cid/ciw126; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Nahid P, 2016, CLIN INFECT DIS, V63, pe147, DOI 10.1093/cid/ciw376; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; Paixao LMM, 2007, REV SAUDE PUBL, V41; Roux AVD, 2001, ANN EPIDEMIOL, V11, P395, DOI 10.1016/S1047-2797(01)00221-6; Silva PD, 2014, CAD SAUDE PUBLICA, V30, P1745, DOI 10.1590/0102-311X00124513; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; World Health Organisation, 2003, ADHERENCE LONG TERM; World Health Organization, 2017, TREATMENT TUBERCULOS	22	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0202593	10.1371/journal.pone.0202593	http://dx.doi.org/10.1371/journal.pone.0202593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204763	Green Published, Green Submitted, gold			2022-12-26	WOS:000444355500008
J	Kobosko, J; Jedrzejczak, WW; Gos, E; Geremek-Samsonowic, A; Ludwikowski, M; Skarzynski, H				Kobosko, Joanna; Jedrzejczak, W. Wiktor; Gos, Elibieta; Geremek-Samsonowic, Anna; Ludwikowski, Maciej; Skarzynski, Henryk			Self-esteem in the deaf who have become cochlear implant users as adults	PLOS ONE			English	Article							HARD-OF-HEARING; MENTAL-HEALTH; COPING STRATEGIES; SOCIAL COMPETENCE; PEER PROBLEMS; LIFE; ADOLESCENTS; QUALITY; SATISFACTION; CHILDREN	Objective Self-esteem is a good predictor of mental health and is crucial for well-being and psychological functioning. It is especially important in situations where there are potential mental health problems, such as in people suffering from hearing loss or total deafness. This study aims to gauge the level of self-esteem in adults with hearing problems, in particular those who, in adulthood, had received a cochlear implant (CI). The subjects had different onset (pre-lingual/post-lingual) and amount (deafness/partial deafness) of hearing loss, and their current level of self-esteem was compared to that of the general population. The association of self-esteem with other deafness-related variables (e.g. satisfaction with their CI or whether they also used a hearing aid) and sociodemographic factors was also investigated. Methods Data were obtained from questionnaires mailed to patients who, when adult, had received a CI. The subjects were divided into four subgroups: subjects with pre-lingual deafness, post-lingual deafness, pre-lingual partial deafness, and post-lingual partial deafness. To evaluate their self-esteem, the Rosenberg Self-Esteem Scale (RSES) was used. For data on sociodemographic status and information related to deafness and CI, we used our own Information Inquiry form. For statistical analysis of the results, we compared means (t-test, ANOVA), investigated correlations, and applied linear regression. Results The self-esteem of deaf and partially deaf CI users was significantly lower than in the general population, especially for post-lingually deafened subjects. The only factor related to deafness and CIs that explained self-esteem was self-rated satisfaction with the CI-meaning that higher satisfaction was associated with higher self-esteem. The major sociodemographic factor that explained self-esteem was marital/partnership status (being in a relationship was helpful). Also men had higher self-esteem than women. Those with higher levels of education, and those working or studying, had higher self-esteem than those who did not. RSES was found to have a single-factor structure. Conclusion Deafness and partial deafness appear to be risk factors for lower self-esteem, a finding that rehabilitation, medical, educational, and employment communities should be made aware of. Medical intervention in the form of a CI supplies the person with improved hearing, but it is not a panacea: their self-esteem is still vulnerable, and reinforcement of self-esteem is an aspect that professionals should focus on. Psychological, psycho-educational, and psychotherapeutic interventions have important roles to play for CI recipients.	[Kobosko, Joanna; Jedrzejczak, W. Wiktor; Gos, Elibieta; Geremek-Samsonowic, Anna; Ludwikowski, Maciej; Skarzynski, Henryk] Inst Physiol & Pathol Hearing, Warsaw, Poland; [Kobosko, Joanna; Jedrzejczak, W. Wiktor; Gos, Elibieta; Geremek-Samsonowic, Anna; Ludwikowski, Maciej; Skarzynski, Henryk] World Hearing Ctr, Kajetany Nadarzyn, Poland	Institute of Physiology & Hearing Pathology; Institute of Physiology & Hearing Pathology	Jedrzejczak, WW (corresponding author), Inst Physiol & Pathol Hearing, Warsaw, Poland.; Jedrzejczak, WW (corresponding author), World Hearing Ctr, Kajetany Nadarzyn, Poland.	w.jedrzejczak@ifps.org.pl	Kobosko, Joanna/AAE-9867-2019; Gos, Elżbieta/AAF-3432-2019; Jedrzejczak, W. Wiktor/L-2529-2015	Kobosko, Joanna/0000-0001-8939-4381; Jedrzejczak, W. Wiktor/0000-0001-8404-0672; Skarzynski, Henryk/0000-0001-7141-9851; Gos, Elzbieta/0000-0003-3173-3867				Alessandri G, 2015, PSYCHOL ASSESSMENT, V27, P621, DOI 10.1037/pas0000073; Bat-Chava Y, 2000, AM ANN DEAF, V145, P420, DOI 10.1353/aad.2012.0176; BATCHAVA Y, 1993, REHABIL PSYCHOL, V38, P221, DOI 10.1037/h0080303; BATCHAVA Y, 1994, PERS SOC PSYCHOL B, V20, P494, DOI 10.1177/0146167294205006; Baumeister RF, 1996, PSYCHOL REV, V103, P5, DOI 10.1037/0033-295X.103.1.5; Baumeister RF, 2003, PSYCHOL SCI, P1, DOI 10.1111/1529-1006.01431; Black PA, 2006, J DEAF STUD DEAF EDU, V11, P303, DOI 10.1093/deafed/enj042; Bosco E, 2013, EUR ARCH OTO-RHINO-L, V270, P2611, DOI 10.1007/s00405-012-2264-4; Brice PJ, 2011, RESILIENCE IN DEAF CHILDREN: ADAPTATION THROUGH EMERGING ADULTHOOD, P115, DOI 10.1007/978-1-4419-7796-0_5; Bruggemann P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00226; Bureau International d' Audiophonologie (BIAP), REC BIAP 02 1BIS CLA; Capretta NR, 2016, LARYNGOSCOPE, V126, P699, DOI 10.1002/lary.25525; Carter MJ, 2016, IDENTITY, V16, P102, DOI 10.1080/15283488.2016.1159963; Chung J, 2012, OTOL NEUROTOL, V33, P566, DOI 10.1097/MAO.0b013e3182536dc2; Clesia K, 2016, EUR ARCH OTO-RHINO-L, V273, P767, DOI [10.1007/s00405-015-3713-7, DOI 10.1007/S00405-015-3713-7]; Cornell SL, 2005, J FEM FAM THER, V16, P31, DOI 10.1300/J086v16n03_02; Crowe Teresa V, 2003, J Deaf Stud Deaf Educ, V8, P199, DOI 10.1093/deafed/eng003; de Graaf R, 2002, PSYCHOSOM MED, V64, P61, DOI 10.1097/00006842-200201000-00009; Dryzalowska G., 2016, INTEGRACJA EDUKACYJN; Du Feu M., 2014, MENTAL HLTH DEAFNESS, P209; du Feu M, 2003, ADV PSYCHIAT TREAT, V9, P95, DOI DOI 10.1192/APT.9.2.95; Dzwonkowska I., 2008, SAMOOCENA JEJ POMIAR; Emmett SD, 2015, OTOL NEUROTOL, V36, P545, DOI 10.1097/MAO.0000000000000562; Erol RY, 2016, EUR PSYCHOL, V21, P274, DOI 10.1027/1016-9040/a000259; Erol RY, 2014, DEV PSYCHOL, V50, P2291, DOI 10.1037/a0037370; Fellinger J, 2007, ACTA PSYCHIAT SCAND, V115, P243, DOI 10.1111/j.1600-0447.2006.00976.x; Fellinger J, 2012, LANCET, V379, P1037, DOI 10.1016/S0140-6736(11)61143-4; Fellinger J, 2009, DEV MED CHILD NEUROL, V51, P635, DOI 10.1111/j.1469-8749.2008.03218.x; Finlay L, 2008, MED HEALTH CARE PHIL, V11, P255, DOI 10.1007/s11019-007-9116-9; Glowny Urzad Statystyczny (Departament Demograficznych Departament Pracy Departament Handlu i Usoug), 2012, RAP WYN NAR SPIS POW; Hallam R, 2006, INT J AUDIOL, V45, P715, DOI 10.1080/14992020600957335; Hintermair M, 2008, J DEAF STUD DEAF EDU, V13, P278, DOI 10.1093/deafed/enm054; Hoffman MF, 2016, OTOL NEUROTOL, V37, P152, DOI 10.1097/MAO.0000000000000938; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huber M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00953; Jambor E, 2005, J DEAF STUD DEAF EDU, V10, P63, DOI 10.1093/deafed/eni004; Kashubeck-West S, 2008, J COUNS PSYCHOL, V55, P463, DOI 10.1037/a0013619; Kobosko J., 2017, TEORIA PRAKTYKA ODDZ, V4, P221; Kobosko J., 2015, MENTAL HLTH SERVICES, P193; Kobosko J, 2017, NOW AUDIOFONOL, V6, P31, DOI [10.17431/1002752, DOI 10.17431/1002752]; Kobosko J., 2007, THESIS; Kobosko J, 2015, EAR HEARING, V36, P605, DOI 10.1097/AUD.0000000000000179; Kobosko J, 2011, VOLTA REV, V111, P39, DOI 10.17955/tvr.111.1.655; Kossewska J., 2016, STUDIES DEAFNESS ECO; Krakowiak K., 2012, DAR METODYKI WYCHOWA; Lane Harlan, 1993, MASK BENEVOLENCE DIS; Lazard DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048739; Leigh I.W., 2017, DEAF PEOPLE SOC EVOL; Leigh I.W., 2009, LENS DEAF IDENTITIES, V59, DOI [10.1093/acprof:oso/9780195320664.001.0001, DOI 10.1093/ACPROF:OSO/9780195320664.001.0001]; Leigh IW, 2009, J DEAF STUD DEAF EDU, V14, P244, DOI 10.1093/deafed/enn038; Levinger M, 2010, J SOC WORK DISABIL R, V9, P27, DOI 10.1080/15367100903526120; Lu AT, 2015, J ADOLESCENCE, V39, P1, DOI 10.1016/j.adolescence.2014.11.005; Maki-Torkko EM, 2015, DISABIL REHABIL, V37, P541, DOI 10.3109/09638288.2014.935490; Marschark M, 2018, J DEAF STUD DEAF EDU, V23, P28, DOI 10.1093/deafed/enx035; Maxwell-McCaw D., 2001, THESIS; McRackan TR, 2018, LARYNGOSCOPE, V128, P982, DOI 10.1002/lary.26738; Mejstad L, 2008, AM ANN DEAF, V153, P504; Meyer JM, 2013, REHABIL PSYCHOL, V58, P124, DOI 10.1037/a0032197; Monzani D, 2008, ACTA OTORHINOLARYNGO, V28, P61; Most T, 2012, J DEAF STUD DEAF EDU, V17, P259, DOI 10.1093/deafed/enr049; Most T, 2010, AM J OTOLARYNG, V31, P418, DOI 10.1016/j.amjoto.2009.07.002; Mund M, 2015, EUR J PERSONALITY, V29, P235, DOI 10.1002/per.1984; Orth U., 2017, PERSONALITY DEV LIFE, P181, DOI [DOI 10.1016/B978-0-12-804674-6.00012-0, 10.1016/B978-0- 12-804674-6.00012-0]; Orth U, 2018, J PERS SOC PSYCHOL, V114, P637, DOI 10.1037/pspp0000143; Orth U, 2015, J PERS SOC PSYCHOL, V109, P707, DOI 10.1037/pspp0000049; Orth U, 2012, J PERS SOC PSYCHOL, V102, P1271, DOI 10.1037/a0025558; Punch R, 2007, J DEAF STUD DEAF EDU, V12, P504, DOI 10.1093/deafed/enm011; Punch R, 2016, AM ANN DEAF, V161, P384, DOI 10.1353/aad.2016.0028; Quittner AL, 2010, PARENT-SCI PRACT, V10, P136, DOI 10.1080/15295190903212851; Ramos-Macias A, 2016, AUDIOL NEURO-OTOL, V21, P36, DOI 10.1159/000448353; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Saunders GH, 1996, EAR HEARING, V17, P505, DOI 10.1097/00003446-199612000-00006; Schmitt DP, 2005, J PERS SOC PSYCHOL, V89, P623, DOI 10.1037/0022-3514.89.4.623; Sinclair SJ, 2010, EVAL HEALTH PROF, V33, P56, DOI 10.1177/0163278709356187; Skarzynski H, 1993, Otolaryngol Pol, V47, P427; Skarzynski H., 1994, OTOLARYNGOL POL S15, V48, P152; Skarzynski Henryk, 2003, Med Sci Monit, V9, pCS20; Skarzynski H, 2010, MED SCI MONITOR, V16, pCR555; Solnica J, 2012, NOW AUDIOFONOL, V1, P31; Spencer LJ, 2012, J DEAF STUD DEAF EDU, V17, P483, DOI 10.1093/deafed/ens024; Suarez M, 2000, J Deaf Stud Deaf Educ, V5, P323, DOI 10.1093/deafed/5.4.323; Szkieoko M, 2014, ZWEISPRACHIGKEIT BIL, P129; Szpitalak M., 2015, SAMOOCENA GENEZA STR; Tambs K, 2004, PSYCHOSOM MED, V66, P776, DOI 10.1097/01.psy.0000133328.03596.fb; Theunissen SCPM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094521; van Gent T, 2012, J DEAF STUD DEAF EDU, V17, P333, DOI 10.1093/deafed/ens002; van Gent T, 2011, J CHILD PSYCHOL PSYC, V52, P720, DOI 10.1111/j.1469-7610.2011.02392.x; Van Gurp S, 2001, J Deaf Stud Deaf Educ, V6, P54, DOI 10.1093/deafed/6.1.54; von Soest T, 2016, J PERS SOC PSYCHOL, V110, P592, DOI 10.1037/pspp0000060; Wallis Delia, 2004, J Deaf Stud Deaf Educ, V9, P2, DOI 10.1093/deafed/enh014; Williams KC, 2015, REHABIL PSYCHOL, V60, P51, DOI 10.1037/rep0000028; Wojda P., 2010, SIGN LANGUAGES, P131, DOI [10.1017/cbo9780511712203.008, DOI 10.1017/CBO9780511712203.008]; Zaborniak-Sobczak M, 2014, ODPOWIEDZIALNOSC MLO; Zalewska M., 1998, DZIECKO AUTOPORTRECI	94	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203680	10.1371/journal.pone.0203680	http://dx.doi.org/10.1371/journal.pone.0203680			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT2UM	30204775	Green Submitted, gold, Green Published			2022-12-26	WOS:000444355500038
J	Bharati, M; Saha, D				Bharati, Minu; Saha, Dhiraj			Multiple insecticide resistance mechanisms in primary dengue vector, Aedes aegypti (Linn.) from dengue endemic districts of sub-Himalayan West Bengal, India	PLOS ONE			English	Article							AEDES-AEGYPTI; ANOPHELES-GAMBIAE; CROSS-RESISTANCE; IDENTIFICATION; ALBOPICTUS; IMPACT; GENE; DDT	Background Mosquitoes belonging to genus Aedes are the prime vectors of several arboviral diseases such as Dengue, Zika and Chikungunya worldwide. Every year numerous cases of dengue infections occur throughout the world, proper control of which depends on efficient vector control. However the onset of insecticide resistance has resulted in failure of vector control approaches. Principal findings This study was carried out to unveil the degree of prevailing insecticide resistance along with its underlying mechanisms among the primary dengue vector in dengue endemic districts of West Bengal, India through standard WHO protocol. It was observed that, the majority of the tested populations were found to possess resistance to more than one insecticide. In adult bioassay, the toxicity levels of the six tested insecticides was found to decrease in the following order: deltamethrin > lambdacyhalothrin > malathion > propoxur > permethrin > DDT. In larval bioassay, one of the tested populations was found to possess moderate resistance against temephos, mortality percentage 92.5% and 79.8% for WHO (0.0200 ppm) and National Vector Borne disease Programme, India recommended dose (0.0125 ppm) respectively. Carboxylesterases were found to be involved in conferring resistance as revealed in synergistic and quantitative assay against temephos in North Dinajpur (NDP) population and malathion in Alipurduar (APD) and Darjeeling (DAR) populations. Similar correlations were also observed in the majority of the tested populations between reduced susceptibilities against pyrethroid insecticides and Cytochrome P450S activity. Conclusion Efficient disease management in this region can only be achieved through proper integrated vector management along with tools to minimize insecticide resistance. This study may help the concerned authorities in the formulation of an effective vector control strategy throughout this region incorporating the knowledge gained through this study.	[Bharati, Minu; Saha, Dhiraj] Univ North Bengal, Dept Zool, Insect Biochem & Mol Biol Lab, PO North Bengal Univ, Siliguri, W Bengal, India	University of North Bengal	Saha, D (corresponding author), Univ North Bengal, Dept Zool, Insect Biochem & Mol Biol Lab, PO North Bengal Univ, Siliguri, W Bengal, India.	dhirajsaha.nbu@gmail.com	Saha, Dhiraj/AEB-7986-2022	Saha, Dhiraj/0000-0002-2309-4068				Aponte HA, 2013, PESTIC BIOCHEM PHYS, V107, P226, DOI 10.1016/j.pestbp.2013.07.005; [Anonymous], 2005, GUIDELINES LAB FIELD; [Anonymous], 2014, ADV ENTOMOL, DOI DOI 10.4236/ae.2014.23019; Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263; Bharati Minu, 2018, Proceedings of the Zoological Society (Calcutta), V71, P239, DOI 10.1007/s12595-016-0193-8; Bharati M, 2017, ACTA TROP, V170, P112, DOI 10.1016/j.actatropica.2017.02.029; Bisset JA, 2013, J MED ENTOMOL, V50, P352, DOI 10.1603/ME12064; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Chatterjee M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006192; Choovattanapakorn N., 2017, Medical Entomology and Zoology, V68, P19; Dia I, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-238; Farajollahi A, 2013, J AM MOSQUITO CONTR, V29, P203, DOI 10.2987/11-6198R.1; Fonseca-Gonzalez I, 2011, PEST MANAG SCI, V67, P430, DOI 10.1002/ps.2081; Gupta N, 2012, INDIAN J MED RES, V136, P373; Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x; Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2; Karunaratne SHPP, 2001, B WORLD HEALTH ORGAN, V79, P1060; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989; Mitchell SN, 2012, P NATL ACAD SCI USA, V109, P6147, DOI 10.1073/pnas.1203452109; Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011; National Vector Borne Disease Control Programme, 2017, NVBDCP DENG; Ngoagouni C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1887-5; Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006; Paiva MHS, 2016, GENOMICS, V107, P40, DOI 10.1016/j.ygeno.2015.11.004; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Poupardin R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002743; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2010, TROP NET, V1, P2078; Sharma S. N., 2004, Journal of Communicable Diseases, V36, P177; Tyagi BK., 2015, INT J MOSQ RES, V50, P50; Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008; Weetman D, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020220; WHO, 2006, GUIDELINES TESTING M; WHO, 1998, TEST PROC INREMO	36	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2018	13	9							e0203207	10.1371/journal.pone.0203207	http://dx.doi.org/10.1371/journal.pone.0203207			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7DK	30199543	Green Submitted, Green Published, gold			2022-12-26	WOS:000444681100012
J	Obodai, E; Odoom, JK; Adiku, T; Goka, B; Wolff, T; Biere, B; Schweiger, B; Reiche, J				Obodai, Evangeline; Odoom, John Kofi; Adiku, Theophilus; Goka, Bamenla; Wolff, Thorsten; Biere, Barbara; Schweiger, Brunhilde; Reiche, Janine			The significance of human respiratory syncytial virus (HRSV) in children from Ghana with acute lower respiratory tract infection: A molecular epidemiological analysis, 2006 and 2013-2014	PLOS ONE			English	Article							GROUP-B GENOTYPE; SUBGROUP-B; GENETIC-VARIABILITY; VIRAL ETIOLOGY; SOUTH-AFRICA; G-PROTEIN; GROUP-A; 60-NUCLEOTIDE DUPLICATION; CIRCULATION PATTERNS; YOUNG-CHILDREN	Background Acute lower respiratory tract infection (ALRI) is a leading cause of childhood morbidity and mortality in developing countries. Globally, human respiratory syncytial virus (HRSV) is the most common pathogen of ALRI in infants and children. However, age-stratified HRSV disease burden data are largely absent from Africa, which is a key gap in informing an evidence-based recommendation for the introduction of an HRSV vaccine by the WHO. Methods This study investigated the presence of HRSV in respiratory specimens from 552 children <5 years old with ALRI from Accra, Ghana in 2006 and 2013-2014 by real-time PCR. Of HRSV-positive samples the second hypervariable region of the viral G protein gene was sequenced and analyzed for phylogeny, characteristic amino acid substitutions, and potential glycosylation patterns. Further, HRSV infections have been characterized by age, symptoms and timely occurrence. Results HRSV was observed in 23% (127/552) of the children with ALRI, with the highest incidence in infants younger than one year (33%, 97/295, p = 0.013). Within the observed seasonal circulation time of HRSV from June (mid-wet season) to December (beginning of the dry season) the incidence of ALRI due to HRSV was as high as 46% (125/273). HRSV disease was significantly associated with (broncho-) pneumonia, bronchiolitis, LRTI, and difficulty in breathing. Phylogenetic characterization of HRSV strains from Ghana identified the circulation of the currently worldwide prevailing genotypes ON1 and BA9, and shows evidence of an independent molecular evolution of ON1 and BA9 strains in Ghana resulting in potentially new subgenotypes within ON1 and BA9, provisionally named ON1.5, ON1.6, and BA9-IV. Conclusion This study addresses important knowledge gaps in the forefront of introducing the HRSV vaccine by providing information on the molecular evolution and incidence of HRSV in Accra (Ghana, Africa).	[Obodai, Evangeline; Odoom, John Kofi] Univ Ghana, Noguchi Mem Inst Med Res, Dept Virol, Legon, Accra, Ghana; [Obodai, Evangeline; Wolff, Thorsten; Biere, Barbara; Schweiger, Brunhilde; Reiche, Janine] Robert Koch Inst, Dept Infect Dis, Unit 17, Influenza & Other Resp Viruses, Berlin, Germany; [Adiku, Theophilus] Univ Hlth & Allied Sci, Sch Basic & Biomed Sci, Dept Biomed Sci, Ho, Volta Region, Ghana; [Goka, Bamenla] Univ Ghana, Coll Hlth Sci, Sch Med & Dent, Dept Child Hlth, Accra, Ghana	University of Ghana; Robert Koch Institute; University of Ghana	Obodai, E (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Dept Virol, Legon, Accra, Ghana.; Obodai, E; Reiche, J (corresponding author), Robert Koch Inst, Dept Infect Dis, Unit 17, Influenza & Other Resp Viruses, Berlin, Germany.	eobodai@noguchi.ug.edu.gh; ReicheJ@rki.de		Obodai, Evangeline/0000-0001-5358-5688; Odoom, John Kofi/0000-0003-0761-4614	DAAD (German Academic Exchange Service)-Government of Ghana scholarship [50015294]	DAAD (German Academic Exchange Service)-Government of Ghana scholarship	A PhD scholarship (EO) was funded by the DAAD (German Academic Exchange Service)-Government of Ghana scholarship (50015294, http://ic.daad.de/accra/en/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiku TK, 2015, PATHOGENS, V4, P22, DOI 10.3390/pathogens4010022; ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Arnott A, 2011, J CLIN MICROBIOL, V49, P3504, DOI 10.1128/JCM.01131-11; Auksornkitti V, 2014, ARCH VIROL, V159, P499, DOI 10.1007/s00705-013-1773-9; Baek YH, 2012, ARCH VIROL, V157, P1039, DOI 10.1007/s00705-012-1267-1; Bashir U, 2017, INFECT GENET EVOL, V47, P125, DOI 10.1016/j.meegid.2016.11.024; Blanc A, 2005, ARCH VIROL, V150, P603, DOI 10.1007/s00705-004-0412-x; Bonney JHK, 2012, J INFECT DIS, V206, pS108, DOI 10.1093/infdis/jis577; Bose ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120098; CANE PA, 1995, J VIROL, V69, P2918, DOI 10.1128/JVI.69.5.2918-2925.1995; CANE PA, 1991, J GEN VIROL, V72, P2091, DOI 10.1099/0022-1317-72-9-2091; Chen YW, 2014, J MICROBIOL IMMUNOL, V47, P116, DOI 10.1016/j.jmii.2012.08.012; Cui GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075020; da Silva ER, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-41; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Esposito S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129369; Fall A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157163; Fan RY, 2017, J MED VIROL, V89, P213, DOI 10.1002/jmv.24619; Ghana Health Service, 2012, GHAN HLTH SERV 2011; Gimferrer L, 2015, J CLIN VIROL, V66, P27, DOI 10.1016/j.jcv.2015.02.018; Guerrier G, 2013, PEDIATR INFECT DIS J, V32, pE8, DOI 10.1097/INF.0b013e31826fd40d; HAMBLING MH, 1964, BRIT J EXP PATHOL, V45, P647; Hazir T, 2004, ARCH DIS CHILD, V89, P1049, DOI 10.1136/adc.2003.035741; International Committee on Taxonomy of Viruses, 2016, ICTV MAST SPEC LIST2; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Jones AH, 2016, INFLUENZA OTHER RESP, DOI [10.3390/pathogens4010022, DOI 10.3390/PATHOGENS4010022]; Khor CS, 2013, INFECT GENET EVOL, V14, P357, DOI 10.1016/j.meegid.2012.12.017; Khor CS, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-32; Kwofie TB, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-78; Lagare A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1251-y; Malasao R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142192; Malm KL, 2014, MALARIA WORLD J; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; NEI M, 1986, MOL BIOL EVOL, V3, P418; Niang MN, 2010, J MED VIROL, V82, P866, DOI 10.1002/jmv.21665; Njouom R, 2012, J INFECT DIS, V206, pS29, DOI 10.1093/infdis/jis573; Obodai E, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.128.4749; Otieno JR, 2017, EMERG INFECT DIS, V23, P264, DOI 10.3201/eid2302.161149; Ouedraogo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110435; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Pierangeli A, 2011, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.26.20843; Pretorius MA, 2013, J INFECT DIS, V208, pS227, DOI 10.1093/infdis/jit477; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; Ren L, 2015, J MED VIROL, V87, P1, DOI 10.1002/jmv.23960; Schulze M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009966; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; SULLENDER WM, 1991, J VIROL, V65, P5425, DOI 10.1128/JVI.65.10.5425-5434.1991; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; Tabatabai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109191; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; van Niekerk S, 2011, J VIROL, V85, P8789, DOI 10.1128/JVI.02623-10; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; World Health Organization UNICEF, 2005, HDB IMCI INT MAN CHI, P19; Yamaguchi M, 2011, J CLIN MICROBIOL, V49, P1034, DOI 10.1128/JCM.02132-10; Zhang ZY, 2010, J CLIN MICROBIOL, V48, P1201, DOI 10.1128/JCM.02258-09; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005	66	14	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2018	13	9							e0203788	10.1371/journal.pone.0203788	http://dx.doi.org/10.1371/journal.pone.0203788			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7DK	30199549	Green Submitted, Green Published, gold			2022-12-26	WOS:000444681100022
J	Al-Jaibaji, O; Swioklo, S; Gijbels, K; Vaes, B; Figueiredo, FC; Connon, CJ				Al-Jaibaji, Olla; Swioklo, Stephen; Gijbels, Kristel; Vaes, Bart; Figueiredo, Francisco C.; Connon, Che J.			Alginate encapsulated multipotent adult progenitor cells promote corneal stromal cell activation via release of soluble factors	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE-MARROW; MYOFIBROBLAST DEVELOPMENT; GROWTH-FACTOR; TRANSPLANTATION; THERAPY; MODEL; DIFFERENTIATION; PHENOTYPES; SCAFFOLDS	To reduce the increasing need for corneal transplantation, attempts are currently aiming to restore corneal clarity, one potent source of cells are multipotent adult progenitor cells (MAPC (R)). These cells release a powerful cocktail of paracrine factors that can guide wound healing and tissue regeneration. However, their role in corneal regeneration has been overlooked. Thus, we sought to explore the potential of combining the cytoprotective storage feature of alginate, with MAPC to generate a storable cell-laden gel for corneal wound healing. 72 hours following hypothermic storage, alginate encapsulation was shown to maintain MAPC viability at either 4 or 15 degrees C. Encapsulated MAPC (2 x10(6) cells/mL) stored at 15 degrees C presented the optimum temperature that allowed for cell recovery. These cells had the ability to reattach to tissue culture plastic whilst exhibiting normal phenotype and this was maintained in serum-free and xenobiotic-free medium. Furthermore, corneal stromal cells presented a significant decrease in scratch-wounds in the presence of alginate encapsulated MAPC compared to a no-cell control (p = 0.018). This study shows that immobilization of MAPC within an alginate hydrogel does not hinder their ability to affect a secondary cell population via soluble factors and that these effects are successfully retained following hypothermic storage.	[Al-Jaibaji, Olla; Swioklo, Stephen; Connon, Che J.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Gijbels, Kristel; Vaes, Bart] ReGenesys BVBA, Heverlee, Belgium; [Figueiredo, Francisco C.] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Connon, CJ (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England.	Che.Connon@newcastle.ac.uk	; Connon, Che/B-3128-2012	Al-Jaibaji, Olla/0000-0002-1185-1973; Connon, Che/0000-0001-8264-6531; Swioklo, Stephen/0000-0001-6494-6346	Biotechnology and Biological Sciences Research Council [BB/K011111/1]; ReGenesys BVBA; BBSRC [BB/K011111/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ReGenesys BVBA; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Biotechnology and Biological Sciences Research Council (BB/K011111/1) for authors SS and CC. The funder for ReGenesys BVBA provided support in the form of salaries for authors BV and KG but did not have any additional role in the study design, data collection and analysis.	Aranguren XL, 2011, CELL TRANSPLANT, V20, P259, DOI 10.3727/096368910X516592; Arnalich-Montiel F, 2008, STEM CELLS, V26, P570, DOI 10.1634/stemcells.2007-0653; Boozer Sherry, 2009, J Stem Cells, V4, P17, DOI jsc.2009.4.1.17; Ceccaldi C, 2012, CELL TRANSPLANT, V21, P1969, DOI 10.3727/096368912X647252; Cejka C, 2016, HISTOL HISTOPATHOL, P11724; Cesselli D, 2009, CIRC RES, V104, P1225, DOI 10.1161/CIRCRESAHA.109.195859; Chen B, 2013, TISSUE ENG PART C-ME, V19, P568, DOI [10.1089/ten.TEC.2012.0489, 10.1089/ten.tec.2012.0489]; Crabbe MAE, 2016, STEM CELL TRANSL MED, V5, P709, DOI 10.5966/sctm.2015-0154; Dapson RW, 2011, BIOTECH HISTOCHEM, V86, P133, DOI 10.3109/10520295.2011.570277; DelMonte DW, 2011, J CATARACT REFR SURG, V37, P588, DOI 10.1016/j.jcrs.2010.12.037; Demirayak B, 2016, EFFECT BONE MARROW A; Desmouliere A, WOUND REPAIR REGENER, V13, P7; Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5; Herdrich BJ, 2008, CYTOTHERAPY, V10, P543, DOI 10.1080/14653240802345820; Hess DC, 2017, LANCET NEUROL, V16, P360, DOI 10.1016/S1474-4422(17)30046-7; Huh MI, 2009, J CELL BIOCHEM, V108, P476, DOI 10.1002/jcb.22277; Jacobs SA, 2013, IMMUNOL CELL BIOL, V91, P32, DOI 10.1038/icb.2012.64; Jester JV, 2002, EXP EYE RES, V75, P645, DOI 10.1006/exer.2002.2066; Jiang YH, 2002, EXP HEMATOL, V30, P896, DOI 10.1016/S0301-472X(02)00869-X; Ke YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119725; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Lee P, 1998, SURV OPHTHALMOL, V43, P245, DOI 10.1016/S0039-6257(98)00035-6; Lee WR, 2009, WOUND REPAIR REGEN, V17, P505, DOI 10.1111/j.1524-475X.2009.00496.x; Ljubimov AV, 1998, EXP EYE RES, V67, P265, DOI 10.1006/exer.1998.0511; LoGuidice A, 2016, J TISSUE ENG, V7, DOI 10.1177/2041731416656148; Ma YL, 2006, STEM CELLS, V24, P315, DOI 10.1634/stemcells.2005-0046; Martens A, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0603-5; Maziarz RT, 2015, BIOL BLOOD MARROW TR, V21, P720, DOI 10.1016/j.bbmt.2014.12.025; NAKAYASU K, 1986, OPHTHALMIC RES, V18, P1, DOI 10.1159/000265406; Niemeyer P, 2010, ACTA BIOMATER, V6, P900, DOI 10.1016/j.actbio.2009.09.007; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; OLIVER MH, 1989, J CELL SCI, V92, P513; Penn MS, 2012, CIRC RES, V110, P304, DOI 10.1161/CIRCRESAHA.111.253427; Plessers J, 2016, STEM CELL TRANSL MED, V5, P1607, DOI 10.5966/sctm.2016-0030; Ravanidis S, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0169-z; Reading JL, 2013, J IMMUNOL, V190, P4542, DOI 10.4049/jimmunol.1202710; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Reyes M, 2001, ANN NY ACAD SCI, V938, P231; Roobrouck VD, 2017, CYTOTHERAPY, V19, P744, DOI 10.1016/j.jcyt.2017.03.009; Schmitt A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118937; Sidney LE, 2016, J TISSUE ENG REGENER; Singh SP, 2017, REGENERATIVE MED; Singh V, 2012, EXP EYE RES, V98, P1, DOI 10.1016/j.exer.2012.03.006; Singh V, 2014, EXP EYE RES, V120, P152, DOI 10.1016/j.exer.2014.01.003; Soeder Y, 2015, STEM CELL TRANSL MED, V4, P899, DOI 10.5966/sctm.2015-0002; Swioklo S, 2016, STEM CELL TRANSL MED, V5, P339, DOI 10.5966/sctm.2015-0131; Tong Z, 2017, MAR DRUGS, V15; Wang S, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3269267; Wang T, 2015, INT J CLIN EXP PATHO, V8, P6636; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; WILSON SE, 1994, EXP EYE RES, V59, P665, DOI 10.1006/exer.1994.1152; Ye J, 2006, EYE, V20, P482, DOI 10.1038/sj.eye.6701913; Zajicova A, 2010, CELL TRANSPLANT, V19, P1281, DOI 10.3727/096368910X509040	55	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202118	10.1371/journal.pone.0202118	http://dx.doi.org/10.1371/journal.pone.0202118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192833	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600018
J	Ferruzzi, J; Di Achille, P; Tellides, G; Humphrey, JD				Ferruzzi, Jacopo; Di Achille, Paolo; Tellides, George; Humphrey, Jay D.			Combining in vivo and in vitro biomechanical data reveals key roles of perivascular tethering in central artery function	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; AORTIC STIFFNESS; CAROTID ARTERIES; PRESSURE; STRAIN; AGE; MODELS; MICE	Considerable insight into effectors of cardiovascular function can be gleaned from controlled studies on mice, especially given the diverse models that are available. Toward this end, however, there is a need for consistent and complementary methods of in vivo and in vitro data analysis, synthesis, and interpretation. The overall objective of this study is twofold. First, we present new semi-automated methods to quantify in vivo measurements of vascular function in anesthetized mice as well as new approaches to synthesize these data with those from in vitro biaxial mechanical characterizations. Second, we contrast regional differences in biomechanical behaviors along the central vasculature by combining biaxial strains measured in vivo with data on the unloaded geometry and biaxial material properties measured in vitro. Results support the hypothesis that the healthy ascending aorta stores significant elastic energy during systole, which is available to work on the heart and blood during diastole, particularly during periods of physical exertion, and further suggest that perivascular tethering allows arteries to work at lower values of wall stress and material stiffness than often assumed. The numerous measurements of vascular function and properties provided herein can also serve as reference values for normal wild-type male and female mice, to which values for myriad genetic, surgical, and pharmacological models can be compared in future studies.	[Ferruzzi, Jacopo; Di Achille, Paolo; Humphrey, Jay D.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Tellides, George] Yale Sch Med, Dept Surg, New Haven, CT USA; [Tellides, George; Humphrey, Jay D.] Yale Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Humphrey, JD (corresponding author), Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.; Humphrey, JD (corresponding author), Yale Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06510 USA.	jay.humphrey@yale.edu		Di Achille, Paolo/0000-0001-9256-0678; Ferruzzi, Jacopo/0000-0001-7195-589X	NIH [R01 HL105297, R03 EB016810]; Yale University; Department of Health Human Services [1S10OD021845]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB016810] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021845] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; Department of Health Human Services(United States Department of Health & Human Services); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in part, by grants to J.D.H. from the NIH (R01 HL105297 and R03 EB016810) and, in part, by Yale University. The ultrasound measurements were supported by a shared instrument grant from the Department of Health & Human Services (1S10OD021845). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adji A, 2011, AM J HYPERTENS, V24, P5, DOI 10.1038/ajh.2010.192; AlGhatrif M, 2013, HYPERTENSION, V62, P934, DOI 10.1161/HYPERTENSIONAHA.113.01445; Baek S, 2007, COMPUT METHOD APPL M, V196, P3070, DOI 10.1016/j.cma.2006.06.018; Barodka VM, 2011, ANESTH ANALG, V112, P1048, DOI 10.1213/ANE.0b013e3182147e3c; Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Bellini C, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2016.1036; Bellini C, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4035551; Bersi MR, 2014, ANN BIOMED ENG, V42, P1207, DOI 10.1007/s10439-014-0988-6; Brunner EJ, 2011, HYPERTENSION, V57, P1003, DOI 10.1161/HYPERTENSIONAHA.110.168864; Bussy C, 2000, HYPERTENSION, V35, P1049, DOI 10.1161/01.HYP.35.5.1049; Butlin M, 2015, AM J PHYSIOL-HEART C, V308, pH1221, DOI 10.1152/ajpheart.00536.2014; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Cinthio M, 2006, AM J PHYSIOL-HEART C, V291, pH394, DOI 10.1152/ajpheart.00988.2005; Cuomo F, 2015, ANN BIOMED ENG, V43, P1555, DOI 10.1007/s10439-015-1272-0; Favreau JT, 2012, J VASC SURG, V56, P462, DOI 10.1016/j.jvs.2012.01.056; Ferruzzi J, 2018, BIOMECH MODEL MECHAN, V17, P1281, DOI 10.1007/s10237-018-1026-7; Ferruzzi J, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029431; Ferruzzi J, 2013, ANN BIOMED ENG, V41, P1311, DOI 10.1007/s10439-013-0799-1; Ferruzzi J, 2011, CARDIOVASC RES, V92, P287, DOI 10.1093/cvr/cvr195; Gaddum NR, 2013, ANN BIOMED ENG, V41, P2617, DOI 10.1007/s10439-013-0854-y; Go OD, 2014, ECHOCARDIOGR-J CARD, V31, P1105, DOI 10.1111/echo.12528; Greenwald SE, 2007, J PATHOL, V211, P157, DOI 10.1002/path.2101; Hickson SS, 2010, JACC-CARDIOVASC IMAG, V3, P1247, DOI 10.1016/j.jcmg.2010.09.016; Humphrey JD, 2016, CIRC RES, V118, P379, DOI 10.1161/CIRCRESAHA.115.307722; Humphrey JD, 2002, ANN BIOMED ENG, V30, P509, DOI 10.1114/1.1467676; Humphrey JD, 2002, CARDIOVASCULAR SOLID, DOI [10.1114/1.1467676, DOI 10.1114/1.1467676]; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; Kim Jungsil, 2013, Int J Exp Comput Biomech, V2, P105; Morrison TM, 2009, J VASC SURG, V49, P1029, DOI 10.1016/j.jvs.2008.11.056; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Oliver JJ, 2003, ARTERIOSCL THROM VAS, V23, P554, DOI 10.1161/01.ATV.0000060460.52916.D6; Reddy AK, 2009, IEEE ENG MED BIO, P1104, DOI 10.1109/IEMBS.2009.5334387; Redheuil A, 2010, HYPERTENSION, V55, P319, DOI 10.1161/HYPERTENSIONAHA.109.141275; Sugawara J, 2008, JACC-CARDIOVASC IMAG, V1, P739, DOI 10.1016/j.jcmg.2008.06.010; Svedlund S, 2011, ATHEROSCLEROSIS, V217, P120, DOI 10.1016/j.atherosclerosis.2011.02.046; Taivainen SH, 2017, CLIN PHYSIOL FUNCT I, V37, P305, DOI 10.1111/cpf.12305; Trachet B, 2011, ANN BIOMED ENG, V39, P2430, DOI 10.1007/s10439-011-0330-5; VANLOON P, 1977, BIORHEOLOGY, V14, P181; Wentland AL, 2014, CARDIOVASC DIAGN THE, V4, P193, DOI 10.3978/j.issn.2223-3652.2014.03.04	40	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0201379	10.1371/journal.pone.0201379	http://dx.doi.org/10.1371/journal.pone.0201379			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192758	Green Submitted, gold, Green Published			2022-12-26	WOS:000444093600011
J	Fraunhoffer, NA; Abuelafia, AM; Barrientos, MA; Cimerman, KV; Olmos, MF; Chuluyan, E; Barrios, M				Fraunhoffer, Nicolas A.; Meilerman Abuelafia, Analia; Aquino Barrientos, Mariangel; Veronica Cimerman, Karen; Florencia Olmos, Maria; Chuluyan, Eduardo; Barrios, Marcela			Long-term apoptosis-related protein expression in the diabetic mouse ovary	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; CELL-DEATH; OOCYTE; RATS; COMPLICATIONS; MELLITUS; IMPROVES; INJURY; WOMEN	Emerging evidence has shown that oocytes from diabetic ovaries exhibit delayed maturation, mitochondrial dysfunction and meiotic defects, which are related increased apoptosis. The main objective of the present study was to analyze the apoptosis pathways activated during follicular loss at multiple time points in a diabetic mouse model. Twenty BALB/c mice were used in this study, and diabetes mellitus was induced by streptozotocin injection. Three diabetic and two control animals were sacrificed on days 15, 20, 70 and 80 posttreatment. The ovaries were then removed; one was used for follicular counting, TUNEL, immunohistochemistry and immunofluorescence, while the other was used for Western blot analysis. The proteins studied were BAX, BCL2, t-BID, FAS, FASL, active caspase 8, active caspase 9 and active caspase 3. Follicular apoptosis decreased over time, with the highest values observed at 15 days posttreatment. Granulosa cells were positive for active caspase 3, which showed constant expression levels at all time points. FAS, FASL, t-BID and active caspase 8 showed strong cytoplasmic immunostaining in the oocytes and granulosa cells of the diabetic mice, with significant increases observed at 15, 20 and 70 days posttreatment. BAX expression was slightly higher in the diabetic mouse ovaries than in the control ovaries at 15, 20 and 70 days posttreatment, whereas the highest active caspase 9 expression was at observed 20 days posttreatment. Low BCL2 protein levels were detected in the diabetic mouse ovaries at all time points. This study describes for the first time the behavior of apoptosis-related proteins in the diabetic mouse ovary and shows not only that the FAS/FASL pathway contributes to follicular loss but also that antral follicles are the most affected.	[Fraunhoffer, Nicolas A.; Meilerman Abuelafia, Analia; Aquino Barrientos, Mariangel; Veronica Cimerman, Karen; Florencia Olmos, Maria; Barrios, Marcela] Univ Maimonides, Fac Ciencias Salud, Carrera Med, Buenos Aires, DF, Argentina; [Fraunhoffer, Nicolas A.; Chuluyan, Eduardo] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Fraunhoffer, Nicolas A.; Chuluyan, Eduardo] CONICET CEFYBO, Ctr Estudios Farmacol & Bot, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Fraunhoffer, NA (corresponding author), Univ Maimonides, Fac Ciencias Salud, Carrera Med, Buenos Aires, DF, Argentina.; Fraunhoffer, NA (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina.; Fraunhoffer, NA (corresponding author), CONICET CEFYBO, Ctr Estudios Farmacol & Bot, Buenos Aires, DF, Argentina.	fraunhoffer.nicolas@maimonides.edu	Chuluyan, Eduardo/H-3702-2019	Chuluyan, Eduardo/0000-0003-3084-2500; Fraunhoffer, Nicolas/0000-0003-1561-2563	Fundacion Cientifica Felipe Fiorellino - Universidad Maimonides, Buenos Aires, Argentina; National Research Council, CONICET-Argentina	Fundacion Cientifica Felipe Fiorellino - Universidad Maimonides, Buenos Aires, Argentina; National Research Council, CONICET-Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was supported by the Fundacion Cientifica Felipe Fiorellino - Universidad Maimonides, Buenos Aires, Argentina. NAF is a recipient of a postdoctoral fellowship from the National Research Council, CONICET-Argentina. AMA is a doctoral fellow from Universidad Maimonides. MAB, KVC and MFO are medical students of the Universidad Maimonides. ECH is a Principal Researcher of the Centro de Estudios Farmacologicos y Botanicos-CONICET (CEFYBO), MB is the director of the School of Medicine at Universidad Maimonides. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artunc-Ulkumen B, 2015, GYNECOL ENDOCRINOL, V31, P196, DOI 10.3109/09513590.2014.975686; Ballester J, 2007, HUM REPROD, V22, P2128, DOI 10.1093/humrep/dem168; Bao W, 2010, AM J PHYSIOL-CELL PH, V299, pC1212, DOI 10.1152/ajpcell.00228.2010; Boumela I, 2011, REPRODUCTION, V141, P549, DOI 10.1530/REP-10-0504; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Carambula Silvia F, 2003, Reprod Biol Endocrinol, V1, P15, DOI 10.1186/1477-7827-1-15; Chang AS, 2005, ENDOCRINOLOGY, V146, P2445, DOI 10.1210/en.2004-1472; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Colton SA, 2002, BIOL REPROD, V67, P220, DOI 10.1095/biolreprod67.1.220; DIAMOND MP, 1989, J REPROD FERTIL, V86, P1; Fleming R, 2015, REPROD BIOMED ONLINE, V31, P486, DOI 10.1016/j.rbmo.2015.06.015; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Guan SL, 2015, THERIOGENOLOGY, V83, P21, DOI 10.1016/j.theriogenology.2014.06.026; Honnma H, 2006, APOPTOSIS, V11, P1525, DOI 10.1007/s10495-006-9148-2; Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001; Hutt KJ, 2015, REPRODUCTION, V149, pR81, DOI 10.1530/REP-14-0422; Karasu Cimen, 2010, Open Cardiovasc Med J, V4, P240, DOI 10.2174/1874192401004010240; Kiriakidis S, 2003, J CELL SCI, V116, P665, DOI 10.1242/jcs.00286; Lee YS, 2016, SCI REP, V6; Matsuda-Minehata F, 2006, J REPROD DEVELOP, V52, P695, DOI 10.1262/jrd.18069; Merhi Z, 2014, HUM REPROD, V29, P135, DOI 10.1093/humrep/det383; Moley KH, 1998, NAT MED, V4, P1421, DOI 10.1038/4013; Nayki U, 2016, GYNECOL OBSTET INVES, V81, P424, DOI 10.1159/000442287; Nayki U, 2016, GYNECOL ENDOCRINOL, V32, P421, DOI 10.3109/09513590.2015.1126819; Pala HG, 2014, GYNECOL OBSTET INVES, V78, P94, DOI 10.1159/000363239; Rasheed NOA, 2017, SCI REP, V2017, P7; Sapi E, 2002, J SOC GYNECOL INVEST, V9, P243, DOI 10.1016/S1071-5576(02)00162-4; Schweiger BM, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-61; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Strotmeyer ES, 2003, DIABETES CARE, V26, P1016, DOI 10.2337/diacare.26.4.1016; Sun TX, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.118604; Wang P, 2016, BIOSCI BIOTECH BIOCH, V80, P250, DOI 10.1080/09168451.2015.1095065; Wang QA, 2010, MITOCHONDRION, V10, P403, DOI 10.1016/j.mito.2010.03.002; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zarzycki W, 2005, NEUROENDOCRINOL LETT, V26, P733	35	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203268	10.1371/journal.pone.0203268	http://dx.doi.org/10.1371/journal.pone.0203268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192809	Green Submitted, gold, Green Published			2022-12-26	WOS:000444093600054
J	Nardi-Ricart, A; Linares, MJ; Villca-Pozo, F; Perez-Lozano, P; Sune-Negre, JM; Bachs-deMiquel, L; Roig-Carreras, M; Sune-Pou, M; Nofrerias-Roig, I; Garcia-Montoya, E				Nardi-Ricart, Anna; Jose Linares, Maria; Villca-Pozo, Faviola; Perez-Lozano, Pilar; Maria Sune-Negre, Josep; Bachs-deMiquel, Lara; Roig-Carreras, Manel; Sune-Pou, Marc; Nofrerias-Roig, Isaac; Garcia-Montoya, Encarna			A new design for the review and appraisal of semi-solid dosage forms: Semi-solid Control Diagram (SSCD)	PLOS ONE			English	Review								The Semi-solid Control Diagram (SSCD) is a new tool designed for the study of different excipients and different semi-solid dosage forms. It can be used to review and evaluate different formulations and/or batches and facilitate the selection of one of them that will present the most suitable galenic characteristics for topical application. It is also useful to track stability studies by comparing the diagrams, which allows to measure the impact of subjecting the formulation to different conditions and times to be examined. In this study, the Semisolid Control Diagram (SSCD) is used as an instrument for studying and evaluating semisolid pharmaceutical dosage forms, by comparing several different semisolid preparations (lipogels). With these results, the tool is validated and the best formulation has been discriminated from the others.	[Nardi-Ricart, Anna; Villca-Pozo, Faviola; Perez-Lozano, Pilar; Maria Sune-Negre, Josep; Bachs-deMiquel, Lara; Roig-Carreras, Manel; Sune-Pou, Marc; Nofrerias-Roig, Isaac; Garcia-Montoya, Encarna] Univ Barcelona, Pharm & Pharmaceut Technol, Barcelona, Spain; [Nardi-Ricart, Anna; Villca-Pozo, Faviola; Perez-Lozano, Pilar; Maria Sune-Negre, Josep; Bachs-deMiquel, Lara; Roig-Carreras, Manel; Sune-Pou, Marc; Nofrerias-Roig, Isaac; Garcia-Montoya, Encarna] Univ Barcelona, Dept Phys Chem, Barcelona, Spain; [Nardi-Ricart, Anna; Perez-Lozano, Pilar; Maria Sune-Negre, Josep; Garcia-Montoya, Encarna] IDIBELL UB Res Grp, Pharmacotherapy Pharmacogen & Pharmaceut Technol, Barcelona, Spain; [Jose Linares, Maria] Viladecans Hosp, Anesthesiol Serv, Barcelona, Spain; [Jose Linares, Maria] IDIBELL UB Res Grp, Patol Tubo Digest, Barcelona, Spain; [Perez-Lozano, Pilar] Fac Pharm & Food Sci, Pharm & Pharmaceut Technol, Campus Diagonal, Barcelona, Spain; [Perez-Lozano, Pilar] Fac Pharm & Food Sci, Pharm & Pharmaceut Technol, Campus Diagonal, Barcelona, Spain; [Perez-Lozano, Pilar] Fac Pharm & Food Sci, Dept Phys Chem, Campus Diagonal, Barcelona, Spain	University of Barcelona; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Valdecans	Perez-Lozano, P (corresponding author), Univ Barcelona, Pharm & Pharmaceut Technol, Barcelona, Spain.; Perez-Lozano, P (corresponding author), Univ Barcelona, Dept Phys Chem, Barcelona, Spain.; Perez-Lozano, P (corresponding author), IDIBELL UB Res Grp, Pharmacotherapy Pharmacogen & Pharmaceut Technol, Barcelona, Spain.; Perez-Lozano, P (corresponding author), Fac Pharm & Food Sci, Pharm & Pharmaceut Technol, Campus Diagonal, Barcelona, Spain.; Perez-Lozano, P (corresponding author), Fac Pharm & Food Sci, Pharm & Pharmaceut Technol, Campus Diagonal, Barcelona, Spain.; Perez-Lozano, P (corresponding author), Fac Pharm & Food Sci, Dept Phys Chem, Campus Diagonal, Barcelona, Spain.	perezlo@ub.edu	Garcia_Montoya, Encarna/C-5787-2015; Lozano, Pilar Perez/W-7485-2018	Garcia_Montoya, Encarna/0000-0003-1576-5586; Perez Lozano, Pilar/0000-0001-6899-066X; Sune Pou, Marc/0000-0002-0730-3077	IDIBELL [VALTEC13-1-0117]	IDIBELL	This research was supported by IDIBELL thorough the program VALTEC13-1-0117.	Aguilar-Diaz E, 2013, FORMULATION TOOLS PH, P109; Bora A, 2014, INT J PHARM SCI RES, V5, P3594, DOI 10.13040/IJPSR.0975-8232.5(9).3594-08; Del Pozo A., 1955, GALEN ACTA, VVIII, P7; Del Pozo Carrascosa A., 1987, B CHIM FARM, V126, P330; Denoel A., 1971, PHARM GALENIQUE; Diaz JEA, 2012, EUR J PHARM BIOPHARM, V80, P638, DOI DOI 10.1016/J.EJPB.2011.12.012; Aguilar-Diaz JE, 2014, DRUG DEV IND PHARM, V40, P222, DOI 10.3109/03639045.2012.756007; Aguilar-Diaz JE, 2009, EUR J PHARM BIOPHARM, V73, P414, DOI 10.1016/j.ejpb.2009.07.001; Fahr A., 2018, VOIGTS PHARM TECHNOL; Fauli C., 1993, TRATADO FARMACIA GAL; Le Hir A., 1995, FARMACIA GALENICA; Perez-Lozano, 2006, EUR J PHARM BIOPHARM, V64, P351, DOI DOI 10.1016/J.EJPB.2006.06.008; Sauri J, 2014, INT J PHARMACEUT, V461, P38, DOI 10.1016/j.ijpharm.2013.11.029; Sune Negre JM, 2011, EUR J PHARM BIOPHARM, V79, P464, DOI DOI 10.1016/J.EJPB.2011.04.002; Sune-Negre J, 2005, CIENC TECNOL PHARM, V15, P125; Sune-Negre JM, 2008, EUR J PHARM BIOPHARM, V69, P1029, DOI 10.1016/j.ejpb.2008.01.020; Sutie-Negre J. M., 2014, INT J PHARMACEUT, V470, P15, DOI [DOI 10.1016/J.IJPHARM.2014.04.068, 10.1016/J.IJPHARM.2014.04.068]; Vila Jato J. L, 2001, FORMAS FARMACEUTICAS, VII	18	0	0	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0201643	10.1371/journal.pone.0201643	http://dx.doi.org/10.1371/journal.pone.0201643			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192759	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600012
J	Schutze, M; Costa, DD; de Paula, JJ; Malloy-Diniz, LF; Malamut, C; Mamede, M; de Miranda, DM; Brammer, M; Romano-Silva, MA				Schutze, Manuel; Costa, Danielle de Souza; de Paula, Jonas Jardim; Malloy-Diniz, Leandro Fernandes; Malamut, Carlos; Mamede, Marcelo; de Miranda, Debora Marques; Brammer, Michael; Romano-Silva, Marco Aurelio			Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL GLUCOSE-METABOLISM; ALZHEIMERS-DISEASE; FDG-PET; CHILDREN; IMPAIRMENT; DEPRESSION; ATTENTION; ADULTS; STATES	Neurofibromatosis Type 1 (NF1) can cause a wide range of cognitive deficits, but its underlying nature is still unknown. We investigated the correlation between cognitive performance and specific patterns of resting-state brain metabolism in a NF1 sample. Sixteen individuals diagnosed with NF1 underwent 18F-FDG PET/CT brain imaging followed by a neuropsychological assessment. Principal component analysis was performed on 17 measures of cognitive function and a machine learning approach based on Gaussian Process Regression was used to individually predict the components that represented most of the variance in the neuropsychological data. The accuracy of the method was estimated using leave-one-out cross-validation and its significance through permutation testing. We found that only the first component could be accurately predicted from resting state metabolism (r = 0.926, p<0.001). Multiple and heterogeneous measures contribute to the first component, mainly WISC/WAIS Procedure and Verbal IQ, verbal memory and fluency. Considering the accurate prediction of measures of neuropsychological performance based on brain metabolism in NF1 patients, this suggests an underlying metabolic pattern that relates to cognitive performance in this group.	[Schutze, Manuel; Costa, Danielle de Souza; de Paula, Jonas Jardim; Malloy-Diniz, Leandro Fernandes; Malamut, Carlos; Mamede, Marcelo; de Miranda, Debora Marques; Brammer, Michael; Romano-Silva, Marco Aurelio] Univ Fed Minas Gerais, Inst Nacl Ciencia & Tecnol Med Mol, Belo Horizonte, MG, Brazil; [Malamut, Carlos] Comissao Nacl Energia Nucl, Ctr Desenvolvimento Tecnol Nucl, Belo Horizonte, MG, Brazil; [Mamede, Marcelo] Univ Fed Minas Gerais, Fac Med, Dept Anat & Imagem, Belo Horizonte, MG, Brazil; [de Miranda, Debora Marques] Univ Fed Minas Gerais, Fac Med, Dept Pediat, Belo Horizonte, MG, Brazil; [Brammer, Michael] Inst Psychiat, Dept Neuroimaging, London, England; [Romano-Silva, Marco Aurelio] Univ Fed Minas Gerais, Dept Saude Mental, Fac Med, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Centro de Desenvolvimento da Tecnologia Nuclear (CDTN); Comissao Nacional de Energia Nuclear (CNEN); Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of London; King's College London; Universidade Federal de Minas Gerais	Schutze, M (corresponding author), Univ Fed Minas Gerais, Inst Nacl Ciencia & Tecnol Med Mol, Belo Horizonte, MG, Brazil.	manuels@ufmg.br	Malloy-Diniz, Leandro/D-7829-2013; Malloy-Diniz, Leandro Fernandes/AAR-4025-2021; Malamut, Carlos/N-1965-2018; Miranda, Debora/AAQ-1952-2020; Romano-Silva, Marco Aurelio/A-1790-2008; de Paula, Jonas J/I-8066-2012; Romano-Silva, Marco Aurelio/T-8321-2019	Malloy-Diniz, Leandro/0000-0002-6606-1354; Malloy-Diniz, Leandro Fernandes/0000-0002-6606-1354; Miranda, Debora/0000-0002-7081-8401; Romano-Silva, Marco Aurelio/0000-0002-6558-4639; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico to MS, the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais to DMdM, and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BR) to MAR-S. All funders are governmental research agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova I, 2015, BRAIN RES, V1625, P97, DOI 10.1016/j.brainres.2015.08.025; BALESTRI P, 1994, J NEUROL NEUROSUR PS, V57, P1479, DOI 10.1136/jnnp.57.12.1479; Berti V, 2014, PET CLIN, V9, P129, DOI 10.1016/j.cpet.2013.10.006; Brucki SMD, 2004, BRAZ J MED BIOL RES, V37, P1771, DOI 10.1590/S0100-879X2004001200002; Buchert R, 2008, NUCL MED COMMUN, V29, P17, DOI 10.1097/MNM.0b013e3282f1bbf5; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Costa DD, 2014, EUR J MED GENET, V57, P216, DOI 10.1016/j.ejmg.2014.02.004; de Paula J. J., 2012, PSYCHOLOGY, V3, P379, DOI [10.4236/psych.2012.35053, DOI 10.4236/PSYCH.2012.35053]; de Paula JJ, 2012, PSYCHOL REP, V110, P477, DOI 10.2466/03.10.13.PR0.110.2.477-488; Doyle OM, 2015, PSYCHOPHARMACOLOGY, V232, P4179, DOI 10.1007/s00213-015-3968-0; Duarte JV, 2014, HUM BRAIN MAPP, V35, P89, DOI 10.1002/hbm.22161; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Ferner RE, 2008, ANN ONCOL, V19, P390, DOI 10.1093/annonc/mdm450; Ferner RE, 2007, J MED GENET, V44, P81, DOI 10.1136/jmg.2006.045906; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; FRISTON KJ, 1990, J CEREBR BLOOD F MET, V10, P458, DOI 10.1038/jcbfm.1990.88; Hahn T, 2011, ARCH GEN PSYCHIAT, V68, P361, DOI 10.1001/archgenpsychiatry.2010.178; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Huijbregts SCJ, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9128-3; Hyman SL, 2005, NEUROLOGY, V65, P1037, DOI 10.1212/01.wnl.0000179303.72345.ce; Kaplan AM, 1997, J CHILD NEUROL, V12, P499, DOI 10.1177/088307389701200807; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Karlsgodt KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047854; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Koini M, 2017, BRAIN IMAGING BEHAV, V11, P1731, DOI 10.1007/s11682-016-9641-3; Krab LC, 2008, J CHILD NEUROL, V23, P1002, DOI 10.1177/0883073808316366; Lehtonen A, 2013, DEV MED CHILD NEUROL, V55, P111, DOI 10.1111/j.1469-8749.2012.04399.x; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Loitfelder M, 2015, BRAIN CONNECT, V5, P312, DOI 10.1089/brain.2014.0334; London K, 2014, EUR J NUCL MED MOL I, V41, P723, DOI 10.1007/s00259-013-2639-9; Machado Thais Helena, 2009, Dement. neuropsychol., V3, P55, DOI 10.1590/S1980-57642009DN30100011; Malloy-Diniz LF, 2007, REV BRAS PSIQUIATR, V29, P324, DOI 10.1590/S1516-44462006005000053; Marquand A, 2010, NEUROIMAGE, V49, P2178, DOI 10.1016/j.neuroimage.2009.10.072; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Mourao-Miranda J, 2012, BIPOLAR DISORD, V14, P451, DOI 10.1111/j.1399-5618.2012.01019.x; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Oliveira M da S., 1999, FIGURAS COMPLEXAS RE; Payne JM, 2010, J NEUROL NEUROSUR PS, V81, P304, DOI 10.1136/jnnp.2009.179630; Petit-Taboue MC, 1998, NEUROIMAGE, V7, P176, DOI 10.1006/nimg.1997.0318; Pyka M, 2013, HUM BRAIN MAPP, V34, P3010, DOI 10.1002/hbm.22121; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Rodrigues J., 2008, GERAIS REV INTERINST, V1, P20; Santos FH, 2005, PERCEPT MOTOR SKILL, V101, P421, DOI 10.2466/pms.101.2.421-433; Sed M., 2007, FDT TEST CINCO DIGIT; Violante IR, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-3; Wang SJ, 2012, MED IMAGE ANAL, V16, P933, DOI 10.1016/j.media.2012.02.005; Wechsler D., 2004, WAIS 3 MANUAL ADM AV; Wechsler D., 2002, WISC 3 ESCALA INTELI, V3rd ed.; Young J, 2013, NEUROIMAGE-CLIN, V2, P735, DOI 10.1016/j.nicl.2013.05.004; Zuendorf G, 2003, HUM BRAIN MAPP, V18, P13, DOI 10.1002/hbm.10069	51	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203520	10.1371/journal.pone.0203520	http://dx.doi.org/10.1371/journal.pone.0203520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192842	Green Submitted, Green Published, gold			2022-12-26	WOS:000444093600090
J	Wosenu, L; Worku, AG; Teshome, DF; Gelagay, AA				Wosenu, Lisanu; Worku, Abebaw Gebeyehu; Teshome, Destaw Fetene; Gelagay, Abebaw Addis			Determinants of birth asphyxia among live birth newborns in University of Gondar referral hospital, northwest Ethiopia: A case-control study	PLOS ONE			English	Article							RISK-FACTORS; PROLONGED 2ND-STAGE; PREVALENCE; TERM	Background Birth asphyxia, which accounts for 31.6% of all neonatal deaths, is one of the leading causes of such mortality in Ethiopia. Early recognition and management of its contributing factors would modify the problem. Thus, this study aimed to identify the determinants of birth asphyxia among live births at the University of Gondar Referral Hospital, northwest Ethiopia. Methods A hospital-based unmatched case-control study was conducted from April to July 2017. Cases were newborn babies with an APGAR score of < 7at 5 minutes of birth; controls were newborn babies with an APGAR score of <= 7 at 5 minutes of birth. Every other asphyxiated baby was selected as a case and every 6 th non-asphyxiated baby as a control. A pretested structured questionnaire was used to collect data on maternal sociodemographic characteristics. A pretested structured checklist was used to retrieve data on ante-partum, intra-partum, and neonatal factors of both cases and controls. Data were entered using Epi Info 7 and analyzed using SPSS 20. The bivariate logistic regression analysis was used to identify the relation of each independent variable to the outcome variable. Variables with p values of up to 0.2 in the bivariate analysis were considered for the multiple logistic regression analysis. An adjusted odds ratio (AOR) with a 95% CI and p-value of < 0.05 was used to identify significant variables associated with birth asphyxia. Results In this study, prolonged labor (AOR = 2.75, 95% CI: 1.18, 6.94), cesarean section delivery (AOR = 3.58, 95% CI: 1.13, 11.31), meconium stained amniotic fluid (AOR = 7.69, 95% CI: 2.99, 17.70), fetal distress (AOR = 5.74, 95% CI: 1.53, 21.55), and low birth weight (AOR = 7.72, 95% CI: 1.88, 31.68) were factors which significantly increased the odds of birth asphyxia. Conclusion Prolonged labor, cesarean section (CS) delivery, meconium stained amniotic fluid (AF), fetal distress, and low birth weight were the determinants of birth asphyxia. Thus, efforts should be made to improve the quality of intra-partum care services in order to prevent prolonged labor and fetal complications, and to identify and make a strict follow up on mothers with meconium stained amniotic fluid.	[Wosenu, Lisanu] Amhara Natl Reg State, Ibex Gen Private Hosp, Gondar, Ethiopia; [Worku, Abebaw Gebeyehu; Gelagay, Abebaw Addis] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Reprod Hlth, Gondar, Ethiopia; [Teshome, Destaw Fetene] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia	University of Gondar; University of Gondar	Teshome, DF (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia.	destaw.fetene@gmail.com		Worku, Abebaw Gebeyehu/0000-0002-1146-3399				Abdissa Z., 2013, J ANESTHE CLIN RES, V4, DOI [10.4172/2155-6148.1000335, DOI 10.4172/2155-6148.1000335]; Abwao S, 2002, CAPE TOWN S AFRICA S; Adebami OJ., 2015, GLO ADV RES J MED ME, V4, P270; Ahearne Caroline E, 2016, World J Clin Pediatr, V5, P67, DOI 10.5409/wjcp.v5.i1.67; Al-Zirqi I, 2008, BJOG-INT J OBSTET GY, V115, P1265, DOI 10.1111/j.1471-0528.2008.01859.x; Altman M, 2015, EUR J EPIDEMIOL, V30, P1209, DOI 10.1007/s10654-015-0043-4; American Academy of Pediatrics, 2006, Adv Neonatal Care, V6, P220; [Anonymous], 2006, COUNTR REG GLOB EST; [Anonymous], 2014, MED INNOVATICA; [Anonymous], 2015, GUID MAT CAR S AFR; [Anonymous], 2017, LEV TRENDS CHILD MOR; Antonucci R, 2014, J PEDIATR NEONATAL I, V3, DOI 10.7363/030269; Aslam HM, 2014, ITAL J PEDIATR, V40, DOI 10.1186/s13052-014-0094-2; Chiabi A, 2013, IRAN J CHILD NEUROL, V7, P46; Ehrenstein Vera, 2009, Clin Epidemiol, V1, P45; Ehrenstein V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-14; Ethiopia Demographic and Health Survey, 2016, KEY IND REP; Gane B, 2013, CURRENT PEDIAT RES, V17; Gudayu TW, 2017, AFR HEALTH SCI, V17, P1, DOI 10.4314/ahs.v17i1.2; Harrison Margo S, 2016, Matern Health Neonatol Perinatol, V2, P6, DOI 10.1186/s40748-016-0033-x; Horsch A, 2017, BMJ PAEDIATR OPEN, V1, DOI 10.1136/bmjpo-2017-000059; Ilah B., 2015, SUBSAHARAN AFR J MED, V2, P64, DOI [DOI 10.4103/2384-5147.157421, 10.4103/2384-5147.157421]; Herrera MI, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/3436943; Kaye D, 2003, East Afr Med J, V80, P140; Kiyani AN, 2014, IRAN J PEDIATR, V24, P637; Laughon SK, 2014, OBSTET GYNECOL, V124, P57, DOI 10.1097/AOG.0000000000000278; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee ACC, 2008, PEDIATRICS, V121, pE1381, DOI 10.1542/peds.2007-1966; Milson I, 2002, ACTA OBSTET GYN SCAN, V81, P909; Nair CC, 2015, CURRENT PEDIAT RES, V19; Nayeri F, 2012, IRAN J REPROD MED, V10, P137; Oswyn G., 2000, Papua New Guinea Medical Journal, V43, P110; Prolonged Labor, PROM PREGN WELLN; Rachatapantanakorn O., 2005, THAILAND SONGKLANAGA, V23, P17; Safe Motherhood, 1999, BAS NEWB RES PRACT G; Sahib HS., 2015, RISK, V2, P50; Sampa RP, 2012, INT J ADV NUTR HLTH, V1, P1; Sheiner E, 2005, J MATERN-FETAL NEO M, V18, P149, DOI 10.1080/14767050500170088; Shireen N, 2009, BANGLADESH J CHILD H, V33, DOI DOI 10.3329/BJCH.V33I3.5688; Torres-Munoz J, 2017, BIOMEDICA, V37, P51, DOI 10.7705/biomedica.v37i1.2844; UNICEF, 2015, MAT NEWB HLTH DISP E; Utomo MT., 2011, FOLIA MEDICA INDONES, V47, P211; Uzel H., 2012, J CLIN EXPT; Vladimir R, 2012, J OBSTET GYN INDIA, V62, P665, DOI 10.1007/s13224-012-0328-4; World Health Organization, 2015, PUBLIC HLTH IMPLICAT; Yurdakok M, 2011, TURKISH J PEDIATR, V53, P121	46	37	37	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203763	10.1371/journal.pone.0203763	http://dx.doi.org/10.1371/journal.pone.0203763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192884	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600140
J	Jorstad, MD; Assmus, J; Marijani, M; Sviland, L; Mustafa, T				Jorstad, Melissa Davidsen; Assmus, Jorg; Marijani, Msafiri; Sviland, Lisbet; Mustafa, Tehmina			Diagnostic delay in extrapulmonary tuberculosis and impact on patient morbidity: A study from Zanzibar	PLOS ONE			English	Article							CARE-SYSTEM DELAYS; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; RISK-FACTORS; HEALTH; MANIFESTATIONS	Background Early and proper treatment of tuberculosis could have an important impact on the morbidity, mortality and the economic situation of patients. There is insufficient knowledge on the extent of diagnostic delay and the associated factors in extrapulmonary tuberculosis (EPTB). The aims of this study were to assess the health care seeking behaviour, EPTB knowledge and diagnostic delay in presumptive EPTB patients at the main referral hospital in Zanzibar, factors associated with longer delay, and the impact of untreated EPTB on self rated health. Materials and methods Prospective data collection using a semi-structured questionnaire in patients presenting with symptoms suggestive of EPTB. The time between the onset of symptoms and first visit to a health care provider (patient delay), and then to the initiation of treatment (health system delay) and total delay were analysed according to sociodemographic and clinical factors and health care seeking trajectories. The EQ-5D-3L was used among the adult EPTB patients to assess the impact of treatment on self-rated health. Results Of the 132 patients with median age of 27 years (interquartile range 8-41), 69 were categorized as TB cases and 63 as non-TB cases. The median patient, health system and total delays were 14,34 and 62 days respectively, among the EPTB patients. A longer health system delay with repeated visits to the same health care level was reported. Significantly better self-rated health status was described after treatment. The knowledge regarding extrapulmonary disease was low. Conclusion Many EPTB patients, presenting to the main referral hospital in Zanzibar, experience a long delay in the initiation of treatment, specially patients with TB lymphadenitis. The health system delay is the major contributor to the total delay. The improvement of self-rated health after treatment implies that timely treatment has the potential to reduce morbidity and the economic loss for the patient.	[Jorstad, Melissa Davidsen; Mustafa, Tehmina] Haukeland Hosp, Dept Thorac Med, Bergen, Norway; [Jorstad, Melissa Davidsen; Mustafa, Tehmina] Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Assmus, Jorg] Haukeland Hosp, Ctr Clin Res, Bergen, Norway; [Marijani, Msafiri] Mnazi Mmoja Hosp, Dept Diagnost Serv, Zanzibar, Tanzania; [Sviland, Lisbet] Univ Bergen, Fac Med, Dept Clin Med, Bergen, Norway; [Sviland, Lisbet] Haukeland Hosp, Dept Pathol, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital	Jorstad, MD (corresponding author), Haukeland Hosp, Dept Thorac Med, Bergen, Norway.; Jorstad, MD (corresponding author), Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	Melissa.Jorstad@uib.no		Davidsen Jorstad, Melissa/0000-0003-3516-5297	Research Council of Norway through the Global Health and Vaccination Programme [234457]; European Union; Department of International Collaboration (DIC), Haukeland University Hospital, Norway	Research Council of Norway through the Global Health and Vaccination Programme(Research Council of Norway); European Union(European Commission); Department of International Collaboration (DIC), Haukeland University Hospital, Norway	This work was partly supported by the Research Council of Norway through the Global Health and Vaccination Programme [project number 234457]. This project is part of the EDCTP2 programme supported by the European Union. The Department of International Collaboration (DIC), Haukeland University Hospital, Norway, provided logistic and financial support for relocation of the first author and her family in Zanzibar during the study period. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2011, EARL DET TUB OV APPR; Basnet R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-236; Belay M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-369; Cai J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120088; Chakravorty S, 2005, J CLIN MICROBIOL, V43, P4357, DOI 10.1128/JCM.43.9.4357-4362.2005; Farah MG, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-33; Finnie RKC, 2011, TROP MED INT HEALTH, V16, P394, DOI 10.1111/j.1365-3156.2010.02718.x; Gele AA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-5; Gonzalez OY, 2003, INT J TUBERC LUNG D, V7, P1178; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; Jorstad MD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196723; Kalra A, 2017, INT J TUBERC LUNG D, V21, P645, DOI 10.5588/ijtld.16.0563; Kamolratanakul P, 1999, INT J TUBERC LUNG D, V3, P596; Leutscher P, 2012, SCAND J INFECT DIS, V44, P29, DOI 10.3109/00365548.2011.608081; Lorent N, 2008, INT J TUBERC LUNG D, V12, P392; Lusignani LS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-168; Malbruny B, 2011, INT J TUBERC LUNG D, V15, P553, DOI 10.5588/ijtld.10.0497; Mauch V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-43; Meintjes G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-72; Memish ZA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095654; Mesfin M. M., 2005, Ethiopian Journal of Health Development, V19, P7; Mfinanga S G M, 2005, East Afr Med J, V82, P173; Ministry of Health Revolutionary Government of Zanzibar, 2014, 2013 14 PERF REP; Ministry of Health Zanzibar, 2016, ZANZ INT HIV TB LEPR; National Bureau of Statistics Ministry of Finance Dar es Salaam Office of Chief Government Statistician President's Office Finance Economy and Development Planning Zanzibar, 2017, POP DISTR AG SEX UN; Osei E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1922-z; Purohit M, 2015, J CLIN DIAGN RES, V9, pEE1, DOI 10.7860/JCDR/2015/12422.5792; Purohit MR, 2012, DIAGN CYTOPATHOL, V40, P782, DOI 10.1002/dc.21637; Revolutionary Government of Zanzibar. Ministry of Health Zanzibar, 2013, ZANZ HLTH SECT STRAT; RIEDER HL, 1990, AM REV RESPIR DIS, V141, P347, DOI 10.1164/ajrccm/141.2.347; Saldana L, 2013, PUBLIC HEALTH, V127, P171, DOI 10.1016/j.puhe.2012.11.010; Senkoro M, 2016, INT J TUBERC LUNG D, V20, P1014, DOI 10.5588/ijtld.15.0340; Sherman LF, 1999, INT J TUBERC LUNG D, V3, P1088; Sreeramareddy CT, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-8; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Tattevin P, 2012, INT J TUBERC LUNG D, V16, P510, DOI 10.5588/ijtld.11.0420; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2018, END TB STRAT GLOB ST; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644; Yimer SA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-19	41	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203593	10.1371/journal.pone.0203593	http://dx.doi.org/10.1371/journal.pone.0203593			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188947	Green Published, gold, Green Submitted			2022-12-26	WOS:000444228700046
J	Merz, PT; Shirts, MR				Merz, Pascal T.; Shirts, Michael R.			Testing for physical validity in molecular simulations	PLOS ONE			English	Article							LINEAR CONSTRAINT SOLVER; DYNAMICS SIMULATIONS; FORCE-FIELD; LIPID-BILAYERS; LIQUID WATER; ENERGY; PHASE; DISTRIBUTIONS; ALGORITHMS; SOLVATION	Advances in recent years have made molecular dynamics (MD) and Monte Carlo (MC) simulations powerful tools in molecular-level research, allowing the prediction of experimental observables in the study of systems such as proteins, membranes, and polymeric materials. However, the quality of any prediction based on molecular dynamics results will strongly depend on the validity of underlying physical assumptions. Unphysical behavior of simulations can have significant influence on the results and reproducibility of these simulations, such as folding of proteins and DNA or properties of lipid bilayers determined by cutoff treatment, dynamics of peptides and polymers affected by the choice of thermostat, or liquid properties depending on the simulation time step. Motivated by such examples, we propose a two-fold approach to increase the robustness of molecular simulations. The first part of this approach involves tests which can be performed by the users of MD programs on their respective systems and setups. We present a number of tests of different complexity, ranging from simple post-processing analysis to more involved tests requiring additional simulations. These tests are shown to significantly increase the reliability of MD simulations by catching a number of common simulation errors violating physical assumptions, such as non-conservative integrators, deviations from the Boltzmann ensemble, and lack of ergodicity between degrees of freedom. To make the usage as easy as possible, we have developed an open-source and platform-independent Python library (https://physical-validation. readthedocs.io) implementing these tests. The second part of the approach involves testing for code correctness. While unphysical behavior can be due to poor or incompatible choices of parameters by the user, it can just as well originate in coding errors within the program. We therefore propose to include physical validation tests in the code-checking mechanism of MD software packages. We have implemented such a validation for the GROMACS software package, ensuring that every major release passes a number of physical sanity checks performed on selected representative systems before shipping. It is, to our knowledge, the first major molecular mechanics software package to run such validation routinely. The tests are, as the rest of the package, open source software, and can be adapted for other software packages.	[Merz, Pascal T.; Shirts, Michael R.] Univ Colorado Boulder, Dept Chem & Biol Engn, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Shirts, MR (corresponding author), Univ Colorado Boulder, Dept Chem & Biol Engn, Boulder, CO 80309 USA.	michael.shirts@colorado.edu		Shirts, Michael/0000-0003-3249-1097	National Institute of Health [R01GM115790]; MRS; National Science Foundation [OCI-1053575]; NSF [ACI-1445606]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115790] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRS; National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financially supported by the National Institute of Health, grant R01GM115790, https://www.nih.gov, recipient: MRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number OCI-1053575. Specifically, it used the Bridges system, which is supported by NSF award number ACI-1445606, at the Pittsburgh Supercomputing Center (PSC).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Babu G. J., 2004, SANKHY, V66, P63; Baron R, 2012, METHODS MOL BIOL, V819, P1, DOI 10.1007/978-1-61779-465-0; Basconi JE, 2013, J CHEM THEORY COMPUT, V9, P2887, DOI 10.1021/ct400109a; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bonthuis DJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.144503; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Daura X, 1996, J AM CHEM SOC, V118, P6285, DOI 10.1021/ja9537944; Eastwood MP, 2010, J CHEM THEORY COMPUT, V6, P2045, DOI 10.1021/ct9002916; Efron B., 1994, INTRO BOOTSTRAP; Field MJ, 2005, PRACTICAL INTRO SIMU; Goga N, 2012, J CHEM THEORY COMPUT, V8, P3637, DOI 10.1021/ct3000876; Hansen N, 2014, J CHEM THEORY COMPUT, V10, P2632, DOI 10.1021/ct500161f; Harvey SC, 1998, J COMPUT CHEM, V19, P726, DOI 10.1002/(SICI)1096-987X(199805)19:7<726::AID-JCC4>3.0.CO;2-S; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hockney R. W., 1970, Methods in computational physics. IX. Plasma physics, P135; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Horta BAC, 2016, J CHEM THEORY COMPUT, V12, P3825, DOI 10.1021/acs.jctc.6b00187; Horta BAC, 2011, J CHEM THEORY COMPUT, V7, P1016, DOI 10.1021/ct1006407; Hunenberger PH, 1998, J CHEM PHYS, V108, P6117, DOI 10.1063/1.476022; JELLINEK J, 1989, PHYS REV LETT, V62, P241, DOI 10.1103/PhysRevLett.62.241; Jones E., 2001, SCIPY OPEN SOURCE SC; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kolmogorov, 1933, GIORNALE DELLISTITUT, V4, P83; Leyssale JM, 2008, CHEM PHYS LETT, V454, P299, DOI 10.1016/j.cplett.2008.02.025; Lingenheil M, 2008, J CHEM THEORY COMPUT, V4, P1293, DOI 10.1021/ct8000365; Merz PT, PHYS VALIDATION REFE; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Ni B, 2011, J MOL MODEL, V17, P2883, DOI 10.1007/s00894-011-0975-x; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Oda K, 1996, MOL SIMULAT, V16, P167, DOI 10.1080/08927029608024070; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patra M, 2003, BIOPHYS J, V84, P3636, DOI 10.1016/S0006-3495(03)75094-2; Shirts MR, 2013, J CHEM THEORY COMPUT, V9, P909, DOI 10.1021/ct300688p; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; SWOPE WC, 1982, J CHEM PHYS, V76, P637, DOI 10.1063/1.442716; Szklarczyk OM, 2014, THESIS; TOXVAERD S, 1994, PHYS REV E, V50, P2271, DOI 10.1103/PhysRevE.50.2271; van Gunsteren WF, 2018, ANGEW CHEM INT EDIT, V57, P884, DOI 10.1002/anie.201702945; VANGUNSTEREN WF, 1981, MOL PHYS, V44, P69, DOI 10.1080/00268978100102291; Venable RM, 2000, J CHEM PHYS, V112, P4822, DOI 10.1063/1.481085; Wang CC, 2014, POLYMER, V55, P979, DOI 10.1016/j.polymer.2013.12.069; White JA, 1999, J CHEM PHYS, V111, P9352, DOI 10.1063/1.479848; Winger M, 2009, PHYS CHEM CHEM PHYS, V11, P1934, DOI 10.1039/b818713d; Wong-ekkabut J, 2016, BBA-BIOMEMBRANES, V1858, P2529, DOI 10.1016/j.bbamem.2016.02.004; Wong-Ekkabut J, 2010, NAT NANOTECHNOL, V5, P555, DOI 10.1038/nnano.2010.152	52	22	22	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0202764	10.1371/journal.pone.0202764	http://dx.doi.org/10.1371/journal.pone.0202764			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188933	Green Published, Green Submitted, gold			2022-12-26	WOS:000444228700011
J	Pross, C; Strumann, C; Geissler, A; Herwartz, H; Klein, N				Pross, Christoph; Strumann, Christoph; Geissler, Alexander; Herwartz, Helmut; Klein, Nadja			Quality and resource efficiency in hospital service provision: A geoadditive stochastic frontier analysis of stroke quality of care in Germany	PLOS ONE			English	Article							PANEL-DATA; TECHNICAL EFFICIENCY; COST INEFFICIENCY; HEALTH; MODEL; MORTALITY; CONTINUITY; SPECIALIZATION; PRODUCTIVITY; VALIDATION	We specify a Bayesian, geoadditive Stochastic Frontier Analysis (SFA) model to assess hospital performance along the dimensions of resources and quality of stroke care in German hospitals. With 1,100 annual observations and data from 2006 to 2013 and risk-adjusted patient volume as output, we introduce a production function that captures quality, resource inputs, hospital inefficiency determinants and spatial patterns of inefficiencies. With high relevance for hospital management and health system regulators, we identify performance improvement mechanisms by considering marginal effects for the average hospital. Specialization and certification can substantially reduce mortality. Regional and hospital level concentration can improve quality and resource efficiency. Finally, our results demonstrate a trade-off between quality improvement and resource reduction and substantial regional variation in efficiency.	[Pross, Christoph; Geissler, Alexander] Berlin Univ Technol, Dept Healthcare Management, Str 17 Juni 135, D-10623 Berlin, Germany; [Strumann, Christoph] Univ Lubeck, Inst Entrepreneurship & Business Dev, Ratzeburger Allee 160, D-23562 Lubeck, Germany; [Herwartz, Helmut] Georg August Univ Gottingen, Chair Econometr, Humboldtallee 3, D-37073 Gottingen, Germany; [Klein, Nadja] Univ Melbourne, Melbourne Business Sch, 200 Leicester St, Carlton, Vic 3053, Australia	Technical University of Berlin; University of Lubeck; University of Gottingen; University of Melbourne	Geissler, A (corresponding author), Berlin Univ Technol, Dept Healthcare Management, Str 17 Juni 135, D-10623 Berlin, Germany.	a.geissler@tu-berlin.de		Klein, Nadja/0000-0002-5072-5347; Geissler, Alexander/0000-0002-7445-2929	German Research Foundation (DFG) [323809466]; Open Access Publication Funds of TU Berlin	German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Funds of TU Berlin	This research was partly funded by the German Research Foundation (DFG), Projekt number 323809466, http://gepris.dfg.de/gepris/projekt/323809466?language=en, and the Open Access Publication Funds of TU Berlin. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetutu M, 2015, J PROD ANAL, V43, P307, DOI 10.1007/s11123-014-0426-7; AHRQ, 2014, SEL QUAL RES US ME 2; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Andersen KK, 2009, STROKE, V40, P2068, DOI 10.1161/STROKEAHA.108.540112; Augursky B, 2010, EFFIZIENZ KRANKENHAU; Augurzky B, 2016, HOSP RATING REPORT T; Barker I, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j84; Battese GE, 1997, J AGR ECON, V48, P250, DOI 10.1111/j.1477-9552.1997.tb01149.x; Bayliss EA, 2015, ANN FAM MED, V13, P123, DOI 10.1370/afm.1739; Bech M, 2008, HEALTH POLICY, V87, P50, DOI 10.1016/j.healthpol.2007.09.008; Bechtold D, 2015, J RURAL HEALTH, DOI 10.11117/jrh.12165; Belitz C., 2015, BAYESX BAYESIAN INFE; Bloom N, 2015, REV ECON STUD, V82, P457, DOI 10.1093/restud/rdu045; Bradford WD, 2001, REV ECON STAT, V83, P302, DOI 10.1162/00346530151143833; Brubakk K, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0933-x; Busse O, 2008, NERVENARZT, V79, P1465, DOI [10.1007/s00115-008-2641-9, DOI 10.1007/S00115-008-2641-9]; Calabrese A, 2012, INT J PROD ECON, V135, P800, DOI 10.1016/j.ijpe.2011.10.014; Cheng SH, 2010, ARCH INTERN MED, V170, P1671, DOI 10.1001/archinternmed.2010.340; Chung SC, 2015, COMP HOSP VARIATION; CIHI, 2005, HLTH CAR CAN; Clark JR, 2012, MANAGE SCI, V58, P708, DOI 10.1287/mnsc.1110.1448; Clement JP, 2008, HEALTH CARE MANAG SC, V11, P67, DOI 10.1007/s10729-007-9025-8; Deily ME, 2006, HEALTH ECON, V15, P419, DOI 10.1002/hec.1078; Dick GPM, 2008, INT J OPER PROD MAN, V28, P687, DOI 10.1108/01443570810881811; Dietzel J, 2015, SUPPORT RES MORBI 1; Donnan PT, 2008, ARCH INTERN MED, V168, P1416, DOI 10.1001/archinte.168.13.1416; DSG, 2015, CERT CRIT 2015 REG C; Eastaugh S R, 2001, J Health Care Finance, V28, P61; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Farsi M, 2008, HEALTH ECON, V17, P335, DOI 10.1002/hec.1268; Fassbender K, 2013, LANCET NEUROL, V12, P585, DOI 10.1016/S1474-4422(13)70100-5; Felder S, 2013, EUR J HEALTH ECON, V14, P21, DOI 10.1007/s10198-011-0345-8; Ferrier GD, 2013, J PROD ANAL, V40, P337, DOI 10.1007/s11123-012-0305-z; Fonarow GC, 2011, STROKE, V42, P159, DOI 10.1161/STROKEAHA.110.601831; Ganesalingam J, 2015, STROKE, V46, P2591, DOI 10.1161/STROKEAHA.115.009396; Geissler A., 2011, DIAGNOSIS RELATED GR, P243; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Giancotti M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174533; Gill JM, 1998, ARCH FAM MED, V7, P352, DOI 10.1001/archfami.7.4.352; Gladstone DJ, 2009, STROKE, V40, P3841, DOI 10.1161/STROKEAHA.108.540377; Glass AJ, 2016, J ECONOMETRICS, V190, P289, DOI 10.1016/j.jeconom.2015.06.011; Gravelle H, 2014, REG SCI URBAN ECON, V49, P203, DOI 10.1016/j.regsciurbeco.2014.09.005; Greene W, 2005, J ECONOMETRICS, V126, P269, DOI 10.1016/j.jeconom.2004.05.003; Grieco PLE, 2016, REV ECON STUD, DOI l0.1093/restud/rdw042; Gutacker N, 2016, J HEALTH ECON, V50, P230, DOI 10.1016/j.jhealeco.2016.08.001; Hakkinen U, 2015, HEALTH ECON, V24, P116, DOI 10.1002/hec.3270; Herr A, 2008, HEALTH ECON, V17, P1057, DOI 10.1002/hec.1388; Herwartz H, 2014, EUR J HEALTH ECON, V15, P175, DOI 10.1007/s10198-013-0464-5; Herwartz H, 2012, HEALTH CARE MANAG SC, V15, P48, DOI 10.1007/s10729-011-9180-9; Hollingsworth B, 2008, HEALTH ECON, V17, P1107, DOI 10.1002/hec.1391; Hollingsworth B, 2006, HEALTH ECON, V15, P1055, DOI 10.1002/hec.1169; Hollingsworth B, 2012, J PROD ANAL, V37, P1, DOI 10.1007/s11123-011-0221-7; Hopman WM, 2003, STROKE, V34, P801, DOI 10.1161/01.STR.0000057978.15397.6F; Jacobs R, 2001, Health Care Manag Sci, V4, P103, DOI 10.1023/A:1011453526849; Jha AK, 2009, HEALTH AFFAIR, V28, P897, DOI 10.1377/hlthaff.28.3.897; Kalanithi L, 2014, STROKE, V45, P3105, DOI 10.1161/STROKEAHA.114.006236; Klein N, 2016, GEOADDITIVE STOCHAST; Koop G, 1997, J ECONOMETRICS, V76, P77, DOI 10.1016/0304-4076(95)01783-6; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; KUMBHAKAR SC, 1991, J BUS ECON STAT, V9, P279, DOI 10.2307/1391292; KUMBHAKAR SC, 1991, ECON LETT, V36, P43, DOI 10.1016/0165-1765(91)90053-N; Lahr MMH, 2012, STROKE, V43, P1336, DOI 10.1161/STROKEAHA.111.641795; Lang S, 2004, J COMPUT GRAPH STAT, V13, P183, DOI 10.1198/1061860043010; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Lichtman JH, 2011, NEUROLOGY, V76, P1976, DOI 10.1212/WNL.0b013e31821e54f3; Lim JH, 2015, J PHYS THER SCI, V27, P799, DOI 10.1589/jpts.27.799; Lindlbauer I, 2016, EUR J OPER RES, V250, P1026, DOI 10.1016/j.ejor.2015.10.029; Lindlbauer I, 2014, HEALTH CARE MANAG SC, V17, P365, DOI 10.1007/s10729-014-9275-1; Martin AB, 2014, HEALTH AFFAIR, V33, P67, DOI 10.1377/hlthaff.2013.1254; McGlynn EA., 2008, IDENTIFYING CATEGORI, V08-0030; McKay NL, 2008, HEALTH ECON, V17, P833, DOI 10.1002/hec.1299; Morris S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4757; Mumford V, 2013, INT J QUAL HEALTH C, V25, P606, DOI 10.1093/intqhc/mzt059; Mutter RL, 2008, HEALTH SERV RES, V43, P1992, DOI 10.1111/j.1475-6773.2008.00892.x; Nayar P, 2013, HEALTH CARE MANAGE R, V38, P137, DOI 10.1097/HMR.0b013e3182527a4c; Nimptsch U, 2014, INT J STROKE, V9, P260, DOI 10.1111/ijs.12193; Nimptsch U, 2012, DTSCH ARZTEBL INT, V109, P885, DOI 10.3238/arztebl.2012.0885; O'Neill L., 2008, SOCIO-ECON PLAN SCI, V42, P158, DOI [DOI 10.1016/J.SEPS.2007.03.001, 10.1016/j.seps.2007.03.001]; OECD, 2015, FOC HLTH SPEND; Pauly MV, 2011, HEALTH AFFAIR, V30, P574, DOI 10.1377/hlthaff.2011.0081; Peltola M, 2015, HEALTH ECON, V24, P38, DOI 10.1002/hec.3264; Picone GA, 2003, REV ECON STAT, V85, P51, DOI 10.1162/003465303762687703; Porter M.E., 2006, REDEFINING HLTH CARE; Prabhakaran S, 2013, JAMA NEUROL, V70, P1126, DOI 10.1001/jamaneurol.2013.293; Pross C, 2017, HEALTH POLICY, V121, P842, DOI 10.1016/j.healthpol.2017.06.009; Reistetter TA, 2015, ARCH PHYS MED REHAB, V96, P1248, DOI 10.1016/j.apmr.2015.02.020; Reistetter TA, 2014, ARCH PHYS MED REHAB, V95, P29, DOI 10.1016/j.apmr.2013.07.018; Rosko MD, 2011, MED CARE RES REV, V68, p75S, DOI [10.1177/1077558710370686, DOI 10.1177/1077558710370686]; Rue H., 2005, GAUSSIAN MARKOV R; Rust RT, 2012, J MARKETING, V76, P47, DOI 10.1509/jm.10.0441; Salinas J, 2016, STROKE, V47, P180, DOI 10.1161/STROKEAHA.115.010898; Saposnik G, 2008, STROKE, V39, P2522, DOI 10.1161/STROKEAHA.107.507145; Sickles, 1984, J BUS ECON STAT, V2, P367, DOI [10.2307/1391278, DOI 10.1080/07350015.1984.10509410]; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Street A., 2014, HLTH SERV DELIV RES, DOI [10.3310/hsdr02010, DOI 10.3310/HSDR02010]; Turner S, 2016, J HEALTH SERV RES PO, V21, P156, DOI 10.1177/1355819615626189; Vidoli F, 2016, REG SCI URBAN ECON, V61, P153, DOI 10.1016/j.regsciurbeco.2016.10.003; Wang HJ, 2002, J PROD ANAL, V18, P129, DOI 10.1023/A:1016565719882; Wang HJ, 2010, J ECONOMETRICS, V157, P286, DOI 10.1016/j.jeconom.2009.12.006; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; WIdO, 2015, REGR WEIGHTS REP YEA; WIdO, 2007, ABSCHLUSSBERICHT; Wiedmann S, 2015, STROKE, V46, P579, DOI 10.1161/STROKEAHA.114.007504; Wu VY, 2014, HEALTH SERV RES, V49, P1596, DOI 10.1111/1475-6773.12185; Zhang DJ, 2016, MANAGE SCI, V62, P3351, DOI 10.1287/mnsc.2015.2280; ZUCKERMAN S, 1994, J HEALTH ECON, V13, P255, DOI 10.1016/0167-6296(94)90027-2	106	7	7	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203017	10.1371/journal.pone.0203017	http://dx.doi.org/10.1371/journal.pone.0203017			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT1KN	30188906	Green Accepted, gold, Green Published			2022-12-26	WOS:000444228700017
J	Leung, YY; Razak, HRB; Talaei, M; Ang, LW; Yuan, JM; Koh, WP				Leung, Ying Ying; Razak, Hamid Rahmatullah Bin Abd; Talaei, Mohammad; Ang, Li-Wei; Yuan, Jian-Min; Koh, Woon-Puay			Duration of physical activity, sitting, sleep and the risk of total knee replacement among Chinese in Singapore, the Singapore Chinese Health Study	PLOS ONE			English	Article							BODY-MASS INDEX; HIP OSTEOARTHRITIS; DAILY WALKING; EATING INDEX; ASSOCIATION; POPULATION; EXERCISE; DISEASE; ADULTS; SMOKING	Objectives While the effect of physical activity on knee osteoarthritis (KOA) remains controversial, how sitting and sleep durations affect KOA is unknown. We evaluated the association between durations of physical activity, sitting and sleep, and incidence of total knee replacement (TKR) due to severe KOA. Methods We used data from the Singapore Chinese Health Study, a prospective cohort of 63,257 Chinese, aged 45-74 years at recruitment from 1993-1998. Height, weight, lifestyle factors, hours of sitting and sleep per day, and hours of moderate activity, strenuous sports or vigorous work per week were assessed through in-person interviews using structured questionnaires. Incident cases of TKR were identified via record linkage with nationwide hospital discharge database. Results Compared to those with <0.5 hour/week of moderate physical activity, participants with >= 5 hour/week had increased risk of TKR risk [hazard ratio (HR) 1.16, 95% confidence interval (CI) 1.00-1.35]. Conversely, duration of sitting activities, especially sitting at work, was associated with reduced risk in a stepwise manner. Compared to <4 hour/day of sitting, those with >= 12 hour/day had the lowest risk (HR 0.76, 95% CI 0.60-0.96, p for trend = 0.02). Sleep duration was inversely associated with reduced risk of TKR in a dose-dependent manner; compared to those with sleep <= 5 hour/day, participants with >= 9 hour/day had the lowest risk (HR 0.55, 95% CI) 0.43-0.70, p for trend < 0.001). Conclusion While prolonged sitting or sleeping duration could be associated with reduced risk of severe KOA, extended duration of physical activity could be associated with increased risk.	[Leung, Ying Ying; Talaei, Mohammad; Koh, Woon-Puay] Duke NUS Med Sch, Hlth Serv & Syst Res, Singapore, Singapore; [Leung, Ying Ying] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore; [Razak, Hamid Rahmatullah Bin Abd] Singapore Gen Hosp, Dept Orthopaed Surg, Singapore, Singapore; [Ang, Li-Wei] Minist Hlth, Epidemiol & Dis Control Div, Singapore, Singapore; [Yuan, Jian-Min] Univ Pittsburgh, UPMC Hillman Canc Ctr, Div Canc Control & Populat Sci, Pittsburgh, PA USA; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Leung, Ying Ying] The Academia, Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore	National University of Singapore; Singapore General Hospital; Singapore General Hospital; Ministry of Health-Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National University of Singapore; Singapore General Hospital	Leung, YY; Koh, WP (corresponding author), Duke NUS Med Sch, Hlth Serv & Syst Res, Singapore, Singapore.; Leung, YY (corresponding author), Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore.; Koh, WP (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Leung, YY (corresponding author), The Academia, Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore.	katyccc@hotmail.com; woonpuay.koh@duke-nus.edu.sg	Razak, Hamid Rahmatullah Bin Abd/H-9849-2019; Leung, Ying Ying/J-9099-2015; Talaei, Mohammad/A-1819-2009	Razak, Hamid Rahmatullah Bin Abd/0000-0002-2701-9057; Leung, Ying Ying/0000-0001-8492-6342; Talaei, Mohammad/0000-0002-6901-3665; Ang, Li Wei/0000-0002-0036-255X	National Institutes of Health, USA [NIH R01 CA144034, UM1 CA182876]; National Medical Research Council, Singapore [NMRC/CSA-INV/0022/2017, NMRC/CSA/0055/2013]; NATIONAL CANCER INSTITUTE [UM1CA182876] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Medical Research Council, Singapore(National Medical Research Council, Singapore); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health, USA (NIH R01 CA144034 and UM1 CA182876). YYL and WPK were supported by the National Medical Research Council, Singapore (NMRC/CSA-INV/0022/2017 and NMRC/CSA/0055/2013, respectively).	Ageberg E, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-73; Alentorn-Geli E, 2017, J ORTHOP SPORT PHYS, V47, P373, DOI 10.2519/jospt.2017.7137; Allen KD, 2010, J RHEUMATOL, V37, P842, DOI 10.3899/jrheum.090302; Apold H, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-217; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Chei CL, 2018, EUR J NUTR, V57, P1333, DOI 10.1007/s00394-017-1412-4; Cheng YL, 2000, J CLIN EPIDEMIOL, V53, P315, DOI 10.1016/S0895-4356(99)00168-7; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Cust AE, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-33; Dai ZL, 2014, J NUTR, V144, P511, DOI 10.3945/jn.113.187955; Dore DA, 2013, ANN RHEUM DIS, V72, P1170, DOI 10.1136/annrheumdis-2012-201691; Dunlop DD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2472; Ezzat AM, 2013, ARTHRIT CARE RES, V65, P1634, DOI 10.1002/acr.22033; Felson DT, 2007, ARTHRIT RHEUM-ARTHR, V57, P6, DOI 10.1002/art.22464; Felson DT, 1997, ARTHRITIS RHEUM, V40, P728, DOI 10.1002/art.1780400420; Fransen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004376.pub2; Gates LS, 2017, RHEUMATOL INT, V37, P469, DOI 10.1007/s00296-017-3672-y; Hankin JH, 2001, NUTR CANCER, V39, P187, DOI 10.1207/S15327914nc392_5; Hart LE, 2008, CLIN J SPORT MED, V18, P508, DOI 10.1097/JSM.0b013e3181865ed4; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Hoeger WWK, 2008, ACSMS HEALTH FIT J, V12, P14, DOI 10.1249/01.FIT.0000298459.30006.8d; Hootman JM, 2003, ARTHRIT RHEUM-ARTHR, V49, P129, DOI 10.1002/art.10911; Hootman JM, 2003, PREV MED, V36, P636, DOI 10.1016/S0091-7435(03)00018-5; Jafar TH, 2015, NEPHROLOGY, V20, P61, DOI 10.1111/nep.12355; Klussmann A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3015; Koh WP, 2010, BRIT J CANCER, V102, P610, DOI 10.1038/sj.bjc.6605496; Kretzschmar M, 2015, ARTHRIT CARE RES, V67, P1272, DOI 10.1002/acr.22586; Leung YY, 2015, OSTEOARTHR CARTILAGE, V23, P41, DOI 10.1016/j.joca.2014.10.011; Leung YY, 2014, OSTEOARTHR CARTILAGE, V22, P764, DOI 10.1016/j.joca.2014.03.013; Loyen A, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0398-2; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Morgenroth DC, 2014, CLIN BIOMECH, V29, P664, DOI 10.1016/j.clinbiomech.2014.04.008; Mork PJ, 2012, J EPIDEMIOL COMMUN H, V66, P678, DOI 10.1136/jech-2011-200834; Muraki S, 2009, ARTHRIT RHEUM-ARTHR, V61, P779, DOI 10.1002/art.24514; Neelakantan N, 2016, J NUTR, V146, P1379, DOI 10.3945/jn.116.231605; O'Kane JW, 2006, OSTEOARTHR CARTILAGE, V14, P71, DOI 10.1016/j.joca.2005.08.003; Odegaard AO, 2008, AM J CLIN NUTR, V88, P979, DOI 10.1093/ajcn/88.4.979; Odegaard AO, 2011, CIRCULATION, V124, P2847, DOI 10.1161/CIRCULATIONAHA.111.048843; Oiestad BE, 2015, J RHEUMATOL, V42, P1685, DOI 10.3899/jrheum.150071; Timmins KA, 2017, AM J SPORT MED, V45, P1447, DOI 10.1177/0363546516657531; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang YY, 2011, J RHEUMATOL, V38, P350, DOI 10.3899/jrheum.091138; White DK, 2014, ARTHRIT CARE RES, V66, P1328, DOI 10.1002/acr.22362; Zhang YQ, 2004, ARTHRITIS RHEUM, V50, P1187, DOI 10.1002/art.20127	45	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0202554	10.1371/journal.pone.0202554	http://dx.doi.org/10.1371/journal.pone.0202554			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180156	Green Published, gold, Green Submitted			2022-12-26	WOS:000444222400008
J	Pfeiffenberger, E; Bates, PA				Pfeiffenberger, Erik; Bates, Paul A.			Predicting improved protein conformations with a temporal deep recurrent neural network	PLOS ONE			English	Article							TEMPLATE-BASED MODELS; STRUCTURE REFINEMENT; MOLECULAR-DYNAMICS; ALGORITHMS; EFFICIENT; PROGRESS; FORCE; CASP	Accurate protein structure prediction from amino acid sequence is still an unsolved problem. The most reliable methods centre on template based modelling. However, the accuracy of these models entirely depends on the availability of experimentally resolved homologous template structures. In order to generate more accurate models, extensive physics based molecular dynamics (MD) refinement simulations are performed to sample many different conformations to find improved conformational states. In this study, we propose a deep recurrent network model, called DeepTrajectory, that is able to identify these improved conformational states, with high precision, from a variety of different MD based sampling protocols. The proposed model learns the temporal patterns of features computed from MD trajectory data in order to classify whether each recorded simulation snapshot is an improved quality conformational state, decreased quality conformational state or whether there is no perceivable change in state with respect to the starting conformation. The model was trained and tested on 904 trajectories from 42 different protein systems with a cumulative number of more than 1.7 million snapshots. We show that our model outperforms other state of the art machine-learning algorithms that do not consider temporal dependencies. To our knowledge, DeepTrajectory is the first implementation of a time-dependent deep-learning protocol that is re-trainable and able to adapt to any new MD based sampling procedure, thereby demonstrating how a neural network can be used to learn the latter part of the protein folding funnel.	[Pfeiffenberger, Erik; Bates, Paul A.] Francis Crick Inst, Biomol Modelling Lab, 1 Midland Rd, London NW1 1AT, England	Francis Crick Institute	Bates, PA (corresponding author), Francis Crick Inst, Biomol Modelling Lab, 1 Midland Rd, London NW1 1AT, England.	paul.bates@crick.ac.uk	Bates, Paul A/AAF-8561-2020	Bates, Paul A/0000-0003-0621-0925	Francis Crick Institute; Cancer Research UK [FC001003]; UK Medical Research Council [FC001003]; Wellcome Trust [FC001003]	Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)	This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001003), the UK Medical Research Council (FC001003), and the Wellcome Trust (FC001003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additionally, the NVIDIA Corporation provided a donation of materials (i.e. GPUs) to the authors.	Agarwal A., CORR; Agius R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003216; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; BENTLEY JL, 1975, COMMUN ACM, V18, P509, DOI 10.1145/361002.361007; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bishop C. M, 2006, PATTERN RECOGNITION; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brunk E, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0271-6; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chae MH, 2015, PROTEINS, V83, P881, DOI 10.1002/prot.24782; Cho K, CORR; Chodera JD, 2014, CURR OPIN STRUC BIOL, V25, P135, DOI 10.1016/j.sbi.2014.04.002; Cozzetto D, 2009, PROTEINS, V77, P18, DOI 10.1002/prot.22561; Cunningham P., 2007, UCDCSI20074, DOI [10.1145/3459665, DOI 10.1145/3459665]; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fa R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198216; Feig M, 2017, WIRES COMPUT MOL SCI, V7, DOI 10.1002/wcms.1307; Feig M, 2016, J CHEM INF MODEL, V56, P1304, DOI 10.1021/acs.jcim.6b00222; Hamp T, 2015, BIOINFORMATICS, V31, P1521, DOI 10.1093/bioinformatics/btu857; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hovan L, 2018, PROTEINS, V86, P152, DOI 10.1002/prot.25409; Huang YJP, 2014, PROTEINS, V82, P43, DOI 10.1002/prot.24488; Jones DT, 2015, BIOINFORMATICS, V31, P999, DOI 10.1093/bioinformatics/btu791; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kingma D. P., CORR; Krol M, 2007, PROTEINS, V68, P159, DOI 10.1002/prot.21391; Kryshtafovych A, 2005, PROTEINS, V61, P225, DOI 10.1002/prot.20740; Lee B, 2016, ARXIV E PRINTS; Li LP, 2004, BIOINFORMATICS, V20, P1638, DOI 10.1093/bioinformatics/bth098; Liao JG, 2007, BIOINFORMATICS, V23, P1945, DOI 10.1093/bioinformatics/btm287; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Liu S, 2004, PROTEINS, V56, P93, DOI 10.1002/prot.20019; Manavalan B, 2017, BIOINFORMATICS, V33, P2496, DOI 10.1093/bioinformatics/btx222; Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177; Mirjalili V, 2014, PROTEINS, V82, P196, DOI 10.1002/prot.24336; Moal IH, 2015, BIOINFORMATICS, V31, P123, DOI 10.1093/bioinformatics/btu594; Modi V, 2016, PROTEINS, V84, P260, DOI 10.1002/prot.25048; Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011; Moult J, 2016, PROTEINS, V84, P4, DOI 10.1002/prot.25064; Moult J, 2014, PROTEINS, V82, P1, DOI 10.1002/prot.24452; Nugent T, 2014, PROTEINS, V82, P98, DOI 10.1002/prot.24377; Park H, 2018, P NATL ACAD SCI USA; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pfeiffenberger E, 2017, PROTEINS, V85, P528, DOI 10.1002/prot.25218; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Schmidt T, 2014, DRUG DISCOV TODAY, V19, P890, DOI 10.1016/j.drudis.2013.10.027; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Tran NH, 2017, P NATL ACAD SCI USA; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vangone A, 2015, ELIFE, V4, DOI 10.7554/eLife.07454; Weber JK, 2011, J CHEM THEORY COMPUT, V7, P3405, DOI 10.1021/ct2004484; Wu Yonghui, 2016, ABS160908144 CORR; Zacharias M, 2010, CURR OPIN STRUC BIOL, V20, P180, DOI 10.1016/j.sbi.2010.02.001; Zemla A, 2001, PROTEINS, P13; Zhang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015386; Zhou HY, 2011, BIOPHYS J, V101, P2043, DOI 10.1016/j.bpj.2011.09.012	62	9	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0202652	10.1371/journal.pone.0202652	http://dx.doi.org/10.1371/journal.pone.0202652			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180164	Green Published, Green Submitted, gold			2022-12-26	WOS:000444222400013
J	Rodriguez-Alonso, L; Rodriguez-Moranta, F; Arajol, C; Gilabert, P; Serra, K; Martin, A; Ibanez-Sanz, G; Moreno, V; Guardiola, J				Rodriguez-Alonso, Lorena; Rodriguez-Moranta, Francisco; Arajol, Claudia; Gilabert, Pau; Serra, Katja; Martin, Albert; Ibanez-Sanz, Gemma; Moreno, Victor; Guardiola, Jordi			Proton pump inhibitors reduce the accuracy of faecal immunochemical test for detecting advanced colorectal neoplasia in symptomatic patients	PLOS ONE			English	Article							OCCULT BLOOD-TESTS; CANCER; POPULATION; COLONOSCOPY; OVERGROWTH; HEMOGLOBIN; INJURY	Background The faecal immunochemical test (FIT) is used in colorectal cancer (CRC) screening and for the detection of advanced colorectal neoplasia (AN) in symptomatic patients, but its accuracy could be improved. Our objective was to assess the impact of proton pump inhibitors (PPI) on the accuracy of the FIT in the detection of AN, namely advanced colorectal adenoma and CRC. Methods and findings We performed a prospective study of 1002 individuals referred for a diagnostic colonoscopy at Bellvitge University Hospital from September 2011 through to October 2012. An exhaustive interview was performed by a gastroenterologist, prescription drug dispensing database was reviewed and the patient was given a FIT prior to colonoscopy. The positivity threshold of FIT used was >= 20 mu g Hb/g feces and the main outcome was AN. AN was detected in 13.2% (133) of patients. The accuracy of FIT for detecting AN in the PPI users and non-PPI users were: sensitivity 43.0% vs 65.6%, P = 0.009; specificity 86.9% vs 92.3%, P = 0.010; and, predictive positive value 34.4% vs 55.5%, P = 0.007, respectively. In multivariate analysis, adjusting for potential confounders, PPIs were associated with false positives in AN detection by FIT (OR 1.63 CI 95% 1.02-2.59, P < 0.037). The ROC curve for the FIT in the detection of AN in the PPI users and non-PPI users was 0.68 (CI 95% 0.61-0.76) and 0.85 (CI 95% 0.79-0.90). Conclusions PPI therapy reduces the accuracy of FIT for detecting AN in symptomatic patients.	[Rodriguez-Alonso, Lorena; Rodriguez-Moranta, Francisco; Arajol, Claudia; Gilabert, Pau; Serra, Katja; Martin, Albert; Ibanez-Sanz, Gemma; Guardiola, Jordi] Univ Hosp Bellvitge IDIBELL, Dept Gastroenterol & Hepatol, Barcelona, Spain; [Ibanez-Sanz, Gemma; Moreno, Victor] IDIBELL, Catalan Inst Oncol, Canc Prevent & Control Programme, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Guardiola, J (corresponding author), Univ Hosp Bellvitge IDIBELL, Dept Gastroenterol & Hepatol, Barcelona, Spain.	jguardiola@bellvitgehospital.cat	Rodriguez-Moranta, Francisco/AAB-8082-2019; Moreno, Victor/A-1697-2010	Rodriguez-Moranta, Francisco/0000-0003-4025-5510; Moreno, Victor/0000-0002-2818-5487; MARTIN-CARDONA, ALBERT/0000-0002-7090-0106; Guardiola, Jordi/0000-0002-0464-241X; Rodriguez Alonso, Lorena/0000-0003-0498-4804; Ibanez Sanz, Gemma/0000-0001-6071-7343	Societat Catalana de Digestolologia (SCD), Catalonia, Spain; Instituto de Salud Carlos III, FIS grants [PI11/01439, PI11/01593]	Societat Catalana de Digestolologia (SCD), Catalonia, Spain; Instituto de Salud Carlos III, FIS grants	This work was supported by a grant from the Societat Catalana de Digestolologia (SCD), Catalonia, Spain. Also the Instituto de Salud Carlos III, FIS grants PI11/01439 and PI11/01593. The sponsor of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Abraham NS, 2012, CURR OPIN GASTROEN, V28, P615, DOI 10.1097/MOG.0b013e328358d5b9; Allison JE, 2014, GUT LIVER, V8, P117, DOI 10.5009/gnl.2014.8.2.117; Cordoba Rodrigo, 2014, Aten Primaria, V46 Suppl 4, P16, DOI 10.1016/S0212-6567(14)70048-4; Cubiella J, 2014, COLORECTAL DIS, V16, pO273, DOI 10.1111/codi.12569; de Wijkerslooth TR, 2012, AM J GASTROENTEROL, V107, P1570, DOI 10.1038/ajg.2012.249; Foltz E, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12269; Freedberg DE, 2014, CLIN LAB MED, V34, P771, DOI 10.1016/j.cll.2014.08.008; Godber IM, 2016, CLIN CHEM LAB MED, V54, P595, DOI 10.1515/cclm-2015-0617; Graser A, 2009, GUT, V58, P241, DOI 10.1136/gut.2008.156448; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Jacobs C, 2013, ALIMENT PHARM THER, V37, P1103, DOI 10.1111/apt.12304; Lee JK, 2014, ANN INTERN MED, V160, P171, DOI 10.7326/M13-1484; Lombardo L, 2010, CLIN GASTROENTEROL H, V8, P504, DOI 10.1016/j.cgh.2009.12.022; Auge JM, 2016, CLIN CHEM LAB MED, V54, P125, DOI 10.1515/cclm-2015-0388; Mulherin SA, 2002, ANN INTERN MED, V137, P598, DOI 10.7326/0003-4819-137-7-200210010-00011; National Institute for Health and Care Excellence, 2011, DIAGN MAN COL CANC; Pallarito K., 2009, US NEWS WORLD REPORT; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Rodriguez-Alonso L, 2015, DIGEST LIVER DIS, V47, P797, DOI 10.1016/j.dld.2015.05.004; Sanz G, 2016, DIGEST LIVER DIS, V48, P1249, DOI [10.1016/j.dld.2016.06.011, DOI 10.1016/J.DLD.2016.06.011]; Schoenfeld AJ, 2016, JAMA INTERN MED, V176, P172, DOI 10.1001/jamainternmed.2015.7927; Symonds EL, 2015, J MED SCREEN, V22, P187, DOI 10.1177/0969141315584783; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; VERDU E, 1994, GUT, V35, P455, DOI 10.1136/gut.35.4.455; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Wang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126432; Washio E, 2016, CLIN GASTROENTEROL H, V14, P809, DOI 10.1016/j.cgh.2015.10.022; Westwood M, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21330; Wilschut JA, 2011, GASTROENTEROLOGY, V141, P1648, DOI 10.1053/j.gastro.2011.07.020; Winawer Sidney J, 2002, Gastrointest Endosc Clin N Am, V12, P1, DOI 10.1016/S1052-5157(03)00053-9	30	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203359	10.1371/journal.pone.0203359	http://dx.doi.org/10.1371/journal.pone.0203359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169524	Green Submitted, Green Published, gold			2022-12-26	WOS:000443374400036
J	Coburn, LA; Singh, K; Asim, M; Barry, DP; Allaman, MM; Al-Greene, NT; Hardbower, DM; Polosukhina, D; Williams, CS; Delgado, AG; Piazuelo, MB; Washington, MK; Gobert, AP; Wilson, KT				Coburn, Lori A.; Singh, Kshipra; Asim, Mohammad; Barry, Daniel P.; Allaman, Margaret M.; Al-Greene, Nicole T.; Hardbower, Dana M.; Polosukhina, Dina; Williams, Christopher S.; Delgado, Alberto G.; Piazuelo, M. Blanca; Washington, M. Kay; Gobert, Alain P.; Wilson, Keith T.			Loss of solute carrier family 7 member 2 exacerbates inflammation-associated colon tumorigenesis	ONCOGENE			English	Article							M1 MACROPHAGE ACTIVATION; AMINO-ACID TRANSPORTER-2; NITRIC-OXIDE PRODUCTION; L-ARGININE TRANSPORT; HELICOBACTER-PYLORI; BOWEL-DISEASE; PLASMA ARGININE; COLITIS; CHEMOKINES; ARGINASE	Solute carrier family 7 member 2 (SLC7A2, also known as CAT2) is an inducible transporter of the semi-essential amino acid L-arginine (L-Arg), which has been implicated in wound repair. We have reported that both SLC7A2 expression and L-Arg availability are decreased in colonic tissues from inflammatory bowel disease patients and that mice lacking Slc7a2 exhibit a more severe disease course when exposed to dextran sulfate sodium (DSS) compared to wild-type (WT) mice. Here, we present evidence that SLC7A2 plays a role in modulating colon tumorigenesis in the azoxymethane (AOM)-DSS model of colitis-associated carcinogenesis (CAC). SLC7A2 was localized predominantly to colonic epithelial cells in WT mice. Utilizing the AOM-DSS model, Slc7a2(-/-) mice had significantly increased tumor number, burden, and risk of high-grade dysplasia vs. WT mice. Tumors from Slc7a2(-/-) mice exhibited significantly increased levels of the proinflammatory cytokines/chemokines IL-1 beta, CXCL1, CXCL5, IL-3, CXCL2, CCL3, and CCL4, but decreased levels of IL-4, CXCL9, and CXCL10 compared to tumors from WT mice. This was accompanied by a shift toward pro-tumorigenic M2 macrophage activation in Slc7a2-deficient mice, as marked by increased colonic CD11b(+)F4/80(+)ARG1(+) cells with no alteration in CD11b(+)F4/80(+)NOS2(+) cells by flow cytometry and immunofluorescence microscopy. The shift toward M2 macrophage activation was confirmed in bone marrow-derived macrophages from Slc7a2(-/-) mice. In bone marrow chimeras between Slc7a2(-/-) and WT mice, the recipient genotype drove the CAC phenotype, suggesting the importance of epithelial SLC7A2 in abrogating neoplastic risk. These data reveal that SLC7A2 has a significant role in the protection from CAC in the setting of chronic colitis, and suggest that the decreased SLC7A2 in inflammatory bowel disease (IBD) may contribute to CAC risk. Strategies to enhance L-Arg availability by supplementing L-Arg and/or increasing L-Arg uptake could represent a therapeutic approach in IBD to reduce the substantial long-term risk of colorectal carcinoma.	[Coburn, Lori A.; Williams, Christopher S.; Wilson, Keith T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA; [Coburn, Lori A.; Singh, Kshipra; Asim, Mohammad; Barry, Daniel P.; Allaman, Margaret M.; Al-Greene, Nicole T.; Hardbower, Dana M.; Polosukhina, Dina; Williams, Christopher S.; Delgado, Alberto G.; Piazuelo, M. Blanca; Gobert, Alain P.; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA; [Coburn, Lori A.; Williams, Christopher S.; Piazuelo, M. Blanca; Gobert, Alain P.; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Ctr Mucosal Inflammat & Canc, Nashville, TN 37232 USA; [Hardbower, Dana M.; Washington, M. Kay; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Williams, Christopher S.; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Wilson, KT (corresponding author), Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA.; Wilson, KT (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA.; Wilson, KT (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Mucosal Inflammat & Canc, Nashville, TN 37232 USA.; Wilson, KT (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.; Wilson, KT (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA.	keith.wilson@vanderbilt.edu	Allaman, Margaret/GNO-9854-2022; Gobert, Alain P/AHB-1368-2022; /B-5647-2008	Allaman, Margaret M./0000-0002-2803-1365; /0000-0002-3972-3914; Coburn, Lori/0000-0003-3249-9806	National Institutes of Health (NIH) [R01AT004821, 3R01AT004821-02S1, R01DK053620, R01CA190612, P01CA116087, P01CA028842]; Veterans Affairs Merit Review [I01BX001453]; Thomas F. Frist Sr. Endowment; Vanderbilt Center for Mucosal Inflammation and Cancer; NIH [5T32DK007673, P30DK058404]; Vanderbilt Physician Scientist Development Award; Veterans Affairs Career Development Award [1IK2BX002126];  [T32GM008554];  [F31DK10715]; NATIONAL CANCER INSTITUTE [P01CA116087, R01CA190612, P01CA028842] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053620, T32DK007673, P30DK058404, T32DK007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002126, I01BX001453] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); Thomas F. Frist Sr. Endowment; Vanderbilt Center for Mucosal Inflammation and Cancer; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Physician Scientist Development Award; Veterans Affairs Career Development Award; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was funded by the National Institutes of Health (NIH) grants R01AT004821, 3R01AT004821-02S1, R01DK053620, R01CA190612, P01CA116087, and P01CA028842 (to KTW), Veterans Affairs Merit Review grant I01BX001453 (to KTW), the Thomas F. Frist Sr. Endowment (to KTW), and the Vanderbilt Center for Mucosal Inflammation and Cancer (to KTW). LAC was supported by the NIH training grant 5T32DK007673, a Vanderbilt Physician Scientist Development Award, and a Veterans Affairs Career Development Award 1IK2BX002126. DMH was supported by T32GM008554 and F31DK10715. Additional support was provided by the NIH grant P30DK058404 (Vanderbilt Digestive Disease Research Center). Whole slide imaging and quantification were performed in the Digital Histology Shared Resource at the Vanderbilt University Medical Center (http://www.mc.vanderbilt.edu/dhsr).	ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Barrett CW, 2011, CANCER RES, V71, P1302, DOI 10.1158/0008-5472.CAN-10-3317; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Beaugerie L, 2015, NEW ENGL J MED, V372, P1441, DOI 10.1056/NEJMra1403718; Brower V, 2005, J NATL CANCER I, V97, P251, DOI 10.1093/jnci/97.4.251; CASTILLO L, 1994, METABOLISM, V43, P114, DOI 10.1016/0026-0495(94)90166-X; CASTILLO L, 1993, P NATL ACAD SCI USA, V90, P7749, DOI 10.1073/pnas.90.16.7749; Chandrasekar B, 2013, J INFECT DIS, V207, P1556, DOI 10.1093/infdis/jit067; Chaturvedi R, 2010, GASTROENTEROLOGY, V139, P1686, DOI 10.1053/j.gastro.2010.06.060; Coburn LA, 2016, INFLAMM BOWEL DIS, V22, P1847, DOI 10.1097/MIB.0000000000000790; Coburn LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033546; Coman D, 2008, CLIN NUTR, V27, P489, DOI 10.1016/j.clnu.2008.05.007; Erreni M, 2011, CANCER MICROENVIRON, V4, P141, DOI 10.1007/s12307-010-0052-5; Feagins LA, 2009, NAT REV GASTRO HEPAT, V6, P297, DOI 10.1038/nrgastro.2009.44; Gobert AP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01242; Gobert AP, 2004, J IMMUNOL, V173, P2109, DOI 10.4049/jimmunol.173.3.2109; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hardbower DM, 2017, ONCOGENE, V36, P3807, DOI 10.1038/onc.2017.23; Hardbower DM, 2017, P NATL ACAD SCI USA, V114, pE751, DOI 10.1073/pnas.1614958114; Hardbower DM, 2016, AMINO ACIDS, V48, P2375, DOI 10.1007/s00726-016-2231-2; Hardbower DM, 2016, J CLIN INVEST, V126, P3296, DOI 10.1172/JCI83585; Herrinton LJ, 2012, GASTROENTEROLOGY, V143, P382, DOI 10.1053/j.gastro.2012.04.054; Hol J, 2010, J LEUKOCYTE BIOL, V87, P501, DOI 10.1189/jlb.0809532; Isidro RA, 2016, AM J PHYSIOL-GASTR L, V311, pG59, DOI 10.1152/ajpgi.00123.2016; Kakuda DK, 1999, BIOCHEM J, V340, P549, DOI 10.1042/0264-6021:3400549; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Martin L, 2006, AM J PHYSIOL-CELL PH, V290, pC1364, DOI 10.1152/ajpcell.00520.2005; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mori M, 2007, J NUTR, V137, p1616S, DOI 10.1093/jn/137.6.1616S; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Nagy TA, 2011, GASTROENTEROLOGY, V141, P553, DOI 10.1053/j.gastro.2011.05.004; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Rmali KA, 2007, COLORECTAL DIS, V9, P3, DOI 10.1111/j.1463-1318.2006.01089.x; ROSE WC, 1949, FED PROC, V8, P546; Rutter M, 2004, GASTROENTEROLOGY, V126, P451, DOI 10.1053/j.gastro.2003.11.010; Shivashankar R, 2017, CLIN GASTROENTEROL H, V15, P857, DOI 10.1016/j.cgh.2016.10.039; Sierra JC, 2018, GUT, V67, P1247, DOI 10.1136/gutjnl-2016-312888; Singh K, 2018, CANCER RES, V78, P4303, DOI 10.1158/0008-5472.CAN-18-0116; Singh K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005984; Singh K, 2013, AM J PHYSIOL-GASTR L, V305, pG225, DOI 10.1152/ajpgi.00091.2013; Singh K, 2012, AM J PHYSIOL-GASTR L, V302, pG1061, DOI 10.1152/ajpgi.00544.2011; Singh K, 2011, J BIOL CHEM, V286, P3839, DOI 10.1074/jbc.M110.176719; Sun P, 2017, J NUTR BIOCHEM, V47, P35, DOI 10.1016/j.jnutbio.2017.04.016; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Valbuena G, 2003, AM J PATHOL, V163, P1357, DOI 10.1016/S0002-9440(10)63494-3; Zimmerman NP, 2008, INFLAMM BOWEL DIS, V14, P1000, DOI 10.1002/ibd.20480	49	24	24	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 14	2019	38	7					1067	1079		10.1038/s41388-018-0492-9	http://dx.doi.org/10.1038/s41388-018-0492-9			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HL3OH	30202097	Green Accepted			2022-12-26	WOS:000458624900010
J	Houghton, MJ; Kerimi, A; Mouly, V; Tumova, S; Williamson, G				Houghton, Michael J.; Kerimi, Asimina; Mouly, Vincent; Tumova, Sarka; Williamson, Gary			Gut microbiome catabolites as novel modulators of muscle cell glucose metabolism	FASEB JOURNAL			English	Article						phenolic; flavonoid; microbiota; insulin; berry	COLONIC METABOLITES; HUMAN PLASMA; QUERCETIN; BUTYRATE; GLUT4; WHEAT; TRANSLOCATION; ANTHOCYANINS; STIMULATION; POLYPHENOLS	The gut microbiome supplies essential metabolites such as short-chain fatty acids to skeletal muscle mitochondria, and the composition and activity of the microbiota is in turn affected by muscle fitness. To further our understanding of the complex interactions between the gut microbiome and muscle, we examined the effect of microbiota-derived phenolic metabolites on the ability of human muscle cells to take up and metabolize glucose. As a model, we used the differentiated human skeletal muscle myoblast line, LHCN-M2, which expresses typical muscle phenotypic markers. We initially tested a selected panel of parent phenolic compounds and microbial metabolites, and their respective phenolic conjugates, as found in blood. Several of the tested compounds increased glucose uptake and metabolism, notably in high glucose- and insulin-treated myotubes. One of the most effective was isovanillic acid 3-O-sulfate (IVAS), a metabolite from the microbiome found in the blood, primarily derived from consumed cyanidin 3-O-glucoside, a major compound in berry fruits. IVAS stimulated a dose-dependent increase in glucose transport through glucose transporter GLUT4- and PI3K-dependent mechanisms. IVAS also up-regulated GLUT1, GLUT4, and PI3K p85 protein, and increased phosphorylation of Akt. The stimulation of glucose uptake and metabolism by a unique microbiome metabolite provides a novel link among diet, gut microbiota, and skeletal muscle energy source utilization.Houghton, M. J., Kerimi, A., Mouly, V., Tumova, S., Williamson, G. Gut microbiome catabolites as novel modulators of muscle cell glucose metabolism.	[Houghton, Michael J.; Kerimi, Asimina; Tumova, Sarka; Williamson, Gary] Univ Leeds, Fac Math & Phys Sci, Sch Food Sci & Nutr, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England; [Mouly, Vincent] Sorbonne Univ, INSERM, Inst Myol, Ctr Res Myol,Unite Mixte Rech Sci 974, Paris, France	University of Leeds; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Williamson, G (corresponding author), Univ Leeds, Fac Math & Phys Sci, Sch Food Sci & Nutr, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England.	g.williamson@leeds.ac.uk	Tumova, Sarka/AAD-6353-2019; Williamson, Gary/AAE-9665-2019; Houghton, Michael J/AAY-7751-2020	Tumova, Sarka/0000-0003-2044-4998; Williamson, Gary/0000-0002-5624-6267; Houghton, Michael J/0000-0001-6579-7995	European Research Council [POLYTRUE? 322467]	European Research Council(European Research Council (ERC)European Commission)	The authors acknowledge the platform for the immortalization of human cells of the Institut de Myologie in Paris, and thank S. Gardner (formerly at School of Food Science and Nutrition, University of Leeds, Leeds, United Kingdom) for helping to establish the muscle cells in our laboratory. The authors acknowledge funding from the European Research Council for an advanced grant (POLYTRUE? 322467). The authors declare no conflicts of interest.	Aft RL, 2002, BRIT J CANCER, V87, P805, DOI 10.1038/sj.bjc.6600547; Al-Khalili L, 2003, CELL MOL LIFE SCI, V60, P991, DOI 10.1007/s00018-003-3001-3; Bareja A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090398; Barton W, 2018, GUT, V67, P625, DOI 10.1136/gutjnl-2016-313627; BASSHAM JA, 1974, ANAL BIOCHEM, V61, P479, DOI 10.1016/0003-2697(74)90415-1; Bhattacharya S, 2013, J AGR FOOD CHEM, V61, P11033, DOI 10.1021/jf402838a; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breen DM, 2008, BIOCHEM BIOPH RES CO, V374, P117, DOI 10.1016/j.bbrc.2008.06.104; Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001; Cheng CW, 2017, CELL, V168, P775, DOI 10.1016/j.cell.2017.01.040; Clark A, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00319; CLARKE JF, 1994, BIOCHEM J, V300, P631, DOI 10.1042/bj3000631; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; Czank C, 2013, AM J CLIN NUTR, V97, P995, DOI 10.3945/ajcn.112.049247; de Ferrars RM, 2014, BRIT J PHARMACOL, V171, P3268, DOI 10.1111/bph.12676; Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581; Duncan SH, 2016, ENVIRON MICROBIOL, V18, P2214, DOI 10.1111/1462-2920.13158; Eid HM, 2015, PHARMACOGN MAG, V11, P74, DOI 10.4103/0973-1296.149708; Eid HM, 2010, MOL NUTR FOOD RES, V54, P991, DOI 10.1002/mnfr.200900218; Ernst Orna, 2010, J Vis Exp, DOI 10.3791/1918; Fardet A, 2010, NUTR RES REV, V23, P65, DOI 10.1017/S0954422410000041; Franco-Obregon A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00018-17; Fumeaux R, 2010, ORG BIOMOL CHEM, V8, P5199, DOI 10.1039/c0ob00137f; Gardner S, 2012, AM J PHYSIOL-CELL PH, V303, pC1292, DOI 10.1152/ajpcell.00259.2012; Giacomoni F., 2014, 11 NUGOWEEK NUTRIGEN, P95; Ho GTT, 2017, J AGR FOOD CHEM, V65, P2677, DOI 10.1021/acs.jafc.6b05582; Goffart S, 2006, CURR GENET, V49, P125, DOI 10.1007/s00294-005-0043-0; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Guy PA, 2009, J CHROMATOGR B, V877, P3965, DOI 10.1016/j.jchromb.2009.10.006; Iovino S, 2016, P NATL ACAD SCI USA, V113, P1889, DOI 10.1073/pnas.1525665113; Jung TH, 2015, J MICROBIOL BIOTECHN, V25, P1555, DOI 10.4014/jmb.1505.05078; Kawabata K, 2011, MOL NUTR FOOD RES, V55, P467, DOI 10.1002/mnfr.201000267; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Lantier L, 2014, FASEB J, V28, P3211, DOI 10.1096/fj.14-250449; Lauritzen HPMM, 2010, AM J PHYSIOL-ENDOC M, V299, pE169, DOI 10.1152/ajpendo.00066.2010; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Mach N, 2017, J SPORT HEALTH SCI, V6, P179, DOI 10.1016/j.jshs.2016.05.001; Manach C, 1998, FEBS LETT, V426, P331, DOI 10.1016/S0014-5793(98)00367-6; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; O'Leary KA, 2003, BIOCHEM PHARMACOL, V65, P479, DOI 10.1016/S0006-2952(02)01510-1; Park CE, 2007, EXP MOL MED, V39, P222, DOI 10.1038/emm.2007.25; Peyron S, 2001, J AGR FOOD CHEM, V49, P4694, DOI 10.1021/jf0106805; Pimpao RC, 2015, BRIT J NUTR, V113, P454, DOI 10.1017/S0007114514003511; Pimpao RC, 2014, MOL NUTR FOOD RES, V58, P1414, DOI 10.1002/mnfr.201300822; Prabhakar PK, 2009, PHYTOMEDICINE, V16, P1119, DOI 10.1016/j.phymed.2009.05.021; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Scazzocchio B, 2015, MOL NUTR FOOD RES, V59, P1472, DOI 10.1002/mnfr.201400816; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005; Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019; Stanford KI, 2014, ADV PHYSIOL EDUC, V38, P308, DOI 10.1152/advan.00080.2014; Steves CJ, 2016, J BONE MINER RES, V31, P261, DOI 10.1002/jbmr.2765; Stilling RM, 2016, NEUROCHEM INT, V99, P110, DOI 10.1016/j.neuint.2016.06.011; Stoupi S, 2010, MOL NUTR FOOD RES, V54, P747, DOI 10.1002/mnfr.200900123; Strober W, 2001, Curr Protoc Immunol, VAppendix 3, p3B, DOI 10.1002/0471142735.ima03bs21; Stull AJ, 2010, J NUTR, V140, P1764, DOI 10.3945/jn.110.125336; Torronen R, 2013, J NUTR, V143, P430, DOI 10.3945/jn.112.169771; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Williamson G, 2005, FREE RADICAL RES, V39, P457, DOI 10.1080/10715760500053610; Williamson G, 2017, BIOCHEM PHARMACOL, V139, P24, DOI 10.1016/j.bcp.2017.03.012; Williamson G, 2010, BRIT J NUTR, V104, pS48, DOI 10.1017/S0007114510003946; Wong CC, 2012, BIOCHEM PHARMACOL, V84, P564, DOI 10.1016/j.bcp.2012.05.011; Wong CC, 2011, BIOCHEM PHARMACOL, V81, P942, DOI 10.1016/j.bcp.2011.01.004; Yamamoto N, 2010, BIOSCI BIOTECH BIOCH, V74, P2036, DOI 10.1271/bbb.100305; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	65	35	38	3	44	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1887	1898		10.1096/fj.201801209R	http://dx.doi.org/10.1096/fj.201801209R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30183376	Green Submitted			2022-12-26	WOS:000457296600030
J	Kodji, X; Arkless, KL; Kee, Z; Cleary, SJ; Aubdool, AA; Evans, E; Caton, P; Pitchford, SC; Brain, SD				Kodji, Xenia; Arkless, Kate L.; Kee, Zizheng; Cleary, Simon J.; Aubdool, Aisah A.; Evans, Elizabeth; Caton, Paul; Pitchford, Simon C.; Brain, Susan D.			Sensory nerves mediate spontaneous behaviors in addition to inflammation in a murine model of psoriasis	FASEB JOURNAL			English	Article						TRP channels; neuropeptides; macrophages; oxidative stress; peroxynitrite	NITRIC-OXIDE SYNTHASE; GENE-RELATED PEPTIDE; SUBSTANCE-P; MOUSE MODEL; MAST-CELLS; SKIN; RECEPTOR; TRPA1; SUPEROXIDE; ITCH	Psoriasis is characterized by keratinocyte hyperproliferation, erythema, as well as a form of pruritus, involving cutaneous discomfort. There is evidence from both clinical and murine models of psoriasis that chemical or surgical depletion of small-diameter sensory nerves/nociceptors benefits the condition, but the mechanisms are unclear. Hence, we aimed to understand the involvement of sensory nerve mediators with a murine model of psoriasis and associated spontaneous behaviors, indicative of cutaneous discomfort. We have established an Aldara model of psoriasis in mice and chemically depleted the small-diameter nociceptors in a selective manner. The spontaneous behaviors, in addition to the erythema and skin pathology, were markedly improved. Attenuated inflammation was associated with reduced dermal macrophage influx and production of reactive oxygen/nitrogen species (peroxynitrite and protein nitrosylation). Subsequently, this directly influenced observed behavioral responses. However, the blockade of common sensory neurogenic mechanisms for transient receptor potential (TRP)V1, TRPA1, and neuropeptides (substance P and calcitonin gene-related peptide) using genetic and pharmacological approaches inhibited the behaviors but not the inflammation. Thus, a critical role of the established sensory TRP-neuropeptide pathway in influencing cutaneous discomfort is revealed, indicating the therapeutic potential of agents that block that pathway. The ongoing inflammation is mediated by a distinct sensory pathway involving macrophage activation.Kodji, X., Arkless, K. L., Kee, Z., Cleary, S. J., Aubdool, A. A., Evans, E., Caton, P., Pitchford, S. C., Brain, S. D. Sensory nerves mediate spontaneous behaviors in addition to inflammation in a murine model of psoriasis.	[Kodji, Xenia; Arkless, Kate L.; Kee, Zizheng; Aubdool, Aisah A.; Brain, Susan D.] Kings Coll London, BHF, Cardiovasc Ctr Res Excellence, Vasc Biol & Inflammat Sect, London, England; [Cleary, Simon J.; Pitchford, Simon C.] Kings Coll London, Sackler Inst Pulm Pharmacol, Inst Pharmaceut Sci, London, England; [Evans, Elizabeth; Caton, Paul] Kings Coll London, Diabet Res Grp, Div Diabet & Nutr Sci, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Brain, SD (corresponding author), Kings Coll London, BHF, Ctr Res Excellence, Vasc Biol & Inflammat, Franklin Wilkins Bldg,Waterloo Campus, London SE1 9NH, England.	sue.brain@kcl.ac.uk		Pitchford, Simon/0000-0003-3961-0407; Aubdool, Dr. Aisah/0000-0002-4712-9421; Cleary, Simon/0000-0001-5573-6363; Brain, Susan/0000-0002-9684-8342	British Pharmacological Society's AJ Clark Studentship; Arthritis Research UK [21541]; Medical Research Council Doctoral Training Programme Studentship; British Heart Foundation	British Pharmacological Society's AJ Clark Studentship; Arthritis Research UK(Versus Arthritis); Medical Research Council Doctoral Training Programme Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation)	X.K. was funded by the British Pharmacological Society's AJ Clark Studentship and Arthritis Research UK (Project Grant 21541), S.J.C. was funded by Medical Research Council Doctoral Training Programme Studentship, and A.A.A. was funded by the British Heart Foundation. The authors declare no conflicts of interest.	Amatya B, 2011, BRIT J DERMATOL, V164, P1023, DOI 10.1111/j.1365-2133.2011.10241.x; Andersson DA, 2015, J BIOL CHEM, V290, P15185, DOI 10.1074/jbc.M115.644476; Andoh T, 2013, J PHARMACOL SCI, V123, P199, DOI 10.1254/jphs.13122SC; Aubdool AA, 2016, BRIT J PHARMACOL, V173, P2419, DOI 10.1111/bph.13519; Aubdool AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6732; Bacchetti T, 2013, BRIT J DERMATOL, V168, P984, DOI 10.1111/bjd.12144; Baek JO, 2012, ARCH DERMATOL RES, V304, P699, DOI 10.1007/s00403-012-1272-y; Banvolgyi A, 2005, J NEUROIMMUNOL, V169, P86, DOI 10.1016/j.jneuroim.2005.08.012; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BERNSTEIN JE, 1986, J AM ACAD DERMATOL, V15, P504, DOI 10.1016/S0190-9622(86)70201-6; Bertin S, 2017, GUT, V66, P1584, DOI 10.1136/gutjnl-2015-310710; Boehncke W. H., 2017, CLIN REV ALLERGY IMM; Carlsson H, 2005, CANCER BIOL THER, V4, P998, DOI 10.4161/cbt.4.9.1969; Chan J, 1997, ARCH DERMATOL RES, V289, P611, DOI 10.1007/s004030050249; Cuzzocrea S, 1998, FREE RADICAL BIO MED, V24, P450, DOI 10.1016/S0891-5849(97)00280-3; Dantas RL, 2016, J PATHOL, V240, P366, DOI 10.1002/path.4786; DEWING SB, 1971, ARCH DERMATOL, V104, P220, DOI 10.1001/archderm.104.2.220; Dimon-Gadal S, 2000, J INVEST DERMATOL, V114, P984, DOI 10.1046/j.1523-1747.2000.00962.x; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; Duval A, 2009, NEW ENGL J MED, V361, P1415, DOI 10.1056/NEJMc0906670; EKBLOM A, 1993, SKIN PHARMACOL, V6, P215; Esancy K, 2018, ELIFE, V7, DOI 10.7554/eLife.32036; Fernandes ES, 2013, FASEB J, V27, P1664, DOI 10.1096/fj.12-221218; Fernandes ES, 2011, ARTHRITIS RHEUM-US, V63, P819, DOI 10.1002/art.30150; Gibson RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100610; Guerard S, 2013, ARCH DERMATOL RES, V305, P879, DOI 10.1007/s00403-013-1404-z; Hajna Z, 2016, J MOL NEUROSCI, V60, P157, DOI 10.1007/s12031-016-0802-z; Hirsch S, 2013, PAIN, V154, P700, DOI 10.1016/j.pain.2013.01.002; HYLDEN JLK, 1981, BRAIN RES, V217, P212, DOI 10.1016/0006-8993(81)90203-1; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; JANCSO G, 1977, NATURE, V270, P741, DOI 10.1038/270741a0; Jiang WY, 1998, INT J DERMATOL, V37, P572, DOI 10.1046/j.1365-4362.1998.00533.x; Kemeny A, 2018, J INVEST DERMATOL, V138, P1774, DOI 10.1016/j.jid.2018.02.040; Khattab MM, 2006, EUR J PHARMACOL, V548, P167, DOI 10.1016/j.ejphar.2006.08.007; Kodji X, 2016, CURR RES TRANSL MED, V64, P195, DOI 10.1016/j.retram.2016.09.002; KOLBBACHOFEN V, 1994, LANCET, V344, P139, DOI 10.1016/S0140-6736(94)91328-5; Kun J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108164; LaMotte RH, 2011, EXP DERMATOL, V20, P778, DOI 10.1111/j.1600-0625.2011.01367.x; Lee Y, 2012, BIOCHEM BIOPH RES CO, V423, P647, DOI 10.1016/j.bbrc.2012.05.162; Liu BY, 2013, FASEB J, V27, P3549, DOI 10.1096/fj.13-229948; Liu T, 2012, J CLIN INVEST, V122, P2195, DOI 10.1172/JCI45414; Liu T, 2010, NAT NEUROSCI, V13, P1460, DOI 10.1038/nn.2683; Ljosaa TM, 2010, ACTA DERM-VENEREOL, V90, P39, DOI 10.2340/00015555-0764; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; NAUKKARINEN A, 1993, ARCH DERMATOL RES, V285, P341, DOI 10.1007/BF00371834; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Old EA, 2014, J CLIN INVEST, V124, P2023, DOI 10.1172/JCI71389; Omari SA, 2017, ADV PHARMACOL, V79, P173, DOI 10.1016/bs.apha.2017.01.002; Onderdijk AJ, 2017, METHODS MOL BIOL, V1559, P75, DOI 10.1007/978-1-4939-6786-5_6; Ostrowski SM, 2011, J INVEST DERMATOL, V131, P1530, DOI 10.1038/jid.2011.60; Prignano F, 2009, CLIN COSMET INVESTI, V2, P9; Quallo T, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.191; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; RODENAS J, 1995, FREE RADICAL BIO MED, V18, P869, DOI 10.1016/0891-5849(94)00215-6; Roller A, 2012, J IMMUNOL, V189, P4612, DOI 10.4049/jimmunol.1103173; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sakai K, 2016, PAIN, V157, P2536, DOI 10.1097/j.pain.0000000000000674; Salmon AM, 2004, NEUROSCI LETT, V360, P73, DOI 10.1016/j.neulet.2004.02.031; Simeoli R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01841-5; Stander S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010968; Stander S, 2004, EXP DERMATOL, V13, P129, DOI 10.1111/j.0906-6705.2004.0178.x; Stratis A, 2006, J CLIN INVEST, V116, P2094, DOI 10.1172/JCI27179; Swindell WR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0415-3; Tattersall FD, 2000, NEUROPHARMACOLOGY, V39, P652, DOI 10.1016/S0028-3908(99)00172-0; Terhorst D, 2015, J IMMUNOL, V195, P4953, DOI 10.4049/jimmunol.1500551; Therene C, 2018, J INVEST DERMATOL, V138, P38, DOI 10.1016/j.jid.2017.05.039; Trevisan G, 2016, BRAIN, V139, P1361, DOI 10.1093/brain/aww038; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang HL, 2006, J CLIN INVEST, V116, P2105, DOI 10.1172/JCI27180; Ward NL, 2011, BRIT J DERMATOL, V164, P750, DOI 10.1111/j.1365-2133.2010.10129.x; WHEELERACETO H, 1990, PAIN, V40, P229, DOI 10.1016/0304-3959(90)90073-M; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954	76	25	28	2	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1578	1594		10.1096/fj.201800395RR	http://dx.doi.org/10.1096/fj.201800395RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30204499	hybrid, Green Published			2022-12-26	WOS:000457296600007
J	Meng, GM; Tang, XY; Yang, ZL; Zhao, Y; Curtis, JM; McMullen, TPW; Brindley, DN				Meng, Guanmin; Tang, Xiaoyun; Yang, Zelei; Zhao, YuanYuan; Curtis, Jonathan M.; McMullen, Todd P. W.; Brindley, David N.			Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer	FASEB JOURNAL			English	Article						adiponectin; cytokines; lipid phosphate phosphatase 1; lysophosphatidic acid receptor; sphingosine 1-phosphate	TUMOR-GROWTH; KAPPA-B; EXPRESSION; INSULIN; CHEMOTHERAPY; OBESITY; GLUCOCORTICOIDS; ADIPOCYTES; CYTOKINES; RECEPTOR	Lysophosphatidate (LPA) signaling through 6 receptors is regulated by the balance of LPA production by autotaxin (ATX) vs. LPA degradation by lipid phosphate phosphatases (LPPs). LPA promotes an inflammatory cycle by increasing the synthesis of cyclooxygenase-2 and multiple inflammatory cytokines that stimulate further ATX production. We aimed to determine whether the anti-inflammatory glucocorticoid (GC) dexamethasone (Dex) functions partly by decreasing the ATX-LPA inflammatory cycle in adipose tissue, a major site of ATX secretion. Treatment of human adipose tissue with 10-1000 nM Dex decreased ATX secretion, increased LPP1 expression, and decreased mRNA expressions of IL-6, TNF-, peroxisome proliferator-activated receptor (PPAR)-, and adiponectin. Cotreatment with rosiglitazone (an insulin sensitizer), insulin, or both abolished Dex-induced decreases in ATX and adiponectin secretion, but did not reverse Dex-induced decreases in secretions of 20 inflammatory cytokines and chemokines. Dex-treated mice exhibited lower ATX activity in plasma, brain, and adipose tissue; decreased mRNA levels for LPA and sphingosine 1-phosphate (S1P) receptors in brain; and decreased plasma concentrations of LPA and S1P. Our results establish a novel mechanism for the anti-inflammatory effects of Dex through decreased signaling by the ATX-LPA-inflammatory axis. The GC action in adipose tissue has implications for the pathogenesis of insulin resistance and obesity in metabolic syndrome and breast cancer treatment.Meng, G., Tang, X., Yang, Z., Zhao, Y., Curtis, J. M., McMullen, T. P. W., Brindley, D. N. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.	[Meng, Guanmin; Tang, Xiaoyun; Yang, Zelei; Brindley, David N.] Univ Alberta, Canc Res Inst Northern Alberta, Dept Biochem, Signal Transduct Res Grp, Edmonton, AB, Canada; [Zhao, YuanYuan; Curtis, Jonathan M.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [McMullen, Todd P. W.] Univ Alberta, Dept Surg, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Brindley, DN (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada.	david.brindley@ualberta.ca		Meng, Guanmin/0000-0002-6701-8980	Canadian Cancer Society Research Institute; Canadian Breast Cancer Foundation (CBCF); University of Alberta	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Breast Cancer Foundation (CBCF); University of Alberta(University of Alberta)	The work was supported by grants from the Canadian Cancer Society Research Institute and the Canadian Breast Cancer Foundation (CBCF) (to D.N.B.) and by a 75th Anniversary Graduate Studentship from the University of Alberta (to Z.Y.). The authors declare no conflicts of interest.	Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; Benesch M.G.K., 2018, CANCERS, V10, pe73; Benesch MGK, 2017, TRENDS CANCER, V3, P748, DOI 10.1016/j.trecan.2017.09.004; Benesch MGK, 2016, J BIOMED RES, V30, P272, DOI 10.7555/JBR.30.20150058; Benesch MGK, 2015, FASEB J, V29, P3990, DOI 10.1096/fj.15-274480; Benesch MGK, 2015, ENDOCR-RELAT CANCER, V22, P593, DOI 10.1530/ERC-15-0045; Benesch MGK, 2015, J LIPID RES, V56, P1134, DOI 10.1194/jlr.M057661; Benesch MGK, 2014, FEBS LETT, V588, P2712, DOI 10.1016/j.febslet.2014.02.009; Benesch MGK, 2014, FASEB J, V28, P2655, DOI 10.1096/fj.13-248641; BERTRAND F, 1995, J BIOL CHEM, V270, P24435, DOI 10.1074/jbc.270.41.24435; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Boucher J, 2005, DIABETOLOGIA, V48, P569, DOI 10.1007/s00125-004-1660-8; Brindley DN, 2013, BBA-MOL CELL BIOL L, V1831, P74, DOI 10.1016/j.bbalip.2012.08.015; BRINDLEY DN, 1989, CLIN SCI, V77, P453, DOI 10.1042/cs0770453; BRINDLEY DN, 1995, INT J OBESITY, V19, pS69; Carswell KA, 2012, METHODS MOL BIOL, V806, P203, DOI 10.1007/978-1-61779-367-7_14; Cook AM, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1066062; Crozier M, 2015, BREAST CANCER RES TR, V154, P33, DOI 10.1007/s10549-015-3588-8; D'Souza K, 2017, ENDOCRINOLOGY, V158, P791, DOI 10.1210/en.2017-00035; Dalezis P, 2017, ANTI-CANCER DRUG, V28, P489, DOI 10.1097/CAD.0000000000000484; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; DROUIN J, 1993, EMBO J, V12, P145, DOI 10.1002/j.1460-2075.1993.tb05640.x; Dusaulcy R, 2011, J LIPID RES, V52, P1247, DOI 10.1194/jlr.M014985; Espaillat Mel Pilar, 2017, Advances in Biological Regulation, V63, P140, DOI 10.1016/j.jbior.2016.11.001; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Fotopoulou S, 2010, DEV BIOL, V339, P451, DOI 10.1016/j.ydbio.2010.01.007; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Gandy K Alexa Orr, 2013, Handb Exp Pharmacol, P275, DOI 10.1007/978-3-7091-1511-4_14; Gershuni VM, 2016, CURR SURG REP, V4, DOI 10.1007/s40137-016-0134-5; Hait NC, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4806541; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Honjo M, 2018, INVEST OPHTH VIS SCI, V59, P21, DOI 10.1167/iovs.17-22807; Honorat M, 2008, BIOCHEM BIOPH RES CO, V375, P308, DOI 10.1016/j.bbrc.2008.07.149; Jordan K, 2007, ONCOLOGIST, V12, P1143, DOI 10.1634/theoncologist.12-9-1143; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Knapp M, 2013, ADV MED SCI-POLAND, V58, P274, DOI 10.2478/ams-2013-0021; Koike S, 2010, BIOCHEM BIOPH RES CO, V400, P66, DOI 10.1016/j.bbrc.2010.08.008; Koike S, 2009, J BIOL CHEM, V284, P33561, DOI 10.1074/jbc.M109.012716; Li Zhenxing, 2016, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V32, P604; Lopez-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053; Mattern J, 2007, CANCER BIOL THER, V6, P1345, DOI 10.4161/cbt.6.9.4765; Meng GM, 2017, FASEB J, V31, P4064, DOI 10.1096/fj.201700159R; Nagahashi M, 2018, CANCER RES, V78, P1713, DOI 10.1158/0008-5472.CAN-17-1423; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nakayama Y, 2015, BREAST CANCER-TOKYO, V22, P177, DOI 10.1007/s12282-013-0472-4; Nematollahi LR, 2009, METABOLISM, V58, P443, DOI 10.1016/j.metabol.2008.10.018; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Pacetti U, 2013, ANTICANCER RES, V33, P1721; Rancoule C, 2014, BIOCHIMIE, V96, P140, DOI 10.1016/j.biochi.2013.04.010; Rancoule C, 2012, J PHYSIOL BIOCHEM, V68, P635, DOI 10.1007/s13105-012-0181-z; Ray R, 2017, BLOOD, V129, P1177, DOI 10.1182/blood-2016-10-743757; SAAD MJA, 1994, MOL ENDOCRINOL, V8, P545, DOI 10.1210/me.8.5.545; Saklatvala J, 2002, ARTHRITIS RES, V4, P146, DOI 10.1186/ar398; Salmenniemi U, 2004, CIRCULATION, V110, P3842, DOI 10.1161/01.CIR.0000150391.38660.9B; Schmidt H, 2006, PROSTAG OTH LIPID M, V81, P162, DOI 10.1016/j.prostaglandins.2006.09.003; Soccio RE, 2014, CELL METAB, V20, P573, DOI 10.1016/j.cmet.2014.08.005; Su Y, 2012, ACTA BIOMATER, V8, P763, DOI 10.1016/j.actbio.2011.11.002; Sukumaran S, 2012, VITAM HORM, V90, P163, DOI 10.1016/B978-0-12-398313-8.00007-5; Sumida H, 2013, CLIN CHIM ACTA, V415, P74, DOI 10.1016/j.cca.2012.10.003; Sundaram Sneha, 2013, J Carcinog, V12, P19, DOI 10.4103/1477-3163.119606; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Tang XY, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0607-x; Tang XY, 2015, J LIPID RES, V56, P2048, DOI 10.1194/jlr.R058362; Tang XY, 2014, J LIPID RES, V55, P2389, DOI 10.1194/jlr.M053462; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Wang H, 2007, INT J ONCOL, V30, P947; Weichhart T, 2010, IMMUNOL LETT, V129, P50, DOI 10.1016/j.imlet.2009.12.025; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Zhang YF, 2012, J IMMUNOL, V189, P3914, DOI 10.4049/jimmunol.1201604	70	16	16	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1899	1910		10.1096/fj.201801226R	http://dx.doi.org/10.1096/fj.201801226R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30192654				2022-12-26	WOS:000457296600031
J	Trotman, JB; Agana, BA; Giltmier, AJ; Wysocki, VH; Schoenberg, DR				Trotman, Jackson B.; Agana, Bernice A.; Giltmier, Andrew J.; Wysocki, Vicki H.; Schoenberg, Daniel R.			RNA-binding proteins and heat-shock protein 90 are constituents of the cytoplasmic capping enzyme interactome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA-binding protein; RNA processing; heat shock protein 90 (HSP90); proteomics; gene expression; capping enzyme; cytoplasmic capping; protein interactome; RNA stability; RNGTT	CAP HOMEOSTASIS; MAMMALIAN-CELLS; HSP90; IDENTIFICATION; TRANSCRIPTOME; REVEALS; CLIENTS	The N-7-methylguanosine cap is added in the nucleus early in gene transcription and is a defining feature of eukaryotic mRNAs. Mammalian cells also possess cytoplasmic machinery for restoring the cap at uncapped or partially degraded RNA 5 ends. Central to both pathways is capping enzyme (CE) (RNA guanylyltransferase and 5-phosphatase (RNGTT)), a bifunctional, nuclear and cytoplasmic enzyme. CE is recruited to the cytoplasmic capping complex by binding of a C-terminal proline-rich sequence to the third Src homology 3 (SH3) domain of NCK adapter protein 1 (NCK1). To gain broader insight into the cellular context of cytoplasmic recapping, here we identified the protein interactome of cytoplasmic CE in human U2OS cells through two complementary approaches: chemical cross-linking and recovery with cytoplasmic CE and protein screening with proximity-dependent biotin identification (BioID). This strategy unexpectedly identified 66 proteins, 52 of which are RNA-binding proteins. We found that CE interacts with several of these proteins independently of RNA, mediated by sequences within its N-terminal triphosphatase domain, and we present a model describing how CE-binding proteins may function in defining recapping targets. This analysis also revealed that CE is a client protein of heat shock protein 90 (HSP90). Nuclear and cytoplasmic CEs were exquisitely sensitive to inhibition of HSP90, with both forms declining significantly following treatment with each of several HSP90 inhibitors. Importantly, steady-state levels of capped mRNAs decreased in cells treated with the HSP90 inhibitor geldanamycin, raising the possibility that the cytotoxic effect of these drugs may partially be due to a general reduction in translatable mRNAs.	[Trotman, Jackson B.; Agana, Bernice A.; Giltmier, Andrew J.; Wysocki, Vicki H.; Schoenberg, Daniel R.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Trotman, Jackson B.; Agana, Bernice A.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Trotman, Jackson B.; Giltmier, Andrew J.; Schoenberg, Daniel R.] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA; [Agana, Bernice A.; Wysocki, Vicki H.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Trotman, Jackson B.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Trotman, Jackson B.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Schoenberg, DR (corresponding author), Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA.	schoenberg.3@osu.edu	Schoenberg, Daniel/J-3423-2019	Schoenberg, Daniel/0000-0003-4570-1946; Trotman, Jackson/0000-0003-3133-2393	NATIONAL CANCER INSTITUTE [T32CA217824, P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084177] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA217824, P30 CA016058] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aregger M, 2017, RNA BIOL, V14, P11, DOI 10.1080/15476286.2016.1251540; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen PS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03443-z; Chu C, 2008, MOL CELL BIOL, V28, P5829, DOI 10.1128/MCB.00021-08; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Fang QM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6513; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Gonatopoulos-Pournatzis T, 2011, MOL CELL, V44, P585, DOI 10.1016/j.molcel.2011.08.041; Ignatochkina AV, 2015, P NATL ACAD SCI USA, V112, P6967, DOI 10.1073/pnas.1424909112; Jiao XF, 2013, MOL CELL, V50, P104, DOI 10.1016/j.molcel.2013.02.017; Karagoz GE, 2015, TRENDS BIOCHEM SCI, V40, P117, DOI 10.1016/j.tibs.2014.12.002; Kiss DL, 2016, NUCLEIC ACIDS RES, V44, P304, DOI 10.1093/nar/gkv1460; Kiss DL, 2015, FEBS LETT, V589, P279, DOI 10.1016/j.febslet.2014.12.009; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Mercer TR, 2010, GENOME RES, V20, P1639, DOI 10.1101/gr.112128.110; Milek M, 2017, GENOME RES, V27, P1344, DOI 10.1101/gr.218438.116; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Mukherjee C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001933; Mukherjee C, 2012, CELL REP, V2, P674, DOI 10.1016/j.celrep.2012.07.011; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Otsuka Y, 2009, MOL CELL BIOL, V29, P2155, DOI 10.1128/MCB.01325-08; Ramanathan A, 2016, NUCLEIC ACIDS RES, V44, P7511, DOI 10.1093/nar/gkw551; Rohl A, 2013, TRENDS BIOCHEM SCI, V38, P253, DOI 10.1016/j.tibs.2013.02.003; Song MG, 2010, MOL CELL, V40, P423, DOI 10.1016/j.molcel.2010.10.010; Srinivasa S, 2015, METHODS, V89, P91, DOI 10.1016/j.ymeth.2015.05.006; Tago K, 2004, MOL CELL ENDOCRINOL, V213, P131, DOI 10.1016/j.mce.2003.10.057; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Trendel J., 2018, BIORXIV, DOI [10.1101/329995, DOI 10.1101/329995]; Trotman JB, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2767; Trotman JB, 2017, NUCLEIC ACIDS RES, V45, P10726, DOI 10.1093/nar/gkx801; ULLRICH SJ, 1989, J BIOL CHEM, V264, P6810; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Youn JY, 2018, MOL CELL, V69, P517, DOI 10.1016/j.molcel.2017.12.020; Zuehlke AD, 2018, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0527	35	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16596	16607		10.1074/jbc.RA118.004973	http://dx.doi.org/10.1074/jbc.RA118.004973			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30166341	Green Published, hybrid			2022-12-26	WOS:000448515100005
J	Young, PA; Senkal, CE; Suchanek, AL; Grevengoed, TJ; Lin, DD; Zhao, LY; Crunk, AE; Klett, EL; Fullekrug, J; Obeid, LM; Coleman, RA				Young, Pamela A.; Senkal, Can E.; Suchanek, Amanda L.; Grevengoed, Trisha J.; Lin, Dennis D.; Zhao, Liyang; Crunk, Amanda E.; Klett, Eric L.; Fuellekrug, Joachim; Obeid, Lina M.; Coleman, Rosalind A.			Long-chain acyl-CoA synthetase 1 interacts with key proteins that activate and direct fatty acids into niche hepatic pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein-protein interaction; ceramide synthase; -oxidation; peroxisome; lipid droplet; mitochondria; hepatocyte; acyl-CoA synthetase-1; BioID; SNAP23	TANDEM MASS-SPECTROMETRY; CONTAINING 3 ACBD3; LIPID DROPLETS; BETA-OXIDATION; SUBCELLULAR-LOCALIZATION; MITOCHONDRIAL FUSION; INTERACTION NETWORKS; INSULIN SENSITIVITY; STATISTICAL-MODEL; MAMMALIAN-CELLS	Fatty acid channeling into oxidation or storage modes depends on physiological conditions and hormonal signaling. However, the directionality of this channeling may also depend on the association of each of the five acyl-CoA synthetase isoforms with specific protein partners. Long-chain acyl-CoA synthetases (ACSLs) catalyze the conversion of long-chain fatty acids to fatty acyl-CoAs, which are then either oxidized or used in esterification reactions. In highly oxidative tissues, ACSL1 is located on the outer mitochondrial membrane (OMM) and directs fatty acids into mitochondria for -oxidation. In the liver, however, about 50% of ACSL1 is located on the endoplasmic reticulum (ER) where its metabolic function is unclear. Because hepatic fatty acid partitioning is likely to require the interaction of ACSL1 with other specific proteins, we used an unbiased protein interaction technique, BioID, to discover ACSL1-binding partners in hepatocytes. We targeted ACSL1 either to the ER or to the OMM of Hepa 1-6 cells as a fusion protein with the Escherichia coli biotin ligase, BirA*. Proteomic analysis identified 98 proteins that specifically interacted with ACSL1 at the ER, 55 at the OMM, and 43 common to both subcellular locations. We found subsets of peroxisomal and lipid droplet proteins, tethering proteins, and vesicle proteins, uncovering a dynamic role for ACSL1 in organelle and lipid droplet interactions. Proteins involved in lipid metabolism were also identified, including acyl-CoA-binding proteins and ceramide synthase isoforms 2 and 5. Our results provide fundamental and detailed insights into protein interaction networks that control fatty acid metabolism.	[Young, Pamela A.; Suchanek, Amanda L.; Grevengoed, Trisha J.; Lin, Dennis D.; Zhao, Liyang; Crunk, Amanda E.; Klett, Eric L.; Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Klett, Eric L.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Senkal, Can E.; Obeid, Lina M.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Fuellekrug, Joachim] Heidelberg Univ, Otto Meyerhof Zentrum, Heidelberg Univ Hosp, Mol Cell Biol Lab,Internal Med 4, D-69120 Heidelberg, Germany	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Ruprecht Karls University Heidelberg	Coleman, RA (corresponding author), Univ N Carolina, Dept Nutr, Michael Hooker Res Ctr 2301, Dauer Dr, Chapel Hill, NC 27599 USA.	rcoleman@unc.edu	Grevengoed, Trisha/AAA-3980-2021; Suchanek, Amanda/HCI-3855-2022; Crunk, Amanda/AGF-2426-2022	Crunk, Amanda/0000-0001-8168-0172; Zhao, Liyang/0000-0003-1960-0199	National Institutes of Health [DK59935, DK56598, DK107481, GM097741]; German Research Foundation (DFG) [FU 340/5-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107481, R56DK056598, R01DK056598, R01DK059935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK59935 and DK56598 (to R. A. C.), DK107481 (to E. L. K.), and GM097741 (to L. M. O.) and German Research Foundation (DFG) Grant FU 340/5-1 (to J. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3; Bernardes A, 2013, J MOL BIOL, V425, P2878, DOI 10.1016/j.jmb.2013.05.010; Bersuker K, 2018, DEV CELL, V44, P97, DOI 10.1016/j.devcel.2017.11.020; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bollu LR, 2014, CELL CYCLE, V13, P2415, DOI 10.4161/cc.29338; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Bowman TA, 2016, MOL METAB, V5, P210, DOI 10.1016/j.molmet.2016.01.001; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Costello JL, 2017, J CELL BIOL, V216, P331, DOI 10.1083/jcb.201607055; Cronan JE, 2005, J NUTR BIOCHEM, V16, P416, DOI 10.1016/j.jnutbio.2005.03.017; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Fan JJ, 2010, PROG LIPID RES, V49, P218, DOI 10.1016/j.plipres.2009.12.003; Ferdinandusse S, 2015, HUM MOL GENET, V24, P361, DOI 10.1093/hmg/ddu448; Frahm Jennifer L, 2011, J Proteomics Bioinform, V4, P129; Gosejacob D, 2016, J BIOL CHEM, V291, P6989, DOI 10.1074/jbc.M115.691212; Grevengoed TJ, 2015, FASEB J, V29, P4641, DOI 10.1096/fj.15-272732; Grevengoed TJ, 2015, J LIPID RES, V56, P1572, DOI 10.1194/jlr.M059717; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Hua R, 2017, J CELL BIOL, V216, P367, DOI 10.1083/jcb.201608128; Jagerstrom S, 2009, CELL BIOL INT, V33, P934, DOI 10.1016/j.cellbi.2009.06.011; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Killion EA, 2018, MOL METAB, V9, P43, DOI 10.1016/j.molmet.2018.01.012; Klett EL, 2017, J LIPID RES, V58, P884, DOI 10.1194/jlr.M072512; Kuerschner L, 2005, NAT METHODS, V2, P39, DOI 10.1038/NMETH728; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Li LO, 2015, DIABETES, V64, P23, DOI 10.2337/db13-1070; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Lin Y, 2016, MOL ENDOCRINOL, V30, P234, DOI 10.1210/me.2015-1281; Liu J, 2003, J STEROID BIOCHEM, V85, P275, DOI 10.1016/S0960-0760(03)00213-9; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Merrick BA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006007; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Papadopoulos V, 2007, MOL CELL ENDOCRINOL, V265, P59, DOI 10.1016/j.mce.2006.12.004; POLOKOFF MA, 1978, J BIOL CHEM, V253, P7173; Poppelreuther M, 2012, J LIPID RES, V53, P888, DOI 10.1194/jlr.M024562; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Sadh K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183022; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; Schaffler A, 2005, NAT CLIN PRACT GASTR, V2, P273, DOI 10.1038/ncpgasthep0186; Schumacher MM, 2015, ELIFE, V4, DOI [10.7554/eLife.05560, 10.7554/eLife.04490]; Senkal CE, 2017, CELL METAB, V25, P686, DOI 10.1016/j.cmet.2017.02.010; Senthivinayagam S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073696; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shinoda Y, 2012, FEBS LETT, V586, P3024, DOI 10.1016/j.febslet.2012.06.050; Steinberg SJ, 1999, BIOCHEM BIOPH RES CO, V257, P615, DOI 10.1006/bbrc.1999.0510; Strauss JA, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12662; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tani M, 2007, J BIOL CHEM, V282, P10047, DOI 10.1074/jbc.M611249200; Tomiuk S, 2000, J BIOL CHEM, V275, P5710, DOI 10.1074/jbc.275.8.5710; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; Vogel K, 1999, BIOCHEM BIOPH RES CO, V258, P407, DOI 10.1006/bbrc.1999.0652; WATKINS PA, 1991, ARCH BIOCHEM BIOPHYS, V289, P329, DOI 10.1016/0003-9861(91)90419-J; Watkins PA, 1996, J LIPID RES, V37, P2288; Watkins PA, 2012, BBA-MOL BASIS DIS, V1822, P1411, DOI 10.1016/j.bbadis.2012.02.010; Wendel AA, 2013, J BIOL CHEM, V288, P27299, DOI 10.1074/jbc.M113.485219; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Yagita Y, 2017, J BIOL CHEM, V292, P691, DOI 10.1074/jbc.M116.760090; Zhan TZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045087; Zhong SS, 2015, CANCER RES, V75, P1801, DOI 10.1158/0008-5472.CAN-14-2005	72	44	44	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16724	16740		10.1074/jbc.RA118.004049	http://dx.doi.org/10.1074/jbc.RA118.004049			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30190326	Green Published, hybrid			2022-12-26	WOS:000448515100015
J	Bera, S; Pandey, KK; Aihara, H; Grandgenett, DP				Bera, Sibes; Pandey, Krishan K.; Aihara, Hideki; Grandgenett, Duane P.			Differential assembly of Rous sarcoma virus tetrameric and octameric intasomes is regulated by the C-terminal domain and tail region of integrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-protein interaction; retrovirus; integrase; human immunodeficiency virus (HIV); DNA enzyme; HIV; strand-transfer inhibitors; intasome; integrase tetrameric and octameric stable synaptic complex; Rous sarcoma virus; viral integration; strand-transfer complex	FULL-SITE INTEGRATION; STRAND TRANSFER INHIBITORS; VIRAL-DNA ENDS; SYNAPTIC COMPLEX; TYPE-1 INTEGRASE; IN-VITRO; CONCERTED INTEGRATION; RETROVIRUS INTEGRASE; CRYSTAL-STRUCTURE; HIV-1 INTEGRASE	Retrovirus integrase (IN) catalyzes the concerted integration of linear viral DNA ends into chromosomes. The atomic structures of five different retrovirus IN-DNA complexes, termed intasomes, have revealed varying IN subunit compositions ranging from tetramers to octamers, dodecamers, and hexadecamers. Intasomes containing two IN-associated viral DNA ends capable of concerted integration are termed stable synaptic complexes (SSC), and those formed with a viral/target DNA substrate representing the product of strand-transfer reactions are strand-transfer complexes (STC). Here, we investigated the mechanisms associated with the assembly of the Rous sarcoma virus SSC and STC. C-terminal truncations of WT IN (286 residues) indicated a role of the last 18 residues (tail region) in assembly of the tetrameric and octameric SSC, physically stabilized by HIV-1 IN strand-transfer inhibitors. Fine mapping through C-terminal truncations and site-directed mutagenesis suggested that at least three residues (Asp-268-Thr-270) past the last -strand in the C-terminal domain (CTD) are necessary for assembly of the octameric SSC. In contrast, the assembly of the octameric STC was independent of the last 18 residues of IN. Single-site substitutions in the CTD affected the assembly of the SSC, but not necessarily of the STC, suggesting that STC assembly may depend less on specific interactions of the CTD with viral DNA. Additionally, we demonstrate that trans-communication between IN dimer-DNA complexes facilitates the association of native long-terminal repeat (LTR) ends with partially defective LTR ends to produce a hybrid octameric SSC. The differential assembly of the tetrameric and octameric SSC improves our understanding of intasomes.	[Bera, Sibes; Pandey, Krishan K.; Grandgenett, Duane P.] St Louis Univ, Hlth Sci Ctr, Dept Mol Microbiol & Immunol, Inst Mol Virol, St Louis, MO 63104 USA; [Aihara, Hideki] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Saint Louis University; University of Minnesota System; University of Minnesota Twin Cities	Grandgenett, DP (corresponding author), St Louis Univ, Hlth Sci Ctr, Dept Mol Microbiol & Immunol, Inst Mol Virol, St Louis, MO 63104 USA.	Duane.Grandgenett@health.slu.edu		Pandey, Krishan/0000-0002-3973-9844	National Institutes of Health [AI127197, GM118047]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI127196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole and in part, by National Institutes of Health Grants AI127197 (to D. G.) and GM118047 (to H. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anstett K, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0360-7; Anstett K, 2015, J VIROL, V89, P4681, DOI 10.1128/JVI.03485-14; Ballandras-Colas A, 2017, SCIENCE, V355, P93, DOI 10.1126/science.aah7002; Ballandras-Colas A, 2016, NATURE, V530, P358, DOI 10.1038/nature16955; Bera S, 2005, BIOCHEMISTRY-US, V44, P15106, DOI 10.1021/bi0508340; Bera S, 2011, J MOL BIOL, V410, P831, DOI 10.1016/j.jmb.2011.01.043; Bera S, 2009, J MOL BIOL, V389, P183, DOI 10.1016/j.jmb.2009.04.007; Brown HEV, 1999, J VIROL, V73, P9011, DOI 10.1128/JVI.73.11.9011-9020.1999; Chen HM, 2001, MOL CELL BIOL, V21, P6758, DOI 10.1128/MCB.21.20.6758-6767.2001; Chen HM, 1999, J BIOL CHEM, V274, P17358, DOI 10.1074/jbc.274.24.17358; Chiu R, 2003, J VIROL, V77, P6482, DOI 10.1128/JVI.77.11.6482-6492.2003; Chiu R, 2000, J VIROL, V74, P8292, DOI 10.1128/JVI.74.18.8292-8298.2000; Engelman A, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0024-2014; Engelman AN, 2017, CURR OPIN STRUC BIOL, V47, P23, DOI 10.1016/j.sbi.2017.04.005; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; HORTON R, 1988, J VIROL, V62, P2067, DOI 10.1128/JVI.62.6.2067-2075.1988; HORTON R, 1991, J VIROL, V65, P1141, DOI 10.1128/JVI.65.3.1141-1148.1991; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Lutzke RAP, 1998, J VIROL, V72, P4841, DOI 10.1128/JVI.72.6.4841-4848.1998; Mackler RM, 2018, JOVE-J VIS EXP, DOI 10.3791/57453; Masuda T, 1998, J VIROL, V72, P8396, DOI 10.1128/JVI.72.10.8396-8402.1998; McCord M, 1999, VIROLOGY, V259, P392, DOI 10.1006/viro.1999.9782; McCord M, 1998, PROTEIN EXPRES PURIF, V14, P167, DOI 10.1006/prep.1998.0954; Mesplede T, 2014, J ANTIMICROB CHEMOTH, V69, P2733, DOI 10.1093/jac/dku199; Pandey KK, 2017, J BIOL CHEM, V292, P5018, DOI 10.1074/jbc.M116.773382; Pandey KK, 2014, J BIOL CHEM, V289, P19648, DOI 10.1074/jbc.M114.573311; Pandey KK, 2010, BIOCHEMISTRY-US, V49, P8376, DOI 10.1021/bi100514s; Passos DO, 2017, SCIENCE, V355, P89, DOI 10.1126/science.aah5163; Quashie PK, 2012, J VIROL, V86, P2696, DOI 10.1128/JVI.06591-11; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056892; Vora A, 2004, J BIOL CHEM, V279, P18670, DOI 10.1074/jbc.M314270200; Vora A, 2001, J VIROL, V75, P3556, DOI 10.1128/JVI.75.8.3556-3567.2001; Vora AC, 1997, J BIOL CHEM, V272, P23938, DOI 10.1074/jbc.272.38.23938; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Yin ZQ, 2016, NATURE, V530, P362, DOI 10.1038/nature16950; Yin ZQ, 2012, PROTEIN SCI, V21, P1849, DOI 10.1002/pro.2166; Zhou HB, 2001, J VIROL, V75, P1359, DOI 10.1128/JVI.75.3.1359-1370.2001	39	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16440	16452		10.1074/jbc.RA118.004768	http://dx.doi.org/10.1074/jbc.RA118.004768			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30185621	hybrid, Green Published			2022-12-26	WOS:000447833600026
J	Silva, LS; Peruchetti, DB; Silva-Aguiar, RP; Abreu, TP; Dal-Cheri, BKA; Takiya, CM; Souza, MC; Henriques, MG; Pinheiro, AAS; Caruso-Neves, C				Silva, Leandro S.; Peruchetti, Diogo B.; Silva-Aguiar, Rodrigo P.; Abreu, Thiago P.; Dal-Cheri, Beatriz K. A.; Takiya, Christina M.; Souza, Mariana C.; Henriques, Maria G.; Pinheiro, Ana Acacia S.; Caruso-Neves, Celso			The angiotensin II/AT1 receptor pathway mediates malaria-induced acute kidney injury	PLOS ONE			English	Article							INDUCED TUBULOINTERSTITIAL INFLAMMATION; PLASMODIUM-FALCIPARUM MALARIA; ACUTE-RENAL-FAILURE; HYPERTENSIVE-RATS; CEREBRAL MALARIA; CELLS; MICE; PROTEINURIA; INFECTION; SYSTEM	Malaria-induced acute kidney injury (MAKI) is a life-threatening complication of severe malaria. Here, we investigated the potential role of the angiotensin II (Ang II)/AT(1) receptor pathway in the development of MAKI. We used C57BL/6 mice infected by Plasmodium berghei ANKA (PbA-infected mice), a well-known murine model of severe malaria. The animals were treated with 20 mg/kg/day losartan, an antagonist of AT(1) receptor, or captopril, an angiotensin-converting enzyme inhibitor. We observed an increase in the levels of plasma creatinine and blood urea nitrogen associated with a significant decrease in creatinine clearance, a marker of glomerular flow rate, and glomerular hypercellularity, indicating glomerular injury. PbA-infected mice also presented proteinuria and a high level of urinary gamma-glutamyltransferase activity associated with an increase in collagen deposition and interstitial space, showing tubule-interstitial injury. PbA-infected mice were also found to have increased fractional excretion of sodium (FENa+) coupled with decreased cortical (Na++K+)ATPase activity. These injuries were associated with an increase in pro-inflammatory cytokines, such as tumor necrosis factor alpha, interleukin-6, interleukin-17, and interferon gamma, in the renal cortex of PbA-infected mice. All modifications of these structural, biochemical, and functional parameters observed in PbA-infected mice were avoided with simultaneous treatment with losartan or captopril. Our data allow us to postulate that the Ang II/AT(1) receptor pathway mediates an increase in renal pro-inflammatory cytokines, which in turn leads to the glomerular and tubular injuries observed in MAKI.	[Silva, Leandro S.; Peruchetti, Diogo B.; Silva-Aguiar, Rodrigo P.; Abreu, Thiago P.; Dal-Cheri, Beatriz K. A.; Takiya, Christina M.; Pinheiro, Ana Acacia S.; Caruso-Neves, Celso] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil; [Souza, Mariana C.; Henriques, Maria G.] Fundacao Oswaldo Cruz, Inst Tecnol Farmacos, Rio De Janeiro, RJ, Brazil; [Caruso-Neves, Celso] Conselho Nacl Desenvolvimento Cient & Tecnol, MCT, Inst Nacl Ciencia & Tecnol Med Regenerat, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Caruso-Neves, C (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.; Caruso-Neves, C (corresponding author), Conselho Nacl Desenvolvimento Cient & Tecnol, MCT, Inst Nacl Ciencia & Tecnol Med Regenerat, Rio De Janeiro, RJ, Brazil.	caruso@biof.ufrj.br	Takiya, Christina/AAU-5959-2021; Silva-Aguiar, Rodrigo Pacheco/AAH-7924-2020; Henriques, Maria das Graças M O/G-2998-2013; Peruchetti, Diogo B/L-3706-2017; Silva, Leandro/B-1381-2018; Caruso-Neves, Celso/C-4014-2013; Souza, Mariana/C-1677-2015	Takiya, Christina/0000-0002-8019-628X; Silva-Aguiar, Rodrigo Pacheco/0000-0003-1975-8033; Henriques, Maria das Graças M O/0000-0003-3065-0541; Peruchetti, Diogo B/0000-0002-7572-9731; Silva, Leandro/0000-0001-8720-0088; Pinheiro, Ana Acacia/0000-0002-3894-1645; Caruso-Neves, Celso/0000-0002-2415-7753; Souza, Mariana/0000-0002-6933-9227	Brazilian agency: Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/202.950/2016, E-26/201.197/2014, E-26/202.833/2017]	Brazilian agency: Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro	This work was supported by grants from the following Brazilian agency: Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (http://www.faperj.br/): E-26/202.950/2016 (AASP); E-26/201.197/2014 and E-26/202.833/2017 (CCN).	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Abreu TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093634; Arnaud-Batista FJ, 2016, BBA-GEN SUBJECTS, V1860, P1431, DOI 10.1016/j.bbagen.2016.04.012; Bonavia A, 2018, PEDIATR NEPHROL, V33, P1629, DOI 10.1007/s00467-017-3774-5; Boushab BM, 2016, INT J NEPHROL RENOV, V9, P249, DOI 10.2147/IJNRD.S116377; Carey RM, 2015, ADV CHRONIC KIDNEY D, V22, P204, DOI 10.1053/j.ackd.2014.11.004; Caruso-Neves C, 2006, P NATL ACAD SCI USA, V103, P18810, DOI 10.1073/pnas.0605029103; Chang KH, 2004, KIDNEY INT, V65, P1640, DOI 10.1111/j.1523-1755.2004.00573.x; Cheng SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34265; Ding Y, 2016, PARASITOLOGY, V143, P1672, DOI 10.1017/S0031182016001475; Eiam-Ong S, 1998, AM J KIDNEY DIS, V32, P361, DOI 10.1053/ajkd.1998.v32.pm9740151; Elias RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044004; Erkan E, 2013, PEDIATR NEPHROL, V28, P1049, DOI 10.1007/s00467-012-2335-1; Feraille E, 2001, PHYSIOL REV, V81, P345, DOI 10.1152/physrev.2001.81.1.345; Fu Y, 2012, J PARASITOL, V98, P310, DOI 10.1645/GE-2825.1; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Gallego-Delgado J, 2016, J CLIN INVEST, V126, P4016, DOI 10.1172/JCI87306; Herbert F, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0731-6; Jones J, 2012, AM J KIDNEY DIS, V60, P402, DOI 10.1053/j.ajkd.2012.03.014; Konigshausen E, 2016, SCI REP-UK, V6, DOI 10.1038/srep39513; Krishnan A, 2003, CRIT CARE MED, V31, P2278, DOI 10.1097/01.CCM.0000079603.82822.69; Landgraf SS, 2011, AM J PHYSIOL-RENAL, V300, pF499, DOI 10.1152/ajprenal.00384.2010; Landgraf SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107549; Liu D, 2014, INT J BIOCHEM CELL B, V57, P7, DOI 10.1016/j.biocel.2014.09.018; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Gorriz JL, 2012, TRANSPLANT REV-ORLAN, V26, P3, DOI 10.1016/j.trre.2011.10.002; Lv LL, 2018, J AM SOC NEPHROL, V29, P919, DOI 10.1681/ASN.2017050523; Lv LL, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00117; Macconi D, 2014, KIDNEY INT SUPPL, V4, P58, DOI 10.1038/kisup.2014.11; Maciel AT, 2017, J CLIN MONIT COMPUT, V31, P539, DOI 10.1007/s10877-016-9871-3; Malhotra R, 2017, CLIN J AM SOC NEPHRO, V12, P149, DOI 10.2215/CJN.01300216; Matejovic M, 2016, J AM SOC NEPHROL, V27, P49, DOI 10.1681/ASN.2015030234; Mehrotra P, 2015, KIDNEY INT, V88, P776, DOI 10.1038/ki.2015.200; Mishra Saroj K, 2008, J Indian Med Assoc, V106, P640; NAVAR LG, 1986, FED PROC, V45, P2851; Norlander AE, 2016, HYPERTENSION, V68, P167, DOI 10.1161/HYPERTENSIONAHA.116.07493; Ozkok A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/967826; Peruchetti DB, 2014, J BIOL CHEM, V289, P16790, DOI 10.1074/jbc.M114.549717; Peruchetti DB, 2011, J BIOL CHEM, V286, P45041, DOI 10.1074/jbc.M111.260737; Portella VG, 2013, CRIT CARE MED, V41, P1056, DOI 10.1097/CCM.0b013e3182746696; Prasad R, 2016, PERITON DIALYSIS INT, V36, P213, DOI 10.3747/pdi.2014.00254; Pulido-Mendez M., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P143; Queiroz-Madeira EP, 2010, BBA-BIOMEMBRANES, V1798, P360, DOI 10.1016/j.bbamem.2009.06.018; Rodriguez-Romo R, 2016, KIDNEY INT, V89, P363, DOI 10.1038/ki.2015.320; Ruster C, 2011, J AM SOC NEPHROL, V22, P1189, DOI 10.1681/ASN.2010040384; Saraiva VB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017174; Sercundes MK, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006054; Silva L. S., 2016, FRONT CELL INFECT MI, V5, DOI DOI 10.3389/fcimb.2015.00103; Silva JL, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00042; Silva JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35997; Silva JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147785; Silva JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062999; Sinniah R, 1999, INT J EXP PATHOL, V80, P87, DOI 10.1046/j.1365-2613.1999.00101.x; Sitprija V, 1996, AM J NEPHROL, V16, P513, DOI 10.1159/000169042; Souza MC, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0093-2; Taub M, 2010, BIOCHEM BIOPH RES CO, V393, P339, DOI 10.1016/j.bbrc.2010.02.037; Taylor Walter R J, 2006, Treat Respir Med, V5, P419, DOI 10.2165/00151829-200605060-00007; Terkawi MA, 2016, INFECT IMMUN, V84, P845, DOI 10.1128/IAI.01005-15; Vallon V, 2016, NEPHRON, V134, P160, DOI 10.1159/000446448; WHO, 2017, WORLD MALARIA REPORT; Wolf G, 2004, KIDNEY INT, V66, P1849, DOI 10.1111/j.1523-1755.2004.00958.x; Zhang JD, 2016, J AM SOC NEPHROL, V27, P2257, DOI 10.1681/ASN.2015060683	62	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203836	10.1371/journal.pone.0203836	http://dx.doi.org/10.1371/journal.pone.0203836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204779	Green Published, gold, Green Submitted			2022-12-26	WOS:000444355500046
J	Baruch, Z; Caddy-Retalic, S; Guerin, GR; Sparrow, B; Leitch, E; Tokmakoff, A; Lowe, AJ				Baruch, Zdravko; Caddy-Retalic, Stefan; Guerin, Greg R.; Sparrow, Ben; Leitch, Emrys; Tokmakoff, Andrew; Lowe, Andrew J.			Floristic and structural assessment of Australian rangeland vegetation with standardized plot-based surveys	PLOS ONE			English	Article							GRASS CENCHRUS-CILIARIS; NORTHERN-TERRITORY; TROPICAL SAVANNAS; FIRE; BIODIVERSITY; IMPACTS; CLASSIFICATION; CONSERVATION; DIVERSITY; PATTERNS	We describe and correlate environmental, floristic and structural vegetation traits of a large portion of Australian rangelands. We analysed 351 one hectare vegetation plots surveyed by Australia's Terrestrial Ecosystem Research Network (TERN) using the AusPlots Rangelands standardized method. The AusPlots Rangelands method involves surveying 1010 one meter-spaced point-intercepts (IPs) per plot. At each IP, species were scored, categorised by growth-form, converted to percentage cover as the input for the plot(x) species matrix. Vegetation structure is depicted by growth-form configuration and relative importance. The floristic and structural distance matrices were correlated with the Mantel test. Canonical correspondence analysis (CCA) related floristic composition to environmental variables sourced from WorldClim, the Atlas of Living Australia and TERN's Soil and Landscape Grid. Differences between clusters were tested with ANOVA while principal component analysis (PCA) ordered the plots within the environmental space. Our plot(x) species matrix required segmentation due to sparsity and high beta-diversity. Based on the ordination of plots latitude within environmental space, the matrix was segmented into three "superclusters" : the winter rain and temperate Mediterranean, the monsoonal rain savannas and the arid deserts. Further classification, with the UPGMA linkage method, generated two, four and five clusters, respectively. All groupings are described by species richness, diversity indices and growth form conformation. Several floristic disjunctions were apparent and their possible causes are discussed. For all superclusters, the correspondence between the floristic and the structural or growth form matrices was statistically significant. CCA ordination clearly demarcated all groupings. Aridity, rainfall, temperature, seasonality, soil nitrogen and pH are significant correlates to the ordination of superclusters and clusters. At present, our results are influenced by incomplete sampling. As more sites are surveyed, this pioneer analysis will be updated and refined providing tools for the effective management of Australian rangelands.	[Baruch, Zdravko; Guerin, Greg R.; Sparrow, Ben; Leitch, Emrys; Tokmakoff, Andrew] Univ Adelaide Node, Terr Ecosyst Res Network, North Terrace, Adelaide, SA, Australia; [Baruch, Zdravko; Caddy-Retalic, Stefan; Guerin, Greg R.; Sparrow, Ben; Leitch, Emrys; Tokmakoff, Andrew; Lowe, Andrew J.] Univ Adelaide, Sch Biol Sci, North Terrace, Adelaide, SA, Australia; [Caddy-Retalic, Stefan] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia	University of Adelaide; University of Sydney	Baruch, Z (corresponding author), Univ Adelaide Node, Terr Ecosyst Res Network, North Terrace, Adelaide, SA, Australia.; Baruch, Z (corresponding author), Univ Adelaide, Sch Biol Sci, North Terrace, Adelaide, SA, Australia.	zdravko.baruch@adelaide.edu.au	Guerin, Greg R./R-8955-2019	Sparrow, Ben/0000-0003-2566-1895; Lowe, Andrew/0000-0003-1139-2516	Australian Government through the Terrestrial Ecosystem Research Network (TERN); National Collaborative Research Infrastructure Strategy (NCRIS)	Australian Government through the Terrestrial Ecosystem Research Network (TERN)(Australian Government); National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science)	AusPlots Rangelands is funded by the Australian Government through the Terrestrial Ecosystem Research Network (TERN), and the National Collaborative Research Infrastructure Strategy (NCRIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie L, 2005, LAMTO STRUCTURE FUNC; Andersen AN, 2005, AUSTRAL ECOL, V30, P155, DOI 10.1111/j.1442-9993.2005.01441.x; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Barrett RL, 2013, ANN BOT-LONDON, V111, P499, DOI 10.1093/aob/mct008; Bastin GN, 2009, RANGELAND J, V31, P111, DOI 10.1071/RJ08072; Bowman DMJS, 2008, J ARID ENVIRON, V72, P34, DOI 10.1016/j.jaridenv.2007.04.001; Bowman DMJS, 2010, J BIOGEOGR, V37, P201, DOI 10.1111/j.1365-2699.2009.02210.x; BOWMAN DMJS, 1987, AUST J BOT, V35, P151, DOI 10.1071/BT9870151; Caddy-Retalic S, 2017, ECOL EVOL, V7, P4607, DOI 10.1002/ece3.2995; Dickman C.R., 2014, BIODIVERSITY ENV CHA, P379; Eldridge DJ, 2016, ECOL APPL, V26, P1273, DOI 10.1890/15-1234; Fensham RJ, 2015, RANGELAND J, V37, P227, DOI 10.1071/RJ14097; Fisher A, 2001, BIOGEOGRAPHY CONSERV; FORAN BD, 1986, J ENVIRON MANAGE, V22, P67; Foulkes J. N., 2014, BIODIVERSITY ENV CHA, P439; Garnett Stephen T., 2010, P191; Gibson N, 2012, J ARID ENVIRON, V77, P25, DOI 10.1016/j.jaridenv.2011.08.021; GRIFFIN GF, 1990, J VEG SCI, V1, P435, DOI 10.2307/3235776; Groves R.H., 1994, AUSTR VEGETATION; Guerin GR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170137; Herrick JE, 2010, FRONT ECOL ENVIRON, V8, P403, DOI 10.1890/100017; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchinson MF, 2005, GLOBAL ECOL BIOGEOGR, V14, P197, DOI [10.1111/j.1466-822X.2005.00154.x, 10.1111/j.1466-822x.2005.00154.x]; IBRA, 2008, INT BIOG REG AUSTR V; Jackson J, 2005, AUSTRAL ECOL, V30, P505, DOI 10.1111/j.1442-9993.2005.01465.x; Kent M., 2011, VOODOO PILCHARD, V2nd ed.; Kooyman RM, 2017, PLANT SOIL, V412, P143, DOI 10.1007/s11104-016-3057-0; Lambers H, 2014, PLANT LIFE SANDPLAIN; MacCune B, 1997, PC ORD MULTIVARIATE; MANTEL N, 1967, CANCER RES, V27, P209; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McDonald R.C., 2009, AUSTR SOIL LAND SURV; McKenzie N. L., 1987, BIOL SURVEY NULLARBO; Miller G, 2010, RANGELAND J, V32, P353, DOI 10.1071/RJ09076; Morton SR, 2011, J ARID ENVIRON, V75, P313, DOI 10.1016/j.jaridenv.2010.11.001; Morton SR, 2009, AUSTRAL ECOL, V34, P1, DOI 10.1111/j.1442-9993.2008.01938.x; Nano CEM, 2012, FLAMMABLE AUSTRALIA: FIRE REGIMES, BIODIVERSITY AND ECOSYSTEMS IN A CHANGING WORLD, P195; Noy-Meir I, 1971, P ECOL SOC AUST; NVIS NVIS, 2012, PRES MAJ VEG GROUPS; Orians GH, 2007, BIOL REV, V82, P393, DOI 10.1111/j.1469-185X.2007.00017.x; Russell-Smith J, 2014, BIODIVERSITY ENV CHA, P335; Scholes R. J., 1997, KALAHARI TRANSECT RE; Smyth AK, 2004, AUSTRAL ECOL, V29, P3, DOI 10.1111/j.1442-9993.2004.01360.x; Sparrow B, 2014, OUR CAPACITY TELL AU; Sparrow BD FJ, 2017, SURVEILLANCE MONITOR; Specht R.L., 1999, AUSTR PLANT COMMUNIT; STAFFORD SMITH DM, 1990, J ARID ENVIRON, V18, P255, DOI 10.1016/S0140-1963(18)30837-1; SYSTAT, 2002, SYSTAT WIND V 10 0; Tokmakoff A, 2016, FUTURE GENER COMP SY, V56, P537, DOI 10.1016/j.future.2015.08.016; van Etten EJB, 2017, FOLIA GEOBOT, V52, P161, DOI 10.1007/s12224-016-9269-5; Vance TR, 2015, GEOPHYS RES LETT, V42, P129, DOI 10.1002/2014GL062447; WERGER MJA, 1982, VEGETATIO, V50, P175, DOI 10.1007/BF00364111; White A., 2014, BIODIVERSITY ENV CHA, P479; White A., 2012, AUSPLOTS RANGELANDS; Williams KJ, 2012, INT J GEOGR INF SCI, V26, P2009, DOI 10.1080/13658816.2012.698015; Williams RJ, 2004, FUNCT PLANT BIOL, V31, P415, DOI 10.1071/FP03215; Williams RJ, 1996, J BIOGEOGR, V23, P747, DOI 10.1111/j.1365-2699.1996.tb00036.x; Woinarski JCZ, 2003, RANGELAND J, V25, P157, DOI 10.1071/RJ03013; Zhou G, 2002, J VEG SCI, V13, P361, DOI 10.1111/j.1654-1103.2002.tb02060.x	60	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202073	10.1371/journal.pone.0202073	http://dx.doi.org/10.1371/journal.pone.0202073			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192858	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600016
J	Li, BJ; Liao, HM; Liu, HB; Tsai, S; Zhang, J; Hung, GC; Chin, PJ; Gao, YM; Lo, SC				Li, Bingjie; Liao, Hsiao-Mei; Liu, Hebing; Tsai, Shien; Zhang, Jing; Hung, Guo-Chiuan; Chin, Pei-Ju; Gao, Yamei; Lo, Shyh-Ching			Comparative genomics, infectivity and cytopathogenicity of Zika viruses produced by acutely and persistently infected human hematopoietic cell lines	PLOS ONE			English	Article							WEST-NILE-VIRUS; BLOOD MONONUCLEAR-CELLS; CONFERS RESISTANCE; 2K PEPTIDE; STRAINS; NS4A; TRANSMISSION; FLAVIVIRUS; MUTATION; PROTEIN	Zika virus (ZIKV), an arthropod-borne virus, has emerged as a major human pathogen. Prolonged or persistent ZIKV infection of human cells and tissues may serve as a reservoir for the virus and present serious challenges to the safety of public health. Human hematopoietic cell lines with different developmental properties revealed differences in susceptibility and outcomes to ZIKV infection. In three separate studies involving the prototypic MR 766 ZIKV strain and the human monocytic leukemia U937 cell line, ZIKV initially developed only a low-grade infection at a slow rate. After continuous culture for several months, persistently ZIKV-infected cell lines were observed with most, if not all, cells testing positive for ZIKV antigen. The infected cultures produced ZIKV RNA (v-RNA) and infectious ZIKVs persistently ("persistent ZIKVs") with distinct infectivity and pathogenicity when tested using various kinds of host cells. When the genomes of ZIKVs from the three persistently infected cell lines were compared with the genome of the prototypic MR 766 ZIKV strain, distinct sets of mutations specific to each cell line were found. Significantly, all three "persistent ZIKVs" were capable of infecting fresh U937 cells with high efficiency at rapid rates, resulting in the development of a new set of persistently ZIKV-infected U937 cell lines. The genomes of ZIKVs from the new set of persistently ZIKV-infected U937 cell lines were further analyzed for their different mutations. The 2nd generation of persistent ZIKVs continued to possess most of the distinct sets of mutations specific to the respective 1st generation of persistent ZIKVs. We anticipate that the study will contribute to the understanding of the fundamental biology of adaptive mutations and selection during viral persistence. The persistently ZIKV-infected human cell lines that we developed will also be useful to investigate critical molecular pathways of ZIKV persistence and to study drugs or countermeasures against ZIKV infections and transmission.	[Li, Bingjie; Liao, Hsiao-Mei; Liu, Hebing; Tsai, Shien; Zhang, Jing; Hung, Guo-Chiuan; Chin, Pei-Ju; Lo, Shyh-Ching] US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Off Tissues & Adv Therapies,Ctr Biol Evaluat & Re, Silver Spring, MD 20993 USA; [Gao, Yamei] US FDA, Lab Pediat & Resp Viral Dis, Div Viral Prod, Off Vaccines Res & Review,Ctr Biol Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Lo, SC (corresponding author), US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Off Tissues & Adv Therapies,Ctr Biol Evaluat & Re, Silver Spring, MD 20993 USA.	shyhching.lo@fda.hhs.gov		, Pei-Ju/0000-0001-8892-7465	FDA Modernizing Science grant; FDA Zika supplement fund; Protein and Nucleic Acid Laboratory under Facility for Biotechnology Resources, Center for Biologics Evaluation and Research, Food and Drug Administration	FDA Modernizing Science grant; FDA Zika supplement fund; Protein and Nucleic Acid Laboratory under Facility for Biotechnology Resources, Center for Biologics Evaluation and Research, Food and Drug Administration	This work was supported in part by the FDA Modernizing Science grant and FDA Zika supplement fund. The funders had no role in study design, data collection and interpretation or preparation of the manuscript for publication.; The viral RNA genome sequencing was supported by the Protein and Nucleic Acid Laboratory under Facility for Biotechnology Resources, Center for Biologics Evaluation and Research, Food and Drug Administration.	Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008; Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241; Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023; Burkhalter KL, 2018, J MED ENTOMOL, V55, P717, DOI 10.1093/jme/tjy005; Cairns DM, 2018, BIOL OPEN, V7, DOI 10.1242/bio.031807; Campbell CL, 2014, VIROLOGY, V464, P228, DOI 10.1016/j.virol.2014.07.009; Carossino M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2852-4; CHAN JFW, 2016, EMERG MICROBES INFEC, V5, DOI DOI 10.1038/EMI.2016.99; Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148; Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517; Ding XH, 2005, AM J TROP MED HYG, V73, P803, DOI 10.4269/ajtmh.2005.73.803; Farfan-Ale JA, 2009, AM J TROP MED HYG, V80, P85, DOI 10.4269/ajtmh.2009.80.85; Feng GH, 2002, CHINESE MED J-PEKING, V115, P1324; Giersing BK, 2019, VACCINE, V37, P7315, DOI 10.1016/j.vaccine.2016.10.090; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2; Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219; Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987; Jean Michel M, 2017, EMERG INFECT DIS, V23, DOI [10.1007/s00705-006-0903-z, DOI 10.1007/S00705-006-0903-Z]; Jun SR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1894-3; Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z; Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019; Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530; Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4; Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0; Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Paz-Bailey G., 2017, N ENGL J MED, DOI [10.1056/NEJMoa1613108, DOI 10.1056/NEJMOA1613108]; RALPH P, 1976, J EXP MED, V143, P1528, DOI 10.1084/jem.143.6.1528; Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Saxena V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002275; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020; Stanley E., 2009, Morbidity and Mortality Weekly Report, V58, P1263; Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120; Zhang SM, 2004, BLOOD, V104, P4252, DOI 10.1182/blood-2004-04-1245; Zou G, 2009, VIROLOGY, V384, P242, DOI 10.1016/j.virol.2008.11.003	39	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203331	10.1371/journal.pone.0203331	http://dx.doi.org/10.1371/journal.pone.0203331			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192813	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600060
J	Singh, M; Rani, S; Malhotra, N; Katna, G; Sarker, A				Singh, Mohar; Rani, Savita; Malhotra, Nikhil; Katna, Gopal; Sarker, Ashutosh			Transgressive segregations for agronomic improvement using interspecific crosses between C. arietinum L. x C. reticulatum Ladiz. and C. arietinum L. x C. echinospermum Davis species	PLOS ONE			English	Article							WILD CICER; GENETIC-RELATIONSHIPS; MORPHOLOGICAL TRAITS; CULTIVATED CHICKPEA; DIVERSITY	The wild species of chickpea have tremendous potential for enhancing genetic gains of cultigen and have resistant accessions against major biotic and abiotic stresses. In the present study, two wild annual accessions, one each of C. reticulatum Ladiz. (ILWC 229) and C. echinospermum Davis (ILWC 246) were assessed for their agro-morphological features and hybridized with different cultivated varieties (BGD 72, PBG 5, ICKG 96029, Pusa 372 and JG 11) of chickpea. Fertile F-1 plants were developed as revealed by their normal meiotic chromosomal configuration including high pollen stainability percentage and seed set. The effect of genetic and non-genetic factors on crossability performance with respect to pod and seed set was also evident under two growing conditions of North-Western Indian Himalayas. The segregation analysis using F-2 phenotypic ratio of some distinct morphological (plant growth habit, stem pigmentation at seedling stage and testa texture) characters indicated their monogenic inheritance pattern. The study would also be useful to chickpea breeders to identify true to type interspecific plants. Further, the F-1, F-2 and F-3 generations of all seven crosses along with parents were evaluated under natural field condition to determine the extent of variability created into the cultivated background of chickpea. There was a wide range of variation in F-3 population against cold stress, suggesting selection of tolerant recombinant lines at an early stage. We also studied fruitful heterosis (%) as a useful approach, instead of residual heterosis to identify better performing transgressive segregants. The values of most of the interspecific crosses for important traits assessed in F-2 and F-3 generations were higher than that of better parent, suggesting isolation of inbred vigour for pod numbers and earliness. The results indicated that wild Cicer annual accessions of C. reticulatum and C. echinospermum species can be exploited after proper screening for traits of interest for diversification of cultivated gene pool and subsequent use in chickpea improvement.	[Singh, Mohar; Malhotra, Nikhil] Natl Bur Plant Genet Resources Reg Stn, Phagli Shimla, India; [Rani, Savita] CSKHP Agr Univ, Dept Plant Biotechnol, Palampur, Himachal Prades, India; [Katna, Gopal] CSKHP Agr Univ, Dept Crop Improvement, Palampur, Himachal Prades, India; [Sarker, Ashutosh] Int Ctr Agr Res Dry Areas, South Asia & China Reg Programme, DPS Marg, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Ch. Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya; Ch. Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya	Singh, M (corresponding author), Natl Bur Plant Genet Resources Reg Stn, Phagli Shimla, India.	singhmohar_2003@yahoo.com	Malhotra, Nikhil/AAG-5968-2021	Malhotra, Nikhil/0000-0001-9517-1029; singh, mohar/0000-0002-5644-9144	Department of Agriculture and Cooperation-Germplasm Evaluation Division-Manuscript Submission Report 10; Department of Agriculture Cooperation and Farmers Welfare, Govt. of India	Department of Agriculture and Cooperation-Germplasm Evaluation Division-Manuscript Submission Report 10; Department of Agriculture Cooperation and Farmers Welfare, Govt. of India	This study was supported by the Department of Agriculture and Cooperation-Germplasm Evaluation Division-Manuscript Submission Report 10.; The authors acknowledge the staff of Biodiversity and Integrated Gene Management (BIGM) Unit at International Centre for Agricultural Research in Dry Areas (ICARDA) Aleppo, Syria for providing the global wild annual Cicer accessions and Department of Agriculture Cooperation and Farmers Welfare, Govt. of India for grant in aid.	Abbo S, 2003, FUNCT PLANT BIOL, V30, P1081, DOI 10.1071/FP03084; Adak A, 2017, PLANT BREEDING, DOI [10.1111/pbr.12464, DOI 10.1111/PBR.12464]; AHMAD F, 1992, THEOR APPL GENET, V83, P620, DOI 10.1007/BF00226907; AHMAD F, 1992, THEOR APPL GENET, V84, P688, DOI 10.1007/BF00224169; Ajay Kumar, 1998, Lens Newsletter, V25, P1; Belling J, 1921, AM NAT, V55, P573, DOI 10.1086/279843; Berger JD, 2007, CHICKPEA BREEDING MA, P193; Croser JS, 2003, AUST J AGR RES, V54, P429, DOI 10.1071/AR02157; Duvick DN, 1984, ECO BOT, V38, P151, DOI DOI 10.1007/BF02858829; Gaur PM, 2007, CHICKPEA BREEDING AND MANAGEMENT, P391, DOI 10.1079/9781845932138.019; Gaur PM, 2008, GRAIN LEGUMES GENETI, P1; GILL KS, 1993, GENETICS, V134, P1231; Kahraman A, 2017, CROP SCI, DOI [10.2135/cropsci2017.06, DOI 10.2135/CROPSCI2017.06]; KAZAN K, 1991, PLANT SYST EVOL, V175, P11, DOI 10.1007/BF00942142; Koseoglu K, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1903-7; Labdi M, 1996, EUPHYTICA, V88, P181, DOI 10.1007/BF00023889; LADIZINSKY G, 1975, ISRAEL J BOT, V24, P183; Lazaro A, 2001, GENET RESOUR CROP EV, V48, P239, DOI 10.1023/A:1011234126154; Luan L, 2009, RUSS J GENET+, V45, P1074, DOI 10.1134/S1022795409090087; MALHORTA RS, 1978, LENS NEWSLET, V5, P7; MARKS GE, 1954, STAIN TECHNOL, V29, P277, DOI 10.3109/10520295409115483; Muehlbauer F.J., 1987, CHICKPEA, P99; Naghavi MR, 2005, J INTEGR PLANT BIOL, V47, P375, DOI 10.1111/j.1744-7909.2005.00058.x; PUNDIR RPS, 1985, EUPHYTICA, V34, P697, DOI 10.1007/BF00035406; Rathore A, 2004, J INDIAN SOC AGR STA, V57, P320; REDDEN RJ, 1974, CROP SCI, V14, P345, DOI 10.2135/cropsci1974.0011183X001400030001x; Salimath PM, 2007, CHICKPEA BREEDING AND MANAGEMENT, P369, DOI 10.1079/9781845932138.018; Sandhu J.S., 2006, 4 INT FOOD LEG RES C, P18; Simon CJ, 1997, J HERED, V88, P115, DOI 10.1093/oxfordjournals.jhered.a023068; SINGH KB, 1989, CROP SCI, V29, P282, DOI 10.2135/cropsci1989.0011183X002900020009x; Singh KB, 1997, THEOR APPL GENET, V95, P418, DOI 10.1007/s001220050578; Singh M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01162; Singh M, 2015, PLANT BREEDING, V134, P186, DOI 10.1111/pbr.12254; Singh M, 2014, CROP SCI, V54, P229, DOI 10.2135/cropsci2013.04.0225; Singh S, 2005, PLANT BREEDING, V124, P477, DOI 10.1111/j.1439-0523.2005.01146.x; Stalker H. T., 1980, Advances in Agronomy, V33, P111, DOI 10.1016/S0065-2113(08)60165-0; Tayyar RI, 1996, THEOR APPL GENET, V92, P245, DOI 10.1007/BF00223381; Thudi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38636; Toker C, 2014, MUTAGENESIS: EXPLORING NOVEL GENES AND PATHWAYS, P215, DOI 10.3920/978-90-8686-787-5_11; Toker C., 2014, LEGUME PERSPECT, V5, P26; Toker C, 2014, ALIEN GENE TRANSFER, P125; TUWAFE S, 1988, J HERED, V79, P170, DOI 10.1093/oxfordjournals.jhered.a110487; van der Maesen LJ, 1972, MONOGRAPH GENUS SPEC, P97; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; VEGA U, 1980, EUPHYTICA, V29, P585, DOI 10.1007/BF00023206	45	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203082	10.1371/journal.pone.0203082	http://dx.doi.org/10.1371/journal.pone.0203082			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192775	Green Submitted, Green Published, gold			2022-12-26	WOS:000444093600046
J	Rassi, C; Gore-Langton, GR; Walimbwa, BG; Strachan, CE; King, R; Basharat, S; Christiansen-Jucht, C; Graham, K; Gudoi, SS				Rassi, Christian; Gore-Langton, Georgia R.; Walimbwa, Badru Gidudu; Strachan, Clare E.; King, Rebecca; Basharat, Sinwan; Christiansen-Jucht, Celine; Graham, Kirstie; Gudoi, Sam Siduda			Improving health worker performance through text messaging: A mixed-methods evaluation of a pilot intervention designed to increase coverage of intermittent preventive treatment of malaria in pregnancy in West Nile, Uganda	PLOS ONE			English	Article							QUALITATIVE RESEARCH; DEVELOPING-COUNTRIES; MHEALTH; CARE; STRATEGIES; ADOPTION	Poor health worker performance is a well-documented obstacle to quality service provision. Due to the increasingly widespread availability of mobile devices, mobile health (mHealth) has received growing attention as a service improvement tool. This pilot study explored feasibility, acceptability and outcomes of an mHealth intervention designed to increase coverage of intermittent preventive treatment of malaria in pregnancy (IPTp) in two districts of West Nile, Uganda. In both districts, selected health workers (N = 48) received classroom training on malaria in pregnancy. All health workers in one district (N = 49) subsequently received 24 text messages reinforcing the training content. The intervention was evaluated using a mixed-methods approach, including four focus group discussions with health workers and three in-depth interviews with district health officials, health worker knowledge assessments one month (N = 90) and six months (N = 89) after the classroom training, and calculation of IPTp coverage from participating health facilities' (N = 16) antenatal care registers covering six months pre- and post-intervention. Complementing classroom training with text messaging was found to be a feasible, acceptable and inexpensive approach to improving health worker performance. The messages served as reminders to those who had attended the classroom training and helped spread information to those who had not. Health workers in the district where text messages were sent had significantly better knowledge of IPTp, achieving an increased composite knowledge score of 6.00 points (maximum score: 40) compared with those in the district where only classroom training was provided. Average facility coverage of three doses of IPTp was also significantly higher where text messages were sent (85.8%) compared with the district where only classroom training was provided (54.1%). This intervention shows promise for the improvement of health worker performance for delivery of IPTp, and could have significant broader application.	[Rassi, Christian; Gore-Langton, Georgia R.; Strachan, Clare E.; Basharat, Sinwan; Christiansen-Jucht, Celine; Graham, Kirstie] Malaria Consortium, London, England; [Walimbwa, Badru Gidudu; Gudoi, Sam Siduda] Malaria Consortium, Kampala, Uganda; [Strachan, Clare E.] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London, England; [Strachan, Clare E.] Cambridge Econ Policy Associates, London, England; [King, Rebecca] Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England	University of London; London School of Hygiene & Tropical Medicine; University of Leeds	Rassi, C (corresponding author), Malaria Consortium, London, England.	c.rassi@malariaconsortium.org	Strachan, Clare/AAG-1585-2020		UK government; Republic of Uganda's Ministry of Health	UK government; Republic of Uganda's Ministry of Health	The study was conducted through COMDIS-HSD (http://comdis-hsd.leeds.ac.uk), a Research Programme Consortium funded by the UK government (https://www.gov.uk/government/organisations/department-for-international-development). It also received Programme Partnership Arrangement funding from the UK Government. However, the views expressed in this article do not necessarily reflect the UK government's official policies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge support received from the Republic of Uganda's Ministry of Health, in particular Dr Jimmy Opigo (National Malaria Control Programme, Program Manager) and Dr Jane Nabakooza (National Malaria Control Programme, Malaria in Pregnancy Focal Person), as well as the members of the study steering committee. We would also like to acknowledge the work of Patrobas Mufubenga, who led the extraction of IPTp data from health facilities' ANC registers, Teddy Etoru, who supported qualitative data collection activities, and Monica Anna De Cola, who performed additional data analysis recommended by the journal's reviewers. We are grateful for the kind support from our colleagues at Malaria Consortium and the COMDIS-HSD Research Programme Consortium, as well as all study participants.	Agarwal S, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1174; Agarwal S, 2015, TROP MED INT HEALTH, V20, P1003, DOI 10.1111/tmi.12525; [Anonymous], 2016, NAT POP HOUS CENS 20; [Anonymous], 2014, WHO POL BRIEF IMPL I; [Anonymous], 2007, MAL PREGN GUID MEAS; [Anonymous], 2004, STRATEGIC FRAMEWORK; Betjeman TJ, 2013, INT J TELEMED APPL, V2013, DOI 10.1155/2013/482324; Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065772; Bull S, 2015, HEALTH EDUC BEHAV, V43, P399; Chen YL, 2014, B WORLD HEALTH ORGAN, V92, P474, DOI 10.2471/BLT.13.127076; Chib A, 2015, J HEALTH COMMUN, V20, P4, DOI 10.1080/10810730.2013.864735; Chopra M, 2008, LANCET, V371, P668, DOI 10.1016/S0140-6736(08)60305-0; Clark VLP, 2010, QUAL INQ, V16, P428, DOI 10.1177/1077800410364609; Creswell J.W., 2007, RES DESIGN QUALITATI; Danish Health Authority, 2019, KRAEFTPL 3; Dieleman M., 2006, IMPROVING HLTH WORKE; Dieleman Marjolein, 2009, Health Res Policy Syst, V7, P7, DOI 10.1186/1478-4505-7-7; Flodgren G, 2013, COCHRANE DB SYST REV, P108; Folaranmi T, 2014, PERSPECT PUBLIC HEAL, V134, P14, DOI 10.1177/1757913913514703; Georgetown University National Center for Education in Maternal and Child Health, 2014, TRANSITION ADULTHOOD; Gurman TA, 2012, J HEALTH COMMUN, V17, P82, DOI 10.1080/10810730.2011.649160; Hall AK, 2015, ANNU REV PUBL HEALTH, V36, P393, DOI 10.1146/annurev-publhealth-031914-122855; Hall CS, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25606; Hampshire K, 2017, HEALTH POLICY PLANN, V32, P34, DOI 10.1093/heapol/czw095; Hodgins S, 2014, GLOB HEALTH-SCI PRAC, V2, P173, DOI 10.9745/GHSP-D-13-00176; Johnson MJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008592; Jones CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045995; Kallander K, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2130; Labrique AB, 2013, GLOB HEALTH-SCI PRAC, V1, P160, DOI 10.9745/GHSP-D-13-00031; Lancaster Gillian A, 2015, Pilot Feasibility Stud, V1, P1, DOI 10.1186/2055-5784-1-1; Maternal and Child Survival Program U. S. President's Malaria Intitiative, 2018, 2016 WHO ANT CAR GUI; Medves J, 2010, INT J EVID-BASED HEA, V8, P79, DOI 10.1111/j.1744-1609.2010.00166.x; Mitchell KJ, 2011, HEALTH EDUC RES, V26, P770, DOI 10.1093/her/cyr022; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; Pew Research Center, 2015, CELL PHON AFR COMM L; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rassi C, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1589-7; Rassi C, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1405-4; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Strachan CE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1526-9; Tomlinson M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001382; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Uganda Bureau of Statistics, 2011, UG DEM HLTH SURV 201; Uganda Bureau of Statistics ICF International, 2015, UG MAL IND SURV MIS; Ugandan Communications Commission, 2015, POST BROADC TEL ANN, VI; White A, 2016, CIN-COMPUT INFORM NU, V34, P206, DOI [10.1097/CIN.0000000000000231, 10.1097/01.NCN.0000484013.73650.48]; WHO, 2011, ASS HLTH FAC DAT QUA; WHO, 2006, WORK TOG HLTH WORLD; World Health Organization, 2016, WHO RECOMMENDATIONS; World Health Organization, 2011, MHEALTH NEW HORIZONS, V3; Zurovac D, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-20; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	52	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203554	10.1371/journal.pone.0203554	http://dx.doi.org/10.1371/journal.pone.0203554			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT1KN	30188956	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000444228700043
J	Bertero, L; Anfossi, V; Osella-Abate, S; Disanto, MG; Mantovani, C; Zenga, F; Ruda, R; Garbossa, D; Soffietti, R; Ricardi, U; Papotti, M; Cassoni, P				Bertero, Luca; Anfossi, Vittorio; Osella-Abate, Simona; Disanto, Maria Giulia; Mantovani, Cristina; Zenga, Francesco; Ruda, Roberta; Garbossa, Diego; Soffietti, Riccardo; Ricardi, Umberto; Papotti, Mauro; Cassoni, Paola			Pathological prognostic markers in central nervous system solitary fibrous tumour/hemangiopericytoma: Evidence from a small series	PLOS ONE			English	Article							TERT PROMOTER MUTATIONS; INTRACRANIAL HEMANGIOPERICYTOMA; PHOSPHOHISTONE H3; TUMOR; CD34; MENINGIOMA; DISTINCT; FUSION	Background Primary central nervous system (CNS) solitary fibrous tumour/ hemangiopericytoma (SFT/HPC) is a rare neoplasm and its classification criteria have been redefined by the latest WHO Classification of CNS Tumours. Outcome can vary significantly among patients, thus reliable prognostic markers are warranted. Methods Primary CNS SFT/HPC diagnosed at the Pathology Unit of our Institution between 2006 and 2016 were retrospectively collected. Tumour grade along with immunohistochemistry for Ki67, STAT6, PHH3, CD34 and Bcl-2 were assessed. TERT promoter status was evaluated by Sanger sequencing. Results Fifteen SFT/HPC were analysed: 9/15 (60%) female, median age at diagnosis 60 (range: 10-67). Six (40%) cases showed a SFT phenotype and mean H&E-mitotic count was 4.8/10 HPF. Tumour grade was I in 6, II in 4 and III in 5 cases. Mean PHH3-mitotic count was higher than H&E count (8.4 versus 4.8/10 HPF), but it would have determined a change in tumour grade in a sole case. Nuclear staining for STAT6 was present in 14/15 (93.3%). CD34 and Bcl-2 expression rates were lower in higher grade tumours. TERT promoter was mutated in two cases. Median follow up time was 2.4 years (6 months-7.4 years) and 5/15 (33%) patients developed local disease recurrence. Partial resection (p = 0.0185), higher WHO grade (p = 0.038), lower CD34 (p = 0.038) and Bcl-2 (p = 0.010) expressions were significantly associated with a poorer disease-free interval. Conclusions WHO grade is the main prognostic tool in CNS SFT/HPC, but it could be integrated by other markers, like CD34 and Bcl-2, in the clinical practice. The relevance of TERT promoter mutations in this subset of CNS tumours needs further evaluation.	[Bertero, Luca; Anfossi, Vittorio; Osella-Abate, Simona; Disanto, Maria Giulia; Cassoni, Paola] Univ Turin, Dept Med Sci, Pathol Unit, Turin, Italy; [Mantovani, Cristina; Ricardi, Umberto] Univ Turin, Dept Oncol, Radiat Oncol Unit, Turin, Italy; [Zenga, Francesco; Garbossa, Diego] Univ Turin, Dept Neurosci, Neurosurg Unit, Turin, Italy; [Ruda, Roberta; Soffietti, Riccardo] Univ Turin, Dept Neurosci, Neurooncol Unit, Turin, Italy; [Papotti, Mauro] Univ Turin, Dept Oncol, Pathol Unit, Turin, Italy	University of Turin; University of Turin; University of Turin; University of Turin; University of Turin	Bertero, L (corresponding author), Univ Turin, Dept Med Sci, Pathol Unit, Turin, Italy.	luca.bertero@unito.it	Bertero, Luca/N-5357-2017; Zenga, Francesco/ABB-8184-2020; Abate, Simona Osella/I-8505-2018; Soffietti, Riccardo/AAA-7965-2022; Garbossa, Diego/AAC-8888-2019	Bertero, Luca/0000-0001-9887-7668; Zenga, Francesco/0000-0001-5440-3276; Abate, Simona Osella/0000-0002-9886-7694; Soffietti, Riccardo/0000-0002-9204-7038; RUDA', Roberta/0000-0001-9134-1537				Bahrami A, 2016, MODERN PATHOL, V29, P1511, DOI 10.1038/modpathol.2016.126; Bisceglia M, 2011, INT J SURG PATHOL, V19, P476, DOI 10.1177/1066896911405655; Bisceglia M, 2011, ADV ANAT PATHOL, V18, P356, DOI 10.1097/PAP.0b013e318229c004; Carneiro SS, 1996, AM J CLIN PATHOL, V106, P217, DOI 10.1093/ajcp/106.2.217; Chmielecki J, 2013, NAT GENET, V45, P131, DOI 10.1038/ng.2522; Cui XY, 2015, APPL IMMUNOHISTO M M, V23, P689, DOI 10.1097/PAI.0000000000000137; Cummings TJ, 2001, ACTA NEUROPATHOL, V102, P349; Damodaran O, 2014, J CLIN NEUROSCI, V21, P1310, DOI 10.1016/j.jocn.2013.11.026; Demicco EG, 2012, MODERN PATHOL, V25, P1298, DOI 10.1038/modpathol.2012.83; Duregon E, 2015, NEURO-ONCOLOGY, V17, P663, DOI 10.1093/neuonc/nov002; Fritchie KJ, 2016, J NEUROPATH EXP NEUR, V75, P263, DOI 10.1093/jnen/nlv026; Ghia AJ, 2013, NEUROSURGERY, V73, P624, DOI 10.1227/NEU.0000000000000064; Ghia AJ, 2013, NEUROSURGERY, V72, P203, DOI 10.1227/NEU.0b013e31827b9e68; Ghose A, 2017, AM J CLIN ONCOL-CANC, V40, P223, DOI 10.1097/COC.0000000000000146; Han YA, 2015, INT J CLIN EXP PATHO, V8, P13166; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Vuong HG, 2017, CRIT REV ONCOL HEMAT, V120, P1, DOI 10.1016/j.critrevonc.2017.09.013; Jiang N, 2017, WORLD NEUROSURG, V99, P584, DOI 10.1016/j.wneu.2016.12.057; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Koelsche C, 2013, ACTA NEUROPATHOL, V126, P907, DOI 10.1007/s00401-013-1195-5; Liu RY, 2016, ENDOCR-RELAT CANCER, V23, pR143, DOI 10.1530/ERC-15-0533; Louis, 2016, WHO CLASSIFICATION G; Mariani S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121815; MENA H, 1991, HUM PATHOL, V22, P84, DOI 10.1016/0046-8177(91)90067-Y; Mendenhall WM, 2004, SKULL BASE-INTERD AP, V14, P53, DOI 10.1055/s-2004-821364; Mendenhall WM, 2004, SKULL BASE, V14, P1; Mosquera JM, 2009, AM J SURG PATHOL, V33, P1314, DOI 10.1097/PAS.0b013e3181a6cd33; Nagore E, 2016, INT J CANCER, V139, P75, DOI 10.1002/ijc.30042; Robinson DR, 2013, NAT GENET, V45, P180, DOI 10.1038/ng.2509; Schweizer L, 2013, ACTA NEUROPATHOL, V125, P651, DOI 10.1007/s00401-013-1117-6; Walsh KM, 2015, NEURO-ONCOLOGY, V17, P1445, DOI 10.1093/neuonc/nov082; Yalcin CE, 2016, ADV ANAT PATHOL, V23, P104, DOI 10.1097/PAP.0000000000000103; Yokoi T, 1998, HISTOPATHOLOGY, V32, P423; Zeng LC, 2017, J NEURO-ONCOL, V131, P153, DOI 10.1007/s11060-016-2282-y	34	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203570	10.1371/journal.pone.0203570	http://dx.doi.org/10.1371/journal.pone.0203570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183767	Green Published, gold, Green Submitted			2022-12-26	WOS:000443789900074
J	Mehta, AS; Lau, DTY; Wang, MJ; Islam, A; Nasir, B; Javaid, A; Poongkunran, M; Block, TM				Mehta, Anand S.; Lau, Daryl T. -Y.; Wang, Mengjun; Islam, Aysha; Nasir, Bilal; Javaid, Asad; Poongkunran, Mugilan; Block, Timothy M.			Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma	PLOS ONE			English	Article							ALPHA-FETOPROTEIN LEVELS; SURVEILLANCE	Background We previously developed a logistic regression algorithm that uses AFP, age, gender, ALK and ALT levels to improve the detection of hepatocellular carcinoma (HCC). In 3,158 patients from 5 independent sites, this algorithm, referred to as the "Doylestown" algorithm, increased the AUROC of AFP 4% to 12% and had equal benefit regardless of tumor size or the etiology of liver disease. Aims Analysis of the Doylestown algorithm using samples from individuals taken before their diagnosis of HCC. Methods Here, the algorithm was tested using samples at multiple time points from (a) patients with established chronic liver disease, without HCC (120 patients) and (b) 116 patients with HCC diagnosis (85 patients with early stage HCC and 31 patients with recurrent HCC), taken at the time of, and up to 12 months prior to cancer diagnosis. Results Among patients who developed HCC, comparing the Doylestown algorithm at a fixed cut-off to AFP at 20 ng/mL, the Doylestown algorithm increased the True Positive Rate (TPR) in identification of HCC from 36 to 50%, at a time point of 12 months prior to the conventional HCC detection. Similar results were obtained in those patients with recurrent HCC, where the Doylestown algorithm increased TPR in detection of HCC from 18% to 59%, at 12 months prior to detection of recurrence. Conclusions This algorithm significantly improves the prediction of HCC by AFP alone and may have value in the early detection of HCC.	[Mehta, Anand S.; Wang, Mengjun] Med Univ South Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC USA; [Lau, Daryl T. -Y.; Islam, Aysha; Nasir, Bilal; Javaid, Asad; Poongkunran, Mugilan] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Liver Res Ctr, Boston, MA USA; [Block, Timothy M.] Baruch Blumberg Inst, Doylestown, PA 18902 USA; [Block, Timothy M.] Hepatitis B Fdn, Doylestown, PA 18902 USA	Medical University of South Carolina; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Block, TM (corresponding author), Baruch Blumberg Inst, Doylestown, PA 18902 USA.; Block, TM (corresponding author), Hepatitis B Fdn, Doylestown, PA 18902 USA.	tim.block@bblumberg.org	lau, daryl/AAH-5057-2020		Hepatitis B Foundation [R01 CA120206, U01 CA168856]; NATIONAL CANCER INSTITUTE [R01CA120206, U01CA168856] Funding Source: NIH RePORTER	Hepatitis B Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01 CA120206 (ASM), U01 CA168856 (ASM) the Hepatitis B Foundation, and an appropriation from The Commonwealth of Pennsylvania.	Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cheema AW, 2004, HEPATO-GASTROENTEROL, V51, P1676; CHEN DS, 1984, GASTROENTEROLOGY, V86, P1404; Cohen J.E., 1988, STAT POWER ANAL BEHA; DIBISCEGLIE AM, 1989, CANCER, V64, P2117, DOI 10.1002/1097-0142(19891115)64:10<2117::AID-CNCR2820641024>3.0.CO;2-7; Ferlay J, 2013, CANC INCIDENCE MORTA, DOI DOI 10.1002/IJC.29210; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Gopal P, 2014, CLIN GASTROENTEROL H, V12, P870, DOI 10.1016/j.cgh.2013.09.053; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Marrero JA, 2005, J HEPATOL, V43, P1007, DOI 10.1016/j.jhep.2005.05.028; Marrero JA, 2011, HEPATOLOGY, V53, P1060, DOI 10.1002/hep.24033; Martin P, 2015, CLIN GASTROENTEROL H, V13, P2071, DOI 10.1016/j.cgh.2015.07.007; Singal AG, 2013, AM J GASTROENTEROL, V108, P425, DOI 10.1038/ajg.2012.449; Singal AG, 2012, CANCER EPIDEM BIOMAR, V21, P793, DOI 10.1158/1055-9965.EPI-11-1005; Wang M, 2015, CANC PREV RES PHILA	15	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203149	10.1371/journal.pone.0203149	http://dx.doi.org/10.1371/journal.pone.0203149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169533	Green Submitted, gold, Green Published			2022-12-26	WOS:000443374400022
J	Lopes, JSS; Micheletti, JK; Machado, AF; Souto, LR; de Lima, HP; Vanderlei, FM; Netto, J; Pastre, CM				Silva Lopes, Jaqueline Santos; Micheletti, Jessica Kirsch; Machado, Aryane Flauzino; Souto, Larissa Rodrigues; de Lima, Heloisa Paes; Vanderlei, Franciele Marques; Netto Junior, Jayme; Pastre, Carlos Marcelo			Test-retest reliability of knee extensors endurance test with elastic resistance	PLOS ONE			English	Article							STATISTICAL-METHODS; SPORTS-MEDICINE; STRENGTH; TRIAL; METAANALYSIS; PERFORMANCE; VALIDITY; BANDS; POWER	Background Reliable clinical tests capable of measuring resistance are important tools for rehabilitation. One alternative that has recently increased in popularity is the use of elastic tubes, which stand out for being easy to handle, low cost, practical, and feasible. Objective Analyze the test-retest reliability of the knee extensors muscle fatigue resistance test (FRT) with elastic tubes. Methods A total of 116 healthy young males, aged between 18 and 30 years old, participated in the study. Participants performed three pre-test stages: orientation, load presentation, and familiarization with equipment, lasting two weeks. Subsequently, they performed the FRT on two occasions (test and retest), with an interval of seven days. The reliability analyzes were performed using the intraclass correlation coefficient (ICC) with 95% confidence interval and typical measurement error (TME), also expressed as coefficient of variation (CV%). Results The findings regarding the reliability of the test demonstrated satisfactory values (time: ICC = 0.66; 95%CI [0.50; 0.76]; CV(%) = 9.34; repetition: ICC = 0.61; 95% CI[0.46; 0.73], CV(%) = 13.66; rhythm: ICC = 0.52; 95%CI[0.35; 0.67], CV(%) = 10.29. Conclusion From the findings presented, it is concluded that the proposed clinical test with elastic tubes demonstrates evidence of acceptable values.	[Silva Lopes, Jaqueline Santos; Micheletti, Jessica Kirsch; Machado, Aryane Flauzino; Souto, Larissa Rodrigues; de Lima, Heloisa Paes; Vanderlei, Franciele Marques; Netto Junior, Jayme; Pastre, Carlos Marcelo] Sao Paulo State Univ Unesp, Sch Technol & Sci, Dept Phys Therapy, Presidente Prudente, SP, Brazil	Universidade Estadual Paulista	Lopes, JSS (corresponding author), Sao Paulo State Univ Unesp, Sch Technol & Sci, Dept Phys Therapy, Presidente Prudente, SP, Brazil.	jaqueee-santosss@hotmail.com	Souto, Larissa/AAP-3646-2021; Pastre, Carlos M/K-2415-2012; Silva, Jaqueline/J-3066-2018; Micheletti, Jéssica Kirsch/C-5871-2017; Machado, Aryane F/F-3298-2016; Vanderlei, Franciele/GQA-4595-2022; Vanderlei, Franciele M/G-7464-2014	Pastre, Carlos M/0000-0002-0213-6679; Silva, Jaqueline/0000-0003-3883-883X; Micheletti, Jéssica Kirsch/0000-0003-1545-3638; Machado, Aryane F/0000-0003-0419-0473; Vanderlei, Franciele/0000-0001-5792-6072; Rodrigues Souto, Larissa/0000-0003-0968-4835; Paes de Lima, Heloisa/0000-0002-1460-0141	Coordination for the Improvement of Higher Education Personnel (CAPES)	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	During the development of the research the main author received financial assistance, in the form of a grant from the Coordination for the Improvement of Higher Education Personnel (CAPES). The money received helped research expenses, which included logistics and purchase of necessary materials, such as elastic tubes. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboodarda SJ, 2016, CLIN BIOMECH, V39, P52, DOI 10.1016/j.clinbiomech.2016.09.008; Almeida AC, 2016, J SCI MED SPORT, V19, P676, DOI 10.1016/j.jsams.2015.10.003; Andersen LL, 2017, SCAND J MED SCI SPOR, V27, P887, DOI 10.1111/sms.12695; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Augustsson J, 2016, INT J SPORTS PHYS TH, V11, P520; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Buchheit M, 2009, AM J PHYSIOL-HEART C, V296, pH421, DOI 10.1152/ajpheart.01017.2008; Ramos EMC, 2014, CLIN REHABIL, V28, P1096, DOI 10.1177/0269215514527842; Colado JC, 2012, J STRENGTH COND RES, V26, P3018, DOI 10.1519/JSC.0b013e318245c0c9; Colado JC, 2008, J STRENGTH COND RES, V22, P1441, DOI 10.1519/JSC.0b013e31817ae67a; Currell K, 2008, SPORTS MED, V38, P297, DOI 10.2165/00007256-200838040-00003; Ferri-Morales A, 2014, ISOKINET EXERC SCI, V22, P17, DOI 10.3233/IES-130522; Ghigiarelli JJ, 2009, J STRENGTH COND RES, V23, P756, DOI 10.1519/JSC.0b013e3181a2b8a2; Guex K, 2015, J SPORT REHABIL, V24, P151, DOI 10.1123/jsr.2013-0131; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, 2001, SPORTS MED, V31, P211, DOI 10.2165/00007256-200131030-00005; Jakobsen MD, 2014, AM J PHYS MED REHAB, V93, P320, DOI 10.1097/PHM.0000000000000043; Jensen J, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2012-091095; Jeukendrup AE, 2005, MED SCI SPORT EXER, V37, P1820, DOI 10.1249/01.mss.0000175095.56646.4b; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Laursen PB, 2007, MED SCI SPORT EXER, V39, P1374, DOI 10.1249/mss.0b013e31806010f5; Lubans DR, 2011, J SPORT SCI, V29, P685, DOI 10.1080/02640414.2010.551215; Machado AF, 2017, SCAND J MED SCI SPOR, V27, P1356, DOI 10.1111/sms.12734; Manor Brad, 2006, J Geriatr Phys Ther, V29, P18; Martins WR, 2013, ARCH GERONTOL GERIAT, V57, P8, DOI 10.1016/j.archger.2013.03.002; Metgud S, 2015, INT J PHYSIOTHER RES, V3, P1091, DOI [10.16965/ijpr.2015.118, DOI 10.16965/IJPR.2015.118]; Newsam CJ, 2005, J SPORT REHABIL, V14, P35, DOI 10.1123/jsr.14.1.35; Nyberg A., 2016, J NOV PHYS REHABIL, DOI [10.17352/2455-5487.000030, DOI 10.17352/2455-5487.000030]; Pageaux B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163979; Pappas E, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-093796; Sundstrup E, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-67; Wells GD, 2009, PAEDIATR RESPIR REV, V10, P83, DOI 10.1016/j.prrv.2009.04.005	32	8	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203259	10.1371/journal.pone.0203259	http://dx.doi.org/10.1371/journal.pone.0203259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169527	Green Published, gold, Green Submitted			2022-12-26	WOS:000443374400029
J	Daly, SC; MacNeela, P; Sarma, KM				Daly, Siobhan C.; MacNeela, Padraig; Sarma, Kiran M.			The female spouse: A process of separation when a husband 'comes out' as gay	PLOS ONE			English	Article							MENTAL DISTRESS; THERAPY; CONSEQUENCES; SUPPORT; ISSUES; GENDER	This study investigated the stories of heterosexual women who experienced a husband coming out as gay and a consequential marital separation. Interpretative phenomenological analysis (IPA) was used. Loss, anger, spousal empathy and concerns regarding societal prejudice were reported. Additional stress was experienced when others minimised the experience due to the gay sexual orientation of their husband. Experiencing positive communication with their husband during and after the disclosure aided the resolution of the emotional injury experienced by them. They all eventually let go' of their husband. This involved a process of reconceptualising the self as separated. Findings indicate the importance of supporting women to re-focus on their needs during and following marital dissolution. The importance of non-judgemental support for marital loss, rather than a focus on the gay sexual orientation of the spouse, was highlighted.	[Daly, Siobhan C.; MacNeela, Padraig; Sarma, Kiran M.] Natl Univ Ireland Galway, Sch Psychol, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	Daly, SC (corresponding author), Natl Univ Ireland Galway, Sch Psychol, Galway, Ireland.	siobhancdaly@gmail.com						Alase A, 2017, IJELS, V5, P1; Atwood JD, 1997, AM J FAM THER, V25, P55, DOI 10.1080/01926189708251055; Beals KP, 2009, PERS SOC PSYCHOL B, V35, P867, DOI 10.1177/0146167209334783; Bracke PF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-224; Brocki JM, 2006, PSYCHOL HEALTH, V21, P87, DOI 10.1080/14768320500230185; Buchanan M, 2010, AM J FAM THER, V29, P435; Buxton A. P., 2001, J BISEXUALITY, V2, P155, DOI [10.1300/J159v01n02_06, DOI 10.1300/J159v01n02_06, 10.1300/J159v01n0206]; Buxton AP, 2006, J GLBT FAM STUD, V2, P49, DOI 10.1300/J461v02n03_04; Buxton AP, 2006, SEX ADDICT COMPULS, V13, P317, DOI 10.1080/10720160600897599; Canham S.L., 2014, J DIVORCE REMARRIAGE, V55, P591, DOI [10.1080/10502556.2014.959097, DOI 10.1080/10502556.2014.959097]; Corley MD, 2006, SEX ADDICT COMPULS, V13, P167, DOI 10.1080/10720160600870737; Creswell J, 1998, QUAL INQ; Daly SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145491; Demo DH, 1996, J FAM ISSUES, V17, P388, DOI 10.1177/019251396017003005; Diamond L.M., 2006, SEXUAL ORIENTATION M, P73, DOI [10.1037/11261-004, DOI 10.1037/11261-004]; Gander AM, 1991, J WOMEN AGING, V3, P37; Greenberg L, 2010, J MARITAL FAM THER, V36, P28, DOI 10.1111/j.1752-0606.2009.00185.x; Greenberg LS, 2008, J COUNS PSYCHOL, V55, P185, DOI 10.1037/0022-0167.55.2.185; Grever C, 2012, J GLBT FAM STUD, V8, P67, DOI 10.1080/1550428X.2012.641372; Haldeman DC, 2004, COUNS PSYCHOL, V32, P691, DOI 10.1177/0011000004267560; HAYS D, 1989, J HOMOSEXUAL, V18, P81, DOI 10.1300/J082v18n01_04; Hecker LL, 2015, AUST NZ J FAM THER, V36, P467, DOI 10.1002/anzf.1121; Hennon CB, 1996, VISION 2010 FAMILIES, P23; Herek GM, 2015, AM J ORTHOPSYCHIAT, V85, pS29, DOI 10.1037/ort0000092; Hernandez BC, 2011, J MARITAL FAM THER, V37, P307, DOI 10.1111/j.1752-0606.2010.00202.x; HETHERINGTON EM, 1994, STEPFAMILIES, P55; Idstad M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1662-0; Janoff-Bulman R., 1992, SHATTERED ASSUMPTION; Jirek SL, 2017, QUAL SOC WORK, V16, P166, DOI 10.1177/1473325016656046; Karen R, 2001, FORGIVING SELF ROAD; Koopmans GT, 2007, SOC SCI MED, V64, P1216, DOI 10.1016/j.socscimed.2006.11.018; Lambert MJ, 2001, PSYCHOTHERAPY, V38, P357, DOI 10.1037/0033-3204.38.4.357; Lehmiller JJ, 2009, PERS SOC PSYCHOL B, V35, P1452, DOI 10.1177/0146167209342594; Lewis R, 1992, HOMOSEXUALITY PSYCHO, P174; Mark N, 2008, J GAY LESBIAN MENT H, V12, P179, DOI 10.1080/19359700802111189; Marks NF, 1996, J MARRIAGE FAM, V58, P917, DOI 10.2307/353980; Mason B., 1993, HUMAN SYSTEMS J SYST, V4, P189; McCarthy B, 2013, J SEX MARITAL THER, V39, P493, DOI 10.1080/0092623X.2012.665820; McCullough ME, 1998, J PERS SOC PSYCHOL, V75, P1586, DOI 10.1037/0022-3514.75.6.1586; Pietkiewicz IJ, 2016, ARCH SEX BEHAV, V45, P1573, DOI 10.1007/s10508-016-0752-0; Radina M. E., 2008, J DIVORCE REMARRIAGE, V49, P142; Rahav G, 2002, J DIVORCE REMARRIAGE, V37, P41; Reygan F, 2014, CULT RELIG-ABINGDON, V15, P298, DOI 10.1080/14755610.2014.942329; Simon RW, 1999, J HEALTH SOC BEHAV, V40, P111, DOI 10.2307/2676367; Slepian ML, 2012, J EXP PSYCHOL GEN, V141, P619, DOI 10.1037/a0027598; Smith J. A., 2008, DOING SOCIAL PSYCHOL, P229, DOI [10.1002/9780470776278.ch10, DOI 10.1002/9780470776278.CH10, DOI 10.4135/9781848607927.N11]; Smith JA, 2009, QUAL RES PSYCHOL; Smith JA, 2011, HEALTH PSYCHOL REV, V5, P9, DOI 10.1080/17437199.2010.510659; Stack S, 2015, J FAM ISSUES, V36, P695, DOI 10.1177/0192513X13494824; Stryker S, 2000, SOC PSYCHOL QUART, V63, P284, DOI 10.2307/2695840; Tovey Hilary, 2003, SOCIOLOGY IRELAND; Vaillant GE, 2000, AM PSYCHOL, V55, P89, DOI 10.1037/0003-066X.55.1.89; Van Langenhove L., 1995, RETHINKING PSYCHOL, P56; Van Zyl J, 2017, J PSYCHOL AFR, V27, P191, DOI 10.1080/14330237.2017.1303126; Vaughan, 2003, MONOGAMY MYTH PERSON; Waite LJ., 2001, CASE MARRIAGE WHY MA; White M., 2004, HDB NARRATIVE PSYCHO, P15; Wilkinson RT, 2012, FAM J, V20, P140, DOI 10.1177/1066480712442051; Zisook S, 1997, J AFFECT DISORDERS, V45, P85, DOI 10.1016/S0165-0327(97)00062-1	59	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203472	10.1371/journal.pone.0203472	http://dx.doi.org/10.1371/journal.pone.0203472			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161234	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900129
J	Gichane, MW; Moracco, KE; Thirumurthy, H; Okitolonda, EW; Behets, F; Yotebieng, M				Gichane, Margaret W.; Moracco, Kathryn E.; Thirumurthy, Harsha; Okitolonda, Emile W.; Behets, Frieda; Yotebieng, Marcel			Intimate partner violence and prevention of mother to child transmission of HIV: Evidence from Kinshasa, Democratic Republic of Congo	PLOS ONE			English	Article							CONDITIONAL CASH TRANSFERS; DOMESTIC VIOLENCE; PREGNANCY; CARE; NONADHERENCE; PREVALENCE; RETENTION; ADHERENCE; BARRIERS; HEALTH	Intimate partner violence (IPV) is a risk factor for non-adherence to HIV treatment for women, however the evidence on the impact of IPV on uptake of the prevention of mother to child transmission of HIV (PMTCT) cascade is inconclusive. We examined data from 433 HIV positive pregnant women in Kinshasa, Democratic Republic of Congo, enrolled between April 2013 and August 2014 and followed-up through 6 weeks postpartum. Participants were asked about their IPV experiences in a face-to-face interview at enrollment. Measures of PMTCT cascade included: uptake of clinical appointments and services, viral suppression, and adherence to antiretrovirals (ARV). Approximately half of the sample (51%) had experienced some form of IPV; 35% had experienced emotional abuse, 29% physical abuse, and 19% sexual abuse. There were no statistically significant associations between experiencing any form of IPV and uptake of clinical appointments and services (Adjusted Prevalence Ratio [aPR] = 1.02; 95% [CI]: 0.89-1.17), viral load suppression (aPR = 1.07, 95% CI:0.96-1.19) and ARV adherence (aPR = 1.01, 95% CI: 0.87-1.18). Findings from this study indicate that, among HIV-infected pregnant women enrolled in PMTCT care, experiencing IPV does not reduce adherence to clinic visits and services, adherence to ARV. The high prevalence of IPV in this population suggests that IPV screening and intervention should be included as part of standard care for PMTCT.	[Gichane, Margaret W.; Moracco, Kathryn E.] Univ N Carolina, Dept Hlth Behav, Chapel Hill, NC 27515 USA; [Thirumurthy, Harsha] Univ Penn, Pearlman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Okitolonda, Emile W.] Univ Kinshasa, Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Behets, Frieda] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Behets, Frieda; Yotebieng, Marcel] Univ N Carolina, Dept Social Med, Chapel Hill, NC 27515 USA; [Yotebieng, Marcel] Ohio State Univ, Div Epidemiol, Coll Publ Hlth, Columbus, OH USA	University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Universite de Kinshasa; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University	Gichane, MW (corresponding author), Univ N Carolina, Dept Hlth Behav, Chapel Hill, NC 27515 USA.	warugich@live.unc.edu	Yotebieng, Marcel/L-2083-2013	Yotebieng, Marcel/0000-0003-2110-2631; Thirumurthy, Harsha/0000-0002-3308-7603; Gichane, Margaret/0000-0001-8499-154X	President's Emergency Plan for AIDS Relief (PEPFAR); National Institute of Health and Child Development [NIHCD 1R01HD075171]; National Institute of Health [1U01AI096299-01, 1R01 HD087993]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Health and Child Development; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by a grant from the President's Emergency Plan for AIDS Relief (PEPFAR) and the National Institute of Health and Child Development: NIHCD 1R01HD075171. MY is partially supported by the National Institute of Health (1U01AI096299-01 and 1R01 HD087993). The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, writing of the report, or the decision to submit the paper for publication.	Alhusen JL, 2015, J WOMENS HEALTH, V24, P100, DOI 10.1089/jwh.2014.4872; Bernstein M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011999; Centers for Disease Control and Prevention, YOUTH RISK BEH SURV; Coker AL, 2002, J WOMEN HEALTH GEN-B, V11, P465, DOI 10.1089/15246090260137644; Ezeanochie MC, 2011, ACTA OBSTET GYN SCAN, V90, P535, DOI 10.1111/j.1600-0412.2011.01083.x; Garcia-Moreno C, 2013, PREVALENCE HLTH EFFE; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gonzalez JS, 2011, JAIDS-J ACQ IMM DEF, V58, P181, DOI [10.1097/QAI.0B013E31822D490A, 10.1097/QAI.0b013e31822d490a]; Goo L, 2012, MATERN CHILD HLTH J, V16, P1131, DOI 10.1007/s10995-011-0838-1; Hampanda KM, 2016, SOC SCI MED, V153, P123, DOI 10.1016/j.socscimed.2016.02.011; Hatcher AM, 2016, SOC SCI MED, V168, P130, DOI 10.1016/j.socscimed.2016.09.013; Hatcher AM, 2015, AIDS, V29, P2183, DOI 10.1097/QAD.0000000000000842; Hatcher AM, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19233; Israel B. A., 1987, ADV HLTH ED PROMOTIO, V2, P1; Karamagi CAS, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-284; Kiarie JN, 2006, AIDS, V20, P1763, DOI 10.1097/01.aids.0000242823.51754.0c; Kohler PK, 2014, AIDS PATIENT CARE ST, V28, P643, DOI 10.1089/apc.2014.0171; Kosia A, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.32307; Lichtenstein B, 2006, AIDS PATIENT CARE ST, V20, P122, DOI 10.1089/apc.2006.20.122; Ludermir AB, 2010, LANCET, V376, P903, DOI 10.1016/S0140-6736(10)60887-2; MCFARLANE J, 1992, JAMA-J AM MED ASSOC, V267, P3176, DOI 10.1001/jama.267.23.3176; Mepham S, 2011, AIDS CARE, V23, P741, DOI 10.1080/09540121.2010.516341; Ministere du Plan et Suivi de la Mise en enure de la Revolution de la Modernite (MPSMRM) MdlS International PMaI, 2014, DEM REP CONG DEM HLH; Mohammed BH, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2121-7; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Rahman M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-913; Ramirez-Avila L, 2012, AIDS BEHAV, V16, P2226, DOI 10.1007/s10461-012-0160-y; Rodriguez VJ, 2018, AIDS CARE, V30, P1380, DOI 10.1080/09540121.2018.1458974; Rurangirwa AA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013155; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Tlapek SM, 2015, J INTERPERS VIOLENCE, V30, P2526, DOI 10.1177/0886260514553118; UNAIDS, 2016, FAST TRACK AIDS FREE; UNAIDS, DEM REP CONG 2015 CO; UNAIDS, 2011, COUNTD ZER GLOB PLAN; WHO, 2016, CONS GUID DIAGN TREA; Yotebieng M, 2016, JAIDS-J ACQ IMM DEF, V72, pS124, DOI 10.1097/QAI.0000000000001062; Yotebieng M, 2016, LANCET HIV, V3, pE85, DOI 10.1016/S2352-3018(15)00247-7	37	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203471	10.1371/journal.pone.0203471	http://dx.doi.org/10.1371/journal.pone.0203471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161260	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900128
J	Kumar, S; Gupte, HA; Isaakidis, P; Mishra, JK; Munjattu, JF				Kumar, Samresh; Gupte, Himanshu A.; Isaakidis, Petros; Mishra, J. K.; Munjattu, Joseph Francis			"They don't like us....": Barriers to antiretroviral and opioid substitution therapy among homeless HIV positive people who inject drugs in Delhi: A mixed method study	PLOS ONE			English	Article							USERS; CARE	Background Provision of Anti-Retroviral Therapy (ART) and Opioid Substitution Therapy (OST) are important components of the targeted intervention (TI) programme for people who inject drugs (PWID). Homeless HIV positive PWIDs in Delhi is a key population experiencing gaps in uptake of these services, especially the ART uptake which is reportedly far from 90%, UNAIDS' 90-90-90 target to end the AIDS epidemic. Objective To assess the gaps and barriers in accessing the ART and OST services uptake among HIV positive homeless PWID in Delhi and to explore experiences and perspectives of the PWIDs and service providers. Methodology We used a convergent parallel mixed methods design which included a cross-sectional quantitative survey and a qualitative study. Two hundred thirty five homeless HIV positive PWID were interviewed and in-depth interviews were conducted with five PWIDs and nine health providers. Results While only 12% of PWIDs were on ART, 80% were availing OST services. The top individual, health system related and structural barriers for ART service access were insufficient and incorrect knowledge (63%), long waiting time (86%) and lack of family support (44%) respectively. Inconvenient timings, stringent registration requirements and negative attitude of health providers were expressed as major barriers of accessing ART services during the interviews while these were not a concern in OST services. Homelessness, poverty, stigma were common barriers for both services. Integrated, 'single window' service and provision of additional support like nutrition and shelter were suggested as measures to improve access by both health providers and the PWIDs themselves. Conclusion There is an urgent need for structural and health systems changes to improve access to ART and OST services. These include integrated service delivery, flexibility in timing of the centers, accelerated ART initiation, simplification of bureaucratic procedures, nutritional and social support to all homeless HIV positive PWIDs.	[Kumar, Samresh] IHAT, Tech Support Unit, Delhi, India; [Gupte, Himanshu A.] Narotam Sekhsaria Fdn, Bombay, Maharashtra, India; [Isaakidis, Petros] Med Sans Frontieres, Operat Res Unit, Luxembourg, Luxembourg; [Mishra, J. K.] DSACS, Delhi, India; [Munjattu, Joseph Francis] IHAT, Tech Support Unit, Bengaluru, India	Doctors Without Borders	Kumar, S (corresponding author), IHAT, Tech Support Unit, Delhi, India.	samreshkumar10@gmail.com		Gupte, Himanshu/0000-0002-6290-2419; Isaakidis, Petros/0000-0002-7881-1554	Department for International Development (DFID), UK; La Fondation Veuve Emile Metz-Tesch (Luxembourg)	Department for International Development (DFID), UK; La Fondation Veuve Emile Metz-Tesch (Luxembourg)	The training programme and open access publication costs were funded by the Department for International Development (DFID), UK and La Fondation Veuve Emile Metz-Tesch (Luxembourg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2015, QUALITY ASSURANCE IM; [Anonymous], 2015, NHMRC STAT EV WIND H; [Anonymous], 2015, NAT INT BIOL BEH SUR; Chakarpani V, 2015, BARRIERS ANTIRETROVI, V26, P835; Chakrapani MD, 2012, BARRIERS OPPORTUNITI; Chakrapani V, 2012, ACCESS COMPREHENSIVE; Chakrapani V, 2014, AIDS CARE, V26, P835, DOI 10.1080/09540121.2013.861573; Creswell JW, 2013, DBER SPEAK SER, P54; DSACS, DELH STAT AIDS CONTR; International Harm Reduction Development Program (IHRD), OPEN SOC I PUBLIC HE; Joshi V, 2012, DIRECTORATE CENSUS O, P2; Latkin C, RELATIONSHIP DRUG US; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; National AIDS Control Organization, HIV SENT SURV REP; National AIDS Control Organization, OST OV PERF FY 2016; Rao R, 2017, INDIAN J PSYCHIAT, V59, P457; Reid G, 2014, J PUBLIC HEALTH RES, V3, P1, DOI 10.4081/jphr.2014.204; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNAIDS, 90 90 90 AMB TREATM; UNAIDS, FACT SHEET PEOPL LIV; UNAIDS, 2016, 2016 PREV GAP REP, P6; UNAIDS (Joint United Nations Programme on HIV/AIDS), 2014, FAST TRACK END AIDS, P1; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; World Health Organization, 2016, CONS GUID US ANT DRU	25	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203262	10.1371/journal.pone.0203262	http://dx.doi.org/10.1371/journal.pone.0203262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161255	gold, Green Published, Green Submitted			2022-12-26	WOS:000443388900096
J	Stevens, AT; Howe, DK; Hunt, AG				Stevens, Ashley T.; Howe, Daniel K.; Hunt, Arthur G.			Characterization of mRNA polyadenylation in the apicomplexa	PLOS ONE			English	Article							CLEAVAGE FACTOR-I; POLY(A) POLYMERASE; TRYPANOSOMA-BRUCEI; ALTERNATIVE POLYADENYLATION; CHLAMYDOMONAS-REINHARDTII; STRUCTURAL BASIS; FACTOR CPSF-73; SITE CHOICE; ARABIDOPSIS; SUBUNIT	Messenger RNA polyadenylation is a universal aspect of gene expression in eukaryotes. In well-established model organisms, this process is mediated by a conserved complex of 15-20 subunits. To better understand this process in apicomplexans, a group of unicellular parasites that causes serious disease in humans and livestock, a computational and high throughput sequencing study of the polyadenylation complex and poly(A) sites in several species was conducted. BLAST-based searches for orthologs of the human polyadenylation complex yielded clear matches to only two-poly(A) polymerase and CPSF73-of the 19 proteins used as queries in this analysis. As the human subunits that recognize the AAUAAA polyadenylation signal (PAS) were not immediately obvious, a computational analysis of sequences adjacent to experimentally-determined apicomplexan poly(A) sites was conducted. The results of this study showed that there exists in apicomplexans an A-rich region that corresponds in position to the AAUAAA PAS. The set of experimentally-determined sites in one species, Sarcocystis neurona, was further analyzed to evaluate the extent and significance of alternative poly(A) site choice in this organism. The results showed that almost 80% of S. neurona genes possess more than one poly(A) site, and that more than 780 sites showed differential usage in the two developmental stages-extracellular merozoites and intracellular schizonts-studied. These sites affected more than 450 genes, and included a disproportionate number of genes that encode membrane transporters and ribosomal proteins. Taken together, these results reveal that apicomplexan species seem to possess a poly(A) signal analogous to AAUAAA even though genes that may encode obvious counterparts of the AAUAAA-recognizing proteins are absent in these organisms. They also indicate that, as is the case in other eukaryotes, alternative polyadenylation is a widespread phenomenon in S. neurona that has the potential to impact growth and development.	[Stevens, Ashley T.; Hunt, Arthur G.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA; [Howe, Daniel K.] Univ Kentucky, Dept Vet Sci, Lexington, KY USA; [Stevens, Ashley T.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky	Hunt, AG (corresponding author), Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA.	aghunt00@uky.edu		Hunt, Arthur/0000-0002-0008-4158; Howe, Daniel K./0000-0003-3704-136X; , Ashley Skaggs/0000-0001-6732-1640	Research Experience for Undergraduates award under National Science Foundation [MCB-1243849, IOS-1353354]; USDA National Institute of Food and Agriculture [227792]; Amerman Family Equine Research Fund; Division Of Integrative Organismal Systems [1353354] Funding Source: National Science Foundation	Research Experience for Undergraduates award under National Science Foundation; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Amerman Family Equine Research Fund; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	ATS was supported by a Research Experience for Undergraduates award under the auspices of National Science Foundation (www.nsf.gov) Awards MCB-1243849 and IOS-1353354 made to Dr. Hunt. Other support was from the USDA National Institute of Food and Agriculture (Hatch project accession # 227792; www.nifa.usda.gov) and funds from the Amerman Family Equine Research Fund, both to Dr. Howe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146107; Bercovich N, 2009, BIOCHEM BIOPH RES CO, V380, P850, DOI 10.1016/j.bbrc.2009.01.182; Blazejewski T, 2015, MBIO, V6, DOI 10.1128/mBio.02445-14; Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2; Cann H, 2004, MOL BIOCHEM PARASIT, V137, P239, DOI 10.1016/j.molbiopara.2004.06.005; Chan SL, 2014, GENE DEV, V28, P2370, DOI 10.1101/gad.250993.114; Chikne V, 2017, J MOL BIOL, V429, P3301, DOI 10.1016/j.jmb.2017.04.015; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; de Lorenzo L, 2017, PLANT CELL, V29, P1262, DOI 10.1105/tpc.16.00746; Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Elliott BJ, 2003, PLANT MOL BIOL, V51, P373, DOI 10.1023/A:1022035219500; Forbes KP, 2006, J BIOL CHEM, V281, P176, DOI 10.1074/jbc.M510964200; FRANZEN O, 2013, PLOS COMPUT BIOL, V0009; Fuentes V, 2012, EUKARYOT CELL, V11, P725, DOI 10.1128/EC.05322-11; Helming S, 2001, MOL CELL BIOL, V21, P2026, DOI 10.1128/MCB.21.6.2026-2037.2001; Hendriks EF, 2003, J BIOL CHEM, V278, P26870, DOI 10.1074/jbc.M302405200; Howe DK, 2005, INFECT IMMUN, V73, P1023, DOI 10.1128/IAI.73.2.1023-1033.2005; Hunt AG, 2008, CURR TOP MICROBIOL, V326, P151; Hunt AG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-220; Hunt AG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-641; Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070; Kim H, 2001, BIOCHEM BIOPH RES CO, V289, P513, DOI 10.1006/bbrc.2001.5992; Klimes V, 2014, GENOME BIOL EVOL, V6, P1956, DOI 10.1093/gbe/evu146; Koch H, 2016, RNA BIOL, V13, P221, DOI 10.1080/15476286.2015.1130208; Li XQ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0162-7; Lohman BK, 2016, MOL ECOL RESOUR, V16, P1315, DOI 10.1111/1755-0998.12529; Loke JC, 2005, PLANT PHYSIOL, V138, P1457, DOI 10.1104/pp.105.060541; Lutz CS, 2011, WIRES RNA, V2, P22, DOI 10.1002/wrna.47; Ma LY, 2014, METHODS, V67, P74, DOI 10.1016/j.ymeth.2013.06.037; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672; Oguariri RM, 2006, MOL BIOCHEM PARASIT, V146, P163, DOI 10.1016/j.molbiopara.2005.12.004; Palencia A, 2017, EMBO MOL MED, V9, P385, DOI 10.15252/emmm.201607370; Pati Pratap Kumar, 2015, Methods Mol Biol, V1255, P159, DOI 10.1007/978-1-4939-2175-1_14; PREKER PJ, 1995, CELL, V81, P379, DOI 10.1016/0092-8674(95)90391-7; RUVOLO V, 1993, MOL BIOCHEM PARASIT, V57, P137, DOI 10.1016/0166-6851(93)90251-R; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; Schonemann L, 2014, GENE DEV, V28, P2381, DOI 10.1101/gad.250985.114; Shen YJ, 2008, GENETICS, V179, P167, DOI 10.1534/genetics.108.088971; Shi YS, 2015, GENE DEV, V29, P889, DOI 10.1101/gad.261974.115; Siegel TN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-150; Sonoiki E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14574; Sun YD, 2018, P NATL ACAD SCI USA, V115, pE1419, DOI 10.1073/pnas.1718723115; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Thomas PE, 2012, PLANT CELL, V24, P4376, DOI 10.1105/tpc.112.096107; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; Tian B, 2017, NAT REV MOL CELL BIO, V18, P18, DOI 10.1038/nrm.2016.116; Wang CX, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4509; Wodniok S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-65; Xing DH, 2011, WIRES RNA, V2, P445, DOI 10.1002/wrna.59; Yang Q, 2010, P NATL ACAD SCI USA, V107, P10062, DOI 10.1073/pnas.1000848107; Yao CG, 2013, RNA, V19, P1781, DOI 10.1261/rna.042317.113; Yao CG, 2012, P NATL ACAD SCI USA, V109, P18773, DOI 10.1073/pnas.1211101109; Zhao ZX, 2014, G3-GENES GENOM GENET, V4, P871, DOI 10.1534/g3.114.010249	57	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203317	10.1371/journal.pone.0203317	http://dx.doi.org/10.1371/journal.pone.0203317			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161237	Green Published, gold, Green Submitted			2022-12-26	WOS:000443388900110
J	Hu, CM; Tsao, N; Wang, YT; Chen, YJ; Chang, ZF				Hu, Chun-Mei; Tsao, Ning; Wang, Yi-Ting; Chen, Yu-Ju; Chang, Zee-Fen			Thymidylate kinase is critical for DNA repair via ATM-dependent Tip60 complex formation	FASEB JOURNAL			English	Article						TMPK; DNA damage; TIP60; ATM	RIBONUCLEOTIDE REDUCTASE; DEOXYRIBONUCLEOTIDE; ACTIVATION	Cellular supply of deoxythymidine triphosphate (dTTP) is crucial for DNA replication and repair. Thymidylate kinase (TMPK) catalyzes the conversion of thymidine monophosphate to thymidine diphosphate, which is an essential step for dTTP synthesis. Despite their major cellular localization in cytosol, TMPK and ribonucleotide reductase (RNR) are detected at DNA damage sites for local dNDP formation. Because deoxyuridine diphosphate is synthesized by RNR, the simultaneous recruitment of TMPK and RNR to DNA damage sites is critical for preventing deoxyuridine triphosphate-mediated toxic repair. This study investigates the mechanism responsible for the recruitment of TMPK to DNA damage sites. Our data demonstrate the requirement of ataxia telangiectasia mutated (ATM) kinase activity for TMPK recruitment to DNA lesion sites. Moreover, we find that TMPK is able to form the complex with histone acetyltransferase Tip60 and RNR. Inhibition of ATM kinase reduces the complex formation and TMPK phosphorylation. Our analysis further shows the presence of TMPK phosphorylation at serine 88, which is an ATM kinase consensus site. A phosphorylation-defective mutation at this site suppresses TMPK recruitment to DNA damage sites and the complex formation with Tip60. Finally, we provide evidence that this site is critical for the function of TMPK in DNA repair but not for catalytic activity. Together, these findings suggest that Tip60-ATM signaling has a functional contribution to the recruitment of TMPK to DNA damage sites, thereby increasing local dTTP synthesis for DNA repair.Hu, C.-M., Tsao, N., Wang, Y.-T., Chen, Y.-J., Chang, Z.-F. Thymidylate kinase is critical for DNA repair via ATM-dependent Tip60 complex formation.	[Hu, Chun-Mei] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Wang, Yi-Ting; Chen, Yu-Ju] Acad Sinica, Inst Chem, Taipei, Taiwan; [Hu, Chun-Mei; Tsao, Ning] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei, Taiwan; [Chang, Zee-Fen] Natl Taiwan Univ, Coll Med, Inst Mol Med, 1 Jen Ai Rd Sec 1, Taipei 100, Taiwan; [Chang, Zee-Fen] Natl Taiwan Univ, Coll Med, Ctr Precis Med, 1 Jen Ai Rd Sec 1, Taipei 100, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University	Chang, ZF (corresponding author), Natl Taiwan Univ, Coll Med, Inst Mol Med, 1 Jen Ai Rd Sec 1, Taipei 100, Taiwan.; Chang, ZF (corresponding author), Natl Taiwan Univ, Coll Med, Ctr Precis Med, 1 Jen Ai Rd Sec 1, Taipei 100, Taiwan.	zfchang@ntu.edu.tw	Chen, Yu-Ju/E-9481-2015	Chen, Yu-Ju/0000-0002-3178-6697	Center of Precision Medicine from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education in Taiwan; Ministry of Scinece and Technology of the Republic of China (MOST) [107-3017-F-002-002, 107-2321-B-002-041]	Center of Precision Medicine from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education in Taiwan; Ministry of Scinece and Technology of the Republic of China (MOST)	The authors thank Dr. Li-Jung Juan (Genomics Research Center, Academia Sinica) for providing the HA-Tip60 plasmid, Dr. Ming-Yun Hsieh (Graduate Institute of Biochemistry and Molecular Biology, National Yang-Ming University) for technical assistance, and the Core Facility at Institute of Biological Chemistry, Academia Sinica, for performing the MS/MS analysis of postmodification of TMPK peptides. This study was supported by the Center of Precision Medicine from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education in Taiwan, and by Ministry of Scinece and Technology of the Republic of China (MOST) Grants 107-3017-F-002-002 and 107-2321-B-002-041. The authors declare no conflicts of interest.	Aye Y, 2015, ONCOGENE, V34, P2011, DOI 10.1038/onc.2014.155; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Boissan M, 2018, LAB INVEST, V98, P164, DOI 10.1038/labinvest.2017.137; Chen CW, 2016, CELL REP, V16, P1287, DOI 10.1016/j.celrep.2016.06.094; Hu CM, 2012, CANCER CELL, V22, P36, DOI 10.1016/j.ccr.2012.04.038; HUANG SH, 1994, DNA CELL BIOL, V13, P461, DOI 10.1089/dna.1994.13.461; Ke PY, 2005, GENE DEV, V19, P1920, DOI 10.1101/gad.1322905; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P237, DOI 10.1023/A:1005532912212; Mathews CK, 2015, NAT REV CANCER, V15, P528, DOI 10.1038/nrc3981; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Niida H, 2010, GENE DEV, V24, P333, DOI 10.1101/gad.1863810; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Si WD, 2010, GENETICS, V185, P443, DOI 10.1534/genetics.110.115196; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; TAKEISHI K, 1985, NUCLEIC ACIDS RES, V13, P2035, DOI 10.1093/nar/13.6.2035; Tsai CF, 2008, J PROTEOME RES, V7, P4058, DOI 10.1021/pr800364d; Tsao N, 2016, BIOCHEM J, V473, P1237, DOI 10.1042/BCJ20160122; Tsao N, 2015, CELL CYCLE, V14, P354, DOI 10.4161/15384101.2014.987618; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001	23	4	4	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2017	2025		10.1096/fj.201800856R	http://dx.doi.org/10.1096/fj.201800856R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30199284				2022-12-26	WOS:000457296600039
J	Herwaldt, EJ; Rivett, ED; White, AJ; Hegg, EL				Herwaldt, Emily J.; Rivett, Elise D.; White, Antoineen J.; Hegg, Eric L.			Cox15 interacts with the cytochrome bc(1) dimer within respiratory supercomplexes as well as in the absence of cytochrome c oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome c oxidase (complex IV); membrane protein; mitochondria; respiratory chain; Saccharomyces cerevisiae; Cox15; cytochrome bc1 (complex III); heme a synthase; mitochondrial respiratory supercomplexes; protein-protein interaction	YEAST MITOCHONDRIA; SACCHAROMYCES-CEREVISIAE; CARRIER PROTEINS; TIM23 MACHINERY; ASSEMBLY FACTOR; ENZYME COMPLEX; INNER MEMBRANE; BARTH-SYNDROME; HUMAN-CELLS; HEME	The heme a molecule is an obligatory cofactor in the terminal enzyme complex of the electron transport chain, cytochrome c oxidase. Heme a is synthesized from heme o by a multi-spanning inner membrane protein, heme a synthase (Cox15 in the yeast Saccharomyces cerevisiae). The insertion of heme a is critical for cytochrome c oxidase function and assembly, but this process has not been fully elucidated. To improve our understanding of heme a insertion into cytochrome c oxidase, here we investigated the protein-protein interactions that involve Cox15 in S. cerevisiae. In addition to observing Cox15 in homooligomeric complexes, we found that a portion of Cox15 also associates with the mitochondrial respiratory supercomplexes. When supercomplex formation was abolished, as in the case of stalled cytochrome bc(1) or cytochrome c oxidase assembly, Cox15 maintained an interaction with select proteins from both respiratory complexes. In the case of stalled cytochrome bc(1) assembly, Cox15 interacted with the late-assembling cytochrome c oxidase subunit, Cox13. When cytochrome c oxidase assembly was stalled, Cox15 unexpectedly maintained its interaction with the cytochrome bc(1) protein, Cor1. Our results indicate that Cox15 and Cor1 continue to interact in the cytochrome bc(1) dimer even in the absence of supercomplexes or when the supercomplexes are destabilized. These findings reveal that Cox15 not only associates with respiratory supercomplexes, but also interacts with the cytochrome bc(1) dimer even in the absence of cytochrome c oxidase.	[Herwaldt, Emily J.; Rivett, Elise D.; White, Antoineen J.; Hegg, Eric L.] Michigan State Univ, Dept Biochem & Mol Biol, 603 Wilson Rd,Rm 510A, E Lansing, MI 48824 USA	Michigan State University	Hegg, EL (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, 603 Wilson Rd,Rm 510A, E Lansing, MI 48824 USA.	erichegg@msu.edu		Hegg, Eric/0000-0003-2055-5495	National Institutes of Health [R01GM101386]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in full by National Institutes of Health Grant R01GM101386. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bareth B, 2013, MOL CELL BIOL, V33, P4128, DOI 10.1128/MCB.00747-13; Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003; Bestwick M, 2010, MOL CELL BIOL, V30, P172, DOI 10.1128/MCB.00869-09; Bianchi C, 2004, J BIOL CHEM, V279, P36562, DOI 10.1074/jbc.M405135200; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Brown KR, 2004, BIOCHEMISTRY-US, V43, P8616, DOI 10.1021/bi049056m; Bundschuh FA, 2009, J BIOL CHEM, V284, P25735, DOI 10.1074/jbc.M109.040295; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; Conte A, 2015, BBA-MOL CELL RES, V1853, P987, DOI 10.1016/j.bbamcr.2015.02.006; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Cui TZ, 2014, J BIOL CHEM, V289, P6133, DOI 10.1074/jbc.M113.523688; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402; DOWHAN W, 1985, EMBO J, V4, P179, DOI 10.1002/j.1460-2075.1985.tb02334.x; Fontanesi F, 2008, HUM MOL GENET, V17, P775, DOI 10.1093/hmg/ddm349; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Frazier AE, 2003, MOL CELL BIOL, V23, P7818, DOI 10.1128/MCB.23.21.7818-7828.2003; GENNIS R, 1995, SCIENCE, V269, P1063, DOI 10.1126/science.7652553; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hederstedt L, 2012, BBA-BIOENERGETICS, V1817, P920, DOI 10.1016/j.bbabio.2012.03.025; Hildenbeutel M, 2014, J CELL BIOL, V205, P511, DOI 10.1083/jcb.201401009; Hildenbeutel M, 2012, J MOL BIOL, V423, P590, DOI 10.1016/j.jmb.2012.07.018; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Khalimonchuk O, 2012, J BIOL CHEM, V287, P26715, DOI 10.1074/jbc.M112.377200; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; Kim HJ, 2012, BBA-MOL CELL RES, V1823, P1604, DOI 10.1016/j.bbamcr.2012.04.008; Lange H, 1999, J BIOL CHEM, V274, P18989, DOI 10.1074/jbc.274.27.18989; Lazarou M, 2009, FEBS J, V276, P6701, DOI 10.1111/j.1742-4658.2009.07384.x; Levchenko M, 2016, BBA-MOL CELL RES, V1863, P1624, DOI 10.1016/j.bbamcr.2016.04.007; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marechal A, 2012, BBA-BIOENERGETICS, V1817, P620, DOI 10.1016/j.bbabio.2011.08.011; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Nijtmans LGJ, 2001, FEBS LETT, V498, P46, DOI 10.1016/S0014-5793(01)02447-4; Pierrel F, 2008, MOL CELL BIOL, V28, P4927, DOI 10.1128/MCB.00057-08; Saddar S, 2008, J BIOL CHEM, V283, P6677, DOI 10.1074/jbc.M708440200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Stuart RA, 2009, METHOD ENZYMOL, V456, P191, DOI 10.1016/S0076-6879(08)04411-X; Stuart RA, 2008, J BIOENERG BIOMEMBR, V40, P411, DOI 10.1007/s10863-008-9168-4; Swenson S, 2016, J BIOL CHEM, V291, P10411, DOI 10.1074/jbc.M115.707539; TAANMAN JW, 1993, J BIOL CHEM, V268, P18754; Taylor NG, 2017, J BIOL CHEM, V292, P1815, DOI 10.1074/jbc.M116.766980; Timon-Gomez A, 2018, SEMIN CELL DEV BIOL, V76, P163, DOI 10.1016/j.semcdb.2017.08.055; van der Laan M, 2006, CURR BIOL, V16, P2271, DOI 10.1016/j.cub.2006.10.025; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wang ZH, 2009, J BIOL CHEM, V284, P839, DOI 10.1074/jbc.M804167200; Wiedemann N, 2007, J CELL BIOL, V179, P1115, DOI 10.1083/jcb.200709087; Zara V, 2007, FEBS J, V274, P4526, DOI 10.1111/j.1742-4658.2007.05982.x; Zee JM, 2006, BIOCHEM CELL BIOL, V84, P859, DOI 10.1139/O06-201; Zhuang JY, 2006, BIOCHEMISTRY-US, V45, P12530, DOI 10.1021/bi060565t	59	7	7	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16426	16439		10.1074/jbc.RA118.002496	http://dx.doi.org/10.1074/jbc.RA118.002496			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30181213	Green Published, hybrid			2022-12-26	WOS:000447833600025
J	Nelson, KJ; Bolduc, JA; Wu, HZ; Collins, JA; Burke, EA; Reisz, JA; Klomsiri, C; Wood, ST; Yammani, RR; Poole, LB; Furdui, CM; Loeser, RF				Nelson, Kimberly J.; Bolduc, Jesalyn A.; Wu, Hanzhi; Collins, John A.; Burke, Elizabeth A.; Reisz, Julie A.; Klomsiri, Chananat; Wood, Scott T.; Yammani, Raghunatha R.; Poole, Leslie B.; Furdui, Cristina M.; Loeser, Richard F.			H2O2 oxidation of cysteine residues in c-Jun N-terminal kinase 2 (JNK2) contributes to redox regulation in human articular chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitogen-activated protein kinase (MAPK); redox regulation; redox signaling; chondrocyte; integrin; reactive oxygen species (ROS); hydrogen peroxide; c-Jun N-terminal kinase (JNK); disulfide; cellular redox status	SIGNAL-TRANSDUCTION PATHWAY; ACTIVATED PROTEIN-KINASE; FIBRONECTIN FRAGMENTS; OSTEOARTHRITIC CARTILAGE; CRYSTAL-STRUCTURE; SULFENIC ACIDS; EXPRESSION; BINDING; STRESS; ALPHA-5-BETA-1	Reactive oxygen species (ROS), in particular H2O2, regulate intracellular signaling through reversible oxidation of reactive protein thiols present in a number of kinases and phosphatases. H2O2 has been shown to regulate mitogen-activated protein kinase (MAPK) signaling depending on the cellular context. We report here that in human articular chondrocytes, the MAPK family member c-Jun N-terminal kinase 2 (JNK2) is activated by fibronectin fragments and low physiological levels of H2O2 and inhibited by oxidation due to elevated levels of H2O2. The kinase activity of affinity-purified, phosphorylated JNK2 from cultured chondrocytes was reversibly inhibited by 5-20 m H2O2. Using dimedone-based chemical probes that react specifically with sulfenylated cysteines (RSOH), we identified Cys-222 in JNK2, a residue not conserved in JNK1 or JNK3, as a redox-reactive site. MS analysis of human recombinant JNK2 also detected further oxidation at Cys-222 and other cysteines to sulfinic (RSO2H) or sulfonic (RSO3H) acid. H2O2 treatment of JNK2 resulted in detectable levels of peptides containing intramolecular disulfides between Cys-222 and either Cys-213 or Cys-177, without evidence of dimer formation. Substitution of Cys-222 to alanine rendered JNK2 insensitive to H2O2 inhibition, unlike C177A and C213A variants. Two other JNK2 variants, C116A and C163A, were also resistant to oxidative inhibition. Cumulatively, these findings indicate differential regulation of JNK2 signaling dependent on H2O2 levels and point to key cysteine residues regulating JNK2 activity. As levels of intracellular H2O2 rise, a switch occurs from activation to inhibition of JNK2 activity, linking JNK2 regulation to the redox status of the cell.	[Nelson, Kimberly J.; Klomsiri, Chananat; Poole, Leslie B.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Wu, Hanzhi; Burke, Elizabeth A.; Reisz, Julie A.; Klomsiri, Chananat; Yammani, Raghunatha R.; Furdui, Cristina M.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Bolduc, Jesalyn A.; Collins, John A.; Wood, Scott T.; Loeser, Richard F.] Univ N Carolina, Div Rheumatol Allergy & Immunol, Chapel Hill, NC 27515 USA; [Bolduc, Jesalyn A.; Collins, John A.; Wood, Scott T.; Loeser, Richard F.] Univ N Carolina, Thurston Arthrit Res Ctr, 3300 Thurston Bldg,CB7280, Chapel Hill, NC 27515 USA; [Burke, Elizabeth A.] NIH, Undiagnosed Dis Program, Bldg 10, Bethesda, MD 20892 USA; [Reisz, Julie A.] Univ Colorado, Dept Biochem & Mol Genet, Anschutz Med Campus, Aurora, CO 80045 USA; [Wood, Scott T.] South Dakota Sch Mines & Technol, Dept Nano Sci & Engn, Rapid City, SD 57701 USA	Wake Forest University; Wake Forest University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; University of Colorado System; University of Colorado Anschutz Medical Campus; South Dakota School Mines & Technology	Loeser, RF (corresponding author), Univ N Carolina, Thurston Arthrit Res Ctr, 3300 Thurston Bldg,CB7280, Chapel Hill, NC 27515 USA.	richard_loeser@med.unc.edu	Wood, Scott/I-6133-2019	Wood, Scott/0000-0002-6747-0547; Bolduc, Jesalyn/0000-0002-3950-7453; Wu, Hanzhi/0000-0001-7822-4432; Poole, Leslie/0000-0003-0334-7328; Furdui, Cristina M./0000-0003-3771-7999; Yammani, Raghunatha/0000-0003-2278-8911; Nelson, Kimberly/0000-0003-2464-7696	Wake Forest Baptist Comprehensive Cancer Center Proteomics and Metabolomics Shared Resource - NCI, National Institutes of Health, Cancer Center Support Grant [P30 CA012197]; Mass Spectrometry Facility in the Chemistry Department at Wake Forest University - National Science Foundation; NATIONAL CANCER INSTITUTE [R33CA177461, P30CA012197, R33CA126659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR049003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R33ES025645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG032796, R01AG044034] Funding Source: NIH RePORTER	Wake Forest Baptist Comprehensive Cancer Center Proteomics and Metabolomics Shared Resource - NCI, National Institutes of Health, Cancer Center Support Grant; Mass Spectrometry Facility in the Chemistry Department at Wake Forest University - National Science Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Bruce King for supplying the DCP-Bio1, Harold Erickson for providing the plasmid construct to produce the FN7-10 fibronectin fragment, and Roger Davis for contributing the pcDNA3-FLAG-JNK2 plasmid. We also thank Dr. Susan Chubinskaya, the Gift of Hope Organ and Tissue Donor Network, and the National Disease Research Interchange for providing donor tissue as well as Robert Currin and the University of North Carolina Hooker Imaging core for assistance with confocal microscopy. We acknowledge the support of the Wake Forest Baptist Comprehensive Cancer Center Proteomics and Metabolomics Shared Resource, supported by the NCI, National Institutes of Health, Cancer Center Support Grant P30 CA012197, and the Mass Spectrometry Facility in the Chemistry Department at Wake Forest University, supported in part by the National Science Foundation.	Antunes F, 2017, REDOX BIOL, V13, P1, DOI 10.1016/j.redox.2017.04.039; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Chen XF, 2017, ACS CHEM BIOL, V12, P2201, DOI 10.1021/acschembio.7b00444; Clancy R, 2001, OSTEOARTHR CARTILAGE, V9, P294, DOI 10.1053/joca.2000.0388; Collins JA, 2016, J BIOL CHEM, V291, P6641, DOI 10.1074/jbc.M115.693523; Cui J, 2005, J BIOL CHEM, V280, P9913, DOI 10.1074/jbc.M412165200; Del Carlo M, 2007, FREE RADICAL BIO MED, V42, P1350, DOI 10.1016/j.freeradbiomed.2007.01.035; Devarie-Baez NO, 2016, FREE RADICAL RES, V50, P172, DOI 10.3109/10715762.2015.1090571; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Forsyth CB, 2002, ARTHRITIS RHEUM, V46, P2368, DOI 10.1002/art.10502; Giannoni E, 2014, ANTIOXID REDOX SIGN, V20, P2011, DOI 10.1089/ars.2013.5525; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Han ZN, 2002, ARTHRITIS RHEUM, V46, P818, DOI 10.1002/art.10104; Haque A, 2011, CELL, V147, P185, DOI 10.1016/j.cell.2011.08.036; Heppner DE, 2016, J BIOL CHEM, V291, P23282, DOI 10.1074/jbc.M116.749028; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Homandberg GA, 1998, OSTEOARTHR CARTILAGE, V6, P231, DOI 10.1053/joca.1998.0116; Homandberg GA, 2002, OSTEOARTHR CARTILAGE, V10, P938, DOI 10.1053/joca.2002.0854; HUHTALA P, 1995, J CELL BIOL, V129, P867, DOI 10.1083/jcb.129.3.867; Ismail HM, 2016, ARTHRITIS RHEUMATOL, V68, P1165, DOI 10.1002/art.39547; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Keyes JD, 2017, FREE RADICAL BIO MED, V112, P534, DOI 10.1016/j.freeradbiomed.2017.08.018; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Kim YJ, 2006, CANCER RES, V66, P7136, DOI 10.1158/0008-5472.CAN-05-4446; Klatt P, 1999, J BIOL CHEM, V274, P15857, DOI 10.1074/jbc.274.22.15857; Klomsiri C, 2011, ANTIOXID REDOX SIGN, V14, P1065, DOI 10.1089/ars.2010.3376; Kuglstatter A, 2010, BIOORG MED CHEM LETT, V20, P5217, DOI 10.1016/j.bmcl.2010.06.157; Labunskyy VM, 2013, ANTIOXID REDOX SIGN, V19, P1362, DOI 10.1089/ars.2012.4891; Liu F, 2015, NAT METHODS, V12, P1179, DOI 10.1038/nmeth.3603; Liu F, 2014, MOL CELL PROTEOMICS, V13, P2776, DOI 10.1074/mcp.O114.039057; Liu RM, 2010, J BIOL CHEM, V285, P16239, DOI 10.1074/jbc.M110.111732; Loeser RF, 2003, ARTHRITIS RHEUM, V48, P2188, DOI 10.1002/art.11209; Loeser RF, 2003, J BIOL CHEM, V278, P24577, DOI 10.1074/jbc.M304530200; Nadeau PJ, 2007, MOL BIOL CELL, V18, P3903, DOI 10.1091/mbc.E07-05-0491; Nadeau PJ, 2009, MOL BIOL CELL, V20, P3628, DOI 10.1091/mbc.E09-03-0211; Nelson KJ, 2010, METHOD ENZYMOL, V473, P95, DOI 10.1016/S0076-6879(10)73004-4; Nelson KJ, 2008, BIOCHEMISTRY-US, V47, P12860, DOI 10.1021/bi801718d; Nitta RT, 2008, J BIOL CHEM, V283, P34935, DOI 10.1074/jbc.M804970200; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Poole LB, 1996, BIOCHEMISTRY-US, V35, P56, DOI 10.1021/bi951887s; Poole LB, 2007, BIOCONJUGATE CHEM, V18, P2004, DOI 10.1021/bc700257a; Pulai JI, 2005, J IMMUNOL, V174, P5781, DOI 10.4049/jimmunol.174.9.5781; Reisz JA, 2013, FEBS J, V280, P6150, DOI 10.1111/febs.12535; Shaw D, 2008, J MOL BIOL, V383, P885, DOI 10.1016/j.jmb.2008.08.086; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Templeton DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015012; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Wani R, 2011, P NATL ACAD SCI USA, V108, P10550, DOI 10.1073/pnas.1011665108; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Wood ST, 2016, ARTHRITIS RHEUMATOL, V68, P117, DOI 10.1002/art.39326; Yoshizumi M, 2000, J BIOL CHEM, V275, P11706, DOI 10.1074/jbc.275.16.11706; Zack MD, 2006, ARTHRITIS RHEUM, V54, P2912, DOI 10.1002/art.22045; Zhang DH, 2012, ORG LETT, V14, P3396, DOI 10.1021/ol301370s; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010	58	17	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16376	16389		10.1074/jbc.RA118.004613	http://dx.doi.org/10.1074/jbc.RA118.004613			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30190325	Green Published, hybrid			2022-12-26	WOS:000447833600021
J	Tanimura, A; Sugita, T; Endoh, R; Ohkuma, M; Kishino, S; Ogawa, J; Shima, J; Takashima, M				Tanimura, Ayumi; Sugita, Takashi; Endoh, Rikiya; Ohkuma, Moriya; Kishino, Shigenobu; Ogawa, Jun; Shima, Jun; Takashima, Masako			Lipid production via simultaneous conversion of glucose and xylose by a novel yeast, Cystobasidium iriomotense	PLOS ONE			English	Article							MICROBIAL OIL PRODUCTION; OLEAGINOUS YEAST; CO-FERMENTATION; BASIDIOMYCETOUS YEASTS; ASCOMYCETOUS YEASTS; IDENTIFICATION; HYDROLYSATE; DNA; SYSTEMATICS; STRAINS	The yeast strains IPM32-16, ISM28-8s(T), and IPM46-17, isolated from plant and soil samples from Iriomote Island, Japan, were explored in terms of lipid production during growth in a mixture of glucose and xylose. Phylogenetically, the strains were most closely related to Cystobasidium slooffiae, based on the sequences of the ITS regions and the D1/D2 domain of the LSU rRNA gene. The strains were oleaginous, accumulating lipids to levels > 20% dry cell weight. Moreover, kinetic analysis of the sugar-to-lipid conversion of a 1:1 glucose/ xylose mixture showed that the strains consumed the two sugars simultaneously. IPM46-17 attained the highest lipid content (33%), mostly C16 and C18 fatty acids. Thus, the yeasts efficiently converted lignocellulosic sugars to lipids, aiding in biofuel production (which benefits the environment, promotes rural jobs, and strengthens fuel security). The strains constituted a novel species of Cystobasidium, for which we propose the name Cystobasidium iriomotense (type strain ISM28-8s(T) = JCM 24594(T) = CBS 15015(T)).	[Tanimura, Ayumi; Kishino, Shigenobu; Ogawa, Jun] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan; [Sugita, Takashi] Meiji Pharmaceut Univ, Dept Microbiol, Tokyo, Japan; [Endoh, Rikiya; Ohkuma, Moriya; Takashima, Masako] RIKEN BioResource Res Ctr, Japan Collect Microorganisms, Tsukuba, Ibaraki, Japan; [Shima, Jun] Ryukoku Univ, Fac Agr, Otsu, Shiga, Japan	Kyoto University; Meiji Pharmaceutical University; RIKEN; Ryukoku University	Takashima, M (corresponding author), RIKEN BioResource Res Ctr, Japan Collect Microorganisms, Tsukuba, Ibaraki, Japan.	masako@jcm.riken.jp	Tanimura, Ayumi/I-7767-2012; Tanimura, Ayumi/AAU-6360-2021	Tanimura, Ayumi/0000-0003-4540-903X; 	Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST) [JPMJAL1607]; KAKENHI from the Japan Society for the Promotion of Science (JSPS) [26650148]; RIKEN Competitive Program for Creative Science and Technology; Biomass Engineering Program of the RIKEN Center for Sustainable Resource Science	Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); RIKEN Competitive Program for Creative Science and Technology; Biomass Engineering Program of the RIKEN Center for Sustainable Resource Science	This work was supported in part by the Advanced Low Carbon Technology Research and Development Program (ALCA, grant no. JPMJAL1607) of the Japan Science and Technology Agency (JST). MT was partially supported by a KAKENHI (no. 26650148) from the Japan Society for the Promotion of Science (JSPS). This work was also supported in part by the RIKEN Competitive Program for Creative Science and Technology and by a grant from the Biomass Engineering Program of the RIKEN Center for Sustainable Resource Science (to MO).	Anschau A, 2014, BIORESOURCE TECHNOL, V157, P214, DOI 10.1016/j.biortech.2014.01.104; Bellasio M, 2015, J IND MICROBIOL BIOT, V42, P681, DOI 10.1007/s10295-015-1590-0; Bommareddy RR, 2015, MICROB CELL FACT, V14, DOI [10.1186/s12934-015-0197-5, DOI 10.1186/S12934-015-0197-5]; Capus A, 2016, BIORESOURCE TECHNOL, V203, P309, DOI 10.1016/j.biortech.2015.12.067; Chang YH, 2013, FUEL, V105, P711, DOI 10.1016/j.fuel.2012.10.033; EVANS CT, 1983, LIPIDS, V18, P623, DOI 10.1007/BF02534673; Farwick A, 2014, P NATL ACAD SCI USA, V111, P5159, DOI 10.1073/pnas.1323464111; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gong ZW, 2012, BIORESOURCE TECHNOL, V117, P20, DOI 10.1016/j.biortech.2012.04.063; Hu CM, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-25; Huang C, 2014, IND ENG CHEM RES, V53, P19034, DOI 10.1021/ie502185u; Huang C, 2009, BIORESOURCE TECHNOL, V100, P4535, DOI 10.1016/j.biortech.2009.04.022; Huang X, 2011, BIORESOURCE TECHNOL, V102, P9705, DOI 10.1016/j.biortech.2011.08.024; Ichihara K, 2010, J LIPID RES, V51, P635, DOI 10.1194/jlr.D001065; Jin MJ, 2015, TRENDS BIOTECHNOL, V33, P43, DOI 10.1016/j.tibtech.2014.11.005; Kim JH, 2010, APPL MICROBIOL BIOT, V88, P1077, DOI 10.1007/s00253-010-2839-1; Kim SR, 2012, TRENDS BIOTECHNOL, V30, P274, DOI 10.1016/j.tibtech.2012.01.005; Knothe G, 2009, ENERG ENVIRON SCI, V2, P759, DOI 10.1039/b903941d; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P87, DOI 10.1016/B978-0-444-52149-1.00007-0; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Liang YN, 2012, RENEW ENERG, V40, P130, DOI 10.1016/j.renene.2011.09.035; Lin JT, 2011, J BIOTECHNOL, V152, P184, DOI 10.1016/j.jbiotec.2011.02.010; Liu YF, 2010, EUR FOOD RES TECHNOL, V230, P759, DOI 10.1007/s00217-010-1217-7; Meng X, 2009, RENEW ENERG, V34, P1, DOI 10.1016/j.renene.2008.04.014; Nichols NN, 2001, APPL MICROBIOL BIOT, V56, P120, DOI 10.1007/s002530100628; Sampaio JP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1419, DOI 10.1016/B978-0-444-52149-1.00110-5; Sampaio JP, 1928, YEASTS TAXONOMIC STU; Sargeant LA, 2016, EUR J LIPID SCI TECH, V118, P777, DOI 10.1002/ejlt.201500143; Scorzetti G, 2002, FEMS YEAST RES, V2, P495, DOI 10.1111/j.1567-1364.2002.tb00117.x; Sitepu IR, 2014, BIOTECHNOL ADV, V32, P1336, DOI 10.1016/j.biotechadv.2014.08.003; Sitepu IR, 2014, APPL MICROBIOL BIOT, V98, P7645, DOI 10.1007/s00253-014-5944-8; Sugita T, 2001, MICROBIOL IMMUNOL, V45, P757, DOI 10.1111/j.1348-0421.2001.tb01312.x; Sugita T, 1999, J CLIN MICROBIOL, V37, P1985, DOI 10.1128/JCM.37.6.1985-1993.1999; Takashima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050784; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tanimura A, 2016, AMB EXPRESS, V6, P1, DOI [10.1186/s13568-015-0169-5, DOI 10.1186/S13568-015-0169-5]; Tanimura A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04776; Tanimura A, 2014, BIORESOURCE TECHNOL, V153, P230, DOI 10.1016/j.biortech.2013.11.086; Tapia EV, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-64; Wang QM, 2015, STUD MYCOL, P149, DOI 10.1016/j.simyco.2015.12.002; Yurkov AM, 2015, ANTON LEEUW INT J G, V107, P173, DOI 10.1007/s10482-014-0315-0; Zhao X, 2008, EUR J LIPID SCI TECH, V110, P405, DOI 10.1002/ejlt.200700224	45	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2018	13	9							e0202164	10.1371/journal.pone.0202164	http://dx.doi.org/10.1371/journal.pone.0202164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7EB	30208038	Green Submitted, Green Published, gold			2022-12-26	WOS:000444683000014
J	Park, S; Kim, MS				Park, Sunyoung; Kim, Myung-Sun			An event-related potential study of spatial working memory in binge drinking college students	PLOS ONE			English	Article							INTERFERENCE CONTROL; COGNITIVE FUNCTION; SOCIAL DRINKERS; ALCOHOL-USE; N-BACK; ADOLESCENT; P300; METAANALYSIS; IMPAIRMENTS; PERFORMANCE	This study used event-related potentials (ERPs) and a modified spatial 2-back task to investigate spatial working memory in binge drinking (BD) college students. Based on the Korean version of the Alcohol Use Disorder Identification Test (AUDIT-K) and Alcohol Use Questionnaire (AUQ) scores, participants were assigned into BD (n = 25) and non-BD (n = 25) groups. The modified spatial 2-back task includes congruent, incongruent, and lure conditions and participants are required to respond as rapidly and accurately as possible to the congruent stimuli but not to the incongruent and lure stimuli. The BD and non-BD groups exhibited comparable performances on the spatial 2-back task but the BD group showed significantly larger P3 amplitudes than the non-BD group. Additionally, the non-BD group showed larger P3 amplitudes in response to the congruent stimuli compared to the incongruent and lure stimuli whereas the P3 amplitudes in the BD group did not differ significantly among the three conditions. These results indicate that the BD individuals exerted greater effort to maintain performance levels comparable to non-BD individuals and that they were less efficient in differentiating or allocating attentional resources between relevant and irrelevant information.	[Park, Sunyoung; Kim, Myung-Sun] Sungshin Womens Univ, Dept Psychol, Seoul, South Korea	Sungshin Women's University	Kim, MS (corresponding author), Sungshin Womens Univ, Dept Psychol, Seoul, South Korea.	kimms@sungshin.ac.kr		Kim, Myung-Sun/0000-0003-3520-1112	Ministry of Education of the Republic of Korea; National Research Foundation of Korea [NRF-2015S1A5A2A03047656]	Ministry of Education of the Republic of Korea(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2015S1A5A2A03047656). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose ML, 2001, ALCOHOL CLIN EXP RES, V25, P185, DOI 10.1111/j.1530-0277.2001.tb02197.x; ARY DV, 1993, INT J ADDICT, V28, P853, DOI 10.3109/10826089309039661; Babor TF., 2001, AUDIT ALCOHOL USE DI; Baddeley A, 1996, P NATL ACAD SCI USA, V93, P13468, DOI 10.1073/pnas.93.24.13468; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Balodis IM, 2009, BEHAV PHARMACOL, V20, P518, DOI 10.1097/FBP.0b013e328330c779; Burgess GC, 2011, J EXP PSYCHOL GEN, V140, P674, DOI 10.1037/a0024695; Campanella S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062260; Carbia C, 2018, NEUROSCI BIOBEHAV R, V90, P332, DOI 10.1016/j.neubiorev.2018.04.013; Chen Yung-Nien, 2009, Acta Neurol Taiwan, V18, P170; Constantinidis C, 2004, NEUROSCIENTIST, V10, P553, DOI 10.1177/1073858404268742; Courtney KE, 2009, PSYCHOL BULL, V135, P142, DOI 10.1037/a0014414; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Crego A, 2012, ALCOHOL, V46, P415, DOI 10.1016/j.alcohol.2011.10.002; Crego A, 2009, ALCOHOL CLIN EXP RES, V33, P1870, DOI 10.1111/j.1530-0277.2009.01025.x; Cservenka A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01111; Curtis CE, 2006, NEUROSCIENCE, V139, P173, DOI 10.1016/j.neuroscience.2005.04.070; Daffner KR, 2011, J COGNITIVE NEUROSCI, V23, P1298, DOI 10.1162/jocn.2010.21540; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Engle Randall W., 1999, MODELS WORKING MEMOR, P102; First MB., 1997, USERS GUIDE STRUCTUR; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; George MRM, 2004, BRAIN COGNITION, V54, P245, DOI 10.1016/j.bandc.2004.02.025; Ham LS, 2003, CLIN PSYCHOL REV, V23, P719, DOI 10.1016/S0272-7358(03)00071-0; Hartley DE, 2004, PHARMACOL BIOCHEM BE, V78, P611, DOI 10.1016/j.pbb.2004.04.027; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; Jennison KM, 2004, AM J DRUG ALCOHOL AB, V30, P659, DOI 10.1081/ADA-200032331; Jeon YW, 2003, PSYCHOPHYSIOLOGY, V40, P684, DOI 10.1111/1469-8986.00070; Jones J., 1983, CHILDREN ALCOHOLICS; Kim JS, 1999, J KOREAN ACAD FAM ME, V20, P1152; Kim M., 1995, J KOREAN NEUROPSYCHI, V34, P1182; Kim Myungsun, 2004, Korean Journal of Clinical Psychology, V23, P313; Kim S, 2016, CLIN PSYCHOPHARM NEU, V14, P64, DOI 10.9758/cpn.2016.14.1.64; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kopera M, 2012, ALCOHOL, V46, P665, DOI 10.1016/j.alcohol.2012.04.005; Lee BO, 2000, J KOREAN ACAD ADDICT, V4, P83; Lopez-Caneda E, 2013, ALCOHOL ALCOHOLISM, V48, P464, DOI 10.1093/alcalc/agt046; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Mariani MA, 1997, DEV NEUROPSYCHOL, V13, P111, DOI 10.1080/87565649709540671; McEvoy LK, 1998, CEREB CORTEX, V8, P563, DOI 10.1093/cercor/8.7.563; McKee SA, 2004, NICOTINE TOB RES, V6, P111, DOI 10.1080/14622200310001656939; MEHRABIAN A, 1978, PSYCHOL REP, V43, P803, DOI 10.2466/pr0.1978.43.3.803; Mota N, 2013, DRUG ALCOHOL DEPEN, V133, P108, DOI 10.1016/j.drugalcdep.2013.05.024; National Institute of Alcohol Abuse and Alcoholism, 2004, NIAAA NEWSLETTER, V3; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Parada M, 2012, ADDICT BEHAV, V37, P167, DOI 10.1016/j.addbeh.2011.09.015; Patel Salil H, 2005, Int J Med Sci, V2, P147; Pfefferbaum A, 2001, NEUROIMAGE, V14, P7, DOI 10.1006/nimg.2001.0785; Pitel AL, 2007, ALCOHOL CLIN EXP RES, V31, P238, DOI 10.1111/j.1530-0277.2006.00301.x; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Saliasi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063701; Scaife JC, 2009, PHARMACOL BIOCHEM BE, V93, P354, DOI 10.1016/j.pbb.2009.05.015; Schweinsburg AD, 2005, DRUG ALCOHOL DEPEN, V79, P201, DOI 10.1016/j.drugalcdep.2005.01.009; Schweinsburg AD, 2010, ALCOHOL, V44, P111, DOI 10.1016/j.alcohol.2009.09.032; Schweinsburg AD, 2011, ADDICTION, V106, P564, DOI 10.1111/j.1360-0443.2010.03197.x; Silveri MM, 2012, HARVARD REV PSYCHIAT, V20, P189, DOI 10.3109/10673229.2012.714642; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Smith JL, 2015, PSYCHIAT RES-NEUROIM, V233, P424, DOI 10.1016/j.pscychresns.2015.07.014; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Squeglia LM, 2011, ALCOHOL CLIN EXP RES, V35, P1831, DOI 10.1111/j.1530-0277.2011.01527.x; Stroux D, 2016, CLIN NEUROPHYSIOL, V127, P452, DOI 10.1016/j.clinph.2015.05.021; Szmalec A, 2011, J EXP PSYCHOL HUMAN, V37, P137, DOI 10.1037/a0020365; Tapert SF, 1999, J INT NEUROPSYCH SOC, V5, P481, DOI 10.1017/S1355617799566010; Tapert SF, 2001, ALCOHOL CLIN EXP RES, V25, P236, DOI 10.1097/00000374-200102000-00012; Townshend JM, 2005, ALCOHOL CLIN EXP RES, V29, P317, DOI 10.1097/01.ALC.0000156453.05028.F5; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Watter S, 2001, PSYCHOPHYSIOLOGY, V38, P998, DOI 10.1111/1469-8986.3860998; WECHSLER H, 1992, JAMA-J AM MED ASSOC, V267, P2929; Wechsler H, 2001, PSYCHOL ADDICT BEHAV, V15, P287, DOI 10.1037/0893-164X.15.4.287; Weissenborn R, 2003, PSYCHOPHARMACOLOGY, V165, P306, DOI 10.1007/s00213-002-1281-1; Wicki M, 2010, ADDICT BEHAV, V35, P913, DOI 10.1016/j.addbeh.2010.06.015; Wilcox CE, 2014, REV NEUROSCIENCE, V25, P1, DOI 10.1515/revneuro-2013-0054; Yoo J-Y, 2016, NEUROPSYCHIATRY, V6, P321, DOI DOI 10.4172/NEUROPSYCHIATRY.1000156; Yum TH, 1992, MANUAL KOREAN WECHSL; Zhang XL, 1997, PSYCHIAT RES-NEUROIM, V75, P75, DOI 10.1016/S0925-4927(97)00043-7; Zhao X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071063; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	79	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2018	13	9							e0203696	10.1371/journal.pone.0203696	http://dx.doi.org/10.1371/journal.pone.0203696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT7DK	30199547	gold, Green Published, Green Submitted			2022-12-26	WOS:000444681100019
J	Dwomoh, D; Tambaa, C; Addo, SA; Wiah, E; Abdulai, M; Bosomprah, S				Dwomoh, Duah; Tambaa, Chrisantus; Addo, Stephen Ayisi; Wiah, Ekow; Abdulai, Marijanatu; Bosomprah, Samuel			Effect of antiretroviral therapy on all-cause mortality among people living with HIV/AIDS in Ghana using Mahalanobis distant metric matching within propensity score caliper analysis: A retrospective cohort study	PLOS ONE			English	Article							INFERENCE; SURVIVAL	Several health interventions have been put in place to improve health outcomes of people living with HIV/AIDS (PLHIV) in Ghana. We evaluated the impact of Antiretroviral Therapy (ART) on all-cause mortality in Ghana using matching procedures. This was a retrospective cohort study of 12,881 HIV/AIDS patients initiated on ART at 40 sentinel sites and 199 treatment centers between 2013 and 2016 countrywide. Patients were included if they had date of ART initiation and if they had mortality outcome recorded. Mahalanobis distant metric matching within propensity score caliper and other matching procedures were used to evaluate the effectiveness of ART in reducing the risk of all-cause mortality among PLHIV in Ghana. We performed sensitivity analysis using different matching procedures including Kernel weighting adjustment and Mahalanobis distance metric matching with nearest neighbour to ascertain the robustness of our results in the presence of unmeasured covariates. The proportion of patients on ART was 60.3% (95% CI: 59.5 +/- 61.1). The total number of mortalities reported was only 734 representing 4.6% (95% CI: 4.2 +/- 4.9) of the studied population. The risk of all-cause mortality has reduced by 11.6 percentage point among HIV/AIDS patients who were on ART compared to those who were not on ART (95% CI: 9.6 +/- 13.4). ART was associated with a decreased risk of all-cause mortality. Effort being made by Government and non-Governmental organizations in support of ART treatment in Ghana should continue unabated to help reduce mortality rate and improve health outcomes among HIV/AIDS. To reduce bias to the barest minimum between treatment and intervention group when evaluating the effectiveness of health interventions, it is recommended to use matching procedures especially when the study design is not a randomized control trial.	[Dwomoh, Duah; Bosomprah, Samuel] Univ Ghana, Sch Publ Hlth, Dept Biostat, Accra, Ghana; [Tambaa, Chrisantus] Ghana Hlth Serv, Accra, Ghana; [Addo, Stephen Ayisi; Wiah, Ekow; Abdulai, Marijanatu] Natl AIDS STI Control Programme, Accra, Ghana	University of Ghana; Ghana Health Service	Dwomoh, D (corresponding author), Univ Ghana, Sch Publ Hlth, Dept Biostat, Accra, Ghana.	duahdwomoh@yahoo.com		Bosomprah, PhD, Prof. Samuel/0000-0002-2826-3887				Afful G. Y., 2012, FACTORS INFLUENICING; Akwara P. A., 2005, DEPTH ANAL HIV PREVA; [Anonymous], 2016, GLOBAL REPORT DIABET; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Barry O., 2013, EFFECTIVENESS 1 LINE, DOI [10.1186/1471-2334-13-476, DOI 10.1186/1471-2334-13-476]; BASER O, 2007, J MED ECON, V10, P379, DOI DOI 10.3111/13696990701646577; Boulle A S. B., PLOS MED, V11; Brechtl JR, 2001, J PAIN SYMPTOM MANAG, V21, P41, DOI 10.1016/S0885-3924(00)00245-1; CDC, 2010, HIV AIDS FACTSH IM G, P1; COCHRAN WG, 1973, SANKHYA SER A, V35, P417; Davies MA, 2016, CURR OPIN HIV AIDS, V11, P455, DOI 10.1097/COH.0000000000000303; Dehejia RH, 1999, J AM STAT ASSOC, V94, P1053, DOI 10.2307/2669919; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Faizi Z., 2016, BR J MED MED RES, V15, P1; Glazerman S, 2003, ANN AM ACAD POLIT SS, V589, P63, DOI 10.1177/0002716203254879; Heckman JJ, 1998, REV ECON STUD, V65, P261, DOI 10.1111/1467-937X.00044; Lesko CR, 2016, INT J EPIDEMIOL, V45, P140, DOI 10.1093/ije/dyv352; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Reniers G, 2014, AIDS, V28, pS533, DOI 10.1097/QAD.0000000000000496; Rosenbaum PR, 2005, AM STAT, V59, P147, DOI 10.1198/000313005X42831; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Rubin DB, 2000, J AM STAT ASSOC, V95, P573, DOI 10.2307/2669400; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Sturge C., 2006, CHILD ADOL MENT H-UK, V11, P46; UNAIDS, 2016, GLOB AIDS UPD, P1	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203461	10.1371/journal.pone.0203461	http://dx.doi.org/10.1371/journal.pone.0203461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT0BU	30192892	Green Submitted, gold, Green Published			2022-12-26	WOS:000444093600080
J	Roda, A; Cong, MY; Donner, B; Dickens, K; Howe, A; Sharma, S; Smith, T				Roda, Amy; Cong, Mary Yong; Donner, Bryce; Dickens, Katrina; Howe, Amy; Sharma, Shweta; Smith, Trevor			Designing a trapping strategy to aid Giant African Snail (Lissachatina fulica) eradication programs	PLOS ONE			English	Article							TERM PEST-MANAGEMENT; SLUG; MOLLUSCICIDES; TRAPS; BARRIERS	In pest eradication programs, traps can directly reduce pest populations; however, their application to gastropod programs remains relatively unexplored. The South Florida Giant African Snail, Liassachatina fulica (Pulmonata: Achatinidae), eradication program allowed a realistic evaluation of their utility. Field studies were conducted to determine the best bait, barrier and trap for use during the eradication program. Immature and adult snails were attracted to banana fruit and a commercially produced bait but only the commercially produced bait did not attract non-target and pest mammals. Four commercially produced traps and 4 barriers were field evaluated for snail retention efficacy. Snails escaped all traps and trap/barrier combinations but the rate of escape ranged from 10-100% after 24 hrs. Laboratory studies confirmed that snails can survive crossing a 5 cm barrier of copper tape, salt, insect stickem or antifouling paint. In the laboratory study snails did not cross copper sulfate but they crossed the barrier in the field. Adding salt to traps as a means to retain snails reduced the number of snails trapped. Laboratory studies confirmed that dry salt decreased the number of snails entering traps and snails did not enter traps when the salt was dissolved in water. Two trap types and the commercial bait were selected for a large-scale program test. For three months, trapping along with hand collection and pesticide application were conducted on 114 properties in five locations. Traps caught snails when surveys and regular pesticide applications on the same properties did not detect them. On 21 occasions snails were only found in traps, and both immature and adult snails were caught. This study showed that traps could be effectively deployed in an eradication program and they could capture snails that may have escaped other control measures.	[Roda, Amy] Anim Plant Hlth Inspect Serv, Miami Lab, Sci & Technol, Plant Protect & Quarantine,USDA, Miami, FL 33158 USA; [Cong, Mary Yong; Dickens, Katrina; Howe, Amy; Sharma, Shweta; Smith, Trevor] Florida Dept Agr & Consumer Serv, Div Plant Ind, Gainesville, FL USA; [Donner, Bryce] Univ Florida, Dept Landscape Architecture, Gainesville, FL USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Roda, A (corresponding author), Anim Plant Hlth Inspect Serv, Miami Lab, Sci & Technol, Plant Protect & Quarantine,USDA, Miami, FL 33158 USA.	Amy.L.Roda@aphis.usda.gov			Farm Bill Section 10007 project [6.0523]; USDA Agriculture Ambassador program	Farm Bill Section 10007 project; USDA Agriculture Ambassador program	This work was supported by Farm Bill Section 10007 project 6.0523 awarded to Florida Department of Agriculture and Consumer Services, and USDA Agriculture Ambassador program awarded to Bryce Donner.	Bhattacharyya B, 2015, INT J PLANT PROT, V7, P476; Borrero Francisco J., 2009, Tentacle, V17, P6; Capinera JL, 2011, GIANT AFRICAN LAND S; Ciomperlik MA, 2013, FLA ENTOMOL, V96, P370, DOI 10.1653/024.096.0257; COLMAN P H, 1977, Malacological Review, V10, P77; Cordoba M, 2011, ANN APPL BIOL, V159, P130, DOI 10.1111/j.1744-7348.2011.00481.x; Douglas MR, 2012, J INTEGR PEST MANAG, V3, DOI 10.1603/IPM11023; El-Sayed AM, 2006, J ECON ENTOMOL, V99, P1550, DOI 10.1603/0022-0493-99.5.1550; El-Sayed AM, 2009, J ECON ENTOMOL, V102, P815, DOI 10.1603/029.102.0301; Fontanilla IKC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105151; Gherardi F., 2007, BIODIVERSITY CONSERV, P274; Global Invasive Species Database, 2012, GLOBAL INVASIVE SPEC; Hagnell J, 2006, CROP PROT, V25, P212, DOI 10.1016/j.cropro.2005.04.008; Hata TY, 1997, CROP PROT, V16, P501, DOI 10.1016/S0261-2194(97)00034-3; Kheirodin A., 2012, African Journal of Agricultural Research, V7, P5701; Koehler CS, 1983, CALIF AGR, V37, P15; Muller K, 1999, P GESELLSCHAFT OKOLO, V29, P337; Myers JH, 2000, TRENDS ECOL EVOL, V15, P316, DOI 10.1016/S0169-5347(00)01914-5; National Center for Biotechnology Information, 2017, COPP SULF; Nelson S., 2012, INJURIES CAUSED GIAN, P1; Poucher C, 1975, ANN M FLA STATE HORT, V88, P523; Prasad GS, 2004, CURR SCI INDIA, V87, P1657; Raut S. K., 2002, P55, DOI 10.1079/9780851993201.0055; Roda A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165408; Sarma RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143724; Schuder I, 2003, CROP PROT, V22, P1033, DOI 10.1016/S0261-2194(03)00120-0; Smith TR, 2013, FLA ENTOMOL, V96, P396, DOI 10.1653/024.096.0202; Sokal R., 2013, BIOMETRY PRINCIPLES; Toit WJ, 1992, FRUITS PARIS, V47, P657; Vanitha K., 2008, Annals of Plant Protection Sciences, V16, P221; Vanitha K., 2011, Pest Management in Horticultural Ecosystems, V17, P38; YOUNG AG, 1990, CROP PROT, V9, P355, DOI 10.1016/0261-2194(90)90006-S; Zar J. H., 2007, BIOSTATISTICAL ANAL	33	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203572	10.1371/journal.pone.0203572	http://dx.doi.org/10.1371/journal.pone.0203572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192843	gold, Green Published, Green Submitted			2022-12-26	WOS:000444093600107
J	Schuez-Havupalo, L; Lahti, E; Junttila, N; Toivonen, L; Aromaa, M; Rautava, P; Peltola, V; Raiha, H				Schuez-Havupalo, Linnea; Lahti, Elina; Junttila, Niina; Toivonen, Laura; Aromaa, Minna; Rautava, Paivi; Peltola, Ville; Raiha, Hannele			Parents' depression and loneliness during pregnancy and respiratory infections in the offspring: A prospective birth cohort study	PLOS ONE			English	Article							PRENATAL STRESS; PSYCHOSOCIAL STRESS; SELF-EFFICACY; HEALTH-CARE; SYMPTOMS; ASSOCIATIONS; ANXIETY; INFANCY; RISK	Background An association between maternal prenatal stress and increased rates of respiratory tract infections in the offspring has been described earlier. Data regarding the father's role is lacking. In this study our aim was to evaluate, whether mothers' and fathers' depressive symptoms and loneliness during pregnancy predict higher rates of respiratory tract infections in the offspring. Methods In this longitudinal cohort study we gathered information on parental psychological risk during gestational week 20 using the BDI-II and UCLA loneliness scale questionnaires for the parents of 929 children. Loneliness was divided into social and emotional components, the former describing patterns of social isolation and the latter a perceived lack of intimate attachments. Episodes of acute otitis media, physician visits due to respiratory tract infections, and antibiotic consumption relating to respiratory tract infections were documented in the infants, excluding twins, from birth until 10 months of age using study diaries. Analyses were carried out by structural equation modeling, which provides dynamic estimates of covariances. Results Maternal depressive symptoms during pregnancy predicted higher rates of acute otitis media in the infant and maternal emotional loneliness predicted higher rates of physician visits. Acute otitis media, physician visits and antibiotic consumption in the infant were slightly less frequent for families who reported social loneliness in the father or mother. Associations remained when taking into account confounders. Conclusions Maternal prenatal depression and emotional loneliness predicted a higher burden of respiratory tract infections in the offspring. The protective influence of parental social loneliness on the burden of respiratory tract infections in infants was not in line with our study hypothesis, but could be explained by reduced use of healthcare services in these socially isolated families.	[Schuez-Havupalo, Linnea; Lahti, Elina; Toivonen, Laura; Peltola, Ville] Turku Univ Hosp, Dept Pediat & Adolescent Med, Turku, Finland; [Schuez-Havupalo, Linnea; Lahti, Elina; Toivonen, Laura; Peltola, Ville] Univ Turku, Turku, Finland; [Lahti, Elina; Aromaa, Minna] Outpatient Clin Children & Adolescents, Turku, Finland; [Junttila, Niina; Raiha, Hannele] Univ Turku, Dept Psychol, Turku, Finland; [Junttila, Niina] Univ Turku, Dept Teacher Educ, Turku, Finland; [Rautava, Paivi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Rautava, Paivi] Turku Univ Hosp, Clin Res Ctr, Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; University of Turku	Peltola, V (corresponding author), Turku Univ Hosp, Dept Pediat & Adolescent Med, Turku, Finland.; Peltola, V (corresponding author), Univ Turku, Turku, Finland.	ville.peltola@utu.fi		Junttila, Niina/0000-0002-9096-377X	Academy of Finland [123571, 140251, 277535]; Foundation for Pediatric Research; Specified Government Transfers; Hospital District of Southwest Finland; City of Turku; University of Turku Foundation; TYKS Foundation	Academy of Finland(Academy of Finland); Foundation for Pediatric Research; Specified Government Transfers; Hospital District of Southwest Finland; City of Turku; University of Turku Foundation; TYKS Foundation	This work was supported by the Academy of Finland, grants 123571, 140251, and 277535; the Foundation for Pediatric Research; research funds from Specified Government Transfers, Hospital District of Southwest Finland and City of Turku. Dr Schuez-Havupalo was supported by the University of Turku Foundation and TYKS Foundation.	Anders KL, 2015, PEDIATR INFECT DIS J, V34, P361, DOI 10.1097/INF.0000000000000643; Ban L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-799; Beck AT, 1996, PSYCHOL ASSESS; Beijers R, 2014, EUR CHILD ADOLES PSY, V23, P943, DOI 10.1007/s00787-014-0566-3; Beijers R, 2010, PEDIATRICS, V126, pE401, DOI 10.1542/peds.2009-3226; Cacioppo JT, 2010, PSYCHOL AGING, V25, P453, DOI 10.1037/a0017216; Ekblad M, 2014, EUR J PUBLIC HEALTH, V24, P544, DOI 10.1093/eurpub/ckt128; Geller JS, 2004, J PSYCHOSOM OBST GYN, V25, P203, DOI 10.1080/01674820400017806; Henriksen RE, 2015, PLOS ONE, V10; HORWITZ SM, 1985, MED CARE, V23, P946, DOI 10.1097/00005650-198508000-00002; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jacobs-van der Bruggen MAM, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-83; Jones TL, 2005, CLIN PSYCHOL REV, V25, P341, DOI 10.1016/j.cpr.2004.12.004; Junttila N., 2013, AUST J PSYCHOL, V50, P98; Junttila N, 2015, SCAND J PSYCHOL, V56, P482, DOI 10.1111/sjop.12241; Kvalevaag AL, 2013, PEDIATRICS, V131, pE463, DOI 10.1542/peds.2012-0804; Lagstrom H, 2013, INT J EPIDEMIOL, V42, P1273, DOI 10.1093/ije/dys150; Little T. D., 2013, LONGITUDINAL STRUCTU; Louhi-Pirkanniemi K, 2004, ACTA PAEDIATR, V93, P1386, DOI 10.1080/08035250410028048; Marques AH, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00120; Mattes E, 2009, BRAIN BEHAV IMMUN, V23, P380, DOI 10.1016/j.bbi.2008.12.004; McKnight P. E., 2007, MISSING DATA GENTLE; Merlot E, 2008, BRAIN BEHAV IMMUN, V22, P42, DOI 10.1016/j.bbi.2007.05.007; Minkovitz CS, 2005, PEDIATRICS, V115, P306, DOI 10.1542/peds.2004-0341; Muthen LK, 2013, MPLUS VERSION 7 STAT; Newall N, 2015, J AGING HEALTH, V27, P500, DOI 10.1177/0898264314552420; Nielsen NM, 2011, AM J EPIDEMIOL, V173, P990, DOI 10.1093/aje/kwq492; O'Connor TG, 2013, BRAIN BEHAV IMMUN, V32, P21, DOI 10.1016/j.bbi.2013.02.002; Perren S, 2005, J PSYCHOSOM OBST GYN, V26, P173, DOI 10.1080/01674820400028407; Pressman SD, 2005, HEALTH PSYCHOL, V24, P297, DOI 10.1037/0278-6133.24.3.297; RILEY AW, 1993, MED CARE, V31, P767, DOI 10.1097/00005650-199309000-00002; RUSSELL D, 1980, J PERS SOC PSYCHOL, V39, P472, DOI 10.1037/0022-3514.39.3.472; Schuez-Havupalo L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014635; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Tegethoff M, 2011, ENVIRON HEALTH PERSP, V119, P1647, DOI 10.1289/ehp.1003253; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Weiss R. S, 1973, LONELINESS EXPERIENC; Wernand JJ, 2014, INFANT MENT HEALTH J, V35, P42, DOI 10.1002/imhj.21425; Zijlmans MAC, 2015, PSYCHONEUROENDOCRINO, V53, P233, DOI 10.1016/j.psyneuen.2015.01.006	41	12	13	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203650	10.1371/journal.pone.0203650	http://dx.doi.org/10.1371/journal.pone.0203650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT0BU	30192872	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600127
J	Khan, ANS; Billah, SM; Mannan, I; Mannan, II; Begum, T; Khan, MA; Islam, M; Ahasan, SMM; Rahman, JN; George, J; El Arifeen, S; Meena, USJ; Rashid, I; de Graft-Johnson, J				Khan, Abdullah Nurus Salam; Billah, Sk Masum; Mannan, Ishtiaq; Mannan, Imteaz Ibne; Begum, Tahmina; Khan, Marufa Aziz; Islam, Munia; Ahasan, S. M. Monirul; Rahman, Jebun Nessa; George, Joby; El Arifeen, Shams; Meena, Umme Salma Jahan; Rashid, Iftekhar; de Graft-Johnson, Joseph			A cross-sectional study of partograph utilization as a decision making tool for referral of abnormal labour in primary health care facilities of Bangladesh	PLOS ONE			English	Article							LOW-RESOURCE SETTINGS; ORGANIZATION PARTOGRAPH; ANGOLAN MIDWIVES; SEEKING BEHAVIOR; OBSTETRIC CARE; IMPLEMENTATION; KNOWLEDGE; DISTRICT; BIRTH	Background In Bangladesh, female paramedics known as Family Welfare Visitors (FWVs), conduct normal deliveries in first-level primary care facilities, or Union Health and Family Welfare Centres (UH&FWC). Utilization of partographs allow for early identification of abnormal labour and referral for advanced care to Emergency Obstetric Care (EmOC) facilities. A systematic assessment of the quality of partograph utilization in clinical-decision making will contribute to understanding the use of the tool by health workers. Methods In 2013, the USAID supported MaMoni HSS project, led in country by Save the Children, trained FWVs on the use of partographs in five UH&FWCs in Habiganj district. As part of the follow-up after training, intrapartum case record forms, accompanying partographs, and referral registers for all obstetric cases managed in these five facilities from July 2013 to June 2014 were reviewed. Partographs were reviewed to identify abnormal labour cases based on pre-defined indications. All referred cases were ascertained from the case records in the referral registers. Five health workers were interviewed to assess their knowledge, attitude and experience in partograph use and to explore the challenges for referral decision making associated with the tool. Results A total of 1,198 deliveries were managed at the study sites, of which 663 presented with cervical dilatation of 8 cm or less. Partographs were initiated in 98% of these cases. Indication of abnormal labour was found in 71 partographs (11%) and among them, only 1 was referred to a higher-level facility. Foetal heart rate and cervical dilatation were appropriately recorded in 61% and 70% of the partographs, respectively. Interviews with health workers revealed poor interpretation of referral indications from the partographs. Limited accessibility to the nearest EmOC facility, inadequate time for referral, and non-compliance to referral by clients were identified by the interviewed health workers as the key barriers for referral decision making. Conclusions Supporting the health workers at first-level primary care facilities to better interpret and act on partograph data in a timely manner, and strengthening the referral systems are needed to ensure that women in labour receive the prompt quality care they and their babies require to survive.	[Khan, Abdullah Nurus Salam; Billah, Sk Masum; Ahasan, S. M. Monirul; El Arifeen, Shams] Int Ctr Diarrhoea Dis Res Bangladesh, Maternal & Child Hlth Div, Dhaka, Bangladesh; [Mannan, Ishtiaq; Mannan, Imteaz Ibne; Khan, Marufa Aziz; Islam, Munia; George, Joby] Save The Children, Dhaka, Bangladesh; [Begum, Tahmina] Int Ctr Diarrhoea Dis Res Bangladesh, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh; [Rahman, Jebun Nessa] Jhpiego Corp, Dhaka, Bangladesh; [Meena, Umme Salma Jahan; Rashid, Iftekhar] USAID Bangladesh, Dhaka, Bangladesh; [de Graft-Johnson, Joseph] Save The Children, Dept Global Hlth, Ellicott City, MD USA	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); United States Agency for International Development (USAID)	Billah, SM (corresponding author), Int Ctr Diarrhoea Dis Res Bangladesh, Maternal & Child Hlth Div, Dhaka, Bangladesh.	billah@icddrb.org	Begum, Tahmina/AAD-5258-2021; George, Joby/AAW-1365-2021; Mannan, Imteaz/AAO-9935-2021; Khan, Abdullah Nurus Salam/J-1661-2018	Begum, Tahmina/0000-0001-8106-2454; Khan, Abdullah Nurus Salam/0000-0002-8694-4349; Arifeen, Shams/0000-0002-5372-5932; Rashid, Iftekhar/0000-0003-2775-3435; George, Joby/0000-0002-4791-901X	American people through the United States Agency for International Development (USAID); Associate Cooperative Agreement Save the Children [AID-338-LA-13-00004]; MaMoni Health Systems Strengthening (MaMoni HSS)	American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Associate Cooperative Agreement Save the Children; MaMoni Health Systems Strengthening (MaMoni HSS)	This study is conducted as a part of MaMoni Health Systems Strengthening (MaMoni HSS) initiative with generous support of the American people through the United States Agency for International Development (USAID); Associate Cooperative Agreement Save the Children no. AID-338-LA-13-00004 - MaMoni Health Systems Strengthening (MaMoni HSS). The contents are the responsibilities of the authors and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker U, 2015, B WORLD HEALTH ORGAN, V93, P380, DOI 10.2471/BLT.14.141879; Bari S, 2006, J HEALTH POPUL NUTR, V24, P519; Barnea O, 2009, J OBSTET GYNAECOL RE, V35, P654, DOI 10.1111/j.1447-0756.2008.00996.x; Bedwell C, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-016-1213-4; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chaturvedi S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006211; Chowdhury ME, 2014, NEEDS ASSESSMENT STU; de Azevedo Aguiar C, 2013, OPEN J OBSTET GYNECO, V3, P1; Directorate general of family planning, 2016, DIR GEN FAM PLANN ST; Dohbit J, 2010, CLIN MOTHER CHILD HL, V7; Fahdhy M, 2005, MIDWIFERY, V21, P301, DOI 10.1016/j.midw.2004.12.010; Fawole AO, 2010, NIGER J CLIN PRACT, V13, P200; Gans-Lartey F, 2013, MIDWIFERY, V29, P461, DOI 10.1016/j.midw.2012.03.002; Grol R, 2004, MED J AUSTRALIA, V180, pS57, DOI 10.5694/j.1326-5377.2004.tb05948.x; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Haines A, 2004, B WORLD HEALTH ORGAN, V82, P724; Haque MA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3296-2; Hofmeyr GJ, 2009, INT J GYNECOL OBSTET, V107, pS21, DOI 10.1016/j.ijgo.2009.07.017; Konlan KD, 2016, MATERN HLTH NEONATOL, V2, P1; KWAST BE, 1994, LANCET, V343, P1399; Lavender DT, 2013, MIDWIFERY, V29, P876, DOI 10.1016/j.midw.2012.10.003; Lavender T, 2013, COCHRANE DB SYST REV, V7; LEIGH B, 1986, J TROP PEDIATRICS, V32, P107, DOI 10.1093/tropej/32.3.107; Markos D, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0074-z; Mathai M, 2009, CLIN OBSTET GYNECOL, V52, P256, DOI 10.1097/GRF.0b013e3181a4f163; MCHIP Save The Children, 2017, NEWSL MAMONI HLTH SY; Ministry of Health and Family Welfare (MOHFW), 2014, BANGL HLTH B 2013; Ministry of Health and Family Welfare (MOHFW), 2015, NAT STRAT MAT HLTH 2; Ministry of Health and Family Welfare (MOHFW), 2017, PROJ IMPL PLAN HLTH; Murray SF, 2006, SOC SCI MED, V62, P2205, DOI 10.1016/j.socscimed.2005.10.025; National Institute of Population Research and Training (NIPORT), 2012, MEASURE EV ICDDR B B; Nyamtema AS, 2008, INT J GYNECOL OBSTET, V100, P37, DOI 10.1016/j.ijgo.2007.06.049; O'Malley AS, 2016, MDM POLICY PRACT, V1; Ogwang S, 2009, AFR HEALTH SCI, V9, pS27; Oladapo O T, 2006, J Obstet Gynaecol, V26, P538, DOI 10.1080/01443610600811243; Panciera R, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1032-7; Pettersson KO, 2000, MIDWIFERY, V16, P82, DOI 10.1054/midw.1999.0206; Pettersson KO, 2001, MIDWIFERY, V17, P102, DOI 10.1054/midw.2000.0250; Qureshi Z P, 2010, East Afr Med J, V87, P235; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Sharma M, 2008, INDIAN J PUBLIC HLTH, V53, P177; Speciale AM, 2013, J MIDWIFERY WOM HEAL, V58, P76, DOI 10.1111/j.1542-2011.2012.00243.x; Wall SN, 2010, SEMINARS PERINATOLOG; WALRAVEN GEL, 1994, LANCET, V344, P617, DOI 10.1016/S0140-6736(94)92004-4; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World Health Organization, 1994, APPL WHO PART MAN LA; World Health Organization, 2003, REPR HLTH PREGN CHIL; World Health Organization, 2008, MAN PROL OBSTR LAB; Yisma E, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-23; Yisma E, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-17	50	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203617	10.1371/journal.pone.0203617	http://dx.doi.org/10.1371/journal.pone.0203617			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT1KN	30188940	Green Published, Green Submitted, gold			2022-12-26	WOS:000444228700048
J	Fan, RH; Chen, YQ; Ye, XX; Wu, JS; Lin, B; Zhong, HQ				Fan, Ronghui; Chen, Yiquan; Ye, Xiuxian; Wu, Jianshe; Lin, Bing; Zhong, Huaiqin			Transcriptome analysis of Polianthes tuberosa during floral scent formation	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; BENZOIC-ACID BIOSYNTHESIS; TERPENE SYNTHASES; PETUNIA FLOWERS; NICOTIANA-SUAVEOLENS; ARABIDOPSIS FLOWERS; SHIKIMATE PATHWAY; PLANTS; GENES; METABOLISM	Polianthes tuberosa is a popular ornamental plant. Its floral scent volatiles mainly consist of terpenes and benzenoids that emit a charming fragrance. However, our understanding of the molecular mechanism responsible for the floral scent of P. tuberosa is limited. Using transcriptome sequencing and de novo assembly, a total of 228,706,703 high-quality reads were obtained, which resulted in the identification of 96,906 unigenes (SRA Accession Number SRP126470, TSA Acc. No. GGEA00000000). Approximately 41.85% of the unigenes were functionally annotated using public databases. A total of 4,694 differentially expressed genes (DEGs) were discovered during flowering. Gas chromatography-mass spectrometry analysis revealed that the majority of the volatiles comprised benzenoids and small amounts of terpenes. Homology analysis identified 13 and 17 candidate genes associated with terpene and benzenoid biosynthesis, respectively. Among these, PtTPS1, PtDAHPSs, PtPAL1, and PtBCMT2 might play important roles in regulating the formation of floral volatiles. The data generated by transcriptome sequencing provide a critical resource for exploring concrete characteristics as well as for supporting functional genomics studies. The results of the present study also lay the foundation for the elucidation of the molecular mechanism underlying the regulation of floral scents in monocots.	[Fan, Ronghui; Ye, Xiuxian; Wu, Jianshe; Lin, Bing; Zhong, Huaiqin] Fujian Acad Agr Sci, Inst Crop Sci, Fuzhou, Fujian, Peoples R China; [Fan, Ronghui; Ye, Xiuxian; Wu, Jianshe; Lin, Bing; Zhong, Huaiqin] Fujian Acad Agr Sci, Flowers Res Ctr, Fuzhou, Fujian, Peoples R China; [Fan, Ronghui; Ye, Xiuxian; Wu, Jianshe; Lin, Bing; Zhong, Huaiqin] Fujian Engn Res Ctr Characterist Floriculture, Fuzhou, Fujian, Peoples R China; [Chen, Yiquan] Fujian Acad Agr Sci, Inst Agr Engn Technol, Fuzhou, Fujian, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Fujian Academy of Agricultural Sciences; Fujian Academy of Agricultural Sciences; Fujian Academy of Agricultural Sciences	Zhong, HQ (corresponding author), Fujian Acad Agr Sci, Inst Crop Sci, Fuzhou, Fujian, Peoples R China.; Zhong, HQ (corresponding author), Fujian Acad Agr Sci, Flowers Res Ctr, Fuzhou, Fujian, Peoples R China.; Zhong, HQ (corresponding author), Fujian Engn Res Ctr Characterist Floriculture, Fuzhou, Fujian, Peoples R China.	zhqeast@163.com			Special Project of Public Welfare Research Institutes in Fujian [2018R1026-6]; Innovation Team Project of the Fujian Academy of Agricultural Science [STIT2017-2-9]	Special Project of Public Welfare Research Institutes in Fujian; Innovation Team Project of the Fujian Academy of Agricultural Science	Special Project of Public Welfare Research Institutes in Fujian (2018R1026-6), and Innovation Team Project of the Fujian Academy of Agricultural Science (STIT2017-2-9) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Boatright J, 2004, PLANT PHYSIOL, V135, P1993, DOI 10.1104/pp.104.045468; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Bussell JD, 2014, PLANT PHYSIOL, V164, P48, DOI 10.1104/pp.113.229807; Chen F, 2003, PLANT CELL, V15, P481, DOI 10.1105/tpc.007989; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Chung PJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2997-3; Colquhoun TA, 2012, J EXP BOT, V63, P4821, DOI 10.1093/jxb/ers153; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; Dudareva N, 2013, NEW PHYTOL, V198, P16, DOI 10.1111/nph.12145; Estevez JM, 2001, J BIOL CHEM, V276, P22901, DOI 10.1074/jbc.M100854200; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guterman I, 2002, PLANT CELL, V14, P2325, DOI 10.1105/tpc.005207; Hamberger B, 2007, CAN J BOT, V85, P1182, DOI 10.1139/B07-098; Hamilton JP, 2012, PLANT J, V70, P177, DOI 10.1111/j.1365-313X.2012.04894.x; Hu ZH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01351; Jin JJ, 2015, J EXP BOT, V66, P3959, DOI 10.1093/jxb/erv196; Kanani M, 2017, HORTIC ENVIRON BIOTE, V58, P136, DOI 10.1007/s13580-017-0055-y; Kao YY, 2002, PLANT PHYSIOL, V130, P796, DOI 10.1104/pp.006262; Klempien A, 2012, PLANT CELL, V24, P2015, DOI 10.1105/tpc.112.097519; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Kwenda S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2967-9; Langer KM, 2014, PHYTOCHEMISTRY, V103, P22, DOI 10.1016/j.phytochem.2014.04.004; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2008, PLANT PHYSIOL, V147, P1017, DOI 10.1104/pp.108.115824; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Maiti S, 2017, PLANT CELL PHYSIOL, V58, P2095, DOI 10.1093/pcp/pcx143; Maiti S, 2014, ACTA PHYSIOL PLANT, V36, P2597, DOI 10.1007/s11738-014-1630-9; Martin DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-226; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Meena S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01129; Muhlemann JK, 2014, PLANT CELL ENVIRON, V37, P1936, DOI 10.1111/pce.12314; Muhlemann JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040381; Murfitt LM, 2000, ARCH BIOCHEM BIOPHYS, V382, P145, DOI 10.1006/abbi.2000.2008; Nagegowda DA, 2008, PLANT J, V55, P224, DOI 10.1111/j.1365-313X.2008.03496.x; Negre F, 2003, PLANT CELL, V15, P2992, DOI 10.1105/tpc.016766; Orlova I, 2006, PLANT CELL, V18, P3458, DOI 10.1105/tpc.106.046227; Pott MB, 2004, PLANT PHYSIOL, V135, P1946, DOI 10.1104/pp.104.041806; Qualley AV, 2012, P NATL ACAD SCI USA, V109, P16383, DOI 10.1073/pnas.1211001109; Rakthaworn P., 2009, Kasetsart Journal, Natural Sciences, V43, P204; Roeder S, 2007, PLANT MOL BIOL, V65, P107, DOI 10.1007/s11103-007-9202-7; Tholl D, 2005, PLANT J, V42, P757, DOI 10.1111/j.1365-313X.2005.02417.x; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Toh Conie, 2017, BMC Res Notes, V10, P554, DOI 10.1186/s13104-017-2872-6; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tzin V, 2012, NEW PHYTOL, V194, P430, DOI 10.1111/j.1469-8137.2012.04052.x; Tzin Vered, 2010, Arabidopsis Book, V8, pe0132, DOI 10.1199/tab.0132; Van Moerkercke A, 2009, PLANT J, V60, P292, DOI 10.1111/j.1365-313X.2009.03953.x; Vandermoten S, 2009, CELL MOL LIFE SCI, V66, P3685, DOI 10.1007/s00018-009-0100-9; Verdonk JC, 2005, PLANT CELL, V17, P1612, DOI 10.1105/tpc.104.028837; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Vranova E, 2013, ANNU REV PLANT BIOL, V64, P665, DOI 10.1146/annurev-arplant-050312-120116; Waithaka K, 2001, J HORTIC SCI BIOTECH, V76, P271, DOI 10.1080/14620316.2001.11511362; Ward JA, 2012, AM J BOT, V99, P267, DOI 10.3732/ajb.1100334; Wildermuth MC, 2006, CURR OPIN PLANT BIOL, V9, P288, DOI 10.1016/j.pbi.2006.03.006; Yue YC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1653-7; [张辉秀 Zhang Huixiu], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P790	59	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0199261	10.1371/journal.pone.0199261	http://dx.doi.org/10.1371/journal.pone.0199261			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183703	gold, Green Published, Green Submitted			2022-12-26	WOS:000443789900083
J	Pettersson, NF; Deronic, A; Nilsson, J; Hannibal, TD; Hansen, L; Schmidt-Christensen, A; Ivars, F; Holmberg, D				Pettersson, Nina Fransen; Deronic, Adnan; Nilsson, Julia; Hannibal, Tine D.; Hansen, Lisbeth; Schmidt-Christensen, Anja; Ivars, Fredrik; Holmberg, Dan			The immunomodulatory quinoline-3-carboxamide paquinimod reverses established fibrosis in a novel mouse model for liver fibrosis	PLOS ONE			English	Article							S100A9; CELLS; ACCUMULATION; INHIBITION; ABR-215757; CANCER	Quinoline-3-carboxamides (Q substances) are small molecule compounds with anti-inflammatory properties. In this study, we used one of these substances, Paquinimod, to treat a novel model for chronic liver inflammation and liver fibrosis, the NOD-Inflammation Fibrosis (N-IF) mouse. We show that treatment of N-IF mice significantly reduced inflammation and resulted in the regression of fibrosis, even when the treatment was initiated after onset of disease. The reduced disease phenotype was associated with a systemic decrease in the number and reduced activation of disease-promoting transgenic natural killer T (NKT)-II cells and their type 2-cytokine expression profile. Paquinimod treatment also led to a reduction of CD115(+) Ly6C(hi) monocytes and CD11b(+) F4/80(+) CD206(+) macrophages.	[Pettersson, Nina Fransen; Deronic, Adnan; Nilsson, Julia; Hannibal, Tine D.; Hansen, Lisbeth; Schmidt-Christensen, Anja; Ivars, Fredrik; Holmberg, Dan] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Holmberg, D (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	dan.holmberg@med.lu.se	Schmidt-Christensen, Anja/L-6284-2016	Schmidt-Christensen, Anja/0000-0001-5813-9118; Fransen Pettersson, Nina/0000-0002-5049-1544; Hannibal, Tine/0000-0001-8036-6704; Nilsson, Julia/0000-0001-8170-2167	NovoNordisk Fonden [NNF15OC0016146]; Diabetesfonden [DIA2017-221]; Barndiabetesfonden; Lundberg Foundation	NovoNordisk Fonden(Novo Nordisk Foundation); Diabetesfonden; Barndiabetesfonden; Lundberg Foundation(European Commission)	This work was supported by (DH) NovoNordisk Fonden, NNF15OC0016146, Diabetesfonden, DIA2017-221, Barndiabetesfonden, and the Lundberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Baeck C, 2014, HEPATOLOGY, V59, P1060, DOI 10.1002/hep.26783; Bengtsson AA, 2012, ARTHRITIS RHEUM-US, V64, P1579, DOI 10.1002/art.33493; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Deronic A, 2014, INT IMMUNOPHARMACOL, V18, P290, DOI 10.1016/j.intimp.2013.12.008; Eberl G, 1999, J IMMUNOL, V162, P6410; Fransen-Pettersson N, J IMMUNOL UNPUB; Fransen-Pettersson N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159850; Giannandrea M, 2014, DIS MODEL MECH, V7, P193, DOI 10.1242/dmm.012062; Hesselstrand R, 2014, ANN RHEUM DIS, V73, P566, DOI 10.1136/annrheumdis-2014-eular.4207; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kaye J, 2016, P NATL ACAD SCI USA, V113, pE6145, DOI 10.1073/pnas.1607843113; Lech M, 2013, BBA-MOL BASIS DIS, V1832, P989, DOI 10.1016/j.bbadis.2012.12.001; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Schelbergen RF, 2015, ANN RHEUM DIS, V74, P2254, DOI 10.1136/annrheumdis-2014-206517; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Shen L, 2015, CANCER IMMUNOL RES, V3, P136, DOI 10.1158/2326-6066.CIR-14-0036; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666	21	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203228	10.1371/journal.pone.0203228	http://dx.doi.org/10.1371/journal.pone.0203228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183741	Green Published, gold, Green Submitted			2022-12-26	WOS:000443789900051
J	Bedford, MT				Bedford, Mark T.			Screening for histone codebreakers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							DOMAIN; H3	The lysine methyltransferase NSD2 is overexpressed and carries gain-of-function mutations in a number of different cancers, making it an attractive therapeutic target. However, no specific small molecule inhibitors have been identified for this enzyme, responsible for depositing the H3K36me2 mark on histones. A new study reports a robust platform for high-throughput screening (HTS) assays to facilitate this discovery.	[Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA	University of Texas System; UTMD Anderson Cancer Center	Bedford, MT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA.	mtbedford@mdanderson.org		bedford, mark/0000-0002-8899-1050	NIGMS NIH HHS [R01 GM126421] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM126421] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Coussens NP, 2018, J BIOL CHEM, V293, P13750, DOI 10.1074/jbc.RA118.004274; Hudlebusch HR, 2011, CLIN CANCER RES, V17, P2919, DOI 10.1158/1078-0432.CCR-10-1302; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Oyer JA, 2014, LEUKEMIA, V28, P198, DOI 10.1038/leu.2013.204; Sankaran SM, 2016, J BIOL CHEM, V291, P8465, DOI 10.1074/jbc.M116.720748; Shen C, 2015, CURR OPIN ONCOL, V27, P57, DOI 10.1097/CCO.0000000000000151; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412	10	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13766	+		10.1074/jbc.H118.005132	http://dx.doi.org/10.1074/jbc.H118.005132			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30171150	hybrid, Green Published			2022-12-26	WOS:000443375500034
J	Peng, ZL; Huang, LW; Yin, J; Zhang, KN; Xiao, K; Qing, GZ				Peng, Zheng-Liang; Huang, Liang-Wei; Yin, Jian; Zhang, Ke-Na; Xiao, Kang; Qing, Guo-Zhong			Association between early serum cholinesterase activity and 30-day mortality in sepsis-3 patients: A retrospective cohort study	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; INTERNATIONAL CONSENSUS DEFINITIONS; BUTYRYLCHOLINESTERASE ACTIVITY; SEPTIC SHOCK; PROGNOSTIC MARKER; VARIANTS; NERVE	Low serum cholinesterase (SCHE) activity has been associated with poor prognoses in a variety of conditions, including sepsis. However, such an association has not been well characterized since the Third International Consensus Definitions Task Force modified the definition of sepsis to "life-threatening organ dysfunction due to a dysregulated host response to infection" (known as sepsis-3) in 2016. In the current retrospective cohort study, we examined whether 30-day mortality in sepsis-3 patients is associated with SCHE activity. A total of 166 sepsis-3 patients receiving treatment at an emergency intensive care unit (EICU) were included. The 30-day death rate was 33.1% (55/166). SCHE activity upon EICU admission was lower in nonsurvivors (3.3 vs. 4.5 KU/L in survivors, p = 0.0002). Subjects with low SCHE activity (defined as <4 KU/L) had higher 30-day mortality rates than subjects with normal SCHE activity (45.5%, 40/88 vs. 19.2%, 15/78; p<0.001). A multivariate logistic regression analysis revealed an association between 30-day mortality and lower SCHE activity after adjustments for relevant factors, such as acute multiple organ dysfunction. The odds ratio (OR) for every unit decrease in SCHE activity was 2.11 (95% confidence interval (CI), 1.37-3.27; p = 0.0008). The area under the curve (AUC) of SCHE activity for predicting 30-day mortality was 0.67 (95% CI 0.59-0.74), and the AUC of lactate for predicting 30-day mortality was 0.64 (95% CI 0.57-0.70). Using a combination of SCHE and lactate, the AUC was 0.74 (95% CI 0.69-0.83). These data suggest that lower SCHE activity is an independent risk factor for 30-day mortality in sepsis-3 patients.	[Peng, Zheng-Liang; Huang, Liang-Wei; Yin, Jian; Zhang, Ke-Na; Xiao, Kang; Qing, Guo-Zhong] Univ South China, Affiliated Hosp 1, EICU, Hengyang, Hunan, Peoples R China	University of South China	Peng, ZL; Qing, GZ (corresponding author), Univ South China, Affiliated Hosp 1, EICU, Hengyang, Hunan, Peoples R China.	pengzhl-2001@163.com; gzqing9923@163.com			Health and Family Planning Commission of Hunan Province Research Project [B2015-54]	Health and Family Planning Commission of Hunan Province Research Project	The study was funded by the Health and Family Planning Commission of Hunan Province Research Project (B2015-54; to Zheng L Peng). The funder had no role in study design, data collection, analysis, interpretation, or manuscript writing.	ALKASSAB AS, 1995, EUR J CLIN CHEM CLIN, V33, P11; Arbel Y, 2014, MOL MED, V20, P38, DOI 10.2119/molmed.2013.00139; Ba L, 2014, J ZHEJIANG UNIV-SC B, V15, P1023, DOI 10.1631/jzus.B1400129; Bahloul M, 2017, J INTENSIVE CARE MED, V32, P346, DOI 10.1177/0885066616636549; Ben Assayag E, 2010, MOL MED, V16, P278, DOI 10.2119/molmed.2010.00015; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Calderon-Margalit R, 2006, CLIN CHEM, V52, P845, DOI 10.1373/clinchem.2005.059857; Chiarla C, 2011, MINERVA CHIR, V66, P323; Coopersmith CM, 2017, SHOCK, V47, P264, DOI 10.1097/SHK.0000000000000763; Das UN, 2007, MED SCI MONITOR, V13, pRA214; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Feng WM, 2013, HEPATO-GASTROENTEROL, V60, P1001, DOI 10.5754/hge13141; Goliasch G, 2012, CLIN CHEM, V58, P1055, DOI 10.1373/clinchem.2011.175984; Jin QH, 2011, CHINESE MED J-PEKING, V124, P2692, DOI 10.3760/cma.j.issn.0366-6999.2011.17.023; Johnson G, 2012, NEUROCHEM INT, V61, P783, DOI 10.1016/j.neuint.2012.06.016; Kanai S, 2008, J CLIN LAB ANAL, V22, P66, DOI 10.1002/jcla.20205; Kanashiro A, 2017, PHARMACOL RES, V117, P1, DOI 10.1016/j.phrs.2016.12.014; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Lampon N, 2012, ANN HEPATOL, V11, P356, DOI 10.1016/S1665-2681(19)30932-9; Lockridge O, 2015, PHARMACOL THERAPEUT, V148, P34, DOI 10.1016/j.pharmthera.2014.11.011; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68; Pereira MR, 2016, J CELL PHYSIOL, V231, P1862, DOI 10.1002/jcp.25307; Santarpia L, 2013, J CACHEXIA SARCOPENI, V4, P31, DOI 10.1007/s13539-012-0083-5; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sun LM, 2016, CLIN LAB, V62, P1093, DOI 10.7754/Clin.Lab.2015.151013; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; WHITTAKER M, 1980, ANAESTHESIA, V35, P174, DOI 10.1111/j.1365-2044.1980.tb03800.x; Williams JM, 2017, CHEST, V151, P586, DOI 10.1016/j.chest.2016.10.057; Yamano S, 2016, J CRIT CARE, V31, P36, DOI 10.1016/j.jcrc.2015.09.033; Zhang QH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129082	33	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203128	10.1371/journal.pone.0203128	http://dx.doi.org/10.1371/journal.pone.0203128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161257	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900082
J	Jiang, RL; Prell, C; Lonnerdal, B				Jiang, Rulan; Prell, Christine; Loennerdal, Bo			Milk osteopontin promotes brain development by up-regulating osteopontin in the brain in early life	FASEB JOURNAL			English	Article						myelination; OPN mouse model; NG2-glia proliferation and differentiation; signaling pathways	MESSENGER-RNA; RECOMBINANT OSTEOPONTIN; PRETERM INFANTS; IN-VIVO; LACTOFERRIN; EXPRESSION; GROWTH; MOUSE; PROTEIN; MYELIN	Osteopontin (OPN) is a pleiotropic protein and is abundantly present in milk. Its functions include immune modulation and cellular proliferation and differentiation. OPN is highly expressed in the brain. We investigated the effects of milk-derived OPN on brain development of mouse pups. Wild-type (WT) dams producing OPN+ milk and OPN knockout (KO) dams producing OPN- milk nursed WT pups (OPN+/+), yielding 2 pup treatment groups, OPN+ OPN+/+ and OPN- OPN+/+, for comparison. Preliminary studies supported use of this model by showing high concentrations of OPN in milk of WT dams and no OPN in milk of OPN KO dams, and production of similar amounts of milk by WT and KO dams. The ability of ingested milk OPN to enter the brain was revealed by appearance of orally gavaged [I-125]-labeled and antibody-probed milk OPN in brains of pups. Brain OPN mRNA levels were similar in both nursed groups, but the brain OPN protein level was significantly lower in the OPN- OPN+/+ group at postnatal days 6 and 8. Behavior tests showed impaired memory and learning ability in OPN- OPN+/+ pups. In addition, our study revealed increased expression of myelination-related proteins and elevated proliferation and differentiation of NG-2 glia into oligodendrocytes in the brain of OPN+ OPN+/+ pups, accompanied by increased activation of ERK-1/2 and PI3K/Akt signaling. We concluded that milk OPN can play an important role in brain development and behavior in infancy by promoting myelination.Jiang, R., Prell, C., Lonnerdal, B. Milk osteopontin promotes brain development by up-regulating osteopontin in the brain in early life.	[Jiang, Rulan; Loennerdal, Bo] Univ Calif Davis, Dept Nutr, 3217C Meyer Hall, Davis, CA 95616 USA; [Prell, Christine] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Munich, Germany	University of California System; University of California Davis; University of Munich	Lonnerdal, B (corresponding author), Univ Calif Davis, Dept Nutr, 3217C Meyer Hall, Davis, CA 95616 USA.	bllonnerdal@ucdavis.edu			Mead Johnson Nutrition	Mead Johnson Nutrition	The authors thank Patricia Kysar (Department of Cell Biology and Human Anatomy, School of Medicine, University of California, Davis), for assistance with the electron microscopy; and Dr. Judy Hills (Department of Nutrition, University of California, Davis) for a critical reading of the manuscript. This study was supported by a research grant from Mead Johnson Nutrition. The authors declare no conflicts of interest.	Albertsson AM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0197-0; Almutairi MMA, 2016, CELL MOL LIFE SCI, V73, P57, DOI 10.1007/s00018-015-2050-8; Anderson JW, 1999, AM J CLIN NUTR, V70, P525; APPLEBY P, 1983, J REPROD IMMUNOL, V5, P203, DOI 10.1016/0165-0378(83)90236-X; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Banks WA, 2012, PHARMACOL THERAPEUT, V136, P82, DOI 10.1016/j.pharmthera.2012.07.006; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bercury KK, 2015, DEV CELL, V32, P447, DOI 10.1016/j.devcel.2015.01.016; Bhatt A, 2014, NEURAL REGEN RES, V9, P1347, DOI 10.4103/1673-5374.137586; Bonestroo HJC, 2015, DEV NEUROSCI-BASEL, V37, P142, DOI 10.1159/000369093; Boudry G, 2010, J PEDIATR GASTR NUTR, V51, P380, DOI 10.1097/MPG.0b013e3181eb5ad6; Bozzola J. J., 1992, ELECT MICROSCOPY PRI; Branchi I, 2002, GENES BRAIN BEHAV, V1, P135, DOI 10.1034/j.1601-183X.2002.10301.x; CATASSI C, 1995, J PEDIATR GASTR NUTR, V21, P383, DOI 10.1097/00005176-199511000-00003; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chatterton DEW, 2004, TRENDS FOOD SCI TECH, V15, P373, DOI 10.1016/j.tifs.2003.12.004; Chen WQ, 2011, STROKE, V42, P764, DOI 10.1161/STROKEAHA.110.599118; Choi JS, 2004, EXP BRAIN RES, V154, P275, DOI 10.1007/s00221-003-1657-4; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Christensen B, 2008, BIOCHEM J, V411, P53, DOI 10.1042/BJ20071021; Chun HB, 2011, J CEREBR BLOOD F MET, V31, P2267, DOI 10.1038/jcbfm.2011.104; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; da Silva APB, 2009, LAB INVEST, V89, P1169, DOI 10.1038/labinvest.2009.80; Dai J, 2009, ONCOGENE, V28, P3412, DOI 10.1038/onc.2009.189; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Dimou L, 2015, GLIA, V63, P1429, DOI 10.1002/glia.22859; Donovan SM, 2014, J NUTR, V144, P1910, DOI 10.3945/jn.114.197558; Doyle KP, 2008, J CEREBR BLOOD F MET, V28, P1235, DOI 10.1038/jcbfm.2008.17; Drozdowski LA, 2010, WORLD J GASTROENTERO, V16, P787, DOI 10.3748/wjg.v16.i7.787; Dubois J, 2014, NEUROSCIENCE, V276, P48, DOI 10.1016/j.neuroscience.2013.12.044; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Ek CJ, 2012, NEUROTOXICOLOGY, V33, P586, DOI 10.1016/j.neuro.2011.12.009; Fillebeen C, 1999, J BIOL CHEM, V274, P7011, DOI 10.1074/jbc.274.11.7011; Fischer R, 2007, INT IMMUNOPHARMACOL, V7, P1387, DOI 10.1016/j.intimp.2007.05.019; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; FOX M. W., 1965, ANIM BEHAV, V13, P234; Gao W, 2015, CEREB CORTEX, V25, P2919, DOI 10.1093/cercor/bhu088; Gao W, 2015, BRAIN STRUCT FUNCT, V220, P1173, DOI 10.1007/s00429-014-0710-3; Gracia-Rubio I, 2016, PROG NEURO-PSYCHOPH, V65, P104, DOI 10.1016/j.pnpbp.2015.09.003; Haarmann A, 2015, ACTA NEUROPATHOL, V129, P639, DOI 10.1007/s00401-015-1417-0; Hamilton GF, 2017, NEUROSCIENCE, V352, P52, DOI 10.1016/j.neuroscience.2017.03.058; Harada E, 2002, J VET MED A, V49, P358, DOI 10.1046/j.1439-0442.2002.00457.x; HUTCHENS TW, 1991, PEDIATR RES, V29, P243, DOI 10.1203/00006450-199103000-00005; HUTCHENS TW, 1991, P NATL ACAD SCI USA, V88, P2994, DOI 10.1073/pnas.88.8.2994; Ishii A, 2013, J NEUROSCI, V33, P175, DOI 10.1523/JNEUROSCI.4403-12.2013; Janssen CIF, 2015, J NUTR BIOCHEM, V26, P24, DOI 10.1016/j.jnutbio.2014.08.002; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jiang RL, 2013, FASEB J, V27; Jiang RL, 2011, J CELL PHYSIOL, V226, P3022, DOI 10.1002/jcp.22650; Jono S, 2000, J BIOL CHEM, V275, P20197, DOI 10.1074/jbc.M909174199; Jou MY, 2013, PEDIATR RES, V73, P596, DOI 10.1038/pr.2013.27; Kalluri HSG, 2012, INT J DEV NEUROSCI, V30, P359, DOI 10.1016/j.ijdevneu.2012.04.003; Kang SJ, 2012, J IMMUNOL, V188, P1108, DOI 10.4049/jimmunol.1102084; Kumari S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06888-4; Lee MY, 2001, CELL TISSUE RES, V306, P179, DOI 10.1007/s004410100456; Lonnerdal B, 2016, J PEDIATR GASTR NUTR, V62, P650, DOI 10.1097/MPG.0000000000001005; LUCAS A, 1992, LANCET, V339, P261, DOI 10.1016/0140-6736(92)91329-7; Lussier C, 2000, MICROSC RES TECHNIQ, V51, P169; Mazaheri N, 2018, CELL MOL NEUROBIOL, V38, P891, DOI 10.1007/s10571-017-0563-4; McDonald JM, 2006, J ANIM SCI, V84, P300, DOI 10.2527/2006.842300x; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; MIKOGAMI T, 1994, AM J PHYSIOL, V267, pG308, DOI 10.1152/ajpgi.1994.267.2.G308; Miyata S, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00390; Nagatomo T, 2004, CLIN EXP IMMUNOL, V138, P47, DOI 10.1111/j.1365-2249.2004.02549.x; Nemir M, 2000, J BIOL CHEM, V275, P969, DOI 10.1074/jbc.275.2.969; Nurliyana AR, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0700-0; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Plantman S, 2012, NEUROREPORT, V23, P647, DOI 10.1097/WNR.0b013e328355380e; Pocivavsek A, 2012, EUR J NEUROSCI, V35, P1605, DOI 10.1111/j.1460-9568.2012.08064.x; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Rittling SR, 2015, J DENT RES, V94, P1638, DOI 10.1177/0022034515605270; Rittling SR, 1997, CELL GROWTH DIFFER, V8, P1061; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Schack L, 2009, J DAIRY SCI, V92, P5378, DOI 10.3168/jds.2009-2360; Selvaraju R, 2004, MOL CELL NEUROSCI, V25, P707, DOI 10.1016/j.mcn.2003.12.014; Shiga T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146136; Shiotsuki H, 2010, J NEUROSCI METH, V189, P180, DOI 10.1016/j.jneumeth.2010.03.026; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Su ZG, 2014, MOL PHARMACEUT, V11, P1823, DOI 10.1021/mp500238m; Suzuki H, 2010, CRIT CARE MED, V38, P612, DOI 10.1097/CCM.0b013e3181c027ae; Takata F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055166; Thinwa J, 2014, J IMMUNOL, V193, P1373, DOI 10.4049/jimmunol.1400145; Tian D, 2015, NAT NEUROSCI, V18, P182, DOI 10.1038/nn.3911; Tong ZX, 2018, BIOMATERIALS, V154, P60, DOI 10.1016/j.biomaterials.2017.10.038; Topkoru BC, 2013, STROKE, V44, P3189, DOI 10.1161/STROKEAHA.113.001574; van Velthoven CTJ, 2011, STROKE, V42, P2294, DOI 10.1161/STROKEAHA.110.608315; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Weber GF, 2002, J LEUKOCYTE BIOL, V72, P752; Willingham K, 2014, JOVE-J VIS EXP, DOI 10.3791/51007; Wu X, 2012, PHARMACOL THERAPEUT, V134, P68, DOI 10.1016/j.pharmthera.2011.12.008; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132	92	20	26	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1681	1694		10.1096/fj.201701290RR	http://dx.doi.org/10.1096/fj.201701290RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30199283	Bronze			2022-12-26	WOS:000457296600015
J	Kato, M; Placencio-Hickok, VR; Madhav, A; Haldar, S; Tripathi, M; Billet, S; Mishra, R; Smith, B; Rohena-Rivera, K; Agarwal, P; Duong, F; Angara, B; Hickok, D; Liu, ZQ; Bhowmick, NA				Kato, Manabu; Placencio-Hickok, Veronica R.; Madhav, Anisha; Haldar, Subhash; Tripathi, Manisha; Billet, Sandrine; Mishra, Rajeev; Smith, Bethany; Rohena-Rivera, Krizia; Agarwal, Priyanka; Duong, Frank; Angara, Bryan; Hickok, David; Liu, Zhenqiu; Bhowmick, Neil A.			Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner	ONCOGENE			English	Article							FRIZZLED-RELATED PROTEIN-1; PROSTATE-CANCER; TGF-BETA; TUMOR PROGRESSION; ENDOGLIN CD105; UP-REGULATION; CELL; INHIBITION; IDENTIFICATION; MORPHOGENESIS	Heterogeneous prostatic carcinoma-associated fibroblasts (CAF) contribute to tumor progression and resistance to androgen signaling deprivation therapy (ADT). CAF subjected to extended passaging, compared to low passage CAF, were found to lose tumor expansion potential and heterogeneity. Cell surface endoglin (CD105), known to be expressed on proliferative endothelia and mesenchymal stem cells, was diminished in high passage CAF. RNA-sequencing revealed SFRP1 to be distinctly expressed by tumor-inductive CAF, which was further demonstrated to occur in a CD105-dependent manner. Moreover, ADT resulted in further expansion of the CD105(+) fibroblastic population and downstream SFRP1 in 3-dimensional cultures and patient-derived xenograft tissues. In patients, CD105(+) fibroblasts were found to circumscribe epithelia with neuroendocrine differentiation. CAF-derived SFRP1, driven by CD105 signaling, was necessary and sufficient to induce prostate cancer neuroendocrine differentiation in a paracrine manner. A partially humanized CD105 neutralizing antibody, TRC105, inhibited fibroblastic SFRP1 expression and epithelial neuroendocrine differentiation. In a novel synthetic lethality paradigm, we found that simultaneously targeting the epithelia and its microenvironment with ADT and TRC105, respectively, reduced castrate-resistant tumor progression, in a model where either ADT or TRC105 alone had little effect.	[Kato, Manabu] Mie Univ Hosp, Nephrourol Surg & Androl, Tsu, Mie, Japan; [Placencio-Hickok, Veronica R.; Madhav, Anisha; Haldar, Subhash; Tripathi, Manisha; Billet, Sandrine; Mishra, Rajeev; Smith, Bethany; Rohena-Rivera, Krizia; Agarwal, Priyanka; Duong, Frank; Angara, Bryan; Hickok, David; Liu, Zhenqiu; Bhowmick, Neil A.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA	Mie University; Cedars Sinai Medical Center	Bhowmick, NA (corresponding author), Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.	bhowmickn@cshs.org	Mishra, Rajeev/AEX-2208-2022; Smith, Bethany/GYT-9168-2022; Bhowmick, Neil/AAA-7302-2019	Mishra, Rajeev/0000-0002-7411-4022; Bhowmick, Neil/0000-0001-8747-5989; Haldar, Subhash/0000-0002-1230-1770	National Cancer Institute [CA108646]; Veterans Affairs [BX001040]; NATIONAL CANCER INSTITUTE [P01CA098912, R01CA108646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007770] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001040] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank Charles Theurer at Tracon Pharmaceuticals, Inc. for the TRC105 and M1043 neutralizing antibodies. The RNA-sequencing and histology slide scanning was performed at the Cedars-Sinai Genomics Core and Microscopy Core, respectively. This work was supported by grants from the National Cancer Institute (CA108646) and Veterans Affairs (BX001040) to NAB.	Aggarwal RR, 2017, ONCOLOGY-NY, V31, P467; Ayala G, 2003, CLIN CANCER RES, V9, P4792; Banerjee J, 2014, ONCOGENE, V33, P4924, DOI 10.1038/onc.2013.431; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Beltran H, 2012, J CLIN ONCOL, V30, pE386, DOI 10.1200/JCO.2011.41.5166; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Bhowmick NA, 2003, P NATL ACAD SCI USA, V100, P15548, DOI 10.1073/pnas.2536483100; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Brennen WN, 2013, ONCOTARGET, V4, P106, DOI 10.18632/oncotarget.805; Bussard KM, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0740-2; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Dayyani F, 2013, PROSTATE, V73, P979, DOI 10.1002/pros.22645; Melo FDE, 2013, EMBO REP, V14, P686, DOI 10.1038/embor.2013.92; DeGraff DJ, 2009, AM J TRANSL RES, V1, P115; Erho N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066855; Esteve P, 2011, DEVELOPMENT, V138, P4179, DOI 10.1242/dev.065839; Fonsatti E, 2003, ONCOGENE, V22, P6557, DOI 10.1038/sj.onc.1206813; Franco OE, 2011, CANCER RES, V71, P1272, DOI 10.1158/0008-5472.CAN-10-3142; Fuyuhiro Y, 2011, BRIT J CANCER, V105, P996, DOI 10.1038/bjc.2011.330; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; GLEAVE M, 1991, CANCER RES, V51, P3753; Hayward SW, 2001, CANCER RES, V61, P8135; Igarashi Atsushi, 2016, Nihon Hinyokika Gakkai Zasshi, V107, P155, DOI 10.5980/jpnjurol.107.155; Joesting MS, 2008, DEV BIOL, V317, P161, DOI 10.1016/j.ydbio.2008.02.021; Joesting MS, 2005, CANCER RES, V65, P10423, DOI 10.1158/0008-5472.CAN-05-0824; Kanayama M, 2017, PROSTATE, V77, P1489, DOI 10.1002/pros.23425; Karzai FH, 2015, BJU INT, V116, P546, DOI 10.1111/bju.12986; Kawano Y, 2009, BRIT J CANCER, V100, P1165, DOI 10.1038/sj.bjc.6604976; Kiskowski MA, 2011, CANCER RES, V71, P3459, DOI 10.1158/0008-5472.CAN-10-2999; Laskaratos FM, 2017, CANCER-AM CANCER SOC, V123, P4770, DOI 10.1002/cncr.31079; Li X, 2008, ONCOGENE, V27, P7118, DOI 10.1038/onc.2008.293; Miyata Y, 2015, PROSTATE, V75, P84, DOI 10.1002/pros.22894; Mu P, 2017, SCIENCE, V355, P84, DOI 10.1126/science.aah4307; Nolan-Stevaux O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050920; Olumi AF, 1999, CANCER RES, V59, P5002; Placencio VR, 2008, CANCER RES, V68, P4709, DOI 10.1158/0008-5472.CAN-07-6289; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Romero D, 2011, CANCER RES, V71, P3482, DOI 10.1158/0008-5472.CAN-10-2665; Siamakpour-Reihani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020412; Stark HJ, 1999, J INVEST DERMATOL, V112, P681, DOI 10.1046/j.1523-1747.1999.00573.x; Sun F, 2016, CARCINOGENESIS, V37, P701, DOI 10.1093/carcin/bgw044; Sun Y, 2016, ONCOGENE, V35, P4321, DOI 10.1038/onc.2015.494; True LD, 2010, MODERN PATHOL, V23, P1346, DOI 10.1038/modpathol.2010.122; Wadosky KM, 2016, ONCOTARGET, V7, P64447, DOI 10.18632/oncotarget.10901; Zhao HJ, 2009, PROSTATE, V69, P991, DOI 10.1002/pros.20946; Zheng L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118276; Zhu YT, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv129; Zikusoka MN, 2005, CANCER-AM CANCER SOC, V104, P2292, DOI 10.1002/cncr.21451	50	43	44	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 31	2019	38	5					716	730		10.1038/s41388-018-0461-3	http://dx.doi.org/10.1038/s41388-018-0461-3			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HJ6LI	30177832	Green Accepted, Green Submitted			2022-12-26	WOS:000457300300008
J	Liu, L; Yang, Y; Liu, SH; Tao, TY; Cai, JC; Wu, JH; Guan, HY; Zhu, X; He, ZJ; Li, J; Song, EW; Zeng, MS; Li, MF				Liu, Lei; Yang, Yi; Liu, Shihua; Tao, Tianyu; Cai, Junchao; Wu, Jueheng; Guan, Hongyu; Zhu, Xun; He, Zhenjian; Li, Jun; Song, Erwei; Zeng, Musheng; Li, Mengfeng			EGF-induced nuclear localization of SHCBP1 activates beta-catenin signaling and promotes cancer progression	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; CREB-BINDING PROTEIN; STEM-CELLS; DOWN-REGULATION; DRUG-RESISTANT; T790M MUTATION; COLON-CANCER; WNT; INHIBITOR	Aberrant activation of EGFR represents a common event in non-small cell lung carcinoma (NSCLC) and activates various downstream signaling pathways. While EGFR activation of beta-catenin signaling was previously reported, the mediating mechanism remains unclear. Our current study found that EGFR activation in NSCLC cells releases SHC-binging protein 1 (SHCBP1) from SHC adaptor protein 1 (SHC1), which subsequently translocates into the nucleus and directly promotes the transactivating activity of beta-catenin, consequently resulting in development of NSCLC cell stemness and malignant progression. Furthermore, SHCBP1 promotes beta-catenin activity through enhancing the CBP/beta-catenin interaction, and most interestingly, a candidate drug that blocks the CBP/beta-catenin binding effectively abrogates the aforementioned biological effects of SHCBP1. Clinically, SHCBP1 level in NSCLC tumors was found to inversely correlate with patient survival. Together, our study establishes a novel convergence between EGFR and beta-catenin pathways and highlights a potential significance of SHCBP1 as a prognostic biomarker and a therapeutic target.	[Liu, Lei; Yang, Yi; Liu, Shihua; Tao, Tianyu; Cai, Junchao; Wu, Jueheng; Zhu, Xun; He, Zhenjian; Li, Jun; Li, Mengfeng] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China; [Liu, Lei; Liu, Shihua; Tao, Tianyu; Cai, Junchao; Wu, Jueheng; Li, Mengfeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China; [Yang, Yi] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China; [Guan, Hongyu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China; [Guan, Hongyu] Sun Yat Sen Univ, Affiliated Hosp 1, Diabet Ctr, Guangzhou, Guangdong, Peoples R China; [Zhu, Xun] Guangdong Prov Key Lab Orthoped & Traumatol, Guangzhou, Guangdong, Peoples R China; [He, Zhenjian] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Li, Jun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou, Guangdong, Peoples R China; [Song, Erwei] Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Med Res Ctr, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China; [Zeng, Musheng] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Yang, Y; Li, MF (corresponding author), Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China.; Li, MF (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China.; Yang, Y (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China.	yangyi23@mail.sysu.edu.cn; limf@mail.sysu.edu.cn	LIU, LEI/AAL-7491-2021; LIU, LEI/AAY-2012-2020	LIU, LEI/0000-0003-4898-5665; zeng, musheng/0000-0003-3509-5591	National Key Research and Development Project of China [2017YFA0505600, 2017YFA0106300]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81621004]; Guangzhou science and technology plan [201803010039, 201804010057]; National Natural Science Foundation of China [81572837, 81330058]; Guangdong Natural Science Foundation [2014A030313036]; Guangdong Natural Science Funds for Distinguished Young Scholar [2014A030306023]; Guangdong Te Zhi program youth science and technology talent of project [2015TQ01R281]; Fundamental Research Funds for the Central Universities [17ykpy06]	National Key Research and Development Project of China; Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou science and technology plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Natural Science Funds for Distinguished Young Scholar; Guangdong Te Zhi program youth science and technology talent of project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by The National Key Research and Development Project of China (No. 2017YFA0505600,2017YFA0106300); The Foundation for Innovative Research Groups of the National Natural Science Foundation of China (No. 81621004); Guangzhou science and technology plan (No. 201803010039, 201804010057); The National Natural Science Foundation of China (No. 81572837, 81330058); Guangdong Natural Science Foundation (No. 2014A030313036); Guangdong Natural Science Funds for Distinguished Young Scholar (No. 2014A030306023); Guangdong Te Zhi program youth science and technology talent of project (No. 2015TQ01R281); the Fundamental Research Funds for the Central Universities (No. 17ykpy06).SS	Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Arensman MD, 2014, MOL CANCER THER, V13, P2303, DOI 10.1158/1535-7163.MCT-13-1005; Berns A, 2005, CELL, V121, P811, DOI 10.1016/j.cell.2005.06.004; Brannon AR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0454-7; Cai JC, 2013, CANCER RES, V73, P756, DOI 10.1158/0008-5472.CAN-12-2651; Casas-Selves M, 2012, CANCER RES, V72, P4154, DOI 10.1158/0008-5472.CAN-11-2848; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen JF, 2012, GENE DEV, V26, P803, DOI 10.1101/gad.187641.112; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; FELD R, 1984, J CLIN ONCOL, V2, P1352, DOI 10.1200/JCO.1984.2.12.1352; Gang EJ, 2014, ONCOGENE, V33, P2169, DOI 10.1038/onc.2013.169; He KJ, 2014, INT J CANCER, V134, P43, DOI 10.1002/ijc.28341; Hwang KE, 2014, EXP CELL RES, V323, P288, DOI 10.1016/j.yexcr.2014.02.026; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Krejci P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035826; Le Pechoux C, 2011, ONCOLOGIST, V16, P672, DOI 10.1634/theoncologist.2010-0150; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lian CJ, 2016, J PINEAL RES, V61, P317, DOI 10.1111/jpi.12349; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Ma L, 2013, FEBS J, V280, P2027, DOI 10.1111/febs.12226; Mazieres J, 2005, CANCER LETT, V222, P1, DOI 10.1016/j.canlet.2004.08.040; Montembault E, 2010, J CELL BIOL, V191, P1351, DOI 10.1083/jcb.201007060; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nakayama S, 2014, CANCER RES, V74, P5891, DOI 10.1158/0008-5472.CAN-14-0184; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Park M, 2015, J PROTEOME RES, V14, P3007, DOI 10.1021/acs.jproteome.5b00423; PASSLICK B, 1994, J CLIN ONCOL, V12, P1827, DOI 10.1200/JCO.1994.12.9.1827; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sato S, 2005, GASTROENTEROLOGY, V129, P1225, DOI 10.1053/j.gastro.2005.07.025; Schmandt R, 1999, ONCOGENE, V18, P1867, DOI 10.1038/sj.onc.1202507; Sequist LV, 2007, ONCOLOGIST, V12, P90, DOI 10.1634/theoncologist.12-1-90; Soeda A, 2008, J BIOL CHEM, V283, P10958, DOI 10.1074/jbc.M704205200; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Su SC, 2017, CELL RES, V27, P461, DOI 10.1038/cr.2017.34; Suzuki M, 2007, CLIN CANCER RES, V13, P6087, DOI 10.1158/1078-0432.CCR-07-0591; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Takebe N, 2015, NAT REV CLIN ONCOL, V12, P445, DOI 10.1038/nrclinonc.2015.61; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013; To KKW, 2017, LUNG CANCER, V103, P58, DOI 10.1016/j.lungcan.2016.11.019; Togashi Y, 2015, J THORAC ONCOL, V10, P93, DOI 10.1097/JTO.0000000000000353; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wend P, 2013, EMBO J, V32, P1977, DOI 10.1038/emboj.2013.127; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yang Y, BIOCH BIOPHYS RES CO, V450, P899; Yang Y, 2014, INT J CANCER, V135, P1531, DOI 10.1002/ijc.28799; Zhang XR, 2013, J BIOL CHEM, V288, P32229, DOI 10.1074/jbc.M113.463554; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	60	32	34	4	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 31	2019	38	5					747	764		10.1038/s41388-018-0473-z	http://dx.doi.org/10.1038/s41388-018-0473-z			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HJ6LI	30177836	Green Published, hybrid			2022-12-26	WOS:000457300300010
J	Choppara, S; Ganga, S; Manne, R; Dutta, P; Singh, S; Santra, MK				Choppara, Srinadh; Ganga, Sankaran; Manne, Rajeshkumar; Dutta, Parul; Singh, Shailza; Santra, Manas Kumar			The SCFFBXO46 ubiquitin ligase complex mediates degradation of the tumor suppressor FBXO31 and thereby prevents premature cellular senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; E3 ubiquitin ligase; flow cytometry; post-translational modification (PTM); post-transcriptional regulation; protein motif; protein turnover; ubiquitin ligase; ubiquitylation (ubiquitination); ATM; cell cycle; F-box protein; senescence; ubiquitination	BOX PROTEIN FBXO31; PROTEASOME-DEPENDENT DEGRADATION; PATHWAY PROMOTES PHOSPHORYLATION; CYCLIN D1 DEGRADATION; DNA-DAMAGE RESPONSE; F-BOX; E3 LIGASE; STRUCTURE PREDICTION; CANCER; ACTIVATION	The tumor suppressor F-box protein 31 (FBXO31) is indispensable for maintaining genomic stability. Its levels drastically increase following DNA damage, leading to cyclin D1 and MDM2 degradation and G(1) and G(2)/M arrest. Prolonged arrest in these phases leads to cellular senescence. Accordingly, FBXO31 needs to be kept at low basal levels in unstressed conditions for normal cell cycle progression during growth and development. However, the molecular mechanism maintaining these basal FBXO31 levels has remained unclear. Here, we identified the F-box family SCF-E3 ubiquitin ligase FBXO46 (SCFFBXO46) as an important proteasomal regulator of FBXO31 and found that FBXO46 helps maintain basal FBXO31 levels under unstressed conditions and thereby prevents premature senescence. Using molecular docking and mutational studies, we showed that FBXO46 recognizes an RXXR motif located at the FBXO31 C terminus to direct its polyubiquitination and thereby proteasomal degradation. Furthermore, FBXO46 depletion enhanced the basal levels of FBXO31, resulting in senescence induction. In response to genotoxic stress, ATM (ataxia telangiectasia-mutated) Ser/Thr kinase-mediated phosphorylation of FBXO31 at Ser-278 maintained FBXO31 levels. In contrast, activated ATM phosphorylated FBXO46 at Ser-21/Ser-67, leading to its degradation via FBXO31. Thus, ATM-catalyzed phosphorylation after DNA damage governs FBXO31 levels and FBXO46 degradation via a negative feedback loop. Collectively, our findings reveal that FBXO46 is a crucial proteasomal regulator of FBXO31 and thereby prevents senescence in normal growth conditions. They further indicate that FBXO46-mediated regulation of FBXO31 is abrogated following genotoxic stress to promote increased FBXO31 levels for maintenance of genomic stability.	[Choppara, Srinadh; Ganga, Sankaran; Manne, Rajeshkumar; Dutta, Parul; Singh, Shailza; Santra, Manas Kumar] Natl Ctr Cell Sci, NCCS Complex,Ganeshkhind Rd, Pune 411007, Maharashtra, India; [Choppara, Srinadh; Manne, Rajeshkumar; Dutta, Parul] Savitribai Phule Pune Univ, Dept Biotechnol, Ganeshkhind Rd, Pune 411007, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Savitribai Phule Pune University	Santra, MK (corresponding author), Natl Ctr Cell Sci, NCCS Complex,Ganeshkhind Rd, Pune 411007, Maharashtra, India.	manas@nccs.res.in	Manne, Rajesh Kumar/ABB-1342-2021		Department of Biotechnology Grant [BT/PR6690/GBD/27/475/2012]; National Centre for Cell Science, Department of Biotechnology, Ministry of Science and Technology, Government of India	Department of Biotechnology Grant; National Centre for Cell Science, Department of Biotechnology, Ministry of Science and Technology, Government of India	This work was supported by Department of Biotechnology Grant BT/PR6690/GBD/27/475/2012 (to M. K. S.) and in part by the National Centre for Cell Science, Department of Biotechnology, Ministry of Science and Technology, Government of India (to M. K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Bassermann F, 2010, CELL DEATH DIFFER, V17, P78, DOI 10.1038/cdd.2009.104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brichese L, 2002, EXP CELL RES, V278, P101, DOI 10.1006/excr.2002.5563; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Choppara S, 2018, P NATL ACAD SCI USA, V115, P998, DOI 10.1073/pnas.1705954115; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; de Zoeten EF, 2009, J BIOL CHEM, V284, P5709, DOI 10.1074/jbc.M807322200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; He W, 2014, ONCOGENE, V33, P3004, DOI 10.1038/onc.2013.256; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Jeffery JM, 2017, ONCOGENE, V36, P1012, DOI 10.1038/onc.2016.268; JENTSCH S, 1995, CELL, V82, P881, DOI 10.1016/0092-8674(95)90021-7; Jia LJ, 2009, PIGM CELL MELANOMA R, V22, P518, DOI 10.1111/j.1755-148X.2009.00611.x; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Johansson P, 2014, J BIOL CHEM, V289, P18514, DOI 10.1074/jbc.M114.559930; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kumar R, 2005, CANCER RES, V65, P11304, DOI 10.1158/0008-5472.CAN-05-0936; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Leung KT, 2008, CARCINOGENESIS, V29, P544, DOI 10.1093/carcin/bgm294; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Liu DY, 2016, ONCOTARGETS THER, V9, P5245, DOI 10.2147/OTT.S110969; Liu J, 2014, J BIOL CHEM, V289, P21508, DOI 10.1074/jbc.M114.560342; Liu YW, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.150; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Malonia SK, 2015, P NATL ACAD SCI USA, V112, P8632, DOI 10.1073/pnas.1510929112; Manne RK, 2017, NEOPLASIA, V19, P483, DOI 10.1016/j.neo.2017.02.013; Marechal A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012716; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Sabin Rebecca J, 2011, Genome Integr, V2, P7, DOI 10.1186/2041-9414-2-7; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; Shiloh Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.296pe73; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vadhvani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057530; Vandenberghe LH, 2006, NAT MED, V12, P967, DOI 10.1038/nm1445; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wang GC, 2012, CHIN J CANCER, V31, P169, DOI 10.5732/cjc.011.10319; Wei SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047298; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Xu J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14002; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zhang XC, 2014, ONCOTARGET, V5, P6178, DOI 10.18632/oncotarget.2183; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou ZA, 2016, CELL DIV, V11, DOI 10.1186/s13008-016-0021-6	56	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16291	16306		10.1074/jbc.RA118.005354	http://dx.doi.org/10.1074/jbc.RA118.005354			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30171069	hybrid, Green Published			2022-12-26	WOS:000447833600015
J	Merriman, C; Li, H; Li, HL; Fu, D				Merriman, Chengfeng; Li, Hua; Li, Huilin; Fu, Dax			Highly specific monoclonal antibodies for allosteric inhibition and immunodetection of the human pancreatic zinc transporter ZnT8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						zinc; transport; monoclonal antibody; inhibitor; pancreatic islet; diabetes; drug discovery; ZnT8; mAb; drug screening; pancreatic beta-cells; HTRF; therapeutic target	GENOME-WIDE ASSOCIATION; EM STRUCTURE DETERMINATION; INSULIN-SECRETION; BETA-CELL; GLUCOSE-HOMEOSTASIS; DIABETES RISK; ZN2+; MICE; IDENTIFICATION; EXPRESSION	Solute carrier family 30 member 8 (SLC30A8), encoding the pancreatic zinc transporter ZnT8, is a susceptibility gene for type 2 diabetes (T2D). Reducing ZnT8 transport activity or down-regulating its cellular expression is hypothesized to be an antidiabetogenic strategy mimicking the protective effect of SLC30A8 haploinsufficiency in humans. However, research tools to inhibit ZnT8 activity and measure cellular ZnT8 levels are not available. Here, we report the identification of two anti-ZnT8 mAbs applicable to addressing these unmet needs. Both mAbs exhibited subnanomolar affinities for human ZnT8 and were selective against homologous zinc transporters with distinct cross-species reactivities and epitope recognition. We showed that antigen-binding fragments (Fabs) protected ZnT8 from unfolding and inhibited ZnT8-mediated zinc transport in proteoliposomes. Negative-stain EM revealed a ternary binding complex of a ZnT8 monomer and two different Fabs at a 1:1:1 stoichiometry. Moreover, dual bindings of two different mAbs to a single ZnT8 protein multiplied the individual anti-ZnT8 specificities, enabling quantification of cellular ZnT8 levels by homogeneous time-resolved fluorescence (HTRF). Our results demonstrate the utilities of the two generated mAbs as allosteric inhibitors and highly specific biosensors of human ZnT8.	[Merriman, Chengfeng; Fu, Dax] Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA; [Li, Hua; Li, Huilin] Van Andel Res Inst, CryoEM Struct Biol Lab, Grand Rapids, MI 49503 USA	Johns Hopkins University; Van Andel Institute	Fu, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	dfu3@jhmi.edu		Li, Huilin/0000-0001-8085-8928; Fu, Dax/0000-0002-2663-1316	National Institutes of Health Shared Instrumentation Grant [S10OD016374]; National Institutes of Health [S10 OD016315, S10 RR13777001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065137] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016315, S10OD016374] Funding Source: NIH RePORTER	National Institutes of Health Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Hao Zhang from the Flow Cytometry and Immunology Core Facility at the Johns Hopkins Bloomberg School of Public Health for assistance in data acquisition and analysis. We also thank Barbara Smith from the microscopy facility of the Johns Hopkins University School of Medicine for assistance in cell imaging. The Zeiss confocal microscope was funded through National Institutes of Health Shared Instrumentation Grant S10OD016374. The MoFlo XDP cell sorter was funded through National Institutes of Health Grants S10 OD016315 and S10 RR13777001.	Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Boesgaard TW, 2008, DIABETOLOGIA, V51, P816, DOI 10.1007/s00125-008-0955-6; Bonnefond A, 2015, CELL METAB, V21, P357, DOI 10.1016/j.cmet.2014.12.020; Cherezov V, 2008, STRUCTURE, V16, P1378, DOI 10.1016/j.str.2008.05.014; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Degorce Francois, 2009, Curr Chem Genomics, V3, P22, DOI 10.2174/1875397300903010022; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; Friend SH, 2014, SCIENCE, V344, P970, DOI 10.1126/science.1255648; Hoch E, 2012, P NATL ACAD SCI USA, V109, P7202, DOI 10.1073/pnas.1200362109; Huang Q, 2017, J BIOL CHEM, V292, P4034, DOI 10.1074/jbc.M116.772152; Kambe T, 2014, CELL MOL LIFE SCI, V71, P3281, DOI 10.1007/s00018-014-1617-0; Kleiner S, 2018, P NATL ACAD SCI USA, V115, pE7642, DOI 10.1073/pnas.1721418115; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Lemaire K, 2012, J DIABETES INVEST, V3, P202, DOI 10.1111/j.2040-1124.2012.00199.x; Li L, 2017, DIABETES, V66, P551, DOI 10.2337/db16-0323; Lim HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024653; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Merriman C, 2018, J BIOL CHEM, V293, P579, DOI 10.1074/jbc.RA117.000195; Merriman C, 2016, J BIOL CHEM, V291, P26950, DOI 10.1074/jbc.M116.764605; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Parsons DS, 2018, FEBS J, V285, P1237, DOI 10.1111/febs.14402; Pearson E, 2014, NAT GENET, V46, P323, DOI 10.1038/ng.2934; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pound LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040972; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; Prasad RB, 2015, GENES-BASEL, V6, P87, DOI 10.3390/genes6010087; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rutter GA, 2010, ISLETS, V2, P49, DOI 10.4161/isl.2.1.10259; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; Vyas NK, 2002, BIOCHEMISTRY-US, V41, P13575, DOI 10.1021/bi0261387; Wong WP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00394-3; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	43	8	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16206	16216		10.1074/jbc.RA118.005136	http://dx.doi.org/10.1074/jbc.RA118.005136			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30181214	Green Published, hybrid			2022-12-26	WOS:000447833600009
J	Harris, BD; Schreiter, J; Chevrier, M; Jordan, JL; Walter, MR				Harris, Bethany D.; Schreiter, Jessica; Chevrier, Marc; Jordan, Jarrat L.; Walter, Mark R.			Human interferon-epsilon and interferon-kappa exhibit low potency and low affinity for cell-surface IFNAR and the poxvirus antagonist B18R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon; receptor structure-function; recombinant protein expression; viral protein; protein complex; protein-protein interaction; structure-function; B18R; IFNAR; IFNE; IFN	JAK-STAT PATHWAY; I-INTERFERON; ESCHERICHIA-COLI; ALPHA RECEPTOR; EXPRESSION; VIRUS; IDENTIFICATION; GENES; BETA; ACTIVATION	IFNE epsilon and IFN kappa are interferons that induce microbial immunity at mucosal surfaces and in the skin. They are members of the type-I interferon (IFN) family, which consists of 16 different IFNs, that all signal through the common IFNAR1/IFNAR2 receptor complex. Although IFN epsilon and IFN kappa have unique expression and functional properties, their biophysical properties have not been extensively studied. In this report, we describe the expression, purification, and characterization of recombinant human IFN epsilon and IFN kappa. In cellular assays, IFN epsilon and IFN kappa exhibit similar to 1000-fold lower potency than IFN alpha 2 and IFN omega. The reduced potency of IFN epsilon and IFN kappa are consistent with their weak affinity for the IFNAR2 receptor chain. Despite reduced IFNAR2-binding affinities, IFN epsilon and IFN epsilon exhibit affinities for the IFNAR1 chain that are similar to other IFN subtypes. As observed for cellular IFNAR2 receptor, the poxvirus antagonist, B18R, also exhibits reduced affinity for IFN epsilon and IFN kappa, relative to the other IFNs. Taken together, our data suggest IFN epsilon and IFN kappa are specialized IFNs that have evolved to weakly bind to the IFNAR2 chain, which allows innate protection of the mucosa and skin and limits neutralization of IFN epsilon and IFN kappa biological activities by viral IFN antagonists.	[Harris, Bethany D.; Walter, Mark R.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35243 USA; [Schreiter, Jessica; Chevrier, Marc; Jordan, Jarrat L.] Janssen Res & Dev LLC, Raritan, NJ 08869 USA	University of Alabama System; University of Alabama Birmingham; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Walter, MR (corresponding author), 845 19th St South,Rm 509, Birmingham, AL 35243 USA.	walter@uab.edu		Jordan, Jarrat/0000-0002-0699-3774	Alliance for Lupus Research; Janssen Research & Development, LLC	Alliance for Lupus Research; Janssen Research & Development, LLC	This work was supported by a Novel Research Grant from the Alliance for Lupus Research and a Research Grant from Janssen Research & Development, LLC. The authors declare that they have no conflicts of interest with the contents of this article.	Abdulhaqq SA, 2016, MUCOSAL IMMUNOL, V9, P1027, DOI 10.1038/mi.2015.116; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; COLAMONICI OR, 1994, J BIOL CHEM, V269, P3518; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Couret J, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0185-z; de Goer de Herve M. G., 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019366, DOI 10.1371/JOURNAL.PONE.0019366]; Delgoffe GM, 2014, NAT MED, V20, P236, DOI 10.1038/nm.3493; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Deshpande A, 2013, PROTEIN SCI, V22, P1100, DOI 10.1002/pro.2285; Domanski P, 1997, J BIOL CHEM, V272, P26388, DOI 10.1074/jbc.272.42.26388; Foster GR, 2010, DRUGS, V70, P147, DOI 10.2165/11531990-000000000-00000; Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321; Garcia-Minambres A, 2017, IMMUNOL CELL BIOL, V95, P478, DOI 10.1038/icb.2016.123; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; Gray RC, 2007, J LEUKOCYTE BIOL, V81, P1075, DOI 10.1189/jlb.1006606; Hardy MP, 2004, GENOMICS, V84, P331, DOI 10.1016/j.ygeno.2004.03.003; Herzer K, 2009, CANCER RES, V69, P855, DOI 10.1158/0008-5472.CAN-08-2831; Huang JY, 2007, P NATL ACAD SCI USA, V104, P9822, DOI 10.1073/pnas.0610352104; Il Yoon S, 2007, PROTEIN EXPRES PURIF, V53, P132, DOI 10.1016/j.pep.2006.12.001; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005; Kirkwood J, 2002, SEMIN ONCOL, V29, P18, DOI 10.1053/sonc.2002.33078; Kuruganti S, 2014, PROTEIN EXPRES PURIF, V103, P75, DOI 10.1016/j.pep.2014.08.010; LaFleur DW, 2001, J BIOL CHEM, V276, P39765, DOI 10.1074/jbc.M102502200; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; Li T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00697; Liu YW, 2014, NAT MED, V20, P272, DOI 10.1038/nm.3485; LOH JE, 1992, EMBO J, V11, P1351, DOI 10.1002/j.1460-2075.1992.tb05180.x; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Pfeffer LM, 1998, CANCER RES, V58, P2489; Piehler J, 1999, J MOL BIOL, V289, P57, DOI 10.1006/jmbi.1999.2726; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Radhakrishnan R, 1996, STRUCTURE, V4, P1453, DOI 10.1016/S0969-2126(96)00152-9; Reiser J, 2011, J VIROL, V85, P11372, DOI 10.1128/JVI.05279-11; Richter MF, 1998, J BIOL CHEM, V273, P24723, DOI 10.1074/jbc.273.38.24723; Samarajiwa SA, 2014, J IMMUNOL, V192, P4425, DOI 10.4049/jimmunol.1302388; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stifter SA, 2018, J BIOL CHEM, V293, P3168, DOI 10.1074/jbc.M117.800755; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Tasker C, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88255; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Walter MR, 2004, ADV PROTEIN CHEM, V68, P171; Yang CH, 2007, J IMMUNOL, V178, P986, DOI 10.4049/jimmunol.178.2.986; Zhao WL, 2007, J IMMUNOL, V179, P463, DOI 10.4049/jimmunol.179.1.463	54	13	14	7	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16057	16068		10.1074/jbc.RA118.003617	http://dx.doi.org/10.1074/jbc.RA118.003617			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30171073	Green Published, hybrid			2022-12-26	WOS:000447256000025
J	Bhavanam, S; Rayat, GR; Keelan, M; Kunimoto, D; Drews, SJ				Bhavanam, Sudha; Rayat, Gina R.; Keelan, Monika; Kunimoto, Dennis; Drews, Steven J.			Characterization of immune responses of human PBMCs infected with Mycobacterium tuberculosis H37Ra: Impact of donor declared BCG vaccination history on immune responses and M. tuberculosis growth	PLOS ONE			English	Article							T-CELL SUBSETS; IFN-GAMMA PRODUCTION; PERIPHERAL-BLOOD; TGF-BETA; ACTIVE TUBERCULOSIS; CYTOKINE RESPONSES; INTERFERON-GAMMA; GRANULOMA; MEMORY; IL-10	This study characterized the immune responses in early Mycobacterium tuberculosis (Mtb) H37Ra infection of human peripheral blood mononuclear cell (PBMC)-collagen matrix culture and the impact of Bacille Calmette-Guerin (BCG) vaccination history of donor PBMCs on the immune responses to Mtb infection. Aggregates of PBMCs were initially observed on day 3 and the size of aggregates continued to increase on day 8 post-infection, where macrophages and T cell subsets were identified to be present. Similarly, mycobacterial load progressively increased in infected PBMCs during the 8 days of culture but were significantly lower in infected PBMCs from BCG vaccinated (BCG+) donors compared to unvaccinated (BCG-) donors. The levels of INF-gamma, TNF-alpha, IL-4, IL-6, IL-10 and IL-17 in the supernatants of Mtb-infected PBMCs peaked at day 3 and decreased on days 5 and 8. The levels of these cytokines except IL-10 were significantly lower in Mtb-infected PBMCs from BCG+ donors compared to infected PBMCs from BCG-donors. The percentages of activated naive Th cells, activated effector memory Th cells and activated central memory Tc cells were significantly higher in Mtb-infected PBMCs compared to uninfected PBMCs at day 8 post-infection. Further, the proportion of activated central memory Tc cells was significantly higher in infected PBMCs from BCG+ donors compared to the BCG-donors. This study highlights the possibility that BCG vaccination may confound results that utilize human PBMCs to study Mtb infection.	[Bhavanam, Sudha; Keelan, Monika; Drews, Steven J.] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Rayat, Gina R.] Univ Alberta, Ray Rajotte Surg Med Res Inst, Alberta Diabet Inst, Dept Surg, Edmonton, AB, Canada; [Kunimoto, Dennis] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Drews, Steven J.] Univ Alberta Hosp, Prov Lab Publ Hlth, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Drews, SJ (corresponding author), Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada.; Drews, SJ (corresponding author), Univ Alberta Hosp, Prov Lab Publ Hlth, Edmonton, AB, Canada.	drews@ualberta.ca		Kunimoto, Dennis/0000-0002-7691-5448	University Hospital Foundation	University Hospital Foundation	Financial support for this work was provided by a medical research grant from the University Hospital Foundation.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Al-Attiyah R, 2006, FEMS IMMUNOL MED MIC, V47, P254, DOI 10.1111/j.1574-695X.2006.00110.x; Andersen P, 2000, INFECT IMMUN, V68, P621, DOI 10.1128/IAI.68.2.621-629.2000; Behr MA, 1999, VACCINE, V17, P915, DOI 10.1016/S0264-410X(98)00277-1; Bhavanam S, 2016, FUTURE MICROBIOL, V11, P1073, DOI 10.2217/fmb-2016-0005; Birkness KA, 2007, IMMUNOL CELL BIOL, V85, P160, DOI 10.1038/sj.icb.7100019; Bonecini-Almeida MG, 2004, INFECT IMMUN, V72, P2628, DOI 10.1128/IAI.72.5.2628-2634.2004; Boom WH, 1996, INFECT AGENT DIS, V5, P73; Braian C, 2015, JOVE-J VIS EXP, DOI 10.3791/53084; Chavez-Galan L, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/984973; Cowan J, 2012, CLIN EXP IMMUNOL, V167, P317, DOI 10.1111/j.1365-2249.2011.04520.x; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Ehlers S, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00411; El Fenniri L, 2011, TUBERCULOSIS, V91, P224, DOI 10.1016/j.tube.2010.12.005; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Fjallbrant H, 2008, SCAND J INFECT DIS, V40, P387, DOI 10.1080/00365540701732905; Flynn JL, 2015, IMMUNOL REV, V264, P60, DOI 10.1111/imr.12258; Freeman S, 2006, J INTERF CYTOK RES, V26, P27, DOI 10.1089/jir.2006.26.27; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gerosa F, 1999, CLIN IMMUNOL, V92, P224, DOI 10.1006/clim.1999.4752; Giacomini E, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/841346; Glickman MS, 2001, CELL, V104, P477, DOI 10.1016/S0092-8674(01)00236-7; Gonzalez-Juarrero M, 2001, INFECT IMMUN, V69, P1127, DOI 10.1128/IAI.69.2.1127-1133.2001; Henao-Tamayo M, 2014, TUBERCULOSIS, V94, P455, DOI 10.1016/j.tube.2014.05.001; Higgins DM, 2009, TUBERCULOSIS, V89, P149, DOI 10.1016/j.tube.2009.01.001; Hill PC, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000068; Hoal-Van Helden EG, 2001, CELL BIOL INT, V25, P83, DOI 10.1006/cbir.2000.0680; Kapoor N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053657; Kheir AEM, 2011, VACCINE, V29, P8189, DOI 10.1016/j.vaccine.2011.08.095; Kumar NP, 2011, CLIN VACCINE IMMUNOL, V18, P1856, DOI 10.1128/CVI.05366-11; Leemans JC, 2003, J CLIN INVEST, V111, P681, DOI 10.1172/JCI200316936; Li L, 2011, IMMUNOBIOLOGY, V216, P477, DOI 10.1016/j.imbio.2010.09.003; Li Q, 2012, EUR REV MED PHARMACO, V16, P2029; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Maggioli MF, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00421; Maggioli MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122571; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Nabeshima Shigeki, 2005, Journal of Infection and Chemotherapy, V11, P18, DOI 10.1007/s10156-004-0357-8; Orme IM, 2014, SEMIN IMMUNOL, V26, P601, DOI 10.1016/j.smim.2014.09.009; Penuelas-Urquides K, 2013, BRAZ J MICROBIOL, V44, P287, DOI 10.1590/S1517-83822013000100042; Puissegur MP, 2004, CELL MICROBIOL, V6, P423, DOI 10.1111/j.1462-5822.2004.00371.x; Robinson RT, 2010, J EXP MED, V207, P591, DOI 10.1084/jem.20091085; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Samstein M, 2013, ELIFE, V2, DOI 10.7554/eLife.01086; Santiago EM, 2003, PEDIATRICS, V112, pE298, DOI 10.1542/peds.112.4.e298; Seimon TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012772; Seitzer U, 2003, CELLS TISSUES ORGANS, V174, P110, DOI 10.1159/000071151; Sinha P, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1450-1; Skold M, 2008, J IMMUNOL, V181, P6349, DOI 10.4049/jimmunol.181.9.6349; Skowronski DM, 2018, EUROSURVEILLANCE, V23, DOI [10.2807/1560-7917.ES, DOI 10.2807/1560-7917.ES]; STEENKEN W, 1946, AM REV TUBERC PULM, V54, P62; Tsukaguchi K, 1999, CELL IMMUNOL, V194, P12, DOI 10.1006/cimm.1999.1497; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; Vasconcelos JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00358; Vogelzang A, 2014, J INFECT DIS, V210, P1928, DOI 10.1093/infdis/jiu347; Wu YE, 2009, J INT MED RES, V37, P1742; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zhang M, 1998, INFECT IMMUN, V66, P794, DOI 10.1128/IAI.66.2.794-799.1998; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	64	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203822	10.1371/journal.pone.0203822	http://dx.doi.org/10.1371/journal.pone.0203822			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204787	Green Published, Green Submitted, gold			2022-12-26	WOS:000444355500045
J	Earl, R; Falkmer, T; Girdler, S; Morris, SL; Falkmer, M				Earl, Robyn; Falkmer, Torbjorn; Girdler, Sonya; Morris, Susan L.; Falkmer, Marita			Viewpoints of pedestrians with and without cognitive impairment on shared zones and zebra crossings	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; QUALITY-OF-LIFE; INTELLECTUAL DISABILITIES; ENVIRONMENTAL-FACTORS; OLDER-ADULTS; PARTICIPATION; PERCEPTIONS; BEHAVIOR; GENDER; SPACE	Background Shared zones are characterised by an absence of traditional markers that segregate the road and footpath. Negotiation of a shared zone relies on an individual's ability to perceive, assess and respond to environmental cues. This ability may be impacted by impairments in cognitive processing, which may lead to individuals experiencing increased anxiety when negotiating a shared zone. Method Q method was used in order to identify and explore the viewpoints of pedestrians, with and without cognitive impairments as they pertain to shared zones. Results Two viewpoints were revealed. Viewpoint one was defined by "confident users" while viewpoint two was defined by users who "know what [they] are doing but drivers might not". Discussion Overall, participants in the study would not avoid shared zones. Pedestrians with intellectual disability were, however, not well represented by either viewpoint, suggesting that shared zones may pose a potential barrier to participation for this group.	[Earl, Robyn; Falkmer, Torbjorn; Girdler, Sonya; Falkmer, Marita] Curtin Univ, Sch Occupat Therapy Social Work & Speech Pathol, Perth, WA, Australia; [Falkmer, Torbjorn] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci IMH, Rehabil Med, Linkoping, Sweden; [Falkmer, Torbjorn] Pain & Rehabil Ctr, Linkoping, Sweden; [Morris, Susan L.] Curtin Univ, Fac Hlth Sci, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia; [Falkmer, Marita] Jonkoping Univ, Inst Disabil Res, CHILD Programme, Sch Educ & Commun, Jonkoping, Sweden	Curtin University; Linkoping University; Curtin University; Jonkoping University	Falkmer, T (corresponding author), Curtin Univ, Sch Occupat Therapy Social Work & Speech Pathol, Perth, WA, Australia.; Falkmer, T (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci IMH, Rehabil Med, Linkoping, Sweden.; Falkmer, T (corresponding author), Pain & Rehabil Ctr, Linkoping, Sweden.	torbjorn.falkmer@curtin.edu.au	Girdler, Sonya/ABC-9629-2021	Falkmer, Torbjorn/0000-0002-0756-6862; Girdler, Sonya/0000-0001-7992-0800; Morris, Susan/0000-0002-5334-5809	Trafikverket, Sweden [H-107500-1930]	Trafikverket, Sweden	This study was funded by Trafikverket, Sweden, grant number H-107500-1930. The funder has played no role in the research.	Abbott S, 2006, J INTELLECT DISABILI, V10, P275, DOI 10.1177/1744629506067618; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Anaby D, 2009, DISABIL REHABIL, V31, P1275, DOI 10.1080/09638280802572940; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; Bernhoft IM, 2008, TRANSPORT RES F-TRAF, V11, P83, DOI 10.1016/j.trf.2007.08.004; Carthy T., 1995, RISK SAFETY ROADS OL; Charman T, 2003, PHILOS T R SOC B, V358, P315, DOI 10.1098/rstb.2002.1199; Chee DYT, 2015, DEV NEUROREHABIL, V18, P26, DOI 10.3109/17518423.2014.964377; Colver A, 2009, DEV MED CHILD NEUROL, V51, P656, DOI 10.1111/j.1469-8749.2009.03321.x; Combes H, 2004, J APPL RES INTELLECT, V17, P149, DOI 10.1111/j.1468-3148.2004.00191.x; Cowan G, 2018, J TRANSP HEALTH, V8, P112, DOI 10.1016/j.jth.2017.12.001; de Nazelle A, 2011, ENVIRON INT, V37, P766, DOI 10.1016/j.envint.2011.02.003; Department of Infrastructure and Transport, 2013, WALK RID ACC PUBL TR; Earl R, 2016, LAND USE POLICY, V57, P327, DOI 10.1016/j.landusepol.2016.06.009; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Esse Zegeer, 2004, I TRANSPORTATION ENG, V74, P34; Falkmer M, 2015, TRANSPORT RES A-POL, V80, P163, DOI 10.1016/j.tra.2015.07.019; Fletcher-Watson S, 2008, J AUTISM DEV DISORD, V38, P1785, DOI 10.1007/s10803-008-0548-8; Foley KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108413; Giles-Corti Billie, 2010, N S W Public Health Bull, V21, P122, DOI 10.1071/NB10027; Gorrie CA, 2013, J AUSTRALAS COLL ROA, V24, P28; Government of Western Australia, 2011, ACT LIV ALL FRAM PHY; Granie MA, 2014, ACCIDENT ANAL PREV, V67, P75, DOI 10.1016/j.aap.2014.02.008; Guttman L., 1954, PSYCHOMETRIKA, V19, P149, DOI 10.1007/BF02289162; Hamilton-Baillie B, 2005, P I CIVIL ENG-CIV EN, V158, P39, DOI 10.1680/cien.2005.158.5.39; Hamilton-Baillie B., 2008, BUILD ENVIRON, V34, P161, DOI [DOI 10.2148/BENV.34.2.161, 10.2148/benv.34.2.161]; Hamilton-Baillie B, 2008, URBAN DES INT, V13, P130, DOI 10.1057/udi.2008.13; Hammond V, 2013, J URBAN DES, V18, P78, DOI 10.1080/13574809.2012.739549; Havard C, 2012, TRANSPORT RES F-TRAF, V15, P249, DOI 10.1016/j.trf.2011.12.007; Holland C, 2007, ACCIDENT ANAL PREV, V39, P224, DOI 10.1016/j.aap.2006.07.003; James M., 2005, BRIT J LEARN DISABIL, V33, P120, DOI DOI 10.1111/bld.2005.33.issue-3; Joosten A, 2016, DEV NEUROREHABIL, V19, P95, DOI 10.3109/17518423.2014.913081; Kaparias I, 2012, TRANSPORT RES F-TRAF, V15, P297, DOI 10.1016/j.trf.2012.02.001; Katzmarzyk PT, 2004, CAN J APPL PHYSIOL, V29, P90, DOI 10.1139/h04-008; Kreuger L, 2008, J APPL RES INTELLECT, V21, P466, DOI 10.1111/j.1468-3148.2007.00408.x; KRUEGER N, 1994, DECISION SCI, V25, P385, DOI 10.1111/j.1540-5915.1994.tb01849.x; Levasseur M, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-30; Moody S, 2014, P I CIVIL ENG TRANSP; Noreau L, 2010, ARCH PHYS MED REHAB, V91, pS44, DOI 10.1016/j.apmr.2009.10.037; Organization W. H, 2009, 2008 2013 ACT PLAN G; Organization WH, 2013, GLOB STAT REP ROAD S; Rabl A, 2012, TRANSPORT POLICY, V19, P121, DOI 10.1016/j.tranpol.2011.09.008; Retting RA, 2003, AM J PUBLIC HEALTH, V93, P1456, DOI 10.2105/AJPH.93.9.1456; Rosen E, 2009, ACCIDENT ANAL PREV, V41, P536, DOI 10.1016/j.aap.2009.02.002; Rosenbloom T, 2009, TRANSPORT RES F-TRAF, V12, P389, DOI 10.1016/j.trf.2009.05.002; Sallis JF, 2004, TRANSPORT RES A-POL, V38, P249, DOI 10.1016/j.tra.2003.11.003; Schmolck P., 2014, PQMETHOD; Smith KRM, 2010, RES DEV DISABIL, V31, P1366, DOI 10.1016/j.ridd.2010.07.002; Thomas C, 2010, SHARED SPACE SAFE SP; Watts S, 2012, DOING Q METHODOLOGIC, DOI [10.3109/17518423.2014.964377, DOI 10.3109/17518423.2014.964377]; Western Australian Planning Commission & Department for Planning and Infrastructure, 2009, LIV NEIGHB W AUSTR G; World Health Organization (WHO), 2013, PED SAF ROAD SAF MAN; World Medical Association, 2008, WMA DECL HELS ETH PR; Zegeer CV, 2012, ACCIDENT ANAL PREV, V44, P3, DOI 10.1016/j.aap.2010.12.007	55	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203765	10.1371/journal.pone.0203765	http://dx.doi.org/10.1371/journal.pone.0203765			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT2UM	30204784	Green Published, Green Submitted, gold			2022-12-26	WOS:000444355500042
J	Torini, JR; Romanello, L; Batista, FAH; Serrao, VHB; Faheem, M; Zeraik, AE; Bird, L; Nettleship, J; Reddivari, Y; Owens, R; DeMarco, R; Borges, JC; Brandao-Neto, J; Pereira, HD				Torini, Juliana Roberta; Romanello, Larissa; Heleno Batista, Fernanda Aparecida; Balasco Serrao, Vitor Hugo; Faheem, Muhammad; Zeraik, Ana Eliza; Bird, Louise; Nettleship, Joanne; Reddivari, Yamini; Owens, Ray; DeMarco, Ricardo; Borges, Julio Cesar; Brandao-Neto, Jose; Pereira, Humberto D'Muniz			The molecular structure of Schistosoma mansoni PNP isoform 2 provides insights into the nucleoside selectivity of PNPs	PLOS ONE			English	Article							NUCLEOTIDE-METABOLISM; ENZYME PROMISCUITY; CRYSTAL-STRUCTURE; PURINE ANALOGS; PHOSPHORYLASE; PATHWAYS; ADENOSINE; EXPRESSION; BINDING; EVOLUTIONARY	Purine nucleoside phosphorylases (PNPs) play an important role in the blood fluke parasite Schistosoma mansoni as a key enzyme of the purine salvage pathway. Here we present the structural and kinetic characterization of a new PNP isoform from S. mansoni, SmPNP2. Thermofluorescence screening of different ligands suggested cytidine and cytosine are potential ligands. The binding of cytosine and cytidine were confirmed by isothermal titration calorimetry, with a K-D of 27 mu M for cytosine, and a K-M of 76.3 mu M for cytidine. SmPNP2 also displays catalytic activity against inosine and adenosine, making it the first described PNP with robust catalytic activity towards both pyrimidines and purines. Crystal structures of SmPNP2 with different ligands were obtained and comparison of these structures with the previously described S. mansoni PNP (SmPNP1) provided clues for the unique capacity of SmPNP2 to bind pyrimidines. When compared with the structure of SmPNP1, substitutions in the vicinity of SmPNP2 active site alter the architecture of the nucleoside base binding site thus permitting an alternative binding mode for nucleosides, with a 180 degrees rotation from the canonical binding mode. The remarkable plasticity of this binding site enhances our understanding of the correlation between structure and nucleotide selectivity, thus suggesting new ways to analyse PNP activity.	[Torini, Juliana Roberta; Romanello, Larissa; Balasco Serrao, Vitor Hugo; Zeraik, Ana Eliza; DeMarco, Ricardo; Pereira, Humberto D'Muniz] Univ Sao Paulo, Inst Fis Sao Carlos, Lab Biol Estrutural, Sao Carlos, SP, Brazil; [Heleno Batista, Fernanda Aparecida; Borges, Julio Cesar] Univ Sao Paulo, Inst Quim Sao Carlos, Sao Carlos, SP, Brazil; [Heleno Batista, Fernanda Aparecida] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Campinas, SP, Brazil; [Faheem, Muhammad] Univ Catolica Brasilia, Programa Pos Grad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil; [Faheem, Muhammad] Univ Brasilia, Dept Biol Celular, Lab Biofis Mol, Brasilia, DF, Brazil; [Bird, Louise; Nettleship, Joanne; Reddivari, Yamini; Owens, Ray] Rutherford Appleton Lab, OPPF UK, Res Complex Harwell, Oxford, England; [Brandao-Neto, Jose] Harwell Sci & Innovat Campus, Diamond Light Source, Didcot, Oxon, England	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Catolica de Brasilia; Universidade de Brasilia; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Diamond Light Source	Pereira, HD (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Lab Biol Estrutural, Sao Carlos, SP, Brazil.	hmuniz.pereira@gmail.com	Torini, Juliana/AAQ-9323-2020; DeMarco, Ricardo/A-7773-2008; Borges, Julio C/C-6160-2008; Serrao, Vitor Hugo Balasco/AAM-2060-2020; Batista, Fernanda A.H./E-1633-2013	Torini, Juliana/0000-0003-3063-201X; DeMarco, Ricardo/0000-0001-8944-1301; Borges, Julio C/0000-0003-4856-748X; Serrao, Vitor Hugo Balasco/0000-0002-9398-2941; Aparecida Heleno Batista, Fernanda/0000-0003-0783-8378; Zeraik, Ana Eliza/0000-0001-9508-4283; Bird, Louise/0000-0002-9846-5716; Faheem, Muhammad/0000-0002-3635-1246; Nettleship, Joanne/0000-0002-1258-1733	Sao Paulo Research Foundation (FAPESP) [2012/14223-9, 2012/10213-9, 2012/23730-1]; CNPq [474402/2013-4]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Grants 2012/14223-9 (HMP), 2012/10213-9 (JRT) and 2012/23730-1 (VHBS) Sao Paulo Research Foundation (FAPESP) and CNPq 474402/2013-4 (HMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bird LE, 2011, METHODS, V55, P29, DOI 10.1016/j.ymeth.2011.08.002; Bzowska A, 2000, PHARMACOL THERAPEUT, V88, P349, DOI 10.1016/S0163-7258(00)00097-8; Castilho MS, 2010, BIOORGAN MED CHEM, V18, P1421, DOI 10.1016/j.bmc.2010.01.022; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cogswell AA, 2011, MOL BIOCHEM PARASIT, V178, P46, DOI 10.1016/j.molbiopara.2011.03.001; CRABTREE GW, 1974, BIOCHEM PHARMACOL, V23, P649, DOI 10.1016/0006-2952(74)90630-3; Dessanti P, 2012, ACTA CRYSTALLOGR D, V68, P239, DOI 10.1107/S090744491200073X; Dillon GP, 2007, PARASITOLOGY, V134, P1589, DOI 10.1017/S0031182007002995; DOVEY HF, 1984, MOL BIOCHEM PARASIT, V11, P157, DOI 10.1016/0166-6851(84)90062-8; ELKOUNI MH, 1990, INT J PARASITOL, V20, P37, DOI 10.1016/0020-7519(90)90170-R; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erion MD, 1997, BIOCHEMISTRY-US, V36, P11725, DOI 10.1021/bi961969w; Erion MD, 1997, BIOCHEMISTRY-US, V36, P11735, DOI 10.1021/bi961970v; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Kicska GA, 2002, BIOCHEMISTRY-US, V41, P14489, DOI 10.1021/bi026636f; KLENOW H, 1952, BIOCHEM J, V50, P404, DOI 10.1042/bj0500404; Logan-Klumpler FJ, 2012, NUCLEIC ACIDS RES, V40, pD98, DOI 10.1093/nar/gkr1032; Lu ZG, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.118; Lu ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep31150; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIECH RP, 1975, BIOCHEM PHARMACOL, V24, P407, DOI 10.1016/0006-2952(75)90226-9; Pandya C, 2014, J BIOL CHEM, V289, P30229, DOI 10.1074/jbc.R114.572990; PEGG AE, 1969, BIOCHEM J, V115, P241, DOI 10.1042/bj1150241; Pereira HD, 2005, J MOL BIOL, V353, P584, DOI 10.1016/j.jmb.2005.08.045; Pereira HM, 2003, ACTA CRYSTALLOGR D, V59, P1096, DOI 10.1107/S090744490300773X; Pereira HM, 2007, ACTA TROP; Pereira HD, 2011, J SYNCHROTRON RADIAT, V18, P62, DOI 10.1107/S0909049510027718; Pereira HM, 2010, ACTA TROP, V114, P97, DOI 10.1016/j.actatropica.2010.01.010; Pereira HM, 2010, ACTA CRYSTALLOGR D, V66, P73, DOI 10.1107/S0907444909045715; Postigo MP, 2011, J BRAZIL CHEM SOC, V22, P583, DOI 10.1590/S0103-50532011000300024; Protasio AV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001455; Pugmire MJ, 2002, BIOCHEM J, V361, P1, DOI 10.1042/0264-6021:3610001; Romanello L, 2017, MOL BIOCHEM PARASIT, V214, P27, DOI 10.1016/j.molbiopara.2017.03.006; Senft A W, 1972, Int J Parasitol, V2, P249, DOI 10.1016/0020-7519(72)90013-6; SENFT AW, 1973, BIOCHEM PHARMACOL, V22, P449, DOI 10.1016/0006-2952(73)90286-4; SENFT AW, 1973, BIOCHEM PHARMACOL, V22, P437, DOI 10.1016/0006-2952(73)90285-2; SENFT AW, 1977, BIOCHEM PHARMACOL, V26, P1847, DOI 10.1016/0006-2952(77)90158-7; SENFT AW, 1983, PHARMACOL THERAPEUT, V20, P341, DOI 10.1016/0163-7258(83)90031-1; Silva RG, 2011, BIOCHEMISTRY-US, V50, P9158, DOI 10.1021/bi2013382; STEGMAN RJ, 1973, BIOCHEM PHARMACOL, V22, P459, DOI 10.1016/0006-2952(73)90287-6; Stoeckler JD, 1997, BIOCHEMISTRY-US, V36, P11749, DOI 10.1021/bi961971n; Tebbe J, 1999, J MOL BIOL, V294, P1239, DOI 10.1006/jmbi.1999.3327; Wang CK, 2012, BIOINFORMATICS, V28, P439, DOI 10.1093/bioinformatics/btr664; Waterman DG, 2016, ACTA CRYSTALLOGR D, V72, P558, DOI 10.1107/S2059798316002187; Wendt GR, 2016, CURR OPIN GENET DEV, V40, P95, DOI 10.1016/j.gde.2016.06.010; Wielgus-Kutrowska B, 2006, BBA-PROTEINS PROTEOM, V1764, P887, DOI 10.1016/j.bbapap.2006.03.001; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Zhou XR, 2013, FEBS J, V280, P1475, DOI 10.1111/febs.12143	51	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203532	10.1371/journal.pone.0203532	http://dx.doi.org/10.1371/journal.pone.0203532			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192840	gold, Green Published			2022-12-26	WOS:000444093600097
J	Kubota, K; Ooba, N; Kamijima, Y; Sato, K; Koide, D				Kubota, Kiyoshi; Ooba, Nobuhiro; Kamijima, Yukari; Sato, Kuniyasu; Koide, Daisuke			The use of anticoagulants in patients with non-valvular atrial fibrillation between 2005 and 2014: A drug utilization study using claims data in Japan	PLOS ONE			English	Article							ORAL ANTICOAGULANTS; STROKE PREVENTION; WARFARIN; GUIDELINES; UNDERUSE; RISK; MANAGEMENT; SCHEMES	Background Anticoagulant therapy is recommended in patients with atrial fibrillation (AF) but remains underused. The proper use of anticoagulants has been encouraged in guidelines frequently published over the past two decades. Materials and methods In this study, we used insurance claims data collected from 2005 to 2014 to investigate the prevalence and incidence of non-valvular AF (NVAF) patients aged 20 to 74 years standardized to the Japanese population in 2012 and subdivided by stroke prevention drug type. We estimated the frequency of coagulation monitoring in patients with incident NVAF undergoing warfarin therapy in 2011 and later. Results From 2005 to 2014, the standardized prevalence of NVAF increased from 117/100,000 to 278/100,000 and the proportion of anticoagulant users increased from 38.4% to 58.0%, while that of antiplatelet monotherapy decreased from 32.3% to 12.0%. The standardized incidence of NVAF was stable at similar to 40/100,000 patient-years. The proportion of those patients who started anticoagulant soon after the initial diagnosis increased from 19.9% to 49.1% from 2006 to 2013. Among patients who started warfarin, switchers to DOAC had more frequent coagulation monitoring than non-switchers. Conclusion The use of anticoagulant therapy has gradually increased in patients with NVAF in Japan during the study period from 2005 to 2014.	[Kubota, Kiyoshi; Ooba, Nobuhiro; Kamijima, Yukari; Sato, Kuniyasu; Koide, Daisuke] NPO Drug Safety Res Unit Japan, Tokyo, Japan; [Kubota, Kiyoshi; Ooba, Nobuhiro] Nihon Univ, Dept Clin Pharm, Sch Pharm, Chiba, Japan; [Sato, Kuniyasu; Koide, Daisuke] Univ Tokyo, Grad Sch Med, Dept Biostat & Bioinformat, Tokyo, Japan	Nihon University; University of Tokyo	Kubota, K (corresponding author), NPO Drug Safety Res Unit Japan, Tokyo, Japan.; Kubota, K (corresponding author), Nihon Univ, Dept Clin Pharm, Sch Pharm, Chiba, Japan.	kubotape-tky@umin.net		Kubota, Kiyoshi/0000-0001-6092-8685; Ooba, Nobuhiro/0000-0003-0579-3946				Akao M, 2014, CIRC J, V78, P2166, DOI 10.1253/circj.CJ-14-0344; [Anonymous], 2001, CIRCULATION, V104, P2118; [Anonymous], 2001, JPN CIRC J, V65, P931; Bahri O, 2015, J AM GERIATR SOC, V63, P71, DOI 10.1111/jgs.13200; Bureau of Statisticsm Ministry of Internal Affairs and Communications, 2012, POPULATION ESTIMATES; Chen Y, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-019037; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Gorelick PB, 1999, JAMA-J AM MED ASSOC, V281, P1112, DOI 10.1001/jama.281.12.1112; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Holster IL, 2013, GASTROENTEROLOGY, V145, P105, DOI 10.1053/j.gastro.2013.02.041; Inoue H, 2014, CIRC J, V78, P1997, DOI 10.1253/circj.CJ-66-0092; Inoue H, 2009, INT J CARDIOL, V137, P102, DOI 10.1016/j.ijcard.2008.06.029; Ishii Masami, 2012, Japan Med Assoc J, V55, P279; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Kimura S, 2010, J EPIDEMIOL, V20, P413, DOI 10.2188/jea.JE20090066; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Lee IH, 2015, J CARDIOL, V66, P475, DOI 10.1016/j.jjcc.2015.06.013; Lip GYH, 2013, CIRC J, V77, P1380, DOI 10.1253/circj.CJ-13-0465; Lip GYH, 2010, STROKE, V41, P2731, DOI 10.1161/STROKEAHA.110.590257; Medical Information System Development Center, COND COD CORR ICD 10; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Palomaki A, 2016, EUR J NEUROL, V23, P133, DOI 10.1111/ene.12820; Patel Manesh R, 2010, N Engl J Med, V362, P886, DOI 10.1056/NEJMoa0907272; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Renoux C, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0269-4; Sattler ELP, 2013, DRUG AGING, V30, P383, DOI 10.1007/s40266-013-0074-z; Schwammenthal Y, 2011, INT J CARDIOL, V152, P356, DOI 10.1016/j.ijcard.2010.08.005; Shah R, 2016, MED CARE, V54, P907, DOI 10.1097/MLR.0000000000000589; Suissa S, 2008, AM J EPIDEMIOL, V168, P329, DOI 10.1093/aje/kwn135; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; The Japanese Circulation Society, 2008, CIRC J S4, V72, P1581; Van Mieghemi W, 2012, ACTA CARDIOL, V67, P161, DOI 10.2143/AC.67.2.2154206; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wong CX, 2015, INT J CARDIOL, V191, P20, DOI 10.1016/j.ijcard.2015.03.064; Zheng HJ, 2017, INT J GEN MED, V10, P69, DOI 10.2147/IJGM.S128047	38	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203380	10.1371/journal.pone.0203380	http://dx.doi.org/10.1371/journal.pone.0203380			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183755	Green Published, Green Submitted, gold			2022-12-26	WOS:000443789900060
J	Patil, PS; Evancho-Chapman, MM; Li, H; Huang, H; George, RL; Shriver, LP; Leipzig, ND				Patil, Pritam S.; Evancho-Chapman, M. Michelle; Li, Hang; Huang, He; George, Richard L.; Shriver, Leah P.; Leipzig, Nic D.			Fluorinated methacrylamide chitosan hydrogel dressings enhance healing in an acute porcine wound model	PLOS ONE			English	Article							COLLAGEN-SYNTHESIS; OXYGEN; MOIST; WET; HYDROXYPROLINE; KERATINOCYTES; SYSTEMS; NERVES; CELLS; PIG	Wound healing involves multiple interrelated processes required to lead to successful healing outcomes. Phagocytosis, inflammation, cell proliferation, angiogenesis, energy production, and collagen synthesis are all directly or indirectly dependent on oxygen. Along with other critical factors, such as nutrition and comorbidities, availability of oxygen is a key determinant of healing success. Previously, we have presented a novel oxygenated hydrogel material that can be made into dressings for continuous localized oxygen delivery to wounds. In this study, an acute porcine wound model was used to test the healing benefits of these oxygenated MACF (MACF + O-2) hydrogel dressings compared to controls, which included commercial Derma-Gel (TM) hydrogel dressings. Wound closure and histological analyses were performed to assess re-epithelialization, collagen synthesis, angiogenesis, and keratinocyte maturation. Results from these assays revealed that wounds treated with MACF + O-2 hydrogel dressings closed faster as compared to Derma-Gel (p<0.05). Targeted metabolomics via liquid chromatography separation and mass spectrometric detection (LC-MS/MS) and a biochemical assay determined the concentration of hydroxyproline in wound samples at days 14 and 21, showing that MACF + O-2 hydrogel dressings improved wound healing via an upregulated collagen synthesis pathway as compared to Derma-Gel (p<0.05). Histological evidence showed that MACF + O-2 hydrogel dressings improve new blood vessel formation and keratinocyte maturation over all other treatments.	[Patil, Pritam S.; Li, Hang; Leipzig, Nic D.] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA; [Evancho-Chapman, M. Michelle; George, Richard L.] Summa Hlth Syst, Dept Surg, Akron Campus, Akron, OH USA; [Huang, He; Shriver, Leah P.] Univ Akron, Dept Chem, Akron, OH 44325 USA	University System of Ohio; University of Akron; Summa Health System; University System of Ohio; University of Akron	Leipzig, ND (corresponding author), Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.	nl21@uakron.edu	Li, Hang/ABO-8259-2022; Leipzig, Nic D/AAM-6654-2021	Leipzig, Nic D/0000-0002-6356-7691; Patil, Pritam/0000-0003-2710-8428	National Institute of General Medical Sciences (NIGMS) [R15GM104851]; Ohio Third Frontier Technology Validation and Start-up Fund (TVSF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM104851] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ohio Third Frontier Technology Validation and Start-up Fund (TVSF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following: ational Institute of General Medical Sciences (NIGMS) under R15GM104851 and the Ohio Third Frontier Technology Validation and Start-up Fund (TVSF), https://www.nigms.nih.gov/Pages/default.aspx and https://development.ohio.gov/bs_thirdfrontier/tvsf.htm.	AHH, 1994, UNDERLYING PROBLEMS; Ashrafi M, 2016, ACTA DERM-VENEREOL, V96, P587, DOI 10.2340/00015555-2321; Blais M, 2014, TISSUE ENG PT A, V20, P2180, DOI 10.1089/ten.tea.2013.0535; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210; Calo E, 2015, EUR POLYM J, V65, P252, DOI 10.1016/j.eurpolymj.2014.11.024; Castilla DM, 2012, ADV WOUND CARE, V1, P225, DOI 10.1089/wound.2011.0319; Celeste CJ, 2011, WOUND REPAIR REGEN, V19, P89, DOI 10.1111/j.1524-475X.2010.00639.x; CHANG N, 1983, ANN SURG, V197, P470, DOI 10.1097/00000658-198304000-00017; Desmet CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144914; DIEGELMANN RF, 1975, J SURG RES, V19, P239, DOI 10.1016/0022-4804(75)90087-6; Dimitrijevich SD, 1999, WOUND REPAIR REGEN, V7, P53; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Junker JPE, 2013, ADV WOUND CARE, V2, P348, DOI 10.1089/wound.2012.0412; KANNON GA, 1995, DERMATOL SURG, V21, P583, DOI 10.1111/j.1524-4725.1995.tb00511.x; Kollenberg L, 1999, CLIN S ADV SKIN WOUN; Ladizinsky D, 2010, WOUNDS, V22, P294; Liu MX, 1999, CELL TISSUE RES, V297, P423, DOI 10.1007/s004410051369; Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]; Moura LIF, 2013, ACTA BIOMATER, V9, P7093, DOI 10.1016/j.actbio.2013.03.033; NEUMAN RE, 1950, J BIOL CHEM, V184, P299; Ngo MA, 2007, J INVEST DERMATOL, V127, P354, DOI 10.1038/sj.jid.5700522; Okan Denis, 2007, Adv Skin Wound Care, V20, P39, DOI 10.1097/00129334-200701000-00013; Oliveria-Gandia M, 1998, WOUNDS, V10, P4; Patil PS, 2017, J BIOMED MATER RES A, V105, P2368, DOI 10.1002/jbm.a.36079; Patil PS, 2016, ACTA BIOMATER, V36, P164, DOI 10.1016/j.actbio.2016.03.022; PROCKOP D, 1963, ARCH BIOCHEM BIOPHYS, V101, P499, DOI 10.1016/0003-9861(63)90509-5; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Rockwell LC, 2006, HIGH ALT MED BIOL, V7, P237, DOI 10.1089/ham.2006.7.237; Rodriguez PG, 2008, DERMATOL SURG, V34, P1159, DOI 10.1111/j.1524-4725.2008.34254.x; Sarkar SD, 2013, J BIOMED MATER RES A, V101, P3482, DOI 10.1002/jbm.a.34660; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott JR, 2007, WOUND REPAIR REGEN, V15, pS27, DOI 10.1111/j.1524-475X.2007.00222.x; Sen CK, 2009, WOUND REPAIR REGEN, V17, P1, DOI 10.1111/j.1524-475X.2008.00436.x; Sheets AR, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0946-1; Svensjo T, 2000, PLAST RECONSTR SURG, V106, P602, DOI 10.1097/00006534-200009030-00012; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; TERENGHI G, 1995, HISTOL HISTOPATHOL, V10, P709; Tonnesen M. G., 2000, ANGIOGENESIS WOUND H, P40; VOGT PM, 1995, ANN PLAS SURG, V34, P493, DOI 10.1097/00000637-199505000-00007; Wang JF, 2001, COMPARATIVE MED, V51, P341; WATANABE S, 1995, HISTOCHEM CELL BIOL, V103, P425, DOI 10.1007/BF01457542; WEBSTER DF, 1979, ANAL BIOCHEM, V96, P220, DOI 10.1016/0003-2697(79)90576-1; Wijekoon A, 2013, ACTA BIOMATER, V9, P5653, DOI 10.1016/j.actbio.2012.10.034; Yan YH, 2007, WOUNDS, V19, P79	45	15	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203371	10.1371/journal.pone.0203371	http://dx.doi.org/10.1371/journal.pone.0203371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183754	gold, Green Submitted, Green Published			2022-12-26	WOS:000443789900059
J	Piccinno, MS; Petrachi, T; Resca, E; Strusi, V; Bergamini, V; Mulas, GA; Mari, G; Dominici, M; Veronesi, E				Piccinno, Maria Serena; Petrachi, Tiziana; Resca, Elisa; Strusi, Valentina; Bergamini, Valentina; Mulas, Giuseppe Antonio; Mari, Giorgio; Dominici, Massimo; Veronesi, Elena			Label-free toxicology screening of primary human mesenchymal cells and iPS-derived neurons	PLOS ONE			English	Article							GUIDE GRATING BIOSENSOR; DRUG DISCOVERY; OPTICAL BIOSENSORS; ASSAYS; CRANIOPLASTY; DEATH	The high-throughput, label-free Corning Epic assay has applications in drug discovery, pharmacogenomics, cell receptor signaling, cell migration, and viral titration. The utility of Epic technology for biocompatibility testing has not been well established. In manufacturing of medical devices, in vitro and in vivo biocompatibility assessments are mandatory, according to ISO 10993. The new medical device regulation MDR 745/2017 specifies that ex vivo assays that can closely recapitulate in vivo scenarios are needed to better evaluate biomedical devices. We propose herein that Epic technology-which enables detection of variations in cell mass distribution-is suitable for biocompatibility screening of compounds. In this study, we challenged primary human osteoblasts, endothelial cells, and neurons derived from induced pluripotent stem cells with specific concentrations of methyl methacrylate (MMA). Polymeric MMA has long been applied in cranioplasty, where it makes contact with multiple cell types. Application of Epic technology yielded real-time cytotoxicity profiles for all considered cell types. The results were compared with those from microscopic observation of the same culture plate used in the Epic analyses. The Epic assay should be further examined for its utility for cell biology, genomics, and proteomics companion assays. Our results suggest that Epic technology can be applied to biocompatibility evaluation of human cells in medical device development.	[Piccinno, Maria Serena; Petrachi, Tiziana; Resca, Elisa; Strusi, Valentina; Mulas, Giuseppe Antonio; Mari, Giorgio; Dominici, Massimo; Veronesi, Elena] Sci & Technol Pk Med TPM, Mirandola, Italy; [Piccinno, Maria Serena; Petrachi, Tiziana; Resca, Elisa; Bergamini, Valentina; Dominici, Massimo; Veronesi, Elena] Univ Hosp Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital	Piccinno, MS; Veronesi, E (corresponding author), Sci & Technol Pk Med TPM, Mirandola, Italy.; Piccinno, MS; Veronesi, E (corresponding author), Univ Hosp Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Modena, Italy.	mariaserena.piccinno@tpm.bio; elena.veronesi@tpm.bio	Resca, Elisa/F-2666-2019; Dominici, Massimo/K-8014-2016	Veronesi, Elena/0000-0001-6262-1388; Bergamini, Valentina/0000-0002-9214-1462; resca, elisa/0000-0001-6405-7522; PETRACHI, TIZIANA/0000-0001-9399-9957	Emilia Romagna region, POR-FESR 2014-2020, Asse 1, Azione 1.2.2; project TECNO EN-P	Emilia Romagna region, POR-FESR 2014-2020, Asse 1, Azione 1.2.2; project TECNO EN-P	This work was funded by the Emilia Romagna region, POR-FESR 2014-2020, Asse 1, Azione 1.2.2, and project TECNO EN-P.	[Anonymous], 2010, 1099310 ISO; [Anonymous], 2009, 10993 ISO; Bortner CD, 2002, CELL DEATH DIFFER, V9, P1307, DOI 10.1038/sj.cdd.4401126; Camp ND, 2016, PHARMACOL RES, V105, P13, DOI 10.1016/j.phrs.2016.01.003; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fang Y, 2005, FEBS LETT, V579, P4175, DOI 10.1016/j.febslet.2005.06.050; Fang Y, 2006, ASSAY DRUG DEV TECHN, V4, P583, DOI 10.1089/adt.2006.4.583; Fang Y, 2006, BIOPHYS J, V91, P1925, DOI [10.1529/biophysj.105.077818, 10.1529/biophysj.105.007818]; Fang Y, 2014, COMB CHEM HIGH T SCR, V17, P566, DOI 10.2174/1386207317666140211100000; Fang Y, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00052; Fang Y, 2009, METHODS MOL BIOL, V552, P239, DOI 10.1007/978-1-60327-317-6_17; Hou T, 2016, PHARMACOL RES, V108, P39, DOI 10.1016/j.phrs.2016.04.018; International Organization for Standardization, 2007, 1099312ISO; Li WJ, 2015, BIOMED REP, V3, P617, DOI 10.3892/br.2015.481; Owens RM, 2009, J RECEPT SIG TRANSD, V29, P195, DOI 10.1080/10799890903079919; Pikis S, 2015, J CLIN NEUROSCI, V22, P139, DOI 10.1016/j.jocn.2014.06.006; Riss TL, 2011, METHODS MOL BIOL, V740, P103, DOI 10.1007/978-1-61779-108-6_12; Riss TL, 2004, CELL VIABILITY ASSAY; Rodriguez-Antona C, 2015, J INTERN MED, V277, P201, DOI 10.1111/joim.12321; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; van Tonder Alet, 2015, BMC Res Notes, V8, P47, DOI 10.1186/s13104-015-1000-8; Zanotti B, 2016, J CRANIOFAC SURG, V27, P2061, DOI 10.1097/SCS.0000000000003025; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng W, 2013, DRUG DISCOV TODAY, V18, P1067, DOI 10.1016/j.drudis.2013.07.001	24	3	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0201671	10.1371/journal.pone.0201671	http://dx.doi.org/10.1371/journal.pone.0201671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180158	gold, Green Published, Green Submitted			2022-12-26	WOS:000444222400003
J	Kim, H; Langohr, IM; Faisal, M; McNulty, M; Thorn, C; Kim, J				Kim, Hana; Langohr, Ingeborg M.; Faisal, Mohammad; McNulty, Margaret; Thorn, Caitlin; Kim, Joomyeong			Ablation of Ezh2 in neural crest cells leads to aberrant enteric nervous system development in mice	PLOS ONE			English	Article							HOX GENES; HIRSCHSPRUNG-DISEASE; STEM-CELLS; HISTONE METHYLTRANSFERASE; MOUSE MODEL; IN-VIVO; SOX10; DIFFERENTIATION; EXPRESSION; INTEGRITY	In the current study, we examined the role of Ezh2 as an epigenetic modifier for the enteric neural crest cell development through H3K27me3. Ezh2 conditional null mice were viable up to birth, but died within the first hour of life. In addition to craniofacial defects, Ezh2 conditional null mice displayed reduced number of ganglion cells in the enteric nervous system. RT-PCR and ChIP assays indicated aberrant up-regulation of Zic1, Pax3, and Sox10 and loss of H3K27me3 marks in the promoter regions of these genes in the myenteric plexus. Overall, these results suggest that Ezh2 is an important epigenetic modifier for the enteric neural crest cell development through repression of Zic1, Pax3, and Sox10.	[Kim, Hana; Faisal, Mohammad; Thorn, Caitlin; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Langohr, Ingeborg M.; McNulty, Margaret] Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu	Langohr, Ingeborg M/H-5570-2019	Langohr, Ingeborg M/0000-0001-7366-4391; McNulty, Margaret/0000-0001-6638-253X; Kim, Joomyeong/0000-0001-6577-5526	National Institute of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097074] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health [J.K. R01-GM066225, R01-GM097074].	Amiel J, 2001, J MED GENET, V38, P729, DOI 10.1136/jmg.38.11.729; Aranda S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500737; Aubin J, 1999, AM J PHYSL, V277; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Betancur P, 2010, ANNU REV CELL DEV BI, V26, P581, DOI 10.1146/annurev.cellbio.042308.113245; Beuchle D, 2001, DEVELOPMENT, V128, P993; Bhatt S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008326; Bondurand N, 2013, DEV BIOL, V382, P330, DOI 10.1016/j.ydbio.2013.04.024; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brooks AS, 1999, J MED GENET, V36, P485; Burns AJ, 2000, DEV BIOL, V219, P30, DOI 10.1006/dbio.1999.9592; Burns AJ, 1998, DEVELOPMENT, V125, P4335; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chan KK, 2005, DEV DYNAM, V233, P473, DOI 10.1002/dvdy.20347; Debbache J, 2018, GENESIS, V56, DOI 10.1002/dvg.23105; Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Fu M, 2003, DEV DYNAM, V228, P1, DOI 10.1002/dvdy.10350; Furness JB, 2004, CELL TISSUE RES, V317, P1, DOI 10.1007/s00441-004-0895-5; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Garcia-Barcelo MM, 2007, ANN HUM GENET, V71, P526, DOI 10.1111/j.1469-1809.2007.00347.x; Gershon MD, 1999, HOSP PRACT, V34, P31, DOI 10.3810/hp.1999.07.153; Grundmann D, 2016, SCI REPORT, V5, P9226; Hemming S, 2017, FASEB J, V31, P1011, DOI 10.1096/fj.201600748R; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Holland PWH, 1996, DEV BIOL, V173, P382, DOI 10.1006/dbio.1996.0034; Hong CS, 2007, MOL BIOL CELL, V18, P2192, DOI 10.1091/mbc.E06-11-1047; Huang ZP, 2010, ARTERIOSCL THROM VAS, V30, P2575, DOI 10.1161/ATVBAHA.110.213306; Jacques-Fricke BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047794; Kam MKM, 2014, CELL DEATH DIFFER, V21, P278, DOI 10.1038/cdd.2013.142; Kashyap V, 2011, J BIOL CHEM, V286, P3250, DOI 10.1074/jbc.M110.157545; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kim YJ, 2014, CELL STEM CELL, V15, P497, DOI 10.1016/j.stem.2014.07.013; Lewis AE, 2013, DEV BIOL, V379, P229, DOI 10.1016/j.ydbio.2013.04.026; Maconochie M, 1996, ANNU REV GENET, V30, P529, DOI 10.1146/annurev.genet.30.1.529; Mallo M, 2003, CURR TOP DEV BIOL, V57, P85, DOI 10.1016/S0070-2153(03)57003-X; Milet C, 2012, DEV BIOL, V366, P22, DOI 10.1016/j.ydbio.2012.01.013; Moore SW, 2005, PEDIATR SURG INT, V21, P255, DOI 10.1007/s00383-005-1383-z; Nagashimada M, 2012, J CLIN INVEST, V122, P3145, DOI 10.1172/JCI63401; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Rhodes LSS, 2006, GENE EXPR PATTERNS, V6, P539, DOI 10.1016/j.modgep.2005.10.006; Rothbart SB, 2015, MOL CELL, V59, P502, DOI 10.1016/j.molcel.2015.06.022; Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823; Schwarz D, 2014, DEVELOPMENT, V141, P867, DOI 10.1242/dev.094342; SERBEDZIJA GN, 1991, DEVELOPMENT, V111, P857; Sham MH, 2001, GUT, V49, P220, DOI 10.1136/gut.49.2.220; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Spazierer D, 2006, MOL CELL BIOL, V26, P559, DOI 10.1128/MCB.26.2.559-568.2006; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; TENNYSON VM, 1993, DEV DYNAM, V198, P28, DOI 10.1002/aja.1001980105; Wu ML, 2008, J CLIN INVEST, V118, P2076, DOI 10.1172/JCI33715; Zakin L, 2004, DEVELOPMENT, V131, P413, DOI 10.1242/dev.00946; Zemke M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0210-9; Zhang JM, 2015, DEV BIOL, V403, P128, DOI 10.1016/j.ydbio.2015.05.010	58	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203391	10.1371/journal.pone.0203391	http://dx.doi.org/10.1371/journal.pone.0203391			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169530	Green Published, gold, Green Submitted			2022-12-26	WOS:000443374400038
J	Lucke, K; Yan, I; Krohn, S; Volmari, A; Klinge, S; Schmid, J; Schumacher, V; Steinmetz, OM; Rose-John, S; Mittrucker, HW				Luecke, Karsten; Yan, Isabell; Krohn, Sonja; Volmari, Annika; Klinge, Stefanie; Schmid, Joanna; Schumacher, Valea; Steinmetz, Oliver M.; Rose-John, Stefan; Mittruecker, Hans-Willi			Control of Listeria monocytogenes infection requires classical IL-6 signaling in myeloid cells	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; REGULATORY T-CELLS; CYCLIC ADP-RIBOSE; IN-VIVO; INTERLEUKIN-6-DEFICIENT MICE; RECEPTOR; INFECTION; CD38; DIFFERENTIATION; INFLAMMATION	IL-6 is required for the response of mice against Listeria monocytogenes. Control of infection depends on classical IL-6 signaling via membrane IL-6R alpha, but IL-6 target cells and protective mechanisms remain unclear. We used mice with IL-6Ra-deficiency in T cells (Il6ra(fl/fl)xCD4(cre)) or myeloid cells (Il6ra(fl/fl)xLysM(cre)) to define the role of these cells in IL-6-mediated protection. Abrogation of IL-6R alpha in T cells did not interfere with bacteria control and induction of T(H)1 and CD8(+) T-cell responses. IL-6R alpha-deficiency in myeloid cells caused significant defects in listeria control. This defect was not associated with reduced recruitment of granulocytes and inflammatory monocytes, and both cell populations were activated and not impaired in cytokine production. However, IL-6R alpha-deficient inflammatory monocytes displayed diminished expression of IL-4R alpha and of CD38, a protein required for phagocytosis and innate control of listeria. In vitro studies revealed that IL-4 and IL-6 cooperated in induction of CD38. In listeria-infected mice, phagocytic activity of inflammatory monocytes correlated with CD38 expression levels on cells and inflammatory monocytes of Il6ra(fl/fl)xLysM(cre) mice were significantly impaired in phagocytosis. In conclusion, we demonstrate that inhibition of classical IL-6 signaling in myeloid cells causes alterations in differentiation and function of these cells, which subsequently prevent effective control of L. monocytogenes.	[Luecke, Karsten; Yan, Isabell; Klinge, Stefanie; Schmid, Joanna; Schumacher, Valea; Mittruecker, Hans-Willi] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany; [Krohn, Sonja; Steinmetz, Oliver M.] Univ Med Ctr Hamburg Eppendorf, Med Clin & Polyclin 3, Hamburg, Germany; [Volmari, Annika] Univ Med Ctr Hamburg Eppendorf, Med Clin & Polyclin 1, Hamburg, Germany; [Rose-John, Stefan] Univ Kiel, Inst Biochem, Med Fac, Kiel, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Kiel	Mittrucker, HW (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany.	h.mittruecker@uke.de		Mittrucker, Hans-Willi/0000-0001-6166-4191; Yan, Karsten/0000-0002-7343-2205	Deutsche Forschungsgemeinschaft (dfg.de) [SFB841]	Deutsche Forschungsgemeinschaft (dfg.de)	This work was supported by Deutsche Forschungsgemeinschaft (dfg.de), grant no.: SFB841, project A3, to HWM; Deutsche Forschungsgemeinschaft (dfg.de) grant no.: SFB841, project C1, to SRJ; Deutsche Forschungsgemeinschaft (dfg.de), grant: Cluster of Excellence 'Inflammation at Interfaces', to SRJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Bottcher JP, 2014, CELL REP, V8, P1318, DOI 10.1016/j.celrep.2014.07.008; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Carr KD, 2011, EUR J IMMUNOL, V41, P2666, DOI 10.1002/eji.201041363; Cervantes-Sandoval I, 2008, PARASITOL INT, V57, P307, DOI 10.1016/j.parint.2008.01.006; Choe CU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019046; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; DALRYMPLE SA, 1995, INFECT IMMUN, V63, P2262, DOI 10.1128/IAI.63.6.2262-2268.1995; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Estrada-Figueroa LA, 2011, PARASITE IMMUNOL, V33, P661, DOI 10.1111/j.1365-3024.2011.01333.x; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Gally F, 2009, AM J RESP CELL MOL, V40, P433, DOI 10.1165/rcmb.2007-0392OC; Guse AH, 2015, BBA-PROTEINS PROTEOM, V1854, P1132, DOI 10.1016/j.bbapap.2014.12.015; Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632; Hoge J, 2013, J IMMUNOL, V190, P703, DOI 10.4049/jimmunol.1201044; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kang J, 2012, J BIOL CHEM, V287, P14502, DOI 10.1074/jbc.M111.329003; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; La Flamme AC, 1999, J IMMUNOL, V162, P5829; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Lauder SN, 2013, EUR J IMMUNOL, V43, P2613, DOI 10.1002/eji.201243018; Lavigne MC, 2002, CELL IMMUNOL, V218, P7, DOI 10.1016/S0008-8749(02)00564-6; Lischke T, 2013, INFECT IMMUN, V81, P4091, DOI 10.1128/IAI.00340-13; Liu FL, 1997, BLOOD, V90, P2583, DOI 10.1182/blood.V90.7.2583.2583_2583_2590; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Longhi MP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000006; Luig M, 2015, J AM SOC NEPHROL, P1; MacLeod MKL, 2011, P NATL ACAD SCI USA, V108, P7914, DOI 10.1073/pnas.1104588108; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Nish SA, 2014, ELIFE, V3, DOI 10.7554/eLife.01949; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Oberg HH, 2006, INT IMMUNOL, V18, P555, DOI 10.1093/intimm/dxh396; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Partida-Sanchez S, 2004, J IMMUNOL, V172, P1896, DOI 10.4049/jimmunol.172.3.1896; Partida-Sanchez S, 2003, MICROBES INFECT, V5, P49, DOI 10.1016/S1286-4579(02)00055-2; Postigo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033534; Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137; Ramaswamy Vidhya, 2007, Journal of Microbiology Immunology and Infection, V40, P4; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Rincon M, 2012, TRENDS IMMUNOL, V33, P571, DOI 10.1016/j.it.2012.07.003; Romani L, 1996, J EXP MED, V183, P1345, DOI 10.1084/jem.183.4.1345; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schneider M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134016; SCHOBITZ B, 1995, FASEB J, V9, P659, DOI 10.1096/fasebj.9.8.7768358; Shi C, 2011, J IMMUNOL, V187, P5293, DOI 10.4049/jimmunol.1101721; Smith KA, 2014, EUR J IMMUNOL, V44, P150, DOI 10.1002/eji.201343746; Tanaka T, 2001, CYTOKINE, V13, P193, DOI 10.1006/cyto.2000.0828; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Viegas MS, 2011, RHEUMATOLOGY, V50, P1569, DOI 10.1093/rheumatology/ker178; Waetzig GH, 2012, EXPERT OPIN THER TAR, V16, P225, DOI 10.1517/14728222.2012.660307; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Yan I, 2016, J LEUKOCYTE BIOL, V99, P749, DOI 10.1189/jlb.3A0515-207R; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; YOSHIZAKI K, 1989, BLOOD, V74, P1360	61	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203395	10.1371/journal.pone.0203395	http://dx.doi.org/10.1371/journal.pone.0203395			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169526	Green Published, gold, Green Submitted			2022-12-26	WOS:000443374400039
J	Liang, SQ; Buhrer, ED; Berezowska, S; Marti, TM; Xu, D; Froment, L; Yang, HT; Hall, SRR; Vassella, E; Yang, Z; Kocher, GJ; Amrein, MA; Riether, C; Ochsenbein, AF; Schmid, RA; Peng, RW				Liang, Shun-Qing; Buhrer, Elias D.; Berezowska, Sabina; Marti, Thomas M.; Xu, Duo; Froment, Laurene; Yang, Haitang; Hall, Sean R. R.; Vassella, Erik; Yang, Zhang; Kocher, Gregor J.; Amrein, Michael A.; Riether, Carsten; Ochsenbein, Adrian F.; Schmid, Ralph A.; Peng, Ren-Wang			mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer	ONCOGENE			English	Article							ACQUIRED-RESISTANCE; MAMMALIAN TARGET; STEM-CELLS; PHASE-II; EVEROLIMUS; DRUG; PHOSPHORYLATION; PROGRESSION; NSCLC; EMT	Oncogenic KRAS mutations comprise the largest subset of lung cancer defined by genetic alterations, but in the clinic no targeted therapies are available that effectively control mutational KRAS activation. Consequently, patients with KRASdriven tumors are routinely treated with cytotoxic chemotherapy, which is often transiently effective owing to development of drug resistance. In this study, we show that hyperactivated mammalian target of rapamycin (mTOR) pathway is a characteristic hallmark of KRAS-mutant lung adenocarcinoma after chemotherapy treatment, and that KRAS-mutant lung cancer cells rely on persistent mTOR signaling to resist chemotherapeutic drugs. Coherently, mTOR inhibition circumvents the refractory phenotype and restores sensitivity of resistant KRAS-mutant lung cancer cells to chemotherapy. Importantly, drug combinations of clinically approved mTOR inhibitors and chemotherapy drugs synergize in inhibiting cell proliferation of KRAS-mutant cancer cells in vitro and in vivo, and the efficacy of this combination treatment correlates with the magnitude of mTOR activity induced by chemotherapy alone. These results pinpoint mTOR as a mechanism of resistance to chemotherapy in KRAS-mutant lung cancer and validate a rational and readily translatable strategy that combines mTOR inhibitors with standard chemotherapy to treat KRAS-mutant adenocarcinoma, the most common and deadliest lung cancer subset.	[Liang, Shun-Qing; Marti, Thomas M.; Xu, Duo; Froment, Laurene; Yang, Haitang; Hall, Sean R. R.; Yang, Zhang; Kocher, Gregor J.; Schmid, Ralph A.; Peng, Ren-Wang] Bern Univ Hosp, Inselspital, Div Gen Thorac Surg, Bern, Switzerland; [Liang, Shun-Qing; Marti, Thomas M.; Xu, Duo; Froment, Laurene; Yang, Haitang; Hall, Sean R. R.; Yang, Zhang; Kocher, Gregor J.; Schmid, Ralph A.; Peng, Ren-Wang] Univ Bern, Dept BioMed Res DBMR, Bern, Switzerland; [Buhrer, Elias D.; Amrein, Michael A.; Riether, Carsten; Ochsenbein, Adrian F.] Univ Bern, Dept BioMed Res DBMR, Tumor Immunol, Bern, Switzerland; [Berezowska, Sabina; Vassella, Erik] Univ Bern, Inst Pathol, Bern, Switzerland; [Xu, Duo; Yang, Haitang; Yang, Zhang] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Riether, Carsten; Ochsenbein, Adrian F.] Bern Univ Hosp, Inselspital, Dept Med Oncol, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern	Schmid, RA; Peng, RW (corresponding author), Bern Univ Hosp, Inselspital, Div Gen Thorac Surg, Bern, Switzerland.; Schmid, RA; Peng, RW (corresponding author), Univ Bern, Dept BioMed Res DBMR, Bern, Switzerland.	Ralph.Schmid@insel.ch; Renwang.Peng@insel.ch	Liang, Shunqing/AHE-6842-2022; Kocher, Gregor Jan/GQZ-1359-2022; Riether, Carsten/ABC-7699-2021; Liang, Shunqing/GXG-2346-2022; Berezowska, Sabina/AAJ-4557-2021; DUO, XU/AAC-8882-2021; Riether, Carsten/K-8603-2013; Marti, Thomas/AAW-5232-2020; Yang, Haitang/AAS-6986-2020; Yang, Haitang/N-5141-2019; Peng, Ren-Wang/AAM-8542-2021	Liang, Shunqing/0000-0003-4664-6029; Kocher, Gregor Jan/0000-0001-6531-2919; Riether, Carsten/0000-0001-7512-513X; Liang, Shunqing/0000-0003-4664-6029; Berezowska, Sabina/0000-0001-5442-9791; Riether, Carsten/0000-0001-7512-513X; Marti, Thomas/0000-0003-3005-220X; Yang, Haitang/0000-0002-8732-5910; Peng, Ren-Wang/0000-0003-1199-6520; Amrein, Michael Alex/0000-0002-0378-8070; Schmid, Ralph Alexander/0000-0003-0699-079X; Ochsenbein, Adrian/0000-0003-1773-5436; Yang, Zhang/0000-0001-8592-5800	Swiss Cancer League [KFS-3772-08-2015]; Cancer League of the Canton of Bern; China Scholarship Council	Swiss Cancer League; Cancer League of the Canton of Bern; China Scholarship Council(China Scholarship Council)	We gratefully acknowledge Lung Cancer Center (LCC), Bern University Hospital and the Tissue Bank Bern (TBB), Institute of Pathology, University of Bern, in acquiring patient tissues. We thank Silvia Suardi and Jose Galvan (Institute of Pathology) and Colin Tieche and Ming Qiao (Division of General Thoracic Surgery) for technical assistance and help with data acquisition and analysis, Dr. med. Michael von Gunten (Pathologie Langgasse, Bern, Switzerland) and Dr. med. Mathias Gugger (Promed SA Laboratoire medical, Freiburg, Switzerland) for providing pre-chemotherapy biopsies, professor Marianne Geiser (Institute of Anatomy, University of Bern, Bern, Switzerland) and Dr. Yitzhak Zimmer (Department of Radiation Oncology, Bern University Hospital, Bern, Switzerland) for cell lines. This work was supported by Swiss Cancer League (#KFS-3772-08-2015; to R.-W. Peng), Cancer League of the Canton of Bern (to R-W. Peng), a PhD fellowship from China Scholarship Council (to S.-Q. Liang) and a MD-PhD fellowship from Swiss Cancer League (to E.D. Buhrer).	Bartucci M, 2012, CELL DEATH DIFFER, V19, P768, DOI 10.1038/cdd.2011.170; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Coffee EM, 2013, CLIN CANCER RES, V19, P2688, DOI 10.1158/1078-0432.CCR-12-2556; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Corcoran RB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005753; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Elkabets M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005747; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Farge T, 2017, CANCER DISCOV, V7, P716, DOI 10.1158/2159-8290.CD-16-0441; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Goffin J, 2010, J THORAC ONCOL, V5, P260, DOI 10.1097/JTO.0b013e3181c6f035; Granville CA, 2007, CLIN CANCER RES, V13, P2281, DOI 10.1158/1078-0432.CCR-06-2570; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hegde GV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045647; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Kahan BD, 2000, LANCET, V356, P194, DOI 10.1016/S0140-6736(00)02480-6; Kawabata S, 2014, CELL REP, V7, P1824, DOI 10.1016/j.celrep.2014.05.039; Kawabata S, 2014, ONCOTARGET, V5, P1062, DOI 10.18632/oncotarget.1760; Kharbanda A, 2014, ONCOTARGET, V5, P8893, DOI 10.18632/oncotarget.2360; Langsch S, 2016, CANCER RES, V76, P4160, DOI 10.1158/0008-5472.CAN-15-2580; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Liang SQ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.195; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manchado E, 2016, NATURE, V534, P647, DOI 10.1038/nature18600; Papadimitrakopoulou VA, 2012, J THORAC ONCOL, V7, P1594, DOI 10.1097/JTO.0b013e3182614835; Pirazzoli V, 2014, CELL REP, V7, P999, DOI 10.1016/j.celrep.2014.04.014; Price KA, 2010, J THORAC ONCOL, V5, P1623, DOI 10.1097/JTO.0b013e3181ec1531; Ramalingam SS, 2013, J THORAC ONCOL, V8, P369, DOI 10.1097/JTO.0b013e318282709c; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Thoma CR, 2014, ADV DRUG DELIVER REV, V69, P29, DOI 10.1016/j.addr.2014.03.001; Vansteenkiste J, 2011, J THORAC ONCOL, V6, P2120, DOI 10.1097/JTO.0b013e3182307ede; Vasan N, 2014, CLIN CANCER RES, V20, P3921, DOI 10.1158/1078-0432.CCR-13-1762; Xia YF, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010382; Yoshizawa A, 2010, CLIN CANCER RES, V16, P240, DOI 10.1158/1078-0432.CCR-09-0986; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zheng YY, 2013, CANCER CELL, V24, P59, DOI 10.1016/j.ccr.2013.05.021	46	28	28	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 31	2019	38	5					622	636		10.1038/s41388-018-0479-6	http://dx.doi.org/10.1038/s41388-018-0479-6			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HJ6LI	30171261				2022-12-26	WOS:000457300300002
J	Checco, JW; Zhang, G; Yuan, WD; Le, ZW; Jing, J; Sweedler, JV				Checco, James W.; Zhang, Guo; Yuan, Wang-ding; Le, Zi-wei; Jing, Jian; Sweedler, Jonathan V.			Aplysia allatotropin-related peptide and its newly identified d-amino acid-containing epimer both activate a receptor and a neuronal target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						post-translational modification (PTM); neuropeptide; peptide hormone; cell signaling; G protein-coupled receptor (GPCR); mass spectrometry (MS); allatotropin; d-amino acid-containing peptides; isomerization	CRUSTACEAN HYPERGLYCEMIC HORMONE; AMINOPEPTIDASE-LIKE ACTIVITY; BAG CELL PEPTIDE; CONTAINING NEUROPEPTIDE; 7-TRANSMEMBRANE RECEPTORS; EXCITATORY PEPTIDE; MOLECULAR-CLONING; MANDUCA-SEXTA; ISOMERIZATION; CALIFORNICA	l- to d-residue isomerization is a post-translational modification (PTM) present in neuropeptides, peptide hormones, and peptide toxins from several animals. In most cases, the d-residue is critical for the biological function of the resulting d-amino acid-containing peptide (DAACP). Here, we provide an example in native neuropeptides in which the DAACP and its all-l-amino acid epimer are both active at their newly identified receptor in vitro and at a neuronal target associated with feeding behavior. On the basis of sequence similarity to a known DAACP from cone snail venom, we hypothesized that allatotropin-related peptide (ATRP), a neuropeptide from the neuroscience model organism Aplysia californica, may form multiple diastereomers in the Aplysia central nervous system. We determined that ATRP exists as a d-amino acid-containing peptide (d2-ATRP) and identified a specific G protein-coupled receptor as an ATRP receptor. Interestingly, unlike many previously reported DAACPs and their all-l-residue analogs, both l-ATRP and d2-ATRP were potent agonists of this receptor and active in electrophysiological experiments. Finally, d2-ATRP was much more stable than its all-l-residue counterpart in Aplysia plasma, suggesting that in the case of ATRP, the primary role of the l- to d-residue isomerization may be to protect this peptide from aminopeptidase activity in the extracellular space. Our results indicate that l- to d-residue isomerization can occur even in an all-l-residue peptide with a known biological activity and that in some cases, this PTM may help modulate peptide signal lifetime in the extracellular space rather than activity at the cognate receptor.	[Checco, James W.; Sweedler, Jonathan V.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Zhang, Guo; Yuan, Wang-ding; Le, Zi-wei; Jing, Jian] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Inst Brain Sci,Adv Inst Life Sci,Sch Life Sci, Collaborat Innovat Ctr Chem Life Sci,Jiangsu Engn, Nanjing 210046, Jiangsu, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Nanjing University	Sweedler, JV (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.; Jing, J (corresponding author), Nanjing Univ, Sch Life Sci, Nanjing 210046, Jiangsu, Peoples R China.	jingj01@live.com; jsweedle@illinois.edu	Sweedler, Jonathan V/A-9405-2009; Checco, James W./AAY-3374-2020	Sweedler, Jonathan V/0000-0003-3107-9922; Checco, James W./0000-0003-1165-6163; Zhang, Guo/0000-0002-6828-5968; Jing, Jian/0000-0003-1422-143X	National Institutes of Health from the National Institute on Drug Abuse [P30 DA018310]; National Institutes of Health from the NINDS [R01 NS031609]; National Resource for Aplysia - Public Health Service [P40 OD010952]; National Natural Science Foundation of China [31671097, 31371104, J1103512, J1210026]; Beckman Institute Postdoctoral Fellowship - Beckman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010952] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute on Drug Abuse; National Institutes of Health from the NINDS; National Resource for Aplysia - Public Health Service; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beckman Institute Postdoctoral Fellowship - Beckman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant P30 DA018310 from the National Institute on Drug Abuse and National Institutes of Health Grant R01 NS031609 from the NINDS (to J. V. S.); by the National Resource for Aplysia, funded by Public Health Service Grant P40 OD010952; and by National Natural Science Foundation of China Grants 31671097 and 31371104 (to J. J.), J1103512, and J1210026 (to the School of Life Sciences). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by a Beckman Institute Postdoctoral Fellowship, funded by a Beckman Foundation gift to the Beckman Institute for Advanced Science and Technology at the University of Illinois at Urbana-Champaign.	Bai L, 2013, J BIOL CHEM, V288, P32837, DOI 10.1074/jbc.M113.486670; Bauknecht P, 2015, CELL REP, V12, P684, DOI 10.1016/j.celrep.2015.06.052; BAWAB W, 1992, BIOCHEM J, V286, P967, DOI 10.1042/bj2860967; BRANTON WD, 1978, NATURE, V274, P70, DOI 10.1038/274070a0; Broichhagen J, 2015, ANGEW CHEM INT EDIT, V54, P15565, DOI 10.1002/anie.201506384; Buczek O, 2005, J BIOL CHEM, V280, P4247, DOI 10.1074/jbc.M405835200; Checco JW, 2018, ACS CHEM BIOL, V13, P1343, DOI 10.1021/acschembio.8b00167; Donnelly D, 2012, BRIT J PHARMACOL, V166, P27, DOI 10.1111/j.1476-5381.2011.01687.x; Dutertre S, 2006, FEBS LETT, V580, P3860, DOI 10.1016/j.febslet.2006.06.011; Dutertre S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4521; Elekonich MM, 2003, PEPTIDES, V24, P1623, DOI 10.1016/j.peptides.2003.08.011; ERSPAMER V, 1989, P NATL ACAD SCI USA, V86, P5188, DOI 10.1073/pnas.86.13.5188; Alzugaray ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077520; Ewing MA, 2008, ANAL CHEM, V80, P2874, DOI 10.1021/ac7025173; Fricker LD, 2018, PHARMACOL THERAPEUT, V185, P26, DOI 10.1016/j.pharmthera.2017.11.006; HECK SD, 1994, SCIENCE, V266, P1065, DOI 10.1126/science.7973665; HURWITZ I, 1994, J NEUROPHYSIOL, V71, P1514, DOI 10.1152/jn.1994.71.4.1514; Iwakoshi E, 2000, PEPTIDES, V21, P623, DOI 10.1016/S0196-9781(00)00201-1; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Jia CX, 2014, ANAL CHEM, V86, P2972, DOI 10.1021/ac4033824; Jing JA, 2010, J NEUROSCI, V30, P16545, DOI 10.1523/JNEUROSCI.4264-10.2010; KAMATANI Y, 1989, BIOCHEM BIOPH RES CO, V160, P1015, DOI 10.1016/S0006-291X(89)80103-2; KATAOKA H, 1989, SCIENCE, V243, P1481, DOI 10.1126/science.243.4897.1481; Kohlbacher O, 2007, BIOINFORMATICS, V23, pE191, DOI 10.1093/bioinformatics/btl299; Livnat I, 2016, ANAL CHEM, V88, P11868, DOI 10.1021/acs.analchem.6b03658; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; MILLER SM, 1995, DRUG DEVELOP RES, V35, P20, DOI 10.1002/ddr.430350105; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; Morishita F, 1997, BIOCHEM BIOPH RES CO, V240, P354, DOI 10.1006/bbrc.1997.7659; Morishita F, 2012, PEPTIDES, V38, P291, DOI 10.1016/j.peptides.2012.08.025; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; Ollivaux C, 2009, FEBS J, V276, P4790, DOI 10.1111/j.1742-4658.2009.07180.x; Pisarewicz K, 2005, J AM CHEM SOC, V127, P6207, DOI 10.1021/ja050088m; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; RICHTER K, 1987, SCIENCE, V238, P200, DOI 10.1126/science.3659910; Robinson SD, 2017, GEN COMP ENDOCR, V244, P11, DOI 10.1016/j.ygcen.2015.07.012; ROTHMAN BS, 1992, J BIOL CHEM, V267, P25135; Santini MS, 2007, J EXP BIOL, V210, P1986, DOI 10.1242/jeb.004291; Serrano L, 2003, J EXP BIOL, V206, P979, DOI 10.1242/jeb.00178; Sheeley SA, 2005, ANALYST, V130, P1198, DOI 10.1039/b504717j; Shigeto M, 2008, J PHARMACOL SCI, V108, P274, DOI 10.1254/jphs.08090FP; Soyez D, 2000, J BIOL CHEM, V275, P37870, DOI 10.1074/jbc.M007302200; SOYEZ D, 1994, J BIOL CHEM, V269, P18295; SQUIRE CR, 1991, J BIOL CHEM, V266, P22355; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Tao YQ, 2014, ANAL CHEM, V86, P9733, DOI 10.1021/ac502296c; Tao YQ, 2012, ANAL CHEM, V84, P6814, DOI 10.1021/ac3013434; Torres AM, 2002, FEBS LETT, V524, P172, DOI 10.1016/S0014-5793(02)03050-8; Trinquet E, 2006, ANAL BIOCHEM, V358, P126, DOI 10.1016/j.ab.2006.08.002; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; VEENSTRA JA, 1994, J EXP BIOL, V188, P347; Verlinden H, 2015, J INSECT PHYSIOL, V80, P2, DOI 10.1016/j.jinsphys.2015.04.004; Wickham L, 1999, COMP BIOCHEM PHYS B, V124, P429, DOI 10.1016/S0305-0491(99)00136-4; Wisner A, 2006, P NATL ACAD SCI USA, V103, P17979, DOI 10.1073/pnas.0605865103; Wood DE, 2002, J NEUROSCI, V22, P4185, DOI 10.1523/JNEUROSCI.22-10-04185.2002; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; YASUDA A, 1994, GEN COMP ENDOCR, V95, P387, DOI 10.1006/gcen.1994.1138; Zappulla JP, 1999, J NEUROSCI, V19, P4280	60	18	18	4	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16862	16873		10.1074/jbc.RA118.004367	http://dx.doi.org/10.1074/jbc.RA118.004367			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30194283	Green Published, hybrid			2022-12-26	WOS:000448515100026
J	Allyn, J; Ferdynus, C; Lo Pinto, H; Bouchet, B; Persichini, R; Vandroux, D; Puech, B; Allou, N				Allyn, Jerome; Ferdynus, Cyril; Lo Pinto, Hugo; Bouchet, Bruno; Persichini, Romain; Vandroux, David; Puech, Berenice; Allou, Nicolas			Complication patterns in patients undergoing venoarterial extracorporeal membrane oxygenation in intensive care unit: Multiple correspondence analysis and hierarchical ascendant classification	PLOS ONE			English	Article							CARDIOGENIC-SHOCK; EPIDEMIOLOGY; INFECTIONS; INJURY; RISK	Background Treatment by venoarterial extracorporeal membrane oxygenation (VA-ECMO) is widely used today, even though it is associated with high risks of complications and death. While studies have focused on the relationship between some of these complications and the risk of death, the relationship between different complications has never been specifically examined, despite the fact that the occurrence of one complication is known to favor the occurrence of others. Our objective was to describe the relationship between complications in patients undergoing VA-ECMO in intensive care unit (ICU) and to identify, if possible, patterns of patients according to complications. Methods and findings As part of a retrospective cohort study, we conducted a multiple correspondence analysis followed by a hierarchical ascendant classification in order to identify patterns of patients according to main complications (sepsis, thromboembolic event, major transfusion, major bleeding, renal replacement therapy) and in-ICU death. Our cohort of 145 patients presented an in-ICU mortality rate of 50.3%. Morbidity was high, with 36.5% of patients presenting three or more of the five complications studied. Multiple correspondence analysis revealed a cumulative inertia of 76.9% for the first three dimensions. Complications were clustered together and clustered close to death, prompting the identification of four patterns of patients according to complications, including one with no complications. Conclusions Our study, based on a large cohort of patients undergoing VA-ECMO in ICU and presenting a mortality rate comparable to that reported in the literature, identified numerous and often interrelated complications. Multiple correspondence analysis and hierarchical ascendant classification yielded clusters of patients and highlighted specific links between some of the complications studied. Further research should be conducted in this area.	[Allyn, Jerome; Lo Pinto, Hugo; Bouchet, Bruno; Persichini, Romain; Vandroux, David; Puech, Berenice; Allou, Nicolas] Ctr Hosp Univ La Reunion Site Felix Guyon, Reanimat Polyvalente, St Denis, Reunion, France; [Allyn, Jerome; Allou, Nicolas] Ctr Hosp Univ La Reunion Site Felix Guyon, Dept Informat Clin, St Denis, Reunion, France; [Ferdynus, Cyril] Ctr Hosp Univ La Reunion, Unite Soutien Methodol, St Denis, Reunion, France; [Ferdynus, Cyril] INSERM, CIC 1410, St Pierre, France	CHU Reunion; CHU Reunion; CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm)	Allyn, J (corresponding author), Ctr Hosp Univ La Reunion Site Felix Guyon, Reanimat Polyvalente, St Denis, Reunion, France.; Allyn, J (corresponding author), Ctr Hosp Univ La Reunion Site Felix Guyon, Dept Informat Clin, St Denis, Reunion, France.	allyn.jer@gmail.com	Vandroux, David/AAK-2574-2020; ferdynus, cyril/AFV-1963-2022	ferdynus, cyril/0000-0003-1502-0672; Allyn, Jerome/0000-0001-8057-0393				Abrams D, 2017, CHEST, V152, P639, DOI 10.1016/j.chest.2017.06.016; Allou N, 2019, ASAIO J, V65, P180, DOI 10.1097/MAT.0000000000000771; Aubron C, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0196-7; Biffi S, 2017, INT J ANTIMICROB AG, V50, P9, DOI 10.1016/j.ijantimicag.2017.02.025; Cannon JW, 2018, NEW ENGL J MED, V378, P370, DOI 10.1056/NEJMra1705649; Carson JL, 2017, NEW ENGL J MED, V377, P1261, DOI 10.1056/NEJMra1612789; De las Cuevas C, 2016, PATIENT PREFER ADHER, V10, P2351, DOI [10.2147/PPA.S122377, 10.2147/PPA.S107299]; Eloy O, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-162; Extracorporeal Life Support Organization, 2014, ELSO ANT GUID, P17; Garcia-Olmos L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032141; Greenacre M, 1992, Stat Methods Med Res, V1, P97, DOI 10.1177/096228029200100106; Han L, 2018, RHEUM DIS CLIN N AM, V44, P349, DOI 10.1016/j.rdc.2018.01.013; Hill GE, 2003, J TRAUMA, V54, P908, DOI 10.1097/01.TA.0000022460.21283.53; Klinzing S, 2017, ANESTH ANALG, V125, P1544, DOI 10.1213/ANE.0000000000002431; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lo Pinto H, 2018, INT J ARTIF ORGANS; Luyt CE, 2016, INTENS CARE MED, V42, P897, DOI 10.1007/s00134-016-4318-3; Schmidt M, 2012, CLIN INFECT DIS, V55, P1633, DOI 10.1093/cid/cis783; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sy E, 2017, J CRIT CARE, V39, P87, DOI 10.1016/j.jcrc.2017.02.014; Trudzinski FC, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0172-2; Vaquer S, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0275-4; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Xie A, 2015, J CARDIOTHOR VASC AN, V29, P637, DOI 10.1053/j.jvca.2014.09.005	24	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203643	10.1371/journal.pone.0203643	http://dx.doi.org/10.1371/journal.pone.0203643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204777	Green Submitted, gold, Green Published			2022-12-26	WOS:000444355500035
J	Lee, CH; Hung, SP; Hong, JH; Chang, JTC; Tsang, NM; Chan, KM; Tseng, JH; Huang, SC; Lin, SM; Lien, JM; Liu, NJ; Lin, CC; Chen, WT; Chen, WY; Chen, PJ; Huang, BS				Lee, Ching-Hsin; Hung, Sheng-Ping; Hong, Ji-Hong; Chang, Joseph Tung-Chieh; Tsang, Ngan-Ming; Chan, Kun-Ming; Tseng, Jeng-Hwei; Huang, Shih-Chiang; Lin, Shi-Ming; Lien, Jau-Min; Liu, Nai-Jen; Lin, Chen-Chun; Chen, Wei-Ting; Chen, Wan-Yu; Chen, Po-Jui; Huang, Bing-Shen			How small is TOO small? New liver constraint is needed- Proton therapy of hepatocellular carcinoma patients with small normal liver	PLOS ONE			English	Article							BODY RADIATION-THERAPY; NORMAL ORGAN WEIGHTS; II-THE-BRAIN; TRANSARTERIAL CHEMOEMBOLIZATION; SURFACE-AREA; BEAM THERAPY; RISK-FACTORS; VOLUME; RADIOTHERAPY; REGENERATION	Purpose This study evaluated the outcomes of hepatocellular carcinoma (HCC) patients with small normal liver volume (NLV) treated with proton beam therapy (PBT) and introduced estimated standard liver volume (eSLV) as a new constraint. Materials and methods HCC patients with NLV < 800 cm(3) and no distant metastasis who received treatment in our proton center were included. The doses of PBT were mainly 72.6 Gray equivalents (GyE) in 22 fractions and 66 GyE in 10 fractions according to tumor locations. The Urata equation was used to calculate eSLV. Results Twenty-two patients were treated between November 2015 and December 2016. The 1-year progression-free and overall survival rates were 40.4% and 81.8%, respectively. The 1-year in-field failure-free rate was 95.5%. NLV ranged from 483.9 to 795.8 cm(3) (median = 673.8 cm(3)), eSLV ranged from 889.3 to 1290.0 cm(3) (median = 1104.5 cm(3)), and the resulting NLV/eSLV ratio ranged from 44.3 to 81.2% (median = 57.7%). Non-irradiated liver volume (NILV) ranged from 232.9 to 531.6 cm(3) (median = 391.2 cm(3)). The NILV/eSLV ratio ranged from 21.2 to 48.0% (median = 33.3%). NLV in the patients who received <30 GyE (rV30) ranged from 319.1 to 633.3 cm(3) (median = 488.2 cm(3)), and their rV30/eSLV ratio ranged from 30.7 to 58.0%. None of our patients developed liver failure. One patient with initial abnormal liver enzyme levels developed non-classic radiation-induced liver disease (RILD). Conclusion From the viewpoint of minimal liver toxicity occurring in our patients with NLV < 800 cm(3), conventional liver constraints involving the use of absolute volume could not accurately predict the risk of RILD. It is reasonable to start using individualized constraints with eSLV for HCC patients undergoing PBT. According to the study results, an NILV/eSLV ratio of >20% and an rV30/eSLV ratio of >30% are acceptable.	[Lee, Ching-Hsin; Hung, Sheng-Ping; Hong, Ji-Hong; Chang, Joseph Tung-Chieh; Tsang, Ngan-Ming; Chen, Po-Jui; Huang, Bing-Shen] Linkou Chang Gung Mem Hosp & Univ, Dept Radiat Oncol, Proton & Radiat Therapy Ctr, Taoyuan, Taiwan; [Chan, Kun-Ming] Linkou Chang Gung Mem Hosp & Univ, Dept Gen Surg, Taoyuan, Taiwan; [Tseng, Jeng-Hwei] Linkou Chang Gung Mem Hosp & Univ, Dept Radiol, Taoyuan, Taiwan; [Huang, Shih-Chiang] Linkou Chang Gung Mem Hosp & Univ, Dept Anat Pathol, Taoyuan, Taiwan; [Lin, Shi-Ming; Lien, Jau-Min; Liu, Nai-Jen; Lin, Chen-Chun; Chen, Wei-Ting] Linkou Chang Gung Mem Hosp & Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Taoyuan, Taiwan; [Chen, Wan-Yu] Natl Taiwan Univ Hosp, Div Radiat Oncol, Dept Oncol, Taipei, Taiwan; [Chen, Wan-Yu] Natl Taiwan Univ, Canc Res Ctr, Coll Med, Taipei, Taiwan; [Chen, Wan-Yu] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Huang, Bing-Shen] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Chang Gung University	Huang, BS (corresponding author), Linkou Chang Gung Mem Hosp & Univ, Dept Radiat Oncol, Proton & Radiat Therapy Ctr, Taoyuan, Taiwan.; Huang, BS (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan.	beanson@cgmh.org.tw		Huang, Shih-Chiang/0000-0002-5092-4434	Chang Gung Memorial Hospital [CIRPG3D0143, CMRPG3H0471, CIRPD1D0071, CIRPD1D0072, CIRPD1D0073]; Chang Gung University [CIRPG3D0143, CMRPG3H0471, CIRPD1D0071, CIRPD1D0072, CIRPD1D0073]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Chang Gung University	This study is supported by the grant CIRPG3D0143, CMRPG3H0471, CIRPD1D0071, CIRPD1D0072, and CIRPD1D0073 from Chang Gung Memorial Hospital and Chang Gung University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported by the grant CIRPG3D0143, CMRPG3H0471, CIRPD1D0071, CIRP D1D0072, and CIRPD1D0073 from Chang Gung Memorial Hospital and Chang Gung University. This manuscript was edited by Wallace Academic Editing.	[Anonymous], 2014, MIN HLTH WELF ANN RE, P38; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bush DA, 2016, INT J RADIAT ONCOL, V95, P477, DOI 10.1016/j.ijrobp.2016.02.027; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Cheng JCH, 2001, INT J CANCER, V96, P243, DOI 10.1002/ijc.1022; DELAND FH, 1968, RADIOLOGY, V91, P1195, DOI 10.1148/91.6.1195; Du Bois D, 1989, Nutrition, V5, P303; FENG MUS, 2016, J CLIN ONCOL S, V34; Haga J, 2008, LIVER TRANSPLANT, V14, P1718, DOI 10.1002/lt.21622; Kaneko K, 2005, WORLD J GASTROENTERO, V11, DOI 10.3748/wjg.v11.i37.5888; Kanemoto A, 2013, ACTA ONCOL, V52, P538, DOI 10.3109/0284186X.2012.718094; Kawashima M, 2005, J CLIN ONCOL, V23, P1839, DOI 10.1200/JCO.2005.00.620; Kim J, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.85; Kim TH, INT J RAD ONCOLOGY B; Lee NH, 1998, BRIT J SURG, V85, P1654; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Liang P, 2016, ONCOTARGETS THER, V9, P7169, DOI 10.2147/OTT.S112290; Liang SX, 2006, INT J RADIAT ONCOL, V65, P426, DOI 10.1016/j.ijrobp.2005.12.031; Liang SX, 2011, RADIOTHER ONCOL, V98, P265, DOI 10.1016/j.radonc.2010.10.014; Liu PH, 2014, ANN SURG ONCOL, V21, P1825, DOI 10.1245/s10434-014-3510-3; Livraghi T, 2000, RADIOLOGY, V214, P761, DOI 10.1148/radiology.214.3.r00mr02761; Lo CM, 1999, TRANSPLANTATION, V68, P1112, DOI 10.1097/00007890-199910270-00009; Maithel SK, 2011, J AM COLL SURGEONS, V212, P638, DOI 10.1016/j.jamcollsurg.2011.01.004; Asencio JM, 2014, J HEPATO-BIL-PAN SCI, V21, P399, DOI 10.1002/jhbp.97; Mizumoto M, 2012, INT J RADIAT ONCOL, V82, pE529, DOI 10.1016/j.ijrobp.2011.05.056; Molina DK, 2015, AM J FOREN MED PATH, V36, P182, DOI 10.1097/PAF.0000000000000175; Molina DK, 2012, AM J FOREN MED PATH, V33, P368, DOI 10.1097/PAF.0b013e31823d29ad; Network NCC, 2018, NCCN CLIN PRACT GUID; Pan CC, 2010, INT J RADIAT ONCOL, V76, pS94, DOI 10.1016/j.ijrobp.2009.06.092; Schefter TE, 2005, INT J RADIAT ONCOL, V62, P1371, DOI 10.1016/j.ijrobp.2005.01.002; Schindl MJ, 2005, GUT, V54, P289, DOI 10.1136/gut.2004.046524; Son SH, 2010, INT J RAD ONCOLOGY B, V78; Sugahara S, 2010, INT J RADIAT ONCOL, V76, P460, DOI 10.1016/j.ijrobp.2009.02.030; Takamatsu S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167155; Tanaka K, 1998, CANCER, V82, P78, DOI 10.1002/(SICI)1097-0142(19980101)82:1<78::AID-CNCR9>3.0.CO;2-G; Toramatsu C, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-48; Um Eun Hae, 2015, Korean J Hepatobiliary Pancreat Surg, V19, P133, DOI 10.14701/kjhbps.2015.19.4.133; URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5; Vauthey JN, 2002, LIVER TRANSPLANT, V8, P233, DOI 10.1053/jlts.2002.31654; Yuan D, 2008, TRANSPL P, V40, P3536, DOI 10.1016/j.transproceed.2008.07.135; Zakareya T, 2017, J LIVER DIS TRANSPLA, V6; Zappa M, 2009, RADIOLOGY, V252, P426, DOI [10.1148/radiol.2523080922, 10.1148/radiol.2522080922]	42	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203854	10.1371/journal.pone.0203854	http://dx.doi.org/10.1371/journal.pone.0203854			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204800	Green Submitted, gold, Green Published			2022-12-26	WOS:000444355500052
J	Han, X; Yin, BL; Lin, SL; Wang, Q; Su, N; Zhang, CL				Han, Xiao; Yin, Baoli; Lin, Shengli; Wang, Qian; Su, Ni; Zhang, Cuilian			Increased maternal hCG concentrations in early in vitro pregnancy with elevated basal FSH	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; DIMINISHED OVARIAN RESERVE; BODY-MASS INDEX; WOMEN; EMBRYO; NUMBER; CELLS; GENE	Objective To investigate factors that influence maternal hCG concentration in early pregnancy and the relationship between hCG concentration in early pregnancy and basal FSH (bFSH) level. Design Retrospective cohort study. Setting Reproductive medical center. Patient(s) In total, 482 women aged 22 to 38 years with elevated basal FSH (> 10 IU/L) and who experienced a single live birth after in vitro fertilization-embryo transfer were selected. These 482 women were age-matched with an equal number of women with normal basal FSH (<= 10 IU/L) who also experienced a single live birth. Intervention(s) None. Main Outcome Measure(s) HCG concentration. Result(s) The hCG concentrations on Day 14 and Day 21 were 560.46 (363.63-842.52) IU/L and 9862.00 (6512.25-14029.50) IU/L, respectively, in the elevated bFSH group, and these values were significantly increased compared with the normal bFSH group. After adjusting for confounding factors, the concentrations of maternal hCG on Day 14 and Day 21 were significantly associated with basal FSH. In addition, crude linear regression analysis demonstrated that hCG concentrations increased as the basal serum levels of FSH increased. Conclusion(s) Elevated basal FSH has implications for the interpretation of hCG concentrations in early pregnancy after in vitro fertilization-embryo transfer (IVF-ET) that led to a single live birth.	[Han, Xiao; Yin, Baoli; Wang, Qian; Su, Ni; Zhang, Cuilian] Zhengzhou Univ, Reprod Med Ctr, Peoples Hosp, Zhengzhou, Henan, Peoples R China; [Han, Xiao] Zhengzhou Univ, Acad Med Sci, Zhengzhou, Henan, Peoples R China; [Lin, Shengli] Peking Univ, Reprod Med Ctr, Dept Obstet & Gynecol, Hosp 3, Beijing, Peoples R China	Zhengzhou University; Zhengzhou University; Peking University	Zhang, CL (corresponding author), Zhengzhou Univ, Reprod Med Ctr, Peoples Hosp, Zhengzhou, Henan, Peoples R China.	luckyzcl@qq.com						Asvold BO, 2014, HUM REPROD, V29, P1153, DOI 10.1093/humrep/deu068; Coticchio G, 2015, HUM REPROD UPDATE, V21, P427, DOI 10.1093/humupd/dmv011; Detti L, 2007, FERTIL STERIL, V88, P152, DOI 10.1016/j.fertnstert.2006.11.124; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; Esh-Broder E, 2015, J ASSIST REPROD GEN, V32, P1491, DOI 10.1007/s10815-015-0550-y; Eskild A, 2012, FERTIL STERIL, V98, P905, DOI 10.1016/j.fertnstert.2012.06.011; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Jahromi BN, 2017, IRAN J MED SCI, V42, P73; Kim Jee Hyun, 2012, Clin Exp Reprod Med, V39, P28, DOI 10.5653/cerm.2012.39.1.28; Laptenko O, 2017, GENE DEV, V31, P955, DOI 10.1101/gad.302364.117; Lin SL, 2017, ONCOTARGET, V8, P14570, DOI 10.18632/oncotarget.14679; Lin SL, 2014, FERTIL STERIL, V102, P1729, DOI 10.1016/j.fertnstert.2014.09.008; Lin SL, 2013, HUM REPROD, V28, P1762, DOI 10.1093/humrep/det095; Oron G, 2015, FERTIL STERIL, V103, P1526, DOI 10.1016/j.fertnstert.2015.02.028; Pacella L, 2012, FERTIL STERIL, V98, P986, DOI 10.1016/j.fertnstert.2012.06.025; Schufreider A, 2015, HUM REPROD, V30, P2686, DOI 10.1093/humrep/dev220; Singh Neeta, 2013, J Hum Reprod Sci, V6, P213, DOI 10.4103/0974-1208.121425; Sohr S, 2011, CELL CYCLE, V10, P3758, DOI 10.4161/cc.10.21.17946; Sung N, 2016, J ASSIST REPROD GEN, V33, P1185, DOI 10.1007/s10815-016-0744-y; Tanbo TG, 2015, HUM REPROD, V30, P2758, DOI 10.1093/humrep/dev269; Zimmermann G, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092429	22	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2018	13	9							e0203610	10.1371/journal.pone.0203610	http://dx.doi.org/10.1371/journal.pone.0203610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7DK	30199550	gold, Green Published, Green Submitted			2022-12-26	WOS:000444681100018
J	Bonczek, O; Bielik, P; Krejci, P; Zeman, T; Izakovicova-Holla, L; Soukalova, J; Vanek, J; Gerguri, T; Balcar, VJ; Sery, O				Bonczek, Ondrej; Bielik, Peter; Krejci, Premysl; Zeman, Tomas; Izakovicova-Holla, Lydie; Soukalova, Jana; Vanek, Jiri; Gerguri, Tereza; Balcar, Vladimir J.; Sery, Omar			Next generation sequencing reveals a novel nonsense mutation in MSX1 gene related to oligodontia	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT OLIGODONTIA; INTEGRATIVE GENOMICS VIEWER; SELECTIVE TOOTH AGENESIS; MISSENSE MUTATION; DENTAL ANOMALIES; WITKOP-SYNDROME; CHINESE FAMILY; CLEFT-LIP; PAX9 GENE; HYPODONTIA	Tooth agenesis is one of the most common craniofacial disorders in humans. More than 350 genes have been associated with teeth development. In this study, we enrolled 60 child patients (age 13 to 17) with various types of tooth agenesis. Whole gene sequences of PAX9, MSX1, AXIN2, EDA, EDAR and WNT10a genes were sequenced by next generation sequencing on the Illumina MiSeq platform. We found previously undescribed heterozygous nonsense mutation g.8177G>T (c.610G>T) in MSX1 gene in one child. Mutation was verified by Sanger sequencing. Sequencing analysis was performed in other family members of the affected child. All family members carrying g.8177G>T mutation suffered from oligodontia (missing more than 6 teeth excluding third molars). Mutation g.8177G>T leads to a stop codon (p.E204X) and premature termination of Msx1 protein translation. Based on previous in vitro experiments on mutation disrupting function of Msx1 homeodomain, we assume that the heterozygous g. 8177G>T nonsense mutation affects the amount and function of Msx1 protein and leads to tooth agenesis.	[Bonczek, Ondrej; Bielik, Peter; Zeman, Tomas; Sery, Omar] Masaryk Univ, Dept Biochem, Lab Neurobiol & Mol Psychiat, Fac Sci, Brno, Czech Republic; [Bonczek, Ondrej; Balcar, Vladimir J.; Sery, Omar] Acad Sci Czech Republ, Inst Anim Physiol & Genet, Lab Neurobiol & Pathol Physiol, Brno, Czech Republic; [Krejci, Premysl] Palacky Univ, Inst Dent & Oral Sci, Fac Med & Dent, Olomouc, Czech Republic; [Izakovicova-Holla, Lydie; Soukalova, Jana; Vanek, Jiri] Masaryk Univ, Fac Med, Clin Stomatol, Brno, Czech Republic; [Izakovicova-Holla, Lydie; Soukalova, Jana; Vanek, Jiri] St Annes Univ Hosp, Brno, Czech Republic; [Gerguri, Tereza] Francis Crick Inst, Biomol Modelling Lab, London, England; [Balcar, Vladimir J.] Univ Sydney, Sydney Med Sch, Sch Med Sci, Lab Neurochem,Bosch Inst, Sydney, NSW, Australia; [Balcar, Vladimir J.] Univ Sydney, Sydney Med Sch, Sch Med Sci, Discipline Anat & Histol, Sydney, NSW, Australia	Masaryk University Brno; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Palacky University Olomouc; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Francis Crick Institute; University of Sydney; University of Sydney	Sery, O (corresponding author), Masaryk Univ, Dept Biochem, Lab Neurobiol & Mol Psychiat, Fac Sci, Brno, Czech Republic.; Sery, O (corresponding author), Acad Sci Czech Republ, Inst Anim Physiol & Genet, Lab Neurobiol & Pathol Physiol, Brno, Czech Republic.	omarsery@sci.muni.cz	Bonczek, Ondřej/ABE-9844-2020; Holla, Lydie Izakovicova/H-7627-2014; Zeman, Tomáš/AAX-6235-2021; Bielik, Peter/AAL-5561-2020; Krejčí, Přemysl/C-8168-2019; Bonczek, Ondrej/GRR-6377-2022; Bonczek, Ondrej/AAH-3415-2020	Bonczek, Ondřej/0000-0003-0745-3136; Holla, Lydie Izakovicova/0000-0002-7610-8929; Krejčí, Přemysl/0000-0002-3810-0061; Bonczek, Ondrej/0000-0003-0745-3136; Clarence, Tereza/0000-0002-0099-2797; Sery, Omar/0000-0002-6062-8997	Internal Grant Agency of the Ministry of Health of the Czech Republic [NT/11420 - 6/2010]	Internal Grant Agency of the Ministry of Health of the Czech Republic	This work was supported by grant of the Internal Grant Agency of the Ministry of Health of the Czech Republic reg. n.: NT/11420 - 6/2010; Web page of grant supplier: http://www.azvcr.cz/en. Omar Sery and Jiri Vanek are main investigators of this project.	Abid MF, 2017, ARCH ORAL BIOL, V75, P8, DOI 10.1016/j.archoralbio.2016.11.018; AlFawaz S, 2015, ARCH ORAL BIOL, V60, P982, DOI 10.1016/j.archoralbio.2015.02.023; [Anonymous], 2017, ROCHE SEQUENCING SOL; Arte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073705; Bergendal B, 2011, AM J MED GENET A, V155A, P1616, DOI 10.1002/ajmg.a.34045; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonczek O, 2017, CLIN GENET, V92, P467, DOI 10.1111/cge.12986; Chen YP, 1996, DEVELOPMENT, V122, P3035; Chishti MS, 2006, J HUM GENET, V51, P872, DOI 10.1007/s10038-006-0037-x; De Muynck S, 2004, AM J MED GENET A, V128A, P401, DOI 10.1002/ajmg.a.30181; Fekonja A, 2005, EUR J ORTHODONT, V27, P457, DOI 10.1093/ejo/cji027; Ghaderi F, 2013, IRAN J MED SCI, V38, P191; Haque S, 2015, MALAYS J MED SCI, V22, P55; Hu GZ, 1998, MOL CELL BIOL, V18, P6044, DOI 10.1128/MCB.18.10.6044; Huang Z, 2014, J MOL HISTOL, V45, P609, DOI 10.1007/s10735-014-9580-5; Humphrey W, 1996, J MOL GRAPHICS, V14, P467, DOI [10.1111/cge.12986, DOI 10.1111/CGE.12986]; ISAAC VE, 1995, BIOCHEMISTRY-US, V34, P7127, DOI 10.1021/bi00021a026; Jumlongras D, 2001, AM J HUM GENET, V69, P67, DOI 10.1086/321271; Jussila M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008425; Kamamoto M, 2011, EUR J HUM GENET, V19, P844, DOI 10.1038/ejhg.2011.47; Kim JW, 2006, J DENT RES, V85, P267, DOI 10.1177/154405910608500312; Kimura M, 2014, EUR J ORAL SCI, V122, P15, DOI 10.1111/eos.12105; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang J, 2012, EUR J ORAL SCI, V120, P278, DOI 10.1111/j.1600-0722.2012.00965.x; Lidral AC, 2002, J DENT RES, V81, P274, DOI 10.1177/154405910208100410; Mostowska A, 2006, J APPL GENETICS, V47, P159, DOI 10.1007/BF03194616; Mostowska A, 2012, ARCH ORAL BIOL, V57, P790, DOI 10.1016/j.archoralbio.2012.01.003; Mu YD, 2013, GENET MOL RES, V12, P4446, DOI 10.4238/2013.October.10.10; Nieminen P, 2001, EUR J HUM GENET, V9, P743, DOI 10.1038/sj.ejhg.5200715; Ogawa T, 2005, ARCH ORAL BIOL, V50, P141, DOI 10.1016/j.archoralbio.2004.09.011; Park ST, 2016, INT NEUROUROL J, V20, P76, DOI 10.5213/inj.1632742.371; Polder BJ, 2004, COMMUNITY DENT ORAL, V32, P217, DOI 10.1111/j.1600-0528.2004.00158.x; Prasad MK, 2016, J MED GENET, V53, P98, DOI 10.1136/jmedgenet-2015-103302; R Core Team, 2013, R LANG ENV STAT COMP; Rakhshan Vahid, 2015, Dent Res J (Isfahan), V12, P1; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Salas-Alanis JC, 2015, ANN DERMATOL, V27, P474, DOI 10.5021/ad.2015.27.4.474; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Sery O, 2013, ORTODONCIE, V22, P173; Sery O, 2015, EUR J ORAL SCI, V123, P65, DOI 10.1111/eos.12170; Shahid M, 2016, EUR J MED GENET, V59, P377, DOI 10.1016/j.ejmg.2016.06.004; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tucker AS, 1999, J DENT RES, V78, P826, DOI 10.1177/00220345990780040201; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Weston JA, 2004, DEV DYNAM, V229, P118, DOI 10.1002/dvdy.10478; Wong SW, 2014, MUTAGENESIS, V29, P319, DOI 10.1093/mutage/geu019; Xuan K, 2008, ARCH ORAL BIOL, V53, P773, DOI 10.1016/j.archoralbio.2008.02.012; Yamaguchi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102944; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920	53	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202989	10.1371/journal.pone.0202989	http://dx.doi.org/10.1371/journal.pone.0202989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192788	Green Submitted, gold, Green Published			2022-12-26	WOS:000444093600041
J	Bozio, CH; Abdul-Karim, A; Abenyeri, J; Abubakari, B; Ofosu, W; Zoya, J; Ouattara, M; Srinivasan, V; Vuong, JT; Opare, D; Asiedu-Bekoe, F; Lessa, FC				Bozio, Catherine H.; Abdul-Karim, Abass; Abenyeri, John; Abubakari, Braimah; Ofosu, Winfred; Zoya, Justina; Ouattara, Mahamoudou; Srinivasan, Velusamy; Vuong, Jeni T.; Opare, David; Asiedu-Bekoe, Franklin; Lessa, Fernanda C.			Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine	PLOS ONE			English	Article							NORTHERN GHANA; DISEASE; IMMUNOGENICITY; OUTBREAK; AFRICA; TRIAL	Background Increases in pneumococcal meningitis were reported from Ghanaian regions that lie in the meningitis belt in 2016-2017, despite introduction of 13-valent pneumococcal conjugate vaccine (PCV13) in 2012 using a 3-dose schedule (6, 10, and 14 weeks). We describe pneumococcal meningitis epidemiology in the Ghanaian Northern and Upper West regions across two meningitis seasons. Methods Suspected meningitis cases were identified using World Health Organization standard definitions. Pneumococcal meningitis was confirmed if pneumococcus was the sole pathogen detected by polymerase chain reaction, culture, or latex agglutination in cerebrospinal fluid collected from a person with suspected meningitis during December 2015-March 2017. Pneumococcal serotyping was done using PCR. Annual age-specific pneumococcal meningitis incidence (cases per 100,000 population) was calculated, adjusting for suspected meningitis cases lacking confirmatory testing. Findings Among 153 pneumococcal meningitis cases, 137 (89.5%) were serotyped; 100 (73.0%) were PCV13-type, including 85 (62.0%) that were serotype 1, a PCV13-targeted serotype. Persons aged >= 5 years accounted for 96.7% (148/153) of cases. Comparing 2015-2016 and 2016-2017 seasons, the proportion of non-serotype 1 PCV13-type cases decreased from 20.0% (9/45) to 4.1% (3/74) (p = 0.008), whereas the proportion that was serotype 1 was stable (71.1% (32/45) vs. 58.1% (43/74); p = 0.16). Estimated adjusted pneumococcal meningitis incidence was 1.8 in children aged < 5 years and ranged from 6.8-10.5 in older children and adults. Conclusions High pneumococcal meningitis incidence with a large proportion of serotype 1 disease in older children and adults suggests infant PCV13 vaccination has not induced herd protection with this schedule in this high-transmission setting.	[Bozio, Catherine H.; Ouattara, Mahamoudou; Srinivasan, Velusamy; Vuong, Jeni T.; Lessa, Fernanda C.] Ctr Dis Control & Prevent, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Bozio, Catherine H.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Abdul-Karim, Abass] Zonal Publ Hlth Lab, Tamale, Ghana; [Abenyeri, John; Abubakari, Braimah] Northern Reg Directorate, Tamale, Ghana; [Ofosu, Winfred; Zoya, Justina] Upper West Reg Directorate, Wa, Ghana; [Opare, David] Ghana Hlth Serv, Natl Publ Hlth Reference Lab, Accra, Ghana; [Asiedu-Bekoe, Franklin] Ghana Hlth Serv, Accra, Ghana	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Ghana Health Service; Ghana Health Service	Bozio, CH (corresponding author), Ctr Dis Control & Prevent, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.; Bozio, CH (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	ise7@cdc.gov		Bozio, Catherine/0000-0001-6566-7138	U.S. Global Health Security funds; Upper West and Northern regional offices	U.S. Global Health Security funds; Upper West and Northern regional offices	This work was part of a public health response and supported by U.S. Global Health Security funds.; The authors thank the Upper West and Northern regional offices for their support and efforts in case-based surveillance. We also appreciate Azure Stebleson and Gladys Ayeebo at the Tamale Zonal Public Health laboratory for their laboratory technical skills and Chastity Walker for her assistance with logistics for this public health response.	Aku FY, 2017, MMWR-MORBID MORTAL W, V66, P806, DOI 10.15585/mmwr.mm6630a2; Chaguza C, 2017, VACCINE, V35, P4594, DOI 10.1016/j.vaccine.2017.07.009; Codjoe SNA, 2014, INT J ENV RES PUB HE, V11, P6923, DOI 10.3390/ijerph110706923; Gessner BD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Jayasinghe S, 2017, CLIN INFECT DIS, V64, P175, DOI 10.1093/cid/ciw720; Kambire D, 2018, J INFECTION, V76, P270, DOI 10.1016/j.jinf.2017.12.002; Kambire D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166384; Klugman KP, 2011, VACCINE, V29, P3372, DOI 10.1016/j.vaccine.2011.02.089; Kwambana-Adams BA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1914-3; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Muthumbi E, 2017, PNEUMONIA, V9, DOI 10.1186/s41479-017-0041-2; Nhantumbo AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177746; Pimenta FC, 2013, J CLIN MICROBIOL, V51, P647, DOI 10.1128/JCM.02927-12; Saaka M, 2008, VACCINE, V26, P3719, DOI 10.1016/j.vaccine.2008.04.066; Spijkerman J, 2013, JAMA-J AM MED ASSOC, V310, P930, DOI 10.1001/jama.2013.228052; Vesikari T, 2009, PEDIATR INFECT DIS J, V28, pS66, DOI 10.1097/INF.0b013e318199f8ef; von Mollendorf C, 2016, EMERG INFECT DIS, V22, P261, DOI 10.3201/eid2202.150967; Vuong J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147765; WHO, 2010, TECHNICAL GUIDELINES; WHO-AFRO, 2009, STANDARD OPERATING P; World Health Organization, 2016, 23 WHO; World Health Organization, WHO UNICEF EST 13 VA; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	24	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203205	10.1371/journal.pone.0203205	http://dx.doi.org/10.1371/journal.pone.0203205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192772	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600049
J	Chung, H; Jung, JH; Jeong, C; Kwak, J; Park, JH; Kim, SS; Yoon, SM; Song, SY; Kim, JH; Choi, EK; Cho, S; Cho, B				Chung, Hyekyun; Jung, Jinhong; Jeong, Chiyoung; Kwak, Jungwon; Park, Jin-hong; Kim, Su Ssan; Yoon, Sang Min; Song, Si Yeol; Kim, Jong Hoon; Choi, Eun Kyung; Cho, Seungryong; Cho, Byungchul			Evaluation of delivered dose to a moving target by 4D dose reconstruction in gated volumetric modulated arc therapy	PLOS ONE			English	Article							STEREOTACTIC BODY RADIOTHERAPY; CELL LUNG-CANCER; PROSPECTIVE PHASE-II; RADIATION-THERAPY; PANCREATIC-CANCER; DOSIMETRIC IMPACT; BREATHING MOTION; LIVER-TUMORS; CARCINOMA; RAPIDARC	Purpose To develop a 4D dose reconstruction method and to evaluate the delivered dose in respiratory-gated volumetric modulated arc therapy (VMAT). Materials and methods A total 112 treatment sessions of gated VMAT for 30 stereotactic body radiotherapy (SBRT) patients (10 lung, 10 liver, and 10 pancreas) were evaluated. For respiratory-gated SBRT, 4DCT was acquired, and the CT data at the end-exhale phase was used for a VMAT plan. The delivered dose was reconstructed using a patient's respiratory motion and machine motion acquired during the beam delivery. The machine motion was obtained from the treatment log file, while the target position was estimated from an external respiratory marker position. The target position was divided into 1-mm position bins, and sub-beams with beam isocenters corresponding to each position bin were created in a motion mimicking plan, reflecting motion data including MLC leaf positions and gantry angle and target position data during beam treatment. The reconstructed 4D dose was compared with the dose of the original plan using these dosimetric parameters; the maximum dose (D-max) and mean dose (D-mean) of gross target volume (GTV) or organs at risk (spinal cord, esophagus, heart, duodenum, kidney, spinal cord, and stomach). The minimum dose (Dmin) to GTV was also calculated to verify cold spots in tumors. Results There was no significant difference of dose parameters regard to the GTV in all tumors. For the liver cases, there were significant differences in the D-max of duodenum (-4.2 +/- 1.4%), stomach (-3.5 +/- 4.2%), left kidney (-4.1 +/- 2.8%), and right kidney (-3.2 +/- 1.3%), and in the D-mean of duodenum (-3.8 +/- 1.4%), stomach (-3.9 +/- 2.2%), left kidney (-3.1 +/- 2.8%), and right kidney (-4.1 +/- 2.6%). For the pancreas cases, there were significant differences in the D-max of stomach (2.1 +/- 3.0%), and in the D-mean of liver (1.5 +/- 0.6%), duodenum (-1.0 +/- 1.4%), stomach (2.1 +/- 1.6%), and right kidney (-1.3 +/- 0.9%). The average gamma pass rates were 97.6 +/- 4.8% for lung cases, 99.6 +/- 0.5% for liver cases, and 99.5 +/- 0.5% for pancreas cases. Most cases showed insignificant dose variation, with gamma pass rates higher than 98%, except for two lung cases with gamma pass rates of 86.9% and 90.6%. The low gamma pass rates showed larger global motion ranges resulting from the baseline shift during beam delivery. Conclusion The actual delivered dose in thoracic and abdominal VMAT under breathing motion was verified by 4D dose reconstruction using typical treatment equipment and software. The proposed method provides a verification method for the actual delivered dose and could be a dosimetric verification QA tool for radiation treatment under various respiratory management techniques.	[Chung, Hyekyun; Jung, Jinhong; Jeong, Chiyoung; Kwak, Jungwon; Park, Jin-hong; Kim, Su Ssan; Yoon, Sang Min; Song, Si Yeol; Kim, Jong Hoon; Choi, Eun Kyung; Cho, Byungchul] Univ Ulsan, Dept Radiat Oncol, Coll Med, Asan Med Ctr, Seoul, South Korea; [Chung, Hyekyun; Cho, Seungryong] Korea Adv Inst Sci & Technol, Dept Nucl & Quantum Engn, Daejeon, South Korea	University of Ulsan; Korea Advanced Institute of Science & Technology (KAIST)	Cho, B (corresponding author), Univ Ulsan, Dept Radiat Oncol, Coll Med, Asan Med Ctr, Seoul, South Korea.	bcho@amc.seoul.kr	Cho, Seungryong/C-1793-2011		Radiation Technology R&D program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning, Republic of Korea [2013M2A2A7043506]	Radiation Technology R&D program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning, Republic of Korea	This research was supported by the Radiation Technology R&D program (2013M2A2A7043506) through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning, Republic of Korea.	Baumann P, 2009, J CLIN ONCOL, V27, P3290, DOI 10.1200/JCO.2008.21.5681; Bortfeld T, 2004, SEMIN RADIAT ONCOL, V14, P41, DOI 10.1053/j.semradonc.2003.10.011; Bujold A, 2013, J CLIN ONCOL, V31, P1631, DOI 10.1200/JCO.2012.44.1659; Chang JY, 2015, LANCET ONCOL, V16, P630, DOI 10.1016/S1470-2045(15)70168-3; Cozzi L, 2008, RADIOTHER ONCOL, V89, P180, DOI 10.1016/j.radonc.2008.06.013; Fakiris AJ, 2009, INT J RADIAT ONCOL, V75, P677, DOI 10.1016/j.ijrobp.2008.11.042; Feng M, 2018, JAMA ONCOL, V4, P40, DOI 10.1001/jamaoncol.2017.2303; Herman JM, 2013, J CLIN ONCOL, V31, P886, DOI 10.1200/JCO.2012.44.7516; Jeong Y, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4340-7; Jung J, 2015, INT J RADIAT ONCOL, V92, P745, DOI 10.1016/j.ijrobp.2015.02.055; Jung SH, 2013, MED PHYS, V40, DOI 10.1118/1.4769427; Keall PJ, 2006, MED PHYS, V33, P3874, DOI 10.1118/1.2349696; Kincaid RE, 2013, MED PHYS, V40, DOI 10.1118/1.4795336; Ko YE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158053; McCammon R, 2009, INT J RADIAT ONCOL, V73, P112, DOI 10.1016/j.ijrobp.2008.03.062; Ng JA, 2012, INT J RADIAT ONCOL, V84, pE655, DOI 10.1016/j.ijrobp.2012.07.2367; Olsen JR, 2011, INT J RADIAT ONCOL, V81, pE299, DOI 10.1016/j.ijrobp.2011.01.038; Ong C, 2011, INT J RADIAT ONCOL, V79, P305, DOI 10.1016/j.ijrobp.2010.02.059; Peulen H, 2014, RADIOTHER ONCOL, V110, P511, DOI 10.1016/j.radonc.2014.01.010; Poulsen PR, 2014, RADIOTHER ONCOL, V111, P424, DOI 10.1016/j.radonc.2014.05.007; Poulsen PR, 2012, MED PHYS, V39, P6237, DOI 10.1118/1.4754297; Poulsen PR, 2008, INT J RADIAT ONCOL, V72, P1587, DOI 10.1016/j.ijrobp.2008.07.037; Rao M, 2012, INT J RADIAT ONCOL, V83, pE251, DOI 10.1016/j.ijrobp.2011.12.001; Rudra S, 2017, INT J RADIAT ONCOL, V99, pE184, DOI 10.1016/j.ijrobp.2017.06.1042; Timmerman RD, 2010, J CLIN ONCOL, V28, P907, DOI 10.1200/JCO.2009.26.5165; Velec M, 2011, INT J RADIAT ONCOL, V80, P265, DOI 10.1016/j.ijrobp.2010.05.023; Verbakel WFAR, 2009, INT J RADIAT ONCOL, V74, P252, DOI 10.1016/j.ijrobp.2008.12.033; Yoon K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166927; Yu CX, 1998, PHYS MED BIOL, V43, P91, DOI 10.1088/0031-9155/43/1/006; Zhang QH, 2007, MED PHYS, V34, P4772, DOI 10.1118/1.2804576	30	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202765	10.1371/journal.pone.0202765	http://dx.doi.org/10.1371/journal.pone.0202765			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192793	Green Submitted, Green Published, gold			2022-12-26	WOS:000444093600034
J	Uemura, Y; Yoshimi, S; Hata, H				Uemura, Yohsuke; Yoshimi, Shotaro; Hata, Hiroki			Hybridization between two bitterling fish species in their sympatric range and a river where one species is native and the other is introduced	PLOS ONE			English	Article							REPRODUCTIVE ECOLOGY; ROSE BITTERLINGS; TANAKIA-LIMBATA; TELEOSTEI; SOFTWARE; HYBRIDS; ACHEILOGNATHINAE; PHYLOGEOGRAPHY; CYPRINIDAE; PHYLOGENY	The distributions of two bitterling fish (subfamily: Acheilognathinae), Tanakia lanceolata and T. limbata, overlap in western Japan. Acheilognathinae fish lay their eggs in the gills of freshwater bivalves, and the early juvenile stage develops in the gills. Populations of freshwater bivalves are declining worldwide, which has limited the number of spawning substrate for bitterlings. T. limbata has been artificially introduced to some rivers in Ehime, Japan, where it coexists with native T. lanceolata, and some hybrids have been observed. We collected both species from several sites in western Japan, and from the Kunichi River system in Ehime, and analyzed genetic population structure based on six microsatellite loci and sequences of the mitochondrial cytochrome b gene. Structure analysis identified three genetically distinct populations: T. lanceolata, T. limbata "West Kyushu", and T. limbata "Setouchi". Two clades of T. limbata were also supported by molecular phylogenetic analyses based on cytochrome b. Hybrids in Ehime originated mostly from interbreeding between male T. lanceolata and female T. limbata "West Kyushu", and made up 10.2% of all collected fish, suggesting that hybrids occurred frequently between females of colonizing species and males of native species. On the other hand, interspecific hybrids were detected at rates of 40.0%, 20.0%, and 17.6% in the Ima River (Fukuoka), Midori River (Kumamoto), and Kase River (Saga), respectively, which are naturally sympatric regions. We found a few T. limbata "Setouchi" in the Midori and Kase Rivers, which were supposed to be introduced from other regions, coexisting with native T. limbata "West Kyushu", and this cryptic invasion may have triggered the interspecific hybridization. These results suggest that artificial introduction of a fish species, a decline in the unionid population, and degradation of habitat have caused broad hybridization of bitterlings in western Japan.	[Uemura, Yohsuke] Ehime Univ, Dept Biol, Fac Sci, Matsuyama, Ehime, Japan; [Yoshimi, Shotaro; Hata, Hiroki] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime, Japan	Ehime University; Ehime University	Hata, H (corresponding author), Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime, Japan.	hata@sci.ehime-u.ac.jp	Uemura, Yohsuke/F-8412-2019	Uemura, Yohsuke/0000-0002-7703-9857; Hata, Hiroki/0000-0001-9438-0646	Environmental Research and Technology Development Fund from Ministry of the Environment, Japan [4RFd-1201]	Environmental Research and Technology Development Fund from Ministry of the Environment, Japan	This study was supported by the Environmental Research and Technology Development Fund from Ministry of the Environment, Japan (4RFd-1201, http://www.env.go.jp/policy/kenkyu/suishin/english/gaiyou/index.html).	Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Anderson EC, 2002, GENETICS, V160, P1217; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Cheng PL, 2014, ZOOL SCI, V31, P300, DOI 10.2108/zs130069; Coyne J.A., 2004, SPECIATION; Crete-Lafreniere A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046662; Dawson DA, 2003, MOL ECOL NOTES, DOI [10.1046/J.1471-8286.2003.00480.X, DOI 10.1046/J.1471-8286.2003.00480.X]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ehime Prefecture Japan, 1979, 2 NAT SURV NAT ENV; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fukuhara S., 2014, INTRO FRESHWATER FIS, P66; Gilles A, 2001, MOL PHYLOGENET EVOL, V19, P22, DOI 10.1006/mpev.2000.0916; Hashiguchi Y, 2006, ZOOL SCI, V23, P309, DOI 10.2108/zsj.23.309; Heath D, 2010, EVOL APPL, V3, P77, DOI 10.1111/j.1752-4571.2009.00100.x; Horreo JL, 2011, J HERED, V102, P237, DOI 10.1093/jhered/esq130; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Kanao S., 2013, DOMESTIC ALIEN FISHE, P169; KANESHIRO KY, 1983, ANNU REV ENTOMOL, V28, P161, DOI 10.1146/annurev.en.28.010183.001113; Kanoh Y, 2000, ENVIRON BIOL FISH, V57, P143, DOI 10.1023/A:1004585405848; Kawamura K, 2001, ZOOL SCI, V18, P1027, DOI 10.2108/zsj.18.1027; Kawamura K, 2000, J HERED, V91, P464, DOI 10.1093/jhered/91.6.464; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KIMURA S, 1992, JPN J ICHTHYOL, V38, P425, DOI 10.1007/BF02905605; Kitamura JI, 2007, ENVIRON BIOL FISH, V78, P37, DOI 10.1007/s10641-006-9076-6; Kitanishi S, 2016, ICHTHYOL RES, V63, P506, DOI 10.1007/s10228-016-0522-y; Kuwahara Akihiro, 2017, Hozen Seitaigaku Kenkyu, V22, P91; Matsuba Hideki, 2014, Japanese Journal of Ichthyology, V61, P89; Matsushima O., 2014, INTRO FRESHWATER FIS, P50; Ministry of the Environment Japan, 2013, 4 VERS JAP RED LISTS; Morais P, 2018, SCI TOTAL ENVIRON, V613, P1438, DOI 10.1016/j.scitotenv.2017.06.133; Muhlfeld CC, 2014, NAT CLIM CHANGE, V4, P620, DOI [10.1038/NCLIMATE2252, 10.1038/nclimate2252]; NAGATA Y, 1976, Memoirs of Osaka Kyoiku University Series III Natural Science and Applied Science, V25, P17; Nagata Y., 1989, FRESHWATER FISHES JA, P354; Nakamura M., 1969, CYPRINID FISHES JAPA; NAKAMURA M, 1955, B BIOGEOGR SOC JAPAN, V16, P333; Negishi Junjiro N., 2008, Japanese Journal of Ecology (Otsu), V58, P37; Onikura N, 2007, J JPN SOC WATER ENV, V30, P277, DOI DOI 10.2965/JSWE.30.277; Onikura N, 2006, J JPN SOC WATER ENV, V29, P837; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; ROSENTHAL A, 1993, NUCLEIC ACIDS RES, V21, P173, DOI 10.1093/nar/21.1.173; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shirai Y, 2009, MOL ECOL RESOUR, V9, P1031, DOI 10.1111/j.1755-0998.2009.02566.x; Smith C, 2004, J ZOOL, V262, P107, DOI 10.1017/S0952836903004497; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suzuki N, 1986, B COLL AGR VET MED N, V43, P151; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WIEPKEMA P. R., 1961, ARCH NEERLAND ZOOL, V14, P103; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144; Yoshimi Shotaro, 2018, Hozen Seitaigaku Kenkyu, V23, P99	55	8	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203423	10.1371/journal.pone.0203423	http://dx.doi.org/10.1371/journal.pone.0203423			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192806	gold, Green Published, Green Submitted			2022-12-26	WOS:000444093600072
J	Cafiero, JH; Lamberti, YA; Surmann, K; Vecerek, B; Rodriguez, ME				Hilario Cafiero, Juan; Andrea Lamberti, Yanina; Surmann, Kristin; Vecerek, Branislav; Eugenia Rodriguez, Maria			A Bordetella pertussis MgtC homolog plays a role in the intracellular survival	PLOS ONE			English	Article							EPITHELIAL-CELLS; PROTEOMICS; PATHOGENICITY; PARAPERTUSSIS; ACIDIFICATION; MODULATION; INVASION; ATPASE	Bordetella pertussis, the causative agent of whooping cough, has the capability to survive inside the host cells. This process requires efficient adaptation of the pathogen to the intracellular environment and the associated stress. Among the proteins produced by the intracellular B. pertussis we identified a protein (BP0414) that shares homology with MgtC, a protein which was previously shown to be involved in the intracellular survival of other pathogens. To explore if BP0414 plays a role in B. pertussis intracellular survival a mutant strain defective in the production of this protein was constructed. Using standard in vitro growth conditions we found that BP0414 is required for B. pertussis growth under low magnesium availability or low pH, two environmental conditions that this pathogen might face within the host cell. Intracellular survival studies showed that MgtC is indeed involved in B. pertussis viability inside the macrophages. The use of bafilomycin A1, which inhibits phagosome acidification, abolished the survival defect of the mgtC deficient mutant strain suggesting that in intracellular B. pertussis the role of MgtC protein is mainly related to the bacterial adaptation to the acidic conditions found inside the of phagosomes. Overall, this work provides an insight into the importance of MgtC in B. pertussis pathogenesis and its contribution to bacterial survival within immune cells.	[Hilario Cafiero, Juan; Andrea Lamberti, Yanina; Eugenia Rodriguez, Maria] Univ Nacl La Plata, Fac Ciencias Exactas, CINDEFI UNLP CONICET La Plata, La Plata, Buenos Aires, Argentina; [Surmann, Kristin] Univ Med Greifswald, Dept Funct Genom, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Vecerek, Branislav] Inst Microbiol ASCR, Vvi, Lab Mol Biol Bacterial Pathogens, Prague, Czech Republic; [Vecerek, Branislav] Inst Microbiol ASCR, Vvi, Lab Posttranscript Control Gene Express, Prague, Czech Republic	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Greifswald Medical School; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Rodriguez, ME (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, CINDEFI UNLP CONICET La Plata, La Plata, Buenos Aires, Argentina.	mer@quimica.unlp.edu.ar	Vecerek, Branislav/H-2545-2014	Vecerek, Branislav/0000-0001-9520-6324	National Agency for Scientific and Technological Promotion (ANPCyT, MINCyT) [PICT 2013-1937, PICT 2016-2363]; CONICET-DFG-MINCYT 2016 [DFG: 357058152]; Czech Science Foundation [16-34825L]	National Agency for Scientific and Technological Promotion (ANPCyT, MINCyT); CONICET-DFG-MINCYT 2016; Czech Science Foundation(Grant Agency of the Czech Republic)	This work was partially supported by the National Agency for Scientific and Technological Promotion (ANPCyT, MINCyT) (www.agencia.mincyt.gob.ar/) grants PICT 2013-1937 and PICT 2016-2363 to MER, CONICET-DFG-MINCYT 2016, DFG: 357058152 to MER, KS, and YL, and the Czech Science Foundation (www.gacr.cz) grant 16-34825L to BV. MER and YAL are members of the Scientific Career of CONICET. JHC is a doctoral fellow of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix E, 2007, TRENDS MICROBIOL, V15, P252, DOI 10.1016/j.tim.2007.03.007; Amman F, 2018, RNA BIOL, V15, P967, DOI 10.1080/15476286.2018.1462655; Bassinet L, 2000, INFECT IMMUN, V68, P1934, DOI 10.1128/IAI.68.4.1934-1941.2000; Belon C, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00052; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Freue GVC, 2012, CIRC-CARDIOVASC GENE, V5, pO10, DOI 10.1161/CIRCGENETICS.111.959528; FRIEDMAN RL, 1992, INFECT IMMUN, V60, P4578, DOI 10.1128/IAI.60.11.4578-4585.1992; Gorgojo J, 2014, INFECT IMMUN, V82, P5175, DOI 10.1128/IAI.02553-14; Groisman EA, 2013, ANNU REV GENET, V47, P625, DOI 10.1146/annurev-genet-051313-051025; Hellwig SMM, 1999, FEMS IMMUNOL MED MIC, V26, P203, DOI 10.1111/j.1574-695X.1999.tb01391.x; Hellwig SMM, 2001, J INFECT DIS, V183, P871, DOI 10.1086/319266; Huynh KK, 2007, MICROBIOL MOL BIOL R, V71, P452, DOI 10.1128/MMBR.00003-07; Inatsuka CS, 2010, INFECT IMMUN, V78, P2901, DOI 10.1128/IAI.00188-10; Kitteringham NR, 2009, J CHROMATOGR B, V877, P1229, DOI 10.1016/j.jchromb.2008.11.013; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lamberti Y, 2016, J PROTEOMICS, V136, P55, DOI 10.1016/j.jprot.2016.02.002; Lamberti Y, 2013, PATHOG DIS, V69, P194, DOI 10.1111/2049-632X.12072; Lamberti Y, 2008, MICROB PATHOGENESIS, V44, P501, DOI 10.1016/j.micpath.2008.01.002; Lamberti YA, 2010, INFECT IMMUN, V78, P907, DOI 10.1128/IAI.01031-09; LEE CK, 1990, INFECT IMMUN, V58, P2516, DOI 10.1128/IAI.58.8.2516-2522.1990; Lee EJ, 2013, CELL, V154, P146, DOI 10.1016/j.cell.2013.06.004; Lelong E, 2011, CELL MICROBIOL, V13, P246, DOI 10.1111/j.1462-5822.2010.01532.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MAGUIRE ME, 1992, J BIOENERG BIOMEMBR, V24, P319; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Maloney KE, 2006, INFECT IMMUN, V74, P5477, DOI 10.1128/IAI.00798-06; Martin-Orozco N, 2006, MOL BIOL CELL, V17, P498, DOI 10.1091/mbc.E04-12-1096; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pontes MH, 2015, J MOL BIOL, V427, P2586, DOI 10.1016/j.jmb.2015.06.021; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Tang HY, 2011, J PROTEOME RES, V10, P4005, DOI 10.1021/pr2002098; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zlamy M, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00052	38	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203204	10.1371/journal.pone.0203204	http://dx.doi.org/10.1371/journal.pone.0203204			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161230	Green Submitted, Green Published, gold			2022-12-26	WOS:000443388900090
J	Kurdyukov, S; Eccles, CA; Desai, AKA; Gonzalez-Garay, M; Yuan, JXJ; Garcia, JGN; Rafikova, O; Rafikov, R				Kurdyukov, Sergey; Eccles, Cody A.; Desai, An Kit A.; Gonzalez-Garay, Manuel; Yuan, Jason X-J; Garcia, Joe G. N.; Rafikova, Olga; Rafikov, Ruslan			New cases of Glucose-6-Phosphate Dehydrogenase deficiency in Pulmonary Arterial Hypertension	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; HEMOLYSIS; MODEL	Pulmonary Arterial Hypertension (PAH) is a fatal disorder with limited treatment options and reduced life expectancy after diagnosis. Complex genetic backgrounds in PAH complicates identification of causative mutations that is essential for an understanding of the disease diagnostics and etiology especially for idiopathic PAH (iPAH). Hemolysis has been implicated as contributing to the pathobiology of PAH. Glucose-6-Phosphate Dehydrogenase (G6PD) expression and activity define erythrocyte's antioxidant capacity, and its decrease contributes to erythrocyte fragility. As G6PD deficiency was previously reported in a limited number of PAH cases, we tested whether iPAH patients exhibit underlying G6PD alterations in erythrocytes. A cohort of 22 PAH patients and 8 non-PAH patients were recruited for this study. DNA isolated from Peripheral Blood Mononuclear Cells (PBMC) was used for detection of mutations in the coding region of the G6PD gene. RNA isolated from PBMC was used for determination of G6PD mRNA expression level. G6PD activity was measured in Red Blood Cell (RBC) pellets. Three patients had missense mutations in G6PD (Val291 Met, Asn126Asp, Asp194Glu), however, only one mutation (Val291Met) results in a severe G6PD deficiency. A single patient with mutation (Asn126Asp) showed a 21% decrease in G6PD activity, two subjects showed G6PD deficiency without mutations, and one patient had a decreased level of G6PD mRNA and reduced enzyme levels. This study demonstrates that a moderate decrease in G6PD activity is associated with PAH. Screening for G6PD activity and mutations in the G6PD gene may provide early detection of individuals predisposed to PAH.	[Kurdyukov, Sergey; Eccles, Cody A.; Rafikova, Olga; Rafikov, Ruslan] Univ Arizona, Coll Med, Dept Med, Div Endocrinol, Tucson, AZ 85721 USA; [Desai, An Kit A.] Univ Arizona, Coll Med, Dept Med, Div Cardiol, Tucson, AZ USA; [Gonzalez-Garay, Manuel; Yuan, Jason X-J] Univ Arizona, Coll Med, Dept Med, Div Translat & Regenerat Med, Tucson, AZ USA; [Garcia, Joe G. N.] Univ Arizona, Coll Med, Dept Med, Div Pulm & Crit Care Med, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona	Rafikova, O; Rafikov, R (corresponding author), Univ Arizona, Coll Med, Dept Med, Div Endocrinol, Tucson, AZ 85721 USA.	orafikova@email.arizona.edu; ruslanrafikov@email.arizona.edu	Kurdyukov, Sergey/AAF-2311-2020; Rafikov, Ruslan/AAG-9352-2019	Kurdyukov, Sergey/0000-0001-5824-0443; Desai, Ankit/0000-0001-6427-616X; Rafikov, Ruslan/0000-0001-5950-4076; Gonzalez-Garay, Manuel/0000-0003-3412-0353	NIH [R01HL133085]; Arizona Health Sciences Center Career Development Award [R01HL132918, R01HL136603]; Scientist Development Grant [14SDG20480354]; National Heart Lung and Blood Institute (PVDOMICS) [HL125208-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL125208, R01HL132918, R35HL135807, R01HL133085, R01HL136603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arizona Health Sciences Center Career Development Award; Scientist Development Grant; National Heart Lung and Blood Institute (PVDOMICS); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants R01HL133085 (to OR) and Arizona Health Sciences Center Career Development Award (to OR); R01HL132918 (to RR); R01HL136603 (to AAD); Scientist Development Grant 14SDG20480354 (to RR). RNAseq was supported by the U01 grant HL125208-01 from the National Heart Lung and Blood Institute (PVDOMICS) (to JXJY).	BATTISTUZZI G, 1977, AM J HUM GENET, V29, P31; Boonyuen U, 2016, MOL GENET METAB, V118, P84, DOI 10.1016/j.ymgme.2016.03.008; Chen LYC, 2010, AM J HEMATOL, V85, P124, DOI 10.1002/ajh.21584; Chun Kook-Jin, 2001, Korean Journal of Internal Medicine, V16, P75; David G., 2017, J APPL LAB MED, V2, P1, DOI DOI 10.1373/JALM.2017.024935; Demir AY, 2009, BLOOD, V113, P2118, DOI 10.1182/blood-2008-12-194746; Fonseca G, 2015, CURR OPIN PULM MED, V21, P432, DOI 10.1097/MCP.0000000000000200; Frei AC, 2008, BLOOD, V112, P398, DOI 10.1182/blood-2007-12-126714; Garcia-Rivas G, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0440-5; Hu WG, 2010, BLOOD, V116, P1613, DOI 10.1182/blood-2010-01-267112; Karamanian VA, 2014, PULM CIRC, V4, P269, DOI 10.1086/675990; Kerstjens-Frederikse WS, 2013, J MED GENET, V50, P500, DOI 10.1136/jmedgenet-2012-101152; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; Mathew R, 2016, WORLD J CARDIOL, V8, P703, DOI 10.4330/wjc.v8.i12.703; NANCE WE, 1977, AM J HUM GENET, V29, P537; Newman JH, 2001, NEW ENGL J MED, V345, P319, DOI 10.1056/NEJM200108023450502; Paulin R, 2014, CELL METAB, V20, P827, DOI 10.1016/j.cmet.2014.08.011; Potoka KP, 2015, AM J PHYSIOL-LUNG C, V308, pL314, DOI 10.1152/ajplung.00252.2014; Rafikova O, 2018, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2017-0308OC, DOI 10.1165/RCMB.2017-03080C]; Rybicki AC, 1998, BLOOD, V92, P2594, DOI 10.1182/blood.V92.7.2594.2594_2594_2596; Shah SS, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0093-6; Taniguchi Misako, 2016, ScientificWorldJournal, V2016, P6382467, DOI 10.1155/2016/6382467; Wang YP, 2014, EMBO J, V33, P1304, DOI 10.1002/embj.201387224	23	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203493	10.1371/journal.pone.0203493	http://dx.doi.org/10.1371/journal.pone.0203493			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161219	gold, Green Submitted, Green Published			2022-12-26	WOS:000443388900130
J	Fang, LS; Wu, SS; Zhu, X; Cai, JC; Wu, JH; He, ZJ; Liu, L; Zeng, MS; Song, EW; Li, J; Li, MF; Guan, HY				Fang, Lishan; Wu, Shanshan; Zhu, Xun; Cai, Junchao; Wu, Jueheng; He, Zhenjian; Liu, Lei; Zeng, Musheng; Song, Erwei; Li, Jun; Li, Mengfeng; Guan, Hongyu			MYEOV functions as an amplified competing endogenous RNA in promoting metastasis by activating TGF-beta pathway in NSCLC	ONCOGENE			English	Article							LONG NONCODING RNA; CANCER STATISTICS; CELL; 11Q13; GENE; AMPLIFICATION; PROGRESSION; EXPRESSION; PTEN; INVASION	Non-small cell lung cancer (NSCLC) remains a major cause of death worldwide. As metastatic disease is primarily responsible for the poor clinical outcome of NSCLC, it is important to understand the process, and its underlying molecular mechanism as well, via which NSCLC cells disseminate. In this study, we identified a new competing endogenous RNA (ceRNA), namely, the MYEOV transcript, and found that it is upregulated in NSCLC and associated with a poor prognosis of the disease. We further uncovered that the MYEOV ceRNA plays a critical role in the invasion and metastasis of NSCLC cells. Intriguingly, the MYEOV ceRNA exerted its pro-metastatic function independent of its protein-coding capacity, but in a miR-30c-2-3p binding-dependent manner. Further experiments demonstrated that the MYEOV ceRNA sequestered miR30c-2-3p from binding its targets TGFBR2 and USP15 mRNAs, which in turn leading to constitutive activation of TGF-beta signaling and tumor progression in NSCLC. By identifying a new layer of regulatory modality for TGF-beta signaling, our findings extend the current understanding on the molecular mechanism mediating NSCLC progression and highlight a potential role of MYEOV transcript to serve as the therapeutic target.	[Fang, Lishan; Wu, Shanshan; Zhu, Xun; Cai, Junchao; Wu, Jueheng; Liu, Lei; Li, Mengfeng] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China; [Fang, Lishan] Sun Yat Sen Univ, Cent Lab, Affiliated Hosp 8, Shenzhen, Peoples R China; [Wu, Shanshan; Cai, Junchao; Wu, Jueheng; Liu, Lei; Li, Mengfeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China; [Zhu, Xun] Guangdong Prov Key Lab Orthoped & Traumatol, Guangzhou, Guangdong, Peoples R China; [He, Zhenjian] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Zeng, Musheng] Sun Yat Sen Univ, Dept Expt Res, State Key Lab Oncol South China, Ctr Canc, Guangzhou, Guangdong, Peoples R China; [Song, Erwei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Breast Surg, Guangzhou, Guangdong, Peoples R China; [Li, Jun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou, Guangdong, Peoples R China; [Guan, Hongyu] Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, MF (corresponding author), Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China.; Li, MF (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China.; Guan, HY (corresponding author), Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	limf@mail.sysu.edu.cn; ghongy@mail.sysu.edu.cn	LIU, LEI/AAY-2012-2020; LIU, LEI/AAL-7491-2021	LIU, LEI/0000-0003-4898-5665; Fang, Lishan/0000-0002-0183-861X	Natural Science Foundation of China [81490752]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81621004]; Guangzhou science and technology plan [201803010039]; "Guangdong Te Zhi program" youth science and technology talent of project [2015TQ01R281]; Guangdong Natural Science Funds for Distinguished Young Scholar [2014A030306023]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou science and technology plan; "Guangdong Te Zhi program" youth science and technology talent of project; Guangdong Natural Science Funds for Distinguished Young Scholar	This work was supported by The Natural Science Foundation of China (No. 81490752); The Foundation for Innovative Research Groups of the National Natural Science Foundation of China (No. 81621004); Guangzhou science and technology plan (No. 201803010039). "Guangdong Te Zhi program" youth science and technology talent of project (No. 2015TQ01R281); Guangdong Natural Science Funds for Distinguished Young Scholar (2014A030306023).	Anumanthan G, 2005, BRIT J CANCER, V93, P1157, DOI 10.1038/sj.bjc.6602831; Brown LA, 2006, GYNECOL ONCOL, V100, P264, DOI 10.1016/j.ygyno.2005.08.026; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Cai JC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15870; Cai JC, 2013, CANCER RES, V73, P5402, DOI 10.1158/0008-5472.CAN-13-0297; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; de Almeida RA, 2006, J BIOL CHEM, V281, P695, DOI 10.1074/jbc.M511467200; Eichhorn PJA, 2012, NAT MED, V18, P429, DOI 10.1038/nm.2619; Enright AJ, 2004, GENOME BIOL, V5; Fang LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9640; Finger EC, 2008, CARCINOGENESIS, V29, P528, DOI 10.1093/carcin/bgm289; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Horie M, 2017, MOL CANCER RES, V15, P1354, DOI 10.1158/1541-7786.MCR-17-0191; Hui ABY, 2005, CANCER RES, V65, P8125, DOI 10.1158/0008-5472.CAN-05-0648; Janssen JWG, 2002, J HUM GENET, V47, P460, DOI 10.1007/s100380200065; Janssen JWG, 2002, INT J CANCER, V102, P608, DOI 10.1002/ijc.10765; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Leyden J, 2006, BRIT J CANCER, V94, P1204, DOI 10.1038/sj.bjc.6603054; Li J, 2008, CLIN CANCER RES, V14, P6996, DOI 10.1158/1078-0432.CCR-08-0754; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mathew LK, 2014, CANCER DISCOV, V4, P53, DOI 10.1158/2159-8290.CD-13-0291; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Moreaux J, 2010, EXP HEMATOL, V38, P1189, DOI 10.1016/j.exphem.2010.09.002; Moss AC, 2006, BIOCHEM BIOPH RES CO, V345, P216, DOI 10.1016/j.bbrc.2006.04.094; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Rodrigo JP, 2009, J PATHOL, V217, P516, DOI 10.1002/path.2462; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shukla K, 2015, MOL ONCOL, V9, P1106, DOI 10.1016/j.molonc.2015.01.008; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takita J, 2011, CANCER SCI, V102, P1645, DOI 10.1111/j.1349-7006.2011.01995.x; Tan XC, 2018, J CLIN INVEST, V128, P3198, DOI 10.1172/JCI122740; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Ying Z, 2017, J CLIN INVEST, V127, P1725, DOI 10.1172/JCI90439; Yu Q, 2000, GENE DEV, V14, P163; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	47	27	28	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 7	2019	38	6					896	912		10.1038/s41388-018-0484-9	http://dx.doi.org/10.1038/s41388-018-0484-9			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HK5LC	30181549	Green Published, hybrid			2022-12-26	WOS:000458006300010
J	Esparza-Molto, PB; Nuevo-Tapioles, C; Chamorro, M; Najera, L; Torresano, L; Santacatterina, F; Cuezva, JM				Esparza-Molto, Pau B.; Nuevo-Tapioles, Cristina; Chamorro, Margarita; Najera, Laura; Torresano, Laura; Santacatterina, Fulvio; Cuezva, Jose M.			Tissue-specific expression and post-transcriptional regulation of the ATPase inhibitory factor 1 (IF1) in human and mouse tissues	FASEB JOURNAL			English	Article						mitochondria; Lrpprc; oxphos; traslational efficiency; protein phosphorylation	BETA-F1-ATPASE MESSENGER-RNA; ENERGY-METABOLISM; MITOCHONDRIAL; SYNTHASE; PROTEIN; CANCER; TRANSLATION; PHOSPHORYLATION; COORDINATION; ORGANIZATION	The ATPase inhibitory factor 1 (IF1) is an intrinsically disordered protein that regulates the activity of the mitochondrial ATP synthase. Phosphorylation of S39 in IF1 prevents it from binding to the enzyme and thus abolishes its inhibitory activity. Dysregulation of IF1 is linked to different human diseases, providing a relevant biomarker of cancer progression. However, the tissue content of IF1 relative to the abundance of the ATP synthase is unknown. In this study, we characterized the tissue-specific expression of IF1 in human and mouse tissues and quantitated the content of IF1 and of ATP synthase. We found relevant differences in IF1 expression between human and mouse tissues and found that in high-energy-demanding tissues, the molar content of IF1 exceeds that of the ATP synthase. In these tissues, a fraction of IF1 is bound to the enzyme, and the other fraction is phosphorylated and hence is unable to bind the enzyme. Post-transcriptional control accounts for most of the regulated expression of IF1, especially in mouse heart, where IF1 mRNA translation is repressed by the leucine-rich pentatricopeptide repeat containing protein. Overall, these findings enlighten the cellular biology of IF1 and pave the way to development of additional models that address its role in pathophysiology.Esparza-Molto, P. B., Nuevo-Tapioles, C., Chamorro, M., Najera, L., Torresano, L., Santacatterina, F., Cuezva, J. M. Tissue-specific expression and post-transcriptional regulation of the ATPase inhibitory factor 1 (IF1) in human and mouse tissues.	[Esparza-Molto, Pau B.; Nuevo-Tapioles, Cristina; Chamorro, Margarita; Torresano, Laura; Santacatterina, Fulvio; Cuezva, Jose M.] Univ Autonoma Madrid, CSIC, CBMSO, Dept Biol Mol, Madrid, Spain; [Esparza-Molto, Pau B.; Nuevo-Tapioles, Cristina; Chamorro, Margarita; Torresano, Laura; Santacatterina, Fulvio; Cuezva, Jose M.] ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Esparza-Molto, Pau B.; Nuevo-Tapioles, Cristina; Chamorro, Margarita; Torresano, Laura; Santacatterina, Fulvio; Cuezva, Jose M.] Inst Invest Hosp 12 Octubre I 12, Madrid, Spain; [Najera, Laura] Hosp Univ Puerta de Hierro, Serv Anat Patol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Hospital Universitario 12 de Octubre; Hospital Puerta de Hierro-Majadahonda	Cuezva, JM (corresponding author), Univ Autonoma Madrid, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Inst Invest Hosp 12 Octubre,ISCIII, Dept Biol Mol,Ctr Biol Mol Severo Ochoa,CSIC, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	jmcuezva@cbm.csic.es	Cuezva, Jose M/AAR-5392-2020; Nuevo-Tapioles, Cristina/F-5970-2016; Nuevo-Tapioles, Cristina/AAT-5772-2021; Esparza-Moltó, Pau B./S-5584-2018; Santacatterina, Fulvio/F-5722-2016	Nuevo-Tapioles, Cristina/0000-0001-5809-2030; Santacatterina, Fulvio/0000-0002-4831-5402; Esparza-Molto, Pau B./0000-0001-9034-1121	Fundacion La Caixa (Obra Social La Caixa); Formacion de Personal Investigador-Ministerio de Economia y Competitividad (FPI-MINECO); Fondo Social Europeo; Ministry of Economy and Enterprise (MINECO) [SAF2016-75916-R]; Centro de Investigacion Biomedica en Red de Enfermedades Raras- Instituto de Salud Carlos III (CIBERER-ISCIII); Fundacion Ramon Areces	Fundacion La Caixa (Obra Social La Caixa); Formacion de Personal Investigador-Ministerio de Economia y Competitividad (FPI-MINECO); Fondo Social Europeo(European Social Fund (ESF)European Commission); Ministry of Economy and Enterprise (MINECO); Centro de Investigacion Biomedica en Red de Enfermedades Raras- Instituto de Salud Carlos III (CIBERER-ISCIII); Fundacion Ramon Areces	The authors thank Cristina Nunez de Arenas and Brenda Sanchez-Garrido [Departamento de Biologia Molecular, Centro de Biologia Molecular Severo Ochoa (CBMSO), Consejo Superior de Investigaciones Cientificas (CSIC) - Universidad Autonoma de Madrid (UAM); Centro de Investigacion Biomedica en Red de Enfermedades Raras-Instituto de Salud Carlos III (CIBERER-ISCIII); Instituto de Investigacion Hospital 12 de Octubre (i+12)] for excellent technical assistance.This work was supported by predoctoral fellowships from Fundacion La Caixa (Obra Social La Caixa) (to P.B.E.-M.) and Formacion de Personal Investigador-Ministerio de Economia y Competitividad (FPI-MINECO) and Fondo Social Europeo (to C.N.-T.). This work was also supported by grants from the Ministry of Economy and Enterprise (MINECO; SAF2016-75916-R), Centro de Investigacion Biomedica en Red de Enfermedades Raras- Instituto de Salud Carlos III (CIBERER-ISCIII), and Fundacion Ramon Areces. The authors declare no conflicts of interest.	Acebo P, 2009, TRANSL ONCOL, V2, P138, DOI 10.1593/tlo.09106; Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024; Bason JV, 2014, P NATL ACAD SCI USA, V111, P11305, DOI 10.1073/pnas.1411560111; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Campanella M, 2009, TRENDS BIOCHEM SCI, V34, P343, DOI 10.1016/j.tibs.2009.03.006; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cuezva JM, 2002, CANCER RES, V62, P6674; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; de Heredia ML, 2000, J BIOL CHEM, V275, P7430, DOI 10.1074/jbc.275.10.7430; Di Benedetto G, 2014, J PHYSIOL-LONDON, V592, P305, DOI 10.1113/jphysiol.2013.259135; Esparza-Molto PB, 2017, CELL MOL LIFE SCI, V74, P2151, DOI 10.1007/s00018-017-2462-8; Faccenda D, 2017, CELL REP, V18, P1869, DOI 10.1016/j.celrep.2017.01.070; Formentini L, 2017, DIABETOLOGIA, V60, P2052, DOI 10.1007/s00125-017-4379-z; Formentini L, 2017, CELL REP, V19, P1202, DOI 10.1016/j.celrep.2017.04.036; Formentini L, 2014, EMBO J, V33, P762, DOI 10.1002/embj.201386392; Formentini L, 2012, MOL CELL, V45, P731, DOI 10.1016/j.molcel.2012.01.008; Garcia-Bermudez J., 2016, BIOPROTOC, V6, pE1905; Garcia-Bermudez J, 2016, BBA-BIOENERGETICS, V1857, P1167, DOI 10.1016/j.bbabio.2016.02.004; Garcia-Bermudez J, 2015, CELL REP, V12, P2143, DOI 10.1016/j.celrep.2015.08.052; Genoux A, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0672-9; Gordon-Smith DJ, 2001, J MOL BIOL, V308, P325, DOI 10.1006/jmbi.2001.4570; Izquierdo JM, 1997, MOL CELL BIOL, V17, P5255, DOI 10.1128/MCB.17.9.5255; IZQUIERDO JM, 1995, J BIOL CHEM, V270, P10342, DOI 10.1074/jbc.270.17.10342; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Lefebvre V, 2013, AUTOPHAGY, V9, P1770, DOI 10.4161/auto.25413; Matic I, 2016, PHARMACOL RES, V103, P56, DOI 10.1016/j.phrs.2015.10.010; Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652; Ortega AD, 2010, J CELL SCI, V123, P2685, DOI 10.1242/jcs.065920; ROUSLIN W, 1989, J BIOL CHEM, V264, P15224; ROUSLIN W, 1993, AM J PHYSIOL, V264, pC209, DOI 10.1152/ajpcell.1993.264.1.C209; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Sanchez-Arago M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.9; Sanchez-Arago M, 2013, EMBO REP, V14, P638, DOI 10.1038/embor.2013.72; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; Santacatterina F, 2016, ONCOTARGET, V7, P490, DOI 10.18632/oncotarget.6357; Shah DI, 2012, NATURE, V491, P608, DOI 10.1038/nature11536; Shen L, 2009, CELL DEATH DIFFER, V16, P603, DOI 10.1038/cdd.2008.184; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Willers IM, 2012, BBA-BIOENERGETICS, V1817, P838, DOI 10.1016/j.bbabio.2012.03.005; Willers IM, 2010, BIOCHEM J, V426, P319, DOI 10.1042/BJ20091570; Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027; Xu J., 2005, CHINA ED TECHNOLOGY; Yang K., 2017, FRONTIERMED, P1, DOI DOI 10.1038/s41598-016-0028-x	44	13	14	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1836	1851		10.1096/fj.201800756R	http://dx.doi.org/10.1096/fj.201800756R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30204502	Bronze			2022-12-26	WOS:000457296600026
J	Fettel, J; Kuhn, B; Guillen, NA; Surun, D; Peters, M; Bauer, R; Angioni, C; Geisslinger, G; Schnutgen, F; zu Heringdorf, DM; Werz, O; Meybohm, P; Zacharowski, K; Steinhilber, D; Roos, J; Maier, TJ				Fettel, Jasmin; Kuehn, Benjamin; Guillen, Nathalie A.; Sueruen, Duran; Peters, Marcus; Bauer, Rebekka; Angioni, Carlo; Geisslinger, Gerd; Schnuetgen, Frank; zu Heringdorf, Dagmar Meyer; Werz, Oliver; Meybohm, Patrick; Zacharowski, Kai; Steinhilber, Dieter; Roos, Jessica; Maier, Thorsten J.			Sphingosine-1-phosphate (S1P) induces potent anti-inflammatory effects in vitro and in vivo by S1P receptor 4-mediated suppression of 5-lipoxygenase activity	FASEB JOURNAL			English	Article						calcium; inactivation of 5-LO; inflammation; leukotriene formation; lipid mediators	SPHINGOSINE 1-PHOSPHATE; EXTRACELLULAR CALCIUM; HUMAN NEUTROPHILS; ARACHIDONIC-ACID; INACTIVATION; ACTIVATION; GENERATION; INHIBITION; TRANSLOCATION; BIOSYNTHESIS	Sphingosine-1-phosphate (S1P) is involved in the regulation of important cellular processes, including immune-cell trafficking and proliferation. Altered S1P signaling is strongly associated with inflammation, cancer progression, and atherosclerosis; however, the mechanisms underlying its pathophysiologic effects are only partially understood. This study evaluated the effects of S1P in vitro and in vivo on the biosynthesis of leukotrienes (LTs), which form a class of lipid mediators involved in the pathogenesis of inflammatory diseases. Here, we report for the first time that S1P potently suppresses LT biosynthesis in Ca2+-ionophore-stimulated intact human neutrophils. S1P treatment resulted in intracellular Ca2+ mobilization, perinuclear translocation, and finally irreversible suicide inactivation of the LT biosynthesis key enzyme 5-lipoxygenase (5-LO). Agonist studies and S1P receptor mRNA expression analysis provided evidence for a S1P receptor 4-mediated effect, which was confirmed by a functional knockout of S1P4 in HL60 cells. Systemic administration of S1P in wild-type mice decreased both macrophage and neutrophil migration in the lungs in response to LPS and significantly attenuated 5-LO product formation, whereas these effects were abrogated in 5-LO or S1P4 knockout mice. In summary, targeting the 5-LO pathway is an important mechanism to explain S1P-mediated pathophysiologic effects. Furthermore, agonism at S1P4 represents a novel effective strategy in pharmacotherapy of inflammation.Fettel, J., Kuhn, B., Guillen, N. A., Surun, D., Peters, M., Bauer, R., Angioni, C., Geisslinger, G., Schnutgen, F., Meyer zu Heringdorf, D., Werz, O., Meybohm, P., Zacharowski, K., Steinhilber, D., Roos, J., Maier, T. J. Sphingosine-1-phosphate (S1P) induces potent anti-inflammatory effects in vitro and in vivo by S1P receptor 4-mediated suppression of 5-lipoxygenase activity.	[Fettel, Jasmin; Kuehn, Benjamin; Guillen, Nathalie A.; Bauer, Rebekka; Steinhilber, Dieter] Goethe Univ, Inst Pharmaceut Chem, Frankfurt, Germany; [Sueruen, Duran; Schnuetgen, Frank] Goethe Univ, Dept Med 2, Hematol Oncol, Frankfurt, Germany; [Meybohm, Patrick; Zacharowski, Kai; Roos, Jessica; Maier, Thorsten J.] Goethe Univ, Dept Anesthesiol Intens Care Med & Pain Therapy, Univ Hosp, Frankfurt, Germany; [Angioni, Carlo; Geisslinger, Gerd] Goethe Univ, Inst Clin Pharmacol, Frankfurt, Germany; [zu Heringdorf, Dagmar Meyer] Goethe Univ, Inst Gen Pharmacol, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Peters, Marcus] Ruhr Univ Bochum, Dept Expt Pneumol, Bochum, Germany; [Werz, Oliver] Friedrich Schiller Univ, Inst Pharm, Dept Pharmaceut Med Chem, Jena, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt; Ruhr University Bochum; Friedrich Schiller University of Jena	Maier, TJ (corresponding author), Univ Hosp Frankfurt, Dept Anesthesiol Intens Care Med & Pain Therapy, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	thorstenjuergen.maier@kgu.de	Bauer, Rebekka/GWV-5012-2022; Heringdorf, Dagmar Meyer zu/A-7705-2018; Schnütgen, Frank/ABD-8637-2020	Heringdorf, Dagmar Meyer zu/0000-0003-1246-9677; Schnütgen, Frank/0000-0002-2426-6685; Zacharowski, Kai/0000-0002-0212-9110; Peters, Marcus/0000-0003-1850-2845	German Research Foundation (DFG) [Sonderforschungsbereich (SFB-1039), Teilprojekt B-01]; Else Kroner-Fresenius-Foundation (EKFS); Graduate School Translational Research Innovation-Pharma (TRIP); DFG [MA-5825/2-1, MA-5825/1-1, SCHN1166/4-1]; Aarhus University Research Foundation (AUFF)	German Research Foundation (DFG)(German Research Foundation (DFG)); Else Kroner-Fresenius-Foundation (EKFS); Graduate School Translational Research Innovation-Pharma (TRIP); DFG(German Research Foundation (DFG)); Aarhus University Research Foundation (AUFF)	The authors thank A. Weigert (Institute of Biochemistry I, Goethe University) for providing S1P4<SUP>-/-</SUP> mice. This work was funded by the German Research Foundation (DFG) Sonderforschungsbereich (SFB-1039, Teilprojekt B-01), the Else Kroner-Fresenius-Foundation (EKFS), and the Graduate School Translational Research Innovation-Pharma (TRIP), the DFG (MA-5825/1-1 and SCHN1166/4-1), and the Aarhus University Research Foundation (AUFF). T.J.M. received support from the Heisenberg Program provided by the DFG (MA-5825/2-1). The authors declare no conflicts of interest.	ABRAMOVITZ M, 1993, EUR J BIOCHEM, V215, P105, DOI 10.1111/j.1432-1033.1993.tb18012.x; AHARONY D, 1986, J BIOL CHEM, V261, P1512; AHARONY D, 1987, PROSTAGLANDINS, V33, P85, DOI 10.1016/0090-6980(87)90307-8; Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brock TG, 1998, BIOCHEM J, V329, P519; BRUNGS M, 1995, P NATL ACAD SCI USA, V92, P107, DOI 10.1073/pnas.92.1.107; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Chen LY, 2008, AM J PHYSIOL-LUNG C, V295, pL326, DOI 10.1152/ajplung.00393.2007; Claas RF, 2010, CELL SIGNAL, V22, P476, DOI 10.1016/j.cellsig.2009.11.001; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; DeCarolis E, 1996, EUR J BIOCHEM, V235, P416; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Gergely P, 2012, BRIT J PHARMACOL, V167, P1035, DOI 10.1111/j.1476-5381.2012.02061.x; Graler MH, 2003, J CELL BIOCHEM, V89, P507, DOI 10.1002/jcb.10537; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hafner AK, 2015, BBA-MOL CELL BIOL L, V1851, P1465, DOI 10.1016/j.bbalip.2015.08.010; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hornig M, 2012, BBA-MOL CELL BIOL L, V1821, P279, DOI 10.1016/j.bbalip.2011.11.001; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Lundqvist H, 1996, J LEUKOCYTE BIOL, V59, P270, DOI 10.1002/jlb.59.2.270; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; MCCOLL SR, 1991, J IMMUNOL, V146, P1204; NOGUCHI M, 1994, BBA-LIPID LIPID MET, V1215, P300, DOI 10.1016/0005-2760(94)90057-4; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; PERCIVAL MD, 1992, EUR J BIOCHEM, V210, P109, DOI 10.1111/j.1432-1033.1992.tb17397.x; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Pettus BJ, 2005, MOL PHARMACOL, V68, P330, DOI 10.1124/mol.104.008722; Pyne NJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00026; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Roos J, 2018, ANTIOXID REDOX SIGN, V28, P1265, DOI 10.1089/ars.2017.7155; Rosengarten M, 2016, EUR J IMMUNOL, V46, P400, DOI 10.1002/eji.201545848; ROUZER CA, 1988, J BIOL CHEM, V263, P10980; Salomone S, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00009; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; SCHATZMUNDING M, 1991, EUR J BIOCHEM, V197, P487, DOI 10.1111/j.1432-1033.1991.tb15936.x; Schulze T, 2011, FASEB J, V25, P4024, DOI 10.1096/fj.10-179028; Skorey KI, 1998, BIOCHEMISTRY-US, V37, P8027, DOI 10.1021/bi980371g; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Song J, 2008, J PHARMACOL EXP THER, V324, P276, DOI 10.1124/jpet.106.119172; STEINHILBER D, 1989, J CHROMATOGR-BIOMED, V493, P361, DOI 10.1016/S0378-4347(00)82742-5; Suomalainen L, 2005, AM J PATHOL, V166, P773, DOI 10.1016/S0002-9440(10)62298-5; Surette ME, 1998, FASEB J, V12, P1521, DOI 10.1096/fasebj.12.14.1521; Takabe K, 2014, J LIPID RES, V55, P1839, DOI 10.1194/jlr.R046656; TATESON JE, 1988, BRIT J PHARMACOL, V94, P528, DOI 10.1111/j.1476-5381.1988.tb11557.x; Urbano M, 2011, BIOORG MED CHEM LETT, V21, P6739, DOI 10.1016/j.bmcl.2011.09.049; Van Brocklyn JR, 2000, BLOOD, V95, P2624; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Volzke A, 2014, BBA-MOL CELL BIOL L, V1841, P11, DOI 10.1016/j.bbalip.2013.09.009; Werz O, 2002, FASEB J, V16, P1441, DOI 10.1096/fj.01-0909fje; Werz O, 2002, BLOOD, V99, P1044, DOI 10.1182/blood.V99.3.1044; Werz Oliver, 2002, Current Drug Targets - Inflammation and Allergy, V1, P23, DOI 10.2174/1568010023344959; WONG A, 1988, BIOCHEMISTRY-US, V27, P6763, DOI 10.1021/bi00418a018; WONG A, 1991, BIOCHEMISTRY-US, V30, P9346, DOI 10.1021/bi00102a030; Yamazaki Y, 2000, BIOCHEM BIOPH RES CO, V268, P583, DOI 10.1006/bbrc.2000.2162; Yatomi Y, 1997, J BIOCHEM, V121, P969	61	23	24	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1711	1726		10.1096/fj.201800221R	http://dx.doi.org/10.1096/fj.201800221R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30188757				2022-12-26	WOS:000457296600017
J	Chen, YX; Chen, XQ; Chen, Y; Wei, H; Lin, S; Tian, HJ; Lin, T; Zhao, JW; Gu, XJ				Chen, Yixin; Chen, Xiuqin; Chen, Yong; Wei, Hui; Lin, Shuo; Tian, Houjun; Lin, Tao; Zhao, Jianwei; Gu, Xiaojun			Preparation, characterisation, and controlled release of sex pheromone-loaded MPEG-PCL diblock copolymer micelles for Spodoptera litura (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							MATING DISRUPTION; DRUG-DELIVERY; COMMUNICATION DISRUPTION; HYDROPHILIC POLYMERS; CROSS-RESISTANCE; NANOPARTICLES; MOTH; MICROCAPSULES; METHOTREXATE; FORMULATIONS	Sex pheromones are important for agricultural pest control. The main sex pheromone components of Spodoptera litura are (Z, E)-9,11- and (Z, E)-9,12-tetradecadienyl acetate (Z9, E11-14: Ac; Z9, E12-14: Ac). In this study, we investigated the optimal conditions for encapsulation of S. litura sex pheromonesin micelles via the self-assembly method using monomethoxy poly (ethylene glycol)-poly (e-caprolactone) (MPEG-PCL) as a biodegradable wallforming material with low toxicity. In the L-9(3(4)) orthogonal experiment, 3 amphiphilic block copolymers, with different hydrophilicity to hydrophobicity ratios, were examined. Optimal encapsulation conditions included stirring of MPEG(5000)-PCL2000 at 1000 rpm at 30 degrees C with 2.5: 1 wall-forming: core material mass ratio. S. litura sex pheromone-loaded MPEG(5000)-PCL2000 micelles presented a homogeneous spherical morphology with apparent core-shell structure. The release kinetics of optimized MPEG(5000)-PCL2000 micelles was best explained by a first-order model. Encapsulated Z(9), E11-14: Ac and Z(9), E12-14: Ac were released slowly, not suddenly. Methyl oleate (MO) was used as an agent to control micellar release performance. When MO content equalled block content, micelle half-life could be prolonged, thereby controlling the release speed. Overall, our results showed MPEG-PCL as a promising controlled-release substrate for sex pheromones.	[Chen, Yixin; Chen, Xiuqin; Chen, Yong; Wei, Hui; Lin, Shuo; Tian, Houjun; Lin, Tao; Zhao, Jianwei] Fujian Acad Agr Sci, Inst Plant Protect, Fuzhou, Fujian, Peoples R China; [Chen, Yixin; Chen, Xiuqin; Chen, Yong; Wei, Hui; Lin, Shuo; Tian, Houjun; Lin, Tao; Zhao, Jianwei] Fujian Key Lab Monitoring & Integrated Management, Fuzhou, Fujian, Peoples R China; [Chen, Yixin; Chen, Xiuqin; Chen, Yong; Wei, Hui; Lin, Shuo; Tian, Houjun; Lin, Tao; Zhao, Jianwei] Minist Agr, Fuzhou Sci Observing & Expt Stn Crop Pests, Fuzhou, Fujian, Peoples R China; [Chen, Yixin] Fujian Agr & Forestry Univ, Key Lab Green Control Insect Pests, Fuzhou, Fujian, Peoples R China; [Gu, Xiaojun] Fujian Agr & Forestry Univ, Coll Plant Protect, Fuzhou, Fujian, Peoples R China	Fujian Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Wei, H (corresponding author), Fujian Acad Agr Sci, Inst Plant Protect, Fuzhou, Fujian, Peoples R China.; Wei, H (corresponding author), Fujian Key Lab Monitoring & Integrated Management, Fuzhou, Fujian, Peoples R China.; Wei, H (corresponding author), Minist Agr, Fuzhou Sci Observing & Expt Stn Crop Pests, Fuzhou, Fujian, Peoples R China.	weihui@faas.cn		WEI, HUI/0000-0003-4110-2698	Natural Science Foundation of Fujian Province [2015J01116, 2015J05061, 2016J01140]; Basic R&D Special Fund Business of Fujian Province [2014R1024-7, 2016R1023-5]; Fujian Science and Technology Agency of China [2017NZ003-1-4]; Fujian Academy of Agricultural Sciences [STIT2017-1-8, AC2017-6, YC2017-10]	Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Basic R&D Special Fund Business of Fujian Province; Fujian Science and Technology Agency of China; Fujian Academy of Agricultural Sciences	This research was funded in part by the Natural Science Foundation of Fujian Province (2015J01116, 2015J05061, 2016J01140), Basic R&D Special Fund Business of Fujian Province (2014R1024-7, 2016R1023-5), Fujian Science and Technology Agency of China (2017NZ003-1-4), Fujian Academy of Agricultural Sciences (STIT2017-1-8, AC2017-6, YC2017-10).	Abbas N, 2014, CROP PROT, V58, P49, DOI 10.1016/j.cropro.2014.01.002; Abdelbary A, 2010, AAPS PHARMSCITECH, V11, P1058, DOI 10.1208/s12249-010-9468-y; Alami-Milani M, 2017, ADV PHARM BULL, V7, P11, DOI 10.15171/apb.2017.003; Andreani T, 2015, CURR PHARM DESIGN, V21, P3090, DOI 10.2174/1381612821666150531163617; Armes NJ, 1997, PESTIC SCI, V50, P240, DOI 10.1002/(SICI)1096-9063(199707)50:3&lt;240::AID-PS579&gt;3.0.CO;2-9; Athanassiou CG, 2004, J ECON ENTOMOL, V97, P321, DOI 10.1603/0022-0493-97.2.321; Bromberg L, 2008, J CONTROL RELEASE, V128, P99, DOI 10.1016/j.jconrel.2008.01.018; CARDE RT, 1995, ANNU REV ENTOMOL, V40, P559, DOI 10.1146/annurev.en.40.010195.003015; Chang TMS, 1997, ARTIF CELL BLOOD SUB, V25, P1, DOI 10.3109/10731199709118893; Chen ZL, 2007, CHINESE SCI BULL, V52, P1365, DOI 10.1007/s11434-007-0209-x; Cocco A, 2013, J APPL ENTOMOL, V137, P16, DOI 10.1111/j.1439-0418.2012.01735.x; Cork A, 2008, CROP PROT, V27, P248, DOI 10.1016/j.cropro.2007.05.011; Danafar H, 2016, DRUG RES, V66, P506, DOI 10.1055/s-0042-109865; Danafar H, 2017, PHARM DEV TECHNOL, V22, P642, DOI 10.3109/10837450.2016.1146296; Danafar H, 2017, DRUG DEV IND PHARM, V43, P1908, DOI 10.1080/03639045.2017.1355922; Danafar H, 2014, ADV PHARM BULL, V4, P501, DOI 10.5681/apb.2014.074; Gharebaghi F, 2017, J BIOMATER APPL, V31, P1305, DOI 10.1177/0885328217698063; Gordon D, 2005, J ECON ENTOMOL, V98, P135, DOI 10.1603/0022-0493-98.1.135; Hegde M. G., 2016, Journal of Experimental Zoology India, V19, P1173; HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210; Hixson AW, 1931, IND ENG CHEM, V23, P1160, DOI 10.1021/ie50262a025; KITAMURA C, 1985, APPL ENTOMOL ZOOL, V20, P222, DOI 10.1303/aez.20.222; KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9; Krober H, 2005, CHEM ENG PROCESS, V44, P215, DOI 10.1016/j.cep.2004.02.014; [李庆燕 Li Qingyan], 2012, [中国生物防治学报, Chinese Journal of Biological Control], V28, P589; Light DM, 2010, J AGR FOOD CHEM, V58, P7838, DOI 10.1021/jf101167p; Lu HJ, 2006, ACTA CHIM SINICA, V64, P2437; Manjili H. R. K., 2016, Pharmaceutical Sciences, V22, P234, DOI 10.15171/PS.2016.37; Manjili HK, 2018, ARTIF CELL NANOMED B, V46, P926, DOI 10.1080/21691401.2017.1347880; Noyes A.A., 1897, J AM CHEM SOC, V19, P930, DOI [DOI 10.1021/JA02086A003, 10.1021/ja02086a003]; Patra D, 2010, CHEM-ASIAN J, V5, P2442, DOI 10.1002/asia.201000301; Punithavalli M, 2014, PHYTOPARASITICA, V42, P213, DOI 10.1007/s12600-013-0354-5; Rafiq, 2013, ASIAN J AGR BIOL, V1, P23; Ragaei M., 2014, INT J SCI ENV TECHNO, V3, P528; Rostamizadeh K, 2018, NEW J CHEM, V42, P5937, DOI 10.1039/c7nj04864e; Shad SA, 2010, PEST MANAG SCI, V66, P839, DOI 10.1002/ps.1950; Shih C. J., 1995, Plant Protection Bulletin (Taichung), V37, P311; Shulkin A, 2002, J MEMBRANE SCI, V209, P421, DOI 10.1016/S0376-7388(02)00348-4; Srinivas K., 1999, Journal of Entomological Research (New Delhi), V23, P115; Stadler T., 2018, INSECTICIDES AGR TOX, P83, DOI DOI 10.5772/INTECHOPEN.72448; Stelinski LL, 2007, J ECON ENTOMOL, V100, P1360, DOI 10.1603/0022-0493(2007)100[1360:SMSPFF]2.0.CO;2; Su JY, 2012, CROP PROT, V42, P217, DOI 10.1016/j.cropro.2012.06.012; TAMAKI Y, 1974, J INSECT PHYSIOL, V20, P1005, DOI 10.1016/0022-1910(74)90142-5; TAMAKI Y, 1973, Applied Entomology and Zoology, V8, P200; Tomaszewska E, 2005, J AGR FOOD CHEM, V53, P2399, DOI 10.1021/jf048163k; Wei HY, 2004, J CHEM ECOL, V30, P1457, DOI 10.1023/B:JOEC.0000037751.86203.10; Wei XW, 2009, INT J PHARMACEUT, V369, P170, DOI 10.1016/j.ijpharm.2008.10.027; Wins-Purdy AH, 2008, J CHEM ECOL, V34, P1096, DOI 10.1007/s10886-008-9500-9; Zamani M, 2018, EUR POLYM J, V103, P260, DOI 10.1016/j.eurpolymj.2018.04.020	49	4	6	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203062	10.1371/journal.pone.0203062	http://dx.doi.org/10.1371/journal.pone.0203062			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192792	gold, Green Submitted, Green Published			2022-12-26	WOS:000444093600044
J	Maarouf, CL; Walker, JE; Sue, LI; Dugger, BN; Beach, TG; Serrano, GE				Maarouf, Chera L.; Walker, Jessica E.; Sue, Lucia I.; Dugger, Brittany N.; Beach, Thomas G.; Serrano, Geidy E.			Impaired hepatic amyloid-beta degradation in Alzheimer's disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; NEUROPATHOLOGIC ASSESSMENT; NATIONAL INSTITUTE; BRAIN; ASSOCIATION	Extensive research strongly suggests that amyloid beta (A beta) aggregates in the brain have a central role in Alzheimer's disease (AD) pathogenesis. Pathological A beta deposition is likely due to an altered balance between overproduction and elimination. Rodent studies have suggested that the liver has a major role in A beta degradation. It is possible alterations of liver function could affect brain A beta levels through changes in blood A beta concentration. In this study, we hypothesized hepatic A beta degradation to be impaired in AD subjects. To test our hypothesis, an A beta degradation assay was developed using synthetic fluorescein-labeled A beta 40 and A beta 42 spiked into human liver homogenates. A beta degradation rates were lower in AD-derived homogenates as compared with those from non-demented (ND) control subjects, even after accounting for such covariates as age, sex, and APOE genotype. The protein expression of potential A beta-degrading enzymes were also examined. Neprilysin levels were not different in AD liver samples, while cathepsin D and insulin-degrading enzyme were significantly altered in AD subjects. The results support the possibility that impaired hepatic A beta degradation could be a factor contributing to increased brain A beta accumulation and AD.	[Maarouf, Chera L.; Walker, Jessica E.; Sue, Lucia I.; Beach, Thomas G.; Serrano, Geidy E.] Banner Sun Hlth Res Inst, Sun City, AZ 85351 USA; [Dugger, Brittany N.] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Sacramento, CA 95817 USA	Banner Research; Banner Health; Banner Sun Health Research Institute; University of California System; University of California Davis	Serrano, GE (corresponding author), Banner Sun Hlth Res Inst, Sun City, AZ 85351 USA.	Geidy.Serrano@bannerhealth.com		Serrano, Geidy/0000-0002-9527-2011	National Institute on Aging (Arizona Alzheimer's Disease Core Center) [P30 AG19610]; Arizona Department of Health Services (Arizona Alzheimer's Research Center) [211002]; Arizona Biomedical Research Commission [ADHS14-082999, 4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research	National Institute on Aging (Arizona Alzheimer's Disease Core Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services (Arizona Alzheimer's Research Center); Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research	This work was supported by the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center to TGB), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center to TGB), the Arizona Biomedical Research Commission (contracts ADHS14-082999 to GS, 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; Beach TG, 2008, ACTA NEUROPATHOL, V116, P277, DOI 10.1007/s00401-008-0409-8; Beach TG, 2015, NEUROPATHOLOGY, V35, P354, DOI 10.1111/neup.12189; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; GALLYAS F, 1971, ACTA MORPHOL HUNG, V19, P1; GALLYAS F, 1981, ACTA MORPHOL HUNG, V29, P185; Ghiso J, 2004, J BIOL CHEM, V279, P45897, DOI 10.1074/jbc.M407668200; Hersh LB, 2006, CELL MOL LIFE SCI, V63, P2432, DOI 10.1007/s00018-006-6238-9; Hersh LB, 2008, CURR ALZHEIMER RES, V5, P225, DOI 10.2174/156720508783954703; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Kawaguchi K, 2010, J ARTIF ORGANS, V13, P31, DOI 10.1007/s10047-010-0482-3; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Leissring MA, 2008, J BIOL CHEM, V283, P29645, DOI 10.1074/jbc.R800022200; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Obi K, 2008, EXP NEUROL, V210, P409, DOI 10.1016/j.expneurol.2007.11.019; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Saido T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006379; TANZI RE, 1989, ANN MED, V21, P91, DOI 10.3109/07853898909149191; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; Wiseman FK, 2015, NAT REV NEUROSCI, V16, P564, DOI 10.1038/nrn3983; Xiang Y, 2015, ACTA NEUROPATHOL, V130, P487, DOI 10.1007/s00401-015-1477-1	31	31	32	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203659	10.1371/journal.pone.0203659	http://dx.doi.org/10.1371/journal.pone.0203659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192871	gold, Green Published			2022-12-26	WOS:000444093600129
J	Strauss, E; Tomczak, J; Staniszewski, R; Oszkinis, G				Strauss, Ewa; Tomczak, Jolanta; Staniszewski, Ryszard; Oszkinis, Grzegorz			Associations and interactions between variants in selenoprotein genes, selenoprotein levels and the development of abdominal aortic aneurysm, peripheral arterial disease, and heart failure	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; GLUTATHIONE-PEROXIDASE 4; MICRONUTRIENT SUPPLEMENTATION; 3'-UNTRANSLATED REGION; ISCHEMIC-STROKE; SELENIUM STATUS; GLUTATHIONE-PEROXIDASE-4; STRESS; BLOOD; MANAGEMENT	Background Little is known on the role of selenoprotein genes in cardiovascular disease. This study examines the associations of the SEPP1, SELENOS, TXNRD1, TXNRD2, GPX4, and SOD2 polymorphisms and selenoprotein P (SeP) and thioredoxin concentrations with the development of abdominal aortic aneurysm (AAA) and aortoiliac occlusive disease (AOID), as well as their influence on cardiac phenotype. Methods 564 patients with AAA, 400 patients with AIOD, and 543 controls were enrolled and characterized for coronary artery disease, myocardial infarction, and systolic heart failure (HF) occurrence. In AAA, the coexistence of peripheral arterial disease (PAD) was examined. Genotypes were determined using TaqMan-based assays. Selenoprotein concentration was assessed using the ELISA method. Results The SELENOS rs34713741T, SEPP1 rs3877899A, and GPX4 rs713041T alleles were related to a 30-60% increase in the AIOD/PAD risk in the recessive or dominant model (all associations at P<.05). The SEPP1 rs3877899A allele was a protective factor for the development of AAA without concomitant PAD (OR = 0.68 for the dominant model, P=.014), but not AAA with concomitant PAD. The cumulative two-locus effects of selenoprotein genes on the AAA/AIOD risk were observed, including the multiplicative interaction between the SELENOS rs34713741T and GPX4 rs713041T alleles (both in the recessive model) affecting the AIOD risk (OR = 5.27, P=.001) and its clinical phenotype. Coexistence of HF in aortic diseases was related to both the SEPP1 rs7579A allele (OR = 1.83 for carriers, P=.013) and increased SeP concentrations; SeP level >8.5 mg/mL caused a 3.5-fold increase in the risk of HF. In AAA, SeP levels were correlated with BMI (r=-0.575, P<.0001). Conclusions Our results provide evidence that selenoprotein polymorphisms constitute a risk factor for HF and peripheral atherosclerosis, but prevent the development of AAA. Excessive weight might result in reduced antioxidant reserve efficiency in AAA. Validation studies are required to establish whether SeP concentration may be a marker for HF.	[Strauss, Ewa] Polish Acad Sci, Inst Human Genet, Poznan, Poland; [Strauss, Ewa; Tomczak, Jolanta; Oszkinis, Grzegorz] Poznan Univ Med Sci, Dept Gen & Vasc Surg, Poznan, Poland; [Staniszewski, Ryszard] Poznan Univ Med Sci, Dept Vasc & Endovasc Surg Angiol & Phlebol, Poznan, Poland	Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences	Strauss, E (corresponding author), Polish Acad Sci, Inst Human Genet, Poznan, Poland.; Strauss, E (corresponding author), Poznan Univ Med Sci, Dept Gen & Vasc Surg, Poznan, Poland.	strauss@man.poznan.pl	Strauss, Ewa/GMX-4857-2022; Strauss, Ewa/C-1689-2013	Tomczak, Jolanta/0000-0003-0482-1351; Oszkinis, Grzegorz/0000-0001-5238-4489; Strauss, Ewa/0000-0001-8275-3126	National Science Centre in Poland [NN403250440]; Poznan University of Medical Sciences [502-14-02214335-10268, 502-01-02214335-05962]; Camillo Di Croce award	National Science Centre in Poland(National Science Centre, Poland); Poznan University of Medical Sciences; Camillo Di Croce award	The work has been supported by the National Science Centre in Poland under grant no. NN403250440 (RS, ES) and the Poznan University of Medical Sciences under grant nos. 502-14-02214335-10268 (JT, ES) and 502-01-02214335-05962 (GO, ES). The Camillo Di Croce award for the best presentation on familial and/or genetic aspects of aneurysms during the 4th International Meeting on Aortic Diseases in Belgium (awarded to ES).; The work has been supported by the National Science Centre in Poland under grant no. NN403250440 (RS, ES) and the Poznan University of Medical Sciences under grant nos. 502-14-02214335-10268 (JT, ES) and 502-01-02214335-05962 (GO, ES). The Camillo Di Croce award for the best presentation on familial and/or genetic aspects of aneurysms during the 4th International Meeting on Aortic Diseases in Belgium (awarded to ES).	Alanne M, 2007, HUM GENET, V122, P355, DOI 10.1007/s00439-007-0402-7; Alehagen U, 2016, EUR J CLIN NUTR, V70, P91, DOI 10.1038/ejcn.2015.92; Anderson JL, 2013, CIRCULATION, V127, P1425, DOI 10.1161/CIR.0b013e31828b82aa; Arslan C, 2010, INT ANGIOL, V29, P489; Batariova A, 2005, SCI TOTAL ENVIRON, V338, P183, DOI 10.1016/j.scitotenv.2004.06.024; Bath MF, 2017, EUR J VASC ENDOVASC, V53, P255, DOI 10.1016/j.ejvs.2016.10.013; Bermano G, 2007, GENES NUTR, V2, P225, DOI 10.1007/s12263-007-0052-3; Brocheriou I, 2011, ATHEROSCLEROSIS, V214, P316, DOI 10.1016/j.atherosclerosis.2010.11.023; BURK RF, 1994, J NUTR, V124, P1891, DOI 10.1093/jn/124.10.1891; Cooper ML, 2008, CANCER RES, V68, P10171, DOI 10.1158/0008-5472.CAN-08-1827; Cox AJ, 2013, ACTA DIABETOL, V50, P391, DOI 10.1007/s00592-012-0440-z; Cox DG, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-217; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Crosley LK, 2013, MOL NUTR FOOD RES, V57, P2185, DOI 10.1002/mnfr.201300216; Curran JE, 2005, NAT GENET, V37, P1234, DOI 10.1038/ng1655; de Lorgeril M, 2001, EUR J HEART FAIL, V3, P661, DOI 10.1016/S1388-9842(01)00179-9; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Du XH, 2012, BRIT J NUTR, V107, P164, DOI 10.1017/S0007114511002704; Egorova N, 2009, J VASC SURG, V50, P1271, DOI 10.1016/j.jvs.2009.06.061; Ellingsen DG, 2009, J TRACE ELEM MED BIO, V23, P107, DOI 10.1016/j.jtemb.2009.01.004; Ge Keyou, 1993, American Journal of Clinical Nutrition, V57, p259S, DOI 10.1093/ajcn/57.2.259S; Giles KA, 2009, J VASC SURG, V50, P256, DOI 10.1016/j.jvs.2009.01.044; Harrison SC, 2011, ATHEROSCLEROSIS, V217, P47, DOI 10.1016/j.atherosclerosis.2011.02.045; Hellwege JN, 2014, GENE, V534, P33, DOI 10.1016/j.gene.2013.10.035; Ishikura K, 2014, DIABETOLOGIA, V57, P1968, DOI 10.1007/s00125-014-3306-9; Jekell A, 2004, EUR J HEART FAIL, V6, P883, DOI 10.1016/j.ejheart.2004.03.003; Joseph J, 2013, NUTRIENTS, V5, P340, DOI 10.3390/nu5020340; Kashyap VS, 2008, J VASC SURG, V48, P1451, DOI 10.1016/j.jvs.2008.07.004; Klapcinska B, 2005, BIOL TRACE ELEM RES, V108, P1, DOI 10.1385/BTER:108:1-3:001; Kurokawa S, 2014, J BIOL CHEM, V289, P9195, DOI 10.1074/jbc.M114.549014; Li XX, 2015, BLOOD COAGUL FIBRIN, V26, P131, DOI 10.1097/MBC.0000000000000202; LLOYD B, 1983, J EPIDEMIOL COMMUN H, V37, P213, DOI 10.1136/jech.37.3.213; McKeag NA, 2014, JACC-HEART FAIL, V2, P308, DOI 10.1016/j.jchf.2013.12.008; Meplan C, 2008, AM J CLIN NUTR, V87, P1019, DOI 10.1093/ajcn/87.4.1019; Meplan C, 2007, FASEB J, V21, P3063, DOI 10.1096/fj.07-8166com; Meplan C, 2010, CARCINOGENESIS, V31, P1074, DOI 10.1093/carcin/bgq076; Mocchegiani E, 2014, MECH AGEING DEV, V136, P29, DOI 10.1016/j.mad.2013.12.007; Olsson M, 2011, METABOLISM, V60, P114, DOI 10.1016/j.metabol.2010.05.011; Polonikov AV, 2012, HYPERTENS RES, V35, P507, DOI 10.1038/hr.2011.213; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ruperez AI, 2014, J NUTRIGENET NUTRIGE, V7, P130, DOI 10.1159/000368833; Slattery ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037312; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Socha K, 2011, VASA, V40, P381, DOI 10.1024/0301-1526/a000135; Strauss E, 2014, SCI REP-UK, V4, DOI 10.1038/srep07061; TAKAHASHI K, 1986, J CLIN INVEST, V77, P1402, DOI 10.1172/JCI112449; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Villette S, 2002, BLOOD CELL MOL DIS, V29, P174, DOI 10.1006/bcmd.2002.0556; Witte KKA, 2005, EUR HEART J, V26, P2238, DOI 10.1093/eurheartj/ehi442; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhou ZX, 2000, J HISTOCHEM CYTOCHEM, V48, P585, DOI 10.1177/002215540004800502	51	14	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203350	10.1371/journal.pone.0203350	http://dx.doi.org/10.1371/journal.pone.0203350			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188935	Green Published, Green Submitted, gold			2022-12-26	WOS:000444228700026
J	Tasca, A; Astleford, K; Blixt, NC; Jensen, ED; Gopalakrishnan, R; Mansky, KC				Tasca, Amy; Astleford, Kristina; Blixt, Nicholas C.; Jensen, Eric D.; Gopalakrishnan, Rajaram; Mansky, Kim C.			SMAD1/5 signaling in osteoclasts regulates bone formation via coupling factors	PLOS ONE			English	Article							CONDITIONAL KNOCKOUT; DIFFERENTIATION; MICE; EXPRESSION; PATHWAYS; SURVIVAL; BMPR1A; MOUSE; GENE	Bone remodeling occurs via coupling between bone resorption by osteoclasts and bone formation by osteoblasts. The mechanisms that regulate osteoclast signals to osteoblasts are not well understood. Published studies have reported that BMP signaling in osteoclasts regulate osteoclast coupling targets. To investigate the necessity of canonical BMP signaling on osteoclast differentiation and coupling, we mated Smad1(fl/fl); Smad5(fl/fl) mice to c-Fms-Cre mice. We analyzed male mice at 3 months of age to determine the skeletal phenotype of the Smad1(fl/fl); Smad5(fl/fl);c-Fms-Cre (SMAD1/5 cKO) mice. There was a 1.2-fold decrease in trabecular BV/TV in SMAD1/5 cKO. Analyses of osteoclast serum markers in SMAD1/5 cKO mice, showed a significant increase in CTX-1 (1.5 fold) and TRAP ELISA (3 fold) compared to control mice. In these same mice, there was a 1.3-fold increase in cortical thickness. Consistent with the increase in cortical thickness, we found a 3-fold increase in osteoblast activity as measured by P1NIP ELISA assay from SMAD1/5 cKO mice. To explain the changes in cortical thickness and P1NP activity, we determined conditioned media from SMAD1/5 cKO osteoclast cultures enhanced mineralization of an osteoblast cell line and coupling factors expressed by osteoclasts that regulate osteoblast activity Wnt1 (4.5-fold increase), Gja1 (3-fold increase) and Sphk1 (1.5-fold increase) were all upregulated in osteoclasts from SMAD1/5 cKO compared to control osteoclasts. Lastly osteoclasts treated with dorso-morphin, a chemical inhibitor of SMAD1/5 signaling, demonstrates an increase in Wnt1 and Gja1 expression similar to the SMAD1/5 cKO mice. Previous studies demonstrated that TGF-beta signaling in osteoclasts leads to increases in WNT1 expression by osteoclasts. Therefore, our data suggest that TGF-beta and BMP signaling pathways in osteoclasts could act in an antagonistic fashion to regulate osteoblast activity through WNT1 and other coupling factors.	[Tasca, Amy; Jensen, Eric D.; Gopalakrishnan, Rajaram] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN USA; [Astleford, Kristina; Mansky, Kim C.] Univ Minnesota, Dept Dev & Surg Sci, Div Orthodont, Minneapolis, MN 55455 USA; [Blixt, Nicholas C.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Mansky, KC (corresponding author), Univ Minnesota, Dept Dev & Surg Sci, Div Orthodont, Minneapolis, MN 55455 USA.	kmansky@umn.edu		Mansky, Kim/0000-0002-2826-5030	National Institutes of Health [AR056642, NIH AR061352, 2T32AR050938, NIH DE024679]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	PThis project was supported by grants from National Institutes of Health (AR056642 (RG), NIH AR061352 (KM and E J), 2T32AR050938 to NCB and NIH DE024679 (AT)).	Broege A, 2013, J BIOL CHEM, V288, P37230, DOI 10.1074/jbc.M113.496950; Chiu WSM, 2004, GENESIS, V39, P178, DOI 10.1002/gene.20041; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Huang SX, 2002, GENESIS, V32, P76, DOI 10.1002/gene.10059; Itoh K, 2001, ENDOCRINOLOGY, V142, P3656, DOI 10.1210/en.142.8.3656; Jensen ED, 2010, J CELL BIOCHEM, V109, P672, DOI 10.1002/jcb.22462; Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Okamoto M, 2011, J BONE MINER RES, V26, P2511, DOI 10.1002/jbmr.477; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Pham L, 2010, J CELL BIOCHEM, V112, P793; Rahman MS, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.5; Rodriguez JES, 2009, J BONE MINER RES, V24, P1917, DOI [10.1359/jbmr.090507, 10.1359/JBMR.090507]; Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430; Shi C, 2017, J CELL BIOCHEM, V118, P605, DOI 10.1002/jcb.25746; Tasca A, 2015, J CELL BIOCHEM, V116, P1350, DOI 10.1002/jcb.25092; Umans L, 2003, GENESIS, V37, P5, DOI 10.1002/gene.10219; Weivoda MM, 2016, J BONE MINER RES, V31, P76, DOI 10.1002/jbmr.2586; Xu C, 2005, GENE, V357, P1, DOI 10.1016/j.gene.2005.06.017	21	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203404	10.1371/journal.pone.0203404	http://dx.doi.org/10.1371/journal.pone.0203404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188920	Green Published, gold, Green Submitted			2022-12-26	WOS:000444228700032
J	Fine, JD; Shpigler, HY; Ray, AM; Beach, NJ; Sankey, AL; Cash-Ahmed, A; Huang, ZY; Astrauskaite, I; Chao, R; Zhao, HM; Robinson, GE				Fine, Julia D.; Shpigler, Hagai Y.; Ray, Allyson M.; Beach, Nathanael J.; Sankey, Alison L.; Cash-Ahmed, Amy; Huang, Zachary Y.; Astrauskaite, Ieva; Chao, Ran; Zhao, Huimin; Robinson, Gene E.			Quantifying the effects of pollen nutrition on honey bee queen egg laying with a new laboratory system	PLOS ONE			English	Article							DIVISION-OF-LABOR; APIS-MELLIFERA L.; WORKER HONEYBEES; JUVENILE-HORMONE; HYPOPHARYNGEAL GLANDS; SEASONAL-CHANGES; UNITED-STATES; COLONIES; BROOD; BEHAVIOR	Honey bee populations have been declining precipitously over the past decade, and multiple causative factors have been identified. Recent research indicates that these frequently co-occurring stressors interact, often in unpredictable ways, therefore it has become important to develop robust methods to assess their effects both in isolation and in combination. Most such efforts focus on honey bee workers, but the state of a colony also depends on the health and productivity of its queen. However, it is much more difficult to quantify the performance of queens relative to workers in the field, and there are no laboratory assays for queen performance. Here, we present a new system to monitor honey bee queen egg laying under laboratory conditions and report the results of experiments showing the effects of pollen nutrition on egg laying. These findings suggest that queen egg laying and worker physiology can be manipulated in this system through pollen nutrition, which is consistent with findings from field colonies. The results generated using this controlled, laboratory-based system suggest that worker physiology controls queen egg laying behavior. Additionally, the quantitative data generated in these experiments highlight the utility of the system for further use as a risk assessment tool.	[Fine, Julia D.; Shpigler, Hagai Y.; Ray, Allyson M.; Beach, Nathanael J.; Sankey, Alison L.; Cash-Ahmed, Amy; Astrauskaite, Ieva; Chao, Ran; Zhao, Huimin; Robinson, Gene E.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Chao, Ran; Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL USA; [Chao, Ran] LifeFoundry Inc, Champaign, IL USA; [Robinson, Gene E.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Robinson, Gene E.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Ray, Allyson M.] Penn State Univ, Dept Entomol, Ctr Pollinator Res, Huck Inst Life Sci, University Pk, PA 16802 USA	University of Illinois System; University of Illinois Urbana-Champaign; Michigan State University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Robinson, GE (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.; Robinson, GE (corresponding author), Univ Illinois, Neurosci Program, Urbana, IL 61801 USA.; Robinson, GE (corresponding author), Univ Illinois, Dept Entomol, Urbana, IL 61801 USA.	generobi@illinois.edu	Huang, Zachary/D-5485-2011; Ray, Allyson/HGU-5430-2022	Huang, Zachary/0000-0001-5354-5547; Beach, Nathanael/0000-0002-7086-2760; Fine, Julia/0000-0002-4461-1802; Ray, Allyson/0000-0002-9354-4247; Zhao, Huimin/0000-0002-9069-6739	Defense Advanced Research Projects Agency [HR0011-16-2-0019]; LifeFoundry Inc.	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); LifeFoundry Inc.	This project was supported by a grant from the Defense Advanced Research Projects Agency # HR0011-16-2-0019 to Gene E. Robinson and Huimin Zhao. LifeFoundry Inc. provided support in the form of a salary for author Ran Chao, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Aase ALTO, 2005, APIDOLOGIE, V36, P293, DOI 10.1051/apido:2005003; Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Al-Ghamdi AA, 2011, SAUDI J BIOL SCI, V18, P73, DOI 10.1016/j.sjbs.2010.10.001; ALLEN M. DELLA, 1960, ANIMAL BEHAVIOUR, V8, P201, DOI 10.1016/0003-3472(60)90028-2; Alqarni A. S., 2006, Journal of Biological Sciences, V6, P734; Butler C.G., 1973, Journal apic Res, V12, P159; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Carroll MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175933; Cavigli I, 2016, APIDOLOGIE, V47, P251, DOI 10.1007/s13592-015-0395-5; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; CRAILSHEIM K, 1992, J COMP PHYSIOL B, V162, P681, DOI 10.1007/BF00301617; CRAILSHEIM K, 1989, J INSECT PHYSIOL, V35, P595, DOI 10.1016/0022-1910(89)90121-2; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; de GROOT A. P., 1953, PHYSIOL COMPARATA ET OECOL, V3, P197; DeGrandi-Hoffman G, 2008, J APICULT RES, V47, P265, DOI 10.3896/IBRA.1.47.4.06; DeGrandi-Hoffman G, 2018, J INSECT PHYSIOL, V109, P114, DOI 10.1016/j.jinsphys.2018.07.002; DEGRANDIHOFFMAN G, 1993, J APICULT RES, V32, P19, DOI 10.1080/00218839.1993.11101283; Di Pasquale G., 2013, PLOS ONE, V8, DOI DOI 10.1371/journal.pone.0072016; DIETZ A, 1980, APIDOLOGIE, V11, P143, DOI 10.1051/apido:19800204; Dively GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118748; Donkersley P, 2014, ECOL EVOL, V4, P4195, DOI 10.1002/ece3.1293; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dunham WE, 1930, OHIO J SCI, V30; Dussutour A, 2008, INSECT SOC, V55, P329, DOI 10.1007/s00040-008-1008-3; EISHCHEN FA, 1982, J APICULT RES, V21, P19, DOI 10.1080/00218839.1982.11100511; ENGELS W, 1974, AM ZOOL, V14, P1229; Fine JD, 2017, J ECON ENTOMOL, V110, P1993, DOI 10.1093/jee/tox220; FLURI P, 1977, EXPERIENTIA, V33, P1240, DOI 10.1007/BF01922354; Francis RM, 2013, J GEN VIROL, V94, P668, DOI 10.1099/vir.0.047019-0; Free J. B., 1961, Proceedings of the Royal Entomological Society of London, V36, P5; Fujiyuki T, 2004, J VIROL, V78, P1093, DOI 10.1128/JVI.78.3.1093-1100.2004; GIRAY T, 1994, BEHAV ECOL SOCIOBIOL, V35, P13, DOI 10.1007/BF00167054; Goblirsch M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058165, 10.1371/journal.pone.0069831]; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; HARRIS JW, 1992, J INSECT PHYSIOL, V38, P29, DOI 10.1016/0022-1910(92)90019-A; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; HERBERT EW, 1978, APIDOLOGIE, V9, P33, DOI 10.1051/apido:19780103; Holldobler B., 2009, SUPERORGANISM; Hrassnigg N, 1998, J INSECT PHYSIOL, V44, P929, DOI 10.1016/S0022-1910(98)00058-4; Huang ZY, 2004, J ECON ENTOMOL, V97, P1517, DOI 10.1603/0022-0493-97.5.1517; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; HUANG ZY, 1995, J COMP PHYSIOL B, V165, P18, DOI 10.1007/BF00264682; Iqbal J, 2007, P R SOC B, V274, P1517, DOI 10.1098/rspb.2007.0022; Kaplan M, 2016, FOOD TECHNOL BIOTECH, V54, P497, DOI [10.17113/ftb.54.04.16.4635, 10.17113/ft b.54.04.16.4635]; Keeling CI, 2003, P NATL ACAD SCI USA, V100, P4486, DOI 10.1073/pnas.0836984100; KUNERT K, 1988, J APICULT RES, V27, P13, DOI 10.1080/00218839.1988.11100775; Li M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00990-3; Mattila HR, 2006, APIDOLOGIE, V37, P533, DOI 10.1051/apido:2006037; Miranda CRE, 2003, J APICULT RES, V42, P35, DOI 10.1080/00218839.2003.11101086; Moore P. A., 2015, HONEY BEE QUEENS EVA; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Navajas M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-301; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; PAGE RE, 1991, ADV INSECT PHYSIOL, V23, P117, DOI 10.1016/S0065-2806(08)60093-4; Pettis JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147220; Piccirillo GA, 2003, GENET MOL RES, V2, P471; Rasband W., 2006, IMAGEJ; Rivero A, 2001, P ROY SOC B-BIOL SCI, V268, P1231, DOI 10.1098/rspb.2001.1645; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; Schulte C, 2014, P NATL ACAD SCI USA, V111, P9003, DOI 10.1073/pnas.1402341111; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; SOUTHWICK EE, 1992, J ECON ENTOMOL, V85, P621, DOI 10.1093/jee/85.3.621; Spivak M, 2011, ENVIRON SCI TECHNOL, V45, P34, DOI 10.1021/es101468w; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Trible W, 2017, CELL, V170, P727, DOI 10.1016/j.cell.2017.07.001; Tsvetkov N, 2017, SCIENCE, V356, P1395, DOI 10.1126/science.aam7470; US EPA O, 2013, WE ASS RISKS POLL; vanEngelsdorp D, 2013, PREV VET MED, V108, P225, DOI 10.1016/j.prevetmed.2012.08.004; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Vasquez A, 2009, J APICULT RES, V48, P189, DOI 10.3896/IBRA.1.48.3.07; Winston M.L., 1991, BIOL HONEY BEE; Woodcock BA, 2017, SCIENCE, V356, P1393, DOI 10.1126/science.aaa1190; Wu-Smart J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32108; Yan H, 2017, CELL, V170, P736, DOI 10.1016/j.cell.2017.06.051; Zaritzky NE, 2010, WOODHEAD PUBL FOOD S, P561, DOI 10.1533/9781845699260.3.561; Zayed A, 2012, ANNU REV GENET, V46, P591, DOI 10.1146/annurev-genet-110711-155517	80	22	22	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203444	10.1371/journal.pone.0203444	http://dx.doi.org/10.1371/journal.pone.0203444			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183759	gold, Green Published, Green Submitted			2022-12-26	WOS:000443789900063
J	Hing, ML; Klanten, OS; Dowton, M; Brown, KR; Wong, MYL				Hing, Martin L.; Klanten, O. Selma; Dowton, Mark; Brown, Kylie R.; Wong, Marian Y. L.			Repeated cyclone events reveal potential causes of sociality in coral-dwelling Gobiodon fishes	PLOS ONE			English	Article							GREAT-BARRIER-REEF; HABITAT PATCH SIZE; ECOLOGICAL CONSTRAINTS; SEX-CHANGE; POPULATION-DYNAMICS; TERRITORY QUALITY; EVOLUTION; PHILOPATRY; BEHAVIOR; HIERARCHIES	Social organization is a key factor influencing a species' foraging and reproduction, which may ultimately affect their survival and ability to recover from catastrophic disturbance. Severe weather events such as cyclones can have devastating impacts to the physical structure of coral reefs and on the abundance and distribution of its faunal communities. Despite the importance of social organization to a species' survival, relatively little is known about how major disturbances such as tropical cyclones may affect social structures or how different social strategies affect a species' ability to cope with disturbance. We sampled group sizes and coral sizes of group-forming and pair-forming species of the Gobiid genus Gobiodon at Lizard Island, Great Barrier Reef, Australia, before and after two successive category 4 tropical cyclones. Group sizes of group-forming species decreased after each cyclone, but showed signs of recovery four months after the first cyclone. A similar increase in group sizes was not evident in group-forming species after the second cyclone. There was no change in mean pair-forming group size after either cyclone. Coral sizes inhabited by both group-and pair-forming species decreased throughout the study, meaning that group-forming species were forced to occupy smaller corals on average than before cyclone activity. This may reduce their capacity to maintain larger group sizes through multiple processes. We discuss these patterns in light of two non-exclusive hypotheses regarding the drivers of sociality in Gobiodon, suggesting that benefits of philopatry with regards to habitat quality may underpin the formation of social groups in this genus.	[Hing, Martin L.; Wong, Marian Y. L.] Univ Wollongong, Sch Biol Sci, Ctr Sustainable Ecosyst Solut, Wollongong, NSW, Australia; [Klanten, O. Selma] Univ Technol Sydney, Sch Life Sci, Fish Ecol Lab, Sydney, NSW, Australia; [Dowton, Mark] Univ Wollongong, Sch Biol Sci, Ctr Med & Mol Biosci, Wollongong, NSW, Australia	University of Wollongong; University of Technology Sydney; University of Wollongong	Hing, ML (corresponding author), Univ Wollongong, Sch Biol Sci, Ctr Sustainable Ecosyst Solut, Wollongong, NSW, Australia.	martinhing@gmail.com	Klanten, Oya S./C-5628-2011; Hing, Martin/X-4567-2019; Wong, Marian YL/H-1871-2013	Klanten, Oya S./0000-0001-6296-4225; Hing, Martin/0000-0001-5385-5473; Wong, Marian/0000-0001-6393-6453	Hermon Slade Foundation [HSF13/8]; Australian Government Research Training Program Scholarship	Hermon Slade Foundation; Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This research has been conducted with the support of the Hermon Slade Foundation (HSF13/8 to M.Y.L.W.) and the Australian Government Research Training Program Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altwegg R, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0141; Ang TZ, 2011, ETHOLOGY, V117, P1111, DOI 10.1111/j.1439-0310.2011.01964.x; Ang TZ, 2010, BEHAV ECOL, V21, P819, DOI 10.1093/beheco/arq062; Aviles L, 2012, ETHOLOGY, V118, P1219, DOI 10.1111/eth.12028; Bourke AFG, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0362; Brandl SJ, 2018, BIOL REV, V93, P1846, DOI 10.1111/brv.12423; Brandl SJ, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1557; Brandl SJ, 2014, OCEANOGR MAR BIOL, V52, P1; BROTHERS EB, 1983, MAR BIOL, V76, P319, DOI 10.1007/BF00393035; BROWN JL, 1974, AM ZOOL, V14, P63; Buston P, 2003, NATURE, V424, P145, DOI 10.1038/424145a; Buston P, 2003, BEHAV ECOL, V14, P576, DOI 10.1093/beheco/arg036; Buston PM, 2007, MOL ECOL, V16, P3671, DOI 10.1111/j.1365-294X.2007.03421.x; Buston PM, 2006, OECOLOGIA, V149, P362, DOI 10.1007/s00442-006-0442-z; Buston PM, 2014, AM SCI, V102, P290, DOI 10.1511/2014.109.290; Buston PM, 2009, MOL ECOL, V18, P4707, DOI 10.1111/j.1365-294X.2009.04383.x; Buston PM, 2004, P ROY SOC B-BIOL SCI, V271, pS252, DOI 10.1098/rsbl.2003.0156; Ceccarelli DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156232; Cheal AJ, 2002, CORAL REEFS, V21, P131, DOI 10.1007/s00338-002-0227-8; Cheal AJ, 2017, GLOBAL CHANGE BIOL, V23, P1511, DOI 10.1111/gcb.13593; Courchamp F, 1999, P ROY SOC B-BIOL SCI, V266, P557, DOI 10.1098/rspb.1999.0672; Duffy JE, 2010, P ROY SOC B-BIOL SCI, V277, P575, DOI 10.1098/rspb.2009.1483; Ebensperger LA, 2001, ACTA THERIOL, V46, P115, DOI 10.1007/BF03192423; EMLEN ST, 1982, AM NAT, V119, P29, DOI 10.1086/283888; Emslie MJ, 2008, MAR ECOL PROG SER, V371, P177, DOI 10.3354/meps07657; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; Ferrari R, 2017, SCI REP, V7, DOI [10.1038/841598-017-16408-z, DOI 10.1038/841598-017-16408-Z]; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; GASTON AJ, 1978, AM NAT, V112, P1091, DOI 10.1086/283348; Gouezo M, 2015, MAR ECOL PROG SER, V540, P73, DOI 10.3354/meps11518; Greenwood AK, 2013, CURR BIOL, V23, P1884, DOI 10.1016/j.cub.2013.07.058; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harmelin-Vivien M.L., 1994, J COASTAL RES, V12, P211, DOI DOI 10.1111/NYAS.13322; Hatchwell BJ, 2000, ANIM BEHAV, V59, P1079, DOI 10.1006/anbe.2000.1394; Heg D, 2004, P ROY SOC B-BIOL SCI, V271, P2367, DOI 10.1098/rspb.2004.2855; Heg D, 2011, BEHAV ECOL, V22, P82, DOI 10.1093/beheco/arq170; Herler J, 2011, BIOL GOBIES, P685; Herler J, 2013, ZOOTAXA, V 3709, P301, DOI 10.11646/zootaxa.3709.4.1; Hing ML, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00100; Hobbs JPA, 2004, MAR ECOL PROG SER, V278, P253, DOI 10.3354/meps278253; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Khan JA, 2017, CORAL REEFS, V36, P1123, DOI 10.1007/s00338-017-1604-7; Killen SS, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0233; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kokko H, 2002, BEHAV ECOL, V13, P291, DOI 10.1093/beheco/13.3.291; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; KOMDEUR J, 1992, NATURE, V358, P493, DOI 10.1038/358493a0; Komyakova V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083178; KUWAMURA T, 1994, MAR ECOL PROG SER, V103, P17, DOI 10.3354/meps103017; Lenth R., EMMEANS ESTIMATED MA; LIRMAN D, 1995, CORAL REEFS, V14, P172; Lucia KE, 2008, BEHAV ECOL, V19, P774, DOI 10.1093/beheco/arn028; Mitchell JS, 2005, CAN J ZOOL, V83, P372, DOI 10.1139/Z05-014; Munday Philip L., 1999, Revue Francaise d'Aquariologie Herpetologie, V26, P53; Munday PL, 2000, ENVIRON BIOL FISH, V58, P355, DOI 10.1023/A:1007689314926; Munday PL, 2004, CURR BIOL, V14, P1498, DOI 10.1016/j.cub.2004.08.029; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Munday PL, 2004, ECOLOGY, V85, P623, DOI 10.1890/03-3100; Munday PL, 1998, BEHAV ECOL SOCIOBIOL, V43, P371, DOI 10.1007/s002650050504; Munday PL, 1997, MAR ECOL PROG SER, V152, P227, DOI 10.3354/meps152227; Munday PL, 2001, OECOLOGIA, V128, P585, DOI 10.1007/s004420100690; Munday PL, 2001, ECOLOGY, V82, P2177, DOI 10.1890/0012-9658(2001)082[2177:ICACIA]2.0.CO;2; Nakashima Y, 1996, ENVIRON BIOL FISH, V46, P281, DOI 10.1007/BF00005004; Nilsson GE, 2004, J EXP BIOL, V207, P33, DOI 10.1242/jeb.00713; Ridley AR, 2012, BEHAVIOUR, V149, P821, DOI 10.1163/1568539X-00003005; Rowley I., 1990, COOPERATIVE BREEDING, P3; Rubenstein DR, 2011, P NATL ACAD SCI USA, V108, P10816, DOI 10.1073/pnas.1100303108; Selander R.K, 1964, SPECIATION WRENS GEN; Skaug H. J., 2014, GEN LINEAR MIXED MOD; STACEY PB, 1991, AM NAT, V137, P831, DOI 10.1086/285196; Taborsky M., 2017, COMP SOCIAL EVOLUTIO; Thompson VJ, 2007, CORAL REEFS, V26, P165, DOI 10.1007/s00338-006-0181-y; Venables WN., 2002, MODERN APPL STAT S 4; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wong MYL, 2008, BEHAV ECOL, V19, P353, DOI 10.1093/beheco/arm141; Wong MYL, 2007, P ROY SOC B-BIOL SCI, V274, P1093, DOI 10.1098/rspb.2006.0284; Wong MYL, 2013, BIOSCIENCE, V63, P453, DOI 10.1525/bio.2013.63.6.7; Wong MYL, 2011, ETHOLOGY, V117, P638, DOI 10.1111/j.1439-0310.2011.01913.x; Wong MYL, 2010, P ROY SOC B-BIOL SCI, V277, P353, DOI 10.1098/rspb.2009.1453; Wong MYL, 2005, ENVIRON BIOL FISH, V74, P141, DOI 10.1007/s10641-005-6715-2; WOOLFENDEN GE, 1975, AUK, V92, P1	82	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202407	10.1371/journal.pone.0202407	http://dx.doi.org/10.1371/journal.pone.0202407			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183723	Green Published, gold, Green Submitted			2022-12-26	WOS:000443789900026
J	Kankondi, SL; McQuaid, CD; Tagliarolo, M				Kankondi, Sebbi L.; McQuaid, Christopher D.; Tagliarolo, Morgana			Influence of respiratory mode on the thermal tolerance of intertidal limpets	PLOS ONE			English	Article							ACCLIMATION-INDUCED VARIATION; SNAILS GENUS TEGULA; CLIMATE-CHANGE; OXYGEN-CONSUMPTION; HEART-RATE; TEMPERATURE RELATIONS; PATELLA-GRANULARIS; CELLANA-TOREUMA; MYTILUS-EDULIS; WAVE EXPOSURE	Predicting ecological responses to climate change requires an understanding of the mechanisms that influence species' tolerances to temperature. Based on the idea that air and water breathing animals are differentially suited to life in either medium due to differences in their respiratory morphology, we examined the possibility that the thermal tolerances of coexisting intertidal pulmonate and patellogastropod limpets may differ in different breathing media. We tested this by determining each species' median lethal temperature (LT50) and cardiac Arrhenius breakpoint temperature (ABT) as measures of upper thermal tolerance limits, in air and water. Although all these species can survive in air and water, we hypothesised that the pulmonate limpets, Siphonaria capensis and S. serrata, would have higher thermal limits than the patellogastropod limpets, Cellana capensis and Scutellastra granularis, in air and vice versa in water. The results did not support our hypotheses, since C. capensis had similar thermal tolerance limits to the pulmonate limpets in air and the pulmonate limpets had thermal tolerance limits similar to or higher than S. granularis in water. Thus, considering pulmonate and patellid limpets as groups, we found no differences in their collective upper thermal tolerance limits in either medium. We conclude that differences between these two limpet groups in their respiratory morphology do not influence thermal tolerance, but that tolerances are species-specific.	[Kankondi, Sebbi L.; McQuaid, Christopher D.; Tagliarolo, Morgana] Rhodes Univ, Dept Zool & Entomol, Grahamstown, Eastern Cape, South Africa; [Tagliarolo, Morgana] IFREMER, UMSR LEEISA, CNRS, UG, Cayenne, France	Rhodes University; Centre National de la Recherche Scientifique (CNRS); Ifremer	Kankondi, SL (corresponding author), Rhodes Univ, Dept Zool & Entomol, Grahamstown, Eastern Cape, South Africa.	ksebbi1989@gmail.com	Tagliarolo, Morgana/H-6303-2019; McQuaid, Christopher/AAT-3725-2020	Tagliarolo, Morgana/0000-0002-9659-4565; McQuaid, Christopher/0000-0002-3473-8308; Kankondi, Sebbi/0000-0002-2511-6590	Rhodes University Research Committee Grant; National Research Foundation of South Africa [64801]	Rhodes University Research Committee Grant; National Research Foundation of South Africa(National Research Foundation - South Africa)	This work is based upon research supported by the Rhodes University Research Committee Grant to Dr Morgana Tagliarolo: https://www.ru.ac.za/staffdevelopment/funding/researchcommitteegrant/; and the National Research Foundation of South Africa (grant number 64801 to SK): http://www.nrf.ac.za/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLANSON B. R., 1958, HYDROBIOLOGIA, V12, P149, DOI 10.1007/BF00034147; Angilletta MJ, 2009, FUNCT ECOL, V23, P231, DOI 10.1111/j.1365-2435.2009.01548.x; Baeza JA, 2002, FUNCT ECOL, V16, P241, DOI 10.1046/j.1365-2435.2002.00616.x; Bates AE, 2011, OECOLOGIA, V167, P613, DOI 10.1007/s00442-011-2014-0; BAYNE BL, 1976, OECOLOGIA, V22, P229, DOI 10.1007/BF00344794; Bjelde BE, 2013, J EXP BIOL, V216, P2858, DOI 10.1242/jeb.084178; BOYDEN CR, 1972, J MAR BIOL ASSOC UK, V52, P661, DOI 10.1017/S0025315400021640; Branch G., 1972, AFR ZOOL, V6, P1; Branch G.M., 1985, P97; Branch G.M., 1981, Oceanography and Marine Biology an Annual Review, V19, P235; BRANCH GM, 1979, COMP BIOCHEM PHYS A, V62, P641, DOI 10.1016/0300-9629(79)90118-X; BRANCH GM, 1978, MAR BIOL, V49, P351, DOI 10.1007/BF00455030; BRANCH GM, 1975, J ANIM ECOL, V44, P575, DOI 10.2307/3612; BRANCH GM, 1985, J EXP MAR BIOL ECOL, V87, P153, DOI 10.1016/0022-0981(85)90088-7; BRITTON JC, 1995, HYDROBIOLOGIA, V309, P129, DOI 10.1007/BF00014480; Cartwright SR, 2012, MAR BIOL, V159, P2323, DOI 10.1007/s00227-012-2017-3; CHAMBERS RJ, 1994, J MOLLUS STUD, V60, P415, DOI 10.1093/mollus/60.4.415; Chapperon C, 2011, FUNCT ECOL, V25, P1040, DOI 10.1111/j.1365-2435.2011.01859.x; Chapperon C, 2011, GLOBAL CHANGE BIOL, V17, P1740, DOI 10.1111/j.1365-2486.2010.02356.x; Clarke AP, 2000, MAR BIOL, V137, P559, DOI 10.1007/s002270000368; Clarke AP, 2000, MAR BIOL, V137, P447, DOI 10.1007/s002270000367; COLEMAN N, 1973, COMP BIOCHEM PHYSIOL, V45, P393, DOI 10.1016/0300-9629(73)90445-3; Compton TJ, 2007, J EXP MAR BIOL ECOL, V352, P200, DOI 10.1016/j.jembe.2007.07.010; Cooke SJ, 2004, FUNCT ECOL, V18, P398, DOI 10.1111/j.0269-8463.2004.00878.x; Cossins A. R., 1987, TEMPERATURE BIOL ANI; Davenport J, 2005, MAR ECOL PROG SER, V292, P41, DOI 10.3354/meps292041; Davenport J, 1997, J MOLLUS STUD, V63, P39, DOI 10.1093/mollus/63.1.39; Denny MW, 2011, J EXP MAR BIOL ECOL, V400, P175, DOI 10.1016/j.jembe.2011.02.006; Denny MW, 2006, J EXP BIOL, V209, P2420, DOI 10.1242/jeb.02258; DEPLEDGE MH, 1990, COMP BIOCHEM PHYS A, V96, P473, DOI 10.1016/0300-9629(90)90664-E; Deshpande RD., 1957, THESIS; Dong YW, 2015, MAR ECOL PROG SER, V529, P107, DOI 10.3354/meps11303; Dong YW, 2011, MAR BIOL, V158, P1223, DOI 10.1007/s00227-011-1642-6; DYE AH, 1987, COMP BIOCHEM PHYS A, V87, P695, DOI 10.1016/0300-9629(87)90384-7; EVANS RG, 1948, J ANIM ECOL, V17, P165, DOI 10.2307/1480; Fangue NA, 2011, PHYSIOL BIOCHEM ZOOL, V84, P341, DOI 10.1086/660113; Finney D.J, 1952, STAT METHOD BIOL ASS; FINNEY DJ, 1948, BIOMETRIKA, V35, P191, DOI 10.1093/biomet/35.1-2.191; Frederich M, 2000, AM J PHYSIOL-REG I, V279, pR1531, DOI 10.1152/ajpregu.2000.279.5.R1531; Fretter V., 1975, PULMONATES FUNCTIONA; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Harley CDG, 2003, LIMNOL OCEANOGR, V48, P1498, DOI 10.4319/lo.2003.48.4.1498; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Harley CDG, 2009, FUNCT ECOL, V23, P292, DOI 10.1111/j.1365-2435.2008.01496.x; HAWKINS SJ, 1983, OCEANOGR MAR BIOL, V21, P195; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Helmuth B, 2006, ECOL MONOGR, V76, P461, DOI 10.1890/0012-9615(2006)076[0461:MPOTSI]2.0.CO;2; Hodgson AN, 1999, OCEANOGR MAR BIOL, V37, P245; HOULIHAN DF, 1979, J EXP MAR BIOL ECOL, V41, P143, DOI 10.1016/0022-0981(79)90049-2; Huang XW, 2015, INTEGR ZOOL, V10, P159, DOI 10.1111/1749-4877.12107; Huxham M, 2001, J MAR BIOL ASSOC UK, V81, P351, DOI 10.1017/S0025315401003885; INNES AJ, 1984, COMP BIOCHEM PHYS A, V77, P441, DOI 10.1016/0300-9629(84)90209-3; IPCC, 2012, CHANG CLIM EXTR THEI; Jones SJ, 2009, BIOL BULL-US, V217, P73, DOI 10.1086/BBLv217n1p73; Judge ML, 2011, HYDROBIOLOGIA, V675, P143, DOI 10.1007/s10750-011-0812-3; Koopman KR, 2016, HYDROBIOLOGIA, V763, P301, DOI 10.1007/s10750-015-2386-y; LITTLE C, 1989, J MOLLUS STUD, V55, P273, DOI 10.1093/mollus/55.2.273; Little C., 2009, BIOL ROCKY SHORES, VSecond edition; Logan CA, 2012, MAR ECOL PROG SER, V450, P93, DOI 10.3354/meps09491; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; MARSHALL DJ, 1994, J EXP MAR BIOL ECOL, V179, P1, DOI 10.1016/0022-0981(94)90013-2; MARSHALL DJ, 1992, COMP BIOCHEM PHYS A, V103, P297, DOI 10.1016/0300-9629(92)90583-C; MARSHALL DJ, 1992, PHYSIOL ZOOL, V65, P1040, DOI 10.1086/physzool.65.5.30158558; Matumba TG, 2013, THESIS; MCMAHON RF, 1990, DEV HYDROB, V56, P241, DOI 10.1007/BF00028081; MCMAHON RF, 1977, BIOL BULL, V152, P182, DOI 10.2307/1540558; MCMAHON RF, 1988, AM ZOOL, V28, P97; OMAHONEY PM, 1984, COMP BIOCHEM PHYS A, V79, P275, DOI 10.1016/0300-9629(84)90429-8; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peck LS, 2002, PHYSIOL BIOCHEM ZOOL, V75, P123, DOI 10.1086/340990; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Portner HO, 1998, S AFR J MARINE SCI, V20, P207; Purchon R. D., 1977, BIOL MOLLUSCA; Santini G, 1999, PHYSIOL BIOCHEM ZOOL, V72, P198, DOI 10.1086/316656; Schmidt-Nielsen K., 1997, Animal physiology: adaptation and environment.; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Stenseng E, 2005, BIOL BULL-US, V208, P138, DOI 10.2307/3593122; Stillman JH, 1996, J EXP BIOL, V199, P1845; Tagliarolo M, 2015, MAR ECOL PROG SER, V535, P145, DOI 10.3354/meps11434; Tagliarolo M, 2013, HYDROBIOLOGIA, V702, P241, DOI 10.1007/s10750-012-1328-1; Tomanek L, 1999, J EXP BIOL, V202, P2925; Tully O, 2000, MAR BIOL, V137, P1031, DOI 10.1007/s002270000410; WIDDOWS J, 1973, MAR BIOL, V20, P269, DOI 10.1007/BF00354270; Xing Q, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-3021-9; YONGE CM, 1947, PHILOS T R SOC B, V232, P56	88	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203555	10.1371/journal.pone.0203555	http://dx.doi.org/10.1371/journal.pone.0203555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183761	Green Submitted, Green Published, gold			2022-12-26	WOS:000443789900072
J	Lunke, K; Meier, B				Lunke, Katrin; Meier, Beat			New insights into mechanisms of enhanced synaesthetic memory: Benefits are synaesthesia-type-specific	PLOS ONE			English	Article							GRAPHEME-COLOR SYNAESTHESIA; PROCESS DISSOCIATION; RECOGNITION MEMORY; RECOLLECTION; SYNESTHESIA; FAMILIARITY; PREVALENCE; SUPERIOR; FORM; ART	The goal of this study was to test the nature of the memory advantage in synaesthesia. We compared four different types of synaesthetes (27 grapheme-colour, 21 sound-colour-, 25 grapheme-colour-and-sound-colour-and 24 sequence-space synaesthetes) to their matched controls. Recognition memory for three types of stimuli (music, words, colour) was tested. We anticipated a general advantage in memory for synaesthetes and potentially additional synaesthesia-specific benefits. The results showed a general advantage for synaesthesia. Further, a benefit for colour stimuli resulted for grapheme-colour synaesthetes and a benefit for music stimuli resulted for grapheme-colour-and-sound-colour synaesthetes, indicating synaesthesia-type specific effects. These results suggest different mechanisms for the explanation of the memory benefit for different types of synaesthesia such as synaesthesia-related colour expertise for grapheme-colour synaesthesia and additional encoding opportunities for grapheme-colour-and-sound-colour synaesthesia.	[Lunke, Katrin; Meier, Beat] Univ Bern, Inst Psychol, Bern, Switzerland	University of Bern	Meier, B (corresponding author), Univ Bern, Inst Psychol, Bern, Switzerland.	beat.meier@psy.unibe.ch	Meier, Beat/E-5306-2011	Meier, Beat/0000-0003-3303-6854	Swiss National Science Foundation [100014_149692]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was supported by the Swiss National Science Foundation, grant # 100014_149692.	Bankieris KR, 2017, PSYCHON B REV, V24, P935, DOI 10.3758/s13423-016-1162-y; Bankieris KR, 2016, I-PERCEPTION, V7, DOI 10.1177/2041669516658488; Barnett KJ, 2008, NEUROIMAGE, V43, P605, DOI 10.1016/j.neuroimage.2008.07.028; Barnett KJ, 2008, COGNITION, V106, P871, DOI 10.1016/j.cognition.2007.05.003; Baron-Cohen S, 2007, J CONSCIOUSNESS STUD, V14, P237; Brugger P., 2004, ACTA NEUROPSYCHOL, V2, P252, DOI DOI 10.1016/J.NEUROSCIENCE.2005.08.057; Chin T, 2018, MEMORY, V26, P844, DOI 10.1080/09658211.2017.1414849; Chiou R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00105; Eagleman DM, 2007, J NEUROSCI METH, V159, P139, DOI 10.1016/j.jneumeth.2006.07.012; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gheri C, 2008, P ROY SOC B-BIOL SCI, V275, P841, DOI 10.1098/rspb.2007.1457; Gross VC, 2011, PERCEPTION, V40, P196, DOI 10.1068/p6647; Hanggi J, 2011, J NEUROSCI, V31, P5816, DOI 10.1523/JNEUROSCI.0964-10.2011; IBM, 2016, IBM SPSS STAT WINDOW; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; JASP T, 2018, INV JASP VERS 0 9; Kadosh RC, 2007, J COGNITIVE NEUROSCI, V19, P2050, DOI 10.1162/jocn.2007.19.12.2050; Kenett YN, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00407; Macmillan N. A., 2004, DETECTION THEORY USE; Meier B, 2007, NEUROSCIENCE, V147, P569, DOI 10.1016/j.neuroscience.2007.04.008; Meier B., 2013, THEORIA HIST SCI, V10, P125, DOI [10.12775/ths-2013-0006, DOI 10.2478/THS-2013-0006, 10.2478/ths-2013-0006]; Meier B, 2013, OXFORD HDB SYNESTHES, P692; Meier B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00129; Meier B, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00787; Meier B, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00632; Paivio, 1986, MENTAL REPRESENTATIO; Pritchard J, 2013, COGNITION, V127, P230, DOI 10.1016/j.cognition.2012.12.012; Radvansky GA, 2011, J EXP PSYCHOL LEARN, V37, P219, DOI 10.1037/a0021329; Rothen N, 2013, CONSCIOUS COGN, V22, P1047, DOI 10.1016/j.concog.2013.07.005; Rothen N, 2012, NEUROSCI BIOBEHAV R, V36, P1952, DOI 10.1016/j.neubiorev.2012.05.004; Rothen N, 2010, NEUROPSYCHOLOGIA, V48, P3482, DOI 10.1016/j.neuropsychologia.2010.07.032; Rothen N, 2010, PERCEPTION, V39, P718, DOI 10.1068/p6680; Rothen N, 2010, MEMORY, V18, P258, DOI 10.1080/09658210903527308; Rothen N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005037; Sagiv N, 2006, COGNITION, V101, P114, DOI 10.1016/j.cognition.2005.09.004; Schmidt K.-H., 1992, WST WORTSCHATZTEST; Simner J, 2006, PERCEPTION, V35, P1024, DOI 10.1068/p5469; Simner J, 2009, CORTEX, V45, P1246, DOI 10.1016/j.cortex.2009.07.007; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Teichmann AL, 2017, J EXP PSYCHOL HUMAN, V43, P1494, DOI 10.1037/xhp0000402; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Ward J, 2008, BRIT J PSYCHOL, V99, P127, DOI 10.1348/000712607X204164; Ward J, 2013, FRONT PSYCHOL, V4, DOI [10.3389/fpsyg.2013.00762, 10.3389/fpsyt.2013.00140]; Yaro C, 2007, Q J EXP PSYCHOL, V60, P681, DOI 10.1080/17470210600785208; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 1998, NEUROPSYCHOLOGY, V12, P323, DOI 10.1037/0894-4105.12.3.323	47	10	10	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203055	10.1371/journal.pone.0203055	http://dx.doi.org/10.1371/journal.pone.0203055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS6HC	30183781	gold, Green Published, Green Submitted			2022-12-26	WOS:000443789900044
J	Matthijsse, SM; Naber, SK; Hontelez, JAC; Bakker, R; van Ballegooijen, M; Lansdorp-Vogelaar, I; de Kok, IMCM; de Koning, HJ; van Rosmalen, J; de Vlas, SJ				Matthijsse, Suzette M.; Naber, Steffie K.; Hontelez, Jan A. C.; Bakker, Roel; van Ballegooijen, Marjolein; Lansdorp-Vogelaar, Iris; de Kok, Inge M. C. M.; de Koning, Harry J.; van Rosmalen, Joost; de Vlas, Sake J.			The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; CERVICAL-CANCER; AS04-ADJUVANTED VACCINE; HPV16/18 VACCINATION; DOUBLE-BLIND; HPV TYPES; NETHERLANDS; WOMEN; EFFICACY; INFECTION	Background Human papillomavirus (HPV) vaccination and the implementation of primary HPV screening in the Netherlands will lead to a lower cervical disease burden. For evaluation and further improvement of prevention, it is important to estimate the magnitude and timing of health benefits of current and alternative vaccination strategies such as vaccination of boys or adults. Methods and findings We evaluated the impact of the current girls-only vaccination program and alternative strategies on cervical disease burden among the first four vaccinated five-year birth cohorts, given the context of primary HPV screening. We integrated the existing microsimulation models STDSIM (HPV transmission model) and MISCAN-Cervix (cervical cancer screening model). Alternative vaccination strategies include: improved vaccination uptake, including routine boys vaccination, and offering adult vaccination at sexual health clinics. Our models show that the current vaccination program is estimated to reduce cervical cancers and cancer deaths by about 35% compared to primary HPV screening in the absence of vaccination. The number needed to vaccinate (NNV) to gain 1 life year is 45. The most efficient alternative vaccination strategies are: 1) improving coverage of girls to 80% (NNV = 42); and 2) routine vaccination for girls and boys at 80% coverage (incremental NNV = 155), with cervical cancer mortality reductions estimated at 50% and 60% respectively. Conclusions While the current program already substantially reduces cervical cancer incidence and mortality, prevention can be further improved by increasing vaccination uptake and extending vaccination to boys. As not all cervical cancer deaths will be prevented, screening participation should still be encouraged.	[Matthijsse, Suzette M.; Naber, Steffie K.; Hontelez, Jan A. C.; Bakker, Roel; van Ballegooijen, Marjolein; Lansdorp-Vogelaar, Iris; de Kok, Inge M. C. M.; de Koning, Harry J.; de Vlas, Sake J.] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Hontelez, Jan A. C.] Heidelberg Univ, Heidelberg Inst Publ Hlth, Fac Med, Heidelberg, Germany; [van Rosmalen, Joost] Univ Med Ctr Rotterdam, Dept Biostat, Erasmus MC, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Ruprecht Karls University Heidelberg; Erasmus University Rotterdam; Erasmus MC	Hontelez, JAC (corresponding author), Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands.; Hontelez, JAC (corresponding author), Heidelberg Univ, Heidelberg Inst Publ Hlth, Fac Med, Heidelberg, Germany.	j.hontelez@erasmusmc.nl	de+Koning, Harry/AAF-9062-2019	de+Koning, Harry/0000-0003-4682-3646; de Vlas, Sake J./0000-0002-1830-5668; Bakker, Roel/0000-0002-1958-0944	Department of Public Health, Erasmus MC	Department of Public Health, Erasmus MC	This work was financially supported by the Department of Public Health, Erasmus MC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accetta G, 2010, J MED SCREEN, V17, P181, DOI 10.1258/jms.2010.010019; Berkhof J, 2005, INT J CANCER, V115, P268, DOI 10.1002/ijc.20846; Bogaards JA, 2011, VACCINE, V29, P8929, DOI 10.1016/j.vaccine.2011.09.055; Bogaards JA, 2011, EPIDEMIOLOGY, V22, P505, DOI 10.1097/EDE.0b013e31821d107b; Brotherton JML, 2016, INT J CANCER, V139, P510, DOI 10.1002/ijc.30063; Bulkmans NWJ, 2004, INT J CANCER, V110, P94, DOI 10.1002/ijc.20076; Burger EA, 2012, BRIT J CANCER, V106, P1571, DOI 10.1038/bjc.2012.94; Canfell K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2244; Casparie M, 2007, CELL ONCOL, V29, P19; Castellsague X, 2009, GYNECOL ONCOL, V115, pS15, DOI 10.1016/j.ygyno.2009.09.021; Chen MK, 2011, J EVAL CLIN PRACT, V17, P1050, DOI 10.1111/j.1365-2753.2010.01453.x; Coupe VMH, 2008, BRIT J CANCER, V98, P646, DOI 10.1038/sj.bjc.6604162; Coupe VMH, 2012, VACCINE, V30, P1813, DOI 10.1016/j.vaccine.2012.01.001; Coupe VMH, 2009, VACCINE, V27, P5111, DOI 10.1016/j.vaccine.2009.06.043; Coupe VMH, 2009, INT J CANCER, V124, P970, DOI 10.1002/ijc.24000; de Kok IMCM, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e670; Diaz M, 2010, EUR J CANCER, V46, P2973, DOI 10.1016/j.ejca.2010.06.016; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Garnett GP, 2005, J INFECT DIS, V191, pS97, DOI 10.1086/425271; Gezondheidsraad, 2011, SCREEN BAARM; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Gok M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1040; Grant LA, 2011, VACCINE, V29, P2365, DOI 10.1016/j.vaccine.2011.01.032; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Hontelez JAC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001534; Huijsmans CJJ, 2015, EUR M MOL DIAGN; Kirby T, 2015, LANCET ONCOL, V16, pE7, DOI 10.1016/S1470-2045(14)71128-3; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Matthijsse SM, 2016, J INFECT DIS, V214, P854, DOI 10.1093/infdis/jiw256; Matthijsse SM, 2015, VACCINE, V33, P5357, DOI 10.1016/j.vaccine.2015.08.079; Matthijsse SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116618; Naber SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145548; Netherlands Cancer Registry, 2014, INC CERV CANC 2004 2; Rogoza RM, 2008, VACCINE, V26, pF46, DOI 10.1016/j.vaccine.2008.02.039; Skinner SR, 2014, LANCET, V384, P2213, DOI 10.1016/S0140-6736(14)60920-X; Suarez E, 2008, VACCINE, V26, pF29, DOI 10.1016/j.vaccine.2008.05.069; Szarewski A, 2012, INT J CANCER, V131, P106, DOI 10.1002/ijc.26362; Van der Ploeg CPB, 1998, INTERFACES, V28, P84, DOI 10.1287/inte.28.3.84; van Rosmalen J, 2012, BJOG-INT J OBSTET GY, V119, P699, DOI 10.1111/j.1471-0528.2011.03228.x; Verdoodt F, 2015, EUR J CANCER, V51, P2375, DOI 10.1016/j.ejca.2015.07.006	43	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0202924	10.1371/journal.pone.0202924	http://dx.doi.org/10.1371/journal.pone.0202924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180203	Green Published, gold, Green Submitted			2022-12-26	WOS:000444222400020
J	Amssoms, K; Born, PA; Beugeling, M; De Clerck, B; Van Gulck, E; Hinrichs, WLJ; Frijlink, HW; Grasmeijer, N; Kraus, G; Sutmuller, R; Simmen, K; Baert, L				Amssoms, Katie; Born, Philip A.; Beugeling, Max; De Clerck, Ben; Van Gulck, Ellen; Hinrichs, Wouter L. J.; Frijlink, Henderik W.; Grasmeijer, Niels; Kraus, Guenter; Sutmuller, Roger; Simmen, Kenny; Baert, Lieven			Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice	PLOS ONE			English	Article							IN-VITRO; VACCINE; FORMULATION; DEGRADATION; MECHANISMS; POWDER	A single-injection vaccine formulation that provides for both a prime and a boost immunization would have various advantages over a multiple-injection regime. For such a vaccine formulation, it is essential that the booster dose is released after a certain, preferably adjustable, lag time. In this study we investigated whether a core-shell based implant, containing ovalbumin as core material and poly(DL-lactic-co-glycolic acid) of various monomer ratios as shell material can be used to obtain such a booster release. An in vitro release study showed that the lag time after which the ovalbumin was released from the core-shell implant increased with increasing lactic to glycolic acid ratio of the polymer and ranged from 3-6 weeks. Fluorescence spectroscopy showed minimal differences between native ovalbumin and ovalbumin from core-shell implants that were incubated until just before the observed in vitro release. In addition, mice immunized with a subcutaneous inserted core-shell implant containing ovalbumin showed an ovalbumin-specific IgG1 antibody response after a lag time of 4 or 6-8 weeks. Moreover, delayed release of ovalbumin caused higher IgG1 antibody titers than conventional subcutaneous vaccination with ovalbumin dissolved in PBS. Collectively, these findings could contribute to the further development of a single-injection vaccine, making multiple injections of the vaccine superfluous.	[Amssoms, Katie; De Clerck, Ben] Janssen Res & Dev, Discovery Sci, Beerse, Belgium; [Born, Philip A.; Beugeling, Max; Hinrichs, Wouter L. J.; Frijlink, Henderik W.; Grasmeijer, Niels] Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands; [Van Gulck, Ellen; Kraus, Guenter; Sutmuller, Roger] Janssen Res & Dev, Infect Dis & Vaccines Therapeut Area, Beerse, Belgium; [Simmen, Kenny] Johnson & Johnson Innovat Ctr, London, England; [Baert, Lieven] Jalima Pharma Bvba, Brugge, Belgium	Johnson & Johnson; Janssen Pharmaceuticals; University of Groningen; Johnson & Johnson; Janssen Pharmaceuticals	Hinrichs, WLJ (corresponding author), Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands.	w.l.j.hinrichs@rug.nl	Hinrichs, Wouter/J-3893-2019; Frijlink, Henderik Willem/AAD-7382-2020	Frijlink, Henderik Willem/0000-0001-7901-8198; Hinrichs, Wouter/0000-0002-1481-2769; Beugeling, Max/0000-0002-5018-347X	Janssen Sciences Ireland UC, an affiliate of Johnson Johnson	Janssen Sciences Ireland UC, an affiliate of Johnson Johnson	Please note that Janssen Sciences Ireland UC, an affiliate of Johnson & Johnson, funded the underlying project. The co-authors employed by this commercial company were actively involved in experimental analysis and drafting of the manuscript. The specific roles of each author are articulated in the 'author contributions' section.	Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004; Cleland JL, 1999, TRENDS BIOTECHNOL, V17, P25, DOI 10.1016/S0167-7799(98)01272-4; Grasmeijer N, 2013, BBA-PROTEINS PROTEOM, V1834, P763, DOI 10.1016/j.bbapap.2013.01.020; Guse C, 2006, INT J PHARMACEUT, V314, P161, DOI 10.1016/j.ijpharm.2005.12.051; Hansson M, 2000, BIOTECHNOL APPL BIOC, V32, P95, DOI 10.1042/BA20000034; Igartua M, 1998, J CONTROL RELEASE, V56, P63, DOI 10.1016/S0168-3659(98)00077-7; Kardani K, 2016, VACCINE, V34, P413, DOI 10.1016/j.vaccine.2015.11.062; Lechevalier V, 2003, J AGR FOOD CHEM, V51, P6354, DOI 10.1021/jf034184n; Lee S, 2015, IMMUNE NETW, V15, P51, DOI 10.4110/in.2015.15.2.51; Leo O, 2011, PERSPECT VACCINOL, V1, P25, DOI DOI 10.1016/J.PERVAC.2011.05.002; Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8; Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F; Mahler HC, 2012, ANAL AGGREGATES PART, DOI [10.1002/9781118150573, DOI 10.1002/9781118150573]; Maurer JM, 2016, INT J PHARMACEUT, V505, P175, DOI 10.1016/j.ijpharm.2016.03.027; McHugh KJ, 2017, SCIENCE, V357, P1138, DOI 10.1126/science.aaf7447; McHugh KJ, 2015, J CONTROL RELEASE, V219, P596, DOI 10.1016/j.jconrel.2015.07.029; Siegrist C-A, 2013, VACCINES, P12; Tonnis WF, 2014, EUR J PHARM SCI, V55, P36, DOI 10.1016/j.ejps.2014.01.005; Tzeng SY, 2018, P NATL ACAD SCI USA, V115, pE5269, DOI 10.1073/pnas.1720970115; Wahjudi M, 2013, EUR J PHARM SCI, V48, P637, DOI 10.1016/j.ejps.2012.12.015; WHO, 2018, IMM COV; Zijlstra GS, 2009, PHARM DEV TECHNOL, V14, P358, DOI 10.1080/10837450802662820	22	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202961	10.1371/journal.pone.0202961	http://dx.doi.org/10.1371/journal.pone.0202961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161264	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900054
J	Yuan, XT; Mu, NN; Wang, N; Straat, K; Sofiadis, A; Guo, YX; Stenman, A; Li, KL; Cheng, GH; Zhang, L; Kong, F; Ekblad, L; Wennerberg, J; Nilsson, IL; Juhlin, CC; Larsson, C; Xu, DW				Yuan, Xiaotian; Mu, Ninni; Wang, Na; Straat, Klas; Sofiadis, Anastasios; Guo, Yanxia; Stenman, Adam; Li, Kailin; Cheng, Guanghui; Zhang, Lu; Kong, Feng; Ekblad, Lars; Wennerberg, Johan; Nilsson, Inga-Lena; Juhlin, C. Christofer; Larsson, Catharina; Xu, Dawei			GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression	ONCOGENE			English	Article							TERT PROMOTER MUTATIONS; TRANSCRIPTION FACTOR; ETS FAMILY; CANCER; TELOMERASE; BRAF; COEXISTENCE; GENES	The ETS family transcription factor GABPA is suggested as an oncogenic element, which is further supported by the recent reporting of it as the sole ETS member to activate the mutant TERT promoter in thyroid carcinomas (TC). However, it remains unclear how GABPA contributes to TC pathogenesis. The present study is designed to address this issue. TERT expression was significantly diminished in TERT promoter-mutated TC cells upon GABPA inhibition. Surprisingly, GABPA depletion led to robustly increased cellular invasion independently of TERT promoter mutations and TERT expression. DICER1, a component of the microRNA machinery, was identified as a downstream effector of GABPA. GABPA facilitated Dicer1 transcription while its depletion reduced Dicer1 expression. The mutation of the GABPA binding site in the DICER1 promoter led to diminished basal levels of DICER1 promoter activity and abolishment of GABPA-stimulated promoter activity as well. The forced DICER1 expression abrogated the invasiveness of GABPA-depleted TC cells. Consistently, the analyses of 93 patients with papillary thyroid carcinoma (PTC) revealed a positive correlation between GABPA and DICER1 expression. GABPA expression was negatively associated with TERT expression and promoter mutations, in contrast to published observations in cancer cell lines. Lower GABPA expression was associated with distant metastasis and shorter overall/disease-free survival in PTC patients. Similar results were obtained for PTC cases in the TCGA dataset. In addition, a positive correlation between GABPA and DICER1 expression was seen in multiple types of malignancies. Taken together, despite its stimulatory effect on the mutant TERT promoter and telomerase activation, GABPA may itself act as a tumor suppressor rather than an oncogenic factor to inhibit invasion/metastasis in TCs and be a useful predictor for patient outcomes.	[Yuan, Xiaotian] Shandong Univ, Reprod Ctr, Jinan 250013, Shandong, Peoples R China; [Yuan, Xiaotian; Straat, Klas; Guo, Yanxia; Xu, Dawei] Karolinska Inst, Karolinska Univ Hosp CMM, Dept Med Solna, SE-17176 Stockholm, Sweden; [Mu, Ninni; Wang, Na; Sofiadis, Anastasios; Stenman, Adam; Juhlin, C. Christofer; Larsson, Catharina] Karolinska Inst, Karolinska Univ Hosp CCK, Dept Oncol Pathol, SE-17176 Stockholm, Sweden; [Guo, Yanxia; Li, Kailin; Cheng, Guanghui; Zhang, Lu; Kong, Feng] Shandong Univ, Hosp 2, Cent Res Lab, Jinan 250033, Shandong, Peoples R China; [Ekblad, Lars] Lund Univ, Fac Med, Dept Clin Sci Lund, Div Oncol & Pathol, Lund, Sweden; [Wennerberg, Johan] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Div Otorhinolaryngol Head & Neck Surg, Lund, Sweden; [Nilsson, Inga-Lena] Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden	Shandong University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Shandong University; Lund University; Lund University; Skane University Hospital; Karolinska Institutet; Karolinska University Hospital	Xu, DW (corresponding author), Karolinska Inst, Karolinska Univ Hosp CMM, Dept Med Solna, SE-17176 Stockholm, Sweden.; Larsson, C (corresponding author), Karolinska Inst, Karolinska Univ Hosp CCK, Dept Oncol Pathol, SE-17176 Stockholm, Sweden.	Catharina.Larsson@ki.se; Dawei.Xu@ki.se	Li, Kai/HCI-8860-2022; Stenman, Adam/AAI-3866-2021; yuan, xiaotian/AAN-6330-2020; Juhlin, Carl Christofer/C-1125-2016; Ekblad, Lars/O-8932-2014	Stenman, Adam/0000-0003-3248-7629; yuan, xiaotian/0000-0002-1501-518X; Juhlin, Carl Christofer/0000-0002-5945-9081; Ekblad, Lars/0000-0003-0152-786X; Xu, Dawei/0000-0003-3141-4524; Zhang, Lu/0000-0002-1580-6774; Nilsson, Inga-Lena/0000-0002-8966-3729	Swedish Cancer Society; Cancer Society in Stockholm; Stockholm County Council; Karolinska Institutet; Shandong Provincial Natural Science Foundation, China [2016ZDJS07A09]	Swedish Cancer Society(Swedish Cancer Society); Cancer Society in Stockholm; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	We thank Dr. J.K., Dr. J.F. Costello (University of California, San Francisco) for the TERT promoter reporters, Ms. L. Ahnfalk for excellent assistance in tumor tissue collection, Dr. B. Guan for evaluation of tumor colonies in mouse lung, and E. Berg (Karolinska Institutet) for expert consultations in the statistical analyses. The study was supported by grants from the Swedish Cancer Society, the Cancer Society in Stockholm, Stockholm County Council and Karolinska Institutet, and Shandong Provincial Natural Science Foundation, China (2016ZDJS07A09).	Bell RJA, 2015, SCIENCE, V348, P1036, DOI 10.1126/science.aab0015; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; De Lellis R.A., 2004, WHO CLASSIFICATION T, V3rd; Ding DQ, 2013, FASEB J, V27, P4375, DOI 10.1096/fj.13-230904; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Grant GD, 2013, MOL BIOL CELL, V24, P3634, DOI 10.1091/mbc.E13-05-0264; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jafarnejad SM, 2013, ONCOGENE, V32, P2131, DOI 10.1038/onc.2012.239; Kitahara CM, 2016, NAT REV ENDOCRINOL, V12, P646, DOI 10.1038/nrendo.2016.110; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Landa I, 2013, J CLIN ENDOCR METAB, V98, pE1562, DOI 10.1210/jc.2013-2383; Lee JJ, 2007, THYROID, V17, P289, DOI 10.1089/thy.2006.0246; Lee SE, 2016, THYROID, V26, P901, DOI 10.1089/thy.2015.0488; Lewis KA, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00083; Liu RY, 2016, ENDOCR-RELAT CANCER, V23, pR143, DOI 10.1530/ERC-15-0533; Liu T, 2014, ONCOGENE, V33, P4978, DOI 10.1038/onc.2013.446; Liu TT, 2016, GENES-BASEL, V7, DOI 10.3390/genes7070038; Liu Z, 2013, ONCOGENE, V32, P4203, DOI 10.1038/onc.2012.441; Lloyd R., 2017, WHO CLASSIFICATION T, V4th; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Melo M, 2017, J CLIN ENDOCR METAB, V102, P1898, DOI 10.1210/jc.2016-2785; Melo M, 2015, J CLIN ONCOL, V33, P667, DOI 10.1200/JCO.2014.59.4614; Molinaro E, 2017, NAT REV ENDOCRINOL, V13, P644, DOI 10.1038/nrendo.2017.76; Odrowaz Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049892; Pacini F, 2011, NAT REV ENDOCRINOL, V7, P420, DOI 10.1038/nrendo.2011.52; Pestana A, 2017, J MOL ENDOCRINOL, V58, pR129, DOI 10.1530/JME-16-0195; Prazeres H, 2011, ONCOGENE, V30, P1302, DOI 10.1038/onc.2010.512; Ramirez-Moya J, 2018, ONCOGENE, V37, P3369, DOI 10.1038/s41388-017-0088-9; Rupaimoole R, 2016, ONCOGENE, V35, P4312, DOI 10.1038/onc.2015.492; Rupaimoole R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6202; Saretzki G, 2014, CURR PHARM DESIGN, V20, P6386, DOI 10.2174/1381612820666140630095606; Schweppe RE, 2013, J CLIN ENDOCR METAB, V98, P956, DOI 10.1210/jc.2012-4182; Sharma NL, 2014, NUCLEIC ACIDS RES, V42, P6256, DOI 10.1093/nar/gku281; Sizemore GM, 2017, NAT REV CANCER, V17, P337, DOI 10.1038/nrc.2017.20; Song YS, 2016, CANCER-AM CANCER SOC, V122, P1370, DOI 10.1002/cncr.29934; Stern JL, 2015, GENE DEV, V29, P2219, DOI 10.1101/gad.269498.115; To SKY, 2017, ONCOGENE, V36, P5927, DOI 10.1038/onc.2017.185; van den Beucken T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6203; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Wang N, 2014, CANCER-AM CANCER SOC, V120, P2965, DOI 10.1002/cncr.28800; Woodward EL, 2017, ENDOCR-RELAT CANCER, V24, P209, DOI 10.1530/ERC-16-0522; Xing MZ, 2014, J CLIN ONCOL, V32, P2718, DOI 10.1200/JCO.2014.55.5094; Yang ZF, 2013, P NATL ACAD SCI USA, V110, P2312, DOI 10.1073/pnas.1212904110; Yu JY, 2018, CANCER LETT, V434, P33, DOI 10.1016/j.canlet.2018.07.013; Zhang K, 2017, CANCER RES, V77, P2534, DOI 10.1158/0008-5472.CAN-16-1887; Zhang L, 2017, J CLIN INVEST, V127, P2159, DOI 10.1172/JCI90077; ZHANG S, 2017, BMC CANCER, V17	48	31	31	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 14	2019	38	7					965	979		10.1038/s41388-018-0483-x	http://dx.doi.org/10.1038/s41388-018-0483-x			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HL3OH	30181547				2022-12-26	WOS:000458624900004
J	Yochum, ZA; Cades, J; Wang, HL; Chatterjee, S; Simons, BW; O'Brien, JP; Khetarpal, SK; Lemtiri-Chlieh, G; Myers, KV; Huang, EHB; Rudin, CM; Tran, PT; Burns, TF				Yochum, Zachary A.; Cades, Jessica; Wang, Hailun; Chatterjee, Suman; Simons, Brian W.; O'Brien, James P.; Khetarpal, Susheel K.; Lemtiri-Chlieh, Ghali; Myers, Kayla V.; Huang, Eric H. -B.; Rudin, Charles M.; Tran, Phuoc T.; Burns, Timothy F.			Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer	ONCOGENE			English	Article							BIM DELETION POLYMORPHISM; ACQUIRED-RESISTANCE; MESENCHYMAL TRANSITION; CONFERS RESISTANCE; AZD9291; OSIMERTINIB; ACTIVATION; EXPRESSION; SENSITIVITY; MECHANISMS	Patients with EGFR-mutant non-small-cell lung cancer (NSCLC) have significantly benefited from the use of EGFR tyrosine kinase inhibitors (TKIs). However, long-term efficacy of these therapies is limited due to de novo resistance (similar to 30%) as well as acquired resistance. Epithelial-mesenchymal transition transcription factors (EMT-TFs), have been identified as drivers of EMTmediated resistance to EGFR TKIs, however, strategies to target EMT-TFs are lacking. As the third generation EGFR TKI, osimertinib, has now been adopted in the first-line setting, the frequency of T790M mutations will significantly decrease in the acquired resistance setting. Previously less common mechanisms of acquired resistance to first generation EGFR TKIs including EMT are now being observed at an increased frequency after osimertinib. Importantly, there are no other FDA approved targeted therapies after progression on osimertinib. Here, we investigated a novel strategy to overcome EGFR TKI resistance through targeting the EMT-TF, TWIST1, in EGFR-mutant NSCLC. We demonstrated that genetic silencing of TWIST1 or treatment with the TWIST1 inhibitor, harmine, resulted in growth inhibition and apoptosis in EGFR-mutant NSCLC. TWIST1 overexpression resulted in erlotinib and osimertinib resistance in EGFR-mutant NSCLC cells. Conversely, genetic and pharmacological inhibition of TWIST1 in EGFR TKI-resistant EGFR-mutant cells increased sensitivity to EGFR TKIs. TWIST1-mediated EGFR TKI resistance was due in part to TWIST1 suppression of transcription of the pro-apoptotic BH3-only gene, BCL2L11 (BIM), by directly binding to BCL2L11 intronic regions and promoter. As such, pan-BCL2 inhibitor treatment overcame TWIST1mediated EGFR TKI resistance and were more effective in the setting of TWIST1 overexpression. Finally, in a mouse model of autochthonous EGFR-mutant lung cancer, Twist1 overexpression resulted in erlotinib resistance and suppression of erlotinibinduced apoptosis. These studies establish TWIST1 as a driver of resistance to EGFR TKIs and provide rationale for use of TWIST1 inhibitors or BCL2 inhibitors as means to overcome EMT-mediated resistance to EGFR TKIs.	[Yochum, Zachary A.; Burns, Timothy F.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Yochum, Zachary A.; Chatterjee, Suman; O'Brien, James P.; Khetarpal, Susheel K.; Myers, Kayla V.; Huang, Eric H. -B.; Burns, Timothy F.] UPMC Hillman Canc Ctr, Div Hematol Oncol, Dept Med, Pittsburgh, PA 15232 USA; [Cades, Jessica] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Wang, Hailun; Lemtiri-Chlieh, Ghali; Tran, Phuoc T.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Cades, Jessica; Tran, Phuoc T.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, 1275 York Ave, New York, NY 10021 USA; [Simons, Brian W.; Tran, Phuoc T.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Memorial Sloan Kettering Cancer Center; Johns Hopkins University	Burns, TF (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.; Burns, TF (corresponding author), UPMC Hillman Canc Ctr, Div Hematol Oncol, Dept Med, Pittsburgh, PA 15232 USA.; Tran, PT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.; Tran, PT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA.; Tran, PT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA.	tranp@jhmi.edu; burnstf@upmc.edu	Tran, Phuoc/W-2084-2019; Wang, Hailun/T-5696-2019; Rudin, Charles/R-2530-2019; Simons, Brian/G-7352-2015	Tran, Phuoc/0000-0002-0147-0376; Rudin, Charles/0000-0001-5204-3465; Myers, Kayla/0000-0002-0748-1092; Simons, Brian/0000-0003-0644-211X; Wang, Hailun/0000-0001-8651-2856	Uniting Against Lung Cancer Foundation; V Foundation Scholar Award; American Lung Association Award [LCD 257864]; Sidney Kimmel Foundation [SKF-15-099, SKF-13-021]; Doris Duke Charitable Foundation Clinical Scientist Award [2015097]; Pittsburgh LUNG SPORE CDA [P50CA090440]; We Wish Foundation; Howard Hughes Medical Institute Medical Fellowship [T32GM008421-22, 1F30CA213765-01]; Nesbitt Family; Movember-Prostate Cancer Foundation; American Lung Association [LCD-339465]; Commonwealth Foundation; ACS [122688-RSG-12-196-01-TBG]; DoD [W81XWH-13-1-0182]; NIH/NCI [R01CA166348];  [P30CA047904]; NATIONAL CANCER INSTITUTE [R01CA166348, F30CA213765, P30CA008748, P50CA090440, U01CA212007, P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008424] Funding Source: NIH RePORTER	Uniting Against Lung Cancer Foundation; V Foundation Scholar Award; American Lung Association Award; Sidney Kimmel Foundation; Doris Duke Charitable Foundation Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Pittsburgh LUNG SPORE CDA; We Wish Foundation; Howard Hughes Medical Institute Medical Fellowship; Nesbitt Family; Movember-Prostate Cancer Foundation; American Lung Association; Commonwealth Foundation; ACS(American Cancer Society); DoD(United States Department of Defense); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following funding sources: HW has received research funding from the Uniting Against Lung Cancer Foundation. TFB was supported for this project from a V Foundation Scholar Award, American Lung Association Award (LCD 257864), Sidney Kimmel Foundation (SKF-15-099) and a Doris Duke Charitable Foundation Clinical Scientist Award (2015097), a Pittsburgh LUNG SPORE CDA P50CA090440 and generous support from the We Wish Foundation. This project used the Hillman Cancer Center Animal, Flow Cytometry and Biostatistics Facilities that are supported in part by award P30CA047904. ZAY has received research funding for this project from the Howard Hughes Medical Institute Medical Fellowship, T32GM008421-22 and a 1F30CA213765-01. PTT has received research funding for this project from the Nesbitt Family; Movember-Prostate Cancer Foundation; Uniting Against Lung Cancer Foundation; American Lung Association (LCD-339465); Commonwealth Foundation; Sidney Kimmel Foundation (SKF-13-021); ACS (122688-RSG-12-196-01-TBG); DoD (W81XWH-13-1-0182); NIH/NCI (R01CA166348). We Laura Stabile, PhD, James G. Herman, MD, and Frank P. Vendetti PhD at the University of Pittsburgh for the discussion, advice regarding experimental design and supply of reagents when applicable. In addition, we would like to acknowledge the helpful discussion and comments provided by the Burns, Rudin, and Tran laboratory members.	Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Burns TF, 2013, MOL CANCER RES, V11, P329, DOI 10.1158/1541-7786.MCR-12-0456; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Chang AT, 2015, GENE DEV, V29, P603, DOI 10.1101/gad.242842.114; Chang TH, 2011, AM J RESP CRIT CARE, V183, P1071, DOI 10.1164/rccm.201009-1440OC; Chen YT, 2007, GENESIS, V45, P588, DOI 10.1002/dvg.20332; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Deng J, 2007, CANCER RES, V67, P11867, DOI 10.1158/0008-5472.CAN-07-1961; Eberlein CA, 2015, CANCER RES, V75, P2489, DOI 10.1158/0008-5472.CAN-14-3167; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Hirsch FR, 2017, LANCET, V389, P299, DOI 10.1016/S0140-6736(16)30958-8; Hwang W, 2017, CANCER RES, V77, P3013, DOI 10.1158/0008-5472.CAN-16-3168; Izumchenko E, 2014, CANCER RES, V74, P3995, DOI 10.1158/0008-5472.CAN-14-0110; Jacqueroud L, 2016, NEOPLASIA, V18, P317, DOI 10.1016/j.neo.2016.03.007; Jakobsen KR, 2016, TRANSL LUNG CANCER R, V5, P172, DOI 10.21037/tlcr.2016.04.07; Jin HO, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.63; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim TM, 2015, J THORAC ONCOL, V10, P1736, DOI 10.1097/JTO.0000000000000688; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Li L, 2017, ONCOTARGET, V8, P18609, DOI 10.18632/oncotarget.14506; McGowan Marc, 2017, Genes Cancer, V8, P497, DOI 10.18632/genesandcancer.136; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Moloudizargari Milad, 2013, Pharmacogn Rev, V7, P199, DOI 10.4103/0973-7847.120524; Ohashi K, 2012, P NATL ACAD SCI USA, V109, pE2127, DOI 10.1073/pnas.1203530109; Ou SHI, 2016, LUNG CANCER, V98, P59, DOI 10.1016/j.lungcan.2016.05.015; Pan DN, 2009, CELL, V137, P73, DOI 10.1016/j.cell.2009.01.051; Pham CG, 2007, MOL CELL BIOL, V27, P3920, DOI 10.1128/MCB.01219-06; Planchard D, 2015, ANN ONCOL, V26, P2073, DOI 10.1093/annonc/mdv319; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Ramalingam SS, 2018, J CLIN ONCOL, V36, P841, DOI 10.1200/JCO.2017.74.7576; Ricordel Charles, 2017, J Thorac Oncol, V12, pe184, DOI 10.1016/j.jtho.2017.07.019; Roberts CM, 2016, SCI REP-UK, V6, DOI 10.1038/srep37652; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2011, CLIN CANCER RES, V17, P1160, DOI 10.1158/1078-0432.CCR-10-2158; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shi PY, 2017, CLIN CANCER RES, V23, P6567, DOI 10.1158/1078-0432.CCR-17-1574; Sionov RV, 2015, ONCOTARGET, V6, P23058, DOI 10.18632/oncotarget.5492; Soh SX, 2017, ONCOTARGET, V8, P41474, DOI 10.18632/oncotarget.17102; Song KA, 2018, CLIN CANCER RES, V24, P197, DOI 10.1158/1078-0432.CCR-17-1577; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Tanimoto A, 2017, CLIN CANCER RES, V23, P3139, DOI 10.1158/1078-0432.CCR-16-2271; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tran PT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002650; Tran PT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002018; Vazquez-Martin A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02560; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yochum ZA, 2017, MOL CANCER RES, V15, P1764, DOI 10.1158/1541-7786.MCR-17-0298; Yochum ZA, 2016, J THORAC DIS, V8, pE1528, DOI 10.21037/jtd.2016.11.59; Yoshida T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147344; Zhang T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12231; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zheng H, 2014, ONCOGENE, V33, P1755, DOI 10.1038/onc.2013.128; Zhuo WL, 2008, BIOCHEM BIOPH RES CO, V369, P1098, DOI 10.1016/j.bbrc.2008.02.143	60	96	100	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 31	2019	38	5					656	670		10.1038/s41388-018-0482-y	http://dx.doi.org/10.1038/s41388-018-0482-y			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HJ6LI	30171258	Green Accepted			2022-12-26	WOS:000457300300004
J	Augustin, IML; Spruit, MA; Houben-Wilke, S; Franssen, FME; Vanfleteren, LEGW; Gaffron, S; Janssen, DJA; Wouters, EFM				Augustin, Ingrid M. L.; Spruit, Martijn A.; Houben-Wilke, Sarah; Franssen, Frits M. E.; Vanfleteren, Lowie E. G. W.; Gaffron, Swetlana; Janssen, Daisy J. A.; Wouters, Emiel F. M.			The respiratory physiome: Clustering based on a comprehensive lung function assessment in patients with COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; EXERCISE INTOLERANCE; STANDARDIZATION; PHENOTYPES; CAPACITY; VALUES; AGE	Background While spirometry and particularly airflow limitation is still considered as an important tool in therapeutic decision making, it poorly reflects the heterogeneity of respiratory impairment in chronic obstructive pulmonary disease (COPD). The aims of this study were to identify pathophysiological clusters in COPD based on an integrated set of standard lung function attributes and to investigate whether these clusters can predict patient-related outcomes and differ in clinical characteristics. Methods Clinically stable COPD patients referred for pulmonary rehabilitation underwent an integrated assessment including clinical characteristics, dyspnea score, exercise performance, mood and health status, and lung function measurements (post-bronchodilator spirometry, body plethysmography, diffusing capacity, mouth pressures and arterial blood gases). Self-organizing maps were used to generate lung function based clusters. Results Clustering of lung function attributes of 518 patients with mild to very severe COPD identified seven different lung function clusters. Cluster 1 includes patients with better lung function attributes compared to the other clusters. Airflow limitation is attenuated in clusters 1 to 4 but more pronounced in clusters 5 to 7. Static hyperinflation is more dominant in clusters 5 to 7. A different pattern occurs for carbon monoxide diffusing capacity, mouth pressures and for arterial blood gases. Related to the different lung function profiles, clusters 1 and 4 demonstrate the best functional performance and health status while this is worst for clusters 6 and 7. All clusters show differences in dyspnea score, proportion of men/women, age, number of exacerbations and hospitalizations, proportion of patients using long-term oxygen and number of comorbidities. Conclusion Based on an integrated assessment of lung function variables, seven pathophysiological clusters can be identified in COPD patients. These clusters poorly predict functional performance and health status.	[Augustin, Ingrid M. L.; Spruit, Martijn A.; Houben-Wilke, Sarah; Franssen, Frits M. E.; Vanfleteren, Lowie E. G. W.; Janssen, Daisy J. A.; Wouters, Emiel F. M.] CIRO, Ctr Expertise Chron Organ Failure, Horn, Netherlands; [Spruit, Martijn A.; Wouters, Emiel F. M.] Maastricht Univ, Dept Resp Med, Med Ctr, Maastricht, Netherlands; [Gaffron, Swetlana] Viscovery Software GmbH, Vienna, Austria	Maastricht University	Augustin, IML (corresponding author), CIRO, Ctr Expertise Chron Organ Failure, Horn, Netherlands.	ingridaugustin@ciro-horn.nl	Wouters, Emiel/ABD-6200-2021; Franssen, Frits M.E./B-6988-2018; Janssen, Daisy J.A./AAW-2248-2021; Franssen, Frits M.E./L-3334-2019	Franssen, Frits M.E./0000-0002-1633-6356; Janssen, Daisy J.A./0000-0002-1827-9869; Franssen, Frits M.E./0000-0002-1633-6356	Lung Foundation Netherlands [3.4.10.015]; GlaxoSmithKline [SC0115406]	Lung Foundation Netherlands; GlaxoSmithKline(GlaxoSmithKline)	The CHANCE study was supported by the Lung Foundation Netherlands (3.4.10.015) and GlaxoSmithKline (SC0115406). These funding organizations provided only financial support not playing a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. These funding organizations provided only financial support in the form of salary for dr. Sarah Houben-Wilke.	Agusti A, 2016, EUR RESPIR J, V47, P410, DOI 10.1183/13993003.01359-2015; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; BLACK LF, 1969, AM REV RESPIR DIS, V99, P696; Boutou AK, 2013, EUR RESPIR J, V42, P616, DOI 10.1183/09031936.00146012; Burgel PR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/420134; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coates A. L., 1997, EUR RESP J, V10; Corbridge T., 1993, PRINCIPLES PRACTICE, P18; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; Crisafulli Ernesto, 2007, Int J Chron Obstruct Pulmon Dis, V2, P19, DOI 10.2147/copd.2007.2.1.19; Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8; Esteban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161710; Farkhooy A, 2013, COPD, V10, P180, DOI 10.3109/15412555.2012.734873; Foreman MG, 2011, AM J RESP CRIT CARE, V184, P414, DOI 10.1164/rccm.201011-1928OC; Garcia-Aymerich J, 2011, THORAX, V66, P430, DOI 10.1136/thx.2010.154484; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Janssen Daisy J A, 2010, Chron Respir Dis, V7, P147, DOI 10.1177/1479972310369285; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Marchand E, 2000, CLIN CHEST MED, V21, P679, DOI 10.1016/S0272-5231(05)70177-5; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; O'Donnell DE, 2001, AM J RESP CRIT CARE, V164, P770, DOI 10.1164/ajrccm.164.5.2012122; O'Donnell DE, 2015, COPD RES PRACTICE, V1, P1; Pinto LM, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0208-4; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Ross JC, 2018, AM J RESP CRIT CARE, V198, P1033, DOI 10.1164/rccm.201707-1405OC; Saure EW, 2016, EUR CLIN RESPIR J, V3, DOI 10.3402/ecrj.v3.29141; SCHOLS AMWJ, 1993, AM REV RESPIR DIS, V147, P1151, DOI 10.1164/ajrccm/147.5.1151; Shimizu K., 1985, J APPL PHYSL; Smid DE, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007536; Spruit MA, 2013, AM J RESP CRIT CARE, V188, pE13, DOI 10.1164/rccm.201309-1634ST; Spruit MA, 2010, RESP MED, V104, P849, DOI 10.1016/j.rmed.2009.12.007; van der Molen Thys, 2003, Health Qual Life Outcomes, V1, P13, DOI 10.1186/1477-7525-1-13; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP; Wedzicha JA, 2013, LANCET RESP MED, V1, P199, DOI 10.1016/S2213-2600(13)70052-3; Ziegelstein RC, 2015, JAMA INTERN MED, V175, P888, DOI 10.1001/jamainternmed.2015.0861; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	42	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2018	13	9							e0201593	10.1371/journal.pone.0201593	http://dx.doi.org/10.1371/journal.pone.0201593			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7EB	30208035	Green Published, Green Submitted, gold			2022-12-26	WOS:000444683000007
J	Gonzalez-Quintial, R; Nguyen, A; Kono, DH; Oldstone, MBA; Theofilopoulos, AN; Baccala, R				Gonzalez-Quintial, Rosana; Nguyen, Anthony; Kono, Dwight H.; Oldstone, Michael B. A.; Theofilopoulos, Argyrios N.; Baccala, Roberto			Lupus acceleration by a MAVS-activating RNA virus requires endosomal TLR signaling and host genetic predisposition	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; SYSTEMIC AUTOIMMUNE-DISEASE; AICARDI-GOUTIERES SYNDROME; CHRONIC VIRAL-INFECTION; I INTERFERON RESPONSES; T-CELLS; AUTOANTIBODY PRODUCTION; MURINE LUPUS; PRONE MICE	Viruses have long been implicated in the pathogenesis of autoimmunity, yet their contribution remains circumstantial partly due to the lack of well-documented information on infections prior to autoimmune disease onset. Here, we used the lymphocytic choriomeningitis virus (LCMV) as a model to mechanistically dissect the impact of viral infection on lupus-like autoimmunity. Virus persistence strongly enhanced disease in mice with otherwise weak genetic predisposition but not in highly predisposed or non-autoimmune mice, indicating a synergistic interplay between genetic susceptibility and virus infection. Moreover, endosomal Toll-like receptors (TLRs) and plasmacytoid dendritic cells (pDCs) were both strictly required for disease acceleration, even though LCMV also induces strong TLR-independent type I interferon (IFN-I) production via RNA helicases and MAVS in conventional DCs. These results suggest that LCMV enhances systemic autoimmunity primarily by providing stimulatory nucleic acids for endosomal TLR engagement, whereas overstimulation of the MAVS-dependent cytosolic pathway in the absence of endosomal TLR signaling is insufficient for disease induction.	[Gonzalez-Quintial, Rosana; Nguyen, Anthony; Kono, Dwight H.; Oldstone, Michael B. A.; Theofilopoulos, Argyrios N.; Baccala, Roberto] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA	Scripps Research Institute	Baccala, R (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.	rbaccala@scripps.edu		Baccala, Roberto/0000-0002-3159-8469	National Institute of Allergy and Infectious Diseases [AI121525]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI121525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068910, R01AR065919] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Allergy and Infectious Diseases, grant AI121525 to RB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Arkatkar T, 2017, J EXP MED; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Baccala R, 2013, P NATL ACAD SCI USA, V110, P2940, DOI 10.1073/pnas.1222798110; Baccala R, 2012, J IMMUNOL, V189, P5976, DOI 10.4049/jimmunol.1201477; Banchereau R, 2017, ANNU REV IMMUNOL, V35, P337, DOI 10.1146/annurev-immunol-051116-052225; Barrat FJ, 2016, ANNU REV MED, V67, P323, DOI 10.1146/annurev-med-052814-023338; BLOCK SR, 1975, AM J MED, V59, P533, DOI 10.1016/0002-9343(75)90261-2; BORROW P, 1995, J VIROL, V69, P1059, DOI 10.1128/JVI.69.2.1059-1070.1995; Buskiewicz IA, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1933; Caielli S, 2016, J EXP MED, V213, P697, DOI 10.1084/jem.20151876; Celhar T, 2015, P NATL ACAD SCI USA, V112, pE6195, DOI 10.1073/pnas.1507052112; Cervantes-Barragan L, 2012, P NATL ACAD SCI USA, V109, P3012, DOI 10.1073/pnas.1117359109; Chen LY, 2017, CURR OPIN RHEUMATOL, V29, P423, DOI 10.1097/BOR.0000000000000411; Chervonsky AV, 2010, NAT IMMUNOL, V11, P28, DOI 10.1038/ni.1801; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Clingan JM, 2012, J IMMUNOL, V188, P4432, DOI 10.4049/jimmunol.1103656; Crampton SP, 2012, J IMMUNOL, V188, P1451, DOI 10.4049/jimmunol.1102705; Crow MK, 2014, J IMMUNOL, V192, P5459, DOI 10.4049/jimmunol.1002795; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Das A, 2017, IMMUNITY, V46, P106, DOI 10.1016/j.immuni.2016.12.014; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Emonet SF, 2009, P NATL ACAD SCI USA, V106, P3473, DOI 10.1073/pnas.0900088106; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Giltiay NV, 2013, J EXP MED, V210, P2773, DOI 10.1084/jem.20122798; Gonzalez-Quintial R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027528; Gorman JA, 2017, NAT IMMUNOL, V18, P744, DOI 10.1038/ni.3766; Gunther C, 2015, J CLIN INVEST, V125, P413, DOI 10.1172/JCI78001; Gupta N, 2017, PEDIATR RHEUMATOL, V15, DOI 10.1186/s12969-017-0156-2; Halenius A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/472978; Hao Y, 2011, BLOOD, V118, P1294, DOI 10.1182/blood-2011-01-330530; Hervas-Stubbs S, 2014, J IMMUNOL, V193, P1151, DOI 10.4049/jimmunol.1301440; Homann D, 2004, J IMMUNOL, V172, P6239, DOI 10.4049/jimmunol.172.10.6239; Hung T, 2015, SCIENCE, V350, P455, DOI 10.1126/science.aac7442; Hwang SH, 2012, J IMMUNOL, V189, P5786, DOI 10.4049/jimmunol.1202195; James JA, 2012, CURR OPIN RHEUMATOL, V24, P383, DOI 10.1097/BOR.0b013e3283535801; JAMIESON BD, 1988, P NATL ACAD SCI USA, V85, P2265, DOI 10.1073/pnas.85.7.2265; JARVINEN P, 1992, J INTERN MED, V231, P67; Kaul A, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.39; Koh YT, 2013, J IMMUNOL, V190, P4982, DOI 10.4049/jimmunol.1202986; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Kunz S, 2001, J CELL BIOL, V155, P301, DOI 10.1083/jcb.200104103; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027; Macal M, 2012, CELL HOST MICROBE, V11, P617, DOI 10.1016/j.chom.2012.04.017; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; Mavragani CP, 2016, ARTHRITIS RHEUMATOL, V68, P2686, DOI 10.1002/art.39795; Morel L, 2010, NAT REV RHEUMATOL, V6, P348, DOI 10.1038/nrrheum.2010.63; Oda H, 2014, AM J HUM GENET, V95, P121, DOI 10.1016/j.ajhg.2014.06.007; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Oldstone MBA, 2011, VIROLOGY, V411, P170, DOI 10.1016/j.virol.2010.11.023; Pavlovic M, 2010, Lupus, V19, P783, DOI 10.1177/0961203310365715; Pisetsky DS, 2011, IMMUNOL RES, V49, P227, DOI 10.1007/s12026-010-8184-8; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Robinson T, 2011, J IMMUNOL, V187, P1298, DOI 10.4049/jimmunol.1100857; Ronnblom L, 2011, UPSALA J MED SCI, V116, P227, DOI 10.3109/03009734.2011.624649; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Santiago-Raber ML, 2009, ARTHRITIS RHEUM-US, V60, P2408, DOI 10.1002/art.24787; Schmitt H, 2016, J EXP MED, V213, P1627, DOI 10.1084/jem.20160189; Shao WH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3206; Sisirak V, 2016, CELL, V166, P88, DOI 10.1016/j.cell.2016.05.034; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Theofilopoulos AN, 2017, NAT IMMUNOL, V18, P716, DOI 10.1038/ni.3731; Theofilopoulos AN, 2011, J INTERF CYTOK RES, V31, P867, DOI 10.1089/jir.2011.0092; TONIETTI G, 1970, J EXP MED, V132, P89, DOI 10.1084/jem.132.1.89; Van Eyck L, 2015, ARTHRITIS RHEUMATOL, V67, P1592, DOI 10.1002/art.39110; Walsh KB, 2012, CELL HOST MICROBE, V11, P643, DOI 10.1016/j.chom.2012.04.016; Wang YM, 2012, CELL HOST MICROBE, V11, P631, DOI 10.1016/j.chom.2012.05.003; Wieland SF, 2014, J VIROL, V88, P752, DOI 10.1128/JVI.01714-13; Xing JJ, 2015, J VIROL, V89, P2944, DOI 10.1128/JVI.03349-14; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10	83	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2018	13	9							e0203118	10.1371/journal.pone.0203118	http://dx.doi.org/10.1371/journal.pone.0203118			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7DK	30199535	gold, Green Published, Green Submitted			2022-12-26	WOS:000444681100008
J	Lopez-Anglada, L; Cueto-Felgueroso, C; Rosinol, L; Oriol, A; Teruel, AI; de la Guia, AL; Bengoechea, E; Palomera, L; de Arriba, F; Hernandez, JM; Granell, M; Penalver, FJ; Garcia-Sanz, R; Besalduch, J; Gonzalez, Y; Martinez, RB; Hernandez, MT; Gutierrez, NC; Puerta, P; Valeri, A; Paiva, B; Blade, J; Mateos, MV; San Miguel, J; Lahuerta, JJ; Martinez-Lopez, J				Lopez-Anglada, Lucia; Cueto-Felgueroso, Cecilia; Rosinol, Laura; Oriol, Albert; Isabel Teruel, Ana; Lopez de la Guia, Ana; Bengoechea, Enrique; Palomera, Luis; de Arriba, Felipe; Mariano Hernandez, Jose; Granell, Miquel; Javier Penalver, Francisco; Garcia-Sanz, Ramon; Besalduch, Juan; Gonzalez, Yolanda; Benigno Martinez, Rafael; Teodoro Hernandez, Miguel; Gutierrez, Norma C.; Puerta, Paloma; Valeri, Antonio; Paiva, Bruno; Blade, Joan; Mateos, Maria-Victoria; San Miguel, Jesus; Jose Lahuerta, Juan; Martinez-Lopez, Joaquin		GEM Grp Espanol MM; PETHEMA Programa El Estudio	Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials	PLOS ONE			English	Article							RISK-FACTOR; PROGRESSION; INDUCTION; DIAGNOSIS; THERAPY; DISEASE; SFLC	We investigated the prognostic impact and clinical utility of serum free light chains (sFLC) and serum heavy-light chains (sHLC) in patients with multiple myeloma treated according to the GEM2005MENOS65, GEM2005MAS65, and GEM2010MAS65 PETHEMA/GEM phase III clinical trials. Serum samples collected at diagnosis were retrospectively analyzed for sFLC (n = 623) and sHLC (n = 183). After induction or autologous transplantation, 309 and 89 samples respectively were available for sFLC and sHLC assays. At diagnosis, a highly abnormal (HA) sFLC ratio (sFLCr) (<0.03 or >32) was not associated with higher risk of progression. After therapy, persistence of involved-sFLC levels >100 mg/L implied worse survival (overall survival [OS], P = 0.03; progression-free survival [PFS], P = 0.007). Among patients that achieved a complete response, sFLCr normalization did not necessarily indicate a higher quality response. We conducted sHLC investigations for IgG and IgA MM. Absolute sHLC values were correlated with monoclonal protein levels measured with serum protein electrophoresis. At diagnosis, HA-sHLCrs (<0.29 or >73) showed a higher risk of progression (P = 0.006). Additionally, involved-sHLC levels >5 g/L after treatment were associated with shorter survival (OS, P = 0.001; PFS, P = 0.018). The HA-sHLCr could have prognostic value at diagnosis; absolute values of involved-sFLC >100 mg/L and involved-sHLC >5 g/L could have prognostic value after treatment.	[Lopez-Anglada, Lucia; Valeri, Antonio; Jose Lahuerta, Juan; Martinez-Lopez, Joaquin] Hosp Univ 12 Octubre, CIBERONC, Dept Hematol, Madrid, Spain; [Cueto-Felgueroso, Cecilia; Puerta, Paloma] Hosp Univ 12 Octubre, Dept Clin Biochem, Madrid, Spain; [Rosinol, Laura; Gutierrez, Norma C.; Mateos, Maria-Victoria] IDIBAPS, Hosp Clin, Dept Hematol, Barcelona, Spain; [Oriol, Albert; Blade, Joan] Hosp Germans & Trials, Barcelona, Spain; [Isabel Teruel, Ana] Hosp Clin Valencia, Dept Hematol, Valencia, Spain; [Lopez de la Guia, Ana] Hosp La Paz, Dept Hematol, Madrid, Spain; [Bengoechea, Enrique] Hosp Donostia, Dept Hematol, San Sebastian, Spain; [Palomera, Luis] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain; [de Arriba, Felipe] Hosp Morales Meseguer, Murcia, Spain; [Mariano Hernandez, Jose] Hosp Gen Segovia, Dept Hematol, Segovia, Spain; [Granell, Miquel] Hosp Univ Santa Creu & St Pau, Haematol, Barcelona, Spain; [Javier Penalver, Francisco] Hosp Univ Fdn Alcorcon, Dept Haematol, Madrid, Spain; [Garcia-Sanz, Ramon] Hosp Univ Salamanca, IBSAL, CSIC, Hematol Dept,IBMCC, Salamanca, Spain; [Besalduch, Juan] Hosp Univ Son Espases, Dept Haematol, Mallorca, Spain; [Gonzalez, Yolanda] Inst Oncol Dr Josep Trueta Girona, Dept Haematol, Girona, Spain; [Benigno Martinez, Rafael] Hosp Univ San Carlos, Dept Haematol, Madrid, Spain; [Teodoro Hernandez, Miguel] Hosp Univ Canarias, Dept Haematol, Tenerife, Spain; [Paiva, Bruno; San Miguel, Jesus] Clin Univ Navarra, CIBERONC, CIMA, Haematol Dept,IDISNA, Pamplona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Universitario La Paz; University Hospital Donostia; Lozano Blesa University Clinical Hospital; Alcorcon Foundation University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Hospital Universitari Son Espases; Universidad de la Laguna; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Navarra	Lopez-Anglada, L; Martinez-Lopez, J (corresponding author), Hosp Univ 12 Octubre, CIBERONC, Dept Hematol, Madrid, Spain.	lucia.lopezanglada@gmail.com; jmarti01@ucm.es	Lopez de la Guia, Ana/ABF-7990-2021; Granell, Miquel/G-1329-2014; martinez, joaquin/AAN-6939-2020; San-Miguel, Jesús F./V-8977-2018; Granell, Miquel/W-4134-2019; de Oteyza, Jaime Perez/K-5514-2012; Paiva, Bruno/AAB-8881-2021; Garcia-Sanz, Ramon/B-7986-2017; Oriol, Albert/K-9923-2017	martinez, joaquin/0000-0001-7908-0063; San-Miguel, Jesús F./0000-0002-9183-4857; de Oteyza, Jaime Perez/0000-0002-8338-2037; Paiva, Bruno/0000-0003-1977-3815; Garcia-Sanz, Ramon/0000-0003-4120-2787; Oriol, Albert/0000-0001-6804-2221; Lopez-Anglada, Lucia/0000-0003-1727-8546	Fondo de Investigacion Sanitaria (FIS) [PI06339, PS09/01370, PI12/01761, CD13/00340, JR14/00016]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) of the Instituto de Salud Carlos III (Ministry of Economy, Industry, and Competitiveness, Madrid, Spain); FEDER from FIS [RD12/0036/0061, RD12/0036/0048m, RD12/0036/0058]; Asociacion Espanola Contra el Cancer (AECC) [GCB120981SAN]; CRIS Foundation	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Red Tematica de Investigacion Cooperativa en Cancer (RTICC) of the Instituto de Salud Carlos III (Ministry of Economy, Industry, and Competitiveness, Madrid, Spain); FEDER from FIS; Asociacion Espanola Contra el Cancer (AECC); CRIS Foundation	This research project was supported by grants PI06339, PS09/01370, and PI12/01761 awarded to Sara Borrell (CD13/00340) and Juan Rodes (JR14/00016) from the Fondo de Investigacion Sanitaria (FIS), the Red Tematica de Investigacion Cooperativa en Cancer (RTICC) of the Instituto de Salud Carlos III (Ministry of Economy, Industry, and Competitiveness, Madrid, Spain), FEDER (RD12/0036/0061, RD12/0036/0048m and RD12/0036/0058) from FIS, the Asociacion Espanola Contra el Cancer (AECC; GCB120981SAN), and the CRIS Foundation.	Bhole MV, 2014, ANN CLIN BIOCHEM, V51, P528, DOI 10.1177/0004563213518758; Boyle EM, 2014, CANCER-AM CANCER SOC, V120, P3952, DOI 10.1002/cncr.28946; Bradwell AR, 2009, CLIN CHEM, V55, P1646, DOI 10.1373/clinchem.2009.123828; Dejoie T, 2016, BLOOD, V128, P2941, DOI 10.1182/blood-2016-07-726778; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; Katzmann JA, 2013, LEUKEMIA, V27, P208, DOI 10.1038/leu.2012.189; Katzmann JA, 2015, CLIN CHEM, V61, P360, DOI 10.1373/clinchem.2014.231985; Kyrtsonis MC, 2007, BRIT J HAEMATOL, V137, P240, DOI 10.1111/j.1365-2141.2007.06561.x; Ludwig H, 2013, LEUKEMIA, V27, P213, DOI 10.1038/leu.2012.197; Maltezas D, 2013, HEMATOL ONCOL, V31, P356, DOI 10.1002/hon.2026; Martinez-Lopez J, 2015, BLOOD, V126, P858, DOI 10.1182/blood-2015-04-638742; Mateos MV, 2016, BLOOD, V127, P420, DOI 10.1182/blood-2015-08-666537; Mateos MV, 2014, BLOOD, V124, P1887, DOI 10.1182/blood-2014-05-573733; Mead GP, 2004, BRIT J HAEMATOL, V126, P348, DOI 10.1111/j.1365-2141.2004.05045.x; Michallet M, 2017, LEUKEMIA; Mollee P, 2016, CLIN CHEM LAB MED, V54, P921, DOI 10.1515/cclm-2015-0938; Moustafa MA, 2015, LEUKEMIA, V29, P2033, DOI 10.1038/leu.2015.118; Murng SHK, 2013, CLIN EXP IMMUNOL, V171, P201, DOI 10.1111/cei.12011; Radocha J, 2016, EUR J HAEMATOL, V96, P119, DOI 10.1111/ejh.12556; Rajkumar SV, 2005, BLOOD, V106, P812, DOI 10.1182/blood-2005-03-1038; Rosinol L, 2012, BLOOD, V120, P1589, DOI 10.1182/blood-2012-02-408922; Snozek CLH, 2008, LEUKEMIA, V22, P1933, DOI 10.1038/leu.2008.171; van Rhee F, 2007, BLOOD, V110, P827, DOI 10.1182/blood-2007-01-067728	24	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203392	10.1371/journal.pone.0203392	http://dx.doi.org/10.1371/journal.pone.0203392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192814	Green Published, gold			2022-12-26	WOS:000444093600068
J	Sanches, IC; Buzin, M; Conti, FF; Dias, DD; dos Santos, CP; Sirvente, R; Salemi, VMC; Llesuy, S; Irigoyen, MC; De Angelis, K				Sanches, Iris Callado; Buzin, Morgana; Conti, Filipe Fernandes; Dias, Danielle da Silva; dos Santos, Camila Paixao; Sirvente, Raquel; Cury Salemi, Vera Maria; Llesuy, Susana; Irigoyen, Maria-Claudia; De Angelis, Katia			Combined aerobic and resistance exercise training attenuates cardiac dysfunctions in a model of diabetes and menopause	PLOS ONE			English	Article							OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; ENDOTHELIAL DYSFUNCTION; BAROREFLEX SENSITIVITY; AUTONOMIC DYSFUNCTION; RISK; 17-BETA-ESTRADIOL; CARDIOMYOPATHY; HYPERGLYCEMIA; GLUTATHIONE	The study aimed at evaluating the effects of combined aerobic and resistance exercise training on cardiac morphometry and function, oxidative stress and inflammatory parameters in diabetic ovariectomized rats. For this, female Wistar rats (10 weeks-old) were divided into 4 groups (n = 8): euglycemic (E), diabetic (streptozotocin, 50 mg/kg, iv) (D), diabetic ovariectomized (DO) and trained diabetic ovariectomized (TDO). The combined exercise training was performed on a treadmill and in a ladder adapted to rats (8 weeks, at 40 +/- 60% of maximal capacity). The left ventricle (LV) morphometry and function were evaluated by echocardiography. Oxidative stress and inflammatory markers were measured on ventricles tissue. The sedentary diabetic animals (D and DO) showed impaired systolic and diastolic functions, as well as increased cardiac overload, evaluated by myocardial performance index (MPI-D: 0.32 +/- 0.05; DO: 0.39 +/- 0.13 vs. E: 0.25 +/- 0.07), in relation to E group. Systolic and MPI dysfunctions were exacerbated in DO when compared to D group. The DO group presented higher protein oxidation and TNF-alpha/IL-10 ratio than D groups. Glutathione redox ratio (GSH/GSSG) and IL-10 were decreased in both D and DO groups when compared to E group. Exercise training improved exercise capacity, systolic and diastolic functions and MPI (0.18 +/- 0.11). The TDO group showed reduced protein oxidation and TNF-alpha/IL-10 ratio and increased GSH/GSSG and IL-10 in relation to the DO group. These results showed that combined exercise training was able to attenuate the cardiac dysfunctions, probably by reducing inflammation and oxidative stress in an experimental model of diabetes and menopause.	[Sanches, Iris Callado] Sao Judas Tadeu Univ USJT, Human Movement Lab, Sao Paulo, Brazil; [Buzin, Morgana; Conti, Filipe Fernandes; Dias, Danielle da Silva; dos Santos, Camila Paixao; Llesuy, Susana; De Angelis, Katia] Univ Nove Julho UNINOVE, Lab Translat Physiol, Sao Paulo, Brazil; [Sirvente, Raquel; Cury Salemi, Vera Maria; Irigoyen, Maria-Claudia] Univ Sao Paulo, Heart Inst InCor, Sch Med, Hypertens Unit, Sao Paulo, Brazil; [Llesuy, Susana] Univ Buenos Aires, Fac Farm & Bioquim, Buenos Aires, DF, Argentina; [De Angelis, Katia] Fed Univ Sao Paulo UNIFESP, Dept Physiol, Sao Paulo, Brazil	Universidade Sao Judas Tadeu; Universidade Nove de Julho; Universidade de Sao Paulo; University of Buenos Aires; Universidade Federal de Sao Paulo (UNIFESP)	De Angelis, K (corresponding author), Univ Nove Julho UNINOVE, Lab Translat Physiol, Sao Paulo, Brazil.; De Angelis, K (corresponding author), Fed Univ Sao Paulo UNIFESP, Dept Physiol, Sao Paulo, Brazil.	prof.kangelis@yahoo.com.br	da Silva Dias, Danielle/AAN-7618-2020; Sanches, Iris Callado/D-5079-2013; Salemi, Vera/AAY-5024-2020; DE ANGELIS, KATIA/I-6098-2016	da Silva Dias, Danielle/0000-0003-4152-0849; Sanches, Iris Callado/0000-0001-6195-4340; DE ANGELIS, KATIA/0000-0002-3640-9049	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PROSUP, CAPES-PVE, CAPES DFAIT) [8881.062178/2014-01]; Sao Paulo Research Foundation (FAPESP) [2012/20141-5]; CNPq [563961/2010-4, 479766/2011-8]; CNPq-BPQ fellowships	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PROSUP, CAPES-PVE, CAPES DFAIT); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq-BPQ fellowships	This study was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PROSUP, CAPES-PVE: 8881.062178/2014-01; CAPES DFAIT), Sao Paulo Research Foundation (FAPESP: 2012/20141-5); and CNPq (563961/2010-4, 479766/2011-8). K.D.A. and M.C.I. are the recipients of CNPq-BPQ fellowships.	Acar E, 2011, ANATOL J CARDIOL, V11, P732, DOI 10.5152/akd.2011.196; AEBI H, 1984, METHOD ENZYMOL, V105, P121; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Battiprolu Pavan K, 2010, Drug Discov Today Dis Mech, V7, pe135; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; CAGNACCI A, 1992, J CLIN ENDOCR METAB, V74, P1396, DOI 10.1210/jc.74.6.1396; Cai L, 2001, Cardiovasc Toxicol, V1, P181, DOI 10.1385/CT:1:3:181; Call JA, 2015, CIRC-HEART FAIL, V8, P188, DOI 10.1161/CIRCHEARTFAILURE.114.001540; DallAgo P, 1997, BRAZ J MED BIOL RES, V30, P119, DOI 10.1590/S0100-879X1997000100018; De Angelis K, 2002, BRAZ J MED BIOL RES, V35, P1091, DOI 10.1590/S0100-879X2002000900010; De Angelis K, 2009, AUTON NEUROSCI-BASIC, V145, P3, DOI 10.1016/j.autneu.2008.10.013; Dhingra R, 2007, AM J MED, V120, P1054, DOI 10.1016/j.amjmed.2007.08.037; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Flues K, 2010, MATURITAS, V65, P267, DOI 10.1016/j.maturitas.2009.11.007; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goff DC, 2007, AM J CARDIOL, V99, p4I, DOI 10.1016/j.amjcard.2007.03.002; Guha M, 2000, J BIOL CHEM, V275, P17728, DOI 10.1074/jbc.275.23.17728; Hernandez I, 2000, AM J PHYSIOL-REG I, V279, pR1599, DOI 10.1152/ajpregu.2000.279.5.R1599; Hsueh WA, 2003, AM J CARDIOL, V92, p10J, DOI 10.1016/S0002-9149(03)00611-8; Irigoyen MC, 2005, HYPERTENSION, V46, P998, DOI 10.1161/01.HYP.0000176238.90688.6b; Jorge L, 2012, EXP DIABETES RES, DOI 10.1155/2012/108680; KANNEL WB, 1976, ANN INTERN MED, V85, P447, DOI 10.7326/0003-4819-85-4-447; Kaseta JR, 1999, J CLIN ENDOCR METAB, V84, P1835, DOI 10.1210/jc.84.6.1835; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim JS, 2014, BIOL SPORT, V31, P73, DOI 10.5604/20831862.1093775; Latour MG, 2001, J APPL PHYSIOL, V90, P235, DOI 10.1152/jappl.2001.90.1.235; Leuzzi C, 2012, G ITAL CARDIOL, V13, P401, DOI 10.1714/1073.11757; LITWIN SE, 1990, J CLIN INVEST, V86, P481, DOI 10.1172/JCI114734; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAEDA CY, 1995, HYPERTENSION, V26, P1100, DOI 10.1161/01.HYP.26.6.1100; MAEDA CY, 1995, BRAZ J MED BIOL RES, V28, P497; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; MATUTE ML, 1973, ENDOCRINOLOGY, V92, P762, DOI 10.1210/endo-92-3-762; Mosca L, 2007, J AM COLL CARDIOL, V49, P1230, DOI 10.1016/j.jacc.2007.02.020; Pinkney JH, 1997, DIABETES, V46, pS9, DOI 10.2337/diab.46.2.S9; Quinteiro H, 2015, MENOPAUSE, V22, P534, DOI [10.1097/GME.0000000000000344, 10.1097/gme.0000000000000344]; Renna NF, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/513251; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Rossi R, 2002, PATHOPHYSIOL HAEMO T, V32, P325, DOI 10.1159/000073591; Rouyer O, 2007, EXP PHYSIOL, V92, P1047, DOI 10.1113/expphysiol.2007.038851; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Samsioe G, 1998, MATURITAS, V30, P11, DOI 10.1016/S0378-5122(98)00054-1; Sanches IC, 2014, INT J SPORTS MED, V35, P323, DOI 10.1055/s-0033-1351254; Sans S, 1997, EUR HEART J, V18, P1231; SATO Y, 1979, BIOCHEM MED METAB B, V21, P104, DOI 10.1016/0006-2944(79)90061-9; Schaan BD, 2004, BRAZ J MED BIOL RES, V37, P1895, DOI 10.1590/S0100-879X2004001200016; Shiguemoto GE, 2012, SCAND J MED SCI SPOR, V22, P607, DOI 10.1111/j.1600-0838.2010.01284.x; Souza SBC, 2007, HYPERTENSION, V50, P786, DOI 10.1161/HYPERTENSIONAHA.107.095000; Sowers MR, 1995, EPIDEMIOL REV, V17, P287, DOI 10.1093/oxfordjournals.epirev.a036194; Strasser B, 2010, SPORTS MED, V40, P397, DOI 10.2165/11531380-000000000-00000; VANNINEN E, 1992, AM J CARDIOL, V70, P371, DOI 10.1016/0002-9149(92)90622-6; Wichi R, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-14	53	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202731	10.1371/journal.pone.0202731	http://dx.doi.org/10.1371/journal.pone.0202731			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192778	Green Submitted, Green Published, gold			2022-12-26	WOS:000444093600031
J	Schrandt, M; Powers, S; Rikard, FS; Thongda, W; Peatman, E				Schrandt, Meagan; Powers, Sean; Rikard, F. Scott; Thongda, Wilawan; Peatman, Eric			Short-term low salinity mitigates effects of oil and dispersant on juvenile eastern oysters: A laboratory experiment with implications for oil spill response activities	PLOS ONE			English	Article							WATER-HORIZON OIL; PETROLEUM-HYDROCARBONS; CRASSOSTREA-VIRGINICA; AMERICAN OYSTER; INTRASPECIFIC DIVERSITY; ECOSYSTEM SERVICES; CRUDE-OIL; GULF; CONSEQUENCES; RESISTANCE	Following the Deepwater Horizon oil spill, eastern oyster (Crassostrea virginica) reefs in the northern Gulf of Mexico were exposed to oil and various associated clean-up activities that may have compromised oyster reef health. Included in the exposure was oil, dispersant, and in some locales, atypical salinity regimes. Oil and dispersants can be detrimental to oysters and the effects of salinity depend on the level. In addition to these extrinsic factors, genetic diversity of oyster populations may help the oysters respond to stressors, as demonstrated in other systems. We used a 3x3x2 factorial design to experimentally examine the effects of oil/dispersed oil, intraspecific genetic diversity, and salinity on juvenile (ca. 25 mm shell height) oyster survivorship and growth during a 21-d exposure in a closed, recirculating system. The genetic effect was weak overall, oil and dispersed oil negatively affected juvenile oyster survivorship, and low salinity mitigated mortality in oil and dispersed oil treatments. Survivorship was about 40% greater in low-salinity than in mesohaline water for both oil and dispersed oil treatments, bringing survivorship in low salinity oil-only treatments to a similar level with low salinity controls (no oil). Oyster growth was minimal after 21 d but appeared to be negatively affected by oil and dispersed oil, and had a significant interaction with salinity. Our results may be informative for future decisions regarding oil spill response activities and suggest that a pulse of low salinity water may be a viable short-term mitigation option for oysters if filtration characteristics, exposure time, and water temperatures are all considered, in addition to weighing the costs and benefits of this type of response on other organisms and habitats.	[Schrandt, Meagan; Powers, Sean] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Schrandt, Meagan; Powers, Sean] Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA; [Rikard, F. Scott] Auburn Univ, Shellfish Lab, Dauphin Isl, AL USA; [Thongda, Wilawan; Peatman, Eric] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA; [Schrandt, Meagan] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL 33701 USA	University of South Alabama; Dauphin Island Sea Lab; Auburn University System; Auburn University; Auburn University System; Auburn University; Florida Fish & Wildlife Conservation Commission	Schrandt, M (corresponding author), Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA.; Schrandt, M (corresponding author), Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA.; Schrandt, M (corresponding author), Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL 33701 USA.	Meagan.Schrandt@MyFWC.com	Thongda, Wilawan/AFQ-7631-2022	Thongda, Wilawan/0000-0002-5611-8441; Powers, Sean/0000-0002-4770-9944; Schrandt, Meagan/0000-0002-0482-5072	The Gulf of Mexico Research Initiative through the Alabama Center for Ecological Resilience Consortium	The Gulf of Mexico Research Initiative through the Alabama Center for Ecological Resilience Consortium	This research was made possible by a grant from The Gulf of Mexico Research Initiative through the Alabama Center for Ecological Resilience Consortium administered by the Dauphin Island Sea Lab.	Allen T. E., 1984, OIL SPILL CHEM DISPE; Almeda R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067212; Beyer J, 2016, MAR POLLUT BULL, V110, P28, DOI 10.1016/j.marpolbul.2016.06.027; Brown BL, 2005, AQUAC RES, V36, P1544, DOI 10.1111/j.1365-2109.2005.01377.x; Burgess R. M., 2003, PAHS ECOTOXICOLOGICA; BUROKER NE, 1983, MAR BIOL, V75, P99, DOI 10.1007/BF00392635; Butler P. A., 1954, Fishery Bulletin United States, V55, P479; Carmichael RH, 2012, ENVIRON SCI TECHNOL, V46, P12787, DOI 10.1021/es302369h; CHAPMAN PM, 1983, MAR POLLUT BULL, V14, P81, DOI 10.1016/0025-326X(83)90305-3; CHATRY M, 1983, CONTRIB MAR SCI, V26, P81; DENBESTEN PJ, 2003, PAHS ECOTOXICOLOGICA; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Fry B, 2014, MAR POLLUT BULL, V80, P282, DOI 10.1016/j.marpolbul.2013.10.018; Galtsoff P.S., 1964, FISHERY B FISH WILDL, V64, P1, DOI DOI 10.1111/J.1439-0388.2007.00702.X; Gamfeldt L, 2005, ECOLOGY, V86, P3219, DOI 10.1890/05-0377; Grabowski JH, 2012, BIOSCIENCE, V62, P900, DOI 10.1525/bio.2012.62.10.10; Hanley TC, 2016, ECOLOGY, V97, P1518, DOI 10.1890/15-1710.1; Hare MP, 1998, MOL BIOL EVOL, V15, P119, DOI 10.1093/oxfordjournals.molbev.a025908; His E, 2000, ADV MAR BIOL, V37, P1; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; INGLE ROBERT M., 1951, BULL MARINE SCI GULF AND CARIBBEAN, V1, P111; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kimbro DL, 2017, ECOSPHERE, V8, P1; Kujawinski EB, 2011, ENVIRON SCI TECHNOL, V45, P1298, DOI 10.1021/es103838p; La Peyre MK, 2013, ESTUAR COAST SHELF S, V135, P146, DOI 10.1016/j.ecss.2013.10.001; Langdon CJ, 2016, ENVIRON TOXICOL CHEM, V35, P2029, DOI 10.1002/etc.3352; Lessard RR, 2000, SPILL SCI TECHNOL B, V6, P59, DOI 10.1016/S1353-2561(99)00061-4; Li M, 1998, MAR POLLUT BULL, V36, P961, DOI 10.1016/S0025-326X(98)00096-4; Liu ZF, 2016, DEEP-SEA RES PT II, V129, P292, DOI 10.1016/j.dsr2.2014.01.013; Martinez ML, 2012, FRONT ECOL ENVIRON, V10, P44, DOI 10.1890/100151; NEWKIRK G, 1978, MAR BIOL, V48, P227, DOI 10.1007/BF00397149; Page CA, 2000, WATER RES, V34, P2507, DOI 10.1016/S0043-1354(99)00398-X; Park K, 2014, MAR ENVIRON RES, V94, P48, DOI 10.1016/j.marenvres.2013.12.003; PIERCE SK, 1992, MAR BIOL, V113, P107, DOI 10.1007/BF00367644; Powers SP, 2017, MAR ECOL PROG SER, V576, P175, DOI 10.3354/meps12147; Powers SP, 2017, MAR ECOL PROG SER, V576, P189, DOI 10.3354/meps12201; REEB CA, 1990, GENETICS, V124, P397; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Rose CG, 2006, J HERED, V97, P158, DOI 10.1093/jhered/esj019; Rosenbauer R.J., 2010, 20101290 US GEOL SUR; Salehi M, 2017, J APPL TOXICOL, V37, P1464, DOI 10.1002/jat.3494; Sammarco PW, 2013, MAR POLLUT BULL, V73, P129, DOI 10.1016/j.marpolbul.2013.05.029; Smee DL, 2013, OECOLOGIA, V173, P947, DOI 10.1007/s00442-013-2645-4; Thongda W, 2018, MAR BIOTECHNOL, V20, P385, DOI 10.1007/s10126-018-9803-y; Venosa AD, 2003, SPILL SCI TECHNOL B, V8, P163, DOI 10.1016/S1353-2561(03)00019-7; Vignier J, 2017, ENVIRON POLLUT, V225, P270, DOI 10.1016/j.envpol.2016.11.052; Vignier J, 2015, MAR POLLUT BULL, V100, P426, DOI 10.1016/j.marpolbul.2015.08.011; Volety AK, 2014, ECOL INDIC, V44, P108, DOI 10.1016/j.ecolind.2014.03.012; Wade TL, 2016, MAR POLLUT BULL, V103, P286, DOI 10.1016/j.marpolbul.2015.12.002; Xia K, 2012, ENVIRON SCI TECHNOL, V46, P5310, DOI 10.1021/es2042433	51	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203485	10.1371/journal.pone.0203485	http://dx.doi.org/10.1371/journal.pone.0203485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192837	gold, Green Published, Green Submitted			2022-12-26	WOS:000444093600083
J	Sioofy-Khojine, AB; Oikarinen, S; Honkanen, H; Huhtala, H; Lehtonen, JP; Briese, T; Hyoty, H				Sioofy-Khojine, Amir-Babak; Oikarinen, Sami; Honkanen, Hanna; Huhtala, Heini; Lehtonen, Jussi P.; Briese, Thomas; Hyoty, Heikki		TEDDY Study Grp	Molecular epidemiology of enteroviruses in young children at increased risk of type 1 diabetes	PLOS ONE			English	Article							HUMAN PARECHOVIRUS SURVEILLANCE; POLYMERASE-CHAIN-REACTION; EMBRYO CELL-CULTURES; HLA CLASS-I; UNITED-STATES; ISLET AUTOIMMUNITY; MOUTH-DISEASE; INFECTIONS; POLIOMYELITIS; RECOMBINATION	Background Young children are susceptible to enterovirus (EV) infections, which cause significant morbidity in this age group. However, the current knowledge regarding the epidemiology of EVs and the circulating virus strains is mostly based on viruses detected in children with severe diseases leading to contact with the health care system, while the vast reservoir of EVs that circulate in the general population is less characterized. Methodology The present study investigates the types and the prevalence of EVs circulating in the young children of the background population in Georgia, Colorado, and Washington State in the USA, and Germany, Sweden, and Finland in Europe. A total of 4018 stool samples, collected monthly from 300 healthy and non-hospitalized children at the age of 3 +/- 18 months in 2005 +/- 2009, were analyzed for the presence of EVs using RT-PCR, followed by sequencing of the VP1-2A region of the viral genome to type the EV(s) present. All of the children carried type HLA-DQ2 or -DQ8 alleles associated with type 1 diabetes. Principal findings Altogether 201 children (67%) were found to be EV positive. The prevalence was much lower in Finnish children (26%) than in the children of the other counties combined (75%). Infections increased by age and showed a nadir during the winter months. Children who carried both the HLA-DQ2 and -DQ8 alleles had less infections than children who were homozygous for these alleles. Coxsackieviruses type A were the most frequently detected viruses in all geographical regions. Coxsackievirus type A4, Echovirus type 18, and Echovirus type 25 were shed for longer time periods than the other EV types. Conclusions Compared to prevalence data from symptomatic patients requiring medical attention, this study provides a better view of EVs circulating in young children in the USA and in Europe. The observations may prove useful for the selection of strategies for designing EV vaccines in the future. The study also confirms our previous serological findings suggesting that EV infections are relatively rare in Finland.	[Sioofy-Khojine, Amir-Babak; Oikarinen, Sami; Honkanen, Hanna; Lehtonen, Jussi P.; Hyoty, Heikki] Univ Tampere, Fac Med & Life Sci, Dept Virol, Tampere, Finland; [Oikarinen, Sami; Hyoty, Heikki] Pirkanmaa Hosp Dist, Fimlab Labs, Tampere, Finland; [Huhtala, Heini] Univ Tampere, Fac Social Sci, Tampere, Finland; [Briese, Thomas] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY USA	Tampere University; Pirkanmaa Hospital District; Tampere University; Columbia University	Sioofy-Khojine, AB (corresponding author), Univ Tampere, Fac Med & Life Sci, Dept Virol, Tampere, Finland.	Amirbabak.Sioofy.Khojine@staff.uta.fi	Sioofy-Khojine, Amir-Babak/M-6008-2019	Sioofy-Khojine, Amir-Babak/0000-0001-5538-5153; Hyoty, Heikki/0000-0003-0370-4145; Kurppa, Kalle/0000-0003-4757-2164	Juvenile Diabetes Research Foundation (JDRF); Reino Lahtikari Foundation; Academy of Finland; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01 DK63829, U01 DK63861, U01 DK63821, U01 DK63865, U01 DK63863, U01 DK63836, U01 DK63790, UC4 DK63829, UC4 DK63861, UC4 DK63821, UC4 DK63865, UC4 DK63863, UC4 DK63836, UC4 DK95300, UC4 DK100238, UC4 DK106955, HHSN267200700014C]; National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Child Health and Human Development (NICHD); National Institute of Environmental Health Sciences (NIEHS); Centers for Disease Control and Prevention (CDC); NIH/NCATS Clinical and Translational Science Awards [UL1 TR000064]; University of Colorado [UL1 TR001082]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK112243, UC4DK117483] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Reino Lahtikari Foundation; Academy of Finland(Academy of Finland); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIH/NCATS Clinical and Translational Science Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of Colorado; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Virus analyses were funded by the Juvenile Diabetes Research Foundation (JDRF), Reino Lahtikari Foundation and the Academy of Finland (grants to HH). The TEDDY study has been funded by U01 DK63829, U01 DK63861, U01 DK63821, U01 DK63865, U01 DK63863, U01 DK63836, U01 DK63790, UC4 DK63829, UC4 DK63861, UC4 DK63821, UC4 DK63865, UC4 DK63863, UC4 DK63836, UC4 DK95300, UC4 DK100238, UC4 DK106955, and contract no. HHSN267200700014C from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development (NICHD), National Institute of Environmental Health Sciences (NIEHS), Juvenile Diabetes Research Foundation (JDRF), and Centers for Disease Control and Prevention (CDC). This work supported in part by the NIH/NCATS Clinical and Translational Science Awards to the University of Florida (UL1 TR000064) and the University of Colorado (UL1 TR001082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi GR, 2015, MMWR-MORBID MORTAL W, V64, P940, DOI 10.15585/mmwr.mm6434a3; CDC U, 2016, NAT ENT SURV SYST NE; Chiang PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048269; Chung Pei-Wen, 2001, Journal of Microbiology Immunology and Infection, V34, P167; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; Hagopian WA, 2011, PEDIATR DIABETES, V12, P733, DOI 10.1111/j.1399-5448.2011.00774.x; Han J, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-178; Honkanen H, 2017, DIABETOLOGIA, V60, P424, DOI 10.1007/s00125-016-4177-z; Hraber P, 2007, HEPATOLOGY, V46, P1713, DOI 10.1002/hep.21889; Hu YF, 2011, J CLIN MICROBIOL, V49, P2426, DOI 10.1128/JCM.00007-11; Hyoty H, 2016, PEDIATR DIABETES, V17, P56, DOI 10.1111/pedi.12370; Khetsuriani N, 2006, MMWR SURVEILL SUMM, V55, P1, DOI DOI 10.1016/j.alit.2017.04.003; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; LANDRY ML, 1981, J CLIN MICROBIOL, V13, P588, DOI 10.1128/JCM.13.3.588-593.1981; LIPSON SM, 1988, J CLIN MICROBIOL, V26, P1298, DOI 10.1128/JCM.26.7.1298-1303.1988; Lonnrot M, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0333-8; Magaret A, 2016, GENES IMMUN, V17, P412, DOI 10.1038/gene.2016.42; Melnick JL, 1990, ENTEROVIRUSES, P590; Miller E, 1997, BIOLOGICALS, V25, P137, DOI 10.1006/biol.1997.0072; NATHANSON N, 1979, AM J EPIDEMIOL, V110, P672, DOI 10.1093/oxfordjournals.aje.a112848; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Pallansch M, 2013, FIELDS VIROLOGY, V1, P490; Pallansch M, 2003, INFECT DIS, P2347; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pons-Salort M, 2018, P NATL ACAD SCI USA, V115, P3078, DOI 10.1073/pnas.1721159115; Ryu WS, 2010, J CLIN MICROBIOL, V48, P2490, DOI 10.1128/JCM.02369-09; Sadeharju K, 2003, DIABETOLOGIA, V46, P1100, DOI 10.1007/s00125-003-1157-x; SCHMIDT NJ, 1975, J CLIN MICROBIOL, V2, P183; Seiskari T, 2007, CLIN EXP IMMUNOL, V148, P47, DOI 10.1111/j.1365-2249.2007.03333.x; Simonen-Tikka ML, 2011, DIABETOLOGIA, V54, P2995, DOI 10.1007/s00125-011-2305-3; Simonen-Tikka ML, 2012, J MED VIROL, V84, P923, DOI 10.1002/jmv.23284; Tan Y, 2016, J VIROL, V90, P1997, DOI 10.1128/JVI.02418-15; Tapia G, 2011, DIABETES CARE, V34, P151, DOI 10.2337/dc10-1413; Tebbens RJD, 2005, AM J EPIDEMIOL, V162, P358, DOI 10.1093/aje/kwi206; Tryfonos C, 2011, J MED MICROBIOL, V60, P1433, DOI 10.1099/jmm.0.029892-0; Tsao LY, 2006, PEDIATR INT, V48, P5, DOI 10.1111/j.1442-200X.2006.02157.x; Villarruel G. R., 2010, Morbidity and Mortality Weekly Report, V59, P1577; Viskari H, 2004, J MED VIROL, V72, P610, DOI 10.1002/jmv.20033; Viskari HR, 2000, DIABETES CARE, V23, P414, DOI 10.2337/diacare.23.3.414; Vuorinen T, 2003, CLIN INFECT DIS, V37, P452, DOI 10.1086/376635; YEUNG WCG, 2011, BMJ-BRIT MED J, V342, DOI DOI 10.1136/BMJ.D35; Zell R, 2017, J GEN VIROL, V98, P2421, DOI 10.1099/jgv.0.000911	44	14	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0201959	10.1371/journal.pone.0201959	http://dx.doi.org/10.1371/journal.pone.0201959			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192755	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600015
J	McClure, SB; Magill, C; Podrug, E; Moore, AMT; Harper, TK; Culleton, BJ; Kennett, DJ; Freeman, KH				McClure, Sarah B.; Magill, Clayton; Podrug, Emil; Moore, Andrew M. T.; Harper, Thomas K.; Culleton, Brendan J.; Kennett, Douglas J.; Freeman, Katherine H.			Fatty acid specific delta C-13 values reveal earliest Mediterranean cheese production 7,200 years ago	PLOS ONE			English	Article							CARBON-ISOTOPE COMPOSITION; RATIO MASS-SPECTROMETRY; ARCHAEOLOGICAL POTTERY; LACTASE-PERSISTENCE; ANIMAL FATS; COLLAGEN EXTRACTION; EASTERN-EUROPE; MILK-PRODUCTS; MILLENNIUM BC; SHEEP MILK	The earliest evidence for cheese production in the Mediterranean is revealed by stable carbon isotope analyses of individual fatty acids in pottery residues from the Dalmatian coast of Croatia. Lipid residue data indicate the presence of milk in the earliest pottery, Impressed Ware, by 5700 cal. BCE (7700 BP). In contrast, by 5200 cal BCE (7200 BP), milk was common in refined Figulina pottery, meat was mostly associated with Danilo ware, cheese occurred in Rhyta, and sieves contained fermented dairy, representing strong links between specific function and stylistically distinctive pottery vessels. Genetic data indicate the prevalence of lactose intolerance among early farming populations. However, young children are lactase persistent until after weaning and could consume milk as a relatively pathogen-free and nutrient rich food source, enhancing their chances of survival into adulthood. Fermentation of milk into yogurt and cheese decreases lactose content. The evidence for fermented dairy products by 5200 cal BCE indicates a larger proportion of the population was able to consume dairy products and benefit from their significant nutritional advantages. We suggest that milk and cheese production among Europe's early farmers reduced infant mortality and helped stimulate demographic shifts that propelled farming communities to expand to northern latitudes.	[McClure, Sarah B.; Harper, Thomas K.; Kennett, Douglas J.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Magill, Clayton] Heriot Watt Univ, Inst Life & Earth Sci, Edinburgh, Midlothian, Scotland; [Podrug, Emil] Muzej Grada Sibenika, Shibenik, Croatia; [Moore, Andrew M. T.] Rochester Inst Technol, Rochester, NY 14623 USA; [Culleton, Brendan J.] Penn State Univ, Energy & Environm Sustainabil Labs, AMS Radiocarbon Facil, University Pk, PA 16802 USA; [Freeman, Katherine H.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Heriot Watt University; Rochester Institute of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	McClure, SB (corresponding author), Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.	sbm19@psu.edu	Freeman, Katherine H/H-5140-2011; McClure, Sarah/I-3359-2015	Freeman, Katherine H/0000-0002-3350-7671; Harper, Thomas Kelley/0000-0002-4969-1653; McClure, Sarah/0000-0002-0763-5725	National Science Foundation [BCS-14-30823, BCS-0422195]; National Geographic Society (NGS) [9146-12]; Rochester Institute of Technology; Pennsylvania State University; Sibenik City Museum; NSF Archaeometry program [BCS-1460369]	National Science Foundation(National Science Foundation (NSF)); National Geographic Society (NGS)(National Geographic Society); Rochester Institute of Technology; Pennsylvania State University; Sibenik City Museum; NSF Archaeometry program	This research was funded by the National Science Foundation (BCS-14-30823 to SBM, EP and DJK; BCS-0422195 to AM), National Geographic Society (NGS#9146-12 to SBM and EP), Rochester Institute of Technology, The Pennsylvania State University, and the Sibenik City Museum. Funding to DJK and BJC for general laboratory support at Penn State University was granted through the NSF Archaeometry program (BCS-1460369).	Auerswald K, 2015, J AGR FOOD CHEM, V63, P10500, DOI 10.1021/acs.jafc.5b03646; Biagi P., 2003, J PREHIST RELIG, V16, P16; Bocquet-Appel JP, 2011, CURR ANTHROPOL, V52, pS497, DOI 10.1086/659243; Bontempo L, 2012, INT DAIRY J, V23, P99, DOI 10.1016/j.idairyj.2011.10.005; Bronk Ramsey C, 2013, OXCAL 4 2 WEB INTERF; Brown L D, 2003, BAR INT SERIES, V1156, P35; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Budja M., 2014, DOC PRAEHIST, V41, P196, DOI [DOI 10.4312/DP.41.11, 10.4312/dp.41.11]; Budja M, 2014, ARCHAEOL ADRIAT, V7, P53; Budja M., 2013, DOCUMENTA PRAEHISTOR, V40, P97; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; COOK GC, 1975, BMJ-BRIT MED J, V3, P135, DOI 10.1136/bmj.3.5976.135; Copley MS, 2003, P NATL ACAD SCI USA, V100, P1524, DOI 10.1073/pnas.0335955100; Craig OE, 2005, ANTIQUITY, V79, P882, DOI 10.1017/S0003598X00115017; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Dudd SN, 1999, J ARCHAEOL SCI, V26, P1473, DOI 10.1006/jasc.1998.0434; Dunne J, 2012, NATURE, V486, P390, DOI 10.1038/nature11186; Evershed R. P, 2002, DOCUMENTA PRAEHISTOR, V21, P73, DOI DOI 10.4312/DP.29.7; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Evershed RP, 2002, ACCOUNTS CHEM RES, V35, P660, DOI 10.1021/ar000200f; Evershed RP, 1997, NATURWISSENSCHAFTEN, V84, P402, DOI 10.1007/s001140050417; Forenbaher S, 2014, NON TRADITIONAL REF, P43; Forenbaher S, 2013, EUR J ARCHAEOL, V16, P589, DOI 10.1179/1461957113Y.0000000038; Gerbault P, 2011, PHILOS T R SOC B, V366, P863, DOI 10.1098/rstb.2010.0268; Greenfield HJ, 2015, WORLD ARCHAEOL, V47, P792, DOI 10.1080/00438243.2015.1029076; Gregg MW, 2009, J ARCHAEOL SCI, V36, P937, DOI 10.1016/j.jas.2008.09.009; Hansel FA, 2004, TETRAHEDRON LETT, V45, P2999, DOI 10.1016/j.tetlet.2004.01.111; Hauff S, 2010, J AGR FOOD CHEM, V58, P707, DOI 10.1021/jf9034805; Herring DA, 1998, AM J PHYS ANTHROPOL, V105, P425, DOI 10.1002/(SICI)1096-8644(199804)105:4<425::AID-AJPA3>3.3.CO;2-7; Heyman MB, 2006, PEDIATRICS, V118, P1279, DOI 10.1542/peds.2006-1721; Hinde K, 2012, J SCI FOOD AGR, V92, P2219, DOI 10.1002/jsfa.5720; JAHREIS G, 1994, J ANIM PHYSIOL AN N, V72, P71, DOI 10.1111/j.1439-0396.1994.tb00373.x; Jensen RG, 2002, J DAIRY SCI, V85, P295, DOI 10.3168/jds.S0022-0302(02)74079-4; Kennett DJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14115; Kindstedt PS., 2012, CHEESE CULTURE HIST; Legge A.J., 2011, DYNAMICS NEOLITHISAT, P176, DOI 10.2307/j.ctvh1dhqm.15; Leonardi M, 2012, INT DAIRY J, V22, P88, DOI 10.1016/j.idairyj.2011.10.010; Lohrke B., 2004, FREIBURGER BEITRAGE, V9; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Magill CR, 2015, ORG GEOCHEM, V88, P29, DOI 10.1016/j.orggeochem.2015.07.009; Marciniak S, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.65; Marijanovic B., 2014, ADRIATICO SENZA CONF, P187; McClure S.B., 2016, FRESH FIELDS PASTURE, P117; McClure SB, 2013, ANTHROPOCENE, V4, P57, DOI 10.1016/j.ancene.2013.11.001; McClure SB, 2014, RADIOCARBON, V56, P1019, DOI 10.2458/56.17918; McClure SB, 2010, RADIOCARBON, V52, P25, DOI 10.1017/S0033822200045008; Mlekuz D, 2005, PREIST DELLITALIA SE, P23; Mlekuz D, 2014, NON TRADITIONAL REF, P139; Moore A.M.T., 2015, EURASIAN PREHISTORY, V11, P155; Moore A, 2007, VJESN ARHEOL MUZ ZAG, V40, P25; Moore A, 2007, VJESN ARHEOL MUZ ZAG, V40, P15; Mottram HR, 1999, J CHROMATOGR A, V833, P209, DOI 10.1016/S0021-9673(98)01041-3; Muehlhoff E., 2013, Milk and dairy products in human nutrition; Necemer M, 2016, J FOOD COMPOS ANAL, V52, P16, DOI 10.1016/j.jfca.2016.07.002; Panetta RJ, 2011, RAPID COMMUN MASS SP, V25, P1373, DOI 10.1002/rcm.5001; Park YW, 2000, SMALL RUMINANT RES, V37, P115, DOI 10.1016/S0921-4488(99)00144-3; Passi S, 2002, J AGR FOOD CHEM, V50, P7314, DOI 10.1021/jf020451y; Pearce Mark, 2016, SUMMER FARMS SEASONA, P47; Pizzillo M, 2005, LIVEST PROD SCI, V94, P33, DOI 10.1016/j.livprodsci.2004.11.024; RADKE M, 1984, ANAL CHEM, V56, P2538, DOI 10.1021/ac00277a061; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Raynal-Ljutovac K, 2008, SMALL RUMINANT RES, V79, P57, DOI 10.1016/j.smallrumres.2008.07.009; Reed K, 2014, NON TRADITIONAL REF, P155; Reed K, 2015, VEG HIST ARCHAEOBOT, V24, P601, DOI 10.1007/s00334-015-0513-3; Regert M, 2011, MASS SPECTROM REV, V30, P177, DOI 10.1002/mas.20271; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Reitz EJ., 1999, ZOOARCHAEOLOGY; Richter EK, 2012, J ANIM SCI, V90, P905, DOI 10.2527/jas.2011-4284; Richter EK, 2012, LIPIDS, V47, P161, DOI 10.1007/s11745-011-3599-0; Rowley-Conwy P, 2011, CURR ANTHROPOL, V52, pS431, DOI 10.1086/658368; Salque M, 2013, NATURE, V493, P522, DOI 10.1038/nature11698; Scampicchio M, 2012, J AGR FOOD CHEM, V60, P11268, DOI 10.1021/jf302846j; Schneider S, 2015, ISOT ENVIRON HEALT S, V51, P33, DOI 10.1080/10256016.2014.988151; SHERRATT A, 1983, WORLD ARCHAEOL, V15, P90, DOI 10.1080/00438243.1983.9979887; Soberl L, 2008, DOC PRAEHIST, V35, P253, DOI 10.4312/dp.35.19; Spangenberg JE, 2006, J ARCHAEOL SCI, V33, P1, DOI 10.1016/j.jas.2005.05.013; Spangenberg JE, 2008, ISOT ENVIRON HEALT S, V44, P189, DOI 10.1080/10256010802066349; Spiteria CD, 2016, P NATL ACAD SCI USA, V113, P13594, DOI 10.1073/pnas.1607810113; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Teoh ML, 2014, J ARCHAEOL SCI, V50, P350, DOI 10.1016/j.jas.2014.07.007; Teter B. B., 2006, Advances in conjugated linoleic acid research, Volume 3, P3; Tolkach A, 2007, LAIT, V87, P301, DOI 10.1051/lait:2007012; Tykot R.H., 2014, ADRIATICO SENZA CONF, P171; Tzedakis PC, 2005, QUATERNARY SCI REV, V24, P1585, DOI 10.1016/j.quascirev.2004.11.012; U.S. Department of Agriculture, 2016, NON TRADITIONAL REF, V1; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; Vlaeminck B, 2006, ANIM FEED SCI TECH, V131, P389, DOI 10.1016/j.anifeedsci.2006.06.017	87	29	30	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202807	10.1371/journal.pone.0202807	http://dx.doi.org/10.1371/journal.pone.0202807			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS6HC	30183735	gold, Green Published, Green Submitted			2022-12-26	WOS:000443789900038
J	Traboulsi, T; El Ezzy, M; Dumeaux, V; Audemard, E; Mader, S				Traboulsi, Tatiana; El Ezzy, Mohamed; Dumeaux, Vanessa; Audemard, Eric; Mader, Sylvie			Role of SUMOylation in differential ER alpha transcriptional repression by tamoxifen and fulvestrant in breast cancer cells	ONCOGENE			English	Article							ESTROGEN-RECEPTOR-ALPHA; SUMO MODIFICATION; POSTMENOPAUSAL WOMEN; HISTONE SUMOYLATION; TISSUE-SPECIFICITY; ANDROGEN RECEPTOR; ENDOCRINE THERAPY; PURE ANTIESTROGEN; ESR1 MUTATIONS; NUCLEAR	Antiestrogens (AEs) are widely used for treatment of estrogen receptor alpha (ER alpha)-positive breast cancer, but display variable degrees of partial agonism in estrogen target tissues and breast cancer (BC) cells. The fact that BC cells resistant to selective ER modulators (SERMs) like tamoxifen (Tam) can still be sensitive to pure AEs, also called selective ER downregulators, suggests different mechanisms of action, some of which may contribute to the more complete suppression of estrogen target genes by pure AEs. We report herein that pure AEs such as fulvestrant induce transient binding of ER alpha to DNA, followed by rapid release after 30-40 min without loss of nuclear localization. Loss of DNA binding preceded receptor degradation and was not prevented by proteasome inhibition. Chromatin was less accessible in the presence of fulvestrant than with estradiol or Tam as early as 20 min following treatment, suggesting that chromatin remodeling by pure AEs at ER alpha target regions prevents transcription in spite of receptor binding. SUMO2/3 marks were detected on chromatin at the peak of ER alpha binding in cells treated with pure AEs, but not SERMs. Furthermore, decreasing SUMOylation by overexpressing the deSUMOylase SENP1 significantly delayed receptor release from DNA and de-repressed expression of estrogen target genes in the presence of fulvestrant, both in ER alpha-expressing MCF-7 cells and in transiently transfected ER-negative SK-BR-3 cells. Finally, mutation V534E, identified in a breast metastasis resistant to hormonal therapies, prevented ER alpha modification and resulted in increased transcriptional activity of estrogen target genes in the presence of fulvestrant in SK-BR-3 cells. Together, our results establish a role for SUMOylation in achieving a more complete transcriptional shut-off of estrogen target genes by pure AEs vs. SERMs in BC cells.	[Traboulsi, Tatiana; El Ezzy, Mohamed; Dumeaux, Vanessa; Audemard, Eric; Mader, Sylvie] Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Traboulsi, Tatiana; Mader, Sylvie] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3C 3J7, Canada; [Dumeaux, Vanessa] Concordia Univ, PERFORM Ctr, Montreal, PQ H4B 1R6, Canada	Universite de Montreal; Universite de Montreal; Concordia University - Canada	Mader, S (corresponding author), Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada.; Mader, S (corresponding author), Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3C 3J7, Canada.	sylvie.mader@umontreal.ca		Audemard, Eric/0000-0002-1661-896X; Traboulsi, Tatiana/0000-0001-9769-0340	Canadian Institutes of Health Research [125863]; Canadian Imperial Bank of Commerce (CIBC) breast cancer research chair at Universite de Montreal; Fonds de recherche Quebec-sante (FRQS) scholarship; Universite de Montreal	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Imperial Bank of Commerce (CIBC) breast cancer research chair at Universite de Montreal; Fonds de recherche Quebec-sante (FRQS) scholarship; Universite de Montreal	This work has been funded by the Canadian Institutes of Health Research (grant 125863 to SM) and from the Canadian Imperial Bank of Commerce (CIBC) breast cancer research chair at Universite de Montreal (to SM). TT was the recipient of a Fonds de recherche Quebec-sante (FRQS) scholarship and both TT and MEE were recipients of several scholarships from the Universite de Montreal.	Ali S, 2011, ANNU REV MED, V62, P217, DOI 10.1146/annurev-med-052209-100305; Angus L, 2017, CANCER TREAT REV, V52, P33, DOI 10.1016/j.ctrv.2016.11.001; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; DAUVOIS S, 1993, J CELL SCI, V106, P1377; Flach KD, 2016, J ENDOCRINOL, V229, pR43, DOI 10.1530/JOE-16-0003; Eeckhoute J, 2009, GENOME RES, V19, P372, DOI 10.1101/gr.084582.108; El Khissiin A, 1999, FEBS LETT, V448, P160, DOI 10.1016/S0014-5793(99)00343-9; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; GALLAGHER A, 1993, ENDOCRINOLOGY, V133, P2787, DOI 10.1210/en.133.6.2787; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gushima M, 2010, MOL CELL ENDOCRINOL, V319, P14, DOI 10.1016/j.mce.2010.01.006; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Harrod A, 2017, ONCOGENE, V36, P2286, DOI 10.1038/onc.2016.382; Heideker J, 2009, DNA REPAIR, V8, P517, DOI 10.1016/j.dnarep.2009.01.010; Hilmi K, 2012, MOL CELL BIOL, V32, P3823, DOI 10.1128/MCB.00290-12; Howell A, 2002, J CLIN ONCOL, V20, P3396, DOI 10.1200/JCO.2002.10.057; Htun H, 1999, MOL BIOL CELL, V10, P471, DOI 10.1091/mbc.10.2.471; HU XF, 1993, INT J CANCER, V55, P873, DOI 10.1002/ijc.2910550529; Hua GQ, 2016, P NATL ACAD SCI USA, V113, pE635, DOI 10.1073/pnas.1522826113; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Lemieux S, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx338; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Lupien M, 2007, MOL ENDOCRINOL, V21, P797, DOI 10.1210/me.2006-0074; LYKKESFELDT AE, 1994, CANCER RES, V54, P1587; LYKKESFELDT AE, 1995, INT J CANCER, V61, P529, DOI 10.1002/ijc.2910610417; Maison C, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2016.1225546; MARTIN L, 1978, J ENDOCRINOL, V78, P125, DOI 10.1677/joe.0.0780125; Martinkovich S, 2014, CLIN INTERV AGING, V9, P1437, DOI 10.2147/CIA.S66690; McDonnell DP, 2015, J MED CHEM, V58, P4883, DOI 10.1021/acs.jmedchem.5b00760; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; METZGER D, 1995, MOL ENDOCRINOL, V9, P579, DOI 10.1210/me.9.5.579; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Neyret-Kahn H, 2013, GENOME RES, V23, P1563, DOI 10.1101/gr.154872.113; Osborne CK, 2002, J CLIN ONCOL, V20, P3386, DOI 10.1200/JCO.2002.10.058; Paakinaho V, 2014, NUCLEIC ACIDS RES, V42, P1575, DOI 10.1093/nar/gkt1033; Pike ACW, 2001, STRUCTURE, V9, P145, DOI 10.1016/S0969-2126(01)00568-8; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Pourcet B, 2010, J BIOL CHEM, V285, P5983, DOI 10.1074/jbc.M109.078311; Rahman S, 2017, NUCLEIC ACIDS RES, V45, P3017, DOI 10.1093/nar/gkw1220; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Sanchez R, 2002, BIOESSAYS, V24, P244, DOI 10.1002/bies.10066; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shih HM, 2007, BIOCHEM SOC T, V35, P1397, DOI 10.1042/BST0351397; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Shin JA, 2005, MOL CELL, V19, P817, DOI 10.1016/j.molcel.2005.08.021; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Stenoien DL, 2000, MOL ENDOCRINOL, V14, P518, DOI 10.1210/me.14.4.518; Stielow B, 2008, EMBO REP, V9, P899, DOI 10.1038/embor.2008.127; Tian S, 2002, BIOCHEM J, V367, P907, DOI 10.1042/BJ20021085; Tiefenbach J, 2006, MOL BIOL CELL, V17, P1643, DOI 10.1091/mbc.E05-07-0610; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Traboulsi T, 2017, J MOL ENDOCRINOL, V58, pR15, DOI 10.1530/JME-16-0024; Uchimura Y, 2006, J BIOL CHEM, V281, P23180, DOI 10.1074/jbc.M602280200; WAKELING AE, 1991, CANCER RES, V51, P3867; WARD RL, 1993, BONE MINER, V22, P87, DOI 10.1016/S0169-6009(08)80220-6; Wardell SE, 2012, MOL ENDOCRINOL, V26, P1235, DOI 10.1210/me.2012-1031; Wardell SE, 2011, BIOCHEM PHARMACOL, V82, P122, DOI 10.1016/j.bcp.2011.03.031; Webb P, 2003, J BIOL CHEM, V278, P6912, DOI 10.1074/jbc.M208501200; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Wijayaratne AL, 2001, J BIOL CHEM, V276, P35684, DOI 10.1074/jbc.M101097200	67	15	15	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 14	2019	38	7					1019	1037		10.1038/s41388-018-0468-9	http://dx.doi.org/10.1038/s41388-018-0468-9			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HL3OH	30190545	Green Published, hybrid			2022-12-26	WOS:000458624900007
J	Hauk, V; Vota, D; Gallino, L; Calo, G; Paparini, D; Merech, F; Ochoa, F; Zotta, E; Ramhorst, R; Waschek, J; Leiros, CP				Hauk, Vanesa; Vota, Daiana; Gallino, Lucila; Calo, Guillermina; Paparini, Daniel; Merech, Fatima; Ochoa, Federico; Zotta, Elsa; Ramhorst, Rosanna; Waschek, James; Perez Leiros, Claudia			Trophoblast VIP deficiency entails immune homeostasis loss and adverse pregnancy outcome in mice	FASEB JOURNAL			English	Article						trophoblast function; immunoregulation; early pregnancy	VASOACTIVE-INTESTINAL-PEPTIDE; REGULATORY T-CELLS; ENDOTHELIAL GROWTH-FACTOR; MATERNAL-FETAL INTERFACE; CIRCADIAN-RHYTHMS; EMBRYONIC GROWTH; VEGF EXPRESSION; GENITAL-TRACT; FEMALE; SYSTEM	Immune homeostasis maintenance throughout pregnancy is critical for normal fetal development. Trophoblast cells differentiate into an invasive phenotype and contribute to the transformation of maternal arteries and the functional shaping of decidual leukocyte populations. Insufficient trophoblast invasion, inadequate vascular remodeling, and a loss of immunologic homeostasis are associated with pregnancy complications, such as preeclampsia and intrauterine growth restriction. Vasoactive intestinal peptide (VIP) is a pleiotropic neuropeptide synthetized in trophoblasts at the maternal-placental interface. It regulates the function of trophoblast cells and their interaction with decidual leukocytes. By means of a murine model of pregnancy in normal maternal background with VIP-deficient trophoblast cells, here we demonstrate that trophoblast VIP is critical for trophoblast function: VIP gene haploinsufficiency results in lower matrix metalloproteinase 9 expression, and reduced migration and invasion capacities. A reduced number of regulatory T cells at the implantation sites along with a lower expression of proangiogenic and antiinflammatory markers were also observed. Findings detected in the implantation sites at early stages were followed by an abnormal placental structure and lower fetal weight. This effect was overcome by VIP treatment of the early pregnant mice. Our results support the relevance of trophoblast-synthesized VIP as a critical factor in vivo for trophoblast-cell function and immune homeostasis maintenance in mouse pregnancy.Hauk, V., Vota, D., Gallino, L., Calo, G., Paparini, D., Merech, F., Ochoa, F., Zotta, E., Ramhorst, R., Waschek, J., Leiros, C. P. Trophoblast VIP deficiency entails immune homeostasis loss and adverse pregnancy outcome in mice.	[Hauk, Vanesa; Vota, Daiana; Gallino, Lucila; Calo, Guillermina; Paparini, Daniel; Merech, Fatima; Ramhorst, Rosanna; Perez Leiros, Claudia] Univ Buenos Aires, Fac Ciencias Exactas & Nat IQUIBICEN, Inst Quim Biol, Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Ochoa, Federico; Zotta, Elsa] Univ Buenos Aires, Fac Med, Dept Ciencias Fisiol, Inst Fisiol & Biofis Bernardo Houssay IFIBIO Hous, Buenos Aires, DF, Argentina; [Zotta, Elsa] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Fisiopatol, Buenos Aires, DF, Argentina; [Waschek, James] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Leiros, CP (corresponding author), Univ Buenos Aires, CONICET, IQUIBICEN, Dept Biol Chem,Lab Immunopharmacol,Sch Sci, Ciudad Univ,Pab 2,Int Guiraldes 2160, RA-1428 Buenos Aires, DF, Argentina.	cpleiros@qb.fcen.uba.ar	Calo, Guillermina/GYU-9098-2022	Paparini, Daniel Esteban/0000-0002-3335-4564	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) National Agency of Science and Technology Projects [PICT 2014-0657, 2015-1281, 2016-0464, 2016-1937]; University of Buenos Aires Secretaria de Ciencia y Tecnica (UBACyT)	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) National Agency of Science and Technology Projects; University of Buenos Aires Secretaria de Ciencia y Tecnica (UBACyT)	The authors acknowledge P. Pomata (Instituto de Biologia y Medicina Experimental-Consejo Nacional de Investigaciones Cientificas y Tecnicas (IByME-CONICET), for expert contribution to LCM assays, and M. Brahamian and Z. Naguila (both from Central Animal Facility of the School of Sciences, University of Buenos Aires, Argentina) for expert technical assistance with the VIP-deficient colony breeding. This work was funded by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) National Agency of Science and Technology Projects (PICT 2014-0657 to C.P.L., 2015-1281 to D.V., 2016-0464 to R.R., and 2016-1937 to V.H.), and the University of Buenos Aires Secretaria de Ciencia y Tecnica (2014-2017 to C.P.L. and UBACyT 2016 to R.R.). The authors declare no conflicts of interest.	Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; BEVILACQUA EMAF, 1988, J MORPHOL, V198, P341, DOI 10.1002/jmor.1051980308; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Calo G, 2017, HUM REPROD, V32, P55, DOI 10.1093/humrep/dew292; Collado B, 2005, BBA-MOL CELL RES, V1744, P224, DOI 10.1016/j.bbamcr.2005.04.009; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Croy B.A., 2013, GUIDE INVESTIGATION; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Delgado M, 2001, NAT MED, V7, P563, DOI 10.1038/87887; El-Dayem T., 2016, INT J REPROD CONTRAC, V5, P1593; Eliezer G, 2007, J MOL NEUROSCI, V33, P278, DOI 10.1007/s12031-007-9003-0; Ernerudh J, 2011, AM J REPROD IMMUNOL, V66, P31, DOI 10.1111/j.1600-0897.2011.01049.x; Fernandez-Martinez AB, 2010, CANCER LETT, V299, P11, DOI 10.1016/j.canlet.2010.07.019; Fest S, 2007, AM J REPROD IMMUNOL, V57, P55, DOI 10.1111/j.1600-0897.2006.00446.x; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Fitzgerald JS, 2010, AM J REPROD IMMUNOL, V63, P492, DOI 10.1111/j.1600-0897.2010.00824.x; Fraccaroli L, 2015, J LEUKOCYTE BIOL, V98, P49, DOI 10.1189/jlb.1A1014-492RR; Fraccaroli L, 2014, NEUROIMMUNOMODULAT, V21, P21, DOI 10.1159/000355039; Fraccaroli L, 2009, BRIT J PHARMACOL, V156, P116, DOI 10.1111/j.1476-5381.2008.00055.x; Gallino L, 2016, SCI REP-UK, V6, DOI 10.1038/srep18633; Gomariz RP, 2010, CURR PHARM DESIGN, V16, P1063, DOI 10.2174/138161210790963841; GRESSENS P, 1993, NATURE, V362, P155, DOI 10.1038/362155a0; GRESSENS P, 1994, J CLIN INVEST, V94, P2020, DOI 10.1172/JCI117555; Hauk V, 2014, AM J REPROD IMMUNOL, V71, P120, DOI 10.1111/aji.12167; Hill JM, 2002, PEPTIDES, V23, P1803, DOI 10.1016/S0196-9781(02)00137-7; Hill JM, 1996, J CLIN INVEST, V97, P202, DOI 10.1172/JCI118391; Hu D, 2010, INT J DEV BIOL, V54, P341, DOI 10.1387/ijdb.082768dh; Huppertz B, 2014, J REPROD IMMUNOL, V101, P74, DOI 10.1016/j.jri.2013.04.003; Kappou D, 2015, EXP THER MED, V9, P1091, DOI 10.3892/etm.2015.2280; Laresgoiti-Servitje E, 2010, HUM REPROD UPDATE, V16, P510, DOI 10.1093/humupd/dmq007; Lash GE, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023010; Li MY, 2006, J CLIN INVEST, V116, P2653, DOI 10.1172/JC128462; Lim MA, 2008, INT J DEV NEUROSCI, V26, P423, DOI 10.1016/j.ijdevneu.2008.03.002; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lodde BM, 2006, ANN RHEUM DIS, V65, P195, DOI 10.1136/ard.2005.038232; Loh DH, 2014, J BIOL RHYTHM, V29, P355, DOI 10.1177/0748730414549767; Maduna T, 2016, J NEUROSCI RES, V94, P1472, DOI 10.1002/jnr.23915; Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043; Marzioni D, 2005, J CLIN ENDOCR METAB, V90, P2378, DOI 10.1210/jc.2004-1512; Matson BC, 2014, CELL MOL IMMUNOL, V11, P456, DOI 10.1038/cmi.2014.71; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Moser G, 2010, HUM REPROD, V25, P1127, DOI 10.1093/humrep/deq035; Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x; Nagashima T, 2013, J CLIN INVEST, V123, P2539, DOI 10.1172/JCI65710; OTTESEN B, 1982, AM J OBSTET GYNECOL, V143, P414, DOI 10.1016/0002-9378(82)90083-7; OTTESEN B, 1995, AM J OBSTET GYNECOL, V172, P1615, DOI 10.1016/0002-9378(95)90506-5; Paparini D, 2015, MOL HUM REPROD, V21, P930, DOI 10.1093/molehr/gav059; Passemard S, 2011, J CLIN INVEST, V121, P3072, DOI 10.1172/JCI43824; Plaisier M, 2007, FERTIL STERIL, V88, P176, DOI 10.1016/j.fertnstert.2006.11.102; Plaks V, 2013, P NATL ACAD SCI USA, V110, P11109, DOI 10.1073/pnas.1309561110; PrabhuDas M, 2015, NAT IMMUNOL, V16, P328, DOI 10.1038/ni.3131; Pringle KG, 2007, PLACENTA, V28, P286, DOI 10.1016/j.placenta.2006.04.006; Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Roca V, 2009, REPRODUCTION, V138, P733, DOI 10.1530/REP-09-0171; Rosignoli F, 2006, ANN NY ACAD SCI, V1070, P525, DOI 10.1196/annals.1317.073; Said SI, 2007, PEPTIDES, V28, P1620, DOI 10.1016/j.peptides.2007.06.007; Sasaki Y, 2007, CLIN EXP IMMUNOL, V149, P139, DOI 10.1111/j.1365-2249.2007.03397.x; Schumacher A, 2014, AM J REPROD IMMUNOL, V72, P158, DOI 10.1111/aji.12238; Smith SD, 2009, AM J PATHOL, V174, P1959, DOI 10.2353/ajpath.2009.080995; Spong CY, 1999, ENDOCRINOLOGY, V140, P917, DOI 10.1210/en.140.2.917; St Hilaire RC, 2010, PEPTIDES, V31, P1517, DOI 10.1016/j.peptides.2010.04.024; Stepan H, 2007, J CLIN ENDOCR METAB, V92, P2831, DOI 10.1210/jc.2006-2774; Valdehita A, 2007, REGUL PEPTIDES, V144, P101, DOI 10.1016/j.regpep.2007.06.006; Vota D, 2016, SCI REP-UK, V6, DOI 10.1038/srep26364; Waschek JA, 2013, BRIT J PHARMACOL, V169, P512, DOI 10.1111/bph.12181; Yang J, 2013, PEPTIDES, V42, P105, DOI 10.1016/j.peptides.2013.01.007	69	11	11	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1801	1810		10.1096/fj.201800592RR	http://dx.doi.org/10.1096/fj.201800592RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30204500				2022-12-26	WOS:000457296600023
J	Hu, YL; Jin, R; Gao, M; Xu, H; Zou, SX; Li, XG; Xing, C; Wang, QY; Wang, HL; Feng, JN; Hu, MR; Song, L				Hu, Yongliang; Jin, Rui; Gao, Ming; Xu, Huan; Zou, Shuxian; Li, Xiaoguang; Xing, Chen; Wang, Qiyu; Wang, Hongli; Feng, Jiannan; Hu, Meiru; Song, Lun			Transcriptional repression of IKK beta by p53 in arsenite-induced GADD45 alpha accumulation and apoptosis	ONCOGENE			English	Article							NF-KAPPA-B; TUMOR-SUPPRESSOR; WILD-TYPE; GENE; ACTIVATION; ALPHA; CELLS; UBIQUITINATION; STABILIZATION; MECHANISMS	Our previous studies revealed that GADD45 alpha is a liable protein, which undergoes MDM2-dependent constitutive ubiquitination and degradation in resting HepG2 hepatoma cells. Arsenite exposure induces ribosomal stress responses mediated by the ribosomal protein S7, which can block MDM2 activity and result in GADD45a accumulation and cell apoptosis. In the present study, we found that one of the catalytic subunits of I.B kinase (IKK), IKK beta, exerted a novel IKK alpha -and NF-kappa B-independent function in stabilizing MDM2 and therefore contributed to ubiquitination-dependent degradation of GADD45 alpha in resting HepG2 cells. Arsenite stimulation induced transactivation of p53, which formed a complex with its downstream target, Ets-1, and then synergistically repressed IKK beta transcription, reduced MDM2 stability, and ultimately removed the inhibitory effect of MDM2 on GADD45 alpha induction. In addition, DAPK1 functioned as an upstream protein kinase triggering p53/Ets-1-dependent IKK beta and MDM2 reduction and GADD45 alpha accumulation, thus promoting apoptosis in HepG2 cells. Subsequent studies further revealed that the activation of the DAPK1/p53/Ets-1/IKK beta/MDM2/GADD45 alpha cascade was a common signaling event in mediating apoptosis of diverse cancer cells induced by arsenite and other tumor therapeutic agents. Therefore, we conclude that data in the current study have revealed a novel role for IKK beta in negatively regulating GADD45 alpha protein stability and the contribution of p53-dependent IKK beta reduction to mediating cancer cell apoptosis.	[Hu, Yongliang; Gao, Ming; Xu, Huan; Zou, Shuxian; Li, Xiaoguang; Xing, Chen; Wang, Qiyu; Wang, Hongli; Feng, Jiannan; Hu, Meiru; Song, Lun] Beijing Inst Brain Sci, Dept Neuroimmunol, 27 Taiping Rd, Beijing 100850, Peoples R China; [Jin, Rui] Beijing Inst Biotechnol, Dept Tumor Biol, 27 Taiping Rd, Beijing 100850, Peoples R China; [Gao, Ming] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Chem & Ecotoxicol, 18 Shuangqing Rd, Beijing 100085, Peoples R China; [Zou, Shuxian; Song, Lun] Guangxi Med Univ, 22 Shuangyong Rd, Nanning 530021, Peoples R China; [Song, Lun] Anhui Med Univ, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China; [Hu, Yongliang] 309 Hosp PLA, Dept Dermatol, 17 Heishanhu St, Beijing 100091, Peoples R China; [Li, Xiaoguang] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, 270 Dongan Rd, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Guangxi Medical University; Anhui Medical University; Fudan University	Song, L (corresponding author), Beijing Inst Brain Sci, Dept Neuroimmunol, 27 Taiping Rd, Beijing 100850, Peoples R China.; Song, L (corresponding author), Guangxi Med Univ, 22 Shuangyong Rd, Nanning 530021, Peoples R China.; Song, L (corresponding author), Anhui Med Univ, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.	lunsong0752@163.com	邢, 陈/GWR-2940-2022	邢, 陈/0000-0003-2784-840X	National Natural Science Foundation of China [31570758, 91743115, 31270797]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Dr. Guojiang Chen to provide the A549 cells. We thank Dr. Ailing Li and Weihua Li to provide the Hep3B cells. This project is supported by the National Natural Science Foundation of China (No. 31570758, 91743115, 31270797) to Dr. Lun Song.	Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Dong W, 2012, NUCLEIC ACIDS RES, V40, P2940, DOI 10.1093/nar/gkr1216; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Fischer M, 2017, ONCOGENE, V36, P3943, DOI 10.1038/onc.2016.502; Gao M, 2013, NUCLEIC ACIDS RES, V41, P5210, DOI 10.1093/nar/gkt223; Gao M, 2010, J CELL BIOCHEM, V109, P1264, DOI 10.1002/jcb.22509; Gao M, 2009, CURR PROTEIN PEPT SC, V10, P388, DOI 10.2174/138920309788922216; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gu LB, 2004, J BIOL CHEM, V279, P52141, DOI 10.1074/jbc.M407915200; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Ho J, 2013, CELL DEATH DIFFER, V10, P403; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Huang WC, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-3; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Kim E, 2003, ONCOGENE, V22, P7716, DOI 10.1038/sj.onc.1207155; Li BQ, 2001, J BIOL CHEM, V276, P29729, DOI 10.1074/jbc.M101167200; Li Y, 2011, MOL CELL BIOCHEM, V358, P61, DOI 10.1007/s11010-011-0921-3; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Mitchell S, 2016, WIRES SYST BIOL MED, V8, P227, DOI 10.1002/wsbm.1331; Moskalev AA, 2012, AGEING RES REV, V11, P51, DOI 10.1016/j.arr.2011.09.003; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Pastorcic M, 2000, J BIOL CHEM, V275, P34938, DOI 10.1074/jbc.M005411200; Song L, 2008, EXP CELL RES, V314, P2187, DOI 10.1016/j.yexcr.2008.04.002; Song L, 2007, MOL CELL BIOL, V27, P2713, DOI 10.1128/MCB.00657-06; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Song L, 2010, BBA-MOL CELL RES, V1803, P323, DOI 10.1016/j.bbamcr.2010.01.006; St Clair S, 2004, MOL CELL, V16, P725; Sullivan KD, 2018, CELL DEATH DIFFER, V25, P133, DOI 10.1038/cdd.2017.174; Sullivan KD, 2012, BBA-REV CANCER, V1825, P229, DOI 10.1016/j.bbcan.2012.01.004; Tamura RE, 2012, CURR MOL MED, V12, P634; Tergaonkar V, 2002, CANCER CELL, V1, P493, DOI 10.1016/S1535-6108(02)00068-5; Tschaharganeh DF, 2014, CELL, V158, P579, DOI 10.1016/j.cell.2014.05.051; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; Xu XD, 2016, AUTOPHAGY, V12, P1832, DOI 10.1080/15548627.2016.1204496; Zhang Y, 2004, J BIOL CHEM, V279, P42545, DOI 10.1074/jbc.M314213200	38	7	7	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 31	2019	38	5					731	746		10.1038/s41388-018-0478-7	http://dx.doi.org/10.1038/s41388-018-0478-7			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HJ6LI	30177839	Green Published, hybrid			2022-12-26	WOS:000457300300009
J	Sheehe, JL; Bonev, AD; Schmoker, AM; Ballif, BA; Nelson, MT; Moon, TM; Dostmann, WR				Sheehe, Jessica L.; Bonev, Adrian D.; Schmoker, Anna M.; Ballif, Bryan A.; Nelson, Mark T.; Moon, Thomas M.; Dostmann, Wolfgang R.			Oxidation of cysteine 117 stimulates constitutive activation of the type I alpha cGMP-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic GMP (cGMP); oxidation-reduction (redox); protein kinase G (PKG); potassium channel; signal transduction; AGC kinases; cGMP-dependent protein kinase; allostery; constitutive activation	BLOOD-PRESSURE; BINDING; PHOSPHORYLATION; IDENTIFICATION; SUBUNIT; CHANNEL; BETA; PKG; HYPERTENSION; PHOSPHATASE	The type I cGMP-dependent protein kinase (PKG I) is an essential regulator of vascular tone. It has been demonstrated that the type I isoform can be constitutively activated by oxidizing conditions. However, the amino acid residues implicated in this phenomenon are not fully elucidated. To investigate the molecular basis for this mechanism, we studied the effects of oxidation using recombinant WT, truncated, and mutant constructs of PKG I. Using an in vitro assay, we observed that oxidation with hydrogen peroxide (H2O2) resulted in constitutive, cGMP-independent activation of PKG I. PKG I C42S and a truncation construct that does not contain Cys-42 (53) were both constitutively activated by H2O2. In contrast, oxidation of PKG I C117S maintained its cGMP-dependent activation characteristics, although oxidized PKG I C195S did not. To corroborate these results, we also tested the effects of our constructs on the PKG I-specific substrate, the large conductance potassium channel (K-Ca 1.1). Application of WT PKG I activated by either cGMP or H2O2 increased the open probabilities of the channel. Neither cGMP nor H2O2 activation of PKG I C42S significantly increased channel open probabilities. Moreover, cGMP-stimulated PKG I C117S increased K-Ca 1.1 activity, but this effect was not observed under oxidizing conditions. Finally, we observed that PKG I C42S caused channel flickers, indicating dramatically altered K-Ca 1.1 channel characteristics compared with channels exposed to WT PKG I. Cumulatively, these results indicate that constitutive activation of PKG I proceeds through oxidation of Cys-117 and further suggest that the formation of a sulfur acid is necessary for this phenotype.	[Sheehe, Jessica L.; Bonev, Adrian D.; Nelson, Mark T.; Dostmann, Wolfgang R.] Univ Vermont, Larner Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; [Schmoker, Anna M.; Ballif, Bryan A.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [Moon, Thomas M.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	University of Vermont; University of Vermont; University of Arizona	Dostmann, WR (corresponding author), Univ Vermont, Larner Coll Med, Dept Pharmacol, Burlington, VT 05405 USA.; Moon, TM (corresponding author), Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA.	thomasmoon@email.arizona.edu; wolfgang.dostmann@uvm.edu	; Moon, Thomas/F-4896-2013	Schmoker, Anna/0000-0003-2830-5650; Nelson, Mark/0000-0002-6608-8784; Moon, Thomas/0000-0003-1568-8808	Vermont Genetics Network through National Institutes of Health (NIH) from the INBRE program of NIGMS [8P20GM103449]; NIH from the COBRE Program of the National Center for Research Resources [5 P30 RR032135]; NIGMS [8 P30 GM103498]; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR032135] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131181, R01HL121706, T32HL007594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103498, P20GM103449] Funding Source: NIH RePORTER	Vermont Genetics Network through National Institutes of Health (NIH) from the INBRE program of NIGMS; NIH from the COBRE Program of the National Center for Research Resources; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Werner Tegge (Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany) for synthesizing the W15 peptide substrate used in the phosphotransferase assays. Mass spectrometry was supported by the Vermont Genetics Network through National Institutes of Health (NIH) Grant 8P20GM103449 from the INBRE program of NIGMS. SDS-PAGE experiments were imaged with support from NIH Grants 5 P30 RR032135 from the COBRE Program of the National Center for Research Resources and 8 P30 GM103498 from NIGMS. We also thank the Hondal Laboratory at the University of Vermont for helpful discussions and use of resources.	AITKEN A, 1984, BIOCHIM BIOPHYS ACTA, V790, P219, DOI 10.1016/0167-4838(84)90025-6; ALIOUA A, 1995, AM J PHYSIOL-LUNG C, V268, pL1057, DOI 10.1152/ajplung.1995.268.6.L1057; Alverdi V, 2008, J MOL BIOL, V375, P1380, DOI 10.1016/j.jmb.2007.11.053; Blanton RM, 2013, J GERONTOL A-BIOL, V68, P1351, DOI 10.1093/gerona/glt042; Brewer TF, 2015, ANNU REV BIOCHEM, V84, P765, DOI 10.1146/annurev-biochem-060614-034018; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Casteel DE, 2005, J BIOL CHEM, V280, P38211, DOI 10.1074/jbc.M507021200; Chan SL, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/793630; Chan SL, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00133; Dostmann WRG, 2000, P NATL ACAD SCI USA, V97, P14772, DOI 10.1073/pnas.97.26.14772; FEIL R, 1995, BIOCHEMISTRY-US, V34, P13152, DOI 10.1021/bi00040a029; Francis SH, 1996, J BIOL CHEM, V271, P20748, DOI 10.1074/jbc.271.34.20748; Friebe A, 2003, CIRC RES, V93, P96, DOI 10.1161/01.RES.0000082524.34487.31; Fukao M, 1999, J BIOL CHEM, V274, P10927, DOI 10.1074/jbc.274.16.10927; Gray SP, 2016, ARTERIOSCL THROM VAS, V36, P295, DOI 10.1161/ATVBAHA.115.307012; Han J, 1996, ANAL BIOCHEM, V234, P107, DOI 10.1006/abio.1996.0059; HEIL WG, 1987, EUR J BIOCHEM, V168, P117, DOI 10.1111/j.1432-1033.1987.tb13395.x; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Kalyanaraman H, 2017, J BIOL CHEM, V292, P8262, DOI 10.1074/jbc.C117.787358; Karplus PA, 2015, FREE RADICAL BIO MED, V80, P183, DOI 10.1016/j.freeradbiomed.2014.10.009; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; Khavandi K, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf6625; Kim JJ, 2016, STRUCTURE, V24, P710, DOI 10.1016/j.str.2016.03.009; Kim YM, 2017, AM J PHYSIOL-CELL PH, V312, pC749, DOI 10.1152/ajpcell.00346.2016; Kyle BD, 2013, FASEB J, V27, P2027, DOI 10.1096/fj.12-223669; LANDGRAF W, 1991, J BIOL CHEM, V266, P16305; Lee E, 2007, J MOL BIOL, V373, P1198, DOI 10.1016/j.jmb.2007.08.049; Moon TM, 2018, J BIOL CHEM, V293, P7916, DOI 10.1074/jbc.RA117.000647; Moon TM, 2015, CHEM BIOL, V22, P1653, DOI 10.1016/j.chembiol.2015.11.005; Muller PM, 2012, FREE RADICAL BIO MED, V53, P1574, DOI 10.1016/j.freeradbiomed.2012.08.011; Nakamura T, 2015, J CLIN INVEST, V125, P2468, DOI 10.1172/JCI80275; Nausch LWM, 2008, P NATL ACAD SCI USA, V105, P365, DOI 10.1073/pnas.0710387105; Osborne BW, 2011, STRUCTURE, V19, P1317, DOI 10.1016/j.str.2011.06.012; Patel D, 2017, ADV EXP MED BIOL, V967, P227, DOI 10.1007/978-3-319-63245-2_13; Prysyazhna O, 2012, NAT MED, V18, P286, DOI 10.1038/nm.2603; Qin LY, 2015, BIOCHEMISTRY-US, V54, P4419, DOI 10.1021/acs.biochem.5b00572; Rashdan NA, 2015, AM J PHYSIOL-HEART C, V309, pH1655, DOI 10.1152/ajpheart.00408.2015; Rudyk O, 2012, CIRCULATION, V126, P287, DOI 10.1161/CIRCULATIONAHA.112.101287; Ruth P, 1997, J BIOL CHEM, V272, P10522; RUTH P, 1991, EUR J BIOCHEM, V202, P1339, DOI 10.1111/j.1432-1033.1991.tb16509.x; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Schiffrin EL, 2012, HYPERTENSION, V59, P367, DOI 10.1161/HYPERTENSIONAHA.111.187021; Schlossmann Jens, 2009, V191, P163, DOI 10.1007/978-3-540-68964-5_9; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sun XG, 2005, MOL PHARMACOL, V67, P631, DOI 10.1124/mol.104.007724; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tan ZJ, 2012, J PHARMACEUT BIOMED, V59, P167, DOI 10.1016/j.jpba.2011.09.034; Warren EAK, 2015, SCI REP-UK, V5, DOI 10.1038/srep16929; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yuen S, 2011, J BIOL CHEM, V286, P37274, DOI 10.1074/jbc.M111.282905; Yuen SL, 2014, ARCH BIOCHEM BIOPHYS, V562, P37, DOI 10.1016/j.abb.2014.08.011; Zhou GP, 2011, PROTEIN PEPTIDE LETT, V18, P966, DOI 10.2174/0929866511107010966	53	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16791	16802		10.1074/jbc.RA118.004363	http://dx.doi.org/10.1074/jbc.RA118.004363			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30206122	hybrid, Green Published			2022-12-26	WOS:000448515100020
J	Smith, RP; Mohanty, B; Mowlaboccus, S; Paxman, JJ; Williams, ML; Headey, SJ; Wang, GQ; Subedi, P; Doak, BC; Kahler, CM; Scanlon, MJ; Heras, B				Smith, Roxanne P.; Mohanty, Biswaranjan; Mowlaboccus, Shakeel; Paxman, Jason J.; Williams, Martin L.; Headey, Stephen J.; Wang, Geqing; Subedi, Pramod; Doak, Bradley C.; Kahler, Charlene M.; Scanlon, Martin J.; Heras, Begona			Structural and biochemical insights into the disulfide reductase mechanism of DsbD, an essential enzyme for neisserial pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microbial pathogenesis; enzyme mechanism; electron transfer; protein folding; protein structure; crystallography; disulfide; DsbD; Neisseria gonorrhoeae	BACTERIAL-CELL ENVELOPE; MEMBRANE-PROTEIN DSBD; N-TERMINAL DOMAIN; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; BOND ISOMERASE; IN-VIVO; X-RAY; OXIDOREDUCTASE	The worldwide incidence of neisserial infections, particularly gonococcal infections, is increasingly associated with antibiotic-resistant strains. In particular, extensively drug-resistant Neisseria gonorrhoeae strains that are resistant to third-generation cephalosporins are a major public health concern. There is a pressing clinical need to identify new targets for the development of antibiotics effective against Neisseria-specific processes. In this study, we report that the bacterial disulfide reductase DsbD is highly prevalent and conserved among Neisseria spp. and that this enzyme is essential for survival of N. gonorrhoeae. DsbD is a membrane-bound protein that consists of two periplasmic domains, n-DsbD and c-DsbD, which flank the transmembrane domain t-DsbD. In this work, we show that the two functionally essential periplasmic domains of Neisseria DsbD catalyze electron transfer reactions through unidirectional interdomain interactions, from reduced c-DsbD to oxidized n-DsbD, and that this process is not dictated by their redox potentials. Structural characterization of the Neisseria n- and c-DsbD domains in both redox states provides evidence that steric hindrance reduces interactions between the two periplasmic domains when n-DsbD is reduced, thereby preventing a futile redox cycle. Finally, we propose a conserved mechanism of electron transfer for DsbD and define the residues involved in domain-domain recognition. Inhibitors of the interaction of the two DsbD domains have the potential to be developed as anti-neisserial agents.	[Smith, Roxanne P.; Paxman, Jason J.; Wang, Geqing; Subedi, Pramod; Heras, Begona] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia; [Mohanty, Biswaranjan; Williams, Martin L.; Headey, Stephen J.; Doak, Bradley C.; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Melbourne, Vic 3052, Australia; [Mowlaboccus, Shakeel; Kahler, Charlene M.] Univ Western Australia, Sch Biomed Sci, Marshall Ctr Infect Dis Res & Training, Perth, WA 6907, Australia	La Trobe University; Monash University; University of Western Australia	Scanlon, MJ (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Melbourne, Vic 3052, Australia.; Heras, B (corresponding author), La Trobe Univ, Dept Biochem & Genet, Melbourne, Vic 3086, Australia.	martin.scanlon@monash.edu; b.heras@latrobe.edu.au	Doak, Bradley C/A-4313-2013; Paxman, Jason/T-6932-2019; Kahler, Charlene M/H-5159-2014; Subedi, Pramod/AAV-6214-2021	Doak, Bradley C/0000-0001-8422-675X; Paxman, Jason/0000-0002-1418-5910; Kahler, Charlene M/0000-0003-4322-3055; Williams, Martin/0000-0002-9483-3008; Smith, Roxanne P./0000-0001-5520-7939; Headey, Stephen/0000-0001-8015-7064; Scanlon, Martin/0000-0002-9230-7506; Mowlaboccus, Shakeel/0000-0001-9408-6068; Wang, Geqing/0000-0002-9419-8657; Subedi, Pramod/0000-0002-3390-9830; Heras, Begona/0000-0003-3469-7988	Australian Research Council [DP150102287]; National Health and Medical Research Council [APP1099151, APP546003]; Australian Research Council Future Fellowship [FT130100580]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council)	This work was supported by Australian Research Council Project Grant DP150102287 and National Health and Medical Research Council Project Grant APP1099151. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Health and Medical Research Council Grant APP546003.; Supported by Australian Research Council Future Fellowship FT130100580.	Adams LA, 2015, ANGEW CHEM INT EDIT, V54, P2179, DOI 10.1002/anie.201410341; Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Arts IS, 2015, FEBS LETT, V589, P1559, DOI 10.1016/j.febslet.2015.04.057; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho SH, 2013, ANTIOXID REDOX SIGN, V18, P1690, DOI 10.1089/ars.2012.4962; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Depuydt M, 2011, ANTIOXID REDOX SIGN, V15, P49, DOI 10.1089/ars.2010.3575; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezraty B, 2017, NAT REV MICROBIOL, V15, P385, DOI 10.1038/nrmicro.2017.26; Goulding CW, 2002, BIOCHEMISTRY-US, V41, P6920, DOI 10.1021/bi016038l; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Kim JH, 2003, FEBS LETT, V543, P164, DOI 10.1016/S0014-5793(03)00434-4; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar P, 2011, MOL MICROBIOL, V79, P1557, DOI 10.1111/j.1365-2958.2011.07546.x; Kurz M, 2009, ANTIOXID REDOX SIGN, V11, P1485, DOI [10.1089/ars.2008.2420, 10.1089/ARS.2008.2420]; MacFadden DR, 2018, LANCET INFECT DIS, V18, P599, DOI 10.1016/S1473-3099(18)30274-3; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mavridou DAI, 2011, J BIOL CHEM, V286, P24943, DOI 10.1074/jbc.M111.236141; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Messens J, 2007, J BIOL CHEM, V282, P31302, DOI 10.1074/jbc.M705236200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace CN, 1998, J MOL BIOL, V279, P271, DOI 10.1006/jmbi.1998.1760; Piek S, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00162; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Quinternet M, 2008, BIOCHEMISTRY-US, V47, P12710, DOI 10.1021/bi801343c; Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Smith RP, 2018, ACTA CRYSTALLOGR F, V74, P31, DOI 10.1107/S2053230X17017800; Smith RP, 2017, BIOMOL NMR ASSIGN, V11, P181, DOI 10.1007/s12104-017-9743-x; Smith RP, 2016, MOLECULES, V21, DOI 10.3390/molecules21070811; Stewart EJ, 1999, EMBO J, V18, P5963, DOI 10.1093/emboj/18.21.5963; Stirnimann CU, 2006, J MOL BIOL, V358, P829, DOI 10.1016/j.jmb.2006.02.030; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; Tinsley CR, 2004, J BIOL CHEM, V279, P27078, DOI 10.1074/jbc.M313404200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	49	7	7	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16559	16571		10.1074/jbc.RA118.004847	http://dx.doi.org/10.1074/jbc.RA118.004847			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30181210	hybrid, Green Published			2022-12-26	WOS:000448515100002
J	Teng, KTY; Devleesschauwer, B; De Noordhout, CM; Bennett, P; McGreevy, PD; Chiu, PY; Toribio, JALML; Dhand, NK				Teng, Kendy Tzu-Yun; Devleesschauwer, Brecht; De Noordhout, Charline Maertens; Bennett, Peter; McGreevy, Paul D.; Chiu, Po-Yu; Toribio, Jenny-Ann L. M. L.; Dhand, Navneet K.			Welfare-Adjusted Life Years (WALY): A novel metric of animal welfare that combines the impacts of impaired welfare and abbreviated lifespan	PLOS ONE			English	Article							QUALITY-OF-LIFE; DISABILITY WEIGHTS MEASUREMENT; TIBIAL TUBEROSITY ADVANCEMENT; CRUCIATE LIGAMENT DISEASE; CHRONIC KIDNEY-DISEASE; DIABETES-MELLITUS; GLOBAL BURDEN; INSURED DOGS; APPENDICULAR OSTEOSARCOMA; SPLENIC HEMANGIOSARCOMA	Currently, separate measures are used to estimate the impact of animal diseases on mortality and animal welfare. This article introduces a novel metric, the Welfare-Adjusted Life Year (WALY), to estimate disease impact by combining welfare compromise and premature death components. Adapting the Disability-Adjusted Life Year approach used in human health audits, we propose WALY as the sum of a) the years lived with impaired welfare due to a particular cause and b) the years of life lost due to the premature death from the same cause. The years lived with impaired welfare are the product of the average duration of each welfare impediment, reflecting the actual condition that compromises animal welfare, the probability of an incident case developing and impaired welfare weights, representing the degree of impaired welfare. The years of life lost are calculated using the standard expected lifespan at the time of premature death. To demonstrate the concept, we estimated WALYs for 10 common canine diseases, namely mitral valve disease, dilated cardiomyopathy, chronic kidney disease, diabetes mellitus, atopic dermatitis, splenic haemangiosarcoma, appendicular osteosarcoma, cranial cruciate ligament disease, thoracolumbar intervertebral disc disease and cervical spondylomyelopathy. A survey of veterinarians (n = 61) was conducted to elicit impaired welfare weights for 35 welfare impediments. Paired comparison was the primary method to elicit weights, whereas visual analogue scale and time trade-off approaches rescaled these weights onto the desired scale, from 0 (the optimal welfare imaginable) to 1 (the worst welfare imaginable). WALYs for the 10 diseases were then estimated using the impaired welfare weights and published epidemiological data on disease impacts. Welfare impediment "amputation: one limb" and "respiratory distress" had the lowest and highest impaired welfare weights at 0.134 and 0.796, rescaled with a visual analogue scale, and 0.117 and 0.857, rescaled with time trade-off. Among the 10 diseases, thoracolumbar intervertebral disc disease and atopic dermatitis had the smallest and greatest adverse impact on dogs with WALYs at 2.83 (95% UI: 1.54-3.94) and 9.73 (95% uncertainty interval [UI]: 7.17-11.8), respectively. This study developed the WALY metric and demonstrated that it summarises welfare compromise as perceived by humans and total impact of diseases in individual animals. The WALY can potentially be used for prioritisation of disease eradication and control programs, quantification of population welfare and longitudinal surveillance of animal welfare in companion animals and may possibly be extended to production animals.	[Teng, Kendy Tzu-Yun; Bennett, Peter; McGreevy, Paul D.; Toribio, Jenny-Ann L. M. L.; Dhand, Navneet K.] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Camperdown, NSW, Australia; [Devleesschauwer, Brecht] Sciensano, Dept Epidemiol & Publ Hlth, Brussels, Belgium; [Devleesschauwer, Brecht] Univ Ghent, Fac Vet Med, Dept Vet Publ Hlth & Food Safety, Merelbeke, Belgium; [De Noordhout, Charline Maertens] Catholic Univ Louvain, Fac Publ Hlth, Inst Hlth & Soc, Brussels, Belgium; [Chiu, Po-Yu] Natl Taiwan Univ, Vet Hosp, Taipei, Taiwan	University of Sydney; Sciensano; Ghent University; Universite Catholique Louvain; National Taiwan University	Teng, KTY (corresponding author), Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Camperdown, NSW, Australia.	kendy.t.teng@gmail.com	Bennett, Peter/AAK-8764-2021; Dhand, Navneet K/H-5762-2019; Toribio, Jenny-Ann LML/B-5032-2011; Devleesschauwer, Brecht/G-9895-2018	Dhand, Navneet K/0000-0002-4362-3596; Devleesschauwer, Brecht/0000-0002-2867-6892; McGreevy, Paul/0000-0001-7220-8378; Bennett, Peter/0000-0002-7209-4996; Teng, Kendy/0000-0003-3200-1545	Sydney School of Veterinary Science, University of Sydney	Sydney School of Veterinary Science, University of Sydney	This study is funded by FS Quiney Bequest and Schnakenberg Bequest from the Sydney School of Veterinary Science, University of Sydney to NKD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa T, 2012, JAVMA-J AM VET MED A, V241, P1617, DOI 10.2460/javma.241.12.1617; Aikawa T, 2012, VET SURG, V41, P381, DOI 10.1111/j.1532-950X.2012.00970.x; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Appleby M.C, 2011, ANIMAL WELFARE; Arluke A. B., 1989, Anthrozoos, V2, P98, DOI 10.2752/089279389787058091; Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; Attema AE, 2013, EUR J HEALTH ECON, V14, pS53, DOI 10.1007/s10198-013-0508-x; Bacon NJ, 2008, JAVMA-J AM VET MED A, V232, P1504, DOI 10.2460/javma.232.10.1504; Badia X, 1999, SOC SCI MED, V49, P943, DOI 10.1016/S0277-9536(99)00182-3; Bartram DJ, 2010, VET REC, V166, P388, DOI 10.1136/vr.b4794; Baskin CR, 2000, J AM ANIM HOSP ASSOC, V36, P404, DOI 10.5326/15473317-36-5-404; Berg J, 1997, CANCER, V79, P1343, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1343::AID-CNCR11>3.0.CO;2-#; Bijsmans ES, 2016, J VET INTERN MED, V30, P183, DOI 10.1111/jvim.13656; Borgarelli M, 2008, J VET INTERN MED, V22, P120, DOI 10.1111/j.1939-1676.2007.0008.x; Cabrera SY, 2008, JAVMA-J AM VET MED A, V232, P889, DOI 10.2460/javma.232.6.889; Collins LM, 2011, VET J, V189, P147, DOI 10.1016/j.tvjl.2011.06.012; da Costa RC, 2008, JAVMA-J AM VET MED A, V233, P1284, DOI 10.2460/javma.233.8.1284; de Boo J, 2005, J VET MED EDUC, V32, P451, DOI 10.3138/jvme.32.4.451; De Causmaecker V, 2009, VLAAMS DIERGEN TIJDS, V78, P327; De Decker S, 2009, J SMALL ANIM PRACT, V50, P136, DOI 10.1111/j.1748-5827.2008.00705.x; de Noordhout CM, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0174-z; Devleesschauwer B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142498; Egenvall A, 2000, VET REC, V146, P519, DOI 10.1136/vr.146.18.519; Fadda A, 2013, J VET INTERN MED, V27, P924, DOI 10.1111/jvim.12095; Fall T, 2007, J VET INTERN MED, V21, P1209, DOI 10.1892/07-021.1; Favrot C, 2010, VET DERMATOL, V21, P63, DOI 10.1111/j.1365-3164.2009.00781.x; Freeman LM, 2012, JAVMA-J AM VET MED A, V240, P1188, DOI 10.2460/javma.240.10.1188; Freeman LM, 2005, JAVMA-J AM VET MED A, V226, P1864, DOI 10.2460/javma.2005.226.1864; Freire R, 2017, J VET MED EDUC, V44, P208, DOI 10.3138/jvme.1215-191R; Gunnarsson S, 2006, ACTA VET SCAND, V48, DOI 10.1186/1751-0147-48-20; Haagsma JA, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0020-2; Hess RS, 2000, J AM VET MED ASSOC, V217, P1166, DOI 10.2460/javma.2000.217.1166; Hills A.M., 1993, SOC ANIM, V1, P111, DOI [10.1163/156853093X00028, DOI 10.1163/156853093X00028]; Iliopoulou MA, 2013, JAVMA-J AM VET MED A, V242, P1679, DOI 10.2460/javma.242.12.1679; Inoue M, 2015, PREV VET MED, V120, P210, DOI 10.1016/j.prevetmed.2015.03.018; Jelsma J, 2000, LANCET, V355, P2079, DOI 10.1016/S0140-6736(05)73538-8; JORGENSON DE, 1981, OMEGA-J DEATH DYING, V11, P281, DOI 10.2190/ADM8-GN9V-DUJH-9RBK; Kahn SA, 2013, CAN VET J, V54, P237; KELLERT SR, 1987, WILDLIFE SOC B, V15, P363; Kim SE, 2007, JAVMA-J AM VET MED A, V231, P1550, DOI 10.2460/javma.231.10.1550; Krabbe P., 2005, EQ 5D CONCEPTS METHO, P171; Lamers LM, 2006, MED DECIS MAKING, V26, P173, DOI 10.1177/0272989X06286480; Lane AE, 2012, AUST VET J, V90, P69, DOI 10.1111/j.1751-0813.2011.00878.x; Lincoln AE, 2010, SOC FORCES, V88, P1969, DOI 10.1353/sof.2010.0043; Lynch S, 2011, VET COMP ONCOL, V9, P172, DOI 10.1111/j.1476-5829.2010.00244.x; Martano M, 2005, VET J, V170, P84, DOI 10.1016/j.tvjl.2004.04.004; Martin MWS, 2009, J SMALL ANIM PRACT, V50, P23, DOI 10.1111/j.1748-5827.2008.00659.x; Mattin M, 2014, VET REC, V174, P349, DOI 10.1136/vr.101950; McGreevy P, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7100074; McKee WM, 1999, J SMALL ANIM PRACT, V40, P465, DOI 10.1111/j.1748-5827.1999.tb02997.x; McMillan FD, 2000, J AM VET MED ASSOC, V216, P1904, DOI 10.2460/javma.2000.216.1904; Mellor D.J., 1994, CONCEPTS ANIMAL WELL; Mont D, 2007, LANCET, V369, P1658, DOI 10.1016/S0140-6736(07)60752-1; Murray, 2002, SUMMARY MEASURES POP, P205; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Noli C, 2016, VET DERMATOL, V27, P247, DOI 10.1111/vde.12341; Noli C, 2011, VET DERMATOL, V22, P335, DOI 10.1111/j.1365-3164.2010.00954.x; O'Neill D, 2013, VET REC, V173, P240, DOI 10.1136/vr.f4519; O'Neill DG, 2013, J VET INTERN MED, V27, P814, DOI 10.1111/jvim.12090; Ock M, 2016, J KOREAN MED SCI, V31, pS129, DOI 10.3346/jkms.2016.31.S2.S129; Oxley B, 2013, VET SURG, V42, P739, DOI 10.1111/j.1532-950X.2013.12033.x; Papazoglou LG, 2002, VET SURG, V31, P561, DOI 10.1053/jvet.2002.34666; Paul ES, 2000, VET REC, V146, P269, DOI 10.1136/vr.146.10.269; Pouillot R, 2010, INT J FOOD MICROBIOL, V142, P330, DOI 10.1016/j.ijfoodmicro.2010.07.011; Rybnicek J, 2009, VET DERMATOL, V20, P115, DOI 10.1111/j.1365-3164.2008.00728.x; Salger F, 2014, VET SURG, V43, P581, DOI 10.1111/j.1532-950X.2014.12157.x; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Saridomichelakis MN, 1999, VET IMMUNOL IMMUNOP, V69, P61, DOI 10.1016/S0165-2427(99)00040-9; Schneider TR, 2010, J VET BEHAV, V5, P287, DOI 10.1016/j.jveb.2010.06.002; Serpell JA, 2005, J VET MED EDUC, V32, P491, DOI 10.3138/jvme.32.4.491; Stein S, 2008, J SMALL ANIM PRACT, V49, P398, DOI 10.1111/j.1748-5827.2008.00592.x; Stouthard MEA, 2000, EUR J PUBLIC HEALTH, V10, P24, DOI 10.1093/eurpub/10.1.24; Stouthard MEA, 1997, DISABILITY WEIGHTS D; Ustun TB, 1999, LANCET, V354, P111, DOI 10.1016/S0140-6736(98)07507-2; Voss K, 2008, VET COMP ORTHOPAED, V21, P243; Webster J., 1995, ANIMAL WELFARE COOL; Wemelsfelder F, 1997, APPL ANIM BEHAV SCI, V53, P75, DOI 10.1016/S0168-1591(96)01152-5; WHO, 2021, WHO GUID HLTH WORKF; Yang ZH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184883	80	7	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2018	13	9							e0202580	10.1371/journal.pone.0202580	http://dx.doi.org/10.1371/journal.pone.0202580			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT7EB	30208045	Green Published, Green Submitted, gold			2022-12-26	WOS:000444683000026
J	Zhang, GQ; DeVos, J; Medina-Moreno, S; Wagar, N; Diallo, K; Beard, RS; Zheng, DP; Mwachari, C; Riwa, C; Jullu, B; Wangari, NE; Kibona, MS; Nganga, LW; Raizes, E; Yang, CF				Zhang, Guoqing; DeVos, Joshua; Medina-Moreno, Sandra; Wagar, Nicholas; Diallo, Karidia; Beard, R. Suzanne; Zheng, Du-Ping; Mwachari, Christine; Riwa, Carolyn; Jullu, Boniface; Wangari, Ngugi Evelyn; Kibona, Mary S.; Nganga, Lucy W.; Raizes, Elliot; Yang, Chunfu			Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; VIRAL LOAD; RNA QUANTIFICATION; STORAGE-CONDITIONS; PCR AMPLIFICATION; GENOTYPING ASSAY; FIELD-EVALUATION; PLASMA; MUTATIONS; CHILDREN	Introduction Surveillance of HIV drug resistance (HIVDR) is crucial to ensuring the continued success of antiretroviral therapy (ART) programs. With the concern of reduced genotyping sensitivity of HIV on dried blood spots (DBS), DBS for HIVDR surveillance have been limited to ART-naive populations. To investigate if DBS under certain conditions may also be a feasible sample type for HIVDR testing in ART patients, we piloted nationwide surveys for HIVDR among ART patients using DBS in two African countries with rapid scale-up of ART. Methods EDTA-venous blood was collected to prepare DBS from adult and pediatric ART patients receiving treatment during the previous 12-36 months. DBS were stored at ambient temperature for two weeks and then at-80 degrees C until shipment at ambient temperature to the WHO-designated Specialized HIVDR Laboratory at CDC in Atlanta. Viral load (VL) was determined using NucliSENS EasyQ (R) HIV-1 v2.0 kits; HIVDR genotyping was performed using the ATCC HIV-1 Drug Resistance Genotyping kits. Results DBS were collected from 1,368 and 1,202 ART patients; 244 and 255 these specimens had VL >= 1,000 copies/mL in Kenya and Tanzania, respectively. The overall genotyping rate of those DBS with VL >= 1,000 copies/mL was 93.0% (95% CI: 89.1%-95.6%) in Kenya and 91.8% (87.7%-94.6%) in Tanzania. The turnaround times for the HIVDR surveys from the time of collecting DBS to completing laboratory testing were 6.5 months and 9.3 months for the Kenya and Tanzania surveys, respectively. Conclusions The study demonstrates a favorable outcome of using DBS for nationwide surveillance of HIVDR in ART patients. Our results confirm that DBS collected and stored at ambient temperature for two weeks, and shipped with routine courier services are a reliable sample type for large-scale surveillance of acquired HIVDR.	[Zhang, Guoqing; DeVos, Joshua; Wagar, Nicholas; Diallo, Karidia; Beard, R. Suzanne; Zheng, Du-Ping; Yang, Chunfu] CDC, Int Lab Branch, Div Global HIV & TB, Ctr Global Hlth, Atlanta, GA 30333 USA; [Medina-Moreno, Sandra] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Mwachari, Christine; Wangari, Ngugi Evelyn; Nganga, Lucy W.] CDC Kenya, Nairobi, Kenya; [Riwa, Carolyn; Jullu, Boniface] Minist Hlth Tanzania, Dar Es Salaam, Tanzania; [Kibona, Mary S.] CDC Tanzania, Dar Es Salaam, Tanzania; [Raizes, Elliot] CDC, Adult Care & Treatment Branch, Div Global HIV & TB, Ctr Global Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; University System of Maryland; University of Maryland Baltimore; Centers for Disease Control & Prevention - USA	Yang, CF (corresponding author), CDC, Int Lab Branch, Div Global HIV & TB, Ctr Global Hlth, Atlanta, GA 30333 USA.	cyang1@cdc.gov	zhang, guoqing/GXG-4800-2022		President's Emergency Plan for AIDS Relief (PEPFAR) through US Centers for Disease Control and Prevention	President's Emergency Plan for AIDS Relief (PEPFAR) through US Centers for Disease Control and Prevention	This project has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through US Centers for Disease Control and Prevention. The funder had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Bank W, 2013, ANT THER COV; Bertagnolio S, 2013, J INFECT DIS, V207, pS45, DOI 10.1093/infdis/jit121; Bertagnolio S, 2010, AIDS REV, V12, P195; Biomerieux, 2010, NUCLISENS EASYQ HIV; Cambiano V, 2013, J INFECT DIS, V207, pS57, DOI 10.1093/infdis/jit111; Dziuban EJ, 2017, PEDIATR INFECT DIS J, V36, P758, DOI [10.1097/INF.0000000000001597, 10.1097/inf.0000000000001597]; Ginocchio CC, 2008, J CLIN MICROBIOL, V46, P1274, DOI 10.1128/JCM.01567-07; Gregson J, 2016, LANCET INFECT DIS, V16, P565, DOI 10.1016/S1473-3099(15)00536-8; Hall T.A., 1999, NUCL ACIDS S SERIES; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Inzaule S, 2013, J CLIN MICROBIOL, V51, P529, DOI 10.1128/JCM.02347-12; Jain V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015510; Johannessen A, 2009, J ANTIMICROB CHEMOTH, V64, P1126, DOI 10.1093/jac/dkp353; Joint United Nations Programme on HIV/AIDS, 2017, FACT SHEET LAT STAT; Joint United Nations Programme on HIV/AIDS, 2013, GLOBAL REPORT UNAIDS; Jordan MR, 2012, CLIN INFECT DIS, V54, pS245, DOI 10.1093/cid/cis206; Jordan MR, 2017, CLIN INFECT DIS, V65, P2018, DOI 10.1093/cid/cix698; Jordan MR, 2011, CLIN INFECT DIS, V52, P1058, DOI 10.1093/cid/cir093; Leitner T., 2005, HIV SEQUENCE COMPEND, P41, DOI DOI 10.1111/J.0031-5990.2005.00003.X; Masciotra S, 2007, AIDS, V21, P2503, DOI 10.1097/QAD.0b013e3281c618db; Mbida AD, 2009, JAIDS-J ACQ IMM DEF, V52, P9, DOI 10.1097/QAI.0b013e3181aeccbc; McNulty A, 2008, ANTIVIR THER, V13, pA117; Monleau M, 2010, J ANTIMICROB CHEMOTH, V65, P1562, DOI 10.1093/jac/dkq205; Monleau M, 2009, J CLIN MICROBIOL, V47, P1107, DOI 10.1128/JCM.02255-08; Mungati More, 2016, BMC Res Notes, V9, P302, DOI 10.1186/s13104-016-2101-8; Parry CM, 2014, J CLIN MICROBIOL, V52, P2868, DOI 10.1128/JCM.00544-14; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Rivadeneira E, 2014, ANTIVIRAL THERAPY; Rottinghaus EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109060; Rottinghaus EK, 2012, CLIN INFECT DIS, V54, P1187, DOI 10.1093/cid/cis015; Sawadogo S, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy014; Schmitz ME, 2017, JAIDS-J ACQ IMM DEF, V74, P399, DOI [10.1097/QAI.0000000000001275, 10.1097/qai.0000000000001275]; Shulman LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039455; Sigaloff KCE, 2011, LANCET INFECT DIS, V11, P769, DOI 10.1016/S1473-3099(11)70141-4; Stadeli KM, 2013, ANTIVIR THER, V18, P115, DOI 10.3851/IMP2437; Stevens W, 2008, Open AIDS J, V2, P17, DOI 10.2174/1874613600802010017; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; WHO, 2010, TEST US DRIED BLOOD; Wood E, 2011, LANCET INFECT DIS, V11, P723, DOI 10.1016/S1473-3099(11)70216-X; Woods CK, 2012, J CLIN MICROBIOL, V50, P1936, DOI 10.1128/JCM.06689-11; World Health Organization, 2012, HIV DRUG RES REP 201; World Health Organization, 2014, SURV HIV DRUG RES AD; World Health Organization, 2018, TREATMENT PREVENTION, DOI DOI 10.1126/SCIENCE.1223389; World Health Organization, 2018, WORLD MAL REP 2018, P1; World Health Organization, 2014, INT HLTH REG COORD; World Health Organization, 2012, WHO PROT CROSS SECT; Zhang G, 2014, ANTIVIRAL THERAPY; Zhou ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028184	49	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203296	10.1371/journal.pone.0203296	http://dx.doi.org/10.1371/journal.pone.0203296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192818	Green Submitted, gold, Green Published			2022-12-26	WOS:000444093600059
J	Ge, Q; Shao, WZ; Wang, LQ				Ge, Qi; Shao, Wenze; Wang, Liqian			Joint bayesian convolutional sparse coding for image super-resolution	PLOS ONE			English	Article							SPATIAL-RESOLUTION; DICTIONARY; NETWORK; FUSION	We propose a convolutional sparse coding (CSC) for super resolution (CSC-SR) algorithm with a joint Bayesian learning strategy. Due to the unknown parameters in solving CSC-SR, the performance of the algorithm depends on the choice of the parameter. To this end, a coupled Beta-Bernoulli process is employed to infer appropriate filters and sparse coding maps (SCM) for both low resolution (LR) image and high resolution (HR) image. The filters and the SCMs are learned in a joint inference. The experimental results validate the advantages of the proposed approach over the previous CSC-SR and other state-of-the-art SR methods.	[Ge, Qi; Shao, Wenze; Wang, Liqian] Nanjing Univ Posts & Telecommun, Coll Telecommun & Informat Engn, Nanjing, Jiangsu, Peoples R China; [Ge, Qi] Nanjing Univ Posts & Telecommun, Natl Engn Res Ctr Commun & Networking, Nanjing, Jiangsu, Peoples R China	Nanjing University of Posts & Telecommunications; Nanjing University of Posts & Telecommunications	Ge, Q (corresponding author), Nanjing Univ Posts & Telecommun, Coll Telecommun & Informat Engn, Nanjing, Jiangsu, Peoples R China.; Ge, Q (corresponding author), Nanjing Univ Posts & Telecommun, Natl Engn Res Ctr Commun & Networking, Nanjing, Jiangsu, Peoples R China.	geqi@njupt.edu.cn	Wang, Liqian/V-7028-2019		Natural Science Foundation of China [61502244, 61771250, 61602257, 61402239]; Science Foundation of Jiangsu Province [BK20150859, BK20160904]; China Postdoctoral Science Foundation [2015M580433]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Jiangsu Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported in part by the Natural Science Foundation of China under Grant 61502244, Grant 61771250, Grant 61602257, Grant 61402239, the Science Foundation of Jiangsu Province under Grant BK20150859, BK20160904, China Postdoctoral Science Foundation 2015M580433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2016, IEEE T PATTERN ANAL, V38, P2374, DOI 10.1109/TPAMI.2016.2527652; Bevilacqua M, 2012, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2012, DOI 10.5244/C.26.135; Chen YJ, 2014, IEEE T IMAGE PROCESS, V23, P1060, DOI 10.1109/TIP.2014.2299065; Cui Z, 2014, LECT NOTES COMPUT SC, V8693, P49, DOI 10.1007/978-3-319-10602-1_4; Dong C, 2014, LECT NOTES COMPUT SC, V8692, P184, DOI 10.1007/978-3-319-10593-2_13; Elad M, 1997, IEEE T IMAGE PROCESS, V6, P1646, DOI 10.1109/83.650118; Fattal R, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1276377.1276441; Gao XB, 2011, IEEE T IMAGE PROCESS, V20, P2738, DOI 10.1109/TIP.2011.2134859; Glasner D, 2009, IEEE I CONF COMP VIS, P349, DOI 10.1109/ICCV.2009.5459271; Gu SH, 2015, IEEE I CONF COMP VIS, P1823, DOI 10.1109/ICCV.2015.212; Ham B, 2015, IEEE T IMAGE PROCESS, V24, P1524, DOI 10.1109/TIP.2015.2405342; He L, 2013, PROC CVPR IEEE, P345, DOI 10.1109/CVPR.2013.51; Lu XQ, 2014, IEEE T CYBERNETICS, V44, P366, DOI 10.1109/TCYB.2013.2256347; Mateos J., 2007, SUPER RESOLUTION IMA; Paisley J, 2009, P 26 ANN INT C MACH, P777, DOI [10.1145/1553374.1553474, DOI 10.1145/1553374.1553474]; Polatkan G, 2015, IEEE T PATTERN ANAL, V37, P346, DOI 10.1109/TPAMI.2014.2321404; Song HH, 2017, IEEE J-STARS, V10, P3055, DOI 10.1109/JSTARS.2017.2665524; Song HH, 2015, IEEE T GEOSCI REMOTE, V53, P1195, DOI 10.1109/TGRS.2014.2335818; Sorel M, 2016, DIGIT SIGNAL PROCESS, V55, P44, DOI 10.1016/j.dsp.2016.04.012; Tai YW, 2010, PROC CVPR IEEE, P2400, DOI 10.1109/CVPR.2010.5539933; Timofte R, 2015, LECT NOTES COMPUT SC, V9006, P111, DOI 10.1007/978-3-319-16817-3_8; Yang JQ, 2008, ITESS: 2008 PROCEEDINGS OF INFORMATION TECHNOLOGY AND ENVIRONMENTAL SYSTEM SCIENCES, PT 1, P1, DOI 10.1109/CVPR.2008.4587647; Yang JC, 2012, IEEE T IMAGE PROCESS, V21, P3467, DOI 10.1109/TIP.2012.2192127; Yang JC, 2010, IEEE T IMAGE PROCESS, V19, P2861, DOI 10.1109/TIP.2010.2050625; Zeiler MD, 2011, IEEE I CONF COMP VIS, P2018, DOI 10.1109/ICCV.2011.6126474; Zeiler MD, 2010, PROC CVPR IEEE, P2528, DOI 10.1109/CVPR.2010.5539957; Zeyde R., 2010, INT C CURVES SURFACE, P711, DOI DOI 10.1007/978-3-642-27413-8_47; Zhang KB, 2013, IEEE T NEUR NET LEAR, V24, P1648, DOI 10.1109/TNNLS.2013.2262001	28	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0201463	10.1371/journal.pone.0201463	http://dx.doi.org/10.1371/journal.pone.0201463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183722	gold, Green Submitted, Green Published			2022-12-26	WOS:000443789900005
J	McIntosh, RR; Kirkman, SP; Thalmann, S; Sutherland, DR; Mitchell, A; Arnould, JPY; Salton, M; Slip, DJ; Dann, P; Kirkwood, R				McIntosh, Rebecca R.; Kirkman, Steve P.; Thalmann, Sam; Sutherland, Duncan R.; Mitchell, Anthony; Arnould, John P. Y.; Salton, Marcus; Slip, David J.; Dann, Peter; Kirkwood, Roger			Understanding meta-population trends of the Australian fur seal, with insights for adaptive monitoring	PLOS ONE			English	Article							ARCTOCEPHALUS-PUSILLUS-DORIFERUS; DENSITY-DEPENDENCE; PUP PRODUCTION; TEMPORAL VARIATION; DETECTING TRENDS; POWER ANALYSIS; HARBOR SEALS; ABUNDANCE; MORTALITY; FORSTERI	Effective ecosystem-based management requires estimates of abundance and population trends of species of interest. Trend analyses are often limited due to sparse or short-term abundance estimates for populations that can be logistically difficult to monitor over time. Therefore it is critical to assess regularly the quality of the metrics in long-term monitoring programs. For a monitoring program to provide meaningful data and remain relevant, it needs to incorporate technological improvements and the changing requirements of stakeholders, while maintaining the integrity of the data. In this paper we critically examine the monitoring program for the Australian fur seal (AFS) Arctocephalus pusillus doriferus as an example of an ad-hoc monitoring program that was co-ordinated across multiple stakeholders as a range-wide census of live pups in the Austral summers of 2002, 2007 and 2013. This 5-yearly census, combined with historic counts at individual sites, successfully tracked increasing population trends as signs of population recovery up to 2007. The 2013 census identified the first reduction in AFS pup numbers (14,248 live pups, -4.2% change per annum since 2007), however we have limited information to understand this change. We analyse the trends at breeding colonies and perform a power analysis to critically examine the reliability of those trends. We then assess the gaps in the monitoring program and discuss how we may transition this surveillance style program to an adaptive monitoring program than can evolve over time and achieve its goals. The census results are used for ecosystem-based modelling for fisheries management and emergency response planning. The ultimate goal for this program is to obtain the data we need with minimal cost, effort and impact on the fur seals. In conclusion we identify the importance of power analyses for interpreting trends, the value of regularly assessing long-term monitoring programs and proper design so that adaptive monitoring principles can be applied.	[McIntosh, Rebecca R.; Sutherland, Duncan R.; Salton, Marcus; Dann, Peter] Phillip Isl Nat Pk, Res Dept, Cowes, Vic, Australia; [Kirkman, Steve P.] Dept Environm Affairs Oceans & Coasts Res, Victoria & Alfred Waterfront, Cape Town, South Africa; [Kirkman, Steve P.] Univ Cape Town, Dept Biol Sci, Anim Demog Unit, Cape Town, South Africa; [Thalmann, Sam] Dept Primary Ind Pk Water & Environm, Hobart, Tas, Australia; [Mitchell, Anthony] Dept Environm Land Water & Planning, Orbost, Vic, Australia; [Arnould, John P. Y.] Deakin Univ, Sch Biol & Chem Sci, Burwood, Vic, Australia; [Salton, Marcus; Slip, David J.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Slip, David J.] Taronga Conservat Soc Australia, Mosman, NSW, Australia; [Kirkwood, Roger] Wageningen Marine Res, Den Helder, Netherlands	University of Cape Town; Deakin University; Macquarie University; Wageningen University & Research	McIntosh, RR (corresponding author), Phillip Isl Nat Pk, Res Dept, Cowes, Vic, Australia.	rmcintosh@penguins.org.au	Salton, Marcus/AAC-1616-2022; Kirkman, Stephen/AAA-9139-2021; Sutherland, Duncan/E-7763-2011	Salton, Marcus/0000-0001-5647-406X; Kirkman, Stephen/0000-0001-5428-7375; Sutherland, Duncan/0000-0003-0893-4425; Slip, David/0000-0002-9010-7236	Australian Marine Mammal Centre [12/27]; Phillip Island Nature Parks; Deakin University; Tasmanian Department of Primary Industries, Parks, Water and the Environment; Victorian Department of Environment, Land, Water and Planning; Australian Research Council Linkage Project grant [LP110200603]; AMMC	Australian Marine Mammal Centre; Phillip Island Nature Parks; Deakin University; Tasmanian Department of Primary Industries, Parks, Water and the Environment; Victorian Department of Environment, Land, Water and Planning; Australian Research Council Linkage Project grant(Australian Research Council); AMMC	The project was funded by Australian Marine Mammal Centre (https://data.marinemammals.gov.au/grants) (Project number 12/27, RK), with contributions from Phillip Island Nature Parks (RM, DS, MS, PD), Deakin University (JA), Tasmanian Department of Primary Industries, Parks, Water and the Environment (ST), Parks Victoria (staff and logistical support), and Victorian Department of Environment, Land, Water and Planning (AM). South Africa's Department of Environmental Affairs, Branch Oceans and Coasts supported SK's time on the project. The Montague Island census was funded by an Australian Research Council Linkage Project grant (http://www.arc.gov.au/linkage-projects) (LP110200603 to Rob Harcourt and DS). The South Australian data was provided by Simon Goldsworthy (South Australian Research and Development Institute Aquatic Sciences) and Peter Shaughnessy (South Australian Museum), funded by AMMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame K, 2017, MAR MAMMAL SCI, V33, P913, DOI 10.1111/mms.12403; Alderman R., 2014, SHY ALBATROSS AUSTR; Angel LP, 2015, BIOL OPEN, V4, P1298, DOI 10.1242/bio.013250; [Anonymous], 1982, ESTIMATION ANIMAL AB; Arianna T, 2004, 22 WAK FISH S SEA LI; Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Arnould JPY, 2003, CAN J ZOOL, V81, P1428, DOI 10.1139/Z03-134; Arnould JPY, 2004, R021702 AFR DEAK U S; Baylis AMM, 2015, ECOLOGY, V96, P2834, DOI 10.1890/14-1948.1.sm; Berlincourt M, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0044-7; Berlincourt M, 2015, MAR BIOL, V162, P1485, DOI 10.1007/s00227-015-2685-x; Boyd IL, 2006, CONSERV BIOL SER, P1, DOI 10.2277/ 052161256X; Bradshaw CJA, 2000, J ZOOL, V250, P105, DOI 10.1111/j.1469-7998.2000.tb00581.x; Bradshaw CJA, 2000, J ZOOL, V252, P41, DOI 10.1111/j.1469-7998.2000.tb00818.x; Bradshaw CJA, 2002, POLAR BIOL, V25, P650, DOI 10.1007/s00300-002-0396-5; Caughley G, 1980, ANAL VERTEBRATE POPU; Chambers LE, 2015, REG ENVIRON CHANGE, V15, P197, DOI 10.1007/s10113-014-0634-8; Connell SD, 2008, J BIOGEOGR, V35, P1608, DOI 10.1111/j.1365-2699.2008.01903.x; DOIDGE DW, 1984, J ZOOL, V202, P449, DOI 10.1111/j.1469-7998.1984.tb05095.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Grandi MF, 2015, MAR BIOL RES, V11, P225, DOI 10.1080/17451000.2014.932912; FOWLER CW, 1990, MAR MAMMAL SCI, V6, P171, DOI 10.1111/j.1748-7692.1990.tb00242.x; Geraci J. R., 1990, SEA MAMMALS OIL CONF; GERRODETTE T, 1991, ECOLOGY, V72, P1889, DOI 10.2307/1940986; GERRODETTE T, 1993, WILDLIFE SOC B, V21, P515; GERRODETTE T, 1987, ECOLOGY, V68, P1364, DOI 10.2307/1939220; Gibbens J, 2009, MAR MAMMAL SCI, V25, P573, DOI 10.1111/j.1748-7692.2008.00270.x; Goldsworthy SD, 2016, SARDI RES REPORT SER, V901; Goldsworthy SD, 2016, SARDI PUBLICATION; Goldsworthy SD, 2003, ASSESSMENT SEAL FISH; Goldsworthy Simon D., 2003, P62; GUINET C, 1994, ANTARCT SCI, V6, P473, DOI 10.1017/S0954102094000714; Hamer DJ, 2006, BIOL CONSERV, V130, P517, DOI 10.1016/j.biocon.2006.01.014; Hardy N, 2017, MAR ECOL PROG SER, V573, P237, DOI 10.3354/meps12165; HARWOOD J, 1978, J APPL ECOL, V15, P401, DOI 10.2307/2402600; Heltzel Jeannie M., 2011, U S National Marine Fisheries Service Marine Fisheries Review, V73, P20; Hodgson JC, 2016, CURR BIOL, V26, pR404, DOI 10.1016/j.cub.2016.04.001; Hooten MB, 2009, J VEG SCI, V20, P639, DOI 10.1111/j.1654-1103.2009.01040.x; Hume F, 2004, MAR BIOL, V144, P407, DOI 10.1007/s00227-003-1219-0; Jewell R, 2012, MAR ECOL PROG SER, V453, P227, DOI 10.3354/meps09636; Kampf J, 2015, OCEAN SCI, V11, P1, DOI 10.5194/os-11-1-2015; Kirkman SP, 2007, AFR J MAR SCI, V29, P161, DOI 10.2989/AJMS.2007.29.2.2.185; Kirkman SP, 2011, AFR J MAR SCI, V33, P495, DOI 10.2989/1814232X.2011.637354; Kirkman SP, 2013, MAR MAMMAL SCI, V29, P497, DOI 10.1111/j.1748-7692.2012.00584.x; Kirkwood R, 2005, MAR MAMMAL SCI, V21, P336, DOI 10.1111/j.1748-7692.2005.tb01234.x; Kirkwood R, 2005, MAR MAMMAL SCI, V21, P260, DOI 10.1111/j.1748-7692.2005.tb01227.x; Kirkwood R, 2011, AUST J ZOOL, V59, P216, DOI 10.1071/ZO11080; Kirkwood R, 2010, MAR FRESHWATER RES, V61, P695, DOI 10.1071/MF09213; Kuhn CE, 2014, J ANIM ECOL, V83, P1169, DOI 10.1111/1365-2656.12202; Lea MA, 2006, MAR ECOL PROG SER, V310, P77, DOI 10.3354/meps310077; Lee OA, 2014, J EXP MAR BIOL ECOL, V451, P25, DOI 10.1016/j.jembe.2013.10.029; Lindenmayer DB, 2011, TRENDS ECOL EVOL, V26, P641, DOI 10.1016/j.tree.2011.08.002; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; Littnan Charles L., 2002, Australian Mammalogy, V24, P57; Lynch M, 2011, J MAMMAL, V92, P342, DOI 10.1644/10-MAMM-A-203.1; Lynch M, 2011, J WILDLIFE DIS, V47, P352, DOI 10.7589/0090-3558-47.2.352; Lyons JE, 2008, J WILDLIFE MANAGE, V72, P1683, DOI 10.2193/2008-141; Makhado AB, 2013, OSTRICH, V84, P191, DOI 10.2989/00306525.2013.863234; Marine and Marine Industries Council, 2002, SEAL FISH INT MAN ST; Marshall R, 2014, W AUSTR OILED WILDLI; McIntosh RR, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00202; McIntosh RR, 2012, WILDLIFE RES, V39, P137, DOI 10.1071/WR10222; McKenzie J, 2007, J MAMMAL, V88, P639, DOI 10.1644/06-MAMM-A-150R1.1; McNally J., 1954, NOTES FOOD VICTORIAN; Meesters E, 2007, 07151 TWG; Middleton JF, 2007, PROG OCEANOGR, V75, P1, DOI 10.1016/j.pocean.2007.07.001; Moore AL, 2010, CONSERV BIOL, V24, P984, DOI 10.1111/j.1523-1739.2009.01443.x; Nilssen K.T., 2014, TESTING UAVS PERFORM; Paleczny M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129342; Pearse R.J., 1979, Victorian Naturalist (Blackburn), V96, P48; PEMBERTON D, 1994, WILDLIFE RES, V21, P341, DOI 10.1071/WR9940341; Pemberton D, 2004, WILDLIFE RES, V31, P301, DOI 10.1071/WR02083; Peter John, 2014, Australian Birdlife, V3, P24; Pomeroy P, 2015, J UNMANNED VEH SYST, V3, P102, DOI 10.1139/juvs-2015-0013; Reid K, 2005, CAN J ZOOL, V83, P604, DOI 10.1139/Z05-045; Ripley B., 2016, PACKAGENNET R PACKAG; Robin Gregory, 2012, STRUCTURED DECISION; Robinson S, 2008, AQUAT CONSERV, V18, P1180, DOI 10.1002/aqc.971; Robinson S, 2008, AQUAT CONSERV, V18, P1189, DOI 10.1002/aqc.972; Sauer JR, 2008, J WILDLIFE MANAGE, V72, P1663, DOI 10.2193/2008-278; Schumann N, 2013, AUST J ZOOL, V61, P146, DOI 10.1071/ZO12131; SEAVY NE, 2005, PSWGTR191 USDA FOR S; Shaughnessy PD, 2015, AUST J ZOOL, V63, P101, DOI 10.1071/ZO14103; Shaughnessy PD, 2000, WILDLIFE RES, V27, P629, DOI 10.1071/WR99046; Shaughnessy PD, 1995, WILDLIFE RES, V22, P625, DOI 10.1071/WR9950625; Shaughnessy PD, 2005, WILDLIFE RES, V32, P85, DOI 10.1071/WR03068; Shaughnessy PD, 2002, WILDLIFE RES, V29, P185, DOI 10.1071/WR01056; Shaughnessy PD, 2012, ABUNDANCE FUR SEAL P; Shaughnessy PD, 1998, AUSTR SEALS SEAL ROC; Shaughnessy PD, 2013, AUST J ZOOL, V61, P112, DOI 10.1071/ZO13015; Shaughnessy PD, 2010, AUST J ZOOL, V58, P94, DOI 10.1071/ZO10017; Shaughnessy Peter D., 2001, Australian Mammalogy, V23, P1; Soto KH, 2004, J ZOOL, V264, P419, DOI 10.1017/s0952836904005965; Steidl RJ, 2013, J WILDLIFE MANAGE, V77, P445, DOI 10.1002/jwmg.505; Sutherland DR, 2014, BIODIVERS CONSERV, V23, P241, DOI 10.1007/s10531-013-0597-y; Suthers IM, 2011, DEEP-SEA RES PT II, V58, P538, DOI 10.1016/j.dsr2.2010.09.029; Taylor S, 2018, SCI TOTAL ENVIRON, V610, P1310, DOI 10.1016/j.scitotenv.2017.08.204; Teilmann J, 2010, ICES J MAR SCI, V67, P952, DOI 10.1093/icesjms/fsq001; Trites AW, 2007, FISH OCEANOGR, V16, P46, DOI 10.1111/j.1365-2419.2006.00408.x; Warneke R.M., 1985, P53; WARNEKE R M, 1975, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V169, P296; Warneke RM., 1982, MAMMALS SEAS FAO FIS, V4, P431; Warneke RM, 1988, REPORT AERIAL SURVEY; Watson DM, 2015, NEW ZEAL J MAR FRESH, V49, P106, DOI 10.1080/00288330.2014.953184; Wege M, 2016, MAR MAMMAL SCI, V32, P960, DOI 10.1111/mms.12306; WICKENS PA, 1992, S AFR J WILDL RES, V22, P65; Williams PJ, 2018, ECOLOGY, V99, P524, DOI 10.1002/ecy.2120; Williams PJ, 2017, METHODS ECOL EVOL, V8, P1679, DOI 10.1111/2041-210X.12815; Williams PJ, 2017, ECOLOGY, V98, P328, DOI 10.1002/ecy.1643; Wintle BA, 2010, ECOL LETT, V13, P1325, DOI 10.1111/j.1461-0248.2010.01514.x; Zuur A. F., 2013, BEGINNERS GUIDE GLM	111	21	21	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0200253	10.1371/journal.pone.0200253	http://dx.doi.org/10.1371/journal.pone.0200253			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183713	Green Published, gold			2022-12-26	WOS:000443789900086
J	Lee, S; Chun, HS; Lee, J; Park, HJ; Kim, KT; Kim, CH; Yoon, S; Kim, WK				Lee, Sangwoo; Chun, Hang-Suk; Lee, Jieon; Park, Han-Jin; Kim, Ki-Tae; Kim, Cheol-Hee; Yoon, Seokjoo; Kim, Woo-Keun			Plausibility of the zebrafish embryos/larvae as an alternative animal model for autism: A comparison study of transcriptome changes	PLOS ONE			English	Article							SPECTRUM DISORDER; VALPROIC ACID; AIR-POLLUTION; RNA-SEQ; MECHANISMS; BEHAVIORS; TOXICITY; EXPOSURE; SHANK3; ARCHITECTURE	Autism spectrum disorder (ASD) is a serious neurodevelopmental disorder characterized by impaired or abnormal social interaction and communication and by restricted and repetitive behaviour. ASD is highly prevalent in Asia, Europe, and the United States, and the frequency of ASD is growing each year. Recent epidemiological studies have indicated that ASD may be caused or triggered by exposure to chemicals in the environment, such as those in the air or water. Thus, toxicological studies are needed to examine chemicals that might be implicated. However, the experimental efficiency of existing experimental models is limited, and many models represent challenges in terms of animal welfare. Thus, alternative ASD animal models are necessary. To address this, we examined the efficacy of the zebrafish embryo/larva as an alternative model of ASD. Specifically, we exposed zebrafish to valproic acid (0, 12.5, 25, 50, or 100 mu M), which is a chemical known to induce autism-like effects. We then analysed subsequent developmental, behavioural, and transcriptomic changes. We found that 100 mu M and 50 mu M valproic acid decreased the hatching rate and locomotor activity of zebrafish embryos/larvae. Transcriptomic analysis revealed significant alterations in a number of genes associated with autism, such as adsl, mbd5, shank3, and tsc1b. Additionally, we found changes in gene ontology that were also reported in previous studies. Our findings indicate that zebrafish embryos/larvae and humans with ASD might have common physiological pathways, indicating that this animal model may represent an alternative tool for examining the causes of and potential treatments for this illness.	[Lee, Sangwoo; Chun, Hang-Suk; Lee, Jieon; Yoon, Seokjoo; Kim, Woo-Keun] Korea Inst Toxicol, Syst Toxicol Res Ctr, Daejeon, South Korea; [Park, Han-Jin] Korea Inst Toxicol, Predict Model Res Ctr, Daejeon, South Korea; [Kim, Ki-Tae] Seoul Natl Univ Sci & Technol, Dept Environm Engn, Seoul, South Korea; [Kim, Cheol-Hee] Chungnam Natl Univ, Dept Biol, Daejeon, South Korea	Korea Institute of Toxicology; Korea Institute of Toxicology; Seoul National University of Science & Technology; Chungnam National University	Kim, WK (corresponding author), Korea Inst Toxicol, Syst Toxicol Res Ctr, Daejeon, South Korea.	wookkim@kitox.re.kr		Kim, Cheol-Hee/0000-0002-3019-0699; Kim, Ki-Tae/0000-0002-1130-8698	project entitled "Development of alternative fish toxicity test methods using zebrafish embryo" - Korea Institute of Toxicology (KIT) [KK-1704]; project entitled "Development of predicting platforms for human toxicity by BIT technology" - Korea Institute of Toxicology (KIT) [KK-1701-01]	project entitled "Development of alternative fish toxicity test methods using zebrafish embryo" - Korea Institute of Toxicology (KIT); project entitled "Development of predicting platforms for human toxicity by BIT technology" - Korea Institute of Toxicology (KIT)	This study was supported by the projects entitled "Development of alternative fish toxicity test methods using zebrafish embryo (KK-1704)" and "Development of predicting platforms for human toxicity by BIT technology (KK-1701-01) funded by Korea Institute of Toxicology (KIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anitha A, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-12; [Anonymous], 2012, CLIN GENET, V81, P363, DOI [10.1111/j.1399-0004.2011.01836.x, DOI 10.1111/J.1399-0004.2011.01836.X]; Bailey JM, 2016, NEUROTOXICOLOGY, V52, P23, DOI 10.1016/j.neuro.2015.10.001; Banerjee S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00058; Becerra TA, 2013, ENVIRON HEALTH PERSP, V121, P380, DOI 10.1289/ehp.1205827; Bourgeron T, 2015, NAT REV NEUROSCI, V16, P551, DOI 10.1038/nrn3992; Braun JM, 2014, ENVIRON HEALTH PERSP, V122, P513, DOI 10.1289/ehp.1307261; Chang J, 2015, NAT NEUROSCI, V18, P191, DOI 10.1038/nn.3907; Christensen D, 2012, PREVALENCE CHARACTER; Costa-Mattioli M, 2013, NAT NEUROSCI, V16, P1537, DOI 10.1038/nn.3546; Dickerson AS, 2015, SCI TOTAL ENVIRON, V536, P245, DOI 10.1016/j.scitotenv.2015.07.024; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Fon EA, 1995, AM J MED GENET, V60, P554, DOI 10.1002/ajmg.1320600614; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Hollis F, 2017, CURR OPIN NEUROBIOL, V45, P178, DOI 10.1016/j.conb.2017.05.018; Idring S, 2015, J AUTISM DEV DISORD, V45, P1766, DOI 10.1007/s10803-014-2336-y; Jasien Joan M, 2014, Front Aging Neurosci, V6, P225, DOI 10.3389/fnagi.2014.00225; Jurecka A, 2008, MOL GENET METAB, V94, P435, DOI 10.1016/j.ymgme.2008.04.013; Kalkbrenner AE, 2014, CURR PROB PEDIATR AD, V44, P277, DOI 10.1016/j.cppeds.2014.06.001; Kalueff AV, 2014, TRENDS PHARMACOL SCI, V35, P63, DOI 10.1016/j.tips.2013.12.002; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Kozol RA, 2015, HUM MOL GENET, V24, P4006, DOI 10.1093/hmg/ddv138; Ku HO, 2009, TOXICOL LETT, V190, P231, DOI 10.1016/j.toxlet.2009.07.022; Kumar R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02522-5; Kurian JR, 2007, EPIGENETICS, V2, P173, DOI 10.4161/epi.2.3.4841; Landrigan PJ, 2010, CURR OPIN PEDIATR, V22, P219, DOI 10.1097/MOP.0b013e328336eb9a; Liu Z, 2016, NATURE, V530, P98, DOI 10.1038/nature16533; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maaswinkel H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075955; Mathur P, 2010, NEUROBIOL DIS, V40, P66, DOI 10.1016/j.nbd.2010.05.016; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Raz R, 2015, ENVIRON HEALTH PERSP, V123, P264, DOI 10.1289/ehp.1408133; Rossignol DA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.4; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Shelton JF, 2014, ENVIRON HEALTH PERSP, V122, P1103, DOI 10.1289/ehp.1307044; Shelton JF, 2012, ENVIRON HEALTH PERSP, V120, P944, DOI 10.1289/ehp.1104553; Shih BB, 2017, J PATHOL, V241, P600, DOI 10.1002/path.4864; Siddiqui M.F., 2016, AUTISM OPEN ACCESS, V6, P1000190, DOI [10.4172/2165-7890.1000190, DOI 10.4172/2165-7890.1000190]; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; State MW, 2012, SCIENCE, V337, P1301, DOI 10.1126/science.1224989; Stewart AM, 2014, PROG NEURO-PSYCHOPH, V50, P27, DOI 10.1016/j.pnpbp.2013.11.014; STONE RL, 1992, NAT GENET, V1, P59, DOI 10.1038/ng0492-59; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; Sztajnkrycer MD, 2002, J TOXICOL-CLIN TOXIC, V40, P789, DOI 10.1081/CLT-120014645; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tropepe V, 2003, GENES BRAIN BEHAV, V2, P268, DOI 10.1034/j.1601-183X.2003.00038.x; van Aerle R, 2013, ENVIRON SCI TECHNOL, V47, P8005, DOI 10.1021/es401758d; van Woudenberg AB, 2014, REPROD TOXICOL, V49, P101, DOI 10.1016/j.reprotox.2014.07.082; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Weintraub K, 2011, NATURE, V479, P22, DOI 10.1038/479022a; Yoo H, 2015, EXP NEUROBIOL, V24, P257, DOI 10.5607/en.2015.24.4.257; Zimmermann FF, 2015, NEUROTOXICOL TERATOL, V52, P36, DOI 10.1016/j.ntt.2015.10.002	58	15	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0203543	10.1371/journal.pone.0203543	http://dx.doi.org/10.1371/journal.pone.0203543			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT1IK	30180205	Green Published, gold, Green Submitted			2022-12-26	WOS:000444222400050
J	Mon, AM; MacKinnon, AC; Traktman, P				Mon, Aye M.; MacKinnon, A. Craig, Jr.; Traktman, Paula			Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells	PLOS ONE			English	Article							VACCINIA-RELATED KINASE-1; DNA-DAMAGE; PHOSPHORYLATION; EXPRESSION; CARCINOMA; PROLIFERATION; VACCINIA-RELATED-KINASE-1; ARCHITECTURE; METASTASIS; NUCLEUS	Vaccinia-related kinase 1 (VRK1) is a pro-proliferative nuclear kinase. Mice engrafted with VRK1-depleted MDA-MB-231 breast cancer cells have been shown to develop fewer distal metastases than controls, suggesting VRK1 might play a role in cell migration, invasion, and/or colonization. In work described herein, we investigated the impact of VRK1 overexpression on human mammary epithelial cells. In 2D culture, VRK1 overexpression diminishes cell migration and invasion and impairs the migration-associated processes of cell spreading and cytoskeletal rearrangement. VRK1-overexpressing cells show reduced accumulation of the mesenchymal marker vimentin and increased accumulation of the epithelial markers E-cadherin and claudin-1. VRK1 overexpression also leads to reduced levels of the transcriptional repressors snail, slug, and twist1. Cumulatively, these data indicate that VRK1 overexpression augments the epithelial properties of both MCF10a and MDA-MB231 cells. We further studied the impact of VRK1 on the epithelial properties of MCF10a cells in 3D matrigel culture, in which cells proliferate and form epithelial sheets that mature into hollow spherical acini. VRK1 overexpression significantly accelerates the initial stages of cell proliferation, leading to larger acini that nevertheless differentiate and mature. Our analysis of human tumor tissue microarrays (TMAs) revealed that VRK1 protein levels are higher in lymph node metastases than in patient-matched mammary tumors. Using public databases, we determined that VRK1 is among the top 10% of overexpressed transcripts in multiple subtypes of invasive breast cancer, and that high levels of VRK1 expression are correlated with decreased relapse-free survival. In sum, overexpression of VRK1, by regulating the transcription repressors snail, slug, and twist1, can promote a mesenchymal-toepithelial transition (MET) in cell culture. VRK1-mediated MET might facilitate the colonization of distal sites by metastatic breast cancer cells, providing some insight into the frequent association of VRK1 overexpression with breast malignancies and the correlation between VRK1 overexpression and poor clinical outcome.	[Mon, Aye M.; Traktman, Paula] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [MacKinnon, A. Craig, Jr.] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Traktman, Paula] Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Traktman, Paula] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical College of Wisconsin; Medical University of South Carolina; Medical University of South Carolina	Traktman, P (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.; Traktman, P (corresponding author), Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA.; Traktman, P (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA.	traktman@musc.edu		Traktman, Paula/0000-0002-6517-0225; Mackinnon, Alexander/0000-0002-2036-8529	Medical College of Wisconsin Cancer Center; Medical College of Medical University of South Carolina	Medical College of Wisconsin Cancer Center; Medical College of Medical University of South Carolina	This work was funded by the Medical College of Wisconsin Cancer Center and Medical University of South Carolina start-up funds.	Barcia R, 2002, ARCH BIOCHEM BIOPHYS, V399, P1, DOI 10.1006/abbi.2001.2746; Bill R, 2015, FEBS LETT, V589, P1577, DOI 10.1016/j.febslet.2015.05.002; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Choi YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015254; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Debnath J, 2003, J CELL BIOL, V163, P315, DOI 10.1083/jcb.200304159; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Fardin MA, 2010, SOFT MATTER, V6, P4788, DOI 10.1039/c0sm00252f; Finetti P, 2008, CANCER RES, V68, P767, DOI 10.1158/0008-5472.CAN-07-5516; Fournier MV, 2006, CANCER RES, V66, P7095, DOI 10.1158/0008-5472.CAN-06-0515; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Huang W, 2016, PATHOL RES PRACT, V212, P171, DOI 10.1016/j.prp.2015.11.015; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Kim IJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2660; Lancaster OM, 2007, J CELL BIOL, V179, P817, DOI 10.1083/jcb.200706067; Lander R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2543; Lee N, 2015, ONCOTARGET, V6, P30130, DOI 10.18632/oncotarget.4967; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Molitor TP, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.11; Monsalve DM, 2016, BBA-MOL CELL RES, V1863, P760, DOI 10.1016/j.bbamcr.2016.02.005; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Nichols RJ, 2004, J BIOL CHEM, V279, P7934, DOI 10.1074/jbc.M310813200; Nogalski MT, 2012, JOVE-J VIS EXP, DOI 10.3791/4165; Palen K, 2016, ONCOTARGET, V7, P43363, DOI 10.18632/oncotarget.9715; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Salzano M, 2015, EPIGENETICS-US, V10, P373, DOI 10.1080/15592294.2015.1028708; Salzano M, 2014, ONCOTARGET, V5, P1770, DOI 10.18632/oncotarget.1678; Santos CR, 2006, MOL CANCER RES, V4, P177, DOI 10.1158/1541-7786.MCR-05-0212; Sanz-Garcia M, 2012, J BIOL CHEM, V287, P23757, DOI 10.1074/jbc.M112.353102; Schneider CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002362; Schober CS, 2011, MECH DEVELOP, V128, P178, DOI 10.1016/j.mod.2011.01.004; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Valbuena A, 2007, LUNG CANC; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Vega FM, 2003, FEBS LETT, V544, P176, DOI 10.1016/S0014-5793(03)00501-5; Vidi Pierre-Alexandre, 2013, Methods Mol Biol, V945, P193, DOI 10.1007/978-1-62703-125-7_13; Wiebe MS, 2010, BIOL REPROD, V82, P182, DOI 10.1095/biolreprod.109.079095; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P16654, DOI 10.1073/pnas.1205822109; Zhi H, 2009, J PATHOL, V217, P389, DOI 10.1002/path.2456; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	48	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0203397	10.1371/journal.pone.0203397	http://dx.doi.org/10.1371/journal.pone.0203397			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180179	Green Published, Green Submitted, gold			2022-12-26	WOS:000444222400040
J	Blomqvist, S; Alexanderson, K; Vahtera, J; Westerlund, H; Hanson, LLM				Blomqvist, Sandra; Alexanderson, Kristina; Vahtera, Jussi; Westerlund, Hugo; Hanson, Linda L. Magnusson			Downsizing and purchases of psychotropic drugs: A longitudinal study of stayers, changers and unemployed	PLOS ONE			English	Article							SELF-RATED HEALTH; ORGANIZATIONAL-CHANGE; WHITEHALL-II; JOB INSECURITY; EMPLOYEES; SWEDEN; DEPRESSION; DISORDERS; WOMEN; UNCERTAINTY	Background The evidence is insufficient regarding the association between organizational downsizing and employee mental health. Our aim was to analyze trajectories of prescribed sedatives and anxiolytics with a sufficiently long follow-up time to capture anticipation, implementation and adaption to a downsizing event among stayers, changers and those who become unemployed compared to unexposed employees. Method Swedish residents aged 20-54 years in 2007, with stable employment between 2004 and 2007, were followed between 2005 and 2013 (n = 2,305,795). Employment at a workplace with staff reductions >= 18% between two subsequent years in 2007-2011 (n = 915,461) indicated exposure to, and timing of, downsizing. The unexposed (n = 1,390,334) were randomized into four corresponding sub-cohorts. With generalized estimating equations, we calculated the odds ratios (OR) of purchasing prescribed anxiolytics or sedatives within nine 12-month periods, from four years before to four years after downsizing. In order to investigate whether the groups changed their probability of purchases over time, odds ratios (OR) and their 95% confidence intervals (95% CI) were calculated contrasting the prevalence of purchases during the first and the last 12-month period within four time periods for each exposure group. Results The odds of purchasing anxiolytics increased more for stayers (OR 1.03, 95% CI 1.01-1.06) and unemployed (OR 1.08, 95% CI 1.03-1.14) compared to unexposed before downsizing, and purchases continued to increase after downsizing for stayers. Among those without previous sickness absence, stayers increased their purchases of anxiolytics from the year before the event up to four years after the event. Trajectories for sedatives were similar but less pronounced. Conclusion This study indicates that being exposed to downsizing is associated with increased use of sedatives and anxiolytics, especially before the event, if the employee stays in the organization or becomes unemployed.	[Blomqvist, Sandra; Westerlund, Hugo; Hanson, Linda L. Magnusson] Stockholm Univ, Stress Res Inst, Stockholm, Sweden; [Alexanderson, Kristina] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland	Stockholm University; Karolinska Institutet; University of Turku	Blomqvist, S (corresponding author), Stockholm Univ, Stress Res Inst, Stockholm, Sweden.	sandra.blomqvist@su.se	Hanson, Linda L Magnusson/D-2435-2017; Westerlund, Hugo/A-3049-2012	Hanson, Linda L Magnusson/0000-0002-2908-1903; Westerlund, Hugo/0000-0002-8806-5698; Vahtera, Jussi/0000-0002-6036-061X	Swedish Research Council for Health, Working Life and Welfare [2009-1758]	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	The study was funded by the Swedish Research Council for Health, Working Life and Welfare recieved by the Stockholm Stress Center [grant number 2009-1758] (http://forte.se/en/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm J, 2013, SCAND J PUBLIC HEALT, V41, P318, DOI 10.1177/1403494812473205; Allen T D, 2000, J Occup Health Psychol, V5, P278, DOI 10.1037/1076-8998.5.2.278; Angst J, 2002, EUR ARCH PSY CLIN N, V252, P201, DOI 10.1007/s00406-002-0381-6; Aslund C, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-22; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bamberger SG, 2012, OCCUP ENVIRON MED, V69, P592, DOI 10.1136/oemed-2011-100381; Bernstrom VH, 2013, SOC SCI MED, V98, P239, DOI 10.1016/j.socscimed.2013.10.001; Bordia P., 2004, EUR J WORK ORGAN PSY, V13, P345, DOI [10.1080/13594320444000128, DOI 10.1080/13594320444000128]; Brenner MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097063; BRENNER SO, 1987, SOC SCI MED, V25, P153, DOI 10.1016/0277-9536(87)90383-2; BROCKNER J, 1985, ORGAN BEHAV HUM DEC, V36, P229, DOI 10.1016/0749-5978(85)90014-7; Brown C, 2003, SOC SCI MED, V57, P1539, DOI 10.1016/S0277-9536(02)00556-7; Cheng GHL, 2008, APPL PSYCHOL-INT REV, V57, P272, DOI 10.1111/j.1464-0597.2007.00312.x; Danielsson U, 2005, SCAND J PRIM HEALTH, V23, P171, DOI 10.1080/02813430510031315; Falkenberg H, 2013, OCCUP ENVIRON MED, V70, P688, DOI 10.1136/oemed-2013-101385; Ferrie JE, 2008, SCAND J WORK ENV HEA, P98; FERRIE JE, 1995, BRIT MED J, V311, P1264, DOI 10.1136/bmj.311.7015.1264; Hanson LLM, 2016, EPIDEMIOLOGY, V27, P257, DOI 10.1097/EDE.0000000000000414; Kivimaki M, 2000, BRIT MED J, V320, P971, DOI 10.1136/bmj.320.7240.971; Kivimaki M, 2003, AM J COMMUN PSYCHOL, V32, P57, DOI 10.1023/A:1025642806557; Kivimaki M, 2001, ANXIETY STRESS COPIN, V14, P59, DOI 10.1080/10615800108248348; Kivimaki M, 2007, J EPIDEMIOL COMMUN H, V61, P154, DOI 10.1136/jech.2006.050955; Laaksonen E, 2007, INT J EPIDEMIOL, V36, P776, DOI 10.1093/ije/dym074; Last JM, 2013, INT J EPIDEMIOL, V42, P1608, DOI 10.1093/ije/dyt113; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; Osthus S, 2012, SOC SCI MED, V75, P946, DOI 10.1016/j.socscimed.2012.04.036; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Paulsen N, 2005, HUM RELAT, V58, P463, DOI 10.1177/0018726705055033; Pollard TM, 2001, WORK STRESS, V15, P14, DOI 10.1080/02678370110064609; Quinlan M, 2009, INT J HEALTH SERV, V39, P1, DOI 10.2190/HS.39.1.a; Riemann D, 2003, J AFFECT DISORDERS, V76, P255, DOI 10.1016/S0165-0327(02)00072-1; Smollan RK, 2015, J ORGAN CHANGE MANAG, V28, P301, DOI 10.1108/JOCM-03-2014-0055; Statistics Sweden, 2016, UN STAT STAT SWED; Sundquist K, 2004, BRIT J PSYCHIAT, V184, P293, DOI 10.1192/bjp.184.4.293; Sverke Magnus, 2002, J Occup Health Psychol, V7, P242, DOI 10.1037/1076-8998.7.3.242; Swedish Board of Health and Welfare, PRESCR DRUGS STAT SW; Swedish Work Environment Authority, 2016, WOM MENS WORK COND I; Theorell T, 2014, J EPIDEMIOL COMMUN H, V68, P78, DOI 10.1136/jech-2012-202294; Vahtera J, 1997, LANCET, V350, P1124, DOI 10.1016/S0140-6736(97)03216-9; Wittchen HU, 2000, ACTA PSYCHIAT SCAND, V102, P14, DOI 10.1111/j.0065-1591.2000.acp29[dash]03.x	40	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203433	10.1371/journal.pone.0203433	http://dx.doi.org/10.1371/journal.pone.0203433			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161241	Green Submitted, gold, Green Published			2022-12-26	WOS:000443388900125
J	Deniz, B; Altincatal, A; Ambavane, A; Rao, S; Doan, J; Malcolm, B; Michaelson, MD; Yang, S				Deniz, Baris; Altincatal, Arman; Ambavane, Apoorva; Rao, Sumati; Doan, Justin; Malcolm, Bill; Michaelson, M. Dror; Yang, Shuo			Application of dynamic modeling for survival estimation in advanced renal cell carcinoma	PLOS ONE			English	Article							ADVANCED MELANOMA; ECONOMIC-EVALUATION; 1ST-LINE TREATMENT; COMBINED NIVOLUMAB; COST-EFFECTIVENESS; OPEN-LABEL; IPILIMUMAB; CHEMOTHERAPY; MULTICENTER; SUNITINIB	Objective In oncology, extrapolation of clinical outcomes beyond trial duration is traditionally achieved by parametric survival analysis using population-level outcomes. This approach may not fully capture the benefit/risk profile of immunotherapies due to their unique mechanisms of action. We evaluated an alternative approach-dynamic modeling-to predict outcomes in patients with advanced renal cell carcinoma. We compared standard parametric fitting and dynamic modeling for survival estimation of nivolumab and everolimus using data from the phase III CheckMate 025 study. Methods We developed two statistical approaches to predict longer-term outcomes (progression, treatment discontinuation, and survival) for nivolumab and everolimus, then compared these predictions against follow-up clinical trial data to assess their proximity to observed outcomes. For the parametric survival analyses, we selected a probability distribution based on its fit to observed population-level outcomes at 14-month minimum follow-up and used it to predict longer-term outcomes. For dynamic modeling, we used a multivariate Cox regression based on patient-level data, which included risk scores, and probability and duration of response as predictors of longer-term outcomes. Both sets of predictions were compared against trial data with 26- and 38-month minimum follow-up. Results Both statistical approaches led to comparable fits to observed trial data for median progression, discontinuation, and survival. However, beyond the trial duration, mean survival predictions differed substantially between methods for nivolumab (30.8 and 51.5 months), but not everolimus (27.2 and 29.8 months). Longer-term follow-up data from CheckMate 025 and phase I/II studies resembled dynamic model predictions for nivolumab. Conclusions Dynamic modeling can be a good alternative to parametric survival fitting for immunotherapies because it may help better capture the longer-term benefit/risk profile and support health-economic evaluations of immunotherapies.	[Deniz, Baris] Evidera Inc, Bethesda, MD 20814 USA; [Altincatal, Arman] Evidera Inc, Waltham, MA USA; [Ambavane, Apoorva] Evidera Inc, London, England; [Rao, Sumati; Doan, Justin; Malcolm, Bill; Yang, Shuo] Bristol Myers Squibb, Princeton, NJ USA; [Michaelson, M. Dror] Massachusetts Gen Hosp, Boston, MA 02114 USA	Evidera; Evidera; Evidera; Bristol-Myers Squibb; Harvard University; Massachusetts General Hospital	Deniz, B (corresponding author), Evidera Inc, Bethesda, MD 20814 USA.	baris.deniz@evidera.com	Ambavane, Apoorva/AAW-4834-2020	Michaelson, Dror/0000-0001-9249-6338; Deniz, Baris/0000-0002-8423-5629	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Bristol-Myers Squibb provided financial support to Evidera in relation to the conduct of the reported research study. The funder (Bristol-Myers Squibb) provided support in the form of salaries for those authors employed by the funder (S. Yang, S. Rao, J. Doan, and B. Malcolm) and had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Evidera, a commercial company, provided support in the form of salaries and research materials to B. Deniz, A. Altincatal, and A. Ambavane. and had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No authors received financial support in direct relation to the preparation of this manuscript. Bristol-Myers Squibb provided funding in relation to professional writing/editorial support as outlined in the Acknowledgments section; Medical writing support was provided by Jenny Lloyd, PhD. Professional editorial assistance was provided by Richard Daniel, PhD, and Lawrence Hargett of PPSI (a PAREXEL company), and was funded by Bristol-Myers Squibb.	Benedict A, 2011, BJU INT, V108, P665, DOI 10.1111/j.1464-410X.2010.09957.x; Bohensky M, 2015, VALUE HEALTH, V18, pA699, DOI 10.1016/j.jval.2015.09.2613; Bristol-Myers Squibb, CHECKMATE 025 STUD D; Caro JJ, 2016, PHARMACOECONOMICS, V34, P665, DOI 10.1007/s40273-016-0394-z; Chabot I, 2010, VALUE HEALTH, V13, P837, DOI 10.1111/j.1524-4733.2010.00738.x; Cherny NI, 2015, ANN ONCOL, V26, P1547, DOI 10.1093/annonc/mdv249; Collett, 2003, MODELLING SURVIVAL D; D'Errico G, 2017, CLIN TRANSL MED, V6, DOI 10.1186/s40169-016-0130-5; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Food and Drug Administration, 1989, GANC INJ INTR US HIG; Furlow B., 2016, ASCO 2016 NIVOLUMAB; Hodi FS, 2016, LANCET ONCOL, V17, P1558, DOI 10.1016/S1470-2045(16)30366-7; Hodi FS, 2016, J CLIN ONCOL, V34, P1510, DOI 10.1200/JCO.2015.64.0391; Hoyle MW, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-139; Huang XL, 2016, STAT MED, V35, P2167, DOI 10.1002/sim.6860; Ishak KJ, 2013, PHARMACOECONOMICS, V31, P663, DOI 10.1007/s40273-013-0064-3; Ishak KJ, 2016, ISPOR 19 ANN EUR M O; Kaufman HL, 2016, LANCET ONCOL, V17, P1374, DOI 10.1016/S1470-2045(16)30364-3; Latimer N., NICE DSU TECHNICAL S; Martin-Liberal J, 2017, CANCER TREAT REV, V54, P74, DOI 10.1016/j.ctrv.2017.01.008; McDermott DF, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.4507; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 2004, J CLIN ONCOL, V22, P454, DOI 10.1200/JCO.2004.06.132; National Comprehensive Cancer Network (NCCN), 2011, NCCN CLIN PRACT GUID; National Institute for Health and Care Excellence (NICE), NIV TREAT ADV UNR ME; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Plimack ER, 2016, 15 INT KIDN CANC S N; Remak E, 2008, J CLIN ONCOL, V26, P3995, DOI 10.1200/JCO.2007.13.2662; Ribas A, 2012, CLIN CANCER RES, V18, P336, DOI 10.1158/1078-0432.CCR-11-2323; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Schadendorf D, 2014, J CLIN ONCOL, V56, P2736, DOI DOI 10.1200/JC0.2014.56.2736; Schnipper LE, 2015, J CLIN ONCOL, V33, P2563, DOI 10.1200/JCO.2015.61.6706; Sharma P, 2017, 16 INT KIDN CANC S N; U.S. Food and drug administration, HIGHL PRESCR INF OPD; US Food and Drug Administration, HIGHL PRESCR INF BAV; US Food and Drug Administration, HIGHL PRESCR INF YER; US Food and Drug Administration, HIGHL PRESCR INF KEY; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Wan XM, 2017, CANCER-AM CANCER SOC, V123, P2634, DOI 10.1002/cncr.30666; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	42	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203406	10.1371/journal.pone.0203406	http://dx.doi.org/10.1371/journal.pone.0203406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161244	gold, Green Submitted, Green Published			2022-12-26	WOS:000443388900122
J	Nakano, M; Kikushige, Y; Miyawaki, K; Kunisaki, Y; Mizuno, S; Takenaka, K; Tamura, S; Okumura, Y; Ito, M; Ariyama, H; Kusaba, H; Nakamura, M; Maeda, T; Baba, E; Akashi, K				Nakano, Michitaka; Kikushige, Yoshikane; Miyawaki, Kohta; Kunisaki, Yuya; Mizuno, Shinichi; Takenaka, Katsuto; Tamura, Shingo; Okumura, Yuta; Ito, Mamoru; Ariyama, Hiroshi; Kusaba, Hitoshi; Nakamura, Masafumi; Maeda, Takahiro; Baba, Eishi; Akashi, Koichi			Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer	ONCOGENE			English	Article							HUMAN COLON; MESENCHYMAL TRANSITION; INITIATING CELLS; TUMOR INITIATION; EMT; IDENTIFICATION; METASTASIS; EXPRESSION; PLASTICITY; SIGNATURE	Cancer stem cells (CSCs) possess the capacity for self-renewal and the potential to differentiate into non-CSCs. The recent discoveries of dynamic equilibrium between CSCs and non-CSCs revealed the significance of acquiring CSC-like properties in non-CSCs as an important process in progression of cancer. The mechanism underlying acquisition of CSC-like properties has mainly been investigated in the context of epithelial-mesenchymal transition. Here, we demonstrate the dedifferentiation process may be an alternative mechanism in acquisition of CSC-like properties in human colorectal cancer cells. By exploring the single-cell gene expression analysis of organoids developed from CD44(+) CSCs, we identified TWIST1 as a key molecule for maintaining the undifferentiated state of cancer cells. Consistent with the finding, we found that TGF-beta signaling pathway, a regulator of TWIST1, was specifically activated in the undifferentiated CD44(+) CSCs in human colorectal cancer using microarray-based gene expression analysis and quantitative pathology imaging system. Furthermore, we showed that external stimulation with TGF-beta and the induction of TWIST1 converted CD44(-) non-CSCs into the undifferentiated CD44(+) CSCs, leading to the significant increment of CSCs in xenograft models. This study strongly suggests dedifferentiation driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer.	[Nakano, Michitaka; Kikushige, Yoshikane; Miyawaki, Kohta; Kunisaki, Yuya; Mizuno, Shinichi; Takenaka, Katsuto; Tamura, Shingo; Okumura, Yuta; Ito, Mamoru; Ariyama, Hiroshi; Kusaba, Hitoshi; Maeda, Takahiro; Baba, Eishi; Akashi, Koichi] Kyushu Univ, Dept Med & Biosyst Sci, Grad Sch Med Sci, Fukuoka, Fukuoka, Japan; [Baba, Eishi] Kyushu Univ, Dept Comprehens Clin Oncol, Fac Med Sci, Fukuoka, Fukuoka, Japan; [Nakamura, Masafumi] Kyushu Univ, Dept Surg & Oncol, Grad Sch Med Sci, Fukuoka, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University	Baba, E (corresponding author), Kyushu Univ, Dept Med & Biosyst Sci, Grad Sch Med Sci, Fukuoka, Fukuoka, Japan.; Baba, E (corresponding author), Kyushu Univ, Dept Comprehens Clin Oncol, Fac Med Sci, Fukuoka, Fukuoka, Japan.	e-baba@intmed1.med.kyushu-u.ac.jp	Maeda, Takahiro/AAC-4563-2019	Maeda, Takahiro/0000-0003-4530-6460; Nakano, Michitaka/0000-0003-1049-5791; Okumura, Yuta/0000-0002-7825-8373	JSPS [16H06391, 16H02662, 15K08970, 16H06250, 25860542, 15H04859]; MEXT, Japan [25115002]; Japan Agency for Medical Research and development, AMED [18cm0106507h0003, 18ck0106196h0003]; Shinnihon Foundation of Advanced Medical Treatment Research; AstraZeneca KK (AZKK Science Promotion Grant)	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); Shinnihon Foundation of Advanced Medical Treatment Research; AstraZeneca KK (AZKK Science Promotion Grant)	We especially thank N Torada, T Ueki, and T Manabe, S Nagai from the Department of Surgery and Oncology, Kyushu University, for providing clinical colorectal cancer tissues. They sincerely thank T. Isobe for development of methods and wonderful lecture. They also thank A. Yurino for providing mice, Yasufumi Uehara for taking confocal microscopy images, T Sugio, T Jiroumaru for performing microarray analysis. Co-workers at our labs, F Hanamura, Yumiko Uehara, K Yamaguchi, K Sagara, K Tsuchihashi, S Arita, supported this work. This study was supported in part by a Grant-in-Aid for Scientific Research (S) (to KA, #16H06391), a Grant-in-Aid for Scientific Research (A) (to KA, #16H02662), a Grant-in-Aid for Scientific Research (C) (to EB, #15K08970), a Grant-in-Aid for Young Scientists (A) (to Y Kikushige #16H06250), a Grant-in-Aid for Young Scientists (B) (to SA, #25860542), a Grant-in-Aid for Scientific Research (B) (to Y Kunisaki, #15H04859), from the JSPS, and a Grant-in-Aid for Scientific Research on Innovative Areas "Stem Cell Aging and Disease" (to TM and Y Kikushige, #25115002) from MEXT, Japan, and the "Project for Cancer Research and Therapeutic Evolution" (to KA, 18cm0106507h0003), and the "Practical Research for Innovative Cancer Control" (to Y Kikushige, 18ck0106196h0003) from Japan Agency for Medical Research and development, AMED, and the Shinnihon Foundation of Advanced Medical Treatment Research (to HA, Y Kikushige, and Y Kunisaki), and a collaborative research grant from AstraZeneca KK (to MN, AZKK Science Promotion Grant).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barriga FM, 2017, CELL STEM CELL, V20, P801, DOI 10.1016/j.stem.2017.02.007; Beck B, 2015, CELL STEM CELL, V16, P67, DOI 10.1016/j.stem.2014.12.002; Beerling E, 2016, CELL REP, V14, P2281, DOI 10.1016/j.celrep.2016.02.034; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Brabletz T, 2018, NAT REV CANCER, V18, P128, DOI 10.1038/nrc.2017.118; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; Foroutan M, 2017, MOL CANCER RES, V15, P619, DOI 10.1158/1541-7786.MCR-16-0313; Fujii M, 2016, CELL STEM CELL, V18, P827, DOI 10.1016/j.stem.2016.04.003; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Jiang JM, 2008, CELL STEM CELL, V3, P127, DOI 10.1016/j.stem.2008.07.011; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Jung P, 2015, STEM CELL REP, V5, P979, DOI 10.1016/j.stemcr.2015.10.003; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kim J, 2011, GENOME MED, V3, DOI 10.1186/gm291; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oshimori N, 2012, CELL STEM CELL, V11, P751, DOI 10.1016/j.stem.2012.11.001; Ovadya Y, 2015, NAT MED, V21, P975, DOI 10.1038/nm.3938; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pino MS, 2010, GASTROENTEROLOGY, V138, P1406, DOI 10.1053/j.gastro.2009.12.010; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shvab A, 2016, ONCOGENE, V35, P549, DOI 10.1038/onc.2015.127; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wang DW, 2018, ONCOL REP, V39, P31, DOI 10.3892/or.2017.6076; Wu Y, 2017, BREAST CANCER RES TR, V163, P449, DOI 10.1007/s10549-017-4211-y; Yaeger R, 2018, CANCER CELL, V33, P125, DOI 10.1016/j.ccell.2017.12.004; Zhang BX, 2010, GASTROENTEROLOGY, V138, P969, DOI 10.1053/j.gastro.2009.11.004; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhu PP, 2015, J CLIN INVEST, V125, P3795, DOI 10.1172/JCI81979	52	52	54	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 7	2019	38	6					780	793		10.1038/s41388-018-0480-0	http://dx.doi.org/10.1038/s41388-018-0480-0			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HK5LC	30181548	Green Accepted			2022-12-26	WOS:000458006300002
J	Bershitsky, SY; Logvinova, DS; Shchepkin, DV; Kopylova, GV; Matyushenko, AM				Bershitsky, Sergey Y.; Logvinova, Daria S.; Shchepkin, Daniil V.; Kopylova, Galina V.; Matyushenko, Alexander M.			Myopathic mutations in the beta-chain of tropomyosin differently affect the structural and functional properties of beta beta- and alpha beta-dimers	FASEB JOURNAL			English	Article						tropomyosin isoforms; actin-myosin interaction; Ca2+-regulation of muscle contraction; in vitro motility assay	2 STABILIZING SUBSTITUTIONS; ACTIN-MYOSIN INTERACTION; SKELETAL-MUSCLE; THIN FILAMENT; CARDIAC MYOSIN; MIDDLE PART; CONTRACTION; ISOFORMS; SUBFRAGMENT-1; PROTEINS	Tropomyosin (Tpm) is an actin-binding protein that plays a vital role in the regulation of muscle contraction. Fast skeletal muscles express 2 Tpm isoforms, (Tpm 1.1) and (Tpm 2.2), resulting in the existence of 2 forms of dimeric Tpm molecule: -homodimer and -heterodimer. -Homodimer is unstable and absent in the native state, despite which most of the studies of myopathy-relating Tpm mutations have been performed on the -homodimer. Here, we applied different methods to investigate the effects of myopathic mutations R133W and N202K in the -chain of Tpm on properties of -heterodimers and to compare them with the features of -homodimers with the same mutations. The results show that properties of -Tpm and -Tpm with substitutions in the -chain differ significantly, and this indicates that the effects of myopathic mutations in the Tpm -chain should be studied on the Tpm -heterodimer.Bershitsky, S. Y., Logvinova, D. S., Shchepkin, D. V., Kopylova, G. V., Matyushenko, A. M. Myopathic mutations in the -chain of tropomyosin differently affect the structural and functional properties of beta beta- and alpha beta-dimers.	[Bershitsky, Sergey Y.; Logvinova, Daria S.; Shchepkin, Daniil V.; Kopylova, Galina V.; Matyushenko, Alexander M.] Russian Acad Sci, Inst Immunol & Physiol, Ekaterinburg, Russia; [Logvinova, Daria S.; Matyushenko, Alexander M.] Russian Acad Sci, Biotechnol Res Ctr, AN Bach Inst Biochem, Leninsky Prospect 33,Bldg 2, Moscow 119071, Russia	Institute of Immunology & Physiology UB RAS; Russian Academy of Sciences; Research Center of Biotechnology RAS; Russian Academy of Sciences	Matyushenko, AM (corresponding author), Russian Acad Sci, Biotechnol Res Ctr, AN Bach Inst Biochem, Leninsky Prospect 33,Bldg 2, Moscow 119071, Russia.	ammatyushenko@mail.ru	Bershitsky, Sergey/AAE-6814-2019; Bershitsky, Sergey/S-4829-2016; Kopylova, Galina/ABF-2117-2020; Shchepkin, Daniil/ABF-1160-2020	Bershitsky, Sergey/0000-0001-5342-1739; Kopylova, Galina/0000-0003-2976-2108; 	Russian Foundation for Basic Research [16-34-00654]; Foundation for Basic Research [16-04-00688];  [01201351368];  [AAAA-A18-118020590135-3]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Foundation for Basic Research; ; 	CD measurements were carried out on the equipment of the Shared-Access Equipment Centre "Industrial Biotechnology" of Federal Research Center "Fundamentals of Biotechnology" of the Russian Academy of Sciences. This work was supported by the Russian Foundation for Basic Research Grant 16-34-00654, State Program 01201351368 to A.M.M., and Foundation for Basic Research Grant 16-04-00688 and State Program AAAA-A18-118020590135-3 to S.Y.B. The authors declare no conflicts of interest.	Abdul-Hussein S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072396; Bacchiocchi C, 2002, BIOPHYS J, V82, P1524, DOI 10.1016/S0006-3495(02)75505-7; BAILEY K, 1953, PROC R SOC SER B-BIO, V141, P45, DOI 10.1098/rspb.1953.0015; Bicer S, 2013, J MUSCLE RES CELL M, V34, P211, DOI 10.1007/s10974-013-9346-9; BRONSON DD, 1982, J BIOL CHEM, V257, P3937; Clemmens EW, 2005, J PHYSIOL-LONDON, V566, P737, DOI 10.1113/jphysiol.2005.084194; Colpan M, 2017, ARCH BIOCHEM BIOPHYS, V630, P18, DOI 10.1016/j.abb.2017.07.006; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GREASER ML, 1971, J BIOL CHEM, V246, P4226; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Janco M, 2012, BIOCHEMISTRY-US, V51, P9880, DOI 10.1021/bi301323n; Jin YT, 2016, J MUSCLE RES CELL M, V37, P41, DOI 10.1007/s10974-016-9443-7; Kalyva A, 2012, BIOCHEMISTRY-US, V51, P6388, DOI 10.1021/bi300340r; Khaitlina SY, 2015, INT REV CEL MOL BIO, V318, P255, DOI 10.1016/bs.ircmb.2015.06.002; Kopylova GV, 2013, BIOCHEMISTRY-MOSCOW+, V78, P260, DOI 10.1134/S0006297913030073; Kremneva E, 2006, FEBS J, V273, P588, DOI 10.1111/j.1742-4658.2005.05092.x; Kremneva E, 2004, BIOPHYS J, V87, P3922, DOI 10.1529/biophysj.104.048793; Lehman W, 2016, COMPR PHYSIOL, V6, P1043, DOI 10.1002/cphy.c150030; LEHRER SS, 1987, ARCH BIOCHEM BIOPHYS, V256, P1, DOI 10.1016/0003-9861(87)90419-X; LEHRER SS, 1975, P NATL ACAD SCI USA, V72, P3377, DOI 10.1073/pnas.72.9.3377; Marston S, 2013, HUM MOL GENET, V22, P4978, DOI 10.1093/hmg/ddt345; Marttila M, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-15; Marttila M, 2014, HUM MUTAT, V35, P779, DOI 10.1002/humu.22554; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; Matyushenko AM, 2015, BIOPHYS CHEM, V196, P77, DOI 10.1016/j.bpc.2014.10.001; Matyushenko AM, 2014, FEBS J, V281, P2004, DOI 10.1111/febs.12756; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Muthuchamy M, 1998, J MOL CELL CARDIOL, V30, P1545, DOI 10.1006/jmcc.1998.0720; Muthuchamy M, 1995, J BIOL CHEM, V270, P30593, DOI 10.1074/jbc.270.51.30593; Nevzorov IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1507, DOI 10.1134/S0006297911130098; Ochala J, 2007, J PHYSIOL-LONDON, V581, P1283, DOI 10.1113/jphysiol.2007.129759; Ochala J, 2010, P NATL ACAD SCI USA, V107, P9807, DOI 10.1073/pnas.1001733107; Oe M, 2016, MEAT SCI, V118, P129, DOI 10.1016/j.meatsci.2016.04.013; Ohlsson M, 2008, NEUROLOGY, V71, P1896, DOI 10.1212/01.wnl.0000336654.44814.b8; Orzechowski M, 2014, BIOPHYS J, V107, P694, DOI 10.1016/j.bpj.2014.06.034; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; Cruz PMR, 2014, NEUROMUSCULAR DISORD, V24, P1103, DOI 10.1016/j.nmd.2014.07.005; Schreckenbach T, 2014, NEUROMUSCULAR DISORD, V24, P117, DOI 10.1016/j.nmd.2013.10.002; Shchepkin DV, 2011, BIOCHEM BIOPH RES CO, V415, P104, DOI 10.1016/j.bbrc.2011.10.022; Shchepkin DV, 2010, BIOCHEM BIOPH RES CO, V401, P159, DOI 10.1016/j.bbrc.2010.09.040; Shchepkin DV, 2017, BIOCHEM BIOPH RES CO, V490, P324, DOI 10.1016/j.bbrc.2017.06.043; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Tajsharghi H, 2007, NEUROLOGY, V68, P772, DOI 10.1212/01.wnl.0000256339.40667.fb; Tajsharghi H, 2012, NEUROMUSCULAR DISORD, V22, P923, DOI 10.1016/j.nmd.2012.05.018; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; WEGNER A, 1979, J MOL BIOL, V131, P839, DOI 10.1016/0022-2836(79)90204-3; WILLIAMS DL, 1981, BIOCHEMISTRY-US, V20, P3856, DOI 10.1021/bi00516a029	49	8	8	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1963	1971		10.1096/fj.201800755R	http://dx.doi.org/10.1096/fj.201800755R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30199282				2022-12-26	WOS:000457296600035
J	Gallot, YS; Bohnert, KR; Straughn, AR; Xiong, GY; Hindi, SM; Kumar, A				Gallot, Yann S.; Bohnert, Kyle R.; Straughn, Alex R.; Xiong, Guangyan; Hindi, Sajedah M.; Kumar, Ashok			PERK regulates skeletal muscle mass and contractile function in adult mice	FASEB JOURNAL			English	Article						ER stress; unfolded protein response; cancer cachexia; proteostasis; lewis lung carcinoma	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; AMINO-ACID-METABOLISM; ER STRESS; TRANSLATIONAL CONTROL; POTENTIAL ROLE; GROWTH; ATROPHY; INHIBITION; PATHWAYS	Skeletal muscle mass is regulated by the coordinated activation of several anabolic and catabolic pathways. The endoplasmic reticulum (ER) is a major site of protein folding and a reservoir for calcium ions. Accretion of misfolded proteins or depletion in calcium concentration causes stress in the ER, which leads to the activation of a signaling network known as the unfolded protein response (UPR). In the present study, we investigated the role of the protein kinase R-like endoplasmic reticulum kinase (PERK) arm of the UPR in the regulation of skeletal muscle mass and function in naive conditions and in a mouse model of cancer cachexia. Our results demonstrate that the targeted inducible deletion of PERK reduces skeletal muscle mass, strength, and force production during isometric contractions. Deletion of PERK also causes a slow-to-fast fiber type transition in skeletal muscle. Furthermore, short hairpin RNA-mediated knockdown or pharmacologic inhibition of PERK leads to atrophy in cultured myotubes. While increasing the rate of protein synthesis, the targeted deletion of PERK leads to the increased expression of components of the ubiquitin-proteasome system and autophagy in skeletal muscle. Ablation of PERK also increases the activation of calpains and deregulates the gene expression of the members of the FGF19 subfamily. Furthermore, the targeted deletion of PERK increases muscle wasting in Lewis lung carcinoma tumor-bearing mice. Our findings suggest that the PERK arm of the UPR is essential for the maintenance of skeletal muscle mass and function in adult mice.Gallot, Y. S., Bohnert, K. R., Straughn, A. R., Xiong, G., Hindi, S. M., Kumar, A. PERK regulates skeletal muscle mass and contractile function in adult mice.	[Gallot, Yann S.; Bohnert, Kyle R.; Straughn, Alex R.; Xiong, Guangyan; Hindi, Sajedah M.; Kumar, Ashok] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, 500 South Preston St, Louisville, KY 40202 USA	University of Louisville	Kumar, A (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, 500 South Preston St, Louisville, KY 40202 USA.	ashok.kumar@louisville.edu	Gallot, Yann Simon/GQI-2372-2022; Straughn, Alex/AAJ-9727-2021; Gallot, Yann Simon/ABC-1826-2021; Gallot, Yann Simon/GNO-9167-2022	Gallot, Yann Simon/0000-0003-4447-1448; Straughn, Alex/0000-0002-6516-8096; Gallot, Yann Simon/0000-0003-4447-1448; Gallot, Yann Simon/0000-0003-4447-1448; Kumar, Ashok/0000-0001-8571-2848	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Disease [AG029623, AR059810, AR068313]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068313, R01AR059810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Disease; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Disease Grants AG029623, AR059810 and AR068313 (to A.K.) Figure 1A was produced with the assistance of Servier Medical Art (https://smart.servier.com).The authors declare no conflicts of interest.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Afroze D, 2019, FEBS J, V286, P379, DOI 10.1111/febs.14358; Agbulut O, 2003, BIOL CELL, V95, P399, DOI 10.1016/S0248-4900(03)00087-X; Alter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029498; Axten JM, 2013, ACS MED CHEM LETT, V4, P964, DOI 10.1021/ml400228e; Bartoli M, 2005, INT J BIOCHEM CELL B, V37, P2115, DOI 10.1016/j.biocel.2004.12.012; Benoit B, 2017, NAT MED, V23, P990, DOI 10.1038/nm.4363; Bhatnagar S, 2012, J CELL PHYSIOL, V227, P1042, DOI 10.1002/jcp.22821; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bohnert KR, 2018, J CELL PHYSIOL, V233, P67, DOI 10.1002/jcp.25852; Bohnert KR, 2016, FASEB J, V30, P3053, DOI 10.1096/fj.201600250RR; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Chalil S, 2015, BIOCHEM BIOPH RES CO, V468, P702, DOI 10.1016/j.bbrc.2015.11.019; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Deldicque L, 2010, AM J PHYSIOL-ENDOC M, V299, pE695, DOI 10.1152/ajpendo.00038.2010; Dutt V, 2018, BBA-GEN SUBJECTS, V1862, P895, DOI 10.1016/j.bbagen.2017.12.015; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Gallot YS, 2017, ONCOTARGET, V8, P112565, DOI 10.18632/oncotarget.22575; Guridi M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3715; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hindi SM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98441; Hindi SM, 2014, HUM MOL GENET, V23, P1492, DOI 10.1093/hmg/ddt536; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hwee DT, 2014, AGING CELL, V13, P92, DOI 10.1111/acel.12150; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kammoun M, 2014, EUR J HISTOCHEM, V58, P163, DOI 10.4081/ejh.2014.2254; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Li CKC, 2009, AM J PATHOL, V175, P1030, DOI 10.2353/ajpath.2009.090196; Li DJ, 2016, METABOLISM, V65, P747, DOI 10.1016/j.metabol.2016.02.009; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Ma L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186128; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; Mielcarek M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005021; Miyake M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179955; Miyake M, 2016, FASEB J, V30, P798, DOI 10.1096/fj.15-275990; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Murachi T, 1980, Adv Enzyme Regul, V19, P407; Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; OHNO S, 1984, NATURE, V312, P566, DOI 10.1038/312566a0; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Rashid HO, 2015, AUTOPHAGY, V11, P1956, DOI 10.1080/15548627.2015.1091141; Rieusset J, 2012, BIOCHEM BIOPH RES CO, V417, P439, DOI 10.1016/j.bbrc.2011.11.135; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021; Vitadello M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2963; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Xiong GY, 2017, ELIFE, V6, DOI 10.7554/eLife.22871; Yu ZG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002321; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002; Zismanov V, 2016, CELL STEM CELL, V18, P79, DOI 10.1016/j.stem.2015.09.020	66	30	30	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1946	1962		10.1096/fj.201800683RR	http://dx.doi.org/10.1096/fj.201800683RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30204503	Green Published			2022-12-26	WOS:000457296600034
J	Stieglitz, D; Lamm, S; Braig, S; Feuerer, L; Kuphal, S; Dietrich, P; Arndt, S; Echtenacher, B; Hellerbrand, C; Karrer, S; Bosserhoff, AK				Stieglitz, David; Lamm, Susanne; Braig, Simone; Feuerer, Lena; Kuphal, Silke; Dietrich, Peter; Arndt, Stephanie; Echtenacher, Bernd; Hellerbrand, Claus; Karrer, Sigrid; Bosserhoff, Anja-Katrin			BMP6-induced modulation of the tumor micro-milieu	ONCOGENE			English	Article							BONE MORPHOGENETIC PROTEINS; NECROSIS-FACTOR-ALPHA; MAST-CELLS; MELANOMA-CELLS; METABOTROPIC GLUTAMATE-RECEPTOR-1; HEPCIDIN EXPRESSION; MALIGNANT-MELANOMA; BMP6; REGULATOR; HISTAMINE	Melanoma is the deadliest form of skin cancer with rising incidence, creating a significant health problem. We discovered increased expression of bone morphogenetic protein 6 (BMP6) in melanoma cells and tissues, and observed that BMP6 deficiency caused significantly delayed tumor onset and decelerated tumor progression in a melanoma mouse model. Moreover, we determined that BMP6 inhibits dermal mast cell recruitment and found that mast cell-derived mediators significantly reduced melanoma growth in vitro. In line with this, mast cell deficiency accelerated tumor onset and progression in a melanoma mouse model. Analysis of human melanoma tissues revealed a strong negative correlation between melanoma proliferation and mast cell infiltration. This study elucidates a novel role of BMP6-induced modulation of the tumor microenvironment.	[Stieglitz, David; Lamm, Susanne; Feuerer, Lena; Kuphal, Silke; Dietrich, Peter; Hellerbrand, Claus; Bosserhoff, Anja-Katrin] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, Dept Biochem & Mol Med, Erlangen, Germany; [Braig, Simone] Univ Munich, Dept Pharm, Pharmaceut Biol, Munich, Germany; [Arndt, Stephanie; Karrer, Sigrid] Univ Med Ctr Regensburg, Dept Dermatol, Regensburg, Germany; [Echtenacher, Bernd] Regensburg Ctr Intervent Immunol RCI, Regensburg, Germany; [Echtenacher, Bernd] Univ Med Ctr Regensburg, Regensburg, Germany; [Hellerbrand, Claus; Bosserhoff, Anja-Katrin] Erlangen EMN, CCC, Erlangen, Germany	University of Erlangen Nuremberg; University of Munich; University of Regensburg; University of Regensburg; University of Erlangen Nuremberg	Bosserhoff, AK (corresponding author), Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, Dept Biochem & Mol Med, Erlangen, Germany.; Bosserhoff, AK (corresponding author), Erlangen EMN, CCC, Erlangen, Germany.	Anja.Bosserhoff@fau.de	Bosserhoff, Anja/GNH-4801-2022; Kuphal, Silke/AAW-2702-2020		German Cancer Aid; German research Foundation (DFG) [HE2458/18, BO1573]; German research Foundation (DFG, Research Training Group "RTG 1962/1"); Interdisciplinary Center for Clinical Research (IZKF) Erlangen [D24 (AB)]	German Cancer Aid(Deutsche Krebshilfe); German research Foundation (DFG)(German Research Foundation (DFG)); German research Foundation (DFG, Research Training Group "RTG 1962/1"); Interdisciplinary Center for Clinical Research (IZKF) Erlangen	This work was supported by the German Cancer Aid, the German research Foundation (DFG, HE2458/18; BO1573, Research Training Group "RTG 1962/1") and the Interdisciplinary Center for Clinical Research (IZKF) Erlangen (D24 (AB)).	Amelio I, 2016, CELL DEATH DIFFER, V23, P912, DOI 10.1038/cdd.2016.12; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arndt S, 2015, GUT, V64, P973, DOI 10.1136/gutjnl-2014-306968; Arndt S, 2010, GASTROENTEROLOGY, V138, P372, DOI 10.1053/j.gastro.2009.09.048; BENYON RC, 1991, J IMMUNOL, V147, P2253; Biswas A, 2014, INT J DERMATOL, V53, P806, DOI 10.1111/j.1365-4632.2012.05745.x; Bosserhoff AK, 2011, EXP DERMATOL, V20, P435, DOI 10.1111/j.1600-0625.2011.01271.x; Botchkarev VA, 2003, J INVEST DERMATOL, V120, P36, DOI 10.1046/j.1523-1747.2003.12002.x; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Braig S, 2010, CELL MOL LIFE SCI, V67, P3535, DOI 10.1007/s00018-010-0394-7; Ch'ng S, 2006, MODERN PATHOL, V19, P149, DOI 10.1038/modpathol.3800474; DROZDOFF V, 1994, P NATL ACAD SCI USA, V91, P5528, DOI 10.1073/pnas.91.12.5528; Dyduch G, 2011, POL J PATHOL, V62, P139; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Forward NA, 2009, J IMMUNOL, V183, P3014, DOI 10.4049/jimmunol.0802509; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Hellstrand K, 2002, SEMIN ONCOL, V29, P35, DOI 10.1053/sonc.2002.33081; Hsu MY, 2008, LAB INVEST, V88, P842, DOI 10.1038/labinvest.2008.55; Hu F, 2016, ONCOL REP, V35, P1823, DOI 10.3892/or.2015.4540; Jensen-Jarolim E, 2008, ALLERGY, V63, P1255, DOI 10.1111/j.1398-9995.2008.01768.x; Katagiri T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021899; Keller HR, 2017, ONCOTARGET, V8, P75675, DOI 10.18632/oncotarget.18523; Khazaie K, 2011, CANCER METAST REV, V30, P45, DOI 10.1007/s10555-011-9286-z; LU C, 1993, J CELL BIOL, V120, P1281, DOI 10.1083/jcb.120.5.1281; LYONS KM, 1989, GENE DEV, V3, P1657, DOI 10.1101/gad.3.11.1657; Marin YE, 2006, CELL SIGNAL, V18, P1279, DOI 10.1016/j.cellsig.2005.10.012; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mueller DW, 2011, INT J CANCER, V129, P1064, DOI 10.1002/ijc.25768; Na YR, 2009, CANCER SCI, V100, P2218, DOI 10.1111/j.1349-7006.2009.01301.x; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Ott CA, 2016, ONCOTARGET, V7, P62292, DOI 10.18632/oncotarget.11410; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Pulluri B, 2017, PHARMACOL RES, V123, P95, DOI 10.1016/j.phrs.2017.07.006; Ribeiro J, 2014, J ETHNOPHARMACOL, V155, P1118, DOI 10.1016/j.jep.2014.06.041; Rothhammer T, 2005, CANCER RES, V65, P448; Rothhammer T, 2008, EUR J CANCER, V44, P2526, DOI 10.1016/j.ejca.2008.07.029; Schiffner S, 2014, EXP EYE RES, V127, P59, DOI 10.1016/j.exer.2014.07.009; Schiffner S, 2012, EXP DERMATOL, V21, P786, DOI 10.1111/j.1600-0625.2012.01560.x; Schiffnery S, 2011, CARCINOGENESIS, V32, P1176, DOI 10.1093/carcin/bgr103; Shin SS, 2010, PIGM CELL MELANOMA R, V23, P103, DOI 10.1111/j.1755-148X.2009.00648.x; Siiskonen H, 2015, MELANOMA RES, V25, P479, DOI 10.1097/CMR.0000000000000192; Solloway MJ, 1998, DEV GENET, V22, P321, DOI 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.3.CO;2-7; SWOPE VB, 1991, J INVEST DERMATOL, V96, P180, DOI 10.1111/1523-1747.ep12460991; Theoharides TC, 2004, TRENDS IMMUNOL, V25, P235, DOI 10.1016/j.it.2004.02.013; Voller D, 2013, BRIT J CANCER, V109, P3116, DOI 10.1038/bjc.2013.646; WALL NA, 1993, J CELL BIOL, V120, P493, DOI 10.1083/jcb.120.2.493; Weller CL, 2011, CLIN SCI, V120, P473, DOI 10.1042/CS20100459; Yang XD, 2011, NAT MED, V17, P87, DOI 10.1038/nm.2278	49	19	19	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 31	2019	38	5					609	621		10.1038/s41388-018-0475-x	http://dx.doi.org/10.1038/s41388-018-0475-x			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HJ6LI	30171260				2022-12-26	WOS:000457300300001
J	Zhang, XP; Liu, L; Deng, XZ; Li, D; Cai, HD; Ma, YS; Jia, CY; Wu, B; Fan, YB; Lv, ZW				Zhang, Xiaoping; Liu, Lin; Deng, Xianzhao; Li, Dan; Cai, Haidong; Ma, Yushui; Jia, Chengyou; Wu, Bo; Fan, Youben; Lv, Zhongwei			MicroRNA 483-3p targets Pard3 to potentiate TGF-beta 1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells	ONCOGENE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; LUNG ADENOCARCINOMA; GENE-EXPRESSION; ONCOGENIC ROLE; TIAM1; CARCINOMA; METASTASIS; MIR-483-3P; PROGNOSIS; MIR-21	Anaplastic thyroid cancer (ATC) is associated with poor prognosis and is often untreatable. MicroRNA 483-3p (miR-483) and partitioning-defective 3 (Pard3), a member of the Pard family, have functions and regulatory mechanisms in ATC. The abnormal regulation of miR-483 may play an important role in tumorigenesis, and Par3 is known to regulate cell polarity, cell migration, and cell division. Tumor proliferation promoted by the regulation of miRNA expression can be regulated in thyroid cancer by upregulating transforming growth factor-beta 1 (TGF-beta 1), which is thought to interact with Pard3. When compared with adjacent non-tumor tissues, we found that miR-483 was upregulated and Pard3 was downregulated in 80 thyroid tumor samples. Disease-free survival was decreased when expression of miR-483 was upregulated and Pard3 expression was downregulated. Cell growth, migration, and invasion were induced by overexpression of miR-483. However, knockdown of miR-483 resulted in a loss of cell invasion and viability, both in vitro and in vivo. The expression of Pard3 was increased by the inhibition of miR-483, but TGF-beta 1-induced cell migration and invasion were decreased by miR-483 inhibition. A dual-luciferase reporter assay determined that Pard3 expression was downregulated when targeted with miR483. The epithelial-mesenchymal transition (EMT), as well as Tiam1-Rac signaling, was induced by TGF-beta 1, which was decreased by the overexpression of Pard3. Pard3 decreased the inhibition of EMT and Tiam-Rac1 signaling, which resulted from transfection of ATC cells with miR-483. Overall, the results showed that downregulation of Pard3 resulted in increased cell invasion and EMT in ATC, which was promoted by treatment with miR-483. These findings suggest novel therapeutic targets and treatment strategies for this disease.	[Zhang, Xiaoping; Liu, Lin; Li, Dan; Cai, Haidong; Ma, Yushui; Jia, Chengyou; Lv, Zhongwei] Tongji Univ, Shanghai Peoples Hosp 10, Dept Nucl Med, Shanghai 200072, Peoples R China; [Zhang, Xiaoping; Liu, Lin; Li, Dan; Cai, Haidong; Ma, Yushui; Jia, Chengyou; Lv, Zhongwei] Shanghai Ctr Thyroid Dis, Shanghai 200072, Peoples R China; [Deng, Xianzhao; Wu, Bo; Fan, Youben] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Gen Surg, Ctr Thyroid, Shanghai 200233, Peoples R China	Tongji University; Shanghai Jiao Tong University	Lv, ZW (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Nucl Med, Shanghai 200072, Peoples R China.; Lv, ZW (corresponding author), Shanghai Ctr Thyroid Dis, Shanghai 200072, Peoples R China.; Wu, B; Fan, YB (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Gen Surg, Ctr Thyroid, Shanghai 200233, Peoples R China.	wubo7421@sohu.com; fanyouben2006@163.com; heyixue163@163.com	Fu, Da/GXF-2656-2022; ma, yushui/HGC-6206-2022; Jia, Chengyou/AAV-1153-2021		National Natural Science Foundation of China [81572626, 81302332, 81371595, 81501505, 81670718]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (81572626, 81302332, 81371595, 81501505, and 81670718).	Abue M, 2015, INT J ONCOL, V46, P539, DOI 10.3892/ijo.2014.2743; Ain KB, 1999, SEMIN SURG ONCOL, V16, P64, DOI 10.1002/(SICI)1098-2388(199901/02)16:1<64::AID-SSU10>3.3.CO;2-L; Aranda V, 2008, ONCOGENE, V27, P6878, DOI 10.1038/onc.2008.340; Archibald A, 2015, ONCOGENE, V34, P3199, DOI 10.1038/onc.2014.242; Bonastre E, 2015, CANCER RES, V75, P1287, DOI 10.1158/0008-5472.CAN-14-2444; Cha BK, 2016, ONCOTARGET, V7, P57213, DOI 10.18632/oncotarget.11127; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng Y, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0290-6; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Cui DM, 2016, INT J BIOCHEM CELL B, V73, P72, DOI 10.1016/j.biocel.2016.02.007; Dong L, 2011, J DENT RES, V90, P804, DOI 10.1177/0022034511401407; Ehtesham Naeim, 2016, Adv Biomed Res, V5, P187, DOI 10.4103/2277-9175.190996; Engers R, 2001, J BIOL CHEM, V276, P41889, DOI 10.1074/jbc.M105049200; Guo XJ, 2016, CLIN EXP MED, V16, P357, DOI 10.1007/s10238-015-0365-2; Hardin H, 2014, AM J PATHOL, V184, P2342, DOI 10.1016/j.ajpath.2014.04.011; Hassan N, 2017, MOL CELL ENDOCRINOL, V456, P36, DOI 10.1016/j.mce.2016.12.011; Hong L, 2010, ANN SURG, V251, P1056, DOI 10.1097/SLA.0b013e3181dd4ea9; Huang YH, 2013, CANCER RES, V73, P2505, DOI 10.1158/0008-5472.CAN-12-2218; Jin J, 2013, ASIAN PAC J CANCER P, V14, P3681, DOI 10.7314/APJCP.2013.14.6.3681; Kitahara CM, 2016, NAT REV ENDOCRINOL, V12, P646, DOI 10.1038/nrendo.2016.110; Li FF, 2014, CELL PHYSIOL BIOCHEM, V34, P2169, DOI 10.1159/000369660; Li HL, 2016, ONCOTARGET, V7, P66267, DOI [10.18632/oncotarget.11411, 10.18632/oncotarget.11728]; Liu L, 2005, WORLD J GASTROENTERO, V11, P705, DOI 10.3748/wjg.v11.i5.705; Liu L, 2018, EXP CELL RES, V362, P532, DOI 10.1016/j.yexcr.2017.12.019; Liu N, 2013, CANCER LETT, V329, P181, DOI 10.1016/j.canlet.2012.10.032; Lu CL, 2015, ONCOTARGET, V6, P24912, DOI 10.18632/oncotarget.4701; Lupini L, 2016, ONCOTARGET, V7, P31361, DOI 10.18632/oncotarget.8913; Ma JJ, 2016, CELL BIOL INT, V40, P448, DOI 10.1002/cbin.10585; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Moriarty CH, 2010, J BIOL CHEM, V285, P20541, DOI 10.1074/jbc.M110.121012; Neff RL, 2008, ENDOCRIN METAB CLIN, V37, P525, DOI 10.1016/j.ecl.2008.02.003; Otsuki Y, 2003, J BIOL CHEM, V278, P5132, DOI 10.1074/jbc.M206733200; Pino MS, 2010, GASTROENTEROLOGY, V138, P1406, DOI 10.1053/j.gastro.2009.12.010; Puppo M, 2016, CELL REP, V16, P967, DOI 10.1016/j.celrep.2016.06.055; Qu XY, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0219-x; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Song QC, 2014, CANCER RES, V74, P3031, DOI 10.1158/0008-5472.CAN-13-2193; Stebel A, 2009, ONCOL REP, V21, P217, DOI 10.3892/or_00000211; Sun RW, 2014, ONCOTARGET, V5, P12398, DOI 10.18632/oncotarget.2643; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456; Warner DR, 2003, FEBS LETT, V539, P167, DOI 10.1016/S0014-5793(03)00155-8; Woodcock SA, 2009, J PROTEOME RES, V8, P5629, DOI 10.1021/pr900716e; Xia X, 2015, ONCOTARGET, V6, P21046, DOI 10.18632/oncotarget.4124; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu Z, 2003, CELL RES, V13, P343, DOI 10.1038/sj.cr.7290179; Xue B, 2013, NAT CELL BIOL, V15, P189, DOI 10.1038/ncb2663; Zhang J, 2014, TUMOR BIOL, V35, P379, DOI 10.1007/s13277-013-1053-z; Zhang K, 2016, ONCOGENE, V35, P1271, DOI 10.1038/onc.2015.184; Zhang KJ, 2016, AM J TRANSL RES, V8, P2196; Zhao Chunling, 2012, BMC Res Notes, V5, P91, DOI 10.1186/1756-0500-5-91; Zhou QY, 2017, CELL SIGNAL, V38, P49, DOI 10.1016/j.cellsig.2017.06.016; Zhou Y, 2013, GENET TEST MOL BIOMA, V17, P470, DOI 10.1089/gtmb.2012.0518; Zhu JH, 2016, TRANSL ONCOL, V9, P592, DOI 10.1016/j.tranon.2016.08.003; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	58	31	36	4	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 31	2019	38	5					699	715		10.1038/s41388-018-0447-1	http://dx.doi.org/10.1038/s41388-018-0447-1			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HJ6LI	30171257	Green Published, hybrid			2022-12-26	WOS:000457300300007
J	Li, QG; Wei, P; Wu, JT; Zhang, M; Li, GC; Li, YQ; Xu, Y; Li, XX; Xie, DC; Cai, SJ; Xie, KP; Li, DW				Li, Qingguo; Wei, Ping; Wu, Jitao; Zhang, Meng; Li, Guichao; Li, Yaqi; Xu, Ye; Li, Xinxiang; Xie, Dacheng; Cai, Sanjun; Xie, Keping; Li, Dawei			The FOXC1/FBP1 signaling axis promotes colorectal cancer proliferation by enhancing the Warburg effect	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; INDICATES POOR-PROGNOSIS; HEPATOCELLULAR-CARCINOMA; COLON-CANCER; GLUCOSE-METABOLISM; TUMOR-METASTASIS; FOXM1 PROMOTES; EXPRESSION; GROWTH; PROGRESSION	Aberrant expression of Forkhead box (FOX) transcription factors plays vital roles in carcinogenesis. However, the function of the FOX family member FOXC1 in maintenance of colorectal cancer (CRC) malignancy is unknown. Herein, FOXC1 expression in CRC specimens in The Cancer Genome Atlas (TCGA) cohort was analyzed and validated using immunohistochemistry with a tissue microarray. The effect of FOXC1 expression on proliferation of and glycolysis in CRC cells was assessed by altering its expression in vitro and in vivo. Mechanistic investigation was carried out using cell and molecular biological approaches. Our results showed that FOXC1 expression was higher in CRC specimens than in adjacent benign tissue specimens. Univariate survival analyses of the patients from whom the study specimens were obtained, and validated cohorts indicated that ectopic FOXC1 expression was significantly correlated with shortened survival. Silencing FOXC1 expression in CRC cells inhibited their proliferation and colony formation and decreased their glucose consumption and lactate production. In contrast, FOXC1 overexpression had the opposite effect. Furthermore, increased expression of FOXC1 downregulated that of a key glycolytic enzyme, fructose-1,6-bisphosphatase 1 (FBP1). Mechanistically, FOXC1 bound directly to the promoter regions of the FBP1 gene and negatively regulated its transcriptional activity. Collectively, aberrant FBP1 expression contributed to CRC tumorigenicity, and decreased FBP1 expression coupled with increased FOXC1 expression provided better prognostic information than did FOXC1 expression alone. Therefore, the FOXC1/FBP1 axis induces CRC cell proliferation, reprograms metabolism in CRCs, and constitutes potential prognostic predictors and therapeutic targets for CRC.	[Li, Qingguo; Li, Yaqi; Xu, Ye; Li, Xinxiang; Cai, Sanjun; Li, Dawei] Fudan Univ, Dept Colorectal Surg, Shanghai Canc Ctr, Shanghai, Peoples R China; [Li, Qingguo; Wei, Ping; Zhang, Meng; Li, Guichao; Li, Yaqi; Xu, Ye; Li, Xinxiang; Cai, Sanjun; Li, Dawei] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China; [Wei, Ping; Zhang, Meng] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China; [Wei, Ping] Fudan Univ, Shanghai Canc Ctr, Inst Canc, Shanghai, Peoples R China; [Wu, Jitao] Yantai Yuhuangding Hosp, Dept Urol, Yantai, Peoples R China; [Li, Guichao] Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China; [Xie, Dacheng; Xie, Keping] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center	Li, DW (corresponding author), Fudan Univ, Dept Colorectal Surg, Shanghai Canc Ctr, Shanghai, Peoples R China.; Li, DW (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.; Xie, KP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA.	kepingxie@gmail.com; li_dawei@fudan.edu.cn	xu, ye/GQO-8972-2022		National Science Foundation of China [81472222, 81702353, 81772583, 81572254, 81372646, 81302097, 81672374]; Shanghai Rising-Star Program [17QA1400900]; Shanghai Municipal Natural Science Foundation [17ZR1406400]; Municipal Human Resources Development Program for Outstanding Young Talents in Medical and Health Sciences in Shanghai [2017YQ046]; National Key Basic Research Program of China [2014CBA02002]; National Cancer Institute, National Institutes of Health [R01-CA129956, R01-CA148954, R01CA152309, R01CA172233, R01CA195651]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Shanghai Municipal Natural Science Foundation; Municipal Human Resources Development Program for Outstanding Young Talents in Medical and Health Sciences in Shanghai; National Key Basic Research Program of China(National Basic Research Program of China); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants from the National Science Foundation of China (81472222, 81702353, 81772583, 81572254, 81372646, 81302097, and 81672374) and Shanghai Rising-Star Program(17QA1400900), Shanghai Municipal Natural Science Foundation (17ZR1406400), Municipal Human Resources Development Program for Outstanding Young Talents in Medical and Health Sciences in Shanghai (2017YQ046), National Key Basic Research Program of China (2014CBA02002) and grants R01-CA129956, R01-CA148954, R01CA152309, R01CA172233, and R01CA195651 from the National Cancer Institute, National Institutes of Health.	Aravalli RN, 2015, GASTROENTEROLOGY, V149, P861, DOI 10.1053/j.gastro.2015.08.032; Cekaite L, 2016, ONCOTARGET, V7, P6476, DOI 10.18632/oncotarget.6390; Courtnay R, 2015, MOL BIOL REP, V42, P841, DOI 10.1007/s11033-015-3858-x; Cui JJ, 2014, CLIN CANCER RES, V20, P2595, DOI 10.1158/1078-0432.CCR-13-2407; Dang CV, 2008, ERNST SCHERING FOUND, V4, P35, DOI 10.1007/2789_2008_088; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Golson ML, 2016, DEVELOPMENT, V143, P4558, DOI 10.1242/dev.112672; Guo K, 2017, CLIN CANCER RES, V23, P687, DOI 10.1158/1078-0432.CCR-16-1064; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirata H, 2016, CANCER RES, V76, P3265, DOI 10.1158/0008-5472.CAN-15-2601; Huang WJ, 2015, GASTROENTEROLOGY, V149, P1053, DOI 10.1053/j.gastro.2015.05.058; Jensen TW, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv148; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Khan AO, 2013, J AAPOS, V17, P105, DOI 10.1016/j.jaapos.2012.09.011; Kondaveeti Y, 2015, CANCER LETT, V364, P44, DOI 10.1016/j.canlet.2015.04.025; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Li DW, 2013, CLIN CANCER RES, V19, P62, DOI 10.1158/1078-0432.CCR-12-1588; Li DW, 2011, CLIN CANCER RES, V17, P3558, DOI 10.1158/1078-0432.CCR-10-2729; Li QG, 2016, INT J CANCER, V139, P2502, DOI 10.1002/ijc.30388; Li QG, 2016, MOL CANCER RES, V14, P830, DOI 10.1158/1541-7786.MCR-16-0032; Li QG, 2015, AM J CANCER RES, V5, P2022; Liu X, 2010, ONCOGENE, V29, P442, DOI 10.1038/onc.2009.332; Marin-Hernandez A, 2006, FEBS J, V273, P1975, DOI 10.1111/j.1742-4658.2006.05214.x; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nagel S, 2014, GENE CHROMOSOME CANC, V53, P917, DOI 10.1002/gcc.22204; Paylakhi SH, 2013, EXP EYE RES, V111, P112, DOI 10.1016/j.exer.2013.03.009; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Quan M, 2015, CANCER RES, V75, P4778, DOI 10.1158/0008-5472.CAN-14-1952; Ray PS, 2010, CANCER RES, V70, P3870, DOI 10.1158/0008-5472.CAN-09-4120; Shi M, 2014, CLIN CANCER RES, V20, P4370, DOI 10.1158/1078-0432.CCR-14-0186; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Somerville TDD, 2015, CANCER CELL, V28, P329, DOI 10.1016/j.ccell.2015.07.017; Sun J, 2016, ONCOTARGET, V7, P43534, DOI 10.18632/oncotarget.9780; Vakiani E, 2012, J CLIN ONCOL, V30, P2956, DOI 10.1200/JCO.2011.38.2994; Velpula KK, 2013, CANCER RES, V73, P7277, DOI 10.1158/0008-5472.CAN-13-1868; Walenta S, 2000, CANCER RES, V60, P916; Wang J, 2012, ONCOGENE, V31, P4798, DOI 10.1038/onc.2011.635; Wang L, 2013, TUMOR BIOL, V34, P853, DOI 10.1007/s13277-012-0617-7; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weber GF, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00257; Wechatekar K, 2005, CLIN RADIOL, V60, P1143, DOI 10.1016/j.crad.2005.05.018; Wei LX, 2013, TUMOR BIOL, V34, P941, DOI 10.1007/s13277-012-0629-3; Weng WH, 2016, CLIN CANCER RES, V22, P4947, DOI 10.1158/1078-0432.CCR-16-0360; Wu WKK, 2011, CARCINOGENESIS, V32, P247, DOI 10.1093/carcin/bgq243; Xia LM, 2013, HEPATOLOGY, V57, P610, DOI 10.1002/hep.26029; Xu ZY, 2012, INT J BIOL SCI, V8, P1130, DOI 10.7150/ijbs.4769; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Zhang J, 2016, MOL CELL BIOCHEM, V411, P331, DOI 10.1007/s11010-015-2595-8; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zhang Y, 2013, CANCER BIOL THER, V14, P81, DOI 10.4161/cbt.22958; Zhou AD, 2016, NAT CELL BIOL, V18, P954, DOI 10.1038/ncb3396; Zhu Y, 2015, ONCOTARGET, V6, P21443, DOI 10.18632/oncotarget.4167	56	35	37	1	27	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 24	2019	38	4					483	496		10.1038/s41388-018-0469-8	http://dx.doi.org/10.1038/s41388-018-0469-8			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HI6UB	30171256				2022-12-26	WOS:000456589800003
J	Vernon, SW; Goodchild, J; Baines, RA				Vernon, Samuel W.; Goodchild, Jim; Baines, Richard A.			The VAChT(Y49N) mutation provides insecticide-resistance but perturbs evoked cholinergic neurotransmission in Drosophila	PLOS ONE			English	Article							VESICULAR ACETYLCHOLINE TRANSPORTER; MOTOR-NERVE TERMINALS; GLUTAMATE TRANSPORTER; SYNAPTIC VESICLES; GLYCINE TRANSPORTER; HOUSE-FLY; IDENTIFICATION; EXPRESSION; RELEASE; DISEASE	Global agriculture and the control of insect disease vectors have developed with a heavy reliance on insecticides. The increasing incidence of resistance, for virtually all insecticides, threatens both food supply and effective control of insect borne disease. CASPP ((5-chloro-1'-[(E)-3-(4-chlorophenyl)allyl]spiro[indoline-3,4'-piperidine]-1-yl}-(2-chloro-4-pyridyl)methanone)) compounds are a potential new class of neuroactive insecticide specifically targeting the Vesicular Acetylcholine Transporter (VAChT). Resistance to CASPP, under laboratory conditions, has been reported following either up-regulation of wildtype VAChT expression or the presence of a specific point mutation (VAChT(Y49N)). However, the underlying mechanism of CASPP-resistance, together with the consequence to insect viability of achieving resistance, is unknown. In this study, we use electrophysiological characterisation of cholinergic release at Drosophila larval interneuron -> motoneuron synapses to investigate the physiological implications of these two identified modes of CASPP resistance. We show that both VAChT up-regulation or the expression of VAChT(Y49N) increases miniature (mini) release frequency. Mini frequency appears deterministic of CASPP activity. However, maintenance of SV release is not indicative of resistance in all cases. This is evidenced through expression of syntaxin or complexin mutants (sytx(3-61)/cpX(SH1)) that show similarly high mini release frequency but are not resistant to CASPP. The VAChT(Y49N) mutation additionally disrupts action potential-evoked cholinergic release and fictive locomotor patterning through depletion of releasable synaptic vesicles. This observation suggests a functional trade-off for this point mutation, which is not seen when wildtype VAChT is up-regulated.	[Vernon, Samuel W.; Baines, Richard A.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Neurosci & Expt Psychol,Sch Biol Sci, Manchester, Lancs, England; [Goodchild, Jim] Syngenta Crop Protect Res, Bracknell, Berks, England	University of Manchester; Syngenta	Baines, RA (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Neurosci & Expt Psychol,Sch Biol Sci, Manchester, Lancs, England.	Richard.Baines@manchester.ac.uk		Vernon, Samuel/0000-0001-6156-2240; Baines, Richard/0000-0001-8571-4376	Biotechnology and Biological Sciences Research Council (BBSRC) CASE studentship; BBSRC project [BB/L027690/1]; Wellcome Trust [087742/Z/08/Z]; BBSRC [BB/L027690/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC) CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC project(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) CASE studentship to SWV and by a BBSRC project grant to RAB (BB/L027690/1). Work on this project benefited from the Manchester Fly Facility, established through funds from University and the Wellcome Trust (087742/Z/08/Z). Syngenta provided support in the form of salaries for SWV, contributed to study design and the preparation of the manuscript, but did not have any additional role in data collection and analysis or decision to publish, The specific roles of these authors are articulated in the 'author contributions' section.; We thank members of the Baines group and Syngenta (Jealotts Hill International Research Centre) for their help and advice in completing this study. We also thank colleagues for provision of fly stocks (Steve Stowers, Bing Zhang and Troy Littleton). This work was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) CASE studentship to SWV and by a BBSRC project grant to RAB (BB/L027690/1). Work on this project benefited from the Manchester Fly Facility, established through funds from University and the Wellcome Trust (087742/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.but did not have any additional role in data collection and analysis or decision to publish, The specific roles of these authors are articulated in the 'author contributions' section.	Aubrey KR, 2016, NEUROCHEM INT, V98, P94, DOI 10.1016/j.neuint.2016.06.002; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Baines RA, 1999, CURR BIOL, V9, P1267, DOI 10.1016/S0960-9822(99)80510-7; Barnstedt O, 2016, NEURON, V89, P1237, DOI 10.1016/j.neuron.2016.02.015; Bass C, 2015, PESTIC BIOCHEM PHYS, V121, P78, DOI 10.1016/j.pestbp.2015.04.004; Belinato TA, 2016, INSECTICIDES RESISTANCE, P243, DOI 10.5772/61826; Belinato TA, 2012, MEM I OSWALDO CRUZ, V107, P916, DOI 10.1590/S0074-02762012000700013; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Carvalho R, 2012, PESTIC BIOCHEM PHYS, V104, P143, DOI 10.1016/j.pestbp.2012.05.009; Cash F, 2016, J NEUROPHYSIOL, V115, P843, DOI 10.1152/jn.01053.2015; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Cassayre J, 2011, ABSTR PAP AM CHEM SO; Cassayre J, 2010, ABSTR PAP AM CHEM SO; Colgan L, 2007, TRAFFIC, V8, P512, DOI 10.1111/j.1600-0854.2007.00555.x; Costa WS, 2017, CURR BIOL, V27, P495, DOI 10.1016/j.cub.2016.12.055; Cubelos B, 2014, NEUROCHEM INT, V73, P204, DOI 10.1016/j.neuint.2013.09.002; Daniels RW, 2011, NEUROBIOL DIS, V41, P415, DOI 10.1016/j.nbd.2010.10.009; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; de Castro BM, 2009, GENES BRAIN BEHAV, V8, P23, DOI 10.1111/j.1601-183X.2008.00439.x; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; Ferreira-Vieira TH, 2016, CURR NEUROPHARMACOL, V14, P101, DOI 10.2174/1570159X13666150716165726; Feyereisen R, 2015, PESTIC BIOCHEM PHYS, V121, P61, DOI 10.1016/j.pestbp.2015.01.004; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; German CL, 2015, PHARMACOL REV, V67, P1005, DOI 10.1124/pr.114.010397; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; HOYER RF, 1966, J ECON ENTOMOL, V59, P495, DOI 10.1093/jee/59.3.495; Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980; Janickova H, 2017, J NEUROCHEMISTRY; Jaramillo N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096379; Kim MH, 2004, J BIOL CHEM, V279, P12580, DOI 10.1074/jbc.M310681200; KING DG, 1980, J NEUROCYTOL, V9, P753, DOI 10.1007/BF01205017; Kitamoto T, 2000, J NEUROBIOL, V42, P161, DOI 10.1002/(SICI)1097-4695(20000205)42:2<161::AID-NEU1>3.0.CO;2-P; Labbe P, 2007, MOL BIOL EVOL, V24, P1056, DOI 10.1093/molbev/msm025; Lagow RD, 2007, PLOS BIOL, V5, P800, DOI 10.1371/journal.pbio.0050072; Li XL, 2002, APPL ENTOMOL ZOOL, V37, P305, DOI 10.1303/aez.2002.305; Lima RD, 2010, J NEUROCHEM, V113, P943, DOI 10.1111/j.1471-4159.2010.06657.x; Maienfisch P, 2011, ABSTR PAP AM CHEM SO; Martins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031889; Mazere J, 2009, ALZHEIMERS DEMENT, V5, pP489; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; METCALF RL, 1989, PESTIC SCI, V26, P333, DOI 10.1002/ps.2780260403; Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9; Nunez E, 2009, TRAFFIC, V10, P829, DOI 10.1111/j.1600-0854.2009.00911.x; Oakeshott J., 2005, COMPREHENSIVE MOL IN, V5; Parsons RL, 1999, J NEUROPHYSIOL, V81, P2696, DOI 10.1152/jn.1999.81.6.2696; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Ranson H., 2005, P383; Rao SS, 2001, EMBO J, V20, P6761, DOI 10.1093/emboj/20.23.6761; Sagne C, 1997, FEBS LETT, V417, P177, DOI 10.1016/S0014-5793(97)01279-9; Salvaterra P M, 2001, Brain Res Gene Expr Patterns, V1, P73; Sandoval GM, 2006, NAT NEUROSCI, V9, P599, DOI 10.1038/nn1685; SEARL T, 1991, J PHYSIOL-LONDON, V444, P99, DOI 10.1113/jphysiol.1991.sp018868; Shono T, 2002, PESTIC BIOCHEM PHYS, V73, P27, DOI 10.1016/S0048-3575(02)00012-3; Sluder A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034712; Sugita S, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0105-7; Suzuki M, 2001, SYNAPSE, V41, P329, DOI 10.1002/syn.1089; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Takamori S., 2016, FRONTIERS SYNAPTIC N, V8; Williams J, 1997, NEURON, V18, P683, DOI 10.1016/S0896-6273(00)80308-6	62	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203852	10.1371/journal.pone.0203852	http://dx.doi.org/10.1371/journal.pone.0203852			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204788	Green Published, gold, Green Submitted			2022-12-26	WOS:000444355500050
J	Cooper, S; Leon, N; Namadingo, H; Bobrow, K; Farmer, AJ				Cooper, Sara; Leon, Natalie; Namadingo, Hazel; Bobrow, Kirsten; Farmer, Andrew J.			"My wife's mistrust. That's the saddest part of being a diabetic": A qualitative study of sexual well-being in men with Type 2 diabetes in sub-Saharan Africa	PLOS ONE			English	Article							ERECTILE DYSFUNCTION; ADHERENCE; CARE; DETERMINANTS; DEPRESSION; PREVALENCE; SUPPORT; ADULTS; WOMEN	Introduction Sexual dysfunction is a common complication for men with diabetes, yet little is known about the lived experiences of sexual difficulties within the context of diabetes, particularly in low-and-middle-income countries. This study explores how men with type 2 diabetes in three sub-Saharan African settings (Cape Town and Johannesburg, South Africa; Lilongwe, Malawi) perceive and experience sexual functioning and sexual well-being, and the biopsychosocial contexts in which these occur and are shaped. Methods We used a qualitative research design, including individual interviews (n = 15) and focus group discussions (n = 4). Forty-seven men were included in the study. We used an inductive thematic analysis approach to develop our findings. A biopsychosocial conceptual model on the relationship between chronic illness and sexuality informed the interpretation of findings. Results Men across the study settings identified sexual difficulties as a central concern of living with diabetes. These difficulties went beyond biomedical issues of erectile dysfunction, comprising complex psychological and relational effects. Low self-esteem, related to a sense of loss of masculinity and reduced sexual and emotional intimacy in partner relationships were common experiences. Specific negative relational effects included suspicion of infidelity, mutual mistrust, general unhappiness, and fear of losing support from partners. These effects may impact on men's ability to cope with their diabetes. Further stressors were a lack of information about the reasons for their sexual difficulties, perceived lack of support from healthcare providers and an inability to communicate with partners about sexual difficulties. Conclusion More in-depth research is needed to better understand sexual functioning and well-being within the context of diabetes, and its potential impact on diabetes self-management. Holistic and patient-centered care should include raising awareness of sexual problems as a potential complication of diabetes amongst patients, their partners and care providers, and incorporating sexual well-being as part of routine clinical care.	[Cooper, Sara] South African Med Res Council, Cochrane South Africa, Cape Town, South Africa; [Cooper, Sara] Univ Cape Town, Sch Publ Hlth & Family Med, Div Social & Behav Sci, Cape Town, South Africa; [Leon, Natalie] South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa; [Namadingo, Hazel] Malawi Epidemiol Intervent Res Unit, Lilongwe, Malawi; [Bobrow, Kirsten; Farmer, Andrew J.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Bobrow, Kirsten] Univ Cape Town, Dept Med, Chron Dis Initiat Africa, Cape Town, South Africa	South African Medical Research Council; University of Cape Town; South African Medical Research Council; Malawi Epidemiology and Intervention Research Unit; University of Oxford; University of Cape Town	Cooper, S (corresponding author), South African Med Res Council, Cochrane South Africa, Cape Town, South Africa.; Cooper, S (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Div Social & Behav Sci, Cape Town, South Africa.	sara.cooper@mrc.ac.za		Cooper, Sara/0000-0001-9894-236X; Farmer, Andrew/0000-0002-6170-4402	Medical Research Council UK through the Global Alliance for Chronic Diseases Diabetes Programme [MR/M016498/1]; NIHR Oxford Biomedical Research Centre; MRC [MR/M016498/1] Funding Source: UKRI	Medical Research Council UK through the Global Alliance for Chronic Diseases Diabetes Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Medical Research Council UK (MR/M016498/1) through the Global Alliance for Chronic Diseases Diabetes Programme. The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are funded by their respective institutions which contributed indirect funding through the author's time; SC (UCT, SAMRC), NL (SAMRC), HN (MEIRU), KB (UCT) and AF (Oxford University). AF is a NIHR Senior Investigator and receives funding from the NIHR Oxford Biomedical Research Centre.	Bhasin S, 2007, LANCET, V369, P597, DOI 10.1016/S0140-6736(07)60280-3; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Carrillo González Gloria Mabel, 2013, Invest. educ. enferm, V31, P295; Chopra M, 2009, LANCET, V374, P1023, DOI 10.1016/S0140-6736(09)61122-3; Coimbra L, 2015, CIENC CUID SAUDE, V14, P970; Corona G, 2004, EUR UROL, V46, P222, DOI 10.1016/j.eururo.2004.03.010; De Berardis G, 2007, J UROLOGY, V177, P252, DOI 10.1016/j.juro.2006.08.102; Debono Miguel, 2007, Psychol Health Med, V12, P545, DOI 10.1080/13548500701235740; DeLamater JD, 2005, J SEX RES, V42, P138, DOI 10.1080/00224490509552267; Egede LE, 2005, CURR DIABETES REV, V1, P235, DOI 10.2174/157339905774574356; Fabian Unyime Aniekpon, 2016, J Reprod Infertil, V17, P17; Fedele D, 2001, J UROLOGY, V166, P1368, DOI 10.1016/S0022-5347(05)65771-0; Foley S., 2015, CURR SEX HEALTH REP, V7, P70, DOI [10.1007/s11930-015-0046-x, DOI 10.1007/S11930-015-0046-X, https://doi.org/10.1007/s11930-015-0046-x]; Giugliano F, 2010, INT J IMPOT RES, V22, P204, DOI 10.1038/ijir.2010.1; Green G, 2004, QUALITATIVE METHODS; Jiann BP, 2009, J SEX MED, V6, P2008, DOI 10.1111/j.1743-6109.2009.01264.x; Jowett A, 2012, J HEALTH PSYCHOL, V17, P409, DOI 10.1177/1359105311412838; Kimmel M, 2007, SEXUAL SELF CONSTRUC; Kizilay F, 2017, SEX MED REV, V5, P45, DOI 10.1016/j.sxmr.2016.07.002; Koetsenruijter J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135079; Kolling M., 2012, NORDIC J MASCULINITY, V7, P91; Lambert SD, 2008, J ADV NURS, V62, P228, DOI 10.1111/j.1365-2648.2007.04559.x; LeMone P, 1993, Image J Nurs Sch, V25, P101; Leon N, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0289-7; Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154; Lindau ST, 2010, DIABETES CARE, V33, P2202, DOI 10.2337/dc10-0524; Lindlof T., 2011, QUALITATIVE COMMUNIC; Lockhat Y, 2013, S AFR FAM PRACT, V55, P289, DOI 10.1080/20786204.2013.10874352; Malavige LS, 2014, DIABETIC MED, V31, P699, DOI 10.1111/dme.12412; Maurice WL, 2010, HANDBOOK OF CLINICAL SEXUALITY FOR MENTAL HEALTH PROFESSIONALS, 2ND EDITION, P469; Merghati-Khoei E, 2016, J RES MED SCI, V21, DOI 10.4103/1735-1995.196618; Miller TA, 2013, DIABET METAB SYND OB, V6, P421, DOI 10.2147/DMSO.S36368; Nusbaum MRH, 2003, AM FAM PHYSICIAN, V67, P347; Owiredu WKBA, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-70; Peltzer K, 2012, GLOBAL HEALTH ACTION, V5, DOI [10.3402/gha.v5i0.18545, 10.3402/gha.v5i0.18668]; Plummer K., 2005, HDB STUDIES MEN MASC, P178, DOI DOI 10.4135/9781452233833.N11; Rad Ghalmreza Sharfi, 2013, J Educ Health Promot, V2, P62, DOI 10.4103/2277-9531.120864; Ramlachan P, 2017, J SEX MED, V14, pS105, DOI 10.1016/j.jsxm.2016.11.244; Rutte A, 2016, J SEX MARITAL THER, V42, P324, DOI 10.1080/0092623X.2015.1033578; Sadovsky Richard, 2002, Rev Urol, V4 Suppl 3, pS54; Sarkadi A, 2003, DIABETES EDUCATOR, V29, P641, DOI 10.1177/014572170302900410; Seid A, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0167-5; Silberschmidt M, 2005, AFRICAN MASCULINITIES: MEN IN AFRICA FROM THE LATE NINETEENTH CENTURY TO THE PRESENT, P189; Verschuren JEA, 2010, J SEX RES, V47, P153, DOI 10.1080/00224491003658227; Verschuren JE, 2015, DISABIL REHABIL, V37, P187, DOI 10.3109/09638288.2014.913704; World Association for Sexual Health, 2008, SEX HLTH MILL DECL T; Yildiz H, 2015, SEX DISABIL, V33, P187, DOI 10.1007/s11195-015-9397-5	47	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2018	13	9							e0202413	10.1371/journal.pone.0202413	http://dx.doi.org/10.1371/journal.pone.0202413			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT7DK	30199531	gold, Green Published, Green Submitted			2022-12-26	WOS:000444681100006
J	Lopez-Idiaquez, D; Vergara, P; Fargallo, JA; Martinez-Padilla, J				Lopez-Idiaquez, David; Vergara, Pablo; Antonio Fargallo, Juan; Martinez-Padilla, Jesus			Providing longer post-fledging periods increases offspring survival at the expense of future fecundity	PLOS ONE			English	Article							KESTREL FALCO-TINNUNCULUS; MELANIN-BASED COLORATION; EURASIAN KESTREL; PARENTAL CARE; REPRODUCTIVE SUCCESS; SEXUAL-DIMORPHISM; TRADE-OFF; SIZE; INDEPENDENCE; BIRD	The cost of reproduction is a key concept in life-history trade-offs. However, our understanding of the reproductive costs is biased towards measures of reproductive effort obtained before offspring independence. During the post-fledging dependence period (PFDP), it is well known that parents feed and protect their offspring. However, the effort devoted to this reproductive activity has never been considered in the context of of the costs of reproduction. Moreover, the potential fitness benefits and costs for offspring and parents, respectively, of the duration of the PFDP are largely unknown. We estimated the duration of the PFDP over 5 years using wild common kestrels (Falco tinnunculus) and studied its association with survival probability and future parental reproductive performance. Our results show that longer PFDPs increase the survival probability of fledglings, probably due to the benefits obtained from parental care. In addition, we found that providing longer PFDPs was associated with reduced clutch sizes but not the number of fledglings in the subsequent breeding season in males. We suggest that increased parental expenditures on offspring during the PFDP may represent a potential cost of reproduction in breeding males.	[Lopez-Idiaquez, David; Vergara, Pablo; Antonio Fargallo, Juan] Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, Madrid, Spain; [Lopez-Idiaquez, David] Univ Complutense Madrid, Dept Ecol, Madrid, Spain; [Martinez-Padilla, Jesus] Oviedo Univ, Res Unit Biodivers, OU CSIC PA, Mieres, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Complutense University of Madrid	Lopez-Idiaquez, D (corresponding author), Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, Madrid, Spain.; Lopez-Idiaquez, D (corresponding author), Univ Complutense Madrid, Dept Ecol, Madrid, Spain.	davididiaquez@gmail.com	Martinez-Padilla, Jesus/C-6446-2008	Martinez-Padilla, Jesus/0000-0003-2956-5163; Lopez-Idiaquez, David/0000-0001-9568-4852	Ministerio de Economia y Competitividad [CGL2004-04479/BOS, CGL2007-61395/BOS, CGL2010-15726/BOS, CGL2015-70639-P]	Ministerio de Economia y Competitividad(Spanish Government)	The long-term monitoring associated to this study was funded by projects CGL2004-04479/BOS, CGL2007-61395/BOS, CGL2010-15726/BOS and CGL2015-70639-P from the Ministerio de Economia y Competitividad. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adriaensen F, 1998, ARDEA, V86, P147; Alonso-Alvarez C, 2006, EVOLUTION, V60, P1913, DOI 10.1111/j.0014-3820.2006.tb00534.x; APARICIO JM, 1993, OIKOS, V68, P186, DOI 10.2307/3545327; Arroyo BE, 2002, ANIM BEHAV, V63, P235, DOI 10.1006/anbe.2001.1899; Bates D, 2015, J STAT SOFTWARE; Boileau N, 2014, J RAPTOR RES, V48, P248, DOI 10.3356/JRR-11-70.1; Bouwhuis S, 2015, J ANIM ECOL, V84, P208, DOI 10.1111/1365-2656.12264; Bowler DE, 2009, J ANIM ECOL, V78, P1234, DOI 10.1111/j.1365-2656.2009.01580.x; Bustamante J., 1994, J RAPTOR RES; Candolin U, 1998, P ROY SOC B-BIOL SCI, V265, P1171, DOI 10.1098/rspb.1998.0415; Cave A. J., 1967, NETHER J ZOOL, V18, P313, DOI DOI 10.1163/002829668X00027; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; DAVIES NB, 1976, BEHAVIOUR, V59, P280, DOI 10.1163/156853976X00415; DIJKSTRA C, 1990, J ANIM ECOL, V59, P269, DOI 10.2307/5172; EMLEN ST, 1995, P NATL ACAD SCI USA, V92, P8092, DOI 10.1073/pnas.92.18.8092; Fargallo JA, 2003, EVOL ECOL RES, V5, P549; Fargallo JA, 2001, BIRD STUDY, V48, P236, DOI 10.1080/00063650109461223; Fargallo JA, 2002, ECOL LETT, V5, P95, DOI 10.1046/j.1461-0248.2002.00290.x; Fargallo JA, 2007, EVOL ECOL, V21, P157, DOI 10.1007/s10682-006-0020-1; Fargallo JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004311; Fox J., 2019, R COMPANION APPL REG, V.; Gruebler MU, 2010, J ANIM ECOL, V79, P334, DOI 10.1111/j.1365-2656.2009.01650.x; GUSTAFSSON L, 1988, NATURE, V335, P813, DOI 10.1038/335813a0; GUSTAFSSON L, 1990, NATURE, V347, P279, DOI 10.1038/347279a0; Hamel S, 2011, OIKOS, V120, P690, DOI 10.1111/j.1600-0706.2011.19382.x; Hanssen SA, 2005, P ROY SOC B-BIOL SCI, V272, P1039, DOI 10.1098/rspb.2005.3057; Johnson SJ, 1986, J RAPTOR RES, V20, P6; Kim SY, 2013, HEREDITY, V111, P139, DOI 10.1038/hdy.2013.29; Kolliker M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7850; Lopez-Idiaquez D, 2016, ECOL EVOL, V6, P1224, DOI 10.1002/ece3.1910; Lopez-Rull I, 2016, J EVOLUTION BIOL, V29, P231, DOI 10.1111/jeb.12779; MARCHETTI K, 1989, BIOL REV, V64, P51, DOI 10.1111/j.1469-185X.1989.tb00638.x; Martinez-Padilla J, 2014, ECOLOGY, V95, P1033, DOI 10.1890/12-1905.1; Martinez-Padilla J, 2007, BEHAV ECOL SOCIOBIOL, V61, P1735, DOI 10.1007/s00265-007-0405-3; Martinez-Padilla J, 2017, PEST MANAG SCI, V73, P364, DOI 10.1002/ps.4435; Martinez-Padilla J, 2010, NATURWISSENSCHAFTEN, V97, P469, DOI 10.1007/s00114-010-0660-4; Masman D, 1988, J ANIM ECOL, P22; Massemin S, 2000, OECOLOGIA, V124, P26, DOI 10.1007/s004420050021; Matthysen E, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P3; Meijer T., 1988, REPROD DECISIONS KES; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Naef-Daenzer B, 2016, J FIELD ORNITHOL, V87, P227, DOI 10.1111/jofo.12157; Navarro-Lopez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128855; Navarro-Lopez J, 2014, OECOLOGIA, V174, P1215, DOI 10.1007/s00442-013-2855-9; OWENS IPF, 1994, P ROY SOC B-BIOL SCI, V257, P1, DOI 10.1098/rspb.1994.0086; PALOKANGAS P, 1994, ANIM BEHAV, V47, P443, DOI 10.1006/anbe.1994.1058; Paz A, 2013, PEST MANAG SCI, V69, P444, DOI 10.1002/ps.3289; Ridley AR, 2007, J EVOLUTION BIOL, V20, P1271, DOI 10.1111/j.1420-9101.2007.01356.x; Ridley AR, 2007, BEHAV ECOL, V18, P994, DOI 10.1093/beheco/arm074; Rivalan P, 2005, OECOLOGIA, V145, P564, DOI 10.1007/s00442-005-0159-4; STAMPS JA, 1990, AM NAT, V135, P671, DOI 10.1086/285068; Stearns S.C., 1992, pi; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Terraube J, 2015, OIKOS, V124, P762, DOI 10.1111/oik.01974; TOLONEN P, 1994, BEHAV ECOL SOCIOBIOL, V35, P355; TRIVERS RL, 1974, AM ZOOL, V14, P249; Valkama J, 1999, BIRD STUDY, V46, P81, DOI 10.1080/00063659909461117; Vergara P, 2008, BEHAV ECOL, V19, P847, DOI 10.1093/beheco/arn035; Vergara P, 2010, BEHAV ECOL, V21, P507, DOI 10.1093/beheco/arq011; Vergara P, 2009, BIOL J LINN SOC, V97, P781, DOI 10.1111/j.1095-8312.2009.01263.x; Village A., 1990, THE KESTREL; Wheelwright NT, 2003, CONDOR, V105, P279, DOI 10.1650/0010-5422(2003)105[0279:DOFSAT]2.0.CO;2; Wheelwright NT, 2003, ANIM BEHAV, V65, P435, DOI 10.1006/anbe.2003.2086; Yoda K, 2004, P ROY SOC B-BIOL SCI, V271, pS240, DOI 10.1098/rsbl.2003.0157	64	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2018	13	9							e0203152	10.1371/journal.pone.0203152	http://dx.doi.org/10.1371/journal.pone.0203152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7DK	30199538	Green Published, Green Submitted, gold			2022-12-26	WOS:000444681100011
J	Yepes-Perez, Y; Lopez, C; Suarez, CF; Patarroyo, MA				Yepes-Perez, Yoelis; Lopez, Carolina; Fernando Suarez, Carlos; Alfonso Patarroyo, Manuel			Plasmodium vivax Pv12 B-cell epitopes and HLA-DR beta 1*-dependent T-cell epitopes in vitro antigenicity	PLOS ONE			English	Article							RED-BLOOD-CELLS; PROTECTIVE IMMUNE-RESPONSES; FALCIPARUM-MALARIA; HLA-DR; UNIVERSAL EPITOPES; MOLECULAR-DYNAMICS; GAMMA-INTERFERON; SURFACE PROTEIN; TRYPTOPHAN-RICH; PEPTIDE MOTIFS	Malaria is an infectious disease caused by parasites from the genus Plasmodium (P. falciparum and P. vivaxare responsible for 90% of all clinical cases); it is widely distributed throughout the world's tropical and subtropical regions. The P. vivax Pv12 protein is involved in invasion, is expressed on merozoite surface and has been recognised by antibodies from individuals exposed to the disease. In this study, B- and T-cell epitopes from Pv12 were predicted and characterised to advance in the design of a peptide-based vaccine against malaria. For evaluating the humoral response of individuals exposed to natural P. vivax infection from two endemic areas in Colombia, BepiPred-1.0 software was used for selecting B-cell epitopes. B-cell epitope 39038 displayed the greatest recognition by naturally-acquired antibodies and induced an IgG2/IgG4 response. NetMHCllpan-3.1 prediction software was used for selecting peptides having high affinity binding for HLA-DR beta 1* allele lineages and this was confirmed by in-vitro binding assays. T-epitopes 39113 and 39117 triggered a memory T-cell response (Stimulation Index >= 2) and significant cytokine production. Combining in-silico, in-vitro and functional assays, two Pv12 protein regions (containing peptides 39038, 39040, 39113 and 39117) have thus been characterised as promising vaccine candidates against P. vivax malaria.	[Yepes-Perez, Yoelis; Lopez, Carolina; Alfonso Patarroyo, Manuel] Fdn Inst Immunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, DC, Colombia; [Yepes-Perez, Yoelis] Univ Nacl Colombia, MSc Programme Microbiol, Bogota, DC, Colombia; [Lopez, Carolina] Univ Rosario, PhD Programme Biomed & Biol Sci, Bogota, DC, Colombia; [Fernando Suarez, Carlos] Fdn Inst Inmunol Colombia FIDIC, Biomath Dept, Bogota, DC, Colombia; [Fernando Suarez, Carlos] Univ Ciencias Aplicadas & Ambientales UDCA, Bogota, DC, Colombia; [Alfonso Patarroyo, Manuel] Univ Rosario, Sch Med & Hlth Sci, Basic Sci Dept, Bogota, DC, Colombia	Universidad Nacional de Colombia; Universidad del Rosario; Universidad del Rosario	Patarroyo, MA (corresponding author), Fdn Inst Immunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, DC, Colombia.; Patarroyo, MA (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Basic Sci Dept, Bogota, DC, Colombia.	mapatarr.fidic@gmail.com	Martínez, Carlos Fernando Suárez/ABH-7784-2020; Patarroyo, Manuel A/I-8046-2016	Martínez, Carlos Fernando Suárez/0000-0001-8423-408X; Patarroyo, Manuel A/0000-0002-4751-2500	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS) [0309-2013]; Colciencias [6172]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was financed by the Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS) through grant RC # 0309-2013. CL received support from Colciencias within the framework of the Convocatoria Nacional para Estudios de Doctorado en Colombia (call for candidates # 6172).	AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Alam MT, 2008, PARASITE IMMUNOL, V30, P379, DOI 10.1111/j.1365-3024.2008.01033.x; Andreatta M, 2015, IMMUNOGENETICS, V67, P641, DOI 10.1007/s00251-015-0873-y; Andrew SM, 2001, CURR PROTOC IMMUNOL, V2, P2; [Anonymous], 2016, WORLD MAL REP 2015; Arevalo-Pinzon G, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-356; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Aucan C, 2000, INFECT IMMUN, V68, P1252, DOI 10.1128/IAI.68.3.1252-1258.2000; Baquero LA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2183-8; Bergmann-Leitner ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071610; Bharadwaj A, 1998, INFECT IMMUN, V66, P3232, DOI 10.1128/IAI.66.7.3232-3241.1998; Chen JH, 2010, J PROTEOME RES, V9, P6479, DOI 10.1021/pr100705g; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng Y, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1837-5; Cheng Y, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0698-z; Cifuentes G, 2004, BIOCHEMISTRY-US, V43, P6545, DOI 10.1021/bi049698+; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; Curtidor H, 2001, VACCINE, V19, P4496, DOI 10.1016/S0264-410X(01)00202-X; Deleage G, 2001, COMPUT BIOL MED, V31, P259, DOI 10.1016/S0010-4825(01)00008-7; Doolan DL, 2000, J IMMUNOL, V165, P1123, DOI 10.4049/jimmunol.165.2.1123; Dutta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008138; EL-Manzalawy Y, 2017, METHODS MOL BIOL, V1484, P255, DOI 10.1007/978-1-4939-6406-2_17; Patarroyo ME, 2011, CHEM REV, V111, P3459, DOI 10.1021/cr100223m; Forero-Rodriguez J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-58; Garcia J, 2009, VACCINE, V27, P3953, DOI 10.1016/j.vaccine.2009.04.039; Good MF, 1999, CURR OPIN IMMUNOL, V11, P412, DOI 10.1016/S0952-7915(99)80069-7; GORGA JC, 1987, J BIOL CHEM, V262, P16087; Hamari S, 2015, PEDIATR DIABETES, V16, P177, DOI 10.1111/pedi.12256; HAMMER J, 1994, J EXP MED, V180, P2353, DOI 10.1084/jem.180.6.2353; HERRINGTON D, 1991, AM J TROP MED HYG, V45, P539, DOI 10.4269/ajtmh.1991.45.539; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INS, 2017, B EP SEM SIVIGILA; Jacobs P, 1996, INFECT IMMUN, V64, P44, DOI 10.1128/IAI.64.1.44-49.1996; Jangpatarapongsa K, 2006, MICROBES INFECT, V8, P680, DOI 10.1016/j.micinf.2005.09.003; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; Kaslow DC, 1996, IMMUNOL LETT, V51, P187, DOI 10.1016/0165-2478(96)02570-9; Kocken CHM, 1999, INFECT IMMUN, V67, P43, DOI 10.1128/IAI.67.1.43-49.1999; Kublin JG, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aad9099; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Li J, 2012, PARASITOL INT, V61, P443, DOI 10.1016/j.parint.2012.02.008; Lopez R, 2004, BIOCHIMIE, V86, P1, DOI 10.1016/j.biochi.2003.11.013; Lyon JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002830; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marsh S. G., 1999, THE HLA FACTSBOOK; Martinez P, 2010, MICROBES INFECT, V12, P1188, DOI 10.1016/j.micinf.2010.08.007; Mojibian M, 2009, DIABETES, V58, P1789, DOI 10.2337/db08-1579; Moreno-Perez DA, 2015, J PROTEOMICS, V113, P268, DOI 10.1016/j.jprot.2014.10.003; Moreno-Perez DA, 2013, PROTIST, V164, P37, DOI 10.1016/j.protis.2012.03.001; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Ocampo M, 2000, J PEPT RES, V55, P216, DOI 10.1034/j.1399-3011.2000.00174.x; Rodriguez JCP, 2011, MEM I OSWALDO CRUZ, V106, P114, DOI 10.1590/S0074-02762011000900015; PAHO, 2017, EP AL INCR CAS MAL; Panda SK, 2017, PARASITOL RES, V116, P1293, DOI 10.1007/s00436-017-5408-z; Parker ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139407; Patarroyo MA, 2012, EXPERT REV VACCINES, V11, P1249, DOI [10.1586/ERV.12.91, 10.1586/erv.12.91]; Patarroyo MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009771; Patarroyo ME, 2008, ACCOUNTS CHEM RES, V41, P377, DOI 10.1021/ar700120t; Patarroyo ME, 2005, BIOCHEMISTRY-US, V44, P6745, DOI 10.1021/bi050214z; Patarroyo ME, 2004, CHEMBIOCHEM, V5, P1588, DOI 10.1002/cbic.200400116; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porollo AA, 2004, BIOINFORMATICS, V20, P2460, DOI 10.1093/bioinformatics/bth248; Racanelli V, 2007, CLIN IMMUNOL, V124, P5, DOI 10.1016/j.clim.2007.04.009; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Raza A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-323; Renia L, 1997, INFECT IMMUN, V65, P4419; RILEY EM, 1988, CLIN EXP IMMUNOL, V73, P17; Rodriguez LE, 2000, PARASITOLOGY, V120, P225, DOI 10.1017/S003118209900551X; Rotman HL, 1999, EXP PARASITOL, V91, P78, DOI 10.1006/expr.1999.4357; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Saravia C, 2008, BIOCHEM BIOPH RES CO, V377, P1279, DOI 10.1016/j.bbrc.2008.10.153; Scragg IG, 1999, EUR J IMMUNOL, V29, P2636, DOI 10.1002/(SICI)1521-4141(199908)29:08&lt;2636::AID-IMMU2636&gt;3.0.CO;2-Y; Siddiqui AA, 2007, VACCINE, V26, P96, DOI 10.1016/j.vaccine.2007.10.042; Solihah B, 2017, 2017 3RD INTERNATIONAL CONFERENCE ON SCIENCE AND TECHNOLOGY - COMPUTER (ICST), P93, DOI 10.1109/ICSTC.2017.8011859; Stern LJ, 2009, CURR PHARM DESIGN, V15, P3249, DOI 10.2174/138161209789105171; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Su Z, 2000, INFECT IMMUN, V68, P4399, DOI 10.1128/IAI.68.8.4399-4406.2000; Suarez CF, 2017, BIOCHEM BIOPH RES CO, V491, P1062, DOI 10.1016/j.bbrc.2017.08.012; Taechalertpaisarn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041937; TAYLORROBINSON AW, 1993, SCIENCE, V260, P1931, DOI 10.1126/science.8100366; Tonkin ML, 2013, J BIOL CHEM, V288, P12805, DOI 10.1074/jbc.M113.455667; TROYEBLOMBERG M, 1984, CLIN EXP IMMUNOL, V58, P380; Udomsangpetch R, 2008, TRENDS PARASITOL, V24, P85, DOI 10.1016/j.pt.2007.09.010; Ujvari B, 2011, INT J MOL SCI, V12, P5168, DOI 10.3390/ijms12085168; Urquiza M, 1996, PARASITE IMMUNOL, V18, P515, DOI 10.1046/j.1365-3024.1996.d01-15.x; Vargas LE, 2003, BIOCHEM BIOPH RES CO, V307, P148, DOI 10.1016/S0006-291X(03)01129-X; Villegas-Mendez A, 2016, J IMMUNOL, V197, P3152, DOI 10.4049/jimmunol.1600968; Wang B, 2013, PARASITOL RES, V112, P585, DOI 10.1007/s00436-012-3170-9; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; ZEVERING Y, 1992, EUR J IMMUNOL, V22, P689, DOI 10.1002/eji.1830220311; Zhang LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030483	97	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2018	13	9							e0203715	10.1371/journal.pone.0203715	http://dx.doi.org/10.1371/journal.pone.0203715			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7DK	30199554	gold, Green Submitted, Green Published			2022-12-26	WOS:000444681100021
J	Kawatsu, L; Uchimura, K; Ohkado, A				Kawatsu, Lisa; Uchimura, Kazuhiro; Ohkado, Akihiro			A situational analysis of latent tuberculosis infection among incarcerated population in Japan	PLOS ONE			English	Article							FOLLOW-UP; JAIL; PROPHYLAXIS; OUTCOMES; THERAPY; RELEASE; BURDEN; TRIAL; HIV	Background The World Health Organization recommends that systematic testing and screening of latent tuberculosis infection (LTBI) among the incarcerated population "should be considered", though based on evidence of either low or very low quality. However, in Japan, a TB middle-burden country, systematic screening for LTBI in correctional facilities is currently not conducted. As part of a larger study to determine the cost-effectiveness of LTBI screening in correctional facilities in Japan, this study was conducted to determine the situation of LTBI, including treatment outcome, among the incarcerated population in Japan, and provide the essential data for cost-effectiveness analysis. Method A cross-sectional study was conducted between 2017 and 2018 with public health centers which have one or more correctional facilities under their jurisdiction. Questionnaire surveys were sent to collect information on their policy of managing LTBI patients notified from correctional facilities, including whether or not there was a standardized procedure for initiating LTBI treatment, and also to collect sociodemographic information and treatment outcome of LTBI patients who were notified from the respective correctional facilities in 2015 and 2016. Results The survey was sent to a total of 163 public health centers, out of which 133 (81.6%) responded. 8 of the 133 public health centers actively guided the correctional facilities regarding LTBI treatment initiation through a standardized procedure, while 115 either had not established such procedure or were unaware of how LTBI treatment was being initiated in the correctional facilities. A total of 91 LTBI patients were notified from the correctional facilities in 2015 and 2016, and the information of 89 were available for analysis. 82 were males, and 83 were Japan-born. Treatment outcome was known for 88 patients, of which 70 had completed treatment. Of the 18 who did not complete the treatment, 15 had been lost to follow-up upon release from the facilities. Among those who had been released whilst on treatment, the proportion of those who completed the treatment was higher in those patients who received pre-release visit by a public health nurse, than those who did not. Conclusions LTBI treatment was often being initiated without consideration for the patients' prison term. The treatment completion rate within jail was high, indicating the possibility that incarcerated population can benefit for LTBI treatment. On the other hand, the completion rate decreased significantly among those who had been released while still on treatment. In order to optimize the benefit, initiation of LTBI must carefully be considered upon the patient's prison term, as well as coordination among the relevant organizations to ensure continuity of care after release.	[Kawatsu, Lisa; Uchimura, Kazuhiro; Ohkado, Akihiro] Japan AntiTB Assoc RIT JATA, Res Inst TB, Dept Epidemiol & Clin Res, Tokyo, Japan		Kawatsu, L (corresponding author), Japan AntiTB Assoc RIT JATA, Res Inst TB, Dept Epidemiol & Clin Res, Tokyo, Japan.	kawatsu@jata.or.jp	Ohkado, Akihiro/HGF-2977-2022		Japan Society for the Promotion of Science [16K09155]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science (grant number: 16K09155) to LK. https://www.jsps.go.jp/j-grantsinaid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Darraji HAA, 2012, INT J TUBERC LUNG D, V16, P871, DOI 10.5588/ijtld.11.0447; ALCABES P, 1989, AM REV RESPIR DIS, V140, P1194, DOI 10.1164/ajrccm/140.5.1194; Altice FL, 2011, JAIDS-J ACQ IMM DEF, V56, pS22, DOI 10.1097/QAI.0b013e318209751e; [Anonymous], 2013, KEKKAKU, V88, P497; Bock NN, 2001, CHEST, V119, P833, DOI 10.1378/chest.119.3.833; Chee CBE, 2005, INT J TUBERC LUNG D, V9, P1248; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Ishikawa N, 2014, HOKENJO NI MUKETA KE; Jereb John A., 2011, Morbidity and Mortality Weekly Report, V60, P1650; Kawatsu L, 2015, INT J TUBERC LUNG D, V19, P921, DOI 10.5588/ijtld.14.0692; Kawatsu L, 2018, INT J PRISONER HLTH; Kawatsu L, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.018588, 10.1371/journal.pone.0186588]; Lincoln T, 2004, INT J TUBERC LUNG D, V8, P306; Nolan CM, 1997, AM J RESP CRIT CARE, V155, P583, DOI 10.1164/ajrccm.155.2.9032198; Pease C, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2377-x; Springer SA, 2010, J URBAN HEALTH, V87, P592, DOI 10.1007/s11524-010-9438-4; Tulsky JP, 1998, AM J PUBLIC HEALTH, V88, P223, DOI 10.2105/AJPH.88.2.223; White MC, 2005, HEALTH EDUC RES, V20, P163, DOI 10.1093/her/cyg109; White MC, 2002, ARCH INTERN MED, V162, P1044, DOI 10.1001/archinte.162.9.1044; White MC, 1998, INT J TUBERC LUNG D, V2, P506; WHO, 2015, IMPLEMENTING END TB; World Health Organization (WHO), 2015, GUIDELINES MANAGEMEN	24	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203815	10.1371/journal.pone.0203815	http://dx.doi.org/10.1371/journal.pone.0203815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192897	gold, Green Submitted, Green Published			2022-12-26	WOS:000444093600146
J	Voysey, M; Sadarangani, M; Pollard, AJ; Fanshawe, TR				Voysey, Merryn; Sadarangani, Manish; Pollard, Andrew J.; Fanshawe, Thomas R.			Computing threshold antibody levels of protection in vaccine clinical trials: An assessment of methodological bias	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; PLACEBO-CONTROLLED TRIAL; RANDOMIZED-TRIAL; TYPHOID VACCINE; EFFICACY TRIAL; DOUBLE-BLIND; CHILDREN; IMMUNOGENICITY; SAFETY; PREVENTION	In the development of new vaccines, understanding the level of vaccine-induced antibody that is sufficient to protect against disease can simplify and expedite the development and licensing process. If there is an accepted threshold antibody level that is indicative of protection, then smaller trials measuring antibody concentration alone can be conducted to test new vaccines, instead of large efficacy studies powered on clinical outcomes. Commonly, threshold levels of protective antibody are determined from clinical efficacy trials in which clinical endpoints are measured on everyone and a small subset of participants have antibody concentrations measured. The proportion of participants with antibody below a threshold in each group in the immunogenicity subset can be compared to the proportions with disease in each group in the larger trial to find an appropriate threshold. Mathematically, this method seeks to compute an absolute threshold whereby antibody above the threshold provides complete, sterilizing immunity. However, in practice it is often understood that such thresholds may only be indicative of a relative degree of protection rather than an absolute one. Although this approach is common, the accuracy of such methods when the underlying mathematical assumptions do not hold true, has never been tested. We simulated data from clinical trial scenarios under varying assumptions of vaccine efficacy and calculated antibody thresholds of protection. We estimated the bias in the calculated thresholds derived from each scenario and showed that in many situations this method produces inflated estimates of thresholds, particularly if a vaccine induces high levels of antibody or when the underlying assumption of sterilizing immunity is violated.	[Voysey, Merryn; Fanshawe, Thomas R.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Voysey, Merryn; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Voysey, Merryn; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Sadarangani, Manish] Univ British Columbia, BC Childrens Hosp Res Inst, Vaccine Evaluat Ctr, Vancouver, BC, Canada	University of Oxford; University of Oxford; University of Oxford; University of British Columbia	Voysey, M (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.; Voysey, M (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England.; Voysey, M (corresponding author), NIHR Oxford Biomed Res Ctr, Oxford, England.	merryn.voysey@phc.ox.ac.uk	Sadarangani, Manish/V-5609-2019	Sadarangani, Manish/0000-0002-9985-6452; Voysey, Merryn/0000-0001-6324-6559	National Institute for Health Research (NIHR) [DRF-2015-08-048]	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	MV is funded by a National Institute for Health Research (NIHR) Doctoral Research Fellowship (DRF-2015-08-048 https://www.nihr.ac.uk/). The funder had no involvement in the design and conduct of the study; analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Andrews N, 2003, CLIN DIAGN LAB IMMUN, V10, P780, DOI 10.1128/CDLI.10.5.780-786.2003; Andrews N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028435; Andrews NJ, 2014, LANCET INFECT DIS, V14, P839, DOI 10.1016/S1473-3099(14)70822-9; Anwar E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001261.pub3; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Balmer P, 2002, J MED MICROBIOL, V51, P717, DOI 10.1099/0022-1317-51-9-717; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Borrow R, 2001, INFECT IMMUN, V69, P1568, DOI 10.1128/IAI.69.3.1568-1573.2001; Campbell H, 2010, CLIN VACCINE IMMUNOL, V17, P840, DOI 10.1128/CVI.00529-09; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 2016, VACCINE, V34, P4313, DOI 10.1016/j.vaccine.2016.06.075; Jin C, 2017, LANCET, V390, P2472, DOI 10.1016/S0140-6736(17)32149-9; Jodar L, 2003, VACCINE, V21, P3265, DOI 10.1016/S0264-410X(03)00230-5; Joensuu J, 1997, LANCET, V350, P1205, DOI 10.1016/S0140-6736(97)05118-0; Khan MI, 2012, VACCINE, V30, P5389, DOI 10.1016/j.vaccine.2012.06.015; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Mohan VK, 2015, CLIN INFECT DIS, V61, P393, DOI 10.1093/cid/civ295; O'Brien KL, 2009, VACCINE, V27, P1863, DOI 10.1016/j.vaccine.2008.12.060; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; Richie E, 2000, VACCINE, V18, P2399, DOI 10.1016/S0264-410X(00)00006-2; Saaka M, 2008, VACCINE, V26, P3719, DOI 10.1016/j.vaccine.2008.04.066; Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119; Sur D, 2009, NEW ENGL J MED, V361, P335, DOI 10.1056/NEJMoa0807521; Voysey M, 2017, CLIN INFECT DIS; Voysey M, 2018, CLIN INFECT DIS, V67, P18, DOI 10.1093/cid/cix1145; World Health Organization, 2013, WORLD HLTH ORG	27	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202517	10.1371/journal.pone.0202517	http://dx.doi.org/10.1371/journal.pone.0202517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192787	gold, Green Submitted, Green Published			2022-12-26	WOS:000444093600025
J	Guedes, L; Jaeger, LH; Liryo, A; Rodrigues-Carvalho, C; de Souza, SM; Iniguez, AM				Guedes, Lucelia; Jaeger, Lauren Hubert; Liryo, Andersen; Rodrigues-Carvalho, Claudia; de Souza, Sheila Mendonca; Iniguez, Alena Mayo			Tuberculosis in post-contact Native Americans of Brazil: Paleopathological and paleogenetic evidence from the Tenetehara-Guajajara	PLOS ONE			English	Article							RIO-DE-JANEIRO; MYCOBACTERIUM-TUBERCULOSIS; HUMAN REMAINS; ANCIENT DNA; ENTEROBIUS-VERMICULARIS; COMPLEX DNA; IDENTIFICATION; SKELETAL; COPROLITES; DIAGNOSIS	Tuberculosis (TB) has been described in Native American populations prior to the arrival of European explorers, and in Brazilian populations dating from the Colonial Period. There are no studies demonstrating TB infection in native Brazilians, and the history and epidemiological scenario of TB in Brazil is still unknown. The aim of this study was to verify the presence of TB infection among the native Tenetehara-Guajajara population from Maranhao State, Brazil, 210 +/- 40 years ago. A Tenetehara-Guajajara skeleton collection was submitted to paleopathological analysis, and rib bone samples (n = 17) were used for paleogenetic analysis based on Mycobacterium tuberculosis complex (MTC) targets. Porotic hyperostosis and cribra orbitalia were found in 10 and 13 individuals, respectively. Maternal ancestry analysis revealed Native American mtDNA haplogroups A and C1 in three individuals. Three samples showed osteological evidence suggestive of TB. katG and mtp40 sequences were detected in three individuals, indicating probable TB infection by two MTC lineages. Tuberculosis infection in the Tenetehara-Guajajara population since the 18th century points to a panorama of the disease resulting, most probably, from European contact. However, the important contribution of African slaves in the population of Maranhao State, could be also considered as a source of the disease. This study provides new data on TB during the Brazilian Colonial Period. This is the first report integrating paleopathological and paleogenetic data for the study of TB in Brazil.	[Guedes, Lucelia; Jaeger, Lauren Hubert; Iniguez, Alena Mayo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Tripanosomatideos, Rio De Janeiro, Brazil; [Guedes, Lucelia] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil; [Liryo, Andersen; Rodrigues-Carvalho, Claudia] Museu Nacl UFRJ, Programa Posgrad Arqueol, Rio De Janeiro, Brazil; [Liryo, Andersen; Rodrigues-Carvalho, Claudia] Museu Nacl UFRJ, Dept Antropol, Setor Antropol Biol, Rio De Janeiro, Brazil; [de Souza, Sheila Mendonca] Fundacao Oswaldo Cruz, Dept Endemias Samuel Pessoa, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Iniguez, AM (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Tripanosomatideos, Rio De Janeiro, Brazil.	alenainiguez@gmail.com	Jaeger, Lauren Hubert/GVU-0797-2022; INIGUEZ, ALENA M/B-7613-2013	INIGUEZ, ALENA M/0000-0002-9788-9533	Fundacao de Amparo a Pesquisa do Rio de Janeiro [26/110.300/2012, 26/202.945/2016]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [307932/2014-1, 312934/2017-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [847/15]	Fundacao de Amparo a Pesquisa do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We declare that all the funding or sources of support received during this specific study are presented. This study was supported by grants-in-aid and fellowships for Fundacao de Amparo a Pesquisa do Rio de Janeiro (http://www.faperj.br/) (AMI, grant numbers 26/110.300/2012 and 26/202.945/2016), fellowships for Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/) (AMI, grant numbers 307932/2014-1 and 312934/2017-3), and grants-in-aid for Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br/) (AMI, grant number 847/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHILLI A, 2008, PLOS ONE, V3, DOI DOI 10.1371/JOURNAL.PONE.0001'764; Alexander KA, 2010, EMERG INFECT DIS, V16, P1296, DOI 10.3201/eid1608.100314; ALLISON MJ, 1973, AM REV RESPIR DIS, V107, P985; Altamirano A, 2000, THESIS; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; ARRIAZA BT, 1995, AM J PHYS ANTHROPOL, V98, P37, DOI 10.1002/ajpa.1330980104; Baron H, 1996, J ARCHAEOL SCI, V23, P667, DOI 10.1006/jasc.1996.0063; Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Buikstra J., 1999, TUBERCULOSIS PRESENT, P293; Buikstra J, 1992, PALEOPATOLOGIA PALEO, P343; BUIKSTRA JE, 1980, ANNU REV ANTHROPOL, V9, P433, DOI 10.1146/annurev.an.09.100180.002245; Buikstra JE, 1994, ARKANSAS ARCHEOLOGIC, DOI DOI 10.1016/j.jasrep.2017.10.033; Cardena MMSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062005; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Daniel TM, 2004, INFECT DIS CLIN N AM, V18, P157, DOI 10.1016/S0891-5520(03)00096-5; Darling MI, 2014, MEM I OSWALDO CRUZ, V109, P131, DOI 10.1590/0074-0276140589; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; Donoghue HD, 2011, CLIN MICROBIOL INFEC, V17, P821, DOI 10.1111/j.1469-0691.2011.03554.x; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fletcher HA, 2003, MICROBIOL-SGM, V149, P143, DOI 10.1099/mic.0.25961-0; Forst J., 2015, THESIS; Forst J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163031; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Golenberg EM, 1996, NUCLEIC ACIDS RES, V24, P5026, DOI 10.1093/nar/24.24.5026; Gomes J, 1992, SERIE PANOMA ENSP; GOMES M. P., 2002, INDIO HIST POVO TENE; Goncalves VF, 2008, HUM HERED, V65, P23, DOI 10.1159/000106059; Goncalves Vanessa F, 2010, Investig Genet, V1, P13, DOI 10.1186/2041-2223-1-13; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Handt O, 1996, AM J HUM GENET, V59, P368; Huard RC, 2003, J CLIN MICROBIOL, V41, P1637, DOI 10.1128/JCM.41.4.1637-1650.2003; Jaeger LH, 2013, INT J PALEOPATHOL, V3, P214, DOI 10.1016/j.ijpp.2013.04.001; IBGE, 2013, IBGE CENS DEM BRAS; Iniguez AM, 2006, INT J PARASITOL, V36, P1419, DOI 10.1016/j.ijpara.2006.07.005; Iniguez AM, 2003, MEM I OSWALDO CRUZ, V98, P67, DOI 10.1590/S0074-02762003000900013; Iniguez AM, 2003, MEM I OSWALDO CRUZ, V98, P63, DOI 10.1590/S0074-02762003000900012; Jaeger LH, 2013, EMERG INFECT DIS, V19, P837, DOI 10.3201/eid1905.120193; Jaeger LH, 2016, J PARASITOL, V102, P222, DOI 10.1645/15-866; Jaeger LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105910; Jaeger LH, 2013, ACTA TROP, V125, P282, DOI 10.1016/j.actatropica.2012.11.007; Jaeger LH, 2012, INFECT GENET EVOL, V12, P642, DOI 10.1016/j.meegid.2011.08.021; Klaus HD, 2010, J ARCHAEOL SCI, V37, P2587, DOI 10.1016/j.jas.2010.05.019; Konomi N, 2002, J CLIN MICROBIOL, V40, P4738, DOI 10.1128/JCM.40.12.4738-4740.2002; Leite D., 2014, J ANTHR, V2014, P1, DOI [10.1155/2014/729120, DOI 10.1155/2014/729120]; Leles D, 2008, MEM I OSWALDO CRUZ, V103, P106, DOI 10.1590/S0074-02762008005000004; Liebana E, 1996, J CLIN MICROBIOL, V34, P933; Lima P, 1946, REV I HIST GEOG BRAS, V190, P77; Lima P, 1954, B MUSEU NACL NS ANTR, V16, P1; Liryo A., 2011, REV MUSEU ARQUEOLOGI, P315, DOI DOI 10.11606/ISSN.2448-1750.REVMAE.2011.89979; Melatti J., 2011, AREAS ETNOGRAFICAS A; Mikic AM, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpla.2015.01006, 10.3389/fpls.2015.01006]; Muller R, 2014, AM J PHYS ANTHROPOL, V153, P178, DOI 10.1002/ajpa.22417; Muller R, 2016, J ARCHAEOL SCI, V68, P5, DOI 10.1016/j.jas.2016.03.002; ORTNER SB, 1984, COMP STUD SOC HIST, V26, P126, DOI 10.1017/S0010417500010811; Poulakakis N, 2006, BIOL LETTERS, V2, P451, DOI 10.1098/rsbl.2006.0467; Prat JGI, 2003, MEM I OSWALDO CRUZ, V98, P151, DOI 10.1590/S0074-02762003000900023; Ramallo V, 2013, AM J PHYS ANTHROPOL, V150, P453, DOI 10.1002/ajpa.22219; Reinhard, 2011, FUNDAMENTOS PALEOPAR, P301; Requena A, 1945, ACTA VENEZOLANA, V1, P141; Ribeiro F., 2009, THESIS; Roberts C.A., 2003, BIOARCHAEOLOGY TUBER; Rollo Franco, 2006, Med Secoli, V18, P725; SALO WL, 1994, P NATL ACAD SCI USA, V91, P2091, DOI 10.1073/pnas.91.6.2091; Soares Diniz E, 1983, J SOC AMERICANISTES, V69, P117, DOI [10.3406/jsa.1983.2227, DOI 10.3406/JSA.1983.222'7]; Sotomayor Hugo, 2004, Biomed., V24, P18; Suzuki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088356; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Taylor GM, 1996, J ARCHAEOL SCI, V23, P789; Taylor GM, 2005, J CLIN MICROBIOL, V43, P2236, DOI 10.1128/JCM.43.5.2236-2240.2005; Varga István van Deursen, 2008, Acta Amaz., V38, P85, DOI 10.1590/S0044-59672008000100010; WAGLEY C, 1949, TENETEHARA INDIANS B; Walker PL, 2009, AM J PHYS ANTHROPOL, V139, P109, DOI 10.1002/ajpa.21031; Wilbur AK, 2006, MEM I OSWALDO CRUZ, V101, P59, DOI 10.1590/S0074-02762006001000011; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Zink AR, 2004, J CLIN PATHOL, V57, P1185, DOI 10.1136/jcp.2003.015719	78	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202394	10.1371/journal.pone.0202394	http://dx.doi.org/10.1371/journal.pone.0202394			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS6HC	30183732	Green Published, Green Submitted, gold			2022-12-26	WOS:000443789900025
J	Perez-Ortega, J; Almanza-Ortega, N; Romero, D				Perez-Ortega, Joaquin; Nely Almanza-Ortega, Nelva; Romero, David			Balancing effort and benefit of K-means clustering algorithms in Big Data realms	PLOS ONE			English	Article							OPTIMIZATION	In this paper we propose a criterion to balance the processing time and the solution quality of k-means cluster algorithms when applied to instances where the number n of objects is big. The majority of the known strategies aimed to improve the performance of k-means algorithms are related to the initialization or classification steps. In contrast, our criterion applies in the convergence step, namely, the process stops whenever the number of objects that change their assigned cluster at any iteration is lower than a given threshold. Through computer experimentation with synthetic and real instances, we found that a threshold close to 0.03n involves a decrease in computing time of about a factor 4/100, yielding solutions whose quality reduces by less than two percent. These findings naturally suggest the usefulness of our criterion in Big Data realms.	[Perez-Ortega, Joaquin; Nely Almanza-Ortega, Nelva] Tecnol Nacl Mexico, Ctr Nacl Invest & Desarrollo Tecnol, Dept Ciencias Computac, Cuernavaca, Morelos, Mexico; [Romero, David] Univ Nacl Autonoma Mexico, Inst Matemat, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Perez-Ortega, J (corresponding author), Tecnol Nacl Mexico, Ctr Nacl Invest & Desarrollo Tecnol, Dept Ciencias Computac, Cuernavaca, Morelos, Mexico.	jpo_cenidet@yahoo.com.mx		Almanza-Ortega, Nelva Nely/0000-0002-5885-7635; PEREZ-ORTEGA, JOAQUIN/0000-0002-5138-7984				Agha Mohammed El, 2012, INT J INTELL SYST, V1, P21, DOI [DOI 10.5815/IJISA.2012, DOI 10.5815/IJISA.2012.01.03]; Aloise D, 2009, MACH LEARN, V75, P245, DOI 10.1007/s10994-009-5103-0; Arthur D., 2007, P 18 ANN ACMS S, P1027, DOI DOI 10.1145/1283383.1283494; Bock H. -H., 2008, ELECT J HIST PROBAB, V4, P1; Broderick Tamara, 2013, P 30 INT C MACH LEAR, P226; Chiang MC, 2011, INFORM SCIENCES, V181, P716, DOI 10.1016/j.ins.2010.10.008; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Elkan C., 2003, P 20 INT C MACHINE L, P147, DOI DOI 10.1016/0026-2714(92)90278-S; Fahim A., 2006, J ZHEJIANG U SCI A, V7, P1626, DOI 10.1631/jzus.2006.A1626; Fayyad U., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P82; Fisher D. H., 1987, Machine Learning, V2, P139, DOI 10.1007/BF00114265; Hamerly G, 2004, ADV NEUR IN, V16, P281; Hamerly G., 2010, P 2010 SIAM INT C DA, P130, DOI DOI 10.1137/1.9781611972801.12; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; JANCEY RC, 1966, AUST J BOT, V14, P127, DOI 10.1071/BT9660127; Kambatla K, 2014, J PARALLEL DISTR COM, V74, P2561, DOI 10.1016/j.jpdc.2014.01.003; Kantardzic M., 2011, DATA MINING CONCEPTS; Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616; Konak A, 2006, RELIAB ENG SYST SAFE, V91, P992, DOI 10.1016/j.ress.2005.11.018; Kulis B., ARXIV11110352; Lai JZC, 2009, PATTERN RECOGN, V42, P2551, DOI 10.1016/j.patcog.2009.02.014; Lam YK, 2012, APPL SOFT COMPUT, V12, P1149, DOI 10.1016/j.asoc.2011.11.008; Laney D, 2001, META GROUP RES NOTE, V6, P1; Lichman M, 2013, UCI MACHINE LEARNING; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mahajan M, 2012, THEOR COMPUT SCI, V442, P13, DOI 10.1016/j.tcs.2010.05.034; McGeoch CC, 2012, GUIDE TO EXPERIMENTAL ALGORITHMICS, P1; Mexicano A, 2016, AIP CONF PROC, V1738, DOI 10.1063/1.4952103; Pelleg D., 2000, P 17 INT C MACH LEAR, P727, DOI DOI 10.1007/3-540-44491-2_3; Perez J., 2013, J INFORM DATA MANAGE, V4, P94; Perez J, 2015, AIP C P, V1648; Perez J, 2016, AIP CONF PROC, V1738, DOI 10.1063/1.4952102; Perez OJ, 2007, LECT NOTES COMPUT SC, V4707, P674; Raykov YP, 2016, ELECTRON J STAT, V10, P3548, DOI 10.1214/16-EJS1196; Raykov YP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162259; Salman R, 2011, COMM COM INF SC, V162, P110; SELIM SZ, 1984, IEEE T PATTERN ANAL, V6, P81, DOI 10.1109/TPAMI.1984.4767478; Steinhaus H., 1957, B ACAD POL SCI, V4, P801; Tsai C-W, 2015, J BIG DATA, V2, P21, DOI [DOI 10.1186/S40537-015-0030-3, 10.1186/s40537-015-0030-3]; Tzortzis G, 2014, PATTERN RECOGN, V47, P2505, DOI 10.1016/j.patcog.2014.01.015; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Xia Zhanguo, 2012, J CONVERGENCE INFORM, V7, P317	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0201874	10.1371/journal.pone.0201874	http://dx.doi.org/10.1371/journal.pone.0201874			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183705	Green Published, Green Submitted, gold			2022-12-26	WOS:000443789900007
J	Temesszentandrasi-Ambrus, C; Toth, S; Verma, R; Banhegyi, P; Szabadkai, I; Baska, F; Szantai-Kis, C; Hartkoorn, RC; Lingerfelt, MA; Sarkadi, B; Szakacs, G; Orfi, L; Nagaraja, V; Ekins, S; Telbisz, A				Temesszentandrasi-Ambrus, Csilla; Toth, Szilard; Verma, Rinkee; Banhegyi, Peter; Szabadkai, Istvan; Baska, Ferenc; Szantai-Kis, Csaba; Hartkoorn, Ruben C.; Lingerfelt, Mary A.; Sarkadi, Balazs; Szakacs, Gergely; Orfi, Laszlo; Nagaraja, Valakunja; Ekins, Sean; Telbisz, Agnes			Characterization of new, efficient Mycobacterium tuberculosis topoisomerase-I inhibitors and their interaction with human ABC multidrug transporters	PLOS ONE			English	Article							RESISTANCE PROTEIN ABCG2; P-GLYCOPROTEIN; DRUGS; CELLS; METABOLISM; EXCRETION; MOLECULE; THERAPY; EFFLUX; GENE	Drug resistant tuberculosis (TB) is a major worldwide health problem. In addition to the bacterial mechanisms, human drug transporters limiting the cellular accumulation and the pharmacological disposition of drugs also influence the efficacy of treatment. Mycobacterium tuberculosis topoisomerase-I (MtTopo-I) is a promising target for antimicrobial treatment. In our previous work we have identified several hit compounds targeting the MtTopo-I by in silico docking. Here we expand the scope of the compounds around three scaffolds associated with potent MtTopo-I inhibition. In addition to measuring the effect of newly generated compounds on MtTopo-I activity, we characterized the compounds' antimicrobial activity, toxicity in human cells, and interactions with human multidrug transporters. Some of the newly developed MtTopo-I inhibitors have strong antimicrobial activity and do not harm mammalian cells. Moreover, our studies revealed significant human ABC drug transporter interactions for several MtTopo-I compounds that may modify their ADME-Tox parameters and cellular effects. Promising new drug candidates may be selected based on these studies for further anti-TB drug development.	[Temesszentandrasi-Ambrus, Csilla; Toth, Szilard; Sarkadi, Balazs; Szakacs, Gergely; Telbisz, Agnes] RCNS HAS, Inst Enzymol, Budapest, Hungary; [Temesszentandrasi-Ambrus, Csilla] Semmelweis Univ, Mol Med Doctoral Sch, Budapest, Hungary; [Verma, Rinkee; Nagaraja, Valakunja] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore, Karnataka, India; [Banhegyi, Peter; Szabadkai, Istvan; Baska, Ferenc; Szantai-Kis, Csaba; Orfi, Laszlo] Vichem Chem Res Ltd, Budapest, Hungary; [Hartkoorn, Ruben C.] Univ Lille, Chem Biol Antibiot, Ctr Infect & Immun,CNRS, Inserm,Inst Pasteur Lille, Lille, France; [Lingerfelt, Mary A.; Ekins, Sean] Collaborat Pharmaceut Inc, Raleigh, NC USA; [Orfi, Laszlo] Semmelweis Univ, Dept Pharmaceut Chem, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University; Indian Institute of Science (IISC) - Bangalore; Vichem Chemie Research Ltd.; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Semmelweis University	Telbisz, A (corresponding author), RCNS HAS, Inst Enzymol, Budapest, Hungary.	telbisz.agnes@ttk.mta.hu	Tóth, Szilárd/AGB-3548-2022; Szakacs, Gergely/A-2580-2009; Orfi, Laszlo/A-2116-2008; Hartkoorn, Ruben C/U-2698-2017; Temesszentandrási-Ambrus, Csilla/AAR-1629-2020	Tóth, Szilárd/0000-0002-0168-3531; Szakacs, Gergely/0000-0002-9311-7827; Orfi, Laszlo/0000-0001-6149-2385; Hartkoorn, Ruben C/0000-0001-7315-1553; Temesszentandrási-Ambrus, Csilla/0000-0002-1348-8725; Baska, Ferenc/0000-0003-0708-2224; Szantai-Kis, Csaba/0000-0002-5240-845X; Szabadkai, Istvan/0000-0002-8686-8382	DST by the Department of Science and Technology, Government of India [TET_13_DST-1-2013-0012]; NKFIH (National Research Development and Innovation Office) Hungary by NKFIH (National Research Development and Innovation Office) Hungary [KFI_16-1-2017-0232]; More Medicines For Tuberculosis (MM4TB) by the European Community Seventh Framework Programme 7 [260872]; DST Government of India; NKFIH; Europian Community Seventh Framework Programme 7; Vichem Chemie Research Ltd; Collaborations Pharmaceuticals Inc	DST by the Department of Science and Technology, Government of India; NKFIH (National Research Development and Innovation Office) Hungary by NKFIH (National Research Development and Innovation Office) Hungary(National Research, Development & Innovation Office (NRDIO) - Hungary); More Medicines For Tuberculosis (MM4TB) by the European Community Seventh Framework Programme 7; DST Government of India(Department of Science & Technology (India)); NKFIH(National Research, Development & Innovation Office (NRDIO) - Hungary); Europian Community Seventh Framework Programme 7; Vichem Chemie Research Ltd; Collaborations Pharmaceuticals Inc	This research was funded by DST TET_13_DST-1-2013-0012 by the Department of Science and Technology, Government of India and the NKFIH (National Research Development and Innovation Office) Hungary, KFI_16-1-2017-0232 by NKFIH (National Research Development and Innovation Office) Hungary, and More Medicines For Tuberculosis (MM4TB), grant agreement no. 260872 by the European Community Seventh Framework Programme 7. All fundings supported experimental research aiming to find new antituberculotic compounds. Grants supported collaborative works of authors SE, RH, VN and LO in MM4TB, VN, LO, BS, GSZ in DST-TEAT funding, and AT in KFI_16-1-2017-0232. The funders (DST Government of India, NKFIH, Europian Community Seventh Framework Programme 7) provided supports in the form of research materials and salaries for AT. Vichem Chemie Research Ltd provided funding in the form of salaries for PB, IS, FB, CSSZ, and LO. Collaborations Pharmaceuticals Inc provided funding in the form of a salary for SE, ML. The specific roles of these authors are articulated in the "Author Contributions" section. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2014, FEMS MICROBIOL LETT, V353, P116, DOI 10.1111/1574-6968.12412; Ando T, 2007, DRUG METAB DISPOS, V35, P1873, DOI 10.1124/dmd.107.014969; Brillault J, 2010, ANTIMICROB AGENTS CH, V54, P543, DOI 10.1128/AAC.00733-09; Chaudhari K, 2016, EUR J MED CHEM, V124, P160, DOI 10.1016/j.ejmech.2016.08.034; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Ekins S, 2017, TUBERCULOSIS, V103, P52, DOI 10.1016/j.tube.2017.01.005; Elkind NB, 2005, CANCER RES, V65, P1770, DOI 10.1158/0008-5472.CAN-04-3303; Fonseca JD, 2015, INT J INFECT DIS, V32, P94, DOI 10.1016/j.ijid.2015.01.014; Godbole AA, 2015, ANTIMICROB AGENTS CH, V59, P1554, DOI 10.1128/AAC.04516-14; Godbole AA, 2012, ARCH BIOCHEM BIOPHYS, V528, P197, DOI 10.1016/j.abb.2012.10.004; GUILHOT C, 1994, J BACTERIOL, V176, P535, DOI 10.1128/JB.176.2.535-539.1994; Hartkoorn RC, 2007, TUBERCULOSIS, V87, P248, DOI 10.1016/j.tube.2006.12.001; Haslam IS, 2011, DRUG METAB DISPOS, V39, P2321, DOI 10.1124/dmd.111.038323; Homolya L, 1996, BRIT J CANCER, V73, P849, DOI 10.1038/bjc.1996.151; Keri G, 2005, ASSAY DRUG DEV TECHN, V3, P543, DOI 10.1089/adt.2005.3.543; Merino G, 2006, DRUG METAB DISPOS, V34, P690, DOI 10.1124/dmd.105.008219; Nagaraja V, 2017, DRUG DISCOV TODAY, V22, P510, DOI 10.1016/j.drudis.2016.11.006; Nerada Z, 2016, CYTOM PART A, V89A, P826, DOI 10.1002/cyto.a.22931; Ravishankar S, 2015, TUBERCULOSIS, V95, P589, DOI 10.1016/j.tube.2015.05.004; Sala C, 2010, ANTIMICROB AGENTS CH, V54, P4150, DOI 10.1128/AAC.00821-10; Sandhaus S, 2016, ANTIMICROB AGENTS CH, V60, P4028, DOI 10.1128/AAC.00288-16; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Scheffer GL, 2002, J CLIN PATHOL, V55, P332, DOI 10.1136/jcp.55.5.332; Sipos A, 2015, TUBERCULOSIS, V95, pS200, DOI 10.1016/j.tube.2015.02.028; Smith NF, 2006, TOXICOL IN VITRO, V20, P163, DOI 10.1016/j.tiv.2005.06.045; Song LL, 2016, INT J ANTIMICROB AG, V47, P421, DOI 10.1016/j.ijantimicag.2016.04.007; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; Tan KM, 2016, J MOL BIOL, V428, P182, DOI 10.1016/j.jmb.2015.11.024; te Brake LHM, 2016, TUBERCULOSIS, V96, P150, DOI 10.1016/j.tube.2015.08.004; Telbisz A, 2007, BBA-BIOMEMBRANES, V1768, P2698, DOI 10.1016/j.bbamem.2007.06.026; Ujhelly O, 2003, HUM GENE THER, V14, P403, DOI 10.1089/104303403321209005; van der Deen M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-59; VANDERVALK P, 1990, ANN ONCOL, V1, P56; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	35	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202749	10.1371/journal.pone.0202749	http://dx.doi.org/10.1371/journal.pone.0202749			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183750	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000443789900036
J	Tian, LX; Chen, H; Zhen, ZL				Tian, Lixin; Chen, Huan; Zhen, Zaili			Research on the forward-looking behavior judgment of heating oil price evolution based on complex networks	PLOS ONE			English	Article							AUTOREGRESSIVE NEURAL-NETWORK; TIME-SERIES; STRUCTURAL BREAKS; SPOT-PRICES; VOLATILITY; MODELS; PREDICTION; PATTERNS; FUTURES; CHINA	Analyzing and predicting the trend of price fluctuation has been receiving more and more attention, as price risk has become the focus of risk control research in heating oil futures market. A novel time series prediction model combined with the complex network method is put forward in the paper. First of all, this paper counts the cumulative time interval of different nodes in the network, and fits its growth trend with the Fourier model. Then a novel price fluctuation prediction model is established based on the effective information such as some topology properties extracted from the network. The results show that the Fourier model can predict the emergence time of new nodes in the next stage, and the established price fluctuation prediction model can infer the names of nodes in the prediction interval, so as to determine the forward-looking behavior of price evolution. Besides, liken to the NAR neural network, the prediction results obtained by the proposed method also show superiority, which has important theoretical value and academic significance for early warning and prediction of price behavior in the heating oil futures market.	[Tian, Lixin; Chen, Huan; Zhen, Zaili] Jiangsu Univ, Energy Dev & Environm Protect Strategy Res Ctr, Zhenjiang, Jiangsu, Peoples R China; [Tian, Lixin] Nanjing Normal Univ, Sch Math Sci, Energy Interdependency Behav & Strategy Res Ctr, Nanjing, Jiangsu, Peoples R China	Jiangsu University; Nanjing Normal University	Tian, LX (corresponding author), Jiangsu Univ, Energy Dev & Environm Protect Strategy Res Ctr, Zhenjiang, Jiangsu, Peoples R China.; Tian, LX (corresponding author), Nanjing Normal Univ, Sch Math Sci, Energy Interdependency Behav & Strategy Res Ctr, Nanjing, Jiangsu, Peoples R China.	tianlx@ujs.edu.cn		Tian, Lixin/0000-0003-4817-8580	National Natural Science Foundation of China [71690242, 91546118, 11731014]; Major Project of Natural Science Foundation of Jiangsu Province Colleges and Universities [14KJA110001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Project of Natural Science Foundation of Jiangsu Province Colleges and Universities	This research is supported by grants from National Natural Science Foundation of China (Grant No. 71690242, 91546118, 11731014), and The Major Project of Natural Science Foundation of Jiangsu Province Colleges and Universities (Grant No. 14KJA110001).	Adhikari R, 2015, NEUROCOMPUTING, V157, P231, DOI 10.1016/j.neucom.2015.01.012; Afshin Tatar, 2016, Natural Gas Industry B, V3, P173, DOI 10.1016/j.ngib.2016.06.002; Alam S, 2017, RENEW SUST ENERG REV, V72, P535, DOI 10.1016/j.rser.2017.01.086; An HZ, 2014, APPL ENERG, V136, P1067, DOI 10.1016/j.apenergy.2014.07.081; Benmouiza K, 2013, ENERG CONVERS MANAGE, V75, P561, DOI 10.1016/j.enconman.2013.07.003; Chen BJ, 2004, IEEE T POWER SYST, V19, P1821, DOI 10.1109/TPWRS.2004.835679; CHEN H, 2017, SUSTAINABILITY-BASEL, V9, DOI DOI 10.3390/SU9040574; Cheng SH, 2016, INFORM SCIENCES, V327, P272, DOI 10.1016/j.ins.2015.08.024; Coogan S, 2016, AUTOMATICA, V66, P246, DOI 10.1016/j.automatica.2015.12.015; Cuaresma JC, 2004, APPL ENERG, V77, P87, DOI 10.1016/S0306-2619(03)00096-5; Dai CY, 2017, SOFT COMPUT, V21, P4197, DOI 10.1007/s00500-016-2030-4; Daut MAM, 2017, RENEW SUST ENERG REV, V70, P1108, DOI 10.1016/j.rser.2016.12.015; De Gooijer JG, 2006, INT J FORECASTING, V22, P443, DOI 10.1016/j.ijforecast.2006.01.001; Feng SM, 2016, PHYSICA A, V441, P85, DOI 10.1016/j.physa.2015.08.030; Ferreira LN, 2016, INFORM SCIENCES, V326, P227, DOI 10.1016/j.ins.2015.07.046; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Hu CY, 2018, EMERG MARK FINANC TR, V54, P1693, DOI 10.1080/1540496X.2017.1412303; Hu JM, 2013, RENEW ENERG, V60, P185, DOI 10.1016/j.renene.2013.05.012; Ibrahim M, 2016, ELECTR POW SYST RES, V136, P262, DOI 10.1016/j.epsr.2016.03.005; Jovani R, 2007, PHYSICA A, V385, P683, DOI 10.1016/j.physa.2007.07.023; Kashyap Y, 2015, RENEW SUST ENERG REV, V49, P825, DOI 10.1016/j.rser.2015.04.077; Khandelwal I, 2015, PROCEDIA COMPUT SCI, V48, P173, DOI 10.1016/j.procs.2015.04.167; Kocadagli O, 2014, EXPERT SYST APPL, V41, P6596, DOI 10.1016/j.eswa.2014.04.035; Kristjanpoller W, 2016, EXPERT SYST APPL, V65, P233, DOI 10.1016/j.eswa.2016.08.045; Li YQ, 2013, COMMUN NONLINEAR SCI, V18, P3226, DOI 10.1016/j.cnsns.2013.04.010; Liu J. P., 2011, J MANAGEMENT SCI, V24, P104; Ma DL, 2017, NUCL ENG DES, V320, P400, DOI 10.1016/j.nucengdes.2017.06.013; Okumus I, 2016, ENERG CONVERS MANAGE, V123, P362, DOI 10.1016/j.enconman.2016.06.053; Pagani GA, 2014, PHYSICA A, V396, P248, DOI 10.1016/j.physa.2013.11.022; Sadaei HJ, 2016, NEUROCOMPUTING, V175, P782, DOI 10.1016/j.neucom.2015.10.079; Shmueli G, 2012, TIME SERIES PREDICTI; Wang MG, 2016, PHYSICA A, V461, P456, DOI 10.1016/j.physa.2016.06.028; [王婷婷 WANG Ting-ting], 2010, [计算机工程与设计, Computer Engineering and Design], V31, P1545; Wen FH, 2018, APPL ECON, V50, P319, DOI 10.1080/00036846.2017.1321838; Wen FH, 2016, ENERG ECON, V59, P400, DOI 10.1016/j.eneco.2016.07.014; Wen FH, 2014, ECON COMPUT ECON CYB, V48, P235; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Yan Y, 2017, PHYSICA A, V477, P149, DOI 10.1016/j.physa.2017.02.040; Zhang Q., 2008, BIFURCATION CHAOS TH; [张雨浓 Zhang Yunong], 2015, [计算机应用研究, Application Research of Computers], V32, P2630; [周长锋 ZHOU Chang-feng], 2009, [中国安全科学学报, China Safety Science Journal], V19, P5; Zhou M, 2017, EMERG MARK FINANC TR, V53, P1973, DOI 10.1080/1540496X.2016.1237353	42	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202209	10.1371/journal.pone.0202209	http://dx.doi.org/10.1371/journal.pone.0202209			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS6HC	30183702	Green Submitted, gold, Green Published			2022-12-26	WOS:000443789900020
J	Ahanger, MA; Alyemeni, MN; Wijaya, L; Alamri, SA; Alam, P; Ashraf, M; Ahmad, P				Ahanger, Mohammad Abass; Alyemeni, Mohammed Nasser; Wijaya, Leonard; Alamri, Saud A.; Alam, Pravej; Ashraf, Muhammad; Ahmad, Parvaiz			Potential of exogenously sourced kinetin in protecting Solanum lycopersicum from NaCl-induced oxidative stress through up-regulation of the antioxidant system, ascorbate-glutathione cycle and glyoxalase system	PLOS ONE			English	Article							2 WHEAT CULTIVARS; SALT-STRESS; SALINITY STRESS; PLANT-GROWTH; PHOTOSYNTHETIC PERFORMANCE; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; GIBBERELLIC-ACID; VIGNA-SINENSIS	The protective role of exogenously applied kinetin (10 mu M KN, a cytokinin) against the adverse effects caused by NaCl-induced (150 mM) stress in Solanum lycopersicum was investigated. Application of KN significantly enhanced growth and biomass production of normally grown plants (non-stressed) and also mitigated the adverse effect of NaCl on stressed plants to a considerable extent. Among the examined parameters, chlorophyll and carotenoid contents, photosynthetic parameters, components of the antioxidant system (both enzymatic and non-enzymatic), osmotica accumulation, and mineral uptake exhibited a significant increase following the application of KN. Furthermore, KN application reduced the generation of reactive free radical hydrogen peroxide, coupled with a significant reduction in lipid peroxidation and an increase in membrane stability. The activities of antioxidant enzymes, and glyoxylase system were found to be promoted in plants exposed to NaCl, and the activities were further promoted by KN application, thereby protecting S. lycopersicum plants against NaCl-induced oxidative damage. Further strengthening of the antioxidant system in KN supplied plants was ascribed to regulation of ascorbate-glutathione cycle, phenols and flavonoids in them. The levels of proline and glycine betaine increased considerably in KN-treated plants, thereby maintaining relative water content. Moreover, exogenous KN application reduced the inhibitory effects of NaCl on K+ and Ca2+ uptake, which resulted in a considerable reduction in tissue Na+/K+ ratio.	[Ahanger, Mohammad Abass] Dept Bot, Govt Postgraduat Coll Rajouri, Rajouri, Jammu & Kashmir, India; [Alyemeni, Mohammed Nasser; Wijaya, Leonard; Alamri, Saud A.; Ashraf, Muhammad; Ahmad, Parvaiz] King Saud Univ, Bot & Microbiol Dept, Coll Sci, Riyadh, Saudi Arabia; [Alam, Pravej] Prince Sattam bin Abdulaziz Univ, Dept Biol, Coll Sci & Humanities, Alkharj, Saudi Arabia; [Ashraf, Muhammad] Univ Karachi, Int Ctr Chem & Biol Sci, Karachi, Pakistan; [Ahmad, Parvaiz] SP Coll, Dept Bot, Srinagar, Jammu & Kashmir, India	King Saud University; Prince Sattam Bin Abdulaziz University; University of Karachi	Ahmad, P (corresponding author), King Saud Univ, Bot & Microbiol Dept, Coll Sci, Riyadh, Saudi Arabia.; Ahmad, P (corresponding author), SP Coll, Dept Bot, Srinagar, Jammu & Kashmir, India.	parvaizbot@yahoo.com	Alamri, Saud/Q-2264-2018; Wijaya, Leonard/AAF-4724-2021; Alyemeni, Mohammed/E-5125-2014; Alam, Pravej/X-7823-2019; Ahmad, Parvaiz/Y-3531-2019; Alam, Pravej/F-3539-2011; ahmad, parvaiz/D-2887-2009; Ashraf, Muhammad/F-6294-2010	Alamri, Saud/0000-0003-2565-1101; Alyemeni, Mohammed/0000-0002-5475-8867; Alam, Pravej/0000-0001-7324-6237; Ahmad, Parvaiz/0000-0003-2734-4180; Alam, Pravej/0000-0001-7324-6237; ahmad, parvaiz/0000-0003-2734-4180; Wijaya, Leonard/0000-0003-0504-5040; Ashraf, Muhammad/0000-0002-8226-7758	Deanship of Scientific Research at King Saud University [RGP-199]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this Research group NO.(RGP-199).	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ahanger M.A., 2014, DROUGHT TOLERANCE RO, VVol. 1, P25, DOI DOI 10.1007/978-1-4614-8591-9_2; Ahanger MA, 2016, PLANT GROWTH DROUGHT, P649; Ahanger MA, 2017, PHYSIOL MOL BIOL PLA, V23, P731, DOI 10.1007/s12298-017-0462-7; Ahanger MA, 2017, PLANT PHYSIOL BIOCH, V115, P449, DOI 10.1016/j.plaphy.2017.04.017; Ahanger MA, 2017, PROTOPLASMA, V254, P1471, DOI 10.1007/s00709-016-1037-0; Ahanger MA, 2015, J PLANT INTERACT, V10, P211, DOI 10.1080/17429145.2015.1056260; Ahmad P, 2011, S AFR J BOT, V77, P36, DOI 10.1016/j.sajb.2010.05.003; Ahmad P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00347; Ahmad P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00868; Ahmad Parvaiz, 2010, Archives of Agronomy and Soil Science, V56, P575, DOI 10.1080/03650340903164231; Al-Hakimi AMA, 2007, PLANT SOIL ENVIRON, V53, P129, DOI 10.17221/2228-PSE; Aldesuquy H., 2014, EGYPT J BASIC APPL S, V1, P77, DOI [DOI 10.1016/J.EJBAS.2014.03.002, 10.1016/j.ejbas.2014.03.002]; Aldesuquy H., 2015, EGYPT J BASIC APPL S, V2, P310, DOI [10.1016/j.ejbas.2015.07.002, DOI 10.1016/J.EJBAS.2015.07.002]; Aremu AO, 2015, PLANT BIOLOGY, V17, P1146, DOI 10.1111/plb.12367; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Bako S. P., 2006, Asian Journal of Plant Sciences, V5, P357; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Behera RK, 2002, J PLANT PHYSIOL, V159, P967, DOI 10.1078/0176-1617-00823; Bhattacharya A, 2010, MOL PLANT PATHOL, V11, P705, DOI [10.1111/J.1364-3703.2010.00625.X, 10.1111/j.1364-3703.2010.00625.x]; Brault M, 1999, PLANT PHYSIOL BIOCH, V37, P403, DOI 10.1016/S0981-9428(99)80046-1; CHEN C T, 1991, Journal of Plant Growth Regulation, V10, P201, DOI 10.1007/BF02279335; Chun OK, 2003, J AGR FOOD CHEM, V51, P8067, DOI 10.1021/jf034740d; Cortleven A, 2016, PLANT PHYSIOL, V172, P464, DOI 10.1104/pp.16.00640; Cortleven A, 2014, PLANT PHYSIOL, V164, P1470, DOI 10.1104/pp.113.224667; Das C, 2002, ACTA PHYSIOL PLANT, V24, P53, DOI 10.1007/s11738-002-0021-9; Davenport RJ, 1997, PHYSIOL PLANTARUM, V99, P323, DOI 10.1034/j.1399-3054.1997.990216.x; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; DHINDSA RS, 1981, J EXP BOT, V32, P79, DOI 10.1093/jxb/32.1.79; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; Ehlert C, 2009, PLANT PHYSIOL, V150, P1093, DOI 10.1104/pp.108.131458; El-Shihaby OA, 2002, PLANT BIOSYST, V136, P277, DOI 10.1080/11263500212331351189; El-Tayeb MA, 2005, PLANT GROWTH REGUL, V45, P215, DOI 10.1007/s10725-005-4928-1; Fatma M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00521; FOSTER JG, 1980, PLANT PHYSIOL, V66, P482, DOI 10.1104/pp.66.3.482; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Gadallah MAA, 1999, PLANT GROWTH REGUL, V29, P151, DOI 10.1023/A:1006245628188; Gangwar S, 2010, SCI HORTIC-AMSTERDAM, V126, P467, DOI 10.1016/j.scienta.2010.08.013; Garg N, 2009, J AGRON CROP SCI, V195, P110, DOI 10.1111/j.1439-037X.2008.00349.x; Gerszberg A, 2015, PLANT CELL TISS ORG, V120, P881, DOI 10.1007/s11240-014-0664-4; GRIEVE CM, 1983, PLANT SOIL, V70, P303, DOI 10.1007/BF02374789; Gupta BK, 2018, PLANT CELL ENVIRON, V41, P1186, DOI 10.1111/pce.12968; Hamayun M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00377; Harinasut P., 2000, SCIENCEASIA, V26, P207, DOI DOI 10.2306/SCIENCEASIA1513-1874.2000.26.207; Hasanuzzaman M, 2013, ECOTOXICOLOGY, V22, P584, DOI 10.1007/s10646-013-1050-4; Huang CH, 2005, J EXP BOT, V56, P3041, DOI 10.1093/jxb/eri301; Iqbal M, 2005, J INTEGR PLANT BIOL, V47, P1315, DOI 10.1111/j.1744-7909.2005.00163.x; Iqbal N, 2015, J PLANT PHYSIOL, V178, P84, DOI 10.1016/j.jplph.2015.02.006; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kaya C, 2010, TURK J AGRIC FOR, V34, P529, DOI 10.3906/tar-0906-173; Khan MIR, 2015, J PLANT PHYSIOL, V173, P9, DOI 10.1016/j.jplph.2014.09.011; Khan MIR, 2014, PLANT PHYSIOL BIOCH, V80, P67, DOI 10.1016/j.plaphy.2014.03.026; Klein A, 2015, S AFR J BOT, V96, P13, DOI 10.1016/j.sajb.2014.10.016; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; Kohler J, 2009, ENVIRON EXP BOT, V65, P245, DOI 10.1016/j.envexpbot.2008.09.008; KUIPER D, 1990, PLANT SOIL, V123, P243, DOI 10.1007/BF00011276; LETHAM DS, 1983, ANNU REV PLANT PHYS, V34, P163, DOI 10.1146/annurev.pp.34.060183.001115; Li PM, 2007, PHYSIOL PLANTARUM, V129, P822, DOI 10.1111/j.1399-3054.2007.00880.x; Li ZG, 2016, BOT REV, V82, P183, DOI 10.1007/s12229-016-9167-9; Liu JP, 1998, SCIENCE, V280, P1943, DOI 10.1126/science.280.5371.1943; Mittal S, 2012, PLANT PHYSIOL BIOCH, V54, P17, DOI 10.1016/j.plaphy.2012.02.003; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MIYAKE C, 1992, PLANT CELL PHYSIOL, V33, P541; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; MURATA N, 1992, FEBS LETT, V296, P187, DOI 10.1016/0014-5793(92)80376-R; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Oteiza Patricia I, 2005, Clin Dev Immunol, V12, P19, DOI 10.1080/10446670410001722168; Paradiso A, 2008, PLANT CELL PHYSIOL, V49, P362, DOI 10.1093/pcp/pcn013; Rahman A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00609; Rao KVM, 2000, PLANT SCI, V157, P113, DOI 10.1016/S0168-9452(00)00273-9; Rasool S, 2013, ACTA PHYSIOL PLANT, V35, P1039, DOI 10.1007/s11738-012-1142-4; Roach T, 2014, CURR PROTEIN PEPT SC, V15, P351, DOI 10.2174/1389203715666140327105143; Sayed SA, 1999, PLANT GROWTH REGUL, V29, P167, DOI 10.1023/A:1006216630915; Shabala S, 2009, PLANT CELL ENVIRON, V32, P194, DOI 10.1111/j.1365-3040.2008.01914.x; Siddiqui MW, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-014-1728-0; Singh S, 2014, SCI HORTIC-AMSTERDAM, V176, P1, DOI 10.1016/j.scienta.2014.06.022; SMART RE, 1974, PLANT PHYSIOL, V53, P258, DOI 10.1104/pp.53.2.258; Thakur M, 2005, J ARID ENVIRON, V62, P517, DOI 10.1016/j.jaridenv.2005.01.005; Tikkanen M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00521; Tuna AL, 2008, ENVIRON EXP BOT, V62, P1, DOI 10.1016/j.envexpbot.2007.06.007; Velikova V, 2000, PLANT SCI, V151, P59, DOI 10.1016/S0168-9452(99)00197-1; Wang ZL, 2003, J AM SOC HORTIC SCI, V128, P648, DOI 10.21273/JASHS.128.5.0648; Wu QS, 2010, PLANT SOIL ENVIRON, V56, P470, DOI 10.17221/54/2010-PSE; Wu XX, 2012, ACTA PHYSIOL PLANT, V34, P2105, DOI 10.1007/s11738-012-1010-2; Yadav SK, 2005, BIOCHEM BIOPH RES CO, V337, P61, DOI 10.1016/j.bbrc.2005.08.263; Yadav Sudesh Kumar, 2005, Physiology and Molecular Biology of Plants, V11, P1; Yaronskaya E, 2006, PLANTA, V224, P700, DOI 10.1007/s00425-006-0249-5; Younis ME, 2003, AGRONOMIE, V23, P277, DOI 10.1051/agro:2003010; Yu CW, 2003, FUNCT PLANT BIOL, V30, P955, DOI 10.1071/FP03091; Zwack PJ, 2015, J EXP BOT, V66, P4863, DOI 10.1093/jxb/erv172	92	122	124	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0202175	10.1371/journal.pone.0202175	http://dx.doi.org/10.1371/journal.pone.0202175			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180173	Green Published, Green Submitted, gold			2022-12-26	WOS:000444222400006
J	Chandy, M; Ishida, M; Shikatani, EA; El-Mounayri, O; Park, LC; Afroze, T; Wang, T; Marsden, PA; Husain, M				Chandy, Mark; Ishida, Masayoshi; Shikatani, Eric A.; El-Mounayri, Omar; Park, Lawrence Changsu; Afroze, Talat; Wang, Tao; Marsden, Philip A.; Husain, Mansoor			c-Myb regulates transcriptional activation of miR-143/145 in vascular smooth muscle cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DNA-BINDING DOMAIN; IN-VITRO; DIFFERENTIATION; MOUSE; MICRORNA-145; EXPRESSION; ATHEROSCLEROSIS; IDENTIFICATION; PROLIFERATION	Background MicroRNAs (miR) are small non-coding RNAs that regulate diverse biological functions. The bicistronic gene miR-143/145 determines cell fate and phenotype of vascular smooth muscle cells (VSMC), in part, by destabilizing Elk-1 mRNA. The transcription factor c-Myb also regulates differentiation and proliferation of VSMC, and here we test whether these effects may be mediated by miR-143/145. Methods & results Flow cytometry of cardiovascular-directed d3.75 embryoid bodies (EBs) isolated smooth muscle progenitors with specific cell surface markers. In c-myb knockout (c-myb(-/-))EB, these progenitors manifest low levels of miR-143 (19%; p<0.05) and miR-145 (6%; p<0.01) expression as compared to wild-type (wt) EB. Primary VSMC isolated from transgenic mice with diminished expression (c-myb(lx/lx)) or reduced activity (c-myb(h/h)) of c-Myb also manifest low levels of m i R-143 (c-myb(lx/lx): 50%; c-myb(h/h): 41%), and miR-145 (c-myb(lx/lx): 49%; c-myb(h/h): 56%), as compared to wt (P<0.05). Sequence alignment identified four putative c-Myb binding sites (MBS1-4) in the proximal promoter (PP) of the miR-143/145 gene. PP-reporter constructs revealed that point mutations in MBS1 and MBS4 abrogated c-Myb-dependent transcription from the miR-143/145 PP (P<0.01). Chromatin immunoprecipitation (ChIP) revealed preferential c-Myb binding at MBS4 (p<0.001). By conjugating Elk-13'-untranslated region (UTR) to a reporter and co-transducing wt VSMC with this plus a miR-143-antagomir, and co-transducing c-myb(lx/lx) VSMC with this plus a miR-143-mimic, we demonstrate that c-Myb's ability to repress Elk-1 is mediated by miR-143. Conclusion c-Myb regulates VSMC gene expression by transcriptional activation of miR-143/145.	[Chandy, Mark; Shikatani, Eric A.; El-Mounayri, Omar; Afroze, Talat; Wang, Tao; Husain, Mansoor] Univ Hlth Network, Ted Rogers Ctr Heart Res, Toronto, ON, Canada; [Chandy, Mark; Shikatani, Eric A.; El-Mounayri, Omar; Afroze, Talat; Wang, Tao; Husain, Mansoor] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada; [Chandy, Mark; Marsden, Philip A.; Husain, Mansoor] Univ Toronto, Dept Med, Toronto, ON, Canada; [Ishida, Masayoshi] Kindai Univ, Dept Physiol & Regenerat Med, Fac Med, Osaka, Japan; [Park, Lawrence Changsu; Marsden, Philip A.] St Michaels Hosp, Li Ka Shing Knowledge Translat Inst, Toronto, ON, Canada; [Wang, Tao; Husain, Mansoor] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Kindai University (Kinki University); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Husain, M (corresponding author), Univ Hlth Network, Ted Rogers Ctr Heart Res, Toronto, ON, Canada.; Husain, M (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada.; Husain, M (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Husain, M (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	mansoor.husain@utoronto.ca	Chandy, Mark Joseph Koonthanam/GLT-9682-2022; Wang, Tao/C-7214-2018	Chandy, Mark Joseph Koonthanam/0000-0002-6741-2822; Husain, Mansoor/0000-0002-3740-6739; Wang, Tao/0000-0002-6348-2794; Ishida, Masayoshi/0000-0003-2807-651X	CIHR [MOP-14648]; Clinician Scientist Training Program; University of Toronto Clinician Investigator Program; Ontario Research Fund [19442, 30961]; 3D (Diet, Digestive Tract and Disease) Centre - Canadian Foundation for Innovation	CIHR(Canadian Institutes of Health Research (CIHR)); Clinician Scientist Training Program; University of Toronto Clinician Investigator Program; Ontario Research Fund; 3D (Diet, Digestive Tract and Disease) Centre - Canadian Foundation for Innovation	This study was funded by a CIHR Grant # MOP-14648 to Mansoor Husain. M.C was supported by the Clinician Scientist Training Program and University of Toronto Clinician Investigator Program. Some of the equipment used in this study was supported by The 3D (Diet, Digestive Tract and Disease) Centre funded by the Canadian Foundation for Innovation and Ontario Research Fund, project number 19442 and 30961. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; M.C was supported by the Clinician Scientist Training Program and University of Toronto Clinician Investigator Program. Some of the equipment used in this study was supported by The 3D (Diet, Digestive Tract and Disease) Centre funded by the Canadian Foundation for Innovation and Ontario Research Fund, project number 19442 and 30961.	Afroze T, 2003, AM J PHYSIOL-CELL PH, V285, pC88, DOI 10.1152/ajpcell.00518.2002; Battistella M, 2015, CLIN PHARMACOL THER, V97, P79, DOI 10.1002/cpt.8; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Handa S, 2008, ATHEROSCLEROSIS, V196, P617, DOI 10.1016/j.atherosclerosis.2007.06.032; Hartmann P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10521; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; Hultgardh-Nilsson A, 2007, CURR OPIN LIPIDOL, V18, P540, DOI 10.1097/MOL.0b013e3282ef77e9; Ishida M, 2012, CIRC RES, V110, P253, DOI 10.1161/CIRCRESAHA.111.259499; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Kolodziejska KM, 2008, CIRC RES, V102, P554, DOI 10.1161/CIRCRESAHA.105.162628; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Liu GC, 2012, DIABETOLOGIA, V55, P2522, DOI 10.1007/s00125-012-2586-1; Long XC, 2011, J BIOL CHEM, V286, P30119, DOI 10.1074/jbc.M111.258814; Lovren F, 2012, CIRCULATION, V126, pS81, DOI 10.1161/CIRCULATIONAHA.111.084186; Naito H, 2012, EMBO J, V31, P842, DOI 10.1038/emboj.2011.465; NOMURA T, 1993, J BIOL CHEM, V268, P21914; RAO VN, 1989, SCIENCE, V244, P66, DOI 10.1126/science.2539641; Regan CP, 2000, J CLIN INVEST, V106, P1139, DOI 10.1172/JCI10522; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; Shikatani EA, 2016, ARTERIOSCL THROM VAS, V36, P1367, DOI 10.1161/ATVBAHA.115.307116; SIMONS M, 1992, CIRC RES, V70, P835, DOI 10.1161/01.RES.70.4.835; SIMONS M, 1992, NATURE, V359, P67, DOI 10.1038/359067a0; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Verbeek W, 1999, BLOOD, V93, P3327, DOI 10.1182/blood.V93.10.3327; Wang WJ, 2015, FEBS LETT, V589, P555, DOI 10.1016/j.febslet.2015.01.012; Winn LM, 2003, CELL CYCLE, V2, P258, DOI 10.4161/cc.2.3.383; Xie CQ, 2011, STEM CELLS DEV, V20, P205, DOI 10.1089/scd.2010.0283; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yamaguchi S, 2011, ATHEROSCLEROSIS, V219, P468, DOI 10.1016/j.atherosclerosis.2011.09.004; You XM, 2003, CIRC RES, V92, P314, DOI 10.1161/01.RES.0000056758.73215.5A; Zippo A, 2004, BLOOD, V103, P4536, DOI 10.1182/blood-2003-11-3827	39	8	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0202778	10.1371/journal.pone.0202778	http://dx.doi.org/10.1371/journal.pone.0202778			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169548	gold, Green Published, Green Submitted			2022-12-26	WOS:000443374400013
J	Damgaard, D; Bawadekar, M; Senolt, L; Stensballe, A; Shelef, MA; Nielsen, CH				Damgaard, Dres; Bawadekar, Mandar; Senolt, Ladislav; Stensballe, Allan; Shelef, Miriam A.; Nielsen, Claus H.			Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3	PLOS ONE			English	Article							EARLY RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID; PROTEIN/PEPTIDE ANTIBODIES; DISEASE-ACTIVITY; ASSOCIATION; PEPTIDES; CCP; NEUTROPHILS; EPITOPES; AUTOANTIBODIES	Objective Peptidylarginine deiminase 2 (PAD2) and PAD4 are expressed in the synovium of rheumatoid arthritis (RA) patients and catalyze citrullination of arginine residues in proteins targeted by anti-citrullinated protein antibodies (ACPAs). Little is known about the relative importance of PAD2 and PAD4 in generating citrullinated self-antigens. Here we investigate the ability of PAD2 and PAD4 to generate citrullinated targets for ACPAs in four human proteins. Methods Synovial fluid (SF) and plasma were collected from 42 RA patients. Human fibrinogen, human alpha-enolase (ENO1), human histone H3, and human serum albumin (HSA) were citrullinated in vitro by PAD2 or PAD4. The total degree of citrullination was determined using the anti-modified citrulline approach. Antibody binding to native and citrullinated proteins was measured by ELISA. Results ACPAs within pooled SF from multiple RA patients reacted equally well with, and cross-reacted with, PAD2- and PAD4-citrullinated fibrinogen. ACPAs from most individual patient SF and plasma samples bound equally well to PAD2- and PAD4-citrullinated fibrinogen or ENO1. When histone H3 was used as target, PAD4 was generally superior in generating epitopes recognized by ACPAs. No binding to citrullinated HSA was observed. Conclusion In most patients, PAD2 and PAD4 are equally efficient in generating citrullinated target sites for ACPAs in fibrinogen and ENO1. The binding of autoantibodies to histone H3 was generally higher after citrullination with PAD4 than with PAD2. Citrullinated HSA is not a target for ACPAs.	[Damgaard, Dres; Nielsen, Claus H.] Copenhagen Univ Hosp, Rigshosp, Ctr Rheumatol & Spine Dis, Inst Inflammat Res, Copenhagen, Denmark; [Damgaard, Dres; Nielsen, Claus H.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Odontol, Sect Periodontol Microbiol & Community Dent, Copenhagen, Denmark; [Bawadekar, Mandar; Shelef, Miriam A.] Univ Wisconsin, Dept Med, Madison, WI USA; [Senolt, Ladislav] Charles Univ Prague, Fac Med 1, Inst Rheumatol, Prague, Czech Republic; [Senolt, Ladislav] Charles Univ Prague, Fac Med 1, Dept Rheumatol, Prague, Czech Republic; [Stensballe, Allan] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Shelef, Miriam A.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Wisconsin System; University of Wisconsin Madison; Charles University Prague; Institute of Rheumatology; Charles University Prague; Aalborg University; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Damgaard, D (corresponding author), Copenhagen Univ Hosp, Rigshosp, Ctr Rheumatol & Spine Dis, Inst Inflammat Res, Copenhagen, Denmark.; Damgaard, D (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Odontol, Sect Periodontol Microbiol & Community Dent, Copenhagen, Denmark.	dres.damgaard@regionh.dk	Stensballe, Allan/K-6756-2019	Stensballe, Allan/0000-0002-9888-1955; Nielsen, Claus Henrik/0000-0001-7543-9016	project of the MHCR [023728]; National Institute of Health (NIH) [K08 AR065500]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR065500] Funding Source: NIH RePORTER	project of the MHCR; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	LS was supported by a project of the MHCR for conceptual research development No. 023728. This work was also supported by the National Institute of Health (NIH) K08 AR065500 to MAS.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Asaga H, 2001, J LEUKOCYTE BIOL, V70, P46; Assohou-Luty C, 2014, BBA-PROTEINS PROTEOM, V1844, P829, DOI 10.1016/j.bbapap.2014.02.019; Bawadekar M, 2017, J AUTOIMMUN, V80, P39, DOI 10.1016/j.jaut.2017.01.006; Blachere NE, 2017, ARTHRITIS RHEUMATOL, V69, P986, DOI 10.1002/art.40035; Burkhardt H, 2005, EUR J IMMUNOL, V35, P1643, DOI 10.1002/eji.200526000; Damgaard D, 2017, J ENZYM INHIB MED CH, V32, P1203, DOI 10.1080/14756366.2017.1368505; Damgaard D, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1000-7; Damgaard D, 2016, RHEUMATOLOGY, V55, P918, DOI 10.1093/rheumatology/kev440; Damgaard D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0498-9; Del Val Del Amno N, 2006, CLIN EXP RHEUMATOL, V24, P281; Feitsma AL, 2010, ARTHRITIS RHEUM-US, V62, P117, DOI 10.1002/art.25059; Fernandes-Cerqueira C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0666-6; Forslind K, 2004, ANN RHEUM DIS, V63, P1090, DOI 10.1136/ard.2003.014233; Foulquier C, 2007, ARTHRITIS RHEUM-US, V56, P3541, DOI 10.1002/art.22983; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Ioan-Facsinay A, 2011, ANN RHEUM DIS, V70, P188, DOI 10.1136/ard.2010.131102; Kastbom A, 2004, ANN RHEUM DIS, V63, P1085, DOI 10.1136/ard.2003.016808; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Kinloch A, 2008, ARTHRITIS RHEUM, V58, P2287, DOI 10.1002/art.23618; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Konig MF, 2016, ANN RHEUM DIS, V75, P2022, DOI 10.1136/annrheumdis-2015-208529; Lee DM, 2003, ANN RHEUM DIS, V62, P870, DOI 10.1136/ard.62.9.870; Lundberg K, 2008, ARTHRITIS RHEUM-US, V58, P3009, DOI 10.1002/art.23936; Makrygiannakis D, 2006, ANN RHEUM DIS, V65, P1219, DOI 10.1136/ard.2005.049403; Makrygiannakis D, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3702; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; Meng XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165501; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Nakayama-Hamada M, 2005, BIOCHEM BIOPH RES CO, V327, P192, DOI 10.1016/j.bbrc.2004.11.152; Ronnelid J, 2005, ANN RHEUM DIS, V64, P1744, DOI 10.1136/ard.2004.033571; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Sebbag M, 2006, EUR J IMMUNOL, V36, P2250, DOI 10.1002/eji.200535790; Snir O, 2009, ANN RHEUM DIS, V68, P736, DOI 10.1136/ard.2008.091355; Sokolove J, 2011, ARTHRITIS RHEUM-US, V63, P53, DOI 10.1002/art.30081; Spengler J, 2015, ARTHRITIS RHEUMATOL, V67, P3135, DOI 10.1002/art.39313; Takizawa Y, 2006, ANN RHEUM DIS, V65, P1013, DOI 10.1136/ard.2005.044743; Tutturen AEV, 2014, J PROTEOME RES, V13, P2867, DOI 10.1021/pr500030x; van Beers JJBC, 2013, ARTHRITIS RHEUM-US, V65, P69, DOI 10.1002/art.37720; van Beers JJBC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3205; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; Wang F, 2016, CLIN RHEUMATOL; Zhou YB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01200	45	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203214	10.1371/journal.pone.0203214	http://dx.doi.org/10.1371/journal.pone.0203214			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161253	Green Published, gold, Green Submitted			2022-12-26	WOS:000443388900091
J	Reichhardt, C; Cegelski, L				Reichhardt, Courtney; Cegelski, Lynette			The Congo red derivative FSB binds to curli amyloid fibers and specifically stains curliated E. coli	PLOS ONE			English	Article							ESCHERICHIA-COLI; EXTRACELLULAR-MATRIX; BIOFILMS; CELLS; PURIFICATION; ARCHITECTURE; INFECTIONS; ATTACHMENT; SECRETION; CELLULOSE	The Congo red derivative (E,E)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy) styrylbenzene (FSB) specifically stains the functional amyloid curli in Escherichia coli biofilms. FSB binds to curli with similar affinity as Congo red, yet exhibits much greater fluorescence upon binding to curli as compared to Congo red and does not exhibit undesired binding to the cellulosic component of the biofilm. Thus, FSB presents a powerful tool to identify and visualize curli in E. coli biofilms and also enables new biophysical investigations of curli.	[Reichhardt, Courtney; Cegelski, Lynette] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Reichhardt, Courtney] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Stanford University; University of Washington; University of Washington Seattle	Reichhardt, C; Cegelski, L (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Reichhardt, C (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	crreich@uw.edu; cegelski@stanford.edu		Reichhardt, Courtney/0000-0002-1022-5110	National Science Foundation Division of Molecular and Cellular Biosciences CAREER Award [1453247]; Althouse Family Stanford Graduate Fellowship	National Science Foundation Division of Molecular and Cellular Biosciences CAREER Award; Althouse Family Stanford Graduate Fellowship	LC acknowledges support from the National Science Foundation Division of Molecular and Cellular Biosciences CAREER Award 1453247. CR acknowledges support from the Althouse Family Stanford Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alteri CJ, 2007, P NATL ACAD SCI USA, V104, P5145, DOI 10.1073/pnas.0602304104; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Gophna U, 2001, INFECT IMMUN, V69, P2659, DOI 10.1128/IAI.69.4.2659-2665.2001; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Higuchi M, 2005, NAT NEUROSCI, V8, P527, DOI 10.1038/nn1422; Inouye H, 2000, AMYLOID, V7, P179, DOI 10.3109/13506120009146832; Kikuchi T, 2005, MICROBIOL IMMUNOL, V49, P875, DOI 10.1111/j.1348-0421.2005.tb03678.x; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; Kudinha T, 2013, PEDIATR INFECT DIS J, V32, P543, DOI 10.1097/INF.0b013e31828ba3f1; Larsen P, 2008, APPL ENVIRON MICROB, V74, P1517, DOI 10.1128/AEM.02274-07; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; Lim JY, 2014, BIOCHEM BIOPH RES CO, V443, P345, DOI 10.1016/j.bbrc.2013.11.026; McCrate OA, 2013, J MOL BIOL, V425, P4286, DOI 10.1016/j.jmb.2013.06.022; McCrate OA, 2013, CHEM COMMUN, V49, P4193, DOI 10.1039/c2cc37792f; Nenninger AA, 2011, MOL MICROBIOL, V81, P486, DOI 10.1111/j.1365-2958.2011.07706.x; Pawar DM, 2005, J APPL MICROBIOL, V99, P418, DOI 10.1111/j.1365-2672.2005.02499.x; Prade E, 2014, NEW DEV NMR, V3, P533; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Reichhardt C, 2016, ANAL BIOANAL CHEM, V408, P7709, DOI 10.1007/s00216-016-9868-2; Reichhardt C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140388; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Ryu JH, 2004, LETT APPL MICROBIOL, V39, P359, DOI 10.1111/j.1472-765X.2004.01591.x; Sato K, 2004, EUR J MED CHEM, V39, P573, DOI 10.1016/j.ejmech.2004.02.013; Schutz AK, 2011, ANGEW CHEM INT EDIT, V50, P5956, DOI 10.1002/anie.201008276; Serra DO, 2014, ENVIRON MICROBIOL, V16, P1455, DOI 10.1111/1462-2920.12483; Serra DO, 2013, MBIO, V4, DOI 10.1128/mBio.00103-13; Thongsomboon W, 2018, SCIENCE, V359, P334, DOI 10.1126/science.aao4096; Westermark GT, 1999, METHOD ENZYMOL, V309, P3	34	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203226	10.1371/journal.pone.0203226	http://dx.doi.org/10.1371/journal.pone.0203226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161215	Green Submitted, gold, Green Published			2022-12-26	WOS:000443388900094
J	Roper, L; Tran, DT; Einarsdottir, K; Preen, DB; Havard, A				Roper, Lucinda; Duong Thuy Tran; Einarsdottir, Kristjana; Preen, David B.; Havard, Alys			Algorithm for resolving discrepancies between claims for smoking cessation pharmacotherapies during pregnancy and smoking status in delivery records: The impact on estimates of utilisation	PLOS ONE			English	Article							NICOTINE REPLACEMENT THERAPY; BIRTH CERTIFICATES; PRIMARY-CARE; WOMEN; QUESTIONNAIRES; VARENICLINE; PREVALENCE; ADHERENCE; ACCURACY; EXPOSURE	Background The linkage of routine data collections are valuable for population-based evaluation of smoking cessation pharmacotherapy in pregnancy where little is known about the utilisation or safety of these pharmacotherapies antenatally. The use of routine data collections to study smoking cessation pharmacotherapy is limited by disparities among data sources. This study developed an algorithm to resolve disparity between the evidence of pharmacotherapy utilisation for smoking cessation and the recording of smoking in pregnancy, examined its face validity and assessed the implications on estimates of smoking cessation pharmacotherapy utilisation. Methods Perinatal records (n = 1,098,203) of women who gave birth in the Australian States of Western Australia and New South Wales (2004-2012) were linked to hospital admissions and pharmaceutical dispensing data. An algorithm, based on dispensing information about the type of smoking therapy, timing and quantity of supply reclassified certain groups of women as smoking during pregnancy. Face validity of the algorithm was tested by examining the distribution of factors associated with inaccurate recording of smoking status among women that the algorithm classified as misreporting smoking in pregnancy. Rate of utilisation among smokers, according to original and reclassified smoking status, was measured, to demonstrate the utility of the algorithm. Results Smoking cessation pharmacotherapy were dispensed to 2184 women during pregnancy, of those 1013 women were originally recorded as non-smoking as per perinatal and hospital data. Application of the algorithm reclassified 730 women as smoking during pregnancy. The algorithm satisfied the test of face validity-the expected demographic factors of marriage, private hospital delivery and higher socioeconomic status, were more common in women whom the algorithm identified as misreporting their smoking status. Application of the algorithm resulted in smoking cessation pharmacotherapy utilisation estimates ranging from 2.3-3.6% of all pregnancies. Conclusion Researchers can use the algorithm presented herein to improve the identification of smoking among women who use cessation pharmacotherapies during pregnancy. Improved identification can improve the validity of safety analyses of smoking cessation pharmacotherapy-providing clinicians with valuable evidence to use when counselling women on the role of pharmacotherapy for smoking cessation during pregnancy.	[Roper, Lucinda; Duong Thuy Tran; Havard, Alys] UNSW, CBDRH, Sydney, NSW, Australia; [Einarsdottir, Kristjana] Univ Iceland, Ctr Publ Hlth Sci, Sch Hlth Sci, Reykjavik, Iceland; [Einarsdottir, Kristjana] Univ Iceland, Unit Nutr Res, Sch Hlth Sci, Reykjavik, Iceland; [Preen, David B.] Univ Western Australia, Ctr Hlth Serv Res, Perth, WA, Australia	University of New South Wales Sydney; University of Iceland; University of Iceland; University of Western Australia	Roper, L (corresponding author), UNSW, CBDRH, Sydney, NSW, Australia.	roper.lucinda@gmail.com	; Einarsdottir, Kristjana/E-8337-2011; Preen, David/H-5663-2014	Havard, Alys/0000-0001-6563-8804; Tran, Duong Thuy/0000-0002-1454-9462; Einarsdottir, Kristjana/0000-0003-4931-7650; Preen, David/0000-0002-2982-2169; Roper, Lucinda/0000-0002-8756-5295	Australian National Health and Medical Research Council [1028543]; National Heart Foundation Future Leader Fellowship [100411]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation Future Leader Fellowship(National Heart Foundation of Australia)	The Smoking MUMS study is supported by an Australian National Health and Medical Research Council Project Grant (#1028543), and AH is supported by a National Heart Foundation Future Leader Fellowship (#100411). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AM, 2008, PUBLIC HEALTH REP, V123, P586, DOI 10.1177/003335490812300508; Ampt Amanda J, 2013, N S W Public Health Bull, V24, P65, DOI 10.1071/NB12116; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Australian Bureau of Statistics, 2011, CENS POP HOUS SOC IN; Berard A, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.06.059; Bruin JE, 2010, TOXICOL SCI, V116, P364, DOI 10.1093/toxsci/kfq103; Carrozzi Laura, 2008, Ther Adv Respir Dis, V2, P301, DOI 10.1177/1753465808096136; Catz SL, 2011, NICOTINE TOB RES, V13, P361, DOI 10.1093/ntr/ntr003; CHeReL, 2009, QUAL ASS REC LINK; Chun-Fai-Chan B, 2005, AM J OBSTET GYNECOL, V192, P932, DOI 10.1016/j.ajog.2004.09.027; Claydon K, 2014, NATL DRUG STRATEGY H; Coleman T, 2012, PHARM INTERVENTIONS; Coleman T, 2011, ADDICTION, V106, P52, DOI 10.1111/j.1360-0443.2010.03179.x; Dhalwani NN, 2014, BRIT J GEN PRACT, V64, pE554, DOI 10.3399/bjgp14X681361; Dietz PM, 1998, AM J EPIDEMIOL, V148, P1048; Downey F, 2007, VALIDATION STUDY W A, DOI [10.1071/NB12116, DOI 10.1071/NB12116]; Tran DT, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0385-6; Tran DT, 2014, AUST NZ J PUBL HEAL, V38, P258, DOI 10.1111/1753-6405.12213; Eitelhuber T, 2016, DATA LINKAGE MAKING; Eldridge D, 2015, AUSTR MOTHERS BABIES; England LJ, 2007, NICOTINE TOB RES, V9, P1005, DOI 10.1080/14622200701491255; Gaither KH, 2009, MATERN CHILD HLTH J, V13, P497, DOI 10.1007/s10995-008-0361-1; Harrison-Woolrych M, 2013, PHARMACOEPIDEM DR S, V22, P1086, DOI 10.1002/pds.3489; Havard A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003692; Hays L, 2010, NICOTINE TOBACCO RES; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Irvine L, 2010, DRUG SAFETY, V33, P593, DOI 10.2165/11532330-000000000-00000; Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x; Land TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034853; Lassen TH, 2010, PAEDIATR PERINAT EP, V24, P272, DOI 10.1111/j.1365-3016.2010.01104.x; Lumley J, 2009, INTERVENTIONS PROMOT; MedicineWise N, 2011, NIC PATCH NIC P NIC; Morales-Suarez-Varela MM, 2006, OBSTET GYNECOL, V107, P51, DOI 10.1097/01.AOG.0000194079.66834.d5; NCCH, INT STAT CLASS DIS R; Pollak KI, 2007, AM J PREV MED, V33, P297, DOI 10.1016/j.amepre.2007.05.006; Pollak KI, 2006, NICOTINE TOB RES, V8, P547, DOI 10.1080/14622200600789882; Price JH, 2006, J COMMUN HEALTH, V31, P160, DOI 10.1007/s10900-005-9009-x; Rao J, 2009, Kathmandu Univ Med J (KUMJ), V7, P162; Richardson JL, 2017, REPROD TOXICOL, V67, P26, DOI [10.1016/j.reProtox.2016.11.010, 10.1016/j.reprotox.2016.11.010]; Rigotti NA, 2008, OBSTET GYNECOL, V111, P348, DOI 10.1097/01.AOG.0000297305.54455.2e; Russell TV, 2004, NICOTINE TOB RES, V6, pS141, DOI 10.1080/14622200410001669141; Schneider S, 2010, DRUG ALCOHOL REV, V29, P81, DOI 10.1111/j.1465-3362.2009.00098.x; Shipton D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4347; Spencer K, 2013, PRENATAL DIAG, V33, P245, DOI 10.1002/pd.4053; Strandberg-Larsen K, 2008, BJOG-INT J OBSTET GY, V115, P1405, DOI 10.1111/j.1471-0528.2008.01867.x; Taylor L., 2000, NEW S WALES PUBLIC H, V11, P97, DOI [DOI 10.1071/NB00S11, 10.1071/NB00045, DOI 10.1071/NB00045]; Tong VT, 2015, ACTA OBSTET GYN SCAN, V94, P106, DOI 10.1111/aogs.12532; Tong VT, 2008, AM J PREV MED, V35, P327, DOI 10.1016/j.amepre.2008.06.033; van Gool K., 2015, MEDICARE AUSTR DATA; Vaz L, 2016, NICOTINE TOB RES; Vinikoor LC, 2010, PAEDIATR PERINAT EP, V24, P102, DOI 10.1111/j.1365-3016.2009.01087.x; West R, 2000, THORAX, V55, P987, DOI 10.1136/thorax.55.12.987; WHO Collaborating Centre for Drug Statistics Methodology, GUID ATC CLASS DDD A; Zhu AZX, 2012, CLIN PHARMACOL THER, V92, P771, DOI 10.1038/clpt.2012.186; Zwar NA, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7535	55	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202999	10.1371/journal.pone.0202999	http://dx.doi.org/10.1371/journal.pone.0202999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161203	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900063
J	Stafuzza, NB; Silva, RMD; Peripolli, E; Bezerra, LAF; Lobo, RB; Magnabosco, CD; Di Croce, FA; Osterstock, JB; Munari, DP; Lourenco, DAL; Baldi, F				Stafuzza, Nedenia Bonvino; de Oliveira Silva, Rafael Medeiros; Peripolli, Elisa; Framartino Bezerra, Luiz Antonio; Lobo, Raysildo Barbosa; Magnabosco, Claudio de Ulhoa; Di Croce, Fernando A.; Osterstock, Jason B.; Munari, Danisio Prado; Lino Lourenco, Daniela A.; Baldi, Fernando			Genome-wide association study provides insights into genes related with horn development in Nelore beef cattle	PLOS ONE			English	Article							EXCHANGE FACTOR TIAM1; BONE HOMEOSTASIS; HOLSTEIN CATTLE; DAIRY-CATTLE; SCURS LOCUS; INHERITANCE; STRATIFICATION; HOMOZYGOSITY; INTERFERON; POLLEDNESS	The causal mutation for polledness in Nelore (Bos taurus indicus) breed seems to have appeared first in Brazil in 1957. The expression of the polled trait is known to be ruled by a few groups of alleles in taurine breeds; however, the genetic basis of this trait in indicine cattle is still unclear. The aim of this study was to identify genomic regions associated with the hornless trait in a commercial Nelore population. A total of 107,294 animals had phenotypes recorded and 2,238 were genotyped/imputed for 777k SNP. The weighted single-step approach for genome-wide association study (WssGWAS) was used to estimate the SNP effects and variances accounted for by 1 Mb sliding SNP windows. A centromeric region of chromosome 1 with 3.11 Mb size (BTA1: 878,631-3,987,104 bp) was found to be associated with hornless in the studied population. A total of 28 protein-coding genes are mapped in this region, including the taurine Polled locus and the IFNAR1, IFNAR2, IFNGR2, KRTAP11-1, MIS18A, OLIG1, OLIG2, and SOD1 genes, which expression can be related to the horn formation as described in literature. The functional enrichment analysis by DAVID tool revealed cytokine-cytokine receptor interaction, JAK-STAT signaling, natural killer cell mediated cytotoxicity, and osteoclast differentiation pathways as significant (P < 0.05). In addition, a runs of homozygosity (ROH) analysis identified a ROH island in polled animals with 2.47 Mb inside the region identified by WssGWAS. Polledness in Nelore cattle is associated with one region in the genome with 3.1 Mb size in chromosome 1. Several genes are harbored in this region, and they may act together in the determination of the polled/horned phenotype. Fine mapping the locus responsible for polled trait in Nelore breed and the identification of the molecular mechanisms regulating the horn growth deserve further investigation.	[Stafuzza, Nedenia Bonvino; Munari, Danisio Prado] Univ Estadual Paulista, UNESP, FCAV, Dept Ciencias Exatas, Jaboticabal, SP, Brazil; [Stafuzza, Nedenia Bonvino; de Oliveira Silva, Rafael Medeiros; Lino Lourenco, Daniela A.] Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA; [de Oliveira Silva, Rafael Medeiros] ARS, USDA, NCCCWA, Leetown, WV USA; [Peripolli, Elisa; Baldi, Fernando] Univ Estadual Paulista, UNESP, FCAV, Dept Zootecnia, Jaboticabal, SP, Brazil; [Framartino Bezerra, Luiz Antonio] Univ Sao Paulo, FMRP, Dept Genet, Ribeirao Preto, SP, Brazil; [Lobo, Raysildo Barbosa] ANCP, Ribeirao Preto, SP, Brazil; [Magnabosco, Claudio de Ulhoa] Empresa Brasileira Pesquisa Agr EMBRAPA, Planaltina, DF, Brazil; [Di Croce, Fernando A.; Osterstock, Jason B.] Zoetis, Kalamazoo, MI USA	Universidade Estadual Paulista; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); Universidade Estadual Paulista; Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Zoetis	Stafuzza, NB (corresponding author), Univ Estadual Paulista, UNESP, FCAV, Dept Ciencias Exatas, Jaboticabal, SP, Brazil.; Stafuzza, NB (corresponding author), Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA.	nedeniabs@gmail.com	Magnabosco, Cláudio Ulhoa/ABC-4494-2021; Stafuzza, Nedenia B./C-4419-2013; Munari, Danisio P/C-6384-2012; Baldi, Fernando/E-5492-2012; Stafuzza, Nedenia Bonvino/M-9224-2019	Magnabosco, Cláudio Ulhoa/0000-0002-7274-0134; Stafuzza, Nedenia B./0000-0001-6432-2330; Munari, Danisio P/0000-0001-6915-038X; Baldi, Fernando/0000-0003-4094-2011; Stafuzza, Nedenia Bonvino/0000-0001-6432-2330; Lourenco, Daniela/0000-0003-3140-1002; Peripolli, Elisa/0000-0002-0962-6603	Zoetis; Coordination for the Improvement of Higher Education Personnel (CAPES/PNPD); Sao Paulo Research Foundation (FAPESP) [16/24084-7]; productivity research fellowship from National Counsel of Technological and Scientific Development (CNPq)	Zoetis; Coordination for the Improvement of Higher Education Personnel (CAPES/PNPD); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); productivity research fellowship from National Counsel of Technological and Scientific Development (CNPq)	The Zoetis provided support in the form of salaries for authors FADC and JBO but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. NBS was supported by a postdoctoral fellowship from Coordination for the Improvement of Higher Education Personnel (CAPES/PNPD). EP received a fellowship from Sao Paulo Research Foundation (FAPESP 16/24084-7). DPM and FB were supported by productivity research fellowship from National Counsel of Technological and Scientific Development (CNPq).	Allais-Bonnet A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063512; Asai M, 2004, ANIM GENET, V35, P34, DOI 10.1111/j.1365-2052.2003.01079.x; Bateson W, 1902, REPORTS EVOLUTIONARY; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Boissier P, 2014, CELL SIGNAL, V26, P483, DOI 10.1016/j.cellsig.2013.11.034; Brem G., 1982, Bayerisches Landwirtschaftliches Jahrbuch, V59, P688; Capitan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022242; Capitan A, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-33; Cargill Edward J, 2008, BMC Res Notes, V1, P128, DOI 10.1186/1756-0500-1-128; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; Dove WF, 1935, J EXP ZOOL, V69, P347, DOI 10.1002/jez.1400690302; FRISCH JE, 1980, ANIM PROD, V31, P119, DOI 10.1017/S000335610002434X; Fujimoto S, 2014, J DERMATOL SCI, V74, P39, DOI 10.1016/j.jdermsci.2013.12.006; GEORGES M, 1993, NAT GENET, V4, P206, DOI 10.1038/ng0693-206; Glatzer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067992; Gong H, 2016, GENES-BASEL, V7, DOI 10.3390/genes7060024; Gurgul A, 2016, J APPL GENET, V57, P527, DOI 10.1007/s13353-016-0337-6; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Howrigan DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-460; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; *IBGE, 2015, PROD PEC MUN; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li Jiliang, 2013, JAKSTAT, V2, pe23930, DOI 10.4161/jkst.23930; LONG CR, 1978, J HERED, V69, P395, DOI 10.1093/oxfordjournals.jhered.a108980; Lutter AH, 2010, J CELL BIOCHEM, V109, P1025, DOI 10.1002/jcb.22485; Magnabosco CU, 1997, DOCUMENTOS EMBRAPA C; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; Mastrangelo S, 2016, ANIMAL, V10, P746, DOI 10.1017/S1751731115002943; Medugorac I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039477; Meijer DH, 2012, NAT REV NEUROSCI, V13, P819, DOI 10.1038/nrn3386; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Nojiri H, 2011, J BONE MINER RES, V26, P2682, DOI 10.1002/jbmr.489; Oliveira JHF, 2002, DOCUMENTOS EMBRAPA C; Park KC, 2017, J INVEST DERMATOL, V137, P414, DOI 10.1016/j.jid.2016.09.012; Prayaga KC, 2007, AUST J AGR RES, V58, P1, DOI 10.1071/AR06044; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purfield DC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-70; Rothammer S, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-44; Santiago AA, 1987, GADO NELORE 100 ANOS; Seichter D, 2012, ANIM GENET, V43, P595, DOI 10.1111/j.1365-2052.2011.02302.x; Smith ADB, 1927, J GENET, V18, P365, DOI 10.1007/BF02983113; Stachowicz K, 2011, J DAIRY SCI, V94, P5160, DOI 10.3168/jds.2010-3308; Ferraz JBS, 2010, MEAT SCI, V84, P238, DOI 10.1016/j.meatsci.2009.06.006; Takayanagi H, 2005, IMMUNOL REV, V208, P181, DOI 10.1111/j.0105-2896.2005.00337.x; Takayanagi H, 2005, J CELL BIOCHEM, V94, P232, DOI 10.1002/jcb.20316; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tetens J, 2015, ANIM GENET, V46, P224, DOI 10.1111/age.12237; Tsuruta S., 2006, P 8 WORLD C GEN APPL; Utsunomiya ATH, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3049-8; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vozzi PA, 2007, GENET MOL RES, V6, P1044; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; Wang HY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00134; Wang L, 2015, CELL DEATH DIFFER, V22, P1654, DOI 10.1038/cdd.2015.14; WARWICK EJ, 1979, BREEDING IMPROVEMENT; White WT, 1936, J GENET, V32, P33, DOI 10.1007/BF02982500; Wiedemar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093435; Wiener DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127691; Wohlke A, 2010, ANIM GENET, V41, P335, DOI 10.1111/j.1365-2052.2009.02009.x; Zhang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012648; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	68	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202978	10.1371/journal.pone.0202978	http://dx.doi.org/10.1371/journal.pone.0202978			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161212	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900058
J	Boudria, A; Abou Faycal, C; Jia, T; Gout, S; Keramidas, M; Didier, C; Lemaitre, N; Manet, S; Coll, JL; Toffart, AC; Moro-Sibilot, D; Albiges-Rizo, C; Josserand, V; Faurobert, E; Brambilla, C; Brambilla, E; Gazzeri, S; Eymin, B				Boudria, Asma; Abou Faycal, Cherine; Jia, Tao; Gout, Stephanie; Keramidas, Michelle; Didier, Chloe; Lemaitre, Nicolas; Manet, Sandra; Coll, Jean-Luc; Toffart, Anne-Claire; Moro-Sibilot, Denis; Albiges-Rizo, Corinne; Josserand, Veronique; Faurobert, Eva; Brambilla, Christian; Brambilla, Elisabeth; Gazzeri, Sylvie; Eymin, Beatrice			VEGF(165)b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a beta 1 integrin/VEGFR autocrine loop	ONCOGENE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DOWN-REGULATION; CELL CARCINOMA; CANCER; EXPRESSION; ISOFORMS; APOPTOSIS; INVASION; PROTEIN; E2F1	Vascular endothelial growth factor-A (VEGF-A) is highly subjected to alternative pre-mRNA splicing that generates several splice variants. The VEGF(xxx) and VEGF(xxx)b families encode splice variants of VEGF-A that differ only at the level of six amino acids in their C-terminal part. The expression level of VEGF(xxx) splice variants and their function as pro-angiogenic factors during tumor neo-angiogenesis have been well-described. The role of VEGF(xxx)b isoforms is less well known, but they have been shown to inhibit VEGF(xxx)-mediated angiogenesis, while being partial or weak activators of VEGFR receptors in endothelial cells. On the opposite, their role on tumor cells expressing VEGFRs at their surface remains largely unknown. In this study, we find elevated levels of VEGF(165)b, the main VEGF(xxx)b isoform, in 36% of non-small cell lung carcinoma (NSCLC), mainly lung adenocarcinoma (46%), and show that a high VEGF(165)b/VEGF(165) ratio correlates with the presence of lymph node metastases. At the molecular level, we demonstrate that VEGF(165)b stimulates proliferation and invasiveness of two lung tumor cell lines through a VEGFR/beta 1 integrin loop. We further provide evidence that the isoform-specific knockdown of VEGF(165)b reduces tumor growth, demonstrating a tumor-promoting autocrine role for VEGF(165)b in lung cancer cells. Importantly, we show that bevacizumab, an anti-angiogenic compound used for the treatment of lung adenocarcinoma patients, increases the expression of VEGF(165)b and activates the invasive VEGFR/beta 1 integrin loop. Overall, these data highlight an unexpected role of the VEGF(165)b splice variant in the progression of lung tumors and their response to anti-angiogenic therapies.	[Boudria, Asma; Abou Faycal, Cherine; Jia, Tao; Gout, Stephanie; Gazzeri, Sylvie; Eymin, Beatrice] CNRS, INSERM, Team RNA Splicing Cell Signaling & Response Thera, U1209,UMR 5309, F-38042 Grenoble, France; [Boudria, Asma; Abou Faycal, Cherine; Jia, Tao; Gout, Stephanie; Keramidas, Michelle; Didier, Chloe; Lemaitre, Nicolas; Manet, Sandra; Coll, Jean-Luc; Toffart, Anne-Claire; Moro-Sibilot, Denis; Albiges-Rizo, Corinne; Josserand, Veronique; Faurobert, Eva; Brambilla, Christian; Brambilla, Elisabeth; Gazzeri, Sylvie; Eymin, Beatrice] Univ Grenoble Alpes, Inst Avancee Biosci, F-38041 Grenoble, France; [Keramidas, Michelle; Didier, Chloe; Coll, Jean-Luc; Josserand, Veronique] CNRS, INSERM, Team Canc Targets & Expt Therapeut, U1209,UMR 5309, F-38042 Grenoble, France; [Lemaitre, Nicolas; Toffart, Anne-Claire; Moro-Sibilot, Denis; Brambilla, Christian; Brambilla, Elisabeth] CNRS, INSERM, Team Tumor Mol Pathol & Biomarkers, U1209,UMR 5309, F-38042 Grenoble, France; [Manet, Sandra; Albiges-Rizo, Corinne; Faurobert, Eva] CNRS, INSERM, Team Cell Adhes Dynam & Differentiat, U1209,UMR 5309, F-38042 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Eymin, B (corresponding author), CNRS, INSERM, Team RNA Splicing Cell Signaling & Response Thera, U1209,UMR 5309, F-38042 Grenoble, France.; Eymin, B (corresponding author), Univ Grenoble Alpes, Inst Avancee Biosci, F-38041 Grenoble, France.	Beatrice.Eymin@ujf-grenoble.fr	josserand, veronique/F-1773-2019; gazzeri, sylvie/U-4669-2019; Eymin, Beatrice/M-1962-2013; eymin, beatrice/U-4670-2019; Coll, Jean-Luc/G-2520-2013; JIA, Tao/AAZ-1963-2020; Albiges-Rizo, Corinne/M-2568-2013; gazzeri, sylvie/M-1961-2013; Toffart, Anne-Claire/N-6820-2013; Faurobert, Eva/M-2735-2013	josserand, veronique/0000-0001-6733-3801; gazzeri, sylvie/0000-0001-5817-1839; Eymin, Beatrice/0000-0002-7311-3810; eymin, beatrice/0000-0002-7311-3810; Coll, Jean-Luc/0000-0002-2453-3552; JIA, Tao/0000-0002-8358-6005; gazzeri, sylvie/0000-0001-5817-1839; Faurobert, Eva/0000-0002-2714-8537; MORO-SIBILOT, Denis/0000-0001-6776-8610; ALBIGES-RIZO, Corinne/0000-0002-6333-4150	Comite Departemental Isere and Comite Departemental Savoie de la Ligue Nationale contre le Cancer; INCa/DHOS (Appel d'Offre Recherche Translationnelle 2010); Fondation de France (Projet Grande Ampleur 2011); ROCHE fellowship (Bourse de Recherche Fondamentale); Fondation ARC pour la Recherche Contre le Cancer; Fonds de dotation AGIR pour les Maladies Chroniques; Ministere de l'Education et de la Recherche Algerien (program PROFAS); Fondation pour La Recherche Medicale; Ligue Nationale Contre Le Cancer; Ligue Nationale Contre Le Cancer (Equipe labellisee Ligue 2014)	Comite Departemental Isere and Comite Departemental Savoie de la Ligue Nationale contre le Cancer; INCa/DHOS (Appel d'Offre Recherche Translationnelle 2010); Fondation de France (Projet Grande Ampleur 2011); ROCHE fellowship (Bourse de Recherche Fondamentale); Fondation ARC pour la Recherche Contre le Cancer; Fonds de dotation AGIR pour les Maladies Chroniques; Ministere de l'Education et de la Recherche Algerien (program PROFAS); Fondation pour La Recherche Medicale(Fondation pour la Recherche Medicale); Ligue Nationale Contre Le Cancer(Ligue nationale contre le cancer); Ligue Nationale Contre Le Cancer (Equipe labellisee Ligue 2014)	Plasmid encoding VEGF<INF>165</INF>b was obtained from David Bates (University of Nottingham, UK). We thank Sophie Michallet, Floriane Albert, Celine Barrial, and Virginie Rouyre for technical assistance. We also thank Laurence David-Boudet and Adrien Mombrun for IHC performance. Thanks to Philippe Lorimier for tumor bank gestion and data retrieving. This work was supported by the Comite Departemental Isere and Comite Departemental Savoie de la Ligue Nationale contre le Cancer, the INCa/DHOS (Appel d'Offre Recherche Translationnelle 2010), by the Fondation de France (Projet Grande Ampleur 2011), ROCHE fellowship (Bourse de Recherche Fondamentale), the Fondation ARC pour la Recherche Contre le Cancer, and the Fonds de dotation AGIR pour les Maladies Chroniques. Stephanie Gout and Tao Jia were supported by a post-doctoral fellowship from the Fondation ARC pour la Recherche Contre le Cancer. Asma Boudria was supported by the Ministere de l'Education et de la Recherche Algerien (program PROFAS) and the Fondation pour La Recherche Medicale. Cherine Abou Faycal was supported by the Ligue Nationale Contre Le Cancer. The CAR team is supported by the Ligue Nationale Contre Le Cancer (Equipe labellisee Ligue 2014).	Bachelder RE, 2001, CANCER RES, V61, P5736; Bachelder RE, 2002, CANCER RES, V62, P7203; Bates DO, 2012, CLIN CANCER RES, V18, P6384, DOI 10.1158/1078-0432.CCR-12-2223; Bates DO, 2002, CANCER RES, V62, P4123; Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; Carbonell WS, 2013, CANCER RES, V73, P3145, DOI 10.1158/0008-5472.CAN-13-0011; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cascone T, 2015, CLIN CANC RES; Catena R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-320; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Diaz R, 2008, INT J CANCER, V123, P1060, DOI 10.1002/ijc.23619; Eymin B, 2003, ONCOGENE, V22, P1822, DOI 10.1038/sj.onc.1206303; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2007, ANNU REV MED, V58, P491, DOI 10.1146/annurev.med.58.061705.145635; Franzini A, 2015, GENE EXPRESSION SIGN; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Goel HL, 2012, CANCER DISCOV, V2, P906, DOI 10.1158/2159-8290.CD-12-0085; Gout S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046539; Grepin R, 2012, ONCOGENE, V31, P1683, DOI 10.1038/onc.2011.360; Hall DMS, 2014, METHODS MOL BIOL, V1070, P1, DOI 10.1007/978-1-4614-8244-4_1; Harris S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035231; Huveldt D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056505; Kawamura H, 2008, CANCER RES, V68, P4683, DOI 10.1158/0008-5472.CAN-07-6577; Ladomery MR, 2007, CANCER LETT, V249, P133, DOI 10.1016/j.canlet.2006.08.015; Lambrechts D, 2013, J CLIN ONCOL, V31, P1219, DOI 10.1200/JCO.2012.46.2762; Lantuejoul S, 2003, J PATHOL, V200, P336, DOI 10.1002/path.1367; Larrayoz M, 2014, EMBO MOL MED, V6, P539, DOI 10.1002/emmm.201303214; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Merdzhanova G, 2010, ONCOGENE, V29, P5392, DOI 10.1038/onc.2010.281; Nowak DG, 2008, J CELL SCI, V121, P3487, DOI 10.1242/jcs.016410; Pajares MJ, 2012, J CLIN ONCOL, V30, P1129, DOI 10.1200/JCO.2011.37.4231; Pritchard-Jones RO, 2007, BRIT J CANCER, V97, P223, DOI 10.1038/sj.bjc.6603839; Rennel ES, 2008, BRIT J CANCER, V98, P1250, DOI 10.1038/sj.bjc.6604309; Rennel ES, 2008, EUR J CANCER, V44, P1883, DOI 10.1016/j.ejca.2008.05.027; Robinson CJ, 2001, J CELL SCI, V114, P853; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Rugo HS, 2012, J CLIN ONCOL, V30, P898, DOI 10.1200/JCO.2011.38.5492; Salon C, 2007, ONCOGENE, V26, P6927, DOI 10.1038/sj.onc.1210499; Salon C, 2006, CELL DEATH DIFFER, V13, P260, DOI 10.1038/sj.cdd.4401739; Suarez SC, 2006, CELL MOL LIFE SCI, V63, P2067, DOI 10.1007/s00018-006-6254-9; Toffart AC, 2014, LUNG CANCER, V83, P182, DOI 10.1016/j.lungcan.2013.12.003; Toth Marta, 2012, Methods Mol Biol, V878, P121, DOI 10.1007/978-1-61779-854-2_8; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Varey AHR, 2008, BRIT J CANCER, V98, P1366, DOI 10.1038/sj.bjc.6604308; Woolard J, 2004, CANCER RES, V64, P7822, DOI 10.1158/0008-5472.CAN-04-0934; Xin H, 2016, CELL, V167, P275, DOI 10.1016/j.cell.2016.08.054; Zhang PF, 2013, ONCOL REP, V30, P341, DOI 10.3892/or.2013.2477	49	29	30	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 14	2019	38	7					1050	1066		10.1038/s41388-018-0486-7	http://dx.doi.org/10.1038/s41388-018-0486-7			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HL3OH	30194450	Green Submitted			2022-12-26	WOS:000458624900009
J	Zhu, C; Liu, Y; Hu, L; Yang, M; He, ZG				Zhu, Chen; Liu, Yu; Hu, Lihua; Yang, Min; He, Zheng-Guo			Molecular mechanism of the synergistic activity of ethambutol and isoniazid against Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; drug resistance; mycobacteria; DNA binding protein; DNA-protein interaction; transcription promoter; anti-TB drug; enoyl-ACP reductase; inhA; mycolic acid; transcriptional repression	DRUG-RESISTANCE; BOVIS BCG; EXPRESSION; SMEGMATIS; MUTATIONS; GENETICS; NETWORK	Isoniazid (INH) and ethambutol (EMB) are two major first-line drugs for managing tuberculosis (TB), caused by the microbe Mycobacterium tuberculosis. Although co-use of these two drugs is common in clinical practice, the mechanism for the potential synergistic interplay between them remains unclear. Here, we present first evidence that INH and EMB act synergistically through a transcriptional repressor of the inhA gene, the target gene of INH encoding an enoyl-acyl carrier protein reductase of the fatty acid synthase type II system required for bacterial cell wall integrity. We report that EMB binds a hypothetical transcription factor encoded by the Rv0273c gene, designated here as EtbR. Using DNA footprinting, we found that EtbR specifically recognizes a motif sequence in the upstream region of the inhA gene. Using isothermal titration calorimetry and surface plasmon resonance assays, we observed that EMB binds EtbR in a 1:1 ratio and thereby stimulates its DNA-binding activity. When a nonlethal dose of EMB was delivered in combination with INH, EMB increased the INH susceptibility of cultured M. tuberculosis cells. In summary, EMB induces EtbR-mediated repression of inhA and thereby enhances the mycobactericidal effect of INH. Our findings uncover a molecular mechanism for the synergistic activity of two important anti-TB drugs.	[Zhu, Chen; Liu, Yu; Hu, Lihua; Yang, Min; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Agr Microbiol, Wuhan 430070, Peoples R China	Huazhong Agricultural University	Yang, M; He, ZG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China.	yangmin@mail.hzau.edu.cn; he.zhengguo@hotmail.com	He, Zheng-Guo/P-3647-2014					da Silva PEA, 2011, FEMS IMMUNOL MED MIC, V63, P1, DOI 10.1111/j.1574-695X.2011.00831.x; Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; Ando H, 2014, MOL MICROBIOL, V91, P538, DOI 10.1111/mmi.12476; Ando H, 2011, MOL MICROBIOL, V79, P1615, DOI 10.1111/j.1365-2958.2011.07547.x; Bolla JR, 2012, NUCLEIC ACIDS RES, V40, P9340, DOI 10.1093/nar/gks677; Brossier F, 2015, ANTIMICROB AGENTS CH, V59, P4800, DOI 10.1128/AAC.00150-15; Choi WH, 2017, J CLIN MED, V6, DOI 10.3390/jcm6030030; Cui ZL, 2014, ANTIMICROB AGENTS CH, V58, P6837, DOI 10.1128/AAC.03285-14; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Gao CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036255; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; Hu JL, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0556-8; Larsen MH, 2002, MOL MICROBIOL, V46, P453, DOI 10.1046/j.1365-2958.2002.03162.x; Li WH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9330; Liu HC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27489; Liu L, 2014, J BIOL CHEM, V289, P9065, DOI 10.1074/jbc.M113.528919; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3907; Minch KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6829; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; Rao MD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.383604; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Yang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13969; Yang M, 2012, NUCLEIC ACIDS RES, V40, P1009, DOI 10.1093/nar/gkr830; Zhang Y, 2015, INT J TUBERC LUNG D, V19, P1276, DOI 10.5588/ijtld.15.0389	27	19	20	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16741	16750		10.1074/jbc.RA118.002693	http://dx.doi.org/10.1074/jbc.RA118.002693			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30185616	Green Published, hybrid			2022-12-26	WOS:000448515100016
J	Benitez-Capistros, F; Camperio, G; Huge, J; Dahdouh-Guebas, F; Koedam, N				Benitez-Capistros, Francisco; Camperio, Giorgia; Huge, Jean; Dahdouh-Guebas, Farid; Koedam, Nico			Emergent conservation conflicts in the Galapagos Islands: Human-giant tortoise interactions in the rural area of Santa Cruz Island	PLOS ONE			English	Article							HUMAN-WILDLIFE CONFLICT; PROTECTED AREAS; BIODIVERSITY CONSERVATION; ECOLOGICAL-SYSTEMS; NATIONAL-PARK; WIRE FENCES; COMMUNITY; PERSPECTIVE; PERCEPTIONS; VEGETATION	The conservation of biodiverse areas around the world has contributed to the protection and recovery of endangered species. This has been the case for 11 species of Galapagos giant tortoises (Chelonoidis spp.) that today are successfully maintained over six islands: Espanola, Santiago, Pinzon, Isabela, San Cristobal and Santa Cruz. A favourable state of conservation will depend however on future development in the islands. In Santa Cruz Island the development of the agricultural areas has encroached on the migratory routes of the southwestern species C. porteri and may be an emergent conflict for tortoise conservation. We investigated the social and ecological inter-linkages using two methods framed under a participatory rural appraisal (PRA) approach: semi-structured interviews and questionnaires to study farmers' perceptions and attitudinal factors regarding giant tortoises; as well as the associated socio-economic impacts of the conflict. Moreover, we coupled the PRA approach with an ecological assessment of giant tortoises' population density by performing transect counts during the two yearly phases of giant tortoises' migration to the lowlands (January to June) and back to the highlands (July to December). Our results indicate that farmers reporting damage and cultivating crops have higher odds of taking actions (fencing and physical actions) towards giant tortoises; regardless of having (or not) a negative perception towards the species. The economic losses for crops and fences averaged 2.8 USD/m(2) and 13USD/m, respectively, and provide an initial step to further analyse and characterise the direct and indirect damage costs. Finally, we estimated a density of 76 and 185 individuals of giant tortoises per km(2) in the rural area for the lowland and highland migratory phases, respectively. Our approach provides grounded scientific social and ecological information to effectively inform and aid managers, policy and decision makers in the selection of adequate social and ecological criteria to implement the best available options in the resolution of this emergent conservation conflict.	[Benitez-Capistros, Francisco] Cent Univ Ecuador, Biomed Res Inst INBIOMED, Quito, Ecuador; [Benitez-Capistros, Francisco; Huge, Jean] Vrije Univ Brussel, Dept Biol, Lab Plant Biol & Nat Management APNA Ecol & Biodi, Brussels, Belgium; [Benitez-Capistros, Francisco; Camperio, Giorgia; Huge, Jean; Dahdouh-Guebas, Farid; Koedam, Nico] Univ Libre Bruxelles, Dept Organism Biol, Lab Syst Ecol & Resource Management SERM, Brussels, Belgium; [Camperio, Giorgia; Dahdouh-Guebas, Farid] Swiss Fed Inst Technol, Dept Earth Sci, Zurich, Switzerland; [Camperio, Giorgia] Eawag, Dept Surface Waters Res & Management Dubendorf, Dubendorf, Switzerland; [Huge, Jean] Univ Hasselt, Ctr Environm Sci, Hasselt, Belgium; [Huge, Jean] Univ Ghent, Ctr Sustainable Dev, Ghent, Belgium	Universidad Central del Ecuador; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Hasselt University; Ghent University	Benitez-Capistros, F (corresponding author), Cent Univ Ecuador, Biomed Res Inst INBIOMED, Quito, Ecuador.; Benitez-Capistros, F (corresponding author), Vrije Univ Brussel, Dept Biol, Lab Plant Biol & Nat Management APNA Ecol & Biodi, Brussels, Belgium.; Benitez-Capistros, F; Camperio, G (corresponding author), Univ Libre Bruxelles, Dept Organism Biol, Lab Syst Ecol & Resource Management SERM, Brussels, Belgium.; Camperio, G (corresponding author), Swiss Fed Inst Technol, Dept Earth Sci, Zurich, Switzerland.; Camperio, G (corresponding author), Eawag, Dept Surface Waters Res & Management Dubendorf, Dubendorf, Switzerland.	fjbenitez@uce.edu.ec; giorgia.camperio@eawag.ch		DAHDOUH-GUEBAS, Farid/0000-0002-5906-8996; Huge, Jean/0000-0002-3695-547X; Benitez-Capistros, Francisco/0000-0002-8317-0229	Ecuadorian National Secretary of Higher Education, Science, Technology and Innovation [SENESCYT 162-2012]; EC-EACEA Erasmus Mundus scholarship from the Erasmus Mundus Masters Course in Tropical Biodiversity and Ecosystems (TROPIMUNDO)	Ecuadorian National Secretary of Higher Education, Science, Technology and Innovation; EC-EACEA Erasmus Mundus scholarship from the Erasmus Mundus Masters Course in Tropical Biodiversity and Ecosystems (TROPIMUNDO)	The Ecuadorian National Secretary of Higher Education, Science, Technology and Innovation (SENESCYT 162-2012) provided a fixed financial support for research related activities under the Doctoral scholarship which was awarded between 2012-2016. The FeAdeAration Wallonie-Bruxelles (FWB BV-1515) provided a 2 month research field trip grant. GC acknowledges with thanks the part funded by EC-EACEA Erasmus Mundus scholarship from the Erasmus Mundus Masters Course in Tropical Biodiversity and Ecosystems (TROPIMUNDO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade GSM, 2012, ECOL SOC, V17, DOI 10.5751/ES-05216-170414; Anthony B.P., 2010, CONSERV SOC, V8, P225, DOI DOI 10.4103/0972-4923.73812; Balmford A, 2012, P ROY SOC B-BIOL SCI, V279, P2714, DOI 10.1098/rspb.2012.0515; Benitez-Capistros F., 2016, SOCIAL ECOLOGICAL SY; Benitez-Capistros F, 2016, AMBIO, V45, P706, DOI 10.1007/s13280-016-0774-9; Benitez-Capistros F, 2014, ECOL INDIC, V38, P113, DOI 10.1016/j.ecolind.2013.10.019; Bennett A. F., 1999, LINKAGES LANDSCAPE R; Blake S, 2015, BIOTROPICA, V47, P246, DOI 10.1111/btp.12195; Blake S, 2013, J ANIM ECOL, V82, P310, DOI 10.1111/1365-2656.12020; Blake S, 2012, J BIOGEOGR, V39, P1961, DOI 10.1111/j.1365-2699.2011.02672.x; Bodin O, 2014, CONSERV BIOL, V28, P1371, DOI 10.1111/cobi.12306; Bogner A, 2009, RES METHODS SER, P1, DOI 10.1057/9780230244276; Brondizio ES, 2016, SCIENCE, V352, P1272, DOI 10.1126/science.aaf5122; Buckland S.T., 2012, DISTANCE SAMPLING ES; Buckland ST, 2010, INT J PRIMATOL, V31, P833, DOI 10.1007/s10764-010-9431-5; Bull JW, 2013, FRONT ECOL ENVIRON, V11, P203, DOI 10.1890/120020; BURNHAM KP, 1980, WILDLIFE MONOGR, P7; Caccone A, 1999, P NATL ACAD SCI USA, V96, P13223, DOI 10.1073/pnas.96.23.13223; Cassey P., 1999, ESTIMATING ANIMAL AB; CGREG, 2014, GALAPAGOS; CGREG, 2014, CONS GOB REG ESP GAL; CHAMBERS R, 1994, WORLD DEV, V22, P953, DOI 10.1016/0305-750X(94)90141-4; Danielsen F, 2005, BIODIVERS CONSERV, V14, P2507, DOI 10.1007/s10531-005-8375-0; DeFries R, 2007, ECOL APPL, V17, P1031, DOI 10.1890/05-1111; DGNP, 2013, MON REC EXPL TRANSP; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Du Toit JT, 2002, BIODIVERS CONSERV, V11, P1403, DOI 10.1023/A:1016263606704; Ellis-Soto D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181333; Flick U., 2017, SAGE HDB QUALITATIVE; Froyd CA, 2014, ECOL LETT, V17, P144, DOI 10.1111/ele.12203; Gaidet N, 2003, BIODIVERS CONSERV, V12, P1571, DOI 10.1023/A:1023646012700; Gates CC, 2012, FENCING FOR CONSERVATION: RESTRICTION OF EVOLUTIONARY POTENTIAL OR A RIPOSTE TO THREATENING PROCESSES?, P277, DOI 10.1007/978-1-4614-0902-1_15; Gibbs JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110742; Godfrey M., 1999, REINO GALAPAGO VOLVI; Guezou A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010276; Gulbrandsen L. H., 2004, GLOBAL ENV POLITICS, V4, P75, DOI [10.1162/152638004323074200, DOI 10.1162/152638004323074200]; Guzman JC., 2015, GALAPAGOS REPORT 201, P25; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Harrington JL, 2006, WILDLIFE SOC B, V34, P1295, DOI 10.2193/0091-7648(2006)34[1295:COUBAM]2.0.CO;2; He QC, 2014, BIOCULTURAL LANDSCAP, P69; He QC, 2011, CHINESE GEOGR SCI, V21, P629, DOI 10.1007/s11769-011-0499-4; Helfand SM, 2004, AGR ECON, V31, P241, DOI 10.1016/j.agecon.2004.09.021; Hill C, 2002, HUMAN WILDLIFE CONFL; Hill CM, 2010, AM J PRIMATOL, V72, P919, DOI 10.1002/ajp.20845; Hill CM, 1997, INT J PEST MANAGE, V43, P77, DOI 10.1080/096708797229022; INEC, 2013, ENC ED 2013; Jachmann H, 2002, J APPL ECOL, V39, P841, DOI 10.1046/j.1365-2664.2002.00752.x; Jachmann H., 2012, ESTIMATING ABUNDANCE; Jachowski DS, 2014, ANIM CONSERV, V17, P187, DOI 10.1111/acv.12082; Jager H, 2007, BIOL CONSERV, V140, P297, DOI 10.1016/j.biocon.2007.08.014; Jager H, 2009, J ECOL, V97, P1252, DOI 10.1111/j.1365-2745.2009.01578.x; Jathanna D, 2003, J ZOOL, V261, P285, DOI 10.1017/S0952836903004278; Kansky R, 2014, CONSERV BIOL, V28, P924, DOI 10.1111/cobi.12275; Karanth KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050433; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Lagabrielle E, 2011, LANDSCAPE URBAN PLAN, V101, P120, DOI 10.1016/j.landurbplan.2011.02.004; LaPoint S, 2015, FUNCT ECOL, V29, P868, DOI 10.1111/1365-2435.12489; Lele S, 2010, CURR OPIN ENV SUST, V2, P94, DOI 10.1016/j.cosust.2010.03.006; Leuteritz TEJ, 2005, BIOL CONSERV, V124, P451, DOI 10.1016/j.biocon.2005.02.003; Linkie M, 2007, ANIM CONSERV, V10, P127, DOI 10.1111/j.1469-1795.2006.00083.x; Mace GM, 2014, SCIENCE, V345, P1558, DOI 10.1126/science.1254704; Mackenzie CA, 2012, ECOL ECON, V75, P72, DOI 10.1016/j.ecolecon.2011.12.018; Madden F, 2014, BIOL CONSERV, V178, P97, DOI 10.1016/j.biocon.2014.07.015; Márquez Cruz, 2004, Ecol. apl., V3, P98; Marshall K, 2007, BIODIVERS CONSERV, V16, P3129, DOI 10.1007/s10531-007-9167-5; McCleary AL, 2013, CHARACTERIZING CONT, P155; McGinnis MD, 2014, ECOL SOC, V19, DOI 10.5751/ES-06387-190230; Menconi ME, 2017, LAND USE POLICY, V60, P1, DOI 10.1016/j.landusepol.2016.10.007; Milner-Gulland EJ, 2012, PHILOS T R SOC B, V367, P270, DOI 10.1098/rstb.2011.0175; Mueller JG, 2010, CONSERV BIOL, V24, P140, DOI 10.1111/j.1523-1739.2009.01392.x; Narayanasamy N., 2009, PARTICIPATORY RURAL; Naughton-Treves L, 1998, J APPL ECOL, V35, P596, DOI 10.1046/j.1365-2664.1998.3540596.x; Naughton-Treves L, 2005, CONSERV BIOL SER, V9, P252; Newing H., 2010, CONDUCTING RES CONSE; Nyhus PJ, 2000, ORYX, V34, P262, DOI 10.1017/S0030605300031331; Nyirenda V. R., 2013, International Journal of Biodiversity and Conservation, V5, P741; Osborn F, 2002, HUMAN WILDLIFE CONFL, V1, P33; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Peterson MN, 2010, CONSERV LETT, V3, P74, DOI 10.1111/j.1755-263X.2010.00099.x; Poulakakis N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138779; Rastogi A, 2013, BIOL CONSERV, V161, P182, DOI 10.1016/j.biocon.2013.03.013; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Resilience Folke C., 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI [10.1016/J.Gloenvcha.2006.04.002, DOI 10.1016/J.GLOENVCHA.2006.04.002]; Rey A, 2012, J NAT CONSERV, V20, P280, DOI 10.1016/j.jnc.2012.05.004; Rissman AR, 2017, CONSERV LETT, V10, P86, DOI 10.1111/conl.12250; Rutten M., 2002, ISSUE PAPER DRYLANDS, V111; Sandbrook C, 2011, CONSERV BIOL, V25, P285, DOI 10.1111/j.1523-1739.2010.01592.x; Smith TS, 2005, URSUS, V16, P1, DOI 10.2192/1537-6176(2005)016[0001:ABBHAH]2.0.CO;2; Sutherland WJ, 2006, ECOLOGICAL CENSUS TECHNIQUES: A HANDBOOK, 2ND EDITION, P1, DOI 10.2277/ 0521606365; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Treves A, 2009, CONSERV BIOL, V23, P1577, DOI 10.1111/j.1523-1739.2009.01242.x; Villa A, 2010, INFORM GALA PAGOS 20; Vogt JM, 2015, ECOL SOC, V20, DOI 10.5751/ES-07239-200155; Walpole MJ, 2005, CONSERV BIOL SER, V9, P122; Watson J, 2010, ORYX, V44, P79, DOI 10.1017/S0030605309990226; Webber AD, 2007, ORYX, V41, P177, DOI 10.1017/S0030605307001792; Wilfred P, 2007, DISCOV INNOVAT, V19, P15; Wood EM, 2014, ECOL APPL, V24, P1445, DOI 10.1890/12-1992.1; Young J, 2007, AMBIO, V36, P545, DOI 10.1579/0044-7447(2007)36[545:CBBCAH]2.0.CO;2; Young JC, 2018, METHODS ECOL EVOL, V9, P10, DOI 10.1111/2041-210X.12828; Zhang L, 2003, BIOL CONSERV, V112, P453, DOI 10.1016/S0006-3207(02)00335-X; Zinn H.C., 2008, HUMAN DIMENSIONS WIL, V13, P388, DOI DOI 10.1080/10871200802427972	102	11	11	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2018	13	9							e0202268	10.1371/journal.pone.0202268	http://dx.doi.org/10.1371/journal.pone.0202268			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT7EB	30208033	Green Submitted, Green Published, gold			2022-12-26	WOS:000444683000015
J	De Groot, N; Birnie, E; Vermolen, JH; Dorscheidt, JJA; Bonsel, GJ				De Groot, Nynke; Birnie, Erwin; Vermolen, Jolanda H.; Dorscheidt, Jacqueline J. A.; Bonsel, Gouke J.			The prevalence of adverse postnatal outcomes for mother and infant in the Netherlands	PLOS ONE			English	Article							MODEL	Background In high-income countries delivery usually takes place in a short-stay hospital setting and includes limited specific care after discharge. Perinatal system performance is therefore predominantly expressed in direct terms of delivery outcomes such as preterm birth (PTB), small for gestational age (SGA) or, in case of the mother, perineal rupture and haemorrhage. Additional postnatal complications may emerge, but their incidence is largely unknown. The Dutch obstetric system includes an 8-10 day episode of professional postnatal home maternity care. Our aim was to establish, under routine conditions, the incidence of a comprehensive set of 67 predefined complications and their predictors. A second aim was to address interaction between maternal and child complications. Methods The study design was a prospective cohort study of all clients of one large maternity care organization receiving home maternity care in November 2014. We combined maternal background and intrapartum and postnatal characteristics with complication data, routinely recorded by home maternity care assistants. Complication prevalence rates per postnatal day were calculated. Univariate and multivariable logistic regression were used to predict the presence of postnatal complications. Results Complications occurred throughout the entire episode of home maternity care and prevalence was high, with 55% of all mother-baby pairs experiencing at least one complication (e.g. cracked nipples, >10% weight loss of the baby) and 5% at least one major complication (e.g. mastitis, cyanosis of the baby). Predictive ability of maternal background and intrapartum and postnatal variables on presence of complications was moderate (max. 62.9%), even when a cumulative risk score was used. Conclusions The prevalence rates of maternal and neonatal postnatal complications with care as usual in high-income countries was higher than expected. Professional postnatal follow-up is to be considered in order to timely detect and manage emerging complications with minimal delay. Opportunities for risk-guided care should be investigated further. The pattern of complications in low-income countries remains to be established.	[De Groot, Nynke; Birnie, Erwin; Bonsel, Gouke J.] Univ Utrecht, Univ Med Ctr Utrecht, Matern Care Acad Res Grp, Dept Obstet & Gynecol, Utrecht, Netherlands; [Vermolen, Jolanda H.; Dorscheidt, Jacqueline J. A.] Matern Care Org De Waarden, Schoonhoven, Netherlands	Utrecht University; Utrecht University Medical Center	De Groot, N (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Matern Care Acad Res Grp, Dept Obstet & Gynecol, Utrecht, Netherlands.	ndegroot-8@umcutrecht.nl		de Groot, Nynke/0000-0002-8625-4145				Battersby C, 2018, ARCH DIS CHILD-FETAL, V103, pF182, DOI 10.1136/archdischild-2017-313880; Byaruhanga R, 2005, J TROP PEDIATRICS, V51, P212, DOI 10.1093/tropej/fmh098; Santos KJD, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0999-4; de Graaf JP, 2013, J MATERN-FETAL NEO M, V26, P473, DOI 10.3109/14767058.2012.735722; Euro Peristat, 2013, EUR PER HLTH REP HLT; EURO-PERISTAT Project with SCPE EUROCAT EURONEOSTAT, 2003, EUR PER HLTH REP; Grover A, 2008, JPEN-PARENTER ENTER, V32, P140, DOI 10.1177/0148607108314373; Guida JP, 2018, INT J GYNECOL OBSTET, V141, P55, DOI 10.1002/ijgo.12467; Lundgren C, 2018, J MATERN-FETAL NEO M, V31, P1595, DOI 10.1080/14767058.2017.1321628; Mediano P, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-195; Oakley L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164462; Posthumus AG, 2016, MIDWIFERY, V38, P78, DOI 10.1016/j.midw.2015.11.006; Quispel C, 2012, J PSYCHOSOM OBST GYN, V33, P7, DOI 10.3109/0167482X.2011.649814; Sardesai SR, 2011, J MATERN-FETAL NEO M, V24, P197, DOI 10.3109/14767051003728245; Scrafford CG, 2013, TROP MED INT HEALTH, V18, P1317, DOI 10.1111/tmi.12189; Vos AA, 2015, INT J INTEGR CARE, V15; WHO, 2017, ALL EYES MAT HLTH; WHO, 2017, WHO REC NEWB HLTH	18	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0202960	10.1371/journal.pone.0202960	http://dx.doi.org/10.1371/journal.pone.0202960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204758	Green Published, Green Submitted, gold			2022-12-26	WOS:000444355500012
J	de Marco, P; Nobrega, CC				de Marco Junior, Paulo; Nobrega, Caroline Correa			Evaluating collinearity effects on species distribution models: An approach based on virtual species simulation	PLOS ONE			English	Article							SAMPLE SELECTION BIAS; GEOGRAPHICAL-DISTRIBUTION; SPATIAL AUTOCORRELATION; BIOTIC INTERACTIONS; POTENTIAL DISTRIBUTIONS; PREDICTIVE PERFORMANCE; PRINCIPAL-COMPONENTS; CONSERVATION STATUS; STOPPING RULES; NICHE	The increasing use of species distribution modeling (SDM) has raised new concerns regarding the inaccuracies, misunderstanding, and misuses of this important tool. One of those possible pitfalls - collinearity among environmental predictors - is assumed as an important source of model uncertainty, although it has not been subjected to a detailed evaluation in recent SDM studies. It is expected that collinearity will increase uncertainty in model parameters and decrease statistical power. Here we use a virtual species approach to compare models built using subsets of PCA-derived variables with models based on the original highly correlated climate variables. Moreover, we evaluated whether modelling algorithms and species data characteristics generate models with varying sensitivity to collinearity. As expected, collinearity among predictors decreases the efficiency and increases the uncertainty of species distribution models. Nevertheless, the intensity of the effect varied according to the algorithm properties: more complex procedures behaved better than simple envelope models. This may support the claim that complex models such as Maxent take advantage of existing collinearity in finding the best set of parameters. The interaction of the different factors with species characteristics (centroid and tolerance in environmental space) highlighted the importance of the so-called "idiosyncrasy in species responses" to model efficiency, but differences in prevalence may represent a better explanation. However, even models with low accuracy to predict suitability of individual cells may provide meaningful information on the estimation of range-size, a key species-trait for macroecological studies. We concluded that the use of PCA-derived variables is advised both to control the negative effects of collinearity and as a more objective solution for the problem of variable selection in studies dealing with large number of species with heterogeneous responses to environmental variables.	[de Marco Junior, Paulo; Nobrega, Caroline Correa] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil; [Nobrega, Caroline Correa] IPAM, Belem, Para, Brazil	Universidade Federal de Goias	de Marco, P (corresponding author), Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil.	pdemarco@ufg.br	De Marco, Paulo/B-2209-2009	De Marco, Paulo/0000-0002-3628-6405	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Conselho Nacional de Pesquisas [308694/2015-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Conselho Nacional de Pesquisas; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Conselho Nacional de Pesquisas, www.cnpq.br/, Grant number: 308694/2015-5 received by PDM; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior received by CCN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Gutierrez Jesus, 2013, PLoS One, V8, pe63708, DOI 10.1371/journal.pone.0063708; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P17, DOI 10.1111/j.1466-822X.2004.00128.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Austin MP, 2006, ECOL MODEL, V199, P197, DOI 10.1016/j.ecolmodel.2006.05.023; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Bahn V, 2006, IMPORTANCE SPATIAL A, V6, P835; Bahn V, 2013, OIKOS, V122, P321, DOI 10.1111/j.1600-0706.2012.00299.x; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Baselga A, 2012, J BIOGEOGR, V39, P760, DOI 10.1111/j.1365-2699.2011.02612.x; Benito BM, 2013, METHODS ECOL EVOL, V4, P327, DOI 10.1111/2041-210x.12022; Bohning-Gaese K, 2006, AM NAT, V167, P555, DOI 10.1086/501078; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Buse J, 2011, ECOL MODEL, V222, P2130, DOI 10.1016/j.ecolmodel.2011.04.010; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Crawford PHC, 2010, J INSECT CONSERV, V14, P511, DOI 10.1007/s10841-010-9280-8; De Almeida MC, 2010, INSECT CONSERV DIVER, V3, P252, DOI 10.1111/j.1752-4598.2010.00096.x; Pena JCD, 2014, BIOL CONSERV, V170, P130, DOI 10.1016/j.biocon.2013.12.015; De Marco P, 2008, BIOL LETTERS, V4, P577, DOI 10.1098/rsbl.2008.0210; Munoz MED, 2011, GEOINFORMATICA, V15, P111, DOI 10.1007/s10707-009-0090-7; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Domisch S, 2013, ECOL MODEL, V257, P1, DOI 10.1016/j.ecolmodel.2013.02.019; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dormann CF, 2008, ECOLOGY, V89, P3371, DOI 10.1890/07-1772.1; Dudik M, 2007, J MACH LEARN RES, V8, P1217; Dupin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020957; Velazco SJE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186025; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franklin J, 2009, EFFECT SPECIES RARIT, P167, DOI [10.1111/j.1472-4642.2008.00536.x, DOI 10.1111/J.1472-4642.2008.00536.X]; Franklin J, 2009, MAPPING SPECIES DIST; Gaston A, 2011, ECOL MODEL, V222, P2037, DOI 10.1016/j.ecolmodel.2011.04.015; Godsoe W, 2014, ECOGRAPHY, V37, P130, DOI 10.1111/j.1600-0587.2013.00403.x; Godsoe W, 2010, SYST BIOL, V59, P298, DOI 10.1093/sysbio/syq005; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hanberry BB, 2012, ECOL MODEL, V227, P29, DOI 10.1016/j.ecolmodel.2011.12.001; Hanspach J, 2011, GLOBAL ECOL BIOGEOGR, V20, P779, DOI 10.1111/j.1466-8238.2011.00649.x; Hastie T, 2013, ECOGRAPHY, V36, P864, DOI 10.1111/j.1600-0587.2013.00321.x; Heikkinen RK, 2012, ECOGRAPHY, V35, P276, DOI 10.1111/j.1600-0587.2011.06999.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; Hirzel AH, 2001, ECOL MODEL, V145, P111, DOI 10.1016/S0304-3800(01)00396-9; Hortal J, 2008, OIKOS, V117, P847, DOI 10.1111/j.0030-1299.2008.16434.x; Hortal J, 2012, NAT CONSERVACAO, V10, P108, DOI 10.4322/natcon.2012.029; International Union for Conservation of Nature [IUCN], 2012, TWSG NEWS; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Jimenez-Alfaro B, 2012, BIOL CONSERV, V147, P190, DOI 10.1016/j.biocon.2011.12.030; Jimenez-Valverde A, 2009, COMMUNITY ECOL, V10, P196, DOI 10.1556/ComEc.10.2009.2.9; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Larson ER, 2012, GLOBAL ECOL BIOGEOGR, V21, P1114, DOI 10.1111/j.1466-8238.2012.00758.x; Liu CR, 2011, ECOGRAPHY, V34, P232, DOI 10.1111/j.1600-0587.2010.06354.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2011, J NAT CONSERV, V19, P1, DOI 10.1016/j.jnc.2010.03.002; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Loyola RD, 2013, BIODIVERS CONSERV, V22, P483, DOI 10.1007/s10531-012-0424-x; Luoto M, 2005, GLOBAL ECOL BIOGEOGR, V14, P575, DOI 10.1111/j.1466-822x.2005.00186.x; Manly B.F.J., 1994, MULTIVARIATE STAT ME; Marcer A, 2013, BIOL CONSERV, V166, P221, DOI 10.1016/j.biocon.2013.07.001; Barbosa AM, 2013, DIVERS DISTRIB, V19, P1333, DOI 10.1111/ddi.12100; Marmion M, 2009, ECOL MODEL, V220, P3512, DOI 10.1016/j.ecolmodel.2008.10.019; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Mateo RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055648; McPherson JM, 2007, ECOGRAPHY, V30, P135, DOI 10.1111/j.2006.0906-7590.04823.x; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Meier ES, 2010, ECOGRAPHY, V33, P1038, DOI 10.1111/j.1600-0587.2010.06229.x; Meynard CN, 2007, J BIOGEOGR, V34, P1455, DOI 10.1111/j.1365-2699.2007.01720.x; Meynard CN, 2013, J BIOGEOGR, V40, P1, DOI 10.1111/jbi.12006; Morin X, 2013, ECOGRAPHY, V36, P300, DOI 10.1111/j.1600-0587.2012.07340.x; Naimi B, 2011, J BIOGEOGR, V38, P1497, DOI 10.1111/j.1365-2699.2011.02523.x; Newbold T, 2009, BIODIVERS CONSERV, V18, P3629, DOI 10.1007/s10531-009-9668-5; Nobrega CC, 2011, DIVERS DISTRIB, V17, P491, DOI 10.1111/j.1472-4642.2011.00749.x; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2012, NAT CONSERVACAO, V10, P102, DOI 10.4322/natcon.2012.019; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Record S, 2013, GLOBAL ECOL BIOGEOGR, V22, P760, DOI 10.1111/geb.12017; Renner IW, 2013, BIOMETRICS, V69, P274, DOI 10.1111/j.1541-0420.2012.01824.x; Roberts DR, 2012, ECOGRAPHY, V35, P792, DOI 10.1111/j.1600-0587.2011.07147.x; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; Rodriguez-Rey M, 2013, ECOL MODEL, V256, P1, DOI 10.1016/j.ecolmodel.2013.01.024; Sanchez-Fernandez D, 2011, DIVERS DISTRIB, V17, P163, DOI 10.1111/j.1472-4642.2010.00716.x; Santika T, 2009, ECOL MODEL, V220, P2365, DOI 10.1016/j.ecolmodel.2009.06.004; Segurado P, 2006, J APPL ECOL, V43, P433, DOI 10.1111/j.1365-2664.2006.01162.x; Silva DP, 2014, ECOL MODEL, V273, P200, DOI 10.1016/j.ecolmodel.2013.11.016; Silva DP, 2013, APIDOLOGIE, V44, P673, DOI 10.1007/s13592-013-0216-7; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Sodhi NS, 2008, DIVERS DISTRIB, V14, P1, DOI 10.1111/j.1472-4642.2007.00398.x; Stankowski PA, 2010, ECOL MODEL, V221, P1655, DOI 10.1016/j.ecolmodel.2010.03.016; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Syfert MM, 2014, BIOL CONSERV, V177, P174, DOI 10.1016/j.biocon.2014.06.012; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; Syphard AD, 2009, ECOGRAPHY, V32, P907, DOI 10.1111/j.1600-0587.2009.05883.x; Tarrant J, 2013, J NAT CONSERV, V21, P369, DOI 10.1016/j.jnc.2013.03.006; Thuiller W, 2006, DIVERS DISTRIB, V12, P49, DOI 10.1111/j.1366-9516.2006.00216.x; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Serra BDV, 2012, NAT CONSERVACAO, V10, P199, DOI 10.4322/natcon.2012.027; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Zhu GP, 2017, BIOL INVASIONS, V19, P2519, DOI 10.1007/s10530-017-1460-y; Zurell D, 2012, ECOGRAPHY, V35, P590, DOI 10.1111/j.1600-0587.2011.07200.x; Zurell D, 2010, OIKOS, V119, P622, DOI 10.1111/j.1600-0706.2009.18284.x	124	127	129	6	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0202403	10.1371/journal.pone.0202403	http://dx.doi.org/10.1371/journal.pone.0202403			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204749	Green Submitted, Green Published, gold			2022-12-26	WOS:000444355500006
J	Frey, S; Cantieni, T; Vuillemin, N; Haine, A; Kammer, R; von Tengg-Kobligk, H; Obrist, D; Baumgartner, I				Frey, Sabrina; Cantieni, Tarcisi; Vuillemin, Nicolas; Haine, Axel; Kammer, Rafael; von Tengg-Kobligk, Hendrik; Obrist, Dominik; Baumgartner, Iris			Angioarchitecture and hemodynamics of microvascular arterio-venous malformations	PLOS ONE			English	Article							RAT SPINOTRAPEZIUS MUSCLE; SKELETAL-MUSCLE; VOLUME; DISTENSIBILITY; ULTRASOUND; DIAGNOSIS; NETWORK; BODY; FLOW	Introduction Arteriovenous malformations (AVMs) are characterized by pathological high flow, low resistance connections between arteries and veins. Treatment is critically dependent on correct interpretation of angioarchitectural features. However, some microfistular AVMs do not match the characteristics described in current AVM classification systems. Therefore, we propose a new subgroup of microfistular AVMs, composed of enlarged, fistulous paths on the venous half of capillaries and/or dilated draining venules (hyperdynamic, capillary-venulous malformation [CV-AVM]). CV-AVMs still ensure arterial flow to the periphery and fistulous venous drainage is less pronounced than in classical AVMs such that these lesions are often misinterpreted as venous malformations. Materials and methods We developed a computational model to study the effects of microvascular anomalies on local hemodynamics, as well as their impact on angiographic contrast propagation. Flow rates and pressures were computed with a lumped parameter description, while contrast propagation was determined by solving the 1D advection-diffusion equation. Results and conclusions For the newly proposed CV-AVM angioarchitecture, the computational model predicts increased arterio-venous contrast agent transit times and highly dispersive transport characteristics, compared to microfistular, interstitial type IV AVMs and high flow type II and III AVMs. We related these findings to time-contrast intensity curves sampled from clinical angiographies and found that there is strong evidence for the existence of CV-AVM.	[Frey, Sabrina; Cantieni, Tarcisi; Obrist, Dominik] Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland; [Vuillemin, Nicolas; Haine, Axel; Kammer, Rafael; Baumgartner, Iris] Univ Bern, Univ Hosp Bern, Div Angiol, Swiss Cardiovasc Ctr, Bern, Switzerland; [von Tengg-Kobligk, Hendrik] Univ Bern, Univ Hosp Bern, Dept Diagnost Intervent & Pediat Radiol, Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Obrist, D (corresponding author), Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland.	dominik.obrist@artorg.unibe.ch	Obrist, Dominik/AAT-3254-2020; von Tengg-Kobligk, Hendrik/N-6792-2019	Obrist, Dominik/0000-0002-6062-9076; von Tengg-Kobligk, Hendrik/0000-0003-3207-3223; Cantieni, Tarcisi/0000-0003-0002-2552				[Anonymous], 2007, COLOR ATLAS VASCULAR; Berczi V, 2005, EUR J APPL PHYSIOL, V95, P283, DOI 10.1007/s00421-005-0002-y; Cho SK, 2006, J ENDOVASC THER, V13, P527, DOI 10.1583/05-1769.1; COLEMONT L, 1981, CARDIOVASC RES, V15, P262, DOI 10.1093/cvr/15.5.262; DEBATIN JF, 1995, EUR RADIOL, V5, P36; Do YS, 2007, TECH VASC INTERV RAD, V10, P291, DOI 10.1053/j.tvir.2008.03.008; Dompmartin A, 2010, PHLEBOLOGY, V25, P224, DOI 10.1258/phleb.2009.009041; ENGELSON ET, 1985, MICROVASC RES, V30, P29, DOI 10.1016/0026-2862(85)90035-4; Erbertseder K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031966; Frey S, 2017, ANN BIOMED ENG, V45, P1449, DOI 10.1007/s10439-017-1821-9; Fung Y. C., 1997, BIOMECHANICS CIRCULA; GAMBLE G, 1994, STROKE, V25, P11, DOI 10.1161/01.STR.25.1.11; Hammerlin G., 1994, NUMERISCHE MATH; Johnson, 1998, HDB FLUID DYNAMICS; Kalayci TO, 2015, MED ULTRASON, V17, P482, DOI 10.11152/mu.2013.2066.174. w; Kim YW, 2006, J VASC SURG, V44, P545, DOI 10.1016/j.jvs.2006.05.035; KING RB, 1993, AM J PHYSIOL, V265, pH2196, DOI 10.1152/ajpheart.1993.265.6.H2196; Kundu P.K, 2011, VORTICITY DYNAMICS F; Landolt A, 2013, EXP FLUIDS, V54, DOI 10.1007/s00348-013-1523-5; LIPOWSKY HH, 1980, MICROVASC RES, V19, P297, DOI 10.1016/0026-2862(80)90050-3; Mayrovitz HN, 2005, LYMPHOLOGY, V38, P20; PRIES AR, 1992, AM J PHYSIOL, V263, pH1770, DOI 10.1152/ajpheart.1992.263.6.H1770; SKALAK TC, 1986, J BIOMECH ENG-T ASME, V108, P193, DOI 10.1115/1.3138602; SKALAK TC, 1986, MICROVASC RES, V32, P333, DOI 10.1016/0026-2862(86)90069-5; Stein M, 2014, PRS-GLOB OPEN, V2, DOI 10.1097/GOX.0000000000000145; Trop I, 1999, RADIOLOGY, V212, P841, DOI 10.1148/radiology.212.3.r99au11841; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Yakes W, 2014, GEFASSCHIRURGIE, V19, P325, DOI 10.1007/s00772-013-1303-9; Yakes W., 2015, HEMANGIOMAS VASCULAR, P263, DOI [10.1007/978-88-470-5673-2_33, DOI 10.1007/978-88-470-5673-2_33]	29	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203368	10.1371/journal.pone.0203368	http://dx.doi.org/10.1371/journal.pone.0203368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192812	Green Submitted, gold, Green Published			2022-12-26	WOS:000444093600064
J	Garapati, P; Pal, B; Siddiqui, NA; Bimal, S; Das, P; Murti, K; Pandey, K				Garapati, Pavan; Pal, Biplab; Siddiqui, Niyamat Ali; Bimal, Sanjiva; Das, Pradeep; Murti, Krishna; Pandey, Krishna			Knowledge, stigma, health seeking behaviour and its determinants among patients with post kalaazar dermal leishmaniasis, Bihar, India	PLOS ONE			English	Article							ONCHOCERCAL SKIN-DISEASE; ATTITUDE; AZAR; AREA	Background Lesishmaniasis is a neglected tropical disease endemic in Bihar, India. Inappropriate health seeking behaviour of post kala-azar dermal leishmaniasis (PKDL) patients may increase the disease duration, severity and transmissibility. Simultaneously, lack of knowledge and perceived stigma may also increase the length of delay in receiving treatment. This ultimately effects the kala-azar elimination program. Methods A cross sectional study was conducted in 120 confirmed PKDL patients, aged 18 years and older. Data related to knowledge and health seeking behaviour was collected by a pretested questionnaire. EMIC stigma scale was used for assessing the perceived stigma. Patients were personally interviewed after taking informed consent. Data analysis was done by using SPSS 16 software. Results The time between appearance of symptoms and first medical consultation (patient delay) ranged from 15 days to 5475 days (15 years) with a median of 285 days. The time between first medical consultations to onset of specific treatment (system delay) ranged from 2 to 5475 days with a median of 365 days. Many patients approached first to quacks (8.4%), homeopathic and ayurvedic practitioners (25.8%) upon recognition of symptoms. Majority of the patients (68.3%) had poor knowledge about PKDL and its vector. Type of skin lesions and gender had significant association with patient delay and system delay respectively (p<0.05). Distance to primary health centre (PHC) had significant association with patients delay as well as system delay (p<0.05). Patients with younger age, unmarried and polymorphic lesions had higher stigma (p<0.05). Patients with PKDL feel stigmatized in different areas. Conclusion PKDL treatment delays were unacceptably high and patients had poor knowledge compounded with feelings of stigmatization. To reduce the delay, a system may be evolved to establish some sort of public-private collaboration, besides awareness programs should be tailored, and implemented for improving the patient education regarding the disease and its linkage with VL.	[Garapati, Pavan; Pal, Biplab; Murti, Krishna] Natl Inst Pharmaceut Educ & Res, Dept Pharm Practice, Hajipur, Bihar, India; [Siddiqui, Niyamat Ali] Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Dept Biostat, Patna, Bihar, India; [Bimal, Sanjiva] Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Dept Immunol, Patna, Bihar, India; [Das, Pradeep] Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Dept Mol Biol, Patna, Bihar, India; [Pandey, Krishna] Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Dept Clin Med, Patna, Bihar, India	National Institute of Pharmaceutical Education & Research (NIPER); Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI); Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI); Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI); Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI)	Murti, K (corresponding author), Natl Inst Pharmaceut Educ & Res, Dept Pharm Practice, Hajipur, Bihar, India.; Pandey, K (corresponding author), Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Dept Clin Med, Patna, Bihar, India.	krishnamurti74@gmail.com; drkrishnapandey@yahoo.com	Pal, Biplab/AGJ-4305-2022; murti, Krishna/N-2535-2015; garapati, pavan/AAP-6161-2020; Garapati, Pavan/AAJ-9580-2021	Garapati, Pavan/0000-0002-0666-2182; Pandey, Krishna/0000-0001-5930-2458; Murti, Krishna/0000-0001-9865-7454				Abebe G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013339; Adhikari B, 2013, J Nepal Health Res Counc, V11, P264; Adhikari B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002940; Akram A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130929; Alemu A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-382; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Aryal S, 2012, Kathmandu Univ Med J (KUMJ), V10, P48; Basher A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/314543; Biya Oladayo, 2014, Pan Afr Med J, V18 Suppl 1, P6, DOI 10.11694/pamj.supp.2014.18.1.4166; Brahmachari U N, 1922, Ind Med Gaz, V57, P125; Brieger WR, 1998, SOC SCI MED, V47, P841, DOI 10.1016/S0277-9536(98)00007-0; Deribe K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1178; Dianatinasab M, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004704; Karim Fazlul, 2007, Anthropol Med, V14, P139, DOI 10.1080/13648470701381440; Kebede N, 2016, ASIAN PAC J TROP BIO, V6, P562, DOI 10.1016/j.apjtb.2016.01.018; Litt E, 2012, TRENDS PARASITOL, V28, P195, DOI 10.1016/j.pt.2012.03.001; Mesfin MM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-53; Rafael F, 2010, EPILEPSIA, V51, P1061, DOI 10.1111/j.1528-1167.2009.02511.x; Ramesh V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2424-8; Singh A, 2016, INDIAN J PSYCHIAT, V58, P291, DOI 10.4103/0019-5545.192024; Singh SP, 2006, AM J TROP MED HYG, V75, P505, DOI 10.4269/ajtmh.2006.75.505; Stienstra Y, 2002, AM J TROP MED HYG, V67, P207, DOI 10.4269/ajtmh.2002.67.207; Vlassoff C, 2000, SOC SCI MED, V50, P1353, DOI 10.1016/S0277-9536(99)00389-5; Weiss MG, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000237; WHO, 2010, WHO TECH REP SER, V949, P1; WHO, 2015, KAL AZ EL PROGR REP; WHO World Health Organization, 2012, WHO CONS M KOLK IND, P2; Zijistra EE, 2003, LANCET INFECT DIS, V3, P87, DOI 10.1016/S1473-3099(03)00517-6	28	15	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203407	10.1371/journal.pone.0203407	http://dx.doi.org/10.1371/journal.pone.0203407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192805	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600071
J	Liu, ZY; Wang, TT; Liu, Y; Wang, AH; Xie, DH; Kong, FJ; Xiong, LL; Chen, LZ; Wang, H				Liu, Zhiyu; Wang, Tingting; Liu, Yuan; Wang, Aihua; Xie, Donghua; Kong, Fanjuan; Xiong, Lili; Chen, Lizhang; Wang, Hua			Evaluating the progress to eliminate mother-to-child transmission (MTCT) of syphilis in Hunan Province, China: A study based on a health service delivery model	PLOS ONE			English	Article							PREGNANCY; OUTCOMES	To prevent mother-to-child transmission (MTCT) of syphilis, Hunan Province launched a free syphilis screening and treatment programme in 2011. Thus far, the programme has been implemented for 6 years. This study aimed to assess progress toward the elimination of MTCT of syphilis in Hunan Province from 2011-2016. Estimates of syphilis-related adverse pregnancy outcomes (APOs) were based on the health service delivery model developed by the WHO, which were then translated into disability-adjusted life years (DALYs). Default values in the model were replaced by a Chinese version. The progress of this programme was assessed through the reduction of estimated DALYs with and without screening and treatment services. The results showed that the estimated number of syphilis-related APOs in Hunan Province from 2011 to 2016 was 3,840, more than 70% of which occurred among women who had at least one antenatal care visit but were not screened or treated for syphilis during pregnancy. The public health burden resulting from maternal syphilis-related APOs was 192,528 DALYs over six years, and with the current screening and treatment coverage, approximately 163,794 expected DALYs (46%) were averted. Our estimates indicate that in Hunan Province, syphilis in pregnancy continues to be an important cause of APOs, which can lead to substantial perinatal morbidity and mortality. Approximately half of the expected public health burden resulting from syphilis-related APOs was averted by the current screening and treatment services, which suggests progress toward the elimination of MTCT of syphilis in Hunan Province.	[Liu, Zhiyu; Wang, Aihua; Xie, Donghua; Kong, Fanjuan; Xiong, Lili] Hunan Prov Maternal & Child Hlth Care Hosp, Informat Management Div, Changsha, Hunan, Peoples R China; [Wang, Tingting; Chen, Lizhang] Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Liu, Yuan] Hunan Prov Ctr Dis Control & Prevent, Dept Chron Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Wang, Hua] Hunan Prov Maternal & Child Hlth Care Hosp, Div Med Genet, Changsha, Hunan, Peoples R China	Central South University	Chen, LZ (corresponding author), Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.; Wang, H (corresponding author), Hunan Prov Maternal & Child Hlth Care Hosp, Div Med Genet, Changsha, Hunan, Peoples R China.	liche4005@126.com; wanghua213@aliyun.com	wang, tingting/AAK-2640-2020		Health and Family Planning Commission of Hunan Province [B2017130]	Health and Family Planning Commission of Hunan Province	This work was supported by Grant number: B2017130; the URLs: http://wjw.hunan.gov.cn/; the name of funding institution: Health and Family Planning Commission of Hunan Province; the author who received the funding: ZYL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai L., 2009, THESIS; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Chen L., 2013, THESIS; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; FIUMARA NJ, 1988, ANN NY ACAD SCI, V549, P187, DOI 10.1111/j.1749-6632.1988.tb23971.x; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Jiao T, 2010, PERINATAL OUTCOMES P, V24, P934; Li YC, 2015, THESIS; MCDERMOTT J, 1993, B WORLD HEALTH ORGAN, V71, P773; Ministry of Health RPC, 2007, 2762007 WS MIN HLTH; National Health and Family Planning Commission of the People's Republic of China, NAT PROGR PREV CONTR; National Health Commission of the People's Republic of China, 2014, PROGR REP PREV CONTR; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Qin JB, 2014, SEX TRANSM DIS, V41, P13, DOI 10.1097/OLQ.0000000000000062; Schackman BR, 2007, PLOS MED, V4, P937, DOI 10.1371/journal.pmed.0040183; WHO, 2013, WHO METHODS DATA SOU; Wijesooriya NS, 2016, GLOBAL BURDEN MATERN, V4, pe525, DOI [10.1016/S2214-109X(16)30135-8, DOI 10.1016/S2214-109X(16)30135-8]; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 2007, GLOB EL CONG SYPH RA; World Health Organization, 2011, METH SURV MON CONG S; World Health Organization, 2012, INV CAS EL MOTH TO C; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2014, GLOB GUID CRIT PROC; [杨凤娟 Yang Fengjuan], 2009, [中国卫生统计, Chinese Journal of Health Statistics], V26, P32	24	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203565	10.1371/journal.pone.0203565	http://dx.doi.org/10.1371/journal.pone.0203565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192825	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600104
J	Bista, M; Panthi, S; Weiskopf, SR				Bista, Manjit; Panthi, Saroj; Weiskopf, Sarah R.			Habitat overlap between Asiatic black bear Ursus thibetanus and red panda Ailurus fulgens in Himalaya	PLOS ONE			English	Article							RARA NATIONAL-PARK; CONSERVATION-AREA; FOOD-HABITS; DISTRICT; MODELS; PERFORMANCE; DISTURBANCE; PREDICTION; PREFERENCE; SELECTION	Studying habitat overlap between sympatric species is one of the best ways to identify inter species relationships and to direct conservation efforts so that multiple species can benefit. However, studies exploring interspecies relationships are very limited in Nepal, making it difficult for the government of Nepal and conservation partners to manage wildlife in their habitats, especially in Himalayan protected areas. In this study, we identified habitat overlap between Asiatic black bear (Ursus thibetanus) and red panda (Ailurus fulgens) as well as important habitat types for both species in the Makalu Barun National Park, Nepal using Maximum Entropy (MaxEnt) modeling. GPS points of species occurrence were collected from the field, and environmental variables were extracted from freely available sources. We found that the study area contained 647 km(2) of Asiatic black bear habitat and 443 km(2) of the red panda habitat. 368 km(2) supported both species, which constituted 57% of the Asiatic black bear habitat and 83% of the red panda habitat. We found that conifer forest was the most important habitat type for both species. Because the largest portions of both species' habitat were located inside the buffer zone, a peripheral zone of national park, conservation efforts for these sympatric species should be focused inside the buffer zone to be most effective.	[Bista, Manjit] Minist Forests & Environm, Dept Natl Pk & Wildlife Conservat, Kathmandu, Nepal; [Panthi, Saroj] Minist Forests & Environm, Dept Forests, Kathmandu, Nepal; [Weiskopf, Sarah R.] US Geol Survey, Natl Climate Adaptat Sci Ctr, 959 Natl Ctr, Reston, VA 22092 USA	United States Department of the Interior; United States Geological Survey	Panthi, S (corresponding author), Minist Forests & Environm, Dept Forests, Kathmandu, Nepal.	mountsaroj@gmail.com	Weiskopf, Sarah/K-1633-2019	Weiskopf, Sarah/0000-0002-5933-8191; Panthi, Saroj/0000-0002-1502-7711	Makalu-Barun National Park office [530-2071/2072, 542-2072/2073]	Makalu-Barun National Park office	The study was conducted with the funding support from Makalu-Barun National Park office (530-2071/2072; 542-2072/2073). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Acharya KP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161717; Ahmadzadeh F, 2008, J NAT HIST, V42, P2379, DOI 10.1080/00222930802262741; Ali A, 2017, J NAT HIST, V51, P689, DOI 10.1080/00222933.2017.1303097; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2017, BRIEF TUTORIAL MAXEN; Aryal A, 2015, J MAMMAL, V96, P47, DOI 10.1093/jmammal/gyu001; Awan MN, 2016, INT J CONSERV SCI, V7, P719; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bhatta Manoj, 2014, Open Journal of Ecology, V4, P989; Bista D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178797; Bista Rabindra, 2013, Zoology and Ecology, V23, P83, DOI 10.1080/21658005.2013.774813; Boubli J, 2009, INT J PRIMATOL, V30, P217, DOI 10.1007/s10764-009-9335-4; Brambilla M, 2013, BIRD CONSERV INT, V23, P502, DOI 10.1017/S0959270913000117; Byers AC, 1996, MT RES DEV, V16, P235, DOI 10.2307/3673946; Chakraborty R, 2015, MAMMALIA, V79, P25, DOI 10.1515/mammalia-2013-0105; Charoo SA, 2011, URSUS, V22, P106, DOI 10.2192/URSUS-D-10-00021.1; Chhetri M., 2013, DISTRIBUTION ABUNDAN; CITES, 2017, CONV INT TRAD END SP; Dasgupta Soumya, 2015, Asian Journal of Conservation Biology, V4, P20; Dendup P, 2017, ORYX, V51, P701, DOI 10.1017/S0030605316000399; Department of National Parks Wildlife and Plant Conservation, 2021, ROY THAI GOVT GAZ; DNPWC, 2012, ANN REPORT; DNPWC, 2010, ANN REPORT; *DNPWC, 2017, PROT AR NEP; Dorji S, 2012, ORYX, V46, P536, DOI 10.1017/S0030605311000780; Dorji S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026483; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Escobar LE, 2015, BIOL CONSERV, V191, P400, DOI 10.1016/j.biocon.2015.06.040; ESRI, 2017, ARCGIS DESKT REL 10; Fei YX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173274; Fleishman E, 2000, ECOL APPL, V10, P569, DOI 10.1890/1051-0761(2000)010[0569:ANMFSO]2.0.CO;2; Garshelis D, 2017, URSUS THIBETANUS; Glatston A, 2015, AILURUS FULGENS; GoN, 2014, NEP 5 NAT REP CONV B; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hu YB, 2017, P NATL ACAD SCI USA, V114, P1081, DOI 10.1073/pnas.1613870114; Huygens Oscar C., 2003, Ursus, V14, P236; Jamtsho Y, 2016, GLOB ECOL CONSERV, V8, P183, DOI 10.1016/j.gecco.2016.09.004; Johnson SA, 2017, J NAT CONSERV, V37, P47, DOI 10.1016/j.jnc.2017.03.003; Kandel Pratikshya, 2016, Journal of Asia-Pacific Biodiversity, V9, P1; Lewis M., 2011, International Zoo Yearbook, V45, P250, DOI 10.1111/j.1748-1090.2011.00135.x; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Mallick Jayanta Kumar, 2010, Small Carnivore Conservation, V43, P30; Manzoor SA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25437-1; Maslo B, 2016, BIOL CONSERV, V203, P233, DOI 10.1016/j.biocon.2016.09.012; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; Panthi S, 2011, THESIS; PANTHI S, 2018, THESIS; Panthi S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180978; Panthi S, 2015, SCI NAT-HEIDELBERG, V102, DOI 10.1007/s00114-015-1307-2; Panthi S, 2012, ZOOL STUD, V51, P701; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pradhan S, 2001, BIOL CONSERV, V98, P11, DOI 10.1016/S0006-3207(00)00079-3; ROBERTS M S, 1984, Mammalian Species, P1, DOI 10.2307/3503840; Rota CT, 2011, ECOGRAPHY, V34, P659, DOI 10.1111/j.1600-0587.2010.06433.x; Sharma HP, 2014, HYSTRIX, V25, P47, DOI 10.4404/hystrix-25.1-9033; Sharma HP, 2014, ORYX, V48, P228, DOI 10.1017/S0030605313001403; Shrestha T., 1989, DEV ECOLOGY ARUN RIV; Steinmetz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014509; Sun Y., 2011, THESIS; Thapa A, 2018, BIOL CONSERV, V220, P112, DOI 10.1016/j.biocon.2018.02.014; Trotta-Moreu N, 2010, ENVIRON ENTOMOL, V39, P42, DOI 10.1603/EN08179; Uddin K, 2015, J ENVIRON MANAGE, V148, P82, DOI 10.1016/j.jenvman.2014.07.047; Wang RL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192153; Wang TJ, 2009, PHOTOGRAMM ENG REM S, V75, P37, DOI 10.14358/PERS.75.1.37; Wei FW, 1999, BIOL CONSERV, V89, P285, DOI 10.1016/S0006-3207(98)00156-6; Wei FW, 2000, J MAMMAL, V81, P448, DOI 10.1644/1545-1542(2000)081<0448:HUASBT>2.0.CO;2; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]; Wu W, 2016, PEERJ, V4, DOI 10.7717/peerj.1756; YONZON PB, 1991, CONSERV BIOL, V5, P196, DOI 10.1111/j.1523-1739.1991.tb00124.x; York P, 2011, FRONT EARTH SCI-PRC, V5, P120, DOI 10.1007/s11707-011-0154-5	74	18	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203697	10.1371/journal.pone.0203697	http://dx.doi.org/10.1371/journal.pone.0203697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188937	Green Published, gold, Green Submitted			2022-12-26	WOS:000444228700049
J	Beekman, CN; Meckler, L; Kim, E; Bennett, RJ				Beekman, Chapman N.; Meckler, Lauren; Kim, Eleanor; Bennett, Richard J.			Galleria mellonella as an insect model for P. destructans, the cause of White-nose Syndrome in bats	PLOS ONE			English	Article							GEOMYCES-DESTRUCTANS; DRUG-RESISTANCE; INFECTION; HEMOCYTES; VIRULENCE	Pseudogymnoascus destructans is the fungal pathogen responsible for White-nose Syndrome (WNS), a disease that has killed millions of bats in North America over the last decade. A major obstacle to research on P. destructans has been the lack of a tractable infection model for monitoring virulence. Here, we establish a high-throughput model of infection using larvae of Galleria mellonella, an invertebrate used to study host-pathogen interactions for a wide range of microbial species. We demonstrate that P. destructans can kill G. mellonella larvae in an inoculum-dependent manner when infected larvae are housed at 13 degrees C or 18 degrees C. Larval killing is an active process, as heat-killed P. destructans spores caused significantly decreased levels of larval death compared to live spores. We also show that fungal spores that were germinated prior to inoculation were able to kill larvae 3-4 times faster than non-germinated spores. Lastly, we identified chemical inhibitors of P. destructans and used G. mellonella to evaluate these inhibitors for their ability to reduce virulence. We demonstrate that amphotericin B can effectively block larval killing by P. destructans and thereby establish that this infection model can be used to screen biocontrol agents against this fungal pathogen.	[Beekman, Chapman N.; Meckler, Lauren; Kim, Eleanor; Bennett, Richard J.] Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA	Brown University	Bennett, RJ (corresponding author), Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.	Richard_Bennett@brown.edu		Bennett, Richard/0000-0001-7563-484X	National Science Foundation [1456787]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Science Foundation (https://www.nsf.gov/) grant number 1456787 to RJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterman RR, 2011, FUNGAL GENET BIOL, V48, P335, DOI 10.1016/j.fgb.2010.11.010; Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Anderson TM, 2014, NAT CHEM BIOL, V10, P400, DOI 10.1038/nchembio.1496; [Anonymous], 2018, WHIT NOS SYNDR FACT; Bain JM, 2014, MBIO, V5, DOI 10.1128/mBio.01874-14; Bergin D, 2005, INFECT IMMUN, V73, P4161, DOI 10.1128/IAI.73.7.4161-4170.2005; Binder U, 2016, FUNGAL BIOL-UK, V120, P288, DOI 10.1016/j.funbio.2015.06.002; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Browne N, 2013, VIRULENCE, V4, P597, DOI 10.4161/viru.25906; Mesa-Arango AC, 2013, MED MYCOL, V51, P461, DOI 10.3109/13693786.2012.737031; Chai LYA, 2010, IMMUNOBIOLOGY, V215, P915, DOI 10.1016/j.imbio.2009.10.002; Chaturvedi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017032; Coleman JJ, 2011, FUNGAL BIOL-UK, V115, P1279, DOI 10.1016/j.funbio.2011.09.005; Cornelison CT, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0246-y; Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835; EILAM Y, 1987, ANTIMICROB AGENTS CH, V31, P834, DOI 10.1128/AAC.31.5.834; Ene IV, 2016, MBIO, V7, DOI [10.1128/mBio.01269-16, 10.1128/mbio.01269-16]; Ene IV, 2012, PROTEOMICS, V12, P3164, DOI 10.1002/pmic.201200228; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; Erwig LP, 2016, NAT REV MICROBIOL, V14, P163, DOI 10.1038/nrmicro.2015.21; Field KA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005168; Flieger M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33200; Frank CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153535; Galardini M, 2014, GENOMICS, V103, P1, DOI 10.1016/j.ygeno.2013.11.005; Garcia-Rodas R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024485; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Li DD, 2013, BIOL PHARM BULL, V36, P1482, DOI 10.1248/bpb.b13-00270; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Maurer E, 2015, VIRULENCE, V6, P603, DOI 10.1080/21505594.2015.1045183; Meteyer CU, 2012, VIRULENCE, V3, P583, DOI 10.4161/viru.22330; Meteyer CU, 2011, J WILDLIFE DIS, V47, P618, DOI 10.7589/0090-3558-47.3.618; Moore MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058976; O'Donoghue AJ, 2015, P NATL ACAD SCI USA, V112, pE3152, DOI 10.1073/pnas.1509071112; Pannkuk EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120508; Pye AE, 1977, INSECT BIOCHEM, V8, P7; Rapin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112285; Reeder SM, 2017, VIRULENCE, V8, P1695, DOI 10.1080/21505594.2017.1342910; Renwick J, 2007, DEV COMP IMMUNOL, V31, P347, DOI 10.1016/j.dci.2006.06.007; REZABEK GH, 1992, DRUGS, V43, P674, DOI 10.2165/00003495-199243050-00004; Slater JL, 2011, MED MYCOL, V49, pS107, DOI 10.3109/13693786.2010.523852; Uwamahoro N, 2014, MBIO, V5, DOI 10.1128/mBio.00003-14; Vitale RG, 2007, MYCOSES, V50, P270, DOI 10.1111/j.1439-0507.2007.01371.x; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Wilson MB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178968	47	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0201915	10.1371/journal.pone.0201915	http://dx.doi.org/10.1371/journal.pone.0201915			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183704	Green Published, Green Submitted, gold			2022-12-26	WOS:000443789900009
J	Cao, HC; Wang, M; Wang, Q; Xu, TT; Du, YH; Li, HY; Qian, CQ; Yin, ZQ; Wang, L; Wei, Y; Wu, P; Guo, X; Yang, B; Liu, B				Cao, Hengchun; Wang, Min; Wang, Qian; Xu, Tingting; Du, Yuhui; Li, Huiying; Qian, Chengqian; Yin, Zhiqiu; Wang, Lu; Wei, Yi; Wu, Pan; Guo, Xi; Yang, Bin; Liu, Bin			Identifying genetic diversity of O antigens in Aeromonas hydrophila for molecular serotype detection	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; ENTEROBACTERIAL COMMON ANTIGEN; SEROLOGICAL CROSS-REACTIONS; RHAMNOSE SYNTHESIS PATHWAY; PROTEIN H-NS; CATALYTIC MECHANISM; FUNCTIONAL-CHARACTERIZATION; SECRETION SYSTEM; BIOSYNTHESIS; LIPOPOLYSACCHARIDE	Aeromonas hydrophila is a globally occurring, potentially virulent, gram-negative opportunistic pathogen that is known to cause water and food-borne diseases around the world. In this study, we use whole genome sequencing and in silico analyses to identify 14 putative O antigen gene clusters (OGCs) located downstream of the housekeeping genes acrB and/or oprM. We have also identified 7 novel OGCs by analyzing 15 publicly available genomes of different A. hydrophila strains. From the 14 OGCs identified initially, we have deduced that O antigen processing genes involved in the wzx/wzy pathway and the ABC transporter (wzm/wzt) pathway exhibit high molecular diversity among different A. hydrophila strains. Using these genes, we have developed a multiplexed Luminex-based array system that can identify up to 14 A. hydrophila strains. By combining our other results and including the sequences of processing genes from 13 other OGCs (7 OGCs identified from publicly available genome sequences and 6 OGCs that were previously published), we also have the data to create an array system that can identify 25 different A. hydrophila serotypes. Although clinical detection, epidemiological surveillance, and tracing of pathogenic bacteria are typically done using serotyping methods that rely on identifying bacterial surface O antigens through agglutination reactions with antisera, molecular methods such as the one we have developed may be quicker and more cost effective. Our assay shows high specificity, reproducibility, and sensitivity, being able to classify A. hydrophila strains using just 0.1 ng of genomic DNA. In conclusion, our findings indicate that a molecular serotyping system for A. hydrophila could be developed based on specific genes, providing an important molecular tool for the identification of A. hydrophila serotypes.	[Cao, Hengchun; Wang, Min; Wang, Qian; Xu, Tingting; Du, Yuhui; Li, Huiying; Qian, Chengqian; Yin, Zhiqiu; Wang, Lu; Wei, Yi; Wu, Pan; Guo, Xi; Yang, Bin; Liu, Bin] Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin Econ Technol Dev Area, Tianjin, Peoples R China; [Cao, Hengchun; Wang, Min; Wang, Qian; Xu, Tingting; Du, Yuhui; Li, Huiying; Qian, Chengqian; Yin, Zhiqiu; Wang, Lu; Wei, Yi; Wu, Pan; Guo, Xi; Yang, Bin; Liu, Bin] Tianjin Key Lab Microbial Funct Genom, Tianjin Econ Technol Dev Area, Tianjin, Peoples R China; [Cao, Hengchun; Wang, Min; Wang, Qian; Xu, Tingting; Du, Yuhui; Li, Huiying; Qian, Chengqian; Yin, Zhiqiu; Wang, Lu; Wei, Yi; Wu, Pan; Guo, Xi; Yang, Bin; Liu, Bin] Nankai Univ, TEDA Inst Biol Sci & Biotechnol, Tianjin Econ Technol Dev Area, Tianjin, Peoples R China	Nankai University	Yang, B; Liu, B (corresponding author), Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin Econ Technol Dev Area, Tianjin, Peoples R China.; Yang, B; Liu, B (corresponding author), Tianjin Key Lab Microbial Funct Genom, Tianjin Econ Technol Dev Area, Tianjin, Peoples R China.; Yang, B; Liu, B (corresponding author), Nankai Univ, TEDA Inst Biol Sci & Biotechnol, Tianjin Econ Technol Dev Area, Tianjin, Peoples R China.	yangbin@nankai.edu.cn; liubin1981@nankai.edu.cn	Yang, Bin/AAH-5164-2021	Yin, Zhiqiu/0000-0003-3355-3683; Cao, Hengchun/0000-0001-7818-4522	National Key Programs for Infectious Diseases of China [2017ZX10303405-001, 2017ZX10104002-001-006]; National Natural Science Foundation of China (NSFC) General Program Grant [81471904, 81772148, 31470194]; Tianjin Municipal Natural Science Foundation Grant [17JCYBJC24300]; Fundamental Research Funds for the Central Universities; Natural Science Foundation of Tianjin [17JCQNJC09300]	National Key Programs for Infectious Diseases of China; National Natural Science Foundation of China (NSFC) General Program Grant; Tianjin Municipal Natural Science Foundation Grant; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work received support from the National Key Programs for Infectious Diseases of China, (2017ZX10303405-001 and 2017ZX10104002-001-006), http://program.most.gov.cn/, BL; National Natural Science Foundation of China (NSFC) General Program Grant (81471904, 81772148, and 31470194), http://www.nsfc.gov.cn/, BL; Tianjin Municipal Natural Science Foundation Grant (17JCYBJC24300), http://kxjs.tj.gov.cn/, BL; the Fundamental Research Funds for the Central Universities, http://www.moe.gov.cn/, BL; the Natural Science Foundation of Tianjin (17JCQNJC09300), http://kxjs.tj.gov.cn/, BY.	ALEKSIC S, 1992, ZBL BAKT-INT J MED M, V276, P221; Allard STM, 2001, J MOL BIOL, V307, P283, DOI 10.1006/jmbi.2000.4470; Amer AO, 2002, MICROBIOL-SGM, V148, P571, DOI 10.1099/00221287-148-2-571; Bengoechea JA, 2002, J BACTERIOL, V184, P4277, DOI 10.1128/JB.184.15.4277-4287.2002; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P14993, DOI 10.1021/bi001627x; CHEASTY T, 1988, Journal of Diarrhoeal Diseases Research, V6, P95; Citterio B, 2015, VIRULENCE, V6, P417, DOI 10.1080/21505594.2015.1058479; Cook PD, 2008, BIOCHEMISTRY-US, V47, P2833, DOI 10.1021/bi702430d; Dunbar SA, 2003, J MICROBIOL METH, V53, P245, DOI 10.1016/S0167-7012(03)00028-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esteve C, 2004, APPL ENVIRON MICROB, V70, P5898, DOI 10.1128/aem.70.10.5898-5904.2004; Ferrieres L, 2007, MICROBIOL-SGM, V153, P1070, DOI 10.1099/mic.0.2006/002907-0; Galindo CL, 2006, MICROB PATHOGENESIS, V40, P56, DOI 10.1016/j.micpath.2005.11.001; Giraud MF, 1999, ACTA CRYSTALLOGR D, V55, P706, DOI 10.1107/S0907444998015042; Giraud MF, 1999, ACTA CRYSTALLOGR D, V55, P2043, DOI 10.1107/S0907444999012251; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo D, 2013, APPL ENVIRON MICROB, V79, P3392, DOI 10.1128/AEM.00225-13; Hossain MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080943; Iguchi A, 2015, J CLIN MICROBIOL, V53, P2427, DOI 10.1128/JCM.00321-15; Islam ST, 2010, MBIO, V1, DOI 10.1128/mBio.00189-10; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Janda JM, 1996, J CLIN MICROBIOL, V34, P1930, DOI 10.1128/JCM.34.8.1930-1933.1996; Ji YC, 2015, VIRULENCE, V6, P515, DOI 10.1080/21505594.2015.1049806; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Kneidinger B, 2001, J BIOL CHEM, V276, P20935, DOI 10.1074/jbc.M100378200; Knirel YA, 2002, CARBOHYD RES, V337, P1381, DOI 10.1016/S0008-6215(02)00136-2; Kowal P, 2008, BIOCHEMISTRY-US, V41, P15410; LaScola B, 1996, J CLIN MICROBIOL, V34, P2270, DOI 10.1128/JCM.34.9.2270-2274.1996; Lehrer J, 2007, J BACTERIOL, V189, P2618, DOI 10.1128/JB.01905-06; Li H, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006280; Li Q, 2000, MICROBIOL-UK, V146, P2291, DOI 10.1099/00221287-146-9-2291; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; Liu B, 2014, FEMS MICROBIOL REV, V38, P56, DOI 10.1111/1574-6976.12034; Marolda CL, 1999, MICROBIOL-UK, V145, P2485, DOI 10.1099/00221287-145-9-2485; Merino S, 1996, FEMS MICROBIOL LETT, V139, P97, DOI 10.1016/0378-1097(96)00068-7; Merino S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131905; Merino S, 2015, MAR DRUGS, V13, P2233, DOI 10.3390/md13042233; Miyagi K, 2017, WATER RES, V119, P171, DOI 10.1016/j.watres.2017.04.002; Najimi M, 2009, VET MICROBIOL, V133, P377, DOI 10.1016/j.vetmic.2008.07.008; Nakano Y, 2000, J BIOL CHEM, V275, P6806, DOI 10.1074/jbc.275.10.6806; Nassau PM, 1996, J BACTERIOL, V178, P1047, DOI 10.1128/jb.178.4.1047-1052.1996; Pang MB, 2015, SCI REP-UK, V5, DOI 10.1038/srep09833; Pfoestl A, 2003, J BIOL CHEM, V278, P26410, DOI 10.1074/jbc.M300858200; Pieretti G, 2011, CARBOHYD RES, V346, P2519, DOI 10.1016/j.carres.2011.08.003; Ponnusamy D, 2016, P NATL ACAD SCI USA, V113, P722, DOI 10.1073/pnas.1523817113; Portoles M, 2001, INFECT IMMUN, V69, P917, DOI 10.1128/IAI.69.2.917-923.2001; Poyraz O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121494; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rasmussen-Ivey CR, 2016, FRONTIERS MICROBIOLO, P7; Reid AN, 2005, J BACTERIOL, V187, P5470, DOI 10.1128/JB.187.15.5470-5481.2005; Rimsky S, 2004, CURR OPIN MICROBIOL, V7, P109, DOI 10.1016/j.mib.2004.02.001; Romero A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01574; Rosano C, 2000, J MOL BIOL, V303, P77, DOI 10.1006/jmbi.2000.4106; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Sha J, 2005, INFECT IMMUN, V73, P6446, DOI 10.1128/IAI.73.10.6446-6457.2005; Shepherd JG, 2000, INFECT IMMUN, V68, P6056, DOI 10.1128/IAI.68.10.6056-6061.2000; Somoza JR, 2000, STRUCTURE, V8, P123, DOI 10.1016/S0969-2126(00)00088-5; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Suarez G, 2008, MICROB PATHOGENESIS, V44, P344, DOI 10.1016/j.micpath.2007.10.005; Sun QZ, 2011, J CLIN MICROBIOL, V49, P3766, DOI 10.1128/JCM.01259-11; Wang HX, 2012, APPL ENVIRON MICROB, V78, P2482, DOI 10.1128/AEM.07629-11; Wang QA, 2010, MOL CELL PROBE, V24, P286, DOI 10.1016/j.mcp.2010.06.002; Wang Y, 2007, J BACTERIOL, V189, P8626, DOI 10.1128/JB.00777-07; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang YL, 2002, INFECT IMMUN, V70, P2326, DOI 10.1128/IAI.70.5.2326-2335.2002; Zhao X, 2000, J BIOL CHEM, V275, P33252, DOI 10.1074/jbc.M004191200; Zourob Mohammed, 2008, P139, DOI 10.1007/978-0-387-75113-9_8; Zuccotti S, 2001, J MOL BIOL, V313, P831, DOI 10.1006/jmbi.2001.5073	71	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203445	10.1371/journal.pone.0203445	http://dx.doi.org/10.1371/journal.pone.0203445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183757	Green Published, Green Submitted, gold			2022-12-26	WOS:000443789900066
J	Ercan, UK; Ibis, F; Dikyol, C; Horzum, N; Karaman, O; Yildirim, C; Cukur, E; Demirci, EA				Ercan, Utku Kursat; Ibis, Fatma; Dikyol, Caner; Horzum, Nesrin; Karaman, Ozan; Yildirim, Cagla; Cukur, Elif; Demirci, Emine Afra			Prevention of bacterial colonization on non-thermal atmospheric plasma treated surgical sutures for control and prevention of surgical site infections	PLOS ONE			English	Article							IN-VITRO; STAPHYLOCOCCUS-AUREUS; BIOFILM FORMATION; ADHERENCE; STERILIZATION; CONTAMINATION; ATTACHMENT; RESISTANCE; ADHESION; SURFACE	Surgical site infections have a remarkable impact on morbidity, extended hospitalization and mortality. Sutures strongly contribute to development of surgical site infections as they are considered foreign material in the human body. Sutures serve as excellent surfaces for microbial adherence and subsequent colonization, biofilm formation and infection on the site of a surgery. Various antimicrobial sutures have been developed to prevent suture-mediated surgical site infection. However, depending on the site of surgery, antimicrobial sutures may remain ineffective, and antimicrobial agents on them might have drawbacks. Plasma, defined as the fourth state of matter, composed of ionized gas, reactive oxygen and nitrogen species, free radical and neutrals, draws attention for the control and prevention of hospital-acquired infections due to its excellent antimicrobial activities. In the present study, the efficacy of non-thermal atmospheric plasma treatment for prevention of surgical site infections was investigated. First, contaminated poly (glycolic-co-lactic acid), polyglycolic acid, polydioxanone and poly (glycolic acid-co-caprolactone) sutures were treated with non-thermal atmospheric plasma to eradicate contaminating bacteria like Staphylococcus aureus and Escherichia coli. Moreover, sutures were pre-treated with non-thermal atmospheric plasma and then exposed to S. aureus and E. coli. Our results revealed that non-thermal atmospheric plasma treatment effectively eradicates contaminating bacteria on sutures, and non-thermal atmospheric plasma pre-treatment effectively prevents bacterial colonization on sutures without altering their mechanical properties. Chemical characterization of sutures was performed with FT-IR and XPS and results showed that non-thermal atmospheric plasma treatment substantially increased the hydrophilicity of sutures which might be the primary mechanism for the prevention of bacterial colonization. In conclusion, plasma-treated sutures could be considered as novel alternative materials for the control and prevention of surgical site infections.	[Ercan, Utku Kursat; Ibis, Fatma; Dikyol, Caner; Karaman, Ozan; Yildirim, Cagla; Cukur, Elif; Demirci, Emine Afra] Izmir Katip Celebi Univ, Fac Engn & Architecture, Dept Biomed Engn, Izmir, Turkey; [Horzum, Nesrin] Izmir Katip Celebi Univ, Fac Engn & Architecture, Dept Engn Sci, Izmir, Turkey	Izmir Katip Celebi University; Izmir Katip Celebi University	Ercan, UK (corresponding author), Izmir Katip Celebi Univ, Fac Engn & Architecture, Dept Biomed Engn, Izmir, Turkey.	utkuercan@gmail.com	yildirim, cagla/GVS-8704-2022; Ercan, Utku Kursat/AAX-1924-2020; Horzum, Nesrin/AAB-3714-2020; Ercan, Utku Kürşat/A-1658-2012	Horzum, Nesrin/0000-0002-2782-0581; Ercan, Utku Kürşat/0000-0002-9762-2265; Dikyol, Caner/0000-0002-1659-1269; Ibis-Ozdemir, Fatma/0000-0001-6230-0269	Izmir Katip Celebi University, Department of Scientific Research Projects (BAP) [2014-1-MUH-20]	Izmir Katip Celebi University, Department of Scientific Research Projects (BAP)	This study was financially supported by Izmir Katip Celebi University, Department of Scientific Research Projects (BAP) with the grant number 2014-1-MUH-20.	Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; Albala L, 2015, INT J PHARMACEUT, V494, P146, DOI 10.1016/j.ijpharm.2015.07.064; Arik N, 2019, POLYM BULL, V76, P797, DOI 10.1007/s00289-018-2409-8; Boybeyi O, 2016, EUR J PLAST SURG, V39, P1, DOI 10.1007/s00238-015-1171-5; Bozic DD, 2014, BRAZ J MICROBIOL, V45, P263, DOI 10.1590/S1517-83822014000100038; Choi JH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06661-7; CHU CC, 1984, AM J SURG, V147, P197, DOI 10.1016/0002-9610(84)90088-6; Clayton EMR, 2011, ENVIRON HEALTH PERSP, V119, P390, DOI 10.1289/ehp.1002883; Conrads H, 2000, PLASMA SOURCES SCI T, V9, P441, DOI 10.1088/0963-0252/9/4/301; Copitch JL, 2010, INT J ANTIMICROB AG, V36, P247, DOI 10.1016/j.ijantimicag.2010.04.012; de Avila ED, 2015, BIOMATERIALS, V67, P84, DOI 10.1016/j.biomaterials.2015.07.030; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; DUNNILL C, 2017, INT WOUND J, V14, P89, DOI DOI 10.1111/iwj.12557; Edmiston CE, 2006, J AM COLL SURGEONS, V203, P481, DOI 10.1016/j.jamcollsurg.2006.06.026; Edmiston CE, 2013, J CLIN MICROBIOL, V51, P417, DOI 10.1128/JCM.02442-12; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Ercan UK., 2017, EUROPEAN RES J; Ercan UK, 2013, PLASMA PROCESS POLYM, V10, P544, DOI 10.1002/ppap.201200104; Eswaramoorthy N, 2017, BIOPHYSICAL REV, P1; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Galal I, 2011, AM J SURG, V202, P133, DOI 10.1016/j.amjsurg.2010.06.011; Grigoras RI, 2016, MATER PLAST, V53, P501; GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9; Henry-Stanley MJ, 2010, SURG INFECT, V11, P433, DOI 10.1089/sur.2010.006; Ibis F, 2016, PLASMA MED, V6; Im JN, 2007, POLYM DEGRAD STABIL, V92, P667, DOI 10.1016/j.polymdegradstab.2006.12.011; Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10; Justinger C, 2009, SURGERY, V145, P330, DOI 10.1016/j.surg.2008.11.007; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kashiwabuchi F, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.1.1; KATZ S, 1981, ANN SURG, V194, P35, DOI 10.1097/00000658-198107000-00007; Kjaergard HK, 2001, AM J SURG, V182, p15S, DOI 10.1016/S0002-9610(01)00772-3; Koban I, 2011, J CLIN PERIODONTOL, V38, P956, DOI 10.1111/j.1600-051X.2011.01740.x; Kubinova S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45183; Kvam E, 2012, ANTIMICROB AGENTS CH, V56, P2028, DOI 10.1128/AAC.05642-11; Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078; Laroussi M., 2012, PLASMA MED APPL LOW; Li Y, 2012, LANGMUIR, V28, P12134, DOI 10.1021/la302732w; Marzo G, 2008, Oral Implantol (Rome), V1, P43; Masini BD, 2011, J SURG EDUC, V68, P101, DOI 10.1016/j.jsurg.2010.09.015; Monetta T, 2011, ANTIBACTERIAL ACTIVI, V1; MURRELL GAC, 1990, BIOCHEM J, V265, P659, DOI 10.1042/bj2650659; Ndazi BS, 2011, EXPRESS POLYM LETT, V5, P119, DOI 10.3144/expresspolymlett.2011.13; Obermeier A, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0523-4; Obermeier A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101426; Oliveira Manuela, 2014, BMC Res Notes, V7, P499, DOI 10.1186/1756-0500-7-499; Pillai CKS, 2010, J BIOMATER APPL, V25, P291, DOI 10.1177/0885328210384890; Poor AE, 2014, SURG INFECT, V15, P233, DOI 10.1089/sur.2013.050; Pratten J, 2004, J BIOMATER APPL, V19, P47, DOI 10.1177/0885328204043200; Rothenburger Stephen, 2002, Surg Infect (Larchmt), V3 Suppl 1, pS79, DOI 10.1089/sur.2002.3.s1-79; Rubin JP, 2014, AESTHET SURG J, V34, P272, DOI 10.1177/1090820X13519264; Schmidt A, 2017, EXP DERMATOL, V26, P156, DOI 10.1111/exd.13156; Seitz JM, 2015, ADV HEALTHC MATER, V4, P1915, DOI 10.1002/adhm.201500189; Storch Mark L, 2004, Surg Infect (Larchmt), V5, P281; Sudha D, 2017, INDIAN J FIBRE TEXT, V42, P286; Thomas S., 2012, NATURAL POLYM BIOPOL; Traylor MJ, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/47/472001; Yang Y, 2016, ARCH ENVIRON OCCUP H, V10, P1, DOI DOI 10.1016/J.J0T.2016.10.001; Yorsaeng S, 2012, PLASMA CHEM PLASMA P, V32, P1275, DOI 10.1007/s11090-012-9405-9; Yost AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139903; Zhang YC, 2017, EUR PHYS J-SPEC TOP, V226, P2901, DOI 10.1140/epjst/e2016-60331-4	61	16	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202703	10.1371/journal.pone.0202703	http://dx.doi.org/10.1371/journal.pone.0202703			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183745	gold, Green Submitted, Green Published			2022-12-26	WOS:000443789900035
J	Matsumoto, Y; Hattori, M				Matsumoto, Yukiko; Hattori, Makoto			The green rice leafhopper, Nephotettix cincticeps (Hemiptera: Cicadellidae), salivary protein NcSP75 is a key effector for successful phloem ingestion	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; BROWN PLANTHOPPER; UHLER HEMIPTERA; PEA APHID; HOMOPTERA CICADELLIDAE; TRANSCRIPTOME ANALYSIS; ACYRTHOSIPHON-PISUM; SHEATH PROTEIN; WATERY SALIVA; GLANDS	Nephotettix cincticeps, a prevalent rice pest, injects gelling and watery saliva into plant tissues during the sucking process. Certain components within the saliva are believed to interact with plant cellular constituents and play important roles in overcoming host plant defense responses. Based on our previous analysis of the salivary gland transcriptome and secreted saliva proteome of N. cincticeps, in this study, we analyzed the biological functions of salivary protein, NcSP75 (N. cincticeps salivary protein 75 kD). NcSP75, a salivary glands-specific gene, showed low similarities to any previously reported sequences. Knockdown of NcSP75 by RNA interference (RNAi) reduced the longevity of treated nymphs to approximately half of the longevity of controls and caused severe developmental retardation. Furthermore, the knockdown of NcSP75 decreased the survival rate of adults, and reduced the number of deposited eggs and hatched nymphs. Thus, the adverse effects caused by the knockdown of NcSP75 were observed throughout the lifetime of N. cincticeps, when feeding on rice plants. In contrast, no reduction was observed in the survival rate of the knockdown of NcSP75 adults fed on an artificial diet. Electrical penetration graph measurements taken from adult females feeding on rice plants showed a significantly shorter duration of phloem ingestion associated with the knockdown of NcSP75 than the knockdown of the enhanced green fluorescent protein (EGFP). Furthermore, the total sugar content of the honeydew was lower when NcSP75 was knocked down. These results suggest that the NcSP75 protein contribute to successful and sustainable ingestion from the sieve elements of rice plants. The NcSP75 protein of N. cincticeps can, accordingly, be considered as a key effector for establishing compatible interaction with rice plants and could be a potential target for controlling this species.	[Matsumoto, Yukiko; Hattori, Makoto] Natl Agr & Food Res Org, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan	Matsumoto, Y (corresponding author), Natl Agr & Food Res Org, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.	matsumt@affrc.go.jp		song ben, you ji zi/0000-0002-9187-0698	JSPS (Japan Society for the promotion of science), KAKENHI [26660274]	JSPS (Japan Society for the promotion of science), KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS (Japan Society for the promotion of science, https://www.jsps.go.jp/english/index.html) KAKENHI Grant number 26660274 to YM. The funder had no roles in study, data collection and analysis, decision to publish, or preparation of the manuscript.	Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; DeLay B, 2012, J INSECT PHYSIOL, V58, P1626, DOI 10.1016/j.jinsphys.2012.10.002; Du B, 2009, P NATL ACAD SCI USA, V106, P22163, DOI 10.1073/pnas.0912139106; Dyck V. A., 1979, International Rice Research Institute: Brown planthopper: threat to rice production in Asia., P3; FUKUMORITA T, 1982, PLANT CELL PHYSIOL, V23, P273; Hao PY, 2008, PLANT PHYSIOL, V146, P1810, DOI 10.1104/pp.107.111484; Hattori M, 2005, J INSECT PHYSIOL, V51, P1359, DOI 10.1016/j.jinsphys.2005.08.010; Hattori M, 1997, APPL ENTOMOL ZOOL, V32, P409, DOI 10.1303/aez.32.409; Hattori M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123671; Hattori M, 2012, INSECT BIOCHEM MOLEC, V42, P1, DOI 10.1016/j.ibmb.2011.10.001; Hattori M, 2010, INSECT BIOCHEM MOLEC, V40, P331, DOI 10.1016/j.ibmb.2010.02.009; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Hirae M, 2008, JPN J APPL ENTOMOL Z, V52, P207, DOI 10.1303/jjaez.2008.207; Huang HJ, 2017, J INSECT PHYSIOL, V98, P223, DOI 10.1016/j.jinsphys.2017.01.012; Huang HJ, 2016, J PROTEOME RES, V15, P1883, DOI 10.1021/acs.jproteome.6b00086; Huang HJ, 2015, INSECT BIOCHEM MOLEC, V66, P77, DOI 10.1016/j.ibmb.2015.10.007; Iwamoto S., 1965, P KANTO TOSAN PLANT, P65, DOI [10.11337/ktpps1954.1965.65, DOI 10.11337/KTPPS1954.1965.65]; JANSSEN JAM, 1989, ENTOMOL EXP APPL, V52, P69, DOI 10.1007/BF00163943; Kaloshian I, 2016, J INTEGR PLANT BIOL, V58, P350, DOI 10.1111/jipb.12438; KATAYAMA E, 1975, Japanese Journal of Applied Entomology and Zoology, V19, P176, DOI 10.1303/jjaez.19.176; KAWABE S, 1985, JARQ-JPN AGR RES Q, V19, P115; Kawabe S., 1994, RES PROGR AGR FOREST, V295, P52; KISIMOTO R., 1959, JAPANESE JOUR APPL ENT AND ZOOL, V3, P128, DOI 10.1303/jjaez.3.128; Liu XQ, 2016, J INSECT PHYSIOL, V89, P60, DOI 10.1016/j.jinsphys.2016.04.002; Matsumoto Y, 2016, ARCH INSECT BIOCHEM, V91, P152, DOI 10.1002/arch.21315; Matsumoto Y, 2014, J INSECT PHYSIOL, V71, P170, DOI 10.1016/j.jinsphys.2014.10.010; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; Mitsumori M, 2014, NEWEST PROTOCOL IMMU, P141; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; NAITO A, 1967, Japanese Journal of Applied Entomology and Zoology, V11, P50, DOI 10.1303/jjaez.11.50; Nakamura M, 2013, APPL ENTOMOL ZOOL, V48, P489, DOI 10.1007/s13355-013-0210-6; NAKASHIMA K, 1991, APPL ENVIRON MICROB, V57, P3570, DOI 10.1128/AEM.57.12.3570-3575.1991; Nasu S., 1963, KYUSHU AGR EXPT STAT, V8, P153; NAULT LR, 1966, ANN ENTOMOL SOC AM, V59, P1185, DOI 10.1093/aesa/59.6.1185; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; OYA S, 1980, APPL ENTOMOL ZOOL, V15, P392, DOI 10.1303/aez.15.392; SATOMI H, 1993, APPL ENTOMOL ZOOL, V28, P207, DOI 10.1303/aez.28.207; SOGAWA K, 1968, Applied Entomology and Zoology, V3, P13; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; SOGAWA K, 1973, Review of Plant Protection Research, V6, P31; SOGAWA K, 1967, Applied Entomology and Zoology, V2, P195; SOGAWA K, 1968, Applied Entomology and Zoology, V3, P67; Sogawa K., 1965, Japanese Journal of Applied Entomology and Zoology, V9, P275; Tilmon KJ, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10016; Tomizawa M, 2013, APPL ENTOMOL ZOOL, V48, P553, DOI 10.1007/s13355-013-0211-5; WALKER GP, 1994, ANN ENTOMOL SOC AM, V87, P363, DOI 10.1093/aesa/87.3.363; Wang W, 2015, FASEB J, V29, P2032, DOI 10.1096/fj.14-266023; Wang W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08885; Will T, 2015, INSECT BIOCHEM MOLEC, V57, P34, DOI 10.1016/j.ibmb.2014.12.005; Yamashita O, 1980, METHODS INSECT STUDY, P45; Ye WF, 2017, SCI REP-UK, V7, DOI 10.1038/srep40498; Youn Young Nam, 1998, Journal of Asia-Pacific Entomology, V1, P147	54	10	12	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202492	10.1371/journal.pone.0202492	http://dx.doi.org/10.1371/journal.pone.0202492			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183736	gold, Green Published, Green Submitted			2022-12-26	WOS:000443789900031
J	Pardo-Este, C; Hidalgo, AA; Aguirre, C; Briones, AC; Cabezas, CE; Castro-Severyn, J; Fuentes, JA; Opazo, CM; Riedel, CA; Otero, C; Pacheco, R; Valvano, MA; Saavedra, CP				Pardo-Este, Coral; Hidalgo, Alejandro A.; Aguirre, Camila; Briones, Alan C.; Cabezas, Carolina E.; Castro-Severyn, Juan; Fuentes, Juan A.; Opazo, Cecilia M.; Riedel, Claudia A.; Otero, Carolina; Pacheco, Rodrigo; Valvano, Miguel A.; Saavedra, Claudia P.			The ArcAB two-component regulatory system promotes resistance to reactive oxygen species and systemic infection by Salmonella Typhimurium	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; OXIDATIVE STRESS RESISTANCE; ESCHERICHIA-COLI; TRANSCRIPTION FACTOR; VIRULENCE FACTORS; INTRACELLULAR SURVIVAL; HAEMOPHILUS-INFLUENZAE; NEUTROPHIL PHAGOSOME; GENE-EXPRESSION; VIBRIO-CHOLERAE	Salmonella enterica Serovar Typhimurium (S. Typhimurium) is an intracellular bacterium that overcomes host immune system barriers for successful infection. The bacterium colonizes the proximal small intestine, penetrates the epithelial layer, and is engulfed by macrophages and neutrophils. Intracellularly, S. Typhimurium encounters highly toxic reactive oxygen species including hydrogen peroxide and hypochlorous acid. The molecular mechanisms of Salmonella resistance to intracellular oxidative stress is not completely understood. The ArcAB two-component system is a global regulatory system that responds to oxygen. In this work, we show that the ArcA response regulator participates in Salmonella adaptation to changing oxygen levels and is also involved in promoting intracellular survival in macrophages and neutrophils, enabling S. Typhimurium to successfully establish a systemic infection.	[Pardo-Este, Coral; Aguirre, Camila; Briones, Alan C.; Cabezas, Carolina E.; Castro-Severyn, Juan; Saavedra, Claudia P.] Univ Andres Bello, Fac Ciencias Vida, Dept Ciencias Biol, Lab Microbiol Mol, Santiago, Chile; [Hidalgo, Alejandro A.] Univ Andres Bello, Fac Med, Lab Patogenesis Bacteriana, Santiago, Chile; [Fuentes, Juan A.] Univ Andres Bello, Fac Ciencias Vida, Dept Ciencias Biol, Lab Genet & Patogenesis Bacteriana, Santiago, Chile; [Opazo, Cecilia M.; Riedel, Claudia A.; Saavedra, Claudia P.] Univ Andres Bello, Millennium Inst Immunol & Immunotherapy, Dept Ciencias Biol, Fac Vida, Santiago, Chile; [Opazo, Cecilia M.; Riedel, Claudia A.; Saavedra, Claudia P.] Univ Andres Bello, Fac Med, Santiago, Chile; [Otero, Carolina] Univ Andres Bello, Fac Med, CIMIS, Santiago, Chile; [Pacheco, Rodrigo] Fdn Ciencia & Vida, Lab Neuroinmunol, Santiago, Chile; [Pacheco, Rodrigo] Univ Andres Bello, Fac Ciencias Vida, Dept Ciencias Biol, Santiago, Chile; [Valvano, Miguel A.] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland	Universidad Andres Bello; Universidad Andres Bello; Universidad Andres Bello; Universidad Andres Bello; Universidad Andres Bello; Universidad Andres Bello; Universidad Andres Bello; Queens University Belfast	Saavedra, CP (corresponding author), Univ Andres Bello, Fac Ciencias Vida, Dept Ciencias Biol, Lab Microbiol Mol, Santiago, Chile.; Saavedra, CP (corresponding author), Univ Andres Bello, Millennium Inst Immunol & Immunotherapy, Dept Ciencias Biol, Fac Vida, Santiago, Chile.; Saavedra, CP (corresponding author), Univ Andres Bello, Fac Med, Santiago, Chile.	csaavedra@unab.cl	; Valvano, Miguel/G-8759-2012	Pacheco, Rodrigo/0000-0001-8057-9806; Fuentes, Juan A./0000-0002-9374-0707; Castro-Severyn, Juan/0000-0002-4301-2226; Opazo, Maria Cecilia/0000-0003-4263-9294; Pardo-Este, Coral/0000-0003-0958-3268; Valvano, Miguel/0000-0001-8229-3641	"Fondo Nacional de Ciencia y Tecnologia" FONDECYT [1120384, 1160315]; "Comision Nacional de Investigacion Cientifica y Tecnologica de Chile" (CONICYT) [PFB-16, 21150592, 21160858, 21151217, 21180743]; Universidad Andres Bello Nucleo [DI-3-17/N]	"Fondo Nacional de Ciencia y Tecnologia" FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); "Comision Nacional de Investigacion Cientifica y Tecnologica de Chile" (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Universidad Andres Bello Nucleo	This work was supported by "Fondo Nacional de Ciencia y Tecnologia" FONDECYT Grants #1120384 and #1160315 (to CPS), Grant PFB-16 (to RP) from "Comision Nacional de Investigacion Cientifica y Tecnologica de Chile" (CONICYT) and Universidad Andres Bello Nucleo Grant DI-3-17/N (to CPS), and Doctoral Fellowships were received from Comision Nacional de Investigacion Cientifica y Tecnologica de Chile" CONICYT (Grant 21150592 to CPE, Grant 21160858 to ACB, Grant 21151217 to JCS, and Grant 21180743 to CEC).	Behnsen J, 2015, TRENDS IMMUNOL, V36, P112, DOI 10.1016/j.it.2014.12.003; Bishayi B, 2015, INFLAMMATION, V38, P812, DOI 10.1007/s10753-014-9991-1; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; Buettner FFR, 2008, INFECT IMMUN, V76, P2284, DOI 10.1128/IAI.01540-07; Burton NA, 2014, CELL HOST MICROBE, V15, P72, DOI 10.1016/j.chom.2013.12.006; Cabezas C. E., 2018, RES MICROBIOL, P1; Calderon IL, 2011, RES MICROBIOL, V162, P214, DOI 10.1016/j.resmic.2010.11.001; Chakraborty S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02030-0; Conlan JW, 1997, INFECT IMMUN, V65, P630, DOI 10.1128/IAI.65.2.630-635.1997; Contreras I, 1997, MICROBIOL-UK, V143, P2665, DOI 10.1099/00221287-143-8-2665; De Souza-Hart JA, 2003, INFECT IMMUN, V71, P163, DOI 10.1128/IAI.71.1.163-172.2003; Dhandayuthapani S, 1997, J BACTERIOL, V179, P2401, DOI 10.1128/jb.179.7.2401-2409.1997; Drazic A, 2014, J BIOL CHEM, V289, P977, DOI 10.1074/jbc.M113.521401; Drazic A, 2013, P NATL ACAD SCI USA, V110, P9493, DOI 10.1073/pnas.1300578110; Echave P, 2003, J BIOL CHEM, V278, P30193, DOI 10.1074/jbc.M304351200; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Eriksson S, 2000, CELL MICROBIOL, V2, P239, DOI 10.1046/j.1462-5822.2000.00051.x; Evans MR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-58; Fenlon LA, 2014, CELL HOST MICROBE, V15, P7, DOI 10.1016/j.chom.2014.01.001; FINN GJ, 1975, J BACTERIOL, V123, P570, DOI 10.1128/JB.123.2.570-579.1975; GOLDMAN R, 1990, J LEUKOCYTE BIOL, V47, P79, DOI 10.1002/jlb.47.1.79; Gray MJ, 2013, J BIOL CHEM, V288, P13789, DOI 10.1074/jbc.M113.454421; Hebrard M, 2011, CURR OPIN BIOTECH, V22, P200, DOI 10.1016/j.copbio.2011.02.007; Hebrard M, 2009, J BACTERIOL, V191, P4605, DOI 10.1128/JB.00144-09; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Ipinza F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111062; ISHIGE K, 1994, EMBO J, V13, P5195, DOI 10.1002/j.1460-2075.1994.tb06850.x; IUCHI S, 1990, MOL MICROBIOL, V4, P715, DOI 10.1111/j.1365-2958.1990.tb00642.x; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Jayaprakash K, 2015, MOL ORAL MICROBIOL, V30, P361, DOI 10.1111/omi.12099; KORONAKIS V, 1988, MOL GEN GENET, V213, P99, DOI 10.1007/BF00333404; Kothary MH, 2001, J FOOD SAFETY, V21, P49, DOI 10.1111/j.1745-4565.2001.tb00307.x; KROGFELT KA, 1991, REV INFECT DIS, V13, P721; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; LI ZY, 1994, J BIOL CHEM, V269, P18371; LIBBY SJ, 1994, P NATL ACAD SCI USA, V91, P489, DOI 10.1073/pnas.91.2.489; Lim S, 2013, J MICROBIOL BIOTECHN, V23, P1664, DOI 10.4014/jmb.1305.05022; Liu XQ, 1998, J BACTERIOL, V180, P3917, DOI 10.1128/JB.180.15.3917-3922.1998; Matsubara M, 2000, GENES CELLS, V5, P555, DOI 10.1046/j.1365-2443.2000.00347.x; MILLER PF, 1994, ANTIMICROB AGENTS CH, V38, P1773, DOI 10.1128/AAC.38.8.1773; Mills SD, 1998, EUR J CELL BIOL, V77, P35, DOI 10.1016/S0171-9335(98)80100-3; Morales EH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-626; Morales EH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-63; Nandi B, 2005, MICROBIOL-SGM, V151, P2975, DOI 10.1099/mic.0.27995-0; NARA F, 1986, MOL GEN GENET, V202, P194, DOI 10.1007/BF00331636; Nauseef WM, 2014, CELL MICROBIOL, V16, P1146, DOI 10.1111/cmi.12312; Olsen JE, 2013, VET MICROBIOL, V165, P373, DOI 10.1016/j.vetmic.2013.04.008; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; Painter RG, 2006, ANAL CHEM, V78, P3133, DOI 10.1021/ac0521706; PAPPSZABO E, 1994, INFECT IMMUN, V62, P2662; Parker BW, 2013, J BIOL CHEM, V288, P32574, DOI 10.1074/jbc.M113.503516; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Portillo FGD, 2001, MICROBES INFECT, V3, P1305, DOI 10.1016/S1286-4579(01)01491-5; Rice JB, 2011, NUCLEIC ACIDS RES, V39, P3806, DOI 10.1093/nar/gkq1219; Ruby T, 2012, FEMS MICROBIOL REV, V36, P600, DOI 10.1111/j.1574-6976.2012.00332.x; Santiviago CA, 2003, J BACTERIOL, V185, P5901, DOI 10.1128/JB.185.19.5901-5905.2003; Schwartz J, 2009, J IMMUNOL, V183, P2632, DOI 10.4049/jimmunol.0804110; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sengupta N, 2003, INFECT IMMUN, V71, P5583, DOI 10.1128/IAI.71.10.5583-5589.2003; Shi L, 2006, J BIOL CHEM, V281, P29131, DOI 10.1074/jbc.M604640200; Slauch JM, 2011, MOL MICROBIOL, V80, P580, DOI 10.1111/j.1365-2958.2011.07612.x; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Swamydas M, 2013, JOVE-J VIS EXP, DOI 10.3791/50586; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Viegas S. C., 2013, APPL ENVIRON MICROB; Wagner C, 2011, ADV EXP MED BIOL, V715, P17, DOI 10.1007/978-94-007-0940-9_2; Wang SY, 2010, APPL ENVIRON MICROB, V76, P5013, DOI 10.1128/AEM.00823-10; Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Wong SMS, 2007, MOL MICROBIOL, V64, P1375, DOI 10.1111/j.1365-2958.2007.05747.x; WU J, 1992, J BACTERIOL, V174, P3915, DOI 10.1128/jb.174.12.3915-3920.1992; Yaku H, 1997, FEBS LETT, V408, P337, DOI 10.1016/S0014-5793(97)00459-6; Zhang L, 2014, HEPATOB PANCREAT DIS, V13, P138, DOI 10.1016/S1499-3872(14)60024-2; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092	75	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0203497	10.1371/journal.pone.0203497	http://dx.doi.org/10.1371/journal.pone.0203497			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180204	Green Published, gold			2022-12-26	WOS:000444222400048
J	Pallikkuth, S; Martin, C; Farzam, F; Edwards, JS; Lakin, MR; Lidke, DS; Lidke, KA				Pallikkuth, Sandeep; Martin, Cheyenne; Farzam, Farzin; Edwards, Jeremy S.; Lakin, Matthew R.; Lidke, Diane S.; Lidke, Keith A.			Sequential super-resolution imaging using DNA strand displacement	PLOS ONE			English	Article							DESIGN; LOCALIZATION; EXCHANGE; STORM	Sequential labeling and imaging in fluorescence microscopy allows the imaging of multiple structures in the same cell using a single fluorophore species. In super-resolution applications, the optimal dye suited to the method can be chosen, the optical setup can be simpler and there are no chromatic aberrations between images of different structures. We describe a method based on DNA strand displacement that can be used to quickly and easily perform the labeling and removal of the fluorophores during each sequence. Site-specific tags are conjugated with unique and orthogonal single stranded DNA. Labeling for a particular structure is achieved by hybridization of antibody-bound DNA with a complimentary dye-labeled strand. After imaging, the dye is removed using toehold-mediated strand displacement, in which an invader strand competes off the dye-labeled strand than can be subsequently washed away. Labeling and removal of each DNA-species requires only a few minutes. We demonstrate the concept using sequential dSTORM super-resolution for multiplex imaging of subcellular structures.	[Pallikkuth, Sandeep; Farzam, Farzin; Lidke, Keith A.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; [Martin, Cheyenne; Lidke, Diane S.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Martin, Cheyenne; Edwards, Jeremy S.; Lidke, Diane S.; Lidke, Keith A.] Univ New Mexico, Comprehens Canc Ctr, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Edwards, Jeremy S.] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA; [Lakin, Matthew R.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Lakin, Matthew R.] Univ New Mexico, Ctr Biomed Engn, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico; University of New Mexico	Lidke, KA (corresponding author), Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA.; Lidke, KA (corresponding author), Univ New Mexico, Comprehens Canc Ctr, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	klidke@unm.edu			NIH [1R21EB019589, P30CA118100]; New Mexico Spatiotemporal Modeling Center (NIH) [P50GM085273]; National Science Foundation [1525553, 1518861, 1318833]; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB019589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Mexico Spatiotemporal Modeling Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH 1R21EB019589, the New Mexico Spatiotemporal Modeling Center (NIH P50GM085273). MRL was additionally supported by the National Science Foundation grants 1525553, 1518861, and 1318833. We thank Shayna Lucero for assistance with cell culture. We gratefully acknowledge use of the University of New Mexico Comprehensive Cancer Center fluorescence microscopy core, as well as the NIH P30CA118100 support for these cores.	[Anonymous], 1999, FAC APPL SCI DELFT U; Chen YJ, 2013, NAT NANOTECHNOL, V8, P755, DOI 10.1038/nnano.2013.189; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Groves B, 2016, NAT NANOTECHNOL, V11, P287, DOI [10.1038/NNANO.2015.278, 10.1038/nnano.2015.278]; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Huang F, 2011, BIOMED OPT EXPRESS, V2, P1377, DOI 10.1364/BOE.2.001377; Jungmann R, 2014, NAT METHODS, V11, P313, DOI [10.1038/nmeth.2835, 10.1038/NMETH.2835]; Lin DY, 2018, BIOPHYS J, V114, P1980, DOI 10.1016/j.bpj.2018.03.023; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schueder F, 2017, ANGEW CHEM INT EDIT, V56, P4052, DOI 10.1002/anie.201611729; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Tam J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101772; Valley CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123941; Wolfe BR, 2017, J AM CHEM SOC, V139, P3134, DOI 10.1021/jacs.6b12693; Wolfe BR, 2015, ACS SYNTH BIOL, V4, P1086, DOI 10.1021/sb5002196; Yi J, 2016, MOL BIOL CELL, V27, P3591, DOI 10.1091/mbc.E16-05-0330; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zhang DY, 2011, NAT CHEM, V3, P103, DOI [10.1038/nchem.957, 10.1038/NCHEM.957]	20	8	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203291	10.1371/journal.pone.0203291	http://dx.doi.org/10.1371/journal.pone.0203291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169528	gold, Green Published, Green Submitted			2022-12-26	WOS:000443374400034
J	Valencia-Mendez, O; Rodriguez-Zaragoza, FA; Calderon-Aguilera, LE; Dominguez-Dominguez, O; Lopez-Perez, A				Valencia-Mendez, Omar; Alejandro Rodriguez-Zaragoza, Fabian; Eduardo Calderon-Aguilera, Luis; Dominguez-Dominguez, Omar; Lopez-Perez, Andres			Gamma-diversity partitioning of gobiid fishes (Teleostei: Gobiidae) ensemble along of Eastern Tropical Pacific: Biological inventory, latitudinal variation and species turnover	PLOS ONE			English	Article							DWELLING FISHES; BETA-DIVERSITY; REEF; SPECIATION; SPECIALIZATION; REDESCRIPTION; GOBIOSOMATINI; BIOGEOGRAPHY; PERCIFORMES; DIVERGENCE	Gobies are the most diverse marine fish family. Here, we analysed the gamma-diversity (gamma-diversity) partitioning of gobiid fishes to evaluate the additive and multiplicative components of alpha and beta-diversity, species replacement and species loss and gain, at four spatial scales: sample units, ecoregions, provinces and realms. The richness of gobies from the realm Eastern Tropical Pacific (ETP) is represented by 87 species. Along latitudinal and longitudinal gradients, we found that the gamma-diversity is explained by the beta-diversity at both spatial scales, ecoregions and provinces. At the ecoregion scale, species are diverse in the north (Cortezian ecoregion) and south (Panama Bight ecoregion) and between insular and coastal ecoregions. At the province scale, we found that the species turnover between the warm temperate Northeast Pacific (WTNP), Tropical East Pacific (TEaP) and the Galapagos Islands (Gala) was high, and the species nestedness was low. At the ecoregion scale, historical factors, and phylogenetic factors have influenced the hotspots of gobiid fish biodiversity, particularly in the Cortezian, Panama Bight and Cocos Island ecoregions, where species turnover is high across both latitudinal and longitudinal gradients. At the provincial level, we found that the contributions of the beta-diversity from north to south, in the WTNP, TEaP and Gala were high, as result of the high number of unique species. Species turnover was also high at this scale, with a low contribution from species nestedness that was probably due to the low species/gene flow within the provinces. These results highlight the importance and successful inclusion of a cryptobenthic fish component in ecological and biogeographical studies.	[Valencia-Mendez, Omar] Univ Autonoma Metropolitana Iztapalapa, Ciencias Biol & Salud, Ciudad De Mexico, Mexico; [Alejandro Rodriguez-Zaragoza, Fabian] Univ Guadalajara, CUCBA, Dept Ecol, Guadalajara, Jalisco, Mexico; [Eduardo Calderon-Aguilera, Luis] CICESE, Dept Ecol Marina, Ensenada, Baja California, Mexico; [Dominguez-Dominguez, Omar] Univ Michoacana, Fac Biol, Morelia, Michoacan, Mexico; [Lopez-Perez, Andres] Univ Autonoma Metropolitana Iztapalapa, Dept Hidrobiol, Ciudad De Mexico, Mexico; [Eduardo Calderon-Aguilera, Luis] Univ Southampton, Southampton, Hants, England	Universidad Autonoma Metropolitana - Mexico; Universidad de Guadalajara; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad Michoacana de San Nicolas de Hidalgo; Universidad Autonoma Metropolitana - Mexico; University of Southampton	Lopez-Perez, A (corresponding author), Univ Autonoma Metropolitana Iztapalapa, Dept Hidrobiol, Ciudad De Mexico, Mexico.	alopez@xanum.uam.mx	Calderon-Aguilera, Luis Eduardo E/E-1522-2015; Zaragoza, Fabian Alejandro Rodriguez/B-3477-2015; Lopez-Perez, Andres/U-1151-2017; MENDEZ, OMAR VALENCIA/AAJ-6099-2020; Lopez-Perez, Andres/GPJ-9537-2022	Calderon-Aguilera, Luis Eduardo E/0000-0001-5427-6043; Zaragoza, Fabian Alejandro Rodriguez/0000-0002-0066-4275; Lopez-Perez, Andres/0000-0003-1246-7401; MENDEZ, OMAR VALENCIA/0000-0002-8623-5446; Lopez-Perez, Andres/0000-0003-1246-7401	Consejo Nacional de Ciencia y Tecnologia [401738]; Consejo Nacional de Ciencia y Tecnologoia [240875, 236654, 257987]; Universidad Michoacana de San NicolaAs de Hidalgo [CIC-2013-2017]; CONACyT (Consejo Nacional de Ciencia y TecnologoAa, Mexico) [401738]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologoia; Universidad Michoacana de San NicolaAs de Hidalgo; CONACyT (Consejo Nacional de Ciencia y TecnologoAa, Mexico)	This work was supported by the Consejo Nacional de Ciencia y Tecnologia, PhD scholarship 401738, MC Omar Valencia-Mendez; Consejo Nacional de Ciencia y Tecnologia, 257987, Dr. FabiaAn Alejandro RodroAguez-Zaragoza; Consejo Nacional de Ciencia y Tecnologoia, 240875, Dr. Omar DomoAnguez-DomoAnguez; Universidad Michoacana de San NicolaAs de Hidalgo, CIC-2013-2017, Dr. Omar DomoAnguez-DomoAnguez; Consejo Nacional de Ciencia y Tecnologia, 236654, Dr. AndreAs LoApez-PeArez and Omar Valencia-Mendez received a Ph.D. scholarship from CONACyT (Consejo Nacional de Ciencia y TecnologoAa, Mexico), fellowship no. 401738. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gonzalez G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065665; Ahmadia GN, 2018, CORAL REEFS, V37, P279, DOI 10.1007/s00338-018-1657-2; Amador JA, 2006, PROG OCEANOGR, V69, P101, DOI 10.1016/j.pocean.2006.03.007; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2015, ARCMAP VERS 10 4 1 S; [Anonymous], NOM062ZOO1999; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032341; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Bermingham Eldredge, 1997, P113, DOI 10.1016/B978-012417540-2/50009-9; Bograd SJ, 2015, DEEP-SEA RES PT II, V112, P42, DOI 10.1016/j.dsr2.2014.04.009; Boschi Enrique E., 2000, Revista de Investigacion y Desarrollo Pesquero, V13, P7; Brandl SJ, 2018, BIOL REV, V93, P1846, DOI 10.1111/brv.12423; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; BUSSING WA, 1990, REV BIOL TROP, V38, P99; Chao A, 2012, ECOLOGY, V93, P2037, DOI 10.1890/11-1817.1; Chapman ASA, 2018, DIVERS DISTRIB, V24, P568, DOI 10.1111/ddi.12712; Clarke KR, 2006, PRIMER V 6 USER MANU; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; Coker DJ, 2018, CORAL REEFS, V37, P193, DOI 10.1007/s00338-017-1647-9; Colwell RK, 2013, ESTIMATES STAT ESTIM; Costello MJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01121-2; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Erisman BE, 2011, ZOOTAXA, P26; Eschmeyer WN, CATALOG FISHES; Fiedler PC, 2017, CORAL REEFS WORLD, V8, P59, DOI 10.1007/978-94-017-7499-4_3; Fourriere M, 2016, ZOOTAXA, V4150, P436, DOI 10.11646/zootaxa.4150.4.4; Francisco-Ramos V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078761; Galland GR, 2017, MAR ECOL PROG SER, V584, P175, DOI 10.3354/meps12364; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gilbert C., 1882, P US NATL MUS, V14, P539; Gilbert C. H., 1890, P US NATL MUS, V13, P49, DOI DOI 10.5479/SI.00963801.13-797.49; Gill AC, 2012, ZOOTAXA, P41; Ginsburg I., 1939, Journal of the Washington Academy of Sciences, V29, P51; Ginsburg I, 1938, A HANCOCK PACIFIC EX, V2, P109; GINSBURG ISAAC, 1932, BULL BINGHAM OCEANOGR COLL, V4, P1; GINSBURG ISAAC, 1933, BULL BINGHAM OCEANOGR COLL, V4, P1; Glynn PW, 2017, CORAL REEFS WORLD, V8, P107, DOI 10.1007/978-94-017-7499-4_5; Glynn PW, 2000, CORAL REEFS, V19, P1, DOI 10.1007/s003380050220; Goatley CHR, 2016, MAR ECOL PROG SER, V544, P271, DOI 10.3354/meps11614; Greve M, 2006, ECOGRAPHY, V29, P347, DOI 10.1111/j.2006.0906-7590.04493.x; Gunther A., 1864, Proceedings of the Zoological Society, P23; Gunther A., 1861, CATALOGUE ACANTHOPTE, V3, P1; Hastings PA, 2000, ZOOL J LINN SOC-LOND, V128, P319, DOI 10.1006/zjls.1998.0196; Herler J, 2007, MAR ECOL-EVOL PERSP, V28, P82, DOI 10.1111/j.1439-0485.2007.00165.x; Herler J, 2012, BIOLOGY OF GOBIES, P493; HOESE DF, 1985, COPEIA, P333, DOI 10.2307/1444842; HOESE DF, 1976, COPEIA, P295; Hoese DF, 2001, REV BIOL TROP, V49, P157; Hoese DF, 2001, REV BIOL TROP, V49, P169; Jenkins O. P., 1889, P US NATL MUS, V11, P137, DOI DOI 10.5479/SI.00963801.11-698.137; Jordan D.S., 1882, B US FISH COMM, V1, P306; Jordan DS, 1882, P US NATL MUS, V4, P338, DOI DOI 10.5479/SI; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Kohda M, 2017, MAR BIOL, V164, DOI 10.1007/s00227-016-3060-2; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Kulbicki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081847; Lasso-Alcala A OM, 2008, MEMORIA FDN SALLE CI, V67, P117; Leitao RP, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0084; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Lessios HA, 2017, CORAL REEFS WORLD, V8, P477, DOI 10.1007/978-94-017-7499-4_16; Lopez-Perez A, 2016, MAR ECOL-EVOL PERSP, V37, P679, DOI 10.1111/maec.12337; Meek S, 1923, ZOOL SER, V15, P1; Miller PJ, 2001, REV BIOL TROP, V49, P141; Mora C, 2005, J BIOGEOGR, V32, P277, DOI 10.1111/j.1365-2699.2004.01155.x; Mora C, 2005, ECOLOGY, V86, P1771, DOI 10.1890/04-0883; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Munday PL, 2004, ECOLOGY, V85, P623, DOI 10.1890/03-3100; Munday PL, 1997, MAR ECOL PROG SER, V152, P227, DOI 10.3354/meps152227; Nelson J. S., 2016, FISHES WORLD, DOI [10.1002/9781119174844, DOI 10.1002/9781119174844]; Qian H, 2013, GLOBAL ECOL BIOGEOGR, V22, P659, DOI 10.1111/geb.12020; R Development Core Team, 2016, R LANG ENV STAT COMP; Robertson D. R., 2015, SHOREFISHES TROPICAL; Robertson DR, 2009, MAR ECOL PROG SER, V380, P1, DOI 10.3354/meps07925; Rocha LA, 2008, J FISH BIOL, V72, P1101, DOI 10.1111/j.1095-8649.2007.01770.x; Rocha LA, 2000, ENVIRON BIOL FISH, V59, P453, DOI 10.1023/A:1026584708092; Rodriguez-Zaragoza FA, 2011, BIODIVERS CONSERV, V20, P1655, DOI 10.1007/s10531-011-0053-9; Romero-Torres M, 2017, ICES J MAR SCI, V74, P613, DOI 10.1093/icesjms/fsw218; Ruber L, 2003, EVOLUTION, V57, P1584; RUBINOFF RW, 1971, EVOLUTION, V25, P88, DOI 10.1111/j.1558-5646.1971.tb01861.x; Smith DG, 1999, P BIOL SOC WASH, V112, P433; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Taylor MS, 2005, EVOLUTION, V59, P374; Thacker C, 2012, BIOLOGY OF GOBIES, P129; Tornabene L, 2016, MOL ECOL, V25, P3662, DOI 10.1111/mec.13704; Tornabene L, 2015, MOL PHYLOGENET EVOL, V82, P200, DOI 10.1016/j.ympev.2014.09.012; Tornabene L, 2014, J NAT HIST, V48, P1413, DOI 10.1080/00222933.2013.840938; Tornabene L, 2013, MOL PHYLOGENET EVOL, V66, P391, DOI 10.1016/j.ympev.2012.10.014; Van Der Laan R, 2014, ZOOTAXA, V3882, P1, DOI 10.11646/zootaxa.3882.1.1; Van Tassell JL, 2012, Biology of Gobies, P139; Van Tassell JL, 2004, ZOOTAXA, P1; Van Tassell JL, 2012, GOBIIDAE; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Veech JA, 2009, PARTITION SOFTWARE H; Violle C, 2017, TRENDS ECOL EVOL, V32, P356, DOI 10.1016/j.tree.2017.02.002; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; WoRMS Editorial Board, 2016, WORLD REGISTER MARIN	98	3	3	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0202863	10.1371/journal.pone.0202863	http://dx.doi.org/10.1371/journal.pone.0202863			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169538	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000443374400014
J	Ishoso, DK; Tshefu, AK; Coppieters, Y				Ishoso, Daniel Katuashi; Tshefu, Antoinette Kitoto; Coppieters, Yves			Analysis of induced abortion-related complications in women admitted to referral health facilities in Kinshasa, Democratic Republic of the Congo	PLOS ONE			English	Article							UNSAFE ABORTION; MATERNAL MORTALITY; POSTABORTION CARE; RISK-FACTORS; AGE	Background Due to a lack of relevant data on induced abortions in the Democratic Republic of the Congo (DRC), as well as the persistence of maternal deaths in the country, this study aims to analyze the extent and characteristics of induced abortion-related complications in women who were admitted to referral health facilities in Kinshasa, including the duration of hospitalization, the mortality rate due to induced abortion complications and their characteristics, and the deaths that occurred after two days of hospitalization. Methods This is a cross-sectional study on 843 obstetric and gynecological patients who were admitted as emergency cases to five referral health facilities in Kinshasa during 2014. These facilities were selected as being representative of five types of districts in Kinshasa, according to their cultural, socioeconomic, and infrastructural characteristics. Patient data were collected from patient records and analyzed. Results From the 843 patients admitted to receive obstetric and gynecological emergency care services in 2014 at the health facilities surveyed, 14.7% (95% CI: 12.4-17.3%) had complications due to induced abortion. These complications were significantly diagnosed in adolescents (p = 0.003) and in single, separated, divorced, or widowed women (p = 0.03). The median duration of hospitalization was nine days, and this period of time was significantly longer for the patients who underwent surgery for pelvic peritonitis due to uterine perforation compared with the patients who underwent Caesarean section/hysterectomy. Furthermore, it was significantly longer for the patients who were treated for other induced-abortion related complications compared with patients treated for spontaneous abortion. The mortality rate related to induced abortions was 5.6% (95% CI: 2.3-11.3%), with an increase in risk of death in the presence of a postabortive pelvic peritonitis-type complication; 42.9% of deaths occurred after two days of hospitalization. Conclusion The complications of induced abortions are a major public health problem due to their frequency among patients admitted to Kinshasa's referral health facilities, their mortality, and their poor medical management. Therefore, there is a need to understand the reason for its poor medical management in order to provide an adequate intervention program.	[Ishoso, Daniel Katuashi; Tshefu, Antoinette Kitoto] Univ Kinshasa, Kinshasa Sch Publ Hlth, Community Hlth Dept, Kinshasa1, Kinshasa, DEM REP CONGO; [Coppieters, Yves] ULB, Res Ctr Policies & Hlth Syst Int Hlth, Sch Publ Hlth, Brussels, Belgium	Universite de Kinshasa; Universite Libre de Bruxelles	Ishoso, DK (corresponding author), Univ Kinshasa, Kinshasa Sch Publ Hlth, Community Hlth Dept, Kinshasa1, Kinshasa, DEM REP CONGO.	dishosok@gmail.com		Ishoso Katuashi, Daniel/0000-0001-9392-1316	DRC government	DRC government	This research was funded by our salaries received from the DRC government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiodun O M, 2013, Afr J Med Med Sci, V42, P111; Adinma E, 2011, West Afr J Med, V30, P245; Ahman E, 2011, INT J GYNECOL OBSTET, V115, P121, DOI 10.1016/j.ijgo.2011.05.027; [Anonymous], 2014, ENQ DEM SANT REP DEM; Basinga P, 2012, STUD FAMILY PLANN, V43, P11, DOI 10.1111/j.1728-4465.2012.00298.x; Bernabe-Ortiz A, 2009, CAN MED ASSOC J, V180, P541, DOI 10.1503/cmaj.090188; Bernabe-Ortiz A, 2009, CAN MED ASSOC J, V180, P298, DOI 10.1503/cmaj.071399; Biddlecom Ann, 2008, Issues Brief (Alan Guttmacher Inst), P1; Boltanski L., 2004, CONDITION FOETALE SO; Chae S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184389; DeTourris H., 1994, ABREGE GYNECOLOGIE O, P671; Dragoman M, 2014, BJOG-INT J OBSTET GY, V121, P25, DOI 10.1111/1471-0528.12689; Ekanem E I, 2009, Niger J Med, V18, P370; Erfani A, 2011, INT PERSPECT SEX R H, V37, P134, DOI 10.1363/3713411; Faundes A, 2012, INT J GYNECOL OBSTET, V119, pS68, DOI 10.1016/j.ijgo.2012.03.021; Fawcus SR, 2008, BEST PRACT RES CL OB, V22, P533, DOI 10.1016/j.bpobgyn.2007.10.006; Ganatra B, 2017, LANCET; Gebreselassie H, 2010, INT PERSPECT SEX R H, V36, P6, DOI 10.1363/ipsrh.36.006.10; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Henshaw SK, 2008, INT FAM PLAN PERSPEC, V34, P40, DOI 10.1363/ifpp.34.140.08; Ibrahim IA, 2012, W INDIAN MED J, V61, P163; Igberase GO, 2008, TROP DOCT, V38, P146, DOI 10.1258/td.2007.070096; Irene T, 2006, ANN HIST SCI SOC, V2, P483; Jain V, 2004, J OBSTET GYNAECOL RE, V30, P197, DOI 10.1111/j.1447-0756.2004.00183.x; Johnson-Hanks J, 2002, SOC SCI MED, V55, P1337, DOI 10.1016/S0277-9536(01)00276-3; Juarez F, 2008, INT FAM PLAN PERSPEC, V34, P158, DOI [10.1363/3415808, 10.1363/ifpp.34.158.08]; Kigbu J H, 2009, Niger J Med, V18, P103; Kinoti S N, 2004, East Afr Med J, V81, P63; Lelo NF, 2004, PAUVRETE URBAINE KIN, P41; Levandowski Brooke A, 2012, Afr J Reprod Health, V16, P253; Major B, 2000, ARCH GEN PSYCHIAT, V57, P777, DOI 10.1001/archpsyc.57.8.777; Mitsunaga TM, 2005, J WOMENS HEALTH, V14, P515, DOI 10.1089/jwh.2005.14.515; Moreau C, 2005, BJOG-INT J OBSTET GY, V112, P430, DOI 10.1111/j.1471-0528.2004.00478.x; Okonofua F, 2006, J OBSTET GYNAECOL CA, V28, P974, DOI 10.1016/S1701-2163(16)32307-6; Rasch V, 2011, ACTA OBSTET GYN SCAN, V90, P692, DOI 10.1111/j.1600-0412.2011.01165.x; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sedgh Gilda, 2010, Issues Brief (Alan Guttmacher Inst), P1; Shah IH, 2012, REPROD HEALTH MATTER, V20, P169, DOI 10.1016/S0968-8080(12)39598-0; Shah L, 2004, REPROD HEALTH MATTER, V12, P9, DOI 10.1016/S0968-8080(04)24002-2; Shah N, 2011, J PAK MED ASSOC, V61, P582; Singh S, 2016, BJOG-INT J OBSTET GY, V123, P1489, DOI 10.1111/1471-0528.13552; Singh S, 2006, LANCET, V368, P1887, DOI 10.1016/S0140-6736(06)69778-X; Sudhinaraset May, 2008, Issues Brief (Alan Guttmacher Inst), P1; Thorp JM, 2003, OBSTET GYNECOL SURV, V58, P67, DOI 10.1097/00006254-200301000-00023	44	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203186	10.1371/journal.pone.0203186	http://dx.doi.org/10.1371/journal.pone.0203186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161265	gold, Green Published, Green Submitted			2022-12-26	WOS:000443388900086
J	van Gijn, SE; Wierenga, E; van den Tempel, N; Kok, YP; Heijink, AM; Spierings, DCJ; Foijer, F; van Vugt, MATM; Fehrmann, RSN				van Gijn, Stephanie E.; Wierenga, Elles; van den Tempel, Nathalie; Kok, Yannick P.; Heijink, Anne Margriet; Spierings, Diana C. J.; Foijer, Floris; van Vugt, Marcel A. T. M.; Fehrmann, Rudolf S. N.			TPX2/Aurora kinase A signaling as a potential therapeutic target in genomically unstable cancer cells	ONCOGENE			English	Article							EMBRYONIC CELLULAR PROLIFERATION; POLO-LIKE KINASE-1; AURORA-A KINASE; BREAST-CANCER; INVESTIGATIONAL AURORA; DNA-DAMAGE; PHASE-II; MLN8237 ALISERTIB; MAMMARY-TUMORS; INHIBITOR	Genomic instability is a hallmark feature of cancer cells, and can be caused by defective DNA repair, for instance due to inactivation of BRCA2. Paradoxically, loss of Brca2 in mice results in embryonic lethality, whereas cancer cells can tolerate BRCA2 loss. This holds true for multiple DNA repair genes, and suggests that cancer cells are molecularly "rewired" to cope with defective DNA repair and the resulting high levels of genomic instability. In this study, we aim to identify genes that genomically unstable cancer cells rely on for their survival. Using functional genomic mRNA (FGmRNA) profiling, 16,172 cancer samples were previously ranked based on their degree of genomic instability. We analyzed the top 250 genes that showed a positive correlation between FGmRNA levels and the degree of genomic instability, in a co-functionality network. Within this co-functionality network, a strong cluster of 11 cell cycle-related genes was identified, including TPX2. We then assessed the dependency on these 11 genes in the context of survival of genomically unstable cancer cells, induced by BRCA2 inactivation. Depletion of TPX2 or its associated kinase Aurora-A preferentially reduced cell viability in a panel of BRCA2-deficient cancer cells. In line with these findings, BRCA2-depleted and BRCA2-mutant human cell lines, or tumor cell lines derived from Brca2(-/-); p53(-/-) mice showed increased sensitivity to the Aurora-A kinase inhibitor alisertib, with delayed mitotic progression and frequent mitotic failure. Our findings reveal that BRCA2-deficient cancer cells show enhanced sensitivity to inactivation of TPX2 or its partner Aurora-A, which points at an actionable dependency of genomically unstable cancers.	[van Gijn, Stephanie E.; Wierenga, Elles; van den Tempel, Nathalie; Kok, Yannick P.; Heijink, Anne Margriet; van Vugt, Marcel A. T. M.; Fehrmann, Rudolf S. N.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [Heijink, Anne Margriet; Spierings, Diana C. J.; Foijer, Floris] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands	University of Groningen; University of Groningen	van Vugt, MATM; Fehrmann, RSN (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands.	m.vugt@umcg.nl; r.s.n.fehrmann@umcg.nl	Fehrmann, Rudolf/E-2551-2011	Fehrmann, Rudolf/0000-0002-7516-315X; Foijer, Floris/0000-0003-0989-3127; Spierings, Diana/0000-0001-8403-474X; Kok, Yannick/0000-0001-7041-5496; van Gijn, Stephanie/0000-0003-2172-1731; Heijink, Anne Margriet/0000-0001-9229-0575	Dutch Cancer Society [RUG 2011-5093, RUG 2012-5549, RUG 2013-5960]; Netherlands Organisation for Scientific Research [NWO-VIDI 917-13334, NWO-VENI 916-16025]; European Research Council (ERC-Consolidator grant "TENSION")	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC-Consolidator grant "TENSION")	This work was financially supported by grants from the Dutch Cancer Society (RUG 2011-5093 to MATMvV, RUG 2012-5549 to FF, and RUG 2013-5960 to RSNF), the Netherlands Organisation for Scientific Research (NWO-VIDI 917-13334 to MATMvV and NWO-VENI 916-16025 to RSNF), and the European Research Council (ERC-Consolidator grant "TENSION" to MATMvV).	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Alcaraz-Sanabria A, 2017, MOL CANCER THER, V16, P2552, DOI 10.1158/1535-7163.MCT-17-0223; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Bakker B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0971-7; Barr PM, 2015, J CLIN ONCOL, V33, P2399, DOI 10.1200/JCO.2014.60.6327; Blanco I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120020; Borges DD, 2018, LEUKEMIA RES, V64, P61, DOI 10.1016/j.leukres.2017.11.013; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Buccitelli C, 2017, GENOME RES, V27, P501, DOI 10.1101/gr.212225.116; Caceres-Gorriti KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091000; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Coleman RL, 2014, ANN ONCOL, V25, piv305; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; Dauch D, 2016, NAT MED, V22, P744, DOI 10.1038/nm.4107; Davies H, 2017, NAT MED, V23, P517, DOI 10.1038/nm.4292; Dickson MA, 2016, ANN ONCOL, V27, P1855, DOI 10.1093/annonc/mdw281; Engebraaten O, 2013, AM J PATHOL, V183, P1064, DOI 10.1016/j.ajpath.2013.05.033; Ertych N, 2016, P NATL ACAD SCI USA, V113, P1817, DOI 10.1073/pnas.1525129113; Evers B, 2008, CLIN CANCER RES, V14, P3916, DOI 10.1158/1078-0432.CCR-07-4953; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Graff JN, 2016, CANCER-AM CANCER SOC, V122, P2524, DOI 10.1002/cncr.30073; Habermann JK, 2009, INT J CANCER, V124, P1552, DOI 10.1002/ijc.24017; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Heijink AM, 2015, P NATL ACAD SCI USA, V112, P15160, DOI 10.1073/pnas.1505283112; Huck JJ, 2014, MOL CANCER THER, V13, P2170, DOI 10.1158/1535-7163.MCT-14-0027; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Jasin M, 2013, COLD SPRING HARB PER, V5; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Ma N, 2010, MOL BIOL CELL, V21, P979, DOI 10.1091/mbc.E09-07-0601; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mankouri HW, 2013, EMBO J, V32, P2661, DOI 10.1038/emboj.2013.211; Matulonis UA, 2012, GYNECOL ONCOL, V127, P63, DOI 10.1016/j.ygyno.2012.06.040; Melichar B, 2015, LANCET ONCOL, V16, P395, DOI 10.1016/S1470-2045(15)70051-3; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Niu H, 2015, FRONT ONCOL, V5, P3052; Perez de Castro Ignacio, 2012, Genes Cancer, V3, P721, DOI 10.1177/1947601912473306; Rottenberg S, 2008, P NATL ACAD SCI USA, V105, P17079, DOI 10.1073/pnas.0806092105; Roy R, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3181-c3; Schoonen PM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15981; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shigeishi H, 2009, INT J ONCOL, V34, P1565, DOI 10.3892/ijo_00000286; Slabicki M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000408; Sloane DA, 2010, ACS CHEM BIOL, V5, P563, DOI 10.1021/cb100053q; Suzuki A, 1997, GENE DEV, V11, P1242, DOI 10.1101/gad.11.10.1242; Takahashi Y, 2015, ANN ONCOL, V26, P935, DOI 10.1093/annonc/mdv034; Tayyar Y, 2017, CRIT REV ONCOL HEMAT, V119, P59, DOI 10.1016/j.critrevonc.2017.09.006; Tomii C, 2017, WORLD J SURG ONCOL, V15, DOI 10.1186/s12957-016-1095-y; van den Bos H, 2016, GENOME BIOL, V17, P1758; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; WEI P, 2013, J CLIN ONCOL S, V31; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Xu J, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-200	63	26	27	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 7	2019	38	6					852	867		10.1038/s41388-018-0470-2	http://dx.doi.org/10.1038/s41388-018-0470-2			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HK5LC	30177840	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000458006300007
J	Kim, WJ; Shea, AE; Kim, JH; Daaka, Y				Kim, Wan-Ju; Shea, Allyson E.; Kim, Joon-Hyung; Daaka, Yehia			Uropathogenic Escherichia coli invades bladder epithelial cells by activating kinase networks in host cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; host-pathogen interaction; secretion; signal transduction; epidermal growth factor receptor (EGFR); conditioned medium; urinary tract infection; uropathogenic E; coli	MEDIATED BACTERIAL INVASION; URINARY-TRACT-INFECTIONS; GROWTH-FACTOR RECEPTOR; FEEDBACK-REGULATION; S-NITROSYLATION; EGFR; CLATHRIN; ENTRY; INVOLVEMENT; PERSISTENCE	Uropathogenic Escherichia coli (UPEC) is the causative bacterium in most urinary tract infections (UTIs). UPEC cells adhere to and invade bladder epithelial cells (BECs) and cause uropathogenicity. Invading UPEC cells may encounter one of several fates, including degradation in the lysosome, expulsion to the extracellular milieu for clearance, or survival as an intracellular bacterial community and quiescent intracellular reservoir that can cause later infections. Here we considered the possibility that UPEC cells secrete factors that activate specific host cell signaling networks to facilitate the UPEC invasion of BECs. Using GFP-based reporters and Western blot analysis, we found that the representative human cystitis isolate E. coli UTI89 and its derivative UTI89FimH, which does not bind to BECs, equally activate phosphatidylinositol 4,5-bisphosphate 3-OH kinase (PI3K), Akt kinase, and mTOR complex (mTORC) 1 and 2 in BECs. We also found that conditioned medium taken from UTI89 and UTI89FimH cultures similarly activates epidermal growth factor receptor (EGFR), PI3K, Akt, and mTORC and that inhibition of EGFR and mTORC2, but not mTORC1, abrogates UTI89 invasion in vitro and in animal models of UTI. Our results reveal a key molecular mechanism of UPEC invasion and the host cells it targets, insights that may have therapeutic utility for managing the ever-increasing number of persistent and chronic UTIs.	[Kim, Wan-Ju; Shea, Allyson E.; Kim, Joon-Hyung; Daaka, Yehia] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Shea, Allyson E.] Univ Michigan, Ann Arbor, MI 48109 USA; [Kim, Joon-Hyung] Kent State Univ, Kent, OH 44240 USA	State University System of Florida; University of Florida; University of Michigan System; University of Michigan; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Daaka, Y (corresponding author), Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA.	ydaaka@ufl.edu		Shea, Allyson/0000-0003-1329-3888	University of Florida; NIAID, National Institutes of Health [R01 AI079014, T32 AI007110]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079014, T32AI007110] Funding Source: NIH RePORTER	University of Florida(University of Florida); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the University of Florida and NIAID, National Institutes of Health Grants R01 AI079014 and T32 AI007110. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson GG, 2004, TRENDS MICROBIOL, V12, P424, DOI 10.1016/j.tim.2004.07.005; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Barber AE, 2013, CLIN INFECT DIS, V57, P719, DOI 10.1093/cid/cit284; Black JB, 2016, SEMIN CELL DEV BIOL, V50, P95, DOI 10.1016/j.semcdb.2015.12.015; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; Chang JD, 2004, J BIOL CHEM, V279, P11672, DOI 10.1074/jbc.M309721200; Cohen LJ, 2017, NATURE, V549, P48, DOI 10.1038/nature23874; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Daaka Y., 2004, SCI STKE, V2004, pre2, DOI [10.1126/stke.2162004re2, DOI 10.1126/STKE.2162004RE2]; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Duncan MJ, 2004, J BIOL CHEM, V279, P18944, DOI 10.1074/jbc.M400769200; Eto DS, 2008, CELL MICROBIOL, V10, P2553, DOI 10.1111/j.1462-5822.2008.01229.x; Eto DS, 2006, CELL MICROBIOL, V8, P704, DOI 10.1111/j.1462-5822.2006.00691.x; Foxman B, 2002, AM J MED, V113, p5S; Foxman B, 2014, INFECT DIS CLIN N AM, V28, P1, DOI 10.1016/j.idc.2013.09.003; Freed DM, 2017, CELL, V171, P683, DOI 10.1016/j.cell.2017.09.017; GALAN JE, 1992, NATURE, V357, P588, DOI 10.1038/357588a0; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Gilbert NM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006238; HAGBERG L, 1981, INFECT IMMUN, V31, P564, DOI 10.1128/IAI.31.2.564-570.1981; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Li QA, 2010, MED MICROBIOL IMMUN, V199, P333, DOI 10.1007/s00430-010-0168-8; Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Miao YX, 2017, CELL HOST MICROBE, V22, P330, DOI 10.1016/j.chom.2017.08.002; Miao YX, 2016, IMMUNITY, V45, P94, DOI 10.1016/j.immuni.2016.06.023; Mulvey MA, 2002, CELL MICROBIOL, V4, P257, DOI 10.1046/j.1462-5822.2002.00193.x; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Oshiumi H, 2015, CELL REP, V11, P1193, DOI 10.1016/j.celrep.2015.04.047; Paczkowski JE, 2015, TRENDS CELL BIOL, V25, P408, DOI 10.1016/j.tcb.2015.02.005; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Pho MT, 2000, J VIROL, V74, P2288, DOI 10.1128/JVI.74.5.2288-2292.2000; Reis CR, 2015, EMBO J, V34, P2132, DOI 10.15252/embj.201591518; Roxas JL, 2014, AM J PHYSIOL-GASTR L, V307, pG374, DOI 10.1152/ajpgi.00312.2013; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Shin JS, 2000, SCIENCE, V289, P785, DOI 10.1126/science.289.5480.785; Slanina H, 2014, INFECT IMMUN, V82, P1243, DOI 10.1128/IAI.01346-13; Totsika M, 2012, CURR DRUG TARGETS, V13, P1386, DOI 10.2174/138945012803530206; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103; Wang ZM, 2012, J GEN VIROL, V93, P2109, DOI 10.1099/vir.0.042713-0; Wang ZM, 2011, J CELL BIOL, V192, P101, DOI 10.1083/jcb.201003027; Wu XR, 1996, P NATL ACAD SCI USA, V93, P9630, DOI 10.1073/pnas.93.18.9630; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Zhu WD, 2012, P NATL ACAD SCI USA, V109, P14194, DOI 10.1073/pnas.1117676109; Zowawi HM, 2015, NAT REV UROL, V12, P570, DOI 10.1038/nrurol.2015.199	45	5	9	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16518	16527		10.1074/jbc.RA118.003499	http://dx.doi.org/10.1074/jbc.RA118.003499			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30166343	Green Published, hybrid			2022-12-26	WOS:000447833600032
J	Obermann, WMJ				Obermann, Wolfgang M. J.			A motif in HSP90 and P23 that links molecular chaperones to efficient estrogen receptor alpha methylation by the lysine methyltransferase SMYD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular chaperone; heat shock protein 90 (HSP90); estrogen receptor; protein methylation; protein folding; post-translational modification (PTM); gel filtration chromatography; P23; SMYD2; gel filtration chromatography	LIGAND-BINDING; MIDDLE DOMAIN; ATP BINDING; PROTEIN; CONTRIBUTES; ACTIVATION; COMPLEX; TARGET	Heat shock protein 90 (HSP90) is a molecular chaperone that supervises folding of cellular signaling proteins such as steroid receptors and many protein kinases. HSP90 relies on ATP hydrolysis for powering a conformational circuit that helps fold the client protein. To that end, HSP90 binds to co-chaperone proteins that regulate ATP hydrolysis rate or interaction with client proteins. Co-chaperones such as P23, cell division cycle 37 (CDC37), or activator of HSP90 ATPase activity 1 (AHA1) interact with the N-terminal or middle domain of HSP90, whereas others, such as HSP70/HSP90-organizing protein (HOP), use tetratricopeptide repeat (TPR) domains to bind the EEVD motif at the very C-terminal end of HSP90. Recently, the lysine methyltransferase SET and MYND domain-containing 2 (SMYD2) has been proposed as an HSP90-binding partner, and interaction analyses indicate that SMYD2 binding to HSP90 is independent of the EEVD motif. Using the amplified luminescence proximity homogeneous assay (Alpha) technique, I identified a new (M/I/L/V)PXL motif at the C termini of HSP90 and P23 that mediates an interaction with SMYD2, and synthetic peptides harboring this motif dissociated this complex. Of note, the HSP90- and P23-dependent client estrogen receptor (ER), was a major methylation target of SMYD2. In a reconstituted system in bacteria, I analyzed HSP90/P23-associated, SMYD2-mediated ER methylation and found that when SMYD2 binds to the molecular chaperones, it considerably increases methylation of Lys-266 in ER. Because methylation represses ER activity, the observed complex formation between SMYD2 and HSP90/P23 may contribute to ER regulation.	[Obermann, Wolfgang M. J.] Ruhr Univ Bochum, Dept Syst Physiol, Univ Str 150, D-44801 Bochum, Germany	Ruhr University Bochum	Obermann, WMJ (corresponding author), Ruhr Univ Bochum, Dept Syst Physiol, Univ Str 150, D-44801 Bochum, Germany.	Wolfgang.Obermann@rub.de	Obermann, Wolfgang/AAN-3896-2020		Mukoviszidose Institut gGmbH (Bonn, Germany) [S03/10]; research and development arm of the German Cystic Fibrosis Association Mukoviszidose e.V.; Ruhr-University Bochum FoRUM Grant [F829]	Mukoviszidose Institut gGmbH (Bonn, Germany); research and development arm of the German Cystic Fibrosis Association Mukoviszidose e.V.; Ruhr-University Bochum FoRUM Grant	This work was supported in part by Mukoviszidose Institut gGmbH (Bonn, Germany) Grant S03/10, the research and development arm of the German Cystic Fibrosis Association Mukoviszidose e.V. (to W. O.), and in part by Ruhr-University Bochum FoRUM Grant F829 (to W. O.). The author declares that he has no conflicts of interest with the contents of this article.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Abu-Farha M, 2011, J MOL CELL BIOL, V3, P301, DOI 10.1093/jmcb/mjr025; Aumais JP, 1997, J BIOL CHEM, V272, P12229, DOI 10.1074/jbc.272.18.12229; Bennesch MA, 2016, NUCLEIC ACIDS RES, V44, P8655, DOI 10.1093/nar/gkw522; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Dhamad AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160312; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Ferguson AD, 2011, STRUCTURE, V19, P1262, DOI 10.1016/j.str.2011.06.011; Fliss AE, 2000, J STEROID BIOCHEM, V72, P223, DOI 10.1016/S0960-0760(00)00037-6; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Ihrig V, 2017, SLAS DISCOV, V22, P923, DOI 10.1177/2472555216688312; Jiang YY, 2014, J MOL BIOL, V426, P3413, DOI 10.1016/j.jmb.2014.02.019; Jiang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021640; Knoblauch R, 1999, MOL CELL BIOL, V19, P3748; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Nguyen H, 2015, J BIOL CHEM, V290, P13641, DOI 10.1074/jbc.M114.626861; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pratt WB, 2015, ANNU REV PHARMACOL, V55, P353, DOI 10.1146/annurev-pharmtox-010814-124332; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Tripathi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071856; Wang L, 2011, J BIOL CHEM, V286, P38725, DOI 10.1074/jbc.M111.262410; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wu SC, 2009, MOL ENDOCRINOL, V23, P1323, DOI 10.1210/me.2009-0131; Zhang X, 2013, P NATL ACAD SCI USA, V110, P17284, DOI 10.1073/pnas.1307959110	32	15	16	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16479	16487		10.1074/jbc.RA118.003578	http://dx.doi.org/10.1074/jbc.RA118.003578			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30190324	Green Published, hybrid			2022-12-26	WOS:000447833600029
J	Iske, CJ; Morris, CL; Colpoys, JD; Kappen, KL; Iennarella, CA; Johnson, AK				Iske, Cayla J.; Morris, Cheryl L.; Colpoys, Jessica D.; Kappen, Kelly L.; Iennarella, Chelsea A.; Johnson, Anna K.			Nutrient evaluation of a pork by-product and its use as environmental enrichment for managed large exotic cats	PLOS ONE			English	Article							CHEETAHS ACINONYX-JUBATUS; DIETARY FIBER; ORAL-HEALTH; BEHAVIOR; DIGESTIBILITY; REQUIREMENTS; FOODS	North American zoological institutions typically feed ground raw meat diets to large exotic cats. These diets typically are nutritionally complete, but lack physical properties characteristic of whole prey. Lack of mastication and prey manipulation may contribute to behavioral and health challenges. Pork by-products may provide environmental enrichment to mitigate these challenges. The objectives of this study were to evaluate a pig head for nutritional composition and to determine if a pig head was biologically relevant environmental enrichment for managed large exotic cats. Pig heads consisted of: DM: 48.5%; OM: 60.7%; CP: 38.4%; fat: 22.0%; CF: 13.5%; TDF: 3.4%; GE: 4.1 kcal/g DM. Five individually housed exotic cats (Panthera tigris tigris, Panthera tigris altaica (n = 2), Panthera tigris jacksoni, Panthera leo) were observed in 2-h blocks, 24-h before pig head introduction (Baseline), at time of pig head introduction (Enrichment) and immediately after the pig head was removed (Post Enrichment) via instantaneous scan sampling for 4 consecutive weeks. Active behaviors were 55.7% higher on Enrichment compared to Baseline days, and 26.4% higher compared to Post Enrichment days (p<0.0001). Active behaviors were 39.8% higher on Post Enrichment compared to Baseline days (p<0.0001). Total active behaviors were highest (p<0.0001) in week 3 and lowest (p<0.0001) in week 4 with differences as high as 64.5% seen among weeks. In conclusion, pig heads have potential to provide nutrient dense enrichment to large exotic cats, and employing a pig head as environmental enrichment increased active behaviors and did not lose novelty.	[Iske, Cayla J.; Colpoys, Jessica D.; Iennarella, Chelsea A.; Johnson, Anna K.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Morris, Cheryl L.; Kappen, Kelly L.] Omahas Henry Doorly Zoo & Aquarium, Omaha, NE 68107 USA	Iowa State University	Morris, CL (corresponding author), Omahas Henry Doorly Zoo & Aquarium, Omaha, NE 68107 USA.	cherylm@omahazoo.com	Johnson, Anna K/E-9319-2015	Johnson, Anna K/0000-0001-7687-0465	Carnivore Essentials; Sustainable Swine Resources	Carnivore Essentials; Sustainable Swine Resources	CLM is an employee of Omaha's Henry Doorly Zoo & Aquarium, a 501c3, non-profit organization. In addition to providing the salary support for CLM throughout the study duration, the zoo also contributed animals for the study and keeper time for accomplishing the data collection. Dr. Morris played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. Carnivore Essentials was a commercial feed manufacturer and provided funding to support the annual salary of CJI along with funding to complete laboratory analyses conducted. They also provided the pork by-products (in-kind) for the evaluation and testing. They did not contribute to study design, data collection or analysis, decision to publish or preparation of the manuscript. The specific roles of both CJI and CLM are specified in the Author Contribution section of the online submission form. We thank Sustainable Swine Resources for financial support and pig heads to conduct the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sustainable Swine Resources for financial support and pig heads to conduct the study. We also thank animal care staff at each zoo for facilities and use of their animals and Iowa State University for use of laboratories and personnel for guidance. We also thank Krysten Fries, Tara Daly, and Roni McClellen for assistance in data collection.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; AOAC, 2000, 98501 AOAC; AOAC, 1995, 99136 AOAC; AOAC, 2006, OFFICIAL METHODS ANA; Association of Zoos and Aquariums, 2014, ACCR BAS; Bashaw MJ, 2003, ZOO BIOL, V22, P189, DOI 10.1002/zoo.10065; BOND JC, 1990, APPL ANIM BEHAV SCI, V26, P373, DOI 10.1016/0168-1591(90)90036-D; Carlstead Kathy, 1998, P172; CARO TM, 1979, BEHAVIOUR, V69, P303, DOI 10.1163/156853979X00520; Catty D, 1969, Monogr Allergy, V5, P1; CHAMOVE AS, 1989, LAB ANIM, V23, P215, DOI 10.1258/002367789780810608; Cho SS, 2001, FOOD SCI, V113, P47; Clauss M, 2010, ZOO BIOL, V29, P687, DOI 10.1002/zoo.20302; de-Oliveira LD, 2012, J ANIM PHYSIOL AN N, V96, P895, DOI 10.1111/j.1439-0396.2011.01203.x; Depauw S, 2013, J ANIM PHYSIOL AN N, V97, P146, DOI 10.1111/j.1439-0396.2011.01252.x; Duckler GL, 1998, ZOO BIOL, V17, P135, DOI 10.1002/(SICI)1098-2361(1998)17:2<135::AID-ZOO8>3.0.CO;2-A; Fahey GC, 2004, DIETARY FIBRE, P295; Farkas J, 1998, INT J FOOD MICROBIOL, V44, P189, DOI 10.1016/S0168-1605(98)00132-9; Felid Taxon Advisory Group, 2014, BAS FEC SCAL FELDS; Fitch H.M., 1982, Zoo Biology, V1, P295, DOI 10.1002/zoo.1430010403; Gamble HR, 2001, AGR RES SERV PARASIT; Greve J.H., 2012, DIS SWINE, V10th, P912; Hartstone-Rose A., 2014, FEL CAND TAX ADV GRO; Hollister N., 1917, P US NATL MUS, P180; Hunter SA, 2002, ZOO BIOL, V21, P375, DOI 10.1002/zoo.10042; HWANG CA, 1995, INT J FOOD MICROBIOL, V27, P91, DOI 10.1016/0168-1605(94)00150-5; Iske C, 2017, TRANSL ANIM SCI, V1, P1; Iske CJ, 2016, J ANIM SCI, V94, P3738, DOI 10.2527/jas.2016-0414; Iske CJ, 2016, 662 AS AN IND; Jayathilakan K, 2012, J FOOD SCI TECH MYS, V49, P278, DOI 10.1007/s13197-011-0290-7; Kapoor V, 2016, RES VET SCI, V107, P213, DOI 10.1016/j.rvsc.2016.06.009; Kienzle E, 1998, J NUTR, V128, p2609S, DOI [10.1093/jn/128.12.2609S, 10.1093/jn/128.12.2598S, 10.1093/jn/128.12.2680S]; LINDBURG DG, 1988, ZOO BIOL, V7, P211, DOI 10.1002/zoo.1430070303; Lindsay D., 2012, DIS SWINE, P899; Margulis SW, 2003, ZOO BIOL, V22, P587, DOI 10.1002/zoo.10115; Martin P.R., 1993, MEASURING BEHAV INTR, P114; Mellen J, 2001, ZOO BIOL, V20, P211, DOI 10.1002/zoo.1021; Miller CS, 2014, BIOL CONSERV, V170, P120, DOI 10.1016/j.biocon.2013.12.012; National Research Council, 2006, NUTR REQ DOGS CATS; Nauwynck H, 2007, VET RES, V38, P229, DOI 10.1051/vetres:200661; PROSKY L, 1994, J AOAC INT, V77, P690; Rastogi NK, 2007, CRIT REV FOOD SCI, V47, P69, DOI 10.1080/10408390600626420; REED HJ, 1993, APPL ANIM BEHAV SCI, V36, P39, DOI 10.1016/0168-1591(93)90097-9; ROLLIN BE, 1985, AM PSYCHOL, V40, P920, DOI 10.1037/0003-066X.40.8.920; Ruskell AD, 2015, ZOO BIOL, V34, P170, DOI 10.1002/zoo.21192; Sambrook TD, 1997, ANIM WELFARE, V6, P207; Skibiel AL, 2007, ZOO BIOL, V26, P371, DOI 10.1002/zoo.20147; SMITH SF, 1993, BRIT POULTRY SCI, V34, P21, DOI 10.1080/00071669308417559; SMUTS GL, 1978, J ZOOL, V185, P115, DOI 10.1111/j.1469-7998.1978.tb03317.x; Thiex N, 2009, J AOAC INT, V92, P61; TRIPP JK, 1985, ZOO BIOL, V4, P225, DOI 10.1002/zoo.1430040303; United States Department of Agriculture, 2008, USDA TECHNICAL B, V1923; Wells DL, 2004, APPL ANIM BEHAV SCI, V85, P107, DOI 10.1016/j.applanim.2003.08.013; Wilson NO, 2015, MMWR SURVIELLANCE SU, P1; Young R.J., 2003, ENV ENRICHMENT CAPTI, DOI [10.1002/9780470751046, DOI 10.1002/9780470751046]; Zordan M, 2012, ZOO BIOL, V31, P181, DOI 10.1002/zoo.20392	56	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2018	13	9							e0202144	10.1371/journal.pone.0202144	http://dx.doi.org/10.1371/journal.pone.0202144			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7EB	30208036	Green Published, Green Submitted, gold			2022-12-26	WOS:000444683000013
J	Habets, THPM; Hepkema, BG; Kouprie, N; Schnijderberg, MCA; van Smaalen, TC; Bungener, LB; Christiaans, MHL; Bos, GMJ; Vanderlocht, J				Habets, Thomas H. P. M.; Hepkema, Bouke G.; Kouprie, Niels; Schnijderberg, Melanie C. A.; van Smaalen, Tim C.; Bungener, Laura B.; Christiaans, Maarten H. L.; Bos, Gerard M. J.; Vanderlocht, Joris			The prevalence of antibodies against the HLA-DRB3 protein in kidney transplantation and the correlation with HLA expression	PLOS ONE			English	Article							ALLELES; GENES; LOCI; MOLECULES; FAILURE; SPECIFICITY; SEQUENCES; ANTIGENS; HISTORY; DISEASE	Human leukocyte antigen (HLA)-DRB3 is a functional HLA class II gene, which has a limited allele diversity in the human population. Furthermore, the HLA-DRB3 gene is only present in a subset of individuals. Therefore, in organ transplantation, this HLA molecule is frequently mismatched between patient and graft donor and thus antibodies against this mismatched HLA molecule can develop. In this study, we aimed to evaluate the prevalence and reactivity of these antibodies and aimed to identify factors that underlie antibody formation against HLA-DRB3. We showed in our patient cohort that HLA-DRB3 antibodies are identified in about 7% of all patients that were screened with solid phase assays. In these assays, we observed multiple antibody reactivity patterns indicating that HLA-DRB3 harbours multiple epitopes. In those cases, where we succeeded at tracing back the induction of these antibodies to the molecular HLA typing of the immunogenic event, we noticed a different frequency of HLA-DRB1 allele groups in the donors as compared to a control group. To a certain extent this distribution (e.g. HLA-DRB1* 11 individuals) could be linked to an altered expression level. However, it also appears that different HLA-DRB3 alleles (e.g. HLA-DRB3* 01 group) vary in their immunogenicity without having an expression difference. In conclusion, our study provides information on the immunogenicity and reactivity patterns of antibodies against HLA-DRB3 in kidney transplantation, and it points towards the possibility of HLA expression as a factor underlying antibody formation.	[Habets, Thomas H. P. M.; Vanderlocht, Joris] Maastricht Univ, Med Ctr, Tissue Typing Lab, Dept Transplantat Immunol, Maastricht, Netherlands; [Habets, Thomas H. P. M.; Schnijderberg, Melanie C. A.; Bos, Gerard M. J.; Vanderlocht, Joris] Maastricht Univ, Med Ctr, Dept Internal Med, Div Hematol, Maastricht, Netherlands; [Hepkema, Bouke G.; Kouprie, Niels; Bungener, Laura B.] Univ Groningen, Univ Med Ctr Groningen, Transplantat Immunol, Dept Lab Med, Groningen, Netherlands; [van Smaalen, Tim C.] Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands; [Christiaans, Maarten H. L.] Maastricht Univ, Med Ctr, Dept Internal Med, Div Nephrol, Maastricht, Netherlands; [Bos, Gerard M. J.] CiMaas BV, Maastricht, Netherlands; [Vanderlocht, Joris] Maastricht Univ, Med Ctr, Cent Diagnost Lab, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; University of Groningen; Maastricht University; Maastricht University; Maastricht University	Vanderlocht, J (corresponding author), Maastricht Univ, Med Ctr, Tissue Typing Lab, Dept Transplantat Immunol, Maastricht, Netherlands.; Vanderlocht, J (corresponding author), Maastricht Univ, Med Ctr, Dept Internal Med, Div Hematol, Maastricht, Netherlands.; Vanderlocht, J (corresponding author), Maastricht Univ, Med Ctr, Cent Diagnost Lab, Maastricht, Netherlands.	joris.vanderlocht@mumc.nl						ANDERSSON G, 1994, IMMUNOL TODAY, V15, P58, DOI 10.1016/0167-5699(94)90134-1; Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; BERDOZ J, 1987, J IMMUNOL, V139, P1336; Bergstrom TF, 1999, IMMUNOL REV, V167, P351, DOI 10.1111/j.1600-065X.1999.tb01404.x; Bos EM, 2007, KIDNEY INT, V72, P797, DOI 10.1038/sj.ki.5002400; Bouwmans EE, 2014, TRANSFUSION, V54, P1478, DOI 10.1111/trf.12502; Chen QY, 1999, J CLIN ENDOCR METAB, V84, P3182, DOI 10.1210/jc.84.9.3182; COTNER T, 1989, J BIOL CHEM, V264, P11107; Dai S, 2008, P NATL ACAD SCI USA, V105, P11893, DOI 10.1073/pnas.0805810105; Davis SJ, 2003, NAT IMMUNOL, V4, P217, DOI 10.1038/ni0303-217; Decary F, 1991, Transfus Med, V1, P55, DOI 10.1111/j.1365-3148.1991.tb00010.x; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Donaldson PT, 2002, AUTOIMMUNITY, V35, P555, DOI 10.1080/0891693021000054093; Einecke G, 2009, AM J TRANSPLANT, V9, P2520, DOI 10.1111/j.1600-6143.2009.02799.x; EMERY P, 1993, HUM IMMUNOL, V38, P137, DOI 10.1016/0198-8859(93)90531-5; Faner R, 2010, EUR J IMMUNOL, V40, P91, DOI 10.1002/eji.200939225; Gandemer V, 1999, BRIT J HAEMATOL, V104, P878, DOI 10.1046/j.1365-2141.1999.01270.x; Gaston RS, 2010, TRANSPLANTATION, V90, P68, DOI 10.1097/TP.0b013e3181e065de; GORSKI J, 1986, NATURE, V322, P67, DOI 10.1038/322067a0; Hill M, 1999, ANN NEUROL, V45, P224, DOI 10.1002/1531-8249(199902)45:2<224::AID-ANA13>3.0.CO;2-B; ISHIHARA M, 1995, BRIT J OPHTHALMOL, V79, P322, DOI 10.1136/bjo.79.4.322; KAUFMAN JF, 1984, CELL, V36, P1, DOI 10.1016/0092-8674(84)90068-0; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; Konvalinka A, 2015, J AM SOC NEPHROL, V26, P1489, DOI 10.1681/ASN.2014080837; Mizutani K, 2007, AM J TRANSPLANT, V7, P1027, DOI 10.1111/j.1600-6143.2006.01721.x; Opelz G, 2007, TRANSPLANTATION, V84, P137, DOI 10.1097/01.tp.0000269725.74189.b9; Otten HG, 2014, TRANSPL IMMUNOL, V31, P184, DOI 10.1016/j.trim.2014.09.008; Parry CS, 2007, J MOL BIOL, V371, P435, DOI 10.1016/j.jmb.2007.05.025; Petersdorf EW, 2015, NEW ENGL J MED, V373, P599, DOI 10.1056/NEJMoa1500140; Petersdorf EW, 2014, BLOOD, V124, P3996, DOI 10.1182/blood-2014-09-599969; Reed EF, 2013, AM J TRANSPLANT, V13, P1859, DOI 10.1111/ajt.12287; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Sanchez-Mazas A, 2012, PHILOS T R SOC B, V367, P830, DOI 10.1098/rstb.2011.0312; Schreuder GMT, 2005, TISSUE ANTIGENS, V65, P1, DOI 10.1111/j.1399-0039.2005.00350.x; Sellares J, 2012, AM J TRANSPLANT, V12, P388, DOI 10.1111/j.1600-6143.2011.03840.x; Susal C, 2013, CURR OPIN ORGAN TRAN, V18, P438, DOI 10.1097/MOT.0b013e3283636ddf; Sukati H, 2005, TRANSFUSION, V45, P1165, DOI 10.1111/j.1537-2995.2005.00188.x; Terasaki PI, 2004, AM J TRANSPLANT, V4, P438, DOI 10.1111/j.1600-6143.2004.00360.x; Texier C, 2001, EUR J IMMUNOL, V31, P1837, DOI 10.1002/1521-4141(200106)31:6&lt;1837::AID-IMMU1837&gt;3.0.CO;2-H; TIERCY JM, 1988, P NATL ACAD SCI USA, V85, P198, DOI 10.1073/pnas.85.1.198; van Balen P., 2017, TRANSPLANTATION; Voorter CEM, 2014, METHODS MOL BIOL, V1109, P101, DOI 10.1007/978-1-4614-9437-9_7; Williamson LM, 1998, BLOOD, V92, P2280, DOI 10.1182/blood.V92.7.2280.2280_2280_2287; Zilinska Z, 2015, TRANSPL IMMUNOL, V33, P159, DOI 10.1016/j.trim.2015.10.001	44	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203381	10.1371/journal.pone.0203381	http://dx.doi.org/10.1371/journal.pone.0203381			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192820	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600066
J	Fernandez, RJ; Liria, IC; Vazquez, RR; Fernandez, SC; Iglesias, MEL; Vallejo, RBD				Jimenez Fernandez, Raquel; Corral Liria, Inmaculada; Rodriguez Vazquez, Rocio; Cabrera Fernandez, Susana; Losa Iglesias, Marta Elena; de Bengoa Vallejo, Ricardo Becerro			Exploring the knowledge, explanatory models of illness, and patterns of healthcare-seeking behaviour of Fang culture-bound syndromes in Equatorial Guinea	PLOS ONE			English	Article							TRADITIONAL HEALERS; CHALLENGES; SYNCHRONICITY; PERCEPTION; WITCHCRAFT; DISORDERS; ATTITUDES; SYMPTOMS; CHILDREN; NIGERIA	In 1994, the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) included "culture-bound syndromes" in its classification of psychiatric disorders and associated them with disease processes that manifest in behavioural or thought disorders that develop within a given cultural context. This study examines the definitions, explanatory models, signs and symptoms, and healthcare-seeking behaviours common to Fang culture-bound syndromes (i.e., kong, eluma, witchcraft, mibili, mikug, and nsamadalu). The Fang ethnic group is the majority ethnic group in Equatorial Guinea. From September 2012 to January 2013, 45 key Fang informants were selected, including community leaders, tribal elders, healthcare workers, traditional healers, and non-Catholic pastors in 39 of 724 Fang tribal villages in 6 of 13 districts in the mainland region of Equatorial Guinea. An ethnographic approach with an emic-etic perspective was employed. Data were collected using semi-structured interviews, participant observation and a questionnaire that included DHS6 key indicators. Interviews were designed based on the Cultural Formulation form in the DSM-5 and explored the definition of Fang cultural syndromes, symptoms, cultural perceptions of cause, and current helpseeking. Participants defined "Fang culture-bound syndromes" as those diseases that cannot be cured, treated, or diagnosed by science. Such syndromes present with the same signs and symptoms as diseases identified by Western medicine. However, they arise because of the actions of enemies, because of the actions of spirits or ancestors, as punishments for disregarding the law of God, because of the violation of sexual or dietary taboos, or because of the violation of a Fang rite of passage, the dzas, which is celebrated at birth. Six Fang culture-bound syndromes were included in the study: 1) Eluma, a disease that is targeted at the victim out of envy and starts out with sharp, intense, focussed pain and aggressiveness; 2) Witchcraft, characterized by isolation from the outside, socially maladaptive behaviour, and the use of hallucinogenic substances; 3) Kong, which is common among the wealthy class and manifests as a disconnection from the environment and a lack of vital energy; 4) Mibili, a possession by evil spirits that manifests through visual and auditory hallucinations; 5) Mikug, which appears after a person has had contact with human bones in a ritual; and 6) Nsamadalu, which emerges after a traumatic process caused by violating traditions through having sexual relations with one's sister or brother. The therapeutic resources of choice for addressing Fang culture-bound syndromes were traditional Fang medicine and the religious practices of the Bethany and Pentecostal churches, among others. Among African ethnic groups, symbolism, the weight of tradition, and the principle of chance in health and disease are underlying factors in the presentation of certain diseases, which in ethno-psychiatry are now referred to as culture-bound syndromes. In this study, traditional healers, elders, healthcare professionals, religious figures, and leaders of the Fang community in Equatorial Guinea referred to six such cultural syndromes: eluma, witchcraft, kong, mibili, mikug, and nsamadalu. In the absence of a multidisciplinary approach to mental illness in the country, the Fang ethnic group seeks healthcare for culture-bound syndromes from traditional healing and religious rites in the Evangelical faiths.	[Jimenez Fernandez, Raquel; Corral Liria, Inmaculada; Rodriguez Vazquez, Rocio; Cabrera Fernandez, Susana; Losa Iglesias, Marta Elena] Univ Rey Juan Carlos, Fac Ciencias Salud, Avda Atenas, Madrid, Spain; [de Bengoa Vallejo, Ricardo Becerro] Univ Complutense Madrid, Escuela Univ Enfermeria Fisioterapia & Podol, Fac Med, Ave Complutense, Madrid, Spain	Universidad Rey Juan Carlos; Complutense University of Madrid	Iglesias, MEL (corresponding author), Univ Rey Juan Carlos, Fac Ciencias Salud, Avda Atenas, Madrid, Spain.	marta.losa@urjc.es	Iglesias, Marta E Losa/B-8830-2009; de Bengoa Vallejo, Ricardo Becerro/P-4153-2019; Becerro de Bengoa Vallejo, Ricardo/B-8857-2009	Iglesias, Marta E Losa/0000-0001-7588-2069; Becerro de Bengoa Vallejo, Ricardo/0000-0003-1568-7602				Abdullahi, 2011, AFR J TRADIT COMPLEM, V8, P115, DOI 10.4314/ajtcam.v8i5S.5; Abubakar A, 2011, RURAL REMOTE HEALTH, V11; African Development Bank Group, 2014, AFR STAT YB 2014; Aguirre Beltran G., 1973, MED MAGIA PROCESO AC; Akinlua JT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154287; Alegria M, 2004, INT J METH PSYCH RES, V13, P270, DOI 10.1002/mpr.181; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596.X00DIAGNOSTICCLASSIFICATION; [Anonymous], 1981, TRADICIONES PUEBLO F; [Anonymous], 2014, OFICINA EC COMERCIAL; [Anonymous], 2004, BRUJERIA FANG GUINEA; Arias D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162305; Arrey AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119653; Asamoah-Gyadu JK, 2015, INT BULL MISSION RES, V39, P23; Astuti R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00136; Atim P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159549; Atmanspacher H, 2014, J ANAL PSYCHOL, V59, P429, DOI 10.1111/1468-5922.12086; Atobrah D, 2012, Ghana Med J, V46, P46; Bennett S, 2014, TROP MED INT HEALTH, V19, P872, DOI 10.1111/tmi.12319; Berenzon-Gorn S, 2006, SALUD PUBLICA MEXICO, V48, P45, DOI 10.1590/s0036-36342006000100008; Bonhomme J, 2012, HAU-J ETHNOGR THEORY, V2, P205, DOI 10.14318/hau2.2.012; Burgos B., CULTURAS AFRICANAS D; Campbell MM, 2017, BMC PSYCHIAT, V17; Casado Aijon I, 2008, 11 C ANTR RET TEOR N, P41; Castillo Franco Armando, 2006, Index Enferm, V15, P18, DOI 10.4321/s1132-12962006000300004; Colman W, 2011, J ANAL PSYCHOL, V56, P471, DOI 10.1111/j.1468-5922.2011.01924.x; Creswell JW., 2012, CONDUCT EVAL, V260, P375; Culqui Dante R., 2008, Rev. perú. med. exp. salud publica, V25, P59; Custodio E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-225; De Sreeja, 2013, Indian J Psychol Med, V35, P268, DOI 10.4103/0253-7176.119484; DÍAZ MUJICA ALEJANDRO, 2004, Cienc. enferm., V10, P9, DOI 10.4067/S0717-95532004000100002; Essen B, 2011, J PSYCHOSOM OBST GYN, V32, P10, DOI 10.3109/0167482X.2010.547966; Foster D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-240; Fottrell E, 2012, J EPIDEMIOL COMMUN H, V66, P704, DOI 10.1136/jech.2010.124305; Gallagher M.R., 2012, Enferm. glob., V11, P1, DOI 10.4321/s1695-61412012000300001; Gonzalez Conesa F., 1950, GUINEA CONTINENTAL E; Gonzalez Echegaray C., 1999, ETNO HIST CULTURAS B; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; GRIMSHAW AD, 1991, CONTEMP SOCIOL, V20, P843, DOI 10.2307/2076144; Guarnaccia PJ, 1999, AM J PSYCHIAT, V156, P1322; Hammersley M, 1994, ETNOGRAFIA METODOS I; HARRIS M, 1976, ANNU REV ANTHROPOL, V5, P329, DOI 10.1146/annurev.an.05.100176.001553; Hodes RM, 1997, WESTERN J MED, V166, P29; ICF International, 2011, DEM HLTH SURV METH Q; Igbinomwanhia NG, 2013, AFR J PSYCHIATRY, V16, P196, DOI [http://dx.doi.org/10.4314/ajpsy.v16i3.26, 10.4314/ajpsy.v16i3.26]; Jacob KS, 2013, INDIAN J PSYCHIAT, V55, P12, DOI 10.4103/0019-5545.105500; Jones CHD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151606; Kohrt BA, 2014, INT J EPIDEMIOL, V43, P365, DOI 10.1093/ije/dyt227; Laplantine F., 1999, ANTROPOLOGIA ENFERMA, P57; Leavey G, 2007, SOC SCI MED, V65, P548, DOI 10.1016/j.socscimed.2007.03.050; Lee Jieun, 2014, Asia Taepyongyang Sangdam Yongu, V4, P49; Leseth AB, 2015, BJPSYCH BULL, V39, P187, DOI 10.1192/pb.bp.114.047936; LETT J, 1990, FRONT ANTHR, P127; Liddell C, 2008, PSYCHOSOM MED, V70, P496, DOI 10.1097/PSY.0b013e31816fdf0e; LOGAN MH, 1987, AM ANTHROPOL, V89, P465, DOI 10.1525/aa.1987.89.2.02a00350; Lopez-Ibor Alino JJ, 2002, DSM 4 TR MANUAL DIAG; Fernandez DL, 2013, REV ESP ANTROPOL AM, V43, P285; Main R, 2014, J ANAL PSYCHOL, V59, P174, DOI 10.1111/1468-5922.12067; Mallart i Guimera L, 2007, SOY HIJO EVUZOK; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Mavhu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032475; Meel BL, 2009, AFR HEALTH SCI, V9, P61; Mianji Fahimeh, 2015, Iran J Psychiatry, V10, P225; Naseef K. A., 2013, International Journal of Developing Societies, V2, P29; Novoa JM, 1984, GUINEA ECUATORIAL HI; Nyabwari BG, 2014, IMPACT MAGIC WITCHCR; Nze Abuy RM, 1984, BREVES DATOS HISTORI; O'Neill S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160464; Okeke TA, 2006, J BIOSOC SCI, V38, P491, DOI 10.1017/S002193200502660X; Olive J. L., 2014, FORUM QUAL SOC RES, V15; Panyella A., 1963, PROCESO TRANSFORMACI; Panyella A, 1958, INDIVIDUO SOC FANG M; Peeters Grietens K, 2012, PLOS ONE, V7; Peltzer K, 2008, AFR J TRADIT COMPLEM, V5, P370; Peretti L, 2010, SCR ETHNOL, V32, P17; Pfeiffer J, 2007, AM ANTHROPOL, V109, P688, DOI 10.1525/AA.2007.109.4.688; PHILLIPS MR, 1988, J PSYCHOHIST, V15, P383; Pilkington H, 2004, J EPIDEMIOL COMMUN H, V58, P826, DOI 10.1136/jech.2003.016089; Price R., 1986, J LAT AM STUD, V18, P241; Reuter KE, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.369.5552; Roura M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-427; Ruano AL, 2014, HEALTH EXPECT, V17, P93, DOI 10.1111/j.1369-7625.2011.00731.x; Sabuni LP, 2007, QUAL HEALTH RES, V17, P1280, DOI 10.1177/1049732307307864; Shringarpure KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150849; Sifunda S, 2007, HEALTH EDUC RES, V22, P805, DOI 10.1093/her/cyl105; Sorsdahl KR, 2010, AFR J PSYCHIATRY, V13, P284; Sumathipala A, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-54; Teuton J, 2007, SOC SCI MED, V65, P1260, DOI 10.1016/j.socscimed.2007.03.055; THOMPSON EE, 1965, B MED LIBR ASSOC, V53, P80; Towns AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105972; Tylor E. B., 1871, PRIMITIVE CULTURE RE, V2; UN_ UNICEF and World Health Organization (WHO), 2013, JOINT MON PROGR EQ G; van Duijl M, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-24; van Duijl M, 2010, CULT MED PSYCHIAT, V34, P380, DOI 10.1007/s11013-010-9171-1; YAP PM, 1967, AUST NZ J PSYCHIAT, V1, P172, DOI 10.3109/00048676709159191	94	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0201339	10.1371/journal.pone.0201339	http://dx.doi.org/10.1371/journal.pone.0201339			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT0BU	30192763	Green Published, gold			2022-12-26	WOS:000444093600010
J	Kinel, E; D'Amico, M; Roncoletta, P				Kinel, Edyta; D'Amico, Moreno; Roncoletta, Piero			Normative 3D opto-electronic stereo-photogrammetric sagittal alignment parameters in a young healthy adult population	PLOS ONE			English	Article							SCOLIOSIS RESEARCH SOCIETY; JOINT CENTER LOCATION; QUALITY-OF-LIFE; LOW-BACK-PAIN; SPINAL DEFORMITY; RADIOGRAPHIC PARAMETERS; PELVIC TILT; BALANCE; VALUES; INCLINATION	This paper describes and presents a stable and reliable set of stereo-photogrammetric normative data for global and spino-pelvic sagittal alignment, as a proven reference system for evaluating/measuring a fully unconstrained natural upright neutral standing attitude in a young healthy adult population. The methodological features described in this article will enable future studies to replicate and/or directly compare a wide range of different postural tests and/or sagittal alignment assessment procedures including the study of sagittal spine shape variations occurring during gait performance. To date, the quantitative evaluation of adult spinal deformity (ASD) has been mainly confined to the X-ray imaging approach and, more recently, to 3D X-ray reconstruction. Within the existing evaluation framework an opportunity exists for an additional approach: a quantitative evaluation procedure which is easy, accurate, relatively speedy and non-ionising, in order to monitor and track the progress of patients in the areas of both surgical and non-surgical treatment. The resources and methodology described in this paper have been proven to meet all these criteria. They have enabled full 3D posture (including 3D spine shape and sagittal alignment of the skeleton) to be consistently and successfully measured in adult volunteers. All the measurement/evaluation procedures and outcomes carried out were based entirely on the new non-ionising 3D opto-electronic stereo-photogrammetric approach described in this article. The protocol for this methodology was based on a standard set of 27 pre-selected anatomical <feminine ordinal indicator> landmarks on the human body, providing standard reference points for observation and measurement. A total of 124 healthy subjects were successfully assessed and, for each subject, 27 individual markers were applied to the corresponding locations on his/her body. Statistical tests to investigate gender differences were also carried out. Descriptive statistics are provided for all 15 of the spino-pelvic parameters under consideration. Results indicated significant differences between genders in five sets of parameters: Kyphosis tilt, Head tilt, Pelvic tilt, Spino-pelvic angle and T1-pelvic angle. The data also demonstrate a high degree of congruity with results obtained using the X-ray method, as evidenced by the existing literature inthe field. In summary, the current study presents a new stereo-photogrammetric opto-electronic technology which can be used successfully for ASD evaluation and introduces a comprehensive set of normative data analogous to those proposed in X-ray analysis for sagittal spino-pelvic and total body alignment.	[Kinel, Edyta] Univ Med Sci, Clin Rehabil, Dept Rheumatol & Rehabil, Poznan, Poland; [D'Amico, Moreno; Roncoletta, Piero] Bioengn & Biomed Co Srl, SMART Lab Skeleton Movement Anal & Adv Rehabil Te, Pescara, Italy; [D'Amico, Moreno] Univ G DAnnunzio, Dept Imaging Neurosci & Clin Sci, Chieti, Italy	G d'Annunzio University of Chieti-Pescara	D'Amico, M (corresponding author), Bioengn & Biomed Co Srl, SMART Lab Skeleton Movement Anal & Adv Rehabil Te, Pescara, Italy.; D'Amico, M (corresponding author), Univ G DAnnunzio, Dept Imaging Neurosci & Clin Sci, Chieti, Italy.	damicomoreno@gmail.com	Kinel, Edyta/AAX-9964-2020; Kinel, Edyta/F-5251-2012	Kinel, Edyta/0000-0001-9106-8016; 	Bioengineering & Biomedicine Company Srl	Bioengineering & Biomedicine Company Srl	The authors received no specific funding for this work. The Bioengineering & Biomedicine Company Srl provided access to its Posture and Movement Biomechanical laboratory for free, letting the authors to freely use without any limitations this facility to carry out the measurements for the study. Bioengineering & Biomedicine Company Srl, also provided funding for the publication fee. The Bioengineering & Biomedicine Company Srl did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailon T, 2015, DEGENERATIVE SPINAL, V77, pS75, DOI [10.1227/NEU.0000000000000938, DOI 10.1227/NEU.0000000000000938]; Ailon T, 2015, PROGR SPINAL KYPHOSI, V77, pS164, DOI [10.1227/NEU.0000000000000944PMID:26378354, DOI 10.1227/NEU.0000000000000944PMID:26378354]; [Anonymous], WHO MEAN BOD MASS IN; Asai Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178697; Barrey Cedric, 2011, Eur Spine J, V20 Suppl 5, P626, DOI 10.1007/s00586-011-1930-3; Berthonnaud E, 2005, J SPINAL DISORD TECH, V18, P40, DOI 10.1097/01.bsd.0000117542.88865.77; Bess S, 2013, NEUROSURG CLIN N AM, V24, P185, DOI 10.1016/j.nec.2012.12.008; Blondel B, 2012, NEUROSURGERY, V71, P341, DOI 10.1227/NEU.0b013e31825d20c0; Chiari L, 2005, GAIT POSTURE, V21, P197, DOI 10.1016/j.gaitpost.2004.04.004; D'Amico M, 2017, 3D SPINE FULL SKELET; D'Amico M., 2007, EUR MED PHYS, V43, P1; D'Amico M, 2001, PROCEEDINGS OF THE X; D'Amico M, 2011, 2011 IEEE INT WORKSH, P605, DOI [DOI 10.1109/MEMEA.2011.5966711, 10.1109/MeMeA.2011.5966711]; D'Amico M, ASAP POSTURE; D'Amico M, 2018, EUR J PHYS REHAB MED, V54, P428, DOI 10.23736/S1973-9087.17.04738-4; D'Amico M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179619; D'Amico M, 2010, STUD HEALTH TECHNOL, V158, P118, DOI 10.3233/978-1-60750-573-0-118; DAMICO M, 1992, MED BIOL ENG COMPUT, V30, P193, DOI 10.1007/BF02446130; DAMICO M, 1990, MED BIOL ENG COMPUT, V28, P407, DOI 10.1007/BF02441963; DAmico M, 1997, ST HEAL T, V37, P151; DAMICO M, 1995, ST HEAL T, V15, P33; De Boor C., 1978, A practical guide to splines; Engsberg JR, 2008, J APPL BIOMECH, V24, P94, DOI 10.1123/jab.24.1.94; Ferrigno G, 1992, FREQUENCY DOMAIN IMP, P1093; Fortin C, 2012, PHYSIOTHERAPY, V98, P64, DOI 10.1016/j.physio.2010.12.006; Furlanetto TS, 2012, COMPUT METH PROG BIO, V108, P203, DOI 10.1016/j.cmpb.2012.03.012; Glassman SD, 2005, SPINE, V30, P682, DOI 10.1097/01.brs.0000155425.04536.f7; Hasegawa K, 2016, EUR SPINE J, V25, P3675, DOI 10.1007/s00586-016-4702-2; Kado DM, 2007, ANN INTERN MED, V147, P330, DOI 10.7326/0003-4819-147-5-200709040-00008; Kado DM, 2004, J AM GERIATR SOC, V52, P1662, DOI 10.1111/j.1532-5415.2004.52458.x; KOSTUIK JP, 1981, SPINE, V6, P268, DOI 10.1097/00007632-198105000-00009; Lafage V, 2009, SPINE, V34, pE599, DOI 10.1097/BRS.0b013e3181aad219; Le Huec JC, 2016, EUR SPINE J, V25, P3630, DOI 10.1007/s00586-016-4485-5; Liu S, 2014, OCHSNER J, V14, P67; Mac-Thiong JM, 2010, SPINE, V35, pE1193, DOI 10.1097/BRS.0b013e3181e50808; Mac-Thiong Jean-Marc, 2009, Spine (Phila Pa 1976), V34, pE519, DOI 10.1097/BRS.0b013e3181a9c7ad; Marks MC, 2003, SPINE, V28, P1176, DOI 10.1097/00007632-200306010-00018; Melhem E, 2016, J CHILD ORTHOP, V10, P1, DOI 10.1007/s11832-016-0713-0; Murphy AJ, 2011, P I MECH ENG H, V225, P1078, DOI 10.1177/0954411911416859; NEGRINI A, 1995, ST HEAL T, V15, P101; Negrini A, 2001, EUR MEDICOPHYS, V37, P135; Obeid Ibrahim, 2011, Eur Spine J, V20 Suppl 5, P681, DOI 10.1007/s00586-011-1936-x; Peng JF, 2015, J BIOMECH, V48, P396, DOI 10.1016/j.jbiomech.2014.11.040; PERENNOU D, 1994, SPINE, V19, P123, DOI 10.1097/00007632-199401001-00001; Protopsaltis T, 2014, J BONE JOINT SURG AM, V96A, P1631, DOI 10.2106/JBJS.M.01459; Rajnics P, 2001, J Spinal Disord, V14, P135, DOI 10.1097/00002517-200104000-00008; Ranavolo A, 2013, APPL ERGON, V44, P192, DOI 10.1016/j.apergo.2012.07.004; Roussouly P, 2005, SPINE, V30, P346, DOI 10.1097/01.brs.0000152379.54463.65; Roussouly P, 2010, EUR SPINE J, V19, P1824, DOI 10.1007/s00586-010-1476-9; Schmid S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135689; Schwab F, 2005, SPINE, V30, P1082, DOI 10.1097/01.brs.0000160842.43482.cd; Schwab F, 2006, SPINE, V31, pE959, DOI 10.1097/01.brs.0000248126.96737.0f; Schwab FJ, 2013, SPINE, V38, pE803, DOI 10.1097/BRS.0b013e318292b7b9; SEIDEL GK, 1995, J BIOMECH, V28, P995, DOI 10.1016/0021-9290(94)00149-X; Silvatti AP, 2012, J BIOMECH, V45, P1112, DOI 10.1016/j.jbiomech.2012.01.004; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; STOKES IAF, 1994, SPINE, V19, P236, DOI 10.1097/00007632-199401001-00020; Taneichi H, 2016, J ORTHOP SCI, V21, P116, DOI 10.1016/j.jos.2015.12.013; Van Royen B J, 1998, Eur Spine J, V7, P408, DOI 10.1007/s005860050098; Vedantam R, 1998, SPINE, V23, P211, DOI 10.1097/00007632-199801150-00012; Vedantam R, 2000, SPINE, V25, P2204, DOI 10.1097/00007632-200009010-00011; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Vrtovec T, 2012, SPINE J, V12, P433, DOI 10.1016/j.spinee.2012.02.013; Vrtovec T, 2012, SPINE, V37, pE479, DOI 10.1097/BRS.0b013e31823770af; Vygodsky M, 1987, MATH HDB HIGHER MATH; Yang MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160957; Zaiontz C, 2016, REAL STAT USING EXCE; Zemp R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095426	68	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203679	10.1371/journal.pone.0203679	http://dx.doi.org/10.1371/journal.pone.0203679			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192866	gold, Green Submitted, Green Published			2022-12-26	WOS:000444093600131
J	Lee, TH; Lee, CC; Ng, CY; Chang, MY; Chang, SW; Fan, PC; Chung, WH; Tian, YC; Chen, YC; Chang, CH				Lee, Tao Han; Lee, Cheng-Chia; Ng, Chau-Yee; Chang, Ming-Yang; Chang, Su-Wei; Fan, Pei-Chun; Chung, Wen-Hung; Tian, Ya-Chung; Chen, Yung-Chang; Chang, Chih-Hsiang			The influence of acute kidney injury on the outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis: The prognostic value of KDIGO staging	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CARE BUNDLE; MORTALITY; RISK; BURN; INVOLVEMENT; NEPHRITIS; SEVERITY; SCORTEN; IMPACT	Background Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome are severe drug-induced cutaneous adverse reactions with high mortality. Acute kidney injury (AKI) was a common complication in an SJS/TEN group and noted as an independent risk factor for mortality in patients with SJS/TEN. To determine whether AKI staging can predict the outcome of patients with SJS/TEN, we compared the discriminative power of an AKI KDIGO staging system with that of SCROTEN, APACHE II, APACHE III, and SOFA. Materials and methods We retrospectively analyzed the data of 75 patients who were diagnosed with SJS, TEN, or SJS/TEN overlap syndrome at a tertiary care university hospital between January 1, 2011 and December 31, 2014. The baseline characteristics, biochemical analysis data, medication use, and outcomes of the patients were assessed, and the discriminative ability for predicting mortality was determined for each prognostic model. Results Of the 75 patients, 23 (30.7%) had AKI, of whom 13 (56.5%) died during the index admission. Of the prognostic risk models analyzed, the KDIGO staging system showed similar discriminative ability in predicting in-hospital mortality as did the other models. In addition, combining KDIGO with other scoring systems yielded significantly more accurate risk prediction for in-hospital mortality compared with the other individual scores alone, as measured by net reclassification index. The patients with KDIGO stages 2 and 3 exhibited a significantly lower 1-year survival rate than did those with KDIGO stages 0 and 1. Conclusion AKI KDIGO staging has good discriminative ability and is easy to utilize for predicting mortality.	[Lee, Tao Han; Lee, Cheng-Chia; Chang, Ming-Yang; Fan, Pei-Chun; Tian, Ya-Chung; Chen, Yung-Chang; Chang, Chih-Hsiang] Change Gung Mem Hosp, Linkou Branch, Dept Nephrol, Kidney Res Ctr, Taoyuan, Taiwan; [Lee, Cheng-Chia; Ng, Chau-Yee; Fan, Pei-Chun; Chang, Chih-Hsiang] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Ng, Chau-Yee; Chung, Wen-Hung] Chang Gung Mem Hosp, Dept Dermatol, Drug Hypersensit Clin & Res Ctr, Taipei, Taiwan; [Ng, Chau-Yee; Chung, Wen-Hung] Chang Gung Mem Hosp, Dept Dermatol, Drug Hypersensit Clin & Res Ctr, Linkou, Taiwan; [Ng, Chau-Yee; Chung, Wen-Hung] Chang Gung Mem Hosp, Dept Dermatol, Drug Hypersensit Clin & Res Ctr, Keelung, Taiwan; [Chang, Su-Wei] Chang Gung Univ, Coll Med, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Chang, Su-Wei] Chang Gung Mem Hosp, Dept Pediat, Div Allergy Asthma & Rheumatol, Taoyuan, Taiwan; [Chen, Yung-Chang] Keelung Chang Gung Mem Hosp, Div Nephrol, Dept Med, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chang, CH (corresponding author), Change Gung Mem Hosp, Linkou Branch, Dept Nephrol, Kidney Res Ctr, Taoyuan, Taiwan.; Chang, CH (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan.	sunchang@cgmh.org.tw	Ng, Chau/AAE-6637-2022; Chang, Ming-Yang/AGH-5397-2022; Chang, Chih-Hsiang/P-8662-2017	Chang, Ming-Yang/0000-0001-8899-0376; Ng, Chau Yee/0000-0001-7576-963X; Lee, Tao Han/0000-0003-3650-7236; Lee, Cheng-Chia/0000-0002-6973-5908; Hung, Shuen-Iu/0000-0001-6531-5538; Chang, Chih-Hsiang/0000-0002-7342-335X	Research Grant of Linkou Chang-Gung Memorial Hospital [CORPG5G0071, CORPG5G0081]	Research Grant of Linkou Chang-Gung Memorial Hospital	This work was supported by the Research Grant of Linkou Chang-Gung Memorial Hospital, grant number CORPG5G0071 (CCL) and CORPG5G0081 (CHC).	Bastuji-Garin S, 2000, J INVEST DERMATOL, V115, P149, DOI 10.1046/j.1523-1747.2000.00061.x; Boehme D H, 1970, J Reticuloendothel Soc, V8, P522; Chung WH, 2015, ANN RHEUM DIS, V74, P2157, DOI 10.1136/annrheumdis-2014-205577; Hesterberg TC, 2015, AM STAT, V69, P371, DOI 10.1080/00031305.2015.1089789; Hsu DY, 2016, J INVEST DERMATOL, V136, P1387, DOI 10.1016/j.jid.2016.03.023; Hsu SIH, 2001, PHARMACOTHERAPY, V21, P1233; Hung CC, 2009, AM J NEPHROL, V29, P633, DOI 10.1159/000195632; Imahara SD, 2006, J BURN CARE RES, V27, P270, DOI 10.1097/01.BCR.0000216532.71360.9B; Jenq CC, 2007, INTENS CARE MED, V33, P1921, DOI 10.1007/s00134-007-0760-6; Joslin J, 2015, CLIN MED, V15, P431, DOI 10.7861/clinmedicine.15-5-431; Kannenberg SMH, 2012, QJM-INT J MED, V105, P839, DOI 10.1093/qjmed/hcs078; Kim GH, 2003, AM J NEPHROL, V23, P55, DOI 10.1159/000066299; Kolhe NV, 2016, NEPHROL DIAL TRANSPL, V31, P1846, DOI 10.1093/ndt/gfw087; Kuo G, 2016, J FORMOS MED ASSOC, V115, P1046, DOI 10.1016/j.jfma.2016.10.012; Letko E, 2005, ANN ALLERG ASTHMA IM, V94, P419, DOI 10.1016/S1081-1206(10)61112-X; Letko E, 2005, ANN ALLERG ASTHMA IM, V94, P56, DOI DOI 10.1016/S1081-1206(10)61112-X; Liano F, 1998, KIDNEY INT, V53, pS16; Lin MS, 2005, INTERN MED J, V35, P188, DOI 10.1111/j.1445-5994.2005.00790.x; Mockenhaupt M, 2011, EXPERT REV CLIN IMMU, V7, P803, DOI [10.1586/eci.11.66, 10.1586/ECI.11.66]; NAG da Silva Ricardo Eccard, 2018, AFRICAN J PHARM PHAR, V12, P61, DOI [10.5897/AJPP2017.4873, DOI 10.5897/AJPP2017.4873]; Palevsky PM, 2013, AM J KIDNEY DIS, V61, P649, DOI 10.1053/j.ajkd.2013.02.349; Palmieri TL, 2002, J BURN CARE REHABIL, V23, P87, DOI 10.1097/00004630-200203000-00004; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Schwartz RA, 2013, J AM ACAD DERMATOL, V69, DOI 10.1016/j.jaad.2013.05.002; Sekula P, 2013, J INVEST DERMATOL, V133, P1197, DOI 10.1038/jid.2012.510; Selby NM, 2016, NEPHRON, V134, P195, DOI 10.1159/000447758; Shiga S, 2010, J BURN CARE RES, V31, P100, DOI 10.1097/BCR.0b013e3181cb8cb8; Spanou Z, 2006, J AM SOC NEPHROL, V17, P2919, DOI 10.1681/ASN.2006050418; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wan Rosdi, 2016, JOURMAL SCI RES DEV, V3, P51; Wu J, 2015, BRIT J DERMATOL, V173, P1224, DOI 10.1111/bjd.14052; ZWEIBAN B, 1986, GASTROENTEROLOGY, V91, P469, DOI 10.1016/0016-5085(86)90585-8	35	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203642	10.1371/journal.pone.0203642	http://dx.doi.org/10.1371/journal.pone.0203642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192870	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600125
J	Shykoff, BE; Florian, JP				Shykoff, Barbara E.; Florian, John P.			Pulmonary effects of repeated six-hour normoxic and hyperoxic dives	PLOS ONE			English	Article							WATER IMMERSION; OXYGEN-TOXICITY; LUNG INJURY; 140 KPA; RESPONSES; PRESSURE; SURFACTANT; MECHANICS; EXERCISE; VASOPRESSIN	This study examines differential effects of immersion, elevated oxygen partial pressure, and exercise on pulmonary function after series of five daily six- hour dives at 130 kPa (1.3 ATA), with 18 hours between dives. Five cohorts of 10 to 14 divers participated. The exposure phases were resting while breathing O-2 or air in the water ("wetO(2)", "wetAir") or O-2 in the hyperbaric chamber ("dryO(2)"), and exercise in the water while breathing O-2 or air ("wetO(2)X", "wetAirX"). Respiratory symptoms were recorded during and after each dive, and pulmonary function (forced flow- volume) was measured twice at baseline before diving, after each dive both immediately and on the following morning, and three days post diving ("Day+3"). The incidences of symptoms and of flow volume changes from baseline greater than normal limits ("Delta FV") were assessed, as were mean Delta FV. The parameters examined were forced vital capacity (FVC), forced expired volume in 1 second (FEV1), and forced expired flow from 25% to 75% volume expired (FEF25 +/- 75). The phases ranked from greatest to least fraction of diver- days with symptoms were wetO(2)X (56%) > dryO(2) (42%) > wetO(2) (13%) > [wetAir (2%) or wetAirX (1%)] (p< 0.05). FEV1 and FEF25 +/- 75 were depressed in the morning following wetO(2) and wetO(2)X and on Day+3 after and wetO(2)X, but increased immediately following each wetAirX dive. O-2 exposures caused symptoms and Delta FV suggestive of pulmonary oxygen toxicity, exacerbated by exercise. Indices of small airway function showed late (17- hour) post- O-2 exposure deficits, but, particularly with exercise, improvement was evident early after exposure with or without O-2. FEF25 +/- 75 and FEV1 remained depressed on Day+3 after wetO(2) and wetO(2)X.	[Shykoff, Barbara E.; Florian, John P.] Navy Expt Diving Unit, Panama City, FL 32407 USA		Florian, JP (corresponding author), Navy Expt Diving Unit, Panama City, FL 32407 USA.	john.florian@navy.mil			U.S. Naval Sea System Command (NAVSEA) Deep Submergence Biomedical Program [N0002411WX02303]; U.S. Office of Naval Research [N0001409WX20220]	U.S. Naval Sea System Command (NAVSEA) Deep Submergence Biomedical Program; U.S. Office of Naval Research(Office of Naval Research)	This study was funded by the U.S. Naval Sea System Command (NAVSEA) Deep Submergence Biomedical Program (N0002411WX02303) and U.S. Office of Naval Research (N0001409WX20220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSTONI E, 1966, J APPL PHYSIOL, V21, P251, DOI 10.1152/jappl.1966.21.1.251; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; BJURSTEDT H, 1980, J APPL PHYSIOL, V48, P977, DOI 10.1152/jappl.1980.48.6.977; Boussuges A, 2009, J SPORT SCI, V27, P641, DOI 10.1080/02640410902717001; CHRISTIE JL, 1990, J APPL PHYSIOL, V69, P657, DOI 10.1152/jappl.1990.69.2.657; CLARK JM, 1971, PHARMACOL REV, V23, P37; DAVIS WB, 1983, NEW ENGL J MED, V309, P878, DOI 10.1056/NEJM198310133091502; Florian JP, 2013, J APPL PHYSIOL, V115, P1275, DOI 10.1152/japplphysiol.00466.2013; Florian JP, 2016, PHYSL REP, V4, P1; GREENLEAF JE, 1983, J APPL PHYSIOL, V55, P1688, DOI 10.1152/jappl.1983.55.6.1688; GUBERAN E, 1969, BRIT J IND MED, V26, P121; HARRISON MH, 1986, J APPL PHYSIOL, V61, P1410, DOI 10.1152/jappl.1986.61.4.1410; HONG SK, 1969, J APPL PHYSIOL, V27, P535, DOI 10.1152/jappl.1969.27.4.535; Iwase S, 2000, J AUTONOM NERV SYST, V79, P156, DOI 10.1016/S0165-1838(99)00076-4; Jimenez C, 2010, EUR J APPL PHYSIOL, V108, P49, DOI 10.1007/s00421-009-1187-2; Kimmerly DS, 2003, AM J PHYSIOL-HEART C, V284, pH1198, DOI 10.1152/ajpheart.00229.2002; Lamonica G, 2014, J APPL PHYSIOL, V116, P210, DOI 10.1152/japplphysiol.01535.2012; NORSK P, 1985, EUR J APPL PHYSIOL O, V54, P71, DOI 10.1007/BF00426302; Pace PW, 2009, EXP LUNG RES, V35, P380, DOI 10.1080/01902140902745166; PREFAUT C, 1976, J APPL PHYSIOL, V40, P320, DOI 10.1152/jappl.1976.40.3.320; Rao DR, 2012, J ASTHMA, V49, P586, DOI 10.3109/02770903.2012.690481; SACKNER MA, 1975, ANN INTERN MED, V82, P40, DOI 10.7326/0003-4819-82-1-40; Shykoff BE, 2008, UNDERSEA HYPERBAR M, V35, P131; Shykoff BE, 2008, UNDERSEA HYPERBAR M, V35, P417; Spengler CM, 2000, AM J RESP CRIT CARE, V162, P1038, DOI 10.1164/ajrccm.162.3.9911107; Zenri H, 2004, CRIT CARE MED, V32, P1155, DOI 10.1097/01.CCM.0000126264.00551.C8	26	4	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202892	10.1371/journal.pone.0202892	http://dx.doi.org/10.1371/journal.pone.0202892			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192774	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600040
J	Hegerle, N; Choi, M; Sinclair, J; Amin, MN; Ollivault-Shiflett, M; Curtis, B; Laufer, RS; Shridhar, S; Brammer, J; Toapanta, FR; Holder, IA; Pasetti, MF; Lees, A; Tennant, SM; Cross, AS; Simon, R				Hegerle, Nicolas; Choi, Myeongjin; Sinclair, James; Amin, Mohammed N.; Ollivault-Shiflett, Morgane; Curtis, Brittany; Laufer, Rachel S.; Shridhar, Surekha; Brammer, Jerod; Toapanta, Franklin R.; Holder, Ian Alan; Pasetti, Marcela F.; Lees, Andrew; Tennant, Sharon M.; Cross, Alan S.; Simon, Raphael			Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE; CAPSULAR TYPE; FLAGELLIN; STRAINS; LIPOPOLYSACCHARIDE; GLYCOSYLATION; IMMUNIZATION; PROTECTION; IMMUNOPROPHYLAXIS	Klebsiella pneumoniae (KP) and Pseudomonas aeruginosa (PA) are important human pathogens that are associated with a range of infection types, including wound and disseminated infections. Treatment has been complicated by rising rates of antimicrobial resistance. Immunoprophylactic strategies are not constrained by antimicrobial resistance mechanisms. Vaccines against these organisms would be important public health tools, yet they are not available. KP surface O polysaccharides (OPS) are protective antigens in animal models of infection. Similarly, PA flagellin (Fla), the major subunit of the flagellar filament, is required for virulence and is a target of protective antibodies in animal models. We report herein the development of a combined KP and PA glycoconjugate vaccine comprised of the four most common KP OPS types associated with human infections (O1, O2, O3, O5), chemically linked to the two Fla types of PA (FIaA, FlaB). Conjugation of KP OPS to PA Fla enhanced anti-polysaccharide immune responses and produced a formulation that generated antibody titers to the four KP OPS types and both PA Fla antigens in rabbits. Passive transfer of vaccine-induced rabbit antisera reduced the bacterial burden and protected mice against fatal intravenous KP infection. Mice passively transferred with conjugate-induced antisera were also protected against PA infection after thermal injury with a FlaB-expressing isolate, but not a FIaA isolate. Taken together, these promising preclinical results provide important proof-of-concept for a broad spectrum human vaccine to prevent KP and PA infections.	[Hegerle, Nicolas; Choi, Myeongjin; Sinclair, James; Amin, Mohammed N.; Curtis, Brittany; Laufer, Rachel S.; Shridhar, Surekha; Brammer, Jerod; Toapanta, Franklin R.; Pasetti, Marcela F.; Tennant, Sharon M.; Cross, Alan S.; Simon, Raphael] Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA; [Ollivault-Shiflett, Morgane; Lees, Andrew] Fina Biosolut, Rockville, MD USA; [Holder, Ian Alan] Univ Cincinnati, Coll Med, Dept Microbiol, Cincinnati, OH USA; [Holder, Ian Alan] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH USA; [Holder, Ian Alan] Shriners Burns Inst, Cincinnati, OH USA	University System of Maryland; University of Maryland Baltimore; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Simon, R (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA.	rsimon@som.umaryland.edu	Lees, Andrew/R-2787-2019; Toapanta, Franklin/Y-1774-2019; Choi, Myeongjin/AAC-9971-2020	Lees, Andrew/0000-0002-8370-4876; Choi, Myeongjin/0000-0001-8891-8286; Shridhar, Surekha/0000-0003-1820-7379; Pasetti, Marcela/0000-0003-0894-4009; Laufer, Rachel/0000-0003-3142-9347	Department of Defense Congressionally Directed Medical Research Programs grant [DM140249]	Department of Defense Congressionally Directed Medical Research Programs grant(United States Department of Defense)	This work was supported by Department of Defense Congressionally Directed Medical Research Programs grant DM140249 (PI:RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for the authors [NH, MC, MOS, BC, RSL, MFP, AL, SMT, ASC, RS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmad TA, 2012, VACCINE, V30, P2411, DOI 10.1016/j.vaccine.2011.11.027; Arora SK, 2004, J BACTERIOL, V186, P2115, DOI 10.1128/JB.186.7.2115-2122.2004; Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012; Baliban SM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005493; Brett PJ, 1996, INFECT IMMUN, V64, P2824, DOI 10.1128/IAI.64.7.2824-2828.1996; Brisse S, 2013, J CLIN MICROBIOL, V51, P4073, DOI 10.1128/JCM.01924-13; Broker M, 2017, VACCINE, V35, P3286, DOI 10.1016/j.vaccine.2017.04.078; Campodonico VL, 2011, INFECT IMMUN, V79, P3455, DOI 10.1128/IAI.00157-11; Campodonico VL, 2010, INFECT IMMUN, V78, P746, DOI 10.1128/IAI.00806-09; Chalker AF, 2001, J BACTERIOL, V183, P1259, DOI 10.1128/JB.183.4.1259-1268.2001; Chhibber S., 2005, Indian Journal of Experimental Biology, V43, P40; CHHIBBER S, 1995, VACCINE, V13, P179, DOI 10.1016/0264-410X(95)93133-T; Clements A, 2008, VACCINE, V26, P5649, DOI 10.1016/j.vaccine.2008.07.100; Cohen TS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92774; Cross AS, 2001, J INFECT DIS, V183, P1079, DOI 10.1086/319297; CROWE BA, 1991, ANTIBIOT CHEMOTHER, V44, P143; Dagan R, 2010, VACCINE, V28, P5513, DOI 10.1016/j.vaccine.2010.06.026; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Doring G, 2008, VACCINE, V26, P1011, DOI 10.1016/j.vaccine.2007.12.007; DORING G, 1995, AM J RESP CRIT CARE, V151, P983; EDELMAN R, 1994, VACCINE, V12, P1288, DOI 10.1016/S0264-410X(94)80054-4; Faezi S, 2014, APMIS, V122, P115, DOI 10.1111/apm.12101; Fang CT, 2016, J CLIN MICROBIOL, V54, P666, DOI 10.1128/JCM.02494-15; Follador R, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000073; Garrett ES, 1999, J BACTERIOL, V181, P7401, DOI 10.1128/JB.181.23.7401-7404.1999; Ghaffar F, 2004, CLIN INFECT DIS, V39, P930, DOI 10.1086/423379; Held TK, 2000, INFECT IMMUN, V68, P2402, DOI 10.1128/IAI.68.5.2402-2409.2000; HOLDER IA, 1986, J TRAUMA, V26, P118, DOI 10.1097/00005373-198602000-00003; HOLDER IA, 1982, INFECT IMMUN, V35, P276, DOI 10.1128/IAI.35.1.276-280.1982; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Hsieh PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033155; Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165; Jansen KU, 2018, NAT MED, V24, P10, DOI 10.1038/nm.4465; Jenney AW, 2006, J CLIN MICROBIOL, V44, P102, DOI 10.1128/JCM.44.1.102-107.2006; Knuf M, 2011, VACCINE, V29, P4881, DOI 10.1016/j.vaccine.2011.04.053; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lees A, 2006, VACCINE, V24, P716, DOI 10.1016/j.vaccine.2005.08.096; Lipsitch M, 2016, MBIO, V7, DOI 10.1128/mBio.00428-16; Luepke KH, 2017, EXPERT REV ANTI-INFE, V15, P425, DOI 10.1080/14787210.2017.1308251; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Martin RM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00261-16; Pan YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080670; Pennini ME, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02223-7; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; RALPH P, 1975, J IMMUNOL, V114, P898; REED L. J., 1938, AMER JOUR HYG, V27, P493; Resistance UKRoA, 2014, REV ANT RES TACKL CR; Roghmann MC, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00210-17; Rollenske T, 2018, NAT IMMUNOL, V19, P617, DOI 10.1038/s41590-018-0106-2; Rukavina T, 1997, INFECT IMMUN, V65, P1754, DOI 10.1128/IAI.65.5.1754-1760.1997; Schaber JA, 2007, INFECT IMMUN, V75, P3715, DOI 10.1128/IAI.00586-07; Schirm M, 2004, J BACTERIOL, V186, P2523, DOI 10.1128/JB.186.9.2523-2531.2004; Shon AS, 2013, VIRULENCE, V4, P107, DOI 10.4161/viru.22718; Simon R, 2007, BIOCHEM BIOPH RES CO, V355, P280, DOI 10.1016/j.bbrc.2007.01.148; Simon R, 2014, PROTEIN EXPRES PURIF, V102, P1, DOI 10.1016/j.pep.2014.07.005; Simon R, 2011, INFECT IMMUN, V79, P4240, DOI 10.1128/IAI.05484-11; STIERITZ DD, 1975, J INFECT DIS, V131, P688, DOI 10.1093/infdis/131.6.688; TAKEYA K, 1966, VIROLOGY, V28, P163, DOI 10.1016/0042-6822(66)90317-5; Tennant SM, 2011, INFECT IMMUN, V79, P4175, DOI 10.1128/IAI.05278-11; TOMAS JM, 1991, INFECT IMMUN, V59, P2006; Trautmann M, 2004, VACCINE, V22, P818, DOI 10.1016/j.vaccine.2003.11.026; Trautmann M, 1997, CLIN DIAGN LAB IMMUN, V4, P550, DOI 10.1128/CDLI.4.5.550-555.1997; Turton JF, 2010, J MED MICROBIOL, V59, P541, DOI 10.1099/jmm.0.015198-0; Verma A, 2006, J BACTERIOL, V188, P4395, DOI 10.1128/JB.01642-05; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200	65	40	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203143	10.1371/journal.pone.0203143	http://dx.doi.org/10.1371/journal.pone.0203143			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188914	Green Submitted, Green Published, gold			2022-12-26	WOS:000444228700022
J	de Waal, R; Cohen, K; Boulle, A; Fox, MP; Maartens, G; Igumbor, EU; Davies, MA				de Waal, Renee; Cohen, Karen; Boulle, Andrew; Fox, Matthew P.; Maartens, Gary; Igumbor, Ehimario U.; Davies, Mary-Ann			Routine data underestimates the incidence of first-line antiretroviral drug discontinuations due to adverse drug reactions: Observational study in two South African cohorts	PLOS ONE			English	Article							TREATMENT PROGRAM; THERAPY; HIV; PHARMACOVIGILANCE; SUBSTITUTIONS; REGIMENS; SAFETY	Introduction Estimating the incidence of antiretroviral discontinuations due to adverse drug reactions (ADRs) is important to inform antiretroviral treatment (ART) regimen recommendations, and to guide prescribing and monitoring policies. Routinely collected clinical data is a useful source of pharmacovigilance data. We estimated the incidences of first-line antiretroviral discontinuations due to ADRs using routine clinical data, and compared them with incidences estimated using data enhanced by folder review, in two South African cohorts. ' Methods We included patients 16 years and older on first-line ART. We selected a stratified random sample of 25% for checking of ART prescription data and reasons for antiretroviral discontinuations retrospectively, including folders reviews where required (enhanced-data sample). We estimated the incidence of antiretroviral discontinuations using Kaplan-Meier and competing risk analyses. Results In 15396 patients, 40% had a first-line antiretroviral discontinuation by three years on ART. We could determine the reason for 65% of discontinuations using routine data only, and 84% of discontinuations, in the enhanced-data sample of 3837 patients. ADR was the most common reason for discontinuations. In the enhanced-data sample, the cumulative incidence of discontinuations due to ADRs by three years was 30.4% (95% CI: 24.4-36.6) for stavudine; 2.0% (95% CI: 1.5-2.6) for tenofovir, and 1.3% (95% CI: 0.8-2.1) for efavirenz. Using routine data only, the cumulative incidences of discontinuations due to ADRs by three years for stavudine, tenofovir, and efavirenz respectively were 23.9% (95% CI: 20.3-27.7), 1.2% (95% CI: 0.9-1.4) and 0.5% (95% CI: 0.3-0.7). Conclusions Although the relative rankings were similar using routine or enhanced data, lack of checking for missing reasons for discontinuation resulted in underestimates of the incidence of antiretroviral discontinuations due to ADRs. Systems to improve data collection of reasons for regimen changes prospectively would increase the capacity of routine data to answer pharmacovigilance questions.	[de Waal, Renee; Boulle, Andrew; Davies, Mary-Ann] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa; [Cohen, Karen; Maartens, Gary] Univ Cape Town, Div Clin Pharmacol, Dept Med, Cape Town, South Africa; [Fox, Matthew P.] Boston Univ, Dept Epidemiol, Boston, MA 02215 USA; [Fox, Matthew P.] Boston Univ, Dept Global Hlth, Boston, MA 02215 USA; [Boulle, Andrew] Univ Witwatersrand, Hlth Econ & Epidemiol Res Off, Dept Internal Med, Sch Clin Med, Johannesburg, South Africa; [Igumbor, Ehimario U.] US Ctr Dis Control & Prevent, Div Global HIV & TB, Pretoria, South Africa	University of Cape Town; University of Cape Town; Boston University; Boston University; University of Witwatersrand	Davies, MA (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa.	mary-ann.davies@uct.ac.za	Fox, Matthew/K-2004-2019; Boulle, Andrew/C-1413-2008; Cohen, Karen/D-4036-2017; Igumbor, Ehimario U/B-2652-2012	Boulle, Andrew/0000-0002-7713-8062; Igumbor, Ehimario U/0000-0002-6313-6031; Cohen, Karen/0000-0002-1892-4207; de Waal, Renee/0000-0001-6171-2181; Fox, Matthew/0000-0001-9887-0634	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [GH000371]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under terms of Cooperative Agreement Number GH000371 (KC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC.	Boulle A, 2007, ANTIVIR THER, V12, P753; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2010, JAIDS-J ACQ IMM DEF, V53, P254, DOI 10.1097/QAI.0b013e3181b8f26e; Brennan AT, 2017, AIDS, V31, P147, DOI 10.1097/QAD.0000000000001307; Carr A, 2002, LANCET, V360, P81, DOI 10.1016/S0140-6736(02)09341-8; Costarelli S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160761; Elzi L, 2010, ARCH INTERN MED, V170, P57, DOI 10.1001/archinternmed.2009.432; Fabbiani M, 2016, HIV MED, V17, P385, DOI 10.1111/hiv.12313; Fox MP, 2013, INT J EPIDEMIOL, V42, P430, DOI 10.1093/ije/dys029; Jaquet A, 2011, PHARMACOEPIDEM DR S, V20, P1303, DOI 10.1002/pds.2182; Leone S, 2018, EUR J CLIN MICROBIOL, V37, P871, DOI 10.1007/s10096-017-3180-8; Mann M, 2016, PHARMACOEPIDEM DR S, V25, P1052, DOI 10.1002/pds.4022; Miller V, 2012, CURR OPIN HIV AIDS, V7, P299, DOI 10.1097/COH.0b013e328354d8e7; Mocroft A, 2001, AIDS, V15, P185, DOI 10.1097/00002030-200101260-00007; National Department of Health, 2010, CLIN GUID MAN HIV AI; National Department of Health, 2013, S AFR ANT TREATM GUI; Njuguna C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063596; Pal SN, 2013, DRUG SAFETY, V36, P75, DOI 10.1007/s40264-012-0014-6; Yuan Y, 2006, HIV MED, V7, P156, DOI 10.1111/j.1468-1293.2006.00355.x	19	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203530	10.1371/journal.pone.0203530	http://dx.doi.org/10.1371/journal.pone.0203530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183766	Green Submitted, gold, Green Published			2022-12-26	WOS:000443789900068
J	Nogueira, IAL; da Cruz, EJSN; Fontenele, AMM; Neto, JAD				Lustosa Nogueira, Iara Antonia; Sousa Nogueira da Cruz, Erika Joseth; Melo Fontenele, Andrea Martins; de Figueiredo Neto, Jose Albuquerque			Alterations in postmenopausal plasmatic lipidome	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CARDIORESPIRATORY FITNESS; INSULIN-RESISTANCE; CERAMIDES; ASSOCIATION; BIOMARKERS; TRIAL; WOMEN	Background Menopause consists of a physiological process in women between 40 and 50 years of age, and it has substantial consequences for health, ranging from disturbances in lipid and glycidic metabolism to psychological stress and sleep alterations, thereby increasing women's risk of cardiovascular diseases. Here, we attempted to identify potential lipid alterations not identified by the classic methods. Methods and results We analyzed the serum lipid profile in 40 women in pre- and post-menopause using a lipidomic approach and mass spectrometry. Lipid species presented increased concentrations, with a difference of more than 25% post-menopause and with the ceramides (N.C23:0.Cer, N.C23:0(OH).Cer and N.C24:0(OH).Cer) standing out with a fold change of 1.68, 1.59, and 1.58, respectively. It was also observed that 14 metabolites presented a significant difference in the average concentrations between pre- and post-menopause, especially the ceramide species. Strong and positive correlations were identified between various metabolites and fasting glucose, glycated hemoglobin, total cholesterol, LDL, and triglycerides. Of note were the association ceramide (N.C10:0.Cer) and lysophosphatidylethanolamine (LPE.a.C18:0) between fasting glucose and glycated hemoglobin. Conclusion This study detected lipid alterations, especially in ceramides, post-menopause, as well as correlations with glycidic and lipid markers, which may in the future be useful to investigate diseases associated with menopause.	[Lustosa Nogueira, Iara Antonia; de Figueiredo Neto, Jose Albuquerque] Univ Fed Maranhao, Postgrad Program Hlth Sci, Sao Luis, MA, Brazil; [Lustosa Nogueira, Iara Antonia; Sousa Nogueira da Cruz, Erika Joseth; Melo Fontenele, Andrea Martins; de Figueiredo Neto, Jose Albuquerque] Univ Fed Maranhao, Univ Hosp, Sao Luis, MA, Brazil; [Sousa Nogueira da Cruz, Erika Joseth; de Figueiredo Neto, Jose Albuquerque] Univ Fed Maranhao, Postgrad Program Adult & Child Hlth, Sao Luis, MA, Brazil; [Melo Fontenele, Andrea Martins] Univ Fed Maranhao, Dept Pharm, Sao Luis, MA, Brazil; [de Figueiredo Neto, Jose Albuquerque] Univ Fed Maranhao, Dept Med 1, Sao Luis, MA, Brazil	Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade Federal do Maranhao	Nogueira, IAL (corresponding author), Univ Fed Maranhao, Postgrad Program Hlth Sci, Sao Luis, MA, Brazil.; Nogueira, IAL (corresponding author), Univ Fed Maranhao, Univ Hosp, Sao Luis, MA, Brazil.	iaraantonia@hotmail.com		de Figueiredo Neto, Jose Albuquerque/0000-0003-3739-7702	Fundacao de Amparo a Pesquisa do Estado do Maranhao (FAPEMA) [PAEDT-01922/15]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [1265/2010]	Fundacao de Amparo a Pesquisa do Estado do Maranhao (FAPEMA)(Fundacao de Amparo a Pesquisa e Desenvolvimento Cientifico do Maranhao (FAPEMA)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by the following: Fundacao de Amparo a Pesquisa do Estado do Maranhao (FAPEMA) PAEDT-01922/15 - http://www.fapema.br/ - IALN; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - No : 1265/2010 - http://www.capes.gov.br/ - JAFN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alshehry ZH, 2016, CIRCULATION, V134, P1637, DOI 10.1161/CIRCULATIONAHA.116.023233; Auro K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5708; Cordova C.M., 2004, ARQ BRAS CARDIOL, V83, P476, DOI [10.1590/S0066-782X2004001800006, DOI 10.1590/S0066-782X2004001800006, 10.1590/s0066-782x2004001800006]; de Mello VDF, 2009, DIABETOLOGIA, V52, P2612, DOI 10.1007/s00125-009-1482-9; De Oliveira L, 2012, CLIN BIOCHEM, V45, P852, DOI 10.1016/j.clinbiochem.2012.04.012; Fabbri E, 2016, AGING CELL, V15, P825, DOI 10.1111/acel.12491; FOLCH J, 1957, J BIOL CHEM, V226, P497; Geloneze Bruno, 2006, Arq Bras Endocrinol Metab, V50, P208, DOI 10.1590/S0004-27302006000200007; Gonzalez-Covarrubias V, 2013, BIOGERONTOLOGY, V14, P663, DOI 10.1007/s10522-013-9450-7; Havulinna AS, 2016, ARTERIOSCL THROM VAS, V36, P2424, DOI 10.1161/ATVBAHA.116.307497; Kanaya AM, 2003, ANN INTERN MED, V138, P1, DOI 10.7326/0003-4819-138-1-200301070-00005; Ke CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141743; Laaksonen R, 2016, EUR HEART J, V37, P1967, DOI 10.1093/eurheartj/ehw148; Mady C, 2008, ARQ BRAS CARDIOL, V91, P46; Manco M, 2006, MENOPAUSE, V13, P809, DOI 10.1097/01.gme.0000233492.38638.74; Margolis KL, 2004, DIABETOLOGIA, V47, P1175, DOI 10.1007/s00125-004-1448-x; Meikle PJ, 2017, NAT REV ENDOCRINOL, V13, P79, DOI 10.1038/nrendo.2016.169; Meikle PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074341; Meikle PJ, 2011, ARTERIOSCL THROM VAS, V31, P2723, DOI 10.1161/ATVBAHA.111.234096; Montero D, 2015, EUR J PREV CARDIOL, V22, P1200, DOI 10.1177/2047487314553780; Montgomery MK, 2016, BBA-MOL CELL BIOL L, V1861, P1828, DOI 10.1016/j.bbalip.2016.08.016; Ng TWK, 2015, J CLIN ENDOCR METAB, V100, P2497, DOI 10.1210/jc.2014-4348; Orsatti CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109259; Quehenberger O, 2011, NEW ENGL J MED, V365, P1812, DOI 10.1056/NEJMra1104901; Stachowiak G, 2015, MENOPAUSE REV, V14, P59, DOI 10.5114/pm.2015.50000; Stahlman M, 2012, DIABETOLOGIA, V55, P1156, DOI 10.1007/s00125-011-2444-6; Tulipani S, 2016, CLIN CHIM ACTA, V463, P53, DOI 10.1016/j.cca.2016.10.005; Wallace M, 2014, MOL BIOSYST, V10, P1586, DOI 10.1039/c3mb70529c; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; Weir JM, 2013, J LIPID RES, V54, P2898, DOI 10.1194/jlr.P035808; Xavier HT, 2013, ARQ BRAS CARDIOL, V101, P1, DOI 10.5935/abc.2013S010; Zhang T, 2013, J PROTEOME RES, V12, P505, DOI 10.1021/pr3009572	33	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0203027	10.1371/journal.pone.0203027	http://dx.doi.org/10.1371/journal.pone.0203027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180197	Green Published, gold, Green Submitted			2022-12-26	WOS:000444222400024
J	Oladeinde, A; Cook, K; Orlek, A; Zock, G; Herrington, K; Cox, N; Lawrence, JP; Hall, C				Oladeinde, Adelumola; Cook, Kimberly; Orlek, Alex; Zock, Greg; Herrington, Kyler; Cox, Nelson; Lawrence, Jodie Plumblee; Hall, Carolina			Hotspot mutations and ColE1 plasmids contribute to the fitness of Salmonella Heidelberg in poultry litter	PLOS ONE			English	Article							ENTERICA SEROVAR HEIDELBERG; TOXIN-ANTITOXIN SYSTEMS; ANTIBIOTIC-RESISTANCE; 6'-N-AMINOGLYCOSIDE ACETYLTRANSFERASE; MOLECULAR EVOLUTION; ESCHERICHIA-COLI; CLINICAL ISOLATE; SUPEROXIDE-DISMUTASE; CURATED DATASET; DNA-REPLICATION	Salmonella enterica subsp. enterica serovar Heidelberg (S. Heidelberg) is a clinically-important serovar linked to food-borne illness, and commonly isolated from poultry. Investigations of a large, multistate outbreak in the USA in 2013 identified poultry litter (PL) as an important extra-intestinal environment that may have selected for specific S. Heidelberg strains. Poultry litter is a mixture of bedding materials and chicken excreta that contains chicken gastrointestinal (GI) bacteria, undigested feed, feathers, and other materials of chicken origin. In this study, we performed a series of controlled laboratory experiments which assessed the microevolution of two S. Heidelberg strains (SH-2813 and SH-116) in PL previously used to raise 3 flocks of broiler chickens. The strains are closely related at the chromosome level, differing from the reference genome by 109 and 89 single nucleotide polymorphisms/InDels, respectively. Whole genome sequencing was performed on 86 isolates recovered after 0, 1, 7 and 14 days of microevolution in PL. Only strains carrying an IncX1 (37kb), 2 ColE1 (4 and 6kb) and 1 ColpVC (2kb) plasmids survived more than 7 days in PL. Competition experiments showed that carriage of these plasmids was associated with increased fitness. This increased fitness was associated with an increased copy number of IncX1 and ColE1 plasmids. Further, all Col plasmid-bearing strains had hotspot mutations in 37 loci on the chromosome and in 3 loci on the IncX1 plasmid. Additionally, we observed a decrease in susceptibility to tobramycin, kanamycin, gentamicin, neomycin and fosfomycin for Col plasmid-bearing strains. Our study demonstrates how positive selection from poultry litter can change the evolutionary path of S. Heidelberg.	[Oladeinde, Adelumola; Cook, Kimberly; Zock, Greg; Lawrence, Jodie Plumblee; Hall, Carolina] USDA ARS, Bacterial Epidemiol & Antimicrobial Resistance Re, US Natl Poultry Res Ctr, Athens, GA 30613 USA; [Orlek, Alex] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford, England; [Herrington, Kyler] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Cox, Nelson] USDA ARS, Poultry Microbiol Safety & Proc Res Unit, US Natl Poultry Res Ctr, Athens, GA 30613 USA	United States Department of Agriculture (USDA); University of Oxford; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA)	Oladeinde, A (corresponding author), USDA ARS, Bacterial Epidemiol & Antimicrobial Resistance Re, US Natl Poultry Res Ctr, Athens, GA 30613 USA.	ade.oladeinde@ars.usda.gov	Orlek, Alex/ABB-4720-2020; Oladeinde, Adelumola/AAR-6208-2021	Oladeinde, Adelumola/0000-0002-8659-7068; Cook, Kimberly/0000-0001-7604-0306	USDA-ARS National Program 108 Food Safety (animal and plant products); National Institute for Health Research, Health Protection Research Unit (NI HR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at Oxford University; Public Health England (PHE) [HPRU-2012-10041]	USDA-ARS National Program 108 Food Safety (animal and plant products); National Institute for Health Research, Health Protection Research Unit (NI HR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at Oxford University; Public Health England (PHE)	This work was supported by USDA-ARS National Program 108 Food Safety (animal and plant products) and the National Institute for Health Research, Health Protection Research Unit (NI HR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at Oxford University in partnership with Public Health England (PHE) [grant HPRU-2012-10041]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions expressed in this paper are those of the authors and do not necessarily reflect the official positions and policies of the USDA and any mention of products or trade names does not constitute recommendation for use.	Actis Luis A., 1999, Frontiers in Bioscience, V4, pD43, DOI 10.2741/Actis; [Anonymous], 2009, KIRBY BAUER DISK DIF; Anton AI, 1999, J BACTERIOL, V181, P2703; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bekal S, 2016, J CLIN MICROBIOL, V54, P289, DOI 10.1128/JCM.02200-15; Bobay LM, 2014, P NATL ACAD SCI USA, V111, P12127, DOI 10.1073/pnas.1405336111; Bruger EL, 2016, APPL ENVIRON MICROB, V82, P6498, DOI 10.1128/AEM.01945-16; Burmolle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041259; Bustamante P, 2017, PLASMID, V91, P19, DOI 10.1016/j.plasmid.2017.02.006; Cadieux N, 2000, J BACTERIOL, V182, P5954, DOI 10.1128/JB.182.21.5954-5961.2000; Casey R, 2005, U GEORGIA COOPERATIV, V1267; Castaneda-Garcia A, 2009, J BACTERIOL, V191, P6968, DOI 10.1128/JB.00748-09; Chattopadhyay S, 2012, J BACTERIOL, V194, P5002, DOI 10.1128/JB.00552-12; Chattopadhyay S, 2009, P NATL ACAD SCI USA, V106, P12412, DOI 10.1073/pnas.0906217106; Chattoraj DK, 2000, MOL MICROBIOL, V37, P467, DOI 10.1046/j.1365-2958.2000.01986.x; Chattoraj DK, 1997, PROG NUCLEIC ACID RE, V57, P145, DOI 10.1016/S0079-6603(08)60280-9; Chou SH, 2016, J BACTERIOL, V198, P32, DOI 10.1128/JB.00333-15; Clinical and Laboratory Standards Institute (CLSI), 2009, PERFORMANCE STANDARD; Cressman MD, 2010, APPL ENVIRON MICROB, V76, P6572, DOI 10.1128/AEM.00180-10; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dewey-Mattia D, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6710a1; Dow JM, 2007, CYCLIC DI GMP INTRAC; Dunlop MW, 2016, J ENVIRON MANAGE, V172, P201, DOI 10.1016/j.jenvman.2016.02.036; Dy RL, 2014, NUCLEIC ACIDS RES, V42, P4590, DOI 10.1093/nar/gkt1419; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edirmanasinghe R, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.01919-16, 10.1128/AAC.01919-16]; Evans PS, 2014, GENOME ANNOUNC, V2; FDA, 2015, NAT ANT RES MON SYST; Feiner R, 2015, NAT REV MICROBIOL, V13, P641, DOI 10.1038/nrmicro3527; Folster JP, 2012, ANTIMICROB AGENTS CH, V56, P3465, DOI 10.1128/AAC.00201-12; Francia MV, 2004, FEMS MICROBIOL REV, V28, P79, DOI 10.1016/j.femsre.2003.09.001; Gieraltowski L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162369; Giraldo R, 2004, PLASMID, V52, P69, DOI 10.1016/j.plasmid.2004.06.002; Golubeva YA, 2006, J BACTERIOL, V188, P7853, DOI 10.1128/JB.00706-06; Haeusser DP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004217; Hall JPJ, 2017, PLASMID, V91, P90, DOI 10.1016/j.plasmid.2017.04.003; Hansen L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029711; Harrison E, 2017, MOL ECOL, V26, P2757, DOI 10.1111/mec.14080; Harrison E, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0361; Harrison E, 2015, CURR BIOL, V25, P2034, DOI 10.1016/j.cub.2015.06.024; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hess JB, 2008, P 2008 NAT POULTR WA; Hoelzer K, 2011, FOODBORNE PATHOG DIS, V8, P1281, DOI 10.1089/fpd.2011.0933; Hoffmann M, 2014, GENOME BIOL EVOL, V6, P1046, DOI 10.1093/gbe/evu079; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; JUKES T H, 1969, P21; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koskella B, 2014, FEMS MICROBIOL REV, V38, P916, DOI 10.1111/1574-6976.12072; Labbe G, 2016, GENOME ANNOUNC, V4; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Leinweber A, 2017, ISME J, V11, P1179, DOI 10.1038/ismej.2016.195; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liakopoulos A, 2016, EMERG INFECT DIS, V22, P1257, DOI 10.3201/eid2207.151377; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftie-Eaton W, 2017, NAT ECOL EVOL, V1, P1354, DOI 10.1038/s41559-017-0243-2; Lopatkin AJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01532-1; Lovanh N, 2007, POULTRY SCI, V86, P1840, DOI 10.1093/ps/86.9.1840; MacDonald JM, 2008, EIB38 USDA EC RES SE; MacLean RC, 2015, CURR BIOL, V25, pR764, DOI 10.1016/j.cub.2015.07.006; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meng XR, 2016, J VET MED SCI, V78, P1261, DOI 10.1292/jvms.16-0071; Nandi S, 2004, P NATL ACAD SCI USA, V101, P7118, DOI 10.1073/pnas.0306466101; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; NORDSTROM K, 1990, CELL, V63, P1121, DOI 10.1016/0092-8674(90)90405-4; Oladeinde A., 2017, THESIS; OPARA OO, 1992, AVIAN DIS, V36, P664, DOI 10.2307/1591762; Orlek A, 2017, DATA BRIEF, V12, P423, DOI 10.1016/j.dib.2017.04.024; Orlek A, 2017, PLASMID, V91, P42, DOI 10.1016/j.plasmid.2017.03.002; Pacello F, 2008, BBA-GEN SUBJECTS, V1780, P226, DOI 10.1016/j.bbagen.2007.12.001; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; Rehman MA, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00410-17, 10.1128/aac.00410-17]; RIGBY CE, 1979, AVIAN DIS, V23, P442, DOI 10.2307/1589575; Roll VFB, 2011, POULTRY SCI, V90, P2257, DOI 10.3382/ps.2011-01583; San Milian A, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0010; San Millan AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6208; San Millan A, 2014, ISME J, V8, P601, DOI 10.1038/ismej.2013.182; Santos-Lopez A, 2017, BIORXIV; Schroder G, 2003, J BACTERIOL, V185, P4371, DOI 10.1128/JB.185.15.4371-4381.2003; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Siryaporn A, 2008, MOL MICROBIOL, V70, P494, DOI 10.1111/j.1365-2958.2008.06426.x; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sun S, 2009, GENETICS, V182, P1183, DOI 10.1534/genetics.109.103028; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tada T, 2016, MICROB DRUG RESIST, V22, P103, DOI 10.1089/mdr.2015.0126; Tada T, 2014, ANTIMICROB AGENTS CH, V58, P6324, DOI 10.1128/AAC.03354-14; Tada T, 2013, ANTIMICROB AGENTS CH, V57, P96, DOI 10.1128/AAC.01105-12; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; USDA NASS, POULTRY PRODUCTION A, P1; Varsaki A, 2012, FEBS LETT, V586, P675, DOI 10.1016/j.febslet.2012.01.060; Varsaki A, 2009, J BACTERIOL, V191, P1446, DOI 10.1128/JB.01342-08; Vasse M, 2017, P NATL ACAD SCI USA, V114, P546, DOI 10.1073/pnas.1612522114; Voss-Rech D, 2017, VET MICROBIOL, V203, P308, DOI 10.1016/j.vetmic.2017.03.020; Wang LL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00593; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Wasilenko JL, 2012, J FOOD PROTECT, V75, P1939, DOI 10.4315/0362-028X.JFP-12-087; Watve MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009328; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	102	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0202286	10.1371/journal.pone.0202286	http://dx.doi.org/10.1371/journal.pone.0202286			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169497	Green Submitted, gold, Green Published			2022-12-26	WOS:000443374400009
J	Afrifa, J; Ogbordjor, WD; Duku-Takyi, R				Afrifa, Justice; Ogbordjor, Wisdom Djange; Duku-Takyi, Ruth			Variation in thyroid hormone levels is associated with elevated blood mercury levels among artisanal small-scale miners in Ghana	PLOS ONE			English	Article							RAT-LIVER; INDIVIDUALS; TOXICITY; EXPOSURE; HEALTH; LEAD; METHYLMERCURY; THYROXINE; POLLUTION; WILDLIFE	Background Mercury can be very toxic to human health even at low dose of exposure. Artisanal small-scale miners (ASGMs) use mercury in gold production, hence are at risk of mercury-induced organ dysfunction. Aim We determined the association between mercury exposure, thyroid function and workrelated factors among artisanal small-scale gold miners in Bibiani- Ghana. Method We conveniently recruited 137 consenting male gold miners at their work site in BibianiGhana, in a comparative cross-sectional study. Occupational activities and socio-demographic data of participants were collected using a questionnaire. Blood sample was analysed for total mercury and thyroid hormones. Results Overall, 58.4% (80/137) of the participants had blood mercury exceeding the occupational exposure threshold (blood mercury >= 5 mu g/L). T3(P<0.0001) and T4(P<0.0001) were significantly reduced among the exposed group compared to the non-exposed. TSH showed no significant variation between the exposed and non-exposed groups. Longer work duration (>= 5years), gold amalgamation, gold smelting and sucking of excess mercury with the mouth were associated with increased odds of mercury exposure. Blood mercury showed negative correlation with T3(r = -0.29, P<0.0001), and T4(r = -0.69, P<0.0001) and positive correlation with work duration (r = 0.88, P<0.001). Even though a positive trend of association between blood mercury and TSH levels was recorded, it was not significant (r = 0.07, P = 0.4121) Conclusion Small scale miners in Bibiani are exposed to mercury above the occupational threshold which may affect thyroid hormone levels.	[Afrifa, Justice; Duku-Takyi, Ruth] Univ Cape Coast, Sch Allied Hlth Sci, Dept Med Lab Sci, Cape Coast, Ghana; [Ogbordjor, Wisdom Djange] Volta River Author, Accra, Ghana	University of Cape Coast	Afrifa, J (corresponding author), Univ Cape Coast, Sch Allied Hlth Sci, Dept Med Lab Sci, Cape Coast, Ghana.	jafrifa@ucc.edu.gh	Afrifa, Justice/GQH-0469-2022; Afrifa, Justice/L-9013-2019	Afrifa, Justice/0000-0003-3399-2969				Abdelouahab N, 2008, ENVIRON RES, V107, P380, DOI 10.1016/j.envres.2008.01.006; Adimado AA, 2002, B ENVIRON CONTAM TOX, V68, P339, DOI [10.1007/s00128-001-0259-8, 10.1007/s001280259]; Afrifa J, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4517-z; Akerstrom M, 2017, TOXICOL APPL PHARM, V320, P17, DOI 10.1016/j.taap.2017.02.007; Aryee BNA, 2002, TRENDS SMALL SCALE M; Chen AM, 2013, ENVIRON HEALTH PERSP, V121, P181, DOI 10.1289/ehp.1205239; Chen CY, 2005, CLIN CHEM, V51, P759, DOI 10.1373/clinchem.2004.042093; CHOPRA IJ, 1977, ENDOCRINOLOGY, V101, P453, DOI 10.1210/endo-101-2-453; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Clarkson TW, 2002, ENVIRON HEALTH PERSP, V110, P11, DOI 10.1289/ehp.02110s111; CURRAN PG, 1991, ENDOCR REV, V12, P135, DOI 10.1210/edrv-12-2-135; DepartmentofHealth, 2016, UND MERC EXP LEV; Drake PL, 2001, INT ARCH OCC ENV HEA, V74, P206, DOI 10.1007/s004200000206; Fontaine M, 2001, MERCURY FREE GOLD MI; Iavicoli I, 2009, J TOXICOL ENV HEAL B, V12, P206, DOI 10.1080/10937400902902062; Jonklaas J, 2008, THYROID, V18, P943, DOI 10.1089/thy.2008.0061; Jonklaas J, 2008, JAMA-J AM MED ASSOC, V299, P769, DOI 10.1001/jama.299.7.769; KAWADA J, 1980, J PHARMACOBIO-DYNAM, V3, P149, DOI 10.1248/bpb1978.3.149; LARSEN PR, 1981, ENDOCR REV, V2, P87, DOI 10.1210/edrv-2-1-87; LIN FM, 1975, B ENVIRON CONTAM TOX, V14, P140, DOI 10.1007/BF01701304; MCGREGOR AJ, 1991, HUM EXP TOXICOL, V10, P199, DOI 10.1177/096032719101000309; Mensah EK, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.supp.2016.25.1.6171; Mensah EK, 2012, EXPOSURE SMALL SCALE; Mol JH, 2001, ENVIRON RES, V86, P183, DOI 10.1006/enrs.2001.4256; Norris DO, 2013, VERTEBRATE ENDOCRINOLOGY, FIFTH EDITION, P1; Obiri S, 2010, ENVIRON TOXICOL PHAR, V29, P209, DOI 10.1016/j.etap.2010.01.001; Osawa T, 2015, INT J HUM CULT STUD, V2015; Ralston NVC, 2010, TOXICOLOGY, V278, P112, DOI 10.1016/j.tox.2010.06.004; Rice Kevin M, 2014, J Prev Med Public Health, V47, P74, DOI 10.3961/jpmph.2014.47.2.74; Risher JF, 2005, MERCURY EXPOSURE, P691; Rolland RM, 2000, J WILDLIFE DIS, V36, P615, DOI 10.7589/0090-3558-36.4.615; Siegel S, 2013, COMMUNITY DEV J, V48, P451, DOI 10.1093/cdj/bst027; SUZUKI TSUGUYOSHI, 1966, INDUST HEALTH, V4, P69; Swain EB, 2007, AMBIO, V36, P45, DOI 10.1579/0044-7447(2007)36[45:SCOMUA]2.0.CO;2; Tan SW, 2009, CRIT REV TOXICOL, V39, P228, DOI 10.1080/10408440802233259; VISSER TJ, 1976, BIOCHEM J, V157, P479, DOI 10.1042/bj1570479; Wada H, 2009, ENVIRON SCI TECHNOL, V43, P6031, DOI 10.1021/es803707f; Wadaan MAM, 2009, J PHARMACOL TOX MET, V4, P126, DOI [10.3923/jpt.2009.126.131, DOI 10.3923/jpt.2009.126.131]; Williams CR, 2011, ENVIRON SCI POLLUT R, V18, P1079, DOI 10.1007/s11356-011-0458-8; YOSHIDA K, 1987, ENVIRON RES, V42, P400, DOI 10.1016/S0013-9351(87)80206-2; Zahir F, 2005, ENVIRON TOXICOL PHAR, V20, P351, DOI 10.1016/j.etap.2005.03.007	42	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203335	10.1371/journal.pone.0203335	http://dx.doi.org/10.1371/journal.pone.0203335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161259	gold, Green Published, Green Submitted			2022-12-26	WOS:000443388900114
J	Galvao, EL; Pedras, MJ; Cota, GF; Simoes, TC; Rabello, A				Galvao, Endi Lanza; Pedras, Mariana Junqueira; Cota, Glaucia Fernandes; Simoes, Taynana Cesar; Rabello, Ana			Development and initial validation of a cutaneous leishmaniasis impact questionnaire	PLOS ONE			English	Article							QUALITY-OF-LIFE; CONTENT VALIDITY; INSTRUMENT; HEALTH; INDEX; RELIABILITY; CRITERIA; DISEASES; NUMBER; ALPHA	Background The impact of cutaneous leishmaniasis (CL) on the quality of life of patients has been neglected in research studies worldwide. The few reported studies have used non-specific questionnaires for the disease, which represents a limitation since generic instruments may not address specific aspects of the disease, compromising the evaluation of its real impact. The aim of this paper is to describe the development and the initial validation of an instrument for evaluating the impact of CL, named the Cutaneous Leishmaniasis Impact Questionnaire. Methodology The formulation and validation of the instrument consisted of the following steps: (1) literature review; (2) conceptual framework construction and initial item generation; (3) tool analysis by health professionals (experts); (4) tool evaluation performed by the patients; and (5) a pilot study with 100 patients with localized CL, evaluated at a reference ambulatory facility in Belo Horizonte, in the state of Minas Gerais, Brazil. The structure of the proposed instrument was analyzed using hierarchical cluster analysis (ICLUST). Results Twenty-seven items were initially proposed by the researchers to compose the questionnaire. Content validity (evaluates if the instrument fully assesses the construct of interest) was evaluated by the panel of experts, while face validity (evaluates how potential participants interpret the items) was evaluated by the target population. In this step, some items were excluded, reformulated and/or included. After evaluating a factorial structure of the items in accordance with the cluster analysis, we assembled a questionnaire with 25 items (alpha = 0.86), with high reliability and homogeneity, which address the following: 1) the general impact of the disease (alpha = 0.91, beta = 0.67) and 2) the evaluation of the perception about the treatment and health services (alpha = 0.72, beta = 0.51). Conclusions The Cutaneous Leishmaniasis Impact Questionnaire, developed with contributions from patients and experts, was confirmed, in this first validation, as a useful and reliable instrument.	[Galvao, Endi Lanza; Pedras, Mariana Junqueira; Cota, Glaucia Fernandes; Simoes, Taynana Cesar; Rabello, Ana] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Rene Rachou, Pesquisa Clin & Polit Publ Doencas Infecto Parasi, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz	Galvao, EL (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Inst Rene Rachou, Pesquisa Clin & Polit Publ Doencas Infecto Parasi, Belo Horizonte, MG, Brazil.	endi.lanza@cpqrr.fiocruz.br	Cota, Glaucia/ABC-5378-2020; Junqueira Pedras, Mariana/ABF-1228-2021; Simões, Taynãna César/ABE-8964-2021	Cota, Glaucia/0000-0003-0538-7403; Junqueira Pedras, Mariana/0000-0003-2494-6178; Galvao, Endi Lanza/0000-0002-5648-3932	CNPq (National Counsel of Technological and Scientific Development) [311641/2009-1]; FAPEMIG (Foundation for Research Support of the State of Minas Gerais)	CNPq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Foundation for Research Support of the State of Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	AR is currently receiving a grant [311641/2009-1] from CNPq (National Counsel of Technological and Scientific Development). ELG is Ph.D. student and is reciving a scholarship from FAPEMIG (Foundation for Research Support of the State of Minas Gerais). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], 2014, CHRON MULT ILLN GULF; AUGUSTIN M, 2000, DERMATOL PSYCHOSOM, V1, P12, DOI DOI 10.1159/000017503; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Bolarinwa Oladimeji Akeem, 2015, Niger Postgrad Med J, V22, P195, DOI 10.4103/1117-1936.173959; Chahed MK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005090; Chen SC, 2002, ARCH DERMATOL, V138, P803, DOI 10.1001/archderm.138.6.803; Chren MM, 1996, J INVEST DERMATOL, V107, P707, DOI 10.1111/1523-1747.ep12365600; Cooksey RW, 2006, ORGAN RES METHODS, V9, P78, DOI 10.1177/1094428105283939; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Toledo Jr ACD, 2013, T ROY SOC TROP MED H, V107, P335, DOI 10.1093/trstmh/trt021; DeVon HA, 2007, J NURS SCHOLARSHIP, V39, P155, DOI 10.1111/j.1547-5069.2007.00161.x; Fayers PM, 2007, QUALITY LIFE ASSESSM; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; FINLAY AY, 1987, CLIN EXP DERMATOL, V12, P8, DOI 10.1111/j.1365-2230.1987.tb01844.x; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Gurel MS, 2005, INT J DERMATOL, V44, P933, DOI 10.1111/j.1365-4632.2004.02225.x; Halyard MY, 2006, CURR PROB CANCER, V30, P319, DOI 10.1016/j.currproblcancer.2006.08.009; Hareendran A, 2007, WOUND REPAIR REGEN, V15, P465, DOI 10.1111/j.1524-475X.2007.00253.x; Heo M, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0070-6; HORN JL, 1979, MULTIVAR BEHAV RES, V14, P283, DOI 10.1207/s15327906mbr1403_1; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Karimkhani C, 2016, LANCET INFECT DIS, V16, P584, DOI 10.1016/S1473-3099(16)00003-7; Kassi M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000259; KIRSHNER B, 1985, J CHRON DIS, V38, P27, DOI 10.1016/0021-9681(85)90005-0; Litt E, 2012, TRENDS PARASITOL, V28, P195, DOI 10.1016/j.pt.2012.03.001; Luo YH, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0246-0; LYNN MR, 1986, NURS RES, V35, P382; Nilforoushzadeh M. A., 2010, SKIN LEISHMANIASIS, V1, P28; Okada K, 2015, RES SYNTH METHODS, V6, P333, DOI 10.1002/jrsm.1155; PAHO, 2013, LEISHM AM REC TRAT C; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Ranawaka R R, 2014, Mymensingh Med J, V23, P345; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Reithinger R, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000285; REVELLE W, 1978, BEHAV RES METH INSTR, V10, P739, DOI 10.3758/BF03205389; Revelle W, ICLUST ITEM CLUSTER; Revelle W, 2013, NON TRADITIONAL REF; Revelle W., 2017, INTRO PSYCH PACKAG 2; Revelle W, 1979, BEHAV RES, V14, P57, DOI [10.1207/s15327906mbr1401_4, DOI 10.1207/S15327906MBR1401_4]; Rossiter JR, 2002, INT J RES MARK, V19, P305, DOI 10.1016/S0167-8116(02)00097-6; Ruscio J, 2012, PSYCHOL ASSESSMENT, V24, P282, DOI 10.1037/a0025697; Studerus E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012412; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Vares B, 2013, ARCH IRAN MED, V16, P474, DOI 013168/AIm.008; Warshaw EM, 2007, INT J DERMATOL, V46, P1279, DOI 10.1111/j.1365-4632.2007.03362.x; WHO, 2010, WHO TECHN REP SER; Yanik M, 2004, CLIN EXP DERMATOL, V29, P464, DOI 10.1111/j.1365-2230.2004.01605.x	49	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203378	10.1371/journal.pone.0203378	http://dx.doi.org/10.1371/journal.pone.0203378			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161222	Green Published, gold, Green Submitted			2022-12-26	WOS:000443388900116
J	Seko, Y; Kato, T; Morita, Y; Yamaji, Y; Haruna, Y; Izumi, T; Miyamoto, S; Nakane, E; Hayashi, H; Haruna, T; Inoko, M				Seko, Yuta; Kato, Takao; Morita, Yusuke; Yamaji, Yuhei; Haruna, Yoshizumi; Izumi, Toshiaki; Miyamoto, Shoichi; Nakane, Eisaku; Hayashi, Hideyuki; Haruna, Tetsuya; Inoko, Moriaki			Impact of left ventricular concentricity on long-term mortality in a hospital-based population in Japan	PLOS ONE			English	Article							EUROPEAN ASSOCIATION; AMERICAN SOCIETY; GEOMETRY; MASS; ECHOCARDIOGRAPHY; RECOMMENDATIONS; DISEASE; UPDATE	Background The prognostic impact of relative wall thickness (RWT), ventricular concentricity, is controversial. Methods We retrospectively analyzed data obtained from 4444 consecutive patients who had undergone both transthoracic echocardiography and electrocardiography at our hospital in 2013. Those who presented with a history of previous episodes of myocardial infarctions and severe or moderate valvular disease were excluded from the analysis. We calculated RWT as follows: (2 x diastolic posterior wall thickness) / (the diastolic LV dimension). We defined high RWT as a ratio > 0.42. A total of 3654 patients were categorized into two groups: 492 with high RWT, and 3162 with normal RWT. Results The mean ages of those in the normal and high RWT groups were 64.6 (+/- standard deviation 16.3) and 71.6 (+/- 12.7) years, respectively (p<0.001). Prevalence of male sex, history of diabetes, hypertension, and chronic kidney disease, and the left atrium volume index was higher for the high RWT group than for the normal RWT group. The median follow-up period was 1274 days (interquartile range, 410-1470). The Kaplan-Meier curves showed a constant increase in all-cause death, with cumulative 3-year incidences of 18.3% and 10.8% for the high RWT and normal RWT groups, respectively (log-rank p<0.001). After adjusting for confounders, the increased mortality risk for those with high RWT relative to normal RWT was significant (hazard ratio, 1.64; 95% confidence interval, 1.27-2.10). This trend was consistent for the composite of deaths and major adverse cardiac events. Conclusion High RWT has a deleterious impact on long-term mortality.	[Seko, Yuta; Morita, Yusuke; Yamaji, Yuhei; Haruna, Yoshizumi; Izumi, Toshiaki; Miyamoto, Shoichi; Nakane, Eisaku; Hayashi, Hideyuki; Haruna, Tetsuya; Inoko, Moriaki] Kitano Hosp, Cardiovasc Ctr, Tazuke Kofukai Med Res Inst, Osaka, Japan; [Kato, Takao] Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Kyoto, Japan	Kitano Hospital; Kyoto University	Kato, T (corresponding author), Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Kyoto, Japan.	tkato75@kuhp.kyoto-u.ac.jp						CASALE PN, 1986, ANN INTERN MED, V105, P173, DOI 10.7326/0003-4819-105-2-173; Gaasch WH, 2011, J AM COLL CARDIOL, V58, P1733, DOI 10.1016/j.jacc.2011.07.022; Ghali JK, 1998, J AM COLL CARDIOL, V31, P1635, DOI 10.1016/S0735-1097(98)00131-4; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Malatino LS, 2003, HYPERTENSION, V41, P88, DOI 10.1161/01.HYP.0000046919.41112.4B; Milani RV, 2006, AM J CARDIOL, V97, P959, DOI 10.1016/j.amjcard.2005.10.030; Minamino-Muta E, 2017, HEART, V103, P1992, DOI 10.1136/heartjnl-2016-311022; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; NEILL WA, 1979, AM J CARDIOL, V44, P747, DOI 10.1016/0002-9149(79)90297-2; Olsen MH, 2002, AM HEART J, V144, P530, DOI 10.1067/mhj.2002.124863; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Saba PS, 1999, J HYPERTENS, V17, P1007, DOI 10.1097/00004872-199917070-00018; Schafer S, 2002, J HYPERTENS, V20, P1431, DOI 10.1097/00004872-200207000-00031; Seko Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24875-1; Verma A, 2008, JACC-CARDIOVASC IMAG, V1, P582, DOI 10.1016/j.jcmg.2008.05.012; Wang TJ, 2003, CIRCULATION, V108, P977, DOI 10.1161/01.CIR.0000085166.44904.79; Zabalgoitia M, 2001, AM J CARDIOL, V88, P646, DOI 10.1016/S0002-9149(01)01807-0	19	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203227	10.1371/journal.pone.0203227	http://dx.doi.org/10.1371/journal.pone.0203227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161243	Green Submitted, Green Published, gold			2022-12-26	WOS:000443388900095
J	Shmueli, MD; Levy-Kanfo, L; Haj, E; Schoenfeld, AR; Gazit, E; Segal, D				Shmueli, Merav D.; Levy-Kanfo, Limor; Haj, Esraa; Schoenfeld, Alan R.; Gazit, Ehud; Segal, Daniel			Arginine refolds, stabilizes, and restores function of mutant pVHL proteins in animal model of the VHL cancer syndrome	ONCOGENE			English	Article							TUMOR-SUPPRESSOR PROTEIN; HIF-ALPHA; LINDAU; DROSOPHILA; HIF-1-ALPHA; COMPLEX; BINDING; HYDROXYPROLINE; UBIQUITINATION; UBIQUITYLATION	The von Hippel-Lindau (VHL) syndrome is a rare inherited cancer, caused by mutations in the VHL gene, many of which render the VHL protein (pVHL) unstable. pVHL is a tumor-suppressor protein implicated in a variety of cellular processes, most notably in response to changes in oxygen availability, due to its role as part of an E3-ligase complex which targets the hypoxia-inducible factor (HIF) for degradation. Previously we reported, using in silico and in vitro analyses, that common oncogenic VHL mutations render pVHL less stable than the wild-type protein, distort its core domain and as a result reduce the ability of the protein to bind its target HIF-1 alpha. Among various chemical chaperones tested, arginine was the most effective in refolding mutant of pVHL. Here we examined the consequences of administering L- or D-arginine to a Drosophila VHL model and to human renal carcinoma cells, both expressing misfolded versions of human pVHL. Arginine treatment increased pVHL solubility in both models and increased the half-life of the mutant pVHL proteins in the cell culture. In both models, L- as well as D-arginine enhanced the ability of wild-type pVHL and certain misfolded mutant versions of pVHL to bind ODD, the HIF-derived target peptide, reflecting restoration of pVHL function. Moreover, continuous feeding of Drosophila expressing misfolded versions of pVHL either L- or D-arginine rich diet rescued their lethal phenotype. Collectively, these in vivo results suggest that arginine supplementation should be examined as a potential novel treatment for VHL cancer syndrome.	[Shmueli, Merav D.; Levy-Kanfo, Limor; Haj, Esraa; Gazit, Ehud; Segal, Daniel] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Schoenfeld, Alan R.] Adelphi Univ, Dept Biol, One South Ave,POB 701, Garden City, NY 11530 USA	Tel Aviv University; Adelphi University	Segal, D (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	dsegal@post.tau.ac.il	Shmueli, Merav/HDM-9859-2022; Gazit, Ehud/C-3715-2011; Gazit, Ehud/M-8026-2019; Gazit, Ehud/AHE-9332-2022	Shmueli, Merav/0000-0002-9196-7633; Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Segal, Daniel/0000-0002-6777-505X	Israel Cancer Association; Cancer Biology Research Center in Tel Aviv University; VHL Alliance	Israel Cancer Association; Cancer Biology Research Center in Tel Aviv University; VHL Alliance	This work was supported in part by the Israel Cancer Association, the Cancer Biology Research Center in Tel Aviv University, and the VHL Alliance (to DS).	Arakawa T, 2007, BIOPHYS CHEM, V127, P1, DOI 10.1016/j.bpc.2006.12.007; Arquier N, 2006, BIOCHEM J, V393, P471, DOI 10.1042/BJ20050675; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bangiyeva V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-229; Beroud C, 1998, NUCLEIC ACIDS RES, V26, P256, DOI 10.1093/nar/26.1.256; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Chen CH, 2009, LANGMUIR, V25, P6717, DOI 10.1021/la9002065; Cho NK, 2002, CELL, V108, P865, DOI 10.1016/S0092-8674(02)00676-1; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Ding ZY, 2012, J BIOMOL SCREEN, V17, P572, DOI 10.1177/1087057112436557; Duchi S, 2010, DEVELOPMENT, V137, P1493, DOI 10.1242/dev.042804; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Guo Y, 2009, ONCOGENE, V28, P1864, DOI 10.1038/onc.2009.35; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Hsouna A, 2010, MOL CELL BIOL, V30, P3779, DOI 10.1128/MCB.01578-09; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Khan SH, 2010, IUBMB LIFE, V62, P891, DOI 10.1002/iub.406; Knauth K, 2006, ONCOGENE, V25, P370, DOI 10.1038/sj.onc.1209062; Kurban G, 2008, ONCOGENE, V27, P1004, DOI 10.1038/sj.onc.1210709; Li JG, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3469790; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McNeal CJ, 2016, J NUTR, V146, P2587, DOI 10.3945/jn.116.234740; Miller F, 2005, J BIOL CHEM, V280, P7985, DOI 10.1074/jbc.M413160200; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Navarro E, 2005, BASIC CLIN PHARMACOL, V97, P149, DOI 10.1111/j.1742-7843.2005.pto_973110.x; Ohh M, 1999, J CLIN INVEST, V104, P1583, DOI 10.1172/JCI8161; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shmueli MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109864; Shmueli MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066333; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Tabaro F, 2016, SCI REP-UK, V6, DOI 10.1038/srep31128; Tarade D, 2018, ONCOGENE, V37, P139, DOI 10.1038/onc.2017.338; Varshney N, 2017, J KIDNEY CANCER VHL, V4, P20, DOI 10.15586/jkcvhl.2017.88; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	43	4	5	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 14	2019	38	7					1038	1049		10.1038/s41388-018-0491-x	http://dx.doi.org/10.1038/s41388-018-0491-x			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HL3OH	30194449				2022-12-26	WOS:000458624900008
J	Ho, SR; Lin, WC				Ho, Shiuh-Rong; Lin, Weei-Chin			RNF144A sustains EGFR signaling to promote EGF-dependent cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; ubiquitylation (ubiquitination); epidermal growth factor receptor (EGFR); vesicles; trafficking; DNA-dependent serine; threonine protein kinase (DNA-PK); RBR	EPIDERMAL-GROWTH-FACTOR; RECEPTOR TYROSINE KINASES; NEGATIVE BREAST-CANCER; E3 UBIQUITIN LIGASE; PROTEIN-KINASE; NUCLEAR-LOCALIZATION; OWN RECEPTOR; DNA-PKCS; IN-VITRO; ENDOCYTOSIS	RNF144A is a single-pass transmembrane RBR E3 ligase that interacts with and degrades cytoplasmic DNA-PKcs, which is an epidermal growth factor receptor (EGFR)-interacting partner. Interestingly, RNF144A expression is positively correlated with EGFR mRNA and protein levels in several types of cancer. However, the relationship between RNF144A and EGFR is poorly understood. This study reports an unexpected role for RNF144A in the regulation of EGF/EGFR signaling and EGF-dependent cell proliferation. EGFR ligands, but not DNA-damaging agents, induce a DNA-PKcs-independent interaction between RNF144A and EGFR. RNF144A promotes EGFR ubiquitination, maintains EGFR protein, and prolongs EGF/EGFR signaling during EGF stimulation. Moreover, depletion of RNF144A by multiple independent approaches results in a decrease in EGFR expression and EGF/EGFR signaling. RNF144A knockout cells also fail to mount an immediate response to EGF for activation of G(1)/S progression genes. Consequently, depletion of RNF144A reduces EGF-dependent cell proliferation. These defects may be at least in part due to a role for RNF144A in regulating EGFR transport in the intracellular vesicles during EGF treatment.	[Ho, Shiuh-Rong; Lin, Weei-Chin] Baylor Coll Med, Dept Med, Hematol Oncol Sect, Houston, TX 77030 USA; [Lin, Weei-Chin] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Lin, Weei-Chin] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lin, WC (corresponding author), One Baylor Plaza,MS BCM187, Houston, TX 77030 USA.	weeichil@bcm.edu	HO, SHIUH-RONG/M-4728-2019	HO, SHIUH-RONG/0000-0002-9612-722X	National Institutes of Health [R01CA100857, R01CA203824, R01CA138641]; Department of Defense [W81XWH-14-1-0339, W81XWH-14-1-0306]; National Institutes of Health, BCM Oncology Scholars T32 Fellowship [T32CA174647]; NATIONAL CANCER INSTITUTE [R01CA138641, R01CA203824, R21CA198041, T32CA174647, R01CA100857] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Institutes of Health, BCM Oncology Scholars T32 Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01CA100857, R01CA203824, and R01CA138641 and Department of Defense Grants W81XWH-14-1-0339 and W81XWH-14-1-0306. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health, BCM Oncology Scholars T32 Fellowship T32CA174647.	An J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-32; Ayyappan S, 2013, ANTICANCER RES, V33, P4139; Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Baumdick M, 2015, ELIFE, V4, DOI 10.7554/eLife.12223; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; Brand TM, 2011, DISCOV MED, V12, P419; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; CLARK AJL, 1985, P NATL ACAD SCI USA, V82, P8374, DOI 10.1073/pnas.82.24.8374; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dittmann K, 2005, RADIOTHER ONCOL, V76, P157, DOI 10.1016/j.radonc.2005.06.022; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; EARP HS, 1986, J BIOL CHEM, V261, P4777; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Ettenberg SA, 2001, J BIOL CHEM, V276, P27677, DOI 10.1074/jbc.M102641200; Friedmann B, 2004, CLIN CANCER RES, V10, P6476, DOI 10.1158/1078-0432.CCR-04-0586; Friedmann BJ, 2006, MOL CANCER THER, V5, P209, DOI 10.1158/1535-7163.MCT-05-0239; GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hanada N, 2006, MOL CARCINOGEN, V45, P10, DOI 10.1002/mc.20147; Henriksen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058148; Ho SR, 2015, J BIOL CHEM, V290, P23026, DOI 10.1074/jbc.M115.645499; Ho SR, 2014, P NATL ACAD SCI USA, V111, pE2646, DOI 10.1073/pnas.1323107111; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Kelsall IR, 2013, EMBO J, V32, P2848, DOI 10.1038/emboj.2013.209; KUDLOW JE, 1986, J BIOL CHEM, V261, P4134; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leung L, 2012, THER ADV MED ONCOL, V4, P173, DOI 10.1177/1758834012440015; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lipkowitz S, 2003, BREAST CANCER RES, V5, P8, DOI 10.1186/bcr541; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Miyamoto Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040752; Nakai K, 2016, AM J CANCER RES, V6, P1609; Nakamura N, 2011, MEMBRANES-BASEL, V1, P354, DOI 10.3390/membranes1040354; Oksvold MP, 2002, J CELL SCI, V115, P793; Park SJ, 2017, CELL METAB, V25, P1135, DOI [10.1016/j.cmet.2017.04.008, 10.1016/j.cmet.2017.07.005]; Ray L Bryan, 2017, Science, V356, P1041, DOI 10.1126/science.356.6342.1041-a; Rush JS, 2012, J BIOL CHEM, V287, P712, DOI 10.1074/jbc.M111.294470; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Smit JJ, 2014, EMBO REP, V15, P142, DOI 10.1002/embr.201338166; Spratt DE, 2014, BIOCHEM J, V458, P421, DOI 10.1042/BJ20140006; Szumiel I, 2006, CELL SIGNAL, V18, P1537, DOI 10.1016/j.cellsig.2006.03.010; Takeuchi K, 2011, BIOL PHARM BULL, V34, P1774, DOI 10.1248/bpb.34.1774; Tang H, 2000, J BIOL CHEM, V275, P13420, DOI 10.1074/jbc.275.18.13420; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Wong H, 2013, THER ADV GASTROENTER, V6, P15, DOI 10.1177/1756283X12453636; Wu YH, 2017, CANCER LETT, V400, P79, DOI 10.1016/j.canlet.2017.04.023	58	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16307	16323		10.1074/jbc.RA118.002887	http://dx.doi.org/10.1074/jbc.RA118.002887			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30171075	Green Published, hybrid			2022-12-26	WOS:000447833600016
J	Zhou, Q; An, T; Pham, KTM; Hu, HQ; Li, ZY				Zhou, Qing; An, Tai; Pham, Kieu T. M.; Hu, Huiqing; Li, Ziyin			The CIF1 protein is a master orchestrator of trypanosome cytokinesis that recruits several cytokinesis regulators to the cytokinesis initiation site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; cell division; cytokinesis; tropomyosin; Trypanosoma brucei; CIF1; cleavage furrow; kinesin; KPP1; sleeping sickness	FLAGELLUM ATTACHMENT ZONE; POLO-LIKE KINASE; LIFE-CYCLE; FISSION YEAST; BRUCEI; TROPOMYOSIN; EXPRESSION; MORPHOLOGY; KATANIN; COMPLEX	To proliferate, the parasitic protozoan Trypanosoma brucei undergoes binary fission in a unidirectional manner along the cell's longitudinal axis from the cell anterior toward the cell posterior. This unusual mode of cell division is controlled by a regulatory pathway composed of two evolutionarily conserved protein kinases, Polo-like kinase and Aurora B kinase, and three trypanosome-specific proteins, CIF1, CIF2, and CIF3, which act in concert at the cytokinesis initiation site located at the distal tip of the newly assembled flagellum attachment zone (FAZ). However, additional regulators that function in this cytokinesis signaling cascade remain to be identified and characterized. Using proximity biotinylation, co-immunofluorescence microscopy, and co-immunoprecipitation, we identified 52 CIF1-associated proteins and validated six CIF1-interacting proteins, including the putative protein phosphatase KPP1, the katanin p80 subunit KAT80, the cleavage furrow-localized proteins KLIF and FRW1, and the FAZ tip-localized proteins FAZ20 and FPRC. Further analyses of the functional interplay between CIF1 and its associated proteins revealed a requirement of CIF1 for localization of a set of CIF1-associated proteins, an interdependence between KPP1 and CIF1, and an essential role of katanin in the completion of cleavage furrow ingression. Together, these results suggest that CIF1 acts as a master regulator of cytokinesis in T. brucei by recruiting a cohort of cytokinesis regulatory proteins to the cytokinesis initiation site.	[Zhou, Qing; An, Tai; Pham, Kieu T. M.; Hu, Huiqing; Li, Ziyin] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, McGovern Med Sch, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Li, ZY (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, McGovern Med Sch, Houston, TX 77030 USA.	Ziyin.Li@uth.tmc.edu	Zhou, Qing/I-6223-2019; Zhou, Qing/A-8296-2019	Zhou, Qing/0000-0003-2096-1960; Zhou, Qing/0000-0003-2096-1960; Li, Ziyin/0000-0002-3960-9716	National Institutes of Health [AI101437, AI118736]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118736, R01AI101437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI101437 and AI118736 (to Z.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Benz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030367; Casanova M, 2009, MOL MICROBIOL, V71, P1353, DOI 10.1111/j.1365-2958.2009.06594.x; Cranz-Mileva S, 2015, BIOL OPEN, V4, P1040, DOI 10.1242/bio.012609; Crozier TWM, 2018, MOL CELL PROTEOMICS, V17, P1184, DOI 10.1074/mcp.RA118.000650; de Graffenried CL, 2008, J CELL BIOL, V181, P431, DOI 10.1083/jcb.200708082; de Jong RN, 2008, STRUCTURE, V16, P149, DOI 10.1016/j.str.2007.10.018; Dean S, 2017, TRENDS PARASITOL, V33, P80, DOI 10.1016/j.pt.2016.10.009; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hilton NA, 2018, MOL MICROBIOL, V109, P306, DOI 10.1111/mmi.13986; Hu HQ, 2017, J CELL SCI, V130, P4108, DOI 10.1242/jcs.207134; Hu HQ, 2015, J BIOL CHEM, V290, P30453, DOI 10.1074/jbc.M115.694109; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; Kurasawa Y, 2018, J BIOL CHEM, V293, P10275, DOI 10.1074/jbc.RA118.003113; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Li ZY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000575; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McNally KP, 2000, J CELL SCI, V113, P1623; Morriswood B, 2013, EUKARYOT CELL, V12, P356, DOI 10.1128/EC.00326-12; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Shen SY, 2001, MOL BIOCHEM PARASIT, V113, P171, DOI 10.1016/S0166-6851(00)00383-2; Sunter JD, 2016, TRENDS PARASITOL, V32, P309, DOI 10.1016/j.pt.2015.12.010; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Whitby FG, 2000, PROTEINS, V38, P49; Wier AD, 2013, P NATL ACAD SCI USA, V110, P17290, DOI 10.1073/pnas.1314754110; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhou Q, 2018, J BIOL CHEM, V293, P8508, DOI 10.1074/jbc.RA118.002106; Zhou Q, 2016, J BIOL CHEM, V291, P14395, DOI 10.1074/jbc.M116.726133; Zhou Q, 2016, P NATL ACAD SCI USA, V113, P3287, DOI 10.1073/pnas.1601596113; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676	38	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16177	16192		10.1074/jbc.RA118.004888	http://dx.doi.org/10.1074/jbc.RA118.004888			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30171070	Green Published, hybrid			2022-12-26	WOS:000447833600007
J	Koenigsberg, AL; Heldwein, EE				Koenigsberg, Andrea L.; Heldwein, Ekaterina E.			The dynamic nature of the conserved tegument protein UL37 of herpesviruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						herpesvirus; viral protein; multifunctional protein; small-angle X-ray scattering (SAXS); structural model; conformational flexibility; multi-angle light scattering; tegument; Thermofluor	HERPES-SIMPLEX-VIRUS; SMALL-ANGLE SCATTERING; SECONDARY ENVELOPMENT; CAPSID TRANSPORT; NULL MUTATION; GENE-PRODUCT; TYPE-1; RESOLUTION; INTERACTS; ALPHAHERPESVIRUSES	In all herpesviruses, the space between the capsid shell and the lipid envelope is occupied by the unique tegument layer composed of proteins that, in addition to structural roles, play many other roles in the viral replication. UL37 is a highly conserved tegument protein that has activities ranging from virion morphogenesis to directional capsid trafficking to manipulation of the host innate immune response and binds multiple partners. The N-terminal half of UL37 (UL37N) has a compact bean-shaped alpha-helical structure that contains a surface region essential for neuroinvasion. However, no biochemical or structural information is currently available for the C-terminal half of UL37 (UL37C) that mediates most of its interactions with multiple binding partners. Here, we show that the C-terminal half of UL37 from pseudorabies virus UL37C is a conformationally flexible monomer composed of an elongated folded core and an unstructured C-terminal tail. This elongated structure, along with that of its binding partner UL36, explains the nature of filamentous tegument structures bridging the capsid and the envelope. We propose that the dynamic nature of UL37 underlies its ability to perform diverse roles during viral replication.	[Heldwein, Ekaterina E.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; Tufts Univ, Sch Med, Grad Program Mol Microbiol, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA	Tufts University; Tufts University	Heldwein, EE (corresponding author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA.	katya.heldwein@tufts.edu		Heldwein, Ekaterina/0000-0003-3113-6958	National Science Foundation; NIGMS/National Institutes of Health under NSF [DMR-0936384]; NIGMS/National Institutes of Health [GM-103485]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056346, T32AI007422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIGMS/National Institutes of Health under NSF; NIGMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Xuanzong Guo for purifying PreScission protease and Abraham Sonenshein for the use of the Roche LightCycler 480 quantitative PCR machine. We thank MacCHESS BioSAXS staff for help with SAXS data collection and analysis, especially Jesse Hopkins for helpful discussions. We also thank Peter Cherepanov (Francis Crick Institute) for the gift of the GST-PreScission protease expression plasmid and Thomas Schwartz (Massachusetts Institute of Technology) for the gift of LoBSTr cells. Multi-angle light scattering experiments were performed at the Center for Macromolecular Interactions in the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. All software was installed and maintained by SBGrid (47). This work is based upon research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation and NIGMS/National Institutes of Health under NSF award DMR-0936384, using the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by NIGMS/National Institutes of Health Grant GM-103485.	Abaitua F, 2012, J VIROL, V86, P8998, DOI 10.1128/JVI.01209-12; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bucks MA, 2011, VIROLOGY, V416, P42, DOI 10.1016/j.virol.2011.04.018; CAMPBELL MEM, 1984, J MOL BIOL, V180, P1, DOI 10.1016/0022-2836(84)90427-3; Dai XH, 2018, SCIENCE, V360, P47, DOI 10.1126/science.aao7298; Darling AL, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00158; Desai P, 2001, J VIROL, V75, P10259, DOI 10.1128/JVI.75.21.10259-10271.2001; Desai PJ, 2000, J VIROL, V74, P11608, DOI 10.1128/JVI.74.24.11608-11618.2000; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franzosa EA., 2009, EXPT STANDARD CONDIT, P99; Fuchs W, 2004, J VIROL, V78, P11879, DOI 10.1128/JVI.78.21.11879-11889.2004; Galzitskaya OV, 2006, BIOINFORMATICS, V22, P2948, DOI 10.1093/bioinformatics/btl504; Grunewald K, 2003, SCIENCE, V302, P1396, DOI 10.1126/science.1090284; Hollinshead M, 2012, EMBO J, V31, P4204, DOI 10.1038/emboj.2012.262; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; Hsu WL, 2013, PROTEIN SCI, V22, P258, DOI 10.1002/pro.2207; Jambunathan N, 2014, J VIROL, V88, P5927, DOI 10.1128/JVI.00278-14; Kattenhorn LM, 2005, MOL CELL, V19, P547, DOI 10.1016/j.molcel.2005.07.003; Kelly BJ, 2009, VIRUS RES, V145, P173, DOI 10.1016/j.virusres.2009.07.007; Klupp BG, 2002, J VIROL, V76, P3065, DOI 10.1128/JVI.76.6.3065-3071.2002; Klupp BG, 2001, J VIROL, V75, P8927, DOI 10.1128/JVI.75.19.8927-8936.2001; Koenigsberg AL, 2017, J VIROL, V91, DOI 10.1128/JVI.01244-17; Laine RF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6980; Leege T, 2009, J GEN VIROL, V90, P1560, DOI 10.1099/vir.0.010322-0; Liu XQ, 2008, P NATL ACAD SCI USA, V105, P11335, DOI 10.1073/pnas.0801617105; Luxton GWG, 2006, J VIROL, V80, P201, DOI 10.1128/JVI.80.1.201-209.2006; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MCLAUCHLAN J, 1992, J GEN VIROL, V73, P269, DOI 10.1099/0022-1317-73-2-269; Merkley ED, 2014, PROTEIN SCI, V23, P747, DOI 10.1002/pro.2458; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Ortega E, 2016, J BIOL CHEM, V291, P18643, DOI 10.1074/jbc.M116.732909; Owen DJ, 2015, VIRUSES-BASEL, V7, P5084, DOI 10.3390/v7092861; Pasdeloup D, 2013, J VIROL, V87, P2857, DOI 10.1128/JVI.02676-12; Phillips Kevin, 2011, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1028s94; Pitts JD, 2014, J VIROL, V88, P5462, DOI 10.1128/JVI.00163-14; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Richards AL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006741; Schipke J, 2012, J VIROL, V86, P3682, DOI 10.1128/JVI.06432-11; Scrima N, 2015, J BIOL CHEM, V290, P8820, DOI 10.1074/jbc.M114.612838; Smiley JR, 2004, J VIROL, V78, P1063, DOI 10.1128/JVI.78.3.1063-1068.2004; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tamarozzi ER, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010198; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Turcotte S, 2005, J VIROL, V79, P8847, DOI 10.1128/JVI.79.14.8847-8860.2005; Tuukkanen AT, 2016, IUCRJ, V3, P440, DOI 10.1107/S2052252516016018; Vittone V, 2005, J VIROL, V79, P9566, DOI 10.1128/JVI.79.15.9566-9571.2005; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Xue B, 2010, PROTEIN PEPTIDE LETT, V17, P932, DOI 10.2174/092986610791498984; Zhao J, 2016, CELL HOST MICROBE, V20, P770, DOI 10.1016/j.chom.2016.10.011	51	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15827	15839		10.1074/jbc.RA118.004481	http://dx.doi.org/10.1074/jbc.RA118.004481			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30166339	Green Published, hybrid			2022-12-26	WOS:000447256000007
J	Torres, S; Cao, L; Gregoric, DEG; de Lucia, M; Brea, F; Darrigran, G				Torres, Santiago; Cao, Luciana; Gutierrez Gregoric, Diego Eduardo; de Lucia, Micaela; Brea, Francisco; Darrigran, Gustavo			Distribution of the Unionida (Bivalvia, Paleoheterodonta) from Argentina and its conservation in the Southern Neotropical Region	PLOS ONE			English	Article							LIMNOPERNA-FORTUNEI; GLOBAL DIVERSITY; HYRIIDAE; UNIONOIDA; MOLLUSCA; MUSSELS; SYSTEMATICS; EXTINCTION; EVOLUTION; PATTERNS	Bivalves are one of the most representative groups in the Phylum Mollusca, with over 1,100 freshwater species around the world except Antarctica. About 900 of these species belong to the Order Unionida Gray, 1854. In South America, the distributional range of the Unionida includes all countries in the region and extends as far south as the lakes and rivers of Argentinean-Chilean Patagonia. With the aim of generating distribution maps for the different genera of Unionida in Argentina, we consulted the databases of the nation's main official malacological collections. The data were analyzed and georeferenced using the point-radius method. Spatial analyses were performed with the software Q-GIS 2.16.3 Nodebo using vector layers under the 2007 Argentinean Geodesic Positions reference system. A total 1,833 lots were analyzed, of which it was possible to georeference 1,503. The distribution of Unionida in Argentinean territory was analyzed according to political provinces, Surface Drainage Basins and the Argentinean Protected Areas. Species richness was analyzed using the surface drainage basins of Argentina. We generate distribution maps for each genus and discuss the species threat status and conservation degree in the region. Only six (18%) of the Unionida present in Argentina have been classified by the IUCN, four are Least Concern and two are Data Deficient. This pattern is also valid for all of South America. More than 95% of the distributional range of the Unionida has no protected area. Conservation management is necessary for the preservation of Unionida diversity in southern South America.	[Torres, Santiago; Cao, Luciana; Gutierrez Gregoric, Diego Eduardo; de Lucia, Micaela; Brea, Francisco; Darrigran, Gustavo] UNLP, FCNyM, Div Zool Invertebrados, Museo La Plata, La Plata, Buenos Aires, Argentina; [Torres, Santiago] Ctr Invest & Transferencia Santa Cruz, La Plata, Buenos Aires, Argentina; [Torres, Santiago] UTN, UNPA, CONICET, Rio Gallegos, Argentina; [Torres, Santiago; Cao, Luciana; Gutierrez Gregoric, Diego Eduardo; Darrigran, Gustavo] Consejo Nacl Invest Cient & Tecn, La Plata, Buenos Aires, Argentina; [de Lucia, Micaela] Comis Invest Cient Prov Buenos Aires CIC, La Plata, Buenos Aires, Argentina	National University of La Plata; Museo La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision de Investigaciones Cientificas	Darrigran, G (corresponding author), UNLP, FCNyM, Div Zool Invertebrados, Museo La Plata, La Plata, Buenos Aires, Argentina.; Darrigran, G (corresponding author), Consejo Nacl Invest Cient & Tecn, La Plata, Buenos Aires, Argentina.	invasion@fcnym.unlp.edu.ar	Darrigran, Gustavo/L-6191-2019; Torres, Santiago/AAE-8531-2019; Darrigran, Gustavo/AAE-5910-2021	Torres, Santiago/0000-0002-2118-0739; 	Universidad de La Plata [11/N795]	Universidad de La Plata(National University of La Plata)	This work was supported by Universidad de La Plata (11/N795) to Gustavo Darrigran.	Beasley CR, 2001, STUD NEOTROP FAUNA E, V36, P159, DOI 10.1076/snfe.36.2.159.2137; BOGAN AE, 1993, AM ZOOL, V33, P599; Bogan AE, 2008, J N AM BENTHOL SOC, V27, P349, DOI 10.1899/07-069.1; Bogan Arthur E., 2006, P373; Bonetto A., 1967, BIOCIENCIAS, V5, P113; Bonetto A., 1961, NOTES SOBRE GENEROS, P1; Bonetto A. A., 1961, Physis, V22, P259; BONETTO A. A., 1962, REV MUS ARGENTINO CIENC NAT BERNARDINO RIVADAVIA INST NAC INVEST CIENC NAT CIENC ZOOL, V8, P173; Bonetto A.A., 1973, Revista Asoc Cienc nat Litoral, V4, P177; BONETTO A.A., 1965, PHYSIS, V25, P187; Bonetto AA, 1994, AUSTRAL RIVERS S AM, P425; Castellanos Z.A., 1990, FAUNA AGUA DULCE REP, V16, P7; Castellanos ZA., 1965, REV MUSEO PLATA ZOOL, V8, P99; Castellanos ZA, 1960, PUBLICACION MISCELAN, V421; Clavijo C, 2013, ESPECIES PRIORITARIA, p[73, 73]; Clavijo Cristhian, 2017, Tentacle, V25, P14; Cowie RH, 2017, NAUTILUS, V131, P3; DARRIGRAN G, 1995, VELIGER, V38, P171; Darrigran G., 1999, MALACOLOGICAL REV S, V8, P1; Darrigran G, 2011, ZOOL SCI, V28, P1, DOI 10.2108/zsj.28.1; dos Santos Sonia Barbosa, 2015, Tentacle, V23, P26; Ehrlen J, 2015, ECOL LETT, V18, P303, DOI 10.1111/ele.12410; Fernandez MLA, 2012, MOLUSCOS LIMNICOS IN, P129; Giraut M, 2000, 10 C NAC CART 7 SEM; Graf DL, 2007, J MOLLUS STUD, V73, P291, DOI 10.1093/mollus/eym029; Graf DL, 2006, ZOOL J LINN SOC-LOND, V148, P343, DOI 10.1111/j.1096-3642.2006.00259.x; Graf DL, 2013, AM MALACOL BULL, V31, P135, DOI 10.4003/006.031.0106; Gregoric DEG, 2016, PEERJ, V4, DOI 10.7717/peerj.2138; Haag WR, 2012, NORTH AMERICAN FRESHWATER MUSSELS: NATURAL HISTORY, ECOLOGY, AND CONSERVATION, P1, DOI 10.1017/CBO9781139048217; Instituto Chico Mendes para a Conservacao da Biodiversidade, 2016, SUM EX FAUN BRAS AM; Instituto Geografico Militar, 2009, AD NUEV MARC REF GEO; Ituarte C., 2009, MACROINVERTEBRADOS B, P567; Ituarte C.F., 1981, Neotropica (La Plata), V27, P79; IUCN, IUCN RED LIST THREAT; IUCN, 2012, GUID APPL IUCN RED L; Klunzinger M. W., 2013, Records of the Western Australian Museum, V28, P1; Letelier S, 2006, AMICI MOLLUSCANUM, V14, P13; Machado ABM, 2008, LIVRO VERMELHO FAUNA; Mansur MCD, 1999, MALACOLOGIA, V41, P475; Miyahira IC, 2017, BIOTA NEOTROP, V17, DOI [10.1590/1676-0611-BN-2017-0341, 10.1590/1676-0611-bn-2017-0341]; Nunez V, 2010, MALACOLOGIA, V53, P47, DOI 10.4002/040.053.0103; Parada Esperanza, 2007, Gayana (Concepc.), V71, P212; Parmalee P., 1998, FRESHWATER MUSSELS T; PARODIZ J. J., 1963, MALACOLOGIA, V1, P179; PARODIZ J J, 1973, Malacologia, V14, P247; Parodiz J.J., 1974, Bulletin Am malac Union, V39, P18; Pereira D, 2014, HYDROBIOLOGIA, V735, P15, DOI 10.1007/s10750-013-1639-x; Pereyra PJ, 2012, AN ACAD BRAS CIENC, V84, P1065, DOI 10.1590/S0001-37652012005000059; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Rocchetta I, 2014, MAR POLLUT BULL, V79, P211, DOI 10.1016/j.marpolbul.2013.12.011; Rumi A, 2008, REV BIOL TROP, V56, P77; Rumi A, 2006, MALACOLOGIA, V49, P189, DOI 10.4002/1543-8120-49.1.189; Santos-Neto GD, 2016, MOL PHYLOGENET EVOL, V100, P148, DOI 10.1016/j.ympev.2016.04.013; SsRH (Subsecretaria de Recursos Hidricos de la Nacion), 2011, ATL DIG CUENC REG HI; Strayer DL, 2004, BIOSCIENCE, V54, P429, DOI 10.1641/0006-3568(2004)054[0429:CPOPMN]2.0.CO;2; Suski CD, 2007, BIODIVERS CONSERV, V16, P2015, DOI 10.1007/s10531-006-9060-7; Torres S, 2013, AUGMDOMUS, V5, P90; Wieczorek J, 2004, INT J GEOGR INF SCI, V18, P745, DOI 10.1080/13658810412331280211; WONG C. M., 2007, WORLDS TOP 10 RIVERS, P14; Yusseppone MS, 2016, MAR FRESHWATER RES, V67, P1938, DOI 10.1071/MF15158	60	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203616	10.1371/journal.pone.0203616	http://dx.doi.org/10.1371/journal.pone.0203616			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204778	Green Published, gold, Green Submitted			2022-12-26	WOS:000444355500032
J	Westerman, TL; Bogomolnaya, L; Andrews-Polymenis, HL; Sheats, MK; Elfenbein, JR				Westerman, Trina L.; Bogomolnaya, Lydia; Andrews-Polymenis, Helene L.; Sheats, M. Katherine; Elfenbein, Johanna R.			The Salmonella type-3 secretion system-1 and flagellar motility influence the neutrophil respiratory burst	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PATHOGENICITY ISLAND 1; TUMOR-NECROSIS-FACTOR; PROINFLAMMATORY CYTOKINES; EPITHELIAL-CELLS; OXIDATIVE BURST; ROS PRODUCTION; COMPLEMENT; INVASION; INTERLEUKIN-8	Neutrophils are innate immune response cells designed to kill invading microorganisms. One of the mechanisms neutrophils use to kill bacteria is generation of damaging reactive oxygen species (ROS) via the respiratory burst. However, during enteric salmonellosis, neutrophil-derived ROS actually facilitates Salmonella expansion and survival in the gut. This seeming paradox led us to hypothesize that Salmonella may possess mechanisms to influence the neutrophil respiratory burst. In this work, we used an in vitro Salmonella-neutrophil co-culture model to examine the impact of enteric infection relevant virulence factors on the respiratory burst of human neutrophils. We report that neutrophils primed with granulocyte-macrophage colony stimulating factor and suspended in serum containing complement produce a robust respiratory burst when stimulated with viable STm. The magnitude of the respiratory burst increases when STm are grown under conditions to induce the expression of the type-3 secretion system-1. STm mutants lacking the type-3 secretion system-1 induce less neutrophil ROS than the virulent WT. In addition, we demonstrate that flagellar motility is a significant agonist of the neutrophil respiratory burst. Together our data demonstrate that both the type-3 secretion system-1 and flagellar motility, which are established virulence factors in enteric salmonellosis, also appear to directly influence the magnitude of the neutrophil respiratory burst in response to STm in vitro.	[Westerman, Trina L.; Sheats, M. Katherine; Elfenbein, Johanna R.] North Carolina State Univ, Dept Clin Sci, Coll Vet Med, Raleigh, NC 27695 USA; [Bogomolnaya, Lydia; Andrews-Polymenis, Helene L.] Texas A&M Univ, Dept Microbial Pathogenesis & Immunol, Coll Med, Bryan, TX USA; [Bogomolnaya, Lydia] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia	University of North Carolina; North Carolina State University; Texas A&M University System; Texas A&M University College Station; Kazan Federal University	Sheats, MK; Elfenbein, JR (corresponding author), North Carolina State Univ, Dept Clin Sci, Coll Vet Med, Raleigh, NC 27695 USA.	mkpeed@ncsu.edu; jrelfenb@ncsu.edu	Sheats, M. Katie/AAF-8663-2020; Elfenbein, Johanna R./V-7895-2019	Sheats, M. Katie/0000-0002-5270-4566; Elfenbein, Johanna R./0000-0002-4764-0713	North Carolina State University College of Veterinary Medicine Intramural Grant; Office of the Director NIH grant [5T32OD011130]; NCSU CVM; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD015136, T32OD011130] Funding Source: NIH RePORTER	North Carolina State University College of Veterinary Medicine Intramural Grant; Office of the Director NIH grant; NCSU CVM; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a North Carolina State University College of Veterinary Medicine Intramural Grant. TLW was supported by Office of the Director NIH grant 5T32OD011130. MKS was supported by start-up funds from the NCSU CVM. JRE was supported by start-up funds from the NCSU CVM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouri S, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0033; Barbuti G, 2010, FEMS IMMUNOL MED MIC, V60, P57, DOI 10.1111/j.1574-695X.2010.00716.x; Bedouhene S, 2017, AM J BLOOD RES, V7, P41; BEHLAU I, 1993, J BACTERIOL, V175, P4475, DOI 10.1128/JB.175.14.4475-4484.1993; Bogomolnaya LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111513; BOYD JF, 1985, GUT, V26, P935, DOI 10.1136/gut.26.9.935; BULLAS LR, 1983, J BACTERIOL, V156, P471, DOI 10.1128/JB.156.1.471-474.1983; Bustamante VH, 2008, P NATL ACAD SCI USA, V105, P14591, DOI 10.1073/pnas.0801205105; COLOTTA F, 1992, BLOOD, V80, P2012; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Dang PMC, 1999, J BIOL CHEM, V274, P20704, DOI 10.1074/jbc.274.29.20704; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Demirdjian S, 2018, INFECT IMMUNITY; Diaz-Ochoa VE, 2016, CELL HOST MICROBE, V19, P814, DOI 10.1016/j.chom.2016.05.005; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Dupre-Crochet S, 2013, J LEUKOCYTE BIOL, V94, P657, DOI 10.1189/jlb.1012544; El-Benna J, 2016, IMMUNOL REV, V273, P180, DOI 10.1111/imr.12447; ELBIM C, 1994, INFECT IMMUN, V62, P2195, DOI 10.1128/IAI.62.6.2195-2201.1994; Faber F, 2016, NATURE, V534, P697, DOI 10.1038/nature18597; Floyd M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005987; Geddes K, 2007, PLOS PATHOG, V3, P2017, DOI 10.1371/journal.ppat.0030196; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gondwe EN, 2010, P NATL ACAD SCI USA, V107, P3070, DOI 10.1073/pnas.0910497107; Green SP, 1996, J BIOL CHEM, V271, P25400, DOI 10.1074/jbc.271.41.25400; GRESHAM HD, 1986, J IMMUNOL, V137, P868; Horstmann JA, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12739; Ibarra JA, 2010, MICROBIOL-SGM, V156, P1120, DOI 10.1099/mic.0.032896-0; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; KHWAJA A, 1992, BLOOD, V79, P745; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Klein JR, 2000, INFECT IMMUN, V68, P3368, DOI 10.1128/IAI.68.6.3368-3376.2000; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Laughlin RC, 2014, MBIO, V5, DOI 10.1128/mBio.00946-13; Lee CA, 2000, P NATL ACAD SCI USA, V97, P12283, DOI 10.1073/pnas.97.22.12283; Loetscher Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034812; Lovewell RR, 2014, AM J PHYSIOL-LUNG C, V306, pL698, DOI 10.1152/ajplung.00319.2013; Maghzal GJ, 2012, FREE RADICAL BIO MED, V53, P1903, DOI 10.1016/j.freeradbiomed.2012.09.002; Martin EM, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00159; Miller JH, 1972, EXPT MOL GENETICS, Vxvi; Mishra M, 2015, INFECT IMMUN, V83, P3006, DOI 10.1128/IAI.00081-15; Mishra M, 2012, CELL MICROBIOL, V14, P95, DOI 10.1111/j.1462-5822.2011.01704.x; Muramoto K, 1998, MOL MICROBIOL, V29, P1191, DOI 10.1046/j.1365-2958.1998.00998.x; Nguyen GT, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00373; Raffatellu M, 2005, INFECT IMMUN, V73, P146, DOI 10.1128/IAI.73.1.146-154.2005; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; Schraidt O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000824; Schurmann N, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.268; Sheats MK, 2014, VET IMMUNOL IMMUNOP, V160, P167, DOI 10.1016/j.vetimm.2014.04.009; Singer HM, 2014, J BACTERIOL, V196, P1448, DOI 10.1128/JB.01438-13; Spinner JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009279; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Stecher B, 2008, CELL MICROBIOL, V10, P1166, DOI 10.1111/j.1462-5822.2008.01118.x; STERNBERG NL, 1991, METHOD ENZYMOL, V204, P18; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; van Bruggen R, 2007, INFECT IMMUN, V75, P2655, DOI 10.1128/IAI.01111-06; van der Heijden J, 2015, P NATL ACAD SCI USA, V112, P560, DOI 10.1073/pnas.1414569112; Vareechon C, 2017, CELL HOST MICROBE, V21, P611, DOI 10.1016/j.chom.2017.04.001; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Volf J, 2007, ZOONOSES PUBLIC HLTH, V54, P286, DOI 10.1111/j.1863-2378.2007.01064.x; VOWELLS SJ, 1995, J IMMUNOL METHODS, V178, P89, DOI 10.1016/0022-1759(94)00247-T; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Watson RWG, 1996, J IMMUNOL, V156, P3986; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Winter SE, 2009, INFECT IMMUN, V77, P1904, DOI 10.1128/IAI.01341-08; Yamazaki Tsuyoshi, 2011, Trop Med Health, V39, P41, DOI 10.2149/tmh.2011-08; YUO A, 1991, BLOOD, V78, P2708; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002	68	5	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203698	10.1371/journal.pone.0203698	http://dx.doi.org/10.1371/journal.pone.0203698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204776	Green Submitted, gold, Green Published			2022-12-26	WOS:000444355500039
J	Burton, LJ; Hawsawi, O; Loyd, Q; Henderson, V; Howard, S; Harlemon, M; Ragin, C; Roberts, R; Bowen, N; Gacii, A; Odero-Marah, V				Burton, Liza J.; Hawsawi, Ohuod; Loyd, Quentin; Henderson, Veronica; Howard, Simone; Harlemon, Maxine; Ragin, Camille; Roberts, Robin; Bowen, Nathan; Gacii, Andrew; Odero-Marah, Valerie			Association of Epithelial Mesenchymal Transition with prostate and breast health disparities	PLOS ONE			English	Article							NUCLEAR CATHEPSIN-L; CANCER-CELLS; E-CADHERIN; CYSTEINE CATHEPSINS; SIGNALING PATHWAY; AFRICAN-AMERICAN; EXPRESSION; SNAIL; LOCALIZATION; KAISO	African Americans (AA) have higher death rates due to prostate and breast cancer as compared to Caucasian Americans (CA), and few biomarkers have been associated with this disparity. In our study we investigated whether epithelial-mesenchymal transition (EMT) with a focus on Snail and Cathepsin L (Cat L), could potentially be two markers associated with prostate and breast health disparities. We have previously shown that Snail can increase Cat L protein and activity in prostate and breast cancer. Western blot and real-time PCR analyses showed that mesenchymal protein expression (Snail, vimentin, Cat L) and Cat L activity (shown by zymography) was higher in AA prostate cancer cells as compared to CA normal transformed RWPE-1 prostate epithelial cells, and androgen-dependent cells, and comparable to metastatic CA cell lines. With respect to breast cancer, mesenchymal markers were higher in TNBC compared to non-TNBC cells. The higher mesenchymal marker expression was functionally associated with higher proliferative and migratory rates. Immunohistochemistry showed that both nuclear Snail and Cat L expression was significantly higher in cancer compared to normal for CA and Bahamas prostate patient tissue. Interestingly, AA normal tissue stained higher for nuclear Snail and Cat L that was not significantly different to cancer tissue for both prostate and breast tissue, but was significantly higher than CA normal tissue. AA TNBC tissue also displayed significantly higher nuclear Snail expression compared to CA TNBC, while no significant differences were observed with Luminal A cancer tissue. Therefore, increased EMT in AA compared to CA that may contribute to the more aggressive disease.	[Burton, Liza J.; Hawsawi, Ohuod; Loyd, Quentin; Henderson, Veronica; Howard, Simone; Harlemon, Maxine; Bowen, Nathan; Odero-Marah, Valerie] Clark Atlanta Univ, Dept Biol Sci, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA; [Harlemon, Maxine; Ragin, Camille; Roberts, Robin; Gacii, Andrew; Odero-Marah, Valerie] African Caribbean Canc Consortium, Philadelphia, PA USA; [Ragin, Camille] Temple Hlth, Fox Chase Canc Ctr, Philadelphia, PA USA; [Roberts, Robin] Univ West Indies, Sch Clin Med & Res, Nassau, Bahamas; [Gacii, Andrew] Kenyatta Natl Hosp, Dept Lab Med, Nairobi, Kenya	Clark Atlanta University; Fox Chase Cancer Center; University West Indies Mona Jamaica; University of the West Indies Open Campus; Kenyatta National Hospital	Odero-Marah, V (corresponding author), Clark Atlanta Univ, Dept Biol Sci, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA.; Odero-Marah, V (corresponding author), African Caribbean Canc Consortium, Philadelphia, PA USA.	vodero_marah@cau.edu	Bowen, Nathan J./M-3202-2019	Bowen, Nathan J./0000-0002-1609-6698	National Institutes of Health [8 G12 MD007590, 2 P20 MD002285];  [5F31CA200362-02]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	This work was supported by National Institutes of Health grant 8 G12 MD007590, and 2 P20 MD002285 (to V.O.M), and 5F31CA200362-02 (to L.J.B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI [10.1152/ajplung.00163.2007, DOI 10.1152/AJPLUNG.00163.2007]; Bassey-Archibong BI, 2017, CANCER CAUSE CONTROL, V28, P1295, DOI 10.1007/s10552-017-0955-2; Brix K, 2008, BIOCHIMIE, V90, P194, DOI 10.1016/j.biochi.2007.07.024; Burton LJ, 2015, CARCINOGENESIS, V36, P1019, DOI 10.1093/carcin/bgv084; Burton LJ, 2016, MOL CELLULAR BIOL; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; CHAUHAN SS, 1991, CANCER RES, V51, P1478; Chen JQ, 2009, BBA-REV CANCER, V1796, P162, DOI 10.1016/j.bbcan.2009.06.003; DeSantis CE, 2016, CA CANC J CLIN, V2016; Elliott B, 2018, CARCINOGENESIS, V39, P546, DOI 10.1093/carcin/bgy020; Etzioni R, 2002, J NATL CANCER I, V94, P981; Fendrich V, 2009, EUR J ENDOCRINOL, V160, P695, DOI 10.1530/EJE-08-0662; Garg Minal, 2013, World J Stem Cells, V5, P188, DOI 10.4252/wjsc.v5.i4.188; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Grotsky DA, 2013, J CELL BIOL, V200, P187, DOI 10.1083/jcb.201204053; Herszenyi L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-194; Jones J, 2014, CLIN EXP METASTAS, V31, P497, DOI 10.1007/s10585-014-9644-7; Jones J, 2012, AM J PATHOL, V181, P1836, DOI 10.1016/j.ajpath.2012.08.008; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Ko H, 2007, CELLS TISSUES ORGANS, V185, P66, DOI 10.1159/000101305; Mikami S, 2016, PATHOL INT, V66, P481, DOI 10.1111/pin.12433; NickKholgh B, 2016, PROSTATE, V76, P245, DOI 10.1002/pros.23116; Razzaghi H, 2016, MMWR-MORBID MORTAL W, V65, P1395, DOI 10.15585/mmwr.mm6549a3; Rose AE SJ, 2010, J TRANSL MED, V8, DOI [10.1186/1479-5876-8-8, DOI 10.1186/1479-5876-8-8]; Rosivatz E, 2006, VIRCHOWS ARCH, V448, P277, DOI 10.1007/s00428-005-0118-9; Shuch B, 2004, J CLIN ONCOL, V22, P4725, DOI 10.1200/JCO.2004.06.134; Smith BN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104987; Smith BN, 2012, CELL ADHES MIGR, V6, P433, DOI 10.4161/cam.21687; Sudhan D, 2015, ROLE CATHEPSIN L BRE; Sudhan DR, 2016, INT J CANC; Sullivan S, 2009, INT J CANCER, V125, P54, DOI 10.1002/ijc.24275; Tamhane T, 2015, BIOCHIMIE; Tedelind S, 2010, BIOL CHEM, V391, P923, DOI 10.1515/BC.2010.109; Timofeeva OA, 2009, INT J ONCOL, V35, P751, DOI 10.3892/ijo_00000388; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Vermeulen JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037864; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Wang Yifan, 2013, Cancer Hallm, V1, P38; Wilder C, 2011, ARCH BIOCHEM BIOPHYS, V516, P187; Wu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078259; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5	43	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2018	13	9							e0203855	10.1371/journal.pone.0203855	http://dx.doi.org/10.1371/journal.pone.0203855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7DK	30199553	gold, Green Published, Green Submitted			2022-12-26	WOS:000444681100024
J	Arthur, S; Singh, S; Sundaram, U				Arthur, Subha; Singh, Soudamani; Sundaram, Uma			Cyclooxygenase pathway mediates the inhibition of Na-glutamine co-transporter B0AT1 in rabbit villus cells during chronic intestinal inflammation	PLOS ONE			English	Article							TRANSPORT; PROSTAGLANDINS; EXPRESSION; IDENTIFICATION	In the mammalian intestine, glutamine assimilation by the absorptive villus cells is mediated by Na-glutamine co-transport, specifically by B0AT1. In a rabbit model of chronic intestinal inflammation, B0AT1 is inhibited secondary to a decrease in the number of co-transporters in the brush border membrane (BBM). This inhibition can be reversed by treatment with a broad-spectrum immune modulator such as glucocorticoid suggesting that immune inflammatory mediators may regulate B0AT1 during chronic intestinal inflammation. Arachidonic acid (AA) metabolites (AAM) are increased during chronic intestinal inflammation. However, whether AAM may regulate B0AT1 during chronic intestinal inflammation is unknown. Treatment of rabbits with ATK, to prevent the release of AAM reversed the inhibition of B0AT1. AAM are products of cyclooxygenase (COX) and/or lipoxygenase (LOX) pathways. Inhibition of COX with piroxicam, therefore reduction of prostaglandin formation in the chronically inflamed intestine, reversed the inhibition of B0AT1 to its normal levels. In contrast, inhibition of LOX with MK886, thus reduction of leukotriene formation during chronic enteritis, did not affect the inhibition of B0AT1. Kinetic studies showed that the mechanism of restoration of B0AT1 by ATK or piroxicam was secondary to the restoration of BBM co-transporter numbers. Western Blot analysis also demonstrated restoration of BBM B0AT1 co-transporter numbers. In conclusion, this study demonstrates that Na-glutamine co-transport mediated by B0AT1 in villus cells is regulated by prostaglandins rather than leukotrienes in the chronically inflamed intestine.	[Arthur, Subha; Singh, Soudamani; Sundaram, Uma] Marshall Univ, Joan C Edwards Sch Med, Dept Clin & Translat Sci, Med Ctr Dr, Huntington, WV 25755 USA	Marshall University	Sundaram, U (corresponding author), Marshall Univ, Joan C Edwards Sch Med, Dept Clin & Translat Sci, Med Ctr Dr, Huntington, WV 25755 USA.	sundaramu@marshall.edu	Singh, Soudamani/R-6167-2016; Sundaram MD, Uma/GLU-4579-2022	Singh, Soudamani/0000-0001-6689-9942; Sundaram MD, Uma/0000-0002-9322-6740	National Institute of Diabetes and Digestive and Kidney Diseases [DK108054, DK067420]; National Institute of General Medical Sciences [1P20GM121299]; U. S. Department of Veterans Affairs [BX003443]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U. S. Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases, Award Number: DK108054 to US; National Institute of Diabetes and Digestive and Kidney Diseases, Award Number: DK067420 to US; National Institute of General Medical Sciences, Award Number: 1P20GM121299 to US and the U. S. Department of Veterans Affairs, Award Number: BX003443 to US. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur S, 2012, INFLAMM BOWEL DIS, V18, P2149, DOI 10.1002/ibd.22924; BASKERVILLE A, 1980, BRIT J EXP PATHOL, V61, P132; Bode BP, 2001, J NUTR, V131, p2475S, DOI 10.1093/jn/131.9.2475S; Boelens PG, 2002, J NUTR, V132, P2580, DOI 10.1093/jn/132.9.2580; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Costa C, 2000, BBA-BIOMEMBRANES, V1509, P95, DOI 10.1016/S0005-2736(00)00281-9; Curi R, 2005, J CELL PHYSIOL, V204, P392, DOI 10.1002/jcp.20339; Curi R, 2007, FRONT BIOSCI-LANDMRK, V12, P344, DOI 10.2741/2068; FORBUSH B, 1983, ANAL BIOCHEM, V128, P159, DOI 10.1016/0003-2697(83)90356-1; Gaurav K, 2012, INDIAN J MED PAEDIAT, V33, P13, DOI 10.4103/0971-5851.96962; GHISHAN FK, 1990, AM J CLIN NUTR, V51, P612, DOI 10.1093/ajcn/51.4.612; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P3824, DOI 10.1073/pnas.71.10.3824; Hendel J, 1997, AM J GASTROENTEROL, V92, P1170; KLIMBERG VS, 1990, ARCH SURG-CHICAGO, V125, P1040, DOI 10.1001/archsurg.1990.01410200104017; Labow BI, 2000, WORLD J SURG, V24, P1503, DOI 10.1007/s002680010269; McCartney SA, 1999, ALIMENT PHARM THERAP, V13, P1115; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; RAMPTON DS, 1984, GUT, V25, P1399, DOI 10.1136/gut.25.12.1399; RENNIE MJ, 1994, J NUTR, V124, pS1503, DOI 10.1093/jn/124.suppl_8.1503S; ROBERT A, 1984, CLIN PHYSIOL BIOCH, V2, P61; ROBERT A, 1976, ADV PROSTAG THROMB R, V2, P507; Saha P, 2012, BBA-BIOMEMBRANES, V1818, P434, DOI 10.1016/j.bbamem.2011.11.005; SHARON P, 1978, GASTROENTEROLOGY, V75, P638; Singer II, 1998, GASTROENTEROLOGY, V115, P297, DOI 10.1016/S0016-5085(98)70196-9; SOUBA WW, 1990, JPEN-PARENTER ENTER, V14, pS45, DOI 10.1177/014860719001400403; SOUBA WW, 1985, JPEN-PARENTER ENTER, V9, P18, DOI 10.1177/014860718500900118; Sozen S, 2012, ANN ITAL CHIR, V83, P143; Sundaram U, 1997, AM J PHYSIOL-GASTR L, V272, pG732, DOI 10.1152/ajpgi.1997.272.4.G732; Sundaram U, 1997, AM J PHYSIOL-GASTR L, V273, pG913, DOI 10.1152/ajpgi.1997.273.4.G913; Talukder JR, 2008, AM J PHYSIOL-GASTR L, V295, pG7, DOI 10.1152/ajpgi.00606.2007; Talukder JR, 2008, AM J PHYSIOL-GASTR L, V294, pG1301, DOI 10.1152/ajpgi.00578.2007; Ziegler T R, 2000, Curr Opin Clin Nutr Metab Care, V3, P355, DOI 10.1097/00075197-200009000-00005; ZIEGLER TR, 1990, JPEN-PARENTER ENTER, V14, pS137, DOI 10.1177/0148607190014004201	33	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203552	10.1371/journal.pone.0203552	http://dx.doi.org/10.1371/journal.pone.0203552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192835	Green Submitted, Green Published, gold			2022-12-26	WOS:000444093600100
J	Kim, SA; Smith, S; Beauchamp, C; Song, Y; Chiang, M; Giuseppetti, A; Frukhtbeyn, S; Shaffer, I; Wilhide, J; Routkevitch, D; Ondov, JM; Kim, JJ				Kim, Shin Ae; Smith, Samuel; Beauchamp, Carlos; Song, Yang; Chiang, Martin; Giuseppetti, Anthony; Frukhtbeyn, Stanislav; Shaffer, Ian; Wilhide, Joshua; Routkevitch, Denis; Ondov, John M.; Kim, Jeffrey J.			Cariogenic potential of sweet flavors in electronic-cigarette liquids	PLOS ONE			English	Article							HIGH-SCHOOL-STUDENTS; NICOTINE DELIVERY-SYSTEMS; TOBACCO PRODUCT USE; STREPTOCOCCUS-MUTANS; DENTAL-CARIES; UNITED-STATES; BIOFILM FORMATION; SURFACE; MIDDLE; PROTEINS	Background Most electronic-cigarette liquids contain propylene glycol, glycerin, nicotine and a wide variety of flavors of which many are sweet. Sweet flavors are classified as saccharides, esters, acids or aldehydes. This study investigates changes in cariogenic potential when tooth surfaces are exposed to e-cigarette aerosols generated from well-characterized reference eliquids with sweet flavors. Methods Reference e-liquids were prepared by combining 20/80 propylene glycol/glycerin (by volume fraction), 10 mg/mL nicotine, and flavors. Aerosols were generated by a Universal Electronic- Cigarette Testing Device (49.2 W, 0.2 Omega). Streptococcus mutans (UA159) were exposed to aerosols on tooth enamel and the biological and physiochemical parameters were measured. Results E-cigarette aerosols produced four-fold increase in microbial adhesion to enamel. Exposure to flavored aerosols led to two-fold increase in biofilm formation and up to a 27% decrease in enamel hardness compared to unflavored controls. Esters (ethyl butyrate, hexyl acetate, and triacetin) in e-liquids were associated with consistent bacteria-initiated enamel demineralization, whereas sugar alcohol (ethyl maltol) inhibited S. mutans growth and adhesion. The viscosity of the e-liquid allowed S. mutans to adhere to pits and fissures. Aerosols contained five metals (mean +/- standard deviation): calcium (0.409 +/- 0.002) mg/L, copper (0.011 +/- 0.001) mg/L, iron (0.0051 +/- 0.0003) mg/L, magnesium (0.017 +/- 0.002) mg/L, and silicon (0.166 +/- 0.005) mg/L. Conclusions This study systematically evaluated e-cigarette aerosols and found that the aerosols have similar physio-chemical properties as high-sucrose, gelatinous candies and acidic drinks. Our data suggest that the combination of the viscosity of e-liquids and some classes of chemicals in sweet flavors may increase the risk of cariogenic potential. Clinical investigation is warranted to confirm the data shown here.	[Kim, Shin Ae; Giuseppetti, Anthony; Frukhtbeyn, Stanislav; Kim, Jeffrey J.] Amer Dent Assoc Fdn, Volpe Res Ctr, Gaithersburg, MD 20899 USA; [Smith, Samuel] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Beauchamp, Carlos; Song, Yang; Chiang, Martin] NIST, US Dept Commerce, Gaithersburg, MD 20899 USA; [Shaffer, Ian; Wilhide, Joshua] Univ Maryland Baltimore Cty, Mol Characterizat & Anal Complex, Baltimore, MD 21228 USA; [Routkevitch, Denis] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Ondov, John M.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Song, Yang] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90024 USA	University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland Baltimore County; Johns Hopkins University; University System of Maryland; University of Maryland College Park; University of California System; University of California Los Angeles	Kim, JJ (corresponding author), Amer Dent Assoc Fdn, Volpe Res Ctr, Gaithersburg, MD 20899 USA.	jeffrey.kim@nist.gov		Routkevitch, Denis/0000-0002-7144-6347; Kim, Shinae/0000-0002-6729-8097	ADA Foundation [CR97200019]	ADA Foundation	This work was supported by the ADA Foundation, CR97200019 (JJK).	Allison DG, 2003, BIOFOULING, V19, P139, DOI [10.1080/0892701031000072190, 10.1038/nrmicro2415]; Ambrose BK, 2015, JAMA-J AM MED ASSOC, V314, P1871, DOI 10.1001/jama.2015.13802; Anderson CA, 2009, OBES REV, V10, P41, DOI 10.1111/j.1467-789X.2008.00564.x; ARANHA H, 1982, INFECT IMMUN, V35, P456, DOI 10.1128/IAI.35.2.456-460.1982; Banas JA, 2003, CRIT REV ORAL BIOL M, V14, P89, DOI 10.1177/154411130301400203; Behar RZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117222; Berg Joel H, 2006, BMC Oral Health, V6 Suppl 1, pS6, DOI 10.1186/1472-6831-6-S1-S6; Berlutti F, 2004, BIOMETALS, V17, P271; Bourbia M, 2013, J DENT RES, V92, P989, DOI 10.1177/0022034513504436; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Cameron JM, 2014, TOB CONTROL, V23, P77, DOI 10.1136/tobaccocontrol-2012-050604; Cheah NP, 2014, TOB CONTROL, V23, P119, DOI 10.1136/tobaccocontrol-2012-050483; Cobb NK, 2010, AM J PUBLIC HEALTH, V100, P2340, DOI 10.2105/AJPH.2010.199281; CRAIG R. G., 1959, JOUR DENTAL RES, V38, P624, DOI 10.1177/00220345590380032701; Diaz-Garrido Natalia, 2016, Eur J Dent, V10, P345, DOI 10.4103/1305-7456.184163; Ervin R Bethene, 2012, NCHS Data Brief, P1; Etter JF, 2016, DRUG ALCOHOL DEPEN, V160, P218, DOI 10.1016/j.drugalcdep.2016.01.003; Etter JF, 2013, ADDICTION, V108, P1671, DOI 10.1111/add.12235; Featherstone J D B, 2004, J Dent Res, V83 Spec No C, pC39; Featherstone JDB, 2000, J AM DENT ASSOC, V131, P887, DOI 10.14219/jada.archive.2000.0307; Food and Drug Administration HHS, 2016, Fed Regist, V81, P28973; FROSTELL G, 1967, J NUTR, V93, P65, DOI 10.1093/jn/93.1.65; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Garcia SS, 2016, MOL ORAL MICROBIOL, V31, P515, DOI 10.1111/omi.12150; Goniewicz ML, 2013, NICOTINE TOB RES, V15, P158, DOI 10.1093/ntr/nts103; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; GUGGENHEIM B, 1970, INT DENT J, V20, P657; Hadwiger ME, 2010, J CHROMATOGR A, V1217, P7547, DOI 10.1016/j.chroma.2010.10.018; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Hayacibara MF, 2004, CARBOHYD RES, V339, P2127, DOI 10.1016/j.carres.2004.05.031; Huilgol P, 2019, J PUBLIC HEALTH-UK, V41, P354, DOI 10.1093/pubmed/fdy082; Hutzler C, 2014, ARCH TOXICOL, V88, P1295, DOI 10.1007/s00204-014-1294-7; Jamal A, 2017, MMWR-MORBID MORTAL W, V66, P597, DOI 10.15585/mmwr.mm6623a1; KEYES PH, 1954, J DENT RES, V33, P830, DOI 10.1177/00220345540330061101; Kilian M, 2016, BRIT DENT J, V221, P657, DOI 10.1038/sj.bdj.2016.865; Kim JJ, 2017, TOB INDUC DIS, V15, DOI 10.1186/s12971-017-0119-x; Kim JN, 2015, APPL ENVIRON MICROB, V81, P5015, DOI 10.1128/AEM.01160-15; Kowitt SD, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040338; Krusemann EJZ, 2019, NICOTINE TOB RES, V21, P1310, DOI 10.1093/ntr/nty101; Leitao TJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191284; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; Leung V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01176; Li QD, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3326-0; Lindblom EN, 2015, FOOD DRUG LAW J, V70, P55; Lippert F, 2014, ARCH ORAL BIOL, V59, P704, DOI 10.1016/j.archoralbio.2014.04.005; Liu SQ, 1998, INT DAIRY J, V8, P651, DOI 10.1016/S0958-6946(98)00100-9; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Matsumoto-Nakano M, 2018, JPN DENT SCI REV, V54, P22, DOI 10.1016/j.jdsr.2017.08.002; Moynihan P, 2004, PUBLIC HEALTH NUTR, V7, P201, DOI 10.1079/PHN2003589; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; ORSTAVIK D, 1974, INFECT IMMUN, V9, P794; Passalacqua KD, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0027-2015; Pearson JL, 2012, AM J PUBLIC HEALTH, V102, P1758, DOI 10.2105/AJPH.2011.300526; Peres MA, 2016, J DENT RES, V95, P388, DOI 10.1177/0022034515625907; Perez DL, 2017, BIOFOULING, V33, P222, DOI 10.1080/08927014.2017.1286476; Pietroiusti A, 2016, TOXICOL APPL PHARM, V299, P90, DOI 10.1016/j.taap.2015.12.017; Pitts NB, 2017, NAT REV DIS PRIMERS, V3, P1, DOI 10.1038/nrdp.2017.30; Rosbrook K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185334; Rosenfeld CS, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00396; Rosinger Asher, 2017, NCHS Data Brief, P1; RUGGGUNN AJ, 1984, ARCH ORAL BIOL, V29, P983, DOI 10.1016/0003-9969(84)90145-6; Sasaki K, 2012, INT OR HLTH SCI 2011, Vxx; SCHILLING KM, 1992, INFECT IMMUN, V60, P284, DOI 10.1128/IAI.60.1.284-295.1992; Schneider S, 2016, NICOTINE TOB RES, V18, P647, DOI 10.1093/ntr/ntv193; Schved F, 1996, LETT APPL MICROBIOL, V22, P189, DOI 10.1111/j.1472-765X.1996.tb01139.x; Sheiham A, 2015, J DENT RES, V94, P1341, DOI 10.1177/0022034515590377; Singh T, 2016, MMWR-MORBID MORTAL W, V65, P1425, DOI 10.15585/mmwr.mm655051a2; Singh T, 2016, MMWR-MORBID MORTAL W, V65, P361, DOI 10.15585/mmwr.mm6514a1; Small DM, 2005, EXP BRAIN RES, V166, P345, DOI 10.1007/s00221-005-2376-9; Smith EG, 2012, J DENT RES, V91, P133, DOI 10.1177/0022034511415415; Soneji S, 2017, JAMA PEDIATR, V171, P788, DOI 10.1001/jamapediatrics.2017.1488; Soneji SS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193328; Soussy S, 2016, TOB CONTROL, V25, pii88, DOI 10.1136/tobaccocontrol-2016-053220; Spear F, 2008, J AM DENT ASSOC, V139, P1399, DOI 10.14219/jada.archive.2008.0052; Spindle TR, 2015, NICOTINE TOB RES, V17, P142, DOI 10.1093/ntr/ntu186; Sutherland IW, 1990, BIOTECHNOLOGY MICROB, Vviii; TATEVOSSIAN A, 1990, J DENT RES, V69, P1309, DOI 10.1177/00220345900690061801; Tierney PA, 2016, TOB CONTROL, V25, pE10, DOI 10.1136/tobaccocontrol-2014-052175; Trehy ML, 2011, J LIQ CHROMATOGR R T, V34, P1442, DOI 10.1080/10826076.2011.572213; Tuson HH, 2013, SOFT MATTER, V9, P4368, DOI 10.1039/c3sm27705d; Villanti AC, 2017, AM J PREV MED, V53, P139, DOI 10.1016/j.amepre.2017.01.026; WILSON RF, 1990, CARIES RES, V24, P203, DOI 10.1159/000261266; Zero D T, 1999, Dent Clin North Am, V43, P635; Zhou JY, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02412-16; Zhu SH, 2014, TOB CONTROL, V23, P3, DOI 10.1136/tobaccocontrol-2014-051670	85	34	35	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203717	10.1371/journal.pone.0203717	http://dx.doi.org/10.1371/journal.pone.0203717			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT0BU	30192874	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600137
J	Marebwa, BK; Adams, RJ; Magwood, GS; Kindy, M; Wilmskoetter, J; Wolf, M; Bonilha, L				Marebwa, Barbara K.; Adams, Robert J.; Magwood, Gayenell S.; Kindy, Mark; Wilmskoetter, Janina; Wolf, Myles; Bonilha, Leonardo			Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes	PLOS ONE			English	Article							FGF23; PHOSPHATE; RISK	Elevated levels of FGF23 in individuals with chronic kidney disease (CKD) are associated with adverse health outcomes, such as increased mortality, large vessel disease, and reduced white matter volume, cardiovascular and cerebrovascular events. Apart from the well-known link between cardiovascular (CV) risk factors, especially diabetes and hypertension, and cerebrovascular damage, elevated FGF23 is also postulated to be associated with cerebrovascular damage independently of CKD. Elevated FGF23 predisposes to vascular calcification and is associated with vascular stiffness and endothelial dysfunction in the general population with normal renal function. These factors may lead to microangiopathic changes in the brain, cumulative ischemia, and eventually to the loss of white matter fibers. The relationship between FGF23 and brain integrity in individuals without CKD has hitherto not been investigated. In this study, we aimed to determine the association between FGF23, and white matter integrity in a cohort of 50 participants with varying degrees of CV risk burden, using high resolution structural human brain connectomes constructed from MRI diffusion images. We observed that increased FGF23 was associated with axonal loss in the frontal lobe, leading to a fragmentation of white matter network organization. This study provides the first description of the relationship between elevated levels of FGF23, white matter integrity, and brain health. We suggest a synergistic interaction of CV risk factors and FGF23 as a potentially novel determinant of brain health.	[Marebwa, Barbara K.; Adams, Robert J.; Wilmskoetter, Janina; Bonilha, Leonardo] Med Univ South Carolina, Dept Neurol, Charleston, SC 29425 USA; [Magwood, Gayenell S.] Med Univ South Carolina, Dept Nursing, Charleston, SC 29425 USA; [Kindy, Mark] Univ S Florida, Dept Pharmaceut Sci, Tampa, FL USA; [Wolf, Myles] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	Medical University of South Carolina; Medical University of South Carolina; State University System of Florida; University of South Florida; Duke University	Bonilha, L (corresponding author), Med Univ South Carolina, Dept Neurol, Charleston, SC 29425 USA.	bonilha@musc.edu	Marebwa, Barbara/AAT-1175-2021; Adams, Robert/GPW-8528-2022; Wilmskoetter, Janina/AAF-9282-2020	Wilmskoetter, Janina/0000-0002-1083-7301; Magwood, Gayenell/0000-0002-2451-4888	American Heart Association [SFDRN26030003]; National Institutes of Health / National Institute on Deafness and Other Communication Disorders (NIDCD) [DC014021]	American Heart Association(American Heart Association); National Institutes of Health / National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by American Heart Association, http://www.heart.org/HEARTORG/, grant number SFDRN26030003; awarded to LB and National Institutes of Health / National Institute on Deafness and Other Communication Disorders (NIDCD): DC014021 awarded to LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Fukumoto Seiji, 2007, Rinsho Byori, V55, P555; Gutierrez OM, 2011, CLIN J AM SOC NEPHRO, V6, P2871, DOI 10.2215/CJN.02740311; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Joliot M, 2015, J NEUROSCI METH, V254, P46, DOI 10.1016/j.jneumeth.2015.07.013; Liu SG, 2007, J AM SOC NEPHROL, V18, P1637, DOI 10.1681/ASN.2007010068; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Quarles LD, 2012, EXP CELL RES, V318, P1040, DOI 10.1016/j.yexcr.2012.02.027; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Wright CB, 2016, STROKE, V47, P923, DOI 10.1161/STROKEAHA.115.012379; Wright CB, 2014, NEUROLOGY, V82, P1700, DOI 10.1212/WNL.0000000000000410	17	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203460	10.1371/journal.pone.0203460	http://dx.doi.org/10.1371/journal.pone.0203460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192823	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600079
J	Matsuda, T; Kozaki, T; Ishii, K; Gotoh, T				Matsuda, Tomoko; Kozaki, Toshinori; Ishii, Kazuo; Gotoh, Tetsuo			Phylogeny of the spider mite sub-family Tetranychinae (Acari: Tetranychidae) inferred from RNA-Seq data	PLOS ONE			English	Article							MITOCHONDRIAL COI SEQUENCES; MISSING DATA; GENERATION; LIFE; TOOL	Phylogenetic trees of spider mites were previously obtained using 18S and 28S rRNA genes. Because some of the bootstrap values were relatively low, these trees were unable to completely resolve the phylogeny. Here, we obtained RNA-Seq data for the 72 known species (73 strains) of spider mites to analyze the phylogeny of the sub-family Tetranychinae. The data were de novo assembled into a total alignment length of 790,047 bases corresponding to 264,133 amino acid residues in 652 genes. The sequence dataset was 200 times larger than the data used in the previous study. The new trees were much more robust and more clearly defined the clades of the tribes and the genera of the sub-family Tetranychinae. The tribe Tetranychini was polyphyletic because a monophyletic clade of Eurytetranychini was placed inside it. The six genera from which two or more species were sampled appeared to be monophyletic, but four genera (Schizotetranychus, Eotetranychus, Oligonychus and Tetranychus) appeared to be polyphyletic. These results strongly support the previous molecular inference of the polyphyletic tribes and genera, although the molecular phylogeny of the sub-family Tetranychinae does not fully agree with the current morphology- based taxonomy. The taxonomy of the sub-family Tetranychinae should be revised according to the molecular relationships revealed by this study.	[Matsuda, Tomoko; Kozaki, Toshinori; Gotoh, Tetsuo] Ibaraki Univ, Fac Agr, Ami, Ibaraki, Japan; [Kozaki, Toshinori; Ishii, Kazuo] Tokyo Univ Agr & Technol, Fac Agr, Fuchu, Tokyo, Japan; [Matsuda, Tomoko] Nihon BioData Corp, Kawasaki, Kanagawa, Japan; [Ishii, Kazuo] Kurume Univ, Biostat Ctr, Kurume, Fukuoka, Japan; [Gotoh, Tetsuo] Ryutsu Keizai Univ, Fac Econ, Ryugasaki, Ibaraki, Japan	Ibaraki University; Tokyo University of Agriculture & Technology; Kurume University	Gotoh, T (corresponding author), Ibaraki Univ, Fac Agr, Ami, Ibaraki, Japan.; Gotoh, T (corresponding author), Ryutsu Keizai Univ, Fac Econ, Ryugasaki, Ibaraki, Japan.	tetsuo.gotoh.acari@vc.ibaraki.ac.jp	Ishii, Kazuo/N-9946-2019	Matsuda, Tomoko/0000-0002-4709-4302; Ishii, Kazuo/0000-0002-8363-8266	Japan Society for the Promotion of Science KAKENHI [JP24792033, JP17H03775]; Nihon BioData Corporation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nihon BioData Corporation	This work was supported by: Tetsuo Gotoh, Japan Society for the Promotion of Science KAKENHI Grant Number JP24792033, http://www.jsps.go.jp/english/; Tetsuo Gotoh, Japan Society for the Promotion of Science KAKENHI Grant Number, JP17H03775, http://www.jsps.go.jp/english/. The funder (Japan Society for the Promotion of Science KAKENHI) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nihon BioData Corporation provided support in the form of salaries for Tomoko Matsuda, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bazinet AL, 2017, SYST ENTOMOL, V42, P305, DOI 10.1111/syen.12217; Ben-David T, 2007, EXP APPL ACAROL, V41, P169, DOI 10.1007/s10493-007-9058-1; Bolland HR, 1998, WORLD CATALOGUE OF T; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; EHARA S, 1987, ZOOL SCI, V4, P375; Ehara Shozo, 1996, Journal of the Acarological Society of Japan, V5, P17; Ehara Shozo, 1999, Species Diversity, V4, P63; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hedin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042888; Hittinger CT, 2010, P NATL ACAD SCI USA, V107, P1476, DOI 10.1073/pnas.0910449107; Hornett EA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-361; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kitashima Yasuki, 1995, Journal of the Acarological Society of Japan, V4, P91; Matsuda T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108672; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; Migeon A., 2006, SPIDER MITES WEB COM; Navajas M, 2003, P ROY SOC B-BIOL SCI, V270, pS124, DOI 10.1098/rsbl.2003.0034; Navajas M, 1996, INSECT MOL BIOL, V5, P281, DOI 10.1111/j.1365-2583.1996.tb00102.x; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Ros VID, 2007, EXP APPL ACAROL, V42, P239, DOI 10.1007/s10493-007-9092-z; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Subramanian AR, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-6; Toda S, 2000, EXP APPL ACAROL, V24, P821, DOI 10.1023/A:1006484018547; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	30	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203136	10.1371/journal.pone.0203136	http://dx.doi.org/10.1371/journal.pone.0203136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192794	gold, Green Published, Green Submitted			2022-12-26	WOS:000444093600047
J	Schulze, M; Schafer, J; Simmet, C; Jung, M; Gabler, C				Schulze, Martin; Schaefer, Jana; Simmet, Christian; Jung, Markus; Gabler, Christoph			Detection and characterization of Lactobacillus spp. in the porcine seminal plasma and their influence on boar semen quality	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; SPERM QUALITY; ARTIFICIAL-INSEMINATION; CLOSTRIDIUM-PERFRINGENS; PSEUDOMONAS-AERUGINOSA; LIQUID STORAGE; IN-VITRO; SPERMATOZOA; IMPACT; SWINE	The presence of pathogenic bacteria in ejaculates has been a topic in boar semen preservation over the last decades. Since little information is available on commensal bacteria in boar semen, the aim of the present study was to identify commensal lactobacilli in fresh cryopreserved boar semen and to examine their influence on boar semen quality. Therefore, 111 boar ejaculates were investigated for the presence of Lactobacillus species. Thirty samples (27%) contained viable Lactobacillus species (e.g. L. amylovorus, L. animalis, L. reuteri and Weisella minor). L. animalis and L. buchneri DSM 32407 (isolated from the bovine uterus) qualified for further examinations based on their growth rate in six antibiotic-free boar semen extenders. After a 120 min short-term incubation with an antibiotic-free BTS-extender, progressive motility was diminished (P = 0.001) upon addition of 10(5) and 10(6) colony forming units (CFU/mL) L. animalis. The supplementation with L. buchneri DSM 32407 had no significant (P > 0.05) influence on sperm quality during short-term co-incubation. After 168 h long-term co-incubation, motility analysis revealed a negative (P = 0.026) impact of 10(5) CFU/mL L. buchneri DSM 32407. A concentration-and storage-dependent effect is particularly obvious (P < 0.001) using 10(6) CFU/mL L. buchneri DSM 32407. Most notably, the thermo-resistance (TRT) for 10(6) CFU/mL L. buchneri DSM 32407 (P = 0.001) was inferior to BTS with and without gentamicin after 72 and 168 h of semen co-incubation. The supplementation of 10(5) CFU/mL L. buchneri DSM 32407 impaired progressive motility to a lesser extent. The percentage of mitochondrially active spermatozoa after 96 h (P = 0.009) and membrane-intact spermatozoa after 168 h (P < 0.001) was lower when 10(6) CFU/mL L. buchneri DSM 32407 were suspended compared with all other groups. Finally, the addition of L. buchneri DSM 32407 to BTS-extended boar semen had no competitive effect on the total amount of bacteria 48 h after co-incubation. In summary, the present study demonstrated that there are Lactobacillus species present in the porcine seminal plasma, which can be cultivated using standard procedures. However, long-term co-incubation of lactic acid bacteria with spermatozoa had a negative influence on spermatozoa.	[Schulze, Martin; Schaefer, Jana; Jung, Markus] Inst Reprod Farm Anim Schonow, Bernau, Germany; [Simmet, Christian] Minitub, Tiefenbach, Germany; [Gabler, Christoph] Free Univ Berlin, Dept Vet Med, Inst Vet Biochem, Berlin, Germany	Free University of Berlin	Schulze, M (corresponding author), Inst Reprod Farm Anim Schonow, Bernau, Germany.	m.schulze@ifn-schoenow.de	郑, 丽丽/HGE-2239-2022; Schulze, Martin/AAR-3244-2020; Jung, Markus/M-2477-2019	Jung, Markus/0000-0002-0599-4417; Schafer, Jana/0000-0003-0009-8549; Schulze, Martin/0000-0001-7932-9412	MinituEb	MinituEb	The funding company (MinituEb) provided financial support for the research materials (lab supply) for this study after presenting (MS and CG) the design of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of CS is stated in the 'author contributions' section. No additional external funding was received for this study.	Althouse GC, 2011, REPROD DOMEST ANIM, V46, P64, DOI 10.1111/j.1439-0531.2011.01863.x; Althouse GC, 2005, THERIOGENOLOGY, V63, P573, DOI 10.1016/j.theriogenology.2004.09.031; Althouse GC, 1998, THERIOGENOLOGY, V50, P535, DOI 10.1016/S0093-691X(98)00159-9; Althouse GC, 2000, THERIOGENOLOGY, V53, P1167, DOI 10.1016/S0093-691X(00)00261-2; Ametaj BN, 2014, RES VET SCI, V96, P365, DOI 10.1016/j.rvsc.2014.02.007; Aneas SB, 2008, THERIOGENOLOGY, V70, P1368, DOI 10.1016/j.theriogenology.2008.07.011; Aroutcheva A, 2001, AM J OBSTET GYNECOL, V185, P375, DOI 10.1067/mob.2001.115867; Barbonetti A, 2011, FERTIL STERIL, V95, P2485, DOI 10.1016/j.fertnstert.2011.03.066; Barone F, 2016, REPROD DOMEST ANIM, V51, P604, DOI 10.1111/rda.12699; Blajman J, 2015, RES VET SCI, V101, P50, DOI 10.1016/j.rvsc.2015.05.017; Borges S, 2014, ARCH GYNECOL OBSTET, V289, P479, DOI 10.1007/s00404-013-3064-9; Boris S, 2000, MICROBES INFECT, V2, P543, DOI 10.1016/S1286-4579(00)00313-0; Bussalleu E, 2011, ANIM REPROD SCI, V127, P176, DOI 10.1016/j.anireprosci.2011.07.018; Dziekonska A, 2017, POL J VET SCI, V20, P77, DOI 10.1515/pjvs-2017-0011; Elmi A, 2017, MOLECULES, V22, DOI 10.3390/molecules22122162; Fantinati P, 2009, ANIMAL, V3, P269, DOI 10.1017/S1751731108003443; Gartner MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119793; Homayouni A, 2014, J LOW GENIT TRACT DI, V18, P79, DOI 10.1097/LGT.0b013e31829156ec; Johnson LA, 2000, ANIM REPROD SCI, V62, P143, DOI 10.1016/S0378-4320(00)00157-3; Kummer V, 1997, VET MED-CZECH, V42, P217; Kuster CE, 2016, THERIOGENOLOGY, V85, P21, DOI 10.1016/j.theriogenology.2015.09.049; Li WI, 2005, EXP BIOL MED, V230, P494; Lievin-Le Moal V, 2014, CLIN MICROBIOL REV, V27, P167, DOI 10.1128/CMR.00080-13; Ubeda JL, 2013, THERIOGENOLOGY, V80, P565, DOI 10.1016/j.theriogenology.2013.05.022; Maes D, 2008, THERIOGENOLOGY, V70, P1337, DOI 10.1016/j.theriogenology.2008.06.018; Martin LOM, 2010, ANIM REPROD SCI, V120, P95, DOI 10.1016/j.anireprosci.2010.03.008; Martin R, 2009, J DAIRY RES, V76, P418, DOI 10.1017/S0022029909990124; Moreno I, 2016, AM J OBSTET GYNECOL, V215, P684, DOI 10.1016/j.ajog.2016.09.075; Morrell JM, 2011, ANIM REPROD SCI, V123, P64, DOI 10.1016/j.anireprosci.2010.11.005; Peter S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22856-y; Pinart E, 2017, ANIM REPROD SCI, V177, P65, DOI 10.1016/j.anireprosci.2016.12.007; Reid G, 2002, MICROBES INFECT, V4, P319, DOI 10.1016/S1286-4579(02)01544-7; Riesenbeck A, 2015, REPROD DOMEST ANIM, V50, P1, DOI 10.1111/rda.12573; Rolfe RD, 2000, J NUTR, V130, p396S, DOI 10.1093/jn/130.2.396S; Schulze M, 2016, THERIOGENOLOGY, V85, P39, DOI 10.1016/j.theriogenology.2015.07.016; Schulze M, 2015, REPROD DOMEST ANIM, V50, P684, DOI 10.1111/rda.12532; Schulze M, 2015, THERIOGENOLOGY, V83, P430, DOI 10.1016/j.theriogenology.2014.10.004; Schulze M, 2013, THERIOGENOLOGY, V80, P990, DOI 10.1016/j.theriogenology.2013.07.026; Schulze M, 2013, ANIM REPROD SCI, V140, P70, DOI 10.1016/j.anireprosci.2013.05.012; Schulze M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100490; Sepulveda L, 2016, THERIOGENOLOGY, V85, P1421, DOI 10.1016/j.theriogenology.2015.12.025; Sepulveda L, 2014, ANIM REPROD SCI, V150, P96, DOI 10.1016/j.anireprosci.2014.09.001; Sepulveda L, 2013, ANIM REPROD SCI, V140, P83, DOI 10.1016/j.anireprosci.2013.04.013; Signorini ML, 2012, RES VET SCI, V93, P250, DOI 10.1016/j.rvsc.2011.05.001; SIVARAMAKRISHNA.G, 2004, REPROD FERT DEVELOP, V16, P261; SONE M, 1982, VET REC, V111, P11, DOI 10.1136/vr.111.1.11; Speck S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105949; Vicariotto F, 2014, J CLIN GASTROENTEROL, V48, pS106, DOI 10.1097/MCG.0000000000000226; Wallmann M, 2003, INT J ANTIMICROB AG, V22, P420, DOI 10.1016/S0924-8579(03)00151-1; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Wang Y, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-19; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yang FJ, 2015, PATHOGENS, V4, P34, DOI 10.3390/pathogens4010034	53	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202699	10.1371/journal.pone.0202699	http://dx.doi.org/10.1371/journal.pone.0202699			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192779	Green Published, gold			2022-12-26	WOS:000444093600030
J	Cui, GW; Li, B; He, WH; Yin, XJ; Liu, SY; Lian, L; Zhang, YL; Liang, WX; Zhang, P				Cui, Guowen; Li, Bing; He, Wenhua; Yin, Xiujie; Liu, Shengyong; Lian, Lu; Zhang, Yaling; Liang, Wenxue; Zhang, Pan			Physiological analysis of the effect of altitudinal gradients on Leymus secalinus on the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							SALT TOLERANCE; SUPEROXIDE DISMUTASES; LIPID-PEROXIDATION; MOLECULAR-BIOLOGY; OXIDATIVE STRESS; NORTHERN CHINA; CLIMATE-CHANGE; WATER-STRESS; PLANTS; DROUGHT	On the Qinghai-Tibetan Plateau, the high-altitudinal gradients can negatively affect plant distribution and limit plant growth and reproduction. Leymus secalinus (Georgi) Tzvel. is an important forage crop on the Qinghai-Tibetan Plateau and has an excellent ability to fix sand and improve soil. To evaluate the effect of altitude on the physiological characteristics of L. secalinus on the Qinghai-Tibetan Plateau, we measured the lipid peroxidation; chlorophyll a (Chl a), chlorophyll b (Chl b), total carotenoid (Car), soluble protein, proline and soluble sugar contents; and the activities of superoxide dismutase (SOD), catalase (CAT) and peroxidase (POD) in leaves from eight different altitudes in Minhe County and Huangzhong County. The leaves were collected at the initial bloom stage, and the average vertical distance between two adjacent collection sites was approximately 100 meters. The reduction in Chl a and Chl b contents and the increase in Car contents can allow plants to weaken their light absorption and avoid photodamage to the chloroplast. The decrease in malondialdehyde (MDA) content associated with lower lipid peroxidation, and the changes of CAT, SOD and POD activities reflect a higher reactive oxygen species (ROS) scavenging capacity in high-altitude plants. The increase in proline and soluble sugar contents with elevation suggests that proline and soluble sugar may play a key role in the osmotic adjustment of plants in alpine regions. The results suggested that altitudinal gradients negatively affect L. secalinus on the Qinghai-Tibetan Plateau and that the adaptation mechanism and survival strategies of L. secalinus were attributed to the combined effects of multiple protective strategies.	[Cui, Guowen; Li, Bing; He, Wenhua; Yin, Xiujie; Liu, Shengyong; Lian, Lu; Zhang, Yaling; Liang, Wenxue; Zhang, Pan] Northeast Agr Univ, Dept Grassland Sci, Coll Anim Sci & Technol, Harbin, Heilongjiang, Peoples R China; [He, Wenhua] Grassland Supervis Stn, Qiqihar, Peoples R China; [Lian, Lu] Chinese Grassland Soc, Beijing, Peoples R China	Northeast Agricultural University - China	Zhang, P (corresponding author), Northeast Agr Univ, Dept Grassland Sci, Coll Anim Sci & Technol, Harbin, Heilongjiang, Peoples R China.	zhangpgrass@126.com	ZHANG, PAN/GWV-6478-2022	Zhang, Pan/0000-0002-2628-4852	National Science Foundation of China [31472145, 31502007]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Science Foundation of China No. 31472145 to G.C. and 31502007 to P.Z. (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KS, 2018, ACTA PHYSIOL PLANT, V40, DOI 10.1007/s11738-018-2637-4; Ahmad KS, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2114-x; Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; Armstrong GA, 1996, FASEB J, V10, P228, DOI 10.1096/fasebj.10.2.8641556; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Barry R. G., 1981, MOUNTAIN WEATHER CLI; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Basu PS, 2007, ANN APPL BIOL, V150, P217, DOI 10.1111/j.1744-7348.2007.00119.x; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen BX, 2014, AGR FOREST METEOROL, V189, P11, DOI 10.1016/j.agrformet.2014.01.002; Cho UH, 2005, PLANT SCI, V168, P113, DOI 10.1016/j.plantsci.2004.07.021; Cui GX, 2016, PLANT ECOL DIVERS, V9, P387, DOI 10.1080/17550874.2016.1261952; Demiral T, 2005, ENVIRON EXP BOT, V53, P247, DOI 10.1016/j.envexpbot.2004.03.017; DEMMIGADAMS B, 1992, PLANT CELL ENVIRON, V15, P411, DOI 10.1111/j.1365-3040.1992.tb00991.x; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DREYWOOD R, 1946, IND ENG CHEM, V18, P499, DOI 10.1021/i560156a015; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Hazrati S, 2016, PLANT PHYSIOL BIOCH, V106, P141, DOI 10.1016/j.plaphy.2016.04.046; He C, 2005, J ARID ENVIRON, V63, P814, DOI 10.1016/j.jaridenv.2005.03.028; HEATH RL, 1965, BIOCHEM BIOPH RES CO, V19, P716, DOI 10.1016/0006-291X(65)90316-5; Huang BR, 2014, CRIT REV PLANT SCI, V33, P141, DOI 10.1080/07352689.2014.870411; Kang JJ, 2017, J PLANT RES, V130, P291, DOI 10.1007/s10265-016-0884-2; Karagiannis E, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01689; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Latef AAA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00243; Li X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099857, 10.1371/journal.pone.0098410]; Li Y, 2013, AUST J BOT, V61, P424, DOI 10.1071/BT13022; Ma L, 2015, J PROTEOMICS, V112, P63, DOI 10.1016/j.jprot.2014.08.009; Ma WH, 2010, SCI CHINA LIFE SCI, V53, P841, DOI 10.1007/s11427-010-4020-6; Manivannan P, 2007, COLLOID SURFACE B, V59, P141, DOI 10.1016/j.colsurfb.2007.05.002; Paleg L. G., 1981, PHYSL BIOCH DROUGHT; Qin JH, 2009, CAN J FOREST RES, V39, P723, DOI 10.1139/X09-001; Rana MS, 2011, J MT SCI-ENGL, V8, P817, DOI 10.1007/s11629-011-2078-7; Raza SH, 2007, ENVIRON EXP BOT, V60, P368, DOI 10.1016/j.envexpbot.2006.12.009; SCANDALIOS JG, 1993, PLANT PHYSIOL, V101, P7, DOI 10.1104/pp.101.1.7; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Simkin AJ, 2003, J PLANT PHYSIOL, V160, P439, DOI 10.1078/0176-1617-00871; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; Suelter CH, 2006, METHOD BIOCHEM ANAL, P357; Van den Ende W, 2009, J EXP BOT, V60, P9, DOI 10.1093/jxb/ern297; Wang YP, 2009, ACTA PHYSIOL PLANT, V31, P839, DOI 10.1007/s11738-009-0300-9; Wellburn A.R., 1984, FORMULAE PROGRAM DET; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; Wu XY, 2015, RANGELAND J, V37, P11, DOI 10.1071/RJ14082; Ye XH, 2006, ANN BOT-LONDON, V98, P187, DOI 10.1093/aob/mcl086; Zaharieva T, 1999, PLANT CELL PHYSIOL, V40, P273, DOI 10.1093/oxfordjournals.pcp.a029538; Zhu PJ, 2015, FIELD CROP RES, V171, P79, DOI 10.1016/j.fcr.2014.11.006; Zhu YJ, 2007, FLORA, V202, P249, DOI 10.1016/j.flora.2006.05.006	54	14	14	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202881	10.1371/journal.pone.0202881	http://dx.doi.org/10.1371/journal.pone.0202881			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183737	Green Submitted, Green Published, gold			2022-12-26	WOS:000443789900040
J	Huang, XL; Liu, DG; Cui, XN; Shi, XQ				Huang, Xianliang; Liu, Deguang; Cui, Xiaoning; Shi, Xiaoqin			Probing behaviors and their plasticity for the aphid Sitobion avenae on three alternative host plants	PLOS ONE			English	Article							FEEDING-BEHAVIOR; DIFFERENTIAL PERFORMANCE; PHENOTYPIC PLASTICITY; PEA APHID; RHOPALOSIPHUM-MAIDIS; GENE-EXPRESSION; DIURAPHIS-NOXIA; FITNESS TRAITS; BIOTYPE 2; RESISTANCE	Insects may develop different behavioral phenotypes in response to heterogeneous environments (e.g., host plants), but the plasticity of their feeding behaviors has been rarely explored. In order to address the issue, clones of the English grain aphid, Sitobion avenae (Fabricius), were collected from wheat, and their probing behaviors were recorded on three plants. Our results demonstrated that S. avenae individuals on the alternative plants (i.e., barley and oat) tended to have higher frequency of non-probing (Np), increased duration of the pathway phase, increased phloem salivation, and decreased phloem ingestion (E2), compared to those on the source plant (i.e., wheat), showing the resistance of barley and oat to this aphid's feeding. This aphid showed apparently high extents of plasticity for all test probing behaviors on barley or oat. Positive selection for higher extents of plasticity in E2 duration was identified on barley and oat. The factor 'clone' alone explained 30.6% to 70.1% of the total variance for each behavioral plasticity, suggesting that the divergence of probing behavior plasticity in S. avenae had a genetic basis. This aphid's fitness correlated positively with the plasticity of Np frequency and E2 frequency. Some behaviors and their corresponding plasticities (e.g., the frequency of xylem ingestion and its plasticity) were found to be correlated characters, probably reflecting the limits for the evolution of higher extents of behavioral plasticity in this aphid. The differential probing behaviors and their plasticity in S. avenae can have significant implications for the adaptation and management of aphids on different plants.	[Huang, Xianliang; Liu, Deguang; Cui, Xiaoning; Shi, Xiaoqin] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Huang, Xianliang; Liu, Deguang; Cui, Xiaoning; Shi, Xiaoqin] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Liu, DG (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Liu, DG (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China.	dgliu@nwsuaf.edu.cn			National Natural Science Foundation of China [31572002]; Northwest AF University [QN2011059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwest AF University	This research was funded by the National Natural Science Foundation of China (No. 31572002 to DL) (http://www.nsfc.gov.cn), and a grant from Northwest A&F University (No. QN2011059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AE, 2006, ENTOMOL EXP APPL, V121, P145, DOI 10.1111/j.1570-8703.2006.00464.x; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Blackman RL., 2008, APHIDS WORLDS HERBAC; Brewer MJ, 2001, ENVIRON ENTOMOL, V30, P1041, DOI 10.1603/0046-225X-30.6.1041; Cabrera-Brandt MA, 2015, J PEST SCI, V88, P259, DOI 10.1007/s10340-014-0614-2; CAILLAUD CM, 1995, J APPL ENTOMOL, V119, P103, DOI 10.1111/j.1439-0418.1995.tb01252.x; Chandran P, 2013, J ECON ENTOMOL, V106, P2234, DOI 10.1603/EC13126; Couchoux C, 2014, J INSECT BEHAV, V27, P283, DOI 10.1007/s10905-013-9420-6; Crispo E, 2008, J EVOLUTION BIOL, V21, P1460, DOI 10.1111/j.1420-9101.2008.01592.x; Dai XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106179; Gao SX, 2014, INSECT SCI, V21, P352, DOI 10.1111/1744-7917.12085; Gao SX, 2013, J ECON ENTOMOL, V106, P1294, DOI 10.1603/EC13017; Garzo E, 2002, PHYTOPARASITICA, V30, P129, DOI 10.1007/BF02979695; George J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173520; Goggin FL, 2007, CURR OPIN PLANT BIOL, V10, P399, DOI 10.1016/j.pbi.2007.06.004; Golawska S, 2012, POL J ENVIRON STUD, V21, P1613; Golawska S, 2012, J PEST SCI, V85, P443, DOI 10.1007/s10340-012-0452-z; Gonzales WL, 2002, ENTOMOL EXP APPL, V103, P107, DOI 10.1023/A:1020303817697; Gorur G, 2007, ARTHROPOD-PLANT INTE, V1, P187, DOI 10.1007/s11829-007-9017-0; Gorur G, 2005, ECOL ENTOMOL, V30, P657, DOI 10.1111/j.0307-6946.2005.00742.x; Greenslade AFC, 2016, ANN APPL BIOL, V168, P435, DOI 10.1111/aab.12274; Guo HJ, 2014, PLANT CELL ENVIRON, V37, P2158, DOI 10.1111/pce.12306; Heylen K, 2008, J INSECT PHYSIOL, V54, P1400, DOI 10.1016/j.jinsphys.2008.07.015; Hou L, 2017, ELIFE, V6, DOI [10.7554/eLife.22526, 10.7554/elife.22526]; Hu Xiang-shun, 2008, Agricultural Sciences in China, V7, P180, DOI 10.1016/S1671-2927(08)60037-1; Huang XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122343; Huang XL, 2013, ENVIRON ENTOMOL, V42, P1174, DOI 10.1603/EN13132; Ingram Krista K., 2011, BMC Ecology, V11, P19, DOI 10.1186/1472-6785-11-19; Kang ZW, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00778; Kelly SA, 2012, COMPR PHYSIOL, V2, P1417, DOI 10.1002/cphy.c110008; Khan SA, 2015, J ECON ENTOMOL, V108, P2465, DOI 10.1093/jee/tov183; Klingler J, 2005, PLANT PHYSIOL, V137, P1445, DOI 10.1104/pp.104.051243; Lazzari S, 2009, J ECON ENTOMOL, V102, P1291, DOI 10.1603/029.102.0356; Lombaert E, 2009, ENTOMOL EXP APPL, V133, P46, DOI 10.1111/j.1570-7458.2009.00904.x; Lu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19344; Miao J, 2011, ENVIRON ENTOMOL, V40, P743, DOI 10.1603/EN10261; Ni XZ, 1998, ENTOMOL EXP APPL, V89, P111, DOI 10.1023/A:1003458406502; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Papura D, 2003, HEREDITY, V90, P397, DOI 10.1038/sj.hdy.6800262; Pointeau S, 2014, IND CROP PROD, V54, P135, DOI 10.1016/j.indcrop.2014.01.018; Pompon J, 2011, J INSECT PHYSIOL, V57, P1317, DOI 10.1016/j.jinsphys.2011.06.007; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; Reaume CJ, 2011, PHILOS T R SOC B, V366, P2100, DOI 10.1098/rstb.2011.0028; SAS, 2008, SAS SYST VERS 9 1 3; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Simon JC, 1999, MOL ECOL, V8, P531, DOI 10.1046/j.1365-294x.1999.00583.x; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; ten Broeke CJM, 2013, ENTOMOL EXP APPL, V148, P130, DOI 10.1111/eea.12084; TJALLINGII WF, 1993, PHYSIOL ENTOMOL, V18, P317, DOI 10.1111/j.1365-3032.1993.tb00604.x; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; Tjallingii WF., 1988, APHIDS THEIR BIOL NA, P98; Tobback J, 2011, ARCH INSECT BIOCHEM, V76, P30, DOI 10.1002/arch.20401; Todd JC, 2016, J ECON ENTOMOL, V109, P426, DOI 10.1093/jee/tov315; Travis AJ, 1996, J AGR SCI-CAMBRIDGE, V127, P1, DOI 10.1017/S0021859600077327; Wang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep23177	55	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203219	10.1371/journal.pone.0203219	http://dx.doi.org/10.1371/journal.pone.0203219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183744	gold, Green Submitted, Green Published			2022-12-26	WOS:000443789900050
J	von Meijenfeldt, GCI; van der Laan, MJ; Zeebregts, CJAM; Christopher, KB				von Meijenfeldt, Gerdine C. I.; van der Laan, Maarten J.; Zeebregts, Clark J. A. M.; Christopher, Kenneth B.			Red cell distribution width at hospital discharge and out-of hospital outcomes in critically ill non-cardiac vascular surgery patients	PLOS ONE			English	Article							INFLAMMATORY CYTOKINES; MEDICARE BENEFICIARIES; 30-DAY READMISSION; RISK-FACTORS; MORTALITY; HEALTH; CARE; ERYTHROPOIESIS; COMPLICATIONS; EPIDEMIOLOGY	Objective Red cell distribution width (RDW) is associated with mortality and bloodstream infection risk in the critically ill. In vascular surgery patients surviving critical care it is not known if RDW can predict subsequent risk of all-cause mortality following hospital discharge. We hypothesized that an increase in RDW at hospital discharge in vascular surgery patients who received critical care would be associated with increased mortality following hospital discharge. Design, setting, and participants We performed a two-center observational cohort study of critically ill non-cardiac vascular surgery patients surviving admission 18 years or older treated between November, 1997, and December 2012 in Boston, Massachusetts. Exposures RDW measured within 24 hours of hospital discharge and categorized a priori as < 13.3%, 13.3-14.0%, 14.0-14.7%, 14.7-15.8%, >15.8%. Main outcomes and measures The primary outcome was all cause mortality in the 90 days following hospital discharge. Results The cohort included 4,715 patients (male 58%; white 83%; mean age 62.9 years). 90 and 365-day post discharge mortality was 7.5% and 14.4% respectively. In the cohort, 47.3% were discharged to a care facility and 14.8% of patients were readmitted within 30 days. After adjustment for age, gender, race, Deyo-Charlson comorbidity Index, patient type, acute organ failures, prior vascular surgery and vascular surgery category, patients with a discharge RDW 14.7-15.8% or > 15.8% have an adjusted OR of 90-day post discharge mortality of 2.52 (95% CI, 1.29-4.90; P = 0.007) or 5.13 (95% CI, 2.70-9.75; P < 0.001) relative to patients with a discharge RDW <= 13.3%. The adjusted odds of 30-day readmission in the RDW > 15.8% group was 1.52 (95% CI, 1.12-2.07; P = 0.007) relative to patients with a discharge RDW <= 13.3%. Similar adjusted discharge RDW-outcome associations are present at 365 days following hospital discharge and for discharge to a care facility. Conclusions In critically ill vascular surgery patients who survive hospitalization, an elevated RDW at hospital discharge is a strong predictor of subsequent mortality, hospital readmission and placement in a care facility. Patients with elevated RDW are at high risk for adverse out of hospital outcomes and may benefit from closer post discharge follow-up and higher intensity rehabilitation.	[von Meijenfeldt, Gerdine C. I.; van der Laan, Maarten J.; Zeebregts, Clark J. A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Div Vasc Surg, Groningen, Netherlands; [von Meijenfeldt, Gerdine C. I.] Deventer Ziekenhuis, Dept Surg, Deventer, Netherlands; [Christopher, Kenneth B.] Brigham & Womens Hosp, Div Renal, Nathan E Hellman Mem Lab, 75 Francis St, Boston, MA 02115 USA	University of Groningen; Deventer Hospital; Harvard University; Brigham & Women's Hospital	Christopher, KB (corresponding author), Brigham & Womens Hosp, Div Renal, Nathan E Hellman Mem Lab, 75 Francis St, Boston, MA 02115 USA.	kbchristopher@bwh.harvard.edu	van der Laan, Maarten/AAQ-3353-2021; Christopher, Kenneth/AAD-6801-2021; Christopher, Kenneth B./C-5243-2012	Christopher, Kenneth/0000-0001-6067-972X; Christopher, Kenneth B./0000-0001-6067-972X	NIH/NIGMS [R01GM115774]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115774] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH/NIGMS R01GM115774.	Allen LA, 2010, J CARD FAIL, V16, P230, DOI 10.1016/j.cardfail.2009.11.003; Bateman AP, 2009, CRIT CARE MED, V37, P1906, DOI 10.1097/CCM.0b013e3181a000cf; Bazick HS, 2011, CRIT CARE MED, V39, P1913, DOI 10.1097/CCM.0b013e31821b85c6; Beier K, 2011, CRIT CARE MED, V39, P305, DOI 10.1097/CCM.0b013e3181ffe22a; Brooke BS, 2015, LANCET, V386, P884, DOI 10.1016/S0140-6736(15)60087-3; Brothers TE, 2016, J VASC SURG, V63, P114, DOI 10.1016/j.jvs.2015.08.063; Calderwood MS, 2014, MED CARE, V52, P918, DOI 10.1097/MLR.0000000000000212; Casey K, 2013, J VASC SURG, V57, P89, DOI 10.1016/j.jvs.2012.07.005; Centers for Medicaid and Medicare, 2019, SERV; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Constantino BT, 2013, LABMEDICINE, V44, pE2, DOI 10.1309/LMZ1GKY9LQTVFBL7; Davenport DL, 2014, J VASC SURG, V60, P1266, DOI 10.1016/j.jvs.2014.05.051; Desai SV, 2011, CRIT CARE MED, V39, P371, DOI 10.1097/CCM.0b013e3181fd66e5; EVANS T C, 1991, Journal of Emergency Medicine, V9, P71, DOI 10.1016/0736-4679(91)90592-4; Fernandes-Taylor S, 2018, J SURG RES, V221, P196, DOI 10.1016/j.jss.2017.08.041; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Forhecz Z, 2009, AM HEART J, V158, P659, DOI 10.1016/j.ahj.2009.07.024; Ghali JK, 2009, CURR OPIN CARDIOL, V24, P172, DOI 10.1097/HCO.0b013e328324ecec; Gupta PK, 2014, J VASC SURG, V59, P473, DOI 10.1016/j.jvs.2013.09.002; Hivert MF, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-170; Hug BL, 2009, SWISS MED WKLY, V139, P737, DOI smw-12686; Iannuzzi JC, 2014, J VASC SURG, V59, P1340, DOI 10.1016/j.jvs.2013.11.089; Jann B, 2014, STATA J, V14, P708, DOI 10.1177/1536867X1401400402; Jelkmann W, 1998, J INTERF CYTOK RES, V18, P555, DOI 10.1089/jir.1998.18.555; Kazaure HS, 2016, J VASC SURG, V63, P731, DOI 10.1016/j.jvs.2015.09.046; Kehlet M, 2016, ANN VASC SURG, V36, P13, DOI 10.1016/j.avsg.2016.02.028; Laftah AH, 2006, BIOCHEM J, V397, P61, DOI 10.1042/BJ20060215; Lin E, 2000, SURGERY, V127, P117, DOI 10.1067/msy.2000.101584; Linde-Zwirble WT, 2004, CRIT CARE, V8, P222, DOI 10.1186/cc2917; Lindholm EE, 2015, ACTA ANAESTH SCAND, V59, P773, DOI 10.1111/aas.12466; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.628; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martin RCG, 2011, ANN SURG, V254, P591, DOI 10.1097/SLA.0b013e3182300a38; Muller Marcella C A, 2010, Crit Care, V14, P438, DOI 10.1186/cc9191; Ozcan F, 2013, BLOOD PRESSURE, V22, P80, DOI 10.3109/08037051.2012.707336; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163; Pierce CN, 2005, PERFUSION-UK, V20, P83, DOI 10.1191/0267659105pf793oa; Purtle SW, 2014, CRIT CARE MED, V42, P918, DOI 10.1097/CCM.0000000000000118; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; RAPOPORT J, 1992, ARCH INTERN MED, V152, P2207, DOI 10.1001/archinte.152.11.2207; Rogiers P, 1997, INTENS CARE MED, V23, P159, DOI 10.1007/s001340050310; Scharte M, 2003, CRIT CARE MED, V31, pS651, DOI 10.1097/01.CCM.0000098036.90796.ED; Semba RD, 2010, CLIN NUTR, V29, P600, DOI 10.1016/j.clnu.2010.03.001; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Teixeira PL, 2017, J AM MED INFORM ASSN, V24, P162, DOI 10.1093/jamia/ocw071; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.727545; Visser A, 2015, SURGERY, V158, P58, DOI 10.1016/j.surg.2015.01.012; von Meijenfeldt GCI, 2014, EUR J VASC ENDOVASC, V47, P479, DOI 10.1016/j.ejvs.2014.01.016; Von Meijenfeldt GCI, 2016, J CARDIOVASC SURG, V57, P162; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216; Ye Z, 2011, AM J CARDIOL, V107, P1241, DOI 10.1016/j.amjcard.2010.12.023; Zager S, 2011, CHEST, V139, P1368, DOI 10.1378/chest.10-2594; Zalawadiya SK, 2012, VASC MED, V17, P155, DOI 10.1177/1358863X12442443	54	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0199654	10.1371/journal.pone.0199654	http://dx.doi.org/10.1371/journal.pone.0199654			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183701	Green Published, gold, Green Submitted			2022-12-26	WOS:000443789900084
J	Lee, KH				Lee, Kyun Ho			Plume influence analysis of small bipropellant thruster on solar array of GEO satellite	PLOS ONE			English	Article							NAVIER-STOKES; SIMULATION; FLOWS; DSMC; CONTINUUM; BACKFLOW; REGION; SCHEME	An exhaust plume gas flow from a bipropellant thruster has been recognized as a potential source of a load, heat, and contamination on the exposed satellite components which can especially degrade the optical properties and performance of solar panel. Therefore, accurate predictions of a bipropellant thruster plume gas flow and assessments of its influences should be considered at the design phase of a satellite. The objective of the present study is to investigate the plume gas flow behavior of a small bipropellant thruster and to evaluate its influence on the solar array of a GEO satellite numerically. To deal with complex plume flow regimes efficiently, the combined approach of computational fluid dynamics (CFD) and Direct Simulation Monte Carlo (DSMC) was applied depending on the flow characteristic conditions. Throughout the numerical results of the present study, the influences of the plume gas flow exhausted from a single bipropellant thruster were considered for the disturbance, heat, and contamination of the three-dimensional satellite configuration equipped with a large solar array.	[Lee, Kyun Ho] Sejong Univ, Dept Aerosp Engn, Seoul, South Korea	Sejong University	Lee, KH (corresponding author), Sejong Univ, Dept Aerosp Engn, Seoul, South Korea.	khlee0406@sejong.ac.kr		Lee, Kyun Ho/0000-0002-0703-1323	Space Core Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT (MSIT) [NRF-2013M1A3A3A02042426]	Space Core Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT (MSIT)	This research was supported by Space Core Technology Development Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (MSIT) (NRF-2013M1A3A3A02042426). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amri R, 2011, ACTA ASTRONAUT, V69, P485, DOI 10.1016/j.actaastro.2011.05.008; Bernard F, 2017, EUR J MECH B-FLUID, V63, P25, DOI 10.1016/j.euromechflu.2017.01.001; Bird GA, 1992, MOL GAS DYNAMICS DIR; BORGNAKKE C, 1975, J COMPUT PHYS, V18, P405, DOI 10.1016/0021-9991(75)90094-7; Dettleff G., 1991, PROG AEROSP SCI, V28, P1, DOI [10.1016/0376-0421(91)90008-R, DOI 10.1016/0376-0421(91)90008-R]; Donev A, 2010, MULTISCALE MODEL SIM, V8, P871, DOI 10.1137/090774501; Gatsonis NA, 2013, J COMPUT PHYS, V233, P148, DOI 10.1016/j.jcp.2012.08.009; George J, 1999, 33 THERM C FLUID DYN, DOI [10.2514/6.1999-3454, DOI 10.2514/6.1999-3454]; Giordano D, 1998, J SPACECRAFT ROCKETS, V35, P502, DOI 10.2514/2.3359; Grabe M, 2014, SPAC PROP C 2014 COL; Ivanov MS, 1999, J PROPUL POWER, V15, P417, DOI 10.2514/2.5460; Ivanov MS, 2008, 14 INT C METH AER RE; Jang YH, 2016, J KOREAN SOC AERONA, V44, P333, DOI 10.5139/JKSAS.2016.44.4.333; Johnson RW, 2016, HANDBOOK OF FLUID DYNAMICS, 2ND EDITION, P1, DOI 10.1201/b19031; La Torre F, 2011, COMPUT FLUIDS, V49, P312, DOI 10.1016/j.compfluid.2011.06.008; Lee KH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176423; Lee KH, 2013, COMPUT FLUIDS, V80, P333, DOI 10.1016/j.compfluid.2012.01.024; Lee KH, 2009, T JPN SOC AERONAUT S, V52, P135, DOI 10.2322/tjsass.52.135; Liu C, 2017, COMMUN COMPUT PHYS, V22, P1175, DOI 10.4208/cicp.OA-2017-0102; Lumpkin F., 2012, 33 JANNAF EXH PLUM S; McBride B.J., 1996, COMPUTER PROGRAM CAL; Modest M., 2003, RAD HEAT TRANSFER, P1; Park JH, 2004, AIAA J, V42, P1622, DOI 10.2514/1.1975; Tiwari S, 2009, J COMPUT PHYS, V228, P7109, DOI 10.1016/j.jcp.2009.06.019; Vashchenkov PV, 2005, AIP CONF PROC, V762, P355, DOI 10.1063/1.1941562; Wadsworth DC, 1992, AIAA 23 PLASM DYN LA, DOI [10.2514/6.1992-2975, DOI 10.2514/6.1992-2975]; Wang LM, 2013, CHINESE J AERONAUT, V26, P522, DOI 10.1016/j.cja.2013.04.049; Wu JS, 2006, J COMPUT PHYS, V219, P579, DOI 10.1016/j.jcp.2006.04.013; Xiao H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13274-7; Xiao Z, 2006, 9 AIAA ASME JOINT TH, DOI [10.2514/6.2006-3599, DOI 10.2514/6.2006-3599]	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0199667	10.1371/journal.pone.0199667	http://dx.doi.org/10.1371/journal.pone.0199667			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180165	Green Published, gold, Green Submitted			2022-12-26	WOS:000444222400001
J	Jakubec, D; Kratochvil, M; Vymetal, J; Vondrasek, J				Jakubec, David; Kratochvil, Miroslav; Vymetal, Jiri; Vondrasek, Jiri			Widespread evolutionary crosstalk among protein domains in the context of multi- domain proteins	PLOS ONE			English	Article							RESIDUE COEVOLUTION; SEQUENCE; INFORMATION; IDENTIFICATION; SIGNALS	Domains are distinct units within proteins that typically can fold independently into recognizable three-dimensional structures to facilitate their functions. The structural and functional independence of protein domains is reflected by their apparent modularity in the context of multi-domain proteins. In this work, we examined the coupling of evolution of domain sequences co-occurring within multi-domain proteins to see if it proceeds independently, or in a coordinated manner. We used continuous information theory measures to assess the extent of correlated mutations among domains in multi-domain proteins from organisms across the tree of life. In all multi-domain architectures we examined, domains co-occurring within protein sequences had to some degree undergone concerted evolution. This finding challenges the notion of complete modularity and independence of protein domains, providing new perspective on the evolution of protein sequence and function.	[Jakubec, David; Kratochvil, Miroslav; Vymetal, Jiri; Vondrasek, Jiri] Czech Acad Sci, Inst Organ Chem & Biochem, Dept Bioinformat, Prague 16610 6, Czech Republic; [Jakubec, David] Charles Univ Prague, Dept Phys & Macromol Chem, Fac Sci, Prague 12843 2, Czech Republic; [Kratochvil, Miroslav] Charles Univ Prague, Dept Software Engn, Fac Math & Phys, CR-11800 Prague 1, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague; Charles University Prague	Vondrasek, J (corresponding author), Czech Acad Sci, Inst Organ Chem & Biochem, Dept Bioinformat, Prague 16610 6, Czech Republic.	jiri.vondrasek@uochb.cas.cz	Kratochvíl, Miroslav/AAR-3520-2021; Vymětal, Jiří/R-1167-2017	Kratochvíl, Miroslav/0000-0001-7356-4075; Vymětal, Jiří/0000-0002-0165-8707; Jakubec, David/0000-0003-4288-0344; vondrasek, jiri/0000-0002-6066-973X	Ministry of Education, Youth and Sports [LM2015047]; Institute of Organic Chemistry and Biochemistry of the CAS [61388963]; National Grid Infrastructure MetaCentrum provided under the programme "Projects of Large Research, Development, and Innovations Infrastructures" [CESNET LM2015042]; ELIXIRCZ project, international ELIXIR infrastructure [LM2015047]	Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Institute of Organic Chemistry and Biochemistry of the CAS; National Grid Infrastructure MetaCentrum provided under the programme "Projects of Large Research, Development, and Innovations Infrastructures"; ELIXIRCZ project, international ELIXIR infrastructure	This work was supported by The Ministry of Education, Youth and Sports, grant number LM2015047, http://www.msmt.cz/ (J Vo) and Institute of Organic Chemistry and Biochemistry of the CAS (RVO), grant number 61388963, www. uochb.cz/(J Vo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank to M. Oliveberg, M. M. Babu, and T. Majerova for reading the manuscript and for their valuable comments and suggestions. We are also grateful to M. Oliveberg for the concept of Fig 1B. Access to computing and storage facilities owned by parties and projects contributing to the National Grid Infrastructure MetaCentrum provided under the programme "Projects of Large Research, Development, and Innovations Infrastructures" (CESNET LM2015042), is greatly appreciated. Computational resources were provided by the ELIXIRCZ project (LM2015047), part of the international ELIXIR infrastructure.	Bashton M, 2007, STRUCTURE, V15, P85, DOI 10.1016/j.str.2006.11.009; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Bjorklund AK, 2005, J MOL BIOL, V353, P911, DOI 10.1016/j.jmb.2005.08.067; Bornberg-Bauer E, 2013, CURR OPIN STRUC BIOL, V23, P459, DOI 10.1016/j.sbi.2013.02.012; Eddy SR, 2018, HMMER USERS GUIDE VE; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Lees JG, 2016, CURR OPIN STRUC BIOL, V38, P44, DOI 10.1016/j.sbi.2016.05.016; Liu Y, 2012, MOL BIOL EVOL, V29, P2253, DOI 10.1093/molbev/mss097; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mao WZ, 2015, BIOINFORMATICS, V31, P1929, DOI 10.1093/bioinformatics/btv103; Buslje CM, 2009, BIOINFORMATICS, V25, P1125, DOI 10.1093/bioinformatics/btp135; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Moore AD, 2008, TRENDS BIOCHEM SCI, V33, P444, DOI 10.1016/j.tibs.2008.05.008; Morcos F, 2013, P NATL ACAD SCI USA, V110, P20533, DOI 10.1073/pnas.1315625110; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Neuwald AF, 2016, CURR OPIN STRUC BIOL, V38, P1, DOI 10.1016/j.sbi.2016.04.006; Ovchinnikov S, 2017, SCIENCE, V355, P294, DOI 10.1126/science.aah4043; Ovchinnikov S, 2015, ELIFE, V4, DOI 10.7554/eLife.09248; Press W. H., 1992, ART SCI COMPUTING; Schueler-Furman O, 2016, CURR OPIN STRUC BIOL, V41, P159, DOI 10.1016/j.sbi.2016.06.017; Sutto L, 2015, P NATL ACAD SCI USA, V112, P13567, DOI 10.1073/pnas.1508584112; Uguzzoni G, 2017, P NATL ACAD SCI USA, V114, pE2662, DOI 10.1073/pnas.1615068114; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yang S, 2011, BIOINFORMATICS, V27, P2972, DOI 10.1093/bioinformatics/btr503; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	34	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203085	10.1371/journal.pone.0203085	http://dx.doi.org/10.1371/journal.pone.0203085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169546	Green Published, gold, Green Submitted			2022-12-26	WOS:000443374400020
J	Xu, ZH; Miao, ZW; Jiang, QZ; Gan, DX; Wei, XG; Xue, XZ; Li, JQ; Zheng, F; Qin, XX; Fang, WG; Chen, YH; Li, B				Xu, Zhi-Hua; Miao, Zi-Wei; Jiang, Qian-Zhu; Gan, Dong-Xue; Wei, Xu-Ge; Xue, Xiao-Zhi; Li, Jue-Qi; Zheng, Fei; Qin, Xiao-Xue; Fang, Wen-Gang; Chen, Yu-Hua; Li, Bo			Brain microvascular endothelial cell exosome-mediated S100A16 up-regulation confers small-cell lung cancer cell survival in brain	FASEB JOURNAL			English	Article						brain metastasis; prohibitin; mitochondrial membrane potential	MITOCHONDRIAL DYNAMICS; OXIDATIVE STRESS; EXPRESSION; METASTASIS; PROHIBITIN; MICROENVIRONMENT; APOPTOSIS; RECEPTOR; PROTEIN; FAMILY	Small cell lung cancer (SCLC) is the most aggressive histologic subtype of lung cancer, with a strong predilection for early brain metastases. Despite efforts and advances in new therapeutics for SCLC, the prognosis of patients with SCLC with brain metastases is consistently poor. Therefore, a better understanding of the mechanisms of SCLC brain metastasis is important in improving current treatments. In this study, elevated S100A16 levels were associated with SCLC brain metastases, which was a possible secondary event arising from the brain metastatic microenvironment. Using an in vitro cell coculture system, we found that the coculturing of SCLC cells with human brain microvascular endothelial cells (HBMECs) led to an increased expression of S100A16 in SCLC cells. Conversely, treatment of HBMECs with GW4869, an inhibitor of exosome release, significantly blocked this effect in the cocultured SCLC cells. Alternatively, the results from Western blot analyses and immunofluorescence indicated that the HBMEC exosomes purified by ultracentrifugation also induced the elevation and translocation from the cytoplasm to the nucleus of S100A16 in the recipient SCLC cells. The inhibition experiments demonstrated that elevated S100A16 contributed a benefit of HBMEC exosomes for the survival of the recipient SCLC cells under stress. Moreover, the elevation of S100A16 in SCLC cells prevented the loss of mitochondrial membrane potential (m) and enhanced resistance to apoptosis under stressful conditions, which were determined by Annexin V/propidium iodide and JC-1 assay. Further results showed that the S100A16-mediated protective effect was caused by the presence of an important element in m, prohibitin (PHB)-1, a protein in the mitochondrial inner membrane. Conversely, the delivery of PHB-1 siRNAs into S100A16 overexpressing SCLC cells weakened these protective effects. Our findings suggest that elevated S100A16 plays an active role in facilitating the survival of SCLC cells through modulating the mitochondrial function, identifying S100A16 as an important potential target in SCLC brain metastasis.Xu, Z.-H., Miao, Z.-W., Jiang, Q.-Z., Gan, D.-X., Wei, X.-G., Xue, X.-Z., Li, J.-Q., Zheng, F., Qin, X.-X., Fang, W.-G., Chen, Y.-H., Li. B. Brain microvascular endothelial cell exosome-mediated S100A16 up-regulation confers small cell lung cancer cell survival in brain.	[Xu, Zhi-Hua; Miao, Zi-Wei; Jiang, Qian-Zhu; Gan, Dong-Xue; Wei, Xu-Ge; Qin, Xiao-Xue; Fang, Wen-Gang; Chen, Yu-Hua; Li, Bo] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Dev Biol, 77 Puhe Rd, Shenyang, Liaoning, Peoples R China; [Xu, Zhi-Hua; Miao, Zi-Wei; Jiang, Qian-Zhu; Gan, Dong-Xue; Wei, Xu-Ge; Qin, Xiao-Xue; Fang, Wen-Gang; Chen, Yu-Hua; Li, Bo] China Med Univ, Key Lab Med Cell Biol, Minist Educ, Shenyang, Liaoning, Peoples R China; [Xue, Xiao-Zhi; Li, Jue-Qi; Zheng, Fei] China Med Univ, Dept Clin Med, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Li, B (corresponding author), China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Dev Biol, 77 Puhe Rd, Shenyang, Liaoning, Peoples R China.	bli28@cmu.edu.cn			National Natural Science Foundation of China [81672881, 81372336]; College Students Innovation and Entrepreneurships Training Foundation of Liaoning Province [201710159000089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); College Students Innovation and Entrepreneurships Training Foundation of Liaoning Province	The authors thank Drs. Monique Stins and Kwang Sik Kim (John Hopkins University School of Medicine, Baltimore, MD, USA) for providing the HBMECs. This work was supported by National Natural Science Foundation of China Grants 81672881 (to B.L.) and 81372336 (to B.L.) and College Students Innovation and Entrepreneurships Training Foundation of Liaoning Province Grant 201710159000089 (to X.-Z.X.). The authors declare no conflicts of interest.	Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Blecharz KG, 2015, BIOL CELL, V107, P342, DOI 10.1111/boc.201500011; Bliss SA, 2016, CANCER RES, V76, P5832, DOI 10.1158/0008-5472.CAN-16-1092; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; Chowdhury I, 2013, APOPTOSIS, V18, P1513, DOI 10.1007/s10495-013-0901-z; Chowdhury I, 2011, LIFE SCI, V89, P295, DOI 10.1016/j.lfs.2011.06.022; Ebben JD, 2016, INT J BIOCHEM CELL B, V78, P288, DOI 10.1016/j.biocel.2016.07.025; Fidler IJ, 2011, SEMIN CANCER BIOL, V21, P107, DOI 10.1016/j.semcancer.2010.12.009; Gill JG, 2016, COLD SH Q B, V81, P163, DOI 10.1101/sqb.2016.81.030791; Haga H, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.24900; Haqqani AS, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-4; Hartmann TN, 2005, ONCOGENE, V24, P4462, DOI 10.1038/sj.onc.1208621; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hoshide R, 2017, CLIN EXP METASTAS, V34, P369, DOI 10.1007/s10585-017-9857-7; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hu L, 2010, MED ONCOL, V27, P708, DOI 10.1007/s12032-009-9273-1; Kafka A, 2014, INT J MOL SCI, V15, P10635, DOI 10.3390/ijms150610635; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Kargi HA, 1997, CANCER LETT, V119, P27, DOI 10.1016/S0304-3835(97)00254-1; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kim B, 2016, FREE RADICAL RES, V50, P1065, DOI 10.1080/10715762.2016.1210141; Kobayashi M, 2018, HUM PATHOL, V74, P148, DOI 10.1016/j.humpath.2018.01.001; Li B, 2013, ONCOGENE, V32, P2952, DOI 10.1038/onc.2012.313; Li B, 2006, FEBS LETT, V580, P4252, DOI 10.1016/j.febslet.2006.06.056; Li L, 2015, NEUROSCIENCE, V286, P27, DOI 10.1016/j.neuroscience.2014.11.037; Li XX, 2015, INT J CLIN EXP PATHO, V8, P14676; Liu Q, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0742-4; Liu Y, 2015, INT J BIOCHEM CELL B, V66, P11, DOI 10.1016/j.biocel.2015.06.019; Lorger M, 2010, AM J PATHOL, V176, P2958, DOI 10.2353/ajpath.2010.090838; Lukanidin E, 2012, SEMIN CANCER BIOL, V22, P216, DOI 10.1016/j.semcancer.2012.02.006; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V313, P237, DOI 10.1016/j.bbrc.2003.11.115; Padilla L, 2017, ONCOGENE, V36, P6749, DOI 10.1038/onc.2017.283; Peng YT, 2015, APOPTOSIS, V20, P1135, DOI 10.1007/s10495-015-1143-z; Preusser M, 2012, ACTA NEUROPATHOL, V123, P205, DOI 10.1007/s00401-011-0933-9; Saito Keita, 2015, Asian Pac J Cancer Prev, V16, P7039; Sapkota D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1622-1; Sapkota D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076058; Senft D, 2016, CURR OPIN CELL BIOL, V39, P43, DOI 10.1016/j.ceb.2016.02.001; Shumakovich MA, 2017, FASEB J, V31, P5049, DOI 10.1096/fj.201700254R; Steinbichler TB, 2017, SEMIN CANCER BIOL, V44, P170, DOI 10.1016/j.semcancer.2017.02.006; Sturchler E, 2006, J BIOL CHEM, V281, P38905, DOI 10.1074/jbc.M605798200; Sun MH, 2009, CLIN CANCER RES, V15, P4829, DOI 10.1158/1078-0432.CCR-08-2921; Trotta AP, 2017, CELL MOL LIFE SCI, V74, P1999, DOI 10.1007/s00018-016-2451-3; Woditschka S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju145; Wolff G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097033; Yadav N, 2014, MITOCHONDRION, V16, P18, DOI 10.1016/j.mito.2013.11.005; Yano S, 2000, CANCER RES, V60, P4959; Yousefi M, 2017, CELL ONCOL, V40, P419, DOI 10.1007/s13402-017-0345-5; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zhou WB, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0097-8	50	37	39	2	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1742	1757		10.1096/fj.201800428R	http://dx.doi.org/10.1096/fj.201800428R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30183374				2022-12-26	WOS:000457296600019
J	Cordshagen, A; Busch, W; Winklhofer, M; Nothwang, HG; Hartmann, AM				Cordshagen, Antje; Busch, Wiebke; Winklhofer, Michael; Nothwang, Hans Gerd; Hartmann, Anna-Maria			Phosphoregulation of the intracellular termini of K+-Cl- cotransporter 2 (KCC2) enables flexible control of its activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						potassium transport; post-translational modification (PTM); protein conformation; phosphorylation; evolution; chloride transport; neurophysiology; cation chloride cotransporter; solute carrier family 12 member 5	ALANINE-RICH KINASE; N-ETHYLMALEIMIDE; INHIBITORY NEUROTRANSMISSION; SEQUENCE ALIGNMENT; NEUROPATHIC PAIN; CHLORIDE; ACTIVATION; PHOSPHORYLATION; TRANSPORT; EPILEPSY	The pivotal role of K+-Cl- cotransporter 2 (KCC2) in inhibitory neurotransmission and severe human diseases fosters interest in understanding posttranslational regulatory mechanisms such as (de)phosphorylation. Here, the regulatory role of the five bona fide phosphosites Ser(31), Thr(34), Ser(932), Thr(999), and Thr(1008) was investigated by the use of alanine and aspartate mutants. Tl+-based flux analyses in HEK-293 cells demonstrated increased transport activity for S932D (mimicking phosphorylation) and T1008A (mimicking dephosphorylation), albeit to a different extent. Increased activity was due to changes in intrinsic activity, as it was not caused by increased cell-surface abundance. Substitutions of Ser(31), Thr(34), or Thr(999) had no effect. Additionally, we show that the indirect actions of the known KCC2 activators staurosporine and N-ethylmaleimide (NEM) involved multiple phosphosites. S31D, T34A, S932A/D, T999A, or T1008A/D abrogated staurosporine mediated stimulation, and S31A, T34D, or S932D abolished NEM-mediated stimulation. This demonstrates for the first time differential effects of staurosporine and NEM on KCC2. In addition, the staurosporine-mediated effects involved both KCC2 phosphorylation and dephosphorylation with Ser(932) and Thr(1008) being bona fide target sites. In summary, our data reveal a complex phosphoregulation of KCC2 that provides the transporter with a toolbox for graded activity and integration of different signaling pathways.	[Cordshagen, Antje; Busch, Wiebke; Nothwang, Hans Gerd; Hartmann, Anna-Maria] Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, Ctr Excellence Hearing4all, Neurogenet Grp, D-26111 Oldenburg, Germany; [Winklhofer, Michael] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci IBU, D-26111 Oldenburg, Germany; [Winklhofer, Michael; Nothwang, Hans Gerd; Hartmann, Anna-Maria] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Hartmann, AM (corresponding author), Carl von Ossietzky Univ Oldenburg, Div Neurogenet, D-26111 Oldenburg, Germany.	anna.maria.hartmann@uol.de	Winklhofer, Michael/B-7349-2009	Winklhofer, Michael/0000-0003-1352-9723; Nothwang, Hans Gerd/0000-0001-7695-6437	Deutsche Forschungsgemeinschaft [NO428/14-1, HA 6338/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants NO428/14-1 (to H.G.N.) and HA 6338/2-1 (to A.-M.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Agez M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15739-1; Alessi DR, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005365; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergeron MJ, 2006, J BIOL CHEM, V281, P15959, DOI 10.1074/jbc.M600015200; Bize I, 2000, J MEMBRANE BIOL, V177, P159, DOI 10.1007/s002320001109; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Conway LC, 2017, J BIOL CHEM, V292, P21253, DOI 10.1074/jbc.M117.817841; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Culliford SJ, 2003, CELL PHYSIOL BIOCHEM, V13, P181, DOI 10.1159/000072420; de los Heros P, 2014, BIOCHEM J, V458, P559, DOI 10.1042/BJ20131478; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Friedel P, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0055-17.2017; Friedel P, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0354; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KB, 2013, AM J PHYSIOL-CELL PH, V304, pC693, DOI 10.1152/ajpcell.00350.2012; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hartmann AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179968; Hartmann AM, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00470; Hartmann AM, 2010, J BIOL CHEM, V285, P23994, DOI 10.1074/jbc.M110.144063; Heubl M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01749-0; HOLM S, 1979, SCAND J STAT, V6, P65; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Inoue K, 2006, J NEUROCHEM, V96, P598, DOI 10.1111/j.1471-4159.2005.03560.x; Inoue K, 2012, J BIOL CHEM, V287, P20839, DOI 10.1074/jbc.M111.319418; JENNINGS ML, 1991, J GEN PHYSIOL, V97, P799, DOI 10.1085/jgp.97.4.799; Kahle KT, 2014, EMBO REP, V15, P766, DOI 10.15252/embr.201438840; Kahle KT, 2014, JAMA NEUROL, V71, P640, DOI 10.1001/jamaneurol.2014.21; Kahle KT, 2013, TRENDS NEUROSCI, V36, P726, DOI 10.1016/j.tins.2013.08.006; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Kim JY, 2012, CELL, V148, P1051, DOI 10.1016/j.cell.2011.12.037; Kopp-Scheinpflug C, 2011, NEURON, V71, P911, DOI 10.1016/j.neuron.2011.06.028; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lee HHC, 2010, MOL CELL NEUROSCI, V45, P173, DOI 10.1016/j.mcn.2010.06.008; Lytle C, 2002, AM J PHYSIOL-CELL PH, V283, pC1422, DOI 10.1152/ajpcell.00130.2002; Markkanen M, 2017, BRAIN RES, V1675, P87, DOI 10.1016/j.brainres.2017.08.034; Markkanen M, 2014, J COMP NEUROL, V522, P1897, DOI 10.1002/cne.23510; Medina I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00027; Melo Z, 2013, J BIOL CHEM, V288, P31468, DOI 10.1074/jbc.M113.475574; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Merner ND, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00386; Monette MY, 2014, J BIOL CHEM, V289, P7569, DOI 10.1074/jbc.M113.542258; Monette Michelle Y, 2012, J Biol Chem, V287, P2210, DOI 10.1074/jbc.M111.309211; Moore YE, 2017, TRENDS NEUROSCI, V40, P555, DOI 10.1016/j.tins.2017.06.008; Papp E, 2008, NEUROSCIENCE, V154, P677, DOI 10.1016/j.neuroscience.2008.03.072; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Puskarjov M, 2015, NEUROPHARMACOLOGY, V88, P103, DOI 10.1016/j.neuropharm.2014.09.005; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Silayeva L, 2015, P NATL ACAD SCI USA, V112, P3523, DOI 10.1073/pnas.1415126112; Song LY, 2002, MOL BRAIN RES, V103, P91, DOI 10.1016/S0169-328X(02)00190-0; Strange K, 2000, AM J PHYSIOL-CELL PH, V279, pC860, DOI 10.1152/ajpcell.2000.279.3.C860; Titz S, 2015, NEUROPHARMACOLOGY, V95, P321, DOI 10.1016/j.neuropharm.2015.03.026; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190; Uvarov P, 2007, J BIOL CHEM, V282, P30570, DOI 10.1074/jbc.M705095200; Uvarov P, 2009, J BIOL CHEM, V284, P13696, DOI 10.1074/jbc.M807366200; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Watanabe M, 2009, J BIOL CHEM, V284, P27980, DOI 10.1074/jbc.M109.043620; Weber M, 2014, J BIOL CHEM, V289, P18668, DOI 10.1074/jbc.M114.567834; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5	71	14	14	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					16984	16993		10.1074/jbc.RA118.004349	http://dx.doi.org/10.1074/jbc.RA118.004349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30201606	Green Published, hybrid			2022-12-26	WOS:000449466500003
J	Gu, X; Bridges, MD; Yan, Y; de Waal, PW; Zhou, XE; Suino-Powell, KM; Xu, HE; Hubbell, WL; Melcher, K				Gu, Xin; Bridges, Michael D.; Yan, Yan; de Waal, Parker W.; Zhou, X. Edward; Suino-Powell, Kelly M.; Xu, H. Eric; Hubbell, Wayne L.; Melcher, Karsten			Conformational heterogeneity of the allosteric drug and metabolite (ADaM) site in AMP-activated protein kinase (AMPK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); biophysics; diabetes; metabolic regulation; cancer; ADaM site; DEER	GAMMA-SUBUNIT ISOFORMS; STRUCTURAL BASIS; SKELETAL-MUSCLE; ENERGY SENSOR; GLYCOGEN; BINDING; MECHANISM; A-769662; PHOSPHORYLATION; HOMEOSTASIS	AMP-activated protein kinase (AMPK) is a master regulator of energy homeostasis and a promising drug target for managing metabolic diseases such as type 2 diabetes. Many pharmacological AMPK activators, and possibly unidentified physiological metabolites, bind to the allosteric drug and metabolite (ADaM) site at the interface between the kinase domain (KD) in the -subunit and the carbohydrate-binding module (CBM) in the -subunit. Here, using double electron-electron resonance (DEER) spectroscopy, we demonstrate that the CBM-KD interaction is partially dissociated and the interface highly disordered in the absence of pharmacological ADaM site activators as inferred from a low depth of modulation and broad DEER distance distributions. ADaM site ligands such as 991, and to a lesser degree phosphorylation, stabilize the KD-CBM association and strikingly reduce conformational heterogeneity in the ADaM site. Our findings that the ADaM site, formed by the KD-CBM interaction, can be modulated by diverse ligands and by phosphorylation suggest that it may function as a hub for integrating regulatory signals.	[Gu, Xin; Yan, Yan; de Waal, Parker W.; Zhou, X. Edward; Suino-Powell, Kelly M.; Xu, H. Eric; Melcher, Karsten] Van Andel Res Inst, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA; [Bridges, Michael D.; Hubbell, Wayne L.] Univ Calif Los Angeles, UCLA Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Bridges, Michael D.; Hubbell, Wayne L.] Univ Calif Los Angeles, UCLA Sch Med, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Yan, Yan; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, VARI SIMM Ctr,Ctr Struct & Funct Drug Targets, Shanghai 201203, Peoples R China	Van Andel Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Melcher, K (corresponding author), Bostwick Ave Northeast, Grand Rapids, MI 49503 USA.	Karsten.melcher@vai.org	Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021	Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144	Jules Stein Professorship endowment; Van Andel Research Institute; National Institutes of Health [R01 GM102545, R01 GM129436, R01 EY05216, T33 EY07026, 5P41EB001980, R01 DK071662]; National Natural Science Foundation of China [31300245]; Ministry of Science and Technology (China) [2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, 2013ZX09507001]; Amway (China); NATIONAL EYE INSTITUTE [P30EY000331, R01EY005216, T32EY007026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM129436, R01GM102545] Funding Source: NIH RePORTER	Jules Stein Professorship endowment; Van Andel Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (China)(Ministry of Science and Technology, China); Amway (China); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Jules Stein Professorship endowment (to W.L.H.), Van Andel Research Institute (to H.E.X. and K.M.), National Institutes of Health Grants R01 GM102545 and R01 GM129436 (to K.M.), R01 EY05216, T33 EY07026, and 5P41EB001980 (to W.L.H.), and R01 DK071662 (to H.E.X.), National Natural Science Foundation of China Grant 31300245 (to H.E.X.), Ministry of Science and Technology (China) Grants 2012ZX09301001 and 2012CB910403, 2013CB910600, XDB08020303, and 2013ZX09507001 (to H.E.X.), and Amway (China) (to H.E.X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072851; Altenbach C., 2017, LONGDISTANCES VERSIO; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Calabrese MF, 2014, STRUCTURE, V22, P1161, DOI 10.1016/j.str.2014.06.009; Chen L, 2012, NAT STRUCT MOL BIOL, V19, P716, DOI 10.1038/nsmb.2319; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Fleissner MR, 2009, P NATL ACAD SCI USA, V106, P21637, DOI 10.1073/pnas.0912009106; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Gu X, 2017, J BIOL CHEM, V292, P12653, DOI 10.1074/jbc.M117.793018; Hardie DG, 2017, SCIENCE, V357, P455, DOI 10.1126/science.aao1913; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2013, DIABETES, V62, P2164, DOI 10.2337/db13-0368; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Jin L, 2004, J BIOL CHEM, V279, P42818, DOI 10.1074/jbc.M407096200; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2015, TRENDS BIOCHEM SCI, V40, P628, DOI 10.1016/j.tibs.2015.09.002; Langendorf CG, 2015, CELL RES, V25, P5, DOI 10.1038/cr.2014.163; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li XD, 2015, CELL RES, V25, P50, DOI 10.1038/cr.2014.150; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Ngoei KRW, 2018, CELL CHEM BIOL, V25, P728, DOI 10.1016/j.chembiol.2018.03.008; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Oligschlaeger Y, 2015, J BIOL CHEM, V290, P11715, DOI 10.1074/jbc.M114.633271; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Scott JW, 2015, CHEM BIOL, V22, P705, DOI 10.1016/j.chembiol.2015.05.011; Scott JW, 2014, CHEM BIOL, V21, P619, DOI 10.1016/j.chembiol.2014.03.006; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Shao D, 2014, CELL METAB, V19, P232, DOI 10.1016/j.cmet.2013.12.013; Smith PA, 1998, NUCLEIC ACIDS RES, V26, P1414, DOI 10.1093/nar/26.6.1414; STAPLETON D, 1994, J BIOL CHEM, V269, P29343; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Willows R, 2017, BIOCHEM J, V474, P3059, DOI 10.1042/BCJ20170458; Willows R, 2017, BIOCHEM J, V474, P1741, DOI 10.1042/BCJ20170046; Wu J, 2013, J BIOL CHEM, V288, P35904, DOI 10.1074/jbc.M113.508747; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932	46	9	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					16994	17007		10.1074/jbc.RA118.004101	http://dx.doi.org/10.1074/jbc.RA118.004101			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30206123	Green Published, hybrid			2022-12-26	WOS:000449466500004
J	Wu, CH; Schut, GJ; Poole, FL; Haja, DK; Adams, MWW				Wu, Chang-Hao; Schut, Gerrit J.; Poole, Farris L.; Haja, Dominik K.; Adams, Michael W. W.			Characterization of membrane-bound sulfane reductase: A missing link in the evolution of modern day respiratory complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sulfur; hydrogen sulfide; hydrogenase; oxidation-reduction (redox); membrane energetics; archaea; respiration; Complex I	ARCHAEON PYROCOCCUS-FURIOSUS; ELEMENTAL SULFUR; HYPERTHERMOPHILIC ARCHAEBACTERIUM; F420H2 DEHYDROGENASE; METABOLISM; HYDROGEN; OXIDOREDUCTASE; POLYSULFIDES; FERREDOXIN; PROTEINS	Hyperthermophilic archaea contain a hydrogen gas-evolving,respiratory membrane-bound NiFe-hydrogenase (MBH) that is very closely related to the aerobic respiratory complex I. During growth on elemental sulfur (S degrees), these microorganisms also produce a homologous membrane-bound complex (MBX), which generates H2S. MBX evolutionarily links MBH to complex I, but its catalytic function is unknown. Herein, we show that MBX reduces the sulfane sulfur of polysulfides by using ferredoxin (Fd) as the electron donor, and we rename it membrane-bound sulfane reductase (MBS). Two forms of affinity-tagged MBS were purified from genetically engineered Pyrococcus furiosus (a hyperthermophilic archaea species): the 13-subunit holoenzyme (S-MBS) and a cytoplasmic 4-subunit catalytic subcomplex (C-MBS). S-MBS and C-MBS reduced dimethyl trisulfide (DMTS) with comparable K-m (approximate to 490 m) and V-max values (12 mol/min/mg). The MBS catalytic subunit (MbsL), but not that of complex I (NuoD), retains two of four NiFe-coordinating cysteine residues of MBH. However, these cysteine residues were not involved in MBS catalysis because a mutant P. furiosus strain (MbsLC85A/C385A) grew normally with S degrees. The products of the DMTS reduction and properties of polysulfides indicated that in the physiological reaction, MBS uses Fd (E-o = -480 mV) to reduce sulfane sulfur (E-o -260 mV) and cleave organic (RSnR, n 3) and anionic polysulfides (S-n(2-), n 4) but that it does not produce H2S. Based on homology to MBH, MBS also creates an ion gradient for ATP synthesis. This work establishes the electrochemical reaction catalyzed by MBS that is intermediate in the evolution from proton- to quinone-reducing respiratory complexes.	[Wu, Chang-Hao; Schut, Gerrit J.; Poole, Farris L.; Haja, Dominik K.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Adams, MWW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adamsm@uga.edu			Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the Department of Energy [DE-FG05-95ER20175]	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the Department of Energy	This work was supported by Grant DE-FG05-95ER20175 (to M. W. A.) from the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the Department of Energy. The authors declare that they have no conflicts of interest with the contents of this article.	Adams MWW, 2001, J BACTERIOL, V183, P716, DOI 10.1128/JB.183.2.716-724.2001; ALBRACHT SPJ, 1993, BIOCHIM BIOPHYS ACTA, V1144, P221, DOI 10.1016/0005-2728(93)90176-G; AONO S, 1989, J BACTERIOL, V171, P3433, DOI 10.1128/jb.171.6.3433-3439.1989; Arnold T, 2007, BIOTECHNIQUES, V43, P427, DOI 10.2144/000112566; Baumer S, 2000, J BIOL CHEM, V275, P17968, DOI 10.1074/jbc.M000650200; Baumer S, 1998, FEBS LETT, V428, P295, DOI 10.1016/S0014-5793(98)00555-9; BLUMENTALS II, 1990, APPL ENVIRON MICROB, V56, P1255, DOI 10.1128/AEM.56.5.1255-1262.1990; Boyd E.S., 2014, MICROBE, V9, P361; Bridger SL, 2011, J BACTERIOL, V193, P6498, DOI 10.1128/JB.05445-11; BRYANT FO, 1989, J BIOL CHEM, V264, P5070; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Chandrayan SK, 2012, J BIOL CHEM, V287, P3257, DOI 10.1074/jbc.M111.290916; CHEN JS, 1977, ANAL BIOCHEM, V79, P157, DOI 10.1016/0003-2697(77)90390-6; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Dias B, 1998, APPL ENVIRON MICROB, V64, P3320; Enemark JH, 2002, MET IONS BIOL SYST, V39, P621; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; GIGGENBACH W, 1972, INORG CHEM, V11, P1201, DOI 10.1021/ic50112a009; Hedderich R, 1998, FEMS MICROBIOL REV, V22, P353, DOI 10.1111/j.1574-6976.1998.tb00376.x; Isogai A, 2009, J AGR FOOD CHEM, V57, P189, DOI 10.1021/jf802582p; Kang J, 2007, RAPID COMMUN MASS SP, V21, P4065, DOI 10.1002/rcm.3311; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Lipscomb GL, 2009, MOL MICROBIOL, V71, P332, DOI 10.1111/j.1365-2958.2008.06525.x; Liu YC, 2012, ENVIRON MICROBIOL, V14, P2632, DOI 10.1111/j.1462-2920.2012.02783.x; MA K, 1993, P NATL ACAD SCI USA, V90, P5341, DOI 10.1073/pnas.90.11.5341; MA K, 1994, J BACTERIOL, V176, P6509, DOI 10.1128/JB.176.21.6509-6517.1994; Ma KS, 2000, J BACTERIOL, V182, P1864, DOI 10.1128/JB.182.7.1864-1871.2000; McTernan PM, 2014, J BIOL CHEM, V289, P19364, DOI 10.1074/jbc.M114.567255; Nguyen DMN, 2017, J BIOL CHEM, V292, P14603, DOI 10.1074/jbc.M117.794172; Philippot P, 2007, SCIENCE, V317, P1534, DOI 10.1126/science.1145861; PICKERING TL, 1967, J AM CHEM SOC, V89, P2364, DOI 10.1021/ja00986a021; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; Prisner T, 2003, J BIOL INORG CHEM, V8, P419, DOI 10.1007/s00775-002-0432-5; RITZAU M, 1993, LIEBIGS ANN CHEM, P871; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; SCHAUDER R, 1993, ARCH MICROBIOL, V160, P377; SCHICHO RN, 1993, J BACTERIOL, V175, P1823, DOI 10.1128/JB.175.6.1823-1830.1993; Schut GJ, 2007, J BACTERIOL, V189, P4431, DOI 10.1128/JB.00031-07; Schut GJ, 2016, BBA-BIOENERGETICS, V1857, P958, DOI 10.1016/j.bbabio.2016.01.010; Schut GJ, 2013, FEMS MICROBIOL REV, V37, P182, DOI 10.1111/j.1574-6976.2012.00346.x; Schut GJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00163; Schut GJ, 2001, J BACTERIOL, V183, P7027, DOI 10.1128/JB.183.24.7027-7036.2001; Silva PJ, 2000, EUR J BIOCHEM, V267, P6541, DOI 10.1046/j.1432-1327.2000.01745.x; Van Kranendonk MJ, 2006, EARTH-SCI REV, V74, P197, DOI 10.1016/j.earscirev.2005.09.005; Yang H, 2010, MOL MICROBIOL, V77, P1111, DOI 10.1111/j.1365-2958.2010.07275.x; Yu HJ, 2018, CELL, V173, P1636, DOI 10.1016/j.cell.2018.03.071	47	17	17	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16687	16696		10.1074/jbc.RA118.005092	http://dx.doi.org/10.1074/jbc.RA118.005092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30181217	Green Published, hybrid			2022-12-26	WOS:000448515100012
J	Mereby, SA; Maehigashi, T; Holler, JM; Kim, DH; Schinazi, RF; Kim, B				Mereby, Sarah A.; Maehigashi, Tatsuya; Holler, Jessica M.; Kim, Dong-Hyun; Schinazi, Raymond F.; Kim, Baek			Interplay of ancestral non-primate lentiviruses with the virus-restricting SAMHD1 proteins of their hosts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lentivirus; SAM domain and HD domain-containing protein 1 (SAMHD1); macrophage; nucleotide; reverse transcription; antiviral defense; proteosomal degradation; dNTPase; immunodeficiency virus	HUMAN-IMMUNODEFICIENCY-VIRUS; INFECTIOUS-ANEMIA VIRUS; HIV-1 INFECTION; REVERSE TRANSCRIPTION; TISSUE MACROPHAGES; DENDRITIC CELLS; GENE-TRANSFER; MOUSE SAMHD1; IN-VIVO; VECTORS	Lentiviruses infect both dividing CD4(+) T cells and nondividing myeloid cells, and the infected myeloid cells serve as long-living viral reservoirs. Host sterile alpha motif- and histidine-aspartate domain-containing protein 1 (SAMHD1) kinetically restricts reverse transcription of primate lentiviruses, including human immunodeficiency virus, type 1 (HIV-1) and simian immunodeficiency virus (SIV), in nondividing myeloid cells. SAMHD1 enforces this restriction through its dNTP triphosphohydrolase (dNTPase) activity that depletes cellular dNTPs. Some primate lentiviruses, such as HIV-2, SIVsm, and SIVagm, counteract SAMHD1 restriction by using their viral accessory proteins (Vpx or Vpr) that induce the proteosomal degradation of SAMHD1 and increase dNTP levels. SAMHD1 is conserved among non-primate mammals such as cats, cows, and horses that also carry their own lentiviruses (feline and bovine immunodeficiency viruses and equine infectious anemia viruses, respectively). However, whether these viruses also target SAMHD1 is unknown. Here, we tested whether these ancestral non-primate lentiviruses also can counteract their host SAMHD1 proteins by promoting their proteosomal degradation. Using biochemical and various cell-based assays, we observed that SAMHD1 proteins from the non-primate host species display dGTP-dependent dNTPase activity, but that the non-primate lentiviruses fail to proteosomally degrade the SAMHD1 proteins of their hosts. Our findings suggest that accessory protein-mediated proteosomal degradation of SAMHD1 did not exist among the ancestral non-primate lentiviruses and was uniquely gained by some primate lentiviruses after their transmission to primate species.	[Mereby, Sarah A.; Maehigashi, Tatsuya; Holler, Jessica M.; Schinazi, Raymond F.; Kim, Baek] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Kim, Dong-Hyun; Kim, Baek] Kyung Hee Univ, Dept Pharm, Seoul 130701, South Korea; [Kim, Baek] Childrens Healthcare Atlanta, Ctr Drug Discovery, Atlanta, GA 30322 USA	Emory University; Kyung Hee University; Children's Healthcare of Atlanta (CHOA)	Kim, B (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.	baek.kim@emory.edu			National Institutes of Health [AI136581, GM104198, MH116695]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI136581, P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH116695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants AI136581 (to B. K.), GM104198 (to B. K.), and MH116695 (to R. F. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amie SM, 2013, J BIOL CHEM, V288, P25001, DOI 10.1074/jbc.C113.493619; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; Bhatia S, 2013, INDIAN J VIROL, V24, P332, DOI 10.1007/s13337-013-0165-9; Bonifati S, 2016, VIROLOGY, V495, P92, DOI 10.1016/j.virol.2016.05.002; BRUNNER D, 1989, J VIROL, V63, P5483, DOI 10.1128/JVI.63.12.5483-5488.1989; Buzovetsky O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02783-8; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; ELDER JH, 1992, J VIROL, V66, P1791, DOI 10.1128/JVI.66.3.1791-1794.1992; Foley B. T., 2000, HIV SEQUENCE COMPEND; Fregoso OI, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003496; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Hansen EC, 2014, P NATL ACAD SCI USA, V111, pE1843, DOI 10.1073/pnas.1401706111; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; JACOBS RM, 1994, VET RES COMMUN, V18, P471, DOI 10.1007/BF01839424; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; MACE K, 1989, VIROLOGY, V168, P399, DOI 10.1016/0042-6822(89)90282-1; Mangeot PE, 2000, J VIROL, V74, P8307, DOI 10.1128/JVI.74.18.8307-8315.2000; McIntosh EM, 1996, ACTA BIOCHIM POL, V43, P583; McKay T, 2006, GENE THER, V13, P715, DOI 10.1038/sj.gt.3302715; Oaks JL, 1998, J VIROL, V72, P7263, DOI 10.1128/JVI.72.9.7263-7269.1998; OBRIEN WA, 1994, J LEUKOCYTE BIOL, V56, P273, DOI 10.1002/jlb.56.3.273; OBRIEN WA, 1994, J VIROL, V68, P1258, DOI 10.1128/JVI.68.2.1258-1263.1994; PANG S, 1990, NATURE, V343, P85, DOI 10.1038/343085a0; Patel M, 2013, J GENE MED, V15, P51, DOI 10.1002/jgm.2695; Poeschla EM, 1998, NAT MED, V4, P354, DOI 10.1038/nm0398-354; Ritchey JW, 2001, VET IMMUNOL IMMUNOP, V79, P83, DOI 10.1016/S0165-2427(01)00250-1; Schwefel D, 2015, CELL HOST MICROBE, V17, P489, DOI 10.1016/j.chom.2015.03.004; Schwefel D, 2014, NATURE, V505, P234, DOI 10.1038/nature12815; SELLON DC, 1992, J VIROL, V66, P5906, DOI 10.1128/JVI.66.10.5906-5913.1992; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sommer AFR, 2016, SCI REP-UK, V6, DOI 10.1038/srep26616; Spragg CJ, 2013, P NATL ACAD SCI USA, V110, P21136, DOI 10.1073/pnas.1316839110; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Swanstrom AE, 2018, CURR HIV RES, V16, P29, DOI 10.2174/1570162X15666171124123116; WEINBERG JB, 1991, J EXP MED, V174, P1477, DOI 10.1084/jem.174.6.1477; Weissman D, 1997, NATURE, V389, P981, DOI 10.1038/40173; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822	47	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16402	16412		10.1074/jbc.RA118.004567	http://dx.doi.org/10.1074/jbc.RA118.004567			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30181218	hybrid, Green Published			2022-12-26	WOS:000447833600023
J	Jansson, M; Laikre, L				Jansson, Mija; Laikre, Linda			Pedigree data indicate rapid inbreeding and loss of genetic diversity within populations of native, traditional dog breeds of conservation concern	PLOS ONE			English	Article							GENOMIC ANALYSES; DOMESTIC DOGS; HEALTH	Increasing concern is directed towards genetic diversity of domestic animal populations because strong selective breeding can rapidly deplete genetic diversity of socio-economically valuable animals. International conservation policy identifies minimizing genetic erosion of domesticated animals as a key biodiversity target. We used breeding records to assess potential indications of inbreeding and loss of founder allelic diversity in 12 native Swedish dog breeds, traditional to the country, ten of which have been identified by authorities as of conservation concern. The pedigrees dated back to the mid-1900, comprising 5-11 generations and 350-66,500 individuals per pedigree. We assessed rates of inbreeding and potential indications of loss of genetic variation by measuring inbreeding coefficients and remaining number of founder alleles at five points in time during 1980-2012. We found average inbreeding coefficients among breeds to double-from an average of 0.03 in 1980 to 0.07 in 2012 -in spite of the majority of breeds being numerically large with pedigrees comprising thousands of individuals indicating that such rapid increase of inbreeding should have been possible to avoid. We also found indications of extensive loss of intra-breed variation; on average 70 percent of founder alleles are lost during 1980-2012. Explicit conservation goals for these breeds were not reflected in pedigree based conservation genetic measures; breeding needs to focus more on retaining genetic variation, and supplementary genomic analyses of these breeds are highly warranted in order to find out the extent to which the trends indicated here are reflected over the genomes of these breeds.	[Jansson, Mija; Laikre, Linda] Stockholm Univ, Dept Zool, Div Populat Genet, Stockholm, Sweden	Stockholm University	Laikre, L (corresponding author), Stockholm Univ, Dept Zool, Div Populat Genet, Stockholm, Sweden.	linda.laikre@popgen.su.se		Laikre, Linda/0000-0001-9286-3361	Swedish Research Council Formas grant [dnr 215-2012-1550, FR-2016/0005]	Swedish Research Council Formas grant(Swedish Research Council Formas)	Funded by Swedish Research Council Formas grant numbers: dnr 215-2012-1550, FR-2016/0005.	Allendorf F. W., 2012, CONSERV GENET; Bartolome N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122558; Baumung R, 2004, J ANIM BREED GENET, V121, P361, DOI 10.1111/j.1439-0388.2004.00479.x; Browne C, 2006, IRISH VET J, V59, P97; Calboli FCF, 2008, GENETICS, V179, P593, DOI 10.1534/genetics.107.084954; Dog Care Professionals, 2016, DOG CARE PROFESSIONA; Donner J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161005; Dreger DL, 2016, DIS MODEL MECH, V9, P1445, DOI 10.1242/dmm.027037; FAO, 2007, GLOB PLAN ACT AN GEN; Frankel OH, 1981, CONSERVATION EVOLUTI; Horvath G, 2008, INTEGR CANCER THER, V7, P76, DOI 10.1177/1534735408319058; Jansson M, 2014, J ANIM BREED GENET, V131, P153, DOI 10.1111/jbg.12060; Jansson M, 2013, CONSERV GENET RESOUR, V5, P651, DOI 10.1007/s12686-013-9874-z; Kardos M, 2015, HEREDITY, V115, P63, DOI 10.1038/hdy.2015.17; Kardos M, 2018, NAT ECOL EVOL, V2, P124, DOI 10.1038/s41559-017-0375-4; Kim ES, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129967; LACY RC, 1989, ZOO BIOL, V8, P111, DOI 10.1002/zoo.1430080203; Lacy RC, 1995, ZOO BIOL, V14, P565, DOI 10.1002/zoo.1430140609; Lacy RC, 2012, METHODS ECOL EVOL, V3, P433, DOI 10.1111/j.2041-210X.2011.00148.x; Laikre L, 1999, HEREDITAS, V130, P203, DOI 10.1111/j.1601-5223.1999.00203.x; Laikre L, 2010, CONSERV GENET, V11, P349, DOI 10.1007/s10592-009-0037-4; Lannek J., 2007, GOALS DOMESTIC ANIMA; Leroy G, 2006, J ANIM BREED GENET, V123, P1, DOI 10.1111/j.1439-0388.2006.00565.x; Leroy G, 2011, VET J, V189, P177, DOI 10.1016/j.tvjl.2011.06.016; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lindholm A., 2007, SWEDISH NATIVE BREED; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Marras G, 2015, ANIM GENET, V46, P110, DOI 10.1111/age.12259; Martyniuk E, 2010, ANIM GENE RESOUR, V46, P31, DOI DOI 10.1017/S2078633610001013; Mellersh C, 2012, MAMM GENOME, V23, P109, DOI 10.1007/s00335-011-9365-z; Parker HG, 2017, CELL REP, V19, P697, DOI 10.1016/j.celrep.2017.03.079; Parker HG, 2012, MAMM GENOME, V23, P19, DOI 10.1007/s00335-011-9387-6; Scherf B.D, 2000, WORLD WATCH LIST DOM; Serres-Armero A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4318-x; Speed D, 2015, NAT REV GENET, V16, P33, DOI 10.1038/nrg3821; Stephens T. D., 2013, Animal Genetic Resources, P31; Swedish Board of Agriculture, 2009, ACT PLAN LONG TERM S; Taberlet P, 2011, CR BIOL, V334, P247, DOI 10.1016/j.crvi.2010.12.007; Unsgard J., 2015, NATIVE DOG BREEDS NO; Voges S, 2009, J ANIM BREED GENET, V126, P357, DOI 10.1111/j.1439-0388.2009.00800.x; Wade CM, 2011, VET J, V189, P183, DOI 10.1016/j.tvjl.2011.06.017; Wells DL, 2007, BRIT J HEALTH PSYCH, V12, P145, DOI 10.1348/135910706X103284; Wiener P, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3933-x; Willes R., 2008, SWEDISH BREEDS DOGS; Willoughby JR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175996; Yang H, 2013, J ANIM BREED GENET, V130, P249, DOI 10.1111/jbg.12045	46	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2018	13	9							e0202849	10.1371/journal.pone.0202849	http://dx.doi.org/10.1371/journal.pone.0202849			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7EB	30208042	Green Published, Green Submitted, gold			2022-12-26	WOS:000444683000035
J	Fan, X; Li, N; Wang, XS; Zhang, JY; Xu, MY; Liu, XT; Wang, BN				Fan, Xin; Li, Ning; Wang, Xiaoshuang; Zhang, Jingyu; Xu, Meiyi; Liu, Xueting; Wang, Beinan			Protective immune mechanisms of Yifei Tongluo, a Chinese herb formulation, in the treatment of mycobacterial infection	PLOS ONE			English	Article							HOST-DIRECTED THERAPIES; INFLAMMATORY RESPONSE; T-CELLS; TUBERCULOSIS; BCG; LUNG; OPPORTUNITIES; MACROPHAGES; ACTIVATION; CHALLENGES	Yifei Tongluo (YFTL) is a traditional Chinese medicine (TCM) formulation which has been shown clinical efficacy in treatment of patients with multidrug-resistant tuberculosis in China. However, the underlying mechanisms of the effects of YFTL are lacking. This study investigated the effects of YFTL on immune regulation with a mouse lung infection model with Bacille Calmette-Guerin (BCG). We found that compared with untreated mice, the lung mycobacterial load in YFTL-treated mice was significantly reduced, accompanied by alleviated pulmonary inflammation with reduction of pro-inflammatory cytokines and increase of prostaglandin E2 (PGE2). Flow cytometry analyses showed that Th1 cells were significantly higher in the lungs of YFTL-treated mice at early infection time. The results suggest that YFTL-treatment down-regulates pulmonary inflammation, which facilitates a rapid infiltration of Thl cells into the lungs. Moreover, the Th1 cells in the lungs were resolved faster at later time concomitant with increased the regulatory T cells (Tregs). The reduction of mycobacterial burden associated with improved tissue pathology, faster Th1 cell trafficking, and accelerated resolution of Th1 cells in the lungs of YFTL-treated mice indicates that YFTL improves mycobacterial clearance by maintaining lung homeostasis and dynamically regulating T cells in the lung parenchyma, and suggests that YFTL can be used as host-directed therapies that target immune responses to mycobacterial infection.	[Fan, Xin; Li, Ning; Wang, Xiaoshuang; Zhang, Jingyu; Xu, Meiyi; Liu, Xueting; Wang, Beinan] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Xu, Meiyi; Wang, Beinan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, BN (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.; Wang, BN (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	wangbn@im.ac.cn		Wang, Beinan/0000-0002-9260-7197	National Major Science and Technology Project [2013ZX10005004-005]; National Natural Science Foundation of China [31370928, 31400760]	National Major Science and Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funding from the National Major Science and Technology Project Grant (2013ZX10005004-005), the National Natural Science Foundation of China Grant (31370928) and Grant (31400760) for Young Scholars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by funding from the National Major Science and Technology Project Grant (2013ZX10005004-005), the National Natural Science Foundation of China Grant (31370928) and Grant (31400760) for Young Scholars.	Altaf M, 2010, TUBERCULOSIS, V90, P333, DOI 10.1016/j.tube.2010.09.002; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Ansari AW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00312; Brighenti S, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0006-2016; Cao YG, 2009, FUND CLIN PHARMACOL, V23, P457, DOI 10.1111/j.1472-8206.2009.00696.x; Chavez-Galan L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00999; Chen K, 2013, ANNU REV IMMUNOL, V31, P605, DOI 10.1146/annurev-immunol-032712-100019; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Dick T, 1998, FEMS MICROBIOL LETT, V163, P159, DOI 10.1111/j.1574-6968.1998.tb13040.x; Divangahi M, 2013, ADV EXP MED BIOL, V783, P103, DOI 10.1007/978-1-4614-6111-1_6; Dovedi SJ, 2005, J UROLOGY, V174, P332, DOI 10.1097/01.ju.0000161589.85869.ae; Erb KJ, 1999, EUR CYTOKINE NETW, V10, P147; Etna MP, 2014, SEMIN IMMUNOL, V26, P543, DOI 10.1016/j.smim.2014.09.011; Fan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107638; Feng WJ, 2012, J NEW CHIN MED, V44, P22; Feng WJ, 2014, J HUNAN U CHIN MED, V34, P46; Friedland JS, 2014, NEW ENGL J MED, V371, P1354, DOI 10.1056/NEJMcibr1408663; Gopal R, 2012, EUR J IMMUNOL, V42, P364, DOI 10.1002/eji.201141569; Haoues M, 2012, Arch Inst Pasteur Tunis, V89, P3; Jaron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002833; Jeevan A, 2007, CLIN EXP IMMUNOL, V149, P387, DOI 10.1111/j.1365-2249.2007.03425.x; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Larson RP, 2013, ADV EXP MED BIOL, V783, P165, DOI 10.1007/978-1-4614-6111-1_9; Lyadova IV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010469; Machelart A, 2017, DRUG DISCOV TODAY, V22, P1250, DOI 10.1016/j.drudis.2017.05.005; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mayer-Barber KD, 2015, COLD SPRING HARB PER, V5, P12; Moliva Juan I, 2017, Front Immunol, V8, P407, DOI 10.3389/fimmu.2017.00407; Orme IM, 2015, NAT IMMUNOL, V16, P57, DOI 10.1038/ni.3048; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sachan M, 2016, CURR PHARM DESIGN, V22, P2599, DOI 10.2174/1381612822666160128150636; Sakai S, 2014, J IMMUNOL, V192, P2965, DOI 10.4049/jimmunol.1400019; Sasindran SJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00002; Shehzad A, 2013, BRAZ J INFECT DIS, V17, P74, DOI 10.1016/j.bjid.2012.10.009; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2015, COLD SPRING HARB PER, V5; Tomioka H, 2017, AM J CHINESE MED, V45, P1597, DOI 10.1142/S0192415X17500860; Tripathi RP, 2012, CURR MED CHEM, V19, P488; Wang XS, 2017, J INFECT DIS, V215, P644, DOI 10.1093/infdis/jiw598; Wang YJ, 2016, J ETHNOPHARMACOL, V194, P72, DOI 10.1016/j.jep.2016.08.046; Winslow GM, 2008, IMMUNOL REV, V225, P284, DOI 10.1111/j.1600-065X.2008.00693.x; World Health Organization, GLOBAL TUBERCULOSIS; YOSHIDA A, 1995, J IMMUNOL, V155, P2057	44	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203678	10.1371/journal.pone.0203678	http://dx.doi.org/10.1371/journal.pone.0203678			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204794	Green Submitted, Green Published, gold			2022-12-26	WOS:000444355500037
J	Higuera-Llanten, S; Vasquez-Ponce, F; Barrientos-Espinoza, B; Mardones, F; Marshall, S; Olivares-Pacheco, J				Higuera-Llanten, Sebastian; Vasquez-Ponce, Felipe; Barrientos-Espinoza, Beatriz; O Mardones, Fernando; H Marshall, Sergio; Olivares-Pacheco, Jorge			Extended antibiotic treatment in salmon farms select multiresistant gut bacteria with a high prevalence of antibiotic resistance genes	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; CLASS 1 INTEGRONS; PISCIRICKETTSIA-SALMONIS; MARINE-BACTERIA; HAFNIA-ALVEI; STAPHYLOCOCCUS-PSEUDINTERMEDIUS; BROCHOTHRIX-THERMOSPHACTA; ANTIMICROBIAL RESISTANCE; RICKETTSIAL SEPTICEMIA; FLORFENICOL RESISTANCE	The high use of antibiotics for the treatment of bacterial diseases is one of the main problems in the mass production of animal protein. Salmon farming in Chile is a clear example of the above statement, where more than 5,500 tonnes of antibiotics have been used over the last 10 years. This has caused a great impact both at the production level and on the environment; however, there are still few works in relation to it. In order to demonstrate the impact of the high use of antibiotics on fish gut microbiota, we have selected four salmon farms presenting a similar amount of fish of the Atlantic salmon species (Salmo salar), ranging from 4,500 to 6,000 tonnes. All of these farms used treatments with high doses of antibiotics. Thus, 15 healthy fish were selected and euthanised in order to isolate the bacteria resistant to the antibiotics oxytetracycline and florfenicol from the gut microbiota. In total, 47 bacterial isolates resistant to florfenicol and 44 resistant to oxytetracycline were isolated, among which isolates with Minimum Inhibitory Concentrations (MIC) exceeding 2048 mu g/mL for florfenicol and 1024 mu g/mL for oxytetracycline were found. In addition, another six different antibiotics were tested in order to demonstrate the multiresistance phenomenon. In this regard, six isolates of 91 showed elevated resistance values for the eight tested antibiotics, including florfenicol and oxytetracycline, were found. These bacteria were called "super-resistant" bacteria. This phenotypic resistance was verified at a genotypic level since most isolates showed antibiotic resistance genes (ARGs) to florfenicol and oxytetracycline. Specifically, 77% of antibiotic resistant bacteria showed at least one gene resistant to florfenicol and 89% showed at least one gene resistant to oxytetracycline. In the present study, it was demonstrated that the high use of the antibiotics florfenicol and oxytetracycline has, as a consequence, the selection of multiresistant bacteria in the gut microbiota of farmed fish of the Salmo salar species at the seawater stage. Also, the phenotypic resistance of these bacteria can be correlated with the presence of antibiotic resistance genes.	[Higuera-Llanten, Sebastian; Vasquez-Ponce, Felipe; Barrientos-Espinoza, Beatriz; H Marshall, Sergio; Olivares-Pacheco, Jorge] Pontificia Univ Catolica Valparaiso, Fac Ciencias, Inst Biol, Lab Genet & Inmunol Mol, Campus Curauma, Valparaiso, CP, Chile; [O Mardones, Fernando] Univ Andres Bello, Fac Ecol & Recursos Nat, Escuela Med Vet, Republ 252, Santiago, Chile; [Olivares-Pacheco, Jorge] Millenium Nucleus Interdisciplinary Approach Anti, Santiago, SP, Chile	Pontificia Universidad Catolica de Valparaiso; Universidad Andres Bello	Olivares-Pacheco, J (corresponding author), Pontificia Univ Catolica Valparaiso, Fac Ciencias, Inst Biol, Lab Genet & Inmunol Mol, Campus Curauma, Valparaiso, CP, Chile.; Olivares-Pacheco, J (corresponding author), Millenium Nucleus Interdisciplinary Approach Anti, Santiago, SP, Chile.	jorge.olivares@pucv.cl	Mardones, Fernando/ABF-6397-2020; Vasquez-Ponce, Felipe/AAA-1195-2022; Olivares Pacheco, Jorge/M-7714-2017; Mardones, Fernando/G-2488-2012	Mardones, Fernando/0000-0003-3019-3432; Vasquez-Ponce, Felipe/0000-0002-9447-8325; Olivares Pacheco, Jorge/0000-0002-6841-7182; Mardones, Fernando/0000-0003-1228-5392	Proyecto de la Comision nacional de ciencia y Tecnologia (CONICYT) [FONDECYT 11150858]; Proyecto de la Direccion de investigacion de la Pontificia Universidad Catolica de Valparaiso, Chile [ENVIROTRACKER: 039.461/2017]	Proyecto de la Comision nacional de ciencia y Tecnologia (CONICYT); Proyecto de la Direccion de investigacion de la Pontificia Universidad Catolica de Valparaiso, Chile	This work was supported by Proyecto de la Comision nacional de ciencia y Tecnologia (CONICYT) FONDECYT 11150858 (http://www.conicyt.cl/fondecyt/) and the Proyecto de la Direccion de investigacion de la Pontificia Universidad Catolica de Valparaiso, Chile. ENVIROTRACKER: 039.461/2017 (http://www.pucv.cl/uuaa/site/edic/base/port/vriea.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Ortega C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00007; Alvarez-Ortega C, 2010, ANTIMICROB AGENTS CH, V54, P4159, DOI 10.1128/AAC.00257-10; Angelakis E, 2017, MICROB PATHOGENESIS, V106, P162, DOI 10.1016/j.micpath.2016.11.002; [Anonymous], 2018, INF US ANT SALM NAC; Antunes P, 2004, J ANTIMICROB CHEMOTH, V54, P429, DOI 10.1093/jac/dkh333; Arkush KD, 2005, DIS AQUAT ORGAN, V63, P139, DOI 10.3354/dao063139; Asche F, 2009, MAR RESOUR ECON, V24, P405, DOI 10.1086/mre.24.4.42629664; Bai XH, 2015, SCI TOTAL ENVIRON, V533, P24, DOI 10.1016/j.scitotenv.2015.06.082; Banerjee S, 2018, MICROBIOL-SGM, V164, P142, DOI 10.1099/mic.0.000597; Baquero F, 2009, ENV MICROBIOL REP, V1, P469, DOI 10.1111/j.1758-2229.2009.00053.x; Baum SE, 2017, ONE HEALTH-AMSTERDAM, V3, P5, DOI 10.1016/j.onehlt.2016.10.004; Berrian AM, 2018, ONE HEALTH-AMSTERDAM, V5, P9, DOI 10.1016/j.onehlt.2017.11.002; Boechat CL, 2017, ENVIRON SCI POLLUT R, V24, P3063, DOI 10.1007/s11356-016-8103-1; Buschmann AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042724; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; Cantas L, 2012, ZEBRAFISH, V9, P26, DOI 10.1089/zeb.2011.0712; Carattoli A, 2001, VET RES, V32, P243, DOI 10.1051/vetres:2001122; Leyva-Diaz JC, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0805-7; Connell SR, 2003, ANTIMICROB AGENTS CH, V47, P3675, DOI 10.1128/AAC.47.12.3675-3681.2003; Corbeil S, 2005, DIS AQUAT ORGAN, V64, P37, DOI 10.3354/dao064037; Couto N, 2016, J GLOB ANTIMICROB RE, V7, P126, DOI 10.1016/j.jgar.2016.08.008; Dehler CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13249-8; Donhofer A, 2012, P NATL ACAD SCI USA, V109, P16900, DOI 10.1073/pnas.1208037109; Done HY, 2015, AAPS J, V17, P513, DOI 10.1208/s12248-015-9722-z; Durao P, 2018, TRENDS MICROBIOL, V26, P677, DOI 10.1016/j.tim.2018.01.005; EUCAST, 2017, BREAKP TABL INT MICS, P3; Evensen O, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00482; FAO, 2016, CONTR FOOD SEC NUTR, P200; Feng J, 2018, ENVIRON MICROBIOL, V20, P355, DOI 10.1111/1462-2920.14009; Fernandez L, 2013, ANTIMICROB AGENTS CH, V57, P110, DOI 10.1128/AAC.01583-12; Fernandez-Alarcon C, 2010, ZOONOSES PUBLIC HLTH, V57, P181, DOI 10.1111/j.1863-2378.2009.01243.x; Fougy L, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00491-17, 10.1128/genomea.00491-17]; Fuentealba P, 2017, BIORESOURCE TECHNOL, V223, P105, DOI 10.1016/j.biortech.2016.10.024; Gillings M, 2008, J BACTERIOL, V190, P5095, DOI 10.1128/JB.00152-08; Gillings MR, 2017, CURR OPIN MICROBIOL, V38, P10, DOI 10.1016/j.mib.2017.03.002; Gillings MR, 2014, MICROBIOL MOL BIOL R, V78, P257, DOI 10.1128/MMBR.00056-13; Gomez-Sanz E, 2013, ANTIMICROB AGENTS CH, V57, P5763, DOI 10.1128/AAC.00948-13; Grossman TH, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025387; Hadley C, 2012, AM J PHYS ANTHROPOL, V149, P72, DOI 10.1002/ajpa.22161; Hambright WS, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00158-16; Han Y, 2018, ENVIRON POLLUT, V242, P1711, DOI 10.1016/j.envpol.2018.07.101; HasinaKarki AM, 2013, UNIVERS J MICROBIOL, V1, P43, DOI [10.13189/UJMR.2013.010303, DOI 10.13189/UJMR.2013.010303]; Haubert L, 2017, MICROB PATHOGENESIS, V113, P242, DOI 10.1016/j.micpath.2017.10.022; House ML, 1999, DIS AQUAT ORGAN, V35, P107, DOI 10.3354/dao035107; Hove RJT, 2017, ANN CLIN MICROB ANTI, V16, DOI 10.1186/s12941-017-0221-1; Kehrenberg C, 2006, ANTIMICROB AGENTS CH, V50, P1156, DOI 10.1128/AAC.50.4.1156-1163.2006; Kehrenberg C, 2004, ANTIMICROB AGENTS CH, V48, P615, DOI 10.1128/AAC.48.2.615-618.2004; Kudo T, 2014, ISOLATED PREFERENTIA, V2, DOI [10.1128/genomeA.00280-14, DOI 10.1128/GENOMEA.00280-14]; Lebov J, 2017, ONE HEALTH-AMSTERDAM, V3, P44, DOI 10.1016/j.onehlt.2017.03.004; Leroi F, 2012, FOOD MICROBIOL, V31, P222, DOI 10.1016/j.fm.2012.02.014; Li DX, 2016, J ANTIMICROB CHEMOTH, V71, P1474, DOI 10.1093/jac/dkw040; Li J, 2017, VET MICROBIOL, V201, P183, DOI 10.1016/j.vetmic.2017.01.017; Liao IC, 2009, ASIA PAC J CLIN NUTR, V18, P564; Loch TP, 2011, J MICROBIOL, V49, P703, DOI 10.1007/s12275-011-0527-1; Lubroth J, 2012, CURR TOP MICROBIOL, P65, DOI [10.1007/82_2011_137, DOI 10.1007/82_2011_137]; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P44, DOI 10.1111/j.1574-6976.2008.00142.x; Maisey K, 2017, EXPERT REV VACCINES, V16, P215, DOI 10.1080/14760584.2017.1244483; Makrinos DL, 2017, J FISH DIS, V40, P1115, DOI 10.1111/jfd.12578; Marshall SH, 2018, J FISH DIS, V41, P501, DOI 10.1111/jfd.12752; Martinez J.L., 2012, ANTIMICROBIAL RESIST, P151; MARTINEZ JL, 2018, MICROBIOL SPECTR, V6, DOI DOI 10.1128/MICR0BI0LSPEC.MTBP-0006-2016; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Miller RA, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.ARBA-0017-2017; Minana-Galbis D, 2004, INT J SYST EVOL MICR, V54, P2073, DOI 10.1099/ijs.0.63202-0; Miranda CD, 2003, ANTIMICROB AGENTS CH, V47, P883, DOI 10.1128/AAC.47.3.883-888.2003; Miranda CD, 2007, AQUACULTURE, V266, P39, DOI 10.1016/j.aquaculture.2007.02.007; Miranda CD, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00233; Navarrete P, 2008, J AQUAT ANIM HEALTH, V20, P177, DOI 10.1577/H07-043.1; Navarrete P, 2010, FEMS MICROBIOL ECOL, V71, P148, DOI 10.1111/j.1574-6941.2009.00769.x; Nwaiwu O, 2018, DATA BRIEF, V16, P10, DOI 10.1016/j.dib.2017.10.073; Olivares J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00103; Orozova P, 2014, J FISH DIS, V37, P891, DOI 10.1111/jfd.12212; Palleroni NJ, 2010, ENVIRON MICROBIOL, V12, P1377, DOI 10.1111/j.1462-2920.2009.02041.x; Papadopoulou OS, 2012, MEAT SCI, V92, P735, DOI 10.1016/j.meatsci.2012.06.030; Papandreou S, 2000, J CHEMOTHERAPY, V12, P267, DOI 10.1179/joc.2000.12.4.267; Parajuli NP, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-016-0168-6; Pourabedin M, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv122; Ringo E, 2016, AQUACULT NUTR, V22, P219, DOI 10.1111/anu.12346; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Rozas M, 2014, J FISH DIS, V37, P163, DOI 10.1111/jfd.12211; Salas-Leiva J, 2017, LAT AM J AQUAT RES, V45, P370, DOI 10.3856/vol45-issue2-fulltext-12; Savini V, 2013, VET MICROBIOL, V163, P202, DOI 10.1016/j.vetmic.2012.12.002; Shah SQA, 2014, ENVIRON MICROBIOL, V16, P1310, DOI 10.1111/1462-2920.12421; Sleeman JM, 2017, J VET SCI, V18, P263, DOI 10.4142/jvs.2017.18.S1.263; Smith P. R., 2009, Guide to antimicrobial use in animals, P207, DOI 10.1002/9781444302639.ch12; Spataro N, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00382-13; Tamang MD, 2017, VET MICROBIOL, V201, P252, DOI 10.1016/j.vetmic.2017.01.035; Tan JY, 2014, SENSORS-BASEL, V14, P6788, DOI 10.3390/s140406788; Tandberg J, 2017, FISH SHELLFISH IMMUN, V67, P189, DOI 10.1016/j.fsi.2017.06.015; Thele R, 2017, J GLOB ANTIMICROB RE, V10, P1, DOI 10.1016/j.jgar.2017.05.007; Thong K., 2012, INDIAN J MED MICROBI, V30, P203, DOI DOI 10.4103/0255-0857.96693; Tomova A, 2018, MICROB ECOL, V75, P104, DOI 10.1007/s00248-017-1016-9; Tomova A, 2015, ENV MICROBIOL REP, V7, P803, DOI 10.1111/1758-2229.12327; Wang MZ, 2018, ENVIRON POLLUT, V238, P291, DOI 10.1016/j.envpol.2018.03.024; Wang Y, 2015, J ANTIMICROB CHEMOTH, V70, P2182, DOI 10.1093/jac/dkv116; Wang Y, 2012, ANTIMICROB AGENTS CH, V56, P1485, DOI 10.1128/AAC.05827-11; Woolhouse M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0083; Wu J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00745	99	53	54	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203641	10.1371/journal.pone.0203641	http://dx.doi.org/10.1371/journal.pone.0203641			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204782	gold, Green Published			2022-12-26	WOS:000444355500034
J	Elosegi, A; Nicolas, A; Richardson, JS				Elosegi, Arturo; Nicolas, Angie; Richardson, John S.			Priming of leaf litter decomposition by algae seems of minor importance in natural streams during autumn	PLOS ONE			English	Article							NUTRITIONAL CONSTRAINTS; AQUATIC DETRITIVORE; PRIMARY PRODUCERS; FRESH-WATER; FOOD WEBS; LAND-USE; ECOSYSTEMS; TERRESTRIAL; CONSUMERS; PHYTOPLANKTON	Allochthonous detritus of terrestrial origin is one of the main energy sources in forested headwater streams, but its poor nutritional quality makes it difficult to use by heterotrophs. It has been suggested that algae growing on this detritus can enhance its nutritional quality and promote decomposition. So far, most evidence of this "priming effect" is derived from laboratory or mesocosm experiments, and its importance under natural conditions is unclear. We measured accrual of algae, phosphorus uptake capacity, and decomposition of poplar leaves in autumn in open-and closed-canopy reaches in 3 forest and 3 agricultural streams. Chlorophyll a abundance did not change significantly with stream type or with canopy cover, although in some agricultural streams it was higher in open than in closed canopy reaches. Canopy cover did not affect either phosphate uptake capacity or microbial decomposition. On the other hand, although there was no effect of canopy cover on invertebrate fragmentation rate, a significant interaction between canopy cover and stream suggests priming occurs at least in some streams. Overall, the results point to a weak or no priming effect of algae on litter decomposition in natural streams during autumn.	[Elosegi, Arturo] Univ Basque Country UPV EHU, Fac Sci & Technol, Bilbao, Spain; [Nicolas, Angie; Richardson, John S.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC, Canada	University of Basque Country; University of British Columbia	Elosegi, A (corresponding author), Univ Basque Country UPV EHU, Fac Sci & Technol, Bilbao, Spain.	arturo.elosegi@ehu.eus	Elosegi, Arturo/B-7796-2009	Elosegi, Arturo/0000-0001-8809-8484	Natural Sciences and Engineering Research Council (Canada); Department of Education, Basque Government [IT951-16]; University of British Columbia [MV-2017-1-0034]	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Department of Education, Basque Government(Basque Government); University of British Columbia	The research was funded by the Natural Sciences and Engineering Research Council (Canada) and by the Department of Education, Basque Government, grant number IT951-16. The latter department also funded a research stage by Arturo Elosegi in the University of British Columbia (grant number MV-2017-1-0034).	Abelho M, 2001, ScientificWorldJournal, V1, P656; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; ANDERSON NH, 1976, ECOLOGY, V57, P1081, DOI 10.2307/1941074; Bengtsson MM, 2018, HYDROBIOLOGIA, V822, P1, DOI 10.1007/s10750-018-3672-2; BIGGS BJF, 1995, FRESHWATER BIOL, V33, P419, DOI 10.1111/j.1365-2427.1995.tb00404.x; Bouletreau S, 2008, RIVER RES APPL, V24, P36, DOI 10.1002/rra.1046; Brett MT, 2017, FRESHWATER BIOL, V62, P833, DOI 10.1111/fwb.12909; Chauvet E, 2016, ADV ECOL RES, V55, P99, DOI 10.1016/bs.aecr.2016.08.006; Crawley M.J., 2007, R BOOK; Crutsinger GM, 2014, MOL ECOL, V23, P5888, DOI 10.1111/mec.12931; Danger M, 2007, FUNCT ECOL, V21, P202, DOI 10.1111/j.1365-2435.2006.01222.x; Danger M, 2013, ECOLOGY, V94, P1604, DOI 10.1890/12-0606.1; Dewson ZS, 2007, ECOL APPL, V17, P1797, DOI 10.1890/06-1901.1; Elosegi A, 2011, LIMNETICA, V30, P183; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Evans-White MA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01184; Findlay S, 2010, J N AM BENTHOL SOC, V29, P170, DOI 10.1899/09-023.1; FISHER SG, 1973, ECOL MONOGR, V43, P421, DOI 10.2307/1942301; Francoeur SN, 2006, HYDROBIOLOGIA, V561, P59, DOI 10.1007/s10750-005-1604-4; Franken RJM, 2005, FRESHWATER BIOL, V50, P459, DOI 10.1111/j.1365-2427.2005.01333.x; Fuller CL, 2015, OECOLOGIA, V177, P837, DOI 10.1007/s00442-014-3154-9; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Guenet B, 2010, ECOLOGY, V91, P2850, DOI 10.1890/09-1968.1; Gulis V, 2006, FRESHWATER BIOL, V51, P1655, DOI 10.1111/j.1365-2427.2006.01615.x; Guo F, 2017, FRESHWATER BIOL, V62, P1325, DOI 10.1111/fwb.12956; Guo F, 2016, FRESHW SCI, V35, P1213, DOI 10.1086/688667; Hagen EM, 2012, OIKOS, V121, P1507, DOI 10.1111/j.1600-0706.2011.19666.x; Haggerty R, 2014, J GEOPHYS RES-BIOGEO, V119, P2220, DOI 10.1002/2013JG002498; Handa IT, 2014, NATURE, V509, P218, DOI 10.1038/nature13247; HANSON BJ, 1985, COMP BIOCHEM PHYS B, V80, P257, DOI 10.1016/0305-0491(85)90206-8; Hieber M, 2002, ECOLOGY, V83, P1026, DOI 10.1890/0012-9658(2002)083[1026:COSDFA]2.0.CO;2; HILL WR, 1995, ECOLOGY, V76, P1297, DOI 10.2307/1940936; Hladyz S, 2011, ADV ECOL RES, V44, P211, DOI 10.1016/B978-0-12-374794-5.00004-3; Huggins K, 2004, FRESHWATER BIOL, V49, P945, DOI 10.1111/j.1365-2427.2004.01236.x; Izagirre O, 2005, ANN LIMNOL-INT J LIM, V41, P35, DOI 10.1051/limn/2005004; Izagirre O, 2008, J N AM BENTHOL SOC, V27, P252, DOI 10.1899/07-022.1; Johnson SL, 2004, CAN J FISH AQUAT SCI, V61, P913, DOI [10.1139/f04-040, 10.1139/F04-040]; Karlsson J, 2007, OIKOS, V116, P1691, DOI 10.1111/j.2007.0030-1299.15825.x; Krauss GJ, 2011, FEMS MICROBIOL REV, V35, P620, DOI 10.1111/j.1574-6976.2011.00266.x; Kuehn KA, 2014, ECOLOGY, V95, P749, DOI 10.1890/13-0430.1; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Lange K, 2016, ECOL EVOL, V6, P23, DOI 10.1002/ece3.1822; Lecerf A, 2017, ECOL MODEL, V362, P65, DOI 10.1016/j.ecolmodel.2017.08.011; Ledger ME, 2000, ARCH HYDROBIOL, V149, P353; Lemoine NP, 2014, OECOLOGIA, V174, P1367, DOI 10.1007/s00442-013-2860-z; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Lovatt C, 2014, FUND APPL LIMNOL, V184, P297, DOI 10.1127/1863-9135/2014/0602; Mindl B, 2005, AQUAT MICROB ECOL, V38, P203, DOI 10.3354/ame038203; Mulholland Patrick J., 1996, P609, DOI 10.1016/B978-012668450-6/50048-5; MULHOLLAND PJ, 1995, J N AM BENTHOL SOC, V14, P357, DOI 10.2307/1467202; PETERSEN RC, 1974, FRESHWATER BIOL, V4, P343, DOI 10.1111/j.1365-2427.1974.tb00103.x; Piggott JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049873; Ponsati L, 2015, RIVER RES APPL, V31, P1003, DOI 10.1002/rra.2807; Proia L, 2017, ECOTOXICOLOGY, V26, P271, DOI 10.1007/s10646-017-1761-z; Shupe SM, 2017, SCI TOTAL ENVIRON, V603, P745, DOI 10.1016/j.scitotenv.2017.02.195; Sterner RW, 2008, LIMNOL OCEANOGR, V53, P1169, DOI 10.4319/lo.2008.53.3.1169; Torres-Ruiz M, 2010, HYDROBIOLOGIA, V651, P265, DOI 10.1007/s10750-010-0305-9; Vonk JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep35785; Woodward G, 2012, SCIENCE, V336, P1438, DOI 10.1126/science.1219534	59	14	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0200180	10.1371/journal.pone.0200180	http://dx.doi.org/10.1371/journal.pone.0200180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192753	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600005
J	Ionescu, AC; Brambilla, E; Azzola, F; Ottobelli, M; Pellegrini, G; Francetti, LA				Ionescu, Andrei C.; Brambilla, Eugenio; Azzola, Francesco; Ottobelli, Marco; Pellegrini, Gaia; Francetti, Luca A.			Laser microtextured titanium implant surfaces reduce in vitro and in situ oral biofilm formation	PLOS ONE			English	Article							PERI-IMPLANTITIS; PLAQUE; NANOPARTICLES; ROUGHNESS; CONSENSUS; ADHESION; GROWTH; CELLS; VIVO	Introduction Micro-or nano-topography can both provide antimicrobial properties and improve osseointegration of dental implant titanium surfaces. Laser treatment is one of the best surface microtexturing techniques. The aim of this study was to evaluate in vitro and in situ biofilm formation on a laser-treated titanium surface, comparing it with two conventional surfaces, machined and grit-blasted. Methods For the in vitro experiment, an oral microcosm biofilm model was developed on the surface of titanium disks and reference human enamel using a bioreactor for 48 h. For the in situ experiment, titanium implants with laser-treated, machined and grit-blasted surfaces were mounted on intraoral trays and worn by ten volunteers for 48 h. Biofilm formation was quantitatively evaluated, and surfaces were analyzed using confocal laser scanning microscopy, scanning electron microscopy and energy-dispersive X-ray spectroscopy. Results-in vitro study Biofilm structures with a prevalence of viable cells covered most of the machined, grit-blasted and human enamel surfaces, whereas less dense biofilm structures with non-confluent microcolonies were observed on the laser-treated titanium. Laser-treated titanium showed the lowest biofilm formation, where microorganisms colonized the edges of the laser-created pits, with very few or no biofilm formation observed inside the pits. Results-in situ study The biofilm formation pattern observed was similar to that in the in vitro experiment. Confocal laser scanning microscopy showed complete coverage of the implant threads, with mostly viable cells in grit-blasted and machined specimens. Unexpectedly, laser-treated specimens showed few dead microbial cells colonizing the bottom of the threads, while an intense colonization was found on the threading sides. Conclusion This data suggests that laser-created microtopography can reduce biofilm formation, with a maximum effect when the surface is blasted orthogonally by the laser beam. In this sense the orientation of the laser beam seems to be relevant for the biological interaction with biofilms.	[Ionescu, Andrei C.; Brambilla, Eugenio; Azzola, Francesco; Ottobelli, Marco; Pellegrini, Gaia; Francetti, Luca A.] Univ Milan, IRCCS Galeazzi Orthoped Inst, Dept Biomed Surg & Dent Sci, Milan, Italy	IRCCS Istituto Ortopedico Galeazzi; University of Milan	Ionescu, AC (corresponding author), Univ Milan, IRCCS Galeazzi Orthoped Inst, Dept Biomed Surg & Dent Sci, Milan, Italy.	andrei.ionescu@unimi.it	Pellegrini, Gaia/K-6865-2019; azzola, francesco/HGD-6586-2022; Francetti, Luca A/C-1758-2017; Francetti, Luca A/CAI-6331-2022	Pellegrini, Gaia/0000-0002-4179-7066; Francetti, Luca A/0000-0001-5775-8961; Francetti, Luca A/0000-0001-5775-8961; IONESCU, Andrei/0000-0001-9051-4109	GEASS srl	GEASS srl	This work was supported by GEASS srl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINAMO J, 1975, INT DENT J, V25, P229; Albrektsson T, 2012, CLIN ORAL IMPLAN RES, V23, P63, DOI 10.1111/j.1600-0501.2012.02557.x; Allaker RP, 2010, J DENT RES, V89, P1175, DOI 10.1177/0022034510377794; Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001; Berardi D, 2008, J BIOL REG HOMEOS AG, V22, P161; Berglundh T, 2007, CLIN ORAL IMPLAN RES, V18, P655, DOI 10.1111/j.1600-0501.2007.01397.x; Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3; Burgers R, 2010, CLIN ORAL IMPLAN RES, V21, P156, DOI 10.1111/j.1600-0501.2009.01815.x; Busscher HJ, 2010, J DENT RES, V89, P657, DOI 10.1177/0022034510368644; Cardelli P, 2014, ORAL IMPLANTOL, V6, P89; Cazzaniga G, 2017, J DENT, V67, P43, DOI 10.1016/j.jdent.2017.07.012; Cazzaniga G, 2015, AM J DENT, V28, P311; Cunha A, 2016, APPL SURF SCI, V360, P485, DOI 10.1016/j.apsusc.2015.10.102; Di Giulio M, 2016, CLIN ORAL IMPLAN RES, V27, P918, DOI 10.1111/clr.12659; Drago L, 2016, J CHEMOTHERAPY, V28, P383, DOI 10.1080/1120009X.2016.1158489; Fadeeva E, 2011, LANGMUIR, V27, P3012, DOI 10.1021/la104607g; Gosau M, 2010, CLIN ORAL IMPLAN RES, V21, P866, DOI 10.1111/j.1600-0501.2009.01908.x; Hahnel S, 2017, J DENT, V60, P14, DOI 10.1016/j.jdent.2017.02.005; He S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0169; Holmberg KV, 2013, ACTA BIOMATER, V9, P8224, DOI 10.1016/j.actbio.2013.06.017; Ionescu AC, 2017, J MATER SCI-MATER M, V28, P1; Ionescu A, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5372-4; Jimbo R, 2008, CLIN IMPLANT DENT R, V10, P55, DOI 10.1111/j.1708-8208.2007.00061.x; Khammissa R A G, 2012, SADJ, V67, P72; Lang NP, 2011, J CLIN PERIODONTOL, V38, P178, DOI 10.1111/j.1600-051X.2010.01674.x; Leonhardt A, 1999, CLIN ORAL IMPLAN RES, V10, P339, DOI 10.1034/j.1600-0501.1999.100501.x; Lepore S, 2013, J BIOL REG HOMEOS AG, V27, P531; Lorenzetti M, 2015, ACS APPL MATER INTER, V7, P1644, DOI 10.1021/am507148n; Lossdorfer S, 2004, J BIOMED MATER RES A, V70A, P361, DOI 10.1002/jbm.a.30025; Machado MC, 2010, PEDIATR RES, V67, P500, DOI 10.1203/PDR.0b013e3181d68e78; McBain AJ, 2003, J APPL MICROBIOL, V94, P655, DOI 10.1046/j.1365-2672.2003.01876.x; Mombelli A, 2012, CLIN ORAL IMPLAN RES, V23, P67, DOI 10.1111/j.1600-0501.2012.02541.x; Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Patil D, 2018, J MICRO NANO-MANUF, V6, DOI 10.1115/1.4038093; Renner LD, 2011, MRS BULL, V36, P347, DOI 10.1557/mrs.2011.65; Schwarz F, 2007, ORAL MAXILLOFAC SURG, V11, P333, DOI 10.1007/s10006-007-0079-z; Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x; Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071; van Hengel IAJ, 2017, BIOMATERIALS, V140, P1, DOI 10.1016/j.biomaterials.2017.02.030; VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326; Vorobyev AY, 2013, LASER PHOTONICS REV, V7, P385, DOI 10.1002/lpor.201200017; Warnakulasuriya S, 2010, INT DENT J, V60, P7, DOI 10.1922/IDJ_2532Warnakulasuriya24; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zaugg LK, 2017, CLIN ORAL IMPLAN RES, V28, P469, DOI 10.1111/clr.12821; Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320	46	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202262	10.1371/journal.pone.0202262	http://dx.doi.org/10.1371/journal.pone.0202262			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192766	gold, Green Published, Green Submitted			2022-12-26	WOS:000444093600023
J	Scioli, MG; Artuso, S; D'Angelo, C; Porru, M; D'Amico, F; Bielli, A; Gentile, P; Cervelli, V; Leonetti, C; Orlandi, A				Scioli, Maria Giovanna; Artuso, Simona; D'Angelo, Carmen; Porru, Manuela; D'Amico, Federico; Bielli, Alessandra; Gentile, Pietro; Cervelli, Valerio; Leonetti, Carlo; Orlandi, Augusto			Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth	PLOS ONE			English	Article							PLATELET-RICH PLASMA; MESENCHYMAL STROMAL CELLS; VASCULAR FRACTION CELLS; IN-VITRO; REGENERATIVE THERAPY; PLASTIC-SURGERY; TISSUE; VIVO; DIFFERENTIATION; MAINTENANCE	Breast cancer represents the main malignancy in women and autologous fat grafting is a diffuse procedure in the management of post-surgical breast defects causing patients' psychosocial problems, with high costs for the public health. Recently, beneficial effects of fat grafting during post-surgical breast reconstruction have been amplified from the enrichment with human adipose-derived stem cells (ASCs) present in the stromal vascular fraction (SVF) of adult adipose tissue isolated during intraoperatory procedures. The major concern about the ASC enrichment during post-surgery breast reconstruction depends on their potential ability to release growth factors and hormones that can promote proliferation of residual or quiescent cancer cells, with the risk of de novo cancer development or recurrence. The recent description that adult stem cells primed in vitro may be vehicle for anticancer drug delivery offers a new vision concerning the role of ASCs in breast reconstruction after cancer surgery. Paclitaxel (PTX) is a chemotherapeutic agent acting as a microtubule-stabilizing drug inhibiting cancer cell mitotic activity. We optimized PTX loading and release in cultured ASCs and then analyzed the effects of PTX-loaded ASCs and their conditioned medium on CG5 breast cancer survival, proliferation and apoptosis in vitro, and inCG5 xenograft in vivo. We documented that ASCs can uptake and release PTX in vitro, with slight cytotoxic effects. Interestingly, PTX-loaded ASCs in co-culture, as well as conditioned medium alone, inhibited CG5 cell proliferation and survival in vitro and xenograft tumor growth in vivo. The antitumor effect of PTX-loaded ASCs may offer a new perspective concerning the use of ASCs during breast reconstruction becoming an additional local preventive chemotherapeutic agent against tumor recurrence. However, further experiments in vitro and in vivo are needed to collect more evidence confirming the efficacy and safety in cancer patients.	[Scioli, Maria Giovanna; D'Amico, Federico; Bielli, Alessandra; Orlandi, Augusto] Tor Vergata Univ, Dept Biomed & Prevent, Anat Pathol, Rome, Italy; [Artuso, Simona; Porru, Manuela; Leonetti, Carlo] IRCCS Regina Elena Natl Canc Inst, SAFU, Rome, Italy; [D'Angelo, Carmen] IRCCS Regina Elena Natl Canc Inst, Unit Oncogen & Epigenet, Rome, Italy; [Gentile, Pietro; Cervelli, Valerio] Tor Vergata Univ, Dept Biomed & Prevent, Plast & Reconstruct Surg, Rome, Italy; [Orlandi, Augusto] Catholic Univ Our Iady Good Counsel, Dept Biomed Sci, Anat Pathol, Tirana, Albania	University of Rome Tor Vergata; University of Rome Tor Vergata	Orlandi, A (corresponding author), Tor Vergata Univ, Dept Biomed & Prevent, Anat Pathol, Rome, Italy.; Orlandi, A (corresponding author), Catholic Univ Our Iady Good Counsel, Dept Biomed Sci, Anat Pathol, Tirana, Albania.	orlandi@uniroma2.it	Scioli, Maria Giovanna/AAC-7612-2022; Porru, Manuela/AAA-5510-2021; Orlandi, Augusto/AHE-8753-2022; Leonetti, Carlo/B-2860-2018	Scioli, Maria Giovanna/0000-0002-8458-4108; Porru, Manuela/0000-0002-6614-9110; Leonetti, Carlo/0000-0002-3526-7827; D'AMICO, Federico/0000-0001-7825-4922				Bielli A, 2015, ADV CLIN EXP MED, V24, P545, DOI 10.17219/acem/31673; Bielli A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-345; Bonomi A, 2013, INT J IMMUNOPATH PH, V26, P33, DOI 10.1177/03946320130260S105; Bonomi A, 2017, HEMATOL ONCOL, V35, P693, DOI 10.1002/hon.2306; Cervelli V, 2009, TISSUE ENG PART C-ME, V15, P625, DOI [10.1089/ten.tec.2008.0518, 10.1089/ten.TEC.2008.0518]; Cervelli V, 2012, STEM CELL TRANSL MED, V1, P206, DOI 10.5966/sctm.2011-0052; Cervelli V, 2011, STEM CELL RES, V6, P103, DOI 10.1016/j.scr.2010.11.003; Choron RL, 2015, J SURG RES, V196, P404, DOI 10.1016/j.jss.2015.03.026; Cocce V, 2017, ANTI-CANCER AGENT ME, V17, P1578, DOI 10.2174/1871520617666170327113932; Coleman SR, 2007, PLAST RECONSTR SURG, V119, P775, DOI 10.1097/01.prs.0000252001.59162.c9; Delay E, 2009, AESTHET SURG J, V29, P360, DOI 10.1016/j.asj.2009.08.010; Desiderio V, 2013, J CELL PHYSIOL, V228, P1762, DOI 10.1002/jcp.24336; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Domenis R, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt536; Donnenberg VS, 2010, TISSUE ENG PART B-RE, V16, P567, DOI [10.1089/ten.teb.2010.0352, 10.1089/ten.TEB.2010.0352]; Eterno V, 2014, ONCOTARGET, V5, P613, DOI 10.18632/oncotarget.1359; Flageng MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074618; Gentile P, 2017, STEM CELLS, V35, P117, DOI 10.1002/stem.2498; Gentile P, 2012, STEM CELL TRANSL MED, V1, P341, DOI 10.5966/sctm.2011-0065; Gentile P, 2012, STEM CELL TRANSL MED, V1, P230, DOI 10.5966/sctm.2011-0054; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Haller H, 2017, ACTA ONCOL, V56, P1665, DOI 10.1080/0284186X.2017.1342862; Harris WM, 2017, CYTOTHERAPY, V19, P211, DOI 10.1016/j.jcyt.2016.10.010; Huang WC, 2017, J CONTROL RELEASE, V254, P119, DOI 10.1016/j.jconrel.2017.03.035; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Kolle SFT, 2013, LANCET, V382, P1113, DOI 10.1016/S0140-6736(13)61410-5; Krumboeck A, 2013, BREAST, V22, P579, DOI 10.1016/j.breast.2013.05.006; Li WJ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7407168; Liu BL, 2009, MOL CANCER RES, V7, P1882, DOI 10.1158/1541-7786.MCR-08-0509; Locke M, 2011, STEM CELLS, V29, P404, DOI 10.1002/stem.593; Lourenco S, 2015, J IMMUNOL, V194, P3463, DOI 10.4049/jimmunol.1402097; Manabe Y, 2003, J PATHOL, V201, P221, DOI 10.1002/path.1430; Missana MC, 2007, EJSO-EUR J SURG ONC, V33, P685, DOI 10.1016/j.ejso.2006.12.002; Nguyen PT, 2013, BRIT J CANCER, V109, P2248, DOI 10.1038/bjc.2013.550; Normanno N, 2005, CURR DRUG TARGETS, V6, P243, DOI 10.2174/1389450053765879; Pacioni S, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0516-3; Papaccio F, 2017, STEM CELL TRANSL MED, V6, P2115, DOI 10.1002/sctm.17-0138; Pascucci L, 2014, J CONTROL RELEASE, V192, P262, DOI 10.1016/j.jconrel.2014.07.042; Pessina A, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0200-3; Pessina A, 2013, BRIT J HAEMATOL, V160, P766, DOI 10.1111/bjh.12196; Petit JY, 2013, ANN ONCOL, V24, P1479, DOI 10.1093/annonc/mds660; Petit JY, 2012, ANN ONCOL, V23, P582, DOI 10.1093/annonc/mdr158; Petrella F, 2017, BIOMED PHARMACOTHER, V87, P755, DOI 10.1016/j.biopha.2017.01.118; Reed JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045877; Rietjens M, 2011, J PLAST RECONSTR AES, V64, P477, DOI 10.1016/j.bjps.2010.06.024; Rigotti G, 2010, AESTHET PLAST SURG, V34, P475, DOI 10.1007/s00266-010-9481-2; Sakurai M, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0863-0; Stellavato A, 2017, CELL PHYSIOL BIOCHEM, V44, P1078, DOI 10.1159/000485414; Wang YY, 2012, CANCER LETT, V324, P142, DOI 10.1016/j.canlet.2012.05.019; Weaver BA, 2014, MOL BIOL CELL, V25, P2677, DOI 10.1091/mbc.E14-04-0916; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wu J, 2016, ACS APPL MATER INTER, V8, P17927, DOI 10.1021/acsami.6b05677; Xu QL, 2012, INT J ONCOL, V41, P959, DOI 10.3892/ijo.2012.1541; Zimmerlin L, 2011, TISSUE ENG PT A, V17, P93, DOI [10.1089/ten.tea.2010.0248, 10.1089/ten.TEA.2010.0248]; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	56	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203426	10.1371/journal.pone.0203426	http://dx.doi.org/10.1371/journal.pone.0203426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192811	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600073
J	Skube, SA; Dushenkov, V; Graf, BL; Niu, QW; Poulev, A; Kalariya, HM; Foxcroft, LC; Raskin, I				Skube, Sarah A.; Dushenkov, Vyacheslav; Graf, Brittany L.; Niu, Qingwei; Poulev, Alexander; Kalariya, Hetalben M.; Foxcroft, Llewellyn C.; Raskin, Ilya			Rapid, field-deployable method for collecting and preserving plant metabolome for biochemical and functional characterization	PLOS ONE			English	Article							NATURAL-PRODUCTS; ORAL MICROBIOME; DRUG DISCOVERY; HEALTH; DISEASE	Study of plant metabolome is a growing field of science that catalogs vast biochemical and functional diversity of phytochemicals. However, collecting and storing samples of plant metabolome, sharing these samples across the scientific community and making them compatible with bioactivity assays presents significant challenges to the advancement of metabolome research. We have developed a RApid Metabolome Extraction and Storage (RAMES) technology that allows efficient, highly compact, field-deployable collection and storage of libraries of plant metabolome. RAMES technology combines rapid extraction with immobilization of extracts on glass microfiber filter discs. Two grams of plant tissue extracted in ethanol, using a specially adapted Dremel (R) rotary tool, produces 25-35 replicas of 10 mm glass fiber discs impregnated with phytochemicals. These discs can be either eluted with solvents (such as 70% ethanol) to study the metabolomic profiles or used directly in a variety of functional assays. We have developed simple, non-sterile, anti-fungal, antibacterial, and anti-oxidant assays formatted for 24-multiwell plates directly compatible with RAMES discs placed inside the wells. Using these methods we confirmed activity in 30 out of 32 randomly selected anti-microbial medicinal plants and spices. Seven species scored the highest activity (total kill) in the anti-bacterial (bacteria from human saliva) and two anti fungal screens (Fusarium spp. and Saccharomyces cerevisiae), providing functional validation of RAMES technology. RAMES libraries showed limited degradation of compounds after 12 months of storage at -20 degrees C, while others remained stable. Fifty-eight percent of structures characterized in the extracts loaded onto RAMES discs could be eluted from the discs without significant losses. Miniaturized RAMES technology, as described and validated in this manuscript offers a labor, cost, and time-effective alternative to conventional collection of phytochemicals. RAMES technology enables creation of comprehensive metabolomic libraries from various ecosystems and geographical regions in a format compatible with further biochemical and functional studies.	[Skube, Sarah A.; Graf, Brittany L.; Niu, Qingwei; Poulev, Alexander; Kalariya, Hetalben M.; Raskin, Ilya] Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA; [Dushenkov, Vyacheslav] CUNY, Hostos Community Coll, New York, NY 10021 USA; [Foxcroft, Llewellyn C.] Stellenbosch Univ & Sci Serv, Dept Bot & Zool, CIB, Skukuza, South Africa	Rutgers State University New Brunswick; City University of New York (CUNY) System	Raskin, I (corresponding author), Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA.	raskin@rutgers.edu	Poulev, Alexander/L-6613-2019; Dushenkov, Vyacheslav/AAE-8520-2019	Poulev, Alexander/0000-0003-0939-0642; Dushenkov, Vyacheslav/0000-0001-5176-7461; Raskin, Ilya/0000-0002-3025-8112; Skubel, Sarah/0000-0003-2525-0682	T.R.E. E. International Institute, Miami; Hostos Community College, City University of New York; South African National Parks; DST-NRF Centre of Excellence for Invasion Biology (C.I.B); National Research Foundation of South Africa [IFR2010041400019, IFR160215158271]; National Center for Complementary and Integrative Health (NIH-NCCIH) [2-P50 AT002776-06]; NIH Office of Dietary Supplements (NIH-ODS); Fogarty International Center of NIH [1D43TW009672-01]; Rutgers University; Stellenbosch University; National Center for Complementary & Integrative Health [P50AT002776] Funding Source: NIH RePORTER	T.R.E. E. International Institute, Miami; Hostos Community College, City University of New York; South African National Parks; DST-NRF Centre of Excellence for Invasion Biology (C.I.B); National Research Foundation of South Africa(National Research Foundation - South Africa); National Center for Complementary and Integrative Health (NIH-NCCIH); NIH Office of Dietary Supplements (NIH-ODS); Fogarty International Center of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Rutgers University; Stellenbosch University; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	SAS, BLG fellowships provided by T.R.E. E. International Institute, Miami, FL. VD salary provided by Hostos Community College, City University of New York. LCF funded by South African National Parks, the DST-NRF Centre of Excellence for Invasion Biology (C.I.B) and Stellenbosch University, and the National Research Foundation of South Africa; Project Numbers IFR2010041400019 and IFR160215158271. IR, AP, HMK partially funded by grant # 2-P50 AT002776-06 from the National Center for Complementary and Integrative Health (NIH-NCCIH) and NIH Office of Dietary Supplements (NIH-ODS) and by grant # 1D43TW009672-01 from Fogarty International Center of NIH. Additional funding from Rutgers University.	Ahmadian S, 2009, JOVE-J VIS EXP, P3; Arseculeratne SN, 2005, MED MYCOL, V43, P261, DOI 10.1080/13693780412331271063; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Balunas MJ, 2005, LIFE SCI, V78, P431, DOI 10.1016/j.lfs.2005.09.012; Blomhoff R, 2006, BR J NUTR S2, V96; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; CHASE MW, 1991, TAXON, V40, P215, DOI 10.2307/1222975; Chibale K., 2012, DRUG DISCOVERY AFRIC, Vfirst; Costalonga M, 2014, IMMUNOL LETT, V162, P22, DOI 10.1016/j.imlet.2014.08.017; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Dykes L, 2007, CEREAL FOOD WORLD, V52, P105, DOI 10.1094/CFW-52-3-0105; Fazekas Aron J, 2012, Methods Mol Biol, V858, P223, DOI 10.1007/978-1-61779-591-6_11; Floegel A, 2011, J FOOD COMPOS ANAL, V24, P1043, DOI 10.1016/j.jfca.2011.01.008; German JB, 2005, METABOLOMICS, V1, P3, DOI 10.1007/s11306-005-1102-8; Ghazali E, 2017, J RETAIL CONSUM SERV, V39, P154, DOI 10.1016/j.jretconser.2017.08.002; Graf B.L., 2016, J BIODIVERS BIOPROS, V3, P1000156, DOI [10.4172/2376-0214.1000156, DOI 10.4172/2376-0214.1000156, 10.4172/2376- 0214.1000156]; Hall RD, 2006, NEW PHYTOL, V169, P453, DOI 10.1111/j.1469-8137.2005.01632.x; Joseph G, 2014, J BIODIVERS BIOPROS, V1, P2376; Kellogg J, 2010, URBANA, V51, P61801; Kellogg J., 2016, NACTA J, V60, P42; Kim ES, 2005, J NATL CANCER I, V97, P468, DOI 10.1093/jnci/dji103; Kingston DGI, 2011, J NAT PROD, V74, P496, DOI 10.1021/np100550t; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; LENNETTE EH, 1985, MANUAL CLIN MICROBIO, P978; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Ortholand JY, 2004, CURR OPIN CHEM BIOL, V8, P271, DOI 10.1016/j.cbpa.2004.04.011; Pimm SL, 2015, ANN MO BOT GARD, V100, P170, DOI 10.3417/2012018; Pye CR, 2017, P NATL ACAD SCI USA, V114, P5601, DOI 10.1073/pnas.1614680114; Rochfort S, 2005, J NAT PROD, V68, P1813, DOI 10.1021/np050255w; Roman S, 2017, TRENDS FOOD SCI TECH, V67, P44, DOI 10.1016/j.tifs.2017.06.010; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; Shahidi F, 2015, J FUNCT FOODS, V18, P820, DOI 10.1016/j.jff.2015.06.018; Tiwari B.K., 2013, HDB PLANT FOOD PHYTO; Turek C, 2013, COMPR REV FOOD SCI F, V12, P40, DOI 10.1111/1541-4337.12006; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489	37	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203569	10.1371/journal.pone.0203569	http://dx.doi.org/10.1371/journal.pone.0203569			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188945	gold, Green Published, Green Submitted			2022-12-26	WOS:000444228700044
J	Gao, XL; Wang, SG; Xu, YY; Li, H; Zhao, H; Pan, X				Gao, Xianlei; Wang, Songgang; Xu, Yeyang; Li, Hao; Zhao, Hua; Pan, Xin			Ferulic acid and PDMS modified medical carbon materials for artificial joint prosthesis	PLOS ONE			English	Article							CALCIUM-PHOSPHATE CERAMICS; CARBON/CARBON COMPOSITES; ANTIMICROBIAL ACTIVITY; IN-VITRO; COATINGS; REGENERATION; OSTEOINDUCTION; CELLS; FILMS; VIVO	Medical carbon material has been extensively studied due to their excellent biological and mechanical properties. However, the dissociation of the surface carbon particles greatly limited the application of medical carbon material (MCM). To overcome this defect, we introduced the polydimethylsiloxane, a polymer-coating material (PCM) that possesses acceptable biocompatibility, into medical carbon material to prevent the shedding of carbon debris. Additionally, to reduce inflammatory reactions and increase surface hydrophilicity, ferulic acid, also called Chinese medicine coating material (CCM), was used to modify the surface of polymer-coating material. We investigated the proliferation and adhesion of NIH-3T3 cells onto MCM, PCM and CCM in vitro. We showed that CCM exhibited excellent biological activity to promote cell growth. Twelve weeks after CCM implantation, bone defects were repaired, and the material showed acceptable chemical stability. The results indicated that the CCM composite possesses excellent mechanical property and favorable biocompatibility, which can be used for clinical bone repair.	[Gao, Xianlei; Wang, Songgang; Li, Hao; Zhao, Hua; Pan, Xin] Shandong Univ, Dept Orthopaed, Qilu Hosp, Jinan, Shandong, Peoples R China; [Xu, Yeyang] Shandong Univ, Canc Res Ctr, Jinan, Shandong, Peoples R China	Shandong University; Shandong University	Pan, X (corresponding author), Shandong Univ, Dept Orthopaed, Qilu Hosp, Jinan, Shandong, Peoples R China.	panxinqilu@163.com						Aceituno-Medina M, 2015, J FUNCT FOODS, V12, P332, DOI 10.1016/j.jff.2014.11.028; Beckmann NA, 2015, J ARTHROPLASTY, V30, P249, DOI 10.1016/j.arth.2014.09.016; Bian YY, 2015, IN VITRO CELL DEV-AN, V51, P722, DOI 10.1007/s11626-015-9876-0; Borges A, 2013, MICROB DRUG RESIST, V19, P256, DOI 10.1089/mdr.2012.0244; BRANDWOOD A, 1992, BIOMATERIALS, V13, P646, DOI 10.1016/0142-9612(92)90035-M; Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; Cao N, 2010, SURF COAT TECH, V205, P1150, DOI 10.1016/j.surfcoat.2010.05.008; Cao N, 2010, J BIOMED MATER RES A, V92A, P1019, DOI 10.1002/jbm.a.32424; Chen Q, 2013, MAT SCI ENG C-MATER, V33, P1530, DOI 10.1016/j.msec.2012.12.058; Fu QG, 2006, SURF COAT TECH, V200, P3473, DOI 10.1016/j.surfcoat.2004.11.022; Fu QG, 2013, MAT SCI ENG A-STRUCT, V563, P133, DOI 10.1016/j.msea.2012.11.053; Garcia-Gareta E, 2015, BONE, V81, P112, DOI 10.1016/j.bone.2015.07.007; Han IH, 2015, J BIOMED MATER RES A, V103, P3642, DOI 10.1002/jbm.a.35488; Hsieh CT, 2005, APPL SURF SCI, V240, P318, DOI 10.1016/j.apsusc.2004.07.016; Kim SH, 2011, BIOMED ENG LETT, V1, P199, DOI 10.1007/s13534-011-0033-8; King KR, 2001, MICROFLUIDICS TISSUE, P247; Kumar Naresh, 2014, Biotechnol Rep (Amst), V4, P86, DOI 10.1016/j.btre.2014.09.002; Lanao RPF, 2013, TISSUE ENG PART B-RE, V19, P380, DOI [10.1089/ten.teb.2012.0443, 10.1089/ten.TEB.2012.0443]; Lee CC, 2015, EVIDENCE BASED COMPL, V2015, DOI DOI 678487; Li HS, 2007, J BIOMED MATER RES B, V81B, P194, DOI 10.1002/jbm.b.30653; Li S, 2015, J BIOMEDICAL MAT R A, V40, P520; Nampoothiri KM, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI 10.1016/j.biortech.2010.05.092; Nile SH, 2016, REV BRAS FARMACOGN, V26, P50, DOI 10.1016/j.bjp.2015.08.013; Perez-Tanoira R, 2015, J MATER SCI-MATER M, V26, P1, DOI DOI 10.HTTPS://D0I.0RG/10.1007/S10856015-55682; Pesakova V, 2000, J MATER SCI-MATER M, V11, P793, DOI 10.1023/A:1008953529111; Pesakova V, 2005, J MATER SCI-MATER M, V16, P143, DOI 10.1007/s10856-005-5933-7; Peterson SL, 2005, J BIOMED MATER RES A, V72A, P10, DOI 10.1002/jbm.a.30166; Richmond SA, 2013, J ORTHOP SPORT PHYS, V43, P515, DOI 10.2519/jospt.2013.4796; Roy T, 2015, CERAM INT, V41, P681, DOI 10.1016/j.ceramint.2014.08.123; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; Samavedi S, 2013, ACTA BIOMATER, V9, P8037, DOI 10.1016/j.actbio.2013.06.014; Shi C, 2016, FOODBORNE PATHOG DIS, V13, P196, DOI 10.1089/fpd.2015.1992; Song Y, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.30323; Spasova M, 2008, BIOORGAN MED CHEM, V16, P7457, DOI 10.1016/j.bmc.2008.06.010; Sui JL, 2004, SURF COAT TECH, V176, P188, DOI 10.1016/S0257-8972(03)00646-7; Usui Y, 2008, SMALL, V4, P240, DOI 10.1002/smll.200700670; Wang J, 2014, J BIOMED MATER RES A, V102, P4234, DOI 10.1002/jbm.a.35102; Wang LX, 2014, BIOMATERIALS, V35, P6758, DOI 10.1016/j.biomaterials.2014.04.085; Wang QS, 2014, J BIOMED MATER RES A, V102, P4098, DOI 10.1002/jbm.a.35083; Yabe T, 2010, NEUROSCIENCE, V165, P515, DOI 10.1016/j.neuroscience.2009.10.023; Zhao XN, 2011, APPL SURF SCI, V257, P3612, DOI 10.1016/j.apsusc.2010.11.088	41	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203542	10.1371/journal.pone.0203542	http://dx.doi.org/10.1371/journal.pone.0203542			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183771	Green Published, Green Submitted, gold			2022-12-26	WOS:000443789900069
J	Ksionzek, KB; Zhang, J; Ludwichowski, KU; Wilhelms-Dick, D; Trimborn, S; Jendrossek, T; Kattner, G; Koch, BP				Ksionzek, Kerstin B.; Zhang, Jing; Ludwichowski, Kai-Uwe; Wilhelms-Dick, Dorothee; Trimborn, Scarlett; Jendrossek, Thomas; Kattner, Gerhard; Koch, Boris P.			Stoichiometry, polarity, and organometallics in solid-phase extracted dissolved organic matter of the Elbe-Weser estuary	PLOS ONE			English	Article							CATHODIC STRIPPING VOLTAMMETRY; INDUCTIVELY-COUPLED PLASMA; RESONANCE MASS-SPECTROMETRY; TRACE-METAL COMPOSITION; FT-ICR-MS; MARINE-PHYTOPLANKTON; NATURAL-WATERS; LIQUID-CHROMATOGRAPHY; COPPER COMPLEXATION; EMILIANIA-HUXLEYI	Dissolved organic matter (DOM) is ubiquitous in natural waters and plays a central role in the biogeochemistry in riverine, estuarine and marine environments. This study quantifies and characterizes solid-phase extractable DOM and trace element complexation at different salinities in the Weser and Elbe River, northern Germany, and the North Sea. Dissolved organic carbon (DOC), total dissolved nitrogen (TDN), Co and Cu concentrations were analyzed in original water samples. Solid-phase extracted (SPE) water samples were analyzed for DOC (DOCSPE), dissolved organic nitrogen (DONSPE), sulfur (DOSSPE) and trace metal (V-51, Cr-52, Co-59, Ni-60, Cu-63, As-75) concentrations. Additionally, different pre-treatment conditions (acidification vs. non-acidification prior to SPE) were tested. In agreement with previous studies, acidification led to generally higher recoveries for DOM and trace metals. Overall, higher DOM and trace metal concentrations and subsequently higher complexation of trace metals with carbon and sulfur-containing organic complexes were found in riverine compared to marine samples. With increasing salinity, the concentrations of DOM decreased due to estuarine mixing. However, the slightly lower relative decrease of both, DOCSPE and DONSPE (similar to 77%) compared to DOSSPE (similar to 86%) suggests slightly faster removal processes for DOSSPE. A similar distribution of trace metal and carbon and sulfur containing DOM concentrations with salinity indicates complexation of trace metals with organic ligands. This is further supported by an increase in Co and Cu concentration after oxidation of organic complexes by UV treatment. Additionally, the complexation of metals with organic ligands (analyzed by comparing metal/DOCSPE and metal/DOSSPE ratios) decreased in the order Cu > As > Ni > Cr > Co and thus followed the Irving-Williams order. Differences in riverine and marine trace metal containing DOMSPE are summarized by their average molar ratios of (C107N4P0.013S1)(1000)V0.05Cr0.33Co0.19Ni0.39Cu3.41As0.47 in the riverine endmember and (C163N7P0.055S1)(1000)V0.05Cr0.47Co0.16Ni0.07Cu4.05As0.58 in the marine endmember.	[Ksionzek, Kerstin B.; Ludwichowski, Kai-Uwe; Wilhelms-Dick, Dorothee; Trimborn, Scarlett; Jendrossek, Thomas; Kattner, Gerhard; Koch, Boris P.] Alfred Wegener Inst, Helmholtz Ctr Polar & Marine Res, Bremerhaven, Germany; [Ksionzek, Kerstin B.; Koch, Boris P.] MARUM Ctr Marine Environm Sci, Leobener Str, Bremen, Germany; [Zhang, Jing] ECNU, State Key Lab Estuarine & Coastal Res SKLEC, Shanghai, Peoples R China; [Koch, Boris P.] Univ Appl Sci, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen; East China Normal University	Ksionzek, KB; Koch, BP (corresponding author), Alfred Wegener Inst, Helmholtz Ctr Polar & Marine Res, Bremerhaven, Germany.; Ksionzek, KB; Koch, BP (corresponding author), MARUM Ctr Marine Environm Sci, Leobener Str, Bremen, Germany.; Koch, BP (corresponding author), Univ Appl Sci, Bremerhaven, Germany.	Kerstin.Ksionzek@awi.de; Boris.Koch@awi.de	Koch, Boris P/B-2784-2009; Trimborn, Scarlett/AAM-1061-2021	Koch, Boris P/0000-0002-8453-731X; Trimborn, Scarlett/0000-0003-1434-9927	Deutsche Forschungsgemeinschaft (DFG)-Research Centre / Cluster of Excellence 309; Helmholtz Association (HGF Young Investigators Group EcoTrace) [VH-NG-901]; Hanse-Wissenschaftskolleg Institute for Advanced Study, Delmenhorst, Germany; strategy fund of the Alfred Wegener Institute [IP76010001]	Deutsche Forschungsgemeinschaft (DFG)-Research Centre / Cluster of Excellence 309; Helmholtz Association (HGF Young Investigators Group EcoTrace); Hanse-Wissenschaftskolleg Institute for Advanced Study, Delmenhorst, Germany; strategy fund of the Alfred Wegener Institute	This work was supported by the Deutsche Forschungsgemeinschaft (DFG)-Research Centre / Cluster of Excellence 309 "The Ocean in the Earth System" (http://gepris.dfg.de/gepris/OCTOPUS;jsessionid=CDDA42EF17D9589DA9686683E059C3FA?context=projekt&id=49926684&language=en&task=showDetail) (KBK, BPK). DWD and ST were funded by the Helmholtz Association (HGF Young Investigators Group EcoTrace, VH-NG-901). JZ was supported by the Hanse-Wissenschaftskolleg Institute for Advanced Study, Delmenhorst, Germany. BPK was supported by the strategy fund of the Alfred Wegener Institute in the framework of the project "Inorganics in organics: Chemical and biological controls on micronutrient and carbon fluxes in the polar ocean" (IP76010001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla HAN, 2013, GEOCHIM COSMOCHIM AC, V118, P231, DOI 10.1016/j.gca.2013.03.036; Abdulla HAN, 2010, GEOCHIM COSMOCHIM AC, V74, P3815, DOI 10.1016/j.gca.2010.04.006; Abril G, 2002, ESTUAR COAST SHELF S, V54, P241, DOI 10.1006/ecss.2001.0844; Al-Farawati R, 2001, ENVIRON SCI TECHNOL, V35, P1902, DOI 10.1021/es000073i; Alling V, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003834; Asmala E, 2014, J GEOPHYS RES-BIOGEO, V119, P1919, DOI 10.1002/2014JG002722; Asmala E, 2012, ESTUAR COAST SHELF S, V111, P107, DOI 10.1016/j.ecss.2012.06.015; Baken S, 2011, ENVIRON SCI TECHNOL, V45, P2584, DOI 10.1021/es103532a; Bell RA, 1999, ENVIRON TOXICOL CHEM, V18, P9, DOI [10.1897/1551-5028(1999)018&lt;0009:SCAGOS&gt;2.3.CO;2, 10.1002/etc.5620180103]; BENNER R, 1992, SCIENCE, V255, P1561, DOI 10.1126/science.255.5051.1561; Benner R, 2001, ORG GEOCHEM, V32, P597, DOI 10.1016/S0146-6380(00)00197-2; Bentley R, 2004, CHEMOSPHERE, V55, P291, DOI 10.1016/j.chemosphere.2003.12.017; Biller DV, 2012, MAR CHEM, V130, P12, DOI 10.1016/j.marchem.2011.12.001; Cai YH, 2012, ESTUAR COAST SHELF S, V96, P96, DOI 10.1016/j.ecss.2011.10.017; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Chen M, 2016, ANAL BIOANAL CHEM, V408, P4809, DOI 10.1007/s00216-016-9569-x; COALE KH, 1988, LIMNOL OCEANOGR, V33, P1084, DOI 10.4319/lo.1988.33.5.1084; Croot PL, 2000, LIMNOL OCEANOGR, V45, P619, DOI 10.4319/lo.2000.45.3.0619; De Schamphelaere KAC, 2004, ENVIRON TOXICOL CHEM, V23, P1248, DOI 10.1897/03-184; Dick D, 2008, ANAL CHIM ACTA, V621, P140, DOI 10.1016/j.aca.2008.05.026; Dittmar T, 2003, MAR CHEM, V82, P115, DOI 10.1016/S0304-4203(03)00068-9; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; DONAT JR, 1994, ANAL CHIM ACTA, V284, P547, DOI 10.1016/0003-2670(94)85061-5; Driscoll CT, 1994, SCOPE 51 BIOGEOCHEMI, P51; Dupont CL, 2006, DEEP-SEA RES PT I, V53, P1961, DOI 10.1016/j.dsr.2006.09.003; Dupont CL, 2005, LIMNOL OCEANOGR, V50, P508, DOI 10.4319/lo.2005.50.2.0508; Dupont CL, 2004, LIMNOL OCEANOGR, V49, P1754, DOI 10.4319/lo.2004.49.5.1754; Elifantz H, 2007, AQUAT MICROB ECOL, V50, P39, DOI 10.3354/ame01145; Ellwood MJ, 2001, MAR CHEM, V75, P33, DOI 10.1016/S0304-4203(01)00024-X; Flerus R, 2012, BIOGEOSCIENCES, V9, P1935, DOI 10.5194/bg-9-1935-2012; Gogou A, 2010, MAR CHEM, V121, P215, DOI 10.1016/j.marchem.2010.05.001; Goncalves-Araujo R, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00108; Gonsior M, 2013, BIOGEOSCIENCES, V10, P6945, DOI 10.5194/bg-10-6945-2013; Gonsior M, 2014, MAR CHEM, V163, P10, DOI 10.1016/j.marchem.2014.04.002; Guo LD, 2000, MAR CHEM, V70, P257, DOI 10.1016/S0304-4203(00)00031-1; Guo WD, 2007, MAR CHEM, V107, P357, DOI 10.1016/j.marchem.2007.03.006; Hansell DA, 2015, BIOGEOCHEMISTRY OF MARINE DISSOLVED ORGANIC MATTER, 2ND EDITION, P1; Hansell DA., 2002, BIOGEOCHEMISTRY MARI, V1; Hathorne EC, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003907; Helms JR, 2013, MAR CHEM, V155, P81, DOI 10.1016/j.marchem.2013.05.015; Ho TY, 2003, J PHYCOL, V39, P1145, DOI 10.1111/j.0022-3646.2003.03-090.x; HOMANN PS, 1990, CAN J FOREST RES, V20, P1535, DOI 10.1139/x90-204; Hopkinson CS, 2005, NATURE, V433, P142, DOI 10.1038/nature03191; HOULE D, 1995, LIMNOL OCEANOGR, V40, P710, DOI 10.4319/lo.1995.40.4.0710; Hsu-Kim H, 2007, ENVIRON SCI TECHNOL, V41, P2338, DOI 10.1021/es062269+; Huguet A, 2009, ORG GEOCHEM, V40, P706, DOI 10.1016/j.orggeochem.2009.03.002; Jochum KP, 2005, GEOSTAND GEOANAL RES, V29, P333, DOI 10.1111/j.1751-908X.2005.tb00904.x; Kaiser K, 2000, ORG GEOCHEM, V31, P711, DOI 10.1016/S0146-6380(00)00046-2; Koch BP, 2008, MAR CHEM, V111, P233, DOI 10.1016/j.marchem.2008.05.008; Koch BP, 2016, DATABASE PANGAEA, DOI [10.1594/PANGAEA.859786, DOI 10.1594/PANGAEA.859786]; KOLBER ZS, 1994, NATURE, V371, P145, DOI 10.1038/371145a0; Kruger BR, 2011, AQUAT SCI, V73, P405, DOI 10.1007/s00027-011-0189-4; Ksionzek KB, 2016, DATABASE PANGAEA, DOI [10.1594/PANGAEA.858564, DOI 10.1594/PANGAEA.858564]; Ksionzek KB, 2016, SCIENCE, V354, P456, DOI 10.1126/science.aaf7796; Laglera LM, 2003, MAR CHEM, V82, P71, DOI 10.1016/S0304-4203(03)00053-7; Lechtenfeld OJ, 2014, GEOCHIM COSMOCHIM AC, V126, P321, DOI 10.1016/j.gca.2013.11.009; Lechtenfeld OJ, 2011, ANAL CHEM, V83, P8968, DOI 10.1021/ac201765a; Lomans BP, 2002, CELL MOL LIFE SCI, V59, P575, DOI 10.1007/s00018-002-8450-6; MANTOURA RFC, 1978, ESTUAR COAST MAR SCI, V6, P387, DOI 10.1016/0302-3524(78)90130-5; Matar Z., 2013, FUNCTIONS NATURAL OR, P517; Matrai PA, 1989, GLOBAL BIOGEOCHEM CY, V3, P89, DOI 10.1029/GB003i001p00089; Miller WL, 1997, LIMNOL OCEANOGR, V42, P1317, DOI 10.4319/lo.1997.42.6.1317; MILLS GL, 1982, MAR CHEM, V11, P355, DOI 10.1016/0304-4203(82)90031-7; Milne A, 2010, ANAL CHIM ACTA, V665, P200, DOI 10.1016/j.aca.2010.03.027; Moffett JW, 1996, LIMNOL OCEANOGR, V41, P388, DOI 10.4319/lo.1996.41.3.0388; Opsahl S, 1997, NATURE, V386, P480, DOI 10.1038/386480a0; Opsahl S, 1998, LIMNOL OCEANOGR, V43, P1297, DOI 10.4319/lo.1998.43.6.1297; Paytan A, 2009, P NATL ACAD SCI USA, V106, P4601, DOI 10.1073/pnas.0811486106; Pohlabeln AM, 2015, MAR CHEM, V168, P86, DOI 10.1016/j.marchem.2014.10.018; Ravichandran M, 2004, CHEMOSPHERE, V55, P319, DOI 10.1016/j.chemosphere.2003.11.011; Raymond PA, 2015, BIOGEOCHEMISTRY OF MARINE DISSOLVED ORGANIC MATTER, 2ND EDITION, P509, DOI 10.1016/B978-0-12-405940-5.00011-X; REDDY KJ, 1995, PLANT SOIL, V171, P53, DOI 10.1007/BF00009564; Rochelle-Newall EJ, 2004, AQUAT MICROB ECOL, V37, P9, DOI 10.3354/ame037009; Romera-Castillo C, 2010, LIMNOL OCEANOGR, V55, P446, DOI 10.4319/lo.2010.55.1.0446; Saito MA, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002216; Santschi PH, 1997, MAR CHEM, V58, P99, DOI 10.1016/S0304-4203(97)00029-7; Schwartz ML, 2004, ENVIRON TOXICOL CHEM, V23, P2889, DOI 10.1897/03-561.1; SEPERS ABJ, 1977, HYDROBIOLOGIA, V52, P39, DOI 10.1007/BF02658081; SHOLKOVITZ ER, 1978, EARTH PLANET SC LETT, V41, P77, DOI 10.1016/0012-821X(78)90043-2; Sleighter RL, 2008, MAR CHEM, V110, P140, DOI 10.1016/j.marchem.2008.04.008; Smith DS, 2002, COMP BIOCHEM PHYS C, V133, P65, DOI 10.1016/S1532-0456(02)00108-4; Stedmon CA, 2003, ESTUAR COAST SHELF S, V57, P973, DOI 10.1016/S0272-7714(03)00003-9; Sunda WG, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00204; Takano S, 2013, ANAL CHIM ACTA, V784, P33, DOI 10.1016/j.aca.2013.04.032; Tang DG, 2000, LIMNOL OCEANOGR, V45, P1289, DOI 10.4319/lo.2000.45.6.1289; TSUTSUKI K, 1984, SOIL SCI PLANT NUTR, V30, P151, DOI 10.1080/00380768.1984.10434679; Twining BS, 2013, ANNU REV MAR SCI, V5, P191, DOI 10.1146/annurev-marine-121211-172322; Twining BS, 2004, DEEP-SEA RES PT I, V51, P1827, DOI 10.1016/j.dsr.2004.08.007; Vega M, 1997, ANAL CHEM, V69, P874, DOI 10.1021/ac960214s; Vraspir JM, 2009, ANNU REV MAR SCI, V1, P43, DOI 10.1146/annurev.marine.010908.163712; Waska H, 2015, MAR CHEM, V173, P78, DOI 10.1016/j.marchem.2014.10.001; Wen LS, 1999, MAR CHEM, V63, P185, DOI 10.1016/S0304-4203(98)00062-0; Ylostalo P, 2016, MAR CHEM, V186, P58, DOI 10.1016/j.marchem.2016.07.004; ZHANG H, 1990, MAR CHEM, V28, P285, DOI 10.1016/0304-4203(90)90049-I; ZYDOWSKY TM, 1986, J AM CHEM SOC, V108, P3152, DOI 10.1021/ja00271a081	95	10	10	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203260	10.1371/journal.pone.0203260	http://dx.doi.org/10.1371/journal.pone.0203260			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183724	Green Published, gold			2022-12-26	WOS:000443789900052
J	Negyesi, J; Mobark, A; Zhang, LY; Hortobagyi, T; Nagatomi, R				Negyesi, Janos; Mobark, Ali; Zhang, Li Yin; Hortobagyi, Tibor; Nagatomi, Ryoichi			An above-knee compression garment does not improve passive knee joint position sense in healthy adults	PLOS ONE			English	Article							RUNNING PERFORMANCE; NEOPRENE SLEEVE; PROPRIOCEPTION; EXERCISE; MUSCLE; STOCKINGS; ASYMMETRIES; RECOVERY; IMAGEJ	We determined the effects of wearing an above-knee compression garment (CG) on knee joint position sense. Healthy young adults (n = 24, age = 27.46 +/- 4.65 years) performed a passive knee position-matching task on an isokinetic dynamometer with each leg separately. We determined the magnitude of compression by measuring anatomical thigh cross sectional area (CSA) in standing using magnetic resonance imaging. Wearing the CG compressed CSA by 2% (t = 2.91, p = 0.010, Cohen's d = 0.68). Repeated measures ANOVA (rANOVA) with three repetition factors (condition: CG, no CG; leg: right dominant, left non-dominant; and target angles: 30 degrees, 45 degrees, 60 degrees) revealed an effect of angles (p < 0.001), where the matching of knee joint position was more accurate at 60 degrees compared to 30 degrees and 45 degrees (p < 0.001). However, CG did not reduce passive joint position sense errors. In fact, joint position error was less without CG (p = 0.014). In conclusion, while CG does compress the thigh it does not afford the purported benefits for proprioception as measured by a target-matching task in the present study.	[Negyesi, Janos; Zhang, Li Yin; Nagatomi, Ryoichi] Tohoku Univ, Grad Sch Med, Dept Med & Sci Sports & Exercise, Sendai, Miyagi, Japan; [Mobark, Ali; Nagatomi, Ryoichi] Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Engn Hlth & Welf, Sendai, Miyagi, Japan; [Mobark, Ali] Tanta Univ, Fac Phys Educ, Dept Sports Hlth Sci, Tanta, Egypt; [Hortobagyi, Tibor] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	Tohoku University; Tohoku University; Egyptian Knowledge Bank (EKB); Tanta University; University of Groningen	Negyesi, J (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med & Sci Sports & Exercise, Sendai, Miyagi, Japan.	negyesi@dc.tohoku.ac.jp	Négyesi, János/AAJ-7192-2020; Nagatomi, Ryoichi/T-5296-2019; Nagatomi, Ryoichi/Q-8792-2016	Négyesi, János/0000-0001-5055-3242; Nagatomi, Ryoichi/0000-0003-3038-7202; Mobark, Ali/0000-0003-3937-2971	Scholarship of Cultural affairs & Mission sectors, Ministry of Higher Education, Egypt	Scholarship of Cultural affairs & Mission sectors, Ministry of Higher Education, Egypt	One of the authors (MA) received the Scholarship of Cultural affairs & Mission sectors, Ministry of Higher Education, Egypt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2007, J SPORT SCI, V25, P413, DOI 10.1080/02640410600718376; Ali A, 2011, J STRENGTH COND RES, V25, P1385, DOI 10.1519/JSC.0b013e3181d6848e; Beliard S, 2015, J SPORT SCI MED, V14, P75; Beynnon BD, 2002, J ORTHOP SPORT PHYS, V32, P11, DOI 10.2519/jospt.2002.32.1.11; Birmingham TB, 1998, AM J SPORT MED, V26, P562, DOI 10.1177/03635465980260041601; Birmingham TB, 2000, MED SCI SPORT EXER, V32, P304, DOI 10.1097/00005768-200002000-00009; Cholewicki J, 2006, J ORTHOP SPORT PHYS, V36, P225, DOI 10.2519/jospt.2006.36.4.225; Collins DF, 1996, J PHYSIOL-LONDON, V496, P857, DOI 10.1113/jphysiol.1996.sp021733; Dieling Simone, 2014, J Dance Med Sci, V18, P143, DOI 10.12678/1089-313X.18.4.143; Doan BK, 2003, J SPORT SCI, V21, P601, DOI 10.1080/0264041031000101971; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Friden T, 2001, J ORTHOP SPORT PHYS, V31, P567, DOI 10.2519/jospt.2001.31.10.567; Gandevia SC, 2006, J PHYSIOL-LONDON, V571, P703, DOI 10.1113/jphysiol.2005.103093; Gandevia SC, 2002, ADV EXP MED BIOL, V508, P61; Ghai S, 2018, GAIT POSTURE, V60, P258, DOI 10.1016/j.gaitpost.2016.08.008; Goble DJ, 2008, J NEUROPHYSIOL, V99, P3063, DOI 10.1152/jn.90259.2008; Goble DJ, 2009, EXP BRAIN RES, V197, P403, DOI 10.1007/s00221-009-1922-2; Gomez-Perez SL, 2016, JPEN-PARENTER ENTER, V40, P308, DOI 10.1177/0148607115604149; Goto K, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0092-1; Han J, 2013, EXP BRAIN RES, V226, P313, DOI 10.1007/s00221-013-3437-0; Herrington Lee, 2005, Res Sports Med, V13, P37, DOI 10.1080/15438620590922077; Jakeman JR, 2010, EUR J APPL PHYSIOL, V109, P1137, DOI 10.1007/s00421-010-1464-0; Jerosch J, 1996, ARCH ORTHOP TRAUM SU, V115, P162, DOI 10.1007/BF00434546; Kaminski Thomas W., 1996, Journal of Athletic Training, V31, P131; Kemmler W, 2009, J STRENGTH COND RES, V23, P101, DOI 10.1519/JSC.0b013e31818eaef3; KRAEMER WJ, 1996, J STRENGTH COND RES, V10, P180; MacRae BA, 2011, SPORTS MED, V41, P815, DOI 10.2165/11591420-000000000-00000; MATTHEWS PBC, 1982, ANNU REV NEUROSCI, V5, P189, DOI 10.1146/annurev.ne.05.030182.001201; MCCLOSKEY DI, 1978, PHYSIOL REV, V58, P763, DOI 10.1152/physrev.1978.58.4.763; Miyamoto N, 2011, J ELECTROMYOGR KINES, V21, P249, DOI 10.1016/j.jelekin.2010.08.006; Mizuno S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00834; Mothes H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180434; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peat JK, 2008, STAT WORKBOOK EVIDEN, Vviii; Proske U, 2005, MUSCLE NERVE, V31, P780, DOI 10.1002/mus.20330; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spry S, 1993, BIOMECHANICS SPORT 1; Trenell MI, 2006, J SPORT SCI MED, V5, P106; Ulkar B, 2004, BRIT J SPORT MED, V38, P549, DOI 10.1136/bjsm.2002.004275; Van Tiggelen D, 2008, SCAND J MED SCI SPOR, V18, P62, DOI 10.1111/j.1600-0838.2007.00649.x	40	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0203288	10.1371/journal.pone.0203288	http://dx.doi.org/10.1371/journal.pone.0203288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180187	Green Submitted, gold, Green Published			2022-12-26	WOS:000444222400035
J	Cobo-Cuenca, AI; Martin-Espinosa, NM; Sampietro-Crespo, A; Rodriguez-Borrego, MA; Carmona-Torres, JM				Isabel Cobo-Cuenca, Ana; Maria Martin-Espinosa, Noelia; Sampietro-Crespo, Antonio; Aurora Rodriguez-Borrego, Maria; Manuel Carmona-Torres, Juan			Sexual dysfunction in Spanish women with breast cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; MASTECTOMY; CHEMOTHERAPY; SURVIVORS; ISSUE	Purpose To determine whether there are changes in sexuality after breast cancer, to better understand the sexual function of women with breast cancer, and to investigate the potential relationship between sexual dysfunction and socio-demographic and clinical variables. Methods A cross-sectional study. This study included 514 women with breast cancer between 21-and 66-years-old. The cases were gathered between June 2016 and January 2017. The instruments used were the questionnaire on Women's Sexual Function and a questionnaire to collect socio-demographic and clinical data. Results The average age (+/- standard deviation, SD) of participants was 46.34 +/- 8.28 years. Their average age at date of diagnosis was 42.26 +/- 8.56 years, and the average time suffering from cancer was 4.05 +/- 5.23 years. There were significant differences (p = 0.002) in the presence of sexual dysfunction before (32.1%) and after (91.2%) cancer. The primary sexual dysfunctions were due to penetration pain (50.6%), lubrication (50.6%), dysfunctional desire (44.6%), and dysfunctional excitement (44.6%). Two-thirds of participants were satisfied with their sexual relations. The women who presented most sexual dysfunction were those that had a bilateral mastectomy (p = 0.009) and those who received chemotherapy, radiotherapy and hormonal-therapy (p < 0.001. Conclusion Sexual function was changed in women with breast cancer. The main problems included penetration pain, desire, lubrication, and dysfunctional excitement. It is important that Health professionals recognize which circumstances influence the sexual function of women with breast cancer and to make interventions that facilitate sexual adjustment.	[Isabel Cobo-Cuenca, Ana; Maria Martin-Espinosa, Noelia; Manuel Carmona-Torres, Juan] UCLM, EU Enfermeria & Fisioterapia Toledo, Dept Enfermeria Fisioterapia & Terapia Ocupac, Toledo, Spain; [Isabel Cobo-Cuenca, Ana; Aurora Rodriguez-Borrego, Maria; Manuel Carmona-Torres, Juan] Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; [Sampietro-Crespo, Antonio] Hosp Virgen de la Salud, Toledo, Spain; [Aurora Rodriguez-Borrego, Maria] Univ Cordoba, Fac Med & Enfermeria, Dept Enfermeria, Cordoba, Spain; [Aurora Rodriguez-Borrego, Maria] Hosp Univ Reina Sofia Cordoba, Cordoba, Spain	Universidad de Castilla-La Mancha; Complejo Hospitalario de Toledo; Universidad de Cordoba; Hospital Universitario Reina Sofia - Cordoba	Cobo-Cuenca, AI (corresponding author), UCLM, EU Enfermeria & Fisioterapia Toledo, Dept Enfermeria Fisioterapia & Terapia Ocupac, Toledo, Spain.; Cobo-Cuenca, AI (corresponding author), Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain.	anaisabel.cobo@uclm.es	Cuenca, Ana Isabel Cobo/AAE-5569-2019; Carmona-Torres, Juan Manuel/E-1579-2018	Cuenca, Ana Isabel Cobo/0000-0001-7873-3835; Carmona-Torres, Juan Manuel/0000-0002-7781-872X; Martin Espinosa, Noelia Maria/0000-0002-1298-6976				Aerts L, 2014, BREAST, V23, P629, DOI 10.1016/j.breast.2014.06.012; Alder J, 2008, J SEX MED, V5, P1898, DOI 10.1111/j.1743-6109.2008.00893.x; Alicikus ZA, 2009, TUMORI J, V95, P212; Andrzejczak E, 2013, PSYCHO-ONCOLOGY, V22, P1653, DOI 10.1002/pon.3197; Biglia N, 2010, J SEX MED, V7, P1891, DOI 10.1111/j.1743-6109.2010.01725.x; Burwell SR, 2006, J CLIN ONCOL, V24, P2815, DOI 10.1200/JCO.2005.04.2499; Carmona-Torres JM, 2017, ATENCION PRIMARIA; Cavalheiro JAC, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-28; de Morais FD, 2016, J CLIN NURS, V25, P1557, DOI 10.1111/jocn.13125; de Oncolog oA a Me A dica (SEOM), 2017, CIFR CANC SEOM; Dizon DS, 2014, ONCOLOGIST, V19, P202, DOI 10.1634/theoncologist.2013-0302; Emilee G, 2010, MATURITAS, V66, P397, DOI 10.1016/j.maturitas.2010.03.027; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Galceran J, 2017, CLIN TRANSL ONCOL, V19, P799, DOI 10.1007/s12094-016-1607-9; Ganz PA, 2004, JNCI-J NATL CANCER I, V96, P376, DOI 10.1093/jnci/djh060; Gilbert E, 2016, EUR J CANCER CARE, V25, P280, DOI 10.1111/ecc.12216; Kedde H, 2013, SUPPORT CARE CANCER, V21, P271, DOI 10.1007/s00520-012-1521-9; Kirshbaum MN, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12577; Lopes Juliane da Silveira Ortiz de Camargo, 2016, Enferm. glob., V15, P350; Malinovszky KM, 2006, BRIT J CANCER, V95, P1626, DOI 10.1038/sj.bjc.6603454; Notari SC, 2018, EUR J CANCER CARE, V27, DOI 10.1111/ecc.12607; Ochsenkuhn R, 2011, J SEX MED, V8, P1486, DOI 10.1111/j.1743-6109.2011.02220.x; Panjari M, 2011, J SEX MED, V8, P294, DOI 10.1111/j.1743-6109.2010.02034.x; Raggio GA, 2014, PSYCHOL HEALTH, V29, P632, DOI 10.1080/08870446.2013.879136; Sadovsky R, 2010, J SEX MED, V7, P349, DOI 10.1111/j.1743-6109.2009.01620.x; Safarinejad MR, 2013, PSYCHO-ONCOLOGY, V22, P1242, DOI 10.1002/pon.3130; Sanchez F, 2004, Aten Primaria, V34, P286, DOI 10.1157/13067028; Ussher JM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1243-8; Ussher JM, 2012, CANCER NURS, V35, P456, DOI 10.1097/NCC.0b013e3182395401; Vaidakis D, 2014, EUR J GYNAECOL ONCOL, V35, P635; Wang FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074473; Webber K, 2011, ONCOLOGIST, V16, P1333, DOI 10.1634/theoncologist.2011-0100	32	13	14	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203151	10.1371/journal.pone.0203151	http://dx.doi.org/10.1371/journal.pone.0203151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169506	Green Submitted, Green Published, gold			2022-12-26	WOS:000443374400023
J	Baldwin, T; Islamovic, E; Klos, K; Schwartz, P; Gillespie, J; Hunter, S; Bregitzer, P				Baldwin, Thomas; Islamovic, Emir; Klos, Kathy; Schwartz, Paul; Gillespie, James; Hunter, Samuel; Bregitzer, Phil			Silencing efficiency of dsRNA fragments targeting Fusarium graminearum TRI6 and patterns of small interfering RNA associated with reduced virulence and mycotoxin production	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DICER-LIKE PROTEINS; HEAD BLIGHT; GC PREFERENCE; GENE; DEOXYNIVALENOL; RESISTANCE; WHEAT; MECHANISMS; MICRORNAS	Deoxynivalenol (DON) contamination of cereal grains caused by Fusarium head blight may be addressed by future RNA interference (RNAi)-based gene silencing approaches. However, utilizing these approaches will require a greater understanding of the principles that govern RNAi effectiveness in the pathogen Fusarium graminearum. RNAi in higher eukaryotes, including fungi, involves processing double stranded RNA (dsRNA) into small interfering RNA (siRNA) that silence gene expression based on base pair complementarity. This study examined virulence, DON production, and the small RNA (sRNA) populations in response to RNAi-based silencing of TRI6, a transcription factor that positively regulates DON synthesis via control of TRI5 expression. Silencing was accomplished via the expression of transgenes encoding inverted repeats targeting various regions of TRI6 (RNAi vectors). Transgene expression was associated with novel, TR/6-specific siRNAs. For RNAi vectors targeting the majority of TRI6 sequence (similar to 600 bp), a discontinuous, repeatable pattern was observed in which most siRNAs mapped to specific regions of TRI6. Targeting shorter regions (250-350 bp) did not alter the siRNA populations corresponding to that region of TRI6. No phased processing was observed. The 5' base of similar to 83% of siRNAs was uracil, consistent with DICER processing and ARGONAUTE binding preferences for siRNA. Mutant lines showed TRI6siRNA-associated reductions of TRI5expression on toxin inducing media and DON in infected wheat and barley spikes. Shorter RNAi vectors resulted in variable levels of silencing that were less than for the similar to 600 bp RNAi vector, with a 343 bp RNAi vector targeting the 5' end of TRI6 having the best silencing efficiency. This work identifies efficient shorter region for silencing of TRI6 and describes the patterns of siRNA corresponding to those regions.	[Baldwin, Thomas; Klos, Kathy; Bregitzer, Phil] USDA ARS, Natl Small Grains Germplasm Res Facil, Aberdeen, ID 83210 USA; [Islamovic, Emir] BASF, Res Triangle Pk, NC USA; [Schwartz, Paul; Gillespie, James] North Dakota State Univ, Dept Plant Sci, Fargo, ND USA; [Hunter, Samuel] Univ Idaho, iBEST, Moscow, ID USA	United States Department of Agriculture (USDA); BASF; North Dakota State University Fargo; Idaho; University of Idaho	Bregitzer, P (corresponding author), USDA ARS, Natl Small Grains Germplasm Res Facil, Aberdeen, ID 83210 USA.	phil.bregitzer@ars.usda.gov			USDA-ARS [2050-21000-031-00D]; U.S. Wheat and Barley Scab Initiative [FY16-BR-013, FY16-BA-005]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); U.S. Wheat and Barley Scab Initiative(United States Department of Agriculture (USDA))	This project was funded by USDA-ARS project 2050-21000-031-00D and by the U.S. Wheat and Barley Scab Initiative projects FY16-BR-013 and FY16-BA-005. The USDA-ARS is an equal opportunity employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BASF had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript, and did not provide salaries to any authors during conduction of the experiments.	Ah-Fong AMV, 2008, FUNGAL GENET BIOL, V45, P1197, DOI 10.1016/j.fgb.2008.05.009; Alexander NJ, 2011, FUNGAL GENET BIOL, V48, P485, DOI 10.1016/j.fgb.2011.01.003; Alexander NJ, 1998, APPL ENVIRON MICROB, V64, P221; Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Bai GH, 2002, MYCOPATHOLOGIA, V153, P91, DOI 10.1023/A:1014419323550; Baldwin TT, 2018, FUNGAL GENET BIOL, V115, P90, DOI 10.1016/j.fgb.2018.01.002; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Chen Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12500; Cuthbert PA, 2006, THEOR APPL GENET, V112, P1465, DOI 10.1007/s00122-006-0249-7; Dahlmann TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125989; Desjardins AE, 1997, MOL PLANT MICROBE IN, V10, P147, DOI 10.1094/MPMI.1997.10.2.147; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fang X, 2016, PLANT CELL; Garcia-Pedrajas MD, 2008, FUNGAL GENET BIOL, V45, P379, DOI 10.1016/j.fgb.2007.11.001; Gardiner DM, 2009, MICROBIOL-SGM, V155, P3149, DOI 10.1099/mic.0.029546-0; Ghag SB, 2014, PLANT BIOTECHNOL J, V12, P541, DOI 10.1111/pbi.12158; Goldoni M, 2004, FUNGAL GENET BIOL, V41, P1016, DOI 10.1016/j.fgb.2004.08.002; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Hallen-Adams HE, 2011, METHODS MOL BIOL, V722, P79, DOI 10.1007/978-1-61779-040-9_6; He KY, 2012, TOXICOL SCI, V127, P382, DOI 10.1093/toxsci/kfs134; Ho T, 2008, BIOCHEM BIOPH RES CO, V368, P433, DOI 10.1016/j.bbrc.2008.01.110; Ho T, 2007, FEBS LETT, V581, P3267, DOI 10.1016/j.febslet.2007.06.022; Iki T, 2017, J PLANT RES, V130, P7, DOI 10.1007/s10265-016-0876-2; Jeong D. H, 2011, PLANT CELL; Kazan K, 2012, MOL PLANT PATHOL, V13, P399, DOI 10.1111/j.1364-3703.2011.00762.x; King R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1756-1; Kobayashi H, 2016, BBA-GENE REGUL MECH, V1859, P71, DOI 10.1016/j.bbagrm.2015.08.007; Koch A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005901; Koch A, 2013, P NATL ACAD SCI USA, V110, P19324, DOI 10.1073/pnas.1306373110; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Li MX, 2008, TOXICOL SCI, V105, P67, DOI 10.1093/toxsci/kfn111; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; McCormick SP, 2011, TOXINS, V3, P802, DOI 10.3390/toxins3070802; McDonald T, 2005, MOL PLANT MICROBE IN, V18, P539, DOI 10.1094/MPMI-18-0539; McMullen M, 2012, PLANT DIS, V96, P1712, DOI 10.1094/PDIS-03-12-0291-FE; Mesterhazy A, 1995, PLANT BREEDING, V114, P377, DOI 10.1111/j.1439-0523.1995.tb00816.x; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Mochizuki K, 2013, BIOCHEM BIOPH RES CO, V436, P497, DOI 10.1016/j.bbrc.2013.05.133; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Nakayashiki H, 2005, FEBS LETT, V579, P5950, DOI 10.1016/j.febslet.2005.08.016; Quoc NB, 2015, FUNG BIOL-US, P107, DOI 10.1007/978-3-319-10503-1_8; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Pan X, 2014, TOXICOL SCI, V138, P217, DOI 10.1093/toxsci/kft270; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Pestka JJ, 2010, ARCH TOXICOL, V84, P663, DOI 10.1007/s00204-010-0579-8; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Roberts AF, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00958; Scherm B, 2011, MOL PLANT PATHOL, V12, P759, DOI 10.1111/J.1364-3703.2011.00709.X; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwab R, 2010, P NATL ACAD SCI USA; Seong KY, 2009, MOL MICROBIOL, V72, P354, DOI 10.1111/j.1365-2958.2009.06649.x; Son H, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006595; Sutton J. C., 1982, Canadian Journal of Plant Pathology, V4, P195; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Tacke BK, 1996, J AOAC INT, V79, P472; Tinoco MLP, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-27; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Weiberg A, 2015, CURR OPIN BIOTECH, V32, P207, DOI 10.1016/j.copbio.2014.12.025; Yang YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069463; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111	66	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202798	10.1371/journal.pone.0202798	http://dx.doi.org/10.1371/journal.pone.0202798			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161200	Green Published, gold			2022-12-26	WOS:000443388900044
J	Hoorntje, ET; Posafalvi, A; Syrris, P; van der Velde, KJ; Bolling, MC; Protonotarios, A; Boven, LG; Amat-Codina, N; Groeneweg, JA; Wilde, AA; Sobreira, N; Calkins, H; Hauer, RNW; Jonkman, MF; McKenna, WJ; Elliott, PM; Sinke, RJ; van den Berg, MP; Chelko, SP; James, CA; van Tintelen, JP; Judge, DP; Jongbloed, JDH				Hoorntje, Edgar T.; Posafalvi, Anna; Syrris, Petros; van der Velde, K. Joeri; Bolling, Marieke C.; Protonotarios, Alexandros; Boven, Ludolf G.; Amat-Codina, Nuria; Groeneweg, Judith A.; Wilde, Arthur A.; Sobreira, Nara; Calkins, Hugh; Hauer, Richard N. W.; Jonkman, Marcel F.; McKenna, William J.; Elliott, Perry M.; Sinke, Richard J.; van den Berg, Maarten P.; Chelko, Stephen P.; James, Cynthia A.; van Tintelen, J. Peter; Judge, Daniel P.; Jongbloed, Jan D. H.			No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy	PLOS ONE			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; MUSCULAR-DYSTROPHY; GENETIC-VARIANTS; ASSOCIATION; MUTATIONS; INTEGRITY; DIAGNOSIS; PATHOLOGY; ISOFORMS; REVEALS	Aims Likely pathogenic/pathogenic variants in genes encoding desmosomal proteins play an important role in the pathophysiology of arrhythmogenic right ventricular cardiomyopathy (ARVC). However, for a substantial proportion of ARVC patients, the genetic substrate remains unknown. We hypothesized that plectin, a cytolinker protein encoded by the PLEC gene, could play a role in ARVC because it has been proposed to link the desmosomal protein desmoplakin to the cytoskeleton and therefore has a potential function in the desmosomal structure. Methods We screened PLEC in 359 ARVC patients and compared the frequency of rare coding PLEC variants (minor allele frequency [MAF] <0.001) between patients and controls. To assess the frequency of rare variants in the control population, we evaluated the rare coding variants (MAF <0.001) found in the European cohort of the Exome Aggregation Database. We further evaluated plectin localization by immunofluorescence in a subset of patients with and without a PLEC variant. Results Forty ARVC patients carried one or more rare PLEC variants (11%, 40/359). However, rare variants also seem to occur frequently in the control population (18%, 4754/26197 individuals). Nor did we find a difference in the prevalence of rare PLEC variants in ARVC patients with or without a desmosomal likely pathogenic/pathogenic variant (14% versus 8%, respectively). However, immunofluorescence analysis did show decreased plectin junctional localization in myocardial tissue from 5 ARVC patients with PLEC variants. Conclusions Although PLEC has been hypothesized as a promising candidate gene for ARVC, our current study did not show an enrichment of rare PLEC variants in ARVC patients compared to controls and therefore does not support a major role for PLEC in this disorder. Although rare PLEC variants were associated with abnormal localization in cardiac tissue, the confluence of data does not support a role for plectin abnormalities in ARVC development.	[Hoorntje, Edgar T.; Posafalvi, Anna; van der Velde, K. Joeri; Boven, Ludolf G.; Sinke, Richard J.; van Tintelen, J. Peter; Jongbloed, Jan D. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Hoorntje, Edgar T.; van Tintelen, J. Peter] Netherlands Heart Inst, Durrer Cardiovasc Res Ctr, Utrecht, Netherlands; [Syrris, Petros; Protonotarios, Alexandros; McKenna, William J.; Elliott, Perry M.] UCL, Ctr Heart Muscle Dis, Inst Cardiovasc Sci, London, England; [Bolling, Marieke C.; Jonkman, Marcel F.] Univ Groningen, Univ Med Ctr Groningen, Dept Dermatol, Groningen, Netherlands; [Amat-Codina, Nuria; Calkins, Hugh; Chelko, Stephen P.; James, Cynthia A.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Groeneweg, Judith A.; Hauer, Richard N. W.; Judge, Daniel P.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Wilde, Arthur A.] Univ Amsterdam, Amsterdam Univ Med Ctr, Cardiovasc Sci, Heart Ctr,Dept Clin & Expt Cardiol, Amsterdam, Netherlands; [Wilde, Arthur A.] Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia; [Sobreira, Nara] Johns Hopkins Univ, Sch Med, Dept Genet, Baltimore, MD USA; [van den Berg, Maarten P.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [van Tintelen, J. Peter] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Clin Genet, Cardiovasc Sci, Amsterdam, Netherlands; [Judge, Daniel P.] Med Univ South Carolina, Charleston, SC 29425 USA	University of Groningen; University of London; University College London; University of Groningen; Johns Hopkins University; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Johns Hopkins University; University of Groningen; University of Amsterdam; Medical University of South Carolina	Jongbloed, JDH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	j.d.h.jongbloed@umcg.nl	Elliott, Perry/AAR-3430-2020; van Tintelen, J. Peter/AAJ-9962-2021; SYRRIS, PETROS/C-1703-2008; McKenna, William J/C-3243-2008; Protonotarios, Alexandros/G-1046-2018	Elliott, Perry/0000-0003-3383-3984; SYRRIS, PETROS/0000-0002-2363-8758; McKenna, William J/0000-0001-7994-2460; Protonotarios, Alexandros/0000-0001-8595-7212; Hoorntje, Edgar/0000-0002-8326-7717; van den Berg, Maarten/0000-0002-1493-2998; Chelko, Stephen/0000-0003-1675-5945; Judge, Daniel/0000-0002-3407-0248; James, Cynthia/0000-0001-8040-4600	Netherlands Cardiovascular Research Initiative of the Dutch Heart Foundation [CVON2012-10 PREDICT, CVON 2014-40 DOSIS]; Baylor-Hopkins Center for Mendelian Genomics - NHGRI/NHLBI [2UM1HG006542]; Netherlands Organisation for Scientific Research (NWO); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER	Netherlands Cardiovascular Research Initiative of the Dutch Heart Foundation; Baylor-Hopkins Center for Mendelian Genomics - NHGRI/NHLBI; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The work was financially supported by the Netherlands Cardiovascular Research Initiative of the Dutch Heart Foundation (CVON2012-10 PREDICT and CVON 2014-40 DOSIS projects), the Baylor-Hopkins Center for Mendelian Genomics, which is funded by a grant from the NHGRI/NHLBI (2UM1HG006542), the Netherlands Organisation for Scientific Research (NWO, visitor's travel grant	Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Basso C, 2009, LANCET, V373, P1289, DOI 10.1016/S0140-6736(09)60256-7; Bhonsale A, 2015, EUR HEART J, V36, P847, DOI 10.1093/eurheartj/ehu509; Bolling MC, 2010, J INVEST DERMATOL, V130, P1178, DOI 10.1038/jid.2009.390; Bolling MC, 2014, J INVEST DERMATOL, V134, P273, DOI 10.1038/jid.2013.277; Castanon MJ, 2013, HISTOCHEM CELL BIOL, V140, P33, DOI 10.1007/s00418-013-1102-0; Chelko SP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85923; Eger A, 1997, J CELL SCI, V110, P1307; Fuchs P, 1999, HUM MOL GENET, V8, P2461, DOI 10.1093/hmg/8.13.2461; Gostynska KB, 2015, HUM MOL GENET, V24, P3155, DOI 10.1093/hmg/ddv066; Groeneweg JA, 2015, CIRC-CARDIOVASC GENE, V8, P437, DOI 10.1161/CIRCGENETICS.114.001003; Hoorntje ET, 2017, CARDIOVASC RES, V113, P1521, DOI 10.1093/cvr/cvx150; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Konieczny P, 2008, J CELL BIOL, V181, P667, DOI 10.1083/jcb.200711058; Koss-Harnes D, 2002, J INVEST DERMATOL, V118, P87, DOI 10.1046/j.0022-202x.2001.01591.x; Lazzarini E, 2015, HUM MUTAT, V36, P403, DOI 10.1002/humu.22765; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Marcus FI, 2013, J AM COLL CARDIOL, V62, P1911, DOI 10.1016/j.jacc.2013.07.064; Marcus FI, 2010, EUR HEART J, V31, P806, DOI [10.1093/eurheartj/ehq025, 10.1161/CIRCULATIONAHA.108.840827]; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; McMilian JR, 1998, J INVEST DERMATOL, V110, P132, DOI 10.1046/j.1523-1747.1998.00102.x; Ortega E, 2016, J BIOL CHEM, V291, P18643, DOI 10.1074/jbc.M116.732909; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schroder R, 2002, J NEUROPATH EXP NEUR, V61, P520, DOI 10.1093/jnen/61.6.520; Sen-Chowdhry S, 2007, CIRCULATION, V115, P1710, DOI 10.1161/CIRCULATIONAHA.106.660241; Sen-Chowdhry S, 2010, ANNU REV MED, V61, P233, DOI 10.1146/annurev.med.052208.130419; te Rijdt WP, 2014, EUR J HUM GENET, V22, DOI 10.1038/ejhg.2013.124; Teekakirikul P, 2013, J MOL DIAGN, V15, P158, DOI 10.1016/j.jmoldx.2012.09.002; Thorolfsdottir RB, 2017, J AM COLL CARDIOL, V70, P2157, DOI 10.1016/j.jacc.2017.09.005; Villa CR, 2015, NEUROMUSCULAR DISORD, V25, P165, DOI 10.1016/j.nmd.2014.09.011; Walko G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002396; Walsh R, 2017, GENET MED, V19, P192, DOI 10.1038/gim.2016.90; WICHE G, 1984, EXP CELL RES, V155, P43, DOI 10.1016/0014-4827(84)90766-3; Winter L, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0314-7; Ye JJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-11	36	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203078	10.1371/journal.pone.0203078	http://dx.doi.org/10.1371/journal.pone.0203078			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161220	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900078
J	Oswald, DM; Sim, ES; Baker, C; Farhan, O; Debanne, SM; Morris, NJ; Rodriguez, BG; Jones, MB; Cobb, BA				Oswald, Douglas M.; Sim, Edward S.; Baker, Courtney; Farhan, Obada; Debanne, Sara M.; Morris, Nathan J.; Rodriguez, Benigno G.; Jones, Mark B.; Cobb, Brian A.			Plasma glycomics predict cardiovascular disease in patients with ART-controlled HIV infections	FASEB JOURNAL			English	Article						biomarker; glycan; glycome; lectin; CVD	MONOCYTE ACTIVATION; IMMUNE ACTIVATION; INCREASED RISK; CELL COUNT; INFLAMMATION; BIOMARKERS; PROTEIN; AIDS; ASSOCIATION; COAGULATION	Despite effective control of HIV infection with antiretroviral drugs, individuals with HIV have high incidences of secondary diseases. These sequelae, such as cardiovascular disease (CVD), are poorly understood and represent a major health burden. To date, predictive biomarkers of HIV-associated secondary disease have been elusive, making preventative clinical management essentially impossible. Here, we applied a newly developed and easy to deploy, multitarget, and high-throughput glycomic analysis to banked HIV+ human plasma samples to determine whether the glycome may include biomarkers that predict future HIV-associated cardiovascular events or CVD diagnoses. Using 324 patient samples, we identified a glycomic fingerprint that was predictive of future CVD events but independent of CD4 counts, diabetes, age, and birth sex, suggesting that the plasma glycome may serve as a biomarker for specific HIV-associated sequelae. Our findings constitute the discovery of novel glycan biomarkers that could classify patients with HIV with elevated risk for CVD and reveal the untapped prognostic potential of the plasma glycome in human disease.Oswald, D. M., Sim, E. S., Baker, C., Farhan, O., Debanne, S. M., Morris, N. J., Rodriguez, B. G., Jones, M. B., Cobb, B. A. Plasma glycomics predict cardiovascular disease in patients with ART-controlled HIV infections.	[Oswald, Douglas M.; Sim, Edward S.; Jones, Mark B.; Cobb, Brian A.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Baker, Courtney; Farhan, Obada; Debanne, Sara M.; Morris, Nathan J.] Case Western Reserve Univ, Sch Med, Dept Populat & Quantitat Hlth Sci, Cleveland, OH USA; [Rodriguez, Benigno G.] Univ Hosp Cleveland, Dept Med, Med Ctr, Div Infect Dis & HIV Med, 2074 Abington Rd, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Cobb, BA (corresponding author), Case Western Reserve Univ, Dept Pathol, 2103 Cornell Rd,WRB 5132, Cleveland, OH 44106 USA.	brian.cobb@case.edu			U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [GM082916, GM115234]; NIH National Institute of Allergy and Infectious Diseases Training Grant [T32 AI089474]; CWRU CFAR grant [AI036219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474, P30AI036219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082916, R01GM115234] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Institute of Allergy and Infectious Diseases Training Grant; CWRU CFAR grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the CFAR staff for assistance in designing the study and in selecting, gathering, and processing the samples; the members of the B.A.C. laboratory for valuable feedback and input; Dr. Michael Lederman (CFAR) for critical evaluation of this manuscript; and Dr. Jonathan Karn (CFAR) for the invitation and encouragement to work in the HIV field. This work was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grants GM082916 and GM115234 (to B.A.C.), an administrative supplement to B.A.C. through the CWRU CFAR grant AI036219 to Jonathan Karn, and NIH National Institute of Allergy and Infectious Diseases Training Grant T32 AI089474 (to D.M.O.). This work has been presented, in part, at the 2017 Society for Glycobiology Meeting. The authors declare no conflicts of interest.	Adedeji AL, 2014, EXCLI J, V13, P761; Baker JV, 2010, CURR OPIN HIV AIDS, V5, P511, DOI 10.1097/COH.0b013e32833ed7ec; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; Breen EC, 2011, CANCER EPIDEM BIOMAR, V20, P1303, DOI 10.1158/1055-9965.EPI-11-0037; Brown TT, 2010, DIABETES CARE, V33, P2244, DOI 10.2337/dc10-0633; Calza L, 2009, JAIDS-J ACQ IMM DEF, V50, P430, DOI 10.1097/QAI.0b013e31819a292c; Cummings R.D., 2015, ESSENTIALS GLYCOBIOL, P611; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Erlandson KM, 2017, J INFECT DIS, V215, P228, DOI 10.1093/infdis/jiw523; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Haab BB, 2012, PROTEOM CLIN APPL, V6, P346, DOI 10.1002/prca.201200014; Hsue PY, 2012, J INFECT DIS, V205, pS375, DOI 10.1093/infdis/jis200; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Jones MB, 2016, P NATL ACAD SCI USA, V113, P7207, DOI 10.1073/pnas.1523968113; Justice AC, 2018, J INFECT DIS, V217, P521, DOI 10.1093/infdis/jix586; Justice AC, 2012, CLIN INFECT DIS, V54, P984, DOI 10.1093/cid/cir989; KAPLAN HA, 1983, J BIOL CHEM, V258, P1505; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kreisman LSC, 2012, GLYCOBIOLOGY, V22, P1019, DOI 10.1093/glycob/cws070; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lauer ME, 2014, J BIOL CHEM, V289, P6791, DOI 10.1074/jbc.M113.512491; Lichtenstein KA, 2010, CLIN INFECT DIS, V51, P435, DOI 10.1086/655144; Longenecker CT, 2013, HIV MED, V14, P385, DOI 10.1111/hiv.12013; Longenecker CT, 2013, INT J CARDIOL, V168, P4039, DOI 10.1016/j.ijcard.2013.06.059; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; Monforte AD, 2013, AIDS, V27, P407, DOI 10.1097/QAD.0b013e32835b2ef1; O'Connell TX, 2005, AM FAM PHYSICIAN, V71, P105; Pagan JD, 2018, CELL, V172, P564, DOI 10.1016/j.cell.2017.11.041; Pereyra F, 2012, AIDS, V26, P2409, DOI 10.1097/QAD.0b013e32835a9950; Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056; Ribeiro JP, 2013, CURR OPIN CHEM BIOL, V17, P827, DOI 10.1016/j.cbpa.2013.06.009; Riddler SA, 2003, JAMA-J AM MED ASSOC, V289, P2978, DOI 10.1001/jama.289.22.2978; Triant VA, 2009, JAIDS-J ACQ IMM DEF, V51, P268, DOI 10.1097/QAI.0b013e3181a9992c; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Wang YC, 2011, CELL RES, V21, P1551, DOI 10.1038/cr.2011.148; Yang WH, 2015, P NATL ACAD SCI USA, V112, P13657, DOI 10.1073/pnas.1515464112; Yue TT, 2009, MOL CELL PROTEOMICS, V8, P1697, DOI 10.1074/mcp.M900135-MCP200; Zanni MV, 2012, CURR HIV-AIDS REP, V9, P200, DOI 10.1007/s11904-012-0123-y	39	7	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1852	1859		10.1096/fj.201800923R	http://dx.doi.org/10.1096/fj.201800923R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30183373	Green Published			2022-12-26	WOS:000457296600027
J	Lau, BW; Huh, K; Madero-Marroquin, R; De Marchi, F; Lim, Y; Wang, QJ; Lobo, F; Marchionni, L; Smith, DB; DeZern, A; Levis, MJ; Aplan, PD; Matsui, W; Gondek, LP				Lau, Bonnie W.; Huh, Kyounghee; Madero-Marroquin, Rafael; De Marchi, Federico; Lim, Yiting; Wang, Qiuju; Lobo, Francisco; Marchionni, Luigi; Smith, Douglas B.; DeZern, Amy; Levis, Mark J.; Aplan, Peter D.; Matsui, William; Gondek, Lukasz P.			Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activity	ONCOGENE			English	Article							ACUTE MYELOID-LEUKEMIA; STEM-CELLS; TRANSCRIPTION FACTOR; PATHWAY ACTIVATION; SIGNALING PATHWAYS; SCORING SYSTEM; HUMAN HOMOLOG; EARLY DEATH; PREDICTION; EVOLUTION	Myelodysplastic syndromes (MDSs) are stem cell disorders with risk of transformation to acute myeloid leukemia (AML). Gene expression profiling reveals transcriptional expression of GLI1, of Hedgehog (Hh) signaling, in poor-risk MDS/AML. Using a murine model of MDS we demonstrated that constitutive Hh/Gli1 activation accelerated leukemic transformation and decreased overall survival. Hh/Gli1 activation resulted in clonal expansion of phenotypically defined granulocyte macrophage progenitors (GMPs) and acquisition of self-renewal potential in a non-self-renewing progenitor compartment. Transcriptome analysis of GMPs revealed enrichment in gene signatures of self-renewal pathways, operating via direct Gli1 activation. Using human cell lines we demonstrated that in addition to canonical Hh signaling, GLI1 is activated in a Smoothened-independent manner. GLI1 knockdown or inhibition with GANT61 resulted in decreased proliferation and clonogenic potential. Our data suggest that GLI1 activation is frequent in MDS during disease progression and inhibition of GLI1 is an attractive therapeutic target for a subset of patients.	[Lau, Bonnie W.; Huh, Kyounghee; Madero-Marroquin, Rafael; De Marchi, Federico; Lim, Yiting; Wang, Qiuju; Lobo, Francisco; Marchionni, Luigi; Smith, Douglas B.; DeZern, Amy; Levis, Mark J.; Gondek, Lukasz P.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Lim, Yiting] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Lobo, Francisco] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Aplan, Peter D.] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; [Matsui, William] Univ Texas Austin, Dell Med Sch, LIVESTRONG Canc Inst, Austin, TX 78712 USA	Johns Hopkins University; Johns Hopkins Medicine; Fred Hutchinson Cancer Center; Universidade Federal de Minas Gerais; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; University of Texas Austin	Gondek, LP (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA.; Matsui, W (corresponding author), Univ Texas Austin, Dell Med Sch, LIVESTRONG Canc Inst, Austin, TX 78712 USA.	matsuwi@jhmi.edu; lgondek1@jhmi.edu	Lobo, Francisco Pereira/AAG-3118-2021; Marchionni, Luigi/S-6774-2017	Lobo, Francisco Pereira/0000-0002-9671-9313; Marchionni, Luigi/0000-0002-7336-8071	National Institute of Health [K08 HL136894]; Edward P. Evans Foundation; Sidney Kimmel Comprehensive Cancer Center Core Facilities [P30 CA006973]; NATIONAL CANCER INSTITUTE [P30CA006973, ZIABC010983, K24CA198315] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL136894] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward P. Evans Foundation; Sidney Kimmel Comprehensive Cancer Center Core Facilities; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to acknowledge Dr. David Huso, previously an Associate Professor in the Department of Molecular and Comparative Pathobiology at Johns Hopkins, for preparing the histology slides; and Dr. Hao Zhang, Research Associate in the Department of Molecular Microbiology and Immunology at Johns Hopkins, for helping to sort the murine bone marrow for cell subpopulations. This work was supported by grants from the National Institute of Health (K08 HL136894) (LPG) and Edward P. Evans Foundation (LPG). Flow cytometry and microarray analysis was performed with the support of the Sidney Kimmel Comprehensive Cancer Center Core Facilities (P30 CA006973).	Altaba ARI, 1997, CELL, V90, P193, DOI 10.1016/S0092-8674(00)80325-6; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Borycki AG, 2000, DEVELOPMENT, V127, P2075; Brechbiel J, 2014, CANCER TREAT REV, V40, P750, DOI 10.1016/j.ctrv.2014.02.003; Chaudhry P, 2017, BLOOD, V129, P3465, DOI 10.1182/blood-2016-05-718585; CORTES JE, 2016, BLOOD, V128; Dagklis A, 2016, BLOOD, V128, P2642, DOI 10.1182/blood-2016-03-703454; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Fenaux P, 2011, BLOOD, V118, P3765, DOI 10.1182/blood-2011-01-330126; Gao J, 2009, CELL STEM CELL, V4, P548, DOI 10.1016/j.stem.2009.03.015; Gerstung M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6901; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hofmann I, 2009, CELL STEM CELL, V4, P559, DOI 10.1016/j.stem.2009.03.016; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Johnson RW, 2011, CANCER RES, V71, P822, DOI 10.1158/0008-5472.CAN-10-2993; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Joo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007608; Kang HJ, 2015, KOREAN J RADIOL, V16, P1068, DOI 10.3348/kjr.2015.16.5.1068; Kobune M, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.36; Krug U, 2010, LANCET, V376, P2000, DOI 10.1016/S0140-6736(10)62105-8; LANCET JE, 2016, BLOOD, V128; Lim Y, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac9303; Lin YW, 2005, BLOOD, V106, P287, DOI 10.1182/blood-2004-12-4794; Liu Z, 2014, ONCOGENE, V33, P65, DOI 10.1038/onc.2012.544; Long B, 2016, CELL PHYSIOL BIOCHEM, V38, P1288, DOI 10.1159/000443075; Makishima H, 2017, NAT GENET, V49, P204, DOI 10.1038/ng.3742; Malcovati L, 2007, J CLIN ONCOL, V25, P3503, DOI 10.1200/JCO.2006.08.5696; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Martinelli G, 2015, LANCET HAEMATOL, V2, pE339, DOI 10.1016/S2352-3026(15)00096-4; McMillan R, 2012, CLIN CANCER RES, V18, P4883, DOI 10.1158/1078-0432.CCR-11-2509; Meggendorfer M, 2015, HAEMATOLOGICA, V100, pE487, DOI 10.3324/haematol.2015.127985; Merchant A, 2010, BLOOD, V115, P2391, DOI 10.1182/blood-2009-09-241703; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Ringuette R, 2016, DEV BIOL, V411, P85, DOI 10.1016/j.ydbio.2016.01.006; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Seto M, 2009, MOL CARCINOGEN, V48, P703, DOI 10.1002/mc.20516; Tefferi A, 2015, AM J HEMATOL, V90, P831, DOI 10.1002/ajh.24102; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; Torchia EC, 2007, MOL CELL BIOL, V27, P7918, DOI 10.1128/MCB.00099-07; Walter RB, 2011, J CLIN ONCOL, V29, P4417, DOI 10.1200/JCO.2011.35.7525; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Wellbrock J, 2015, CLIN CANCER RES, V21, P2388, DOI 10.1158/1078-0432.CCR-14-1059; Xavier-Ferrucio JM, 2015, HAEMATOLOGICA, V100, pE491, DOI 10.3324/haematol.2015.124040; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zou JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136843; Zou JX, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/957502; Zwerner JP, 2008, ONCOGENE, V27, P3282, DOI 10.1038/sj.onc.1210991	51	13	14	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 31	2019	38	5					687	698		10.1038/s41388-018-0431-9	http://dx.doi.org/10.1038/s41388-018-0431-9			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HJ6LI	30171262	Green Accepted			2022-12-26	WOS:000457300300006
J	Aubol, BE; Serrano, P; Fattet, L; Wuthrich, K; Adams, JA				Aubol, Brandon E.; Serrano, Pedro; Fattet, Laurent; Wuethrich, Kurt; Adams, Joseph A.			Molecular interactions connecting the function of the serine-arginine-rich protein SRSF1 to protein phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphorylation; phosphatase; protein kinase; enzyme kinetics; enzyme mutation	SPLICING FACTOR ASF/SF2; RNA RECOGNITION MOTIF; SR PROTEINS; BACKBONE ASSIGNMENT; CATALYTIC SUBUNIT; SITE SELECTION; RS DOMAIN; APSY-NMR; PHOSPHORYLATION; KINASES	Splicing generates many mRNA strands from a single precursor mRNA, expanding the proteome and enhancing intracellular diversity. Both initial assembly and activation of the spliceosome require an essential family of splicing factors called serine-arginine (SR) proteins. Protein phosphatase 1 (PP1) regulates the SR proteins by controlling phosphorylation of a C-terminal arginine-serine-rich (RS) domain. These modifications are vital for the subcellular localization and mRNA splicing function of the SR protein. Although PP1 has been shown to dephosphorylate the prototype SR protein splicing factor 1 (SRSF1), the molecular nature of this interaction is not understood. Here, using NMR spectroscopy, we identified two electrostatic residues in helix 2 and a hydrophobic residue in helix 1 in the RNA recognition motif 1 (RRM1) of SRSF1 that constitute a binding surface for PP1. Substitution of these residues dissociated SRSF1 from PP1 and enhanced phosphatase activity, reducing phosphorylation in the RS domain. These effects lead to shifts in alternative splicing patterns that parallel increases in SRSF1 diffusion from speckles to the nucleoplasm brought on by regiospecific decreases in RS domain phosphorylation. Overall, these findings establish a molecular and biological connection between PP1-targeted amino acids in an RRM with the phosphorylation state and mRNA-processing function of an SR protein.	[Aubol, Brandon E.; Fattet, Laurent; Adams, Joseph A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Serrano, Pedro; Wuethrich, Kurt] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Wuethrich, Kurt] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Wuethrich, Kurt] Scripps Res Inst, Struct Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Adams, JA (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	j2adams@ucsd.edu	FATTET, Laurent/W-8392-2019; Fattet, Laurent/ABH-5434-2020	Fattet, Laurent/0000-0001-5152-4937; Wuthrich, Kurt/0000-0001-8739-6965	National Institutes of Health [GM67969, GM98528]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067969, R01GM098528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM67969 and GM98528. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aubol BE, 2003, P NATL ACAD SCI USA, V100, P12601, DOI 10.1073/pnas.1635129100; Aubol BE, 2018, BIOCHEM J, V475, P677, DOI 10.1042/BCJ20170672; Aubol BE, 2017, J MOL BIOL, V429, P2178, DOI 10.1016/j.jmb.2017.05.022; Aubol BE, 2014, BIOCHEM J, V462, P143, DOI 10.1042/BJ20140494; Aubol BE, 2011, BIOCHEMISTRY-US, V50, P6888, DOI 10.1021/bi2007993; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Cho SY, 2011, P NATL ACAD SCI USA, V108, P8233, DOI 10.1073/pnas.1017700108; Clery A, 2013, P NATL ACAD SCI USA, V110, pE2802, DOI 10.1073/pnas.1303445110; Dauksaite V, 2004, BIOCHEM J, V381, P343, DOI 10.1042/BJ20040408; Duncan PI, 1998, EXP CELL RES, V241, P300, DOI 10.1006/excr.1998.4083; Dutta SK, 2015, J BIOMOL NMR, V61, P47, DOI 10.1007/s10858-014-9881-8; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Gibbons JA, 2005, J BIOL CHEM, V280, P15903, DOI 10.1074/jbc.M500871200; Gutfreund H., 1995, KINETICS LIFE SCI RE; Hiller S, 2005, P NATL ACAD SCI USA, V102, P10876, DOI 10.1073/pnas.0504818102; Hiller S, 2008, J BIOMOL NMR, V42, P179, DOI 10.1007/s10858-008-9266-y; Jeong S, 2017, MOL CELLS, V40, P1, DOI 10.14348/molcells.2017.2319; Keshwani MM, 2015, BIOCHEM J, V466, P311, DOI 10.1042/BJ20141373; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Ma CT, 2009, J MOL BIOL, V390, P618, DOI 10.1016/j.jmb.2009.05.060; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Muller S, 1998, J MOL BIOL, V283, P383, DOI 10.1006/jmbi.1998.2078; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; PICKING WD, 1991, BIOCHEMISTRY-US, V30, P10280, DOI 10.1021/bi00106a028; Prasad J, 2003, MOL CELL BIOL, V23, P4139, DOI 10.1128/MCB.23.12.4139-4149.2003; Ragusa MJ, 2010, NAT STRUCT MOL BIOL, V17, P459, DOI 10.1038/nsmb.1786; Sacco-Bubulya P, 2002, J CELL BIOL, V156, P425, DOI 10.1083/jcb.200107017; Serrano P, 2016, J MOL BIOL, V428, P2430, DOI 10.1016/j.jmb.2016.04.009; Stojdl DF, 1999, BIOCHEM CELL BIOL, V77, P293, DOI 10.1139/bcb-77-4-293; Velazquez-Dones A, 2005, J BIOL CHEM, V280, P41761, DOI 10.1074/jbc.M504156200; Volk J, 2008, J BIOMOL NMR, V41, P127, DOI 10.1007/s10858-008-9243-5; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	37	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16751	16760		10.1074/jbc.RA118.004587	http://dx.doi.org/10.1074/jbc.RA118.004587			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30185622	Green Published, hybrid			2022-12-26	WOS:000448515100017
J	Radford, Z; Hyder, K; Zarauz, L; Mugerza, E; Ferter, K; Prellezo, R; Strehlow, HV; Townhill, B; Lewin, WC; Weltersbach, MS				Radford, Zachary; Hyder, Kieran; Zarauz, Lucia; Mugerza, Estanis; Ferter, Keno; Prellezo, Raul; Strehlow, Harry Vincent; Townhill, Bryony; Lewin, Wolf-Christian; Weltersbach, Marc Simon			The impact of marine recreational fishing on key fish stocks in European waters	PLOS ONE			English	Article							CATCH-AND-RELEASE; FISHERIES CATCHES; NORTH-SEA; COD; MANAGEMENT; RECONSTRUCTION; MORTALITY; COLLAPSE; CONSERVATION; HARVEST	Marine recreational fishing (MRF) has been shown to substantially contribute to fishing mortality of marine fish. However, European MRF catches are only quantified for a small number of stocks, so it is unclear whether a significant part of fishing mortality is excluded from stock assessments. This study estimated: (i) European MRF removals, which were defined as landings plus dead releases; and (ii) impact at stock level by comparing the percentage contribution to total removal by MRF and commercial fishing. As MRF data were limited for some European countries, catches were reconstructed using a mixture of average release proportions, average fish weights, and extrapolation using the catch per fisher of the nearest country providing catch estimates. Where catch reconstructions exceeded 50%, data were excluded from further analysis. Furthermore, as MRF survey methodology can be variable, semi-quantitative estimates of bias and error were calculated for each stock. Only 10 of the 20 stocks assessed in this study had sufficient MRF data for full reliable estimates. Percentage contribution to total removals (MRF + commercial removals) by MRF ranged between 2% for Atlantic mackerel in the North Sea and Skagerrak and 43% for Atlantic pollack in the Celtic Seas and English Channel. The biomass removed ranged between 297 (+/- 116) tonnes (Atlantic cod in the western English Channel and southern Celtic seas) and 4820 (+/- 1889) tonnes (Atlantic mackerel in the North Sea and Skagerrak), but the errors were substantial. Additionally, the bias in the estimated removals was low for most stocks, with some positive biases found. The present study indicates that removals by MRF can represent a high proportion of the total removals for some European marine fish stocks, so inclusion in stock assessments should be routine. To achieve this, regular surveys of MRF are required to collect data essential for stock assessments.	[Radford, Zachary; Hyder, Kieran; Townhill, Bryony] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England; [Hyder, Kieran] Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England; [Zarauz, Lucia; Mugerza, Estanis; Prellezo, Raul] AZTI Tecnalia, Sukarrieta, Spain; [Ferter, Keno] Inst Marine Res, Bergen, Norway; [Strehlow, Harry Vincent; Lewin, Wolf-Christian; Weltersbach, Marc Simon] Thunen Inst Baltic Sea Fisheries Thunen OF, Rostock, Germany	Centre for Environment Fisheries & Aquaculture Science; University of East Anglia; AZTI; Institute of Marine Research - Norway; Johann Heinrich von Thunen Institute	Radford, Z (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England.	zachary.radford@cefas.co.uk	Prellezo, Raul/B-8231-2009	Prellezo, Raul/0000-0001-5998-8146; Radford, Zachary/0000-0002-6820-5913; Hyder, Kieran/0000-0003-1428-5679; Lewin, Wolf-Christian/0000-0001-6598-6489; Zarauz, Lucia/0000-0002-2785-2727; Weltersbach, Marc Simon/0000-0001-9173-5157; Mugerza, Estanis/0000-0003-4175-8750	European Parliaments PECH committee fund [IP/B/PECH/IC/2016-131]; UK Department for Environment, Food and Rural Affairs (DEFRA) [MI001A]; European Commission's Data Collection Framework (DCF); project: "A framework for science-based management of marine recreational fisheries in Norway" - Research Council of Norway [267808]	European Parliaments PECH committee fund; UK Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); European Commission's Data Collection Framework (DCF); project: "A framework for science-based management of marine recreational fisheries in Norway" - Research Council of Norway	The European Parliaments PECH committee funded this project (Contract code IP/B/PECH/IC/2016-131). ZR, KH and BT were also supported by the UK Department for Environment, Food and Rural Affairs (DEFRA) under contract code MI001A. HVS and MSW were funded by European Commission's Data Collection Framework (DCF). KF was funded by the project: "A framework for science-based management of marine recreational fisheries in Norway" financed by the Research Council of Norway (project number: 267808). These funders but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arlinghaus R, 2015, FISHERIES MANAG ECOL, V22, P45, DOI 10.1111/fme.12075; Armstrong M., 2013, SEA ANGLING 2012 SUR; Bartholomew A, 2005, REV FISH BIOL FISHER, V15, P129, DOI 10.1007/s11160-005-2175-1; Beardmore B, 2015, CAN J FISH AQUAT SCI, V72, P500, DOI 10.1139/cjfas-2014-0177; Capizzano CW, 2016, ICES J MAR SCI, V73, P2342, DOI 10.1093/icesjms/fsw058; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Cook RM, 1997, NATURE, V385, P521, DOI 10.1038/385521a0; Cooke SJ, 2006, BIOL CONSERV, V128, P93, DOI 10.1016/j.biocon.2005.09.019; Depestele J, 2014, FISH RES, V154, P82, DOI 10.1016/j.fishres.2014.01.018; EFSA Scientific Committee, 2015, GUID UNC EFSA SCI AS; Ferter K, 2013, FISHERIES MANAG ECOL, V20, P137, DOI 10.1111/j.1365-2400.2012.00862.x; Ferter K, 2013, ICES J MAR SCI, V70, P1319, DOI 10.1093/icesjms/fst104; Herfaut J, 2013, OCEAN COAST MANAGE, V78, P121, DOI 10.1016/j.ocecoaman.2013.02.026; Hilborn R, 2003, ANNU REV ENV RESOUR, V28, P359, DOI 10.1146/annurev.energy.28.050302.105509; Hyder K, 2014, RECREATIONAL SEA FIS, P8; Hyder K, 2018, FISH FISH, V19, P225, DOI 10.1111/faf.12251; ICCAT, 2017, ACC ICCAT STAT DAT; ICES, 2016, SEA BASS DIC LABR DI; ICES, 2017, COD GAD MORH SUBD 22; ICES, 2010, CMACOM34 ICES; ICES, 2017, 2017ACOM15 ICES CM; ICES, 2013, 2013ACOM23 ICES CM; ICES, 2017, 2017ACOM10 ICES CM; ICES, 2016, COD GAD MORH SUBD 22; ICES, 2017, 2016SSGIEOM10 ICES C; ICES, 2017, SEA BASS DIC LABR DI; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Karlsson M, 2016, NATL DATA COLLECTION; Keskin C, 2014, FISH CTR WORK PAP, V27, P12; Keskin C, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00053; Khalfallah M, 2017, MEDITERR MAR SCI, V18, P241, DOI 10.12681/mms.1683; Kleiven AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149595; Lewin WC, 2018, ICES J MAR SCI, V75, P1483, DOI 10.1093/icesjms/fsx240; Mark Freeberg J.G.Pope, 1994, GLOBAL ASSESSMENT FI; Matic-Skoko S., 2014, CROATIAN MARINE FISH; Morales-Nin B, 2015, FISH RES, V164, P45, DOI 10.1016/j.fishres.2014.10.010; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; Pauly D., 2003, CONSERVATION PRACTIC, V4, P20; Pawson MG, 2008, MAR POLICY, V32, P339, DOI 10.1016/j.marpol.2007.07.001; Pawson MG, 2007, FISH2004011662 EU; Piroddi C, 2015, FISH RES, V172, P137, DOI 10.1016/j.fishres.2015.06.028; Policansky D., 2002, RECREATIONAL FISHERI, P74, DOI DOI 10.1002/9780470995402.CH6; Pollock K. H, 1994, ANGLER SURVEY METHOD; Rocklin D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087271; Ryan KL, 2016, FISHERIES MANAG ECOL, V23, P218, DOI 10.1111/fme.12151; Sparrevohn CR, 2012, ICES J MAR SCI, V69, P323, DOI 10.1093/icesjms/fss005; STECF, 2014, SCI TECHN EC COMM FI; Stokesbury MJW, 2011, BIOL CONSERV, V144, P2684, DOI 10.1016/j.biocon.2011.07.029; Strehlow HV, 2012, ICES J MAR SCI, V69, P1769, DOI 10.1093/icesjms/fss152; U.S. Fish and Wildlife Service, 2006, NAT SURV FISH HUNT W; Ulman Aylin, 2015, Journal of the Black Sea Mediterranean Environment, V21, P103; van der Hammen T, 2015, C04215 CVO; van der Hammen T, 2016, ICES J MAR SCI, V73, P441, DOI 10.1093/icesjms/fsv190; Veiga P, 2010, J FISH BIOL, V76, P2216, DOI 10.1111/j.1095-8649.2010.02665.x; Venturini S, 2017, FISHERIES MANAG ECOL, V24, P382, DOI 10.1111/fme.12241; Weltersbach MS, 2013, ICES J MAR SCI, V70, P864, DOI 10.1093/icesjms/fst038	57	48	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2018	13	9							e0201666	10.1371/journal.pone.0201666	http://dx.doi.org/10.1371/journal.pone.0201666			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7EB	30208030	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000444683000008
J	Blasch, K; Hundt, S; Wurster, P; Sando, R; Berthelote, A				Blasch, Kyle; Hundt, Stephen; Wurster, Patrick; Sando, Roy; Berthelote, Antony			Streamflow contributions from tribal lands to major river basins of the United States	PLOS ONE			English	Article							CLIMATE-CHANGE	While many studies on tribal water resources of individual tribal lands in the United States (US) have been conducted, the importance of tribal water resources at a national scale has largely gone unrecognized because their combined totals have not been quantified. Thus, we sought to provide a numerical estimate of major water budget components on tribal lands within the conterminous US and on USGS hydrologic unit codes (HUC2) regions. Using existing national-scale data and models, we estimated mean annual precipitation, evapotranspiration, excess precipitation, streamflow, and water use for the period 1971-2000. Tribal lands represent about 3.4 percent of the total land area of the conterminous US and on average account for 1.9 percent of precipitation, 2.4 percent of actual evapotranspiration, 0.95 percent of excess precipitation, 1.6 percent of water use, and 0.43 percent of streamflow origination. Additionally, approximately 9.5 and 11.3 percent of US streamflow flows through or adjacent as boundaries to tribal lands, respectively. Streamflow through or adjacent to tribal lands accounts for 42 and 48 percent of streamflow in the Missouri region, respectively; and for 86 and 88 percent in the Lower Colorado region, respectively. On average, 5,600 million cubic meters of streamflow per year was produced on tribal lands in the Pacific Northwest region, nearly five times greater than tribal lands in any other region. Tribal lands in the Great Lakes, Missouri, Arkansas-White-Red, and California regions all produced between 1,000 and 1,400 million cubic meters per year.	[Blasch, Kyle; Hundt, Stephen] US Geol Survey, Idaho Water Sci Ctr, Boise, ID 83702 USA; [Wurster, Patrick; Berthelote, Antony] Salish Kootenai Coll, Nat Resources Program, Pablo, MT USA; [Sando, Roy] US Geol Survey, Wyoming Montana Water Sci Ctr, Helena, MT USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Blasch, K (corresponding author), US Geol Survey, Idaho Water Sci Ctr, Boise, ID 83702 USA.	Kblasch@usgs.gov	blasch, kyle/AAK-8948-2020	Wurster, Patrick/0000-0003-2668-2014; Hundt, Stephen/0000-0002-6484-0637; Sando, Roy/0000-0003-0704-6258	United States Geological Survey; Salish Kootenai College	United States Geological Survey(United States Geological Survey); Salish Kootenai College	The United States Geological Survey funded the design and execution of this study. Participation by personnel from Salish Kootenai College were funded by that institution.; The authors would like to thank the many thoughtful reviewers who contributed to the content of this paper. Funding for this study was provided exclusively by the U.S Geological Survey.	Andrews WJ, 2013, ANAL ENV SETTING SUR; [Anonymous], 2015, PUB LAND RESOURCES L; [Anonymous], 2017, SCIENCEBASE, DOI [10.5066/F7959GR6, DOI 10.5066/F7959GR6]; Benson L, 2007, CLIMATIC CHANGE, V83, P187, DOI 10.1007/s10584-006-9065-y; Brubaker MY, 2011, INT J CIRCUMPOL HEAL, V70, P266, DOI 10.3402/ijch.v70i3.17820; Cochran P, 2013, CLIMATIC CHANGE, V120, P557, DOI 10.1007/s10584-013-0735-2; Cozzetto K, 2013, CLIMATIC CHANGE, V120, P569, DOI 10.1007/s10584-013-0852-y; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Dittmer K, 2013, CLIMATIC CHANGE, V120, P627, DOI 10.1007/s10584-013-0745-0; Doyle JT, 2013, CLIMATIC CHANGE, V120, P643, DOI 10.1007/s10584-013-0799-z; Drost B., 1985, APPRAISAL GROUND WAT; EPA USGS, 2012, SURV USG; FELDMAN SM, 1994, HARVARD ENVIRON LAW, V18, P433; Fitzpatrick FA, 1850, MENOMINEE INDIAN RES; Frans LM, 2001, WATER RESOURCES TULA; Gautam MR, 2013, CLIMATIC CHANGE, V120, P585, DOI 10.1007/s10584-013-0737-0; Gellis AC, 1998, 984083 ZUN IND RES; Gowan C, 2006, ECOL ECON, V56, P508, DOI 10.1016/j.ecolecon.2005.03.018; Hoffmann JP, 2001, FORT MCDOWELL INDIAN; Jones PM, 2015, 23280328 US GEOL SUR; Kalluri S, 2003, ENVIRON SCI POLICY, V6, P487, DOI 10.1016/j.envsci.2003.08.002; Kapinos F.P., 1987, US GEOLOGICAL SURVEY; Konieczki AD, 1989, 894148 GIL RIV IND R; Kresch DL, 1989, BOOKS OPEN FILE REPO; Lawrence SJ, 1989, BOOKS OPEN FILE REPO; Lewis Yale O., 2002, AM INDIAN LAW REV, V27, P281, DOI DOI 10.2307/20070691; Lidwin RA, 1993, HYDROLOGY WATER QUAL; Lillengreen K, 1996, ANN REPORT; Littin GR, WATER RESOURCES INVE, V2000, P112; Lynn K, 2013, CLIMATIC CHANGE, V120, P545, DOI 10.1007/s10584-013-0736-1; MacDonnell L. J., 2015, WYOMING LAW REV, V15, P313, DOI [10.2139/ssrn.2691068, DOI 10.2139/SSRN.2691068]; Maldonado JK, 2013, CLIMATIC CHANGE, V120, P601, DOI 10.1007/s10584-013-0746-z; McCool D., 1987, COMMAND WATERS IRON; McKay L, 2012, NHDPLUS VERSION 2 US, P180; Montag JM, 2014, CLIMATIC CHANGE, V124, P385, DOI 10.1007/s10584-013-1001-3; NCAR, 2015, RES NCFA; Osborn B., 2009, J WATER LAW, V20, P224; Redsteer MH, 2013, NCA REGION INPUT REP, P385, DOI 10.5822/978-1-61091-484-0_17; Ruhl JF, 1995, GROUND WATER STREAMF; Sanford WE, 2013, J AM WATER RESOUR AS, V49, P217, DOI 10.1111/jawr.12010; Solley W.B., 1998, ESTIMATED USE WATER; Solley W.B., 1988, ESTIMATED USE WATER; Solley W. B., 1993, ESTIMATED USE WATER; Suagee Dean, 2008, NATURAL RESOURCES EN, V22, P45; Thompson KE, 1971, STREAM FLOW REQUIREM; Thomsen B, 1991, PREDEVELOPMENT HYDRO; USDA, 2015, SURV USG SERV	48	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203872	10.1371/journal.pone.0203872	http://dx.doi.org/10.1371/journal.pone.0203872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204802	Green Published, Green Submitted, gold			2022-12-26	WOS:000444355500053
J	Goyal, A; Romero-Severson, EO				Goyal, Ashish; Romero-Severson, Ethan Obie			Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil	PLOS ONE			English	Article							D VIRUS-INFECTION; B-VIRUS; MATHEMATICAL-MODEL; TRANSMISSION DYNAMICS; COST-EFFECTIVENESS; AMAZON; CHINA; DELTA; DISEASE; EPIDEMIOLOGY	Background Hepatitis D virus (HDV), which requires the presence of hepatitis B virus (HBV), is a deadly yet neglected disease that rapidly leads to liver cancer and disease-induced mortality. This co-dependence creates complex transmission dynamics that make it difficult to predict the efficacy of interventions aimed at HBV and/or HDV control in endemic regions, such as certain municipalities of Brazil, where up to 65% of HBV-infected persons are co-infected. Methodology We created a mathematical model that captures the joint transmission dynamics of HBV and HDV, incorporating mother-to-child, sexual and household transmission. With an aim to minimize the number of total infections and disease-induced mortality in 2027, we then determined optimal strategies for Brazil and its sub-regions under a constrained budget, which was dynamically allocated among HBV and HDV screening, HBV and HDV treatment, HBV newborn and adult vaccination, and awareness programs. Three treatment options were considered, namely: Tenofovir, PEGylated-Interferon, and nucleic acid polymers (NAP). Results The additional cost of HDV screening and the use of a more expensive PEGylated-Interferon are offset by not wasting resources on treating co-infected persons with Tenofovir. The introductory price of NAP treatment must be less than $ 16,000 per course to become competitive with Tenofovir and PEGylated-Interferon in Brazil. Conclusion Additional screening for HDV is beneficial, even in a low HBV and HDV endemic regions of Brazil. We recommend PEGylated-Interferon, wherever possible, for both HBV and HDV. If PEGylated-Interferon is not available in abundance, PEGylated-Interferon for co-infections and 4-year Tenofovir treatment for mono-infections is recommended.	[Goyal, Ashish; Romero-Severson, Ethan Obie] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Goyal, A (corresponding author), Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM 87545 USA.	ashish.goyal@lanl.gov	Romero-Severson, Ethan Obie/ABB-1185-2021; Goyal, Ashish/AAE-9948-2022; Goyal, Ashish/AFF-7955-2022; Goyal, Ashish/E-9727-2013	Goyal, Ashish/0000-0003-1582-3379	National Institutes of Health [R01-AI116868, R01-AI028433, R01-OD011095, R01-AI087520]; U.S. Department of Energy [DE-AC52-06NA25396]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028433, R01AI087520, R01AI116868] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011095] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (grant numbers R01-AI116868, R01-AI028433, R01-OD011095 and R01-AI087520). Portions of this work were performed under the auspices of the U.S. Department of Energy under contract DE-AC52-06NA25396. The funding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.	Abara WE, 2017, ANN INTERN MED, V167, P794, DOI 10.7326/M17-1106; Al-Mahtab M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156667; Alvarez AMR, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4227-6; Ayoub WS, 2011, ALIMENT PHARM THER, V34, P1145, DOI 10.1111/j.1365-2036.2011.04869.x; Bazinet M, 2017, LIV M 2017 WASH DC A; Blatt Carine Raquel, 2012, Value Health Reg Issues, V1, P129, DOI 10.1016/j.vhri.2012.10.001; Castilho MD, 2012, AM J TROP MED HYG, V87, P768, DOI 10.4269/ajtmh.2012.12-0083; Chen GF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155934; Ciancio A, 2013, TREATMENT HEPATITIS, p410 ; Cicero MF, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1856-9; CRAXI A, 1991, AM J EPIDEMIOL, V134, P641, DOI 10.1093/oxfordjournals.aje.a116136; da Fonseca JCF, 2007, ERADICATION HEPATITI; Costa RMD, 2015, CLINICS, V70, P237, DOI 10.6061/clinics/2015(04)03; de Soarez PC, 2011, VALUE HEALTH, V14, P1019, DOI 10.1016/j.jval.2011.05.045; Souto FJD, 2016, REV SOC BRAS MED TRO, V49, P11, DOI 10.1590/0037-8682-0176-2015; Eckman MH, 2011, CLIN INFECT DIS, V52, P1294, DOI 10.1093/cid/cir199; El Sherbini A, 2014, DIGEST LIVER DIS, V46, P1103, DOI 10.1016/j.dld.2014.08.032; Elazar M, 2017, BEST PRACT RES CL GA, V31, P321, DOI 10.1016/j.bpg.2017.05.001; Crispim MAE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-94; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Fan R, 2016, LANCET INFECT DIS, V16, P1103, DOI 10.1016/S1473-3099(16)30327-9; Franco E, 2012, WORLD J HEPATOL, V4, P74, DOI 10.4254/wjh.v4.i3.74; Alexandre KVF, 2012, MEM I OSWALDO CRUZ, V107, P1060, DOI 10.1590/S0074-02762012000800016; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Goyal A, 2017, J THEOR BIOL, V423, P41, DOI 10.1016/j.jtbi.2017.04.007; Goyal A, 2016, THEOR POPUL BIOL, V112, P60, DOI 10.1016/j.tpb.2016.08.004; Goyal A, 2016, J THEOR BIOL, V398, P9, DOI 10.1016/j.jtbi.2016.03.018; Goyal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110143; Grimm D, 2011, HEPATOL INT, V5, P644, DOI 10.1007/s12072-011-9261-3; Hanus JS, 2015, REV SOC BRAS MED TRO, V48, P665, DOI 10.1590/0037-8682-0230-2015; Heidrich B, 2014, HEPATOLOGY, V60, P87, DOI 10.1002/hep.27102; Hemming J., 1985, CHANGE AMAZON BASIN; Jonas Maureen M, 2010, Hepatology, V52, P2192, DOI 10.1002/hep.23934; Kershenobich D., 2015, 4 LAT AM M TREATM VI; Komatsu H, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.11.52; Lempp FA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070172; Lok AS, 2017, HEPATOLOGY, V66, P1296, DOI 10.1002/hep.29323; Luna EJA, 2009, VACCINE, V27, P5326, DOI 10.1016/j.vaccine.2009.06.096; MacLachlan JH, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021410; Braga WSM, 2006, REV SOC BRAS MED TRO, V39, P519, DOI 10.1590/S0037-86822006000600001; Braga WSM, 2014, J HEPATOL, V61, P1205, DOI 10.1016/j.jhep.2014.05.041; Braga WSM, 2012, REV SOC BRAS MED TRO, V45, P691, DOI 10.1590/S0037-86822012000600007; Nwokediuko SC, 2011, HEPAT MON, V11, P786, DOI 10.5812/kowsar.1735143X.757; PAHO, 2016, PUBL HLTH RESP AM; Parana R., 2013, Current Hepatitis Reports, V12, P305, DOI 10.1007/s11901-013-0186-2; Parana R, 2008, BRAZ J INFECT DIS, V12, P253, DOI 10.1590/S1413-86702008000300017; Patel R, 2005, J THEOR BIOL, V234, P201, DOI 10.1016/j.jtbi.2004.11.032; Pham Edward A, 2016, Curr Hepatol Rep, V15, P237, DOI 10.1007/s11901-016-0315-9; Rizzetto M, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021576; Sellier PO, 2018, LIVER INT, V38, P611, DOI 10.1111/liv.13556; Andrade HHSM, 2009, CAD SAUDE PUBLICA, V25, P1167, DOI 10.1590/S0102-311X2009000500023; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Viana S, 2005, AM J TROP MED HYG, V73, P808, DOI 10.4269/ajtmh.2005.73.808; Villar LM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/324638; WHO, 2015, WHO GUID PREV CAR TR; Wiens A, 2013, BRAZ J INFECT DIS, V17, P418, DOI 10.1016/j.bjid.2012.12.005; Williams JR, 1996, EPIDEMIOL INFECT, V116, P71, DOI 10.1017/S0950268800058970; WorldBank, 2016, LIF EXP BIRTH TOT YE; Wranke A, 2018, LIVER INT, V38, P842, DOI 10.1111/liv.13604; Xiridou M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005247; Xue MM, 2015, J PEDIATR GASTR NUTR, V61, P271, DOI 10.1097/MPG.0000000000000859; Zarrilli S., 2000, THE CASE OF BRAZIL; Zhao SJ, 2000, INT J EPIDEMIOL, V29, P744, DOI 10.1093/ije/29.4.744; Zou L, 2010, J THEOR BIOL, V262, P330, DOI 10.1016/j.jtbi.2009.09.035	64	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203831	10.1371/journal.pone.0203831	http://dx.doi.org/10.1371/journal.pone.0203831			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192887	gold, Green Submitted, Green Published			2022-12-26	WOS:000444093600148
J	Martinez-Laguna, D; Tebe, C; Nogues, X; Javaid, MK; Cooper, C; Moreno, V; Diez-Perez, A; Collins, GS; Prieto-Alhambra, D				Martinez-Laguna, Daniel; Tebe, Cristian; Nogues, Xavier; Javaid, M. Kassim; Cooper, Cyrus; Moreno, Victor; Diez-Perez, Adolfo; Collins, Gary S.; Prieto-Alhambra, Daniel			Fracture risk in type 2 diabetic patients: A clinical prediction tool based on a large population-based cohort	PLOS ONE			English	Article							BONE-MINERAL DENSITY; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; PEPTIDE-1 RECEPTOR AGONISTS; HIP FRACTURE; POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURES; GLUCOSE CONTROL; OLDER-ADULTS; MELLITUS; METAANALYSIS	Background An increased fracture risk has been described as a complication of Type 2 diabetes mellitus (T2DM). Clinical prediction models for general population have a limited predictive accuracy for fractures in T2DM patients. The aim was to develop and validate a clinical prediction tool for the estimation of 5-year hip and major fracture risk in T2DM patients. Methods and results A cohort of newly diagnosed T2DM patients (n = 51,143, aged 50-85, 57% men) was extracted from the Information System for the Development of Research in Primary Care (SIDIAP) database, containing computerized primary care records for >80% of the population of Catalonia, Spain (>6 million people). Patients were followed up from T2DM diagnosis until the earliest of death, transfer out, fracture, or end of study. Cox proportional hazards regression was used to model the 5-year risk of hip and major fracture. Calibration and discrimination were assessed. Hip and major fracture incidence rates were 1.84 [95% CI 1.64 to 2.05] and 7.12 [95% CI 6.72 to 7.53] per 1,000 person-years, respectively. Both hip and major fracture prediction models included age, sex, previous major fracture, statins use, and calcium/vitamin D supplements; previous ischemic heart disease was also included for hip fracture and stroke for major fracture. Discrimination (0.81 for hip and 0.72 for major fracture) and calibration plots support excellent internal validity. Conclusions The proposed prediction models have good discrimination and calibration for the estimation of both hip and major fracture risk in incident T2DM patients. These tools incorporate key T2DM macrovascular complications generally available in primary care electronic medical records, as well as more generic fracture risk predictors. Future work will focus on validation of these models in external cohorts.	[Martinez-Laguna, Daniel; Prieto-Alhambra, Daniel] Autonomous Univ Barcelona, IDIAP Jordi Gol Primary Care Res Inst, GREMPAL Res Grp, Barcelona, Spain; [Martinez-Laguna, Daniel; Nogues, Xavier; Prieto-Alhambra, Daniel] Inst Salud Carlos III, CIBER Hlth Ageing & Frailty Res CIBERFes, Majadahonda, Spain; [Martinez-Laguna, Daniel] Inst Catala Salut, Ambit Barcelona, Primary Care Dept, Barcelona, Spain; [Tebe, Cristian] Bellvitge Biomed Res Inst IDIBELL, Biostat Unit, Barcelona, Spain; [Tebe, Cristian; Moreno, Victor] Univ Barcelona, Dept Basic Med Sci, Barcelona, Spain; [Tebe, Cristian] Univ Rovira & Virgili, Dept Basic Med Sci, Tarragona, Spain; [Nogues, Xavier; Diez-Perez, Adolfo] IMIM Hosp Mar, Musculoskeletal Res Unit, Barcelona, Spain; [Javaid, M. Kassim; Cooper, Cyrus; Collins, Gary S.; Prieto-Alhambra, Daniel] Univ Oxford, Oxford Natl Inst Hlth, Biomed Res Ctr, Windmill Rd, Oxford, England; [Cooper, Cyrus] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England; [Cooper, Cyrus; Collins, Gary S.; Prieto-Alhambra, Daniel] Univ Oxford, NDORMS, CSM, Oxford, England; [Moreno, Victor] Catalan Inst Oncol IDIBELL, Canc Prevent & Control Program, Lhospitalet De Llobregat, Spain; [Moreno, Victor] CIBERESP, Madrid, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERFES; Instituto de Salud Carlos III; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Universitat Rovira i Virgili; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Oxford; University of Southampton; University of Oxford; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Tebe, C (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Biostat Unit, Barcelona, Spain.; Tebe, C (corresponding author), Univ Barcelona, Dept Basic Med Sci, Barcelona, Spain.; Tebe, C (corresponding author), Univ Rovira & Virgili, Dept Basic Med Sci, Tarragona, Spain.	ctebe@idibell.cat	Collins, Gary Stephen/A-2258-2014; Tebé, Cristian/K-1991-2019; Moreno, Victor/A-1697-2010; MARTINEZ LAGUNA, DANIEL/Q-1891-2016	Collins, Gary Stephen/0000-0002-2772-2316; Tebé, Cristian/0000-0003-2320-1385; Cooper, Cyrus/0000-0003-3510-0709; Moreno, Victor/0000-0002-2818-5487; MARTINEZ LAGUNA, DANIEL/0000-0001-5374-8176; Nogues, Xavier/0000-0002-5537-1859	Spanish Society for Bone and Mineral Research (SEIOMM Grants for Clinical Research); NIHR Biomedical Research Centre, Oxford; NIHR Clinician Scientist award [CS-2013-13-012]; MRC [MC_U147585819, G0400491, MC_UP_A620_1015, MC_U147585827, MC_UU_12011/2] Funding Source: UKRI	Spanish Society for Bone and Mineral Research (SEIOMM Grants for Clinical Research); NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); NIHR Clinician Scientist award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was partially funded with a grant from the Spanish Society for Bone and Mineral Research (SEIOMM Grants for Clinical Research http://seiomm.org/) (BECAS SEIOMM/FEIOMM 2011) and also by the NIHR Biomedical Research Centre, Oxford. Moreover, DPA is funded by a NIHR Clinician Scientist award (CS-2013-13-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed LA, 2006, OSTEOPOROSIS INT, V17, P495, DOI 10.1007/s00198-005-0013-x; Anaforoglu I, 2009, J DIABETES COMPLICAT, V23, P12, DOI 10.1016/j.jdiacomp.2007.06.004; Ardawi MSM, 2013, BONE, V56, P355, DOI 10.1016/j.bone.2013.06.029; Avenell A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub4; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Carnevale V, 2014, DIABETES-METAB RES, V30, P313, DOI 10.1002/dmrr.2497; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; de Liefde II, 2005, OSTEOPOROSIS INT, V16, P1713, DOI 10.1007/s00198-005-1909-1; Driessen JHM, 2015, CALCIFIED TISSUE INT, V97, P104, DOI 10.1007/s00223-015-9993-5; Driessen JHM, 2014, BONE, V68, P124, DOI 10.1016/j.bone.2014.07.030; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Dytteld J, 2017, AGING CLIN EXP RES, V29, P301, DOI [10.1111/j.1463-1326.2012.01630.x, DOI 10.1111/J.1463-1326.2012.01630.X]; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Farr JN, 2016, BONE, V82, P28, DOI 10.1016/j.bone.2015.07.027; Garcia-Gil M Del Mar, 2011, Inform Prim Care, V19, P135; Garcia-Martin A, 2012, J CLIN ENDOCR METAB, V97, P234, DOI 10.1210/jc.2011-2186; Giangregorio LM, 2012, J BONE MINER RES, V27, P301, DOI 10.1002/jbmr.556; Heymans MW, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-33; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; Home PD, 2007, DIABETIC MED, V24, P626, DOI 10.1111/j.1464-5491.2007.02160.x; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Janghorbani M, 2006, DIABETES CARE, V29, P1573, DOI 10.2337/dc06-0440; Jeyabalan J, 2013, OSTEOPOROSIS INT, V24, P2659, DOI 10.1007/s00198-013-2371-0; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Lapane KL, 2013, DRUG AGING, V30, P527, DOI 10.1007/s40266-013-0081-0; Leslie WD, 2014, OSTEOPOROSIS INT, V25, P2817, DOI 10.1007/s00198-014-2822-2; Leslie WD, 2012, J BONE MINER RES, V27, P2231, DOI 10.1002/jbmr.1759; Levitzky YS, 2008, J AM COLL CARDIOL, V51, P264, DOI 10.1016/j.jacc.2007.09.038; Little R.J.A., 2002, STAT ANAL MISSING DA; Ljunggren O, 2012, DIABETES OBES METAB, V14, P990, DOI 10.1111/j.1463-1326.2012.01630.x; Ma LL, 2012, EUR J EPIDEMIOL, V27, P319, DOI 10.1007/s10654-012-9674-x; Mabilleau G, 2014, J DIABETES, V6, P260, DOI 10.1111/1753-0407.12102; Majima T, 2005, OSTEOPOROSIS INT, V16, P907, DOI 10.1007/s00198-004-1786-z; Martinez- Laguna, 2014, REV OSTEOPOR METAB M, V6, P36; Martinez-Laguna D, 2015, OSTEOPOROSIS INT, V26, P827, DOI 10.1007/s00198-014-2986-9; Meier C, 2008, ARCH INTERN MED, V168, P820, DOI 10.1001/archinte.168.8.820; Moayeri A, 2017, THER CLIN RISK MANAG, V13, DOI 10.2147/TCRM.S131945; Monami M, 2011, DIABETES CARE, V34, P2474, DOI 10.2337/dc11-1099; Morales-Santana S, 2013, DIABETES CARE, V36, P1667, DOI 10.2337/dc12-1691; NOGG, 2017, NOGG 2017 CLIN GUID; Pages-Castella A, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-79; Patel S, 2008, CALCIFIED TISSUE INT, V82, P87, DOI 10.1007/s00223-007-9082-5; Pijpers E, 2012, AGE AGEING, V41, P358, DOI 10.1093/ageing/afr145; Premaor MO, 2013, J BONE MINER RES, V28, P1771, DOI 10.1002/jbmr.1878; Prieto-Alhambra D, 2014, J BONE MINER RES, V29, P1737, DOI 10.1002/jbmr.2209; Prieto-Alhambra D, 2012, J BONE MINER RES, V27, P294, DOI 10.1002/jbmr.1466; Roman de Mettelinge T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067055; Rubin MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.1; Schacter GI, 2017, CALCIFIED TISSUE INT, V100, P150, DOI 10.1007/s00223-016-0191-x; Schwartz AV, 2008, DIABETES CARE, V31, P391, DOI 10.2337/dc07-1152; Schwartz AV, 2011, JAMA-J AM MED ASSOC, V305, P2184, DOI 10.1001/jama.2011.715; Starup-Linde J, 2014, OSTEOPOROSIS INT, V25, P1697, DOI 10.1007/s00198-014-2676-7; Toh S, 2007, PHARMACOEPIDEM DR S, V16, P627, DOI 10.1002/pds.1363; VANDAELE PLA, 1995, ANN INTERN MED, V122, P409, DOI 10.7326/0003-4819-122-6-199503150-00002; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Vestergaard P, 2003, J INTERN MED, V254, P572, DOI 10.1111/j.1365-2796.2003.01232.x; Vinagre I, 2012, DIABETES CARE, V35, P774, DOI 10.2337/dc11-1679; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Yaturu S, 2009, MED SCI MONITOR, V15, pCR5; Zhang X, 2015, OSTEOPOROSIS INT, V26, P531, DOI 10.1007/s00198-014-2879-y; Zhu ZN, 2014, BONE, V68, P115, DOI 10.1016/j.bone.2014.08.010	62	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203533	10.1371/journal.pone.0203533	http://dx.doi.org/10.1371/journal.pone.0203533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192850	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000444093600098
J	Omar, SI; Lepre, MG; Morbiducci, U; Deriu, MA; Tuszynski, JA				Omar, Sara Ibrahim; Lepre, Marco Gaetano; Morbiducci, Umberto; Deriu, Marco Agostino; Tuszynski, Jack A.			Virtual screening using covalent docking to find activators for G245S mutant p53	PLOS ONE			English	Article							DRUG DISCOVERY; CORE DOMAIN; IN-VITRO; RESTORATION; RESCUE; REACTIVATION; BINDING	TP53 is the most mutated gene in all cancers. The mutant protein also accumulates in cells. The high frequency of p53 mutations makes the protein a promising target for anti-cancer therapy. Only a few molecules have been found, using in vitro screening, to reactivate the mutant protein. APR-246 is currently the most successful mutant p53 activator, which reactivates the transcriptional activity of p53 by covalently binding to C124 of the protein. We have recently created in silico models of G245S-mp53 in its apo and DNA-bound forms. In this paper we further report on our in silico screening for potential activators of G245S-mp53. We filtered the ZINC15 database (13 million compounds) to only include drug-like molecules with moderate to standard reactivity. Our filtered database of 130,000 compounds was screened using the DOCKTITE protocol in the Molecular Operating Environment software. We performed covalent docking at C124 of G245S-mp53 to identify potential activators of the mutant protein. The docked compounds were ranked using a consensus scoring approach. We also used ADMET Predictor (TM) to predict pharmacokinetics and the possible toxicities of the compounds. Our screening procedure has identified compounds, mostly thiosemicarbazones and halo-carbonyls, with the best potential as G245S-mp53 activators, which are described in this work. Based on its binding scores and ADMET risk score, compound 2 is likely to have the best potential as a G245S-mp53 activator compared to the other top hits.	[Omar, Sara Ibrahim; Tuszynski, Jack A.] Univ Alberta, Fac Med & Dent, Dept Oncol, Edmonton, AB, Canada; [Lepre, Marco Gaetano; Morbiducci, Umberto; Deriu, Marco Agostino; Tuszynski, Jack A.] Politecn Torino, Dept Mech & Aerosp Engn, Turin, Italy; [Deriu, Marco Agostino] USI, SUPSI, Ist Dalle Molle Studi SullIntelligenza Artificial, Ctr Galleria 2, Manno, Switzerland; [Tuszynski, Jack A.] Univ Alberta, Dept Phys, Fac Sci, Edmonton, AB, Canada	University of Alberta; Polytechnic University of Turin; Universita della Svizzera Italiana; University of Alberta	Tuszynski, JA (corresponding author), Univ Alberta, Fac Med & Dent, Dept Oncol, Edmonton, AB, Canada.; Tuszynski, JA (corresponding author), Politecn Torino, Dept Mech & Aerosp Engn, Turin, Italy.; Tuszynski, JA (corresponding author), Univ Alberta, Dept Phys, Fac Sci, Edmonton, AB, Canada.	jackt@ualberta.ca	Tuszynski, Jack/AAA-2073-2020; Deriu, Marco Agostino Agostino/GPW-8179-2022	Tuszynski, Jack/0000-0001-9976-0429; Deriu, Marco Agostino Agostino/0000-0003-1918-1772; Morbiducci, Umberto/0000-0002-9854-1619	Natural Sciences and Engineering Research Council of Canada; Allard Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Allard Foundation	JAT acknowledges funding from the Natural Sciences and Engineering Research Council of Canada and the Allard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PYMOL MOL GRAPHICS S; Boeckler FM, 2008, P NATL ACAD SCI USA, V105, P10360, DOI 10.1073/pnas.0805326105; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Bullock AN, 2001, NATURE REVISIONS CAN, V10; Bykov VJN, 2005, J BIOL CHEM, V280, P30384, DOI 10.1074/jbc.M501664200; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Case D.A., 2022, AMBER; Chen YH, 2013, NUCLEIC ACIDS RES, V41, P8368, DOI 10.1093/nar/gkt584; Demma MJ, 2004, J BIOL CHEM, V279, P45887, DOI 10.1074/jbc.M401854200; Duffy MJ, 2017, EUR J CANCER, V83, P258, DOI 10.1016/j.ejca.2017.06.023; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; Katritch V, 2007, J COMPUT AID MOL DES, V21, P549, DOI 10.1007/s10822-007-9138-7; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Kumalo HM, 2015, MOLECULES, V20, P1984, DOI 10.3390/molecules20021984; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lawandi J, 2009, J MED CHEM, V52, P6672, DOI 10.1021/jm901013a; Lehmann S, 2012, J CLIN ONCOL, V30, P3633, DOI 10.1200/JCO.2011.40.7783; Lepre MG, 2017, MOL BASEL SWITZERLAN, V22; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; MOE, 2014, 201409 MOE; Neudert G, 2011, J CHEM INF MODEL, V51, P2731, DOI 10.1021/ci200274q; Omar SI, 2014, CHEM BIOL DRUG DESIG; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Rippin TM, 2002, ONCOGENE, V21, P2119, DOI 10.1038/sj.onc.1205362; Sabapathy K, 2018, NAT REV CLIN ONCOL, V15, P13, DOI 10.1038/nrclinonc.2017.151; Scholz C, 2015, J CHEM INF MODEL, V55, P398, DOI 10.1021/ci500681r; Selivanova G, 2007, ONCOGENE, V26, P2243, DOI 10.1038/sj.onc.1210295; Shao J, 2007, J CHEM THEORY COMPUT, V3; Tanner Stefan, 2004, J Negat Results Biomed, V3, P5, DOI 10.1186/1477-5751-3-5; Teague Sterling, 2015, J CHEM INF MODEL, V55, P2324, DOI [10.1021/acs.jcim.5b00559, DOI 10.1021/ACS.JCIM.5B00559]; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wassman CD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2361; Zhang SW, 2009, J MOL MODEL, V15, P1481, DOI 10.1007/s00894-009-0515-0	38	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0200769	10.1371/journal.pone.0200769	http://dx.doi.org/10.1371/journal.pone.0200769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192754	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600007
J	Park, GHJ; Yang, SH; Baek, HM				Park, Gregory Hyung Jin; Yang, Seung-Ho; Baek, Hyeon-Man			900MHz H-1-/C-13-NMR analysis of 2-hydroxyglutarate and other brain metabolites in human brain tumor tissue extracts	PLOS ONE			English	Article							MAGNETIC-RESONANCE; MUTATIONS; HMDB; CHOLINE; IDH1; METABOLOMICS; DATABASE; H-1; MRS	Purpose To perform in vitro high-resolution 900 MHz magnetic resonance spectroscopy (NMR) analysis of human brain tumor tissue extracts and analyze for the oncometabolite 2-hydroxyglutarate (2HG) and other brain metabolites, not only for H-1 but also for C-13 with indirect detection by heteronuclear single quantum correlation (HSQC). Material and methods Four surgically removed human brain tumor tissue samples were used for extraction and preparation of NMR samples. These tissue samples were extracted with 4% perchloric acid and chloroform, freeze-dried, then dissolved into 0.28 mL of deuterium oxide (D2O, 99.9 atom% deuterium) containing 0.025 wt% sodium 3-(trimethylsilyl)propionate-2,2,3,3-d(4) (TSP). All samples were adjusted to pH range of 6.9-7.1 before finally transferred to 5 mm Shigemi (TM) NMR microtube. NMR experiments were performed on Bruker DRX 900 MHz spectrometer with H-1/C-13/N-15 Cryo-probe (TM) with Z-gradient, without further temperature control for the samples. All chemical shift values were presented relative to TSP at 0.00 ppm for both H-1 and C-13. (1)H1D, H-1-C-13 HSQC, H-1-H-1 correlation spectroscopy (COSY) and H-1-C-13 heteronuclear multiple bond correlation (HMBC) spectra were acquired and analyzed. Results 2-hydroxyglutarate, an oncometabolite associated with gliomas with IDH mutations, was successfully detected and assigned by both H-1-C-13 HSQC and H-1-H-1 COSY experiments as well as H-1 1D experiments in two of the tissue samples. In particular, to our knowledge this work shows the first example of detecting 900 MHz C-13-NMR spectral lines of 2-hydroxyglutarate in human brain tumor tissue samples. In addition to the oncometabolite 2-hydroxyglutarate, at least 42 more metabolites were identified from our series of NMR experiment. Conclusion The detection of 2-hydroxyglutarate and other metabolites can be facilitated by homonuclear and heteronuclear two-dimensional 900 MHz NMR spectroscopy even in case of real tumor tissue sample extracts without physical separation of metabolites.	[Park, Gregory Hyung Jin] PYCh Sci Inc, Iksan, Jeollabuk Do, South Korea; [Yang, Seung-Ho] Catholic Univ Korea, St Vincents Hosp, Dept Neurosurg, Suwon, Gyeonggi Do, South Korea; [Baek, Hyeon-Man] Gachon Univ, Sch Med, Dept Mol Med, Incheon, South Korea	Catholic University of Korea; Gachon University	Baek, HM (corresponding author), Gachon Univ, Sch Med, Dept Mol Med, Incheon, South Korea.	hyeonmanbaek@gmail.com			Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT [NRF-2017M3C7A1044367]; Gachon University Research Fund of 2017 [GCU-2017-0212]	Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT; Gachon University Research Fund of 2017	This work was supported by part by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2017M3C7A1044367) and the Gachon University Research Fund of 2017 (GCU-2017-0212).	Andronesi OC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002693; [Anonymous], 1984, PURE APPL CHEM, V56, P595; Baek HM, 2013, P INT SOC MAG RESON, V21, P965; Bal D, 2002, MAGN RESON CHEM, V40, P533, DOI 10.1002/mrc.1053; Barker PB, 2010, CLINICAL MR SPECTROS; Bluml S, 1999, MAGNET RESON MED, V42, P643, DOI 10.1002/(SICI)1522-2594(199910)42:4<643::AID-MRM5>3.0.CO;2-N; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; CORNISHBOWDEN A, 1984, EUR J BIOCHEM, V138, P9, DOI 10.1111/j.1432-1033.1984.tb07877.x; Cuperlovic-Culf M, 2012, J BIOL CHEM, V287, P20164, DOI 10.1074/jbc.M111.337196; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Goodenberger ML, 2012, CANCER GENET-NY, V205, P613, DOI 10.1016/j.cancergen.2012.10.009; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Hartmann C, 2010, ACTA NEUROPATHOL, V120, P707, DOI 10.1007/s00401-010-0781-z; Izquierdo-Garcia JL, 2015, PLOS ONE, V56, P2355; Kaiser LG, 2008, NMR BIOMED, V21, P22, DOI 10.1002/nbm.1150; Kalinina J, 2012, J MOL MED, V90, P1161, DOI 10.1007/s00109-012-0888-x; Kreis R, 2012, NMR BIOMED, V25, P1401, DOI 10.1002/nbm.2810; Miller BL, 1996, LIFE SCI, V58, P1929, DOI 10.1016/0024-3205(96)00182-8; Pandey R, 2017, MOL CARCINOGEN, V56, P2355, DOI 10.1002/mc.22694; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Struys EA, 2013, P NATL ACAD SCI USA, V110, pE4939, DOI 10.1073/pnas.1318777110; Tan J, 1998, MAGN RESON MED, V39, P1005, DOI 10.1002/mrm.1910390619; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Willker W, 1998, NMR BIOMED, V11, P47, DOI 10.1002/(SICI)1099-1492(199804)11:2<47::AID-NBM500>3.0.CO;2-G; Wishart DS, 2008, TRAC-TREND ANAL CHEM, V27, P228, DOI 10.1016/j.trac.2007.12.001; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Ye YF, 2011, CHINESE J ANAL CHEM, V39, P1186, DOI 10.1016/S1872-2040(10)60462-8; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	34	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203379	10.1371/journal.pone.0203379	http://dx.doi.org/10.1371/journal.pone.0203379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192797	Green Submitted, Green Published, gold			2022-12-26	WOS:000444093600065
J	Tracey, JA; Rochester, CJ; Hathaway, SA; Preston, KL; Syphard, AD; Vandergast, AG; Diffendorfer, JE; Franklin, J; MacKenzie, JB; Oberbauer, TA; Tremor, S; Winchell, CS; Fisher, RN				Tracey, Jeff A.; Rochester, Carlton J.; Hathaway, Stacie A.; Preston, Kristine L.; Syphard, Alexandra D.; Vandergast, Amy G.; Diffendorfer, Jay E.; Franklin, Janet; MacKenzie, Jason B.; Oberbauer, Tomas A.; Tremor, Scott; Winchell, Clark S.; Fisher, Robert N.			Prioritizing conserved areas threatened by wildfire and fragmentation for monitoring and management	PLOS ONE			English	Article							COASTAL SOUTHERN CALIFORNIA; HABITAT FRAGMENTATION; CLIMATE-CHANGE; SPECIES DISTRIBUTION; POPULATION-MODELS; HIERARCHY PROCESS; DECISION-ANALYSIS; VEGETATION; FIRE; DISTRIBUTIONS	In many parts of the world, the combined effects of habitat fragmentation and altered disturbance regimes pose a significant threat to biodiversity. This is particularly true in Mediterranean-type ecosystems (MTEs), which tend to be fire-prone, species rich, and heavily impacted by human land use. Given the spatial complexity of overlapping threats and species' vulnerability along with limited conservation budgets, methods are needed for prioritizing areas for monitoring and management in these regions. We developed a multi-criteria Pareto ranking methodology for prioritizing spatial units for conservation and applied it to fire threat, habitat fragmentation threat, species richness, and genetic biodiversity criteria in San Diego County, California, USA. We summarized the criteria and Pareto ranking results (from west to east) within the maritime, coastal, transitional, inland climate zones within San Diego County. Fire threat increased from the maritime zone eastward to the transitional zone, then decreased in the mountainous inland climate zone. Number of fires and fire return interval departure were strongly negatively correlated. Fragmentation threats, particularly road density and development density, were highest in the maritime climate zone, declined towards the east, and were positively correlated. Species richness criteria showed distributions among climate zones similar to those of the fire threat variables. When using species richness and fire threat criteria, most lower-ranked (higher conservation priority) units occurred in the coastal and transitional zones. When considering genetic biodiversity, lower-ranked units occurred more often in the mountainous inland zone. With Pareto ranking, there is no need to select criteria weights as part of the decision-making process. However, negative correlations and larger numbers of criteria can result in more units assigned to the same rank. Pareto ranking is broadly applicable and can be used as a standalone decision analysis method or in conjunction with other methods.	[Tracey, Jeff A.; Rochester, Carlton J.; Hathaway, Stacie A.; Preston, Kristine L.; Vandergast, Amy G.; Fisher, Robert N.] US Geol Survey, Western Ecol Res Ctr, San Diego, CA 92101 USA; [Preston, Kristine L.] San Diego Management & Monitoring Program, San Diego, CA USA; [Syphard, Alexandra D.] Conservat Biol Inst, La Mesa, CA USA; [Diffendorfer, Jay E.] US Geol Survey, Geosci & Environm Change Sci Ctr, Denver, CO USA; [Franklin, Janet] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [MacKenzie, Jason B.] ACT Govt, Environm & Planning Directorate, Canberra, ACT, Australia; [Oberbauer, Tomas A.] AECOM, San Diego, CA USA; [Tremor, Scott] San Diego Nat Hist Museum, San Diego, CA USA; [Winchell, Clark S.] US Fish & Wildlife Serv, Carlsbad, CA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of California System; University of California Riverside; United States Department of the Interior; US Fish & Wildlife Service	Tracey, JA (corresponding author), US Geol Survey, Western Ecol Res Ctr, San Diego, CA 92101 USA.	jatracey@usgs.gov	Fisher, Robert/AAA-7301-2022; Franklin, Janet/G-6538-2013	Fisher, Robert/0000-0002-2956-3240; Syphard, Alexandra/0000-0003-3070-0596; Franklin, Janet/0000-0003-0314-4598; Tracey, Jeff/0000-0002-1619-1054	U.S. Geological Survey Ecosystems Mission Area; San Diego Association of Governments (SanDAG); San Diego Management and Monitoring Program (SDMMP); California Department of Fish and Wildlife; AECOM	U.S. Geological Survey Ecosystems Mission Area; San Diego Association of Governments (SanDAG); San Diego Management and Monitoring Program (SDMMP); California Department of Fish and Wildlife; AECOM	U.S. Geological Survey Ecosystems Mission Area, San Diego Association of Governments (SanDAG), San Diego Management and Monitoring Program (SDMMP), and the California Department of Fish and Wildlife provided funding for this research to JAT. AECOM provided support in the form of salary for author TAO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ager AA, 2014, ENVIRONMETRICS, V25, P384, DOI 10.1002/env.2269; ANSELIN A, 1989, BIOL CONSERV, V49, P215, DOI 10.1016/0006-3207(89)90037-2; BARTON NH, 1983, HEREDITY, V50, P139, DOI 10.1038/hdy.1983.15; Batllori E, 2013, GLOBAL ECOL BIOGEOGR, V22, P1118, DOI 10.1111/geb.12065; Bolger DT, 1997, ECOL APPL, V7, P552, DOI 10.1890/1051-0761(1997)007[0552:RORTHF]2.0.CO;2; Bolger DT, 1997, CONSERV BIOL, V11, P406, DOI 10.1046/j.1523-1739.1997.96307.x; Brehme CS, 2011, FIRE ECOL, V7, P81, DOI 10.4996/fireecology.0702081; Burgman M., 2005, RISKS DECISIONS CONS; CalFire, 2015, FIR PER FIR 15 1; Crooks KR, 2004, BIOL CONSERV, V115, P451, DOI 10.1016/S0006-3207(03)00162-9; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Davies AL, 2013, CONSERV BIOL, V27, P936, DOI 10.1111/cobi.12090; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Diffendorfer J, 2012, INT J WILDLAND FIRE, V21, P436, DOI 10.1071/WF10060; Diffendorfer JE, 2006, 37 SPECIES DISTRIBUT; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; Drechsler M, 2004, BIODIVERS CONSERV, V13, P115, DOI 10.1023/B:BIOC.0000004315.09433.f6; Eddelbuettel D, 2011, J STAT SOFTW, V40, P1; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Franklin J, 2014, ENVIRON CONSERV, V41, P97, DOI 10.1017/S0376892913000453; Franklin J, 2009, DIVERS DISTRIB, V15, P167, DOI 10.1111/j.1472-4642.2008.00536.x; Guitouni A, 1998, EUR J OPER RES, V109, P501, DOI 10.1016/S0377-2217(98)00073-3; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Keeley JE, 2004, J FOREST, V102, P26; Keeley JE, 2005, PSWGTR195 USDA FOR S; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Marvier M, 2004, RISK ANAL, V24, P869, DOI 10.1111/j.0272-4332.2004.00485.x; Merriam KE, 2006, ECOL APPL, V16, P515, DOI 10.1890/1051-0761(2006)016[0515:FBANSA]2.0.CO;2; Moilanen A., 2009, SPATIAL CONSERVATION, P28; Moilanen A., 2009, SPATIAL CONSERVATION; Mortensen DA, 2009, INVAS PLANT SCI MANA, V2, P191, DOI 10.1614/IPSM-08-125.1; Mulligan CJ, 2006, SCIENCE, V314, DOI 10.1126/science.1132585; Nettel A, 2008, MOL ECOL, V17, P2680, DOI 10.1111/j.1365-294X.2008.03766.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pausas JC, 2008, INT J WILDLAND FIRE, V17, P713, DOI 10.1071/WF07151; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pollak D., 2001, NCCP EXPERIENCE SO C; Principe Z, 2013, 50 YEAR CLIMATE SCEN; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rochester CJ, 2010, J HERPETOL, V44, P333, DOI 10.1670/08-143.1; Saaty TL., 2008, INT J SERV SCI, V1, P2008, DOI [DOI 10.1504/IJSSCI.2008.017590, 10.1504/IJSSCI.2008.017590]; Safford H.D., 2011, CALIFORNIA FIRE RETU; Salvati L, 2015, INT FOREST REV, V17, P485, DOI 10.1505/146554815817476431; SANGIS, 2015, SAN DIEG REG GIS DAT; Soule M., 1976, Molecular evolution., P60; SOULE ME, 1992, OIKOS, V63, P39, DOI 10.2307/3545514; Stefanopoulos K, 2014, SCI TOTAL ENVIRON, V470, P26, DOI 10.1016/j.scitotenv.2013.09.008; Syphard AD, 2012, PLOS ONE, V7; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Syphard AD, 2016, ECOL SOC, V21, DOI 10.5751/ES-08410-210302; Syphard AD, 2015, INT J WILDLAND FIRE, V24, P37, DOI 10.1071/WF14024; The Nature Conservancy, 2013, PROT NAT SAN DIEG CO; Vaidya OS, 2006, EUR J OPER RES, V169, P1, DOI 10.1016/j.ejor.2004.04.028; Vandergast AG, 2008, BIOL CONSERV, V141, P1648, DOI 10.1016/j.biocon.2008.04.009; Velasquez M, 2013, INT J OPERAT RES, V10, P56, DOI DOI 10.1007/978-3-319-12586-2; Wu XL, 2011, LANDSCAPE ECOL, V26, P425, DOI 10.1007/s10980-011-9571-9; Xiao N, 2001, ENVIRON PLANN A, V34, P639; Yemshanova D, 2010, J ENVIRON MANAGE, V91, P2535, DOI 10.1016/j.jenvman.2010.07.009; ZEDLER PH, 1983, ECOLOGY, V64, P809, DOI 10.2307/1937204	60	6	6	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0200203	10.1371/journal.pone.0200203	http://dx.doi.org/10.1371/journal.pone.0200203			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192760	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600006
J	Dagher, C; Salloum, T; Alousi, S; Arabaghian, H; Araj, GF; Tokajian, S				Dagher, Christel; Salloum, Tamara; Alousi, Sahar; Arabaghian, Harout; Araj, George F.; Tokajian, Sima			Molecular characterization of Carbapenem resistant Escherichia coli recovered from a tertiary hospital in Lebanon	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; BETA-LACTAMASES; INCF PLASMIDS; ENTEROBACTERIACEAE; IDENTIFICATION; OXA-181; BLA(CTX-M-15); EMERGENCE; VIRULENCE; CTX-M-15	The emergence of carbapenem resistant Escherichia coli represents a serious public health concern. This study investigated the resistome, virulence, plasmids content and clonality of 27 carbapenem resistant E. coli isolated from 27 hospitalized patients at the American University of Beirut Medical Center (AUBMC) in Lebanon between 2012 and 2016. Whole-genome sequencing (WGS) data were used to identify resistance determinants. Multilocus sequence typing (MLST), pulsed field gel electrophoresis (PFGE), phylogenetic grouping and PCR-based replicon typing (PBRT) were also performed. The 27 isolates were distributed into 15 STs, of which ST405 (14.8%; n = 4) was the most prevalent. All of the 27 isolates were carbapenem resistant and 20 (74%) were extended-spectrum beta-lactamase (ESBL) gene carriers. The predominant detected carbapenemases were bla(OXA-48) (48.1%; n = 13) and bla(OXA-181) (7.4%; n = 2), for the ESBLs it was bla(CTX-M-15) (55.6%; n = 15) and bla(CTX-M-24) (18.5%; n = 5), and for the AmpC-type beta lactamases, bla(CMY-42) (40.7%; n = 11) and bla(CMY-2) (3.7%; n = 1). Thirteen replicons were identified among the 27 E. coli isolates including: IncL/M, IncFIA, IncFIB, IncFII, IncI1, and IncX3. PFGE revealed a high genetic diversity with the 27 isolates being grouped in 21 different pulsotypes. SNPs analysis and PFGE showed a possible clonal dissemination of ST405, ST1284, ST354 and ST410 and the dominance of certain STs, monitoring of which could help in elucidating routes of transmission. This study represents the first WGS-based in depth analysis of the resistomes and mobilomes of carbapenem resistant E. coli in Lebanon.	[Dagher, Christel; Salloum, Tamara; Alousi, Sahar; Arabaghian, Harout; Tokajian, Sima] Lebanese Amer Univ, Sch Arts & Sci, Dept Nat Sci, Byblos, Lebanon; [Araj, George F.] Amer Univ Beirut, Med Ctr, Fac Med, Dept Pathol & Lab Med, Beirut, Lebanon	Lebanese American University; American University of Beirut	Tokajian, S (corresponding author), Lebanese Amer Univ, Sch Arts & Sci, Dept Nat Sci, Byblos, Lebanon.	stokajian@lau.edu.lb	Tokajian, Sima T/G-9644-2018; Salloum, Tamara/ADW-9091-2022	Tokajian, Sima T/0000-0002-3653-8940; Salloum, Tamara/0000-0002-2689-4175				Alousi S, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3036143; Araj George F, 2012, J Med Liban, V60, P125; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baran I, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0136-2; Beyrouthy R, 2014, ANTIMICROB AGENTS CH, V58, P3785, DOI 10.1128/AAC.02669-14; Bitar I, 2018, J GLOB ANTIMICROB RE, V12, P113, DOI 10.1016/j.jgar.2018.01.002; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Carlos C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-161; Carrer A, 2010, ANTIMICROB AGENTS CH, V54, P1369, DOI 10.1128/AAC.01312-09; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; Daoud Z, 2003, Rev Esp Quimioter, V16, P233; Daoud Ziad, 2011, Chemother Res Pract, V2011, P218431, DOI 10.1155/2011/218431; Diab M, 2018, VET MICROBIOL, V217, P97, DOI 10.1016/j.vetmic.2018.03.007; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; Falgenhauer L, 2016, EMERG INFECT DIS, V22, P1689, DOI 10.3201/eid2209.160692; Falgenhauer L, 2016, INT J ANTIMICROB AG, V47, P457, DOI 10.1016/j.ijantimicag.2016.03.019; Froehlich B, 2005, J BACTERIOL, V187, P6509, DOI 10.1128/JB.187.18.6509-6516.2005; Gamal D, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.24; Grobner S, 2009, J MED MICROBIOL, V58, P912, DOI 10.1099/jmm.0.005850-0; Guo SY, 2015, MICROBES INFECT, V17, P266, DOI 10.1016/j.micinf.2014.12.016; Hentschke M, 2011, MICROB DRUG RESIST, V17, P165, DOI 10.1089/mdr.2010.0137; Ingti B, 2018, J GLOB ANTIMICROB RE, V14, P78, DOI 10.1016/j.jgar.2018.02.021; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Karlowsky JA, 2017, J CLIN MICROBIOL; Lanza VF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004766; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Lecointre G, 1998, MOL BIOL EVOL, V15, P1685, DOI 10.1093/oxfordjournals.molbev.a025895; Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Matar GM, 2010, ANN TROP MED PARASIT, V104, P271, DOI 10.1179/136485910X12647085215651; Matsumura Y, 2013, ANTIMICROB AGENTS CH, V57, P4736, DOI 10.1128/AAC.00641-13; NAKAYA R, 1960, BIOCHEM BIOPH RES CO, V3, P654, DOI 10.1016/0006-291X(60)90081-4; Nikolic E, 2018, TOHOKU J EXP MED, V244, P271, DOI 10.1620/tjem.244.271; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Papp-Wallace KM, 2011, ANTIMICROB AGENTS CH, V55, P4943, DOI 10.1128/AAC.00296-11; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Poirel L, 2012, J ANTIMICROB CHEMOTH, V67, P1597, DOI 10.1093/jac/dks121; Rocha-Gracia RC, 2015, VET J, V203, P315, DOI 10.1016/j.tvjl.2014.12.026; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Salipante SJ, 2015, GENOME RES, V25, P119, DOI 10.1101/gr.180190.114; Samuelsen O, 2013, J ANTIMICROB CHEMOTH, V68, P1682, DOI 10.1093/jac/dkt058; Singh NS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00382; Tangden T, 2013, J ANTIMICROB CHEMOTH, V68, P1319, DOI 10.1093/jac/dkt044; Tian GB, 2011, ANTIMICROB AGENTS CH, V55, P3966, DOI 10.1128/AAC.00652-11; Tokajian S, 2017, FUTURE MICROBIOL, V12, P213, DOI 10.2217/fmb-2017-0171; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; van Boxtel R, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01413-16, 10.1128/aac.01413-16]; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Wayne P., 2010, CLIN LAB STANDARDS I; Yang P, 2014, ANTIMICROB AGENTS CH, V58, P7548, DOI 10.1128/AAC.03911-14; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	58	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203323	10.1371/journal.pone.0203323	http://dx.doi.org/10.1371/journal.pone.0203323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188911	Green Submitted, Green Published, gold			2022-12-26	WOS:000444228700025
J	Chung, SC; Pujades-Rodriguez, M; Duyx, B; Denaxas, SC; Pasea, L; Hingorani, A; Timmis, A; Williams, B; Hemingway, H				Chung, Sheng-Chia; Pujades-Rodriguez, Mar; Duyx, Bram; Denaxas, Spiros C.; Pasea, Laura; Hingorani, Aroon; Timmis, Adam; Williams, Bryan; Hemingway, Harry			Time spent at blood pressure target and the risk of death and cardiovascular diseases	PLOS ONE			English	Article							ASSOCIATION TASK-FORCE; AMERICAN-COLLEGE; RANDOMIZED-TRIAL; PRIMARY-CARE; HYPERTENSION; MANAGEMENT; PREVALENCE; COHORT; METAANALYSIS; VARIABILITY	Background The time a patient spends with blood pressure at target level is an intuitive measure of successful BP management, but population studies on its effectiveness are as yet unavailable. Method We identified a population-based cohort of 169,082 individuals with newly identified high blood pressure who were free of cardiovascular disease from January 1997 to March 2010. We used 1.64 million clinical blood pressure readings to calculate the TIme at TaRgEt (TITRE) based on current target blood pressure levels. Result The median (Inter-quartile range) TITRE among all patients was 2.8 (0.3, 5.6) months per year, only 1077 (0.6%) patients had a TITRE >= 11 months. Compared to people with a 0% TITRE, patients with a TITRE of 3-5.9 months, and 6-8.9 months had 75% and 78% lower odds of the composite of cardiovascular death, myocardial infarction and stroke (adjusted odds ratios, 0.25 (95% confidence interval: 0.21, 0.31) and 0.22 (0.17, 0.27), respectively). These associations were consistent for heart failure and any cardiovascular disease and death (comparing a 3-5.9 month to 0% TITRE, 63% and 60% lower in odds, respectively), among people who did or did not have blood pressure 'controlled' on a single occasion during the first year of follow-up, and across groups defined by number of follow-up BP measure categories. Conclusion Based on the current frequency of measurement of blood pressure this study suggests that few newly hypertensive patients sustained a complete, year-round on target blood pressure over time. The inverse associations between a higher TITRE and lower risk of incident cardiovascular diseases were independent of widely-used blood pressure 'control' indicators. Randomized trials are required to evaluate interventions to increase a person's time spent at blood pressure target.	[Chung, Sheng-Chia; Pujades-Rodriguez, Mar; Duyx, Bram; Denaxas, Spiros C.; Pasea, Laura; Hingorani, Aroon; Timmis, Adam; Hemingway, Harry] UCL, Hlth Data Res UK London, London, England; [Chung, Sheng-Chia; Denaxas, Spiros C.; Pasea, Laura; Hemingway, Harry] UCL, Inst Hlth Informat, London, England; [Pujades-Rodriguez, Mar] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Duyx, Bram] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [Hingorani, Aroon; Williams, Bryan] UCL, Inst Cardiovasc Sci, London, England; [Hingorani, Aroon; Williams, Bryan; Hemingway, Harry] Univ Coll London Hosp, Biomed Res Ctr, NIHR, London, England; [Timmis, Adam] Barts Heart Ctr, London, England	University of London; University College London; University of London; University College London; University of Leeds; Maastricht University; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; King's College London; University College London	Chung, SC (corresponding author), UCL, Hlth Data Res UK London, London, England.; Chung, SC (corresponding author), UCL, Inst Hlth Informat, London, England.	s.chung@ucl.ac.uk	Duyx, Bram/W-8668-2019; Pujades-Rodriguez, Mar/T-1129-2018; Hemingway, Harry/C-1219-2009	Duyx, Bram/0000-0002-8879-5391; Pujades-Rodriguez, Mar/0000-0002-1375-1028; Chung, Sheng-Chia/0000-0001-6025-9207; Hingorani, Aroon/0000-0001-8365-0081; Denaxas, Spiros/0000-0001-9612-7791; Hemingway, Harry/0000-0003-2279-0624; Williams, Bryan/0000-0002-8094-1841	MRC Population Health Scientist Fellowship [MR/M015084/1]; UK Medical Research Council, Engineering and Physical Sciences Research Council; Economic and Social Research Council; Department of Health and Social Care (England); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Health and Social Care Research and Development Division (Welsh Government); Public Health Agency (Northern Ireland); British Heart Foundation; Wellcome Trust; Innovative Medicines Initiative-2 Joint Undertaking [116074]; European Union; NIHR University College London Hospitals / UCL Biomedical Research Centre; Health Data Research UK; BigData@Heart Consortium; MRC [MR/M015084/1] Funding Source: UKRI	MRC Population Health Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council, Engineering and Physical Sciences Research Council; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health and Social Care (England); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Health and Social Care Research and Development Division (Welsh Government); Public Health Agency (Northern Ireland); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Innovative Medicines Initiative-2 Joint Undertaking; European Union(European Commission); NIHR University College London Hospitals / UCL Biomedical Research Centre; Health Data Research UK; BigData@Heart Consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by the MRC Population Health Scientist Fellowship (MR/M015084/1). The Health Data Research UK, which is funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation and Wellcome Trust. The BigData@Heart Consortium is funded by the Innovative Medicines Initiative-2 Joint Undertaking under grant agreement No. 116074. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA; it is chaired, by DE Grobbee and SD Anker, partnering with 20 academic and industry partners and ESC. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.; The study was approved by the Independent Scientific Advisory Committee of the Medicines and Healthcare products Regulatory Agency, and the MINAP Academic Group. SCC is supported by the MRC Population Health Scientist Fellowship (MR/M015084/1). AH and HH are National Institute for Health Research (NIHR) Senior Investigators. BW is a NIHR Emeritus Senior Investigator. BW, AH and HH are supported by the NIHR University College London Hospitals / UCL Biomedical Research Centre. HH's work is further supported by the Health Data Research UK and BigData@Heart Consortium. SCC had full access to all the data in the study and had final responsibility for the decision to submit for publication.	A'Court C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X593884; [Anonymous], QUAL OUTC FRAM IND; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Brook RD, 2018, J AM SOC HYPERTENS, V12, P238, DOI 10.1016/j.jash.2018.01.004; Buse JB, 2007, AM J CARDIOL, V99, p21I, DOI 10.1016/j.amjcard.2007.03.003; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Chowdhury R, 2013, EUR HEART J, V34, P2940, DOI 10.1093/eurheartj/eht295; Denaxas SC, 2012, INT J EPIDEMIOL, V41, P1625, DOI 10.1093/ije/dys188; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Falaschetti E, 2014, LANCET, V383, P1912, DOI 10.1016/S0140-6736(14)60688-7; George J, 2015, CIRCULATION, V132, P1320, DOI 10.1161/CIRCULATIONAHA.114.013797; Giannattasio C, 2012, AM J HYPERTENS, V25, P1182, DOI 10.1038/ajh.2012.108; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2099; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Kengne AP, 2009, HYPERTENSION, V54, P399, DOI 10.1161/HYPERTENSIONAHA.109.133041; Koudstaal S, 2016, EUR J HEART FAIL, V18, P161; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Margolis KL, 2013, JAMA-J AM MED ASSOC, V310, P46, DOI 10.1001/jama.2013.6549; McManus R, 2010, LANCET, V376, P163, DOI 10.1016/S0140-6736(10)60964-6; Morley KI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110900; National Institute for Clinical Excellence, 2004, CLIN GUID 18 HYP MAN; National Institute for Clinical Excellence, 2006, ESS HYP MAN AD PAT P; NICE, 2019, HYP AD DIAGN MAN; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; Pujades-Rodriguez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104671; Ramsay LE, 1999, J HUM HYPERTENS, V13, P569, DOI 10.1038/sj.jhh.1000917; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Shah AD, 2015, LANCET DIABETES ENDO, V3, P105, DOI 10.1016/S2213-8587(14)70219-0; Sharma AM, 2004, J HYPERTENS, V22, P479, DOI 10.1097/00004872-200403000-00009; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Sundstrom J, 2014, LANCET, V384, P591, DOI 10.1016/S0140-6736(14)61212-5; Tocci G, 2017, J HUM HYPERTENS, V31, P258, DOI 10.1038/jhh.2016.71; Verdecchia P, 2009, LANCET, V374, P525, DOI 10.1016/S0140-6736(09)61340-4; Whelton PK, 2018, CIRCULATION, V138, pE484, DOI 10.1161/CIR.0000000000000596; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3; XU W, 2015, BMJ-BRIT MED J, DOI [10.1136/bmj.h158, DOI 10.1136/BMJ.H158]	44	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202359	10.1371/journal.pone.0202359	http://dx.doi.org/10.1371/journal.pone.0202359			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183734	Green Published, Green Submitted, gold			2022-12-26	WOS:000443789900024
J	Liu, B; Krishnaswamyreddy, S; Muraleedharan, MN; Olson, A; Broberg, A; Stahlberg, J; Sandgren, M				Liu, Bing; Krishnaswamyreddy, Sumitha; Muraleedharan, Madhu Nair; Olson, Ake; Broberg, Anders; Stahlberg, Jerry; Sandgren, Mats			Side-by-side biochemical comparison of two lytic polysaccharide monooxygenases from the white-rot fungus Heterobasidion irregulare on their activity against crystalline cellulose and glucomannan	PLOS ONE			English	Article							LIGNOCELLULOSIC BIOMASS HYDROLYSIS; GLYCOSIDE HYDROLASE FAMILY; OXIDATIVE CLEAVAGE; GLOEOPHYLLUM-TRABEUM; PODOSPORA-ANSERINA; WOOD-DECAY; DEGRADATION; CELLOBIOHYDROLASE; REVEALS; DEPOLYMERIZATION	Our comparative studies reveal that the two lytic polysaccharide monooxygenases HiLP-MO9B and HiLPMO9I from the white-rot conifer pathogen Heterobasidion irregulare display clear difference with respect to their activity against crystalline cellulose and glucomannan. HiLPMO9I produced very little soluble sugar on bacterial microcrystalline cellulose (BMCC). In contrast, HiLPMO9B was much more active against BMCC and even released more soluble sugar than the H. irregulare cellobiohydrolase I, HiCel7A. Furthermore, HiLPMO9B was shown to cooperate with and stimulate the activity of HiCel7A, both when the BMCC was first pretreated with HiLPMO9B, as well as when HiLPMO9B and HiCel7A were added together. No such stimulation was shown by HiLPMO9I. On the other hand, HiLPMO9I was shown to degrade glucomannan, using a C4-oxidizing mechanism, whereas no oxidative cleavage activity of glucomannan was detected for HiLPMO9B. Structural modeling and comparison with other glucomannan-active LPMOs suggest that conserved sugar-interacting residues on the L2, L3 and LC loops may be essential for glucomannan binding, where 4 out of 7 residues are shared by HiLPMO9I, but only one is found in HiLPMO9B. The difference shown between these two H. irregulare LPMOs may reflect distinct biological roles of these enzymes within deconstruction of different plant cell wall polysaccharides during fungal colonization of softwood.	[Liu, Bing; Krishnaswamyreddy, Sumitha; Broberg, Anders; Stahlberg, Jerry; Sandgren, Mats] Swedish Univ Agr Sci, Dept Mol Sci, Uppsala, Sweden; [Muraleedharan, Madhu Nair] Lulea Univ Technol, Dept Civil Environm & Nat Resources Engn, Lulea, Sweden; [Olson, Ake] Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden	Swedish University of Agricultural Sciences; Lulea University of Technology; Swedish University of Agricultural Sciences	Sandgren, M (corresponding author), Swedish Univ Agr Sci, Dept Mol Sci, Uppsala, Sweden.	mats.sandgren@slu.se	Stahlberg, Jerry/D-4163-2013	Sandgren, Mats/0000-0002-2358-4534	Swedish Energy Agency [40144-1]	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC))	This work was financially supported by the Swedish Energy Agency (http://www.energimyndigheten.se/) through the grant 40144-1 to M.S. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; [Anonymous], 2012, POLYMERIZATION; Asiegbu FO, 2005, MOL PLANT PATHOL, V6, P395, DOI 10.1111/J.1364-3703.2005.00295.X; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Bennati-Granier C, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0274-3; Bey M, 2013, APPL ENVIRON MICROB, V79, P488, DOI 10.1128/AEM.02942-12; Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]; BLANCHETTE RA, 1990, ADV CHEM SER, P141; Borisova AS, 2015, J BIOL CHEM, V290, P22955, DOI 10.1074/jbc.M115.660183; Busk PK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1601-6; CAPRETTI P, 1990, EUR J FOREST PATHOL, V20, P231; Couturier M, 2018, NAT CHEM BIOL, V14, P306, DOI [10.1038/nchembio.2558, 10.1038/NCHEMBIO.2558]; Cragg SM, 2015, CURR OPIN CHEM BIOL, V29, P108, DOI 10.1016/j.cbpa.2015.10.018; Eibinger M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01028-y; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Fanuel M, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0749-5; Frommhagen M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01080; Frommhagen M, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0594-y; Garbelotto M, 2013, ANNU REV PHYTOPATHOL, V51, P39, DOI 10.1146/annurev-phyto-082712-102225; Guo ZP, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0990-y; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2015, TRENDS BIOTECHNOL, V33, P747, DOI 10.1016/j.tibtech.2015.09.006; Hollingsworth Scott A, 2010, Biomol Concepts, V1, P271, DOI 10.1515/BMC.2010.022; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Johansen KS, 2016, TRENDS PLANT SCI, V21, P926, DOI 10.1016/j.tplants.2016.07.012; Jung S, 2015, ENZYME MICROB TECH, V77, P38, DOI 10.1016/j.enzmictec.2015.05.006; Karnaouri A, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0813-1; Karnaouri AC, 2014, APPL MICROBIOL BIOT, V98, P231, DOI 10.1007/s00253-013-4895-9; Kim IJ, 2016, PROCESS BIOCHEM, V51, P1445, DOI 10.1016/j.procbio.2016.06.017; Kojima Y, 2016, APPL ENVIRON MICROB, V82, P6557, DOI 10.1128/AEM.01768-16; Kont R, 2016, J BIOL CHEM, V291, P26013, DOI 10.1074/jbc.M116.756007; Korhonen K., 1978, Metsantutkimuslaitoksen Julkaisuja, V94; Kracher D, 2018, J BIOL CHEM, V293, P1676, DOI 10.1074/jbc.RA117.000109; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lind M, 2014, ADV BOT RES, V70, P371, DOI 10.1016/B978-0-12-397940-7.00012-4; Lionetti V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00612; Liu B, 2018, FEBS J, V285, P2225, DOI 10.1111/febs.14472; Liu B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189479; Lo Leggio L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6961; Makela MR, 2014, FUNGAL GENET BIOL, V72, P2, DOI 10.1016/j.fgb.2014.08.010; Momeni MH, 2013, J BIOL CHEM, V288, P5861, DOI 10.1074/jbc.M112.440891; Olson A, 2012, NEW PHYTOL, V194, P1001, DOI 10.1111/j.1469-8137.2012.04128.x; Otrosina WJ, 2010, FUNGAL BIOL-UK, V114, P16, DOI 10.1016/j.mycres.2009.09.001; Pierce BC, 2017, CARBOHYD RES, V449, P85, DOI 10.1016/j.carres.2017.07.004; Sabbadin F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03142-x; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Simmons TJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01247-3; Song B, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1023-1; SZAKMARY K, 1991, J GEN MICROBIOL, V137, P2873, DOI 10.1099/00221287-137-12-2873; Ullman Michael T., NEUROBIOLOGY LANGUAG, P953, DOI [DOI 10.HTTPS://D0I.0RG/10.1016/B978-0-12-033706-4.50037-2, 10.1016/B978-0-12-407794-2.00076-6, DOI 10.1016/B978-0-12-407794-2.00076-6]; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Valjamae P, 1999, EUR J BIOCHEM, V266, P327, DOI 10.1046/j.1432-1327.1999.00853.x; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Vermaas JV, 2015, J PHYS CHEM B, V119, P6129, DOI 10.1021/acs.jpcb.5b00778; Villares A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40262; Voshol Gerben P, 2017, BMC Res Notes, V10, P105, DOI 10.1186/s13104-017-2429-8; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Woodward S, 1998, CAB INT CAMB, DOI [10.1046/j.1365-3059.1999.0366b.x/abstract, DOI 10.1046/J.1365-3059.1999.0366B.X/ABSTRACT]; Yakovlev IA, 2013, FUNGAL GENET BIOL, V56, P17, DOI 10.1016/j.fgb.2013.04.011	61	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203430	10.1371/journal.pone.0203430	http://dx.doi.org/10.1371/journal.pone.0203430			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183773	Green Submitted, Green Published, gold			2022-12-26	WOS:000443789900061
J	da Costa, ACC; Codeco, CT; Krainski, ET; Gomes, MFD; Nobre, AA				Carioca da Costa, Ana Carolina; Codeco, Claudia Torres; Krainski, Elias Teixeira; da Costa Gomes, Marcelo Ferreira; Nobre, Aline Araujo			Spatiotemporal diffusion of influenza A (H1N1): Starting point and risk factors	PLOS ONE			English	Article							PANDEMIC INFLUENZA; BRAZIL; TRAVELERS; SPREAD; VIRUS; MODELS	Influenza constitutes a major challenge to world health authorities due to high transmissibility and the capacity to generate large epidemics. This study aimed to characterize the diffusion process of influenza A (H1N1) by identifying the starting point of the epidemic as well as climatic and sociodemographic factors associated with the occurrence and intensity of transmission of the disease. The study was carried out in the Brazilian state of Parana A, where H1N1 caused the largest impact. The units of spatial and temporal analysis were the municipality of residence of the cases and the epidemiological weeks of the year 2009, respectively. Under the Bayesian paradigm, parametric inference was performed through a two-part spatiotemporal model and the integrated nested Laplace approximation (INLA) algorithm. We identified the most likely starting points through the effective distance measure based on mobility networks. The proposed estimation methodology allowed for rapid and efficient implementation of the spatiotemporal model, and provided evidence of different patterns for chance of occurrence and risk of influenza throughout the epidemiological weeks. The results indicate the capital city of Curitiba as the probable starting point, and showed that the interventions that focus on municipalities with greater migration and density of people, especially those with higher Human Development Indexes (HDIs) and the presence of municipal air and road transport, could play an important role in mitigation of effects of future influenza pandemics on public health. These results provide important information on the process of introduction and spread of influenza, and could contribute to the identification of priority areas for surveillance as well as establishment of strategic measures for disease prevention and control. The proposed model also allows identification of epidemiological weeks with high chance of influenza occurrence, which can be used as a reference criterion for creating an immunization campaign schedule.	[Carioca da Costa, Ana Carolina] Fundacao Oswaldo Cruz, Dept Clin Res, Natl Inst Women Children & Adolescents Hlth Ferna, Rio De Janeiro, Brazil; [Codeco, Claudia Torres; da Costa Gomes, Marcelo Ferreira; Nobre, Aline Araujo] Fundacao Oswaldo Cruz, Sci Comp Program, Rio De Janeiro, Brazil; [Krainski, Elias Teixeira] Univ Fed Parana, Curitiba, Parana, Brazil; [Krainski, Elias Teixeira] Norwegian Univ Sci & Technol, Trondheim, Norway	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Parana; Norwegian University of Science & Technology (NTNU)	da Costa, ACC (corresponding author), Fundacao Oswaldo Cruz, Dept Clin Res, Natl Inst Women Children & Adolescents Hlth Ferna, Rio De Janeiro, Brazil.	ana.costa@iff.fiocruz.br	Krainski, Elias T/AGP-2119-2022; Ferreira da Costa Gomes, Marcelo/K-4469-2013	Krainski, Elias T/0000-0002-7063-2615; Ferreira da Costa Gomes, Marcelo/0000-0003-4693-5402; Carioca da Costa, Ana Carolina/0000-0002-9456-3319	Fundo Nacional de Saude do Brasil [337810550001/14-076]; PAPES [407740/2012-0]; CNPq [400823/2014-4]	Fundo Nacional de Saude do Brasil; PAPES(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was partially funded by the Fundo Nacional de Saude do Brasil (gescon n. 337810550001/14-076). AAN was partially supported by PAPES (407740/2012-0). AC CC received a scholarship from CNPq and MFCG was partially supported by CNPq (400823/2014-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INFORM TECNICO CAMPA; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2010, MED RIO GRANDE SUL, V54, P206; Askling HH, 2010, CURR OPIN INFECT DIS, V23, P421, DOI 10.1097/QCO.0b013e32833c6863; BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200; Carneiro M., 2010, REV AMRIGS, V54, P206; Caron LF, 2010, VIRUS GRIPE SUINA ES; CDC. H1N1 flu, 2009, CTR DIS CONTR PREV W; Charaudeau S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083002; Codeco CT, 2012, CAD SAUDE PUBLICA, V28, P1325, DOI 10.1590/S0102-311X2012000700011; Codeco CT, 2004, T ROY SOC TROP MED H, V98, P702, DOI 10.1016/j.trstmh.2003.12.019; Deyle ER, 2016, P NATL ACAD SCI USA, V113, P13081, DOI 10.1073/pnas.1607747113; Fang LQ, 2012, AM J EPIDEMIOL, V175, P890, DOI 10.1093/aje/kwr411; Freedman DO, 2005, J TRAVEL MED, V12, P36, DOI 10.2310/7060.2005.00007; Hastie T.J., 1990, MONOGRAPHS STAT APPL, V43; Hu WB, 2012, ENVIRON INT, V45, P39, DOI 10.1016/j.envint.2012.03.010; IBGE, 2010, DIR PESQ COORD POP I; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; Leggat PA, 2009, J TRAVEL MED, V16, P373, DOI 10.1111/j.1708-8305.2009.00372.x; Leroux BG, 2000, STAT MODELS EPIDEMIO, P179, DOI [10.1007/978-1-4612-1284-3_4, DOI 10.1007/978-1-4612-1284-3]; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Liu YN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025934; Lopez Daphne, 2014, Proc IEEE Int Conf Big Data, V2014, P19, DOI 10.1109/BigData.2014.7004422; Maciel-Lima SM, 2015, HIST CIENC SAUDE-MAN, V22, P275, DOI 10.1590/S0104-59702015000100016; Maliszewski PJ, 2011, GEOSPATIAL HEALTH, V6, P95, DOI 10.4081/gh.2011.161; Merler S, 2015, LANCET INFECT DIS, V15, P204, DOI 10.1016/S1473-3099(14)71074-6; Mukherjee P, 2010, EMERG INFECT DIS, V16, P21, DOI 10.3201/eid1601.091376; MULLAHY J, 1986, J ECONOMETRICS, V33, P341, DOI 10.1016/0304-4076(86)90002-3; Neghina AM, 2010, VECTOR-BORNE ZOONOT, V10, P935, DOI 10.1089/vbz.2009.0169; Oliveira CR, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1456-8; Piontti APY, 2014, NETW SCI, V2, P132, DOI 10.1017/nws.2014.5; Pastore-Piontti A. etal, 2016, MATH STAT MODELING E, P39; Poggensee G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-155; Poletto C, 2014, Euro Surveill, V19, DOI 10.2807/1560-7917.ES2014.19.23.20824; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; RVACHEV LA, 1985, MATH BIOSCI, V75, P1; Schneider T, 2001, J CLIMATE, V14, P853, DOI 10.1175/1520-0442(2001)014<0853:AOICDE>2.0.CO;2; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Suhaila J, 2008, ASIA-PAC J ATMOS SCI, V44, P93; Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165; Wein LM, 2009, RISK ANAL, V29, P949, DOI 10.1111/j.1539-6924.2009.01232.x; Xiao Hong, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P587; Yang W, 2018, INFLUENZA OTHER RESP, V12, P446, DOI 10.1111/irv.12556; Zepeda-Lopez HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013256	46	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0202832	10.1371/journal.pone.0202832	http://dx.doi.org/10.1371/journal.pone.0202832			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180215	Green Published, Green Submitted, gold			2022-12-26	WOS:000444222400017
J	Zou, H; Jakovlic, I; Zhang, D; Chen, R; Mahboob, S; Al-Ghanim, KA; Al-Misned, F; Li, WX; Wang, GT				Zou, Hong; Jakovlic, Ivan; Zhang, Dong; Chen, Rong; Mahboob, Shahid; Al-Ghanim, Khalid Abdullah; Al-Misned, Fahad; Li, Wen-Xiang; Wang, Gui-Tang			The complete mitochondrial genome of Cymothoa indica has a highly rearranged gene order and clusters at the very base of the Isopoda clade	PLOS ONE			English	Article							TRANSFER-RNA GENES; TERRESTRIAL ISOPODS; DEEP-SEA; INVERTED REPEATS; CRUSTACEA; EVOLUTION; SEQUENCE; PERACARIDA; HETEROPLASMY; SELECTION	As a result of great diversity in life histories and a large number of described species, taxonomic and phylogenetic uncertainty permeates the entire crustacean order of Isopoda. Large molecular datasets capable of providing sufficiently high phylogenetic resolution, such as mitochondrial genomes (mitogenomes), are needed to infer their evolutionary history with confidence, but isopod mitogenomes remain remarkably poorly represented in public databases. We sequenced the complete mitogenome of Cymothoa indica, a species belonging to a family from which no mitochondrial genome was sequenced yet, Cymothoidae. The mitogenome (circular, 14484 bp, A+T = 63.8%) is highly compact, appears to be missing two tRNA genes (trnI and trnE), and exhibits a unique gene order with a large number of rearrangements. High compactness and the existence of palindromes indicate that the mechanism behind these rearrangements might be associated with linearization events in its evolutionary history, similar to those proposed for isopods from the Armadillidium genus (Oniscidea). Isopods might present an important model system to study the proposed discontinuity in the dynamics of mitochondrial genomic architecture evolution. Phylogenetic analyses (Bayesian Inference and Maximum Likelihood) conducted using nucleotide sequences of all mitochondrial genes resolved Oniscidea and Cymothoida suborders as paraphyletic. Cymothoa indica was resolved as a sister group (basal) to all remaining isopods, which challenges the accepted isopod phylogeny, where Cymothoida are the most derived, and Phreatoicidea the most basal isopod group. There is growing evidence that Cymothoida suborder might be split into two evolutionary distant clades, with parasitic species being the most basal split in the Isopoda clade, but a much larger amount of molecular resources carrying a high phylogenetic resolution will be needed to infer the remarkably complex evolutionary history of this group of animals with confidence.	[Zou, Hong; Zhang, Dong; Li, Wen-Xiang; Wang, Gui-Tang] Chinese Acad Sci, Key Lab Aquaculture Dis Control, Minist Agr, Inst Hydrobiol, Wuhan, Hubei, Peoples R China; [Zou, Hong; Zhang, Dong; Li, Wen-Xiang; Wang, Gui-Tang] Chinese Acad Sci, State Key Lab Freshwater Ecol & Biotechnol, Inst Hydrobiol, Wuhan, Hubei, Peoples R China; [Jakovlic, Ivan; Chen, Rong] Biotransduct Lab, Wuhan, Hubei, Peoples R China; [Zhang, Dong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Mahboob, Shahid; Al-Ghanim, Khalid Abdullah; Al-Misned, Fahad] King Saud Univ, Dept Zool, Coll Sci, Riyadh, Saudi Arabia; [Mahboob, Shahid] GC Univ, Dept Zool, Faisalabad, Pakistan	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; King Saud University; Government College University Faisalabad	Wang, GT (corresponding author), Chinese Acad Sci, Key Lab Aquaculture Dis Control, Minist Agr, Inst Hydrobiol, Wuhan, Hubei, Peoples R China.; Wang, GT (corresponding author), Chinese Acad Sci, State Key Lab Freshwater Ecol & Biotechnol, Inst Hydrobiol, Wuhan, Hubei, Peoples R China.	gtwang@ihb.ac.cn	El-Serehy, Hamed/GVT-7938-2022; Rana, Shahid Mahboob/P-1131-2014	Rana, Shahid Mahboob/0000-0003-4969-5387; Jakovlic, Ivan/0000-0002-2461-3712	Earmarked Fund for China Agriculture Research System [CARS-45-15]; National Natural Science Foundation of China [31572658]; Major Scientific and Technological Innovation Project of Hubei Province [2015ABA045]; Deanship of Scientific Research at King Saud University [1435-012]	Earmarked Fund for China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Scientific and Technological Innovation Project of Hubei Province; Deanship of Scientific Research at King Saud University(King Saud University)	This work was supported by the Earmarked Fund for China Agriculture Research System (CARS-45-15); the National Natural Science Foundation of China (grant number 31572658); the Major Scientific and Technological Innovation Project of Hubei Province (grant number 2015ABA045); and the Deanship of Scientific Research at King Saud University (Research Group Project No. 1435-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Boore JL, 2000, COMP GENOMICS, V1, P133, DOI DOI 10.1007/978-94-011-4309-7_13; Brazda V, 2016, BIOCHEM BIOPH RES CO, V478, P1739, DOI 10.1016/j.bbrc.2016.09.015; BRUSCA RC, 1981, ZOOL J LINN SOC-LOND, V73, P117, DOI 10.1111/j.1096-3642.1981.tb01592.x; Burland T G, 2000, Methods Mol Biol, V132, P71; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chandler CH, 2015, G3-GENES GENOM GENET, V5, P1317, DOI 10.1534/g3.115.018283; Doublet V, 2015, RNA BIOL, V12, P1159, DOI 10.1080/15476286.2015.1090078; Doublet V, 2013, J MOL EVOL, V77, P107, DOI 10.1007/s00239-013-9587-7; Doublet V, 2012, GENOME, V55, P234, DOI [10.1139/g2012-008, 10.1139/G2012-008]; Doublet V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002938; Duchene AM, 2009, CURR GENET, V55, P1, DOI 10.1007/s00294-008-0223-9; Fogelman RM, 2009, INT J PARASITOL, V39, P577, DOI 10.1016/j.ijpara.2008.10.013; Force A, 1999, GENETICS, V151, P1531; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Hata H, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3138-5; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Joca LK, 2015, J CRUSTACEAN BIOL, V35, P292, DOI 10.1163/1937240X-00002312; Jones CM, 2008, INT J PARASITOL, V38, P477, DOI 10.1016/j.ijpara.2007.07.013; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kilpert F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-241; Kilpert F, 2012, MOL PHYLOGENET EVOL, V64, P106, DOI 10.1016/j.ympev.2012.03.013; Lan TY, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1804; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lavrov DV, 2000, MOL BIOL EVOL, V17, P813, DOI 10.1093/oxfordjournals.molbev.a026360; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lins LSF, 2017, ORG DIVERS EVOL, V17, P813, DOI 10.1007/s13127-017-0346-2; Lins LSF, 2012, BIOL LETTERS, V8, P979, DOI 10.1098/rsbl.2012.0774; Liu FF, 2017, EUR J ENTOMOL, V114, P407, DOI 10.14411/eje.2017.052; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Martin MB, 2016, ZOOTAXA, V4119, P1, DOI 10.11646/zootaxa.4119.1.1; Nagasawa K, 2012, CRUSTACEANA, V85, P893, DOI 10.1163/156854012X649900; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Peccoud J, 2017, GENETICS, V207, P269, DOI 10.1534/genetics.117.203380; Podsiadlowski L, 2006, MOL PHYLOGENET EVOL, V40, P893, DOI 10.1016/j.ympev.2006.04.008; Poore GCB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043529; Raimond R, 1999, GENETICS, V151, P203; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sarkissian CD, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.1058; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Segovia R, 2011, MOL BIOL EVOL, V28, P2873, DOI 10.1093/molbev/msr113; Shen X, 2011, GENOME, V54, P911, DOI [10.1139/G11-053, 10.1139/g11-053]; Shen YJ, 2017, ECOL EVOL, V7, P1869, DOI 10.1002/ece3.2737; Smit Nico J., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P188, DOI 10.1016/j.ijppaw.2014.03.004; Smith DR, 2016, BRIEF FUNCT GENOMICS, V15, P47, DOI 10.1093/bfgp/elv027; Smith DR, 2015, P NATL ACAD SCI USA, V112, P10177, DOI 10.1073/pnas.1422049112; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Wetzer R, 2002, J CRUSTACEAN BIOL, V22, P1, DOI 10.1651/0278-0372(2002)022[0001:MGAIPP]2.0.CO;2; Wilson GDF, 1999, CRUSTACEANA, V72, P1019, DOI 10.1163/156854099503915; Wilson GDF, 2008, HYDROBIOLOGIA, V595, P231, DOI 10.1007/s10750-007-9019-z; Wilson GDF, 2011, J CRUSTACEAN BIOL, V31, P509, DOI 10.1651/10-3432.1; Wilson George D. F., 2009, Arthropod Systematics & Phylogeny, V67, P159; Yu Haiyan, 2003, Studia Marina Sinica, V45, P223; Yu JL, 2018, SYST PARASITOL, V95, P465, DOI 10.1007/s11230-018-9792-2; Zhang D., MITOTOOL; Zhang D., BIOSUITE; Zhang D, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2404-1; Zou H, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4237-x	64	9	9	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0203089	10.1371/journal.pone.0203089	http://dx.doi.org/10.1371/journal.pone.0203089			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180209	gold, Green Published			2022-12-26	WOS:000444222400027
J	Chatterjee, R; Davenport, CA; Raffield, LM; Maruthur, N; Lange, L; Selvin, E; Butler, K; Yeh, HC; Wilson, JG; Correa, A; Edelman, D; Hauser, E				Chatterjee, Ranee; Davenport, Clemontina A.; Raffield, Laura M.; Maruthur, Nisa; Lange, Leslie; Selvin, Elizabeth; Butler, Kenneth; Yeh, Hsin-Chieh; Wilson, James G.; Correa, Adolfo; Edelman, David; Hauser, Elizabeth			KCNJ11 variants and their effect on the association between serum potassium and diabetes risk in the Atherosclerosis Risk in Communities (ARIC) Study and Jackson Heart Study (JHS) cohorts	PLOS ONE			English	Article							K-ATP CHANNELS; GLUCOSE-INTOLERANCE; THIAZIDE DIURETICS; TYPE-2; POLYMORPHISM; POPULATION; PREVENTION; VARIANTS; MELLITUS; DISEASE	Background In the Atherosclerosis Risk in Communities (ARIC) Study and Jackson Heart Study (JHS) cohorts, serum potassium (K) is an independent predictor of diabetes risk, particularly among African-American participants. Experimental studies show that serum K levels affects insulin secretion. The KCNJ11 gene encodes for a K channel that regulates insulin secretion and whose function is affected by serum K levels. Variants in KCNJ11 are associated with increased diabetes risk. We hypothesized that there could be a gene-by-environment interaction between KCNJ11 variation and serum K on diabetes risk. Methods Evaluating a combined cohort of ARIC and JHS participants, we sought to determine if KCNJ11 variants are risk factors for diabetes; and if KCNJ11 variants modify the association between serum K and diabetes risk. Among participants without diabetes at baseline, we performed multivariable logistic regression to determine the effect of serum K, KCNJ11 variants, and their interactions on the odds of incident diabetes mellitus over 8-9 years in the entire cohort and by race. Results Of 11,812 participants, 3220 (27%) participants developed diabetes. 48% and 47% had 1 or 2 diabetes risk alleles of rs5215 and rs5219, respectively. Caucasians had higher proportions of these risk alleles compared to African Americans (60% vs 17% for rs5215 and 60% vs 13% for rs5219, p<0.01). Serum K was a significant independent predictor of incident diabetes. Neither rs5215 nor rs5219 was associated with incident diabetes. In multivariable models, we found no statistically significant interactions between race and either rs5215 or rs5219 (P-values 0.493 and 0.496, respectively); nor between serum K and either rs5215 or rs5219 on odds of incident diabetes (P-values 0.534 and 0.687, respectively). Conclusion In this cohort, rs5215 and rs5219 of KCNJ11 were not significant predictors of incident diabetes nor effect modifiers of the association between serum K and incident diabetes.	[Chatterjee, Ranee; Davenport, Clemontina A.; Edelman, David; Hauser, Elizabeth] Duke Univ, Durham, NC 27708 USA; [Raffield, Laura M.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Maruthur, Nisa; Selvin, Elizabeth; Yeh, Hsin-Chieh] Johns Hopkins Univ, Baltimore, MD USA; [Lange, Leslie] Univ Colorado, Denver, CO 80202 USA; [Butler, Kenneth; Wilson, James G.; Correa, Adolfo] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of Colorado System; University of Colorado Denver; University of Mississippi; University of Mississippi Medical Center	Chatterjee, R (corresponding author), Duke Univ, Durham, NC 27708 USA.	ranee.chatterjee@duke.edu	Butler, Kenneth Ray/S-3328-2019; Correa, Adolfo/E-7883-2011	Correa, Adolfo/0000-0002-9501-600X; Hauser, Elizabeth/0000-0003-0367-9189; Raffield, Laura/0000-0002-7892-193X; Edelman, David/0000-0001-7112-6151	NIH/Duke Clinical and Translational Science Awards [KL2TR001115-02]; National Center for Advancing Translational Sciences (NCATS) [UL1TR001117]; Johns Hopkins-University of Maryland Diabetes Research Center [P30DK079637]; National Institute of General Medical Sciences [U54GM115428]; NIH [T32 HL129982]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001115] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL129982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, P30DK096493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM115428] Funding Source: NIH RePORTER	NIH/Duke Clinical and Translational Science Awards; National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Johns Hopkins-University of Maryland Diabetes Research Center; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Chatterjee was supported by a NIH/Duke Clinical and Translational Science Awards KL2TR001115-02. Dr. Davenport was partially supported by UL1TR001117 from the National Center for Advancing Translational Sciences (NCATS). Dr. Yeh was supported by the Johns Hopkins-University of Maryland Diabetes Research Center grant (P30DK079637). Dr. James Wilson is supported by U54GM115428 from the National Institute of General Medical Sciences. Dr. Laura Raffield was funded by NIH (T32 HL129982) as she assisted with additional requested analyses in the Jackson Heart Study.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2016, CLIN J AM SOC NEPHRO, V11, P1384, DOI 10.2215/CJN.13111215; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; Babenko AP, 1998, CIRC RES, V83, P1132, DOI 10.1161/01.RES.83.11.1132; Barzilay JI, 2006, ARCH INTERN MED, V166, P2191, DOI 10.1001/archinte.166.20.2191; Bressler J, 2017, AM J MED GENET B, V174, P269, DOI 10.1002/ajmg.b.32509; Brunetti A, 2014, WORLD J DIABETES, V5, P128, DOI 10.4239/wjd.v5.i2.128; Burke TA, 2007, PHARMACOEPIDEM DR S, V16, P979, DOI 10.1002/pds.1444; Carpenter MA, 2004, AM J MED SCI, V328, P131, DOI 10.1097/00000441-200409000-00001; Chatterjee R, 2017, AM J CLIN NUTR, V105, P442, DOI 10.3945/ajcn.116.143255; Chatterjee R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157252; Chatterjee R, 2014, J GEN INTERN MED, V29, P290, DOI 10.1007/s11606-013-2569-z; Chatterjee R, 2011, AM J CLIN NUTR, V93, P1087, DOI 10.3945/ajcn.110.007286; Chatterjee R, 2010, ARCH INTERN MED, V170, P1745, DOI 10.1001/archinternmed.2010.362; Doenyas-Barak K, 2014, DIABETES VASC DIS RE, V11, P103, DOI 10.1177/1479164114521227; Florez JC, 2007, DIABETES, V56, P531, DOI 10.2337/db06-0966; Fuqua SR, 2005, ETHNIC DIS, V15, pS18; Gong B, 2012, DNA CELL BIOL, V31, P801, DOI 10.1089/dna.2011.1445; GORDEN P, 1973, DIABETES, V22, P544, DOI 10.2337/diab.22.7.544; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; Heianza Y, 2011, DIABETOLOGIA, V54, P762, DOI 10.1007/s00125-010-2029-9; HELDERMAN JH, 1983, DIABETES, V32, P106, DOI 10.2337/diabetes.32.2.106; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Meisinger C, 2013, DIABETOLOGIA, V56, P484, DOI 10.1007/s00125-012-2786-8; Ng MCY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004517; Qiu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093961; ROWE JW, 1980, METABOLISM, V29, P498, DOI 10.1016/0026-0495(80)90074-8; Schwanstecher C, 2002, DIABETES, V51, pS363, DOI 10.2337/diabetes.51.2007.S363; Shafi T, 2008, HYPERTENSION, V52, P1022, DOI 10.1161/HYPERTENSIONAHA.108.119438; Taylor EN, 2006, DIABETES CARE, V29, P1065, DOI 10.2337/dc05-2366; van Dam RM, 2005, DIABETIC MED, V22, P590, DOI 10.1111/j.1464-5491.2005.01465.x; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Zillich AJ, 2006, HYPERTENSION, V48, P219, DOI 10.1161/01.HYP.0000231552.10054.aa	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203213	10.1371/journal.pone.0203213	http://dx.doi.org/10.1371/journal.pone.0203213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169531	Green Submitted, gold, Green Published			2022-12-26	WOS:000443374400025
J	Sharrock, A; Ruthe, A; Andrews, ESV; Arcus, VA; Hicks, JL				Sharrock, Abigail; Ruthe, Alaine; Andrews, Emma S. V.; Arcus, Vickery A.; Hicks, Joanna L.			VapC proteins from Mycobacterium tuberculosis share ribonuclease sequence specificity but differ in regulation and toxicity	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; CRYSTAL-STRUCTURE; RNA-BINDING; TRANSLATION; REVEALS; INHIBITION; PEPTIDES; DOMAINS; COMPLEX; OPERON	The chromosome of Mycobacterium tuberculosis (Mtb) contains a large number of Type II toxin-antitoxin (TA) systems. The majority of these belong to the VapBC TA family, characterised by the VapC protein consisting of a PIN domain with four conserved acidic residues, and proposed ribonuclease activity. Characterisation of five VapC (VapC1, 19, 27, 29 and 39) proteins from various regions of the Mtb chromosome using a combination of pentaprobe RNA sequences and mass spectrometry revealed a shared ribonuclease sequence-specificity with a preference for UAGG sequences. The TA complex VapBC29 is auto-regulatory and interacts with inverted repeat sequences in the vapBC29 promoter, whereas complexes VapBC1 and VapBC27 display no auto-regulatory properties. The difference in regulation could be due to the different properties of the VapB proteins, all of which belong to different VapB protein families. Regulation of the vapBC29 operon is specific, no cross-talk among Type II TA systems was observed. VapC29 is bacteriostatic when expressed in Mycobacterium smegmatis, whereas VapC1 and VapC27 displayed no toxicity upon expression in M. smegmatis. The shared sequence specificity of the five VapC proteins characterised is intriguing, we propose that the differences observed in regulation and toxicity is the key to understanding the role of these TA systems in the growth and persistence of Mtb.	[Sharrock, Abigail; Ruthe, Alaine; Andrews, Emma S. V.; Arcus, Vickery A.; Hicks, Joanna L.] Univ Waikato, Sch Sci, Hamilton, New Zealand	University of Waikato	Hicks, JL (corresponding author), Univ Waikato, Sch Sci, Hamilton, New Zealand.	joanna.hicks@waikato.ac.nz	Sharrock, Abigail/GWC-8967-2022; Andrews, Emma/P-9877-2016	Sharrock, Abigail/0000-0003-2837-9481; Andrews, Emma/0000-0003-2153-4346; Hicks, Joanna/0000-0002-0307-0923	New Zealand Royal Society, Te Aparangi, Marsden Fund [10-UOW-091]	New Zealand Royal Society, Te Aparangi, Marsden Fund	VAA received funding from the New Zealand Royal Society, Te Aparangi, Marsden Fund, grant number: 10-UOW-091, https://www.royalsociety.org.nz/what-we-do/funds-and-opportunities/marsden/marsden-fund-standard/. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Ahidjo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021738; Albrethsen J, 2013, MOL CELL PROTEOMICS, V12, P1180, DOI 10.1074/mcp.M112.018846; Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Bashiri G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015803; Bashyam MD, 1996, J BACTERIOL, V178, P4847, DOI 10.1128/jb.178.16.4847-4853.1996; Beste DJV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005349; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Bunker RD, 2008, PROTEINS, V72, P510, DOI 10.1002/prot.22048; Chiang CY, 2013, RESPIROLOGY, V18, P596, DOI 10.1111/resp.12067; Das U, 2014, J STRUCT BIOL, V188, P249, DOI 10.1016/j.jsb.2014.10.002; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Esmail H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0437; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gupta A, 2009, FEMS MICROBIOL LETT, V290, P45, DOI 10.1111/j.1574-6968.2008.01400.x; Gupta A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06003-7; Hayes F, 2014, TOXINS, V6, P337, DOI 10.3390/toxins6010337; Kang SM, 2017, NUCLEIC ACIDS RES, V45, P8564, DOI 10.1093/nar/gkx489; Keren I, 2011, MBIO, V2, DOI 10.1128/mBio.00100-11; Kwan AHY, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng124; Lee IG, 2015, NUCLEIC ACIDS RES, V43, P7624, DOI 10.1093/nar/gkv689; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; McKenzie JL, 2012, RNA, V18, P1267, DOI 10.1261/rna.031229.111; McKenzie JL, 2012, J BACTERIOL, V194, P2189, DOI 10.1128/JB.06790-11; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Min AB, 2012, PROTEIN SCI, V21, P1754, DOI 10.1002/pro.2161; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Rustad TR, 2013, NUCLEIC ACIDS RES, V41, P509, DOI 10.1093/nar/gks1019; Sharp JD, 2012, J BIOL CHEM, V287, P12835, DOI 10.1074/jbc.M112.340109; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Tadokoro T, 2009, FEBS J, V276, P1482, DOI 10.1111/j.1742-4658.2009.06907.x; Winther K, 2016, NUCLEIC ACIDS RES, V44, P9860, DOI 10.1093/nar/gkw781; Winther KS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3796; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672; Zhu L, 2010, J BIOL CHEM, V285, P39732, DOI 10.1074/jbc.M110.163105	39	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203412	10.1371/journal.pone.0203412	http://dx.doi.org/10.1371/journal.pone.0203412			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169502	Green Published, Green Submitted, gold			2022-12-26	WOS:000443374400040
J	Unakafov, AM; Moller, S; Kagan, I; Gail, A; Treue, S; Wolf, F				Unakafov, Anton M.; Moeller, Sebastian; Kagan, Igor; Gail, Alexander; Treue, Stefan; Wolf, Fred			Using imaging photoplethysmography for heart rate estimation in non-human primates	PLOS ONE			English	Article							NEUROSCIENCE RESEARCH; CYNOMOLGUS MONKEYS; RHESUS-MONKEYS; SKIN; NONCONTACT; SYSTEM; LIGHT; RESTRAINT; VALUES; GREEN	For humans and for non-human primates heart rate is a reliable indicator of an individual's current physiological state, with applications ranging from health checks to experimental studies of cognitive and emotional state. In humans, changes in the optical properties of the skin tissue correlated with cardiac cycles (imaging photoplethysmogram, iPPG) allow non-contact estimation of heart rate by its proxy, pulse rate. Yet, there is no established simple and non-invasive technique for pulse rate measurements in awake and behaving animals. Using iPPG, we here demonstrate that pulse rate in rhesus monkeys can be accurately estimated from facial videos. We computed iPPGs from eight color facial videos of four awake head-stabilized rhesus monkeys. Pulse rate estimated from iPPGs was in good agreement with reference data from a contact pulse-oximeter: the error of pulse rate estimation was below 5% of the individual average pulse rate in 83% of the epochs; the error was below 10% for 98% of the epochs. We conclude that iPPG allows non-invasive and non-contact estimation of pulse rate in non-human primates, which is useful for physiological studies and can be used toward welfare-assessment of non-human primates in research.	[Unakafov, Anton M.; Moeller, Sebastian; Gail, Alexander; Treue, Stefan] Univ Goettingen, Georg Elias Muller Inst Psychol, Gottingen, Germany; [Unakafov, Anton M.; Wolf, Fred] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Unakafov, Anton M.; Moeller, Sebastian; Kagan, Igor; Gail, Alexander; Treue, Stefan; Wolf, Fred] Leibniz ScienceCampus Primate Cognit, Gottingen, Germany; [Moeller, Sebastian; Kagan, Igor; Gail, Alexander; Treue, Stefan] Leibniz Inst Primate Res, German Primate Ctr, Gottingen, Germany; [Gail, Alexander; Treue, Stefan; Wolf, Fred] Bernstein Ctr Computat Neurosci, Gottingen, Germany	University of Gottingen; Max Planck Society; Deutsches Primatenzentrum (DPZ)	Unakafov, AM (corresponding author), Univ Goettingen, Georg Elias Muller Inst Psychol, Gottingen, Germany.; Unakafov, AM (corresponding author), Max Planck Inst Dynam & Self Org, Gottingen, Germany.; Unakafov, AM (corresponding author), Leibniz ScienceCampus Primate Cognit, Gottingen, Germany.	anton@nld.ds.mpg.de	; Kagan, Igor/C-6182-2009	Unakafov, Anton/0000-0001-6782-5099; Wolf, Fred/0000-0002-7068-3762; Kagan, Igor/0000-0002-1814-4200	Hermann and Lilly Schilling Foundation (Germany); Ministry for Science and Education of Lower Saxony; Volkswagen Foundation through the program "NiedersaEchsisches Vorab"; DFG research unit [2591, 321137804]; Leibniz Association through Leibniz ScienceCampus Primate Cognition; Max Planck Society	Hermann and Lilly Schilling Foundation (Germany); Ministry for Science and Education of Lower Saxony; Volkswagen Foundation through the program "NiedersaEchsisches Vorab"; DFG research unit(German Research Foundation (DFG)); Leibniz Association through Leibniz ScienceCampus Primate Cognition; Max Planck Society(Max Planck Society)	We acknowledge funding from Hermann and Lilly Schilling Foundation (Germany), https:// www.deutsches-stiftungszentrum.de/stiftungen/hermann-und-lilly-schilling-stiftung-f%C3%BCr-medizinische-forschung (received by IK). We acknowledge funding from the Ministry for Science and Education of Lower Saxony and the Volkswagen Foundation through the program "NiedersaEchsisches Vorab," https://www.volkswagenstiftung.de/unsere-foerderung/unser-foerderangebot-im-ueberblick/vorab.html. We acknowledge funding from the DFG research unit 2591 "Severity assessment in animal based research," http://gepris.dfg.de/gepris/projekt/ 321137804 (received by AG, ST). We acknowledge additional support by the Leibniz Association through funding for the Leibniz ScienceCampus Primate Cognition and the Max Planck Society, https://www.leibniz-gemeinschaft.de/en/home/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison PS, 2016, IEEE ENG MED BIO, P4747, DOI 10.1109/EMBC.2016.7591788; Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; [Anonymous], 2016, CHAMELEON3 USB 3 0 D; Bamji CS, 2015, IEEE J SOLID-ST CIRC, V50, P303, DOI 10.1109/JSSC.2014.2364270; Bashkatov AN, 2005, J PHYS D APPL PHYS, V38, P2543, DOI 10.1088/0022-3727/38/15/004; Berger M, 2018, J NEUROPHYSIOL, V119, P796, DOI 10.1152/jn.00614.2017; Blackford EB, 2016, PROC SPIE, V9715, DOI 10.1117/12.2208130; Blanik N., 2014, P 15 INT C BIOM ENG, P92, DOI DOI 10.1007/978-3-319-02913-9_; Blazek V, 1996, QUANTITATIVE PHOTOPL; Bousefsaf F, 2016, BIO-MED MATER ENG, V27, P527, DOI 10.3233/BME-161606; Bousefsaf F, 2017, J MED BIOL ENG, V37, P374, DOI 10.1007/s40846-017-0229-1; Bousefsaf F, 2013, BIOMED SIGNAL PROCES, V8, P568, DOI 10.1016/j.bspc.2013.05.010; Calapai A, 2017, BEHAV RES METHODS, V49, P35, DOI 10.3758/s13428-016-0707-3; Challoner A., 1979, NONINVASIVE PHYSL ME, V1, P125; Chui RW, 2012, J PHARMACOL TOX MET, V66, P84, DOI 10.1016/j.vascn.2012.05.002; CLARKE AS, 1994, AM J PRIMATOL, V33, P133, DOI 10.1002/ajp.1350330207; Damianou D, 1995, WAVELENGTH DEPENDENC; Derakhchan K, 2014, BRIT J PHARMACOL, V171, P509, DOI 10.1111/bph.12484; Dominguez-Vargas AU, 2017, J NEUROSCI, V37, P2234, DOI 10.1523/JNEUROSCI.1984-16.2016; Downs ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125911; Elgendi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076585; Feng LT, 2015, IEEE T CIRC SYST VID, V25, P879, DOI 10.1109/TCSVT.2014.2364415; Gacsi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058475; Grandi LC, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00050; Hassimoto M, 2004, J MED PRIMATOL, V33, P175, DOI 10.1111/j.1600-0684.2004.00069.x; Hassimoto M, 2002, INT J BIOELECTROMAGN, V4; Higham JP, 2010, BEHAV ECOL, V21, P739, DOI 10.1093/beheco/arq047; Hoffmann P, 2014, TOXICOL PATHOL, V42, P684, DOI 10.1177/0192623313516828; Holton BD, 2013, PHYSIOL MEAS, V34, P1499, DOI 10.1088/0967-3334/34/11/1499; Hulsbusch M, 2002, PROC SPIE, V4683, P110, DOI 10.1117/12.463573; Hulsbusch M, 2008, IMAGE BASED FUNCTION; Huss MK, 2015, J AM ASSOC LAB ANIM, V54, P25; KAMAL AAR, 1989, COMPUT METH PROG BIO, V28, P257, DOI 10.1016/0169-2607(89)90159-4; Kamshilin AA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10494; Kremer JJ, 2011, J PHARM TOXICOL METH, V1, pe47, DOI [10.1016/j.vascn.2011.03.164, DOI 10.1016/J.VASCN.2011.03.164]; Kumar M, 2015, BIOMED OPT EXPRESS, V6, P1565, DOI 10.1364/BOE.6.001565; Kviesis-Kipge E, 2010, INT SOC OPTICS PHOTO; Lee J, 2013, IEEE ENG MED BIO, P1724, DOI 10.1109/EMBC.2013.6609852; Lewandowska M., 2011, 2011 Federated Conference on Computer Science and Information Systems (FedCSIS), P405; Lewis S, 2012, IEEE IMTC P, P996; LINDBERG LG, 1991, MED BIOL ENG COMPUT, V29, P48, DOI 10.1007/BF02446295; Lindqvist A, 2016, REMOTE HEART RATE EX; Maeda Y, 2008, IEEE ENG MED BIO, P2270, DOI 10.1109/IEMBS.2008.4649649; McDuff DJ, 2015, IEEE ENG MED BIO, P6398, DOI 10.1109/EMBC.2015.7319857; Moco AV, 2016, BIOMED OPT EXPRESS, V7, P1737, DOI 10.1364/BOE.7.001737; MONTAGNA W, 1964, AM J PHYS ANTHROPOL, V22, P307, DOI 10.1002/ajpa.1330220317; Morel P, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016002; Niehoff M, 2014, J PHARMACOL TOX MET, V70, P338, DOI 10.1016/j.vascn.2014.03.102; Pagliari D, 2015, SENSORS-BASEL, V15, P27569, DOI 10.3390/s151127569; Pfefferle D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190190; Poh MZ, 2011, IEEE T BIO-MED ENG, V58, P7, DOI 10.1109/TBME.2010.2086456; Prescott Mark J., 2003, Journal of Applied Animal Welfare Science, V6, P157, DOI 10.1207/S15327604JAWS0603_01; Roelfsema PR, 2014, NEURON, V82, P1200, DOI 10.1016/j.neuron.2014.06.003; Schafer A, 2013, INT J CARDIOL, V166, P15, DOI 10.1016/j.ijcard.2012.03.119; Schwedhelm P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18153-9; Shin HS, 2009, COMPUT BIOL MED, V39, P1145, DOI 10.1016/j.compbiomed.2009.10.006; Smith AM, 2009, NAT NANOTECHNOL, V4, P710, DOI 10.1038/nnano.2009.326; Spigulis J, 2007, APPL OPTICS, V46, P1754, DOI 10.1364/AO.46.001754; Stricker R, 2014, IEEE ROMAN, P1056, DOI 10.1109/ROMAN.2014.6926392; Sun XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071876; Sun Y, 2016, IEEE T BIO-MED ENG, V63, P463, DOI 10.1109/TBME.2015.2476337; Tamura T, 2014, ELECTRONICS-SWITZ, V3, P282, DOI 10.3390/electronics3020282; TATSUMI T, 1990, EXP ANIM TOKYO, V39, P361, DOI 10.1538/expanim1978.39.3_361; Unakafov AM, 2017, ARXIV171008369; van Gastel M, 2015, IEEE T BIO-MED ENG, V62, P1425, DOI 10.1109/TBME.2015.2390261; van Hoof RHM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179024; Vezhnevets V, 2003, P GRAPH; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Vizbara V, 2013, BIOMEDICAL ENG, V17; Wang WJ, 2017, IEEE T BIO-MED ENG, V64, P1479, DOI 10.1109/TBME.2016.2609282; Wang WJ, 2016, IEEE T BIO-MED ENG, V63, P1974, DOI 10.1109/TBME.2015.2508602; Witham CL, 2018, J NEUROSCI METH, V300, P157, DOI 10.1016/j.jneumeth.2017.07.020; Wu T, 2000, PROC SPIE, V4163, P62, DOI 10.1117/12.407646; Yamaoka A, 2013, J AM ASSOC LAB ANIM, V52, P491; Zarit B. D., 1999, Proceedings International Workshop on Recognition, Analysis, and Tracking of Faces and Gestures in Real-Time Systems. In Conjunction with ICCV'99 (Cat. No.PR00378), P58, DOI 10.1109/RATFG.1999.799224; Zhao F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071384	79	14	15	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0202581	10.1371/journal.pone.0202581	http://dx.doi.org/10.1371/journal.pone.0202581			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169537	gold, Green Submitted, Green Published			2022-12-26	WOS:000443374400012
J	El-Say, KM; Hosny, KM				El-Say, Khalid Mohamed; Hosny, Khaled Mohamed			Optimization of carvedilol solid lipid nanoparticles: An approach to control the release and enhance the oral bioavailability on rabbits	PLOS ONE			English	Article							IN-VITRO; SILDENAFIL CITRATE; TOPICAL DELIVERY; DRUG-DELIVERY; FORMULATION; SLN; CARRIERS; TABLETS; SURFACE; DESIGN	Solid lipid nanoparticles (SLNs) are prospective carriers for oral delivery of poorly soluble drugs with low bioavailability. Therefore, the study aimed at developing carvedilol (CVD) in SLNs to control its release and enhance its bioavailability in the management of hypertension, and cardiac diseases. Box-Behnken design (BBD) was applied to optimize the variables affecting the quality of CVD-SLNs which prepared by homogenization-ultrasonication technique. The concentrations of Percirol (X-1), Gelucire (X-2), and stearylamine (X-3) were chosen as the crucial independent variables. The dependent variables were estimated and analyzed by Statgraphics software to achieve the optimum characteristics of the developed SLNs. The optimized SLNs was evaluated in vitro and in vivo for pharmacokinetic parameters on male New Zealand white rabbits. The results of this study revealed that the CVD-SLNs have a colloidal size of 31.3 nm with zeta potential of 24.25 mV indicating good stability and 91.43% entrapment efficiency. The in vitro release of CVD from the SLNs was best fitted to Hixon-Crowell model that describes the release from the particles with uniform size. The in vivo pharmacokinetics results indicated the prolongation in the mean residence time of CVD to 23 h when delivered in SLNs and its oral bioavailability enhanced by more than 2-folds.	[El-Say, Khalid Mohamed; Hosny, Khaled Mohamed] King Abdulaziz Univ, Fac Pharm, Dept Pharmaceut, Jeddah, Saudi Arabia; [Hosny, Khaled Mohamed] Beni Suef Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Bani Suwayf, Egypt	King Abdulaziz University; Egyptian Knowledge Bank (EKB); Beni Suef University	El-Say, KM (corresponding author), King Abdulaziz Univ, Fac Pharm, Dept Pharmaceut, Jeddah, Saudi Arabia.	kelsay1@kau.edu.sa	El-Say, Khalid/I-7339-2012; Hosny, Khaled M/H-9793-2012; Hosny, Khaled/GWC-2586-2022	El-Say, Khalid/0000-0002-5539-3193; 	King Abdulaziz University, Jeddah [D-169-166-1437]; DSR	King Abdulaziz University, Jeddah; DSR	This work was supported by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. D-169-166-1437. The authors, therefore, gratefully acknowledge the DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (D-169-166-1437). The authors, therefore, gratefully acknowledge the DSR technical and financial support.	Ahmed TA, 2016, DRUG DES DEV THER, V10, P405, DOI 10.2147/DDDT.S98078; Al-Subaie MM, 2015, INT J NANOMED, V10, P3973, DOI 10.2147/IJN.S83962; Aljimaee YHM, 2015, DRUG DES DEV THER, V9, P1379, DOI 10.2147/DDDT.S80294; Becker K, 2015, PHARM RES-DORDR, V32, P1519, DOI 10.1007/s11095-015-1661-y; Cavalli R, 2002, INT J PHARM, V238, P241, DOI 10.1016/S0378-5173(02)00080-7; Chakraborty S., 2009, Current Drug Delivery, V6, P291; El-Housiny S, 2018, DRUG DELIV, V25, P78, DOI 10.1080/10717544.2017.1413444; El-Say KM, 2016, J LIPOSOME RES, V26, P57, DOI 10.3109/08982104.2015.1029495; El-Say KM, 2015, PHARM DEV TECHNOL, V20, P738, DOI 10.3109/10837450.2014.920353; Elshafeey AH, 2009, AAPS PHARMSCITECH, V10, P361, DOI 10.1208/s12249-009-9213-6; Harbi I, 2016, AAPS PHARMSCITECH, V17, P1404, DOI 10.1208/s12249-016-0481-7; Harde H, 2011, EXPERT OPIN DRUG DEL, V8, P1407, DOI 10.1517/17425247.2011.604311; Hixson AW, 1931, IND ENG CHEM, V23, P1160, DOI 10.1021/ie50262a025; Hosny KM, 2018, J DRUG DELIV SCI TEC, V45, P168, DOI 10.1016/j.jddst.2018.03.010; Hosny KM, 2014, EXPERT OPIN DRUG DEL, V11, P1015, DOI 10.1517/17425247.2014.912212; Jeon HS, 2013, INT J PHARMACEUT, V452, P311, DOI 10.1016/j.ijpharm.2013.05.023; Kassem MA, 2017, J PHARM SCI-US, V106, P111, DOI 10.1016/j.xphs.2016.07.007; Khalil RM, 2014, BRIT J PHARM RES, V4, P490, DOI 10.9734/BJPR/2014/7055; Kim S-H., 2010, AM J ANAL CHEM, V01, P135, DOI [10.4236/AJAC.2010.13017, DOI 10.4236/AJAC.2010.13017]; KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9; Lingayat VJ., 2017, J NANOSCI NANOTECHNO, V2, P67, DOI DOI 10.12691/NNR-4-2-5; Mukherjee S, 2009, INDIAN J PHARM SCI, V71, P349, DOI 10.4103/0250-474X.57282; Muller RH, 2000, EUR J PHARM BIOPHARM, V50, P161, DOI 10.1016/S0939-6411(00)00087-4; Naseri N, 2015, ADV PHARM BULL, V5, P305, DOI 10.15171/apb.2015.043; Nimbalkar UA, 2011, INT J PHARM SCI RES, V2, P2974, DOI 10.13040/IJPSR.0975-8232.2(11).2974-82; Padhye SG, 2013, INDIAN J PHARM SCI, V75, P591; Pandita D, 2009, PHARMAZIE, V64, P301, DOI 10.1691/ph.2009.8338; PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110; Ponchel G, 1997, EUR J PHARM BIOPHARM, V44, P25, DOI 10.1016/S0939-6411(97)00098-2; Potluri RHK, 2011, ARCH PHARM RES, V34, P51, DOI 10.1007/s12272-011-0106-3; Runge S., 1996, European Journal of Pharmaceutical Sciences, V4, pS132, DOI 10.1016/S0928-0987(97)86381-6; Sarangi M.K., 2016, J CRIT REV, V3, P5, DOI DOI 10.5958/0975-4377.2016.00030.6; Shidhaye S. S., 2008, Current Drug Delivery, V5, P324, DOI 10.2174/156720108785915087; Stancampiano A.H.S., 2008, OPEN DRUG DELIV, V2, P26; Tanwar Yuveraj Singh, 2007, Acta Pharmaceutica (Zagreb), V57, P151, DOI 10.2478/v10007-007-0012-x; Ubaidulla U, 2007, AAPS PHARMSCITECH, V8, DOI 10.1208/pt0801002; Uner M, 2007, INT J NANOMED, V2, P289; Venishetty VK, 2012, COLLOID SURFACE B, V95, P1, DOI 10.1016/j.colsurfb.2012.01.001; Verma S, 2016, J CHEM RES, V8, P102, DOI DOI 10.20959/WJPPS20164-6495; Wissing SA, 2004, ADV DRUG DELIVER REV, V56, P1257, DOI 10.1016/j.addr.2003.12.002; Xie SY, 2011, INT J NANOMED, V6, P547, DOI 10.2147/IJN.S17083; Zirak MB., 2015, INT J CURR MICROBIOL, V4, P924, DOI 10.20964/2016.10.30	42	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203405	10.1371/journal.pone.0203405	http://dx.doi.org/10.1371/journal.pone.0203405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161251	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900121
J	Huizinga, P; Schrauwen, E; Garcia-Cobos, S; Willemsen, I; Verhulst, C; Friedrich, AW; Savelkoul, PHM; Rossen, JW; Kluytmans, J				Huizinga, Pepijn; Schrauwen, Eefje; Garcia-Cobos, Silvia; Willemsen, Ina; Verhulst, Carlo; Friedrich, Alexander W.; Savelkoul, Paul H. M.; Rossen, John W.; Kluytmans, Jan			Extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-E) isolated from bean sprouts in the Netherlands	PLOS ONE			English	Article							AMPC-PRODUCING ENTEROBACTERIACEAE; ESCHERICHIA-COLI; CHICKEN MEAT; RISK-FACTORS; PREVALENCE; CARRIAGE; COLONIZATION; COMMUNITY; PLASMIDS; HUMANS	Community-acquired carriage and infections due to extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-E) are increasing worldwide, resulting in increased morbidity, mortality and healthcare costs. The origins of community-acquired ESBL-E-carriage and infections remain unclear. Bean sprouts are a potential source of Enterobacteriaceae for the community, as illustrated by outbreaks of pathogenic Enterobacteriaceae in the past. The current study focuses on contamination of retail bean sprouts with ESBL-E in the Netherlands. Of 131 bean sprout samples purchased between 2013 and 2016, 25 (19%) were contaminated with ESBL-E. The detected isolates were almost exclusively Klebsiella spp. and co-resistance to other antibiotics was observed frequently. Over time there was substantial genetic diversity between isolates. On the other hand, isolates from samples closely matched in time were frequently clonally related, indicative of batch contamination. Remarkably, no Escherichia colt was found. In conclusion, bean sprouts frequently harbor ESBL-E, which is a potential source for consumers.	[Huizinga, Pepijn; Willemsen, Ina; Verhulst, Carlo; Kluytmans, Jan] Amphia Hosp, Dept Infect Control, Breda, Netherlands; [Huizinga, Pepijn] Elisabeth TweeSteden Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Schrauwen, Eefje; Willemsen, Ina] Avans Univ Appl Sci, Acad Technol & Environm Hlth, Breda, Netherlands; [Garcia-Cobos, Silvia; Friedrich, Alexander W.; Rossen, John W.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Savelkoul, Paul H. M.] Maastricht Univ, Med Ctr, Caphri Sch Publ Hlth & Primary Care, Dept Med Microbiol, Maastricht, Netherlands; [Savelkoul, Paul H. M.] Univ Amsterdam, Med Ctr, Vrije Univ Amsterdam, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Kluytmans, Jan] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Amphia Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); University of Groningen; Maastricht University; University of Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center	Huizinga, P (corresponding author), Amphia Hosp, Dept Infect Control, Breda, Netherlands.; Huizinga, P (corresponding author), Elisabeth TweeSteden Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands.	pepijnhuizinga@gmail.com	Rossen, John W/G-7564-2011; Friedrich, Alex/ABG-9823-2020; GARCIA-COBOS, SILVIA/A-7087-2017	Rossen, John W/0000-0002-7167-8623; GARCIA-COBOS, SILVIA/0000-0002-1417-5691	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank the team of curators of the Institut Pasteur MLST and whole genome MLST databases for curating the data and making them publicly available at http://bigsdb.pasteur.fr. This publication also made use of the PubMLST website (https://pubmlst.org/) developed by Keith Jolley (Jolley & Maiden 2010, BMC Bioinformatics, 11: 595) and sited at the University of Oxford. The development of that website was funded by the Wellcome Trust.	Arcilla MS, 2017, LANCET INFECT DIS, V17, P78, DOI 10.1016/S1473-3099(16)30319-X; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Blaak H, 2014, INT J FOOD MICROBIOL, V168, P8, DOI 10.1016/j.ijfoodmicro.2013.10.006; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; De Boeck H, 2012, EMERG INFECT DIS, V18, P1019, DOI 10.3201/eid1806.111214; Egervarn M, 2017, SCI TOTAL ENVIRON, V587, P466, DOI 10.1016/j.scitotenv.2017.02.157; EUCAST T, 2017, BREAKPOINT TABLES IN; European Centre for Disease Prevention and Control, 2015, ANN REPORT EUROPEAN, DOI [10.2900/23549, DOI 10.2900/23549]; European Committee on Antimicrobial Susceptibility Testing, 2013, EUCAST GUID DET RES; Evers EG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169589; German institut for risk Assesment (BfR), 2011, EHEC OUTBR BFR CONF; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Karanika S, 2016, CLIN INFECT DIS, V63, P195, DOI 10.1093/cid/ciw240; Kim HS, 2015, INT J FOOD MICROBIOL, V207, P83, DOI 10.1016/j.ijfoodmicro.2015.04.049; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Kluytmans-van den Bergh MFQ, 2016, J CLIN MICROBIOL, V54, P2919, DOI 10.1128/JCM.01648-16; Larsen MV, 2014, J CLIN MICROBIOL, V52, P1529, DOI 10.1128/JCM.02981-13; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Martinez-Romero E, 2018, SALUD PUBLICA MEXICO, V60, P56, DOI 10.21149/8149; Meyer E, 2012, INFECTION, V40, P685, DOI 10.1007/s15010-012-0324-8; Miranda IB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav024; Netherlands Society for Medical Microbiology, 2012, NVMM GUID LAB DET HI; Overdevest ITMA, 2011, J CLIN MICROBIOL, V49, P519, DOI 10.1128/JCM.01953-10; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; P Huizinga, 2016, CLIN INFECT DIS, V702; Reuland EA, 2016, J ANTIMICROB CHEMOTH, V71, P1076, DOI 10.1093/jac/dkv441; Reuland EA, 2014, EUR J CLIN MICROBIOL, V33, P1843, DOI 10.1007/s10096-014-2142-7; Reuland EA, 2013, CLIN MICROBIOL INFEC, V19, P542, DOI 10.1111/j.1469-0691.2012.03947.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shitrit P, 2013, J HOSP INFECT, V85, P230, DOI 10.1016/j.jhin.2013.07.014; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stuart JC, 2010, J ANTIMICROB CHEMOTH, V65, P1377, DOI 10.1093/jac/dkq146; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomsen MCF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157718; Tumbarello M, 2010, ANTIMICROB AGENTS CH, V54, P4085, DOI 10.1128/AAC.00143-10; Valverde A, 2008, J CLIN MICROBIOL, V46, P2796, DOI 10.1128/JCM.01008-08; van der Bij AK, 2011, ANTIMICROB AGENTS CH, V55, P3576, DOI 10.1128/AAC.00074-11; van Hoek AHAM, 2015, INT J FOOD MICROBIOL, V204, P1, DOI 10.1016/j.ijfoodmicro.2015.03.014; Voets GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052102; Willemsen I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141765; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203338	10.1371/journal.pone.0203338	http://dx.doi.org/10.1371/journal.pone.0203338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161223	Green Submitted, Green Published, gold			2022-12-26	WOS:000443388900115
J	Wu, CW; Chiu, WT; Hsieh, TH; Hsieh, CH; Chen, JJJ				Wu, Chun-Wei; Chiu, Wen-Tai; Hsieh, Tsung-Hsun; Hsieh, Cho-Han; Chen, Jia-Jin Jason			Modulation of motor excitability by cortical optogenetic theta burst stimulation	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ELECTRICAL-STIMULATION; NEURAL CIRCUITRY; IN-VIVO; PLASTICITY; CORTEX; INTERROGATION; TECHNOLOGY; RATS	Intermittent theta burst stimulation (iTBS) and continuous theta burst stimulation (cTBS) are protocols used in repetitive transcranial magnetic stimulation (rTMS) or cortical electrical stimulation (CES) to facilitate or suppress corticospinal excitability. However, rTMS and CES excite all types of neuron in the target cortex probed by the coil or electrode, making it difficult to differentiate the effect of TBS on specific neural circuits involved in motor plasticity. In this study, TBS protocols were converted into an optogenetic model to achieve focalized and cell-type-specific cortical modulation. Light-sensitive channelrhodopsin-2 (ChR2) was expressed in the glutamatergic neuron in the primary motor cortex (M1) driven by the CaMKI la promoter. A custom-made optrode comprising an optical fiber and a metal cannula electrode was fabricated to achieve optogenetic stimulation and simultaneous local field potential (LFP) recording. Single-pulse CES was delivered into M1 to elicit motor-evoked potential (MEP), which served as an indicator of motor excitability, before and after TBS intervention. Results show that both CES-iTBS and optogenetic iTBS (Opto-iTBS) can potentiate MEP activity. However, CES-cTBS suppressed MEP activity whereas Opto-cTBS enhanced it. This discrepancy may have resulted from the different neural networks targeted by the two TBS modalities, with CES-cTBS exciting all types of neuron and Opto-cTBS targeting excitatory neuron specifically. The results support the idea that intra-cortical networks determine the variation of TBS-induced neuroplasticity. This study shows that focalized and cell-type-specific brain stimulation using the optogenetic approach is viable and can be extended for further exploration of neuroplasticity.	[Wu, Chun-Wei; Chiu, Wen-Tai; Hsieh, Cho-Han; Chen, Jia-Jin Jason] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Sch Phys Therapy, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Grad Inst Rehabil Sci, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Mem Hosp, Neurosci Res Ctr, Taoyuan, Taiwan	National Cheng Kung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Chen, JJJ (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan.	chenjj@mail.ncku.edu.tw	Hsieh, Tung-Hsun/AAZ-5010-2020	Hsieh, Tung-Hsun/0000-0002-1794-7941	National Health Research Institutes of Taiwan [NHRI-EX103-10139EI]; Ministry of Science and Technology of Taiwan [MOST104-2314-B-006-007-MY3]	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	The authors would like to thank the National Health Research Institutes of Taiwan (http://www.nhri.org.tw/) (NHRI-EX103-10139EI) and the Ministry of Science and Technology of Taiwan (www.most.gov.tw) (MOST104-2314-B-006-007-MY3) for financially supporting this study to J-JJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardenas-Morales L, 2010, BRAIN TOPOGR, V22, P294, DOI 10.1007/s10548-009-0084-7; Di Lazzaro V, 2014, J PHYSIOL-LONDON, V592, P4115, DOI 10.1113/jphysiol.2014.274316; Fonoff ET, 2009, BEHAV BRAIN RES, V202, P138, DOI 10.1016/j.bbr.2009.03.018; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Hess G, 1996, ACTA NEUROBIOL EXP, V56, P397; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Hsieh T-H, 2014, CEREBRAL CORTEX; Hsieh TH, 2015, J MED BIOL ENG, V35, P62, DOI 10.1007/s40846-015-0006-y; Huang X, 2017, MOL PSYCHIATR, V22, P1274, DOI 10.1038/mp.2017.143; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Larson J, 2015, BRAIN RES, V1621, P38, DOI 10.1016/j.brainres.2014.10.034; Schulz R, 2013, NEUROPHARMACOLOGY, V64, P579, DOI 10.1016/j.neuropharm.2012.05.016; Seeger-Armbruster S, 2015, J NEUROSCI, V35, P1211, DOI 10.1523/JNEUROSCI.3277-14.2015; Suppa A, 2016, BRAIN STIMUL, V9, P323, DOI 10.1016/j.brs.2016.01.006; Wischnewski M, 2015, BRAIN STIMUL, V8, P685, DOI 10.1016/j.brs.2015.03.004; Xie YF, 2013, ACTA PHARMACOL SIN, V34, P1381, DOI 10.1038/aps.2013.150; Xiong WH, 2012, J NEUROSCI METH, V210, P119, DOI 10.1016/j.jneumeth.2012.07.019; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	24	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203333	10.1371/journal.pone.0203333	http://dx.doi.org/10.1371/journal.pone.0203333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161250	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900113
J	Bao, Y; Wang, ZX; Liu, B; Lu, X; Xiong, Y; Shi, JZ; Li, P; Chen, JM; Zhang, ZQ; Chen, M; Wang, LH; Wu, ZJ				Bao, Yi; Wang, Zhixiang; Liu, Bing; Lu, Xin; Xiong, Ying; Shi, Jiazi; Li, Peng; Chen, Junming; Zhang, Zongqin; Chen, Ming; Wang, Linhui; Wu, Zhenjie			A feed-forward loop between nuclear translocation of CXCR4 and HIF-1 alpha promotes renal cell carcinoma metastasis	ONCOGENE			English	Article							CHEMOKINE RECEPTOR CXCR4; BREAST-CANCER; EXPRESSION; HYPOXIA; SDF-1-ALPHA; BIOLOGY; SDF-1	CXC chemokine receptor 4 (CXCR4) has been suggested to play a critical role in cancer metastasis. Some studies have described CXCR4 nuclear localization in metastatic lesions of renal cell carcinoma (RCC), which has been suggested to be correlated with cancer metastasis. However, the underlying mechanism and clinical significance of CXCR4 nuclear localization remains unknown. Here, we show that CXCR4 nuclear localization is more likely to occur in RCC tissues, especially in metastases, and is associated with poor prognosis. CXCR4 nuclear localization requires its nuclear localization sequence (NLS, residues 146-RPRK-149). After the mutation of NLS in CXCR4, CXCR4 nuclear localization in RCC cells is lost. Nuclear localization of CXCR4 promoted RCC tumorigenicity both in vitro and in vivo. Mechanistically, we found that CXCR4 and hypoxia-inducible factor-1 alpha (HIF-1 alpha) colocalized in RCC cells and interacted with each other. Moreover, CXCR4 nuclear localization promoted nuclear accumulation of HIF-1 alpha, thereby promoting the expression of genes downstream of HIF-1 alpha. Reciprocally, nuclear HIF-1 alpha promoted CXCR4 transcription, thus forming a feed-forward loop. Subcellular CXCR4 and HIF-1 alpha expression levels were independent adverse prognostic factors and could be combined with TNM stage to generate a predictive nomogram of the clinical outcome of patients with RCC. Therefore, our findings indicate that CXCR4 nuclear translocation plays a critical role in RCC metastasis and may serve as a prognostic biomarker and potential therapeutic target.	[Bao, Yi; Liu, Bing; Xiong, Ying; Shi, Jiazi; Li, Peng; Chen, Junming; Zhang, Zongqin; Chen, Ming; Wang, Linhui; Wu, Zhenjie] Second Mil Med Univ, Changzheng Hosp, Dept Urol, Shanghai 200003, Peoples R China; [Wang, Zhixiang] 458th Hosp PLA, Dept Urol, Guangzhou 510602, Guangdong, Peoples R China; [Lu, Xin] Second Mil Med Univ, Changhai Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Li, Peng] 153 Hosp PLA, Dept Urol, Zhengzhou 450042, Henan, Peoples R China; [Chen, Junming] Chinese Peoples Armed Police Forces, Dept Urol, Henan Prov Corps Hosp, Zhengzhou 450052, Henan, Peoples R China	Naval Medical University; Naval Medical University	Wang, LH; Wu, ZJ (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Urol, Shanghai 200003, Peoples R China.	wanglinhui@smmu.edu.cn; wuzhenjie17@smmu.edu.cn	wang, lili/HDL-7210-2022; wang, lin/GSE-3040-2022; wang, lin/HHM-2225-2022; Wu, Zhenjie/GRJ-0184-2022	Wu, Zhenjie/0000-0002-6487-5207	National Natural Science Foundation of China [81272817, 81874093, 81572521, 81730073]; Leading Talent Project of Shanghai [2013046]; Translation and Application of Precise Medicine of Second Military Medical University [2017JZ22]; Youth Talent Sailing Programme of Shanghai Science and Technology Committee [16YF1403600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leading Talent Project of Shanghai; Translation and Application of Precise Medicine of Second Military Medical University; Youth Talent Sailing Programme of Shanghai Science and Technology Committee	We thank Dr. Taoyong Chen for valuable comments and expert technical support. This study was supported by the National Natural Science Foundation of China (81272817, 81874093, 81572521 and 81730073), the Leading Talent Project of Shanghai (2013046), the Translation and Application of Precise Medicine of Second Military Medical University (No. 2017JZ22) (to L.W.); the Youth Talent Sailing Programme of Shanghai Science and Technology Committee (16YF1403600) (to Z.W.).	Brocato J, 2014, MOL PHARMACOL, V85, P651, DOI 10.1124/mol.113.089623; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Cabioglu N, 2007, ANN ONCOL, V18, P1021, DOI 10.1093/annonc/mdm060; Cabioglu N, 2005, CLIN EXP METASTAS, V22, P39, DOI 10.1007/s10585-005-3222-y; Capitanio U, 2016, LANCET, V387, P894, DOI 10.1016/S0140-6736(15)00046-X; Caruz A, 1998, FEBS LETT, V426, P271, DOI 10.1016/S0014-5793(98)00359-7; Choudhry H, 2018, CELL METAB, V27, P281, DOI 10.1016/j.cmet.2017.10.005; Don-Salu-Hewage AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057194; Figlin RA, 1999, J UROLOGY, V161, P381, DOI 10.1016/S0022-5347(01)61897-4; Gong J, 2016, ASIAN J UROL, V3, P286, DOI 10.1016/j.ajur.2016.08.006; Han MZ, 2014, TUMOR BIOL, V35, P4589, DOI 10.1007/s13277-013-1603-4; He X, 2010, PATHOL RES PRACT, V206, P712, DOI 10.1016/j.prp.2010.05.003; Kizaka-Kondoh S, 2009, ADV DRUG DELIVER REV, V61, P623, DOI 10.1016/j.addr.2009.01.006; Marechal R, 2009, BRIT J CANCER, V100, P1444, DOI 10.1038/sj.bjc.6605020; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nikkhoo B, 2014, J ONCOL, V2014, DOI 10.1155/2014/808012; Pan JD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-56; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Shannon AM, 2003, CANCER TREAT REV, V29, P297, DOI 10.1016/S0305-7372(03)00003-3; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Singh D, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0190-2; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Sun WD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05685-3; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wang LH, 2009, ONCOL REP, V22, P1333, DOI 10.3892/or_00000572; Wang LH, 2009, CLIN EXP METASTAS, V26, P1049, DOI 10.1007/s10585-009-9294-3; Wang SC, 2010, INT J COLORECTAL DIS, V25, P1185, DOI 10.1007/s00384-010-0999-1; Xu ZP, 2016, ONCOL REP, V36, P2681, DOI 10.3892/or.2016.5082; Yoshitake N, 2008, BRIT J CANCER, V98, P1682, DOI 10.1038/sj.bjc.6604363; Zagzag D, 2006, LAB INVEST, V86, P1221, DOI 10.1038/labinvest.3700482	32	31	31	2	20	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 7	2019	38	6					881	895		10.1038/s41388-018-0452-4	http://dx.doi.org/10.1038/s41388-018-0452-4			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HK5LC	30177838	Green Published, hybrid			2022-12-26	WOS:000458006300009
J	Li, YS; Zhang, HY; Zhao, Y; Wang, CY; Cheng, ZG; Tang, LN; Gao, YL; Liu, FR; Li, JB; Li, Y; Li, Y; Geng, NX; Rui, X; Teng, YE; Liu, YP; Cao, L; Kumar, R; Jin, F; Li, F				Li, Yanshu; Zhang, Hongyan; Zhao, Yue; Wang, Chunyu; Cheng, Zhenguo; Tang, Lina; Gao, Yunling; Liu, Furong; Li, Jiabin; Li, Yan; Li, Yang; Geng, Nanxi; Rui, Xue; Teng, Yuee; Liu, Yunpeng; Cao, Liu; Kumar, Rakesh; Jin, Feng; Li, Feng			A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ER alpha-positive breast cancer cells	ONCOGENE			English	Article							ESTROGEN-RECEPTOR-ALPHA; ANDROGEN RECEPTOR; PAK4; INVASION; PROLIFERATION; MIGRATION; PROMOTES; PROTEIN; EXPRESSION; INHIBITOR	The mechanism of estrogen receptor alpha (ER alpha)-positive breast cancer-associated bone metastasis is poorly understood. In this article, we report that nuclear p21-activated kinase 4 (nPAK4) is a novel repressor of ER alpha-mediated transactivation in a 17 beta-estradiol (E2)-dependent manner and promotes PAK4-ER alpha axis-mediated bone metastasis by targeting leukemia inhibitory factor receptor (LIFR) in ER alpha-positive breast cancer. An evaluation of clinical breast cancer samples revealed that nPAK4 is linked to ERa expression and appears to be associated with a poor prognosis in bone metastatic breast cancer. PAK4 bound and co-translocated with ERa from the cytoplasm to the nucleus upon stimulation with E2. nPAK4 enhanced the invasive potential of ER alpha-positive breast cancer cells in vitro and promoted breast cancer metastasis in vivo. Mechanistically, nPAK4 promoted the metastasis of ER alpha-positive breast cancer cells by targeting LIFR, a bone metastasis suppressor. Strikingly, the nuclear accumulation of PAK4 might promote aggressive phenotypes, highlighting nPAK4 as a novel predictive biomarker for ER alpha-positive breast cancer bone metastasis.	[Li, Yanshu; Zhang, Hongyan; Zhao, Yue; Wang, Chunyu; Cheng, Zhenguo; Tang, Lina; Gao, Yunling; Liu, Furong; Li, Jiabin; Li, Yan; Li, Yang; Geng, Nanxi; Cao, Liu; Li, Feng] China Med Univ, Dept Cell Biol, Key Lab Cell Biol, Minist Publ Hlth, 77 Puhe Rd,Shenyang North New Area, Shenyang 110122, Liaoning, Peoples R China; [Li, Yanshu; Zhang, Hongyan; Zhao, Yue; Wang, Chunyu; Cheng, Zhenguo; Tang, Lina; Gao, Yunling; Liu, Furong; Li, Jiabin; Li, Yan; Li, Yang; Geng, Nanxi; Cao, Liu; Li, Feng] China Med Univ, Key Lab Med Cell Biol, Minist Educ, 77 Puhe Rd,Shenyang North New Area, Shenyang 110122, Liaoning, Peoples R China; [Rui, Xue; Jin, Feng] China Med Univ, Dept Surg Oncol, Hosp 1, 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China; [Teng, Yuee; Liu, Yunpeng] China Med Univ, Dept Med Oncol, Hosp 1, 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China; [Kumar, Rakesh] Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram 695014, Kerala, India	China Medical University; China Medical University; China Medical University; China Medical University; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Li, F (corresponding author), China Med Univ, Dept Cell Biol, Key Lab Cell Biol, Minist Publ Hlth, 77 Puhe Rd,Shenyang North New Area, Shenyang 110122, Liaoning, Peoples R China.; Li, F (corresponding author), China Med Univ, Key Lab Med Cell Biol, Minist Educ, 77 Puhe Rd,Shenyang North New Area, Shenyang 110122, Liaoning, Peoples R China.; Jin, F (corresponding author), China Med Univ, Dept Surg Oncol, Hosp 1, 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China.	jinfeng@cmu.edu.cn; lifeng@cmu.edu.cn	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803; Li, Feng/0000-0001-5868-7456	MD Anderson cancer center; National Natural Science Foundation of China [31371424, 31571457, 90813038, 81372337]; Ministry of Education of China [IRT13101]; Basic Research Project of Education Department of Liaoning Province [LZ2015071]	MD Anderson cancer center; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Basic Research Project of Education Department of Liaoning Province	We thank Raabe T. for the gifts of the Mbt and Mbt<SUP>P1</SUP> mutants fly stocks. We thank Dr. Yu Tong from MD Anderson cancer center for the gifts of the LIFR plasmids. This research was supported by Grants from the National Natural Science Foundation of China No. 31371424 (Feng Li), No. 31571457 (Feng Li), No. 90813038 (Feng Li), No. 81372337 (Yan Li) and Ministry of Education of China IRT13101 (Liu Cao), and Basic Research Project of Education Department of Liaoning Province, No. LZ2015071 (Feng Li).	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Ahmed T, 2008, CELL SIGNAL, V20, P1320, DOI 10.1016/j.cellsig.2008.02.021; BERCHUCK A, 1989, CANCER RES, V49, P2091; Bi YQ, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0913-6; Blanco MA, 2012, CELL RES, V22, P1339, DOI 10.1038/cr.2012.89; Cai SW, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0165-2; Chen DH, 2012, NAT MED, V18, P1511, DOI 10.1038/nm.2940; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Choi SW, 2015, J BONE MINER RES, V30, P1494, DOI 10.1002/jbmr.2468; Eswaran J, 2009, CANCER METAST REV, V28, P209, DOI 10.1007/s10555-008-9181-4; Fujiki R, 2005, EMBO J, V24, P3881, DOI 10.1038/sj.emboj.7600853; Guo Q, 2014, ONCOGENE, V33, P3277, DOI 10.1038/onc.2013.296; Johnson RW, 2016, NAT CELL BIOL, V18, P1078, DOI 10.1038/ncb3408; Kobayashi K, 2016, J CLIN PATHOL, V69, P580, DOI 10.1136/jclinpath-2015-203330; Kumar R, 2016, ADV CANCER RES, V130, P137, DOI 10.1016/bs.acr.2016.01.002; Li Y, 2012, BBA-MOL CELL RES, V1823, P465, DOI 10.1016/j.bbamcr.2011.11.013; Li YS, 2013, ANAT REC, V296, P1561, DOI 10.1002/ar.22754; Lindberg MK, 2002, J BONE MINER RES, V17, P2183, DOI 10.1359/jbmr.2002.17.12.2183; Liu FA, 2017, MOL THER-NUCL ACIDS, V8, P370, DOI 10.1016/j.omtn.2017.07.005; Liu Y, 2010, ONCOGENE, V29, P5883, DOI 10.1038/onc.2010.329; Liu YY, 2008, MOL CANCER RES, V6, P1215, DOI 10.1158/1541-7786.MCR-08-0087; Lu W, 2013, NEOPLASMA, V60, P493, DOI 10.4149/neo_2013_064; Melzig J, 1998, CURR BIOL, V8, P1223, DOI 10.1016/S0960-9822(07)00514-3; Menzel N, 2008, BIOCHEM J, V416, P231, DOI 10.1042/BJ20080465; Minden Audrey, 2012, ISRN Oncol, V2012, P694201, DOI 10.5402/2012/694201; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Rayala SK, 2006, CANCER RES, V66, P1694, DOI 10.1158/0008-5472.CAN-05-2922; Siu MKY, 2010, P NATL ACAD SCI USA, V107, P18622, DOI 10.1073/pnas.0907481107; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vershinin Z, 2016, J BIOL CHEM, V291, P6786, DOI 10.1074/jbc.M115.697292; Vesuna F, 2012, ONCOGENE, V31, P3223, DOI 10.1038/onc.2011.483; Wang CY, 2015, NUCLEIC ACIDS RES, V43, P4893, DOI 10.1093/nar/gkv394; Wang RA, 2002, EMBO J, V21, P5437, DOI 10.1093/emboj/cdf543; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wong LE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.13; Wright LE, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.31; Xu HT, 2016, CANCER RES, V76, P5732, DOI 10.1158/0008-5472.CAN-15-3373; Yanagisawa J, 2002, MOL CELL, V9, P553, DOI 10.1016/S1097-2765(02)00478-1; Zhang HY, 2017, AM J TRANSL RES, V9, P2736; Zhang HJ, 2011, CARCINOGENESIS, V32, P765, DOI 10.1093/carcin/bgr033; Zhang J, 2012, CANCER LETT, V317, P24, DOI 10.1016/j.canlet.2011.11.007; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011; Zhao Y, 2009, MOL CELL BIOL, V29, P1017, DOI 10.1128/MCB.02123-07; Zhuang T, 2015, ONCOTARGET, V6, P43853, DOI 10.18632/oncotarget.6081	45	24	25	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 7	2019	38	6					808	821		10.1038/s41388-018-0456-0	http://dx.doi.org/10.1038/s41388-018-0456-0			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HK5LC	30177834	Green Published, hybrid			2022-12-26	WOS:000458006300004
J	DeGuire, SM; Ruggeri, FS; Fares, MB; Chiki, A; Cendrowska, U; Dietler, G; Lashuel, HA				DeGuire, Sean M.; Ruggeri, Francesco S.; Fares, Mohamed-Bilal; Chiki, Anass; Cendrowska, Urszula; Dietler, Giovanni; Lashuel, Hilal A.			N-terminal Huntingtin (Htt) phosphorylation is a molecular switch regulating Htt aggregation, helical conformation, internalization, and nuclear targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT HUNTINGTIN; POSTTRANSLATIONAL MODIFICATIONS; FLANKING SEQUENCES; WILD-TYPE; DISEASE; PROTEIN; EXON-1; LOCALIZATION; PATHOGENESIS; CYSTEINE	Huntington's disease is a fatal neurodegenerative disorder resulting from a CAG repeat expansion in the first exon of the gene encoding the Huntingtin protein (Htt). Phosphorylation of this protein region (Httex1) has been shown to play important roles in regulating the structure, toxicity, and cellular properties of N-terminal fragments and full-length Htt. However, increasing evidence suggests that phosphomimetic substitutions in Htt result in inconsistent findings and do not reproduce all aspects of true phosphorylation. Here, we investigated the effects of bona fide phosphorylation at Ser-13 or Ser-16 on the structure, aggregation, membrane binding, and subcellular properties of the Httex1-Q18A variant and compared these effects with those of phosphomimetic substitutions. We show that phosphorylation at either Ser-13 and/or Ser-16 or phosphomimetic substitutions at both these residues inhibit the aggregation of mutant Httex1, but that only phosphorylation strongly disrupts the amphipathic alpha-helix of the N terminus and prompts the internalization and nuclear targeting of preformed Httex1 aggregates. In synthetic peptides, phosphorylation at Ser-13, Ser-16, or both residues strongly disrupted the amphipathic alpha-helix of the N-terminal 17 residues (Nt17) of Httex1 and Nt17 membrane binding. Experiments with peptides bearing different combinations of phosphorylation sites within Nt17 revealed a phosphorylation-dependent switch that regulates the Httex1 structure, involving cross-talk between phosphorylation at Thr-3 and Ser-13 or Ser-16. Our results provide crucial insights into the role of phosphorylation in regulating Httex1 structure and function, and underscore the critical importance of identifying the enzymes responsible for regulating Htt phosphorylation, and their potential as therapeutic targets for managing Huntington's disease.	[DeGuire, Sean M.; Fares, Mohamed-Bilal; Chiki, Anass; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Lab Mol & Chem Biol Neurodegenerat, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Ruggeri, Francesco S.; Cendrowska, Urszula; Dietler, Giovanni] Ecole Polytech Fed Lausanne, Lab Phys Living Matter, Inst Phys Biol Syst, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Lab Mol & Chem Biol Neurodegenerat, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Lashuel, Hilal/M-3500-2017; Ruggeri, Francesco Simone/C-8004-2012	Ruggeri, Francesco Simone/0000-0002-1232-1907; Fares, Mohamed-Bilal/0000-0002-9243-0336	CHDI Foundation [A_7627]; Swiss National Science Foundation [31003A-146680]	CHDI Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by CHDI Foundation Grant A_7627 and Swiss National Science Foundation Grant 31003A-146680. The authors declare that they have no conflicts of interest with the contents of this article.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Ait-Bouziad N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01575-4; Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; Ansaloni A, 2014, ANGEW CHEM INT EDIT, V53, P1928, DOI 10.1002/anie.201307510; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Babcock DT, 2015, P NATL ACAD SCI USA, V112, pE5427, DOI 10.1073/pnas.1516217112; Blanco-Canosa JB, 2008, ANGEW CHEM INT EDIT, V47, P6851, DOI 10.1002/anie.200705471; Branco-Santos J, 2017, HUM MOL GENET, V26, P3763, DOI 10.1093/hmg/ddx260; Bustos V, 2017, P NATL ACAD SCI USA, V114, P7142, DOI 10.1073/pnas.1705235114; Cariulo C, 2017, P NATL ACAD SCI USA, V114, pE10809, DOI 10.1073/pnas.1705372114; Caron NS, 2013, P NATL ACAD SCI USA, V110, P14610, DOI 10.1073/pnas.1301342110; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Chen SM, 2001, PROTEIN SCI, V10, P887, DOI 10.1110/ps.42301; Chiki A, 2017, ANGEW CHEM INT EDIT, V56, P5202, DOI 10.1002/anie.201611750; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752; Choudhury KR, 2015, BIOCHEM BIOPH RES CO, V456, P66, DOI 10.1016/j.bbrc.2014.11.035; Cicchetti F, 2014, ANN NEUROL, V76, P31, DOI 10.1002/ana.24174; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Costanzo M, 2013, J CELL SCI, V126, P3678, DOI 10.1242/jcs.126086; Crick SL, 2013, P NATL ACAD SCI USA, V110, P20075, DOI 10.1073/pnas.1320626110; Daldin M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05336-7; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; Di Pardo A, 2012, P NATL ACAD SCI USA, V109, P3528, DOI 10.1073/pnas.1114502109; Espinoza-Fonseca LM, 2014, MOL BIOSYST, V10, P2693, DOI 10.1039/c4mb00364k; Fares MB, 2014, HUM MOL GENET, V23, P4491, DOI 10.1093/hmg/ddu165; Gentle IE, 2004, BIOCONJUGATE CHEM, V15, P658, DOI 10.1021/bc049965o; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Havel LS, 2011, HUM MOL GENET, V20, P1424, DOI 10.1093/hmg/ddr023; Jayaraman M, 2012, J MOL BIOL, V415, P881, DOI 10.1016/j.jmb.2011.12.010; Kelley NW, 2009, J MOL BIOL, V388, P919, DOI 10.1016/j.jmb.2009.01.032; Lakhani VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000772; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Lee CC, 2007, BIOCHEMISTRY-US, V46, P12810, DOI 10.1021/bi700806c; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; MacDonald ME, 2003, NEUROMOL MED, V4, P7, DOI 10.1385/NMM:4:1-2:7; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Michalek M, 2013, BIOPHYS J, V105, P699, DOI 10.1016/j.bpj.2013.06.030; Mishra R, 2012, J MOL BIOL, V424, P1, DOI 10.1016/j.jmb.2012.09.011; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Pandey NK, 2018, J BIOL CHEM, V293, P2597, DOI 10.1074/jbc.M117.813667; Pearce MMP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7768; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Pecho-Vrieseling E, 2014, NAT NEUROSCI, V17, P1064, DOI 10.1038/nn.3761; Rangone H, 2004, EUR J NEUROSCI, V19, P273, DOI 10.1111/j.0953-816X.2003.03131.x; Ratovitski T, 2017, J PROTEOME RES, V16, P2692, DOI 10.1021/acs.jproteome.6b00991; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Ruggeri FS, 2016, SCI REP-UK, V6, DOI 10.1038/srep31155; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; Steffan JS, 2010, CELL CYCLE, V9, P3401, DOI [10.4161/cc.9.17.12718, 10.4161/cc.9.17.12671]; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tan Z, 2015, MOL PSYCHIATR, V20, P1286, DOI 10.1038/mp.2015.81; Tenreiro S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00042; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Trevino RS, 2012, J BIOL CHEM, V287, P29722, DOI 10.1074/jbc.M112.372474; Vieweg S, 2016, J BIOL CHEM, V291, P12074, DOI 10.1074/jbc.M116.713982; Wan Q, 2007, ANGEW CHEM INT EDIT, V46, P9248, DOI 10.1002/anie.200704195; Warner JB, 2017, J AM CHEM SOC, V139, P14456, DOI 10.1021/jacs.7b06659; Yan LZ, 2001, J AM CHEM SOC, V123, P526, DOI 10.1021/ja003265m	67	36	37	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18540	18558		10.1074/jbc.RA118.004621	http://dx.doi.org/10.1074/jbc.RA118.004621			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30185623	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000458467300011
J	Lahham, M; Pavkov-Keller, T; Fuchs, M; Niederhauser, J; Chalhoub, G; Daniel, B; Kroutil, W; Gruber, K; Macheroux, P				Lahham, Majd; Pavkov-Keller, Tea; Fuchs, Michael; Niederhauser, Johannes; Chalhoub, Gabriel; Daniel, Bastian; Kroutil, Wolfgang; Gruber, Karl; Macheroux, Peter			Oxidative cyclization of N-methyl-dopa by a fungal flavoenzyme of the amine oxidase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oxidation-reduction (redox); flavoprotein; flavin adenine dinucleotide (FAD); X-ray crystallography; biosynthesis; amine oxidase; fructose amine oxidase; fumisoquin biosynthesis; isoquinolines; oxidative cyclization	MONOMERIC SARCOSINE OXIDASE; OXYGEN ACTIVATION; FLAVOPROTEIN OXIDASES; SITE; MECHANISM; BIOSYNTHESIS	Flavin-dependent enzymes catalyze many oxidations, including formation of ring structures in natural products. The gene cluster for biosynthesis of fumisoquins, secondary metabolites structurally related to isoquinolines, in the filamentous fungus Aspergillus fumigatus harbors a gene that encodes a flavoprotein of the amine oxidase family, termed fsqB (fumisoquin biosynthesis gene B). This enzyme catalyzes an oxidative ring closure reaction that leads to the formation of isoquinoline products. This reaction is reminiscent of the oxidative cyclization reported for berberine bridge enzyme and tetrahydrocannabinol synthase. Despite these similarities, amine oxidases and berberine bridge enzyme-like enzymes possess distinct structural properties, prompting us to investigate the structure-function relationships of FsqB. Here, we report the recombinant production and purification of FsqB, elucidation of its crystal structure, and kinetic analysis employing five putative substrates. The crystal structure at 2.6 angstrom resolution revealed that FsqB is a member of the amine oxidase family with a covalently bound FAD cofactor. N-methyl-dopa was the best substrate for FsqB and was completely converted to the cyclic isoquinoline product. The absence of the meta-hydroxyl group, as e.g. in l-N-methyl-tyrosine, resulted in a 25-fold lower rate of reduction and the formation of the demethylated product l-tyrosine, instead of a cyclic product. Surprisingly, FsqB did not accept the d-stereoisomer of N-methyltyrosine, in contrast to N-methyl-dopa, for which both stereoisomers were oxidized with similar rates. On the basis of the crystal structure and docking calculations, we postulate a substrate-dependent population of distinct binding modes that rationalizes stereospecific oxidation in the FsqB active site.	[Lahham, Majd; Niederhauser, Johannes; Chalhoub, Gabriel; Daniel, Bastian; Macheroux, Peter] Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria; [Pavkov-Keller, Tea; Gruber, Karl] Karl Franzens Univ Graz, Inst Mol Biosci, Humboldtstr 50, A-8010 Graz, Austria; [Fuchs, Michael; Kroutil, Wolfgang] Karl Franzens Univ Graz, Inst Chem, Heinrichstr 28-2, A-8010 Graz, Austria	Graz University of Technology; University of Graz; University of Graz	Macheroux, P (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	peter.macheroux@tugraz.at	Kroutil, Wolfgang/V-1155-2019; Gruber, Karl/GPP-6706-2022; Macheroux, Peter/AAB-5157-2019; Pavkov-Keller, Tea/K-9234-2015	Kroutil, Wolfgang/0000-0002-2151-6394; Gruber, Karl/0000-0002-3485-9740; Macheroux, Peter/0000-0002-0242-454X; Pavkov-Keller, Tea/0000-0001-7871-6680; Fuchs, Michael/0000-0001-6757-7638	Austrian Science Fund doctoral program "Molecular Enzymology" [W901, P28678]; Erasmus Mundus Action 2 Project Avempace + Fellowship Grant [2014-0659/001-001-EMA2]	Austrian Science Fund doctoral program "Molecular Enzymology"; Erasmus Mundus Action 2 Project Avempace + Fellowship Grant	This work was supported by Austrian Science Fund doctoral program "Molecular Enzymology" Grants W901 (to W.K., K.G., and P.M.) and P28678 (to K.G. and P.M.) and by Erasmus Mundus Action 2 Project Avempace + Fellowship Grant 2014-0659/001-001-EMA2 (to M.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2017, PHYS CHEM CHEM PHYS, V19, P9811, DOI 10.1039/c6cp08172j; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2018, SMALL MOL DRUG DISC; Augustin P, 2016, FEBS J, V283, P3587, DOI 10.1111/febs.13828; Baccile JA, 2016, NAT CHEM BIOL, V12, P419, DOI [10.1038/NCHEMBIO.2061, 10.1038/nchembio.2061]; Carrell CJ, 2007, STRUCTURE, V15, P928, DOI 10.1016/j.str.2007.06.010; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daniel B, 2017, ARCH BIOCHEM BIOPHYS, V632, P88, DOI 10.1016/j.abb.2017.06.023; DeLano W. L., 2018, THE PYMOL MOLECULAR; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzpatrick PF, 2010, ARCH BIOCHEM BIOPHYS, V493, P13, DOI 10.1016/j.abb.2009.07.019; Forneris F, 2009, FEBS J, V276, P4304, DOI 10.1111/j.1742-4658.2009.07142.x; Gadda G, 2012, BIOCHEMISTRY-US, V51, P2662, DOI 10.1021/bi300227d; Gan W., 2015, ACTA CRYSTALLOGR F, V71; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ilari A, 2008, PROTEINS, V71, P2065, DOI 10.1002/prot.21898; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karasulu B, 2015, ACS CATAL, V5, P1227, DOI 10.1021/cs501694q; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Kommoju PR, 2011, BIOCHEMISTRY-US, V50, P5521, DOI 10.1021/bi200388g; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Macheroux P, 1999, METH MOL B, V131, P1; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ravindranath PA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004586; Rigoldi F, 2016, PROTEINS, V84, P744, DOI 10.1002/prot.25015; Shoyama Y, 2012, J MOL BIOL, V423, P96, DOI 10.1016/j.jmb.2012.06.030; Trickey P, 1999, STRUCTURE, V7, P331, DOI 10.1016/S0969-2126(99)80043-4; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wagner MA, 2000, BIOCHEMISTRY-US, V39, P8813, DOI 10.1021/bi000349z; Wagner MA, 2000, BIOCHEMISTRY-US, V39, P8825, DOI 10.1021/bi000350y; Wagner MA, 1999, BIOCHEMISTRY-US, V38, P5588, DOI 10.1021/bi982955o; Winkler A, 2008, NAT CHEM BIOL, V4, P739, DOI 10.1038/nchembio.123; Wolfbeis OS, 2015, BIOESSAYS, V37, P921, DOI 10.1002/bies.201500002; Zhao GH, 2008, BIOCHEMISTRY-US, V47, P9124, DOI 10.1021/bi8008642	36	3	3	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17021	17032		10.1074/jbc.RA118.004227	http://dx.doi.org/10.1074/jbc.RA118.004227			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30194285	Green Published, hybrid			2022-12-26	WOS:000449466500006
J	Holliday, MJ; Ferrao, R; Boenig, GD; Estevez, A; Helgason, E; Rohou, A; Dueber, EC; Fairbrother, WJ				Holliday, Michael J.; Ferrao, Ryan; Boenig, Gladys de Leon; Estevez, Alberto; Helgason, Elizabeth; Rohou, Alexis; Dueber, Erin C.; Fairbrother, Wayne J.			Picomolar zinc binding modulates formation of Bcl10-nucleating assemblies of the caspase recruitment domain (CARD) of CARD9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); metal ion-protein interaction; oligomerization; protein dynamic; cell signaling; innate immunity; crystallography; electron microscopy (EM); structural biology; Bcl10; CARD9; cell signaling	TORSION ANGLE DYNAMICS; C-TYPE LECTIN; CROHNS-DISEASE; PROTEIN; CELL; CRYSTALLOGRAPHY; SUSCEPTIBILITY; RECOGNITION; HOMEOSTASIS; ASSIGNMENT	The caspase recruitment domain-containing protein 9 (CARD9)-B-cell lymphoma/leukemia 10 (Bcl10) signaling axis is activated in myeloid cells during the innate immune response to a variety of diverse pathogens. This signaling pathway requires a critical caspase recruitment domain (CARD)-CARD interaction between CARD9 and Bcl10 that promotes downstream activation of factors, including NF-B and the mitogen-activated protein kinase (MAPK) p38. Despite these insights, CARD9 remains structurally uncharacterized, and little mechanistic understanding of its regulation exists. We unexpectedly found here that the CARD in CARD9 binds to Zn2+ with picomolar affinitya concentration comparable with the levels of readily accessible Zn2+ in the cytosol. NMR solution structures of the CARD9-CARD in the apo and Zn2+-bound states revealed that Zn2+ has little effect on the ground-state structure of the CARD; yet the stability of the domain increased considerably upon Zn2+ binding, with a concomitant reduction in conformational flexibility. Moreover, Zn2+ binding inhibited polymerization of the CARD9-CARD into helical assemblies. Here, we also present a 20- resolution negative-stain EM (NS-EM) structure of these filamentous assemblies and show that they adopt a similar helical symmetry as reported previously for filaments of the Bcl10 CARD. Using both bulk assays and direct NS-EM visualization, we further show that the CARD9-CARD assemblies can directly template and thereby nucleate Bcl10 polymerization, a capacity considered critical to propagation of the CARD9-Bcl10 signaling cascade. Our findings indicate that CARD9 is a potential target of Zn2+-mediated signaling that affects Bcl10 polymerization in innate immune responses.	[Holliday, Michael J.; Helgason, Elizabeth; Dueber, Erin C.; Fairbrother, Wayne J.] Genentech Inc, Early Discovery Biochem Dept, 1 DNA Way, San Francisco, CA 94080 USA; [Ferrao, Ryan; Boenig, Gladys de Leon; Estevez, Alberto; Rohou, Alexis] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Ferrao, Ryan] Gilead Sci, Dept Struct Chem, Foster City, CA 94404 USA	Roche Holding; Genentech; Roche Holding; Genentech; Gilead Sciences	Dueber, EC; Fairbrother, WJ (corresponding author), Genentech Inc, Early Discovery Biochem Dept, 1 DNA Way, San Francisco, CA 94080 USA.	dueber.erin@gene.com; fairbrother.wayne@gene.com		Holliday, Michael/0000-0002-1112-9892; Estevez, Alberto/0000-0002-9141-5003; Rohou, Alexis/0000-0002-3343-9621				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ADEBODUN F, 1995, J CELL PHYSIOL, V163, P80, DOI 10.1002/jcp.1041630109; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Bafaro E, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.29; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Bozym RA, 2006, ACS CHEM BIOL, V1, P103, DOI 10.1021/cb500043a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; David L, 2018, P NATL ACAD SCI USA, V115, P1499, DOI 10.1073/pnas.1721967115; Desfosses A, 2014, J STRUCT BIOL, V185, P15, DOI 10.1016/j.jsb.2013.11.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haase H, 2008, J IMMUNOL, V181, P6491, DOI 10.4049/jimmunol.181.9.6491; Haase H, 2009, ANNU REV NUTR, V29, P133, DOI 10.1146/annurev-nutr-080508-141119; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hessels AM, 2015, ACS CHEM BIOL, V10, P2126, DOI 10.1021/acschembio.5b00211; Hojyo S, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/6762343; Hong SN, 2016, GUT, V65, P788, DOI 10.1136/gutjnl-2014-308617; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; IRVING H, 1953, J CHEM SOC, P3192, DOI 10.1039/jr9530003192; JEFFERSON JR, 1990, ANAL BIOCHEM, V187, P328, DOI 10.1016/0003-2697(90)90465-L; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Lanternier F, 2015, J ALLERGY CLIN IMMUN, V135, P1558, DOI 10.1016/j.jaci.2014.12.1930; Lanternier F, 2013, NEW ENGL J MED, V369, P1704, DOI 10.1056/NEJMoa1208487; Lee EJ, 2016, J IMMUNOL, V196, P3148, DOI 10.4049/jimmunol.1502355; Li Y, 2009, EXP CELL RES, V315, P2463, DOI 10.1016/j.yexcr.2009.05.016; Maret W, 2013, ADV NUTR, V4, P82, DOI 10.3945/an.112.003038; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McCranor BJ, 2014, METALLOMICS, V6, P1034, DOI 10.1039/c3mt00305a; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; PECK EJ, 1971, J BIOL CHEM, V246, P1160; Peterson MR, 2016, DRUG DES DEV THER, V10, P3799, DOI 10.2147/DDDT.S122508; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Qiao Q, 2013, MOL CELL, V51, P766, DOI 10.1016/j.molcel.2013.08.032; Qin Y, 2013, ACS CHEM BIOL, V8, P2366, DOI 10.1021/cb4003859; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rieber N, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89890; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Roth S, 2014, NAT IMMUNOL, V15, P538, DOI 10.1038/ni.2888; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; SENN H, 1989, FEBS LETT, V249, P113, DOI 10.1016/0014-5793(89)80027-4; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIMONS TJB, 1993, J BIOCHEM BIOPH METH, V27, P25, DOI 10.1016/0165-022X(93)90065-V; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang SD, 2017, J CELL MOL MED, V21, P1182, DOI 10.1111/jcmm.13050; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	60	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16803	16817		10.1074/jbc.RA118.004821	http://dx.doi.org/10.1074/jbc.RA118.004821			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30206119	hybrid, Green Published			2022-12-26	WOS:000448515100021
J	Sjogren, L; Floris, M; Barghetti, A; Vollmy, F; Linding, R; Brodersen, P				Sjoegren, Lars; Floris, Maina; Barghetti, Andrea; Voellmy, Franziska; Linding, Rune; Brodersen, Peter			Farnesylated heat shock protein 40 is a component of membrane-bound RISC in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; Argonaute; chaperone DnaJ (DnaJ); microRNA mechanism; membrane; ARGONAUTE; Chaperones; Protein farnesylation; Rough Endoplasmic Reticulum; Small RNA	REGULATES MICRORNA ACTIVITY; DISEASE RESISTANCE PROTEIN; ABSCISIC-ACID; ENDOPLASMIC-RETICULUM; MEVALONATE PATHWAY; RNA INTERFERENCE; MIRNA ACTIVITY; HSP90; ARGONAUTE; DROSOPHILA	ARGONAUTE1 (AGO1) binds directly to small regulatory RNA and is a key effector protein of post-transcriptional gene silencing mediated by microRNA (miRNA) and small interfering RNA (siRNA) in Arabidopsis. The formation of an RNA-induced silencing complex (RISC) of AGO1 and small RNA requires the function of the heat shock protein 70/90 chaperone system. Some functions of AGO1 occur in association with endomembranes, in particular the rough endoplasmic reticulum (RER), but proteins interacting with AGO1 in membrane fractions remain unidentified. In this study, we show that the farnesylated heat shock protein 40 homologs, J2 and J3, associate with AGO1 in membrane fractions in a manner that involves protein farnesylation. We also show that three changes in AGO1 function are detectable in mutants in protein farnesylation and J2/J3. First, perturbations of the HSP40/70/90 pathway by mutation of J3, HSP90, and farnesyl transferase affect the amounts of AGO1 associated with membranes. Second, miRNA association with membrane-bound polysomes is increased in farnesyl transferase and farnesylation-deficient J2/J3 mutants. Third, silencing by noncell autonomously acting short interfering RNAs is impaired. These observations highlight the involvement of farnesylated J2/J3 in small RNA-mediated gene regulation, and suggest that the importance of chaperone-AGO1 interaction is not limited to the RISC assembly process.	[Sjoegren, Lars; Floris, Maina; Barghetti, Andrea; Brodersen, Peter] Univ Copenhagen, Dept Biol, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark; [Voellmy, Franziska; Linding, Rune] Biotech Res & Innovat Ctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark; [Sjoegren, Lars] Lund Univ, Box 117, S-22100 Lund, Sweden	University of Copenhagen; Lund University	Brodersen, P (corresponding author), Univ Copenhagen, Dept Biol, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	pbrodersen@bio.ku.dk	Voellmy, Franziska/H-4939-2017; Brodersen, Peter/T-8818-2017	Voellmy, Franziska/0000-0002-0345-1910; Linding, Rune/0000-0003-0420-4839; Barghetti, Andrea/0000-0002-5805-9289; Brodersen, Peter/0000-0003-1083-1150				Alvira S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6484; Barghetti A, 2017, GENE DEV, V31, P2282, DOI 10.1101/gad.301242.117; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brodersen P, 2012, P NATL ACAD SCI USA, V109, P1778, DOI 10.1073/pnas.1112500109; CHOJNACKI T, 1988, BIOCHEM J, V251, P1; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crowell DN, 2009, TRENDS PLANT SCI, V14, P163, DOI 10.1016/j.tplants.2008.12.001; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; Derrien B, 2012, P NATL ACAD SCI USA, V109, P15942, DOI 10.1073/pnas.1209487109; Dufourc Erick J, 2008, J Chem Biol, V1, P63, DOI 10.1007/s12154-008-0010-6; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Dunoyer P, 2007, NAT GENET, V39, P848, DOI 10.1038/ng2081; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Flom GA, 2008, MOL BIOL CELL, V19, P5249, DOI 10.1091/mbc.E08-04-0435; Flores-Jasso CF, 2013, RNA, V19, P271, DOI 10.1261/rna.036921.112; Fu HW, 1999, RECENT PROG HORM RES, V54, P315; Ghosh S, 2015, MOL BIOL CELL, V26, P1072, DOI 10.1091/mbc.E14-11-1521; Gibbings D, 2012, NAT CELL BIOL, V14, P1314, DOI 10.1038/ncb2611; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Graaf MR, 2004, CANCER TREAT REV, V30, P609, DOI 10.1016/j.ctrv.2004.06.010; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Holt BF, 2005, SCIENCE, V309, P929, DOI 10.1126/science.1109977; Huang S, 2014, PLANT J, V79, P427, DOI 10.1111/tpj.12573; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Iki T, 2012, EMBO J, V31, P267, DOI 10.1038/emboj.2011.395; Iki T, 2010, MOL CELL, V39, P282, DOI 10.1016/j.molcel.2010.05.014; Iwasaki S, 2015, NATURE, V521, P533, DOI 10.1038/nature14254; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Johnson CD, 2005, PLANT PHYSIOL, V139, P722, DOI 10.1104/pp.105.065045; Kanazawa M, 1997, J BIOCHEM-TOKYO, V121, P890; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lecampion C, 2016, JOVE-J VIS EXP, DOI 10.3791/54231; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Li SB, 2016, ELIFE, V5, DOI 10.7554/eLife.22750; Li SB, 2013, CELL, V153, P562, DOI 10.1016/j.cell.2013.04.005; Li ST, 2014, P NATL ACAD SCI USA, V111, P6970, DOI 10.1073/pnas.1322545111; LORD JM, 1987, METHOD ENZYMOL, V148, P576; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martinez NJ, 2013, RNA, V19, P1583, DOI 10.1261/rna.040790.113; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Miyoshi T, 2010, NAT STRUCT MOL BIOL, V17, P1024, DOI 10.1038/nsmb.1875; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Pontier D, 2012, MOL CELL, V48, P121, DOI 10.1016/j.molcel.2012.07.027; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Sahoo MR, 2017, EMBO REP, V18, P241, DOI 10.15252/embr.201642386; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Shi Z, 2012, P NATL ACAD SCI USA, V109, P4568, DOI 10.1073/pnas.1202421109; Sjogren LLE, 2004, PLANT PHYSIOL, V136, P4114, DOI 10.1104/pp.104.053835; Smibert P, 2013, NAT STRUCT MOL BIOL, V20, P789, DOI 10.1038/nsmb.2606; Smith MR, 2009, P NATL ACAD SCI USA, V106, P5424, DOI 10.1073/pnas.0812729106; Stalder L, 2013, EMBO J, V32, P1115, DOI 10.1038/emboj.2013.52; Stempfle D, 2010, MOL CELL BIOL, V30, P3165, DOI 10.1128/MCB.00030-10; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; Tahbaz N, 2001, J BIOL CHEM, V276, P43294, DOI 10.1074/jbc.M107808200; TRUERNIT E, 1995, PLANTA, V196, P564, DOI 10.1007/BF00203657; Tsuboyama K, 2018, MOL CELL, V70, P722, DOI 10.1016/j.molcel.2018.04.010; Vasquez-Rifo A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003961; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vranova E, 2013, ANNU REV PLANT BIOL, V64, P665, DOI 10.1146/annurev-arplant-050312-120116; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Yang L, 2012, P NATL ACAD SCI USA, V109, P315, DOI 10.1073/pnas.1114673109; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhang JF, 2008, PLANT CELL ENVIRON, V31, P562, DOI 10.1111/j.1365-3040.2008.01786.x	77	9	10	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16608	16622		10.1074/jbc.RA118.003887	http://dx.doi.org/10.1074/jbc.RA118.003887			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30194279	Green Published, hybrid			2022-12-26	WOS:000448515100006
J	Yao, QY; Liu, J; Zhang, ZH; Li, F; Zhang, C; Lai, BC; Xiao, L; Wang, NP				Yao, Qinyu; Liu, Jia; Zhang, Zihui; Li, Fan; Zhang, Chao; Lai, Baochang; Xiao, Lei; Wang, Nanping			Peroxisome proliferator-activated receptor (PPAR gamma) induces the gene expression of integrin (V5) to promote macrophage M2 polarization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						integrin; peroxisome proliferator-activated receptor (PPAR); gene regulation; protein-protein interaction; inflammation; integrin alpha V; integrin beta 5; macrophage polarization	CELLS; ACID	Peroxisome proliferator-activated receptor (PPAR) is a member of the nuclear receptor superfamily and polarizes the macrophages into an anti-inflammatory M2 state. Integrins are transmembrane receptors that drive various cellular functions, including monocyte adhesion and foam cell formation. In this study, we first reported that the expression of integrins (V) and (5) was up-regulated by PPAR activation in RAW264.7 cells and human peripheral blood monocytes. Luciferase reporter and ChIP assay revealed that PPAR directly bound to the potential PPAR-responsive elements sites in the 5-flanking regions of both murine and human integrin (V) and (5) genes, respectively. In addition, we showed that PPAR augmented the ligation of integrins (V) and (5). Knockdown of integrin (V5) by siRNA strategy or treatment with cilengitide, a potent inhibitor of integrin (V5), attenuated PPAR-induced expression of Ym1 (chitinase-like protein 3), Arg1 (Arginase1), Fizz1 (resistin-like molecule RELM), and other M2 marker genes, suggesting that the heterodimers of integrin (V5) were involved in PPAR-induced M2 polarization. In conclusion, these results provided novel evidence that PPAR-mediated gene expression and the ensuing ligation of integrins (V) and (5) are implicated in macrophage M2 polarization.	[Yao, Qinyu; Liu, Jia; Zhang, Zihui; Li, Fan; Zhang, Chao; Lai, Baochang; Xiao, Lei] Xi An Jiao Tong Univ, Sch Basic Med Sci, Cardiovasc Res Ctr, Xian 710061, Shaanxi, Peoples R China; [Wang, Nanping] Dalian Med Univ, Adv Inst Med Sci, Dalian 116044, Peoples R China	Xi'an Jiaotong University; Dalian Medical University	Wang, NP (corresponding author), Dalian Med Univ, Adv Inst Med Sci, Dalian 116044, Peoples R China.	nanpingwang2003@yahoo.com						Antonov AS, 2004, AM J PATHOL, V165, P247, DOI 10.1016/S0002-9440(10)63293-2; Aziz MH, 2017, J IMMUNOL, V198, P4855, DOI 10.4049/jimmunol.1602175; Bermudez B, 2017, ARTERIOSCL THROM VAS, V37, P1157, DOI 10.1161/ATVBAHA.116.308187; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Chen Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep30322; Chung KJ, 2017, NAT IMMUNOL, V18, P654, DOI 10.1038/ni.3728; Cory TJ, 2014, J CYST FIBROS, V13, P164, DOI 10.1016/j.jcf.2013.08.007; Covarrubias AJ, 2015, SEMIN IMMUNOL, V27, P286, DOI 10.1016/j.smim.2015.08.001; Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394; Fang L, 2016, PPAR RES, V2016, DOI 10.1155/2016/6042162; Ge Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep40253; Gliem M, 2015, STROKE, V46, P2935, DOI 10.1161/STROKEAHA.115.010557; Guo XH, 2017, J BIOL CHEM, V292, P14003, DOI 10.1074/jbc.M117.802066; Guri AJ, 2008, J NUTR BIOCHEM, V19, P216, DOI 10.1016/j.jnutbio.2007.02.010; Halabi CM, 2008, CELL METAB, V7, P215, DOI 10.1016/j.cmet.2007.12.008; HOSHIGA M, 1995, CIRC RES, V77, P1129, DOI 10.1161/01.RES.77.6.1129; Kahn CR, 2000, J CLIN INVEST, V106, P1305, DOI 10.1172/JCI11705; Ketsawatsomkron P, 2010, J BIOL CHEM, V285, P9311, DOI 10.1074/jbc.R109.025031; Kim KH, 2015, J CLIN INVEST, V125, P1886, DOI 10.1172/JCI79327; Kobori T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00334; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee J, 2016, NAT MATER, V15, P856, DOI [10.1038/NMAT4610, 10.1038/nmat4610]; Mccall-Culbreath KD, 2008, BLOOD, V111, P3562, DOI 10.1182/blood-2007-08-107664; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Park YK, 2016, NAT REV NEUROSCI, V17, P745, DOI 10.1038/nrn.2016.138; Pello OM, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1151991; Ploeger DTA, 2012, IMMUNOBIOLOGY, V217, P299, DOI 10.1016/j.imbio.2011.10.007; Rahal OM, 2018, INT J RADIAT ONCOL, V100, P1034, DOI 10.1016/j.ijrobp.2017.11.043; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rotty JD, 2017, DEV CELL, V42, P498, DOI 10.1016/j.devcel.2017.08.003; Schittenhelm L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01866; St-Pierre J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006592; Steiger S, 2017, J IMMUNOL, V199, P1440, DOI 10.4049/jimmunol.1601982; Su XM, 2016, CANCER RES, V76, P3484, DOI 10.1158/0008-5472.CAN-15-2663; Tian JW, 2010, HYPERTENSION, V56, P129, DOI 10.1161/HYPERTENSIONAHA.110.150375; Vergadi E, 2017, J IMMUNOL, V198, P1006, DOI 10.4049/jimmunol.1601515; Vitillo L, 2017, CURR STEM CELL REP, V3, P358, DOI 10.1007/s40778-017-0100-x; Wang DK, 2018, KIDNEY INT, V94, P91, DOI 10.1016/j.kint.2017.12.025; Xiao L, 2016, MOL IMMUNOL, V80, P17, DOI 10.1016/j.molimm.2016.10.006; Zandi S, 2015, CELL REP, V10, P1173, DOI 10.1016/j.celrep.2015.01.050; Zhang LP, 2012, J BIOL CHEM, V287, P6177, DOI 10.1074/jbc.M111.292649	43	38	44	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16572	16582		10.1074/jbc.RA118.003161	http://dx.doi.org/10.1074/jbc.RA118.003161			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30181212	hybrid, Green Published			2022-12-26	WOS:000448515100003
J	Vashist, A; Malhotra, V; Sharma, G; Tyagi, JS; Clark-Curtiss, JE				Vashist, Atul; Malhotra, Vandana; Sharma, Gunjan; Tyagi, Jaya Sivaswami; Clark-Curtiss, Josephine E.			Interplay of PhoP and DevR response regulators defines expression of the dormancy regulon in virulent Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; bacterial signal transduction; gene expression; protein-protein interaction; protein-DNA interaction; DevR; DosR; dormancy regulon; negative regulation; PhoP; two-component system	DNA-BINDING DOMAIN; 2-COMPONENT SYSTEM; ESCHERICHIA-COLI; HYPOXIC RESPONSE; CARBON-MONOXIDE; DOSR; TRANSCRIPTION; OPERON; SENSOR; GENE	The DevR response regulator of Mycobacterium tuberculosis is an established regulator of the dormancy response in mycobacteria and can also be activated during aerobic growth conditions in avirulent strains, suggesting a complex regulatory system. Previously, we reported culture medium-specific aerobic induction of the DevR regulon genes in avirulent M. tuberculosis H37Ra that was absent in the virulent H37Rv strain. To understand the underlying basis of this differential response, we have investigated aerobic expression of the Rv3134c-devR-devS operon using M. tuberculosis H37Ra and H37Rv devR overexpression strains, designated as LIX48 and LIX50, respectively. Overexpression of DevR led to the up-regulation of a large number of DevR regulon genes in aerobic cultures of LIX48, but not in LIX50. To ascertain the involvement of PhoP response regulator, also known to co-regulate a subset of DevR regulon genes, we complemented the naturally occurring mutant phoP(Ra) gene of LIX48 with the WT phoP(Rv) gene. PhoP(Rv) dampened the induced expression of the DevR regulon by >70-80%, implicating PhoP in the negative regulation of devR expression. Electrophoretic mobility shift assays confirmed phosphorylation-independent binding of PhoP(Rv) to the Rv3134c promoter and further revealed that DevR and PhoP(Rv) proteins exhibit differential DNA binding properties to the target DNA. Through co-incubations with DNA, ELISA, and protein complementation assays, we demonstrate that DevR forms a heterodimer with PhoP(Rv) but not with the mutant PhoP(Ra) protein. The study puts forward a new possible mechanism for coordinated expression of the dormancy regulon, having implications in growth adaptations critical for development of latency.	[Malhotra, Vandana] Univ Delhi, Sri Venkateswara Coll, Dept Biochem, New Delhi 110021, India; [Malhotra, Vandana; Clark-Curtiss, Josephine E.] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA; [Clark-Curtiss, Josephine E.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Vashist, Atul; Sharma, Gunjan; Tyagi, Jaya Sivaswami] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Clark-Curtiss, Josephine E.] Univ Florida, Coll Med, Dept Med, Div Infect Dis & Global Med, Gainesville, FL 32610 USA	University of Delhi; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; All India Institute of Medical Sciences (AIIMS) New Delhi; State University System of Florida; University of Florida	Malhotra, V (corresponding author), Univ Delhi, Sri Venkateswara Coll, Dept Biochem, New Delhi 110021, India.	vmal71@gmail.com	Vashist, Atul/AAX-6219-2021	Vashist, Atul/0000-0002-2843-1166; Sharma, Gunjan/0000-0003-3110-9239	Department of Science and Technology, Government of India, Start-Up Research Grant [YSS/2015/000562/LS]; Department of Biotechnology, Government of India [BT/Bio-CARe/07/9843]; Department of Science and Technology, Government of India, J. C. Bose National Fellowship; National Institutes of Health Public Health Service Grant [AI46428]; Arizona State University start-up funding	Department of Science and Technology, Government of India, Start-Up Research Grant; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India, J. C. Bose National Fellowship; National Institutes of Health Public Health Service Grant; Arizona State University start-up funding	Supported by Department of Science and Technology, Government of India, Start-Up Research Grant YSS/2015/000562/LS.; Supported by Department of Biotechnology, Government of India, Grant BT/Bio-CARe/07/9843.; Supported by the Department of Science and Technology, Government of India, J. C. Bose National Fellowship.; Supported by National Institutes of Health Public Health Service Grant AI46428 and Arizona State University start-up funding.	Al-Bassam MM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004554; Flores-Valdez MA, 2015, ANN MICROBIOL, V65, P713, DOI 10.1007/s13213-014-0910-3; Bae HJ, 2017, MOL CELLS, V40, P632, DOI 10.14348/molcells.2017.0076; Bagchi G, 2005, MICROBIOL-SGM, V151, P4045, DOI 10.1099/mic.0.28333-0; Bansal R, 2017, MOL MICROBIOL, V104, P400, DOI 10.1111/mmi.13635; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Boon C, 2012, FUTURE MICROBIOL, V7, P513, DOI [10.2217/fmb.12.14, 10.2217/FMB.12.14]; Bretl DJ, 2012, INFECT IMMUN, V80, P3018, DOI 10.1128/IAI.00520-12; Chao JD, 2010, J BIOL CHEM, V285, P29239, DOI 10.1074/jbc.M110.132894; Chauhan S, 2008, J BACTERIOL, V190, P4301, DOI 10.1128/JB.01308-07; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Chen YH, 2003, J BACTERIOL, V185, P262, DOI 10.1128/JB.185.1.262-273.2003; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Das AK, 2010, J MOL BIOL, V398, P647, DOI 10.1016/j.jmb.2010.03.056; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; De Majumdar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009448; Domenech P, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00696-16; Fallow A, 2010, J BACTERIOL, V192, P2228, DOI 10.1128/JB.01597-09; Fol M, 2006, MOL MICROBIOL, V60, P643, DOI 10.1111/j.1365-2958.2006.05137.x; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Gao R, 2008, MOL MICROBIOL, V69, P1358, DOI 10.1111/j.1365-2958.2008.06355.x; Gautam US, 2015, AM J RESP CELL MOL, V52, P708, DOI 10.1165/rcmb.2014-0230OC; Gautam US, 2014, J BACTERIOL, V196, P790, DOI 10.1128/JB.01270-13; Gonzalo-Asensio J, 2014, P NATL ACAD SCI USA, V111, P11491, DOI 10.1073/pnas.1406693111; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; He HJ, 2011, J BACTERIOL, V193, P5105, DOI 10.1128/JB.05562-11; Kaur K., 2011, THESIS; KINGER AK, 1993, GENE, V131, P113, DOI 10.1016/0378-1119(93)90678-V; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Majumdar SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035847; Malhotra V, 2004, FEMS MICROBIOL LETT, V231, P237, DOI 10.1016/S0378-1097(04)00002-3; Malhotra V, 2015, J BIOL CHEM, V290, P8294, DOI 10.1074/jbc.M114.591800; Malhotra V, 2009, TUBERCULOSIS, V89, P169, DOI 10.1016/j.tube.2008.12.003; Mehra S, 2015, AM J RESP CRIT CARE, V191, P1185, DOI 10.1164/rccm.201408-1502OC; Minch K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035935; Pannen D, 2016, J BIOL CHEM, V291, P2357, DOI 10.1074/jbc.M115.696815; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Saini DK, 2004, FEBS LETT, V565, P75, DOI 10.1016/j.febslet.2004.02.092; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Salscheider SL, 2014, NUCLEIC ACIDS RES, V42, P2999, DOI 10.1093/nar/gkt1298; Sharma S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160723; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Sikri K, 2015, MICROBIOL-SGM, V161, P739, DOI 10.1099/mic.0.000049; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; Sinha A, 2008, J BACTERIOL, V190, P1317, DOI 10.1128/JB.01074-07; Sun RG, 2004, MOL MICROBIOL, V52, P25, DOI 10.1111/j.1365-2958.2003.03958.x; Taneja NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010860; Vashist A, 2016, FEBS J, V283, P1286, DOI 10.1111/febs.13664; Voskuil Martin I., 2009, P119; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wang S, 2007, BIOCHEMISTRY-US, V46, P14751, DOI 10.1021/bi700970a; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	57	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16413	16425		10.1074/jbc.RA118.004331	http://dx.doi.org/10.1074/jbc.RA118.004331			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30181216	Green Published, hybrid			2022-12-26	WOS:000447833600024
J	Macdonald, EA; Cushman, SA; Landguth, EL; Hearn, AJ; Malhi, Y; Macdonald, DW				Macdonald, Ewan A.; Cushman, Samuel A.; Landguth, Erin L.; Hearn, Andrew J.; Malhi, Yadvinder; Macdonald, David W.			Simulating impacts of rapid forest loss on population size, connectivity and genetic diversity of Sunda clouded leopards (Neofelis diardi) in Borneo	PLOS ONE			English	Article							EXPERT-OPINION; LANDSCAPE CONNECTIVITY; DISPERSAL DISTANCE; MARTES-AMERICANA; CLIMATE-CHANGE; CONSERVATION; FRAGMENTATION; ECOLOGY; MODELS; AMPHIBIANS	Habitat loss is the greatest threat to biodiversity in Borneo, and to anticipate and combat its effects it is important to predict the pattern of loss and its consequences. Borneo is a region of extremely high biodiversity from which forest is being lost faster than in any other. The little-known Sunda clouded leopard (Neofelis diardi) is the top predator in Borneo and is likely to depend critically on habitat connectivity that is currently being rapidly lost to deforestation. We modeled the effects of landscape fragmentation on population size, genetic diversity and population connectivity for the Sunda clouded leopard across the entirety of Borneo. We modelled the impacts of land use change between the years 2000, 2010 and projected forwards to 2020. We found substantial reductions across all metrics between 2000 and 2010: the proportion of landscape connected by dispersal fell by approximately 12.5% and the largest patch size declined by around 15.1%, leading to a predicted 11.4% decline in clouded leopard numbers. We also predict that these trends will accelerate greatly towards 2020, with the percentage of the landscape being connected by dispersal falling by about 57.8%, the largest patch size falling by around 62.8% and the predicted clouded leopard population falling by 62.5% between 2010 and 2020. We predicted that these large declines in clouded leopard population size and connectivity will also substantially reduce the genetic diversity of the remaining clouded leopard population.	[Macdonald, Ewan A.; Malhi, Yadvinder] Univ Oxford, Sch Geog & Environm, Environm Change Inst, Oxford, England; [Macdonald, Ewan A.; Hearn, Andrew J.; Macdonald, David W.] Univ Oxford, Zool Dept, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Abingdon, Oxon, England; [Cushman, Samuel A.] US Forest Serv, Rocky Mt Res Stn, Flagstaff, AZ USA; [Landguth, Erin L.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Oxford; University of Oxford; United States Department of Agriculture (USDA); United States Forest Service; University of Montana System; University of Montana	Macdonald, EA (corresponding author), Univ Oxford, Sch Geog & Environm, Environm Change Inst, Oxford, England.; Macdonald, EA (corresponding author), Univ Oxford, Zool Dept, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Abingdon, Oxon, England.	ewan.macdonald@zoo.ox.ac.uk	Landguth, Erin/ABB-8941-2020	Macdonald, Ewan A/0000-0002-6420-9255	Robertson Foundation; Recanati-Kaplan Foundation; Epply Foundation; Woodspring Trust; US Forest Service, Rocky Mountain Research Station	Robertson Foundation; Recanati-Kaplan Foundation; Epply Foundation; Woodspring Trust; US Forest Service, Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service)	This work was funded by grants to D.W.M. by the Robertson Foundation and the Recanati-Kaplan Foundation; E.A.M. is a Kaplan Scholar and supported by the Epply Foundation and Woodspring Trust. S.A.C. was supported by the US Forest Service, Rocky Mountain Research Station during this work.	[Anonymous], 2012, SCIENCE, DOI DOI 10.1126/science.1215904; Austin Sean C., 2007, Acta Zoologica Sinica, V53, P1; Baguette M, 2013, BIOL REV, V88, P310, DOI 10.1111/brv.12000; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Bennett A. F., 1999, LINKAGES LANDSCAPE R; Bowman J, 2002, ECOLOGY, V83, P2049, DOI 10.2307/3071786; Brodie J, 2012, ORYX, V46, P427, DOI 10.1017/S0030605312000087; Brodie JF, 2015, CONSERV BIOL, V29, P122, DOI 10.1111/cobi.12337; Bull RAS, 2011, MOL ECOL, V20, P1092, DOI 10.1111/j.1365-294X.2010.04944.x; Burgman M, 2011, CONSERV LETT, V4, P81, DOI 10.1111/j.1755-263X.2011.00165.x; Castillo JA, 2014, MOL ECOL, V23, P843, DOI 10.1111/mec.12650; Cheyne SM, 2013, ENDANGER SPECIES RES, V22, P1, DOI 10.3354/esr00525; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Compton BW, 2007, CONSERV BIOL, V21, P788, DOI 10.1111/j.1523-1739.2007.00674.x; Cushman S, 2012, ECOLOGICAL ASS DISPE; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Cushman SA, KEY TOPICS CONSERVAT; Cushman SA, 2013, EVALUATING INTERSECT; Cushman SA, LANDSCAPE ECOL; Cushman Samuel A., 2014, Diversity-Basel, V6, P844; Cushman SA, 2013, BIODIVERS CONSERV, V22, P2583, DOI 10.1007/s10531-013-0541-1; Cushman SA, 2012, DIVERS DISTRIB, V18, P873, DOI 10.1111/j.1472-4642.2012.00895.x; Cushman SA, 2012, ECOL MODEL, V231, P101, DOI 10.1016/j.ecolmodel.2012.02.011; Cushman SA, 2012, LANDSCAPE ECOL, V27, P369, DOI 10.1007/s10980-011-9693-0; Cushman SA, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P349, DOI 10.1007/978-4-431-87771-4_19; Cushman SA, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P369, DOI 10.1007/978-4-431-87771-4_20; Cushman SA, 2010, LANDSCAPE ECOL, V25, P967, DOI 10.1007/s10980-010-9467-0; Cushman SA, 2009, CONSERV BIOL, V23, P368, DOI 10.1111/j.1523-1739.2008.01111.x; Elliot NB, 2014, ECOLOGY, V95, P2860, DOI 10.1890/13-1793.1; Epperson BK, 2010, MOL ECOL, V19, P3549, DOI 10.1111/j.1365-294X.2010.04678.x; Evans JS, 2009, LANDSCAPE ECOL, V24, P673, DOI 10.1007/s10980-009-9341-0; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Gaveau DLA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101654; Grassman LI, 2005, J MAMMAL, V86, P29, DOI 10.1644/1545-1542(2005)086&lt;0029:EOTSFI&gt;2.0.CO;2; Hand BK, 2014, BIODIVERS CONSERV, V23, P2761, DOI 10.1007/s10531-014-0747-x; Hearn A., 2015, IUCN RED LIST THREAT, pe.T136603A97212874; Hearn AJ, 2013, RAFFLES B ZOOL, V61, P871; Kabir M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187027; Khosravi R, 2018, DIVERS DISTRIB, V24, P193, DOI 10.1111/ddi.12672; Kuhnert PM, 2011, ENVIRONMETRICS, V22, P662, DOI 10.1002/env.1115; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Landguth EL, 2010, MOL ECOL RESOUR, V10, P156, DOI 10.1111/j.1755-0998.2009.02719.x; Macdonald DW, 2012, FOLIA PRIMATOL, V83, P171, DOI 10.1159/000342399; Macdonald EA, 2017, GLOB ECOL CONSERV, V12, P204, DOI 10.1016/j.gecco.2017.11.006; Macdonald EA, 2015, GLOB ECOL CONSERV, V3, P851, DOI 10.1016/j.gecco.2015.04.006; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; Mateo-Sanchez MC, 2015, LANDSCAPE ECOL, V30, P1405, DOI 10.1007/s10980-015-0194-4; McGarigal K., 2012, TECH REP; Miettinen J, 2012, REMOTE SENS LETT, V3, P11, DOI 10.1080/01431161.2010.526971; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Noon BR, 2009, MULTISPECIES CONSERV, DOI [10.1111/j.1523-1739.2008.00942.x, DOI 10.1111/J.1523-1739.2008.00942.X]; Pielke RA, 2002, PHILOS T ROY SOC A, V360, P1705, DOI 10.1098/rsta.2002.1027; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Rabinowitz A., 1987, Oryx, V6, P107; Reed GC, 2017, ANIM CONSERV, V20, P308, DOI 10.1111/acv.12325; Rudnick, 2012, ISSUES ECOLOGY, P16; SANTIAPILLAI C, 1988, Oryx, V22, P44; Selous E. M., 1935, Sarawak Museum Journal, V4, P263; Seoane J, 2005, CONSERV BIOL, V19, P512, DOI 10.1111/j.1523-1739.2005.00364.x; Shirk AJ, 2011, MOL ECOL RESOUR, V11, P922, DOI 10.1111/j.1755-0998.2011.03035.x; Shirk AJ, 2010, MOL ECOL, V19, P3603, DOI 10.1111/j.1365-294X.2010.04745.x; Shirk AJ, 2014, FRONTIERS ECOLOGY EV, P2; Shirk AJ, 2015, LANDSCAPE ECOL, V30, P1837, DOI 10.1007/s10980-015-0214-4; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Siegel S, 1988, NONPARAMETRIC STAT B, V2; van der Werf GR, 2009, NATURE GEOSCIENCE, P2; Wasserman TN, 2012, LANDSCAPE ECOL, V27, P211, DOI 10.1007/s10980-011-9653-8; Wasserman TN, 2010, LANDSCAPE ECOL, V25, P1601, DOI 10.1007/s10980-010-9525-7; Whitmee S, 2013, J ANIM ECOL, V82, P211, DOI 10.1111/j.1365-2656.2012.02030.x; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0; [No title captured], DOI DOI 10.1111/j.1600-0587.2011.07149.x	72	19	19	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2018	13	9							e0196974	10.1371/journal.pone.0196974	http://dx.doi.org/10.1371/journal.pone.0196974			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7EB	30208031	Green Published, gold, Green Submitted			2022-12-26	WOS:000444683000001
J	MUckl, A; Schwarz-Schilling, M; Fischer, K; Simmel, FC				Muckl, Andrea; Schwarz-Schilling, Matthaeus; Fischer, Katrin; Simmel, Friedrich C.			Filamentation and restoration of normal growth in Escherichia coli using a combined CRISPRi sgRNA/antisense RNA approach	PLOS ONE			English	Article							CELL-DIVISION; PLASMID REPLICATION; FLOW-CYTOMETRY; RING STRUCTURE; FTSZ; DYNAMICS; GENE; TRANSCRIPTION; BINDING; EXPRESSION	CRISPR interference (CRISPRi) using dCas9-sgRNA is a powerful tool for the exploration and manipulation of gene functions. Here we quantify the reversible switching of a central process of the bacterial cell cycle by CRISPRi and an antisense RNA mechanism. Reversible induction of filamentous growth in E. coli has been recently demonstrated by controlling the expression levels of the bacterial cell division proteins FtsZ/FtsA via CRISPRi. If FtsZ falls below a critical level, cells cannot divide. However, the cells remain metabolically active and continue with DNA replication. We surmised that this makes them amenable to an inducible antisense RNA strategy to counteract FtsZ inhibition. We show that both static and inducible thresholds can adjust the characteristics of the switching process. Combining bulk data with single cell measurements, we characterize the efficiency of the switching process. Successful restoration of division is found to occur faster in the presence of antisense sgRNAs than upon simple termination of CRISPRi induction.	[Muckl, Andrea; Schwarz-Schilling, Matthaeus; Fischer, Katrin; Simmel, Friedrich C.] Tech Univ Munich, Phys Dept, Garching, Bavaria, Germany; [Simmel, Friedrich C.] Nanosyst Initiat Munich, Munich, Bavaria, Germany	Technical University of Munich	Simmel, FC (corresponding author), Tech Univ Munich, Phys Dept, Garching, Bavaria, Germany.; Simmel, FC (corresponding author), Nanosyst Initiat Munich, Munich, Bavaria, Germany.	simmel@tum.de	Simmel, Friedrich/G-3281-2010	Simmel, Friedrich/0000-0003-3829-3446	Bundesministerium fur Bildung und Forschung - Erasynbio project [UNACS - 031L0011]; Deutsche Forschungsgemeinschaft - Research Training Group 2062	Bundesministerium fur Bildung und Forschung - Erasynbio project; Deutsche Forschungsgemeinschaft - Research Training Group 2062	This work is supported by: 1. Bundesministerium fur Bildung und Forschung - Erasynbio project UNACS - 031L0011 (FCS), http://www.bmbf.de, https://www.erasynbio.eu/; 2. Deutsche Forschungsgemeinschaft - Research Training Group 2062 (FCS), http://www.dfg.de, http://www.grk2062.uni-muenchen.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinall SG, 1997, J BACTERIOL, V179, P4277, DOI 10.1128/jb.179.13.4277-4284.1997; Addinall SG, 1996, J BACTERIOL, V178, P3877, DOI 10.1128/jb.178.13.3877-3884.1996; ALDEA M, 1990, EMBO J, V9, P3787, DOI 10.1002/j.1460-2075.1990.tb07592.x; Athale CA, 2011, BIOINFORMATICS, V27, P2944, DOI 10.1093/bioinformatics/btr501; BEGG KJ, 1985, J BACTERIOL, V163, P615, DOI 10.1128/JB.163.2.615-622.1985; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BOYE E, 1983, J GEN MICROBIOL, V129, P973; Boyle EA, 2017, P NATL ACAD SCI USA, V114, P5461, DOI 10.1073/pnas.1700557114; Cho S, 2018, ACS SYNTH BIOL, V7, P1085, DOI 10.1021/acssynbio.7b00462; DAI K, 1991, J BACTERIOL, V173, P3500, DOI 10.1128/jb.173.11.3500-3506.1991; DAI K, 1992, J BACTERIOL, V174, P6145, DOI 10.1128/JB.174.19.6145-6151.1992; den Blaauwen T, 2017, CURR OPIN MICROBIOL, V36, P85, DOI 10.1016/j.mib.2017.01.007; Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d; Du SS, 2017, MOL MICROBIOL, V105, P177, DOI 10.1111/mmi.13696; Elhadi D, 2016, METAB ENG, V38, P358, DOI 10.1016/j.ymben.2016.09.001; Flardh K, 1998, MOL MICROBIOL, V30, P305, DOI 10.1046/j.1365-2958.1998.01064.x; GANT VA, 1993, J MED MICROBIOL, V39, P147, DOI 10.1099/00222615-39-2-147; Gottfredsson M, 1998, ANTIMICROB AGENTS CH, V42, P1005, DOI 10.1128/AAC.42.5.1005; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Lee YJ, 2016, NUCLEIC ACIDS RES, V44, P2462, DOI 10.1093/nar/gkw056; Li XT, 2016, SCI REP-UK, V6, DOI 10.1038/srep39076; LUTKENHAUS JF, 1980, J BACTERIOL, V142, P615, DOI 10.1128/JB.142.2.615-620.1980; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Potvin-Trottier L, 2016, NATURE, V538, P514, DOI 10.1038/nature19841; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramalho T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145829; RICARD M, 1973, J BACTERIOL, V116, P314, DOI 10.1128/JB.116.1.314-322.1973; Robertson BR, 1998, APPL ENVIRON MICROB, V64, P3900; Sanchez-Gorostiaga A, 2016, MBIO, V7, DOI 10.1128/mBio.01620-16; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Soderstrom B, 2014, MOL MICROBIOL, V92, P1, DOI 10.1111/mmi.12534; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; STUEBER D, 1982, EMBO J, V1, P1399, DOI 10.1002/j.1460-2075.1982.tb01329.x; Sun ZZ, 2013, JOVE-J VIS EXP, DOI 10.3791/50762; Szwedziak P, 2014, ELIFE, V3, DOI 10.7554/eLife.04601; Takahashi MK, 2015, ACS SYNTH BIOL, V4, P503, DOI 10.1021/sb400206c; TOMIZAWA J, 1986, CELL, V47, P89, DOI 10.1016/0092-8674(86)90369-7; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Vigouroux A, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20177899; WARD JE, 1985, CELL, V42, P941, DOI 10.1016/0092-8674(85)90290-9; Wehrens M, 2018, CURR BIOL, V28, P972, DOI 10.1016/j.cub.2018.02.006; Wickens HJ, 2000, ANTIMICROB AGENTS CH, V44, P682, DOI 10.1128/AAC.44.3.682-687.2000; Yu XC, 1999, MOL MICROBIOL, V32, P315, DOI 10.1046/j.1365-2958.1999.01351.x; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zheng H, 2016, P NATL ACAD SCI USA, V113, P15000, DOI 10.1073/pnas.1617932114; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	47	17	17	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0198058	10.1371/journal.pone.0198058	http://dx.doi.org/10.1371/journal.pone.0198058			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204770	gold, Green Published, Green Submitted			2022-12-26	WOS:000444355500001
J	Temprana, CF; Arguelles, MH; Gutierrez, NM; Barril, PA; Esteban, LE; Silvestre, D; Mandile, MG; Glikmann, G; Castello, AA				Facundo Temprana, C.; Arguelles, Marcelo H.; Gutierrez, Nicolas M.; Barril, Patricia A.; Esteban, Laura E.; Silvestre, Dalila; Mandile, Marcelo G.; Glikmann, Graciela; Castello, Alejandro A.			Rotavirus VP6 protein mucosally delivered by cell wall-derived particles from Lactococcus lactis induces protection against infection in a murine model	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; GROUP-A ROTAVIRUS; INTRANASAL IMMUNIZATION; ORAL IMMUNIZATION; PRECLINICAL EVALUATION; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; BUENOS-AIRES; ETEC VACCINE; LIVE VECTOR	Rotaviruses are the primary cause of acute gastroenteritis in children worldwide. Although the implementation of live attenuated vaccines has reduced the number of rotavirus-associated deaths, variance in their effectiveness has been reported in different countries. This fact, among other concerns, leads to continuous efforts for the development of new generation of vaccines against rotavirus. In this work, we describe the obtention of cell wall-derived particles from a recombinant Lactococcus lactis expressing a cell wall-anchored version of the rotavirus VP6 protein. After confirming by SDS-PAGE, Western blot, flow cytometry and electronic immunomicroscopy that these particles were carrying the VP6 protein, their immunogenic potential was evaluated in adult BALB/c mice. For that, mucosal immunizations (oral or intranasal), with or without the dmLT [(double mutant Escherichia coli heat labile toxin LT(R192G/L211A)] adjuvant were performed. The results showed that these cell wall-derived particles were able to generate anti-rotavirus IgG and IgA antibodies only when administered intranasally, whether the adjuvant was present or not. However, the presence of dmLT was necessary to confer protection against rotavirus infection, which was evidenced by a 79.5 percent viral shedding reduction. In summary, this work describes the production of cell wall-derived particles which were able to induce a protective immune response after intranasal immunization. Further studies are needed to characterize the immune response elicited by these particles as well as to determine their potential as an alternative to the use of live L. lactis for mucosal antigen delivery.	[Facundo Temprana, C.; Arguelles, Marcelo H.; Gutierrez, Nicolas M.; Esteban, Laura E.; Silvestre, Dalila; Mandile, Marcelo G.; Glikmann, Graciela; Castello, Alejandro A.] Univ Nacl Quilmes, Dept Ciencia & Tecnol, LIV, Bernal, Buenos Aires, Argentina; [Facundo Temprana, C.; Silvestre, Dalila; Mandile, Marcelo G.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Barril, Patricia A.] Consejo Nacl Invest Cient & Tecn, Ctr Invest & Asistencia Tecn Ind CIATI AC, Lab Microbiol Alimentos, Centenario, Neuquen, Argentina; [Castello, Alejandro A.] Univ Nacl Arturo Jauretche, Inst Ciencias Salud, Florencio Varela, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Temprana, CF; Castello, AA (corresponding author), Univ Nacl Quilmes, Dept Ciencia & Tecnol, LIV, Bernal, Buenos Aires, Argentina.; Temprana, CF (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.; Castello, AA (corresponding author), Univ Nacl Arturo Jauretche, Inst Ciencias Salud, Florencio Varela, Buenos Aires, Argentina.	ctemprana@unq.edu.ar; acastello@unq.edu.ar			Agencia Nacional de Promocion Cientifica y Tecnologica (ANCyPT), Argentina [PICT-2012-300]; Universidad Nacional de Quilmes [PUNQ1407/15]; Universidad Nacional Arturo Jauretche [290/12, 404/15]; CONICET	Agencia Nacional de Promocion Cientifica y Tecnologica (ANCyPT), Argentina(ANPCyT); Universidad Nacional de Quilmes; Universidad Nacional Arturo Jauretche; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was supported by PICT-2012-300 to C.F.T from Agencia Nacional de Promocion Cientifica y Tecnologica (ANCyPT), Argentina; and grant from the Universidad Nacional de Quilmes for the research program "Basic and Applied Molecular Microbiology" (PUNQ1407/15) and the research grants issued by Universidad Nacional Arturo Jauretche, Res.(R) 290/12 and 404/15. Doctoral and Postdoctoral Fellowship from CONICET for D. Silvestre and M.G. Mandile, respectively, are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguelles MH, 2000, J CLIN MICROBIOL, V38, P252; Audouy SAL, 2006, VACCINE, V24, P5434, DOI 10.1016/j.vaccine.2006.03.054; Bermudez-Humaran LG, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S4; Bermudez-Humaran LG, 2009, HUM VACCINES, V5, P264, DOI 10.4161/hv.5.4.7553; Bosma T, 2006, APPL ENVIRON MICROB, V72, P880, DOI 10.1128/AEM.72.1.880-889.2006; Bouvet JP, 1999, INFECT IMMUN, V67, P2687, DOI 10.1128/IAI.67.6.2687-2691.1999; Bucardo F, 2015, INFECT GENET EVOL, V34, P106, DOI 10.1016/j.meegid.2015.06.013; Bucardo F, 2012, INFECT GENET EVOL, V12, P1282, DOI 10.1016/j.meegid.2012.03.007; Burnett E, 2017, J INFECT DIS, V215, P1666, DOI 10.1093/infdis/jix186; Burns JW, 1996, SCIENCE, V272, P104, DOI 10.1126/science.272.5258.104; Choi AH, 2002, VACCINE, V20, P3310, DOI 10.1016/S0264-410X(02)00315-8; Choi AH, 2002, VACCINE, V20, P1733, DOI 10.1016/S0264-410X(02)00043-9; Choi AHC, 1999, J VIROL, V73, P7574, DOI 10.1128/JVI.73.9.7574-7581.1999; de Haan A, 2012, VACCINE, V30, P4884, DOI 10.1016/j.vaccine.2012.04.032; Dieye Y, 2001, J BACTERIOL, V183, P4157, DOI 10.1128/JB.183.14.4157-4166.2001; Donato CM, 2012, J INFECT DIS, V206, P377, DOI 10.1093/infdis/jis361; El-Kamary SS, 2013, CLIN VACCINE IMMUNOL, V20, P1764, DOI 10.1128/CVI.00464-13; Enouf V, 2001, APPL ENVIRON MICROB, V67, P1423, DOI 10.1128/AEM.67.4.1423-1428.2001; Esteban LE, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/298598; Estes MK, 2007, FIELDS VIROLOGY, P1917; Feng NG, 2002, J CLIN INVEST, V109, P1203, DOI 10.1172/JCI200214397; Franco MA, 1999, J INFECT DIS, V179, pS466, DOI 10.1086/314805; Franco MA, 1997, VIROLOGY, V238, P169, DOI 10.1006/viro.1997.8843; FRANCO MA, 1995, J VIROL, V69, P7800, DOI 10.1128/JVI.69.12.7800-7806.1995; Fredj MB, 2013, INFECT GENET EVOL, V18, P132, DOI 10.1016/j.meegid.2013.05.008; Gil MT, 2001, FEMS MICROBIOL LETT, V203, P269, DOI 10.1016/S0378-1097(01)00367-6; Gray J., 2000, METHODS MOL MED, V34, P198; Hemming M, 2013, INFECT GENET EVOL, V19, P51, DOI 10.1016/j.meegid.2013.06.026; Hemming M, 2012, PEDIATR INFECT DIS J, V31, P992, DOI 10.1097/INF.0b013e31825d611e; Holmgren J, 2013, VACCINE, V31, P2457, DOI 10.1016/j.vaccine.2013.03.027; Jalilvand S, 2015, VACCINE, V33, P3281, DOI 10.1016/j.vaccine.2015.05.026; Jiang V, 2010, HUM VACCINES, V6, P532, DOI 10.4161/hv.6.7.11278; Kaminski RW, 2014, CLIN VACCINE IMMUNOL, V21, P366, DOI 10.1128/CVI.00683-13; Keijzer C, 2014, VACCINE, V32, P2904, DOI 10.1016/j.vaccine.2014.02.019; Lappalainen S, 2015, ARCH VIROL, V160, P2075, DOI 10.1007/s00705-015-2461-8; Larena M, 2015, J IMMUNOL, V194, P3829, DOI 10.4049/jimmunol.1401633; Li XY, 2014, PATHOG DIS, V72, P78, DOI 10.1111/2049-632X.12173; Li Yi-jing, 2010, J Biomed Biotechnol, V2010, P708460, DOI 10.1155/2010/708460; Lundgren A, 2014, VACCINE, V32, P7077, DOI 10.1016/j.vaccine.2014.10.069; Mandile MG, 2014, J CLIN VIROL, V60, P282, DOI 10.1016/j.jcv.2014.04.022; Marelli B, 2011, J VIROL METHODS, V175, P28, DOI 10.1016/j.jviromet.2011.04.011; Martinez-Becerra FJ, 2012, INFECT IMMUN, V80, P1222, DOI 10.1128/IAI.06174-11; McNeal MM, 2006, VIROLOGY, V346, P338, DOI 10.1016/j.virol.2005.11.016; McNeal MM, 2002, J VIROL, V76, P560, DOI 10.1128/JVI.76.2.560-568.2002; Mercenier A, 2000, Curr Issues Mol Biol, V2, P17; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Morello E, 2008, J MOL MICROB BIOTECH, V14, P48, DOI 10.1159/000106082; Nandre R, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw246; Nganou-Makamdop K, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-50; Norton EB, 2015, VACCINE, V33, P1909, DOI 10.1016/j.vaccine.2015.02.069; Norton EB, 2011, CLIN VACCINE IMMUNOL, V18, P546, DOI 10.1128/CVI.00538-10; Nouaille Sebastien, 2003, Genet Mol Res, V2, P102; Ottsjo LS, 2017, IMMUNOLOGY, V150, P172, DOI 10.1111/imm.12676; Parker EPK, 2018, FUTURE MICROBIOL, V13, P97, DOI 10.2217/fmb-2017-0128; Patel MM, 2009, EXPERT REV VACCINES, V8, P1555, DOI 10.1586/ERV.09.106; Patel NC, 2010, NEW ENGL J MED, V362, P314, DOI 10.1056/NEJMoa0904485; Perez CA, 2005, J APPL MICROBIOL, V99, P1158, DOI 10.1111/j.1365-2672.2005.02709.x; Piard JC, 1997, J BACTERIOL, V179, P3068, DOI 10.1128/jb.179.9.3068-3072.1997; Pontes DS, 2011, PROTEIN EXPRES PURIF, V79, P165, DOI 10.1016/j.pep.2011.06.005; Ramirez K, 2010, MUCOSAL IMMUNOL, V3, P159, DOI 10.1038/mi.2009.131; Rigter A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071072; Rodriguez-Diaz J, 2011, BIOTECHNOL LETT, V33, P1169, DOI 10.1007/s10529-011-0551-6; Rose TL, 2013, EMERG INFECT DIS, V19, P1843, DOI 10.3201/eid1911.121407; Saluja V, 2010, VACCINE, V28, P7963, DOI 10.1016/j.vaccine.2010.09.066; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Song AAL, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0669-x; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Van Braeckel-Budimir N, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00282; van Roosmalen ML, 2006, METHODS, V38, P144, DOI 10.1016/j.ymeth.2005.09.015; VanCott JL, 2001, EUR J IMMUNOL, V31, P3380, DOI 10.1002/1521-4141(200111)31:11<3380::AID-IMMU3380>3.0.CO;2-0; Almeida TNV, 2017, ACTA TROP, V173, P153, DOI 10.1016/j.actatropica.2017.06.009; Ward RL, 2010, J INFECT DIS, V202, pS101, DOI 10.1086/653556; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; White JA, 2017, J IMMUNOL METHODS, V451, P83, DOI 10.1016/j.jim.2017.09.003; World health Organization, 2013, WKLY EPIDEMIOL REC, V88, P49; YEN C, 2014, HUM VACC IMMUNOTHER, V10, P1436, DOI DOI 10.4161/hv.28857; Zeller M, 2017, PEERJ, V5, DOI 10.7717/peerj.2733; Zeller M, 2015, GENOME BIOL EVOL, V7, P2473, DOI 10.1093/gbe/evv157	79	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203700	10.1371/journal.pone.0203700	http://dx.doi.org/10.1371/journal.pone.0203700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192869	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600134
J	George, DM; Huntley, RJ; Cusack, K; Duignan, DB; Hoemann, M; Loud, J; Mario, R; Melim, T; Mullen, K; Somal, G; Wang, L; Edmunds, JJ				George, Dawn M.; Huntley, Raymond J.; Cusack, Kevin; Duignan, David B.; Hoemann, Michael; Loud, Jacqueline; Mario, Regina; Melim, Terry; Mullen, Kelly; Somal, Gagandeep; Wang, Lu; Edmunds, Jeremy J.			Prodrugs for colon-restricted delivery: Design, synthesis, and in vivo evaluation of colony stimulating factor 1 receptor (CSF1R) inhibitors	PLOS ONE			English	Article							MULTIPLE-DOSE PHARMACOKINETICS; APPENDED ALPHA-CYCLODEXTRIN; TISSUE IMPLICATIONS; BETA-CYCLODEXTRIN; CSF-1R INHIBITOR; P-GLYCOPROTEIN; RECTAL TISSUE; MACROPHAGES; EXPRESSION; CANCER	The ability to restrict low molecular weight compounds to the gastrointestinal (GI) tract may enable an enhanced therapeutic index for molecular targets known to be associated with systemic toxicity. Using a triazolopyrazine CSF1R inhibitor scaffold, a broad range of prodrugs were synthesized and evaluated for enhanced delivery to the colon in mice. Subsequently, the preferred cyclodextrin prodrug moiety was appended to a number of CSF1R inhibitory active parent molecules, enabling GI-restricted delivery. Evaluation of a cyclodextrin prodrug in a dextran sodium sulfate (DSS)-induced mouse colitis model resulted in enhanced GI tissue levels of active parent. At a dose where no significant depletion of systemic monocytes were detected, the degree of pharmacodynamic effect-measured as reduction in macrophages in the colon +/- was inferior to that observed with a systemically available positive control. This suggests that a suitable therapeutic index cannot be achieved with CSF1R inhibition by using GI-restricted delivery in mice. However, these efforts provide a comprehensive frame-work in which to pursue additional gut-restricted delivery strategies for future GI targets.	[George, Dawn M.] AbbVie Biores Ctr, Immunol Discovery, Worcester, MA 01605 USA; [Huntley, Raymond J.; Cusack, Kevin; Hoemann, Michael; Mullen, Kelly; Somal, Gagandeep; Wang, Lu; Edmunds, Jeremy J.] AbbVie Biores Ctr, Dept Chem, Immunol Discovery, Worcester, MA USA; [Duignan, David B.] AbbVie Biores Ctr, Dept Drug Metab Pharmacokinet & Bioanal, Worcester, MA USA; [Loud, Jacqueline; Mario, Regina; Melim, Terry] AbbVie Biores Ctr, Dept Pharmacol, Immunol Discovery, Worcester, MA USA	AbbVie; AbbVie; AbbVie; AbbVie	George, DM (corresponding author), AbbVie Biores Ctr, Immunol Discovery, Worcester, MA 01605 USA.	dawn.george@abbvie.com		Hoemann, Michael/0000-0001-9259-7702	AbbVie	AbbVie(AbbVie)	This work was supported by AbbVie. All authors are employees of AbbVie. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.	[Anonymous], 2015, OMICSOFT R ARRAYSUIT; Bendell JC, 2013, MOL CANC THERAPEUTIC, V12; Brown KC, 2012, JAIDS-J ACQ IMM DEF, V61, P138, DOI 10.1097/QAI.0b013e31825cb645; Brown KC, 2011, J INFECT DIS, V203, P1484, DOI 10.1093/infdis/jir059; Cannarile MA, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0257-y; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Clas SD, 2014, DRUG DISCOV TODAY, V19, P79, DOI 10.1016/j.drudis.2013.08.014; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Dhaneshwar SS, 2011, CURR TOP MED CHEM, V11, P2318; Huynh D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056951; Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Genovese MC, 2015, J RHEUMATOL, V42, P1752, DOI 10.3899/jrheum.141580; George DM, 2017, MED CHEM REV, V52, P165; Greener BN, 2013, JAIDS-J ACQ IMM DEF, V64, P39, DOI 10.1097/QAI.0b013e31829ed7a4; Hirayama F, 2000, J PHARM SCI, V89, P1486, DOI 10.1002/1520-6017(200011)89:11<1486::AID-JPS11>3.0.CO;2-D; Kagan L, 2010, DRUG METAB DISPOS, V38, P1560, DOI 10.1124/dmd.110.033019; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; KIMURA T, 1994, BIOL PHARM BULL, V17, P327; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Laharie D, 2008, GASTROEN CLIN BIOL, V32, P134, DOI 10.1016/j.gcb.2007.11.002; Landis MS, 2013, THER DELIV, V4, P225, DOI [10.4155/tde.12.150, 10.4155/TDE.12.150]; Lebakken CS, 2009, J BIOMOL SCREEN, V14, P924, DOI 10.1177/1087057109339207; MacLean C, 2008, DRUG METAB DISPOS, V36, P1249, DOI 10.1124/dmd.108.020859; Manthey CL, 2009, MOL CANCER THER, V8, P3151, DOI 10.1158/1535-7163.MCT-09-0255; McConnell EL, 2008, J PHARM PHARMACOL, V60, P63, DOI 10.1211/jpp.60.1.0008; MCLEOD AD, 1993, INT J PHARM, V92, P105, DOI 10.1016/0378-5173(93)90269-L; Moore B, 2014, GASTROENTEROLOGY, V146, pS900; Moss DM, 2014, J ANTIMICROB CHEMOTH, V69, P3275, DOI 10.1093/jac/dku312; Mulvihill MJ, Patent No. [WO2011243645, 2011243645]; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Patel S, 2009, CURR TOP MED CHEM, V9, P599, DOI 10.2174/156802609789007327; Patterson KB, 2013, AIDS, V27, P1413, DOI 10.1097/QAD.0b013e32835f2b49; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Pridans C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03013; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Radi ZA, 2011, AM J PATHOL, V179, P240, DOI 10.1016/j.ajpath.2011.03.029; Ramsay RG, 2004, J INTERF CYTOK RES, V24, P416, DOI 10.1089/1079990041535638; Ries CH, 2015, CURR OPIN PHARMACOL, V23, P45, DOI 10.1016/j.coph.2015.05.008; Rugtveit J, 1997, GASTROENTEROLOGY, V112, P1493, DOI 10.1016/S0016-5085(97)70030-1; Sadis S, 2009, ARTHRITIS RHEUM S10, V60, P408, DOI DOI 10.1002/ART.25491; Schubert C, 2007, J BIOL CHEM, V282, P4094, DOI 10.1074/jbc.M608183200; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Thiesen S, 2014, J LEUKOCYTE BIOL, V95, P531, DOI 10.1189/jlb.0113021; Thorn M, 2005, BRIT J CLIN PHARMACO, V60, P54, DOI 10.1111/j.1365-2125.2005.02389.x; Tian Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1083, DOI 10.1152/ajpcell.00381.2005; Wang T, 2011, INT J TOXICOL, V30, P300, DOI 10.1177/1091581811401920; Yano H, 2002, J CONTROL RELEASE, V79, P103, DOI 10.1016/S0168-3659(01)00532-6; Yano H, 2001, J PHARM SCI-US, V90, P493, DOI 10.1002/1520-6017(200104)90:4<493::AID-JPS1007>3.3.CO;2-N; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhou L, 2015, ARTHRITIS RHEUMATOL, P67; Zwicker S, 2015, CLIN SCI, V129, P281, DOI 10.1042/CS20150176	54	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203567	10.1371/journal.pone.0203567	http://dx.doi.org/10.1371/journal.pone.0203567			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192846	Green Submitted, gold, Green Published			2022-12-26	WOS:000444093600105
J	Hundertmark, T; Gartner, SMK; Rathke, C; Renkawitz-Pohl, R				Hundertmark, Tim; Gaertner, Stefanie M. K.; Rathke, Christina; Renkawitz-Pohl, Renate			Nejire/dCBP-mediated histone H3 acetylation during spermatogenesis is essential for male fertility in Drosophila melanogaster	PLOS ONE			English	Article							PROTAMINE-BASED CHROMATIN; BROMODOMAIN-CONTAINING PROTEIN; GENE-EXPRESSION PROGRAM; MOUSE SPERMATOGENESIS; TRICHOSTATIN-A; IN-VIVO; SPERMIOGENESIS; DEACETYLASE; MST77F; TESTIS	Spermatogenesis in many species including Drosophila melanogaster is accompanied by major reorganisation of chromatin in post-meiotic stages, involving a nearly genome-wide displacement of histones by protamines, Mst77F and Protamine-like 99C. A proposed prerequisite for the histone-to-protamine transition is massive histone H4 hyper-acetylation prior to the switch. Here, we investigated the pattern of histone H3 lysine acetylation and general lysine crotonylation in D. melanogaster spermiogenesis to elucidate a possible role of these marks in chromatin reorganisation. Lysine crotonylation was strongest prior to remodelling and the deposition of this mark depended on the acetylation status of the spermatid chromatin. In contrast to H4 acetylation, individual H3 acetylation marks displayed surprisingly distinct patterns during the histone-to-protamine transition. We observed that Nejire, a histone acetyl transferase, is expressed during the time of histone-to-protamine transition. Nejire knock down led to strongly reduced fertility, which correlated with mis-shaped spermatid nuclei and a lack of mature sperm. protA and prtl99C transcript levels were reduced after knocking down Nejire. ProtB-eGFP, Mst77F-eGFP and Prtl99C-eGFP were synthesized at the late canoe stage, while histones were often not detectable. However, in some cysts histones persist in parallel to protamines. Therefore, we hypothesize that complete histone removal requires multiple histone modifications besides H3K18ac and H3K27ac. In summary, H3K18 and H3K27 acetylation during Drosophila spermatogenesis is dependent on Nejire or a yet uncharacterized acetyl transferase. We show that Nejire is required for male fertility since Nejire contributes to efficient transcription of protA and prtl99C, but not Mst77F, in spermatocytes, and to maturation of sperm.	[Hundertmark, Tim; Gaertner, Stefanie M. K.; Rathke, Christina; Renkawitz-Pohl, Renate] Philipps Univ Marburg, Dept Biol, Dev Biol, Marburg, Germany	Philipps University Marburg	Renkawitz-Pohl, R (corresponding author), Philipps Univ Marburg, Dept Biol, Dev Biol, Marburg, Germany.	renkawit@biologie.uni-marburg.de			Deutsche Forschungsgemeinschaft [SFB TRR81]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB TRR81 "Chromatin Changes in Differentiation and Malignancies" to C.R. and R. R.-P.).	Awe S, 2010, SYST BIOL REPROD MED, V56, P44, DOI 10.3109/19396360903490790; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Barckmann B, 2013, DEV BIOL, V377, P33, DOI 10.1016/j.ydbio.2013.02.018; Barreau C, 2008, DEVELOPMENT, V135, P1897, DOI 10.1242/dev.021949; Berkovits BD, 2013, CURR TOP DEV BIOL, V102, P293, DOI 10.1016/B978-0-12-416024-8.00011-8; Boussouar F, 2014, ANDROLOGY-US, V2, P351, DOI 10.1111/j.2047-2927.2014.00184.x; Braun RE, 2001, NAT GENET, V28, P10, DOI 10.1038/88194; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Dottermusch-Heidel C, 2014, ANDROLOGY-US, V2, P655, DOI 10.1111/j.2047-2927.2014.00248.x; Dottermusch-Heidel C, 2014, BIOL OPEN, V3, P444, DOI 10.1242/bio.20147302; Doyen CM, 2015, CELL REP, V13, P1310, DOI 10.1016/j.celrep.2015.10.010; Doyen CM, 2013, CELL REP, V4, P59, DOI 10.1016/j.celrep.2013.06.002; Eren-Ghiani Z, 2015, CELL REP, V13, P2327, DOI 10.1016/j.celrep.2015.11.023; Fenic I, 2004, J ANDROL, V25, P811; Fuller Margaret T., 1993, P71; Gartner SMK, 2015, EUR J CELL BIOL, V94, P46, DOI 10.1016/j.ejcb.2014.10.005; Gartner SMK, 2014, JOVE-J VIS EXP, DOI 10.3791/51868; Gaucher J, 2010, FEBS J, V277, P599, DOI 10.1111/j.1742-4658.2009.07504.x; Goudarzi A, 2014, J MOL BIOL, V426, P3342, DOI 10.1016/j.jmb.2014.02.023; Govin J, 2004, EUR J BIOCHEM, V271, P3459, DOI 10.1111/j.1432-1033.2004.04266.x; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; Hime GR, 1996, J CELL SCI, V109, P2779; KENNEDY BP, 1980, J BIOL CHEM, V255, P2533; Kimura S, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160207; Kost N, 2015, NUCLEIC ACIDS RES, V43, P3033, DOI 10.1093/nar/gkv015; Leser K, 2012, BIOL OPEN, V1, P597, DOI 10.1242/bio.20121255; Lilja T, 2003, DEV BIOL, V262, P294, DOI 10.1016/S0012-1606(03)00392-0; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Montellier E, 2012, BIOESSAYS, V34, P187, DOI 10.1002/bies.201100141; Nair M, 2008, DEV BIOL, V320, P446, DOI 10.1016/j.ydbio.2008.05.553; Petruk S, 2001, SCIENCE, V294, P1331, DOI 10.1126/science.1065683; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Raja SJ, 2005, MOL CELL BIOL, V25, P6165, DOI 10.1128/MCB.25.14.6165-6177.2005; Rathke C, 2007, J CELL SCI, V120, P1689, DOI 10.1242/jcs.004663; Rathke C, 2014, BBA-GENE REGUL MECH, V1839, P155, DOI 10.1016/j.bbagrm.2013.08.004; Rathke C, 2010, EUR J CELL BIOL, V89, P326, DOI 10.1016/j.ejcb.2009.09.001; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Song N, 2011, ACTA HISTOCHEM CYTOC, V44, P183, DOI 10.1267/ahc.11027; Sonnack V, 2002, ANDROLOGIA, V34, P384, DOI 10.1046/j.1439-0272.2002.00524.x; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Theofel I, 2017, BIOL OPEN, V6, P439, DOI 10.1242/bio.022467; Theofel I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108267; White-Cooper H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002626; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	46	7	7	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203622	10.1371/journal.pone.0203622	http://dx.doi.org/10.1371/journal.pone.0203622			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192860	Green Submitted, Green Published, gold			2022-12-26	WOS:000444093600119
J	Karnati, S; Garikapati, V; Liebisch, G; Van Veldhoven, PP; Spengler, B; Schmitz, G; Baumgart-Vogt, E				Karnati, Srikanth; Garikapati, Vannuruswamy; Liebisch, Gerhard; Van Veldhoven, Paul P.; Spengler, Bernhard; Schmitz, Gerd; Baumgart-Vogt, Eveline			Quantitative lipidomic analysis of mouse lung during postnatal development by electrospray ionization tandem mass spectrometry	PLOS ONE			English	Article							HIGH-THROUGHPUT QUANTIFICATION; RESPIRATORY-DISTRESS-SYNDROME; PULMONARY SURFACTANT; RAT LUNG; BRONCHOPULMONARY DYSPLASIA; PHOSPHOLIPID-COMPOSITION; ESI-MS/MS; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLCHOLINE; METABOLISM	Lipids play very important roles in lung biology, mainly reducing the alveolar surface tension at the air-liquid interface thereby preventing end-expiratory collapse of the alveoli. In the present study we performed an extensive quantitative lipidomic analysis of mouse lung to provide the i) total lipid quantity, ii) distribution pattern of the major lipid classes, iii) composition of individual lipid species and iv) glycerophospholipid distribution pattern according to carbon chain length (total number of carbon atoms) and degree of unsaturation (total number of double bonds). We analysed and quantified 160 glycerophospholipid species, 24 sphingolipid species, 18 cholesteryl esters and cholesterol from lungs of a) newborn (P1), b) 15-day-old (P15) and c) 12-week-old adult mice (P84) to understand the changes occurring during postnatal pulmonary development. Our results revealed an increase in total lipid quantity, correlation of lipid class distribution in lung tissue and significant changes in the individual lipid species composition during postnatal lung development. Interestingly, we observed significant stage-specific alterations during this process. Especially, P1 lungs showed high content of monounsaturated lipid species; P15 lungs exhibited myristic and palmitic acid containing lipid species, whereas adult lungs were enriched with polyunsaturated lipid species. Taken together, our study provides an extensive quantitative lipidome of the postnatal mouse lung development, which may serve as a reference for a better understanding of lipid alterations and their functions in lung development and respiratory diseases associated with lipids.	[Karnati, Srikanth; Garikapati, Vannuruswamy; Baumgart-Vogt, Eveline] Justus Liebig Univ Giessen, Div Med Cell Biol, Inst Anat & Cell Biol 2, Giessen, Germany; [Garikapati, Vannuruswamy; Spengler, Bernhard] Justus Liebig Univ Giessen, Inst Inorgan & Analyt Chem, Giessen, Germany; [Liebisch, Gerhard; Schmitz, Gerd] Univ Hosp Regensburg, Inst Clin Chem & Lab Med, Regensburg, Germany; [Van Veldhoven, Paul P.] Katholieke Univ Leuven, Lab Lipid Biochem & Prot Interact, Campus Gasthuisberg, Leuven, Belgium; [Karnati, Srikanth] Julius Maximilians Univ Wurzburg, Inst Anat & Cell Biol, Wurzburg, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; University of Regensburg; KU Leuven; University of Wurzburg	Karnati, S; Baumgart-Vogt, E (corresponding author), Justus Liebig Univ Giessen, Div Med Cell Biol, Inst Anat & Cell Biol 2, Giessen, Germany.; Karnati, S (corresponding author), Julius Maximilians Univ Wurzburg, Inst Anat & Cell Biol, Wurzburg, Germany.	Srikanth.Karnati@anatomie.med.uni-giessen.de; Eveline.Baumgart-Vogt@anatomie.med.uni-giessen.de	Garikapati, Vannuruswamy/Y-5922-2019; Baumgart-Vogt, Eveline/I-5945-2013; Karnati, Srikanth/AAP-9038-2021; , Van Veldhoven Paul/U-6359-2019; Liebisch, Gerhard/G-6130-2010	Garikapati, Vannuruswamy/0000-0003-1204-349X; Baumgart-Vogt, Eveline/0000-0002-8265-3763; Karnati, Srikanth/0000-0001-9083-2916; , Van Veldhoven Paul/0000-0002-4478-2564; Liebisch, Gerhard/0000-0003-4886-0811; Spengler, Bernhard/0000-0003-0179-5653	German Academic Exchange Service (DAAD); LOM (Leistungsorientierte Mittel) performance related resource allocation-funds of the Medical Faculty of the Justus Liebig University Giessen, Germany; Deutsche Forschungsgemeinschaft (DFG) [Sp 314/13-1]; European Community's Seventh Framework Programme (FP7/2007-2013) [202272];  [DAAD-ID91566181]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); LOM (Leistungsorientierte Mittel) performance related resource allocation-funds of the Medical Faculty of the Justus Liebig University Giessen, Germany; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Community's Seventh Framework Programme (FP7/2007-2013); 	We thank German Academic Exchange Service (DAAD) for granting the Graduate School Scholarship Programme "Lipids in Nutrition and Metabolism" (DAAD-GSSP-2015). V.G. is a holder of a doctoral fellowship (DAAD-ID91566181) within this programme. Our study was supported also by LOM (Leistungsorientierte Mittel) performance related resource allocation-funds of the Medical Faculty of the Justus Liebig University Giessen, Germany. Financial support by the Deutsche Forschungsgemeinschaft (DFG, Sp 314/13-1) is gratefully acknowledged. The research leading to these results also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 202272, IP-Project LipidomicNet.	AMY RWM, 1977, J ANAT, V124, P131; BATENBURG JJ, 1992, AM J PHYSIOL, V262, pL367, DOI 10.1152/ajplung.1992.262.4.L367; BENSON BJ, 1983, BIOCHIM BIOPHYS ACTA, V753, P83, DOI 10.1016/0005-2760(83)90101-7; Bernhard W, 1997, AM J RESP CELL MOL, V17, P41, DOI 10.1165/ajrcmb.17.1.2594; Bernhard W, 2001, AM J RESP CELL MOL, V25, P725, DOI 10.1165/ajrcmb.25.6.4616; Bernhard W, 2001, AM J PHYSIOL-REG I, V281, pR327, DOI 10.1152/ajpregu.2001.281.1.R327; Bernhard W, 2007, PEDIATR PULM, V42, P794, DOI 10.1002/ppul.20657; Bernhard W, 2011, J APPL PHYSIOL, V111, P449, DOI 10.1152/japplphysiol.00766.2010; Berry KAZ, 2011, J LIPID RES, V52, P1551, DOI 10.1194/jlr.M015750; Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; Blanco O, 2007, EUR J PHARMACOL, V568, P1, DOI 10.1016/j.ejphar.2007.04.035; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BODY DR, 1971, LIPIDS, V6, P625, DOI 10.1007/BF02531518; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; BURRI PH, 1974, ANAT REC, V178, P711, DOI 10.1002/ar.1091780405; CLEMENT A, 1987, PEDIATR PULM, V3, P67, DOI 10.1002/ppul.1950030205; CLEMENTS JA, 1970, SCIENCE, V169, P603, DOI 10.1126/science.169.3945.603; Dautel SE, 2017, SCI REP-UK, V7, DOI 10.1038/srep40555; EGBERTS J, 1987, BIOCHIM BIOPHYS ACTA, V919, P90, DOI 10.1016/0005-2760(87)90221-9; Fisher AB, 2015, COMP BIOL NORMAL LUN, P423, DOI [10.1016/B978-0-12-404577-4.00022-9, DOI 10.1016/B978-0-12-404577-4.00022-9]; FLEMING BD, 1988, CHEM PHYS LIPIDS, V49, P81, DOI 10.1016/0009-3084(88)90067-9; Freedman SD, 1999, P NATL ACAD SCI USA, V96, P13995, DOI 10.1073/pnas.96.24.13995; Gille C, 2007, J LIPID RES, V48, P307, DOI 10.1194/jlr.M600451-JLR200; GODINEZ RI, 1975, BIOCHEMISTRY-US, V14, P830, DOI 10.1021/bi00675a029; Griese M, 1999, EUR RESPIR J, V13, P1455, DOI 10.1034/j.1399-3003.1999.13f36.x; Griese M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117985; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Gunther A, 1996, AM J RESP CRIT CARE, V153, P176; HAHN P, 1986, BIOL NEONATE, V50, P205, DOI 10.1159/000242601; Hakomori S, 1996, CANCER RES, V56, P5309; HALLMAN M, 1985, PEDIATR RES, V19, P286, DOI 10.1203/00006450-198503000-00006; HALLMAN M, 1986, PEDIATR RES, V20, P1228, DOI 10.1203/00006450-198612000-00008; HALLMAN M, 1982, J CLIN INVEST, V70, P673, DOI 10.1172/JCI110662; HAMM H, 1992, CLIN INVESTIGATOR, V70, P637; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HAUMONT D, 1992, BIOL NEONATE, V61, P37; Holm BA, 1996, PEDIATR RES, V39, P805, DOI 10.1203/00006450-199605000-00010; Karnati S, 2008, HISTOCHEM CELL BIOL, V130, P719, DOI 10.1007/s00418-008-0462-3; Karnati S, 2016, CELL TISSUE RES, V364, P543, DOI 10.1007/s00441-015-2354-x; King R. J., 2011, COMPREHENSIVE PHYSL; Lang CJ, 2005, AM J PHYSIOL-REG I, V289, pR1426, DOI 10.1152/ajpregu.00496.2004; LEWIS JF, 1990, J APPL PHYSIOL, V69, P2303, DOI 10.1152/jappl.1990.69.6.2303; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Liebisch G, 1999, J LIPID RES, V40, P1539; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liebisch G, 2002, CLIN CHEM, V48, P2217; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Longo CA, 1997, AM J RESP CELL MOL, V16, P605, DOI 10.1165/ajrcmb.16.5.9160843; Ma Christopher Cheng-Hwa, 2012, Open Respir Med J, V6, P44, DOI 10.2174/1874306401206010044; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Meaney S, 2004, J LIPID RES, V45, P2354, DOI 10.1194/jlr.M400302-JLR200; Nkadi PO, 2009, MOL GENET METAB, V97, P95, DOI 10.1016/j.ymgme.2009.01.015; NOTTER RH, 1980, J LIPID RES, V21, P10; Numata M, 2012, AM J RESP CELL MOL, V46, P479, DOI 10.1165/rcmb.2011-0194OC; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; Orgeig S, 2001, COMP BIOCHEM PHYS A, V129, P75, DOI 10.1016/S1095-6433(01)00307-5; Perino J, 2011, ANTIVIR RES, V89, P89, DOI 10.1016/j.antiviral.2010.11.009; PFLEGER RC, 1971, ARCH INTERN MED, V127, P863, DOI 10.1001/archinte.127.5.863; Polin RA, 2014, PEDIATRICS, V133, P156, DOI 10.1542/peds.2013-3443; Postle AD, 2001, COMP BIOCHEM PHYS A, V129, P65, DOI 10.1016/S1095-6433(01)00306-3; Rau GA, 2004, AM J RESP CELL MOL, V30, P694, DOI 10.1165/rcmb.2003-0351OC; RICARDO MJ, 1986, J IMMUNOL, V136, P1054; Ridsdale R, 2005, AM J RESP CRIT CARE, V172, P225, DOI 10.1164/rccm.200501-109OC; ROONEY SA, 1974, BIOCHIM BIOPHYS ACTA, V360, P56, DOI 10.1016/0005-2760(74)90179-9; Rudiger M, 1998, AM J PHYSIOL-LUNG C, V274, pL143, DOI 10.1152/ajplung.1998.274.1.L143; Rudiger M, 2000, CRIT CARE MED, V28, P1572, DOI 10.1097/00003246-200005000-00052; Rudiger M, 2005, AM J PHYSIOL-LUNG C, V288, pL379, DOI 10.1152/ajplung.00176.2004; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; SCHRAKAMP G, 1985, BIOCHIM BIOPHYS ACTA, V833, P170, DOI 10.1016/0005-2760(85)90266-8; Serhan CN, 2008, BRIT J PHARMACOL, V153, pS200, DOI 10.1038/sj.bjp.0707489; Stables MJ, 2011, PROG LIPID RES, V50, P35, DOI 10.1016/j.plipres.2010.07.005; Uhlig S, 2008, AM J RESP CRIT CARE, V178, P1100, DOI 10.1164/rccm.200804-595SO; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; Wallner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094102; Wang-Sattler R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003863; WHITTLE MJ, 1983, BRIT J OBSTET GYNAEC, V90, P134, DOI 10.1111/j.1471-0528.1983.tb08897.x; WILLIAMS HH, 1945, J BIOL CHEM, V161, P475; Yoder M, 2014, ALLERGY ASTHMA IMMUN, V6, P61, DOI 10.4168/aair.2014.6.1.61; YU S, 1983, LIPIDS, V18, P522, DOI 10.1007/BF02535391; YU SH, 1992, BIOCHIM BIOPHYS ACTA, V1126, P26, DOI 10.1016/0005-2760(92)90212-E; ZELTNER TB, 1987, RESP PHYSIOL, V67, P269, DOI 10.1016/0034-5687(87)90058-2; Zoeller RA, 2002, AM J PHYSIOL-HEART C, V283, pH671, DOI 10.1152/ajpheart.00524.2001	85	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203464	10.1371/journal.pone.0203464	http://dx.doi.org/10.1371/journal.pone.0203464			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192799	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600081
J	Sadinski, W; Gallant, AL; Roth, M; Brown, J; Senay, G; Brininger, W; Jones, PM; Stoker, J				Sadinski, Walt; Gallant, Alisa L.; Roth, Mark; Brown, Jesslyn; Senay, Gabriel; Brininger, Wayne; Jones, Perry M.; Stoker, Jason			Multi-year data from satellite-and ground-based sensors show details and scale matter in assessing climate's effects on wetland surface water, amphibians, and landscape conditions	PLOS ONE			English	Article							DIFFERENCE VEGETATION INDEX; FRESH-WATER; ECOLOGICAL RESPONSES; ECOSYSTEM STRUCTURE; POTENTIAL IMPACTS; INTEGRATED NDVI; LAND-USE; NORTHERN; EVAPOTRANSPIRATION; PHENOLOGY	Long-term, interdisciplinary studies of relations between climate and ecological conditions on wetland-upland landscapes have been lacking, especially studies integrated across scales meaningful for adaptive resource management. We collected data in situ at individual wetlands, and via satellite for surrounding 4-km(2) landscape blocks, to assess relations between annual weather dynamics, snow duration, phenology, wetland surface-water availability, amphibian presence and calling activity, greenness, and evapotranspiration in four U.S. conservation areas from 2008 to 2012. Amid recent decades of relatively warm growing seasons, 2012 and 2010 were the first and second warmest seasons, respectively, dating back to 1895. Accordingly, we observed the earliest starts of springtime biological activity during those two years. In all years, early-season amphibians first called soon after daily mean air temperatures were >= 0 degrees C and snow had mostly melted. Similarly, satellite-based indicators suggested seasonal leaf-out happened soon after snowmelt and temperature thresholds for plant growth had occurred. Daily fluctuations in weather and water levels were related to amphibian calling activity, including decoupling the timing of the onset of calling at the start of season from the onset of calling events later in the season. Within-season variation in temperature and precipitation also was related to vegetation greenness and evapotranspiration, but more at monthly and seasonal scales. Wetland water levels were moderately to strongly associated with precipitation and early or intermittent wetland drying likely reduced amphibian reproduction success in some years, even though Pseudacris crucifer occupied sites at consistently high levels. Notably, satellite-based indicators of landscape water availability did not suggest such consequential, intra-seasonal variability in wetland surface-water availability. Our cross-disciplinary data show how temperature and precipitation interacted to affect key ecological relations and outcomes on our study landscapes. These results demonstrate the value of multi-year studies and the importance of scale for understanding actual climate-related effects in these areas.	[Sadinski, Walt; Roth, Mark] US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI 54601 USA; [Gallant, Alisa L.; Brown, Jesslyn; Senay, Gabriel] US Geol Survey, Earth Resources Observat & Sci Ctr, Sioux Falls, SD USA; [Brininger, Wayne] US Fish & Wildlife Serv, Tamarac Natl Wildlife Refuge, Rochert, MN USA; [Jones, Perry M.] US Geol Survey, Minnesota Water Sci Ctr, Mounds View, MN USA; [Stoker, Jason] US Geol Survey, Natl Geospatial Program, Reston, VA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Sadinski, W (corresponding author), US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI 54601 USA.	wsadinski@usgs.gov			U.S. Department of the Interior; Amphibian Research and Monitoring Initiative; WaterSMART Initiative; Land Remote Sensing program; National Geospatial Program	U.S. Department of the Interior; Amphibian Research and Monitoring Initiative; WaterSMART Initiative; Land Remote Sensing program; National Geospatial Program	All authors are employees of the U.S. Department of the Interior, which provided all the funding for this work. For the employees of the U.S. Geological Survey, funding was via the Amphibian Research and Monitoring Initiative (WS, MR, PMJ), WaterSMART Initiative (GS), Land Remote Sensing program (ALG, JB), and the National Geospatial Program (JS). The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in the design, data collection, analyses for this study, or in the decision to prepare the manuscript or in helping to create it.	Adams MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064347; Aide TM, 2013, PEERJ, V1, DOI 10.7717/peerj.103; Alcaraz-Segura D, 2009, ENVIRON MANAGE, V43, P38, DOI 10.1007/s00267-008-9154-y; Amburgey SM, 2014, CAN J ZOOL, V92, P927, DOI 10.1139/cjz-2014-0106; Andresen J.A., 2014, CLIMATE CHANGE MIDWE, P8; [Anonymous], 2005, EC HUM WELL BEING WE; Ault TR., 2013, EOS T AM GEOPHYS UN, V94, P181, DOI [10.1002/2013EO200001, DOI 10.1002/2013EO200001]; Barraza V, 2013, INT J REMOTE SENS, V34, P5429, DOI 10.1080/01431161.2013.791759; Bateman BL, 2016, GLOBAL CHANGE BIOL, V22, P1130, DOI 10.1111/gcb.13154; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bischof MM, 2013, WETLANDS, V33, P245, DOI 10.1007/s13157-012-0374-9; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; BRAND ALBERT R., 1935, AUK, V52, P40; Brauer CL, 2016, WILDLIFE SOC B, V40, P140, DOI 10.1002/wsb.619; Brooks Robert T., 2005, Wetlands Ecology and Management, V13, P335, DOI 10.1007/s11273-004-7526-5; Brooks RT, 2009, CLIMATIC CHANGE, V95, P469, DOI 10.1007/s10584-008-9531-9; Brooks RT, 2004, WETLANDS, V24, P104, DOI 10.1672/0277-5212(2004)024[0104:WEOWVP]2.0.CO;2; Brower J.A., 1977, FIELD LAB METHODS GE; Brown JF, 2015, REMOTE SENS-BASEL, V7, P16226, DOI 10.3390/rs71215825; Brown ME, 2012, REMOTE SENS ENVIRON, V126, P174, DOI 10.1016/j.rse.2012.08.009; Butterfield BP, 2005, AMPHIBIAN DECLINES C, P472; Chambers JQ, 2007, TRENDS ECOL EVOL, V22, P414, DOI 10.1016/j.tree.2007.05.001; Chiew FHS, 2014, STOCH ENV RES RISK A, V28, P3, DOI 10.1007/s00477-013-0755-5; Cohen MJ, 2016, P NATL ACAD SCI USA, V113, P1978, DOI 10.1073/pnas.1512650113; Conroy MJ, 2011, BIOL CONSERV, V144, P1204, DOI 10.1016/j.biocon.2010.10.019; Cowardin L.M., 1979, CLASSIFICATION WETLA; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; de Beurs KM, 2010, PHENOLOGICAL RESEARCH: METHODS FOR ENVIRONMENTAL AND CLIMATE CHANGE ANALYSIS, P177, DOI 10.1007/978-90-481-3335-2_9; de Beurs KM, 2009, ENVIRON RES LETT, V4, DOI [10.1088/1748-9326/4/1/014011, DOI 10.1088/1748-9326/4/1/014011]; Depraetere M, 2012, ECOL INDIC, V13, P46, DOI 10.1016/j.ecolind.2011.05.006; Dodd Jr CK, 2013, FROGS US CANADA, V1; Dodds WK, 2012, BIOSCIENCE, V62, P709, DOI 10.1525/bio.2012.62.8.4; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Erwin KL, 2009, WETL ECOL MANAG, V17, P71, DOI 10.1007/s11273-008-9119-1; Gallant AL, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18030880; Gibbons JW, 2006, CONSERV BIOL, V20, P1457, DOI 10.1111/j.1523-1739.2006.00443.x; Gibbons JW, 2003, WETLANDS, V23, P630, DOI 10.1672/0277-5212(2003)023[0630:THAVCF]2.0.CO;2; Gibbs JP, 2001, CONSERV BIOL, V15, P1175, DOI 10.1046/j.1523-1739.2001.0150041175.x; Grant EHC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25625; Groffman PM, 2012, BIOSCIENCE, V62, P1056, DOI 10.1525/bio.2012.62.12.7; Gu YX, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029127; Haase P, 2016, ECOL INDIC, V65, P1, DOI 10.1016/j.ecolind.2016.01.040; Hall KR, 2014, CLIMATE CHANGE MIDWE, P83; Hinzman LD, 2005, CLIMATIC CHANGE, V72, P251, DOI 10.1007/s10584-005-5352-2; Hlasny T, 2015, ANN FOREST SCI, V72, P109, DOI 10.1007/s13595-014-0404-2; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hossack BR, 2013, CONSERV BIOL, V27, P1410, DOI 10.1111/cobi.12119; Hu MQ, 2011, INT J APPL EARTH OBS, V13, P24, DOI 10.1016/j.jag.2010.06.003; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Ivanovic RF, 2009, HYDROL PROCESS, V23, P2549, DOI 10.1002/hyp.7406; Jenkerson CB, 2010, 20101055 US GEOL SUR; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Jung M, 2010, NATURE, V467, P951, DOI 10.1038/nature09396; Kamble B, 2013, REMOTE SENS-BASEL, V5, P1588, DOI 10.3390/rs5041588; Kanamitsu M, 1989, WEA FORECASTING, p[4, 335], DOI [10.1175/1520-0434(1989)004&LT;0335:DOTNGD&GT;2.0.CO;2, DOI 10.1175/1520-0434(1989)004<0335:D0TNGD>2.0.C0;2, 10.1175/1520-0434(1989)0042.0.CO;2]; Kim Y, 2013, INT J REMOTE SENS, V34, P4889, DOI [10.1080/01431161.2013.772309, 10.1080/2150704X.2013.781700]; Krause B, 2016, BIOL CONSERV, V195, P245, DOI 10.1016/j.biocon.2016.01.013; Kunkel KE, 2013, 1423 NESDIS US NAT O; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; Lawler JJ, 2010, FRONT ECOL ENVIRON, V8, P35, DOI 10.1890/070146; Leonelli S., 2010, WELL FACTS TRAVEL DI, P325, DOI DOI 10.1017/CBO9780511762154.017; Leonelli S, 2015, PHILOS SCI, V82, P810, DOI 10.1086/684083; Leonelli Sabina, 2014, Perspectives on Science, V22, P397, DOI 10.1162/POSC_a_00140; Li YM, 2013, INTEGR ZOOL, V8, P145, DOI 10.1111/1749-4877.12001; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; Liu ML, 2008, J AM WATER RESOUR AS, V44, P1193, DOI 10.1111/j.1752-1688.2008.00243.x; Loesch CR, 2012, J FISH WILDL MANAG, V3, P1, DOI 10.3996/032011-JFWM-020; Lovett GM, 2007, FRONT ECOL ENVIRON, V5, P253, DOI 10.1890/1540-9295(2007)5[253:WNEM]2.0.CO;2; McCaffery RM, 2014, BIOL CONSERV, V170, P169, DOI 10.1016/j.biocon.2013.12.013; McMaster GS, 1997, AGR FOREST METEOROL, V87, P291, DOI 10.1016/S0168-1923(97)00027-0; McMenamin SK, 2008, P NATL ACAD SCI USA, V105, P16988, DOI 10.1073/pnas.0809090105; Melchior RC, 2014, 20135165 US GEOL SUR, DOI [10.3133/sir20135165, DOI 10.3133/SIR20135165]; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Multi-Resolution Land Cover Characteristics Consortium, 2017, NAT LAND COV DAT; Muths E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17105-7; National Action Plan, 2011, PRIOR MAN FRESHW RES; National Research Council of the National Academy of Sciences, 2010, ADAPTING IMPACTS CLI; Nichols JD, 2011, J WILDLIFE MANAGE, V75, P6, DOI 10.1002/jwmg.33; NOAA b, 2016, TIM SER US CLIM DIV; Noonan MJ, 2015, GLOBAL CHANGE BIOL, V21, P3575, DOI 10.1111/gcb.12942; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Oren R, 2006, GLOBAL CHANGE BIOL, V12, P883, DOI 10.1111/j.1365-2486.2006.01131.x; Parmesan C, 2015, ANN BOT-LONDON, V116, P849, DOI 10.1093/aob/mcv169; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Primack RB, 2009, BIOL CONSERV, V142, P2569, DOI 10.1016/j.biocon.2009.06.003; Qian BD, 2010, J APPL METEOROL CLIM, V49, P604, DOI 10.1175/2009JAMC2275.1; Rains MC, 2016, HYDROL PROCESS, V30, P153, DOI 10.1002/hyp.10610; REED BC, 1994, J VEG SCI, V5, P703, DOI 10.2307/3235884; Reed B, 2009, REMOTE SENS ENVIRON, V113, P1443, DOI 10.1016/j.rse.2008.07.020; Reed BC, 2006, GISCI REMOTE SENS, V43, P24, DOI 10.2747/1548-1603.43.1.24; Renton DA, 2015, CLIMATE CHANGE PRAIR, V5004, P1, DOI [10.3133/sir20155004, DOI 10.3133/SIR20155004]; Riggs GA, 2006, MODIS SNOW PRODUCT U; Rittenhouse TAG, 2007, J HERPETOL, V41, P645, DOI 10.1670/07-015.1; Sadinski W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107018; Senay GB, 2008, J AM WATER RESOUR AS, V44, P969, DOI 10.1111/j.1752-1688.2008.00195.x; Senay GB, 2007, SENSORS-BASEL, V7, P979, DOI 10.3390/s7060979; Senay GB, 2013, J AM WATER RESOUR AS, V49, P577, DOI 10.1111/jawr.12057; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Srivastava SK, 1997, INT J REMOTE SENS, V18, P2931, DOI 10.1080/014311697217134; Studer S, 2007, INT J BIOMETEOROL, V51, P405, DOI 10.1007/s00484-006-0080-5; Swets DL, P 1999 ASPRS ANN C P; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; Thornton PE, 2012, DAYMET DAILY SURFACE; Todd BD, 2011, P ROY SOC B-BIOL SCI, V278, P2191, DOI 10.1098/rspb.2010.1768; Tucker CJ, 2001, INT J BIOMETEOROL, V45, P184, DOI 10.1007/s00484-001-0109-8; U.S. Fish and Wildlife Service (USFWS), 2010, RIS URG CHALL STRAT; van Leeuwen WJD, 2013, REMOTE SENS-BASEL, V5, P1177, DOI 10.3390/rs5031177; Vicente-Serrano SM, 2013, P NATL ACAD SCI USA, V110, P52, DOI 10.1073/pnas.1207068110; Waddle JH, 2009, HERPETOL CONSERV BIO, V4, P384; Wake DB, 2012, SCIENCE, V335, P1052, DOI 10.1126/science.1218364; Walls Susan C., 2013, Biology - Basel, V2, P399, DOI 10.3390/biology2010399; Walls SC, 2013, WETLANDS, V33, P345, DOI 10.1007/s13157-013-0391-3; Walpole AA, 2012, HERPETOL CONSERV BIO, V7, P249; Walter H., 1973, Vegetation of the earth in relation to climate and the eco-physiological conditions.; Wan Z., 2007, COLLECTION 5 MODIS L; White MA, 2009, GLOBAL CHANGE BIOL, V15, P2335, DOI 10.1111/j.1365-2486.2009.01910.x; Whitehead PG, 2009, HYDROLOG SCI J, V54, P101, DOI 10.1623/hysj.54.1.101; Winkler J. A., 2014, CLIMATE CHANGE MIDWE, P37; Wrona FJ, 2006, AMBIO, V35, P359, DOI 10.1579/0044-7447(2006)35[359:CCEOAB]2.0.CO;2; Yang LM, 1998, REMOTE SENS ENVIRON, V65, P25, DOI 10.1016/S0034-4257(98)00012-1; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x; Yang W, 1997, INT J REMOTE SENS, V18, P2161, DOI 10.1080/014311697217819; Zerger A, 2010, INT J APPL EARTH OBS, V12, P303, DOI 10.1016/j.jag.2010.05.001; Zhang XY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031447; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	126	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0201951	10.1371/journal.pone.0201951	http://dx.doi.org/10.1371/journal.pone.0201951			60	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192764	gold, Green Submitted, Green Published			2022-12-26	WOS:000444093600014
J	Watanabe, S; Ohtani, Y; Aoki, W; Uno, Y; Sukekiyo, Y; Kubokawa, S; Ueda, M				Watanabe, Sho; Ohtani, Yuta; Aoki, Wataru; Uno, Yuko; Sukekiyo, Yasunori; Kubokawa, Seiichi; Ueda, Mitsuyoshi			Detection of betacyanin in red-tube spinach (Spinacia oleracea) and its biofortification by strategic hydroponics	PLOS ONE			English	Article							BETA-VULGARIS L.; SUCROSE-SPECIFIC INDUCTION; HAIRY ROOT CULTURES; ABIOTIC ELICITORS; TRANSCRIPTION FACTORS; PHYTOLACCA-AMERICANA; SUSPENSION-CULTURES; BETALAINS; PIGMENTS; ANTHOCYANINS	Betacyanins have been reported as water-soluble, nitrogenous pigments found in the order Caryophyllales, and they are known for powerful natural antioxidant. The biofortification of secondary metabolites such as anthocyanins and betacyanins has recently been performed in food crops by metabolic engineering through genetic modification. However, the distribution of genetically modified foods is strictly regulated. Therefore, we aimed to develop a new method for biofortifying natural antioxidants, betacyanins, without genetic modification. We first detected the presence of betacyanins in red-tube spinach (Spinacia oleracea) through ultraviolet-visible spectroscopy and mass spectrometry. We then hydroponically cultivated plants in the presence of three candidate compounds for betacyanin biofortification: dopamine, Ca2+, and sucrose. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) and antioxidant activity analyses showed that sucrose was most successful in biofortifying betacyanins, and reverse transcription polymerase chain reaction (RT-PCR) indicated that several genes involved in betacyanin biosynthesis were induced by sucrose. Therefore, strategic hydroponics represents a new approach for cultivating betacyanin-enriched vegetables.	[Watanabe, Sho; Ohtani, Yuta; Aoki, Wataru; Ueda, Mitsuyoshi] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan; [Aoki, Wataru; Ueda, Mitsuyoshi] Kyoto Integrated Sci & Technol Bioanal Ctr, Shimogyo Ku, Kyoto, Japan; [Uno, Yuko; Sukekiyo, Yasunori; Kubokawa, Seiichi] Mitsubishi Chem, Chiyoda Ku, Tokyo, Japan	Kyoto University	Ueda, M (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan.; Ueda, M (corresponding author), Kyoto Integrated Sci & Technol Bioanal Ctr, Shimogyo Ku, Kyoto, Japan.	miueda@kais.kyoto-u.ac.jp		Aoki, Wataru/0000-0002-3118-9390; Watanabe, Sho/0000-0002-3277-097X	Mitsubishi chemical	Mitsubishi chemical	The funder (Mitsubishi chemical) provided spinach materials and support in the form of salaries for authors [YU, YS, and SK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Cai YZ, 2005, J CHROMATOGR SCI, V43, P454, DOI 10.1093/chromsci/43.9.454; Cai YZ, 2001, J AGR FOOD CHEM, V49, P1971; CHRISTOU P, 1989, PLANT PHYSIOL, V89, P564, DOI 10.1104/pp.89.2.564; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Harris NN, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-34; HIRANO H, 1994, PHYSIOL PLANTARUM, V90, P239, DOI 10.1111/j.1399-3054.1994.tb00383.x; James C., 2014, GLOBAL STATUS COMMER; Kapadia GJ, 2011, ANTI-CANCER AGENT ME, V11, P280; Khan MI, 2016, COMPR REV FOOD SCI F, V15, P316, DOI 10.1111/1541-4337.12185; Kobayashi N, 2001, PHYTOCHEMISTRY, V56, P429, DOI 10.1016/S0031-9422(00)00383-6; Kriznik B, 2010, ACTA BOT CROAT, V69, P173; Lai Yunsong, 2013, [Frontiers in Biology, 生物学前沿], V8, P577; Lakhotia P, 2014, INDIAN J HORTIC, V71, P373; Lee YM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101089; Lloyd A, 2017, PLANT CELL PHYSIOL, V58, P1431, DOI 10.1093/pcp/pcx075; MONROY MR, 1994, BIOTECHNOL LETT, V16, P853, DOI 10.1007/BF00133967; Moreno Diego A., 2008, Phytochemistry Reviews, V7, P261, DOI 10.1007/s11101-007-9084-y; Pavokovic D, 2011, FOOD TECHNOL BIOTECH, V49, P145; Pitta-Alvarez SI, 2000, ENZYME MICROB TECH, V26, P252, DOI 10.1016/S0141-0229(99)00137-4; Polturak G, 2017, P NATL ACAD SCI USA, V114, P9062, DOI 10.1073/pnas.1707176114; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; PROTACIO CM, 1992, PLANT PHYSIOL, V98, P89, DOI 10.1104/pp.98.1.89; SAKUTA M, 1987, PHYSIOL PLANTARUM, V71, P455, DOI 10.1111/j.1399-3054.1987.tb02883.x; Sakuta M, 2014, PLANT BIOTECHNOL REP, V8, P37, DOI 10.1007/s11816-013-0294-z; Savitha BC, 2006, PROCESS BIOCHEM, V41, P50, DOI 10.1016/j.procbio.2005.03.071; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Sreekanth D, 2007, PHYTOMEDICINE, V14, P739, DOI 10.1016/j.phymed.2007.03.017; Strack D, 2003, PHYTOCHEMISTRY, V62, P247, DOI 10.1016/S0031-9422(02)00564-2; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Tohge T, 2015, PLANT J, V83, P686, DOI 10.1111/tpj.12920; Van den Ende W, 2014, ENVIRON EXP BOT, V108, P4, DOI 10.1016/j.envexpbot.2013.09.017; Watanabe S, 2017, J AGR FOOD CHEM, V65, P4605, DOI 10.1021/acs.jafc.7b01375; Wybraniec S, 2005, J AGR FOOD CHEM, V53, P3483, DOI 10.1021/jf048088d; Xu CX, 2015, SCI REP-UK, V5, DOI 10.1038/srep17706	36	3	3	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203656	10.1371/journal.pone.0203656	http://dx.doi.org/10.1371/journal.pone.0203656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192863	Green Submitted, Green Published, gold			2022-12-26	WOS:000444093600128
J	Chung, CJ; Cha, SH; Grimm, AL; Ajithdoss, D; Rzepka, J; Chung, G; Yu, J; Davis, WC; Ho, CS				Chung, Chungwon J.; Cha, Sang-Ho; Grimm, Amanda L.; Ajithdoss, Dharani; Rzepka, Joanna; Chung, Grace; Yu, Jieun; Davis, William C.; Ho, Chak-Sum			Pigs that recover from porcine reproduction and respiratory syndrome virus infection develop cytotoxic CD4(+)CD8(+) and CD4(+)CD8(-) T-cells that kill virus infected cells	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; NONSTRUCTURAL PROTEINS; IMMUNE-RESPONSES; SWINE; PRRSV; VACCINE; IDENTIFICATION; EPITOPES; LYMPHOCYTES; CHALLENGE	Porcine reproductive and respiratory syndrome virus (PRRSV) infection is difficult to control because the virus undergoes antigenic variation during infection and also modulates the protective host immune response. Although current vaccines do not provide full protection, they have provided insight into the mechanisms of protection. Live PRRSV vaccines induce partial protection before the appearance of neutralizing antibody, suggesting cell-mediated immunity or other mechanisms may be involved. Herein, we demonstrate recovery from infection is associated with development of cytotoxic T-lymphocytes (CTL) that can kill PRRSV-infected target cells. Initial experiments showed survival of PRRSV-infected monocyte derived macrophage (MDM) targets is reduced when overlaid with peripheral blood mononuclear cells (PBMC) from gilts that had recovered from PRRSV infection. Further studies with PBMC depleted of either CD4(+) or CD8(+) T-cells and positively selected subpopulations of CD4(+) and CD8(+) T-cells showed that both CD4(+) and CD8(+) T-cells were involved in killing. Examination of killing at different time points revealed killing was biphasic and mediated by CTL of different phenotypes. CD4(+)CD8(+high) were associated with killing target cells infected for 3-6 hours. CD4(+)CD8(-) CTL were associated with killing at 16-24 hours. Thus, all the anti-PRRSV CTL activity in pigs was attributed to two phenotypes of CD4(+) cells which is different from the anti-viral CD4(-)CD8(+) CTL phenotype found in most other animals. These findings will be useful for evaluating CTL responses induced by current and future vaccines, guiding to a novel direction for future vaccine development.	[Chung, Chungwon J.; Ajithdoss, Dharani; Davis, William C.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Chung, Chungwon J.; Grimm, Amanda L.; Rzepka, Joanna; Chung, Grace] VMRD Inc, Pullman, WA 99163 USA; [Cha, Sang-Ho; Yu, Jieun] Anim & Plant Quarantine Agcy, Gimcheon, South Korea; [Ho, Chak-Sum] Gift Life Michigan, Ann Arbor, MI USA; [Chung, Chungwon J.] Plum Isl Anim Dis Ctr, Orient Point, NY 11957 USA	Washington State University; Animal & Plant Quarantine Agency	Chung, CJ (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.; Chung, CJ (corresponding author), VMRD Inc, Pullman, WA 99163 USA.; Cha, SH (corresponding author), Anim & Plant Quarantine Agcy, Gimcheon, South Korea.; Chung, CJ (corresponding author), Plum Isl Anim Dis Ctr, Orient Point, NY 11957 USA.	chungcw68@yahoo.com; virusmania@korea.kr		Chung, Chungwon/0000-0002-4525-5539	Animal and Plant Quarantine Agency (APQA); APQA; Washington State University, Institute for Animal and Plant Disease Research (APDR) in APQA; VMRD Inc.	Animal and Plant Quarantine Agency (APQA); APQA; Washington State University, Institute for Animal and Plant Disease Research (APDR) in APQA; VMRD Inc.	Animal and Plant Quarantine Agency (APQA) is a government agency including multiple institutes and units in Republic of Korea. The funding agency is one of units (Research planning and administration unit) in APQA. Our research project was funded to an international collaboration team including scientists in Washington State University, Institute for Animal and Plant Disease Research (APDR) in APQA and VMRD Inc. Two scientists in APDR truly contributed to crucial roles including conceptualization, study design, data collection/analysis, decision to publish, and preparation of the manuscript. Authors' affiliation with VMRD Inc. had specific contributions to development of flow cytometry and other assays as well as preparation of monoclonal antibodies.	Allende R, 2000, J VIROL, V74, P10834, DOI 10.1128/JVI.74.22.10834-10837.2000; An TQ, 2011, EMERG INFECT DIS, V17, P1782, DOI 10.3201/eid1709.110411; An TQ, 2010, EMERG INFECT DIS, V16, P365, DOI 10.3201/eid1602.090005; Batista L, 2004, CAN J VET RES, V68, P267; Bautista EM, 1999, ARCH VIROL, V144, P117, DOI 10.1007/s007050050489; Bautista EM, 1997, VIRAL IMMUNOL, V10, P83, DOI 10.1089/vim.1997.10.83; Brar MS, 2015, J GEN VIROL, V96, P1570, DOI 10.1099/vir.0.000104; Brar MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088807; Burgara-Estrella A, 2013, VIRUSES-BASEL, V5, P663, DOI 10.3390/v5020663; Charerntantanakul Wasin, 2012, World J Virol, V1, P23, DOI 10.5501/wjv.v1.i1.23; CHRISTIANSON WT, 1992, AM J VET RES, V53, P485; Chung C, 2014, P 23 INT PIG VET SOC, P286; Chung C, 2007, J VIROL, V81, P1517, DOI 10.1128/JVI.01780-06; Chung CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165450; Costers S, 2009, VET RES, V40, DOI 10.1051/vetres/2009029; Diaz I, 2009, VACCINE, V27, P5603, DOI 10.1016/j.vaccine.2009.07.029; Duan X, 1997, VET MICROBIOL, V56, P9, DOI 10.1016/S0378-1135(96)01347-8; Feng WH, 2001, J VIROL, V75, P4889, DOI 10.1128/JVI.75.10.4889-4895.2001; Franzoni G, 2013, CLIN VACCINE IMMUNOL, V20, P1604, DOI 10.1128/CVI.00415-13; Fuertes LL, 1999, VIRUS RES, V64, P33, DOI 10.1016/S0168-1702(99)00073-8; Geldhof MF, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-182; Gerner W, 2015, MOL IMMUNOL, V66, P3, DOI 10.1016/j.molimm.2014.10.025; Grimm AL, 2015, P 7 INT S EM RE EM P, P127; Ho CS, 2010, ANIM GENET, V41, P428, DOI 10.1111/j.1365-2052.2010.02019.x; Ho CS, 2009, ANIM GENET, V40, P468, DOI 10.1111/j.1365-2052.2009.01860.x; Holtkamp DJ, 2008, P 20 INT PIG VET SOC, P86; Jeong HJ, 2010, CLIN VACCINE IMMUNOL, V17, P503, DOI 10.1128/CVI.00365-09; Karniychuk UU, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-30; Leng X, 2012, CLIN VACCINE IMMUNOL, V19, P1199, DOI 10.1128/CVI.05646-11; Li B, 2009, EMERG INFECT DIS, V15, P2032, DOI 10.3201/eid1512.090390; Li J, 2012, VIROLOGY, V433, P367, DOI 10.1016/j.virol.2012.08.026; Li YH, 2014, P NATL ACAD SCI USA, V111, pE2172, DOI 10.1073/pnas.1321930111; Li YH, 2012, J GEN VIROL, V93, P829, DOI 10.1099/vir.0.039289-0; Loffredo JT, 2005, J VIROL, V79, P14986, DOI 10.1128/JVI.79.23.14986-14991.2005; Lohse L, 2004, VIRAL IMMUNOL, V17, P594, DOI 10.1089/vim.2004.17.594; Lopez OJ, 2007, CLIN VACCINE IMMUNOL, V14, P269, DOI 10.1128/CVI.00304-06; Meier WA, 2003, VIROLOGY, V309, P18, DOI 10.1016/S0042-6822(03)00009-6; Meng XJ, 2000, VET MICROBIOL, V74, P309, DOI 10.1016/S0378-1135(00)00196-6; Metwally S, 2010, TRANSBOUND EMERG DIS, V57, P315, DOI 10.1111/j.1865-1682.2010.01152.x; Mokhtar H, 2014, VACCINE, V32, P6828, DOI 10.1016/j.vaccine.2014.04.054; Morgan SB, 2013, VET MICROBIOL, V163, P13, DOI 10.1016/j.vetmic.2012.11.024; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Ni JQ, 2012, J VET DIAGN INVEST, V24, P349, DOI 10.1177/1040638711434111; Nielsen HS, 2001, J GEN VIROL, V82, P1263, DOI 10.1099/0022-1317-82-6-1263; OIE, 2015, MAN DIAGN TESTS VACC; Opriessnig T, 2002, J VIROL, V76, P11837, DOI 10.1128/JVI.76.23.11837-11844.2002; ORENTAS RJ, 1990, SCIENCE, V248, P1234, DOI 10.1126/science.2190315; Packard BZ, 2007, J IMMUNOL, V179, P3812, DOI 10.4049/jimmunol.179.6.3812; Packard BZ, 1996, P NATL ACAD SCI USA, V93, P11640, DOI 10.1073/pnas.93.21.11640; Parida R, 2012, VIRUS RES, V169, P13, DOI 10.1016/j.virusres.2012.06.024; Park C, 2014, VET MICROBIOL, V172, P432, DOI 10.1016/j.vetmic.2014.05.030; Patch JR, 2013, VIRAL IMMUNOL, V26, P239, DOI 10.1089/vim.2013.0011; PAULY T, 1995, J GEN VIROL, V76, P3039, DOI 10.1099/0022-1317-76-12-3039; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shi M, 2013, J VIROL, V87, P10904, DOI 10.1128/JVI.01270-13; Shi M, 2010, VIRUS RES, V154, P7, DOI 10.1016/j.virusres.2010.08.014; Shimizu M, 1996, VET IMMUNOL IMMUNOP, V50, P19, DOI 10.1016/0165-2427(95)05494-4; Talker SC, 2013, DEV COMP IMMUNOL, V40, P51, DOI 10.1016/j.dci.2013.01.003; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Tong GZ, 2007, EMERG INFECT DIS, V13, P1434, DOI 10.3201/eid1309.070399; Van Breedam W, 2010, J GEN VIROL, V91, P1659, DOI 10.1099/vir.0.020503-0; Van Gorp H, 2008, J GEN VIROL, V89, P2943, DOI 10.1099/vir.0.2008/005009-0; Vashisht K, 2008, VACCINE, V26, P4747, DOI 10.1016/j.vaccine.2008.06.047; Wang YX, 2011, VIRUS RES, V158, P108, DOI 10.1016/j.virusres.2011.03.018; Weesendorp E, 2013, VET MICROBIOL, V163, P1, DOI 10.1016/j.vetmic.2012.09.013; Wei YW, 2013, VET MICROBIOL, V166, P337, DOI 10.1016/j.vetmic.2013.05.014; Welch SKW, 2010, VIRUS RES, V154, P98, DOI 10.1016/j.virusres.2010.07.018; Zapata JM, 1998, J BIOL CHEM, V273, P6916, DOI 10.1074/jbc.273.12.6916; Zheng N, 2009, J VIROL, V83, P7668, DOI 10.1128/JVI.00513-09; Zuckermann FA, 2007, VET MICROBIOL, V123, P69, DOI 10.1016/j.vetmic.2007.02.009	70	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203482	10.1371/journal.pone.0203482	http://dx.doi.org/10.1371/journal.pone.0203482			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188946	Green Submitted, Green Published, gold			2022-12-26	WOS:000444228700037
J	Bijak, AL; van Dijk, KJ; Waycott, M				Bijak, Alexandra L.; van Dijk, Kor-jent; Waycott, Michelle			Population structure and gene flow of the tropical seagrass, Syringodium filiforme, in the Florida Keys and subtropical Atlantic region	PLOS ONE			English	Article							BANKS EX KONIG; GULF-OF-MEXICO; THALASSIA-TESTUDINUM; HALODULE-WRIGHTII; GLACIER FORELANDS; PLANT-POPULATIONS; SPECIES COMPLEX; ZOSTERA-MARINA; TIDAL CHANNELS; SOUTH FLORIDA	Evaluating genetic diversity of seagrasses provides insight into reproductive mode and adaptation potential, and is therefore integral to broader conservation strategies for coastal ecosystems. In this study, we assessed genetic diversity, population structure and gene flow in an opportunistic seagrass, Syringodium filiforme, in the Florida Keys and subtropical Atlantic region. We used microsatellite markers to analyze 20 populations throughout the Florida Keys, South Florida, Bermuda and the Bahamas primarily to understand how genetic diversity of S. filiforme partitions across the Florida Keys archipelago. We found low allelic diversity within populations, detecting 35-106 alleles across all populations, and in some instances moderately high clonal diversity (R = 0.04-0.62). There was significant genetic differentiation between Atlantic and Gulf of Mexico (Gulf) populations (F-ST = 0.109 +/- 0.027, p-value = 0.001) and evidence of population structure based on cluster assignment, dividing the region into two major genetic demes. We observed asymmetric patterns in gene flow, with a few instances in which there was higher than expected gene flow from Atlantic to Gulf populations. In South Florida, clustering into Gulf and Atlantic groups indicate dispersal in S. filiforme may be limited by historical or contemporary geographic and hydrologic barriers, though genetic admixture between populations suggests exchange may occur between narrow channels in the Florida Keys, or has occurred through other mechanisms in recent evolutionary history, maintaining regional connectivity. The variable genotypic diversity, low genetic diversity and evidence of population structure observed in populations of S. filiforme resemble the population genetics expected for a colonizer species.	[Bijak, Alexandra L.] Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA; [van Dijk, Kor-jent; Waycott, Michelle] Univ Adelaide, Sch Biol Sci, Inst Environm, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia; [Waycott, Michelle] State Herbarium South Australia, Dept Environm Water & Nat Resources, Adelaide, SA, Australia	University of Virginia; University of Adelaide	Bijak, AL (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	alb5bd@virginia.edu	Waycott, Michelle/AAR-8809-2021	Waycott, Michelle/0000-0002-0822-0564	Jones Environmental Research Endowment	Jones Environmental Research Endowment	Financial support for this study was provided by the Jones Environmental Research Endowment to the Department of Environmental Sciences at the University of Virginia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala N, 2014, THEOR POPUL BIOL, V93, P75, DOI 10.1016/j.tpb.2014.02.003; Angel R, 2002, AQUAT BOT, V74, P165, DOI 10.1016/S0304-3770(02)00079-7; [Anonymous], 2002, EVERGLADES FLORIDA B; [Anonymous], 2014, R LANG ENV STAT COMP; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2005, J HERED, V96, P434, DOI 10.1093/jhered/esi043; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; AVISE JC, 1992, OIKOS, V63, P62, DOI 10.2307/3545516; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; BARRETT SCH, 1993, AQUAT BOT, V44, P105, DOI 10.1016/0304-3770(93)90068-8; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Bijak AL, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400082; Billingham MR, 2003, MAR ECOL PROG SER, V265, P77, DOI 10.3354/meps265077; Briceno HO, 2013, MAR POLLUT BULL, V75, P187, DOI 10.1016/j.marpolbul.2013.07.034; Bricker E, 2011, MAR ECOL PROG SER, V423, P57, DOI 10.3354/meps08962; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Creed J. C., 2003, WORLD ATLAS SEAGRASS, P234; Diekmann OE, 2012, MOL ECOL, V21, P1647, DOI 10.1111/j.1365-294X.2012.05500.x; Digiantonio G.B., 2017, THESIS; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; Duffy JE, 2006, MAR ECOL PROG SER, V311, P233, DOI 10.3354/meps311233; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FELDER DL, 1994, J CRUSTACEAN BIOL, V14, P191, DOI 10.2307/1548900; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Fourqurean JW, 2003, ECOL APPL, V13, P474, DOI 10.1890/1051-0761(2003)013[0474:FROSDT]2.0.CO;2; Fourqurean JW, 2001, MAR BIOL, V138, P341, DOI 10.1007/s002270000448; Giles BE, 1997, AM NAT, V149, P507, DOI 10.1086/286002; Gray Alan, 1996, Biodiversity Letters, V3, P71, DOI 10.2307/2999720; Hall MO, 2016, MAR ECOL PROG SER, V560, P243, DOI 10.3354/meps11923; Hall MO, 1999, ESTUARIES, V22, P445, DOI 10.2307/1353210; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hughes AR, 2011, J ECOL, V99, P445, DOI 10.1111/j.1365-2745.2010.01767.x; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Johansen JD., 2002, SIGNS USE INTRO SEMI, P246; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2006, CONSERV GENET, V7, P991, DOI 10.1007/s10592-006-9134-9; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kendall MS, 2004, AQUAT BOT, V78, P15, DOI 10.1016/j.aquabot.2003.09.004; Kendrick GA, 2005, MAR ECOL PROG SER, V290, P291, DOI 10.3354/meps290291; Kendrick GA, 2017, BIOL REV, V92, P921, DOI 10.1111/brv.12261; Kendrick GA, 2012, BIOSCIENCE, V62, P56, DOI 10.1525/bio.2012.62.1.10; Kilminster K, 2015, SCI TOTAL ENVIRON, V534, P97, DOI 10.1016/j.scitotenv.2015.04.061; Kirsten JH, 1998, AQUAT BOT, V61, P269, DOI 10.1016/S0304-3770(98)00070-9; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; van Dijk JK, 2009, MAR ECOL PROG SER, V390, P67, DOI 10.3354/meps08190; Kurokochi H, 2016, CONSERV GENET, V17, P103, DOI 10.1007/s10592-015-0764-7; Larkin PD, 2017, MAR ECOL PROG SER, V567, P95, DOI 10.3354/meps12037; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Lee T, 2004, MOL ECOL, V13, P3527, DOI 10.1111/j.1365-294X.2004.02337.x; Lee TN, 2002, CONT SHELF RES, V22, P1361, DOI 10.1016/S0278-4343(02)00003-1; Lee TN, 1999, B MAR SCI, V64, P35; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; Lewis RR, 1985, TAMPA BAY AREA SCI I, P210; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Marba N, 1998, MAR ECOL PROG SER, V174, P269, DOI 10.3354/meps174269; Mathews LM, 2006, MOL ECOL, V15, P4049, DOI 10.1111/j.1365-294X.2006.03077.x; MCCOMMAS SA, 1982, MAR BIOL, V68, P169, DOI 10.1007/BF00397603; McMahon K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0878; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Oliva S, 2014, MOL ECOL, V23, P5698, DOI 10.1111/mec.12973; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; PARKS JC, 1993, AM J BOT, V80, P537, DOI 10.2307/2445369; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PETUCH EJ, 1982, PALAEOGEOGR PALAEOCL, V37, P277, DOI 10.1016/0031-0182(82)90041-4; Pritchard JK, 2000, GENETICS, V155, P945; Raffl C, 2008, HEREDITY, V100, P526, DOI 10.1038/hdy.2008.8; Raffl C, 2006, MOL ECOL, V15, P2433, DOI 10.1111/j.1365-294X.2006.02964.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; ROBBLEE MB, 1991, MAR ECOL PROG SER, V71, P297, DOI 10.3354/meps071297; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sargent F. J., 1995, TR1 FMRI; Schlueter MA, 1998, AQUAT BOT, V61, P147, DOI 10.1016/S0304-3770(98)00063-1; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; Sherwood ET, 2017, SOUTHEAST GEOGR, V57, P294, DOI 10.1353/sgo.2017.0026; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Sinclair EA, 2014, MAR ECOL PROG SER, V506, P87, DOI 10.3354/meps10812; SMITH NP, 1994, B MAR SCI, V54, P602; Sundqvist L, 2016, ECOL EVOL, V6, P3461, DOI 10.1002/ece3.2096; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WILLIAMS SL, 1990, ECOL MONOGR, V60, P449, DOI 10.2307/1943015; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yeung C, 2002, FISH OCEANOGR, V11, P286, DOI 10.1046/j.1365-2419.2002.00209.x; Young AM, 2002, MAR BIOL, V140, P1059, DOI 10.1007/s00227-002-0780-2; Zieman JC, 1999, ESTUARIES, V22, P460, DOI 10.2307/1353211	88	5	5	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203644	10.1371/journal.pone.0203644	http://dx.doi.org/10.1371/journal.pone.0203644			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183774	gold, Green Submitted, Green Published			2022-12-26	WOS:000443789900079
J	Mu, XX; Zhang, CL; Zhang, C; Xu, BD; Xue, Y; Ren, YP				Mu, Xiuxia; Zhang, Chongliang; Zhang, Chi; Xu, Binduo; Xue, Ying; Ren, Yiping			Age determination for whitespotted conger Conger myriaster through somatic and otolith morphometrics	PLOS ONE			English	Article							FISH SIZE; GROWTH; EEL; FISHERIES	It is difficult to determine ages of eels via otoliths, because multiple alternating translucent and opaque zones in the otoliths are hard to identify. In this study, we developed an efficient age determination method for whitespotted conger (Conger myriaster), using random forest models with otolith weight and length, total body length, capture location and season as predictors. 409 specimens were collected from six locations in Yellow and East China Sea between October 2016 and December 2017. Overall OOB error rate was 17.36% compared with 16.26% for the external cross-validation dataset, and the error of age was within one year. Otolith weight and total length were the most important predictors, followed by otolith length, capture locations and seasons. There were no significant differences between the results derived from otolith/somatic morphometrics and otoliths annuli in the estimation of age composition and von Betalanffy Growth Functions growth curve. Our results demonstrated that random forest model with otolith and somatic morphometrics is an efficient and reliable approach for age determination of C. myriaster, which may also be applied to other eel species.	[Mu, Xiuxia; Zhang, Chongliang; Zhang, Chi; Xu, Binduo; Xue, Ying; Ren, Yiping] Ocean Univ China, Coll Fisheries, Qingdao, Shandong, Peoples R China; [Ren, Yiping] Natl Lab Marine Sci & Technol, Lab Marine Sci & Food Prod Proc, Qingdao, Shandong, Peoples R China	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Ren, YP (corresponding author), Ocean Univ China, Coll Fisheries, Qingdao, Shandong, Peoples R China.; Ren, YP (corresponding author), Natl Lab Marine Sci & Technol, Lab Marine Sci & Food Prod Proc, Qingdao, Shandong, Peoples R China.	renyip@ouc.edu.cn		Ren, Yiping/0000-0003-2482-0284; Zhang, Chongliang/0000-0002-4753-9973	Fundamental Research Funds for the National Natural Science Foundation of China [31772852]; Fundamental Research Funds for the Central Universities [201562030]	Fundamental Research Funds for the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Fundamental Research Funds for the National Natural Science Foundation of China (Grant No 31772852), http://fund.sciencenet.cn/index.php/item/view/555947/, the Fundamental Research Funds for the Central Universities (Grant No. 201562030).	ANDERSON JR, 1992, AUST J MAR FRESH RES, V43, P983, DOI 10.1071/MF9920983; Bae JH, 2018, J APPL ICHTHYOL, V34, P542, DOI 10.1111/jai.13587; Benchetrit J, 2017, ECOL FRESHW FISH, V26, P19, DOI 10.1111/eff.12246; Bermejo S, 2017, COMPUT ELECTRON AGR, V134, P27, DOI 10.1016/j.compag.2017.01.007; Bermejo S, 2014, COMPUT ELECTRON AGR, V107, P1, DOI 10.1016/j.compag.2014.06.001; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen DG, 1991, FISH ECOLOGY YELLOW; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Correia AT, 2009, FISH RES, V99, P196, DOI 10.1016/j.fishres.2009.06.002; DOERING P, 1990, INT REV GES HYDROBIO, V75, P737, DOI 10.1002/iroh.19900750607; Dub JD, 2013, CAN J FISH AQUAT SCI, V70, P1396, DOI 10.1139/cjfas-2013-0169; Francis RICC, 2004, CAN J FISH AQUAT SCI, V61, P1269, DOI [10.1139/f04-063, 10.1139/F04-063]; Gorie Shigeaki, 2004, Suisan Zoshoku, V52, P407; Hanson SD, 2017, T AM FISH SOC, V146, P778, DOI 10.1080/00028487.2017.1310138; HOOD PB, 1988, MAR BIOL, V98, P587, DOI 10.1007/BF00391549; Katayama S, 2002, ICHTHYOL RES, V49, P81, DOI 10.1007/s102280200009; Kim Yeong Hye, 2011, Korean Journal of Fisheries and Aquatic Sciences, V44, P689; Kubota S. S., 1961, Journal of the Faculty of Fisheries University of Mie, V5, P190; Lee TW, 1996, MAR BIOL, V125, P259, DOI 10.1007/BF00346306; Lepak JM, 2012, CAN J FISH AQUAT SCI, V69, P1569, DOI 10.1139/F2012-081; Lythgoe J, 1971, FISHES SEA COASTAL W; Maceina MJ, 2007, FISHERIES, V32, P329, DOI 10.1577/1548-8446(2007)32[329:CSAROF]2.0.CO;2; O'Sullivan S, 2003, FISH RES, V64, P55, DOI 10.1016/S0165-7836(03)00100-0; OGDEN JC, 1970, T AM FISH SOC, V99, P54, DOI 10.1577/1548-8659(1970)99<54:RAFHAA>2.0.CO;2; Ogle DH, 2016, INTRO FISHERIES ANAL, V32; Quintanilla JM, 2014, FISH RES, V157, P7, DOI 10.1016/j.fishres.2014.03.012; RADTKE RL, 1985, J EXP MAR BIOL ECOL, V90, P259, DOI 10.1016/0022-0981(85)90171-6; SECOR DH, 1989, CAN J FISH AQUAT SCI, V46, P113, DOI 10.1139/f89-015; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Takai T, 1959, J SHIMONOSEKI COLL F, V8, P1; Tokimura M, 2001, NIPPON SUISAN GAKK, V67, P125; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; Williams AJ, 2015, ICES J MAR SCI, V72, P2098, DOI 10.1093/icesjms/fsv042; Wu C.W, 1988, J ZHEJIANG FISH COLL, V6, P19; Zan XX, 2015, J APPL ICHTHYOL, V31, P544, DOI 10.1111/jai.12751	35	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203537	10.1371/journal.pone.0203537	http://dx.doi.org/10.1371/journal.pone.0203537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183762	Green Submitted, Green Published, gold			2022-12-26	WOS:000443789900070
J	Sanchez-Fernandez, MDM; del Paso, GAR; Gil-Cunquero, JM; Fernandez-Serrano, MJ				del Mar Sanchez-Fernandez, Maria; Reyes del Paso, Gustavo A.; Manuel Gil-Cunquero, Jose; Jose Fernandez-Serrano, Maria			Executive function in end-stage renal disease: Acute effects of hemodialysis and associations with clinical factors	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; QUALITY-OF-LIFE; COGNITIVE FUNCTION; PSYCHOMOTOR FUNCTIONS; DIALYSIS PATIENTS; DIALYZED PATIENTS; TRANSPLANTATION; IMPAIRMENT; HYPONATREMIA; COMPONENTS	Objective There is evidence of cognitive impairment in patients with end-stage renal disease in hemodialysis (ESRD-HD). However, few studies have exhaustively analyzed executive functions (EFs) in this population, especially considering the influence of a wide range of clinical variables. This study analyzes performance in different EF components in ESRD-HD patients compared to a group of healthy controls (HCs), in addition to the acute effects of HD and the associations of cognitive performance with clinical variables. Method EFs were evaluated pre- and post-HD in 43 ESRD-HD patients and 42 HCs, using a battery of tests designed to assess EF domains. Age, schooling, mood and blood pressure were statistically controlled. Associations between performance and clinical factors were computed by correlations and hierarchical multiple regression analyses. Results The performance of the ESRD-HD patients was significantly lower than that of HCs in all the EF domains except for planning. Group differences were marginally significant for reasoning. HD produced no acute changes in global performance, with improvements see only in inhibition and working memory. EF scores were positively associated with total number of months previously transplanted, body mass index (BMI), dry weight, and levels of hemoglobin, albumin, ferritin, calcium, phosphorus, sodium, urea, and creatinine. Conclusions Global EF functioning was lower in ESRD-HD patients than in HCs. No major acute HD-related EF changes were detected. These findings underline the importance of an adequate nutritional status for maintaining executive functioning in ESRD-HD patients.	[del Mar Sanchez-Fernandez, Maria; Reyes del Paso, Gustavo A.; Jose Fernandez-Serrano, Maria] Univ Jaen, Dept Psychol, Jaen, Spain; [Manuel Gil-Cunquero, Jose] Jaen Hosp Complex, Dept Nephrol, Jaen, Spain	Universidad de Jaen; Complejo Hospitalario de Jaen	Sanchez-Fernandez, MDM (corresponding author), Univ Jaen, Dept Psychol, Jaen, Spain.	mmsanche@ujaen.es	Serrano, M Josefa Fernández/V-3124-2019; Reyes del Paso, Gustavo A./G-4179-2011; Fernandez-Serrano, Maria Jose/AGA-6711-2022	Serrano, M Josefa Fernández/0000-0002-6158-237X; Reyes del Paso, Gustavo A./0000-0002-2188-8673; 	Council of Equality, Health, and Social Policy, Junta de Andalucia [PI-0674-2012]	Council of Equality, Health, and Social Policy, Junta de Andalucia	This research was supported by grant PI-0674-2012 from the Council of Equality, Health, and Social Policy, Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albabtain M, 2016, MED SCI MONITOR, V22, P4978, DOI 10.12659/MSM.898538; Anwar W, 2015, NEFROLOGIA, V35, P567, DOI [10.1016/j.nefro.2015.07.004, 10.1016/j.nefroe.2015.09.005]; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Benton A, 1978, PSYCHOL ASSESSMENT R; Caro I., 1992, BOL PSICOL, V36, P43; Cortese S, 2014, POSTGRAD MED, V126, P155, DOI 10.3810/pgm.2014.07.2793; Costa AS, 2014, AM J KIDNEY DIS, V64, P434, DOI 10.1053/j.ajkd.2014.02.012; Darcet F, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9010009; Filiopoulos Vasilis, 2009, Inflammation & Allergy Drug Targets, V8, P369; Gelb S, 2008, NEPHROL DIAL TRANSPL, V23, P1032, DOI 10.1093/ndt/gfm659; Giang LM, 2011, AM J NEPHROL, V33, P33, DOI 10.1159/000322611; Gilbert SJ, 2008, CURR BIOL, V18, pR110, DOI 10.1016/j.cub.2007.12.014; Grant DA, 1993, WISCONSIN CARD SORTI; Griva K, 2003, HEALTH PSYCHOL, V22, P570, DOI 10.1037/0278-6133.22.6.570; Griva K, 2006, NEPHROL DIAL TRANSPL, V21, P3275, DOI 10.1093/ndt/gfl385; Gupta A, 2016, AM J NEPHROL, V43, P50, DOI 10.1159/000444334; Harciarek M, 2012, J INT NEUROPSYCH SOC, V18, P162, DOI 10.1017/S1355617711001445; Harciarek M, 2009, J INT NEUROPSYCH SOC, V15, P684, DOI 10.1017/S1355617709990221; Hoffmann A, 2017, BRAIN COGNITION, V118, P108, DOI 10.1016/j.bandc.2017.08.003; Huarte-Loza E., 2006, DIAL TRASPL, V27, P138; Fernandez-Serrano MJ, 2010, J PSYCHOPHARMACOL, V24, P1317, DOI 10.1177/0269881109349841; Koushik NS, 2010, NEUROPSYCHOL REV, V20, P33, DOI 10.1007/s11065-009-9110-5; Lee SY, 2004, J PSYCHOSOM RES, V57, P5, DOI 10.1016/S0022-3999(03)00528-2; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Montilla CMP, 2016, NEFROLOGIA, V36, P275, DOI 10.1016/j.nefro.2015.12.002; Pereira Arema A, 2007, Hemodial Int, V11, P309, DOI 10.1111/j.1542-4758.2007.00185.x; Pi HC, 2016, KIDNEY BLOOD PRESS R, V41, P986, DOI 10.1159/000452603; Post JB, 2012, AM J NEPHROL, V35, P120, DOI 10.1159/000334871; Radic J, 2010, NETH J MED, V68, P153; Radic J, 2011, THER APHER DIAL, V15, P532, DOI 10.1111/j.1744-9987.2011.00995.x; Radic J, 2011, AM J NEPHROL, V34, P399, DOI 10.1159/000330849; Ruff R. M., 1996, RUFF FIGURAL FLUENCY; Schneider SM, 2015, SEMIN NEPHROL, V35, P304, DOI 10.1016/j.semnephrol.2015.06.002; Schneider SM, 2015, NEPHROL DIAL TRANSPL, V30, P1551, DOI 10.1093/ndt/gfv213; SEDO M, 2005, TEST CINCO DIGITOS 5; Shavit L, 2014, CLIN NEPHROL, V82, P313, DOI 10.5414/CN108335; Tamura MK, 2013, AM J KIDNEY DIS, V61, P228, DOI 10.1053/j.ajkd.2012.09.009; Thornton WL, 2007, J INT NEUROPSYCH SOC, V13, P344, DOI 10.1017/S1355617707070361; Verdejo-Garcia A, 2007, PSYCHOPHARMACOLOGY, V190, P517, DOI 10.1007/s00213-006-0632-8; Wechsler D, 1997, ESCALA INTELIGENCIA; Wilson BA, 1996, BEHARIORAL ASSESSMEN	42	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0203424	10.1371/journal.pone.0203424	http://dx.doi.org/10.1371/journal.pone.0203424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT1IK	30180208	Green Published, gold, Green Submitted			2022-12-26	WOS:000444222400041
J	Vancampfort, D; Smith, L; Stubbs, B; Swinnen, N; Firth, J; Schuch, FB; Koyanagi, A				Vancampfort, Davy; Smith, Lee; Stubbs, Brendon; Swinnen, Nathalie; Firth, Joseph; Schuch, Felipe B.; Koyanagi, Ai			Associations between active travel and physical multi-morbidity in six low- and middle-income countries among community-dwelling older adults: A cross-sectional study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; MAJOR DEPRESSIVE DISORDER; SKELETAL-MUSCLE MASS; SEDENTARY BEHAVIOR; NONCOMMUNICABLE DISEASES; GENERAL-POPULATION; MULTIMORBIDITY; HEALTH; PEOPLE; METAANALYSIS	Background There is little evidence on the potential health benefits of active travel in low- and middle-income countries (LMICs). The aim of this study was to assess the association between levels of active travel and physical multi-morbidity (i.e., two or more chronic physical conditions) and individual physical conditions among community-dwelling adults aged 65 or older in six LMICs. Methods Data were analyzed from the World Health Organization's Study on Global Ageing and Adult Health (China, Ghana, India, Mexico, Russia, South Africa). Active travel (minutes/week) was assessed with questions of the Global Physical Activity Questionnaire (GPAQ) and presented in tertiles. Eleven chronic conditions (angina, arthritis, asthma, chronic back pain, chronic lung disease, diabetes, edentulism, hearing problems, hypertension, stroke, visual impairment) were assessed by self-report of diagnosis, symptoms, or blood pressure measurement. Multivariable logistic regression analysis was conducted to assess the association between levels of active travel, physical conditions and physical multi-morbidity. Results The final sample consisted of 14,585 individuals aged >= 65 years (mean age = 72.6 +/- 0.1 years; 54.9% female). In the fully adjusted model, compared to the highest tertile, those in the lowest tertile of active travel had a 1.28 (95%CI = 1.06-1.54) times higher odds for physical multi-morbidity. The association between active travel and physical multi-morbidity was significantly mediated by affect (14.4%) and cognition (9.7%). With regard to individual conditions, hearing problems, hypertension, stroke, and visual impairment were particularly strongly associated with less active travel. Conclusion The current data suggest that lower levels of active travel are associated with the presence of physical health conditions and physical multi-morbidity. This multi-national study offers potentially valuable insight for a number of hypotheses which may influence this relationship, although testing with longitudinal studies is needed.	[Vancampfort, Davy; Swinnen, Nathalie] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [Vancampfort, Davy; Swinnen, Nathalie] Katholieke Univ Leuven, Univ Psychiat Ctr, Kortenberg, Belgium; [Smith, Lee] Anglia Ruskin Univ, Cambridge Ctr Sport & Exercise Sci, Dept Life Sci, Cambridge, England; [Stubbs, Brendon] South London & Maudsley NHS Fdn Trust, Physiotherapy Dept, Denmark Hill, London, England; [Stubbs, Brendon] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, London, England; [Stubbs, Brendon] Anglia Ruskin Univ, Fac Hlth Social Care & Educ, Chelmsford, Essex, England; [Firth, Joseph] Univ Western Sydney, Sch Sci & Hlth, NICM Hlth Res Unit, Sydney, NSW, Australia; [Firth, Joseph] Univ Manchester, Fac Biol Med & Hlth, Div Psychol & Mental Hlth, Manchester, Lancs, England; [Schuch, Felipe B.] Univ La Salle Unilasalle, Canoas, Brazil; [Schuch, Felipe B.] Escola Educ Fis Fisioterapia & Danca, Porto Alegre, RS, Brazil; [Schuch, Felipe B.] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Koyanagi, Ai] Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, CIBERSAM, Madrid, Spain; [Koyanagi, Ai] Univ Barcelona, Res & Dev Unit, Fundacio St Joan Deu, Barcelona, Spain	KU Leuven; KU Leuven; Anglia Ruskin University; University of London; King's College London; Anglia Ruskin University; Western Sydney University; University of Manchester; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; University of Barcelona	Vancampfort, D (corresponding author), Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium.; Vancampfort, D (corresponding author), Katholieke Univ Leuven, Univ Psychiat Ctr, Kortenberg, Belgium.	davy.vancampfort@kuleuven.be	Koyanagi, Ai/D-3833-2018; Firth, Joseph/ABE-6809-2020; Vancampfort, Davy/AAD-1987-2019; Stubbs, Brendon/X-1904-2018; Vancampfort, Davy/ABF-2439-2020; Schuch, Felipe/AAH-2586-2019; Schuch, Felipe/AAF-5028-2019	Koyanagi, Ai/0000-0002-9565-5004; Firth, Joseph/0000-0002-0618-2752; Stubbs, Brendon/0000-0001-7387-3791; Vancampfort, Davy/0000-0002-4592-8625; Schuch, Felipe/0000-0002-5190-4515; Schuch, Felipe/0000-0002-5190-4515; Swinnen, Nathalie/0000-0003-0087-8967	ISCIII General Branch Evaluation and Promotion of Health Research; European Regional Development Fund (ERDF-FEDER); National Institute for Health Research Collaboration for Leadership in Applied Health Research & Care Funding scheme;  [CP13/00150];  [PI15/00862]	ISCIII General Branch Evaluation and Promotion of Health Research; European Regional Development Fund (ERDF-FEDER)(European Commission); National Institute for Health Research Collaboration for Leadership in Applied Health Research & Care Funding scheme; ; 	Ai Koyanagi's work is supported by the Miguel Servet contract financed by the CP13/00150 and PI15/00862 projects, integrated into the National R + D + I and funded by the ISCIII General Branch Evaluation and Promotion of Health Research - and the European Regional Development Fund (ERDF-FEDER). Brendon Stubbs receives funding from the National Institute for Health Research Collaboration for Leadership in Applied Health Research & Care Funding scheme. The funders had no role in: design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; An KO, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.07.005; Arokiasamy P, 2017, AM J EPIDEMIOL, V185, P414, DOI 10.1093/aje/kww125; Arokiasamy P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0402-8; Bertheussen GF, 2011, MED SCI SPORT EXER, V43, P1220, DOI 10.1249/MSS.0b013e318206c66e; Breen R, 2013, SOCIOL METHOD RES, V42, P164, DOI 10.1177/0049124113494572; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; de Souto Barreto P, 2017, J GERONTOL A-BIOL; Foong YC, 2016, J CACHEXIA SARCOPENI, V7, P275, DOI 10.1002/jcsm.12065; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Freeman EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063315; Garin N, 2016, J GERONTOL A-BIOL, V71, P205, DOI 10.1093/gerona/glv128; Gispen FE, 2014, J AM GERIATR SOC, V62, P1427, DOI 10.1111/jgs.12938; Hamer M, 2008, PREV MED, V46, P9, DOI 10.1016/j.ypmed.2007.03.006; Helbig AK, 2017, SLEEP MED, V33, P151, DOI 10.1016/j.sleep.2017.01.016; Hupin D, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094306; Kubesch NJ, 2015, OCCUP ENVIRON MED, V72, P284, DOI 10.1136/oemed-2014-102106; Kelly P, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0132-x; Kivimaki M, 2017, LANCET PUBLIC HEALTH, V2, pE277, DOI 10.1016/S2468-2667(17)30074-9; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Koyanagi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114742; Lara E, 2016, INT J GERIATR PSYCH, V31, P858, DOI 10.1002/gps.4398; Laverty AA, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0223-3; Lear SA, 2017, LANCET, V390, P2643, DOI 10.1016/S0140-6736(17)31634-3; Lee RC, 2000, AM J CLIN NUTR, V72, P796, DOI 10.1093/ajcn/72.3.796; Loprinzi PD, 2018, PHYSICIAN SPORTSMED, V46, P123, DOI 10.1080/00913847.2018.1407619; Marmeleira J, 2014, ADAPT PHYS ACT Q, V31, P283, DOI 10.1123/apaq.2013-0039; Mijinarends DM, 2016, AGE AGEING, V45, P614, DOI 10.1093/ageing/afw090; Millett C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001459; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Nuevo R, 2013, ACTA PSYCHIAT SCAND, V127, P482, DOI 10.1111/acps.12010; Organization WH, 2015, SUMM WORLD REP AG HL; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Pengpid S, 2015, INT J PUBLIC HEALTH, V60, P539, DOI 10.1007/s00038-015-0680-0; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Qin L, 2012, AM J PREV MED, V43, P1, DOI 10.1016/j.amepre.2012.03.022; Read JR, 2017, J AFFECT DISORDERS, V221, P36, DOI 10.1016/j.jad.2017.06.009; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Saunders LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069912; Schuch FB, 2018, AM J PSYCHIAT; Schuch F, 2017, J AFFECT DISORDERS, V210, P139, DOI 10.1016/j.jad.2016.10.050; Smit W, 2016, HEALTH PLACE, V39, P196, DOI 10.1016/j.healthplace.2016.04.006; Smith L, 2016, BMJ OPEN OPHTHALMOL, V1, DOI 10.1136/bmjophth-2016-000046; Stubbs B, 2017, PSYCHOL MED, V47, P2107, DOI 10.1017/S0033291717000551; Stubbs B, 2018, J AFFECT DISORDERS, V229, P231, DOI 10.1016/j.jad.2017.12.104; Stubbs B, 2018, MATURITAS, V107, P84, DOI 10.1016/j.maturitas.2017.10.007; Tyrovolas S, 2016, J CACHEXIA SARCOPENI, V7, P312, DOI 10.1002/jcsm.12076; Urie Y, 2016, TRAFFIC INJ PREV, V17, P686, DOI 10.1080/15389588.2016.1146823; Vancampfort D, 2017, MILD COGNITIVE UNPUB; Vancampfort D, 2017, EXP GERONTOL, V100, P100, DOI 10.1016/j.exger.2017.10.028; Vancampfort D, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0602-z; Vancampfort D, 2017, WORLD PSYCHIATRY, V16, P308, DOI 10.1002/wps.20458; Vancampfort D, 2017, GEN HOSP PSYCHIAT, V45, P1, DOI 10.1016/j.genhosppsych.2016.11.002; Vancampfort D, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0463-5; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	59	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203277	10.1371/journal.pone.0203277	http://dx.doi.org/10.1371/journal.pone.0203277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161211	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000443388900100
J	Iness, AN; Felthousen, J; Ananthapadmanabhan, V; Sesay, F; Saini, S; Guiley, KZ; Rubin, SM; Dozmorov, M; Litovchick, L				Iness, Audra N.; Felthousen, Jessica; Ananthapadmanabhan, Varsha; Sesay, Fatmata; Saini, Siddharth; Guiley, Keelan Z.; Rubin, Seth M.; Dozmorov, Mikhail; Litovchick, Larisa			The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb	ONCOGENE			English	Article							CARCINOMA IN-SITU; GENE-EXPRESSION; TRANSCRIPTION; TARGET; INTEGRATION; ACTIVATION; MECHANISMS; PHASE; FOXM1; LINE	Overexpression of the oncogene MYBL2 (B-Myb) is associated with increased cell proliferation and serves as a marker of poor prognosis in cancer. However, the mechanism by which B-Myb alters the cell cycle is not fully understood. In proliferating cells, B-Myb interacts with the MuvB core complex including LIN9, LIN37, LIN52, RBBP4, and LIN54, forming the MMB (Myb-MuvB) complex, and promotes transcription of genes required for mitosis. Alternatively, the MuvB core interacts with Rb-like protein p130 and E2F4-DP1 to form the DREAM complex that mediates global repression of cell cycle genes in G0/G1, including a subset of MMB target genes. Here, we show that overexpression of B-Myb disrupts the DREAM complex in human cells, and this activity depends on the intact MuvB-binding domain in B-Myb. Furthermore, we found that B-Myb regulates the protein expression levels of the MuvB core subunit LIN52, a key adapter for assembly of both the DREAM and MMB complexes, by a mechanism that requires S28 phosphorylation site in LIN52. Given that high expression of B-Myb correlates with global loss of repression of DREAM target genes in breast and ovarian cancer, our findings offer mechanistic insights for aggressiveness of cancers with MYBL2 amplification, and establish the rationale for targeting B-Myb to restore cell cycle control.	[Iness, Audra N.; Felthousen, Jessica; Ananthapadmanabhan, Varsha; Sesay, Fatmata; Saini, Siddharth; Litovchick, Larisa] Virginia Commonwealth Univ, Div Hematol Oncol & Palliat Care, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Iness, Audra N.; Felthousen, Jessica; Ananthapadmanabhan, Varsha; Sesay, Fatmata; Saini, Siddharth; Litovchick, Larisa] Virginia Commonwealth Univ, Massey Canc Ctr, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Guiley, Keelan Z.; Rubin, Seth M.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Dozmorov, Mikhail] Virginia Commonwealth Univ, Dept Biostat, Med Coll Virginia Campus, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; University of California System; University of California Santa Cruz; Virginia Commonwealth University	Litovchick, L (corresponding author), Virginia Commonwealth Univ, Div Hematol Oncol & Palliat Care, Med Coll Virginia Campus, Richmond, VA 23298 USA.; Litovchick, L (corresponding author), Virginia Commonwealth Univ, Massey Canc Ctr, Med Coll Virginia Campus, Richmond, VA 23298 USA.	larisa.litovchick@vcuhealth.org	Iness, Audra Nicole/HDM-4123-2022; Dozmorov, Mikhail/B-1374-2009	Iness, Audra Nicole/0000-0001-5194-1319; Litovchick, Larisa/0000-0002-9540-597X; Ananthapadmanabhan, Varsha/0000-0002-6909-1460; Dozmorov, Mikhail/0000-0002-0086-8358; Rubin, Seth/0000-0002-1670-4147; Sesay, Fatmata/0000-0002-9973-3639	 [R01CA188571];  [R01CA132685];  [R01GM124148];  [F30CA221004]; NATIONAL CANCER INSTITUTE [R01CA132685, R01CA188571, F30CA221004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM090084, R01GM124148] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank James DeCaprio and Iain Morgan for critically reading the manuscript, and Sophia Gruszecki for technical support. This project was supported in part by R01CA188571 (L.L.), R01CA132685 and R01GM124148 (S.M.R.), and F30CA221004 (A.N.I.).	Allegra CJ, 2010, J NATL CANCER I, V102, P161, DOI 10.1093/jnci/djp485; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Becker W, 2011, FEBS J, V278, P246, DOI 10.1111/j.1742-4658.2010.07956.x; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Chen X, 2013, MOL CELL BIOL, V33, P227, DOI 10.1128/MCB.00881-12; Dedic PN, 2013, MED ONCOL, V30, P523; Fischer M, 2017, CRIT REV BIOCHEM MOL, V52, P638, DOI 10.1080/10409238.2017.1360836; Fischer M, 2016, NUCLEIC ACIDS RES, V44, P6070, DOI 10.1093/nar/gkw523; Forristal C, 2014, MOL CELL BIOL, V34, P2221, DOI 10.1128/MCB.01523-13; Guiley KZ, 2018, P NATL ACAD SCI USA, V115, P10016, DOI 10.1073/pnas.1808136115; Guiley KZ, 2015, GENE DEV, V29, P961, DOI 10.1101/gad.257568.114; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Iltzsche F, 2017, ONCOGENE, V36, P110, DOI 10.1038/onc.2016.181; Inoue Kazushi, 2016, Biomark Cancer, V8, P25, DOI 10.4137/BIC.S38394; Iwahori S, 2017, VIROLOGY, V512, P95, DOI 10.1016/j.virol.2017.09.009; Korenjak M, 2005, CURR OPIN GENET DEV, V15, P520, DOI 10.1016/j.gde.2005.07.001; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; LUNDIN A, 1986, METHOD ENZYMOL, V133, P27; Mages CFS, 2017, ELIFE, V6, DOI 10.7554/eLife.26876; Musa J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.244; Ness SA, 2003, BLOOD CELL MOL DIS, V31, P192, DOI 10.1016/S1079-9796(03)00151-7; NOMURA N, 1988, NUCLEIC ACIDS RES, V16, P11075, DOI 10.1093/nar/16.23.11075; Odajima J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006429; Pilkinton M, 2007, ONCOGENE, V26, P7535, DOI 10.1038/sj.onc.1210562; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sadasivam S, 2013, NAT REV CANCER, V13, P585, DOI 10.1038/nrc3556; Sadasivam S, 2012, GENE DEV, V26, P474, DOI 10.1101/gad.181933.111; Sala A, 2005, EUR J CANCER, V41, P2479, DOI 10.1016/j.ejca.2005.08.004; Sala A, 1996, J BIOL CHEM, V271, P9363, DOI 10.1074/jbc.271.16.9363; Sala A, 1997, P NATL ACAD SCI USA, V94, P532, DOI 10.1073/pnas.94.2.532; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Solin LJ, 2013, JNCI-J NATL CANCER I, V105, P701, DOI 10.1093/jnci/djt067; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; Thorner AR, 2009, ONCOGENE, V28, P742, DOI 10.1038/onc.2008.430; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Ukleja M, 2016, BIOESSAYS, V38, P1048, DOI 10.1002/bies.201600092; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	44	34	38	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 14	2019	38	7					1080	1092		10.1038/s41388-018-0490-y	http://dx.doi.org/10.1038/s41388-018-0490-y			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HL3OH	30206359	Green Submitted, Green Accepted			2022-12-26	WOS:000458624900011
J	Mikawa, S; Kondo, M; Kaji, N; Mihara, T; Yoshitake, R; Nakagawa, T; Takamoto, M; Nishimura, R; Shimada, S; Ozaki, H; Hori, M				Mikawa, Shoma; Kondo, Makoto; Kaji, Noriyuki; Mihara, Taiki; Yoshitake, Ryohei; Nakagawa, Takayuki; Takamoto, Masaya; Nishimura, Ryohei; Shimada, Shoichi; Ozaki, Hiroshi; Hori, Masatoshi			Serotonin 3 receptor signaling regulates 5-fluorouracil-mediated apoptosis indirectly via TNF- production by enhancing serotonin release from enterochromaffin cells	FASEB JOURNAL			English	Article						anti-apoptosis; anti-inflammatory; intestinal epithelial cells; intestinal organoids	NICOTINIC ACETYLCHOLINE-RECEPTOR; GASTROINTESTINAL TOXICITY; GUINEA-PIG; 5-HT3; TROPISETRON; 5-HYDROXYTRYPTAMINE; ANTAGONIST; EXPRESSION; INVOLVEMENT; MUCOSITIS	Antagonists of the 5-hydroxytryptamine (serotonin) 3 receptor (5-HT3R) have anti-inflammatory and anti-apoptotic activities, but the detailed, underlying mechanisms are not well understood. We focused on anti-apoptotic activities via 5-HT3R signaling to clarify the underlying mechanisms. Mice were administered 5-fluorouracil (5-FU), which induced apoptosis in intestinal epithelial cells. Coadministration with 5-HT3R antagonists or agonists tended to decrease or increase the number of apoptotic cells, respectively. In serotonin 3A receptor (5-HT3AR) null (HTR3A(-/-)) mice, the number of apoptotic cells induced by 5-FU was decreased compared with that in wild-type (WT) mice. Bone marrow (BM) transplantation was performed to determine if BM-derived immune cells regulated 5-FU-induced apoptosis, but they were found to be unrelated to this process. Data from 5-HT3AR/enhanced green fluorescent protein reporter mice revealed that 50% of enterochromaffin (EC) cells expressed 5-HT3AR, but the number of apoptotic cells induced by 5-FU in the intestinal crypt organoids of HTR3A(-/-) mice was not altered compared with WT mice. In contrast, plasma 5-HT concentrations in WT mice but not in HTR3A(-/-) mice administered 5-FU were increased significantly. In conclusion, 5-HT3R signaling may enhance 5-HT release, possibly from EC cells intravascularly, or paracrine, resulting in increases in plasma 5-HT concentration, which in turn, enhances apoptotic activities induced by 5-FU.Mikawa, S., Kondo, M., Kaji, N., Mihara, T., Yoshitake, R., Nakagawa, T., Takamoto, M., Nishimura, R., Shimada, S., Ozaki, H., Hori, M. Serotonin 3 receptor signaling regulates 5-fluorouracil-mediated apoptosis indirectly via TNF- production by enhancing serotonin release from enterochromaffin cells.	[Mikawa, Shoma; Kaji, Noriyuki; Mihara, Taiki; Ozaki, Hiroshi; Hori, Masatoshi] Univ Tokyo, Dept Vet Pharmacol, Grad Sch Agr & Life Sci, Tokyo, Japan; [Yoshitake, Ryohei; Nakagawa, Takayuki; Nishimura, Ryohei] Univ Tokyo, Lab Vet Surg, Grad Sch Agr & Life Sci, Tokyo, Japan; [Kondo, Makoto; Shimada, Shoichi] Osaka Univ, Grad Sch Med, Dept Neurosci & Cell Biol, Osaka, Japan; [Takamoto, Masaya] Shinshu Univ, Sch Med, Dept Infect & Host Def & Pathobiol, Nagano, Japan	University of Tokyo; University of Tokyo; Osaka University; Shinshu University	Hori, M (corresponding author), Univ Tokyo, Dept Vet Pharmacol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ahori@mail.ecc.u-tokyo.ac.jp		Kaji, Noriyuki/0000-0001-7423-5679	KAKENHI [JP 16J05803]; Japan Ministry of Education [24248050, 25221205]; Smoking Research Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation	The authors thank Dr. Shigeru Kakuta (Department of Biomedical Science, Graduate School of Agriculture and Life Sciences, The University of Tokyo) for receiving great support. This work was supported by a Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) Research Fellow (KAKENHI; Grant JP 16J05803 to S.M.), Grants-in-Aid for Scientific Research from the Japan Ministry of Education (24248050 to M.H.; 25221205 to H.O.), and, in part, by the Smoking Research Foundation (to M.H.). The authors declare no conflicts of interest.	Bohorquez DV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089881; Boussios S, 2012, ANN GASTROENTEROL, V25, P106; Camilleri M, 2017, GUT, V66, P966, DOI 10.1136/gutjnl-2016-313425; Coates MD, 2017, ALIMENT PHARM THER, V46, P569, DOI 10.1111/apt.14226; Fiebich BL, 2004, SCAND J RHEUMATOL, V33, P9, DOI 10.1080/03009740410006952; GEBAUER A, 1993, N-S ARCH PHARMACOL, V347, P137; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Grabinger T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.183; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Inomata A, 2002, TOXICOL LETT, V133, P231, DOI 10.1016/S0378-4274(02)00204-7; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Koyama Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep42884; Lee CS, 2014, WORLD J GASTROENTERO, V20, P3751, DOI 10.3748/wjg.v20.i14.3751; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Macor JE, 2001, BIOORG MED CHEM LETT, V11, P319, DOI 10.1016/S0960-894X(00)00670-3; Maehara T, 2015, BRIT J PHARMACOL, V172, P1136, DOI 10.1111/bph.13006; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Matsumoto K, 2013, DIGEST DIS SCI, V58, P3440, DOI 10.1007/s10620-013-2709-7; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; Mousavizadeh K, 2009, EUR J CLIN INVEST, V39, P375, DOI 10.1111/j.1365-2362.2009.02102.x; Navari RM, 2016, NEW ENGL J MED, V374, P1356, DOI 10.1056/NEJMra1515442; O'Rourke KP., 2016, BIOPROTOC, V6, pe1732, DOI DOI 10.21769/BI0PR0T0C.1732; Papke RL, 2004, BIOORG MED CHEM LETT, V14, P1849, DOI 10.1016/j.bmcl.2003.09.104; Racke K, 1996, BEHAV BRAIN RES, V73, P83; RACKE K, 1991, PHARMACOL RES, V23, P13, DOI 10.1016/S1043-6618(05)80101-X; Rahimian R, 2013, EUR J CLIN INVEST, V43, P1039, DOI 10.1111/eci.12141; Rammes G, 2004, MOL PSYCHIATR, V9, P846, DOI 10.1038/sj.mp.4001490; Rao Kamakshi V, 2012, Am Health Drug Benefits, V5, P232; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SATOH Y, 1995, GASTROENTEROLOGY, V108, P1345, DOI 10.1016/0016-5085(95)90681-9; SCHWORER H, 1991, N-S ARCH PHARMACOL, V344, P143, DOI 10.1007/BF00167211; SIBER GR, 1980, CANCER RES, V40, P3430; Spangrude G. J., 2008, CURR PROTOC IMMUNOL, V4; Spohn SN, 2017, NAT REV GASTRO HEPAT, V14, P412, DOI 10.1038/nrgastro.2017.51; Stegemann A, 2013, ARTHRITIS RHEUM-US, V65, P792, DOI 10.1002/art.37809; Stein Alexander, 2010, Ther Adv Med Oncol, V2, P51, DOI 10.1177/1758834009355164; Tasaka Y, 2015, J PHARMACOL SCI, V127, P275, DOI 10.1016/j.jphs.2014.12.016; Thompson AJ, 2006, CURR PHARM DESIGN, V12, P3615, DOI 10.2174/138161206778522029; Tsukamoto A, 2017, INFLAMMATION, V40, P1409, DOI 10.1007/s10753-017-0584-7; Utsumi D, 2016, BRIT J PHARMACOL, V173, P1835, DOI 10.1111/bph.13482; Walker DP, 2006, BIOORGAN MED CHEM, V14, P8219, DOI 10.1016/j.bmc.2006.09.019; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155; Yasuda M, 2013, BRIT J PHARMACOL, V168, P1388, DOI 10.1111/bph.12019	44	6	6	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1669	1680		10.1096/fj.201701200RR	http://dx.doi.org/10.1096/fj.201701200RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30207796				2022-12-26	WOS:000457296600014
J	Sun, J; Cai, X; Yung, MMH; Zhou, W; Li, J; Zhang, Y; Li, ZQ; Liu, SS; Cheung, ANY; Ngan, HYS; Li, YL; Dai, ZJ; Kai, Y; Tzatsos, A; Peng, WQ; Chan, DW; Zhu, WG				Sun, Jing; Cai, Xin; Yung, Mingo M. H.; Zhou, Wei; Li, Jing; Zhang, Yi; Li, Zhuqing; Liu, Stephanie S.; Cheung, Annie N. Y.; Ngan, Hextan Y. S.; Li, Yiliang; Dai, Zhijun; Kai, Yan; Tzatsos, Alexandros; Peng, Weiqun; Chan, David W.; Zhu, Wenge			miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer	ONCOGENE			English	Article							MOLECULAR-MECHANISMS; IN-VITRO; ANTISENSE OLIGODEOXYNUCLEOTIDES; INHIBITS PROLIFERATION; CELL CARCINOMA; BREAST-CANCER; TUMOR-CELLS; SENSITIVITY; EXPRESSION; MICRORNA-137	Platinum drugs are used in first-line to treat ovarian cancer, but most of the patients eventually generate resistance after treatment with these drugs. Although both c-Myc and EZH2 have been implicated in regulating cisplatin resistance in ovarian cancer, the interplay between these two regulators is poorly understood. Using RNA sequence analysis (RNA-seq), for the first time we find that miR-137 level is extremely low in cisplatin resistant ovarian cancer cells, correlating with higher levels of c-Myc and EZH2 expression. Further analyses indicate that in resistant cells c-Myc enhances the expression of EZH2 by directly suppressing miR-137 that targets EZH2 mRNA, and increased expression of EZH2 activates cellular survival pathways, resulting in the resistance to cisplatin. Inhibition of c-Myc-miR-137-EZH2 pathway re-sensitizes resistant cells to cisplatin. Both in vivo and in vitro analyses indicate that cisplatin treatment activates c-Myc-miR-137-EZH2 pathway. Importantly, elevated c-Myc-miR-137-EZH2 pathway in resistant cells is sustained by dual oxidase maturation factor 1 (DUOXA1)-mediated production of reactive oxygen species (ROS). Significantly, clinical studies further confirm the activated c-Myc-miR-137-EZH2 pathway in platinum drug-resistant or recurrent ovarian cancer patients. Thus, our studies elucidate a novel role of miR-137 in regulating c-Myc-EZH2 axis that is crucial to the regulation of cisplatin resistance in ovarian cancer.	[Sun, Jing; Cai, Xin; Zhou, Wei; Li, Jing; Zhang, Yi; Li, Zhuqing; Zhu, Wenge] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Sun, Jing; Cai, Xin; Zhou, Wei; Li, Jing; Zhang, Yi; Li, Zhuqing; Kai, Yan; Tzatsos, Alexandros; Zhu, Wenge] George Washington Univ, GW Canc Ctr, Washington, DC 20052 USA; [Yung, Mingo M. H.; Liu, Stephanie S.; Ngan, Hextan Y. S.; Chan, David W.] Univ Hong Kong, LKS Fac Med, Dept Obstet & Gynaecol, Hong Kong, Peoples R China; [Zhou, Wei] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Colorectal Surg, Hangzhou 310016, Zhejiang, Peoples R China; [Cheung, Annie N. Y.] Univ Hong Kong, LKS Fac Med, Dept Pathol, Hong Kong, Peoples R China; [Li, Yiliang] Peking Union Med Coll, Inst Radiat Med, Tianjin Key Lab Radiat Med & Mol Nucl Med, Tianjin 300192, Peoples R China; [Li, Yiliang] Chinese Acad Med Sci, Tianjin 300192, Peoples R China; [Dai, Zhijun] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Oncol, Xian 710004, Shaanxi, Peoples R China; [Kai, Yan; Peng, Weiqun] George Washington Univ, Dept Phys, Columbian Coll Arts & Sci, Washington, DC 20052 USA; [Tzatsos, Alexandros] George Washington Univ, Sch Med & Hlth Sci, Dept Anat & Regenerat Biol, Washington, DC 20037 USA	George Washington University; George Washington University; University of Hong Kong; Zhejiang University; University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Xi'an Jiaotong University; George Washington University; George Washington University	Zhu, WG (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA.; Zhu, WG (corresponding author), George Washington Univ, GW Canc Ctr, Washington, DC 20052 USA.; Chan, DW (corresponding author), Univ Hong Kong, LKS Fac Med, Dept Obstet & Gynaecol, Hong Kong, Peoples R China.	dwchan@hku.hk; wz6812@gwu.edu	Li, Zhuqing/AEW-9886-2022; YUNG, Mingo Ming Ho/AHB-5775-2022; /AAI-2516-2019; Kai, Yan/ABH-8469-2020; Chan, David/O-9896-2018; Dai, Zhi-Jun/O-6826-2014; Cheung, Annie Nga Yin/C-4231-2009	YUNG, Mingo Ming Ho/0000-0003-0903-1164; Kai, Yan/0000-0003-3262-4160; Chan, David/0000-0002-6951-3467; Ngan, Hextan Y S/0000-0003-3945-159X; Peng, Weiqun/0000-0001-5521-9091; Li, Jing/0000-0002-0079-693X; Dai, Zhi-Jun/0000-0001-5209-8626; Cheung, Annie Nga Yin/0000-0002-1584-7568	National Institutes of Health [CA177898, CA184717]; McCormick Genomic and Proteomic Center [RSG-13-214-01-DMC]; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA177898, R01CA184717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McCormick Genomic and Proteomic Center; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by funding from the National Institutes of Health (CA177898 and CA184717 to WZ), the McCormick Genomic and Proteomic Center. W. Zhu was supported by a Research Scholar Grant, RSG-13-214-01-DMC from the American Cancer Society.	Adelaiye-Ogala R, 2017, CANCER RES, V77, P6651, DOI 10.1158/0008-5472.CAN-17-0899; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Banno K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/232817; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; Blower PE, 2008, MOL CANCER THER, V7, P1, DOI 10.1158/1535-7163.MCT-07-0573; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Brennecke J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-228; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Choi YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135083; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Citro G, 1998, CANCER RES, V58, P283; Crea F, 2012, CANCER METAST REV, V31, P753, DOI 10.1007/s10555-012-9387-3; Cui SC, 2017, MOL MED REP, V16, P9494, DOI 10.3892/mmr.2017.7828; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; Dong S, 2016, ONCOL REP, V35, P2151, DOI 10.3892/or.2016.4604; Fabbri M, 2011, CURR OPIN HEMATOL, V18, P266, DOI 10.1097/MOH.0b013e3283476012; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Haenisch S, 2012, EPIGENOMICS-UK, V4, P369, DOI [10.2217/EPI.12.39, 10.2217/epi.12.39]; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hodzic J, 2011, NUCLEOS NUCLEOT NUCL, V30, P1214, DOI 10.1080/15257770.2011.629271; Hu S, 2010, CANCER BIOL THER, V10, P788, DOI 10.4161/cbt.10.8.12913; Jazaeri AA, 2013, MOL CANCER THER, V12, P1958, DOI 10.1158/1535-7163.MCT-12-1028; Knapp DC, 2003, ANTI-CANCER DRUG, V14, P39, DOI 10.1097/00001813-200301000-00006; LANGDON SP, 1988, CANCER RES, V48, P6166; Leonetti C, 1999, CLIN CANCER RES, V5, P2588; Lin CP, 2007, ANTI-CANCER DRUG, V18, P161, DOI 10.1097/CAD.0b013e3280109424; Liu X, 2017, EUR REV MED PHARMACO, V21, P511; Luo YW, 2016, TUMOR BIOL, V37, P7749, DOI 10.1007/s13277-015-4611-8; Marullo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081162; Meng YX, 2018, CANCER LETT, V428, P104, DOI 10.1016/j.canlet.2018.04.029; MIZUTANI Y, 1994, CANCER, V74, P2546, DOI 10.1002/1097-0142(19941101)74:9<2546::AID-CNCR2820740924>3.0.CO;2-Y; Moitra K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045268; Neri F, 2012, MOL CELL BIOL, V32, P840, DOI 10.1128/MCB.06148-11; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Norouzi-Barough L, 2018, J CELL PHYSIOL, V233, P4546, DOI 10.1002/jcp.26289; Passetti F, 2009, PHARMACOGENOMICS J, V9, P1, DOI 10.1038/tpj.2008.14; Prathapam T, 2010, J BIOL CHEM, V285, P32529, DOI 10.1074/jbc.M110.151902; Pyndiah S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001556; Raman JD, 2005, CLIN CANCER RES, V11, P8570, DOI 10.1158/1078-0432.CCR-05-1047; Reyes-Gonzalez JM, 2015, MOL CANCER THER, V14, P2260, DOI 10.1158/1535-7163.MCT-14-0801; Samanta D, 2014, P NATL ACAD SCI USA, V111, pE5429, DOI 10.1073/pnas.1421438111; Sandiford SDE, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-5; Shen JF, 2010, INVEST OPHTH VIS SCI, V51, P35, DOI 10.1167/iovs.09-3544; SKLAR MD, 1991, CANCER RES, V51, P2118; Smonskey Matthew, 2016, Oncoscience, V3, P21; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stronach EA, 2015, ONCOTARGET, V6, P31593, DOI 10.18632/oncotarget.3415; Sun J, 2016, AM J TRANSL RES, V8, P3077; Sun J, 2016, ONCOTARGETS THER, V9, P21, DOI 10.2147/OTT.S93305; Sun J, 2015, DRUG DES DEV THER, V9, P6327, DOI 10.2147/DDDT.S92777; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; van Jaarsveld MTM, 2013, ONCOGENE, V32, P4284, DOI 10.1038/onc.2012.433; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Walker TL, 1996, BRIT J CANCER, V73, P610, DOI 10.1038/bjc.1996.105; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Warburton A, 2015, SCHIZOPHRENIA BULL, V41, P698, DOI 10.1093/schbul/sbu117; Wu YM, 2018, CANCER RES, V78, P671, DOI 10.1158/0008-5472.CAN-17-1327; Xie XK, 2006, CANCER INVEST, V24, P1, DOI 10.1080/07357900500449520; Zhao X, 2013, LEUKEMIA, V27, P2341, DOI 10.1038/leu.2013.94; Zhou W, 2018, ONCOGENE, V37, P3981, DOI 10.1038/s41388-018-0238-8; Zingg D, 2017, CELL REP, V20, P854, DOI 10.1016/j.celrep.2017.07.007	64	73	77	3	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 24	2019	38	4					564	580		10.1038/s41388-018-0459-x	http://dx.doi.org/10.1038/s41388-018-0459-x			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HI6UB	30166592	Green Accepted			2022-12-26	WOS:000456589800008
J	Maziarz, M; Broselid, S; DiGiacomo, V; Park, JC; Luebbers, A; Garcia-Navarrete, L; Blanco-Canosa, JB; Baillie, GS; Garcia-Marcos, M				Maziarz, Marcin; Broselid, Stefan; DiGiacomo, Vincent; Park, Jong-Chan; Luebbers, Alex; Garcia-Navarrete, Lucia; Blanco-Canosa, Juan B.; Baillie, George S.; Garcia-Marcos, Mikel			A biochemical and genetic discovery pipeline identifies PLC4b as a nonreceptor activator of heterotrimeric G-proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G-protein-coupled receptor (GPCR); guanine nucleotide exchange factor (GEF); GTPase; bioluminescence resonance energy transfer (BRET); heterotrimeric G-protein; phospholipase C	PHOSPHOLIPASE C-DELTA-4; STRUCTURAL INSIGHTS; REGULATORY MOTIF; HIGH-THROUGHPUT; EXCHANGE FACTOR; RGS PROTEINS; ALPHA; MECHANISM; RECEPTORS; GIV/GIRDIN	Recent evidence has revealed that heterotrimeric G-proteins can be activated by cytoplasmic proteins that share an evolutionarily conserved sequence called the G-binding-and-activating (GBA) motif. This mechanism provides an alternative to canonical activation by G-protein-coupled receptors (GPCRs) and plays important roles in cell function, and its dysregulation is linked to diseases such as cancer. Here, we describe a discovery pipeline that uses biochemical and genetic approaches to validate GBA candidates identified by sequence similarity. First, putative GBA motifs discovered in bioinformatics searches were synthesized on peptide arrays and probed in batch for G(i3) binding. Then, cDNAs encoding proteins with G(i3)-binding sequences were expressed in a genetically-modified yeast strain that reports mammalian G-protein activity in the absence of GPCRs. The resulting GBA motif candidates were characterized by comparison of their biochemical, structural, and signaling properties with those of all previously described GBA motifs in mammals (GIV/Girdin, DAPLE, Calnuc, and NUCB2). We found that the phospholipase C4 (PLC4) GBA motif binds G-proteins with high affinity, has guanine nucleotide exchange factor activity in vitro, and activates G-protein signaling in cells, as indicated by bioluminescence resonance energy transfer (BRET)-based biosensors of G-protein activity. Interestingly, the PLC4 isoform b (PLC4b), which lacks the domains required for PLC activity, bound and activated G-proteins more efficiently than the full-length isoform a, suggesting that PLC4b functions as a G-protein regulator rather than as a PLC. In summary, we have identified PLC4 as a nonreceptor activator of G-proteins and established an experimental pipeline to discover and characterize GBA motif-containing proteins.	[Maziarz, Marcin; Broselid, Stefan; DiGiacomo, Vincent; Park, Jong-Chan; Luebbers, Alex; Garcia-Navarrete, Lucia; Garcia-Marcos, Mikel] Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K,Rm K208 Off, Boston, MA 02118 USA; [Blanco-Canosa, Juan B.] CSIC, IQAC, Inst Adv Chem Catalonia, Dept Biol Chem & Mol Modelling, ES-08034 Barcelona, Spain; [Baillie, George S.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [DiGiacomo, Vincent] Hartwell Fdn, Memphis, TN USA	Boston University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); University of Glasgow	Garcia-Marcos, M (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K,Rm K208 Off, Boston, MA 02118 USA.	mgm1@bu.edu	Blanco-Canosa, Juan B./H-4544-2015	Blanco-Canosa, Juan B./0000-0001-5738-6993	National Institutes of Health [R01GM108733, R01GM130120]; American Cancer Society [RSG-13-362-01-TBE]; Medical Research Council [MR/M013944/1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM130120, R01GM108733] Funding Source: NIH RePORTER; MRC [MR/J007412/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by National Institutes of Health Grants R01GM108733 and R01GM130120, American Cancer Society Grant RSG-13-362-01-TBE (to M.G.-M.), and by Medical Research Council Grant MR/M013944/1 (to G.S.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Austin RJ, 2008, J MOL BIOL, V377, P1406, DOI 10.1016/j.jmb.2008.01.032; Aznar N, 2015, ELIFE, V4, DOI 10.7554/eLife.07091; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blumer JB, 2012, ACTA PHYSIOL, V204, P202, DOI 10.1111/j.1748-1716.2011.02327.x; Cabrita LD, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-12; Chan P, 2011, J BIOL CHEM, V286, P19932, DOI 10.1074/jbc.M110.163675; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cismowski MJ, 2002, METHOD ENZYMOL, V344, P153; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Coleman BD, 2016, MOL BIOL EVOL, V33, P820, DOI 10.1093/molbev/msv336; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; de Alba E, 2004, BIOCHEMISTRY-US, V43, P10039, DOI 10.1021/bi049310a; de Mendoza A, 2014, GENOME BIOL EVOL, V6, P606, DOI 10.1093/gbe/evu038; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DiGiacomo V, 2018, BIOCHEMISTRY-US, V57, P255, DOI 10.1021/acs.biochem.7b00845; DiGiacomo V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08829-7; Druey KM, 1997, P NATL ACAD SCI USA, V94, P12851, DOI 10.1073/pnas.94.24.12851; Ehrenberger T, 2015, METHODS MOL BIOL, V1278, P57, DOI 10.1007/978-1-4939-2425-7_4; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Fukami K, 2003, J CELL BIOL, V161, P79, DOI 10.1083/jcb.200210057; Fukami K, 2001, SCIENCE, V292, P920, DOI 10.1126/science.1059042; Garcia-Marcos M, 2011, MOL BIOL CELL, V22, P673, DOI 10.1091/mbc.E10-08-0738; Garcia-Marcos M, 2015, J BIOL CHEM, V290, P6697, DOI 10.1074/jbc.R114.613414; Garcia-Marcos M, 2012, P NATL ACAD SCI USA, V109, P1961, DOI 10.1073/pnas.1120538109; Garcia-Marcos M, 2011, J BIOL CHEM, V286, P28138, DOI 10.1074/jbc.M110.204099; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2015, AGING-US, V7, P469, DOI 10.18632/aging.100781; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Harden TK, 2011, CHEM REV, V111, P6120, DOI 10.1021/cr200209p; Hepler JR, 1999, TRENDS PHARMACOL SCI, V20, P376, DOI 10.1016/S0165-6147(99)01369-3; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; de Opakua AI, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15163; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Klarenbeek JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019170; KLEUSS C, 1994, P NATL ACAD SCI USA, V91, P9828, DOI 10.1073/pnas.91.21.9828; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; KROLL S, 1989, J BIOL CHEM, V264, P4490; Lee MJ, 2008, CELL, V135, P65, DOI 10.1016/j.cub.2008.01.007; Lee SB, 1996, J BIOL CHEM, V271, P25, DOI 10.1074/jbc.271.1.25; Lee SB, 2004, J BIOL CHEM, V279, P24362, DOI 10.1074/jbc.M312772200; Leung DW, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-15; Leyme A, 2017, P NATL ACAD SCI USA, V114, pE10319, DOI 10.1073/pnas.1707992114; Leyme A, 2015, J CELL BIOL, V210, P1165, DOI 10.1083/jcb.201506041; Lin CS, 2014, MOL BIOL CELL, V25, P3654, DOI 10.1091/mbc.E14-05-0978; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; Lopez-Sanchez I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5451; Lyon AM, 2013, MOL PHARMACOL, V84, P488, DOI 10.1124/mol.113.087403; Ma GS, 2015, P NATL ACAD SCI USA, V112, pE2602, DOI 10.1073/pnas.1505543112; Marivin A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad2429; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Maziarz M, 2017, METHOD CELL BIOL, V142, P145, DOI 10.1016/bs.mcb.2017.08.001; Midde KK, 2015, P NATL ACAD SCI USA, V112, pE937, DOI 10.1073/pnas.1420140112; Mukhopadhyay S, 2002, METHOD ENZYMOL, V344, P350; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; NAKASHIMA S, 1995, BIOCHEM BIOPH RES CO, V211, P364, DOI 10.1006/bbrc.1995.1822; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Parag-Sharma K, 2016, J BIOL CHEM, V291, P27098, DOI 10.1074/jbc.M116.764431; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Peterson YK, 2002, J BIOL CHEM, V277, P6767, DOI 10.1074/jbc.C100699200; Preininger AM, 2003, BIOCHEMISTRY-US, V42, P7931, DOI 10.1021/bi0345438; Ramachandran S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.166538; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Sasaki K, 2015, J CELL SCI, V128, P2244, DOI 10.1242/jcs.160879; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Sjogren B, 2010, PROG MOL BIOL TRANSL, V91, P81, DOI 10.1016/S1877-1173(10)91004-1; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Weiss TS, 2001, P NATL ACAD SCI USA, V98, P14961, DOI 10.1073/pnas.261572098	82	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					16964	16983		10.1074/jbc.RA118.003580	http://dx.doi.org/10.1074/jbc.RA118.003580			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30194280	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000449466500002
J	Adin, A; Martinez-Bello, DA; Lopez-Quilez, A; Ugarte, MD				Adin, Aritz; Adyro Martinez-Bello, Daniel; Lopez-Quilez, Antonio; Dolores Ugarte, Maria			Two-level resolution of relative risk of dengue disease in a hyperendemic city of Colombia	PLOS ONE			English	Article							CROSS-VALIDATION; MODELS; MORTALITY; CHILDREN; VACCINE	Risk maps of dengue disease offer to the public health officers a tool to model disease risk in space and time. We analyzed the geographical distribution of relative incidence risk of dengue disease in a high incidence city from Colombia, and its evolution in time during the period January 2009-December 2015, identifying regional effects at different levels of spatial aggregations. Cases of dengue disease were geocoded and spatially allocated to census sectors, and temporally aggregated by epidemiological periods. The census sectors are nested in administrative divisions defined as communes, configuring two levels of spatial aggregation for the dengue cases. Spatio-temporal models including census sector and commune-level spatially structured random effects were fitted to estimate dengue incidence relative risks using the integrated nested Laplace approximation (INLA) technique. The final selected model included two-level spatial random effects, a global structured temporal random effect, and a census sector-level interaction term. Risk maps by epidemiological period and risk profiles by census sector were generated from the modeling process, showing the transmission dynamics of the disease. All the census sectors in the city displayed high risk at some epidemiological period in the outbreak periods. Relative risk estimation of dengue disease using INLA offered a quick and powerful method for parameter estimation and inference.	[Adin, Aritz; Dolores Ugarte, Maria] Univ Publ Navarra, Dept Stat Comp Sci & Math, Navarra, Spain; [Adin, Aritz; Dolores Ugarte, Maria] Univ Publ Navarra, Inst Adv Mat InaMat, Navarra, Spain; [Adyro Martinez-Bello, Daniel; Lopez-Quilez, Antonio] Univ Valencia, Fac Matemat, Dept Estadist & Invest Operat, Valencia, Spain	Universidad Publica de Navarra; Universidad Publica de Navarra; University of Valencia	Ugarte, MD (corresponding author), Univ Publ Navarra, Dept Stat Comp Sci & Math, Navarra, Spain.; Ugarte, MD (corresponding author), Univ Publ Navarra, Inst Adv Mat InaMat, Navarra, Spain.	lola@unavarra.es	López-Quílez, Antonio/H-5945-2011; Ugarte, Maria Dolores/J-8834-2014; Adin, Aritz/J-6646-2017	López-Quílez, Antonio/0000-0002-7022-9260; Ugarte, Maria Dolores/0000-0002-3505-8400; Adin, Aritz/0000-0003-3232-6147; Martinez-Bello, Daniel Adyro/0000-0003-3219-0753	Spanish Ministry of Economy and Competitiveness [MTM2014-51992-R -MDU-, MTM2016-77501-P -ALQ-]; European Regional Development Fund; Spanish Ministry of Economy, Industry, and Competitiveness [MTM2017-82553-R]; European Regional Development Fund (FEDER); Colombian Administrative Department of Science and Technology [646-2014]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund(European Commission); Spanish Ministry of Economy, Industry, and Competitiveness(Spanish Government); European Regional Development Fund (FEDER)(European Commission); Colombian Administrative Department of Science and Technology	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (projects MTM2014-51992-R -MDU- and MTM2016-77501-P -ALQ-, jointly financed with the European Regional Development Fund), the Spanish Ministry of Economy, Industry, and Competitiveness (MTM2017-82553-R jointly financed with the European Regional Development Fund (FEDER). MDU, AA), and the Colombian Administrative Department of Science and Technology (grant 646-2014 for doctoral studies abroad) DAMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martinez-Bello DA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005696; Martinez-Bello DA, 2017, INT J HEALTH GEOGR, V16, DOI 10.1186/s12942-017-0104-x; Alva-Urcia C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187897; Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499; [Anonymous], 2021, LANG ENV STAT COMP; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Colombia Ministry of Social Protection Colombia National Institute of Health. Pan American Health Organization, 2013, MAN GUID ENT SURV CO; Departamento Administrativo Nacional de Estadistica Colombia. Direccion de Geoestadistica. (National Administrative Department of Statistics Colombia. Direction of Geostatistics), 2005, CAP NIV SECT URB; Ugarte MD, 2016, STAT METHODS MED RES, V25, P1080, DOI 10.1177/0962280216660423; Ugarte MD, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2354-5; Ugarte MD, 2014, STAT METHODS MED RES, V23, P507, DOI 10.1177/0962280214527528; Ferreira GS., 2006, BRAZ J PROBAB STAT; Fuentes-Vallejo M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2610-7; Gelman A, 2014, STAT COMPUT, V24, P997, DOI 10.1007/s11222-013-9416-2; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; Goicoa T, 2018, STOCH ENV RES RISK A, V32, P749, DOI 10.1007/s00477-017-1405-0; Hodges JS, 2010, AM STAT, V64, P325, DOI 10.1198/tast.2010.10052; Knorr-Held L, 2000, STAT MED, V19, P2555, DOI 10.1002/1097-0258(20000915/30)19:17/18<2555::AID-SIM587>3.0.CO;2-#; Laughlin CA, 2012, J INFECT DIS, V206, P1121, DOI 10.1093/infdis/jis351; Lawson AB, 2009, CHAPMAN HALL CRC INT; Louis VR, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-50; Lowe R, 2016, STOCH ENV RES RISK A, V30, P2067, DOI 10.1007/s00477-015-1053-1; Lowe R, 2014, LANCET INFECT DIS, V14, P619, DOI 10.1016/S1473-3099(14)70781-9; Lowe R, 2013, STAT MED, V32, P864, DOI 10.1002/sim.5549; Lowe R, 2011, COMPUT GEOSCI-UK, V37, P371, DOI 10.1016/j.cageo.2010.01.008; Martinez-Bello D, 2018, STOCH ENV RES RISK A, V32, P1587, DOI 10.1007/s00477-017-1461-5; Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649; Naish S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-167; Olivera-Botello G, 2016, J INFECT DIS, V214, P994, DOI 10.1093/infdis/jiw297; Plummer M, 2008, BIOSTATISTICS, V9, P523, DOI 10.1093/biostatistics/kxm049; Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648; Ramos-Castaneda J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005224; Restrepo AC, 2014, TROP MED INT HEALTH, V19, P863, DOI 10.1111/tmi.12325; Romero-Vega Liliana, 2014, Rev. Saúde Pública, V48, P899, DOI [10.1590/S0034-8910.2014048005321, 10.1590/s0034-8910.2014048005321]; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stewart-Ibarra AM, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0610-4; Ugarte MD, 2015, CANCER EPIDEMIOL, V39, P480, DOI 10.1016/j.canep.2015.03.013; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; Villabona-Arenas CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004653; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; Wijayanti SPM, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004964, 10.1371/journal.pntd.0004500]; World Health Organization, 2012, GLOB STRAT DENG PREV	47	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203382	10.1371/journal.pone.0203382	http://dx.doi.org/10.1371/journal.pone.0203382			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204762	Green Submitted, Green Published, gold			2022-12-26	WOS:000444355500026
J	Jorgensen, LV; Korbut, R; Jeberg, S; Kania, PW; Buchmann, K				Jorgensen, Louise Von Gersdorff; Korbut, Rozalia; Jeberg, Sandra; Kania, Per Walter; Buchmann, Kurt			Association between adaptive immunity and neutrophil dynamics in zebrafish (Danio rerio) infected by a parasitic ciliate	PLOS ONE			English	Article							CARP CYPRINUS-CARPIO; ICHTHYOPHTHIRIUS-MULTIFILIIS FOUQUET; ONCORHYNCHUS-MYKISS WALBAUM; RAINBOW-TROUT; INFLAMMATORY RESPONSE; CHANNEL CATFISH; EXPRESSION ANALYSIS; RELEVANT GENES; UP-REGULATION; TELEOST FISH	The protective immune response in zebrafish (Danio rerio) against the parasitic ciliate Ichthyophthirius multifiliis, targeting host skin, fins and gills, comprises an accelerated and manifold elevated immunoglobulin gene expression as well as a significantly elevated number of neutrophils at infected sites. Experimental fish were subjected to a primary I. multifiliis infection followed by a series of secondary exposures before they were challenged by a high dosage of infective theronts. Immunized fish responded immediately with a protective response suggesting existence of immunological memory whereas fish exposed to the parasite for the first time obtained a marked infection. The primary response to infection was dominated by expression of genes encoding acute phase reactants and inflammatory cytokines as well as recruitment of neutrophils at infected locations. Immunized fish showed a significantly upregulated immunoglobulin gene expression following challenge, which indicates existence of a secondary response effected by antibodies. Both responses induced a significantly elevated expression of the Th2 signature cytokine II13. The increased presence of neutrophils in immunized fish suggests that innate cell mediated immunity supplements or influence the protective response against the parasite.	[Jorgensen, Louise Von Gersdorff; Korbut, Rozalia; Jeberg, Sandra; Kania, Per Walter; Buchmann, Kurt] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Sect Parasitol & Aquat Pathobiol, Frederiksberg C, Denmark	University of Copenhagen	Jorgensen, LV (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Sect Parasitol & Aquat Pathobiol, Frederiksberg C, Denmark.	lvgj@sund.ku.dk		Buchmann, Kurt/0000-0002-2747-237X; Jorgensen, Louise von Gersdorff/0000-0002-6005-3249	Villum Foundation [VKR022858]	Villum Foundation(Villum Fonden)	This work was supported by Villum Foundation (http://veluxfoundations.dk/da) grant VKR022858 received by KB.; This study was supported by the Villum Foundation grant VKR022858. Imaging data were collected at the Centre for Advanced Bioimaging (CAB) Denmark, University of Copenhagen.	Alvarez-Pellitero P, 2008, VET IMMUNOL IMMUNOP, V126, P171, DOI 10.1016/j.vetimm.2008.07.013; AVTALION RR, 1969, IMMUNOLOGY, V17, P927; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Brudeseth BE, 2013, FISH SHELLFISH IMMUN, V35, P1759, DOI 10.1016/j.fsi.2013.05.029; Buchmann K, 1999, J HELMINTHOL, V73, P189, DOI 10.1017/S0022149X9900030X; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; Chettri JK, 2014, J FISH DIS, V37, P771, DOI 10.1111/jfd.12169; Chettri JK, 2015, AQUACULTURE, V440, P1, DOI 10.1016/j.aquaculture.2015.01.027; Chettri JK, 2013, VET IMMUNOL IMMUNOP, V154, P42, DOI 10.1016/j.vetimm.2013.04.001; Chorny A, 2016, J EXP MED, V213, P2167, DOI 10.1084/jem.20150282; Christoffersen TB, 2017, J FISH DIS, V40, P847, DOI 10.1111/jfd.12543; CLARK TG, 1987, J FISH BIOL, V31, P203, DOI 10.1111/j.1095-8649.1987.tb05314.x; Costa MM, 2013, DEV COMP IMMUNOL, V41, P746, DOI 10.1016/j.dci.2013.08.021; CROSS ML, 1992, J FISH DIS, V15, P497, DOI 10.1111/j.1365-2761.1992.tb00681.x; de Oliveira S, 2013, J IMMUNOL, V190, P4349, DOI 10.4049/jimmunol.1203266; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Dinarello CA, 1997, J BIOL REG HOMEOS AG, V11, P91; ELLIS AE, 1988, DIS AQUAT ORGAN, V4, P159, DOI 10.3354/dao004159; Gonzalez SF, 2007, DEV COMP IMMUNOL, V31, P576, DOI 10.1016/j.dci.2006.08.010; Gonzalez SF, 2007, FISH SHELLFISH IMMUN, V22, P641, DOI 10.1016/j.fsi.2006.08.011; Gonzalez SF, 2007, VET IMMUNOL IMMUNOP, V115, P172, DOI 10.1016/j.vetimm.2006.09.007; GRAVES SS, 1985, COMP IMMUNOL MICROB, V8, P43, DOI 10.1016/0147-9571(85)90053-0; Gudding R, 1999, VET IMMUNOL IMMUNOP, V72, P203, DOI 10.1016/S0165-2427(99)00133-6; Harvie EA, 2015, J LEUKOCYTE BIOL, V98, P523, DOI 10.1189/jlb.4MR1114-524R; Hatton RD, 2011, IMMUNITY, V34, P288, DOI 10.1016/j.immuni.2011.03.009; Havixbeck JJ, 2016, J LEUKOCYTE BIOL, V99, P241, DOI 10.1189/jlb.3HI0215-064R; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Hu YL, 2010, MOL IMMUNOL, V47, P738, DOI 10.1016/j.molimm.2009.10.010; Jorgensen L. v. G., 2017, J FISH DIS; Jorgensen LV, 2011, J FISH DIS, V34, P749, DOI 10.1111/j.1365-2761.2011.01291.x; Jorgensen LV, 2008, DIS AQUAT ORGAN, V80, P189, DOI 10.3354/dao01935; Jorgensen LV, 2016, FISH SHELLFISH IMMUN, V57, P335, DOI 10.1016/j.fsi.2016.08.042; Jorgensen LV, 2016, FISH SHELLFISH IMMUN, V55, P159, DOI 10.1016/j.fsi.2016.05.026; Krauss J, 2013, BIOL OPEN, V2, P703, DOI 10.1242/bio.20135132; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; MILLER NW, 1984, J IMMUNOL METHODS, V72, P367, DOI 10.1016/0022-1759(84)90006-1; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Ogryzko NV, 2014, DIS MODEL MECH, V7, P259, DOI 10.1242/dmm.013029; Olsen MM, 2011, FISH SHELLFISH IMMUN, V30, P859, DOI 10.1016/j.fsi.2011.01.010; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; RIJKERS GT, 1980, IMMUNOLOGY, V41, P91; Sigh J, 2004, J FISH DIS, V27, P409, DOI 10.1111/j.1365-2761.2004.00558.x; Sigh J, 2001, J FISH DIS, V24, P49, DOI 10.1046/j.1365-2761.2001.00258.x; Siupka P, 2014, GENES IMMUN, V15, P293, DOI 10.1038/gene.2014.18; Slifka MK, 1996, TRENDS MICROBIOL, V4, P394, DOI 10.1016/0966-842X(96)10059-7; Stavnezer J, 2004, SEMIN IMMUNOL, V16, P257, DOI 10.1016/j.smim.2004.08.005; Uribe C, 2011, VET MED-CZECH, V56, P486, DOI 10.17221/3294-VETMED; Villumsen KR, 2013, FISH SHELLFISH IMMUN, V35, P1649, DOI 10.1016/j.fsi.2013.09.013; WALKER C, 1983, GENETICS, V103, P125; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Whyte SK, 2007, FISH SHELLFISH IMMUN, V23, P1127, DOI 10.1016/j.fsi.2007.06.005; Woo PTK, 2012, FISH PARASITES: PATHOBIOLOGY AND PROTECTION, P1, DOI 10.1079/9781845938062.0000; Xu Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10728; Xu Z, 2013, P NATL ACAD SCI USA, V110, P13097, DOI 10.1073/pnas.1304319110; Yano T, 1996, FISH IMMUNE SYSTEM O; Zhang N, 2017, DEV COMP IMMUNOL, V70, P94, DOI 10.1016/j.dci.2017.01.001; Zhu LY, 2012, J IMMUNOL, V188, P5571, DOI 10.4049/jimmunol.1102259; Zou Jun, 2016, Biology-Basel, V5, P23, DOI 10.3390/biology5020023	63	18	18	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203297	10.1371/journal.pone.0203297	http://dx.doi.org/10.1371/journal.pone.0203297			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204772	gold, Green Submitted, Green Published			2022-12-26	WOS:000444355500021
J	Luk, KC; Coller, KE; Dawson, GJ; Cloherty, GA				Luk, Ka-Cheung; Coller, Kelly E.; Dawson, George J.; Cloherty, Gavin A.			Identification of a putative novel genotype 3/rabbit hepatitis E virus (HEV) recombinant	PLOS ONE			English	Article							FULL-LENGTH GENOME; FARMED RABBITS; WILD RABBITS; RNA VIRUSES; CHINA; TRANSMISSION; PREVALENCE; SEQUENCES; SUBTYPES; STRAINS	Hepatitis E virus (HEV) is a viral pathogen transmitted by the fecal-oral route and is a major cause of waterborne acute hepatitis in many developing countries. In addition to infecting humans, HEV has been identified in swine, wild boars, rabbits and other mammals; with swine and wild boars being main reservoirs for zoonotic transmission of HEV. There are four major HEV genotypes known to infect humans; genotypes 1 (HEV-1) and 2 (HEV-2) are restricted to humans, and genotypes 3 (HEV-3) and 4 (HEV-4) are zoonotic. Herein, three human HEV strains originating in France were sequenced and near full-length genomes were characterized. Phylogenetic analysis showed that two strains were genotype 3 and closely grouped (a 100% bootstrap value) with subtype 3i reference strains. In percent nucleotide identities, these two strains were 94% identical to each other, 90-93% identical to subtype 3i strains, 82-86% identical to other HEV-3, and 77-79% identical to rabbit HEV strains excluding the two divergent strains KJ013414 and KJ013415 (74%); these two strains were less than 77% identical to strains of HEV genotypes 1, 2 and 4. The third strain was found distinct from any known HEV strains in the database, and located between the clusters of HEV-3 and rabbit HEV strains. This unique strain was 74-75% identical to HEV-1, 73% to HEV-2, 81-82% to HEV-3, 77-79% to rabbit HEV again excluding the two divergent strains KJ013414 and KJ013415 (74%), and 74-75% to HEV-4, suggesting a novel unclassified strain associated with HEV-3 and rabbit HEV. SimPlot and BootScan analyses revealed a putative recombination of HEV-3 and rabbit HEV sequences at four breakpoints. Phylogenetic trees of the five fragments of the genome confirmed the presence of two HEV-3 derived and three unclassified sequences. Analyses of the amino acid sequences of the three open reading frames (ORF1-3) encoded proteins of these three novel strains showed that some amino acid residues specific to rabbit HEV strains were found solely in this unclassified strain but not in the two newly identified genotype 3i strains. The results obtained by SimPlots, BootScans, phylogenetic analyses, and amino acid sequence comparisons in this study all together appear to suggest that this novel unclassified strain is likely carrying a mosaic genome derived from HEV-3 and rabbit HEV sequences, and is thus designated as a putative genotype 3/rabbit HEV recombinant.	[Luk, Ka-Cheung; Coller, Kelly E.; Dawson, George J.; Cloherty, Gavin A.] Abbott Diagnost, Infect Dis Res, Abbott Pk, IL 60064 USA		Luk, KC (corresponding author), Abbott Diagnost, Infect Dis Res, Abbott Pk, IL 60064 USA.	ka-cheung.luk@abbott.com			Abbott Laboratories	Abbott Laboratories(Abbott Laboratories)	This work was funded by and conducted at Abbott Laboratories. The funder provided support in the form of salaries for authors KCL, KC, GD and GC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abravanel F, 2017, EMERG INFECT DIS, V23, P1191, DOI 10.3201/eid2307.170318; Ahn HS, 2017, J MED VIROL, V89, P1995, DOI 10.1002/jmv.24875; Bouquet J, 2011, EMERG INFECT DIS, V17, P2018, DOI 10.3201/eid1711.110616; Burt SA, 2016, FOOD ENVIRON VIROL, V8, P227, DOI 10.1007/s12560-016-9239-3; Cao DJ, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.7; Caruso C, 2015, TRANSBOUND EMERG DIS, V62, P229, DOI 10.1111/tbed.12348; Chare ER, 2006, ARCH VIROL, V151, P933, DOI 10.1007/s00705-005-0675-x; Chen EC, 2011, JOVE-J VIS EXP, DOI 10.3791/2536; Cossaboom CM, 2012, J VIROL, V86, P13124, DOI 10.1128/JVI.02414-12; Cossaboom CM, 2011, EMERG INFECT DIS, V17, P2047, DOI 10.3201/eid1711.110428; Di Bartolo I, 2016, ARCH VIROL, V161, P1343, DOI 10.1007/s00705-016-2778-y; Doceul V, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100270; Eiden M, 2016, FOOD ENVIRON VIROL, V8, P105, DOI 10.1007/s12560-015-9222-4; Emerson SU, 2001, TRENDS MOL MED, V7, P462, DOI 10.1016/S1471-4914(01)02106-2; Hammerschmidt F, 2017, ZOONOSES PUBLIC HLTH, V64, P612, DOI 10.1111/zph.12355; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Izopet J, 2012, EMERG INFECT DIS, V18, P1274, DOI 10.3201/eid1808.120057; Kaiser M, 2018, GENOME ANNOUNCEMENTS, V6, DOI [10.1128/genomea.00292-18, 10.1128/genomeA.00292-18]; Kamar N, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.86; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kelly AG, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0785-y; Khuroo MS, 2016, WORLD J GASTROENTERO, V22, P7030, DOI 10.3748/wjg.v22.i31.7030; Lhomme S, 2013, J CLIN VIROL, V58, P357, DOI 10.1016/j.jcv.2013.02.006; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Luk KC, 2007, AIDS RES HUM RETROV, V23, P297, DOI 10.1089/aid.2006.0177; Moreno P, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-203; Najera R, 2002, AIDS, V16, pS3, DOI 10.1097/00002030-200216004-00002; Nan YC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01419; Pickett BE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-165; Rein DB, 2012, HEPATOLOGY, V55, P988, DOI 10.1002/hep.25505; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Ryll R, 2018, INFECT GENET EVOL, V61, P155, DOI 10.1016/j.meegid.2018.03.019; Schielke A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-58; Slot E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176414; Smith DB, 2016, J GEN VIROL, V97, P537, DOI 10.1099/jgv.0.000393; Smith DB, 2014, J GEN VIROL, V95, P2223, DOI 10.1099/vir.0.068429-0; Sridhar S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040869; Sztuba-Solinska J, 2011, ANNU REV PHYTOPATHOL, V49, P415, DOI 10.1146/annurev-phyto-072910-095351; Takahashi M, 2002, J GEN VIROL, V83, P1931, DOI 10.1099/0022-1317-83-8-1931; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; van Cuyck H, 2005, J VIROL, V79, P9306, DOI 10.1128/JVI.79.14.9306-9314.2005; Wang H, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-129; Wang L, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1961; Wang L, 2016, EMERG INFECT DIS, V22, P2157, DOI 10.3201/eid2212.160131; Wichmann Ole, 2008, J Infect Dis, V198, P1732, DOI 10.1086/593211; Woo PCY, 2016, EMERG INFECT DIS, V22, P2219, DOI 10.3201/eid2212.160979; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Xie XT, 2017, VET MICROBIOL, V208, P146, DOI 10.1016/j.vetmic.2017.07.015; Zhai LJ, 2006, VIRUS RES, V120, P57, DOI 10.1016/j.virusres.2006.01.013; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536	50	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203618	10.1371/journal.pone.0203618	http://dx.doi.org/10.1371/journal.pone.0203618			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204796	Green Submitted, Green Published, gold			2022-12-26	WOS:000444355500033
J	Agrelius, T; Dudycha, JL; Morris, JT				Agrelius, Trenton; Dudycha, Jeffry L.; Morris, James T.			Global DNA cytosine methylation variation in Spartina alterniflora at North Inlet, SC	PLOS ONE			English	Article							SALT-MARSH DIEBACK; TRANSPOSABLE ELEMENTS; EPIGENETIC VARIATION; INVASION; GENOME; PLANTS; DEMETHYLATION; INHERITANCE; ADAPTATION; PLASTICITY	Spartina alterniflora, marsh grass, is a vegetative apomicticly-reproducing halophyte native to marshes along the east coast of the United States and invasive across the world. S. alterniflora provides many ecosystem services including, but not limited to, water filtration, habitats for invertebrates, and sediment retention. Widespread diebacks of longstanding marsh grass colonies launched extensive investigations into probable mechanisms leading to patchy diebacks. There is still current debate as to the causes of a marsh dieback but environmental stress is acknowledged as a constant. Spatial epigenetic variation could contribute to variation of stress susceptibility, but the scale and structure of epigenetic variation is unknown. The current study investigates patterns of epigenetic variation in a natural population of S. alterniflora. This study examines variation of global DNA methylation within and among clones of the marsh grass Spartina alterniflora using an ELISA-like microplate reaction and observed significant heterogeneity of global DNA methylation within and among clones of S. alterniflora across the North Inlet basin, as well as significant differences of global methylation between adults and sexually produced seedlings. The present study also characterized differences for plants in a section of the population that experienced an acute marsh dieback in the year 2001 and have subsequently recolonized, finding a significant positive correlation between cytosine methylation and time period of colonization. The significant heterogeneity of global DNA methylation both within and among clones observed within this natural population of S. alterniflora and potential impacts from hypersaline environments at North Inlet suggests the need for more in-depth epigenetic studies to fully understand DNA methylation within an ecological context. Future studies should consider the effects of varying saline conditions on both global DNA and gene specific methylation.	[Agrelius, Trenton; Morris, James T.] Univ South Carolina, Belle W Baruch Inst Marine & Coastal Sci, Columbia, SC 29208 USA; [Agrelius, Trenton; Dudycha, Jeffry L.; Morris, James T.] Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia	Agrelius, T (corresponding author), Univ South Carolina, Belle W Baruch Inst Marine & Coastal Sci, Columbia, SC 29208 USA.; Agrelius, T (corresponding author), Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	agrelius@email.sc.edu	morris, james/ABC-8111-2020; morris, james/AAQ-5605-2020	morris, james/0000-0002-0511-642X	South Carolina Sea Grant Consortium [R/CP 20]; F. John Vernberg Bicentennial Fellowship in Marine Science; Wade T. Batson Fellowship	South Carolina Sea Grant Consortium; F. John Vernberg Bicentennial Fellowship in Marine Science; Wade T. Batson Fellowship	The authors would like to thank the South Carolina Sea Grant Consortium grant number R/CP 20 awarded to JM, the F. John Vernberg Bicentennial Fellowship in Marine Science awarded to TA, and the Wade T. Batson Fellowship for funding awarded to TA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnes Y, 2013, PNAS, V110, P2389, DOI [10.1073/pnas.1211757110, DOI 10.1073/PNAS.1211757110]; Ainouche ML, 2009, BIOL INVASIONS, V11, P1159, DOI 10.1007/s10530-008-9383-2; Alber M, 2008, ESTUAR COAST SHELF S, V80, P1, DOI 10.1016/j.ecss.2008.08.009; Albert M, 2009, CURR OPIN GENET DEV, V19, P113, DOI 10.1016/j.gde.2009.03.004; Allis CD, EPIGENETICS, P2; Alonso C, 2014, AM J BOT, V101, P1309, DOI 10.3732/ajb.1400126; Ayres DR, 2004, BIOL INVASIONS, V6, P221, DOI 10.1023/B:BINV.0000022140.07404.b7; Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bonchev G, 2013, MOL ECOL RESOUR, V13, P765, DOI 10.1111/1755-0998.12133; Bourne J, 2000, SCIENCE, V289, P1860, DOI 10.1126/science.289.5486.1860; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Buzzelli C, 2004, J COASTAL RES, P59, DOI 10.2112/SI45-059.1; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Carlson PR, 2001, COAST MARSH DIEB C J; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chen JQ, 2008, J PLANT ECOL, V1, P79, DOI 10.1093/jpe/rtn007; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Civille JC, 2005, ECOSCIENCE, V12, P330, DOI 10.2980/i1195-6860-12-3-330.1; Day JW, 2001, ESTUARIES, V24, P647, DOI 10.2307/1353265; Dyachenko OV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P461, DOI 10.1134/S000629790604016X; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Foust CM, 2016, MOL ECOL, V25, P1639, DOI 10.1111/mec.13522; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Herrera CM, 2014, MOL ECOL, V23, P1085, DOI 10.1111/mec.12679; Herrera CM, 2013, BOT J LINN SOC, V171, P441, DOI 10.1111/boj.12007; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Hughes ALH, 2012, ESTUAR COAST SHELF S, V111, P95, DOI 10.1016/j.ecss.2012.06.016; Huh JH, 2008, CELL, V132, P735, DOI 10.1016/j.cell.2008.02.018; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Keller TE, 2016, MOL ECOL, V25, P1823, DOI 10.1111/mec.13573; Lindstedt DM, 2006, CASE DYING MAR UNPUB; Massicotte R, 2012, GENET RES INT, V2012, DOI 10.1155/2012/317175; Massicotte R, 2011, EPIGENETICS-US, V6, P422, DOI 10.4161/epi.6.4.14532; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; MESSEGUER R, 1991, PLANT MOL BIOL, V16, P753, DOI 10.1007/BF00015069; Newell-Price J, 2000, TRENDS ENDOCRIN MET, V11, P142, DOI 10.1016/S1043-2760(00)00248-4; Ogburn MB, 2006, ESTUAR COAST, V29, P54, DOI 10.1007/BF02784698; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Pennings SC, 2001, MARINE COMMUNITY ECOLOGY, P289; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Proffitt CE, 2003, ECOL APPL, V13, P180, DOI 10.1890/1051-0761(2003)013[0180:GAEISA]2.0.CO;2; R Core Team, 2021, R LANGUAGE ENV STAT; Raj S, 2011, P NATL ACAD SCI USA, V108, P12521, DOI 10.1073/pnas.1103341108; Rakyan V, 2003, CURR BIOL, V13, pR6, DOI 10.1016/S0960-9822(02)01377-5; Rangwala SH, 2006, PLOS GENET, V2, P270, DOI 10.1371/journal.pgen.0020036; Richards CL, 2008, AM J BOT, V95, P931, DOI 10.3732/ajb.2007364; Richards CL, 2012, ECOL LETT, V15, P1016, DOI 10.1111/j.1461-0248.2012.01824.x; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Robertson M, 2017, EVOL APPL, V10, P792, DOI 10.1111/eva.12482; Saze H, 2008, SEMIN CELL DEV BIOL, V19, P527, DOI 10.1016/j.semcdb.2008.07.017; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Testillano PS, 2013, PHYSIOL PLANTARUM, V149, P104, DOI 10.1111/ppl.12015; *USGS, 2001, COAST MARSH DIEB BRO; VANYUSHI.BF, 1973, GERONTOLOGY, V19, P138, DOI 10.1159/000211967; Vanyushin BF, 2011, BBA-GENE REGUL MECH, V1809, P360, DOI 10.1016/j.bbagrm.2011.04.006; Vergeer P, 2012, BIOL LETTERS, V8, P798, DOI 10.1098/rsbl.2012.0494; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Wang M, 2014, PLANT CELL PHYSIOL, V55, P1354, DOI 10.1093/pcp/pcu059; Wassenegger M, 2005, CELL, V122, P13, DOI 10.1016/j.cell.2005.06.034; WILSON VL, 1987, J BIOL CHEM, V262, P9948	67	0	0	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2018	13	9							e0203230	10.1371/journal.pone.0203230	http://dx.doi.org/10.1371/journal.pone.0203230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7DK	30199541	Green Published, gold, Green Submitted			2022-12-26	WOS:000444681100013
J	Claxton, JS; MacLehose, RF; Lutsey, PL; Norby, FL; Chen, LY; O'Neal, WT; Chamberlain, AM; Bengtson, LGS; Alonso, A				Claxton, J'Neka S.; MacLehose, Richard F.; Lutsey, Pamela L.; Norby, Faye L.; Chen, Lin Y.; O'Neal, Wesley T.; Chamberlain, Alanna M.; Bengtson, Lindsay G. S.; Alonso, Alvaro			A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants	PLOS ONE			English	Article							CLINICAL CLASSIFICATION SCHEMES; NATIONAL REGISTRY; RISK; STROKE; VALIDATION; HEMORRHAGE; SCORE; CARE	Background No scores presently exist to predict bleeding in atrial fibrillation (AF) populations using direct oral anticoagulants (DOACs). We used data from two independent healthcare claims databases to develop and validate a predictive model of major bleeding in a contemporary AF population. Methods Patients with non-valvular AF initiating oral anticoagulation were identified in the MarketScan databases from 2007-2014. Using Cox regression models in 1000 bootstrapped samples, we developed a model that selected variables predicting major bleeding in the first year after anticoagulant initiation. The final model was validated in patients with non-valvular AF in the Optum Clinformatics database in the period 2009-2015. The discriminative ability of existing bleeding scores were individually evaluated and compared with the new bleeding model termed Anticoagulation-specific Bleeding Score (ABS) in both MarketScan and Optum. Results Among 119,083 patients with AF initiating oral anticoagulation in the derivation cohort, 4,030 experienced a bleeding event. The variable selection model identified 15 variables (including individual type of oral anticoagulant) associated with major bleeding. Discrimination of the model was modest [c-statistic 0.68, 95% confidence interval (CI) 0.67-0.69]. The model was subsequently applied to 81,285 AF patients in the validation data set (3,238 bleeding events), showing similar discrimination (c-statistic 0.68, 95% CI 0.67-0.69). In both cohorts, the predictive performance of the ABS was better than the existing models for bleeding prediction in AF. Conclusions We developed a model that uses administrative healthcare data for the identification of AF patients at higher risk of bleeding after initiation of oral anticoagulation, taking into account the lower bleeding risk in DOAC compared to warfarin users.	[Claxton, J'Neka S.; Alonso, Alvaro] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [MacLehose, Richard F.; Lutsey, Pamela L.; Norby, Faye L.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Chen, Lin Y.] Univ Minnesota, Sch Med, Dept Med, Cardiovasc Div, Minneapolis, MN 55455 USA; [O'Neal, Wesley T.] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA; [Chamberlain, Alanna M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Bengtson, Lindsay G. S.] Optum, Life Sci, Hlth Econ & Outcomes Res, Eden Prairie, MN USA	Emory University; Rollins School Public Health; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Emory University; Mayo Clinic; Optum	Claxton, JS (corresponding author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	jneka.claxton@emory.edu	Norby, Faye/FNA-7255-2022; Alonso, Alvaro/A-4917-2010	Norby, Faye/0000-0002-1975-0405; Alonso, Alvaro/0000-0002-2225-8323; Chen, Lin/0000-0002-0700-814X; Lutsey, Pamela/0000-0002-1572-1340; Chamberlain, Alanna/0000-0003-1888-9584	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01-HL122200, R01-HL131579, R21-AG058445]; National Institute of Aging of the National Institutes of Health [R01-HL122200, R01-HL131579, R21-AG058445]; American Heart Association [6EIA26410001]; Optum; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131579, R01HL122200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG058445] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association(American Heart Association); Optum; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National Heart, Lung, and Blood Institute (https://www.nhlbi.nih.gov/grants-andtraining/funding-opportunities-and-contacts) and the National Institute of Aging (https://www.nia.nih.gov/research/grants-funding) of the National Institutes of Health under awards number R01-HL122200 [AA], R01-HL131579 [PLL], and R21-AG058445 [AA], as well as support from the American Heart Association (http://professional.heart.org/professional/ResearchPrograms/UCM_316889_Research.jsp) grant 6EIA26410001 [AA]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Optum provided support in the form of salaries for authors [LGSB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Andrade SE, 2012, PHARMACOEPIDEM DR S, V21, P100, DOI 10.1002/pds.2312; Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Camm AJ, 2012, EUR HEART J, V33; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cunningham A, 2011, PHARMACOEPIDEM DR S, V20, P560, DOI 10.1002/pds.2109; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Garg RK, 2011, PHARMACOEPIDEM DR S, V20, P313, DOI 10.1002/pds.2041; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Lip GYH, 2007, LANCET NEUROL, V6, P981, DOI 10.1016/S1474-4422(07)70264-8; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Morimoto T, 2015, J CARDIOL, V66, P466, DOI 10.1016/j.jjcc.2015.05.018; O'Brien EC, 2015, EUR HEART J, V36, P3258, DOI 10.1093/eurheartj/ehv476; Patel Manesh R, 2010, N Engl J Med, V362, P886, DOI 10.1056/NEJMoa0907272; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rowan SB, 2007, J AM COLL CARDIOL, V49, P1561, DOI 10.1016/j.jacc.2006.11.045; Vallakati A, 2016, POSTGRAD MED, V128, P191, DOI 10.1080/00325481.2016.1132939; Wahl PM, 2010, PHARMACOEPIDEM DR S, V19, P596, DOI 10.1002/pds.1924	23	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2018	13	9							e0203599	10.1371/journal.pone.0203599	http://dx.doi.org/10.1371/journal.pone.0203599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7DK	30199542	gold, Green Published, Green Submitted			2022-12-26	WOS:000444681100017
J	Luhtala, N; Hunter, T				Luhtala, Natalie; Hunter, Tony			Failure to detect functional transfer of active K-Ras protein from extracellular vesicles into recipient cells in culture	PLOS ONE			English	Article							CANCER EXOSOMES; CELLULAR UPTAKE; LEUKEMIA-CELLS; MICROENVIRONMENT; INTERNALIZATION; IDENTIFICATION; ANGIOGENESIS; EXPRESSION; INDUCTION; SECRETION	Exosomes, extracellular nanovesicles that carry nucleic acids, lipids, and proteins, have been the subject of several studies to assess their ability to transfer functional cargoes to cells. We recently characterized extracellular nanovesicles released from glioblastoma cells that carry active Ras in complex with proteins regulating exosome biogenesis. Here, we investigated whether a functional transfer of Ras from exosomes to other cells can initiate intercellular signaling. We observed that treatment of serum-starved, cultured glioblastoma cells with exogenous glioblastoma exosomes caused a significant increase in cellular viability over time. Moreover, we detected fluorescent signal transfer from lipophilic dye-labeled exogenous glioblastoma exosomes into cultured glioblastoma cells. To probe possible signaling from cell-to-cell, we utilized bimolecular luciferase complementation to examine the ability of K-Ras in exosomes to interact with the Raf-Ras Binding domain (Raf-RBD) expressed in a recipient cell line. Although the K-Ras/Raf-RBD interaction was readily detectable upon co-expression in a single cell line, or following lysis of co-cultured cell lines separately expressing K-Ras and RBD, bearing in mind the limitations of our assay, we were unable to detect the interaction in the intact, co-cultured cell lines or upon treatment of the Raf-RBD-expressing cells with exosomes containing K-Ras. Furthermore, HA-Tag-BFP fused to the K-Ras hypervariable region and CAAX sequence failed to be transferred at significant levels from extracellular vesicles into recipient cells, but remained detectable in the cell supernatants even after 96 hours of culture of naive cells with extracellular vesicles. We conclude that if transfer of functional K-Ras from extracellular vesicles into the cytoplasm of recipient cells occurs, it must do so at an extremely low efficiency and therefore is unlikely to initiate Ras-ERK MAP kinase pathway signaling. These results suggest that studies claiming functional transfer of protein cargoes from exosomes should be interpreted with caution.	[Luhtala, Natalie; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute	Hunter, T (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hunter@salk.edu		Luhtala, Natalie/0000-0001-7079-6225	Renato Dulbecco Chair in Cancer Research, Frank and Else Schilling American Cancer Society [CA014195, CA080100, CA082683]; George E. Hewitt Foundation Postdoctoral Fellowship; American Cancer Society Postdoctoral Fellowship [127795-PF-15-030-01-CSM]	Renato Dulbecco Chair in Cancer Research, Frank and Else Schilling American Cancer Society; George E. Hewitt Foundation Postdoctoral Fellowship; American Cancer Society Postdoctoral Fellowship(American Cancer Society)	This study was supported by CA014195, CA080100, CA082683, Renato Dulbecco Chair in Cancer Research, Frank and Else Schilling American Cancer Society Professor, to TH; and George E. Hewitt Foundation Postdoctoral Fellowship, American Cancer Society Postdoctoral Fellowship 127795-PF-15-030-01-CSM to NL. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aga M, 2014, ONCOGENE, V33, P4613, DOI 10.1038/onc.2014.66; Allen M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6853; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Banfer S, 2018, P NATL ACAD SCI USA, V115, pE4396, DOI 10.1073/pnas.1718921115; Beckler MD, 2013, MOL CELL PROTEOMICS, V12, P343, DOI 10.1074/mcp.M112.022806; Bissig C, 2014, TRENDS CELL BIOL, V24, P19, DOI 10.1016/j.tcb.2013.10.009; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BRTVA TR, 1995, J BIOL CHEM, V270, P9809, DOI 10.1074/jbc.270.17.9809; Cai ZJ, 2012, J IMMUNOL, V188, P5954, DOI 10.4049/jimmunol.1103466; Ceder S, 2015, NATURE; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Goetzl EJ, 2015, ANN CLIN TRANSL NEUR, V2, P769, DOI 10.1002/acn3.211; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Gui YX, 2015, ONCOTARGET; Happonen KE, 2016, J BIOL CHEM, V291, P10586, DOI 10.1074/jbc.M115.699058; Heusermann W, 2016, J CELL BIOL, V213, P173, DOI 10.1083/jcb.201506084; Hong BS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-556; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Hood JL, 2009, LAB INVEST, V89, P1317, DOI 10.1038/labinvest.2009.94; Hung ME, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.31027; Kahlert C, 2014, J BIOL CHEM, V289, P3869, DOI 10.1074/jbc.C113.532267; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Lai CP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8029; Lai CP, 2014, ACS NANO, V8, P483, DOI 10.1021/nn404945r; Lee TH, 2016, ONCOTARGET, V7, P51991, DOI 10.18632/oncotarget.10627; Lee TH, 2015, CELL MOL BIOL LETT, V20, P117, DOI 10.1515/cmble-2015-0003; Li YC, 2014, CELL REP, V9, P1946, DOI 10.1016/j.celrep.2014.10.058; Luga V, 2013, CANCER RES, V73, P6843, DOI 10.1158/0008-5472.CAN-13-1791; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Lugli G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139233; Luhtala N, 2017, J BIOL CHEM, V292, P611, DOI 10.1074/jbc.M116.747618; Majumdar R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002336; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Nakase I, 2015, SCI REP-UK, V5, DOI 10.1038/srep10300; Nakase I, 2015, SCI REP-UK, V5, DOI 10.1038/srep10112; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Ostenfeld MS, 2014, CANCER RES, V74, P5758, DOI 10.1158/0008-5472.CAN-13-3512; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; RCore Team, 2020, R LANG ENV STAT COMP; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Rodriguez M, 2015, ONCOTARGET; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068451; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider A, 2013, CELL TISSUE RES, V352, P33, DOI 10.1007/s00441-012-1428-2; Sharghi-Namini S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04031; Shurtleff MJ, 2018, ANN REV CANC BIOL, V2, DOI [10.1146/annurev-cancerbio-030617-050224, DOI 10.1146/ANNUREV-CANCERBIO-030617-050224]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Squadrito ML, 2014, CELL REP, V8, P1432, DOI 10.1016/j.celrep.2014.07.035; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Suetsugu A, 2013, ADV DRUG DELIVER REV, V65, P383, DOI 10.1016/j.addr.2012.08.007; Sung BH, 2017, CELL ADHES MIGR, V11, P187, DOI 10.1080/19336918.2016.1273307; Sung BH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8164; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Tadokoro H, 2013, J BIOL CHEM, V288, P34343, DOI 10.1074/jbc.M113.480822; Taverna S, 2012, INT J CANCER, V130, P2033, DOI 10.1002/ijc.26217; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tian TA, 2010, J CELL BIOCHEM, V111, P488, DOI 10.1002/jcb.22733; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tomlinson PR, 2015, ANN CLIN TRANSL NEUR, V2, P353, DOI 10.1002/acn3.175; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Will E, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf059; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zhang L, 2013, MOL MED REP, V8, P272, DOI 10.3892/mmr.2013.1458; Zomer A, 2015, CELL, V161, P1046, DOI 10.1016/j.cell.2015.04.042	79	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203290	10.1371/journal.pone.0203290	http://dx.doi.org/10.1371/journal.pone.0203290			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192821	gold, Green Published, Green Submitted			2022-12-26	WOS:000444093600057
J	Ryan, KA; Slack, GS; Marriott, AC; Kane, JA; Whittaker, CJ; Silman, NJ; Carroll, MW; Gooch, KE				Ryan, Kathryn A.; Slack, Gillian S.; Marriott, Anthony C.; Kane, Jennifer A.; Whittaker, Catherine J.; Silman, Nigel J.; Carroll, Miles W.; Gooch, Karen E.			Cellular immune response to human influenza viruses differs between H1N1 and H3N2 subtypes in the ferret lung	PLOS ONE			English	Article							T-CELLS; PANDEMIC INFLUENZA; INTERFERON-GAMMA; ANIMAL-MODELS; TRANSMISSION; PATHOGENESIS; INFECTION; VACCINE; INNATE; EXPRESSION	Seasonal influenza virus infections cause yearly epidemics which are the source of a significant public health burden worldwide. The ferret model for human influenza A virus (IAV) is widely used and has several advantages over other animal models such as comparable symptomology, similar receptor distribution in the respiratory tract to humans and the ability to be infected with human isolates without the need for adaptation. However, a major disadvantage of the model has been a paucity of reagents for the evaluation of the cellular immune response. Investigation of T-cell mediated immunity in ferrets is crucial to vaccine development and efficacy studies. In this study we have used commercially produced antibodies to ferret interferon gamma (IFN-gamma) allowing us to reliably measure influenza-specific IFN-gamma as a marker of the cellular immune response using both enzyme-linked immunospot (ELISpot) and enzyme-linked immunosorbent (ELISA) techniques. Here we demonstrate the application of these tools to evaluate cellular immunity in ferrets infected with clinically relevant seasonal H1N1 and H3N2 IAV subtypes at equivalent doses. Using small heparinised blood samples we were able to observe the longitudinal influenza-specific IFN-gamma responses of ferrets infected with both seasonal subtypes of IAV and found a notable increase in influenza-specific IFN-gamma responses in circulating peripheral blood within 8 days post-infection. Both seasonal strains caused a well-defined pattern of influenza-specific IFN-gamma responses in infected ferrets when compared to naive animals. Additionally, we found that while the influenza specific IFN-gamma responses found in peripheral circulating blood were comparable between subtypes, the influenza specific IFN-gamma responses found in lung lymphocytes significantly differed. Our results suggest that there is a distinct difference between the ability of the two seasonal influenza strains to establish an infection in the lung of ferrets associated with distinct signatures of acquired immunity.	[Ryan, Kathryn A.; Slack, Gillian S.; Marriott, Anthony C.; Kane, Jennifer A.; Whittaker, Catherine J.; Silman, Nigel J.; Carroll, Miles W.; Gooch, Karen E.] Publ Hlth England, Natl Infect Serv, Porton Down, Wilts, England	Public Health England	Gooch, KE (corresponding author), Publ Hlth England, Natl Infect Serv, Porton Down, Wilts, England.	karen.gooch@phe.gov.uk		Ryan, Kathryn Ann/0000-0001-8608-1144; Marriott, Anthony/0000-0002-8862-9852; Slack, Gillian S/0000-0002-4361-7516	Department of Health	Department of Health	This work was supported by the Department of Health, grant in aid, (https://www.gov.uk/government/organisations/department-of-health-and-social-care). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Bot A, 1998, J VIROL, V72, P6637, DOI 10.1128/JVI.72.8.6637-6645.1998; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Carolan LA, 2014, J VIROL METHODS, V205, P38, DOI 10.1016/j.jviromet.2014.04.014; CHEN KS, 1995, INT J EXP PATHOL, V76, P55; DiPiazza A, 2016, J VIROL, V90, P7991, DOI 10.1128/JVI.01001-16; Enkirch T, 2015, VIROLOGY, V479, P259, DOI 10.1016/j.virol.2015.03.017; Fischer WA, 2014, VACCINE, V32, P1761, DOI 10.1016/j.vaccine.2013.12.069; Gustin KM, 2011, P NATL ACAD SCI USA, V108, P8432, DOI 10.1073/pnas.1100768108; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hua S, 2015, SCI CHINA LIFE SCI, V58, P882, DOI 10.1007/s11427-015-4899-z; Koster F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033118; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Margine I, 2014, PATHOGENS, V3, P845, DOI 10.3390/pathogens3040845; Marriott AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094090; Martel CJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022891; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Music N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100926; Nakata M, 2009, VET IMMUNOL IMMUNOP, V130, P88, DOI 10.1016/j.vetimm.2008.12.009; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ochi A, 2008, DEV COMP IMMUNOL, V32, P890, DOI 10.1016/j.dci.2007.12.008; Pappas C, 2015, VIROLOGY, V477, P61, DOI 10.1016/j.virol.2015.01.002; Pillet S, VACCINE; Pillet S, 2011, VACCINE, V29, P6793, DOI 10.1016/j.vaccine.2010.12.059; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; Roberts KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043303; Roberts KL, 2011, J GEN VIROL, V92, P1822, DOI 10.1099/vir.0.031203-0; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Sridhar S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00195; Sridhar S, 2012, EUR J IMMUNOL, V42, P2913, DOI 10.1002/eji.201242504; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Stohr K, 2002, LANCET INFECT DIS, V2, P517, DOI 10.1016/S1473-3099(02)00366-3; Talker SC, 2016, J VIROL, V90, P9364, DOI 10.1128/JVI.01211-16; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Wendel I, 2015, J VIROL, V89, P4170, DOI 10.1128/JVI.03194-14; Whitmire JK, 2005, J EXP MED, V201, P1053, DOI 10.1084/jem.20041463; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	41	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202675	10.1371/journal.pone.0202675	http://dx.doi.org/10.1371/journal.pone.0202675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192789	Green Submitted, gold, Green Published			2022-12-26	WOS:000444093600027
J	Watanabe, K; Yasumoto, A; Amano, Y; Kage, H; Goto, Y; Yatomi, Y; Takai, D; Nagase, T				Watanabe, Kousuke; Yasumoto, Atsushi; Amano, Yosuke; Kage, Hidenori; Goto, Yasushi; Yatomi, Yutaka; Takai, Daiya; Nagase, Takahide			Mean platelet volume and lymphocyte-to-monocyte ratio are associated with shorter progression-free survival in EGFR-mutant lung adenocarcinoma treated by EGFR tyrosine kinase inhibitor	PLOS ONE			English	Article							GROWTH-FACTOR; CANCER; THROMBOCYTOSIS; METAANALYSIS; RESISTANCE; INDICATOR; IMPACT; CELLS	Background A growing body of evidence supports the role of platelets in cancer metastasis, escape from immune surveillance, and angiogenesis. Mean platelet volume (MPV), which reflects platelet turnover, is reported routinely as part of automated complete blood count. Accumulating evidence suggests that MPV is a useful biomarker in several diseases including cancer. However, its role in cancer patients receiving molecular targeted therapy has not been described in the literature. Materials and methods We retrospectively analysed the prognostic impact of MPV in advanced or recurrent EGFR mutant lung adenocarcinoma treated with EGFR tyrosine kinase inhibitors (EGFR-TKIs). Lymphocyte-to-monocyte ratio (LMR) has been previously reported to be a poor prognostic factor in EGFR mutant non-small cell lung cancer and was also included as a covariate. Results Using the previously described Cutoff Finder algorithm, the cut-off points for MPV and LMR that best predicted progression free survival (PFS) of EGFR-TKI were determined as 10.3 and 2.8, respectively. The median PFS was 14.7 and 8.2 months in MPV low and high groups (p = 0.013, log-rank test). The median PFS was 13.5 and 6.2 months in LMR high and low groups (p < 0.001, log-rank test). MPV and LMR were independently distributed (chi square test) and the multivariate analysis using Cox's proportional hazards regression model revealed that high MPV, low LMR, and pleural effusion were significant predictors for shorter PFS. Conclusion MPV and LMR, measured as part of routine complete blood count, can be utilized to predict the outcome of EGFR-TKI therapy with no additional costs. Our results suggest a mechanism of EGFR-TKI resistance which is associated with the functional status of the platelets.	[Watanabe, Kousuke; Amano, Yosuke; Kage, Hidenori; Goto, Yasushi; Nagase, Takahide] Univ Tokyo Hosp, Dept Resp Med, Bunkyo Ku, Tokyo, Japan; [Yasumoto, Atsushi; Yatomi, Yutaka; Takai, Daiya] Univ Tokyo Hosp, Dept Clin Lab, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo	Watanabe, K (corresponding author), Univ Tokyo Hosp, Dept Resp Med, Bunkyo Ku, Tokyo, Japan.	kwatanabe-tky@umin.ac.jp		Yatomi, Yutaka/0000-0003-1719-4297; Watanabe, Kousuke/0000-0003-4670-3679				Aoe K, 2004, RESPIRATION, V71, P170, DOI 10.1159/000076679; ASSOIAN RK, 1986, J CELL BIOL, V102, P1217, DOI 10.1083/jcb.102.4.1217; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x; Bottsford-Miller J, 2015, CLIN CANCER RES, V21, P602, DOI 10.1158/1078-0432.CCR-14-0870; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; CHEN CH, 1985, STAT MED, V4, P39, DOI 10.1002/sim.4780040107; Chen YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136252; Chu SG, 2010, J THROMB HAEMOST, V8, P148, DOI 10.1111/j.1538-7836.2009.03584.x; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Gasparyan AY, 2011, CURR PHARM DESIGN, V17, P47; Inagaki N, 2014, LUNG CANCER, V83, P97, DOI 10.1016/j.lungcan.2013.08.020; KARPATKI.S, 1969, J CLIN INVEST, V48, P1083, DOI 10.1172/JCI106064; Kisacik B, 2008, JOINT BONE SPINE, V75, P291, DOI 10.1016/j.jbspin.2007.06.016; Kumagai S, 2015, MOL CLIN ONCOL, V3, P197, DOI 10.3892/mco.2014.436; Latger-Cannard V, 2012, INT J LAB HEMATOL, V34, P300, DOI 10.1111/j.1751-553X.2011.01396.x; Lian L, 2015, ONCOL LETT, V10, P3419, DOI 10.3892/ol.2015.3784; Lin RJ, 2014, BLOOD, V124, P184, DOI 10.1182/blood-2014-03-562538; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; NAKAMURA T, 1986, P NATL ACAD SCI USA, V83, P6489, DOI 10.1073/pnas.83.17.6489; Omar M, 2016, CLIN RESP J; Pyo JS, 2016, PLATELETS, V27, P722, DOI 10.3109/09537104.2016.1169265; Rachidi S, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai7911; Radziwon-Balicka A, 2012, BRIT J PHARMACOL, V167, P787, DOI 10.1111/j.1476-5381.2012.01991.x; Slavka G, 2011, ARTERIOSCL THROM VAS, V31, P1215, DOI 10.1161/ATVBAHA.110.221788; Speiser DE, 2016, NAT REV IMMUNOL, V16, P500, DOI 10.1038/nri.2016.80; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Yuksel O, 2009, PLATELETS, V20, P277, DOI 10.1080/09537100902856781; Zhang YX, 2015, CLIN LUNG CANCER, V16, P144, DOI 10.1016/j.cllc.2014.09.008	29	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203625	10.1371/journal.pone.0203625	http://dx.doi.org/10.1371/journal.pone.0203625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192878	Green Submitted, gold, Green Published			2022-12-26	WOS:000444093600122
J	Matsui, TS; Wu, H; Deguchi, S				Matsui, Tsubasa S.; Wu, Hugejile; Deguchi, Shinji			Deformable 96-well cell culture plate compatible with high-throughput screening platforms	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; IN-VITRO; MECHANICAL STRETCH; FOCAL ADHESIONS; SHEAR-STRESS; MECHANOTRANSDUCTION; STRAIN; REORIENTATION; SYSTEM; FORCE	Adherent cells such as endothelial cells sense applied mechanical stretch to adapt to changes in their surrounding mechanical environment. Despite numerous studies, signaling pathways underlying the cellular mechanosensing and adaptation remain to be fully elucidated partly because of the lack of tools that allow for a comprehensive screening approach. Conventionally, multi-well cell culture plates of standard configurations are used for comprehensive analyses in cell biology study to identify key molecules in a high-throughput manner. Given that situation, here we design a 96-well cell culture plate made of elastic silicone and mechanically stretchable using a motorized device. Computational analysis suggested that highly uniform stretch can be applied to each of the wells other than the peripheral wells. Elastic image registration-based experimental evaluation on stretch distributions within individual wells revealed the presence of larger variations among wells compared to those in the computational analysis, but a stretch level of 10%-that has been employed in conventional studies on cellular response to stretch-was almost achieved with our setup. We exposed vascular smooth muscle cells to cyclic stretch using the device to demonstrate morphological repolarization of the cells, i.e. typical cellular response to cyclic stretch. Because the deformable multi-well plate validated here is compatible with other high throughput screening-oriented technologies, we expect this novel system to be utilized for future comprehensive analyses of stretch-related signaling pathways.	[Matsui, Tsubasa S.; Deguchi, Shinji] Osaka Univ, Grad Sch Engn Sci, Div Bioengn, Toyonaka, Osaka, Japan; [Matsui, Tsubasa S.; Wu, Hugejile; Deguchi, Shinji] Nagoya Inst Technol, Dept Nanopharmaceut Sci, Nagoya, Aichi, Japan	Osaka University; Nagoya Institute of Technology	Deguchi, S (corresponding author), Osaka Univ, Grad Sch Engn Sci, Div Bioengn, Toyonaka, Osaka, Japan.; Deguchi, S (corresponding author), Nagoya Inst Technol, Dept Nanopharmaceut Sci, Nagoya, Aichi, Japan.	deguchi@me.es.osaka-u.ac.jp	Matsui, Tsubasa S/B-6337-2009	Matsui, Tsubasa S/0000-0002-6699-9131; Deguchi, Shinji/0000-0002-0556-4599	KAKENHI [15H03004, 16K12872, 16H05907, 17H02159]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funded by KAKENHI grants (no. 15H03004, 16K12872, 16H05907, and 17H02159); https://kaken.nii.ac.jp/en/index/.	Abiko H, 2015, J CELL SCI, V128, P1683, DOI 10.1242/jcs.157503; Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; Chagnon-Lessard S, 2017, INTEGR BIOL-UK, V9, P607, DOI 10.1039/c7ib00019g; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Deguchi S., 2017, J BIOMECH SCI ENG, V12, P16, DOI [10.1299/jbse. 16-00670, DOI 10.1299/JBSE.16-00670]; Deguchi S, 2015, J MICROMECH MICROENG, V25, DOI 10.1088/0960-1317/25/9/097002; Deguchi S, 2015, AIP ADV, V5, DOI 10.1063/1.4922220; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; GILBERT JA, 1994, J BIOMECH, V27, P1169, DOI 10.1016/0021-9290(94)90057-4; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; Howard AB, 1997, AM J PHYSIOL-CELL PH, V272, pC421, DOI 10.1152/ajpcell.1997.272.2.C421; Kamble H, 2016, LAB CHIP, V16, P3193, DOI 10.1039/c6lc00607h; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kaunas R, 2006, CELL SIGNAL, V18, P1924, DOI 10.1016/j.cellsig.2006.02.008; Kaunas R, 2011, CELL MOL BIOENG, V4, P182, DOI 10.1007/s12195-011-0175-x; Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200; Lee CF, 2010, BIOCHEM BIOPH RES CO, V401, P344, DOI 10.1016/j.bbrc.2010.09.046; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Matsui TS, 2011, INTERFACE FOCUS, V1, P754, DOI 10.1098/rsfs.2011.0031; Matsui TS, 2010, BIOCHEM BIOPH RES CO, V395, P301, DOI 10.1016/j.bbrc.2010.03.150; Naruse K, 1998, ONCOGENE, V17, P455, DOI 10.1038/sj.onc.1201950; NARUSE K, 1993, AM J PHYSIOL, V264, pC1037, DOI 10.1152/ajpcell.1993.264.4.C1037; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Nguyen BNB, 2012, CELL MOL BIOENG, V5, P504, DOI 10.1007/s12195-012-0245-8; Oest ME, 2014, J BIOMECH, V47, P518, DOI 10.1016/j.jbiomech.2013.10.036; Ohishi T, 2017, J MICROMECH MICROENG, V27, DOI 10.1088/0960-1317/27/1/015015; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Putnam AJ, 1998, J CELL SCI, V111, P3379; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; Sato K, 2015, J BIOMECH SCI ENG, V10, P1, DOI [10.1299/JBSE0.15-00242, DOI 10.1299/JBSE0.15-00242]; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Sherman SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34097; Spruell C, 2013, BIOTECHNOL BIOENG, V110, P1782, DOI 10.1002/bit.24823; Voyvodic PL, 2012, LAB CHIP, V12, P3322, DOI 10.1039/c2lc40526a; Wang D, 2010, INTEGR BIOL-UK, V2, P288, DOI 10.1039/b920644b; Wang JHC, 2001, J BIOMECH, V34, P1563, DOI 10.1016/S0021-9290(01)00150-6; Yokoyama S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102735	41	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203448	10.1371/journal.pone.0203448	http://dx.doi.org/10.1371/journal.pone.0203448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188938	Green Published, gold, Green Submitted			2022-12-26	WOS:000444228700035
J	Raberahona, M; Razafinambinintsoa, T; Andriananja, V; Ravololomanana, N; Tongavelona, J; Rakotomalala, R; Andriamamonjisoa, J; Andrianasolo, RL; Rakotoarivele, RA; Randria, MJD				Raberahona, Mihaja; Razafinambinintsoa, Tiana; Andriananja, Volatiana; Ravololomanana, Njaratiana; Tongavelona, Juliana; Rakotomalala, Rado; Andriamamonjisoa, Johary; Andrianasolo, Radonirina Lazasoa; Rakotoarivele, Rivonirina Andry; Randria, Mamy Jean de Dieu			Hospitalization of HIV positive patients in a referral tertiary care hospital in Antananarivo Madagascar, 2010-2016: Trends, causes and outcome	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; COHORT; RATES; METAANALYSIS; MORTALITY; WORLDWIDE; MARKERS; COST; ERA	Background During the last few years, significant efforts have been made to improve access to antiretroviral therapy which led to dramatic reduction in AIDS-related events and mortality in HIV positive patients at the global level. However, current data in Africa suggested modest impact of widespread antiretroviral therapy scale-up especially regarding HIV-related hospitalization. In this study, we aimed to describe causes of hospitalization and factors associated with AIDS-defining events and inpatient mortality. Materials and methods A retrospective study was performed on medical records of HIV positive patients admitted for at least 24 hours in the Infectious Diseases Unit of the University Hospital Joseph Raseta Befelatanana Antananarivo. Cause of hospitalization was considered as the main diagnosis related to the symptoms at admission. Diagnostic criteria were based on criteria described in WHO guidelines. AIDS-defining events were defined as diseases corresponding to WHO stage 4 or category C of CDC classification. Results From 2010 to 2016, 236 hospital admissions were included. AIDS-defining events were the most frequent cause of hospitalization (61.9%) with an increasing trend during the study period. Tuberculosis (28.4%), pneumocystis pneumonia (11.4%), cerebral toxoplasmosis (7.2%) and cryptococcosis (5.5%) were the most frequent AIDS-defining events. Tuberculosis was also the most frequent cause of overall hospitalization. In multivariate analysis, recent HIV diagnosis (aOR = 2.0, 95% CI: 1.0-3.9), CD4<200 cells/mu l (aOR = 4.0, 95% CI: 1.9-8.1), persistent fever (aOR = 4.4, 95%Cl: 2.1-9.0), duration of symptoms >= 6 weeks (aOR = 2.6, 95%Cl: 1.2-5.4) were associated with AIDS-defining events. Overall inpatient mortality was 19.5%. Age >= 55 years (aOR = 4.9, 95%Cl: 1.5-16.6), neurological signs (aOR = 3.2, 95%Cl: 1.5-6.9) and AIDS-defining events (aOR = 2.9, 95%Cl: 1.2-7.2) were associated with inpatient mortality. Conclusions AIDS-defining events were the most frequent cause of hospitalization during the study period. Factors associated with AIDS-defining events mostly reflected delay in HIV diagnosis. Factors associated with mortality were advanced age, neurological signs and AIDS-defining events.	[Raberahona, Mihaja; Andriananja, Volatiana; Randria, Mamy Jean de Dieu] Univ Hosp Antananar, Univ Hosp Joseph Raseta Befelatanana, Infect Dis Unit, Antananarivo, Madagascar; [Razafinambinintsoa, Tiana; Ravololomanana, Njaratiana; Tongavelona, Juliana; Rakotomalala, Rado; Andriamamonjisoa, Johary; Andrianasolo, Radonirina Lazasoa; Randria, Mamy Jean de Dieu] Univ Antananar, Fac Med, Antananarivo, Madagascar; [Tongavelona, Juliana; Rakotoarivele, Rivonirina Andry] Univ Hosp Tambohobe, Infect Dis Unit, Fianarantsoa, Madagascar; [Rakotoarivele, Rivonirina Andry] Univ Fianarantsoa, Fianarantsoa, Madagascar		Raberahona, M (corresponding author), Univ Hosp Antananar, Univ Hosp Joseph Raseta Befelatanana, Infect Dis Unit, Antananarivo, Madagascar.	raberahona@gamil.com		Rakotoarivelo, Rivonirina Andry/0000-0003-3438-8624				Agbor AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115211; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Assen A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3263-y; Buchacz K, 2008, AIDS, V22, P1345, DOI 10.1097/QAD.0b013e328304b38b; Buve A, 1997, TROP MED INT HEALTH, V2, P136, DOI 10.1046/j.1365-3156.1997.d01-235.x; Chi BH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001111; Coelho LE, 2017, BRAZ J INFECT DIS, V21, P190, DOI 10.1016/j.bjid.2016.10.007; Druyts EF, 2009, HIV MED, V10, P88, DOI 10.1111/j.1468-1293.2008.00656.x; Falster K, 2010, AIDS, V24, P1329, DOI 10.1097/QAD.0b013e328339e245; Fielden SJ, 2008, AIDS CARE, V20, P297, DOI 10.1080/09540120701561296; Ford N, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20714; Ford N, 2015, LANCET HIV, V2, pE438, DOI 10.1016/S2352-3018(15)00137-X; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Lewden C, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18797; Luo B, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003802; Mahlab-Guri K, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000006812, 10.1097/md.0000000000006812]; Meintjes G, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002269; Mocroft A, 2004, HIV MED, V5, P437, DOI 10.1111/j.1468-1293.2004.00250.x; Paul S, 2002, AIDS RES HUM RETROV, V18, P501, DOI 10.1089/088922202317406646; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; UNAIDS, AMB TREATM TARG HELP; UNAIDS, 2018, COUNTR FACTSH MAD; UNAIDS, 2016, GLOB AIDS UPD; van der Kop ML, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1500-8; WHO (World Health Organization), 2017, TREAT ALL POL AD IMP; World Health Organisation, 2007, WHO CAS DEF HIV SURV; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2016, TUB PROF MAD	30	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203437	10.1371/journal.pone.0203437	http://dx.doi.org/10.1371/journal.pone.0203437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161228	gold, Green Published, Green Submitted			2022-12-26	WOS:000443388900126
J	Dey, T; Rao, KK; Khatun, J; Rangarajan, PN				Dey, Trishna; Rao, Kamisetty Krishna; Khatun, Jesminara; Rangarajan, Pundi N.			The nuclear transcription factor Rtg1p functions as a cytosolic, post-transcriptional regulator in the methylotrophic yeast Pichia pastoris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Saccharomyces cerevisiae; signaling; basic helix-loop-helix transcription factor (bHLH); post-transcriptional regulation; metabolism; alcohol oxidase; metabolic pathway; methanol metabolism; Pichia pastoris; retrograde transcription factor	METHANOL UTILIZATION PATHWAY; RETROGRADE RESPONSE; AMINO-ACIDS; 1 MXR1P; EXPRESSION; GENES; MITOCHONDRIA; COMPLEX; TARGET	Rtg1p and Rtg3p are two basic helix-loop-helix, retrograde transcription factors in the budding yeast Saccharomyces cerevisiae. Both factors heterodimerize to activate the transcription of nuclear genes in response to mitochondrial dysfunction and glutamate auxotrophy, but are not well characterized in other yeasts. Here, we demonstrate that the Rtg1p/Rtg3p-mediated retrograde signaling pathway is absent in the methylotrophic yeast Pichia pastoris. We observed that P. pastoris Rtg1p (PpRtg1p) heterodimerizes with S. cerevisiae Rtg3p and functions as a nuclear, retrograde transcription factor in S. cerevisiae, but not in P. pastoris. We noted that P. pastoris Rtg3p lacks a functional leucine zipper and interacts with neither S. cerevisiae Rtg1p (ScRtg1p) nor PpRtg1p. In the absence of an interaction with Rtg3p, PpRtg1p has apparently acquired a novel function as a cytosolic regulator of multiple P. pastoris metabolic pathways, including biosynthesis of glutamate dehydrogenase 2 and phosphoenolpyruvate carboxykinase required for the utilization of glutamate as the sole carbon source. PpRtg1p also had an essential role in methanol metabolism and regulated alcohol oxidase synthesis and was required for the metabolism of ethanol, acetate, and oleic acid, but not of glucose and glycerol. Although PpRtg1p could functionally complement ScRtg1p, ScRtg1p could not complement PpRtg1p, indicating that ScRtg1p is not a functional PpRtg1p homolog. Thus, PpRtg1p functions as a nuclear, retrograde transcription factor in S. cerevisiae and as a cytosolic, post-transcriptional regulator in P. pastoris. We conclude that PpRtg1p is a key component of a signaling pathway that regulates multiple metabolic processes in P. pastoris.	[Dey, Trishna; Rao, Kamisetty Krishna; Khatun, Jesminara; Rangarajan, Pundi N.] Indian Inst Sci, Dept Biochem, Bangalore 60012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rangarajan, PN (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 60012, Karnataka, India.	pnr@iisc.ac.in	Rangarajan, Pundi/A-7365-2009	Rangarajan, Pundi/0000-0002-6536-9891	Science and Engineering Research Board, Department of Science and Technology, New Delhi, India [EMR/2015/000567, SB/S2/JCB-025/2015]; Department of Science and Technology Fund for Improvement of Science and Technology (S&T) Infrastructure in Higher Educational Institutions (DST-FIST); University Grants Commission	Science and Engineering Research Board, Department of Science and Technology, New Delhi, India; Department of Science and Technology Fund for Improvement of Science and Technology (S&T) Infrastructure in Higher Educational Institutions (DST-FIST); University Grants Commission(University Grants Commission, India)	This work was supported by the Research Grant EMR/2015/000567 and J. C. Bose Fellowship Grant SB/S2/JCB-025/2015 awarded by the Science and Engineering Research Board, Department of Science and Technology, New Delhi, India (to P. N. R.) and by the Department of Science and Technology Fund for Improvement of Science and Technology (S&T) Infrastructure in Higher Educational Institutions (DST-FIST) and University Grants Commission. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad M, 2014, APPL MICROBIOL BIOT, V98, P5301, DOI 10.1007/s00253-014-5732-5; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; CREGG JM, 1989, MOL CELL BIOL, V9, P1316, DOI 10.1128/MCB.9.3.1316; Dilova I, 2002, CURR BIOL, V12, P389, DOI 10.1016/S0960-9822(02)00677-2; Dilova I, 2004, J BIOL CHEM, V279, P46527, DOI 10.1074/jbc.M409012200; Freese S, 2011, YEAST, V28, P375, DOI 10.1002/yea.1845; Higgins DR, 1998, METH MOL B, V103, P1; Jazwinski SM, 2014, PROG MOL BIOL TRANSL, V127, P133, DOI 10.1016/B978-0-12-394625-6.00005-2; Jia YK, 1997, MOL CELL BIOL, V17, P1110, DOI 10.1128/MCB.17.3.1110; Kang Z, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-016-2185-2; Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863; Kranthi BV, 2009, BBA-GENE REGUL MECH, V1789, P460, DOI 10.1016/j.bbagrm.2009.05.004; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; Lin-Cereghino GP, 2006, MOL CELL BIOL, V26, P883, DOI 10.1128/MCB.26.3.883-897.2006; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ruiz-Roig C, 2012, MOL BIOL CELL, V23, P4286, DOI 10.1091/mbc.E12-04-0289; Sahu U, 2016, J BIOL CHEM, V291, P20588, DOI 10.1074/jbc.M116.740191; Sahu U, 2016, J BIOL CHEM, V291, P3648, DOI 10.1074/jbc.M115.673640; Sahu U, 2014, BIOCHEM BIOPH RES CO, V451, P158, DOI 10.1016/j.bbrc.2014.07.094; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Shen W, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0578-4; Unlu ES, 2013, FEMS YEAST RES, V13, P495, DOI 10.1111/1567-1364.12055; Vogl T, 2018, BIOTECHNOL BIOENG, V115, P1037, DOI 10.1002/bit.26529; Vogl T, 2014, ACS SYNTH BIOL, V3, P188, DOI 10.1021/sb400091p; Vogl T, 2013, CURR OPIN BIOTECH, V24, P1094, DOI 10.1016/j.copbio.2013.02.024; Wang JJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41850; Yan HB, 2014, FEMS YEAST RES, V14, P614, DOI 10.1111/1567-1364.12148; Zhang F, 2013, GENES-BASEL, V4, P86, DOI 10.3390/genes4010086	30	4	4	2	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16647	16660		10.1074/jbc.RA118.004486	http://dx.doi.org/10.1074/jbc.RA118.004486			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30185617	Green Published, hybrid			2022-12-26	WOS:000448515100009
J	Fleet, AJ; Hamel, PA				Fleet, Andrew J.; Hamel, Paul A.			The protein-specific activities of the transmembrane modules of Ptch1 and Ptch2 are determined by their adjacent protein domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hedgehog signaling pathway; sonic hedgehog (SHH); transmembrane domain; membrane protein; protein chimera; transporter; NPC1; Patched-1; Patched-2; sterol-sensing domain	BASAL-CELL CARCINOMA; STEROL-SENSING DOMAIN; PATCHED GENE; HEDGEHOG; SHH; MUTATION; MEDULLOBLASTOMA; ACTIVATION; INHIBITION; REVEALS	Signaling through the Hedgehog (Hh) pathway is mediated by the Patched (Ptch) family of proteins. Although the vertebrate Ptch proteins Ptch1 and Ptch2 harbor two closely related transmembrane modules related to sterol-sensing domains (SSDs), the role of these closely related receptors in the Hh pathway are not equivalent. Ptch1 is essential for development and appears to be the principal receptor mediating responses to Hh ligands, whereas Ptch2 is nonessential, and its role in Hh-signaling remains ambiguous. We hypothesized that the SSDs of the Ptch proteins function as generic modules whose protein-specific activities are determined by the adjacent cytoplasmic and luminal domains. We first showed that individual N-terminal and C-terminal halves of Ptch1 associated noncovalently to mediate ligand-dependent regulation of Hh signaling. The analogous regions of Ptch2 also interacted noncovalently but did not repress the Hh pathway. However, the SSD of Ptch2 were capable of repressing Hh signaling, as determined using chimeric proteins where the SSDs of Ptch1 were replaced by those from Ptch2. Replacement of the SSDs of Ptch1 with the analogous regions from the cholesterol transporter NPC1 failed to produce a chimeric protein capable of Hh repression. Further refinement of the specific regions in Ptch1 and Ptch2 revealed that specific cytoplasmic domains of Ptch1 were necessary but not sufficient for repression of Hh signaling and that the two principal luminal domains of Ptch1 and Ptch2 were interchangeable. These data support a model where the SSDs of the Ptch family proteins exhibit generic activities and that the adjacent cytoplasmic and luminal domains determine their protein-specific activities.	[Fleet, Andrew J.; Hamel, Paul A.] Univ Toronto, Dept Lab Med & Pathobiol, Fac Med, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada	University of Toronto	Hamel, PA (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Fac Med, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	paul.hamel@utoronto.ca			Canadian Institutes of Health Research Grant [MOP-142490]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was funded by Canadian Institutes of Health Research Grant MOP-142490 (to P. A. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alfaro AC, 2014, DEVELOPMENT, V141, P3331, DOI 10.1242/dev.110056; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Canterini S, 2017, HUM MOL GENET, V26, P2277, DOI 10.1093/hmg/ddx118; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Chang H, 2010, INT J BIOCHEM CELL B, V42, P1462, DOI 10.1016/j.biocel.2010.04.016; Chen XLL, 2014, MOL CELL BIOL, V34, P3855, DOI 10.1128/MCB.00960-14; Chen Y, 1998, DEVELOPMENT, V125, P4943; Chidambaram A, 1996, CANCER RES, V56, P4599; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Fleet A, 2016, J BIOL CHEM, V291, P17557, DOI 10.1074/jbc.M116.731745; Formichi P, 2018, J CELL PHYSIOL, V233, P663, DOI 10.1002/jcp.25926; Gong X, 2018, SCIENCE, V361, DOI 10.1126/science.aas8935; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Harvey MC, 2014, J BIOL CHEM, V289, P10939, DOI 10.1074/jbc.M113.514844; Hausmann G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000146; Holtz AM, 2013, DEVELOPMENT, V140, P3423, DOI 10.1242/dev.095083; Huang SJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001721; Incardona JP, 2000, DEV BIOL, V224, P440, DOI 10.1006/dbio.2000.9775; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Johnson RL, 2000, MOL CELL, V6, P467, DOI 10.1016/S1097-2765(00)00045-9; Kim J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa5622; Klein C, 2016, J EXP MED, V213, P273, DOI 10.1084/jem.20150556; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee Y, 2006, CANCER RES, V66, P6964, DOI 10.1158/0008-5472.CAN-06-0505; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lu Y, 2008, CHINESE MED J-PEKING, V121, P118, DOI 10.1097/00029330-200801020-00005; Martin V, 2001, CURR BIOL, V11, P601, DOI 10.1016/S0960-9822(01)00178-6; Motoyama J, 1998, NAT GENET, V18, P104, DOI 10.1038/ng0298-104; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Nieuwenhuis E, 2006, MOL CELL BIOL, V26, P6609, DOI 10.1128/MCB.00295-06; Okolowsky N, 2014, DEV BIOL, V391, P219, DOI 10.1016/j.ydbio.2014.04.007; Polizio AH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002396; Qi XF, 2018, NATURE, V560, P128, DOI 10.1038/s41586-018-0308-7; Rahnama F, 2004, BIOCHEM J, V378, P325, DOI 10.1042/BJ20031200; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; SAIER MH, 1994, MICROBIOL REV, V58, P71, DOI 10.1128/MMBR.58.1.71-93.1994; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Smyth I, 1999, HUM MOL GENET, V8, P291, DOI 10.1093/hmg/8.2.291; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Tukachinsky H, 2016, P NATL ACAD SCI USA, V113, pE5866, DOI 10.1073/pnas.1606719113; Wakabayashi Y, 2007, NATURE, V445, P761, DOI 10.1038/nature05489; Yue S, 2014, ELIFE, V3, DOI 10.7554/eLife.02555; Zaphiropoulos PG, 1999, CANCER RES, V59, P787; Zhang Y., 2018, BIORXIV, DOI [10.1101/352443, DOI 10.1101/352443]; Zhong Y, 2014, GENET MOL RES, V13, P7318, DOI 10.4238/2014.February.13.11; Zhulyn O, 2015, DEV BIOL, V397, P191, DOI 10.1016/j.ydbio.2014.10.023; Zhulyn O, 2014, DEV CELL, V29, P241, DOI 10.1016/j.devcel.2014.03.002	55	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16583	16595		10.1074/jbc.RA118.004478	http://dx.doi.org/10.1074/jbc.RA118.004478			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30166346	Green Published, hybrid			2022-12-26	WOS:000448515100004
J	Goyal, AR; Bergh, S; Engedal, K; Kirkevold, M; Kirkevold, O				Goyal, Alka R.; Bergh, Sverre; Engedal, Knut; Kirkevold, Marit; Kirkevold, Oyvind			Trajectories of quality of life and their association with anxiety in people with dementia in nursing homes: A 12-month follow-up study	PLOS ONE			English	Article							LATE-STAGE DEMENTIA; NEUROPSYCHIATRIC SYMPTOMS; NORWEGIAN VERSION; RATING ANXIETY; DRUG TREATMENT; CORNELL SCALE; CARE; RESIDENTS; VALIDITY; RELIABILITY	Objectives This study aimed to identify possible groups of people with dementia (PWD) in nursing homes with different trajectories of proxy-rated quality of life (QoL), and to explore how anxiety (along with other characteristics) was associated with these trajectories of QoL of PWD in nursing homes at a 12-month follow-up. Methods We included 298 PWD aged 65 years and older from 17 Norwegian nursing homes. The Norwegian version of the Rating Anxiety in Dementia scale (RAID-N) was used to assess anxiety, defined as RAID-N score >= 12; proxy-rated QoL was assessed by Quality of Life in Late-Stage Dementia (QUALID). The assessments were made at baseline and after a mean follow-up period of 350 days (SD 12.3). A growth mixture model identified two distinct trajectories of QUALID scores. Association between the QUALID score trajectories and demographic and clinical characteristics were analyzed with logistic regression models. Results Trajectory group 1 (206 participants) had a lower proportion of participants with anxiety, and a more stable and better QoL, compared to trajectory group 2 (92 participants) at a 12-month follow-up. In a multivariate logistic regression analysis, more severe impairment in activities of daily living, along with presence of anxiety, depression, agitation, and use of antipsychotics at baseline, were associated with belonging to the trajectory group with proxy-rated poor QoL. Significances This study reveals that anxiety is associated with proxy-rated poor QoL of PWD at a 12-month follow-up. Efforts should be made to identify anxiety among nursing home residents with dementia to initiate treatment.	[Goyal, Alka R.; Bergh, Sverre; Kirkevold, Oyvind] Innlandet Hosp Trust, Res Ctr Age Related Funct Decline & Dis, Ottestad, Norway; [Goyal, Alka R.; Bergh, Sverre; Engedal, Knut; Kirkevold, Oyvind] Vesffold Hosp Trust, Norwegian Natl Advisory Unit Aging & Hlth, Tonsberg, Norway; [Goyal, Alka R.; Kirkevold, Marit] Univ Oslo, Inst Hlth & Soc, Dept Nursing Sci, Oslo, Norway; [Kirkevold, Oyvind] Norwegian Univ Sci & Technol NTNU Gjovik, Fac Hlth Care & Nursing, Gjovik, Norway	Innlandet Hospital Trust; University of Oslo; Norwegian University of Science & Technology (NTNU)	Goyal, AR (corresponding author), Innlandet Hosp Trust, Res Ctr Age Related Funct Decline & Dis, Ottestad, Norway.; Goyal, AR (corresponding author), Vesffold Hosp Trust, Norwegian Natl Advisory Unit Aging & Hlth, Tonsberg, Norway.; Goyal, AR (corresponding author), Univ Oslo, Inst Hlth & Soc, Dept Nursing Sci, Oslo, Norway.	alkgoy@sykehuset-innlandet.no		Kirkevold, Oyvind/0000-0001-5698-5636	Research Centre for Age Related Functional Decline and Diseases, Innlandet Hospital Trust, Ottestad, Norway [150279]; Norwegian National Advisory Unit on Ageing and Health [150279]	Research Centre for Age Related Functional Decline and Diseases, Innlandet Hospital Trust, Ottestad, Norway; Norwegian National Advisory Unit on Ageing and Health	This study was supported by The Research Centre for Age Related Functional Decline and Diseases, Innlandet Hospital Trust, Ottestad, Norway under grant number 150279 to OK; and the Norwegian National Advisory Unit on Ageing and Health under grant number 150279 to ARG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank JurateS I altyte Benth for assistance in the analysis and interpretation of the results. This study was supported by The Research Centre for Age Related Functional Decline and Diseases, Innlandet Hospital Trust, Ottestad, Norway under grant number 150279 to OK, and the Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital Trust, under grant number 150279 to ARG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8; Altman D.G., 1991, PRACTICAL STATISTIC; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V44; [Anonymous], 2011, WHO ICD 10 PSYK LID; Ballard CG, 2004, J CLIN PSYCHIAT, V65, P114; Ballard C, 2009, LANCET NEUROL, V8, P151, DOI 10.1016/S1474-4422(08)70295-3; Barca ML, 2011, DEMENT GERIATR COGN, V31, P435, DOI 10.1159/000328969; Barca ML, 2010, DEMENT GERIATR COGN, V29, P438, DOI 10.1159/000313533; Barca ML, 2010, J AFFECT DISORDERS, V120, P141, DOI 10.1016/j.jad.2009.04.028; Beerens HC, 2013, INT J NURS STUD, V50, P1259, DOI 10.1016/j.ijnurstu.2013.02.005; Bergh S., 2012, Norsk Epidemiologi, V22, P225; Bergh S, 2008, INT J GERIATR PSYCH, V23, P877, DOI 10.1002/gps.2008; Bowling A, 2015, AGING MENT HEALTH, V19, P13, DOI 10.1080/13607863.2014.915923; Engedal K., 2009, DEMENS FAKTA UTFORDR; Ettema TP, 2005, INT PSYCHOGERIATR, V17, P353, DOI 10.1017/S1041610205002073; Fossey J, 2006, BMJ-BRIT MED J, V332, P756, DOI 10.1136/bmj.38782.575868.7C; Goyal AR, 2017, AGING MENT HEALTH, V21, P1256, DOI 10.1080/13607863.2016.1220921; Goyal AR, 2017, DEMENT GERIATR COGN, V43, P294, DOI 10.1159/000471796; Helvik AS, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0047-7; Hoe J, 2006, BRIT J PSYCHIAT, V188, P460, DOI 10.1192/bjp.bp.104.007658; Hoe J, 2009, ALZ DIS ASSOC DIS, V23, P285, DOI 10.1097/WAD.0b013e318194fc1e; HofmansOkkes IM, 1996, FAM PRACT, V13, P294, DOI 10.1093/fampra/13.3.294; Hongisto K, 2018, INT J GERIATR PSYCH, V33, P47, DOI 10.1002/gps.4666; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lichtwarck B, 2018, AM J GERIAT PSYCHIAT, V26, P25, DOI 10.1016/j.jagp.2017.05.015; Lyketsos CG, 2003, INT J GERIATR PSYCH, V18, P275, DOI 10.1002/gps.796; Lyketsos CG, 1999, J AM GERIATR SOC, V47, P487, DOI 10.1111/j.1532-5415.1999.tb07245.x; Martin-Cook K, 2005, DEMENT GERIATR COGN, V19, P82, DOI 10.1159/000082353; Mjorud M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115248; Mjorud M, 2014, AGING MENT HEALTH, V18, P1013, DOI 10.1080/13607863.2014.903468; Nakanishi K, 2011, DEMENT GERIATR COGN, V32, P39, DOI 10.1159/000329443; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; Roen I, 2015, DEMENT GERIATR COGN, V40, P233, DOI 10.1159/000437093; Rokstad AMM, 2013, DEMENT GERIATR COGN, V36, P340, DOI 10.1159/000354366; Sami MB, 2015, INT PSYCHOGERIATR, V27, P1061, DOI 10.1017/S1041610214001847; Samus QM, 2005, GERONTOLOGIST, V45, P19, DOI 10.1093/geront/45.suppl_1.19; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Schoevers RA, 2005, AM J GERIAT PSYCHIAT, V13, P31, DOI 10.1176/appi.ajgp.13.1.31; Seignourel PJ, 2008, CLIN PSYCHOL REV, V28, P1071, DOI 10.1016/j.cpr.2008.02.008; Selbaek G, 2007, INT J GERIATR PSYCH, V22, P843, DOI 10.1002/gps.1749; Selwood A, 2005, INT J GERIATR PSYCH, V20, P232, DOI 10.1002/gps.1271; Shankar KK, 1999, AGING MENT HEALTH, V3, P39, DOI 10.1080/13607869956424; Spector A, 2006, ALZ DIS ASSOC DIS, V20, P160, DOI 10.1097/00002093-200607000-00007; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Trigg R, 2007, AGE AGEING, V36, P663, DOI 10.1093/ageing/afm077; Wang SY, 2013, ARCH GERONTOL GERIAT, V57, P16, DOI 10.1016/j.archger.2013.03.007; Weiner M F, 2000, J Am Med Dir Assoc, V1, P114; Wergeland JN, 2015, DEMENT GER COGN D EX, V5, P320, DOI 10.1159/000437382; Wetzels RB, 2010, DEMENT GERIATR COGN, V29, P189, DOI 10.1159/000280437; WHO, 2017, INT LANG DRUG UT RES	53	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203773	10.1371/journal.pone.0203773	http://dx.doi.org/10.1371/journal.pone.0203773			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT2UM	30204812	Green Published, gold, Green Submitted			2022-12-26	WOS:000444355500043
J	Kwon, JW; Jee, D				Kwon, Jin-Woo; Jee, Donghyun			Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment	PLOS ONE			English	Article							ENDOTHELIAL-CELL PERMEABILITY; RANDOMIZED CLINICAL-TRIAL; RETINAL VEIN OCCLUSION; INTRAVITREAL BEVACIZUMAB; KAPPA-B; RETINOPATHY; DEXAMETHASONE; INTERLEUKIN-8; PREVALENCE; IL-10	Purpose To determine aqueous cytokines association with response to intravitreal bevacizumab (IVB) injection in diabetic macular edema (DME). Method We compared the concentrations of IL (interleukin)-1 beta, 1L-2, IL-8, IL-10, IL-17, placental growth factor (PIGF), and vascular endothelial growth factor (VEGF) in the aqueous humor of 64 naive DME patients with those of 13 cataract patients. Factors associated with central subfield thickness (CST) in DME patients were identified. DME patients were then sub-grouped in terms of responsiveness to three IVB injections; cytokine concentrations were compared, and factors associated with responsiveness were identified. Results Levels of IL-2, IL-8, PIGF, and VEGF were significantly elevated in DME patients (p = 0.007, p < 0.001, p < 0.001, and p = 0.004 respectively). Regression analysis showed that the preoperative CST was associated with the preoperative best-corrected visual acuity and the aqueous IL-10 level (p < 0.001, p = 0.006, respectively). Of the 64 DME patients, 28 (43.75%) exhibited either CST < 300 mu m or reduction in CST >= 50 mu m after three consecutive IVB injections. On sub-group analysis, the mean IL-8 concentration was higher in the refractory group than in the responsive group, and multivariate logistic regression analysis showed that the IL-8 was the only factor associated with responsiveness (OR = 0.95, p = 0.017). Conclusions The IL-8 concentration in the aqueous humor was associated with responsiveness to IVB in DME patients.	[Kwon, Jin-Woo; Jee, Donghyun] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Ophthalmol & Visual Sci, Suwon, Kyunggi Do, South Korea	Catholic University of Korea	Jee, D (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Ophthalmol & Visual Sci, Suwon, Kyunggi Do, South Korea.	doj087@mail.harvard.edu		Kwon, Jin-woo/0000-0003-2093-4284	National Research Foundation of Korea - Korean government (MSIP) [NRF-2016R1D1A1B03932606]	National Research Foundation of Korea - Korean government (MSIP)	This work was supported by the National Research Foundation of Korea Grant funded by the Korean government (MSIP), No.NRF-2016R1D1A1B03932606 (http://www.nrf.re.kr/nrf_ tot_cms/index.jsp?pmi-sso-return2=none) to Donghyun Jee. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Behzadian MA, 2001, INVEST OPHTH VIS SCI, V42, P853; Boyer DS, 2014, OPHTHALMOLOGY, V121, P1904, DOI 10.1016/j.ophtha.2014.04.024; Campochiaro PA, 2016, AM J OPHTHALMOL, V168, P13, DOI 10.1016/j.ajo.2016.04.017; Cassoux N, 2007, INVEST OPHTH VIS SCI, V48, P3253, DOI 10.1167/iovs.06-0031; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381; Das A, 2015, OPHTHALMOLOGY, V122, P1375, DOI 10.1016/j.ophtha.2015.03.024; Dong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125329; Feng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068149; Ghasemi H, 2012, OCUL IMMUNOL INFLAMM, V20, P406, DOI 10.3109/09273948.2012.723109; Gillies MC, 2014, OPHTHALMOLOGY, V121, P2473, DOI 10.1016/j.ophtha.2014.07.002; Hayreh SS, 2007, PROG RETIN EYE RES, V26, P470, DOI 10.1016/j.preteyeres.2007.06.001; Hillier RJ, 2017, RETINA-J RET VIT DIS, V37, P761, DOI 10.1097/IAE.0000000000001210; Jeon S, 2014, RETINA-J RET VIT DIS, V34, P1606, DOI 10.1097/IAE.0000000000000109; Jonas JB, 2012, RETINA-J RET VIT DIS, V32, P2150, DOI 10.1097/IAE.0b013e3182576d07; Jung SH, 2014, INVEST OPHTH VIS SCI, V55, P2290, DOI 10.1167/iovs.13-13587; Kaneda S, 2011, INVEST OPHTH VIS SCI, V52, P2982, DOI 10.1167/iovs.10-6299; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kwon JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159720; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045264; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; Mitrovic S, 2016, OCUL IMMUNOL INFLAMM, V24, P159, DOI 10.3109/09273948.2014.949779; Owen LA, 2013, CURR DIABETES REP, V13, P476, DOI 10.1007/s11892-013-0382-z; Petering H, 1999, BLOOD, V93, P694, DOI 10.1182/blood.V93.2.694.402k31_694_702; Rezar-Dreindl S, 2017, ACTA OPHTHALMOL, V95, pE119, DOI 10.1111/aos.13152; Roh MI, 2009, OPHTHALMOLOGY, V116, P80, DOI 10.1016/j.ophtha.2008.09.036; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Scott IU, 2007, OPHTHALMOLOGY, V114, P1860, DOI 10.1016/j.ophtha.2007.05.062; Sivaprasad S, 2012, SURV OPHTHALMOL, V57, P347, DOI 10.1016/j.survophthal.2012.01.004; Sonoda S, 2013, INVEST OPHTH VIS SCI, V54, P5367, DOI 10.1167/iovs.13-12382; Sugimoto M, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006406; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Ting DSW, 2016, CLIN EXP OPHTHALMOL, V44, P260, DOI 10.1111/ceo.12696; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264; Wu HL, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/9402198; Yoshida A, 1998, INVEST OPHTH VIS SCI, V39, P1097; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	40	28	30	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203408	10.1371/journal.pone.0203408	http://dx.doi.org/10.1371/journal.pone.0203408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204781	Green Submitted, Green Published, gold			2022-12-26	WOS:000444355500028
J	Mannaerts, D; Faes, E; Cos, P; Briede, JJ; Gyselaers, W; Cornette, J; Gorbanev, Y; Bogaerts, A; Spaanderman, M; Van Craenenbroeck, E; Jacquemyn, Y				Mannaerts, Dominique; Faes, Ellen; Cos, Paul; Briede, Jacob J.; Gyselaers, Wilfried; Cornette, Jerome; Gorbanev, Yury; Bogaerts, Annemie; Spaanderman, Marc; Van Craenenbroeck, Emeline; Jacquemyn, Yves			Oxidative stress in healthy pregnancy and preeclampsia is linked to chronic inflammation, iron status and vascular function	PLOS ONE			English	Article							BLOOD; SUPEROXIDE; PARAMETERS; ISCHEMIA; DAMAGE; COUNT; RATIO; DNA	Background During normal pregnancy, placental oxidative stress (OS) is present during all three trimesters and is necessary to obtain normal cell function. However, if OS reaches a certain level, pregnancy complications might arise. In preeclampsia (PE), a dangerous pregnancy specific hypertensive disorder, OS induced in the ischemic placenta causes a systemic inflammatory response and activates maternal endothelial cells. In this study, we aimed to quantify superoxide concentrations (as a measure of systemic OS) using electron paramagnetic resonance (EPR) and correlate them to markers of systemic inflammation, iron status and vascular function. Methods Fifty-nine women with a healthy pregnancy (HP), 10 non-pregnant controls (NP) and 28 PE patients (32 +/- 3.3weeks) were included. During HP, blood samples for superoxide, neutrophil to lymphocyte ratio (NLR), mean platelet volume (MPV) and iron status were taken at 10, 25 and 39 weeks. Vascular measurements for arterial stiffness (carotid-femoral pulse wave velocity (CF-PWV), augmentation index (Alx), augmentation Pressure (AP)) and microvascular endothelial function (reactive hyperemia index (RHI)) were performed at 35 weeks. In PE, all measurements were performed at diagnosis. CMH (1-hydroxy-3-methoxycarbonyl- 2,2,5,5-tetramethylpyrrolidine) was used as spin probe for EPR, since the formed CM radical corresponds to the amount of superoxide. Results Superoxide concentration remains stable during pregnancy (p = 0.92), but is significantly higher compared to the NP controls (p<0.0001). At 25 weeks, there is a significant positive correlation between superoxide and ferritin concentration. (p = 0.04) In PE, superoxide, systemic inflammation and iron status are much higher compared to HP (all p<0.001). During HP, superoxide concentrations correlate significantly with arterial stiffness (all p<0.04), while in PE superoxide is significantly correlated to microvascular endothelial function (p = 0.03). Conclusions During HP there is an increased but stable oxidative environment, which is correlated to ferritin concentration. If superoxide levels increase, there is an augmentation in arterial stiffness. In PE pregnancies, systemic inflammation and superoxide concentrations are higher and result in a deterioration of endothelial function. Together, these findings support the hypothesis that vascular function is directly linked to the amount of OS and that measurement of OS in combination with vascular function tests might be used in the prediction of PE.	[Mannaerts, Dominique; Faes, Ellen; Jacquemyn, Yves] Univ Antwerp, Anat & Res Ctr, Antwerp Surg Training, Res Grp ASTARC, Antwerp, Belgium; [Mannaerts, Dominique; Faes, Ellen; Jacquemyn, Yves] Antwerp Univ Hosp, Dept Obstet & Gynaecol, Edegem, Belgium; [Cos, Paul] Univ Antwerp, LMPH, Antwerp, Belgium; [Briede, Jacob J.] Maastricht Univ, Sch Oncol & Dev Biol GROW, Dept Toxicogen, Maastricht, Netherlands; [Gyselaers, Wilfried] Ziekenhuis Oost Limburg, Dept Obstet & Gynaecol, Genk, Belgium; [Cornette, Jerome] Erasmus MG Rotterdam, Dept Obstet & Gynaecol, Rotterdam, Netherlands; [Gorbanev, Yury; Bogaerts, Annemie] Univ Antwerp, Dept Chem, Res Grp PLASMANT, Antwerp, Belgium; [Spaanderman, Marc] MUMC Maastricht Univ, Dept Obstet & Gynaecol, Maastricht, Netherlands; [Van Craenenbroeck, Emeline] Antwerp Univ Hosp, Lab Cellular & Mol Cardiol, Edegem, Belgium; [Van Craenenbroeck, Emeline] Antwerp Univ Hosp, Dept Cardiol, Edegem, Belgium; [Van Craenenbroeck, Emeline] Univ Antwerp, Translat Pathophysiol Res, Res Grp Cardiovasc Dis, Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp; Maastricht University; East Limburg Hospital; University of Antwerp; Maastricht University; Maastricht University Medical Centre (MUMC); University of Antwerp; University of Antwerp; University of Antwerp	Mannaerts, D (corresponding author), Univ Antwerp, Anat & Res Ctr, Antwerp Surg Training, Res Grp ASTARC, Antwerp, Belgium.; Mannaerts, D (corresponding author), Antwerp Univ Hosp, Dept Obstet & Gynaecol, Edegem, Belgium.	mannaerts.dominique@gmail.com	cos, paul/AAU-3896-2020; Gorbanev, Yury/AAN-8779-2021; Bogaerts, Annemie/L-8338-2016; Van Craenenbroeck, Emeline/AAG-4540-2020; Cos, Paul/L-9717-2015	cos, paul/0000-0003-4361-8911; Gorbanev, Yury/0000-0002-8059-4464; Bogaerts, Annemie/0000-0001-9875-6460; Van Craenenbroeck, Emeline/0000-0001-7686-2668; Cos, Paul/0000-0003-4361-8911; Briede, Jacco/0000-0003-1405-5232; Mannaerts, Dominique/0000-0003-4955-1586	University of Antwerp; Department Obstetrics and Gynaecology of the Antwerp University Hospital; Antwerp University Hospital; fund for scientific research-Flanders (FWO)	University of Antwerp; Department Obstetrics and Gynaecology of the Antwerp University Hospital; Antwerp University Hospital; fund for scientific research-Flanders (FWO)(FWO)	This study is part of a PhD-thesis which is supported by the University of Antwerp and the Department Obstetrics and Gynaecology of the Antwerp University Hospital. The University of Antwerp provides the earnings for the principal investigator (DM) who is responsible for the design of the study, data collection and interpretation and writing of the manuscript. The Antwerp University Hospital supports the financial part of data collection. EMVC is supported by the fund for scientific research-Flanders (FWO) as senior clinical investigator.	Berg K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090964; Burton GJ, 2011, BEST PRACT RES CL OB, V25, P287, DOI 10.1016/j.bpobgyn.2010.10.016; Casanueva E, 2003, J NUTR, V133, p1700S, DOI 10.1093/jn/133.5.1700S; Cetin I, 2011, ANN NUTR METAB, V59, P55, DOI 10.1159/000332133; Chandra S, 2012, INDIAN J HEMATOL BLO, V28, P144, DOI 10.1007/s12288-012-0175-6; Degendorfer G, 2015, FREE RADICAL BIO MED, V89, P721, DOI 10.1016/j.freeradbiomed.2015.09.018; Demir M, 2013, VASC HEALTH RISK MAN, V9, P365, DOI 10.2147/VHRM.S48778; Dikalov SI, 2007, BIOCHEM PHARMACOL, V73, P972, DOI 10.1016/j.bcp.2006.12.012; Dogan K, 2015, HYPERTENS PREGNANCY, V34, P434, DOI 10.3109/10641955.2015.1060244; Dong Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158672; Ferguson KK, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.12.174; Furukawa S, 2016, J MATERN-FETAL NEO M, V29, P2994, DOI 10.3109/14767058.2015.1112370; GATTI L, 1994, INT J CLIN LAB RES, V24, P217, DOI 10.1007/BF02592466; Gevaert AB, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4865756; Gielis JF, 2015, EUR J CARDIO-THORAC, V48, P622, DOI 10.1093/ejcts/ezu518; Gorbanev Y, 2018, PHYS CHEM CHEM PHYS, V20, P2797, DOI 10.1039/c7cp07616a; Grzywna E, 2017, CELL BIOCHEM BIOPHYS, V75, P351, DOI 10.1007/s12013-017-0820-7; Hodzic Jasmin, 2017, Med Glas (Zenica), V14, P211, DOI 10.17392/915-17; Jacquemyn Y, 2013, FACTS VIEWS VIS OBGY, V5, P3; Khalil A, 2015, AMINO ACIDS, V47, P1715, DOI 10.1007/s00726-015-2014-1; Khalil A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006134; Kirbas A, 2015, J CLIN DIAGN RES, V9, pQC20, DOI 10.7860/JCDR/2015/15397.6833; Kurlak LO, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00310; Little RE, 1999, REPROD TOXICOL, V13, P347, DOI 10.1016/S0890-6238(99)00033-7; Macedo ML, 2008, HYPERTENSION, V51, P1047, DOI 10.1161/HYPERTENSIONAHA.107.106062; Mannaerts D, 2019, J MATERN-FETAL NEO M, V32, P1412, DOI 10.1080/14767058.2017.1410701; Mannaerts D, 2017, AM J PHYSIOL-REG I, V313, pR518, DOI 10.1152/ajpregu.00514.2016; Garcia RMM, 2016, NUTR HOSP, V33, P3, DOI 10.20960/nh.336; Rinnerthaler M, 2015, BIOMOLECULES, V5, P545, DOI 10.3390/biom5020545; Sanchez-Aranguren LC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00372; Sari I, 2015, KARDIOL POL, V73, P1310, DOI 10.5603/KP.a2015.0098; Sciences NIoEH, SPIN TRAP DAT; Siddiqui IA, 2011, ARCH GYNECOL OBSTET, V284, P587, DOI 10.1007/s00404-010-1728-2; Sikkema JM, 2001, PLACENTA, V22, P304, DOI 10.1053/plac.2001.0629; Sultana Z, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12653; Szkandera J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078225; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Urbina EM, 2009, HYPERTENSION, V54, P919, DOI 10.1161/HYPERTENSIONAHA.109.192639; Walter PB, 2002, P NATL ACAD SCI USA, V99, P2264, DOI 10.1073/pnas.261708798; Wu F, 2016, AM J REPROD IMMUNOL, V76, P258, DOI 10.1111/aji.12454; Yury Gorbanev Nicola S, 2016, PLASMA SOURCES SCI T, P25; Zein S, 2014, J TRACE ELEM MED BIO, V28, P65, DOI 10.1016/j.jtemb.2013.09.009	43	69	70	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0202919	10.1371/journal.pone.0202919	http://dx.doi.org/10.1371/journal.pone.0202919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204759	gold, Green Submitted, Green Published			2022-12-26	WOS:000444355500010
J	Saraiva, MMS; Moreira, ALB; Freitas Neto, OC; Silva, NMV; Givisiez, PEN; Gebreyes, WA; Oliveira, CJB				Saraiva, Mauro M. S.; Moreira Filho, Alexandre L. B.; Freitas Neto, Oliveiro C.; Silva, Nubia M., V; Givisiez, Patricia E. N.; Gebreyes, Wondwossen A.; Oliveira, Celso J. B.			Off-label use of ceftiofur in one-day chicks triggers a short-term increase of ESBL- producing E. coli in the gut	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; FARM-ANIMALS; FOOD ANIMALS; GENES; MEAT; SALMONELLA; ENTEROBACTERIACEAE; DISSEMINATION	This trial was designed to evaluate the off-label use of ceftiofur with Marek's vaccine in one-day-old broiler chicks, a prophylactic treatment that has been done in some commercial hatcheries, on the emergence of extended-spectrum beta-lactamase producing Escherichia coli (ESBL-E. coli). A total of 168 chicks (Cobb500 (R)) were used in a completely randomized design. Birds were assigned to two treatments (Marek's vaccine plus saline vs Marek's vaccine plus ceftiofur) and six repetitions, with 14 animals each. Cloacal swabs were collected from 1 to 14 days post-hatch. The majority (86%; p<0.0001) of the ESBL-producing isolates harboring bla(CTX-M) and bla(SHV) genes originated from animals receiving the antimicrobial. None of the isolates were positive for plasmid-mediated AmpC betalactamase genes (bla(ACC), bla(CMY-2), bla(DHA), bla(FOX), bla(MOX) and bla(MIR)). These findings indicate that the off-label use of ceftiofur with Marek's vaccine is associated with the short-term increase in ESBL-producing Escherichia coli in the gut of chicks.	[Saraiva, Mauro M. S.; Moreira Filho, Alexandre L. B.; Silva, Nubia M., V; Givisiez, Patricia E. N.; Oliveira, Celso J. B.] Fed Univ Paraiba CCA UFPB, Ctr Agr Sci, Dept Anim Sci, Areia, Paraiba, Brazil; [Moreira Filho, Alexandre L. B.; Oliveira, Celso J. B.] Natl Inst Res Antimicrobial Resistance INPRA, Porto Alegre, RS, Brazil; [Freitas Neto, Oliveiro C.] Fed Univ Paraiba CCA UFPB, Ctr Agr Sci, Dept Vet Sci, Areia, Paraiba, Brazil; [Gebreyes, Wondwossen A.] Ohio State Univ, Coll Vet Med, Dept Prevent Vet Med, Columbus, OH 43210 USA; [Gebreyes, Wondwossen A.; Oliveira, Celso J. B.] Ohio State Univ, GOHi, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Oliveira, CJB (corresponding author), Fed Univ Paraiba CCA UFPB, Ctr Agr Sci, Dept Anim Sci, Areia, Paraiba, Brazil.; Oliveira, CJB (corresponding author), Natl Inst Res Antimicrobial Resistance INPRA, Porto Alegre, RS, Brazil.; Oliveira, CJB (corresponding author), Ohio State Univ, GOHi, Columbus, OH 43210 USA.	celso.bruno.oliveira@gmail.com	GIVISIEZ, PATRICIA/V-2140-2019; de Oliveira, Celso José Bruno/V-2167-2019; Saraiva, Mauro M S/T-1745-2018; de, Freitas Neto O. C./E-8713-2012; Saraiva, Mauro/AAR-3642-2020	GIVISIEZ, PATRICIA/0000-0002-2480-1780; de Oliveira, Celso José Bruno/0000-0002-7761-0697; Saraiva, Mauro M S/0000-0003-1875-4495; de, Freitas Neto O. C./0000-0002-1437-069X; Saraiva, Mauro/0000-0003-1875-4495; Silva, Nubia Michelle Vieira/0000-0002-9800-9585	Coordination for the Improvement of Higher Education Personnel (CAPE); Brazilian National Council for Scientific and Technological Development (CNPq); Institute of International Education / Global Innovation Initiative [S-ECAGD-13-CA 149 DT]; Department of Animal Science of The University of Illinois at Urbana-Champaign under CAPES [BEX 1910/14-0, BEX 1853/14-7]	Coordination for the Improvement of Higher Education Personnel (CAPE); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Institute of International Education / Global Innovation Initiative; Department of Animal Science of The University of Illinois at Urbana-Champaign under CAPES	This study was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES; https://www.capes.gov.br/) that provided scholarships to graduate students (MMSS) and post-docs (ALBMF, NMVS). This study was also granted by The Brazilian National Council for Scientific and Technological Development (CNPq: http://cnpq.br/in-english-summary) (CJBO) and The Institute of International Education / Global Innovation Initiative / S-ECAGD-13-CA 149 DT (IIE: https://www.iie.org/) (WAG). The project has been conceptualized, written and submitted during CJBO and PENG time as visiting scholars at the Department of Animal Science of The University of Illinois at Urbana-Champaign under senior fellowship grants from CAPES (BEX 1910/14-0 and BEX 1853/14-7, respectively).; This study was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES; https://www.capes.gov.br/) that provided scholarships to graduate students (MMSS) and post-docs (ALBMF, NMVS). This study was also granted by The Brazilian National Council for Scientific and Technological Development (CNPq: http://cnpq.br/in-english-summary) (CJBO) and The Institute of International Education / Global Innovation Initiative / S-ECAGD-13-CA 149 DT (IIE: https://www.iie.org/) (WAG). The project has been conceptualized, written and submitted during CJBO and PENG time as visiting scholars at the Department of Animal Science of The University of Illinois at Urbana-Champaign under senior fellowship grants from CAPES (BEX 1910/14-0 and BEX 1853/14-7, respectively. Fertile eggs were provided by Guaraves Alimentos Ltda, Guarabira-PB. We are in debt with Prof. Walter Esfrain Pereira (CCA/UFPB) for the valuable support in the statistical analyses, Prof. Eloiza H. Campana (CCS/UFPB) for providing the primers and the positive controls for the PCR assays, and also for critically reviewing the manuscript, and Priscylla C. Vasconcelos (PDIZ/CCA/UFPB) for performing the MICs of ceftiofur of the E. coli isolates.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Baron S, 2014, ANTIMICROB AGENTS CH, V58, P5428, DOI 10.1128/AAC.03106-14; Beyer A, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0578-3; Borjesson S, 2016, EMERG INFECT DIS, V22, P634, DOI 10.3201/eid2204.151142; Casella T, 2015, INT J FOOD MICROBIOL, V197, P88, DOI 10.1016/j.ijfoodmicro.2014.12.001; CLSI, 2021, PERFORMANCE STANDARD, V5th; Collignon PC, 2016, CLIN INFECT DIS, V63, P1087, DOI 10.1093/cid/ciw475; Dropa M, 2015, J INFECT DEV COUNTR, V9, P890, DOI 10.3855/jidc.6241; Dutil L, 2010, EMERG INFECT DIS, V16, P48, DOI 10.3201/eid1601.090729; Fang LX, 2015, INT J ANTIMICROB AG, V46, P209, DOI 10.1016/j.ijantimicag.2015.04.003; Founou LL, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00188; Fritsch E.F., 1989, MOL CLONING LAB MANU; Gibbons JF, 2016, ZOONOSES PUBLIC HLTH, V63, P241, DOI 10.1111/zph.12225; Heider LC, 2009, FOODBORNE PATHOG DIS, V6, P1235, DOI 10.1089/fpd.2009.0294; Hiki M, 2017, J VET DIAGN INVEST, V29, P716, DOI 10.1177/1040638717713794; Horton RA, 2011, APPL ENVIRON MICROB, V77, P3715, DOI 10.1128/AEM.02831-10; HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903, DOI 10.1128/JCM.28.9.1903-1905.1990; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Kojima A, 2005, ANTIMICROB AGENTS CH, V49, P3533, DOI 10.1128/AAC.49.8.3533-3537.2005; KRUSE H, 1994, APPL ENVIRON MICROB, V60, P4015, DOI 10.1128/AEM.60.11.4015-4021.1994; Liu H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9494; Martin LC, 2012, APPL ENVIRON MICROB, V78, P1285, DOI 10.1128/AEM.06498-11; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Queenan AM, 2004, J CLIN MICROBIOL, V42, P269, DOI 10.1128/JCM.42.1.269-275.2004; Randall LP, 2017, INT J FOOD MICROBIOL, V241, P283, DOI 10.1016/j.ijfoodmicro.2016.10.036; Touzain F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188768; Warjri I, 2015, VET WORLD, V8, P599, DOI 10.14202/vetworld.2015.599-604; Webster P, 2009, CAN MED ASSOC J, V181, P21, DOI 10.1503/cmaj.091009; Ye YW, 2011, FOODBORNE PATHOG DIS, V8, P935, DOI 10.1089/fpd.2010.0799; Zhao SH, 2001, ANTIMICROB AGENTS CH, V45, P3647, DOI 10.1128/AAC.45.12.3647-3650.2001	31	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203158	10.1371/journal.pone.0203158	http://dx.doi.org/10.1371/journal.pone.0203158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204766	gold, Green Published, Green Submitted			2022-12-26	WOS:000444355500019
J	Gruppuso, PA; Boylan, JM; Zabala, V; Neretti, N; Abshiru, NA; Sikora, JW; Doud, EH; Camarillo, JM; Thomas, PM; Kelleher, NL; Sanders, JA				Gruppuso, Philip A.; Boylan, Joan M.; Zabala, Valerie; Neretti, Nicola; Abshiru, Nebiyu A.; Sikora, Jacek W.; Doud, Emma H.; Camarillo, Jeannie M.; Thomas, Paul M.; Kelleher, Neil L.; Sanders, Jennifer A.			Stability of histone post-translational modifications in samples derived from liver tissue and primary hepatic cells	PLOS ONE			English	Article							QUANTITATIVE PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; GENE-EXPRESSION; DNA-REPLICATION; RAT HEPATOCYTES; FETAL-RAT; METHYLATION; REVEALS; GROWTH; CYCLE	Chromatin structure, a key contributor to the regulation of gene expression, is modulated by a broad array of histone post-translational modifications (PTMs). Taken together, these "histone marks" comprise what is often referred to as the "histone code". The quantitative analysis of histone PTMs by mass spectrometry (MS) offers the ability to examine the response of the histone code to physiological signals. However, few studies have examined the stability of histone PTMs through the process of isolating and culturing primary cells. To address this, we used bottom-up, MS-based analysis of histone PTMs in liver, freshly isolated hepatocytes, and cultured hepatocytes from adult male Fisher F344 rats. Correlations between liver, freshly isolated cells, and primary cultures were generally high, with R-2 values exceeding 0.9. However, a number of acetylation marks, including those on H2A K9, H2A1 K13, H3 K4, H3 K14, H4 K8, H4 K12 and H4 K16 differed significantly among the three sources. Inducing proliferation of primary adult hepatocytes in culture affected several marks on histones H3.1/3.2 and H4. We conclude that hepatocyte isolation, culturing and cell cycle status all contribute to steady-state changes in the levels of a number of histone PTMs, indicating changes in histone marks that are rapidly induced in response to alterations in the cellular milieu. This has implications for studies aimed at assigning biological significance to histone modifications in tumors versus cancer cells, the developmental behavior of stem cells, and the attribution of changes in histone PTMs to altered cell metabolism.	[Gruppuso, Philip A.; Boylan, Joan M.; Zabala, Valerie; Sanders, Jennifer A.] Brown Univ, Dept Pediat, Providence, RI 02912 USA; [Gruppuso, Philip A.; Boylan, Joan M.; Zabala, Valerie; Sanders, Jennifer A.] Rhode Isl Hosp, Providence, RI 02903 USA; [Gruppuso, Philip A.; Neretti, Nicola] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Abshiru, Nebiyu A.; Sikora, Jacek W.; Doud, Emma H.; Camarillo, Jeannie M.; Thomas, Paul M.; Kelleher, Neil L.] Northwestern Univ, Natl Resource Translat & Dev Prote, Evanston, IL USA; [Thomas, Paul M.; Kelleher, Neil L.] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA; [Kelleher, Neil L.] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Kelleher, Neil L.] Northwestern Univ, Dept Chem, Evanston, IL USA; [Sanders, Jennifer A.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Northwestern University; Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; Brown University	Sanders, JA (corresponding author), Brown Univ, Dept Pediat, Providence, RI 02912 USA.; Sanders, JA (corresponding author), Rhode Isl Hosp, Providence, RI 02903 USA.; Sanders, JA (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	Jennifer_sanders@brown.edu	Thomas, Paul M/A-6233-2011	Thomas, Paul M/0000-0003-2887-4765; Doud, Emma/0000-0003-0049-0073	National Institutes of Health [R01DK100301, P41GM108569]; Rhode Island Hospital Department of Pediatrics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD024455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM077995, P41GM108569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhode Island Hospital Department of Pediatrics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by National Institutes of Health grants R01DK100301 (PAG and JAS) and P41GM108569 (NLK) and by the Rhode Island Hospital Department of Pediatrics. Valerie Zabala is a Howard Hughes Medical Institute Gilliam Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabert C, 2014, NAT CELL BIOL, V16, P281, DOI 10.1038/ncb2918; Arzate-Mejia RG, 2011, IUBMB LIFE, V63, P881, DOI 10.1002/iub.557; Beck HC, 2006, MOL CELL PROTEOMICS, V5, P1314, DOI 10.1074/mcp.M600007-MCP200; Bhanu NV, 2016, PROTEOMICS, V16, P448, DOI 10.1002/pmic.201500231; Boylan JM, 2002, ENDOCRINOLOGY, V143, P4178, DOI 10.1210/en.2002-220321; Boylan JM, 2001, J BIOL CHEM, V276, P44457, DOI 10.1074/jbc.M103457200; Boylan JM, 2017, TRANSPLANTATION, V101, P2349, DOI 10.1097/TP.0000000000001882; Boylan JM, 2015, AM J PHYSIOL-REG I, V309, pR22, DOI 10.1152/ajpregu.00114.2015; BRAUN L, 1988, P NATL ACAD SCI USA, V85, P1539, DOI 10.1073/pnas.85.5.1539; Dong XJ, 2013, EPIGENOMICS-UK, V5, P113, DOI [10.2217/EPI.13.13, 10.2217/epi.13.13]; Fan J, 2015, ACS CHEM BIOL, V10, P95, DOI 10.1021/cb500846u; Francois-Vaughan H, 2016, CARCINOGENESIS, V37, P408, DOI 10.1093/carcin/bgw016; GRUPPUSO PA, 1994, ENDOCRINOLOGY, V134, P769, DOI 10.1210/en.134.2.769; Gruppuso PA, 2016, J MOL ENDOCRINOL, V56, pR115, DOI 10.1530/JME-15-0313; Gruppuso PA, 2011, CELL CYCLE, V10, P1050, DOI 10.4161/cc.10.7.15230; Huang H, 2015, CHEM REV, V115, P2376, DOI 10.1021/cr500491u; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Kammers Kai, 2015, EuPA Open Proteom, V7, P11; Karachentsev D, 2007, DEV BIOL, V304, P46, DOI 10.1016/j.ydbio.2006.12.019; Lawrence M, 2016, TRENDS GENET, V32, P42, DOI 10.1016/j.tig.2015.10.007; Li MX, 2013, PROTEOMICS, V13, P2585, DOI 10.1002/pmic.201200298; Lin S, 2012, METHOD ENZYMOL, V512, P3, DOI 10.1016/B978-0-12-391940-3.00001-9; Ma YQ, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00019; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MEAD JE, 1989, P NATL ACAD SCI USA, V86, P1558, DOI 10.1073/pnas.86.5.1558; MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819; Nestor CE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0576-y; Noberini R, 2018, NUCLEIC ACIDS RES, V46, P3817, DOI 10.1093/nar/gky224; Onder O, 2015, EXPERT REV PROTEOMIC, V12, P499, DOI 10.1586/14789450.2015.1084231; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Petruk S, 2012, CELL, V150, P922, DOI 10.1016/j.cell.2012.06.046; Sanders J, 2012, ADV MED BIOL, P123; Sanders JA, 2017, METHODS MOL BIOL, V1506, P45, DOI 10.1007/978-1-4939-6506-9_3; Schneider TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022548; Schwammle V, 2016, MOL CELL PROTEOMICS, V15, P2715, DOI 10.1074/mcp.M115.054460; SEGLEN PO, 1972, EXP CELL RES, V74, P450, DOI 10.1016/0014-4827(72)90400-4; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; VINTERMYR OK, 1987, J CELL PHYSIOL, V132, P12, DOI 10.1002/jcp.1041320103; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; Zhao YM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a025064; Zheng YP, 2016, CURR OPIN CHEM BIOL, V33, P142, DOI 10.1016/j.cbpa.2016.06.007; Zheng YP, 2014, PROTEOMICS, V14, P2190, DOI 10.1002/pmic.201400060; Zheng YP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3203; Zheng YP, 2012, P NATL ACAD SCI USA, V109, P13549, DOI 10.1073/pnas.1205707109	44	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203351	10.1371/journal.pone.0203351	http://dx.doi.org/10.1371/journal.pone.0203351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192817	Green Submitted, gold, Green Published			2022-12-26	WOS:000444093600062
J	Schenkein, HA; Thomas, RR				Schenkein, Harvey A.; Thomas, Ravindar R.			Anticardiolipin (aCL) in sera from periodontitis subjects activate Toll-like receptor 4 (TLR4)	PLOS ONE			English	Article							ANTIPHOSPHOLIPID ANTIBODIES INDUCE; INTERNATIONAL CONSENSUS STATEMENT; ENDOTHELIAL-CELLS; CLASSIFICATION CRITERIA; BETA-2-GLYCOPROTEIN-I; PREGNANCY; DISEASE; AUTOANTIBODIES; PATHOGENESIS; TROPHOBLAST	Anticardiolipin antibodies (aCL) have been reported to be present in 15-20% of sera from subjects with periodontitis at concentrations exceeding those found in 95% of the healthy adult population. These antibodies, albeit at concentrations exceeding those generally found in periodontitis subjects, are typically present in patients with the antiphospholipid syndrome (APS), an autoimmune disease characterized by thrombosis and recurrent pregnancy loss. aCL from APS patients are proinflammatory and can activate trophoblasts, macrophages, and platelets via cell-surface interactions with their target antigen beta-2-glycoprotein-I (beta 2GPI). beta 2GPI is an anionic phospholipid-binding serum protein that can associate with toll-like receptors (TLR's) on the cell-surface, leading to cell activation following interaction with autoimmune aCL. We examined an expanded series of 629 sera from clinically characterized subjects for aCL content, and observed that 14-19% of these sera contained elevated (>95th%-tile) levels of aCL. We purified IgG from 16 subjects with elevated or normal levels of aCL and examined their ability to activate TLR2- or TLR4-transfected human embryonic kidney (HEK) cells, and observed that IgG from periodontitis patients with elevated aCL activated HEK-TLR4 cells, but not HEK-TLR2 cells. Prior removal of aCL by immunoabsorption significantly reduced the ability of IgG preparations from these sera to activate TLR4. Further experiments using a human first trimester trophoblastic cell line (HTR8 sv/neo) revealed that aCL from periodontitis patients stimulated IL-8 production, which was profoundly decreased if aCL was removed by immunoabsorption or if HTR8 sv/neo were pretreated with blocking anti-TLR4 antibodies. Thus, it appears that aCL from periodontitis patients can be proinflammatory, activating cells via TLR4. Since these antibodies are likely produced via molecular mimicry due to similarities between oral bacterial antigens and beta 2GPI, the data indicate that circulating serum aCL may induce or influence inflammatory responses at sites distant from the oral cavity.	[Schenkein, Harvey A.; Thomas, Ravindar R.] Virginia Commonwealth Univ, Sch Dent, Dept Periodont, Richmond, VA 23298 USA	Virginia Commonwealth University	Schenkein, HA (corresponding author), Virginia Commonwealth Univ, Sch Dent, Dept Periodont, Richmond, VA 23298 USA.	haschenk@vcu.edu		Schenkein, Harvey/0000-0002-7397-643X	National Institutes of Health, National Institute of Dental and Craniofacial Research [RO1DE018125]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018125] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by grant RO1DE018125 from the National Institutes of Health, National Institute of Dental and Craniofacial Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2009, THROMB RES, V124, P521, DOI 10.1016/j.thromres.2009.07.011; Alard JE, 2010, J IMMUNOL, V185, P1550, DOI 10.4049/jimmunol.1000526; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Bai AP, 2017, IMMUNOL LETT, V186, P15, DOI 10.1016/j.imlet.2017.03.013; Blank M, 2002, J CLIN INVEST, V109, P797, DOI 10.1172/JCI200212337; Boggess KA, 2003, OBSTET GYNECOL, V101, P227, DOI 10.1016/S0029-7844(02)02314-1; Borghi MO, 2014, LUPUS, V23, P1302, DOI 10.1177/0961203314536479; Burazor I, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/613157; Chaston R, 2014, J PERIODONTOL, V85, P683, DOI 10.1902/jop.2013.130408; Chen YW, 2009, J CLIN PERIODONTOL, V36, P830, DOI 10.1111/j.1600-051X.2009.01467.x; Colasanti T, 2012, BLOOD, V120, P3360, DOI 10.1182/blood-2011-09-378851; de Jesus GR, 2014, 14 INT C ANT ANT TAS; Doring Y, 2010, IMMUNOBIOLOGY, V215, P230, DOI 10.1016/j.imbio.2009.03.002; Garcia-Carrasco M, 2009, CLIN REV ALLERG IMMU, V36, P104, DOI 10.1007/s12016-008-8103-0; Gharavi AE, 2001, RHEUM DIS CLIN N AM, V27, P551, DOI 10.1016/S0889-857X(05)70219-2; Gierman LM, 2015, PLACENTA, V36, P1246, DOI 10.1016/j.placenta.2015.09.004; Horton AL, 2008, J PERIODONTOL, V79, P1127, DOI [10.1902/jop.2008.070655, 10.1902/jop.2008.070655 ]; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mulla MJ, 2009, AM J REPROD IMMUNOL, V62, P96, DOI 10.1111/j.1600-0897.2009.00717.x; Muller-Calleja N, 2017, SEMIN THROMB HEMOST; Offenbacher S, 2006, OBSTET GYNECOL, V107, P29, DOI 10.1097/01.AOG.0000190212.87012.96; Offenbacher S, 2001, Ann Periodontol, V6, P164, DOI 10.1902/annals.2001.6.1.164; PENGO V, 1993, THROMB RES, V72, P423, DOI 10.1016/0049-3848(93)90242-G; Petri M, 2000, J AUTOIMMUN, V15, P145, DOI 10.1006/jaut.2000.0409; Salem D, 2014, LUPUS, V23, P1327, DOI 10.1177/0961203314548248; Sanz M, 2013, J PERIODONTOL, V84, pS164, DOI [10.1902/jop.2013.1340016, 10.1111/jcpe.12083]; Satta Nathalie, 2011, Blood, V117, P5523, DOI 10.1182/blood-2010-11-316158; Schenkein HA, 2013, J DENT RES, V92, P814, DOI 10.1177/0022034513497959; Schenkein HA, 2003, J DENT RES, V82, P919, DOI 10.1177/154405910308201114; Schenkein HA, 2007, J PERIODONTOL, V78, P459, DOI 10.1902/jop.2007.060305; Schenkein HA, 2013, J CLIN PERIODONTOL, V40, P212, DOI 10.1111/jcpe.12043; Sciascia S, 2014, THROMB HAEMOSTASIS, V111, P354, DOI 10.1160/TH13-06-0509; Shen CY, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002665; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Tong M, 2015, HUM REPROD UPDATE, V21, P97, DOI 10.1093/humupd/dmu049; Wang D, 2008, ORAL MICROBIOL IMMUN, V23, P401, DOI 10.1111/j.1399-302X.2008.00442.x; Willis R, 2012, SEMIN THROMB HEMOST, V38, P305, DOI 10.1055/s-0032-1311827; Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F; Xie HX, 2014, BRIT J HAEMATOL, V164, P165, DOI 10.1111/bjh.12587	40	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203494	10.1371/journal.pone.0203494	http://dx.doi.org/10.1371/journal.pone.0203494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192824	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600085
J	Touret, T; Oliveira, M; Semedo-Lemsaddek, T				Touret, Tiago; Oliveira, Manuela; Semedo-Lemsaddek, Teresa			Putative probiotic lactic acid bacteria isolated from sauerkraut fermentations	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; DAIRY MICROORGANISMS; SAFETY ASSESSMENT; STARTER CULTURES; GENUS; LACTOBACILLI; LEUCONOSTOC; OLIVES; KIMCHI; FOOD	Probiotics are live microorganisms which confer health benefits to the host, and may be isolated from several sources, such as vegetable foodstuffs. Sauerkraut is a cabbage product resulting from fermentation by a lactic acid bacteria microbial succession, and is a potential source for probiotics. The aim of the present study was the isolation and characterization of probiotic microorganisms from sauerkraut fermentations. Four distinct fermentations were performed, from which lactic acid bacteria were recovered. Overall, 114 isolates were obtained, phenotypically and genotypically characterized, identified to the genus level and evaluated regarding safety and probiotic potential. Representative bacteria were selected for further analysis, 52% being Lactobacillus spp. and 33% belonging to Leuconostoc spp. genus. One isolate revealed to be beta-hemolytic, 42% possessed potentially mobile antimicrobial resistance, 88% were resistant to bile and 20% to low pH. The six most promising candidates were further characterized and presented antimicrobial activity against Listeria monocytogenes, three being resistant to lower pH values. Thus, global analysis of data gathered during this study highlighted the identification of three Lactobacillus strains with putative probiotic potential, suggesting the applicability of sauerkraut fermentations as a source for probiotic isolation. Due to their origin these strains should be suited for future application in the food industry, namely vegetable products such as sauerkraut itself.	[Touret, Tiago; Oliveira, Manuela; Semedo-Lemsaddek, Teresa] Univ Lisbon, Fac Vet Med, CIISA Ctr Interdisciplinary Res Anim Hlth, Lisbon, Portugal; [Touret, Tiago] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Lab Mol Microbiol Human Pathogens, Oeiras, Portugal	Universidade de Lisboa; Universidade Nova de Lisboa	Oliveira, M (corresponding author), Univ Lisbon, Fac Vet Med, CIISA Ctr Interdisciplinary Res Anim Hlth, Lisbon, Portugal.	moliveira@fmv.ulisboa.pt	Semedo-Lemsaddek, Teresa ML/J-3010-2013	Semedo-Lemsaddek, Teresa ML/0000-0002-8349-3802; de oliveira, manuela/0000-0003-2557-6412; Oliveira, Manuela/0000-0002-3910-1525	CIISA - Centre for Interdisciplinary Research in Animal Health, Faculty of Veterinary Medicine, University of Lisbon [UID/CVT/276/2013]; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/108123/2015]	CIISA - Centre for Interdisciplinary Research in Animal Health, Faculty of Veterinary Medicine, University of Lisbon; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors would like to thank CIISA - Centre for Interdisciplinary Research in Animal Health, Faculty of Veterinary Medicine, University of Lisbon for the financial support (Project UID/CVT/276/2013). T. Semedo-Lemsaddek holds a scholarship from "Fundacao para a Ciencia e Tecnologia" (SFRH/BPD/108123/2015).	Argyri AA, 2013, FOOD MICROBIOL, V33, P282, DOI 10.1016/j.fm.2012.10.005; Aureli P, 2011, PHARMACOL RES, V63, P366, DOI 10.1016/j.phrs.2011.02.006; Beganovic J, 2014, MICROBIOL RES, V169, P623, DOI 10.1016/j.micres.2013.09.015; Bernardeau M, 2008, INT J FOOD MICROBIOL, V126, P278, DOI 10.1016/j.ijfoodmicro.2007.08.015; Botta C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094457; Chang JH, 2010, J APPL MICROBIOL, V109, P220, DOI 10.1111/j.1365-2672.2009.04648.x; CLSI, 2012, M02A11 CLSI, V7th; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Dahiya DK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00563; Devirgiliis C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00301; Dubernet S, 2002, FEMS MICROBIOL LETT, V214, P271, DOI [10.1111/j.1574-6968.2002.tb11358.x, 10.1016/S0378-1097(02)00895-9]; FAO/WHO, 2001, PROB FOOD HLTH NUTR, P85; Fontana L, 2013, BRIT J NUTR, V109, pS35, DOI 10.1017/S0007114512004011; Fraqueza MJ, 2015, INT J FOOD MICROBIOL, V212, P76, DOI 10.1016/j.ijfoodmicro.2015.04.035; Gahan CGM, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00009; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Grazul H, 2016, GUT MICROBES, V7, P101, DOI 10.1080/19490976.2016.1138197; HARRIS LJ, 1998, MICROBIOLOGY FERMENT, P45; Holzapfel W, 2008, FUNCT FOOD NUTRA SER, P395; Kastner S, 2006, SYST APPL MICROBIOL, V29, P145, DOI 10.1016/j.syapm.2005.07.009; Lee H, 2011, INT J FOOD MICROBIOL, V145, P155, DOI 10.1016/j.ijfoodmicro.2010.12.003; Lee J, 2011, INT J FOOD MICROBIOL, V148, P80, DOI 10.1016/j.ijfoodmicro.2011.05.003; Lu Z, 2003, APPL ENVIRON MICROB, V69, P3192, DOI 10.1128/AEM.69.6.3192-3202.2003; Macian MC, 2004, J APPL MICROBIOL, V97, P384, DOI 10.1111/j.1365-2672.2004.02317.x; Miller BC, 2000, J MICROBIOL METH, V42, P139, DOI 10.1016/S0167-7012(00)00174-3; Min M, 2019, CRIT REV FOOD SCI, V59, P2626, DOI 10.1080/10408398.2018.1462760; Ogier JC, 2008, INT J FOOD MICROBIOL, V126, P286, DOI 10.1016/j.ijfoodmicro.2007.08.012; Papadimitriou K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00058; Peres CM, 2014, LWT-FOOD SCI TECHNOL, V59, P234, DOI 10.1016/j.lwt.2014.03.003; Peres CM, 2012, TRENDS FOOD SCI TECH, V26, P31, DOI 10.1016/j.tifs.2012.01.006; Plengvidhya V, 2007, APPL ENVIRON MICROB, V73, P7697, DOI 10.1128/AEM.01342-07; Rosa E, 2001, J SCI FOOD AGR, V81, P1145, DOI 10.1002/jsfa.919; Ammor MS, 2007, FOOD MICROBIOL, V24, P559, DOI 10.1016/j.fm.2006.11.001; Son SH, 2017, LWT-FOOD SCI TECHNOL, V85, P181, DOI 10.1016/j.lwt.2017.07.018; YADAV R, 2017, RECENT ADV APPL MICR, P133, DOI DOI 10.1007/978-981-10-5275-0; Yadav R, 2017, CRIT REV FOOD SCI, V57, P3233, DOI 10.1080/10408398.2015.1108957; Yu ZH, 2013, WORLD J MICROB BIOT, V29, P489, DOI 10.1007/s11274-012-1202-3; Zabat MA, 2018, FOODS, V7, DOI 10.3390/foods7050077	38	30	30	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203501	10.1371/journal.pone.0203501	http://dx.doi.org/10.1371/journal.pone.0203501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192827	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600087
J	Wang, D; Gladysheva, IP; Sullivan, RD; Fan, THM; Mehta, RM; Tripathi, R; Sun, Y; Reed, GL				Wang, Dong; Gladysheva, Inna P.; Sullivan, Ryan D.; Fan, Tai-Hwang M.; Mehta, Radhika M.; Tripathi, Ranjana; Sun, Yao; Reed, Guy L.			Increases in plasma corin levels following experimental myocardial infarction reflect the severity of ischemic injury	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; HEART-FAILURE; SOLUBLE CORIN; DILATED CARDIOMYOPATHY; SERUM CORIN; ATRIAL; EXPRESSION; MOUSE; MODEL; SURVIVAL	Following acute myocardial infarction, clinical studies show alterations in the blood levels of corin, a cardiac-selective activator of the natriuretic peptides pro-atrial natriuretic peptide (pro-ANP) and pro-B-type natriuretic peptide (pro-BNP). However, the temporal changes in circulating and cardiac corin levels and their relationships to the severity of myocardial infarction have not been studied. The main objective of this study was to examine the relationship between cardiac and circulating corin levels and their association with cardiac systolic function and infarct size during the early phase of acute myocardial infarction (<72 h) in a translationally relevant induced coronary ligation mouse model. This acute phase timeline was chosen to correlate with the clinical practice within which blood samples are collected from myocardial infarction patients. Heart and plasma samples were examined at 3, 24, and 72 hours post acute myocardial infarction. Plasma corin levels were examined by enzyme-linked immunosorbent assay, transcripts of cardiac corin, pro-ANP and pro-BNP by quantitative real-time polymerase chain reaction, cardiac corin expression by immunohistology, infarct size by histology and heart function by echocardiography. Plasma corin levels were significantly increased at 3 (P<0.05), 24 (P<0.001), and 72 hours (P<0.01) post-acute myocardial infarction. In contrast, cardiac corin transcript levels dropped by 5% (P>0.05), 69% (P<0.001) and 65% (P<0.001) and immunoreactive cardiac corin protein levels dropped by 30% (P<0.05), 76% (P<0.001) and 75% (P<0.001), while cardiac pro-ANP and pro-BNP transcript levels showed an opposite pattern. Plasma corin levels were negatively correlated with immunoreactive cardiac corin (P<0.01), ejection fraction (P<0.05) and fractional shortening (P<0.05), but positively correlated with infarct size (P<0.01). In conclusion, acute myocardial infarction induces rapid increases in plasma corin and decreases in cardiac corin levels. In the early phase of acute myocardial infarction, plasma corin levels are inversely correlated with heart function and may reflect the severity of myocardial damage.	[Wang, Dong; Gladysheva, Inna P.; Fan, Tai-Hwang M.; Mehta, Radhika M.; Tripathi, Ranjana; Sun, Yao; Reed, Guy L.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38104 USA; [Sullivan, Ryan D.] Univ Tennessee, Hlth Sci Ctr, Dept Comparat Med, Memphis, TN USA; [Wang, Dong; Gladysheva, Inna P.; Sullivan, Ryan D.; Mehta, Radhika M.; Tripathi, Ranjana; Reed, Guy L.] Univ Arizona, Coll Med, Dept Internal Med, Phoenix, AZ USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Arizona	Wang, D (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38104 USA.; Wang, D (corresponding author), Univ Arizona, Coll Med, Dept Internal Med, Phoenix, AZ USA.	dwang16@email.arizona.edu	Gladysheva, Inna/AAU-9465-2020; Sullivan, Ryan D./AAX-6919-2020	Gladysheva, Inna/0000-0002-2501-9029; Sullivan, Ryan D./0000-0001-7633-2210	American Heart Association [14SDG20510068]; NIH [HL092750, NS089707, HL115036]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089707] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Heart Association grant (14SDG20510068 to D. Wang) and NIH grants (HL092750, NS089707 to G.L.Reed and HL115036 to I. P. Gladysheva). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Armaly Z, 2013, CURR OPIN NEPHROL HY, V22, P713, DOI 10.1097/01.mnh.0000435609.35789.32; Barnet CS, 2015, J CARDIOTHOR VASC AN, V29, P374, DOI 10.1053/j.jvca.2014.11.001; BOLLI R, 1983, J AM COLL CARDIOL, V2, P671, DOI 10.1016/S0735-1097(83)80307-6; Brush JE, 2016, J AM COLL CARDIOL, V68, P2365, DOI 10.1016/j.jacc.2016.08.066; Chen FF, 2015, CLIN CHIM ACTA, V447, P79, DOI 10.1016/j.cca.2015.05.017; Cleutjens JPM, 1999, CARDIOVASC RES, V44, P232, DOI 10.1016/S0008-6363(99)00212-6; Dominici R, 2004, CLIN CHEM LAB MED, V42, P945, DOI 10.1515/CCLM.2004.154; Dong NZ, 2010, CIRC-HEART FAIL, V3, P207, DOI 10.1161/CIRCHEARTFAILURE.109.903849; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Feistritzer HJ, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.17; Feistritzer HJ, 2015, INT J CARDIOL, V192, P22, DOI 10.1016/j.ijcard.2015.05.050; FISHBEIN MC, 1978, CHEST, V73, P843, DOI 10.1378/chest.73.6.843; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Gladysheva IP, 2008, J MOL CELL CARDIOL, V44, P131, DOI 10.1016/j.yjmcc.2007.10.002; Gladysheva IP, 2013, HYPERTENSION, V61, P327, DOI 10.1161/HYPERTENSIONAHA.112.193631; HAMA N, 1995, CIRCULATION, V92, P1558, DOI 10.1161/01.CIR.92.6.1558; Hooper JD, 2000, EUR J BIOCHEM, V267, P6931, DOI 10.1046/j.1432-1327.2000.01806.x; Houng AK, 2009, AM J PHYSIOL-HEART C, V296, pH655, DOI 10.1152/ajpheart.00684.2008; Ibebuogu UN, 2011, CIRC-HEART FAIL, V4, P114, DOI 10.1161/CIRCHEARTFAILURE.109.895581; Ichiki T, 2013, AM J PHYSIOL-REG I, V304, pR102, DOI 10.1152/ajpregu.00233.2012; Iyer RP, 2016, AM J PHYSIOL-HEART C, V311, pH822, DOI 10.1152/ajpheart.00067.2016; Jiang JJ, 2011, J BIOL CHEM, V286, P10066, DOI 10.1074/jbc.M110.185082; Jordan JE, 1999, CARDIOVASC RES, V43, P860, DOI 10.1016/S0008-6363(99)00187-X; Lee R, 2014, J AM HEART ASSOC, V3, DOI [10.1161/JAHA.114.001104, 10.1161/JAHA.114.]; Liu Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009085; Miyazaki J, 2016, PLACENTA, V48, P20, DOI 10.1016/j.placenta.2016.10.002; Pagani F, 2000, CLIN CHEM, V46, P1020; Pang AM, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0298-9; Peleg A, 2013, EUR HEART J-ACUTE CA, V2, P159, DOI 10.1177/2048872613483588; Peng H, 2015, STROKE, V46, P1758, DOI 10.1161/STROKEAHA.114.008368; Phatharajaree W, 2007, CAN J CARDIOL, V23, P727, DOI 10.1016/S0828-282X(07)70818-8; Salto-Tellez M, 2004, CARDIOVASC PATHOL, V13, P91, DOI 10.1016/s1054-8807(03)00129-7; Sergeeva IA, 2013, BBA-MOL BASIS DIS, V1832, P2403, DOI 10.1016/j.bbadis.2013.07.003; Tripathi R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189315; Tripathi R, 2016, HYPERTENSION, V67, P362, DOI 10.1161/HYPERTENSIONAHA.115.06300; Wang D, 2014, HYPERTENSION, V63, P514, DOI 10.1161/HYPERTENSIONAHA.113.02164; Wang H, 2015, J BIOL CHEM, V290, P1654, DOI 10.1074/jbc.M114.606442; Yang SF, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008157; Zaidi SS, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7279036; Zhang SM, 2016, CLIN CHIM ACTA, V452, P134, DOI 10.1016/j.cca.2015.11.012; Zhou X, 2016, JACC-HEART FAIL, V4, P664, DOI 10.1016/j.jchf.2016.03.006; Zhou X, 2016, J AM COLL CARDIOL, V67, P2008, DOI 10.1016/j.jacc.2016.02.035	43	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202571	10.1371/journal.pone.0202571	http://dx.doi.org/10.1371/journal.pone.0202571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192780	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600026
J	Thakong, M; Phimoltares, S; Jaiyen, S; Lursinsap, C				Thakong, Mongkhon; Phimoltares, Suphakant; Jaiyen, Saichon; Lursinsap, Chidchanok			One-pass-throw-away learning for cybersecurity in streaming non-stationary environments by dynamic stratum network	PLOS ONE			English	Article							CONCEPT DRIFT; ENSEMBLE	Throughout recent times, cybersecurity problems have occurred in various business applications. Although previous researchers proposed to cope with the occurrence of cybersecurity issues, their methods repeatedly replicated the training processes for several times to classify datasets of these problems in streaming non-stationary environments. In dynamic environments, the conventional methods possibly deteriorate the adaptive solution to prevent these issues. This research proposes a one-pass-throw-away learning using the dynamical structure of the network to solve these problems in dynamic environments. Furthermore, to speed up the computational time and to maintain a minimum space complexity for streaming data, the new concepts of learning in forms of recursive functions were introduced. The information gain-based feature selection was also applied to reduce the learning time during the training process. The experimental results signified that the proposed algorithm outperformed the others in incremental-like and online ensemble learning algorithms in terms of classification accuracy, space complexity, and computational time.	[Thakong, Mongkhon; Phimoltares, Suphakant; Lursinsap, Chidchanok] Chulalongkorn Univ, Fac Sci, Dept Math & Comp Sci, Bangkok, Thailand; [Jaiyen, Saichon] King Mongkuts Inst Technol Ladkrabang, Fac Sci, Dept Comp Sci, Bangkok, Thailand	Chulalongkorn University; King Mongkuts Institute of Technology Ladkrabang	Phimoltares, S (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Math & Comp Sci, Bangkok, Thailand.	suphakant.p@chula.ac.th	Jaiyen, Saichon/AAE-4485-2022		Thailand Research Fund (TRF) [RTA6080013]	Thailand Research Fund (TRF)(Thailand Research Fund (TRF))	This work is supported by the Thailand Research Fund (TRF) under grant number RTA6080013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the Thailand Research Fund (TRF) under grant number RTA6080013.	Abdelhamid N, 2014, EXPERT SYST APPL, V41, P5948, DOI 10.1016/j.eswa.2014.03.019; Abramson M., 2015, ADVERSARIAL ONLINE L, P2; Aburomman AA, 2017, INFORM SCIENCES, V414, P225, DOI 10.1016/j.ins.2017.06.007; Aburomman AA, 2017, COMPUT SECUR, V65, P135, DOI 10.1016/j.cose.2016.11.004; Agrawal S, 2015, PROCEDIA COMPUT SCI, V60, P708, DOI 10.1016/j.procs.2015.08.220; Ahmed M, 2016, J NETW COMPUT APPL, V60, P19, DOI 10.1016/j.jnca.2015.11.016; Alaba FA, 2017, J NETW COMPUT APPL, V88, P10, DOI 10.1016/j.jnca.2017.04.002; Alhaj TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166017; Aljawarneh S, 2019, CLUSTER COMPUT, V22, P10549, DOI 10.1007/s10586-017-1109-8; Bache Kevin, 2013, UCI MACHINE LEARNING; Bennasar H, 2017, LECT NOTES COMPUT SC, V10194, P56, DOI 10.1007/978-3-319-55589-8_4; Brzezinski D, 2014, INFORM SCIENCES, V265, P50, DOI 10.1016/j.ins.2013.12.011; Brzezinski D, 2014, IEEE T NEUR NET LEAR, V25, P81, DOI 10.1109/TNNLS.2013.2251352; Burnap P, 2018, COMPUT SECUR, V73, P399, DOI 10.1016/j.cose.2017.11.016; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Crawford M., 2015, J BIG DATA-GER, V2, P23, DOI [10.1186/s40537-015-0029-9, DOI 10.1186/S40537-015-0029-9]; Ditzler G, 2014, IEEE IJCNN, P595, DOI 10.1109/IJCNN.2014.6889909; Ditzler G, 2015, IEEE COMPUT INTELL M, V10, P12, DOI 10.1109/MCI.2015.2471196; Elwell R, 2011, IEEE T NEURAL NETWOR, V22, P1517, DOI 10.1109/TNN.2011.2160459; Ghosh P., 2018, ERCICA 2016, P393, DOI [10.1007/978-981-10-4741-1_35, DOI 10.1007/978-981-10-4741-1_35]; Gomes HM, 2017, MACH LEARN, V106, P1469, DOI 10.1007/s10994-017-5642-8; Huh JH, 2011, LECT NOTES COMPUT SC, V6888, P194, DOI 10.1007/978-3-642-27901-0_15; Hulten G., 2001, KDD-2001. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P97, DOI 10.1145/502512.502529; Jaber Ghazal, 2013, Neural Information Processing. 20th International Conference, ICONIP 2013. Proceedings: LNCS 8227, P595, DOI 10.1007/978-3-642-42042-9_74; Jaiyen S, 2010, IEEE T NEURAL NETWOR, V21, P381, DOI 10.1109/TNN.2009.2037148; Junsawang P, 2016, EXPERT SYST APPL, V63, P249, DOI 10.1016/j.eswa.2016.07.002; Katakis I, 2010, KNOWL INF SYST, V22, P371, DOI 10.1007/s10115-009-0206-2; Kolter JZ, 2007, J MACH LEARN RES, V8, P2755; Krawczyk B, 2017, INFORM FUSION, V37, P132, DOI 10.1016/j.inffus.2017.02.004; Li Bo, 2014, ADV NEURAL INFORM PR, P2087; Mohammad RM, 2014, NEURAL COMPUT APPL, V25, P443, DOI 10.1007/s00521-013-1490-z; Rabai LB, 2013, J KING SAUD UNIV-COM, V25, P63, DOI 10.1016/j.jksuci.2012.06.002; Sethi TS, 2017, LECT NOTES COMPUT SC, V10241, P49, DOI 10.1007/978-3-319-57463-9_4; Street W. N., 2001, KDD-2001. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P377, DOI 10.1145/502512.502568; Suthaharan Shan, 2014, ACM SIGMETRICS Performance Evaluation Review, V41, P70; Tavallaee M., 2009, P IEEE S COMP INT SE, P1, DOI [10.1109/CISDA. 2009.5356528, DOI 10.1109/CISDA.2009.5356528]; Thakong M, 2013, INT C INFO SCI APPL; Vinayakumar R, 2017, 2017 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P259; Wang G, 2012, ACM T INTEL SYST TEC, V3, DOI 10.1145/2337542.2337546; Weber RH, 2016, COMPUT LAW SECUR REV, V32, P715, DOI 10.1016/j.clsr.2016.07.002; Youn S, 2007, ADVANCES AND INNOVATIONS IN SYSTEMS, COMPUTING SCIENCES AND SOFTWARE ENGINEERING, P387, DOI 10.1007/978-1-4020-6264-3_67; Zhao MC, 2016, AAAI CONF ARTIF INTE, P658	44	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0202937	10.1371/journal.pone.0202937	http://dx.doi.org/10.1371/journal.pone.0202937			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188908	Green Submitted, Green Published, gold			2022-12-26	WOS:000444228700016
J	Topirceanu, A; Udrescu, M; Udrescu, L; Ardelean, C; Dan, R; Reisz, D; Mihaicuta, S				Topirceanu, Alexandru; Udrescu, Mihai; Udrescu, Lucretia; Ardelean, Carmen; Dan, Rodica; Reisz, Daniela; Mihaicuta, Stefan			SAS score: Targeting high-specificity for efficient population-wide monitoring of obstructive sleep apnea	PLOS ONE			English	Article							BERLIN QUESTIONNAIRE; RESPIRATORY EVENTS; ASSOCIATION; PREVALENCE; VALIDATION; DISEASE; RISK	Proposal This paper investigates a novel screening tool for Obstructive Sleep Apnea Syndrome (OSAS), which aims at efficient population-wide monitoring. To this end, we introduce SAS(score) which provides better OSAS prediction specificity while maintaining a high sensitivity. Methods We process a cohort of 2595 patients from 4 sleep laboratories in Western Romania, by recording over 100 sleep, breathing, and anthropometric measurements per patient; using this data, we compare our SAS(score) with state of the art scores STOP-Bang and NoSAS through area under curve (AUC), sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV). We also evaluate the performance of SAS(score) by considering different Apnea-Hypopnea Index (AHI) diagnosis cut-off points and show that custom refinements are possible by changing the score's threshold. Results SAS(score) takes decimal values within the interval (2, 7) and varies linearly with AHI; it is based on standardized measures for BMI, neck circumference, systolic blood pressure and Epworth score. By applying the STOP-Bang and NoSAS questionnaires, as well as the SAS(score) on the patient cohort, we respectively obtain the AUC values of 0.69 (95% CI 0.66-0.73, p < 0.001), 0.66 (95% CI 0.63-0.68, p < 0.001), and 0.73 (95% CI 0.71-0.75, p < 0.001), with sensitivities values of 0.968, 0.901, 0.829, and specificity values of 0.149, 0.294, 0.359, respectively. Additionally, we cross-validate our score with a second independent cohort of 231 patients confirming the high specificity and good sensitivity of our score. When raising SAS(score)'s diagnosis cut-off point from 3 to 3.7, both sensitivity and specificity become roughly 0.6. Conclusions In comparison with the existing scores, SAS(score) is a more appropriate screening tool for monitoring large populations, due to its improved specificity. Our score can be tailored to increase either sensitivity or specificity, while balancing the AUC value.	[Topirceanu, Alexandru; Udrescu, Mihai] Politehn Univ Timisoara, Dept Comp & Informat Technol, Timisoara, Romania; [Udrescu, Lucretia] Victor Babes Univ Med & Pharm Timisoara, Fac Pharm, Timisoara, Romania; [Ardelean, Carmen; Mihaicuta, Stefan] Victor Babes Univ Med & Pharm Timisoara, Dept Pulmonol, Timisoara, Romania; [Dan, Rodica] Victor Babes Univ Med & Pharm Timisoara, Dept Cardiol, Timisoara, Romania; [Reisz, Daniela] Victor Babes Univ Med & Pharm Timisoara, Dept Neurol, Timisoara, Romania; [Udrescu, Mihai] Timisoara Inst Complex Syst, Timisoara, Romania	Polytechnic University of Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara	Udrescu, M (corresponding author), Politehn Univ Timisoara, Dept Comp & Informat Technol, Timisoara, Romania.; Udrescu, M (corresponding author), Timisoara Inst Complex Syst, Timisoara, Romania.	mudrescu@cs.upt.ro	Reisz, Daniela/AAA-1564-2022; Udrescu, Mihai/B-6130-2012; Reisz, Daniela/AAP-6810-2021; Mihaicuta, Stefan/AAD-4531-2019; Topirceanu, Alexandru/AAK-6609-2020	Reisz, Daniela/0000-0001-6288-3601; Mihaicuta, Stefan/0000-0001-8897-8342; Udrescu, Mihai/0000-0002-7607-9240; Udrescu, Lucretia/0000-0002-3084-6301	Romanian National Authority for Scientific Research and Innovation, CNCS/CCCDI - UEFIS within PNCDI IIICDI [PN-III-P2-2.1-PED-2016-1145]	Romanian National Authority for Scientific Research and Innovation, CNCS/CCCDI - UEFIS within PNCDI IIICDI	This work was supported by Romanian National Authority for Scientific Research and Innovation, CNCS/CCCDI - UEFISCDI, project number PN-III-P2-2.1-PED-2016-1145, within PNCDI III.	Arnardottir ES, 2016, J SLEEP RES, V25, P144, DOI 10.1111/jsr.12353; Babu AR, 2005, ARCH INTERN MED, V165, P447, DOI 10.1001/archinte.165.4.447; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bonsignore MR, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0069-2017; Campos-Rodriguez F, 2013, AM J RESP CRIT CARE, V187, P99, DOI 10.1164/rccm.201209-1671OC; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; Chung F, 2008, ANESTHESIOLOGY, V108, P822, DOI 10.1097/ALN.0b013e31816d91b5; Chung F, 2014, J CLIN SLEEP MED, V10, P951, DOI 10.5664/jcsm.4022; Eijsvogel MM, 2016, J CLIN SLEEP MED, V12, P555, DOI 10.5664/jcsm.5690; Fischer J, 2012, J SLEEP RES, V21, P357, DOI 10.1111/j.1365-2869.2011.00987.x; Floras JS, 2014, J CARDIOL, V63, P3, DOI 10.1016/j.jjcc.2013.08.009; Heinzer R, 2015, LANCET RESP MED, V3, P310, DOI 10.1016/S2213-2600(15)00043-0; Ibanez V, 2018, PEERJ, V6, DOI 10.7717/peerj.4849; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Levy P, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.15; Marrone O, 2016, J SLEEP RES, V25, P739, DOI 10.1111/jsr.12426; Marti-Soler H, 2016, LANCET RESP MED, V4, P742, DOI 10.1016/S2213-2600(16)30075-3; McNicholas WT, 2007, EUR RESPIR J, V29, P156, DOI 10.1183/09031936.00027406; McNicholas WT, 2018, LANCET RESP MED, V6, P170, DOI 10.1016/S2213-2600(18)30059-6; McNicholas WT, 2016, LANCET RESP MED, V4, P826, DOI 10.1016/S2213-2600(16)30146-1; Memtsoudis SG, 2013, NEW ENGL J MED, V368, P2352, DOI 10.1056/NEJMp1302941; Mihaicuta S, 2017, PEERJ, V5, DOI 10.7717/peerj.3289; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Randerath W, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.02616-2017; Randerath W, 2014, SLEEP MED, V15, P1285, DOI 10.1016/j.sleep.2014.08.008; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rossi VA, 2013, EUR RESPIR J, V41, P1439, DOI 10.1183/09031936.00128412; Saaresranta T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163439; Sanchez-de-la-Torre M, 2013, LANCET RESP MED, V1, P61, DOI 10.1016/S2213-2600(12)70051-6; Silva GE, 2011, J CLIN SLEEP MED, V7, P468, DOI 10.5664/JCSM.1308; Simon S, 2012, CHEST, V142, P1645, DOI 10.1378/chest.12-2391; Tan A, 2017, SLEEP BREATH, P1; Utriainen KT, 2013, EUR RESPIR J, V41, P616, DOI 10.1183/09031936.00227611; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	37	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202042	10.1371/journal.pone.0202042	http://dx.doi.org/10.1371/journal.pone.0202042			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183715	gold, Green Published, Green Submitted			2022-12-26	WOS:000443789900013
J	Tomomori, S; Nakano, Y; Ochi, H; Onohara, Y; Sairaku, A; Tokuyama, T; Motoda, C; Matsumura, H; Amioka, M; Hironobe, N; Ookubo, Y; Okamura, S; Kawazoe, H; Chayama, K; Kihara, Y				Tomomori, Shunsuke; Nakano, Yukiko; Ochi, Hidenori; Onohara, Yuko; Sairaku, Akinori; Tokuyama, Takehito; Motoda, Chikaaki; Matsumura, Hiroya; Amioka, Michitaka; Hironobe, Naoya; Ookubo, Yousaku; Okamura, Shou; Kawazoe, Hiroshi; Chayama, Kazuaki; Kihara, Yasuki			Maintenance of low inflammation level by the ZFHX3 SNP rs2106261 minor allele contributes to reduced atrial fibrillation recurrence after pulmonary vein isolation	PLOS ONE			English	Article							EXPERT CONSENSUS STATEMENT; RESEARCH TRIAL DESIGN; CATHETER ABLATION; NEUTROPHIL/LYMPHOCYTE RATIO; PROCEDURAL TECHNIQUES; PATIENT-MANAGEMENT; SURGICAL ABLATION; END-POINTS; FOLLOW-UP; METAANALYSIS	Introduction The single nucleotide polymorphism (SNP) rs2106261 in the transcription factor gene ZFHX3 (16q22), a major regulator of inflammation, has been reported linking to atrial fibrillation (AF) by genome-wide association studies. Inflammation is known to be a strong predictor of atrial fibrillation recurrence after ablation, so we examined the association of the ZFHX3 SNP rs2106261 to inflammation marker expression and recurrence after AF ablation. Methods We genotyped ZFHX3 SNP rs2106261 and compared the minor (T) allele frequency between 362 paroxysmal AF (PAF) patients underwent pulmonary vein isolation (PVI) and 627 non-AF controls. We also analyzed associations between ZFHX3 SNP rs2106261 genotype and recurrence rate after pulmonary vein isolation and the inflammation markers. Results The minor (T) allele frequency of the ZFHX3 SNP rs2106261 was significantly higher in AF patients than non-AF controls (odds ratio 1.52, p = 2.2x10(-5)). Multivariable analysis revealed that the minor allele (T) decreased AF recurrence rate after pulmonary vein isolation (hazard ratio 0.53, p = 0.04). Further, neutrophil/lymphocyte (N/L) ratio, C-reactive protein (CRP), and interleukin-6 (IL-6) expression levels were lower in PAF patients with the ZFHX3 SNP rs2106261 minor allele (TT+TC) than in CC patients (N/L ratio: CC 2.22 +/- 0.08, TT+TC 1.98 +/- 0.06, p = 0.018; CRP: CC 0.103 +/- 0.009 mg/dl, TT+TC 0.076 +/- 0.007 mg/dl, p = 0.016; IL-6: CC 60.3 +/- 3.0 pg/ml, TT+TC 52.8 +/- 2.3 pg/ml, p = 0.04). Conclusions The ZFHX3 SNP rs2106261 minor allele is associated with lower AF recurrence rate after pulmonary vein isolation. Low baseline inflammation conferred by this allele may reduce AF recurrence risk.	[Tomomori, Shunsuke; Nakano, Yukiko; Onohara, Yuko; Sairaku, Akinori; Tokuyama, Takehito; Motoda, Chikaaki; Matsumura, Hiroya; Amioka, Michitaka; Hironobe, Naoya; Ookubo, Yousaku; Okamura, Shou; Kawazoe, Hiroshi; Kihara, Yasuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima, Japan; [Ochi, Hidenori; Chayama, Kazuaki] Hiroshima Univ, Dept Gastroenterol & Metab, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci, Hiroshima, Japan; [Ochi, Hidenori] Chugoku Elect Power Co Inc, Chuden Hosp, Dept Internal Med, Hiroshima, Japan	Hiroshima University; Hiroshima University; Chugoku Electric Power Company	Nakano, Y (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima, Japan.	nakanoy@hiroshima-u.ac.jp	chayama, Kazuaki/G-2917-2019	Chayama, Kazuaki/0000-0002-5530-5341				Akari S., 2003, NATURE GENETICS, V34; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Balk EM, 2010, J CARDIOVASC ELECTR, V21, P1208, DOI 10.1111/j.1540-8167.2010.01798.x; Berruezo A, 2007, EUR HEART J, V28, P836, DOI 10.1093/eurheartj/ehm027; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Canpolat U, 2013, AM J CARDIOL, V112, P513, DOI 10.1016/j.amjcard.2013.04.015; Choi EK, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002046; Christophersen IE, 2017, NAT GENET, V49, P946, DOI 10.1038/ng.3843; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Huang YF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005393; Husser D, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1170-3; Jiang ZQ, 2013, CLIN CARDIOL, V36, P548, DOI 10.1002/clc.22157; Kao YH, 2016, INT J CARDIOL, V210, P85, DOI 10.1016/j.ijcard.2016.02.091; Khaykin Y, 2011, J CARDIOVASC ELECTR, V22, P1206, DOI 10.1111/j.1540-8167.2011.02108.x; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lin YJ, 2010, AM J CARDIOL, V105, P495, DOI 10.1016/j.amjcard.2009.10.019; Makita Y, 2012, J CARDIOL, V60, P236, DOI 10.1016/j.jjcc.2012.03.007; Mommersteeg MTM, 2007, CIRC RES, V101, P902, DOI 10.1161/CIRCRESAHA.107.161182; Nojiri S, 2004, BIOCHEM BIOPH RES CO, V314, P97, DOI 10.1016/j.bbrc.2003.12.054; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Park JK, 2017, J CARDIOL, V69, P584, DOI 10.1016/j.jjcc.2016.04.017; Shao QM, 2015, ARCH MED RES, V46, P199, DOI 10.1016/j.arcmed.2015.03.011; Shoemaker MB, 2015, CIRC-ARRHYTHMIA ELEC, V8, P296, DOI 10.1161/CIRCEP.114.001909; Turcot V, 2018, NAT GENET, V50, P26, DOI 10.1038/s41588-017-0011-x; Wu N, 2013, INT J CARDIOL, V169, P62, DOI 10.1016/j.ijcard.2013.08.078	26	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0203281	10.1371/journal.pone.0203281	http://dx.doi.org/10.1371/journal.pone.0203281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180182	Green Submitted, gold, Green Published			2022-12-26	WOS:000444222400034
J	Alam, M; Neal, J; O'Connor, K; Kilian, A; Topp, B				Alam, Mobashwer; Neal, Jodi; O'Connor, Katie; Kilian, Andrzej; Topp, Bruce			Ultra-high-throughput DArTseq-based silicoDArT and SNP markers for genomic studies in macadamia	PLOS ONE			English	Article							ARRAYS TECHNOLOGY DART; GENETIC DIVERSITY; MOLECULAR MARKERS; POPULATION-STRUCTURE; ASSISTED SELECTION; CROP; SSR; INTEGRIFOLIA; VARIABILITY; RESISTANCE	Macadamia (Macadamia integrifolia, M. tetraphylla and hybrids) is an Australian native nut crop and has a significant economic value in the food industries worldwide. Long juvenility along with traditional breeding strategies impede quick genetic improvement of this crop. The existing cultivars constitute only second to fourth generation of the wild germplasm in the rainforest. The utilisation of molecular markers for genomic selection and genome-wide association studies may accelerate genetic gains. Identification of a robust, reproducible, and cost-effective marker system is instrumental in increasing the efficiency of genomic studies. This study is the first to report the potential of two ultra-high-throughput diversity array technology (DArT) markers (silicoDArT and SNP) in macadamia. Both markers were used to identify the genetic diversity and population structure in 80 macadamia cultivars. Parentage analysis of 25 scions in a rootstock trial was conducted to confirm plant identity where recorded identities did not corroborate with phenotypic field observations. A total of 22,280 silicoDArT and 7,332 SNP markers were reported, of which 11,526 silicoDArT and 3,956 SNP markers were used for analyses after screening with quality control parameters including >95% call rate, >95% reproducibility, and >0.05 one ratio. The average polymorphic information content (PIC) values of silicoDArT and SNP markers were 0.29 and 0.21, respectively. Genetic variance among the cultivars ranged from 0.003 to 0.738 in silicoDArT and 0.004 to 0.412 in SNP markers. Four distinct population groups were identified from SNP data analysis. Most of the accessions used in this study were descended from two or more populations. Cluster analysis clearly separated genotypes of distinct origins, such as the Hawaii Agricultural Experiment Station and Hidden Valley Plantation accessions. Two wild accessions of Macadamia jansenii and M. ternifolia were found to be distantly related to the cultivars. Wild germplasm individuals and their hybrids with cv. '660' formed separate clusters, suggesting that crossing between wild and cultivated genepools can extend genetic diversity. DArTseq-based SNP markers were successfully utilized to confirm the genetic identity of 25 scions in a rootstock trial. Our study suggests that DArT platforms are a robust system for the facilitation of genomic studies with regard to macadamia.	[Alam, Mobashwer; O'Connor, Katie; Topp, Bruce] Univ Queensland, Ctr Hort Sci, Queensland Alliance Agr & Food Innovat, Nambour, Qld, Australia; [Neal, Jodi] Maroochy Res Facil, Dept Agr & Forestry, Nambour, Qld, Australia; [Kilian, Andrzej] Univ Canberra, Divers Arrays Technol Pty Ltd, Monana St, Canberra, ACT, Australia	University of Queensland; Queensland Department of Agriculture & Fisheries; University of Canberra	Alam, M (corresponding author), Univ Queensland, Ctr Hort Sci, Queensland Alliance Agr & Food Innovat, Nambour, Qld, Australia.	m.alam@uq.edu.au	Alam, Mobashwer/F-9833-2010; O'Connor, Katie/T-1385-2019	Alam, Mobashwer/0000-0003-1502-5617; O'Connor, Katie/0000-0003-3052-8300; TOPP, Bruce/0000-0001-5647-3737; Kilian, Andrzej/0000-0002-2730-7462	Hort Innovation Australia; Diversity Arrays Technology Pty Ltd.	Hort Innovation Australia; Diversity Arrays Technology Pty Ltd.	This research has been funded by Hort Innovation Australia, using the Macadamia research and development levy and contributions from the Australian Government. Diversity Arrays Technology Pty Ltd. provided support in the form of salaries for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Alam MM, 2014, THEOR APPL GENET, V127, P2253, DOI 10.1007/s00122-014-2377-9; Ambawat S, 2016, EUPHYTICA, V209, P461, DOI 10.1007/s10681-016-1671-9; Aradhya MK, 1998, GENET RESOUR CROP EV, V45, P19, DOI 10.1023/A:1008634103954; Baloch FS, 2016, TURK J AGRIC FOR, V40, P352, DOI 10.3906/tar-1508-27; Bolibok-Bragoszewska H, 2009, BMC GENOMICS, V10, P1; Cruz VMV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064062; Dierig D, 2009, NEW CROPS BREEDING L, P507; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Gan L-p, 2004, J GANSU AGR U, V1; Gitonga LN, 2011, ACTA HORTIC, V918, P877, DOI 10.17660/ActaHortic.2011.918.116; Gitonga L.N., 2009, J PLANT BREED CROP S, V1, P049, DOI [10.5897/jpbcs.9000122, DOI 10.5897/JPBCS.9000122]; Grzebelus D, 2014, MOL BREEDING, V33, P625, DOI 10.1007/s11032-013-9979-9; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hardner C, 2005, ACTA HORTIC, P85, DOI 10.17660/ActaHortic.2005.694.10; Hardner C. M., 2009, Horticultural Reviews, V35, P1; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Hudson CJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-240; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; James KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001682; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kilian A., 2003, P INT C WAK DOUBL HE, P443; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Laido G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067280; Mace ES, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-26; Neto NBM, 2010, CROP BREED APPL BIOT, V10, P266, DOI 10.1590/S1984-70332010000300013; Matthies IE, 2012, MOL BREEDING, V30, P951, DOI 10.1007/s11032-011-9678-3; McHargue L. T., 1996, Progress in new crops: Proceedings of the Third National Symposium, Indianapolis, Indiana, USA, 22-25 October, 1996., P458; Melchinger AE, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P99; Mohan M, 1997, MOL BREEDING, V3, P87, DOI 10.1023/A:1009651919792; NAGAO MA, 1992, CRIT REV PLANT SCI, V10, P441, DOI 10.1080/07352689209382321; Nock CJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3272-3; Nock CJ, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1300089; O'Connor K, 2018, TREE GENET GENOMES, V14, DOI 10.1007/s11295-017-1221-1; O'Connor K, 2015, BIOL CONSERV, V191, P504, DOI 10.1016/j.biocon.2015.08.001; Peace C., 2002, WANATCA Yearbook, V26, P19; Peace C, 2005, GENETIC CHARACTERISA; Peace C. P., 2005, South African Journal of Plant and Soil, V22, P71; Peace Cameron, 2008, V1, P313; Peace CP, 2004, J HORTIC SCI BIOTECH, V79, P965, DOI 10.1080/14620316.2004.11511874; Peace CP, 2003, EUPHYTICA, V134, P17, DOI 10.1023/A:1026190529568; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X, 2003, METHODS DATA ANAL GE, P31; Pritchard JK, 2010, DOCUMENTATION STRUCT; Sanchez-Sevilla JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144960; Sanewski G, 2017, AUSTRALAS PLANT PATH, V46, P499, DOI 10.1007/s13313-017-0512-1; Sansaloni CP, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-16; Schouten HJ, 2012, MOL BREEDING, V29, P645, DOI 10.1007/s11032-011-9579-5; Sharp D, 1997, AUSTR MAC SOC ANN, P20; Shigeura GT, 1984, MACADAMIA NUTS HAWAI; Simko I, 2012, PLANT SCI, V184, P54, DOI 10.1016/j.plantsci.2011.12.009; Steiger DL, 2003, EUPHYTICA, V132, P269, DOI 10.1023/A:1025025522276; Stephenson R., 2005, Chronica Horticulturae, V45, P11; Tabangin Meredith E, 2009, BMC Proc, V3 Suppl 7, pS41, DOI 10.1186/1753-6561-3-S7-S41; Tang J, 2015, PLANTA, V242, P985, DOI 10.1007/s00425-015-2335-z; Topp B, 2016, ACTA HORTIC, V1127, P45, DOI 10.17660/ActaHortic.2016.1127.8; Vishwakarma MK, 2017, COMPEND PL GENOME, P93, DOI 10.1007/978-3-319-63935-2_7; Vithanage V, 1997, INT S BIOT TROP SU 2, P461; Waldron Julie, 2002, Journal of Biomedicine & Biotechnology, V2, P141, DOI 10.1155/S1110724302206026; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Xia L, 2005, THEOR APPL GENET, V110, P1092, DOI 10.1007/s00122-005-1937-4; Yang SY, 2006, THEOR APPL GENET, V113, P585, DOI 10.1007/s00122-006-0317-z; Yang XP, 2016, PLANT GENET RESOUR-C, V14, P226, DOI 10.1017/S1479262115000659; ZENG ZB, 1994, GENETICS, V136, P1457	68	50	50	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203465	10.1371/journal.pone.0203465	http://dx.doi.org/10.1371/journal.pone.0203465			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169500	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000443374400042
J	Le Gall, G; Kirchgesner, J; Bejaoui, M; Landman, C; Nion-Larmurier, I; Bourrier, A; Sokol, H; Seksik, P; Beaugerie, L				Le Gall, Guillaume; Kirchgesner, Julien; Bejaoui, Mohamed; Landman, Cecilia; Nion-Larmurier, Isabelle; Bourrier, Anne; Sokol, Harry; Seksik, Philippe; Beaugerie, Laurent			Clinical activity is an independent risk factor of ischemic heart and cerebrovascular arterial disease in patients with inflammatory bowel disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; RHEUMATOID-ARTHRITIS; CARDIOVASCULAR EVENTS; STROKE; METAANALYSIS; MORTALITY	Background and aims In inflammatory bowel disease (IBD), the impact of established cardiovascular risk factors and disease-related factors on the risk of acute arterial events is still unclear. We aimed to identify risk factors of acute arterial events in patients with IBD. Methods All consecutive patients followed at Saint-Antoine Hospital between 1996 and 2015 with subsequent occurrence of acute arterial events (acute coronary syndrome or ischemic stroke) were identified. Traditional cardiovascular risk factors, treatment exposure, systemic inflammation (mean serum CRP level greater than or equal to 5 mg/L) and IBD clinical activity were assessed. A nested case-control study was performed including cases and controls without arterial ischemic event, matched on age, gender, and disease extent. Results A total of 30 patients (median age at acute vascular event occurrence: 42 years (interquartile range: 25-59)) developed acute coronary syndrome (n = 22) or ischemic stroke (n = 8). In univariate analysis, clinical disease activity and the persistence of systemic inflammation, diabetes, dyslipidemia and hypertension were significantly associated with an increased risk of acute arterial events. Neither protective nor aggravating effects associated with treatment exposure were identified. In multivariate analysis, the presence of diabetes (Odds ratio (OR): 14.5, 95% confidence interval (CI): 1.1-184.7) and clinical disease activity (OR: 10.4, 95% CI: 2.1-49.9) remained significantly associated with the risk of acute arterial event. Conclusion Disease activity may have an independent impact on the risk of acute arterial events in patients with IBD. These findings may highlight new potential benefits of optimizing anti-inflammatory treatment in patients with persisting clinical activity.	[Le Gall, Guillaume; Kirchgesner, Julien; Bejaoui, Mohamed; Landman, Cecilia; Nion-Larmurier, Isabelle; Bourrier, Anne; Sokol, Harry; Seksik, Philippe; Beaugerie, Laurent] Hop St Antoine, AP HP, Dept Gastroenterol, Paris, France; [Kirchgesner, Julien] INSERM, UMR S 1136, Paris, France; [Kirchgesner, Julien] UPMC Univ Paris 06, Paris, France; [Sokol, Harry; Seksik, Philippe; Beaugerie, Laurent] Sorbonne Univ, INSERM, ERL INSERM Unite Mixte Rech 1057, Paris, France; [Sokol, Harry; Seksik, Philippe; Beaugerie, Laurent] Sorbonne Univ, Grp Rech Clin 03, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Le Gall, G (corresponding author), Hop St Antoine, AP HP, Dept Gastroenterol, Paris, France.	guillaumelegall1@hotmail.com	Sokol, Harry/E-2290-2019; Kirchgesner, Julien/ABA-1398-2021; sokol, harry/ABA-8991-2020; SEKSIK, Philippe/ABE-2962-2020	Sokol, Harry/0000-0002-2914-1822; sokol, harry/0000-0002-2914-1822; Kirchgesner, Julien/0000-0002-2314-9284; LE GALL, Guillaume/0000-0003-1917-4433; Bejaoui, Mohamed/0000-0002-9977-2304				Avina-Zubieta JA, 2012, ANN RHEUM DIS, V71, P1524, DOI 10.1136/annrheumdis-2011-200726; Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; Bergeron V, 2010, AM J GASTROENTEROL, V105, P2405, DOI 10.1038/ajg.2010.248; Chung AR, 2011, J GASTROEN HEPATOL, V26, P60; Cosnes J, 2016, ALIMENT PHARM THER, V44, P1102, DOI 10.1111/apt.13808; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Fumery M, 2014, J CROHNS COLITIS, V8, P469, DOI 10.1016/j.crohns.2013.09.021; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kirchgesner J, 2018, GUT, V67, P1261, DOI 10.1136/gutjnl-2017-314015; Kristensen SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056944; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; Pepys MB, 2003, J CLIN INVEST, V112, P299, DOI 10.1172/JCI200318921C; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Ridker PM, 2007, J AM COLL CARDIOL, V49, P2129, DOI 10.1016/j.jacc.2007.02.052; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Shankar A, 2007, AM HEART J, V154, P495, DOI 10.1016/j.ahj.2007.04.060; Singh S, 2014, CLIN GASTROENTEROL H, V12, P382, DOI 10.1016/j.cgh.2013.08.023; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Xiao ZL, 2015, J STROKE CEREBROVASC, V24, P2774, DOI 10.1016/j.jstrokecerebrovasdis.2015.08.008; Zakroysky P, 2015, AM J MED, V128, P303, DOI 10.1016/j.amjmed.2014.10.033; Zanoli L, 2014, ATHEROSCLEROSIS, V234, P346, DOI 10.1016/j.atherosclerosis.2014.03.023	22	23	23	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0201991	10.1371/journal.pone.0201991	http://dx.doi.org/10.1371/journal.pone.0201991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169521	Green Published, gold, Green Submitted			2022-12-26	WOS:000443374400006
J	Giacco, A; delli Paoli, G; Senese, R; Cioffi, F; Silvestri, E; Moreno, M; Ruoppolo, M; Caterino, M; Costanzo, M; Lombardi, A; Goglia, F; Lanni, A; de Lange, P				Giacco, Antonia; delli Paoli, Giuseppe; Senese, Rosalba; Cioffi, Federica; Silvestri, Elena; Moreno, Maria; Ruoppolo, Margherita; Caterino, Marianna; Costanzo, Michele; Lombardi, Assunta; Goglia, Fernando; Lanni, Antonia; de Lange, Pieter			The saturation degree of fatty acids and their derived acylcarnitines determines the direct effect of metabolically active thyroid hormones on insulin sensitivity in skeletal muscle cells	FASEB JOURNAL			English	Article						skeletal muscle; acylcarnitines; 3,5,3 '-triiodo-L-thyronine; 3,5-diiodo-L-thyronine; insulin resistance	RAT GASTROCNEMIUS; PROTEIN-KINASE; 3,5-DIIODO-L-THYRONINE; OXIDATION; HYPOTHYROIDISM; RESISTANCE; PATHWAYS; SERUM; AXIS	Using differentiated rat L6 cells, we studied the direct effect of 3,5,3-triiodo-l-thyronine (T3) and 3,5-diiodo-l-thyronine (T2) on the response to insulin in presence of fatty acids with a varying degree of saturation. We found that T3 and T2 both invert the response to insulin by modulating Akt Ser473 phosphorylation in the presence of palmitate and oleate. Both hormones prevented palmitate-induced insulin resistance, whereas increased insulin sensitivity in the presence of oleate was reduced, with normalization to (or, in the case of T3, even below) control levels. Both hormones effectively reduced intracellular acylcarnitine concentrations. Interestingly, insulin sensitization was lowered by incubation of the myotubes with relevant concentrations of palmitoylcarnitines (C16) and increased by oleylcarnitines and linoleylcarnitines (C18:1 and C18:2, respectively). The efficiency of mitochondrial respiration decreased in the order palmitate-oleate-linoleate; in the presence of palmitate, only T3 increased ATP synthesis-independent cellular respiration and mitochondrial respiratory complex activities. Both hormones modulated gene expression and enzyme activities related to insulin sensitivity, glucose metabolism, and lipid handling. Although T2 and T3 differentially regulated the expression of relevant genes involved in glucose metabolism, they equally stimulated related metabolic activities. T2 and T3 differentially modulated mitochondrial fatty acid uptake and oxidation in the presence of each fatty acid. The results show that T2 and T3 both invert the fatty acid-induced response to insulin but through different mechanisms, and that the outcome depends on the degree of saturation of the fatty acids and their derived acylcarnitines.Giacco, A., delli Paoli, G., Senese, R., Cioffi, F., Silvestri, E., Moreno, M., Ruoppolo, M., Caterino, M., Costanzo, M., Lombardi, A., Goglia, F., Lanni, A., de Lange, P. The saturation degree of fatty acids and their derived acylcarnitines determines the direct effect of metabolically active thyroid hormones on insulin sensitivity in skeletal muscle cells.	[Giacco, Antonia; Cioffi, Federica; Silvestri, Elena; Moreno, Maria; Goglia, Fernando] Univ Sannio, Dipartimento Sci & Tecnol, Benevento, Italy; [delli Paoli, Giuseppe; Senese, Rosalba; Lanni, Antonia; de Lange, Pieter] Univ Campania Luigi Vanvitelli, Dipartimento Sci & Tecnol Ambientali Biol & Farma, I-81100 Caserta, Italy; [Ruoppolo, Margherita; Caterino, Marianna; Costanzo, Michele] Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Lombardi, Assunta] Univ Napoli Federico II, Dipartimento Biol, Naples, Italy; [Ruoppolo, Margherita; Caterino, Marianna; Costanzo, Michele] Ceinge Biotecnol Avanzate, Naples, Italy; [Ruoppolo, Margherita; Caterino, Marianna; Costanzo, Michele] Divulgaz Sci Multidisciplinare Sostenibilita Ric, Naples, Italy	University of Sannio; Universita della Campania Vanvitelli; University of Naples Federico II; University of Naples Federico II; CEINGE Biotecnologie Avanzate	Lanni, A (corresponding author), Univ Campania Luigi Vanvitelli, Dipartimento Sci & Tecnol Ambientali Biol & Farma, I-81100 Caserta, Italy.; de Lange, P (corresponding author), Univ Campania, Dipartimento Sci & Tecnol Ambientali Biol & Farma, Via Vivaldi 43, I-81100 Caserta, Italy.	antonia.lanni@unicampania.it; pieter.delange@unicampania.it	de Lange, Pieter/GXA-3052-2022; Caterino, Marianna/K-4531-2016; Costanzo, Michele/AAO-5873-2020; Caterino, Marianna/AAR-3526-2020	Costanzo, Michele/0000-0002-6386-2009; Caterino, Marianna/0000-0001-6035-8213; Silvestri, Elena/0000-0002-0592-9033; CIOFFI, Federica/0000-0002-1530-8556; MORENO, Maria/0000-0002-6218-5501; SENESE, Rosalba/0000-0003-1571-0980	University of Sannio Research Grants	University of Sannio Research Grants	This work was funded by University of Sannio Research Grants. The authors declare no conflicts of interest.	Abu Bakar MH, 2017, MOL BIOSYST, V13, P1838, DOI 10.1039/c7mb00333a; Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Aguer C, 2015, FASEB J, V29, P336, DOI 10.1096/fj.14-255901; Bouchouirab FZ, 2018, CAN J DIABETES, V42, P382, DOI 10.1016/j.jcjd.2017.09.002; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Cao ZM, 2009, ENDOCR RES, V34, P101, DOI 10.3109/07435800903204082; Caterino M, 2016, MOL BIOSYST, V12, P566, DOI 10.1039/c5mb00736d; Cavaliere G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149033; Cavallo A, 2016, J BIOENERG BIOMEMBR, V48, P521, DOI 10.1007/s10863-016-9686-4; Crescenzo R, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00512; de Lange P, 2011, DIABETES, V60, P2730, DOI 10.2337/db11-0207; de Lange P, 2008, ENDOCRINOLOGY, V149, P6462, DOI 10.1210/en.2008-0202; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; Grasselli E, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00418; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Iossa S, 2004, DIABETES, V53, P2861, DOI 10.2337/diabetes.53.11.2861; Jonas W, 2015, ENDOCRINOLOGY, V156, P389, DOI 10.1210/en.2014-1604; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lanni A, 2005, FASEB J, V19, DOI 10.1096/fj.05.3977fje; Lombardi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116498; Lombardi A, 2012, AM J PHYSIOL-ENDOC M, V303, pE1222, DOI 10.1152/ajpendo.00037.2012; Martinez-Sanchez N, 2017, CELL METAB, V26, P212, DOI 10.1016/j.cmet.2017.06.014; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; Moreno M, 2011, FASEB J, V25, P3312, DOI 10.1096/fj.11-181982; Nardi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092255; Oliveira AF, 2015, BIOTECHNIQUES, V58, P228, DOI 10.2144/000114285; OPIE LH, 1967, BIOCHEM J, V103, P391, DOI 10.1042/bj1030391; Padron AS, 2014, J ENDOCRINOL, V221, P415, DOI 10.1530/JOE-13-0502; Ruoppolo M, 2014, AM J TRANSL RES, V6, P614; Schooneman MG, 2013, DIABETES, V62, P1, DOI 10.2337/db12-0466; Scolamiero E, 2015, MOL BIOSYST, V11, P1525, DOI 10.1039/c4mb00729h; Sears B, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0123-1; Senese R, 2011, PFLUG ARCH EUR J PHY, V461, P153, DOI 10.1007/s00424-010-0892-3; Silvestri E, 2010, MOL BIOSYST, V6, P2256, DOI 10.1039/c0mb00040j; Vatner DF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140837; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318	37	17	17	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1811	1823		10.1096/fj.201800724R	http://dx.doi.org/10.1096/fj.201800724R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30204501				2022-12-26	WOS:000457296600024
J	Ji, CC; Nagaoka, K; Zou, J; Casulli, S; Lu, SL; Cao, KY; Zhang, HY; Iwagami, Y; Carlson, RI; Brooks, K; Lawrence, J; Mueller, W; Wands, JR; Huang, CK				Ji, Chengcheng; Nagaoka, Katsuya; Zou, Jing; Casulli, Sarah; Lu, Shaolei; Cao, Kevin Y.; Zhang, Hongyu; Iwagami, Yoshifumi; Carlson, Rolf I.; Brooks, Keri; Lawrence, Jonathan; Mueller, William; Wands, Jack R.; Huang, Chiung-Kuei			Chronic ethanol-mediated hepatocyte apoptosis links to decreased TET1 and 5-hydroxymethylcytosine formation	FASEB JOURNAL			English	Article						epigenetic modification; DNA methylation; 2-oxoglutarate; Krebs cycle; 5-azacytidine	GENOMIC DNA HYPERMETHYLATION; METHIONINE ADENOSYLTRANSFERASE; S-ADENOSYLMETHIONINE; LIVER-DISEASE; METHYLATION; REPAIR; 5-METHYLCYTOSINE; DEMETHYLATION; GAMMA-H2AX; ACTIVATION	The 5-hydroxymethylcytosine (5hmc) is a newly identified epigenetic modification thought to be regulated by the TET family of proteins. Little information is available about how ethanol consumption may modulate 5hmC formation and alcoholic liver disease (ALD) progression. A rat ALD model was used to study 5hmC in relationship to hepatocyte apoptosis. Human ALD liver samples were also used to validate these findings. It was found that chronic ethanol feeding significantly reduced 5hmC formation in a rat ALD model. There were no significant changes in TET2 and TET3 between the control- and ethanol-fed animals. In contrast, methylcytosine dioxygenase TET1 (TET1) expression was substantially reduced in the ethanol-fed rats and was accompanied by increased hepatocyte apoptosis. Similarly, knockdown of TET1 in human hepatocyte-like cells also significantly promoted apoptosis. Down-regulation of TET1 resulted in elevated expression of the DNA damage marker, suggesting a role for 5hmc in hepatocyte DNA damage as well. Mechanistic studies revealed that inhibition of TET1 promoted apoptotic gene expression. Similarly, targeting TET1 activity by removing cosubstrate promoted apoptosis and DNA damage. Furthermore, treatment with 5-azacitidine significantly mimics these effects, suggesting that chronic ethanol consumption promotes hepatocyte apoptosis and DNA damage by diminishing TET1-mediated 5hmC formation and DNA methylation. In summary, the current study provides a novel molecular insight that TET1-mediated 5hmC is involved in hepatocyte apoptosis in ALD progression.Ji, C., Nagaoka, K., Zou, J., Casulli, S., Lu, S., Cao, K. Y., Zhang, H., Iwagami, Y., Carlson, R. I., Brooks, K., Lawrence, J., Mueller, W., Wands, J. R., Huang, C.-K. Chronic ethanol-mediated hepatocyte apoptosis links to decreased TET1 and 5-hydroxymethylcytosine formation.	[Ji, Chengcheng; Nagaoka, Katsuya; Zou, Jing; Casulli, Sarah; Cao, Kevin Y.; Zhang, Hongyu; Iwagami, Yoshifumi; Carlson, Rolf I.; Brooks, Keri; Lawrence, Jonathan; Mueller, William; Wands, Jack R.; Huang, Chiung-Kuei] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Gastroenterol, Providence, RI 02903 USA; [Ji, Chengcheng; Nagaoka, Katsuya; Zou, Jing; Casulli, Sarah; Cao, Kevin Y.; Zhang, Hongyu; Iwagami, Yoshifumi; Carlson, Rolf I.; Brooks, Keri; Lawrence, Jonathan; Mueller, William; Wands, Jack R.; Huang, Chiung-Kuei] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Liver Res Ctr, 55 Claverick St, Providence, RI 02903 USA; [Lu, Shaolei] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Pathol & Lab Med, Providence, RI 02903 USA; [Ji, Chengcheng] Beijing 302 Hosp, Crit Care Ctr, Beijing, Peoples R China; [Zou, Jing] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Fifth Medical Center of Chinese PLA General Hospital; Southern Medical University - China	Huang, CK (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Liver Res Ctr, 55 Claverick St, Providence, RI 02903 USA.	chiung-kuei_huang@brown.edu	Nagaoka, Katsuya/ABU-5640-2022; NAGAOKA, Katsuya/GQZ-0492-2022; Iwagami, Yoshifumi/AAJ-3184-2021	Nagaoka, Katsuya/0000-0002-7152-6101; NAGAOKA, Katsuya/0000-0002-7152-6101; Lu, Shaolei/0000-0003-2870-5793	Common Fund of the Office of the Director of the U.S. National Institutes of Health (NIH); National Cancer Institute, National Human Genome Research Institute, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; NIH [P20GM103430-12]; Rhode Island Foundation [134279]; American Association; 302 Hospital President Foundation [YNKT 2014018]; Brown University Karen T. Romer Undergraduate Teaching and Research awards; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER	Common Fund of the Office of the Director of the U.S. National Institutes of Health (NIH); National Cancer Institute, National Human Genome Research Institute, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhode Island Foundation; American Association; 302 Hospital President Foundation; Brown University Karen T. Romer Undergraduate Teaching and Research awards; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Z. Cheng (Warren Alpert Medical School of Brown University and Rhode Island Hospital), X. Bai (Warren Alpert Medical School of Brown University and Rhode Island Hospital), and G. Zhou (Beijing 302 Hospital) for their technical support. The GTEx Project is supported by the Common Fund of the Office of the Director of the U.S. National Institutes of Health (NIH), and by the National Cancer Institute, National Human Genome Research Institute, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health, and National Institute of Neurological Disorders and Stroke. The data used for the analyses described here were obtained from the GTEx data set. Funding for this work was provided by NIH (P20GM103430-12), the Rhode Island Foundation (134279), American Association for the Study of Liver Diseases pinnacle research award, the 302 Hospital President Foundation (YNKT 2014018), and Brown University Karen T. Romer Undergraduate Teaching and Research awards. The authors declare no conflicts of interest.	Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bonsch D, 2006, J NEURAL TRANSM, V113, P1299, DOI 10.1007/s00702-005-0413-2; Bonsch D, 2004, J NEURAL TRANSM, V111, P1611, DOI 10.1007/s00702-004-0232-x; Breitling LP, 2013, ARTERIOSCL THROM VAS, V33, P1468, DOI 10.1161/ATVBAHA.112.300157; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Feng J, 2015, NAT NEUROSCI, V18, P536, DOI 10.1038/nn.3976; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Fukaya KI, 2001, IN VITRO CELL DEV-AN, V37, P266, DOI 10.1007/bf02577541; GARRO AJ, 1991, ALCOHOL CLIN EXP RES, V15, P395, DOI 10.1111/j.1530-0277.1991.tb00536.x; Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Huang CK, 2015, J HEPATOL, V63, P191, DOI 10.1016/j.jhep.2015.02.030; Huang Y, 2014, TRENDS GENET, V30, P464, DOI 10.1016/j.tig.2014.07.005; Inoue S, 2016, CANCER CELL, V30, P337, DOI 10.1016/j.ccell.2016.05.018; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kuo LJ, 2008, IN VIVO, V22, P305; Lang CH, 2014, ALCOHOL CLIN EXP RES, V38, P897, DOI 10.1111/acer.12343; Liu CY, 2013, TOUR MANAG PERSPECT, V5, P1, DOI 10.1016/j.tmp.2012.09.003; Liu X, 2016, NAT REV GASTRO HEPAT, V13, P126, DOI 10.1038/nrgastro.2016.16; Lu SC, 2000, AM J PHYSIOL-GASTR L, V279, pG178, DOI 10.1152/ajpgi.2000.279.1.G178; Lu SC, 2005, ALCOHOL, V35, P227, DOI 10.1016/j.alcohol.2005.03.011; Page A, 2016, J HEPATOL, V64, P661, DOI 10.1016/j.jhep.2015.11.024; Pirola CJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001480; Ratib S, 2015, AM J GASTROENTEROL, V110, P1149, DOI 10.1038/ajg.2015.191; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Shen H, 2015, EXP MOL PATHOL, V99, P326, DOI 10.1016/j.yexmp.2015.08.001; Somineni HK, 2016, J ALLERGY CLIN IMMUN, V137, P797, DOI 10.1016/j.jaci.2015.10.021; Sorensen HT, 2003, J CLIN EPIDEMIOL, V56, P88, DOI 10.1016/S0895-4356(02)00531-0; Stepanova M, 2014, JAMA INTERN MED, V174, P1407, DOI 10.1001/jamainternmed.2014.2903; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Thomson JP, 2016, CANCER RES, V76, P3097, DOI 10.1158/0008-5472.CAN-15-1910; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu J, 2012, MOL CELL, V46, P351, DOI 10.1016/j.molcel.2012.02.018; Xin YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07645; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014	41	6	6	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1824	1835		10.1096/fj.201800736R	http://dx.doi.org/10.1096/fj.201800736R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30188753	Green Published			2022-12-26	WOS:000457296600025
J	Singh, SS; Naiyer, S; Bharadwaj, R; Kumar, A; Singh, YP; Ray, AK; Subbarao, N; Bhattacharya, A; Bhattacharya, S				Singh, Shashi Shekhar; Naiyer, Sarah; Bharadwaj, Ravi; Kumar, Amarjeet; Singh, Yatendra Pratap; Ray, Ashwini Kumar; Subbarao, Naidu; Bhattacharya, Alok; Bhattacharya, Sudha			Stress-induced nuclear depletion of Entamoeba histolytica 3'-5' exoribonuclease EhRrp6 and its role in growth and erythrophagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						exosome complex; stress response; ribosomal RNA processing (rRNA processing); precursor ribosomal RNA (pre-rRNA); RNA processing; phagocytosis; confocal microscopy; homology modeling; protein degradation; RNA degradation; 5-ETS; amoebiasis; amoebic dysentery; EhRrp6; Entamoeba histolytica	EUKARYOTIC MESSENGER-RNA; 5.8S RIBOSOMAL-RNA; HUMAN PM-SCL; QUALITY-CONTROL; CRYSTAL-STRUCTURE; EXOSOME COMPLEX; GENE-EXPRESSION; RRP6; DEGRADATION; PROTEIN	The 3-5 exoribonuclease Rrp6 is a key enzyme in RNA homeostasis involved in processing and degradation of many stable RNA precursors, aberrant transcripts, and noncoding RNAs. We previously have shown that in the protozoan parasite Entamoeba histolytica, the 5-external transcribed spacer fragment of pre-rRNA accumulates under serum starvation-induced growth stress. This fragment is a known target of degradation by Rrp6. Here, we computationally and biochemically characterized EhRrp6 and found that it contains the catalytically important EXO and HRDC domains and exhibits exoribonuclease activity with both unstructured and structured RNA substrates, which required the conserved DEDD-Y catalytic-site residues. It lacked the N-terminal PMC2NT domain for binding of the cofactor Rrp47, but could functionally complement the growth defect of a yeast rrp6 mutant. Of note, no Rrp47 homologue was detected in E. histolytica. Immunolocalization studies revealed that EhRrp6 is present both in the nucleus and cytosol of normal E. histolytica cells. However, growth stress induced its complete loss from the nuclei, reversed by proteasome inhibitors. EhRrp6-depleted E. histolytica cells were severely growth restricted, and EhRrp6 overexpression protected the cells against stress, suggesting that EhRrp6 functions as a stress sensor. Importantly EhRrp6 depletion reduced erythrophagocytosis, an important virulence determinant of E. histolytica. This reduction was due to a specific decrease in transcript levels of some phagocytosis-related genes (Ehcabp3 and Ehrho1), whereas expression of other genes (Ehcabp1, Ehcabp6, Ehc2pk, and Eharp2/3) was unaffected. This is the first report of the role of Rrp6 in cell growth and stress responses in a protozoan parasite.	[Singh, Shashi Shekhar; Naiyer, Sarah; Singh, Yatendra Pratap; Ray, Ashwini Kumar; Bhattacharya, Sudha] Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India; [Kumar, Amarjeet; Subbarao, Naidu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Bharadwaj, Ravi; Bhattacharya, Alok] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Bhattacharya, S (corresponding author), Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India.	sbjnu110@gmail.com	Bharadwaj, Ravi/ABE-6055-2021; Subbarao, Prof Naidu/AAZ-1832-2020; Singh, Shashi Shekhar/AAD-7584-2021; Naiyer, Sarah/AAB-4939-2019	Subbarao, Prof Naidu/0000-0002-1720-2165; Singh, Shashi Shekhar/0000-0002-9294-4855; Naiyer, Sarah/0000-0002-3961-5489; Kumar, Amarjeet/0000-0001-7740-9881	J.C. Bose National fellowship; Board of Research in Nuclear Sciences (BRNS); Council of Scientific and Industrial Research fellowship; University Grants Commission UPE-II	J.C. Bose National fellowship; Board of Research in Nuclear Sciences (BRNS)(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS)); Council of Scientific and Industrial Research fellowship(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission UPE-II(University Grants Commission, India)	This work was supported by a J.C. Bose National fellowship and by the Board of Research in Nuclear Sciences (BRNS) (to S. B.), and by a Council of Scientific and Industrial Research fellowship (to S. S. S., A. K., and S. N.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by University Grants Commission UPE-II.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Aslam S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003055; Assenholt J, 2008, RNA, V14, P2305, DOI 10.1261/rna.1108008; Babuta M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005310; Barbosa RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089138; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bharadwaj R, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12851; Bharadwaj R, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12751; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Costello JL, 2011, J BIOL CHEM, V286, P4535, DOI 10.1074/jbc.M110.162826; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Delan-Forino C, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006699; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Feigenbutz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080752; Feigenbutz M, 2013, J BIOL CHEM, V288, P15959, DOI 10.1074/jbc.M112.445759; Fox MJ, 2016, WIRES RNA, V7, P91, DOI 10.1002/wrna.1317; Gaurav AK, 2017, MOL BIOCHEM PARASIT, V211, P84, DOI 10.1016/j.molbiopara.2016.11.004; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Graham AC, 2009, MOL BIOL CELL, V20, P2242, DOI 10.1091/mbc.E08-08-0825; Gupta AK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00303; Haile S, 2007, MOL BIOCHEM PARASIT, V151, P52, DOI 10.1016/j.molbiopara.2006.10.005; Hamann L, 1997, MOL BIOCHEM PARASIT, V84, P83, DOI 10.1016/S0166-6851(96)02771-5; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jain R, 2008, CELL MICROBIOL, V10, P1373, DOI 10.1111/j.1462-5822.2008.01134.x; Januszyk K, 2011, RNA, V17, P1566, DOI 10.1261/rna.2763111; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Lange H, 2008, MOL CELL BIOL, V28, P3038, DOI 10.1128/MCB.02064-07; Lange H, 2011, PLANT J, V68, P51, DOI 10.1111/j.1365-313X.2011.04675.x; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Lykke-Andersen S, 2011, RNA BIOL, V8, P61, DOI 10.4161/rna.8.1.14237; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Makioka A, 2002, PARASITOL RES, V88, P454, DOI 10.1007/s00436-002-0601-z; Malet H, 2010, EMBO REP, V11, P936, DOI 10.1038/embor.2010.164; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Nozaki T, 2015, AMEBIASIS BIOL PATHO; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips S, 2003, RNA, V9, P1098, DOI 10.1261/rna.5560903; Ramakrishnan G, 1997, MOL BIOCHEM PARASIT, V84, P93, DOI 10.1016/S0166-6851(96)02784-3; Rastew E, 2012, INT J PARASITOL, V42, P1007, DOI 10.1016/j.ijpara.2012.08.006; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schilders G, 2007, NUCLEIC ACIDS RES, V35, P2564, DOI 10.1093/nar/gkm082; Scholze H, 1996, J BIOL CHEM, V271, P6212, DOI 10.1074/jbc.271.11.6212; Schuch B, 2014, EMBO J, V33, P2829, DOI 10.15252/embj.201488757; Shirai A., 2006, NAT PROTOC, DOI [10.1038/nprot.2006.191, DOI 10.1038/NPROT.2006.191]; Sikorski PJ, 2015, PLANT J, V83, P991, DOI 10.1111/tpj.12943; Sloan KE, 2014, RNA, V20, P540, DOI 10.1261/rna.043471.113; Somlata, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1199; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; Thomson E, 2010, MOL CELL BIOL, V30, P976, DOI 10.1128/MCB.01359-09; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Van Hooser AA, 2005, CHROMOSOMA, V114, P377, DOI 10.1007/s00412-005-0021-9; Verma D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006332; Wang MS, 2011, NUCLEIC ACIDS RES, V39, P1811, DOI 10.1093/nar/gkq1050; Wasmuth EV, 2017, NUCLEIC ACIDS RES, V45, P846, DOI 10.1093/nar/gkw1152; Wasmuth EV, 2014, NATURE, V511, P435, DOI 10.1038/nature13406; Wasmuth EV, 2012, ENZYMES, V31, P53, DOI 10.1016/B978-0-12-404740-2.00003-3; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Williams CW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-586; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Yadava N, 1997, MOL BIOCHEM PARASIT, V84, P69, DOI 10.1016/S0166-6851(96)02782-X; Zakrzewska-Placzek M, 2010, NUCLEIC ACIDS RES, V38, P4487, DOI 10.1093/nar/gkq172; Zinder JC, 2017, GENE DEV, V31, P88, DOI 10.1101/gad.294769.116; Zuo YH, 2005, STRUCTURE, V13, P973, DOI 10.1016/j.str.2005.04.015	81	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16242	16260		10.1074/jbc.RA118.004632	http://dx.doi.org/10.1074/jbc.RA118.004632			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30171071	Green Published, hybrid			2022-12-26	WOS:000447833600012
J	Lopez-Lopez, I; Rodelo-Haad, C; Aguera, ML; Cabello-Jabalquinto, R; Esquivias-Motta, E; Navarro, MD; Aljama, P; Rodriguez-Benot, A				Lopez-Lopez, Isabel; Rodelo-Haad, Cristian; Aguera, Maria Luisa; Cabello-Jabalquinto, Rosario; Esquivias-Motta, Elvira; Navarro, M. Dolores; Aljama, Pedro; Rodriguez-Benot, Alberto			Administration of mycophenolic acid is not associated with malformations in descendants from kidney transplanted males	PLOS ONE			English	Article							MOFETIL; RECIPIENTS	Background In pregnant women, the use of Mycophenolic acid (MPA) is associated with teratogenicity. Recently, the European Medicines Agency (EMEA) and the Spanish Agency of Medicine and Sanitary Products (AEMPS) warned about the potential teratogenic effects of MPA. These adverse events may occur even in children from males on treatment with MPA. However, evidence of malformations in offsprings of male kidney transplanted patients (KT) exposed to MPA is limited. Thus, the present study aimed to evaluate the incidence of offspring malformations in children of renal transplanted males under MPA. Materials and methods We conducted a retrospective study in which we evaluated the incidence of malformations in descendants from male recipients that were exposed or not to MPA before and at the time of conception. Two groups of patients were evaluated. Those exposed to MPA (MPA group, n = 20) and the non-MPA group (n = 13) that included patients that did not receive AZA (n = 5) and eight that did receive AZA (n = 8) at the time of conception. Results A total of forty-nine post-transplant conceptions were identified from 33 different renal transplanted males. MPA was used as the immunosuppressant in 28 of the conceptions. Males from the non-MPA group fathered the other 21 children. Median time from grafting to conception was 6.1 (IQR 2.4-11.1) years, and it was similar between groups. There were eight miscarriage episodes, 2 in the non-MPA group and 6 in the MPA group although differences were not reached. After that, all patients had children without problems. No malformations were detected in any of the 49 regardless whether they were exposed or not to MPA. Conclusions No evidence of MPA-associated malformations was observed in descendants of kidney transplanted males on treatment with MPA. Further research is warranted to confirm our findings to properly advice transplanted males keen to procreate.	[Lopez-Lopez, Isabel; Rodelo-Haad, Cristian; Aguera, Maria Luisa; Esquivias-Motta, Elvira; Navarro, M. Dolores; Aljama, Pedro; Rodriguez-Benot, Alberto] Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain; [Lopez-Lopez, Isabel; Rodelo-Haad, Cristian; Aguera, Maria Luisa; Esquivias-Motta, Elvira; Navarro, M. Dolores; Aljama, Pedro; Rodriguez-Benot, Alberto] Reina Sofia Univ Hosp, Cordoba, Spain; [Cabello-Jabalquinto, Rosario] Univ Cordoba, Dept Med, Cordoba, Spain	Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba	Rodelo-Haad, C (corresponding author), Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain.; Rodelo-Haad, C (corresponding author), Reina Sofia Univ Hosp, Cordoba, Spain.	crisroha@yahoo.com		Rodriguez Benot, Alberto/0000-0003-1385-4526; Rodelo-Haad, Cristian/0000-0002-8139-3840; Aguera Morales, Maria Luisa/0000-0002-7736-908X; Lopez-Lopez, Isabel/0000-0002-4269-3808				AEMPS, 2015, MIC MOF MIC SOD RIES; Coscia LA, 2015, J PEDIATR GENET, V4, P42, DOI 10.1055/s-0035-1556743; Deshpande Neha A, 2013, Rev Obstet Gynecol, V6, P116; European Medicines Agency, 2017, MYC UPD REC CONTR ME; European Medicines Agency, MA REC ADD MEAS PREV; Gilda Sedgh, 2017, GLOBAL REGIONAL SUBR, V388, P258, DOI [10.1016/S0140-6736(16)30380-4, DOI 10.1016/S0140-6736(16)30380-4]; Grinyo JM, 2010, KIDNEY INT, V78, pS66, DOI 10.1038/ki.2010.426; Jones A, 2013, PROG TRANSPLANT, V23, P153, DOI 10.7182/pit2013636; Midtvedt K, 2017, TRANSPLANTATION, V101, pE214, DOI 10.1097/TP.0000000000001747; Perez-Aytes A, 2017, EUR J MED GENET, V60, P16, DOI 10.1016/j.ejmg.2016.09.014; Staatz CE, 2007, CLIN PHARMACOKINET, V46, P13, DOI 10.2165/00003088-200746010-00002; Tett SE, 2011, TRANSPLANT REV-ORLAN, V25, P47, DOI 10.1016/j.trre.2010.06.001; Vento M, 2008, PEDIATRICS, V122, P184, DOI 10.1542/peds.2008-0348; Wiseman AC, 2016, CLIN J AM SOC NEPHRO, V11, P332, DOI 10.2215/CJN.08570814	14	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2018	13	9							e0202589	10.1371/journal.pone.0202589	http://dx.doi.org/10.1371/journal.pone.0202589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7EB	30208043	Green Published, Green Submitted, gold			2022-12-26	WOS:000444683000027
J	Ioannidis, K; Niazi, S; Deb, S; Mannocci, F; Smith, D; Turner, C				Ioannidis, Konstantinos; Niazi, Sadia; Deb, Sanjukta; Mannocci, Francesco; Smith, David; Turner, Claire			Quantification by SIFT-MS of volatile compounds produced by the action of sodium hypochlorite on a model system of infected root canal content	PLOS ONE			English	Article							DISINFECTION BY-PRODUCTS; ION FLOW TUBE; DRINKING-WATER; GUTTA-PERCHA; CHLOROFORM; EFFICACY; INSTRUMENTATION; CHROMATOGRAPHY; OXIDATION; SOLVENTS	Root canal irrigation with sodium hypochlorite (NaOCI) is an indispensable part of the chemomechanical preparation of infected root canals in Endodontology. However, there is limited information on the emergence of toxic or hazardous volatile compounds (VOCs) from the interaction of NaOCI with the infected content of tooth biomaterials. The aim of this study was to assess the formation of VOCs and disinfection by-products (DBPs) following the interaction of NaOCI 2.5% v/v with a model system of different sources of natural organic matter (NOM) present in infected root canals, including dentine powder, planktonic multimicrobial suspensions (Propionibacterium acnes, Staphylococcus epidermidis, Actinomyces radicidentis, Streptococcus mitis and Enterococcus faecalis strain OMGS3202), bovine serum albumin 4%w/v and their combination. NaOCI was obtained from a stock solution with iodometric titration. Ultrapure water served as negative control. Samples were stirred at 37 degrees C in aerobic and anaerobic conditions for 30min to approximate a clinically realistic time. Centrifugation was performed and the supernatants were collected and stored at -80 degrees C until analysis. The reaction products were analysed in real time by selected ion flow tube mass spectrometry (SIFT-MS) in triplicates. SIFT-MS analysis showed that the released VOCs included chlorinated hydrocarbons, particularly chloroform, together with unexpected higher levels of some nitrogenous compounds, especially acetonitrile. No difference was observed between aerobic and anaerobic conditions. The chemical interaction of NaOCI with NOM resulted in the formation of toxic chlorinated VOCs and DBPs. SIFT-MS analysis proved to be an effective analytical method. The risks from the rise of toxic compounds require further consideration in dentistry.	[Ioannidis, Konstantinos; Deb, Sanjukta; Mannocci, Francesco] Kings Coll London, Dent Inst, Div Tissue Engn & Biophoton, London, England; [Niazi, Sadia] Kings Coll London, Dent Inst, Dept Restorat Dent, London, England; [Smith, David] Trans Spectra Ltd, Newcastle Under Lyme, England; [Turner, Claire] Open Univ, Sch Life Hlth & Chem Sci, Walton Hall, Milton Keynes, Bucks, England	University of London; King's College London; University of London; King's College London; Open University - UK	Mannocci, F (corresponding author), Kings Coll London, Dent Inst, Div Tissue Engn & Biophoton, London, England.	francesco.mannocci@kcl.ac.uk	Smith, David/GQQ-8257-2022; Smith, David/A-3622-2010	Smith, David/0000-0002-7860-9452; Niazi, Sadia/0000-0003-0334-4119				Abbott SM, 2003, INT J MASS SPECTROM, V228, P655, DOI 10.1016/S1387-3806(03)00212-4; ALLARD U, 1992, ENDOD DENT TRAUMATOL, V8, P155; [Anonymous], 2005, MASS SPECTROM REV, V24, P661, DOI [10.1002/mas.20033, DOI 10.1002/MAS.20033]; Ashley DL, 2005, ARCH ENVIRON HEALTH, V60, P7, DOI 10.3200/AEOH.60.1.7-15; Backer LC, 2000, J EXPO ANAL ENV EPID, V10, P321, DOI 10.1038/sj.jea.7500098; BELLAR TA, 1974, J AM WATER WORKS ASS, V66, P703, DOI 10.1002/j.1551-8833.1974.tb02129.x; Bernier SP, 2011, MOL MICROBIOL, V81, P705, DOI 10.1111/j.1365-2958.2011.07724.x; Bode H., 1962, ELEM INSTRUM ANAL, V74, P665; BUTTLER TK, 1982, J ENDODONT, V8, P59, DOI 10.1016/S0099-2399(82)80259-8; BYSTROM A, 1981, SCAND J DENT RES, V89, P321; Chaidez C, 2003, INT J ENVIRON HEAL R, V13, P295, DOI 10.1080/0960312031000122442; Chen BY, 2010, WATER RES, V44, P3755, DOI 10.1016/j.watres.2010.04.009; Chowdhury S, 2014, WATER RES, V53, P68, DOI 10.1016/j.watres.2014.01.017; Chutich MJ, 1998, J ENDODONT, V24, P213, DOI 10.1016/S0099-2399(98)80098-8; Clarkson RM, 2006, AUST DENT J, V51, P245, DOI 10.1111/j.1834-7819.2006.tb00437.x; CVEK M, 1976, ODONTOL REVY, V27, P1; Dahlen G, 2000, ORAL MICROBIOL IMMUN, V15, P309, DOI 10.1034/j.1399-302x.2000.150507.x; de Paz LC, 2007, J ENDODONT, V33, P652, DOI 10.1016/j.joen.2006.11.004; Di Renzo M, 2001, BIOMATERIALS, V22, P793, DOI 10.1016/S0142-9612(00)00239-8; Frais S, 2001, INT ENDOD J, V34, P206, DOI 10.1046/j.1365-2591.2001.00371.x; Fuson RC, 1934, CHEM REV, V15, P275, DOI 10.1021/cr60052a001; Golfinopoulos S.K., 2005, GLOBAL NEST J, V7, P106; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Jillavenkatesa A., 2001, NIST SPECIAL PUBLICA, P1; Khan MR, 2016, TALANTA, V152, P513, DOI 10.1016/j.talanta.2016.02.036; Kimura SY, 2015, ENVIRON SCI TECHNOL, V49, P9954, DOI 10.1021/acs.est.5b01875; Krasner SW, 2009, PHILOS T R SOC A, V367, P4077, DOI 10.1098/rsta.2009.0108; KRASNER SW, 1989, J AM WATER WORKS ASS, V81, P41; Lin TF, 1999, SCI TOTAL ENVIRON, V246, P41; Margelos J, 1996, J ENDODONT, V22, P547, DOI 10.1016/S0099-2399(96)80016-1; Martos J, 2011, INT ENDOD J, V44, P1024, DOI 10.1111/j.1365-2591.2011.01912.x; Niazi SA, 2010, J CLIN MICROBIOL, V48, P3859, DOI 10.1128/JCM.01326-10; NIKOLAOU AD, 1999, GLOBAL NEST J, V1, P143, DOI DOI 10.30955/GNJ.000111; Oyarzun A, 2002, J ENDODONT, V28, P152, DOI 10.1097/00004770-200203000-00002; QUIMBY BD, 1980, ANAL CHEM, V52, P259, DOI 10.1021/ac50052a010; Richardson SD, 2007, MUTAT RES-REV MUTAT, V636, P178, DOI 10.1016/j.mrrev.2007.09.001; Sedgley Christine, 2004, J Hist Dent, V52, P61; SHARONOV BP, 1989, BIOCHEM INT, V19, P27; Siqueira JF, 2000, J ENDODONT, V26, P331, DOI 10.1097/00004770-200006000-00006; Spanel P, 1998, INT J MASS SPECTROM, V176, P203, DOI 10.1016/S1387-3806(98)14031-9; Spanel P, 1999, INT J MASS SPECTROM, V184, P175, DOI 10.1016/S1387-3806(98)14296-3; Spanel P, 2011, MASS SPECTROM REV, V30, P236, DOI 10.1002/mas.20303; Tanalp J, 2014, INT ENDOD J, V47, P211, DOI 10.1111/iej.12137; Tokmak B, 2004, ENVIRON RES, V96, P345, DOI 10.1016/j.envres.2003.11.005; Torabinejad M, 2002, ORAL SURG ORAL MED O, V94, P658, DOI 10.1067/moe.2002.128962; Turner C, 2008, RAPID COMMUN MASS SP, V22, P526, DOI 10.1002/rcm.3402; Ura S, 2007, ULLMANNS ENCY IND CH; van Zyl SP, 2005, INT ENDOD J, V38, P658, DOI 10.1111/j.1365-2591.2005.01005.x; Varise Tiago Gilioli, 2014, Braz. Dent. J., V25, P109, DOI 10.1590/0103-6440201302404; Villanueva CM, 2007, AM J EPIDEMIOL, V165, P148, DOI 10.1093/aje/kwj364; Wallace B, 2002, J ENVIRON MONITOR, V4, P35, DOI 10.1039/b106049j; Wang JJ, 2013, WATER RES, V47, P2701, DOI 10.1016/j.watres.2013.02.038; Warner RC, 1942, J BIOL CHEM, V142, P725; Wong AWY, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0025-7	54	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2018	13	9							e0198649	10.1371/journal.pone.0198649	http://dx.doi.org/10.1371/journal.pone.0198649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7DK	30199524	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000444681100001
J	Gilmore, SJ				Gilmore, Stephen J.			Automated decision support in melanocytic lesion management	PLOS ONE			English	Article							SKIN-CANCER; MELANOMA; DIAGNOSIS; CLASSIFICATION; NUMBER; DERMOSCOPY; PHYSICIANS; COMPUTER; EXCISE; RATES	An automated melanocytic lesion image-analysis algorithm is described that aims to reproduce the decision-making of a dermatologist. The utility of the algorithm lies in its ability to identify lesions requiring excision from lesions not requiring excision. Using only wavelet coefficients as features, and testing three different machine learning algorithms, a cohort of 250 images of pigmented lesions is classified based on expert dermatologists' recommendations of either excision (165 images) or no excision (85 images). It is shown that the best algorithm utilises the Shannon4 wavelet coupled to the support vector machine, where the latter is used as the classifier. In this case the algorithm, utilising only 22 othogonal features, achieves a 10-fold cross validation sensitivity and specificity of 0.96 and 0.87, resulting in a diagnostic-odds ratio of 261. The advantages of this method over diagnostic algorithms-which make a melanoma/no melanoma decision-are twofold: first, by reproducing the decision-making of a dermatologist, the average number of lesions excised per melanoma among practioners in general can be reduced without compromising the detection of melanoma; and second, the intractable problem of clinically differentiating between many atypical dysplastic naevi and melanoma is avoided. Since many atypical naevi that require excision on clinical grounds will not be melanoma, the algorithm-in contrast to diagnostic algorithms-can aim for perfect specificities without clinical concerns, thus lowering the excision rate of non-melanoma. Finally, the algorithm has been implemented as a smart phone application to investigate its utility in clinical practice and to streamline the assimilation of hitherto unseen tested images into the training set.	[Gilmore, Stephen J.] Skin & Canc Fdn, Melbourne, Vic, Australia; [Gilmore, Stephen J.] Univ Queensland, Diamantina Inst, Dermatol Res Ctr, Brisbane, Qld, Australia	SKIN & CANCER FOUNDATION AUSTRALIA; University of Queensland	Gilmore, SJ (corresponding author), Skin & Canc Fdn, Melbourne, Vic, Australia.; Gilmore, SJ (corresponding author), Univ Queensland, Diamantina Inst, Dermatol Res Ctr, Brisbane, Qld, Australia.	s.gilmore1@uq.edu.au			Skin and Cancer Foundation, Victoria, Australia	Skin and Cancer Foundation, Victoria, Australia	This work was supported by Skin and Cancer Foundation, Victoria, Australia.	Ahnlide I, 2014, ACTA DERM-VENEREOL, V94, P683, DOI 10.2340/00015555-1831; Baade PD, 2008, ARCH DERMATOL, V144, P1468, DOI 10.1001/archderm.144.11.1468; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Boulesteix AL, 2012, WIRES DATA MIN KNOWL, V2, P493, DOI 10.1002/widm.1072; Celebi M. E., 2015, DERMOSCOPY IMAGE ANA, V1st, P98; Celebi ME, 2007, COMPUT MED IMAG GRAP, V31, P362, DOI 10.1016/j.compmedimag.2007.01.003; Chan T. F., 2001, IEEE T IMAGE PROCESS, V10, P2; Dreiseitl S, 2005, ARTIF INTELL MED, V33, P25, DOI 10.1016/j.artmed.2004.07.007; Dreiseitl S, 2009, MELANOMA RES, V19, P180, DOI 10.1097/CMR.0b013e32832a1e41; English DR, 2004, MED J AUSTRALIA, V180, P16, DOI 10.5694/j.1326-5377.2004.tb05766.x; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Farmer ER, 1996, HUM PATHOL, V27, P528, DOI 10.1016/S0046-8177(96)90157-4; Garnavi R, 2012, IEEE T INF TECHNOL B, V16, P1239, DOI 10.1109/TITB.2012.2212282; Gilmore S, 2010, EXP DERMATOL, V19, P830, DOI 10.1111/j.1600-0625.2010.01112.x; Gilmore S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007449; Gutman D, 2016, INT S BIOM IM ISBI I; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hansen C, 2009, J AM ACAD DERMATOL, V61, P599, DOI 10.1016/j.jaad.2009.04.021; Hira Zena M., 2015, Advances in Bioinformatics, V2015, P198363, DOI 10.1155/2015/198363; Joliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Komarek P., 2004, LOGISTIC REGRESSION; Marks R, 1997, J AM ACAD DERMATOL, V36, P721, DOI 10.1016/S0190-9622(97)80324-6; Masood A, 2013, INT J BIOMED IMAGING, V2013, DOI 10.1155/2013/323268; Patwardhan SV, 2003, COMPUT METH PROG BIO, V72, P223, DOI 10.1016/S0169-2607(02)00147-5; Rajpara SM, 2009, BRIT J DERMATOL, V161, P591, DOI 10.1111/j.1365-2133.2009.09093.x; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Rolfe H, 2012, AUSTRALAS J DERMATOL, V53, P240, DOI [10.1111/j.1440-0960.2012.00935.x, 10.1111/j.1440-0960.2012.00933.x]; Rosado B, 2003, ARCH DERMATOL, V139, P361, DOI 10.1001/archderm.139.3.361; Sadri AR, 2017, IET IMAGE PROCESS, V11, P475, DOI 10.1049/iet-ipr.2016.0681; Sarveniazi A., 2014, AM J COMPUTATIONAL M, V04, P55, DOI [10.4236/ajcm.2014.42006, DOI 10.4236/AJCM.2014.42006]; Scholkopf B., 2002, LEARNING KERNELS; Scope A, 2008, ARCH DERMATOL, V144, P58, DOI 10.1001/archdermatol.2007.15; Sidhu S, 2012, CLIN EXP DERMATOL, V37, P6, DOI 10.1111/j.1365-2230.2011.04148.x; Van der Maaten L., 2009, 2009005 TICC TR; Vapnik V., 2013, NATURE STAT LAERNING; Wazaefi Y, 2013, J INVEST DERMATOL, V133, P2355, DOI 10.1038/jid.2013.183; Weinstock MA, 2017, BRIT J DERMATOL, V176, P949, DOI 10.1111/bjd.15077; Whiteman DC, 2016, J INVEST DERMATOL, V136, P1161, DOI 10.1016/j.jid.2016.01.035; Wolfram S., MATH V10; Youl PH, 2007, CLIN EXP DERMATOL, V32, P365, DOI 10.1111/j.1365-2230.2007.02414.x	42	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203459	10.1371/journal.pone.0203459	http://dx.doi.org/10.1371/journal.pone.0203459			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192804	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600078
J	Lin, CW; Chen, YS; Lin, CC; Lee, PH; Lo, GH; Hsu, CC; Hsieh, PM; Koh, KW; Bair, MJ; Dai, CY; Huang, JF; Chuang, WL; Chen, YL; Yu, ML				Lin, Chih-Wen; Chen, Yaw-Sen; Lin, Chih-Che; Lee, Po-Huang; Lo, Gin-Ho; Hsu, Chia-Chang; Hsieh, Pei-Min; Koh, Kah Wee; Bair, Ming-Jong; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Chen, Yao-Li; Yu, Ming-Lung			Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; LIVER RESECTION; RISK-FACTORS; HEPATITIS-C; AUTOPHAGY; RECURRENCE; MANAGEMENT; CIRRHOSIS; FIBROSIS; IMPACT	Background The predictive factors of overall survival after hepatectomy for HCC remain controversial and need to be investigated. Methods In total, 535 consecutive HCC patients undergoing resection were included and their clinicopathological data and overall survival were recorded. Both the tumor and adjacent nontumor (ANT) tissues were subjected to immunohistochemistry analysis for the expression of autophagy-related markers. Results Death was observed for 219 patients, and the cumulative overall survival rates at 1, 3, 5 and 7 years were 91.0%, 72.3%, 58.8%, and 27.7%, respectively. In the multivariate analysis, mortality was significantly associated with the following: diminished LC3 expression in both the tumor and ANT tissues, in the HCC tissues alone and in the ANT tissues alone (hazard ratio/95% confidence interval: 6.74/2.052 +/- 22.19, 6.70/1.321 +/- 33.98 and 2.58/1.499 +/- 4.915, respectively); recurrent HCC (5.11/3.136 +/- 8.342); HBV infection (2.75/1.574 +/- 4.784); cirrhosis (1.78/1.059 +/- 2.974); and antiviral therapy (0.42/0.250 +/- 0.697). The 5-year overall survival rates were 70.2%, 57.3%, 49.6% and 10.7% for patients with positive LC3 expression in both tissue types, in the HCC tissues alone, in the ANT tissues alone, and in neither tissue type, respectively. The 5-year overall survival rates were 56.7%, 47.3%, 51.2% and 38.7% for patients with HBV-related HCC, cirrhosis, no antiviral therapy, and recurrent HCC, respectively, and these rates were significantly lower than those in their counterparts. Conclusions Patients with recurrent HCC, HBV-related HCC, cirrhosis, and the absence of antiviral therapy showed significantly lower overall survival rates. Furthermore, LC3 expression in both the tumor and liver microenvironments were significantly predictive of overall survival after resection for HCC.	[Lin, Chih-Wen] I Shou Univ, E Da Dachang Hosp, Div Gastroenterol & Hepatol, Kaohsiung, Taiwan; [Lin, Chih-Wen; Lo, Gin-Ho; Koh, Kah Wee] I Shou Univ, E Da Hosp, Dept Med, Div Gastroenterol & Hepatol, Kaohsiung, Taiwan; [Lin, Chih-Wen; Hsu, Chia-Chang; Koh, Kah Wee] I Shou Univ, E Da Hosp, Hlth Examinat Ctr, Kaohsiung, Taiwan; [Lin, Chih-Wen; Chen, Yaw-Sen; Lee, Po-Huang; Lo, Gin-Ho] I Shou Univ, Sch Med, Coll Med, Kaohsiung, Taiwan; [Chen, Yaw-Sen; Lee, Po-Huang; Hsieh, Pei-Min] I Shou Univ, E Da Hosp, Dept Surg, Kaohsiung, Taiwan; [Lin, Chih-Che] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Kaohsiung, Taiwan; [Lin, Chih-Che] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Bair, Ming-Jong] Taitung Mackay Mem Hosp, Dept Internal Med, Div Gastroenterol, New Taipei, Taiwan; [Bair, Ming-Jong] Mackay Med Coll, New Taipei, Taiwan; [Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan; [Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung] Kaohsiung Med Univ Hosp, Hepatitis Ctr, Kaohsiung, Taiwan; [Yu, Ming-Lung] Natl Chiao Tung Univ, Coll Biol Sci & Technol, Hsinchu, Taiwan; [Chen, Yao-Li] Changhua Christian Hosp, Div Gen Surg, Dept Surg, Changhua, Taiwan; [Yu, Ming-Lung] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan	E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; I Shou University; E-Da Hospital; I Shou University; Chang Gung Memorial Hospital; Chang Gung University; Mackay Medical College; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Yang Ming Chiao Tung University; Changhua Christian Hospital; National Sun Yat Sen University	Lin, CW (corresponding author), I Shou Univ, E Da Dachang Hosp, Div Gastroenterol & Hepatol, Kaohsiung, Taiwan.; Lin, CW (corresponding author), I Shou Univ, E Da Hosp, Dept Med, Div Gastroenterol & Hepatol, Kaohsiung, Taiwan.; Lin, CW (corresponding author), I Shou Univ, E Da Hosp, Hlth Examinat Ctr, Kaohsiung, Taiwan.; Lin, CW (corresponding author), I Shou Univ, Sch Med, Coll Med, Kaohsiung, Taiwan.	lincw66@gmail.com	Chuang, Wan-Long/ABF-7427-2021; Huang, Jee-Fu/AAX-4622-2020; Yu, Ming-Lung/AAZ-4306-2020; Dai, Chia-Yen/V-6560-2019	Chuang, Wan-Long/0000-0002-2376-421X; Huang, Jee-Fu/0000-0002-2752-7051; Yu, Ming-Lung/0000-0001-8145-1900; Dai, Chia-Yen/0000-0003-2296-3054; LEE, PO-HUANG/0000-0001-5831-035X; Lin, Chih-Wen/0000-0003-2344-5056	Ministry of Science and Technology, Taiwan [MOST 105-2314-B-037-062-MY2, MOST 105-2314-B-650-004-MY3, MOST 106-2314-B-037-074]; E-Da Hospital [EDAHP106036, EDAHP106048, EDAHP106054, EDAHP107040, EDAHP107041, EDAHP107064]; Kaohsiung Medical University Hospital [KMUH105-5R06]; Liver Disease Prevention and Treatment Research Foundation, Taiwan	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); E-Da Hospital; Kaohsiung Medical University Hospital; Liver Disease Prevention and Treatment Research Foundation, Taiwan	This study was supported by grants from the Ministry of Science and Technology, Taiwan (MOST 105-2314-B-037-062-MY2 to Ming-Lung Yu, MOST 105-2314-B-650-004-MY3 to Chih-Wen Lin, and MOST 106-2314-B-037-074 to Ming-Lung Yu), E-Da Hospital (EDAHP106036, EDAHP106048, EDAHP106054, EDAHP107040, EDAHP107041, and EDAHP107064) to Chih-Wen Lin, Kaohsiung Medical University Hospital (KMUH105-5R06) to Ming-Lung Yu, and the Liver Disease Prevention and Treatment Research Foundation, Taiwan to Chih-Wen Lin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphonso A, 2009, NEOPLASIA, V11, P1264, DOI 10.1593/neo.91302; Ao L, 2016, ONCOTARGET, V7, P24097, DOI 10.18632/oncotarget.8212; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Cheng ZJ, 2015, HPB, V17, P422, DOI 10.1111/hpb.12367; Chong CCN, 2015, ALIMENT PHARM THER, V41, P199, DOI 10.1111/apt.13034; Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; Dhir M, 2016, ANN SURG, V263, P1112, DOI 10.1097/SLA.0000000000001556; Ding ZB, 2008, CANCER RES, V68, P9167, DOI 10.1158/0008-5472.CAN-08-1573; DOH ROC, 2012, REP LEAD CANC REL DE; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Esnaola NF, 2003, ANN SURG, V238, P711, DOI 10.1097/01.sla.0000094436.34556.ac; Forner A, 2008, HEPATOLOGY, V47, P97, DOI 10.1002/hep.21966; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gassmann P, 2010, WORLD J SURG, V34, P2442, DOI 10.1007/s00268-010-0655-5; Grazi GL, 2003, ALIMENT PHARM THER, V17, P119, DOI 10.1046/j.1365-2036.17.s2.9.x; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kim MY, 2011, J HEPATOL, V55, P1004, DOI 10.1016/j.jhep.2011.02.012; Lee YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081540; Lin CW, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/s41424-018-0033-4; Lin CW, 2017, ONCOTARGET, V8, P91902, DOI 10.18632/oncotarget.19763; Lin CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15807; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Manthravadi S, 2017, INT J CANCER, V140, P1042, DOI 10.1002/ijc.30521; Nault JC, 2013, A HEPATOCELLULAR CAR, V145, DOI [10.1053/j.gastro.2013.03.051, DOI 10.1053/J.GASTRO.2013.03.051]; Omata M, 2017, HEPATOL INT, V11, P317, DOI 10.1007/s12072-017-9799-9; Poon RT, 2004, ANN SURG, V240, P698, DOI 10.1097/01.sla.0000141195.66155.0c; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Poon RTP, 2001, ANN SURG, V234, P63, DOI 10.1097/00000658-200107000-00010; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Qiu DM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-327; Rahbari NN, 2008, BRIT J SURG, V95, P424, DOI 10.1002/bjs.6141; Roayaie S, 2013, HEPATOLOGY, V57, P1426, DOI 10.1002/hep.25832; Schneider JL, 2014, NAT REV GASTRO HEPAT, V11, P187, DOI 10.1038/nrgastro.2013.211; Shindoh J, 2013, J CLIN ONCOL, V31, P766, DOI 10.1200/JCO.2012.44.3234; Singal AG, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001624; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Sohn W, 2013, J CLIN ONCOL OFF J A, V31, DOI [10.18632/oncotarget.10026, DOI 10.18632/ONCOTARGET.10026]; Tanimoto Y, 2012, ANN SURG ONCOL, V19, P418, DOI 10.1245/s10434-011-1866-1; TaylorRobinson SD, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63789-0; Toshima T, 2014, J GASTROENTEROL, V49, P907, DOI 10.1007/s00535-013-0835-9; Umemura A, 2016, CANCER CELL, V29, P935, DOI 10.1016/j.ccell.2016.04.006; Wang Q, 2013, BRIT J CANCER, V109, P573, DOI 10.1038/bjc.2013.352; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu DH, 2014, TUMOR BIOL, V35, P12225, DOI 10.1007/s13277-014-2531-7; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yu ML, 2006, ANTIVIR THER, V11, P985	48	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0202650	10.1371/journal.pone.0202650	http://dx.doi.org/10.1371/journal.pone.0202650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180193	Green Submitted, Green Published, gold			2022-12-26	WOS:000444222400012
J	Ranasinghe, SL; Boyle, GM; Fischer, K; Potriquet, J; Mulvenna, JP; McManus, DP				Ranasinghe, Shiwanthi L.; Boyle, Glen M.; Fischer, Katja; Potriquet, Jeremy; Mulvenna, Jason P.; McManus, Donald P.			Kunitz type protease inhibitor EgKI-1 from the canine tapeworm Echinococcus granulosus as a promising therapeutic against breast cancer	PLOS ONE			English	Article							CELL; NEUTROPHILS; PEGYLATION; MIGRATION; PROTEINS; DRUGS; ASSAY	EgKI-1, a member of the Kunitz type protease inhibitor family, is highly expressed by the oncosphere of the canine tapeworm Echinococcus granulosus, the stage that is infectious to humans and ungulates, giving rise to a hydatid cyst localized to the liver and other organs. Larval protoscoleces, which develop within the hydatid cyst, have been shown to possess anti-cancer properties, although the precise molecules involved have not been identified. We show that recombinant EgKI-1 inhibits the growth and migration of a range of human cancers including breast, melanoma and cervical cancer cell lines in a dose-dependent manner in vitro without affecting normal cell growth. Furthermore, EgKI-1 treatment arrested the cancer cell growth by disrupting the cell cycle and induced apoptosis of cancer cells in vitro. An in vivo model of triple negative breast cancer (MDA-MB-231) in BALB/c nude mice showed significant tumor growth reduction in EgKI-1-treated mice compared with controls. These findings indicate that EgKI-1 shows promise for future development as an anti-cancer therapeutic.	[Ranasinghe, Shiwanthi L.; McManus, Donald P.] QIMR Berghofer Med Res Inst, Immunol Dept, Mol Parasitol Lab, Brisbane, Qld, Australia; [Boyle, Glen M.] QIMR Berghofer Med Res Inst, Cell & Mol Biol Dept, Canc Drug Mech Grp, Brisbane, Qld, Australia; [Fischer, Katja] QIMR Berghofer Med Res Inst, Cell & Mol Biol Dept, Scabies Grp, Brisbane, Qld, Australia; [Potriquet, Jeremy] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Australia; [Mulvenna, Jason P.] QIMR Berghofer Med Res Inst, Biomarkers & Biol Infect Related Cancers Lab, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; James Cook University; QIMR Berghofer Medical Research Institute	Ranasinghe, SL (corresponding author), QIMR Berghofer Med Res Inst, Immunol Dept, Mol Parasitol Lab, Brisbane, Qld, Australia.	shiwanthi.ranasinghe@qimrberghofer.edu.au	Boyle, Glen/G-1347-2013; Fischer, Katja/H-4989-2014; McManus, Don/AAC-5394-2020	Boyle, Glen/0000-0002-1385-529X; Fischer, Katja/0000-0003-3408-3337; McManus, Don/0000-0001-6443-1449	Australian National Health and Medical Research Council (NHMRC) [APP1037304]; Senior Scientist at QIMR Berghofer	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Senior Scientist at QIMR Berghofer	This project was funded by program (APP1037304 to DPM) from the Australian National Health and Medical Research Council (NHMRC). DPM is a NHMRC Senior Principal Research Fellow and Senior Scientist at QIMR Berghofer.	Atayde VD, 2008, MELANOMA RES, V18, P172, DOI 10.1097/CMR.0b013e3282feeaab; Baig S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.275; Bergstrom FC, 2009, J IMMUNOL, V182, P7809, DOI 10.4049/jimmunol.0804205; Boyle GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108887; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Comsa S, 2015, ANTICANCER RES, V35, P3147; Craig PS, 2003, PARASITOLOGY, V127, pS5, DOI 10.1017/S0031182003004384; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Hemler ME, 2014, NAT REV CANCER, V14, P49, DOI 10.1038/nrc3640; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Tong HV, 2017, EBIOMEDICINE, V15, P12, DOI 10.1016/j.ebiom.2016.11.034; Ivankovic M, 2007, BIOGERONTOLOGY, V8, P163, DOI 10.1007/s10522-006-9043-9; Kintzing JR, 2016, TRENDS PHARMACOL SCI, V37, P993, DOI 10.1016/j.tips.2016.10.005; Kruger N J, 1994, Methods Mol Biol, V32, P9; Li LT, 2015, MOL MED REP, V11, P1566, DOI 10.3892/mmr.2014.2914; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mattheolabakis G, 2014, J PHARMACOL EXP THER, V351, P61, DOI 10.1124/jpet.114.217208; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Mishra P, 2016, ASIAN J PHARM SCI, V11, P337, DOI 10.1016/j.ajps.2015.08.011; Paul CD, 2017, NAT REV CANCER, V17, P131, DOI 10.1038/nrc.2016.123; Pellegrini M, 2013, CASPASES BCL 2 FAMIL; Ponce D, 2016, TOXINS, V8, DOI 10.3390/toxins8040102; Potriquet J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175967; Qi WJ, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-3; RANASINGHE S, 2016, TREATMENT INFLAMMATI; Ranasinghe SL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004268; Rayburn Elizabeth R, 2009, Mol Cell Pharmacol, V1, P29; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Schubert OT, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.015; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shirzad H, 2012, TOXOPLASMA GONDII NO; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; So E. Y., 2013, J CANC BIOL RES, V1, P1; Srikanth S, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00470; Toomey P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068561; Uribe-Querol E, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/983698; Wahba HA, 2015, CANCER BIOL MED, V12, P106, DOI 10.7497/j.issn.2095-3941.2015.0030; Wei BJ, 2016, ONCOTARGETS THER, V9, P5567, DOI 10.2147/OTT.S108419; Wittrup KD, 2012, METHOD ENZYMOL, V503, P255, DOI 10.1016/B978-0-12-396962-0.00010-0; Young RE, 2007, BRIT J PHARMACOL, V151, P628, DOI 10.1038/sj.bjp.0707267; Yousofi Darani Hossein, 2012, J Parasitol Res, V2012, P304183, DOI 10.1155/2012/304183	47	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0200433	10.1371/journal.pone.0200433	http://dx.doi.org/10.1371/journal.pone.0200433			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169534	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000443374400003
J	Rule, AM; Apau, O; Ahrenholz, SH; Brueck, SE; Lindsley, WG; de Perio, MA; Noti, JD; Shaffer, RE; Rothman, R; Grigorovitch, A; Noorbakhsh, B; Beezhold, DH; Yorio, PL; Perl, TM; Fisher, EM				Rule, Ana M.; Apau, Otis; Ahrenholz, Steven H.; Brueck, Scott E.; Lindsley, William G.; de Perio, Marie A.; Noti, John D.; Shaffer, Ronald E.; Rothman, Richard; Grigorovitch, Alina; Noorbakhsh, Bahar; Beezhold, Donald H.; Yorio, Patrick L.; Perl, Trish M.; Fisher, Edward M.			Healthcare personnel exposure in an emergency department during influenza season	PLOS ONE			English	Article							FILTERING FACEPIECE RESPIRATORS; VIRUS; STATES	Introduction Healthcare personnel are at high risk for exposure to influenza by direct and indirect contact, droplets and aerosols, and by aerosol generating procedures. Information on air and surface influenza contamination is needed to assist in developing guidance for proper prevention and control strategies. To understand the vulnerabilities of healthcare personnel, we measured influenza in the breathing zone of healthcare personnel, in air and on surfaces within a healthcare setting, and on filtering facepiece respirators worn by healthcare personnel when conducting patient care. Methods Thirty participants were recruited from an adult emergency department during the 2015 influenza season. Participants wore personal bioaerosol samplers for six hours of their work shift, submitted used filtering facepiece respirators and medical masks and completed questionnaires to assess frequency and types of interactions with potentially infected patients. Room air samples were collected using bioaerosol samplers, and surface swabs were collected from high-contact surfaces within the adult emergency department. Personal and room bioaerosol samples, surface swabs, and filtering facepiece respirators were analyzed for influenza A by polymerase chain reaction. Results Influenza was identified in 42% (53/125) of personal bioaerosol samples, 43% (28/96) of room bioaerosol samples, 76% (23/30) of pooled surface samples, and 25% (3/12) of the filtering facepiece respirators analyzed. Influenza copy numbers were greater in personal bioaerosol samples (17 to 631 copies) compared to room bioaerosol samples (16 to 323 copies). Regression analysis suggested that the amount of influenza in personal samples was approximately 2.3 times the amount in room samples (Wald chi 2 = 16.21, p<0.001). Conclusions Healthcare personnel may encounter increased concentrations of influenza virus when in close proximity to patients. Occupations that require contact with patients are at an increased risk for influenza exposure, which may occur throughout the influenza season. Filtering facepiece respirators may become contaminated with influenza when used during patient care.	[Rule, Ana M.; Apau, Otis; Grigorovitch, Alina] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD USA; [Ahrenholz, Steven H.; Brueck, Scott E.; de Perio, Marie A.] NIOSH, DSHEFS, Cincinnati, OH 45226 USA; [Lindsley, William G.; Noti, John D.; Noorbakhsh, Bahar; Beezhold, Donald H.] NIOSH, HELD, Morgantown, WV USA; [Shaffer, Ronald E.; Yorio, Patrick L.; Fisher, Edward M.] NIOSH, NPPTL, Pittsburgh, PA 15222 USA; [Rothman, Richard] Johns Hopkins Univ Hosp, Adult Emergency Dept, Baltimore, MD 21287 USA; [Perl, Trish M.] UT Southwestern Med Ctr, Div Infect Dis, Dallas, TX USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fisher, EM (corresponding author), NIOSH, NPPTL, Pittsburgh, PA 15222 USA.	fxw7@cdc.gov	Shaffer, Ronald/ABI-6508-2020	Shaffer, Ronald/0000-0001-6352-7967; Lindsley, William/0000-0003-0720-5829	Centers for Disease Control and Prevention; NIH [HHSN272201400007C];  [BARDA 1 IDSEP130014-01-00]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	This research was funded by the Centers for Disease Control and Prevention and in part by BARDA 1 IDSEP130014-01-00 and NIH HHSN272201400007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrenholz SH, 2018, J OCCUP ENV HYG; Aizenberg V, 2000, AM IND HYG ASSOC J, V61, P398, DOI 10.1080/15298660008984550; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P281; [Anonymous], 2021, HIV US GLANC; Appiah GD, 2015, MMWR-MORBID MORTAL W, V64, P583; Bischoff WE, 2013, J INFECT DIS, V207, P1037, DOI 10.1093/infdis/jis773; Blachere FM, 2011, J VIROL METHODS, V176, P120, DOI 10.1016/j.jviromet.2011.05.030; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brady TM, 2017, J OCCUP ENVIRON HYG, V14, P898, DOI 10.1080/15459624.2017.1346799; *CDCP, 2009, FLUVIEW 2008 2009 IN; Centers for Disease Control and P, 2008, 2007 2008 INFL FLU S; Centers for Disease Control and Prevention, INT GUID US MASKS CO; Centers for Disease Control and Prevention, 2014, RECOMMENDED GUIDANCE; Centers for Disease Control and Prevention, 2014, EST INFL ILLN HOSP A; Cummings KJ, 2014, J INFECT DIS; Fisher EM, 2014, J OCCUP ENVIRON HYG, V11, pD115, DOI 10.1080/15459624.2014.902954; Glaser CA, 2002, EMERG INFECT DIS, V8, P569, DOI 10.3201/eid0806.010370; Heimbuch BK, 2016, J OCCUP ENVIRON HYG, V13, pD11, DOI 10.1080/15459624.2015.1091966; Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797; Killingley B, 2011, J INFECT DIS; Killingley B, 2016, J INFECT PUBLIC HEAL, V9, P278, DOI 10.1016/j.jiph.2015.10.009; Kuster SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026239; Leung NHL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148669; Li J, 2017, OPEN FORUM INFECT DI, V4, pS34; Lietz J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162061; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Luksamijarulkul Pipat, 2014, Oman Med J, V29, P346, DOI 10.5001/omj.2014.92; Mubareka S, 2015, J CLIN VIROL, V73, P105, DOI 10.1016/j.jcv.2015.11.002; Nikitin N, 2014, ADV VIROL, V2014, DOI 10.1155/2014/859090; Occupational Safety Health Administration (OSHA), 2007, PAND INFL PREP RESP PAND INFL PREP RESP; Peterson K, 2015, AM J INFECT CONTROL, V43, P63, DOI 10.1016/j.ajic.2014.10.008; Santos CD, 2010, DISASTER MED PUBLIC, V4, P47, DOI 10.1017/S193578930000241X; Tang JW, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020238; Tang JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107338; Thompson KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056278; Wise ME, 2011, CLIN INFECT DIS, V52, pS198, DOI 10.1093/cid/ciq038	36	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203223	10.1371/journal.pone.0203223	http://dx.doi.org/10.1371/journal.pone.0203223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169507	gold, Green Published, Green Submitted			2022-12-26	WOS:000443374400026
J	Fuseya, Y; Muro, S; Sato, S; Tanabe, N; Sato, A; Tanimura, K; Hasegawa, K; Uemasu, K; Kubo, T; Kido, A; Fujimoto, K; Fushimi, Y; Kusahara, H; Sakashita, N; Ohno, Y; Togashi, K; Mishima, M; Hirai, T				Fuseya, Yoshinori; Muro, Shigeo; Sato, Susumu; Tanabe, Naoya; Sato, Atsuyasu; Tanimura, Kazuya; Hasegawa, Koichi; Uemasu, Kiyoshi; Kubo, Takeshi; Kido, Aki; Fujimoto, Koji; Fushimi, Yasutaka; Kusahara, Hiroshi; Sakashita, Naotaka; Ohno, Yoshiharu; Togashi, Kaori; Mishima, Michiaki; Hirai, Toyohiro			Complementary regional heterogeneity information from COPD patients obtained using oxygen-enhanced MRI and chest CT	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LOW ATTENUATION AREAS; LUNG-FUNCTION; COMPUTED-TOMOGRAPHY; DIFFUSING-CAPACITY; EMPHYSEMA; HYPOXEMIA; THERAPY; PROGRESSION; MORTALITY	Background The heterogeneous distribution of emphysema is a key feature of chronic obstructive pulmonary disease (COPD) patients that typically is evaluated using high-resolution chest computed tomography (HRCT). Oxygen-enhanced pulmonary magnetic resonance imaging (OEMRI) is a new method to obtain information regarding regional ventilation, diffusion, and perfusion in the lung without radiation exposure. We aimed to compare OEMRI with HRCT for the assessment of heterogeneity in COPD patients. Methods Forty patients with stable COPD underwent quantitative HRCT, OEMRI, and pulmonary function tests, including arterial blood gas analysis. OEMRI was also performed on nine healthy control subjects. We measured the severity of emphysema (percent low attenuation volume; LAV%) in whole lungs and the standard deviations (SDs) of the LAV% values of 10 isovolumetric partitions (SD-LAV) as an index of cranial-caudal heterogeneity. Similarly, relative enhancement ratios of oxygen (RERs) in whole lungs from OEMRI and SD-RER were analyzed. Results COPD patients showed a lower mean RER than control subjects (12.6% vs 22.0%, p<0.01). The regional heterogeneity of the RERs was not always consistent with the LAV distribution. Both the HRCT (LAV% and SD-LAV) and the OEMRI (RER and SD-RER) indices were significantly associated with the diffusion capacity (DLCO) and partial pressure of oxygen in arterial blood (PaO2). The PaO2 was associated only with the heterogeneity index of HRCT (SD-LAV) (R-2 = 0.39); however, the PaO2 was associated with both the mean RER and heterogeneity (SD-RER) in the multivariate analysis (R-2 = 0.38). Conclusions OEMRI-derived parameters were directly associated with oxygen uptake in COPD patients. Although the OEMRI-derived parameters were not identical to the HRCT-derived parameters, the cranial-caudal heterogeneity in HRCT or OEMRI was complementary to that in evaluations of oxygen uptake in the lungs. Functional imaging seems to provide new insights into COPD pathophysiology without radiation exposure.	[Fuseya, Yoshinori; Muro, Shigeo; Sato, Susumu; Tanabe, Naoya; Sato, Atsuyasu; Tanimura, Kazuya; Hasegawa, Koichi; Uemasu, Kiyoshi; Mishima, Michiaki; Hirai, Toyohiro] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Kubo, Takeshi; Kido, Aki; Fujimoto, Koji; Fushimi, Yasutaka; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Kusahara, Hiroshi; Sakashita, Naotaka] Toshiba Med Syst Corp, Otawara, Tochigi, Japan; [Ohno, Yoshiharu] Kobe Univ, Grad Sch Med, Dept Radiol, Div Funct & Diagnost Imaging Res, Kobe, Hyogo, Japan; [Ohno, Yoshiharu] Kobe Univ, Adv Biomed Imaging Res Ctr, Grad Sch Med, Kobe, Hyogo, Japan	Kyoto University; Kyoto University; Toshiba Corporation; Kobe University; Kobe University	Muro, S; Sato, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan.	smuro@kuhp.kyoto-u.ac.jp; ssato@kuhp.kyoto-u.ac.jp	Fushimi, Yasutaka/L-8922-2017; Sato, Atsuyasu/H-9690-2016; Sato, Susumu/R-8976-2019; Ohno, Yoshiharu/AAE-2970-2020	Fushimi, Yasutaka/0000-0002-1982-3168; Sato, Atsuyasu/0000-0001-8068-9984; Sato, Susumu/0000-0002-9626-1090; Tanimura, Kazuya/0000-0002-3406-9394; Uemasu, Kiyoshi/0000-0002-5818-3028; Kido, Aki/0000-0001-5131-2870	Ministry of Education, Culture, Sports, Science and Technology, Japan [25461156]; Toshiba Medical Systems Incorporated, Japan [150100700014]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toshiba Medical Systems Incorporated, Japan	This study is supported by a Grant-in-Aid for Scientific Research (25461156) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by a sponsored research program "Research for improvement of MR visualization" (No.150100700014) provided to Professor Kaori Togashi by Toshiba Medical Systems Incorporated, Japan. The funder provided support in the form of salaries for authors [N.S. and H.K.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Cardus J, 1997, AM J RESP CRIT CARE, V156, P648, DOI 10.1164/ajrccm.156.2.9606016; Coxson HO, 2014, AM J RESP CRIT CARE, V190, P135, DOI 10.1164/rccm.201402-0256PP; de Torres JP, 2011, CHEST, V139, P36, DOI 10.1378/chest.10-0984; Gietema HA, 2010, RESP MED, V104, P76, DOI 10.1016/j.rmed.2009.08.004; GOULD GA, 1991, EUR RESPIR J, V4, P141; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; Ito I, 2005, AM J RESP CRIT CARE, V172, P1378, DOI 10.1164/rccm.200506-953OC; Kent BD, 2011, INT J CHRONIC OBSTR, V6, P199, DOI 10.2147/COPD.S10611; Kim DK, 2011, RESP MED, V105, P1211, DOI 10.1016/j.rmed.2011.02.015; Kim Victor, 2008, Proc Am Thorac Soc, V5, P513, DOI 10.1513/pats.200708-124ET; Laszlo G, 2006, THORAX, V61, P744, DOI 10.1136/thx.2006.061648; Madani A, 2008, RADIOLOGY, V248, P1036, DOI 10.1148/radiol.2483071434; Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; Muller CJ, 2002, RADIOLOGY, V222, P499, DOI 10.1148/radiol.2222000869; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Nakano Y, 1999, THORAX, V54, P384, DOI 10.1136/thx.54.5.384; Ogawa E, 2009, THORAX, V64, P20, DOI 10.1136/thx.2008.097543; Ohno Y, 2005, RADIOLOGY, V236, P704, DOI 10.1148/radiol.2361040005; Ohno Y, 2001, EUR J RADIOL, V37, P164, DOI 10.1016/S0720-048X(00)00299-0; Ohno Y, 2008, AM J RESP CRIT CARE, V177, P1095, DOI 10.1164/rccm.200709-1322OC; Ohno Y, 2007, EUR J RADIOL, V64, P320, DOI 10.1016/j.ejrad.2007.08.006; Okubadejo AA, 1996, THORAX, V51, P44, DOI 10.1136/thx.51.1.44; Petersson J, 2014, EUR RESPIR J, V44, P1023, DOI 10.1183/09031936.00037014; SAKAI N, 1994, CHEST, V106, P1319, DOI 10.1378/chest.106.5.1319; Stadler A, 2007, INT J BIOMED IMAGING, V2007, DOI 10.1155/2007/23624; Stavngaard T, 2006, ACTA RADIOL, V47, P914, DOI 10.1080/02841850600917170; Stolk J, 2007, EUR RESPIR J, V29, P1138, DOI 10.1183/09031936.00056206; Stoller JK, 2010, CHEST, V138, P179, DOI 10.1378/chest.09-2555; Tanabe N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044993; Tanabe N, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-31; Tanabe N, 2011, AM J RESP CRIT CARE, V183, P1653, DOI 10.1164/rccm.201009-1535OC; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; WAKAYAMA K, 1993, EUR RESPIR J, V6, P1362	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203273	10.1371/journal.pone.0203273	http://dx.doi.org/10.1371/journal.pone.0203273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161221	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900099
J	Zoccolotti, JD; Tasso, CO; Arbelaez, MIA; Malavolta, IF; Pereira, ECD; Esteves, CSG; Jorge, JH				Zoccolotti, Jacqueline de Oliveira; Tasso, Camilla Olga; Amaya Arbelaez, Maria Isabel; Malavolta, Isadore Ferreira; da Silva Pereira, Eduarda Carolina; Gomes Esteves, Caroline Stefanie; Jorge, Janaina Habib			Properties of an acrylic resin after immersion in antiseptic soaps: Low-cost, easy-access procedure for the prevention of denture stomatitis	PLOS ONE			English	Article							COLOR STABILITY; SURFACE-ROUGHNESS; CANDIDA-ALBICANS; BIOFILM FORMATION; HYGIENE HABITS; BASE MATERIALS; WOUND CARE; WATER BATH; IN-VITRO; DISINFECTION	Denture stomatitis triggered by Candida species requires better preventive measures. This study evaluated the physical and biological properties of a denture base acrylic resin after immersion in antiseptic soaps. Acrylic resin specimens were prepared and stored in distinct solutions for 0, 7, 14, 21, and 28 days. The solutions were as follows: DW: distilled water at 37 degrees C (control group); DS: cycles of daily immersion in Dettol soap for 8 hours at room temperature, followed by immersion in distilled water for 16 hours at 37 degrees C; PS: cycles of daily immersion in Protex soap, as described for the previous group; LS: cycles of daily immersion in Lifebuoy soap, as described for the DS group. The parameters evaluated at each time point were the following: biofilm formation capacity by Candida albicans and reduction of preformed fungal biofilms, cytotoxicity, surface roughness, hardness, and color change. For the fungal adhesion phase, the type of soap had a statistically significant effect (p = 0.0292), but after 24 hours, no differences were found between solutions or between storage times. Regarding the efficacy of biofilm reduction, there was a significant difference when the groups were compared to each other (p = 0.014). Dettol and Lifebuoy eliminated the preformed biofilm on the specimens. Moreover, all the soaps were classified as noncytotoxic (on HaCaT cell line) because there was no difference in cell viability between the different groups, except after 21 days, when a decrease in cell viability occurred, regardless of the type of soap. Regarding the roughness, there was no statistically significant difference (p > 0.05) between the groups. Lifebuoy decreased resin hardness regardless of storage time (p = 0.003). After 21 and 28 days of storage, there was an increase in hardness value, regardless of the type of soap. The specimens' color, according to the National Bureau of Standards values, ranged from 0.27 to 0.58 (i.e., imperceptible or mild color changes). In general, the disinfectant soaps were not able to prevent biofilm formation, but all the soaps were effective in reducing the preformed biofilm. In addition, all soaps were non-cytotoxic and did not change surface roughness, hardness (except Lifebuoy), and color (except Lifebuoy). Therefore, immersion in two antiseptic soaps (Protex and Dettol) may be a cheap and easy procedure for preventing denture stomatitis.	[Zoccolotti, Jacqueline de Oliveira; Tasso, Camilla Olga; Amaya Arbelaez, Maria Isabel; Malavolta, Isadore Ferreira; da Silva Pereira, Eduarda Carolina; Gomes Esteves, Caroline Stefanie; Jorge, Janaina Habib] Sao Paulo State Univ UNESP, Dent Sch, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil	Universidade Estadual Paulista	Jorge, JH (corresponding author), Sao Paulo State Univ UNESP, Dent Sch, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil.	janainahj@foar.unesp.br	Jorge, Janaina Habib/Q-2197-2019; Jorge, Janaina Habib/H-7896-2013	Jorge, Janaina Habib/0000-0002-9135-3455; Jorge, Janaina Habib/0000-0002-9135-3455	Sao Paulo Research Foundation (FAPESP) [2014/22055-4, 2014/22875-1]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Sao Paulo Research Foundation (FAPESP) [grants number 2014/22055-4 and 2014/22875-1].	Altieri Karen Tereza, 2013, Braz. Dent. J., V24, P487, DOI 10.1590/0103-6440201302289; Asad Tehmina, 1993, International Journal of Prosthodontics, V6, P9; Bagheri R, 2005, J DENT, V33, P389, DOI 10.1016/j.jdent.2004.10.018; BELL JA, 1989, J PROSTHET DENT, V61, P580, DOI 10.1016/0022-3913(89)90280-1; Bettencourt AF, 2010, DENT MATER, V26, pE171, DOI 10.1016/j.dental.2010.01.006; BUDTZJORGENSEN E, 1979, J PROSTHET DENT, V42, P619, DOI 10.1016/0022-3913(79)90190-2; Cakan U, 2015, NIGER J CLIN PRACT, V18, P511, DOI 10.4103/1119-3077.154224; Ciancio Sebastian, 2010, J Clin Dent, V21, P93; da Silva Francine Cristina, 2008, J Prosthodont, V17, P627, DOI 10.1111/j.1532-849X.2008.00358.x; Devine DA, 2007, J APPL MICROBIOL, V103, P2516, DOI 10.1111/j.1365-2672.2007.03491.x; Panariello BHD, 2015, AM J DENT, V28, P150; DorockaBobkowska B, 1996, J ORAL PATHOL MED, V25, P411, DOI 10.1111/j.1600-0714.1996.tb00288.x; Estrela Cyntia R.A., 2003, Braz. Dent. J., V14, P187, DOI 10.1590/S0103-64402003000300009; Faot F, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-77; Farzana K, 2011, SCI RES ESSAYS, V6, P3514; Fernandes FHCN, 2013, GERODONTOLOGY, V30, P18, DOI 10.1111/j.1741-2358.2012.00640.x; Finnegan S, 2015, ADV WOUND CARE, V4, P415, DOI 10.1089/wound.2014.0577; Goiato MC, 2013, GERODONTOLOGY, V30, P276, DOI 10.1111/j.1741-2358.2012.00676.x; Goiato MC, 2014, J PROSTHODONT, V23, P559, DOI 10.1111/jopr.12151; Hollis S, 2015, J PROSTHET DENT, V114, P709, DOI 10.1016/j.prosdent.2015.06.001; International Standard, 2007, 109935 ISO; Izumida FE, 2014, J PROSTHET DENT, V112, P1523, DOI 10.1016/j.prosdent.2014.06.001; Javed F, 2017, J BIOL REG HOMEOS AG, V31, P343; JOHNSTON WM, 1989, J DENT RES, V68, P819, DOI 10.1177/00220345890680051301; Jorge Janaina Habib, 2009, Quintessence Int, V40, pe93; Jorge Janaina Habib, 2006, J. Appl. Oral Sci., V14, P203, DOI 10.1590/S1678-77572006000300011; Jorge JH, 2004, INT J PROSTHODONT, V17, P340; Kellesarian SV, 2017, PHOTODIAGN PHOTODYN, V17, P103, DOI 10.1016/j.pdpdt.2016.12.001; Kulak-Ozkan Y, 2002, J ORAL REHABIL, V29, P300, DOI 10.1046/j.1365-2842.2002.00816.x; Larson EL, 2004, ANN INTERN MED, V140, P321, DOI 10.7326/0003-4819-140-5-200403020-00007; Lefebvre C A, 1995, Int J Prosthodont, V8, P122; Low IM, 1998, MATER RES BULL, V33, P1753, DOI 10.1016/S0025-5408(98)00179-2; Machado AL, 2012, GERODONTOLOGY, V29, pE375, DOI 10.1111/j.1741-2358.2011.00484.x; Machado AL, 2009, J PROSTHET DENT, V102, P115, DOI 10.1016/S0022-3913(09)60120-7; Marcos-Arias C, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-119; MCCOURTIE J, 1985, J MED MICROBIOL, V20, P97, DOI 10.1099/00222615-20-1-97; Minnich KE, 2012, OSTOMY WOUND MANAG, V58, P32; Moffa EB, 2011, J DENT, V39, pE65, DOI 10.1016/j.jdent.2011.10.008; MOLINARI J A, 1991, Dental Clinics of North America, V35, P323; Morgan TD, 2001, J APPL MICROBIOL, V91, P47, DOI 10.1046/j.1365-2672.2001.01338.x; Neppelenbroek KH, 2005, J PROSTHET DENT, V93, P171, DOI 10.1016/j.prosdent.2004.10.020; Nikawa H, 1999, INT J PROSTHODONT, V12, P153; Nimeroff I, 1968, NBS MONOGRAPH, V104, P47; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Patel SB, 2004, J AM DENT ASSOC, V135, P587, DOI 10.14219/jada.archive.2004.0246; Pavarina AC, 2003, J ORAL REHABIL, V30, P532, DOI 10.1046/j.1365-2842.2003.01093.x; Bianchi CMPD, 2016, REV INST MED TROP SP, V58, DOI [10.1590/S1678-9946201658017, 10.1590/s1678-9946201658017]; Radford DR, 1998, J DENT, V26, P577, DOI 10.1016/S0300-5712(97)00034-1; Rawlf HR, 2005, PHILLIPS DENT MAT, P135; Russell AD, 2004, J ANTIMICROB CHEMOTH, V53, P693, DOI 10.1093/jac/dkh171; Sagripanti J L, 2000, Surg Infect (Larchmt), V1, P3, DOI 10.1089/109629600321245; Schuster G S, 1995, Int J Prosthodont, V8, P580; Shay K, 2000, J CONT DENT PRACT, V1, P15; Sheridan PJ, 1997, INT J PROSTHODONT, V10, P73; Smith K, 2008, J MED MICROBIOL, V57, P966, DOI 10.1099/jmm.0.47668-0; Vallittu PK, 1995, DENT MATER, V11, P338, DOI 10.1016/0109-5641(95)80031-X; Verran J, 1997, J PROSTHET DENT, V77, P535, DOI 10.1016/S0022-3913(97)70148-3; Villalta P, 2006, J PROSTHET DENT, V95, P137, DOI 10.1016/j.prosdent.2005.11.019; Webb BC, 1998, AUST DENT J, V43, P160, DOI 10.1111/j.1834-7819.1998.tb00157.x; Webb BC, 1998, AUST DENT J, V43, P45, DOI 10.1111/j.1834-7819.1998.tb00152.x; Webb BC, 1998, AUST DENT J, V43, P244, DOI 10.1111/j.1834-7819.1998.tb00172.x; WENNBERG A, 1979, J BIOMED MATER RES, V13, P109, DOI 10.1002/jbm.820130112; Wiegand C, 2008, GMS HYG INFECT CONTR, V3	63	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203187	10.1371/journal.pone.0203187	http://dx.doi.org/10.1371/journal.pone.0203187			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161256	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900087
J	Godoy, JC; Niesman, IR; Busija, AR; Kassan, A; Schilling, JM; Schwarz, A; Alvarez, EA; Dalton, ND; Drummond, JC; Roth, DM; Kararigas, G; Patel, HH; Zemljic-Harpf, AE				Godoy, Joseph C.; Niesman, Ingrid R.; Busija, Anna R.; Kassan, Adam; Schilling, Jan M.; Schwarz, Anna; Alvarez, Erika A.; Dalton, Nancy D.; Drummond, John C.; Roth, David M.; Kararigas, Georgios; Patel, Hemal H.; Zemljic-Harpf, Alice E.			Atorvastatin, but not pravastatin, inhibits cardiac Akt/mTOR signaling and disturbs mitochondrial ultrastructure in cardiac myocytes	FASEB JOURNAL			English	Article						Statins; statin-induced myopathy; cardiomyocytes; oxygen consumption rate; heart failure	COA REDUCTASE INHIBITION; SERUM TOTAL CHOLESTEROL; COENZYME-A REDUCTASE; HEART-FAILURE; LDL CHOLESTEROL; STATIN THERAPY; RAT; SIMVASTATIN; GLUCOSE; CERIVASTATIN	Statins, which reduce LDL-cholesterol by inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, are among the most widely prescribed drugs. Skeletal myopathy is a known statin-induced adverse effect associated with mitochondrial changes. We hypothesized that similar effects would occur in cardiac myocytes in a lipophilicity-dependent manner between 2 common statins: atorvastatin (lipophilic) and pravastatin (hydrophilic). Neonatal cardiac ventricular myocytes were treated with atorvastatin and pravastatin for 48 h. Both statins induced endoplasmic reticular (ER) stress, but only atorvastatin inhibited ERK1/2(T202/Y204), Akt(Ser473), and mammalian target of rapamycin signaling; reduced protein abundance of caveolin-1, dystrophin, epidermal growth factor receptor, and insulin receptor-; decreased Ras homolog gene family member A activation; and induced apoptosis. In cardiomyocyte-equivalent HL-1 cells, atorvastatin, but not pravastatin, reduced mitochondrial oxygen consumption. When male mice underwent atorvastatin and pravastatin administration per os for up to 7 mo, only long-term atorvastatin, but not pravastatin, induced elevated serum creatine kinase; swollen, misaligned, size-variable, and disconnected cardiac mitochondria; alteration of ER structure; repression of mitochondria- and endoplasmic reticulum-related genes; and a 21% increase in mortality in cardiac-specific vinculin-knockout mice during the first 2 months of administration. To our knowledge, we are the first to demonstrate in vivo that long-term atorvastatin administration alters cardiac ultrastructure, a finding with important clinical implications.Godoy, J. C., Niesman, I. R., Busija, A. R., Kassan, A., Schilling, J. M., Schwarz, A., Alvarez, E. A., Dalton, N. D., Drummond, J. C., Roth, D. M., Kararigas, G., Patel, H. H., Zemljic-Harpf, A. E. Atorvastatin, but not pravastatin, inhibits cardiac Akt/mTOR signaling and disturbs mitochondrial ultrastructure in cardiac myocytes.	[Godoy, Joseph C.; Kassan, Adam; Schilling, Jan M.; Schwarz, Anna; Drummond, John C.; Roth, David M.; Patel, Hemal H.; Zemljic-Harpf, Alice E.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Niesman, Ingrid R.; Busija, Anna R.; Kassan, Adam; Schilling, Jan M.; Drummond, John C.; Roth, David M.; Patel, Hemal H.; Zemljic-Harpf, Alice E.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Alvarez, Erika A.; Dalton, Nancy D.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kassan, Adam] West Coast Univ, Dept Pharmaceut Sci, Sch Pharm, North Hollywood, CA USA; [Kararigas, Georgios] Charite Univ Med Berlin, Berlin, Germany; [Kararigas, Georgios] German Ctr Cardiovasc Res DZHK, Berlin, Germany	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research	Zemljic-Harpf, AE (corresponding author), Univ Calif San Diego, Dept Anesthesiol, Vet Affairs San Diego Healthcare Syst, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	azemljicharpf@ucsd.edu	Stefanadis, Christodoulos/ABH-2232-2020; Patel, Hemal/C-7325-2019	Stefanadis, Christodoulos/0000-0001-5974-6454; Niesman, Ingrid/0000-0001-9767-6629; Patel, Hemal/0000-0001-6722-9625; Kararigas, Georgios/0000-0002-8187-0176	U.S. National Institutes of Health (National Heart, Lung, and Blood Institute) [HL107200, HL091071]; U.S. National Institutes of Health (National Institute on Aging) [AG052722]; American Heart Association Beginning Grant-in-Aid (BGIA) [2260359]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG052722] Funding Source: NIH RePORTER	U.S. National Institutes of Health (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. National Institutes of Health (National Institute on Aging)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association Beginning Grant-in-Aid (BGIA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Drs. Marilyn Farquhar (University of California, San Diego), Velia Fowler, and Malcom Wood (both from Scripps Research, La Jolla, CA, USA) for helpful discussions regarding the TEM analysis; Ying Jones (University of California, San Diego) for excellent technical assistance in preparation of tissues for electron microscopic analysis; Drs. Joan Heller Brown and Sunny Y. Xiang (both from the University of California, San Diego) for providing the GST plasmid; the Veterans Affairs/Veterans Medical Research Foundation (VA/VMRF) Microarray and Next Generation Sequencing (NGS) Core (San Diego, CA, USA) for microarray profiling; and Dr. Benedict Lucchesi (University of Michigan, Ann Arbor, MI, USA) for valuable scientific discussions and encouragement to pursue this project. The authors declare no conflicts of interest. This work was funded by the U.S. National Institutes of Health HL107200, HL091071 (National Heart, Lung, and Blood Institute), and AG052722 (National Institute on Aging) (to H.H.P.), and by American Heart Association Beginning Grant-in-Aid (BGIA) 2260359 (to A.E.Z.-H.).	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Allard NAE, 2018, J CLIN ENDOCR METAB, V103, P75, DOI 10.1210/jc.2017-01561; Apostolopoulou M, 2015, EUR J CLIN INVEST, V45, P745, DOI 10.1111/eci.12461; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bakakos A, 2017, CURR PHARM DESIGN, V23, P7128, DOI 10.2174/1381612823666170926125754; Baker SK, 2001, CLIN INVEST MED, V24, P258; Bergt Stefan, 2017, JACC Basic Transl Sci, V2, P149, DOI 10.1016/j.jacbts.2017.01.009; Brault M, 2014, METABOLISM, V63, P735, DOI 10.1016/j.metabol.2014.02.014; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chen YH, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1828071; Chung HR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168065; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Crane FL, 2007, MITOCHONDRION, V7, pS2, DOI 10.1016/j.mito.2007.02.011; Crespo MJ, 2014, PHARMACOLOGY, V93, P84, DOI 10.1159/000358256; Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a; Demeulder B, 2013, BBA-MOL BASIS DIS, V1832, P780, DOI 10.1016/j.bbadis.2013.02.015; Dong QT, 2011, INT J CARDIOL, V153, P311, DOI 10.1016/j.ijcard.2010.08.047; ENDO A, 1992, J LIPID RES, V33, P1569; FOLKERS K, 1990, P NATL ACAD SCI USA, V87, P8931, DOI 10.1073/pnas.87.22.8931; Fox J, 2007, MOUSE BIOMEDICAL RES, DOI DOI 10.1016/B978-012369454-6/50094-7; Gambelli S., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P85; Ghavami S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.61; Giordano N, 1997, LANCET, V349, P1600, DOI 10.1016/S0140-6736(05)61628-5; Glembotski CC, 2008, J MOL CELL CARDIOL, V44, P453, DOI 10.1016/j.yjmcc.2007.10.017; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Gray DF, 2000, CARDIOVASC RES, V47, P329, DOI 10.1016/S0008-6363(00)00106-1; Greene SJ, 2013, AM J CARDIOL, V111, P574, DOI 10.1016/j.amjcard.2012.10.042; Guder G, 2009, CIRC-HEART FAIL, V2, P563, DOI 10.1161/CIRCHEARTFAILURE.108.825059; Hasegawa H, 2003, J MOL CELL CARDIOL, V35, P953, DOI 10.1016/S0022-2828(03)00180-9; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Horwich TB, 2008, AM HEART J, V156, P1170, DOI 10.1016/j.ahj.2008.07.004; Horwich TB, 2002, J CARD FAIL, V8, P216, DOI 10.1054/jcaf.2002.126519a; Inoue R, 2003, J PHARMACOL SCI, V93, P279, DOI 10.1254/jphs.93.279; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Jarcho JA, 2015, NEW ENGL J MED, V372, P2448, DOI 10.1056/NEJMe1507041; Jiang ZH, 2016, MED SCI MONITOR, V22, P2825, DOI 10.12659/MSM.897047; Johnson TE, 2004, TOXICOL APPL PHARM, V200, P237, DOI 10.1016/j.taap.2004.04.010; Kadota S, 2008, J CARDIOL, V51, P171, DOI 10.1016/j.jjcc.2008.02.003; Kaufmann P, 2006, CELL MOL LIFE SCI, V63, P2415, DOI 10.1007/s00018-006-6235-z; Kobayashi M, 2008, LIFE SCI, V82, P969, DOI 10.1016/j.lfs.2008.02.019; Krols M, 2016, J CELL BIOL, V214, P367, DOI 10.1083/jcb.201607124; Kumazaki M, 2013, EUR J PHARMACOL, V707, P71, DOI 10.1016/j.ejphar.2013.03.022; Ky B, 2008, J AM COLL CARDIOL, V51, P1653, DOI 10.1016/j.jacc.2008.01.026; Larsen S, 2013, J AM COLL CARDIOL, V61, P44, DOI 10.1016/j.jacc.2012.09.036; Laufs U, 2002, CARDIOVASC RES, V53, P911, DOI 10.1016/S0008-6363(01)00540-5; Liantonio A, 2007, J PHARMACOL EXP THER, V321, P626, DOI 10.1124/jpet.106.118331; Liao Y, 2008, HYPERTENS RES, V31, P335, DOI 10.1291/hypres.31.335; Liao Y, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00307; Martin KA, 2004, AM J PHYSIOL-CELL PH, V286, pC507, DOI 10.1152/ajpcell.00201.2003; Martinet W, 2014, ATHEROSCLEROSIS, V233, P601, DOI 10.1016/j.atherosclerosis.2014.01.040; Marz W, 2000, J Cardiovasc Pharmacol Ther, V5, P275, DOI 10.1054/JCPT.2000.16695; Mikus CR, 2013, J AM COLL CARDIOL, V62, P709, DOI 10.1016/j.jacc.2013.02.074; Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283; Mita T, 2007, ENDOCR J, V54, P441, DOI 10.1507/endocrj.K06-198; Mullen PJ, 2011, BBA-MOL CELL RES, V1813, P2079, DOI 10.1016/j.bbamcr.2011.07.019; NAKAHARA K, 1994, BIOCHEM BIOPH RES CO, V202, P1579, DOI 10.1006/bbrc.1994.2112; Nakao T, 2007, J PHARMACOL SCI, V105, P334, DOI 10.1254/jphs.FP0070682; Nochioka K, 2015, CIRC J, V79, P574, DOI 10.1253/circj.CJ-14-0865; Oesterle A, 2017, CIRC RES, V120, P229, DOI 10.1161/CIRCRESAHA.116.308537; Omar MA, 2002, ANN PHARMACOTHER, V36, P288, DOI 10.1345/aph.1A289; Omar MA, 2001, ANN PHARMACOTHER, V35, P1096, DOI 10.1345/aph.10228; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; Sarr FS, 2008, J CHROMATOGR B, V868, P20, DOI 10.1016/j.jchromb.2008.03.034; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Teshima Y, 2009, J CARDIOL, V53, P58, DOI 10.1016/j.jjcc.2008.08.008; Thompson PD, 2016, J AM COLL CARDIOL, V67, P2395, DOI 10.1016/j.jacc.2016.02.071; Tousoulis D, 2014, PHARMACOL THERAPEUT, V141, P79, DOI 10.1016/j.pharmthera.2013.09.001; Trapani L, 2011, FASEB J, V25, P4037, DOI 10.1096/fj.11-184218; Vaduganathan M, 2014, HEART FAIL REV, V19, P695, DOI 10.1007/s10741-014-9423-1; Vallejo-Vaz AJ, 2015, ATHEROSCLEROSIS, V241, P409, DOI 10.1016/j.atherosclerosis.2015.06.001; Wagner RJ, 2010, AM J PHYSIOL-CELL PH, V299, pC119, DOI 10.1152/ajpcell.00429.2009; Wang JC, 2018, CANCER SCI, V109, P1627, DOI 10.1111/cas.13570; Wiggins BS, 2016, CIRCULATION, V134, pE468, DOI 10.1161/CIR.0000000000000456; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1161/CIR.0000000000000509, 10.1016/j.jacc.2017.04.025]; Zemljic-Harpf AE, 2004, AM J PATHOL, V165, P1033, DOI 10.1016/S0002-9440(10)63364-0; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Zemljic-Harpf AE, 2014, J CELL SCI, V127, P1104, DOI 10.1242/jcs.143743; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhao H, 2008, HYPERTENS RES, V31, P1977, DOI 10.1291/hypres.31.1977; Zheng G, 2015, J INTERV CARDIOL, V28, P514, DOI 10.1111/joic.12245; Zhou Q, 2010, CIRC J, V74, P818, DOI 10.1253/circj.CJ-10-0110; Zhu YQ, 2016, J MOL CELL CARDIOL, V97, P204, DOI 10.1016/j.yjmcc.2016.05.013	89	18	19	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1209	1225		10.1096/fj.201800876R	http://dx.doi.org/10.1096/fj.201800876R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30169110	Green Published, Bronze			2022-12-26	WOS:000457401500096
J	Tokmina-Roszyk, M; Fields, GB				Tokmina-Roszyk, Michal; Fields, Gregg B.			Dissecting MMP P-10 and P-11 subsite sequence preferences, utilizing a positional scanning, combinatorial triple-helical peptide library	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; matrix metalloproteinase (MMP); extracellular matrix; connective tissue; proteolysis; fluorescence resonance energy transfer (FRET); activity-based fingerprinting; peptide library; triple helix	TYPE-1 MATRIX-METALLOPROTEINASE; COLLAGEN-BINDING DOMAIN; SUBSTRATE RECOGNITION; QUENCHED FLUOROPHORES; RAPID IDENTIFICATION; STRUCTURAL INSIGHTS; TRIGGERED RELEASE; MODEL PEPTIDES; IN-VIVO; CLEAVAGE	Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that remodel the extracellular matrix environment and mitigate outside-in signaling. Loss of regulation of MMP activity plays a role in numerous pathological states. In particular, aberrant collagenolysis affects tumor invasion and metastasis, osteoarthritis, and cardiovascular and neurodegenerative diseases. To evaluate the collagen sequence preferences of MMPs, a positional scanning synthetic combinatorial library was synthesized herein and was used to investigate the P-10 and P-11 substrate subsites. The scaffold for the library was a triple-helical peptide mimic of the MMP cleavage site in types I-III collagen. A FRET-based enzyme activity assay was used to evaluate the sequence preferences of eight MMPs. Deconvolution of the library data revealed distinct motifs for several MMPs and discrimination among closely related MMPs. On the basis of the screening results, several individual peptides were designed and evaluated. A triple-helical substrate incorporating Asp-Lys in the P-10-P-11 subsites offered selectivity between MMP-14 and MMP-15, whereas Asp-Lys or Trp-Lys in these subsites discriminated between MMP-2 and MMP-9. Future screening of additional subsite positions will enable the design of selective triple-helical MMP probes that could be used for monitoring in vivo enzyme activity and enzyme-facilitated drug delivery. Furthermore, selective substrates could serve as the basis for the design of specific triple-helical peptide inhibitors targeting only those MMPs that play a detrimental role in a disease of interest.	[Tokmina-Roszyk, Michal; Fields, Gregg B.] Florida Atlantic Univ, Dept Chem & Biochem, Jupiter, FL 33458 USA; [Fields, Gregg B.] Scripps Res Inst Scripps Florida, Dept Chem, Jupiter, FL 33458 USA	State University System of Florida; Florida Atlantic University; Scripps Research Institute; State University System of Florida; University of Florida	Fields, GB (corresponding author), Florida Atlantic Univ, 5353 Parkside Dr, Jupiter, FL 33458 USA.; Fields, GB (corresponding author), Scripps Res Inst Scripps Florida, 130 Scripps Way, Jupiter, FL 33458 USA.	fieldsg@fau.edu			National Institutes of Health Grant [CA098799]; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant CA098799 (to G.B.F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akers WJ, 2012, BIOCONJUGATE CHEM, V23, P656, DOI 10.1021/bc300027y; Amar S, 2017, BBA-MOL CELL RES, V1864, P1940, DOI 10.1016/j.bbamcr.2017.04.015; Arnold LH, 2011, J BIOL CHEM, V286, P45073, DOI 10.1074/jbc.M111.285213; Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097; Bertini I, 2012, J AM CHEM SOC, V134, P2100, DOI 10.1021/ja208338j; Bhowmick M, 2017, J MED CHEM, V60, P3814, DOI 10.1021/acs.jmedchem.7b00018; Bhowmick M, 2015, CHEMBIOCHEM, V16, P1084, DOI 10.1002/cbic.201402716; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Byrne C, 2011, CHEM COMMUN, V47, P2589, DOI 10.1039/c0cc04795c; Cerofolini L, 2016, SCI REP-UK, V6, DOI 10.1038/srep29511; Chen EI, 2002, J BIOL CHEM, V277, P4485, DOI 10.1074/jbc.M109469200; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; DeLano W. L., 2018, THE PYMOL MOLECULAR; Deng SJ, 2000, J BIOL CHEM, V275, P31422, DOI 10.1074/jbc.M004538200; Diaz N, 2015, BIOCHEMISTRY-US, V54, P1243, DOI 10.1021/bi501014w; Eckhard U, 2016, DATA BRIEF, V7, P299, DOI 10.1016/j.dib.2016.02.036; Eckhard U, 2016, MATRIX BIOL, V49, P37, DOI 10.1016/j.matbio.2015.09.003; Elegbede AI, 2008, J AM CHEM SOC, V130, P10633, DOI 10.1021/ja801548g; Fallas JA, 2012, J BIOL CHEM, V287, P8039, DOI 10.1074/jbc.M111.296574; Fan CY, 2008, FASEB J, V22, P3795, DOI 10.1096/fj.08-111484; Fields GB, 1996, BIOPOLYMERS, V40, P345, DOI 10.1002/(SICI)1097-0282(1996)40:4<345::AID-BIP1>3.0.CO;2-W; Fields GB, 2013, J BIOL CHEM, V288, P8785, DOI 10.1074/jbc.R113.451211; Fields Gregg B., 2008, P827, DOI 10.1007/978-0-387-69057-5_39; FURKA A, 1991, INT J PEPT PROT RES, V37, P487, DOI 10.1111/j.1399-3011.1991.tb00765.x; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Giulianotti MA, 2012, ACS COMB SCI, V14, P503, DOI 10.1021/co300060s; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0; HOUGHTEN RA, 1992, BIOTECHNIQUES, V13, P412; Hynes RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a004903; Kim DH, 2012, J PEPT SCI, V18, P394, DOI 10.1002/psc.2409; Koide T, 2016, BIOL PHARM BULL, V39, P135, DOI 10.1248/bpb.b15-00561; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; Kukreja M, 2015, CHEM BIOL, V22, P1122, DOI 10.1016/j.chembiol.2015.07.008; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Lauer JL, 2014, J BIOL CHEM, V289, P1981, DOI 10.1074/jbc.M113.513408; Lauer JL, 2010, CANCER DRUG DISCOV D, P477, DOI 10.1007/978-1-4419-6615-5_23; Lauer-Fields J, 2007, J AM CHEM SOC, V129, P10408, DOI 10.1021/ja0715849; Lauer-Fields JL, 2008, J BIOL CHEM, V283, P20087, DOI 10.1074/jbc.M801438200; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; Lauer-Fields JL, 2002, BIOL CHEM, V383, P1095, DOI 10.1515/BC.2002.118; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019; Mekkat A, 2018, J STRUCT BIOL, V203, P247, DOI 10.1016/j.jsb.2018.05.002; Mikhailova M, 2012, MATRIX BIOL, V31, P380, DOI 10.1016/j.matbio.2012.10.001; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Muller JCD, 2000, BIOCHEMISTRY-US, V39, P5111, DOI 10.1021/bi992724x; Ndinguri MW, 2012, J DRUG DELIV, V2012, DOI 10.1155/2012/592602; Newby AC, 2012, VASC PHARMACOL, V56, P232, DOI 10.1016/j.vph.2012.01.007; Ohkubo S, 1999, BIOCHEM BIOPH RES CO, V266, P308, DOI 10.1006/bbrc.1999.1816; OSTRESH JM, 1994, BIOPOLYMERS, V34, P1681, DOI 10.1002/bip.360341212; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pan WJ, 2003, J BIOL CHEM, V278, P27820, DOI 10.1074/jbc.M304436200; Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2005, BIOCHEMISTRY-US, V44, P1414, DOI 10.1021/bi048216r; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Persikov AV, 2000, BIOPOLYMERS, V55, P436, DOI 10.1002/1097-0282(2000)55:6<436::AID-BIP1019>3.0.CO;2-D; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PINILLA C, 1992, BIOTECHNIQUES, V13, P901; Ratnikov BI, 2014, P NATL ACAD SCI USA, V111, pE4148, DOI 10.1073/pnas.1406134111; Robichaud TK, 2011, J BIOL CHEM, V286, P37535, DOI 10.1074/jbc.M111.273391; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruddy JM, 2016, J VASC RES, V53, P1, DOI 10.1159/000446703; Sarkar N, 2008, BIOCONJUGATE CHEM, V19, P57, DOI 10.1021/bc070081p; Sarkar NR, 2005, CHEM COMMUN, P999, DOI 10.1039/b416827e; Schenk S, 2003, TRENDS CELL BIOL, V13, P366, DOI 10.1016/S0962-8924(03)00129-6; Shinde A, 2015, J PEPT SCI, V21, P77, DOI 10.1002/psc.2725; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Stawikowski MJ, 2017, METHODS MOL BIOL, V1579, P137, DOI 10.1007/978-1-4939-6863-3_8; Subiros-Funosas R, 2013, ALDRICHIM ACTA, V46, P21; Sun HY, 2007, BIOPOLYMERS, V88, P141, DOI 10.1002/bip.20664; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tokmina-Roszyk M, 2013, BIOPOLYMERS, V100, P347, DOI 10.1002/bip.22222; Troeberg L, 2012, BBA-PROTEINS PROTEOM, V1824, P133, DOI 10.1016/j.bbapap.2011.06.020; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Webb Benjamin, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi0506s47; Woessner J.F., 2000, PROTEIN PROFILE SER; Xiao JX, 2010, J BIOL CHEM, V285, P34181, DOI 10.1074/jbc.M110.128355; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yamazaki CM, 2013, ANGEW CHEM INT EDIT, V52, P5497, DOI 10.1002/anie.201301266; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yao Q, 2018, TRENDS PHARMACOL SCI, V39, P766, DOI 10.1016/j.tips.2018.06.003; Yasui H, 2013, BIOPOLYMERS, V100, P705, DOI 10.1002/bip.22234; Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979; Zhang X, 2014, BIOORG MED CHEM LETT, V24, P3786, DOI 10.1016/j.bmcl.2014.06.072; Zhang X, 2014, MOLECULES, V19, P8571, DOI 10.3390/molecules19068571; Zhao YC, 2015, STRUCTURE, V23, P257, DOI 10.1016/j.str.2014.11.021	96	2	2	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16661	16676		10.1074/jbc.RA118.003266	http://dx.doi.org/10.1074/jbc.RA118.003266			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30185620	Green Published, hybrid			2022-12-26	WOS:000448515100010
J	Backes, CS; Friedmann, KS; Mang, S; Knorck, A; Hoth, M; Kummerow, C				Backes, Christian S.; Friedmann, Kim S.; Mang, Sebastian; Knoerck, Arne; Hoth, Markus; Kummerow, Carsten			Natural killer cells induce distinct modes of cancer cell death: Discrimination, quantification, and modulation of apoptosis, necrosis, and mixed forms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						natural killer cells (NK cells); cancer; apoptosis; necrosis (necrotic death); cell death; calcium; caspase; cellular immune response; imaging; immunology	CYTOTOXIC T-LYMPHOCYTES; CALCIUM INFLUX; PERFORIN; THERAPY; IMMUNOTHERAPY; EXOCYTOSIS; EXPRESSION; GRANULES; SYNAPSE; LIGHT	Immune therapy of cancer is among the most promising recent advances in medicine. Whether the immune system can keep cancer in check depends on, among other factors, the efficiency of immune cells to recognize and eliminate cancer cells. We describe a time-resolved single-cell assay that reports the quality, quantity, and kinetics of target cell death induced by single primary human natural killer (NK) cells. The assay reveals that single NK cells induce cancer cell death by apoptosis and necrosis but also by mixed forms. Inhibition of either one of the two major cytotoxic pathways, perforin/granzyme release or FasL/FasR interaction, unmasked the parallel activity of the other one. Ca2+ influx through Orai channels is important for tuning killer cell function. We found that the apoptosis/necrosis ratio of cancer cell death by NK cells is controlled by the magnitude of Ca2+ entry and furthermore by the relative concentrations of perforin and granzyme B. The possibility to change the apoptosis/necrosis ratio employed by NK cells offers an intriguing possibility to modulate the immunogenicity of the tumor microenvironment.	[Backes, Christian S.; Friedmann, Kim S.; Mang, Sebastian; Knoerck, Arne; Hoth, Markus; Kummerow, Carsten] Univ Saarland, Sch Med, Dept Biophys, Ctr Integrat Physiol & Mol Med, D-66421 Homburg, Germany	Saarland University	Hoth, M; Kummerow, C (corresponding author), Univ Saarland, Sch Med, Dept Biophys, Ctr Integrat Physiol & Mol Med, D-66421 Homburg, Germany.	markus.hoth@uks.eu; carsten.kummerow@uks.eu		Hoth, Markus/0000-0001-7080-4643; Knorck, Arne/0000-0001-8980-6673; Kummerow, Carsten/0000-0001-5667-2293	Deutsche Forschungsgemeinschaft (DFG) [SFB 894, SFB 1027, IRTG 1830]; Bundesministerium fur Bildung und Forschung (BMBF) [031LO133]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This project was supported by Deutsche Forschungsgemeinschaft (DFG) Grants SFB 894 (project A1 MH), SFB 1027 (project A2 MH), and IRTG 1830 (to M. H. and Barbara Niemeyer). This work was also supported by Bundesministerium fur Bildung und Forschung (BMBF) Grant 031LO133. The authors declare that they have no conflicts of interest with the contents of this article.	Benkova B, 2009, ANAL BIOCHEM, V394, P68, DOI 10.1016/j.ab.2009.07.012; Bhat SS, 2016, BBA-MOL CELL RES, V1863, P1653, DOI 10.1016/j.bbamcr.2016.04.014; Boudreau JE, 2018, TRENDS IMMUNOL, V39, P222, DOI 10.1016/j.it.2017.12.001; Caricchio R, 1998, J IMMUNOL, V161, P241; Chia J, 2009, P NATL ACAD SCI USA, V106, P9809, DOI 10.1073/pnas.0903815106; Clausen J, 2003, IMMUNOBIOLOGY, V207, P85, DOI 10.1078/0171-2985-00219; de Saint Basile G, 2010, NAT REV IMMUNOL, V10, P568, DOI 10.1038/nri2803; Frey M, 1998, J IMMUNOL, V161, P400; Griffin MM, 2013, EXPERT OPIN BIOL TH, V13, P803, DOI 10.1517/14712598.2013.786698; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Gwalani LA, 2018, J IMMUNOL, V200, P3231, DOI 10.4049/jimmunol.1701500; Hernandez-Ilizaliturri FJ, 2005, CLIN CANCER RES, V11, P5984, DOI 10.1158/1078-0432.CCR-05-0577; Hoth M, 2016, BBA-MOL CELL RES, V1863, P1408, DOI 10.1016/j.bbamcr.2015.12.009; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Janka GE, 2012, ANNU REV MED, V63, P233, DOI 10.1146/annurev-med-041610-134208; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kataoka T, 1996, J IMMUNOL, V156, P3678; Kershaw MH, 2013, NAT REV CANCER, V13, P525, DOI 10.1038/nrc3565; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kummerow C, 2014, EUR J IMMUNOL, V44, P1870, DOI 10.1002/eji.201444518; Lopez JA, 2013, J IMMUNOL, V191, P2328, DOI 10.4049/jimmunol.1301205; Lyubchenko TA, 2001, IMMUNITY, V15, P847, DOI 10.1016/S1074-7613(01)00233-3; Maul-Pavicic A, 2011, P NATL ACAD SCI USA, V108, P3324, DOI 10.1073/pnas.1013285108; Nisihara T, 2001, J IMMUNOL, V167, P3266, DOI 10.4049/jimmunol.167.6.3266; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Schoppmeyer R, 2018, JOVE-J VIS EXP, DOI 10.3791/57651; Schwarz EC, 2013, BBA-MOL CELL RES, V1833, P1603, DOI 10.1016/j.bbamcr.2012.11.016; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shcherbo D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-24; Smaglo BG, 2014, NAT REV CLIN ONCOL, V11, P637, DOI 10.1038/nrclinonc.2014.159; Smith MB, 2011, BIOPHYS J, V101, P1794, DOI 10.1016/j.bpj.2011.09.007; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Strobl F, 2017, NAT PROTOC, V12, P1103, DOI 10.1038/nprot.2017.028; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thakur A, 2018, BLOOD REV, V32, P339, DOI 10.1016/j.blre.2018.02.004; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Weiner LM, 2007, NAT REV CANCER, V7, P701, DOI 10.1038/nrc2209; Wenning AS, 2011, BBA-MOL CELL RES, V1813, P412, DOI 10.1016/j.bbamcr.2010.12.022; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zhou X, 2018, J PHYSIOL-LONDON, V596, P2681, DOI 10.1113/JP274964; Zhu YT, 2016, ONCOTARGET, V7, P47163, DOI 10.18632/oncotarget.9980	47	44	44	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16348	16363		10.1074/jbc.RA118.004549	http://dx.doi.org/10.1074/jbc.RA118.004549			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30190323	Green Published, hybrid			2022-12-26	WOS:000447833600019
J	Gridley, T; Elwen, SH; Harris, G; Moore, DM; Hoelzel, AR; Lampen, F				Gridley, T.; Elwen, S. H.; Harris, G.; Moore, D. M.; Hoelzel, A. R.; Lampen, F.			Hybridization in bottlenose dolphins -A case study of Tursiops aduncus x T. truncatus hybrids and successful backcross hybridization events	PLOS ONE			English	Article							WHALE BALAENOPTERA-MUSCULUS; POPULATION-STRUCTURE; FIN WHALE; GENUS TURSIOPS; BLUE WHALE; INTERGENERIC HYBRID; GENETIC ISOLATION; LIFE-HISTORY; B-PHYSALUS; MITOCHONDRIAL	The bottlenose dolphin, genus Tursiops is one of the best studied of all the Cetacea with a minimum of two species widely recognised. Common bottlenose dolphins (T. truncatus), are the cetacean species most frequently held in captivity and are known to hybridize with species from at least 6 different genera. In this study, we document several intra-generic hybridization events between T. truncatus and T. aduncus held in captivity. We demonstrate that the F-1 hybrids are fertile and can backcross producing apparently healthy offspring, thereby showing introgressive inter-specific hybridization within the genus. We document that female F-1 hybrids can reach sexual maturity at 4 yr and 3 mo of age, and can become pregnant and give birth before being fully weaned. The information presented has implications for understanding hybrid reticulation among cetacean species and practical implications for captive facilities housing either Tursiops species or hybrids thereof.	[Gridley, T.] Univ Cape Town, Ctr Stat Ecol Environm & Conservat, Dept Stat Sci, Sea Search Res & Conservat NPC, Muizenberg Cape Town, South Africa; [Elwen, S. H.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Sea Search Res & Conservat NPC, Muizenberg Cape Town, South Africa; [Harris, G.; Lampen, F.] uShaka Sea World, South African Assoc Marine Biol Res, Durban, South Africa; [Moore, D. M.; Hoelzel, A. R.] Univ Durham, Dept Biosci, Durham, England	University of Cape Town; University of Pretoria; Durham University	Gridley, T (corresponding author), Univ Cape Town, Ctr Stat Ecol Environm & Conservat, Dept Stat Sci, Sea Search Res & Conservat NPC, Muizenberg Cape Town, South Africa.	tessgridley@yahoo.co.uk		Gridley, Teresa/0000-0003-0925-5782; Elwen, Simon/0000-0002-7467-6121; Moore, Daniel/0000-0003-1157-0968	Claude Leon Post Doctoral Fellowship; National Research Foundation Fellowship; Sea Search Africa Pty; SAAMBR uShaka Sea World	Claude Leon Post Doctoral Fellowship; National Research Foundation Fellowship; Sea Search Africa Pty; SAAMBR uShaka Sea World	This research was supported in part by a Claude Leon Post Doctoral Fellowship to TG (www.leonfoundation.co.za) and National Research Foundation Fellowship to SE (www.nrf.ac.za/). Sea Search Africa Pty provided travel funding to TG (www.seasearch.co.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author(s) GH and FL received no specific funding for this work. The funder provided support in the form of salaries for authors as follows: Claude Leon Post Doctoral Fellowship to TG, National Research Foundation Fellowship to SE. Salaries from SAAMBR uShaka Sea World to GH and FL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen SJ, 2016, MOL ECOL, V25, P2735, DOI 10.1111/mec.13622; Amaral AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083645; Amir Omar A., 2005, Western Indian Ocean Journal of Marine Science, V4, P85; ARNASON U, 1993, J MOL EVOL, V37, P312; ARNASON U, 1991, HEREDITAS, V115, P183, DOI 10.1111/j.1601-5223.1991.tb03554.x; Arnold M.L., 2015, DIVERGENCE GENETIC E; Baird RW, 1998, CAN J ZOOL, V76, P198, DOI 10.1139/z97-175a; Berube M, 1998, MAR MAMMAL SCI, V14, P82, DOI 10.1111/j.1748-7692.1998.tb00692.x; Best P, 2007, WHALES DOLPHINS SO A; Brown AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101427; Caballero S, 2010, ZOO BIOL, V29, P647, DOI 10.1002/zoo.20299; Charlton Kate, 2006, Journal of Cetacean Research and Management, V8, P173; Charlton-Robb K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024047; Chen I, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3232-8; COCKCROFT VG, 1990, FISH B-NOAA, V88, P289; DOHL TP, 1974, J MAMMAL, V55, P217, DOI 10.2307/1379276; Duffield DA, 1998, WORLD MAR MAMM SCI C, DOI [10.1644/13-mamm-a-007.1, DOI 10.1644/13-MAMM-A-007.1]; Erbs F, 2017, J ACOUST SOC AM, V141, P2489, DOI 10.1121/1.4978000; Falush D, 2003, GENETICS, V164, P1567; Glover KA, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-25; Glover KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015197; Gridley T, 2012, J ACOUST SOC AM, V132, P4032, DOI 10.1121/1.4763990; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hale P. T., 2000, Aquatic Mammals, V26, P101; HEIDEJORGENSEN MP, 1993, MAR MAMMAL SCI, V9, P258, DOI 10.1111/j.1748-7692.1993.tb00454.x; HERSHKOVITZ P, 1966, US NATL MUSEUM B, V246, P1; Hodgins Nicola K., 2014, Marine Biodiversity Records, V7, pe97, DOI 10.1017/S175526721400089X; Hoelzel AR, 1992, MOL GENETIC ANAL POP; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hybridism Berube M., 2009, ENCY MARINE MAMMALS, P588; Kasuya T., 1985, P253; Kemper CM, 2014, J MAMMAL, V95, P357, DOI 10.1644/13-MAMM-A-007.1; Kingston Sarah E., 2009, BMC Evolutionary Biology, V9; Krzyszczyk E, 2012, MAR MAMMAL SCI, V28, P295, DOI 10.1111/j.1748-7692.2011.00483.x; LeDuc RG, 1999, MAR MAMMAL SCI, V15, P619, DOI 10.1111/j.1748-7692.1999.tb00833.x; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Martien KK, 2012, MAR MAMMAL SCI, V28, pE208, DOI 10.1111/j.1748-7692.2011.00506.x; McClellan HL, 2008, NUTR RES REV, V21, P97, DOI 10.1017/S0954422408100749; McGowen MR, 2011, MOL PHYLOGENET EVOL, V60, P345, DOI 10.1016/j.ympev.2011.05.003; Miralles L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160080; Miralles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069511; Moura AE, 2013, SYST BIOL, V62, P865, DOI 10.1093/sysbio/syt051; Natoli A, 2005, P ROY SOC B-BIOL SCI, V272, P1217, DOI 10.1098/rspb.2005.3076; Natoli A, 2004, J EVOLUTION BIOL, V17, P363, DOI 10.1046/j.1420-9101.2003.00672.x; Nowak R, 2000, REV REPROD, V5, P153, DOI 10.1530/ror.0.0050153; O'Regan HJ, 2005, MAMMAL REV, V35, P215, DOI 10.1111/j.1365-2907.2005.00070.x; Oftedal OT, 1997, J MAMMARY GLAND BIOL, V2, P205, DOI 10.1023/A:1026328203526; Oremus M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140524; PEDDEMORS VM, 1989, S AFR J MARINE SCI, V8, P345, DOI 10.2989/02577618909504574; PEDDEMORS VM, 1992, S AFR J ZOOL, V27, P74, DOI 10.1080/02541858.1992.11448265; Plon S, 2012, ORGAN WEIGHTS 3 DOLP, P265; Pritchard JK, 2000, GENETICS, V155, P945; Reyes JC, 1996, MAR MAMMAL SCI, V12, P301, DOI 10.1111/j.1748-7692.1996.tb00581.x; Rice D. W., 1998, SOC MARINE MAMMALOGY, V4, P1; RIDGWAY S, 1995, MAR MAMMAL SCI, V11, P172, DOI 10.1111/j.1748-7692.1995.tb00516.x; Robeck TR, 2015, J MAMMAL, V96, P1055, DOI 10.1093/jmammal/gyv113; Ross G.J.B., 1990, P101; ROSS G J B, 1977, Annals of the Cape Provincial Museums Natural History, V11, P135; Schaurich Miriane do Nascimento, 2012, Neotropical Biology and Conservation, V7, P199, DOI 10.4013/nbc.2012.73.06; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; SPILLIAERT R, 1991, J HERED, V82, P269, DOI 10.1093/oxfordjournals.jhered.a111085; SYLVESTRE J-P, 1985, Aquatic Mammals, V11, P101; Viaud-Martinez KA, 2008, BIOL CONSERV, V141, P1600, DOI 10.1016/j.biocon.2008.04.004; Vilstrup JT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-65; Wang JY, 2000, J MAMMAL, V81, P1157, DOI 10.1644/1545-1542(2000)081<1157:DITEMO>2.0.CO;2; Wang JY, 1999, MOL ECOL, V8, P1603, DOI 10.1046/j.1365-294x.1999.00741.x; Willis PM, 2004, CAN J ZOOL, V82, P828, DOI 10.1139/Z04-059; Yang GA, 2005, RAFFLES B ZOOL, V53, P157; Zornetzer HR, 2003, CAN J ZOOL, V81, P1755, DOI 10.1139/Z03-150	69	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2018	13	9							e0201722	10.1371/journal.pone.0201722	http://dx.doi.org/10.1371/journal.pone.0201722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7EB	30208020	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000444683000010
J	Orlacchio, A; Stark, AE; Foray, C; Amari, F; Sheetz, T; Reese, E; Tessari, A; La Perle, K; Palmieri, D; Tsichlis, PN; Coppola, V				Orlacchio, Arturo; Stark, Aaron E.; Foray, Claudia; Amari, Foued; Sheetz, Tyler; Reese, Erika; Tessari, Anna; La Perle, Krista; Palmieri, Dario; Tsichlis, Philip N.; Coppola, Vincenzo			Genetic ablation of interacting with Spt6 (Iws1) causes early embryonic lethality	PLOS ONE			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; IN-VIVO; TRANSCRIPTION; PROTEIN; EXPORT; METHYLATION; EXPRESSION; ABUNDANCE; REVEALS	IWS1 is an RNA-polymerase II (RNAPII)-associated transcription elongation factor whose biological functions are poorly characterized. To shed some light on the function of this protein at the organismal level, we performed a systematic tissue analysis of its expression and generated IWS1-deficient mice. A thorough immunohistochemical characterization shows that IWS1 protein is present in the nucleus of all cells in most of the examined tissues, with few notable exceptions. We also report that ablation of IWS1 consistently causes lethality at the pre-implantation stage with high expression of the gene in fertilized oocytes. In summary, we are providing evidence that IWS1 is expressed in all adult organs and it is an essential gene for mouse embryonic development.	[Orlacchio, Arturo; Foray, Claudia; Sheetz, Tyler; Reese, Erika; Tessari, Anna; Palmieri, Dario; Coppola, Vincenzo] Ohio State Univ, Coll Med, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Orlacchio, Arturo; Stark, Aaron E.; Foray, Claudia; Amari, Foued; Sheetz, Tyler; Reese, Erika; Tessari, Anna; La Perle, Krista; Palmieri, Dario; Coppola, Vincenzo] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Stark, Aaron E.; Amari, Foued] Ohio State Univ, Genetically Engn Mouse Modeling Core, Columbus, OH 43210 USA; [La Perle, Krista] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA; [La Perle, Krista] Comparat Pathol & Mouse Phenotyping Shared Resour, Columbus, OH USA; [Tsichlis, Philip N.] Tufts Med Sch, Mol Oncol Res Inst, Boston, MA USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Tufts Medical Center; Tufts University	Coppola, V (corresponding author), Ohio State Univ, Coll Med, Dept Canc Biol & Genet, Columbus, OH 43210 USA.; Coppola, V (corresponding author), Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA.	vincenzo.coppola@osumc.edu	Foray, Claudia/AAU-5895-2021; Coppola, Vincenzo/D-5352-2014; Amari, Foued/AAA-2504-2022; orlacchio, arturo/Q-3110-2019; La Perle, Krista Marie DuBray/B-3099-2015	Coppola, Vincenzo/0000-0001-6163-1779; Amari, Foued/0000-0003-4904-877X; orlacchio, arturo/0000-0002-6044-4258; Foray, Claudia/0000-0003-0384-5765; Palmieri, Dario/0000-0002-0797-4268; Sheetz, Tyler/0000-0002-4440-1477	NIH/NCI [5R01CA198117]; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA198117] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH/NCI grant 5R01CA198117 to V.C. and P.N.T.	Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Caserta E, 2015, GENE DEV, V29, P1707, DOI 10.1101/gad.262568.115; Diebold ML, 2010, EMBO J, V29, P3979, DOI 10.1038/emboj.2010.272; Fischbeck JA, 2002, GENETICS, V162, P1605; Hoernes TP, 2016, RNA BIOL, V13, P760, DOI 10.1080/15476286.2016.1203504; Johnson AW, 2014, CURR BIOL, V24, pR127, DOI 10.1016/j.cub.2013.12.013; Koch M, 2010, ACTA CRYSTALLOGR F, V66, P207, DOI 10.1107/S1744309109052749; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Liu ZG, 2007, BIOCHEM BIOPH RES CO, V353, P47, DOI 10.1016/j.bbrc.2006.11.133; McDonald SM, 2010, MOL CELL, V40, P725, DOI 10.1016/j.molcel.2010.11.014; Piovan C, 2014, METHODS MOL BIOL, V1194, P203, DOI 10.1007/978-1-4939-1215-5_11; Pujari V, 2010, J MOL BIOL, V404, P1, DOI 10.1016/j.jmb.2010.09.040; Sanidas I, 2014, MOL CELL, V53, P577, DOI 10.1016/j.molcel.2013.12.018; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; SWANSON MS, 1990, MOL CELL BIOL, V10, P4935, DOI 10.1128/MCB.10.9.4935; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008	22	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2018	13	9							e0201030	10.1371/journal.pone.0201030	http://dx.doi.org/10.1371/journal.pone.0201030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7EB	30208029	Green Published, gold, Green Submitted			2022-12-26	WOS:000444683000006
J	Mozaffari, SV; Stein, MM; Magnaye, KM; Nicolae, DL; Ober, C				Mozaffari, Sahar, V; Stein, Michelle M.; Magnaye, Kevin M.; Nicolae, Dan L.; Ober, Carole			Parent of origin gene expression in a founder population identifies two new candidate imprinted genes at known imprinted regions	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; DNA METHYLATION ANALYSIS; NONCODING RNA; HUMAN-DISEASE; GENOME; GROWTH; MOUSE; MALIGNANCIES; MICROARRAY; P57(KIP2)	Genomic imprinting is the phenomena that leads to silencing of one copy of a gene inherited from a specific parent. Mutations in imprinted regions have been involved in diseases showing parent of origin effects. Identifying genes with evidence of parent of origin expression patterns in family studies allows the detection of more subtle imprinting. Here, we use allele specific expression in lymphoblastoid cell lines from 306 Hutterites related in a single pedigree to provide formal evidence for parent of origin effects. We take advantage of phased genotype data to assign parent of origin to RNA-seq reads in individuals with gene expression data. Our approach identified known imprinted genes, two putative novel imprinted genes, PXDC1 and PWAR6, and 14 genes with asymmetrical parent of origin gene expression. We used gene expression in peripheral blood leukocytes (PBL) to validate our findings, and then confirmed imprinting control regions (ICRs) using DNA methylation levels in the PBLs.	[Mozaffari, Sahar, V; Nicolae, Dan L.; Ober, Carole] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Mozaffari, Sahar, V; Stein, Michelle M.; Magnaye, Kevin M.; Nicolae, Dan L.; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Nicolae, Dan L.] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Mozaffari, SV (corresponding author), Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA.; Mozaffari, SV (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	smozaffari@uchicago.edu		Stein, Michelle/0000-0002-7680-9012; Magnaye, Kevin/0000-0002-9425-1825; Mozaffari, Sahar/0000-0002-8216-1670; Nicolae, Dan/0000-0002-0918-4630; Ober, Carole/0000-0003-4626-9809	National Institutes of Health (NIH) [HL085197, HD21244]; NIH [1S10OD018495-01, T32 GM007197]; Ruth L. Kirschstein NRSA Award [F31HL134315]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL143891, F31HL134315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein NRSA Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) (http://www.nih.gov/) grants HL085197 (C.O.) and HD21244 (C.O.); and in part by NIH through resources provided by the Computation Institute and the Biological Sciences Division of the University of Chicago and Argonne National Laboratory, under grant 1S10OD018495-01. S.V.M. has been supported by NIH Grant T32 GM007197 and the Ruth L. Kirschstein NRSA Award F31HL134315. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz LK, 2012, CURR OPIN GENET DEV, V22, P72, DOI 10.1016/j.gde.2011.12.001; Al Adhami H, 2015, GENOME RES, V25, P353, DOI 10.1101/gr.175919.114; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Babak T, 2015, NAT GENET, V47, P544, DOI 10.1038/ng.3274; Banovich NE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004663; Baran Y, 2015, GENOME RES, V25, P927, DOI 10.1101/gr.192278.115; Barlow DP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018382; Benonisdottir S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13490; Boucher J, 2014, P NATL ACAD SCI USA, V111, P14512, DOI 10.1073/pnas.1415475111; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; Cusanovich DA, 2016, HUM MOL GENET, V25, P2104, DOI 10.1093/hmg/ddw061; Daelemans C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-25; Dobin A, 2002, MAPPING RNA SEQ READ, DOI [10.1002/0471250953.bi1114s51, DOI 10.1002/0471250953.BI1114S51]; Docherty LE, 2014, J MED GENET, V51, P229, DOI 10.1136/jmedgenet-2013-102116; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Falls JG, 1999, AM J PATHOL, V154, P635, DOI 10.1016/S0002-9440(10)65309-6; Garg P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041695; HATADA I, 1995, NAT GENET, V11, P204, DOI 10.1038/ng1095-204; Hoffmann AK, 2014, FASEB J, V28, P3075, DOI 10.1096/fj.13-247049; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Joshi RS, 2016, AM J HUM GENET, V99, P555, DOI 10.1016/j.ajhg.2016.06.032; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kalish JM, 2014, INT J DEV BIOL, V58, P291, DOI 10.1387/ijdb.140077mb; KALSCHEUER VM, 1993, NAT GENET, V5, P74, DOI 10.1038/ng0993-74; Kang LH, 2015, EUR J CANCER, V51, P260, DOI 10.1016/j.ejca.2014.10.031; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li J, 2004, P NATL ACAD SCI USA, V101, P7341, DOI 10.1073/pnas.0308195101; Livne OE, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004139; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Luo WW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163915; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matsuoka S, 1996, P NATL ACAD SCI USA, V93, P3026, DOI 10.1073/pnas.93.7.3026; Nicholls RD, 1989, GENETIC IMPRINTING S; Nicodemus-Johnson J, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90151; Pariante P, 2016, J CELL PHYSIOL, V231, P2172, DOI 10.1002/jcp.25330; Peters J, 2014, NAT REV GENET, V15, P517, DOI 10.1038/nrg3766; Plasschaert RN, 2014, DEVELOPMENT, V141, P1805, DOI 10.1242/dev.101428; REIK W, 1989, TRENDS GENET, V5, P331, DOI 10.1016/0168-9525(89)90138-8; Santoni FA, 2017, AM J HUM GENET, V100, P444, DOI 10.1016/j.ajhg.2017.01.028; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Strichman-Almashanu LZ, 2003, GENOME RES, V13, P800, DOI 10.1101/gr.893803; Sun JN, 2014, NUCLEIC ACIDS RES, V42, P9588, DOI 10.1093/nar/gku549; van de Geijn B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/nmeth.3582]; Zoledziewska M, 2015, NAT GENET, V47, P1352, DOI 10.1038/ng.3403	47	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203906	10.1371/journal.pone.0203906	http://dx.doi.org/10.1371/journal.pone.0203906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204804	Green Published, Green Submitted, gold			2022-12-26	WOS:000444355500057
J	Cheng, HY; Tay, SKL; Wen, CJ; Lin, CF; Wang, AYL; Shih, LY; Liu, SC; Kobayashi, E; Lin, CH; Wei, FC				Cheng, Hui-Yun; Tay, Sheri K. L.; Wen, Chih-Jen; Lin, Chih-Fan; Wang, Aline Yen-Ling; Shih, Ling-Yi; Liu, Shiao-Chin; Kobayashi, Eiji; Lin, Cheng-Hung; Wei, Fu-Chan			Bioimaging of alloantigen-stimulated regulatory T cells in rat vascularized composite allotransplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; STEM-CELLS; LIVER-TRANSPLANTATION; FACE TRANSPLANTATION; IMMUNE-RESPONSE; TOLERANCE; EXPRESSION; MIGRATION; RECEPTOR; TISSUE	Background Tipping the balance toward regulatory T cells (Tregs) through adoptive cell therapy has shown promise to induce transplantation tolerance. Although such strategy has been explored in many mice organ transplantation studies, less knowledge was available in rat systems. Furthermore, the behaviors of the transferred cells have not been well studied in real-time fashion. Methods Tregs from naive LEW rats were purified in two steps with the autoMACS system. Immunosuppression potential of these cells was examined with mixed lymphocyte reaction. Following stimulation by the alloantigen in vitro, the purified Tregs were infused into the recipients of vascularized composite allotransplantation (VCA). Secondary allogeneic skin grafting challenge was performed on the recipients with long-term survived VCA. Live optical imaging was performed to track luciferase-expressing Tregs following infusion to the VCA recipients. Expression of relevant molecules was studied by flow cytometry or quantitative RTPCR. Results Rat Tregs were enriched following two-step cell sorting and showed immunosuppressive capacity. Upon infusion into the VCA recipients that have been treated with antilymphocyte serum and short-term Cyclosporin A, the antigen-stimulated Tregs significantly prolonged VCA survival and induced donor-specific tolerance. Tracking of the infused bioluminescent Tregs showed their specific homing to lymph nodes, and then to the VCAs. Following secondary skin grafting, Tregs specifically gathered at the donor-derived skin that was not rejected by the recipient. The in vivo migratory pattern coincided with the altered expression of cell surface molecules of CD62L, CD103, CD134, and CD278, following donor-antigen stimulation. Elevated expression of CCR4 and CCL22 in allograft may also participate in recruiting Tregs for maintenance of VCA survival and promoting donor-specific tolerance. Conclusion Sorted Tregs induced donor-specific tolerance to VCA in rats. Live cell tracking demonstrated that activated CD4(+)CD25(+)FoxP3(+) Tregs targeted primarily to the lymph nodes and VCA. The Tregs migrated to the secondary grafted donor skin and contributed to the maintenance of donor-specific tolerance. These behaviors were associated with phenotypic changes induced by donor antigen stimulation. Increased expression of CCR4 and CCL22 in VCA skin may also be relevant.	[Cheng, Hui-Yun; Wen, Chih-Jen; Lin, Chih-Fan; Wang, Aline Yen-Ling; Lin, Cheng-Hung; Wei, Fu-Chan] Linkou Chang Gung Mem Hosp, Ctr Vascularized Composite Allotransplantat, Taoyuan, Taiwan; [Tay, Sheri K. L.; Shih, Ling-Yi; Liu, Shiao-Chin; Lin, Cheng-Hung; Wei, Fu-Chan] Linkou Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Taoyuan, Taiwan; [Tay, Sheri K. L.] Glasgow Royal Infirm, Canniesburn Plast Surg Unit, Glasgow, Lanark, Scotland; [Kobayashi, Eiji] Keio Univ, Dept Organ Fabricat, Sch Med, Tokyo, Japan; [Wei, Fu-Chan] Chang Gung Univ, Sch Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; University of Glasgow; Keio University; Chang Gung University	Cheng, HY (corresponding author), Linkou Chang Gung Mem Hosp, Ctr Vascularized Composite Allotransplantat, Taoyuan, Taiwan.	hycheng21@gmail.com	Wang, Aline/ABE-7593-2021	Wang, Aline/0000-0001-6272-6948; LIN, Chih-Fan/0000-0002-7529-4475	Chang Gung Medical Foundation [CMRPG3E1511, CMRPG3F2171]; National Science Council [NSC 102-2314-B-182-015, NSC 99-2314-B-182-016-MY2]	Chang Gung Medical Foundation; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by Chang Gung Medical Foundation: CMRPG3E1511, CMRPG3F2171 and National Science Council: NSC 102-2314-B-182-015, NSC 99-2314-B-182-016-MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CM, 2009, TRANSPLANTATION, V87, P857, DOI 10.1097/TP.0b013e318199fa57; Bestard O, 2007, J IMMUNOL, V179, P4901, DOI 10.4049/jimmunol.179.7.4901; Bluestone JA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad4134; Braun A, 2015, J INVEST DERMATOL, V135, P2982, DOI 10.1038/jid.2015.287; Brinkman CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12021; Burrell BE, 2012, J IMMUNOL, V189, P4705, DOI 10.4049/jimmunol.1202027; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Carvalho-Gaspar M, 2008, J IMMUNOL, V180, P6640, DOI 10.4049/jimmunol.180.10.6640; Chauhan SK, 2014, J IMMUNOL, V192, P817, DOI 10.4049/jimmunol.1203469; Chen Y, 2012, J IMMUNOL, V188, P1698, DOI 10.4049/jimmunol.1102448; Cheng HY, 2014, CYTOTHERAPY, V16, P369, DOI 10.1016/j.jcyt.2013.06.020; Ding YZ, 2012, TRENDS IMMUNOL, V33, P174, DOI 10.1016/j.it.2012.01.002; Edozie FC, 2014, TRANSPLANTATION, V98, P370, DOI 10.1097/TP.0000000000000243; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Foster AE, 2004, BLOOD, V104, P2403, DOI 10.1182/blood-2003-12-4431; Hakamata Y, 2006, TRANSPLANTATION, V81, P1179, DOI 10.1097/01.tp.0000203137.06587.4a; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Kuo YR, 2011, PLAST RECONSTR SURG, V128, p661E, DOI 10.1097/PRS.0b013e318230c60b; Kuo YR, 2011, PLAST RECONSTR SURG, V127, P569, DOI 10.1097/PRS.0b013e318200a92c; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Leonard DA, 2014, IMMUNOTHERAPY-UK, V6, P499, DOI [10.2217/IMT.14.29, 10.2217/imt.14.29]; Lin JY, 2012, J SURG RES, V178, P974, DOI 10.1016/j.jss.2012.06.061; Miura Y, 2005, TRANSPL P, V37, P57, DOI 10.1016/j.transproceed.2005.01.014; Murphy BD, 2013, J PLAST RECONSTR AES, V66, P1449, DOI 10.1016/j.bjps.2013.06.037; Nguyen VH, 2007, BLOOD, V109, P2649, DOI 10.1182/blood-2006-08-044529; Page EK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00198; Pu LY, 2007, SURGERY, V142, P67, DOI 10.1016/j.surg.2007.02.014; Qu YY, 2007, INT REV IMMUNOL, V26, P145, DOI 10.1080/08830180701365917; Roos A, 1998, J LEUKOCYTE BIOL, V64, P503, DOI 10.1002/jlb.64.4.503; Sanchez-Fueyo A, 2006, J IMMUNOL, V176, P329, DOI 10.4049/jimmunol.176.1.329; Schneeberger S, 2011, TRANSPL INT, V24, P760, DOI 10.1111/j.1432-2277.2011.01261.x; Siemionow M, 2013, CURR OPIN ORGAN TRAN, V18, P633, DOI 10.1097/MOT.0000000000000021; Siemionow M, 2012, CLIN PLAST SURG, V39, P425, DOI 10.1016/j.cps.2012.07.011; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Todo S, 2016, HEPATOLOGY, V64, P632, DOI 10.1002/hep.28459; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Xia G, 2008, AM J TRANSPLANT, V8, P298, DOI 10.1111/j.1600-6143.2007.02088.x; Xiong YB, 2016, J IMMUNOL, V196, P2526, DOI 10.4049/jimmunol.1502537; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022; Zhao DC, 2008, BLOOD, V112, P2129, DOI 10.1182/blood-2008-02-140277	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203624	10.1371/journal.pone.0203624	http://dx.doi.org/10.1371/journal.pone.0203624			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192879	gold, Green Submitted, Green Published			2022-12-26	WOS:000444093600121
J	Kofink, D; Muller, SA; Patel, RS; Dorresteijn, JAN; Berkelmans, GFN; de Groot, MCH; van Solinge, WW; Haitjema, S; Leiner, T; Visseren, FLJ; Hoefer, IE; Asselbergs, FW				Kofink, Daniel; Muller, Steven A.; Patel, Riyaz S.; Dorresteijn, Jannick A. N.; Berkelmans, Gijs F. N.; de Groot, Mark C. H.; van Solinge, Wouter W.; Haitjema, Saskia; Leiner, Tim; Visseren, Frank L. J.; Hoefer, Imo E.; Asselbergs, Folkert W.		Smart Study Grp	Routinely measured hematological parameters and prediction of recurrent vascular events in patients with clinically manifest vascular disease	PLOS ONE			English	Article							CELL DISTRIBUTION WIDTH; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; ARTERIAL-DISEASE; LYMPHOCYTE COUNT; UNSTABLE ANGINA; RISK; MORTALITY; ACTIVATION	Background and aims The predictive value of traditional risk factors for vascular events in patients with manifest vascular disease is limited, underscoring the need for novel biomarkers to improve risk stratification. Since hematological parameters are routinely assessed in clinical practice, they are readily available candidates. Methods We used data from 3,922 vascular patients, who participated in the Second Manifestations of ARTerial Disease (SMART) study. We first investigated associations between recurrent vascular events and 22 hematological parameters, obtained from the Utrecht Patient Oriented Database (UPOD), and then assessed whether parameters associated with outcome improved risk prediction. Results After adjustment for all SMART risk score (SRS) variables, lymphocyte %, neutrophil count, neutrophil % and red cell distribution width (RDW) were significantly associated with vascular events. When individually added to the SRS, lymphocyte % improved prediction of recurrent vascular events with a continuous net reclassification improvement (cNRI) of 17.4% [95% CI: 2.1, 32.1%] and an increase in c-statistic of 0.011 [0.000, 0.022]. The combination of lymphocyte % and neutrophil count resulted in a cNRI of 22.2% [3.2, 33.4%] and improved c-statistic by 0.011 [95% CI: 0.000, 0.022]. Lymphocyte % and RDW yielded a cNRI of 18.7% [3.3, 31.9%] and improved c-statistic by 0.016 [0.004, 0.028]. However, the addition of hematological parameters only modestly increased risk estimates for patients with an event during follow-up. Conclusions Several hematological parameters were independently associated with recurrent vascular events. Lymphocyte % alone and in combination with other parameters enhanced discrimination and reclassification. However, the incremental value for patients with a recurrent event was limited.	[Kofink, Daniel; Muller, Steven A.; Asselbergs, Folkert W.] Univ Utrecht, Univ Med Utrecht, Dept Cardiol, Utrecht, Netherlands; [Patel, Riyaz S.; Asselbergs, Folkert W.] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London, England; [Patel, Riyaz S.] St Bartholomews Hosp, Barts Heart Ctr, London, England; [Dorresteijn, Jannick A. N.; Berkelmans, Gijs F. N.; Visseren, Frank L. J.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Vasc Med, Utrecht, Netherlands; [de Groot, Mark C. H.] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [van Solinge, Wouter W.; Haitjema, Saskia; Hoefer, Imo E.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Clin Chem & Hematol, Utrecht, Netherlands; [Leiner, Tim] Univ Utrecht, Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Asselbergs, Folkert W.] ICIN Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands	Utrecht University; University of London; University College London; University of London; Queen Mary University London; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Asselbergs, FW (corresponding author), Univ Utrecht, Univ Med Utrecht, Dept Cardiol, Utrecht, Netherlands.; Asselbergs, FW (corresponding author), UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London, England.; Asselbergs, FW (corresponding author), ICIN Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands.	f.w.asselbergs@umcutrecht.nl	de Groot, Mark CH/A-9891-2012; Asselbergs, Folkert W./ABD-6752-2021	de Groot, Mark CH/0000-0002-5764-5788; Asselbergs, Folkert W./0000-0002-1692-8669; Muller, Steven/0000-0002-2674-8709; Van Solinge, Wouter/0000-0003-2867-2581; Visseren, Frank/0000-0003-3951-5223	Dekker scholarship-Junior Staff Member - Netherlands Heart Foundation [2014T001]; UCL Hospitals NIHR Biomedical Research Centre	Dekker scholarship-Junior Staff Member - Netherlands Heart Foundation; UCL Hospitals NIHR Biomedical Research Centre	Folkert W. Asselbergs is supported by a Dekker scholarship-Junior Staff Member 2014T001 - Netherlands Heart Foundation and UCL Hospitals NIHR Biomedical Research Centre.	Ani C, 2009, J NEUROL SCI, V277, P103, DOI 10.1016/j.jns.2008.10.024; Antolini L, 2004, COMMUN STAT-THEOR M, V33, P2117, DOI 10.1081/STA-200026579; Azab B, 2012, J THROMB THROMBOLYS, V34, P326, DOI 10.1007/s11239-012-0718-6; Azab B, 2010, AM J CARDIOL, V106, P470, DOI 10.1016/j.amjcard.2010.03.062; Balta S, 2016, CLIN APPL THROMB-HEM, V22, P405, DOI 10.1177/1076029615569568; Beatty AL, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001646; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dabbah S, 2010, AM J CARDIOL, V105, P312, DOI 10.1016/j.amjcard.2009.09.027; DAGOSTINO RB, 1991, BRIT MED J, V303, P385, DOI 10.1136/bmj.303.6799.385; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Dorresteijn JAN, 2013, HEART, V99, P866, DOI 10.1136/heartjnl-2013-303640; Dragu R, 2008, ATHEROSCLEROSIS, V196, P405, DOI 10.1016/j.atherosclerosis.2006.11.022; Eggers KM, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0840-3; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gijsberts CM, 2016, EUR J PREV CARDIOL, V23, P1211, DOI 10.1177/2047487315621832; Gijsberts CM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001992; Hartaigh BO, 2012, ATHEROSCLEROSIS, V224, P161, DOI 10.1016/j.atherosclerosis.2012.04.012; Horne BD, 2005, J AM COLL CARDIOL, V45, P1638, DOI 10.1016/j.jacc.2005.02.054; Liuzzo G, 2007, J AM COLL CARDIOL, V49, P185, DOI 10.1016/j.jacc.2006.07.071; Mendis S, 2011, GLOBAL ATLAS VASCULA; Montagnana M, 2012, CLIN CHEM LAB MED, V50, P635, DOI [10.1515/CCLM.2011.831, 10.1515/cclm.2011.831]; Nunez J, 2009, ATHEROSCLEROSIS, V206, P251, DOI 10.1016/j.atherosclerosis.2009.01.029; Ommen SR, 1997, AM J CARDIOL, V79, P812, DOI 10.1016/S0002-9149(96)00878-8; Pasqui AL, 2003, CLIN EXP MED, V3, P37, DOI 10.1007/s102380300014; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Ridker PM, 2017, N ENGL J MED; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Simons PCG, 1999, EUR J EPIDEMIOL, V15, P773, DOI 10.1023/A:1007621514757; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.727545; Ye Z, 2011, AM J CARDIOL, V107, P1241, DOI 10.1016/j.amjcard.2010.12.023; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zouridakis EG, 2000, AM J CARDIOL, V86, P449, DOI 10.1016/S0002-9149(00)00963-2	34	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202682	10.1371/journal.pone.0202682	http://dx.doi.org/10.1371/journal.pone.0202682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192769	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600028
J	Reese, MJ; Knapp, DW; Anderson, KM; Mund, JA; Case, J; Jones, DR; Packer, RA				Reese, Michael J.; Knapp, Deborah W.; Anderson, Kimberly M.; Mund, Julie A.; Case, Jamie; Jones, David R.; Packer, Rebecca A.			In vitro effect of chlorambucil on human glioma cell lines (SF767 and U87-MG), and human microvascular endothelial cell (HMVEC) and endothelial progenitor cells (ECFCs), in the context of plasma chlorambucil concentrations in tumor-bearing dogs	PLOS ONE			English	Article							DOSE METRONOMIC CHEMOTHERAPY; RECURRENT GLIOBLASTOMA; MALIGNANT GLIOMAS; PHASE-II; ANGIOGENESIS; PHARMACOKINETICS; DRUG; CANCER; TRIAL; NEUROONCOLOGY	The objective of this study was to investigate a possible mechanism of action of metronomic chlorambucil on glioma by studying the in vitro cytotoxicity and anti-angiogenic effects on glioma and endothelial cells, respectively. The in vitro LD50 and IC50 of chlorambucil were determined using human SF767 and U87-MG glioma cell lines, human microvascular endothelial cells (HMVECs) and human endothelial colony forming cells (ECFCs). Results were analyzed in the context of chlorambucil concentrations measured in the plasma of tumorbearing dogs receiving 4 mg m(-2) metronomic chlorambucil. The LD50 and IC50 of chlorambucil were 270 mu M and 114 mu M for SF767, and 390 mu M and 96 mu M for U87-MG, respectively. The IC50 of chlorambucil was 0.53 mu M and 145 mu M for the HMVECs and ECFCs, respectively. In pharmacokinetic studies, the mean plasma C-max of chlorambucil was 0.06 mu M. Results suggest that metronomic chlorambucil in dogs does not achieve plasma concentrations high enough to cause direct cytotoxic or growth inhibitory effects on either glioma or endothelial cells.	[Reese, Michael J.; Knapp, Deborah W.; Anderson, Kimberly M.; Packer, Rebecca A.] Purdue Univ, Dept Vet Clin Sci, Coll Vet Med, W Lafayette, IN 47907 USA; [Knapp, Deborah W.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Mund, Julie A.; Case, Jamie] Indiana Univ, Simon Canc Ctr, Angio BioCore, Indianapolis, IN 46204 USA; [Jones, David R.] Indiana Univ Sch Med, Dept Med, Div Clin Pharmacol, Indianapolis, IN 46202 USA; [Reese, Michael J.] Southeast Vet Neurol, Miami, FL USA; [Anderson, Kimberly M.] Univ Tennessee, Coll Vet Med, Dept Small Anim Clin Sci, Knoxville, TN USA; [Case, Jamie] Scripps Ctr Organ & Cell Transplantat, Scripps Clin Med Grp, La Jolla, CA USA; [Packer, Rebecca A.] Colorado State, Dept Clin Sci, Coll Vet Med & Biomed Sci, Ft Collins, CO 80521 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Scripps Research Institute	Packer, RA (corresponding author), Purdue Univ, Dept Vet Clin Sci, Coll Vet Med, W Lafayette, IN 47907 USA.; Packer, RA (corresponding author), Colorado State, Dept Clin Sci, Coll Vet Med & Biomed Sci, Ft Collins, CO 80521 USA.	Rebecca.Packer@colostate.edu			Clinical Pharmacology Analytical Core laboratory, a core laboratory of the Indiana University Melvin and Bren Simon Cancer Center - National Cancer Institute [P30 CA082709]; Purdue University College of Veterinary Medicine; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER	Clinical Pharmacology Analytical Core laboratory, a core laboratory of the Indiana University Melvin and Bren Simon Cancer Center - National Cancer Institute; Purdue University College of Veterinary Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Analytical work was performed by the Clinical Pharmacology Analytical Core laboratory, a core laboratory of the Indiana University Melvin and Bren Simon Cancer Center supported by the National Cancer Institute grant P30 CA082709. Funding was provided by the Purdue University College of Veterinary Medicine to RAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS DS, 1979, CANCER TREAT REV, V6, P9, DOI 10.1016/S0305-7372(79)80005-5; Bertolini F, 2003, CANCER RES, V63, P4342; Bocci G, 2003, P NATL ACAD SCI USA, V100, P12917, DOI 10.1073/pnas.2135406100; Browder T, 2000, CANCER RES, V60, P1878; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Chen YL, 2017, CANCER LETT, V400, P282, DOI 10.1016/j.canlet.2017.01.040; Choi LMR, 2008, PEDIATR BLOOD CANCER, V50, P970, DOI 10.1002/pbc.21381; Custead MR, 2017, VET COMP ONCOL, V15, P808, DOI 10.1111/vco.12222; Decaris ML, 2009, ANGIOGENESIS, V12, P303, DOI 10.1007/s10456-009-9152-6; Dickinson PJ, 2016, J NEUROPATH EXP NEUR, V75, P700, DOI 10.1093/jnen/nlw042; EHRSSON H, 1983, EUR J CLIN PHARMACOL, V24, P251, DOI 10.1007/BF00613827; Ferguson SD, 2011, DM-DIS MON, V57, P558, DOI 10.1016/j.disamonth.2011.08.020; GREIG NH, 1988, CANCER CHEMOTH PHARM, V21, P1; Hanahan D, 2000, J CLIN INVEST, V105, P1045, DOI 10.1172/JCI9872; Herrlinger U, 2005, J NEURO-ONCOL, V71, P295, DOI 10.1007/s11060-004-1726-y; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kargiotis O, 2006, J NEURO-ONCOL, V78, P281, DOI 10.1007/s11060-005-9097-6; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kesari S, 2007, NEURO-ONCOLOGY, V9, P354, DOI 10.1215/15228517-2007-006; Kimmelman J, 2007, CANCER RES, V67, P4541, DOI 10.1158/0008-5472.CAN-06-3792; Kong DS, 2010, NEURO-ONCOLOGY, V12, P289, DOI 10.1093/neuonc/nop030; Koumarianou A, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-3; Leach TN, 2012, VET COMP ONCOL, V10, P102, DOI 10.1111/j.1476-5829.2011.00280.x; LEIFER CE, 1986, J AM VET MED ASSOC, V189, P214; Lima FRS, 2012, BBA-REV CANCER, V1826, P338, DOI 10.1016/j.bbcan.2012.05.004; MACEWEN EG, 1977, VET CLIN N AM, V7, P119; Moliterno JA, 2012, CANCER J, V18, P20, DOI 10.1097/PPO.0b013e3183243f6e3; NEWELL DR, 1983, BRIT J CLIN PHARMACO, V15, P253, DOI 10.1111/j.1365-2125.1983.tb01494.x; Perry JR, 2008, CANCER, V113, P2152, DOI 10.1002/cncr.23813; PLATE KH, 1995, GLIA, V15, P339, DOI 10.1002/glia.440150313; POLVERINI PJ, 1986, BIOCHEM BIOPH RES CO, V140, P901, DOI 10.1016/0006-291X(86)90720-5; Ponce ML, 2001, METH MOLEC MED, V46, P205, DOI 10.1385/1-59259-143-4:205; Reardon DA, 2011, EXPERT OPIN DRUG DIS, V6, P739, DOI 10.1517/17460441.2011.584530; Reitman ZJ, 2010, INT J CANCER, V127, P245, DOI 10.1002/ijc.25017; Schmidt A, 2009, TOXICOLOGY, V263, P32, DOI 10.1016/j.tox.2008.09.015; Schrempp DR, 2013, JAVMA-J AM VET MED A, V242, P1534, DOI 10.2460/javma.242.11.1534; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Snyder JM, 2006, J VET INTERN MED, V20, P669, DOI 10.1892/0891-6640(2006)20[669:CIPNC]2.0.CO;2; Stoica G, 2004, VET PATHOL, V41, P10, DOI 10.1354/vp.41-1-10; Stoica G, 2011, VET PATHOL, V48, P266, DOI 10.1177/0300985810389543; Thomas R, 2009, J NEURO-ONCOL, V94, P333, DOI 10.1007/s11060-009-9877-5; Vail DM., 2013, WITHROW MACEWENS SMA, P608; Veterinary cooperative oncology group D common terminology criteria for adverse events (VCOG-CTCAE), 2011, VET COMP ONCOL, DOI [10.1111/j.1476-5829.2011.00283.x, DOI 10.1111/J.1476-5829.2011.00283.X]	43	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203517	10.1371/journal.pone.0203517	http://dx.doi.org/10.1371/journal.pone.0203517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192852	Green Submitted, Green Published, gold			2022-12-26	WOS:000444093600089
J	Sollgruber, A; Bornemann-Cimenti, H; Szilagyi, IS; Sandner-Kiesling, A				Sollgruber, Anja; Bornemann-Cimenti, Helmar; Szilagyi, Istvan-Szilard; Sandner-Kiesling, Andreas			Spirituality in pain medicine: A randomized experiment of pain perception, heart rate and religious spiritual well-being by using a single session meditation methodology	PLOS ONE			English	Article							MINDFULNESS MEDITATION; STRESS REDUCTION; HEALTH; LIFE; IMPACT; COMPLEMENTARY	The aim of this study is to investigate different effects on pain perception among randomly assigned volunteers practicing meditation compared to a relaxation condition. The study examines whether participants of the experimental conditions (meditation versus relaxation) differ in the change of pain perception and heart rate measurement and in religious and spiritual well-being after an intervention. Method: 147 volunteers (long-term practitioners and novices) were randomly assigned to the experimental conditions with a headphone guided 20-minute single session intervention. The change in their pre- and post-intervention pain perception was measured using Quantitative Sensory Testing and Cold Pressor Testing (CPTest), their stress-level was compared by monitoring heart rate, and their religious and spiritual well-being by using the Multidimensional Inventory for Religious/Spiritual Well-Being (MI-RSB48). Additionally, dimensions of the Brief Symptom Inventory (BSI) measured the psychological resilience of the participants; pain and stress experience, and the state of relaxation and spirituality experience were assessed. Five persons were excluded due to failure in measuring the heart rate and 29 participants had to be excluded because of high values on the BSI. Results: The meditation group showed an increase in their pain tolerance on the CPTest and a decrease in their pain intensity for heat after the experimental condition, in contrast to the relaxation group. Futhermore, the meditation group showed a higher level of religious spiritual well-being (MI-RSB48 Total score) as well as in the sub-dimensions General Religiosity, Forgiveness, and Connectedness after the experimental condition, compared to the relaxation group. Our data is consistent with the hypothesis that meditation increases pain tolerance and reduces pain intensity, however, further work is required to determine whether meditation contains similar implications for pain patients.	[Sollgruber, Anja] Univ Med, Dept Anaesthesiol Pain & Intens Care Med, Graz, Austria; [Bornemann-Cimenti, Helmar; Szilagyi, Istvan-Szilard; Sandner-Kiesling, Andreas] Univ Med, Dept Special Anaesthesiol Pain & Intens Care Med, Graz, Austria		Sollgruber, A (corresponding author), Univ Med, Dept Anaesthesiol Pain & Intens Care Med, Graz, Austria.	anja.sollgruber@stud.medunigraz.at	Bornemann-Cimenti, Helmar/C-1252-2009	Bornemann-Cimenti, Helmar/0000-0002-1201-3752	Doctoral School of General and Clinical Pathophysiology	Doctoral School of General and Clinical Pathophysiology	Special thanks to the Doctoral School of General and Clinical Pathophysiology for the financial assistance for publication fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER CN, 1991, J SOC BEHAV PERS, V6, P189; American Psychological Association, 2009, APA CONC DICT PSYCH; Ang DC, 2006, RHEUMATOL INT, V26, P567, DOI 10.1007/s00296-005-0025-z; Astin JA, 1997, PSYCHOTHER PSYCHOSOM, V66, P97, DOI 10.1159/000289116; Backonja MM, 2009, CLIN J PAIN, V25, P641, DOI 10.1097/AJP.0b013e3181a68c7e; Baer RA, 2003, CLIN PSYCHOL-SCI PR, V10, P125, DOI 10.1093/clipsy/bpg015; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Barnett JE, 2006, RES PRACTICE, V43, P576; Bawa FLM, 2015, BRIT J GEN PRACT, V65, pE387, DOI 10.3399/bjgp15X685297; Bond K, 2009, PSYCHOL RELIG SPIRIT, V1, P129, DOI 10.1037/a0015736; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Brugnoli MP, 2009, CLIN HYPNOSIS SPIRIT; Bussing A, 2009, PAIN MED, V10, P327, DOI 10.1111/j.1526-4637.2009.00572.x; Bush EG, 1999, APPL PSYCHOPHYS BIOF, V24, P249, DOI 10.1023/A:1022234913899; Carmody J, 2008, J BEHAV MED, V31, P23, DOI 10.1007/s10865-007-9130-7; Cohen MM, 2005, J ALTERN COMPLEM MED, V11, P995, DOI 10.1089/acm.2005.11.995; Creswell JD, 2014, CURR DIR PSYCHOL SCI, V23, P401, DOI 10.1177/0963721414547415; Davidson RJ, 2015, AM PSYCHOL, V70, P581, DOI 10.1037/a0039512; Derogatis L.R, 1993, BRIEF SYMPTOM INVENT; Dezutter J, 2010, J SCI STUD RELIG, V49, P507, DOI 10.1111/j.1468-5906.2010.01525.x; Dezutter J, 2010, PAIN MED, V11, P765, DOI 10.1111/j.1526-4637.2010.00827.x; Frankowski G, 2000, P SOC PHOTO-OPT INS, V3958, P90, DOI 10.1117/12.380051; FRUHSTORFER H, 1976, J NEUROL NEUROSUR PS, V39, P1071, DOI 10.1136/jnnp.39.11.1071; Gamelin FX, 2006, MED SCI SPORT EXER, V38, P887, DOI 10.1249/01.mss.0000218135.79476.9c; Grom B, 2007, RELIGIONSPSYCHOLOGIE, P182; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Henschke N, 2015, MAYO CLIN PROC, V90, P139, DOI 10.1016/j.mayocp.2014.09.010; Hilton L, 2017, ANN BEHAV MED, V51, P199, DOI 10.1007/s12160-016-9844-2; Holmes DA, 1985, AM PSYCHOL, V39, P1; Holmes DA, 1987, PSYCHOL MEDITATION, P81; Huguelet P., 2009, RELIG SPIRITUALITY P, P65; Hussain D., 2010, INT J PSYCHOL PSYCHO, V10, P439; Infante JR, 1998, PHYSIOL BEHAV, V64, P311, DOI 10.1016/S0031-9384(98)00071-7; John PJ, 2007, HEADACHE, V47, P654, DOI 10.1111/j.1526-4610.2007.00789.x; Jonckheer-Sheehy VSM, 2012, J VET BEHAV, V7, P205, DOI 10.1016/j.jveb.2011.10.006; Keefe FJ, 2001, J PAIN, V2, P101, DOI 10.1054/jpai.2001.19296; Koenig HG, 2004, SOUTH MED J, V97, P1194, DOI 10.1097/01.SMJ.0000146489.21837.CE; Koenig HG, 2012, HDB RELIG HLTH; Linton SJ, 2005, EUR J PAIN, V9, P355, DOI 10.1016/j.ejpain.2004.08.002; Linton SJ, 2011, PHYS THER, V91, P700, DOI 10.2522/ptj.20100330; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Maier C, 2017, SCHMERZMEDIZIN INTER, P4; Manhas M., 2011, JK SCI, V13, P145; McCracken LM, 2009, J PSYCHOPATHOL BEHAV, V31, P75, DOI 10.1007/s10862-008-9099-8; Melzack R, 2001, J Dent Educ, V65, P1378; Merskey H., 1994, CLASSIFICATION CHRON, P207, DOI DOI 10.1002/ANA.20394; Michenbaum D, 1974, SELF CONTROL POWER P; Miller C, 2006, PAIN MANAG NURS, V7, P148, DOI 10.1016/j.pmn.2006.09.004; Moreira-Almeida A, 2008, CURR PAIN HEADACHE R, V12, P327, DOI 10.1007/s11916-008-0055-9; Nilges P, 2013, PRAKTISCHE SCHMERZME, P79; Pargament K.I., 2013, INT J PSYCHOL RELIG, V1, P3, DOI [DOI 10.1207/S15327582IJPR0901_2, 10.1207/s15327582ijpr0901_2, DOI 10.1037/E568022011-002]; Paul G, 1974, J ABNORM PSYCHOL, V74, P425; PECKERMAN A, 1994, PSYCHOPHYSIOLOGY, V31, P282, DOI 10.1111/j.1469-8986.1994.tb02217.x; Pruitt IT, 2010, VOICES EXPERIENCED M, DOI [10.1007/s10591-009-9112-8, DOI 10.1007/S10591-009-9112-8]; Rashiq S, 2009, PAIN RES MANAG, V14, P454, DOI 10.1155/2009/919628; Reiner K, 2013, PAIN MED, V14, P230, DOI 10.1111/pme.12006; Rippentrop AE, 2005, REHABIL PSYCHOL, V50, P278, DOI 10.1037/0090-5550.50.3.278; Rippentrop AE, 2005, PAIN, V116, P311, DOI 10.1016/j.pain.2005.05.008; Rolke R, 2002, STANDARDISIERTE TEST; Rosenberg EI, 2008, PAIN MED, V9, P1065, DOI 10.1111/j.1526-4637.2008.00477.x; SHAPIRO DH, 1985, AM PSYCHOL, V40, P719; Shapiro DH, 1974, AM J PSYCHIAT, V139, P267; Siddall PJ, 2015, PAIN MED, V16, P51, DOI 10.1111/pme.12511; Thomas JW, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00074; Thorn BE, 2004, COGNITIVE THERAPY CH; Traue H, 2013, PRAKTISCHE SCHMERZME, P117; Turk D. C., 2002, PSYCHOL APPROACHES P, P3; TURNER JA, 1986, PAIN, V24, P355, DOI 10.1016/0304-3959(86)90121-1; Unruh AM, 2007, CAN J NURS RES, V39, P66; Unterrainer HF, 2010, DIAGNOSTICA, V56, P82, DOI 10.1026/0012-1924/a000001; Wachholtz AB, 2005, J BEHAV MED, V28, P369, DOI 10.1007/s10865-005-9008-5; Wachholtz AB, 2006, THESIS; Wachholtz AB, 2008, J BEHAV MED, V31, P351, DOI 10.1007/s10865-008-9159-2; Wachholtz AB, 2007, J BEHAV MED, V30, P311, DOI 10.1007/s10865-007-9114-7; Wachholtz AB, 2017, BEHAV MED, V43, P1, DOI 10.1080/08964289.2015.1024601; Wachholtz AB, 2009, CURR PAIN HEADACHE R, V13, P127, DOI 10.1007/s11916-009-0022-0; Walsh R, 2006, AM PSYCHOL, V61, P227, DOI 10.1037/0003-066X.61.3.227; Wenneberg SR, 1997, INT J NEUROSCI, V89, P15, DOI 10.3109/00207459708988461; Wiech K, 2008, PAIN, V139, P467, DOI 10.1016/j.pain.2008.07.030; Williams ACD, 2016, PAIN, V157, P2420, DOI 10.1097/j.pain.0000000000000613; Wong S. Y. S., 2009, Hong Kong Medical Journal, V15, P13; Zeidan F., 2009, J PAIN, V10, P1016, DOI DOI 10.1016/J.JPAIN.2009.07.015; Zeidan F, 2015, J NEUROSCI, V35, P15307, DOI 10.1523/JNEUROSCI.2542-15.2015; Znoj H. J., 2004, RELIG MESSVERFAHREN, P277	84	10	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203336	10.1371/journal.pone.0203336	http://dx.doi.org/10.1371/journal.pone.0203336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT0BU	30192807	gold, Green Published, Green Submitted			2022-12-26	WOS:000444093600061
J	Agostini, F; Ruzza, M; Corpillo, D; Biondi, L; Acquadro, E; Canepa, B; Viale, A; Battiston, M; Serra, F; Aime, S; Mazzucato, M				Agostini, Francesco; Ruzza, Marta; Corpillo, Davide; Biondi, Luca; Acquadro, Elena; Canepa, Barbara; Viale, Alessandra; Battiston, Monica; Serra, Fabrizio; Aime, Silvio; Mazzucato, Mario			H-1-NMR and MALDI-TOF MS as metabolomic quality control tests to classify platelet derived medium additives for GMP compliant cell expansion procedures	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELL; EX-VIVO EXPANSION; GROWTH-FACTOR; RICH PLASMA; STEM-CELLS; MASS-SPECTROMETRY; THROMBOXANE A(2); STROMAL CELLS; QUANTIFICATION; PROLIFERATION	Introduction Ex vivo cell expansion under Good Manufacturing Practice (GMP) guidelines can be performed using medium additives containing human growth factors from platelets. These products can differently affect proliferation of adipose mesenchymal stromal stem cells (ASC). Qualification of medium additive performance is required for validation under GMP regulations: assessment of growth factor concentrations is not sufficient to predict the biological activity of the product batch. Proton nuclear magnetic resonance spectrometry (H-1-NMR) and matrix-assisted laser desorption/ionization time of flight mass spectroscopy (MALDI-TOF MS) provide wide molecular characterization of samples. Aims We aimed to assess if H-1-NMR and MALDI-TOF MS techniques can be used as quality control test potentially predicting the impact of a medium additive on cell proliferation. Methods We tested the impact on ASC growth rate (cell proliferation assessment and cell morphology analysis) of four medium additives, obtained by different methods from human platelet apheresis product. In order to classify each medium additive, we evaluated growth factor concentrations and spectra obtained by H-1-NMR and by MALDI-TOF MS. Results Medium additive obtained by CaCl2 activation of platelet rich products induced higher proliferation rate vs additive derived from platelet depleted ones. Additives obtained by freeze and-thaw methods weakly induced ASC proliferation. As expected, principal component analysis of growth factor concentrations did not unravel specific biochemical features characterizing medium additives in relation with their biological activity. Otherwise, while (HNMR)-H-1 showed a partial resolution capacity, analysis of MALDI-TOF MS spectra allowed unambiguous distinction between the medium additives we used to differently stimulate cell growth in vitro. Discussion MALDI-TOF and, despite limitations, H-1-NMR are promising cost effective and reliable quality controls to classify the potential of a medium additive to promote ASC growth. This can represent, after further investigations and appropriate validation, a significant advantage for GMP compliant manufacturing of advanced cell therapy products.	[Agostini, Francesco; Battiston, Monica; Mazzucato, Mario] CRO Aviano Natl Canc Inst, Dept Translat Res, Stem Cell Unit, Aviano, PN, Italy; [Ruzza, Marta; Corpillo, Davide; Acquadro, Elena; Canepa, Barbara] GEMFORLAB SrL, Colleretto Giacosa, TO, Italy; [Biondi, Luca] BRACCO Imaging Italia Srl, Milan, Italy; [Viale, Alessandra; Aime, Silvio] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Mol Imaging Ctr, Turin, Italy; [Serra, Fabrizio] CRO Aviano Natl Canc Inst, Dept Translat Res, Clin & Expt Oncohematol Unit, Aviano, PN, Italy	IRCCS Aviano (CRO); University of Turin; IRCCS Aviano (CRO)	Agostini, F (corresponding author), CRO Aviano Natl Canc Inst, Dept Translat Res, Stem Cell Unit, Aviano, PN, Italy.	fagostini@cro.it	Mazzucato, Mario/ABF-5472-2020; Battiston, Monica/S-8997-2019; Agostini, Francesco/U-2488-2019	Mazzucato, Mario/0000-0001-8319-053X; Battiston, Monica/0000-0001-6657-4195; Agostini, Francesco/0000-0002-2808-9348	Progetto di Ricerca Finalizzata [J32114001830001]	Progetto di Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF))	The present study was funded by Progetto di Ricerca Finalizzata (no : J32114001830001; Recipient: M. Mazzucato). The funder provided support for research materials and in the form of salaries for authors (F.A. and M.B.), but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. GEMFORLAB SrL and BRACCO Imaging Italia SrL were not funders of this study. A free, scientific partnership agreement between CRO Aviano National Cancer Institute and Bioindustry Park Silvano Fumero S.p. A. - Colloretto Giacosa (Turin, Italy), was officially ruled by the General Director of the CRO Aviano National Cover Letter Cancer Institute on 26th of May, 2015. The Bioindustry Park Silvano Fumero encloses GEMFORLAB SrL and BRACCO Imaging Italia SrL. The partnership agreement was principally aimed to accomplish the present pilot study without any financial reward and reciprocally sharing personnel competences and obtained results. Collection and analysis of metabolomic data of the present study were performed by personnel of the GEMFORLAB SrL and BRACCO Imaging Italia SrL. Specimens, collected at CRO Aviano National Cancer Institute, were provided to metabolomic laboratories as blind samples: this was done to completely avoid potential biases on results. Growth factor concentration measurements and analysis as well as cell culture experimental procedures and data analysis were performed by personnel of the CRO Aviano National Cancer Institute.	Agostini F, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0886-1; Agostini F, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1210-z; AlaKorpela M, 1995, NMR BIOMED, V8, P235, DOI 10.1002/nbm.1940080603; Amable PR, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt218; ANDERSEN NH, 1984, BIOCHEM BIOPH RES CO, V120, P512, DOI 10.1016/0006-291X(84)91284-1; Araki J, 2012, TISSUE ENG PART C-ME, V18, P176, DOI [10.1089/ten.tec.2011.0308, 10.1089/ten.TEC.2011.0308]; Astori G, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0352-x; Bernardi M, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1185-9; Bernardi M, 2013, CYTOTHERAPY, V15, P920, DOI 10.1016/j.jcyt.2013.01.219; Borghese C, 2016, VOX SANG, V111, P197, DOI 10.1111/vox.12405; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; CHEN JK, 1986, J CELL PHYSIOL, V129, P207, DOI 10.1002/jcp.1041290212; Chieregato K, 2011, CYTOTHERAPY, V13, P933, DOI 10.3109/14653249.2011.583232; Committeee for medicinal products for human use (CHMP), 2012, EUR MED AGENCY, V1, P1; Coppinger JA, 2007, BLOOD, V109, P4786, DOI 10.1182/blood-2006-07-038539; COSTA JL, 1979, FEBS LETT, V99, P141, DOI 10.1016/0014-5793(79)80266-5; Docheva D, 2008, J CELL MOL MED, V12, P537, DOI 10.1111/j.1582-4934.2007.00138.x; Durante C, 2013, VOX SANG, V105, P129, DOI 10.1111/vox.12039; Eppley BL, 2004, PLAST RECONSTR SURG, V114, P1502, DOI 10.1097/01.PRS.0000138251.07040.51; Heller R, 1999, ATHEROSCLEROSIS, V144, P49, DOI 10.1016/S0021-9150(99)00041-6; Huang TL, 2013, CLIN CHIM ACTA, V424, P175, DOI 10.1016/j.cca.2013.06.003; Kibbe MR, 2000, J VASC SURG, V31, P1214, DOI 10.1016/S0741-5214(00)90112-5; Li X, 2014, J CELL MOL MED, V18, P2445, DOI 10.1111/jcmm.12424; Liu Y, 2013, CARDIOVASC PATHOL, V22, P451, DOI 10.1016/j.carpath.2013.03.003; Paglia G, 2015, TRANSFUSION, V55, P301, DOI 10.1111/trf.12834; Pakala R, 1998, J LAB CLIN MED, V131, P527, DOI 10.1016/S0022-2143(98)90061-0; Park CW, 2013, ANAL BIOCHEM, V443, P58, DOI 10.1016/j.ab.2013.07.048; Petersen M, 2005, CLIN CHEM, V51, P1457, DOI 10.1373/clinchem.2004.046748; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Rodrigues M, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt32; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Senzel L, 2009, CURR OPIN HEMATOL, V16, P329, DOI 10.1097/MOH.0b013e32832e9dc6; Sheedy JR, 2013, METHODS MOL BIOL, V1055, P81, DOI 10.1007/978-1-62703-577-4_7; STEFFAN B, 1992, PHARMACEUT RES, V9, P575, DOI 10.1023/A:1015865002470; Suzen S, 2017, MOLECULES, V22, DOI 10.3390/molecules22010181; Tassini M, 2002, ARCH BIOCHEM BIOPHYS, V404, P163, DOI 10.1016/S0003-9861(02)00221-7; Tejedo JR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.57; Tighe PJ, 2015, PROTEOM CLIN APPL, V9, P406, DOI 10.1002/prca.201400130; UGURBIL K, 1979, P NATL ACAD SCI USA, V76, P2227, DOI 10.1073/pnas.76.5.2227; Van Den Dolder J, 2006, TISSUE ENG, V12, P3067, DOI 10.1089/ten.2006.12.3067; Weibrich G, 2002, GROWTH FACTORS, V20, P93, DOI 10.1080/08977190290031950; Wong JC, 2011, J CELL BIOCHEM, V112, P829, DOI 10.1002/jcb.22981; Woulfe D, 2001, J CLIN INVEST, V107, P1503, DOI 10.1172/JCI13361; Yun DH, 2009, EXP MOL MED, V41, P17, DOI 10.3858/emm.2009.41.1.003; Zhang FX, 2015, EXP THER MED, V10, P1224, DOI 10.3892/etm.2015.2590	46	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203048	10.1371/journal.pone.0203048	http://dx.doi.org/10.1371/journal.pone.0203048			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188924	Green Submitted, Green Published, gold			2022-12-26	WOS:000444228700018
J	Moorthy, ND; Ramalingam, BM; Iqbal, S; Mohanakrishnan, AK; Gunasekaran, K; Vellaichamy, E				Moorthy, Nachiappan Dhatchana; Ramalingam, Bose Muthu; Iqbal, Saleem; Mohanakrishnan, Arasambattu K.; Gunasekaran, Krishnasamy; Vellaichamy, Elangovan			Novel isothiacalothrixin B analogues exhibit cytotoxic activity on human colon cancer cells in vitro by inducing irreversible DNA damage	PLOS ONE			English	Article							INDUCED APOPTOSIS; COMET ASSAY; ACCURATE DOCKING; DRUG DESIGN; BINDING; SEQUENCE; P53; ANTHRAQUINONE; RECOGNITION; PERSPECTIVE	Preliminary cytotoxic analysis of sulphur containing isosteric analogues of calothrixin B identified the useful anti-tumour activity of thia/isothiacalothrixin B which necessitated it's biological evaluation in colon and lung cancer cell lines. The isothia analogues induced cytotoxicity of HCT116 in a time-dependent manner and inhibited the clonogenic survival of HCT116 and NCI-H460 cells in a dose-dependent manner comparable to the standard anti-cancer drug camptothecin. Herein employing flow cytometry, we demonstrate that isothiacalothrixin B analogues inhibited proliferation of colon cancer cells by the arrest of cells in S and G2/M phases over a period of 48 hours at a concentration of 5 mu M. Our results also suggest that the cytotoxicity of thia analogues of calothrixin B is partially mediated by induction of cellular DNA strand breaks. The UV-Vis spectroscopic studies with CT-DNA revealed groove binding for calothrixin B and its thia analogues wherein subsequent in silico molecular modelling studies indicated preferential binding to the AT-rich regions of minor groove of DNA. Furthermore, thiacalothrixin B caused transcriptional activation of p21(waf1/cip1) promoter and upregulation of its protein levels independent of p53. The induction of DNA damage response pathway leads to apoptosis in isothiacalothrixin B but not in thiacalothrixin B treated cells. The isothia analogues SCAB 4 induced DNA strand breaks and cell cycle arrest even after treatment for a short period (i.e., 4 hours) and the cell cycle effects were irreversible. For the first time, this study provides detailed cellular effects on the potential use of isothiacalothrixin B analogues as cytotoxic agents.	[Moorthy, Nachiappan Dhatchana; Vellaichamy, Elangovan] Univ Madras, Dept Biochem, Guindy Campus, Madras, Tamil Nadu, India; [Moorthy, Nachiappan Dhatchana] Orchid Pharma Ltd, Dept Biotechnol, Madras, Tamil Nadu, India; [Ramalingam, Bose Muthu; Mohanakrishnan, Arasambattu K.] Univ Madras, Dept Organ Chem, Guindy Campus, Madras, Tamil Nadu, India; [Iqbal, Saleem; Gunasekaran, Krishnasamy] Univ Madras, Ctr Adv studies Crystallog & Biophys, Madras, Tamil Nadu, India	University of Madras; University of Madras; University of Madras	Vellaichamy, E (corresponding author), Univ Madras, Dept Biochem, Guindy Campus, Madras, Tamil Nadu, India.	vellaie@unom.ac.in	IQBAL, DR SALEEM/GLR-6539-2022; Moorthy, Dhatchana/AAD-7680-2019	IQBAL, DR SALEEM/0000-0002-8676-3361; Moorthy, Dhatchana/0000-0002-0071-4762	UPE-Phase II grant, India [C3/UPE-Phase II/Theme A/2013/338]	UPE-Phase II grant, India	This work was supported by UPE-Phase II (C3/UPE-Phase II/Theme A/2013/338) grant, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (Orchid Pharma) provided support in the form of salaries for author NDM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.; Dr. EV greatly acknowledges UPE-Phase II (C3/UPE-Phase II/Theme A/2013/338) grant, India, for the financial support. The authors thank Dr Priya Ramanathan, Department of Molecular Oncology, Cancer Institute (WIA), Adyar, Chennai, for helping with flow cytometry analysis. The authors also thank Mr Raj Pranap, Research Scholar, Department of Biotechnology, IIT-Madras and Dr Sowmya Parameswaran, Principal Scientist and Assistant Professor, Vision Research Foundation, Sankara Nethralaya for help with fluorescence microscopy.	Anantharaman A, 2015, SPECTROCHIM ACTA A, V144, P163, DOI 10.1016/j.saa.2015.02.049; Azqueta A, 2011, DNA REPAIR, P615, DOI [10.5772/22504, DOI 10.5772/22504]; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Bauer MKA, 1998, J BIOL CHEM, V273, P8048, DOI 10.1074/jbc.273.14.8048; Beno BR, 2015, J MED CHEM, V58, P4383, DOI 10.1021/jm501853m; Bhakta D, 2012, APPL BIOCHEM BIOTECH, V167, P885, DOI 10.1007/s12010-012-9744-2; Bischoff G, 2002, CURR MED CHEM, V9, P321, DOI 10.2174/0929867023371085; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; DICKERSON RE, 1982, SCIENCE, V216, P475, DOI 10.1126/science.7071593; DICKERSON RE, 1992, METHOD ENZYMOL, V211, P67; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fujiwara AN, 1969, J HET CHEM; Ghosh P, 2013, APPL BIOCHEM BIOTECH, V170, P1127, DOI 10.1007/s12010-013-0259-2; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hannon MJ, 2007, CHEM SOC REV, V36, P280, DOI 10.1039/b606046n; Haq I, 2000, J MOL RECOGNIT, V13, P188, DOI 10.1002/1099-1352(200007/08)13:4<188::AID-JMR503>3.0.CO;2-1; HERRMANN M, 1994, NUCLEIC ACIDS RES, V22, P5506, DOI 10.1093/nar/22.24.5506; Ho JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016815; Kasibhatla Shailaja, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4493; Kumaravel TS, 2009, CELL BIOL TOXICOL, V25, P53, DOI 10.1007/s10565-007-9043-9; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Li ZJ, 2004, J CHEM INF COMP SCI, V44, P1886, DOI 10.1021/ci049794h; Lian CY, 1996, J AM CHEM SOC, V118, P8791, DOI 10.1021/ja961631p; Lill MA, 2011, J COMPUT AID MOL DES, V25, P13, DOI 10.1007/s10822-010-9395-8; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Miller CM, 2012, ORG BIOMOL CHEM, V10, P7912, DOI 10.1039/c2ob26181b; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mrozek-Wilczkiewicz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142678; Nandhakumar S, 2011, J PHARMACOL PHARMACO, V2, P107, DOI 10.4103/0976-500X.81903; Neidle S, 1999, CHEM COMMUN, P929, DOI 10.1039/a901074b; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pett L, 2015, CURR TOP MED CHEM, V15, P1293, DOI 10.2174/1568026615666150413155431; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Politzer P, 2015, CHALLENGES ADV COMPU, V19, P291; Ramalingam BM, 2018, J MED CHEM, V61, P1285, DOI 10.1021/acs.jmedchem.7b01797; Ramalingam BM, 2017, SYNLETT, V28, P133, DOI 10.1055/s-0036-1588072; Ricci CG, 2009, J CHEM INF MODEL, V49, P1925, DOI 10.1021/ci9001537; Rickards RW, 1999, TETRAHEDRON, V55, P13513, DOI 10.1016/S0040-4020(99)00833-9; Russell EG, 2014, INVEST NEW DRUG, V32, P1113, DOI 10.1007/s10637-014-0140-3; Russell EG, 2016, INVEST NEW DRUG, V34, P15, DOI 10.1007/s10637-015-0302-y; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Sugawara E, 2014, ANTIMICROB AGENTS CH, V58, P7250, DOI 10.1128/AAC.03728-14; Tian K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072303; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200	50	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0202903	10.1371/journal.pone.0202903	http://dx.doi.org/10.1371/journal.pone.0202903			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188913	gold, Green Submitted, Green Published			2022-12-26	WOS:000444228700015
J	Kim, HT; Lee, JM				Kim, Hyoung Tae; Lee, Je Min			Organellar genome analysis reveals endosymbiotic gene transfers in tomato	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; CHLOROPLAST GENOME; PLASTID GENOME; HORIZONTAL TRANSFER; PROVIDES INSIGHTS; INVERTED REPEAT; DNA INSERTIONS; SEQUENCE; EVOLUTION; ANGIOSPERM	We assembled three complete mitochondrial genomes (mitogenomes), two of Solanum lycopersicum and one of Solanum pennellii, and analyzed their intra- and interspecific variations. The mitogenomes were 423,596 +/- 446,257 bp in length. Despite numerous rearrangements between the S. lycopersicum and S. pennellii mitogenomes, over 97% of the mitogenomes were similar to each other. These mitogenomes were compared with plastid and nuclear genomes to investigate genetic material transfers among DNA-containing organelles in tomato. In all mitogenomes, 9,598 bp of plastome sequences were found. Numerous nuclear copies of mitochondrial DNA (NUMTs) and plastid DNA (NUPTs) were observed in the S. lycopersicum and S. pennellii nuclear genomes. Several long organellar DNA fragments were tightly clustered in the nuclear genome; however, the NUMT and NUPT locations differed between the two species. Our results demonstrate the recent occurrence of frequent endosymbiotic gene transfers in tomato genomes.	[Kim, Hyoung Tae; Lee, Je Min] Kyungpook Natl Univ, Dept Hort Sci, Daegu, South Korea	Kyungpook National University	Lee, JM (corresponding author), Kyungpook Natl Univ, Dept Hort Sci, Daegu, South Korea.	jemin@knu.ac.kr	Lee, Je Min/AAE-7496-2020	Lee, Je Min/0000-0002-0446-1336; HyoungTae, Kim/0000-0002-2482-6064; Kim, Hyoung Tae/0000-0003-1823-4369	National Research Foundation of Korea [2018R1A2B6002620, 2017R1A6A3A01007551]; Golden Seed Project (Center for Horticultural Seed Development), the Ministry of Agriculture, Food and Rural Affairs, Republic of Korea	National Research Foundation of Korea(National Research Foundation of Korea); Golden Seed Project (Center for Horticultural Seed Development), the Ministry of Agriculture, Food and Rural Affairs, Republic of Korea	This work was supported by the National Research Foundation of Korea under grant 2018R1A2B6002620 (JML) and 2017R1A6A3A01007551 (HTK); and the Golden Seed Project (Center for Horticultural Seed Development), the Ministry of Agriculture, Food and Rural Affairs, Republic of Korea (JML).	Adams KL, 2002, PLANT CELL, V14, P931, DOI 10.1105/tpc.010483; Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; ANDRE C, 1992, TRENDS GENET, V8, P128, DOI 10.1016/0168-9525(92)90370-J; Auguie B, 2012, GRIDEXTRA FUNCTIONS; Blanchard JL, 1996, MOL BIOL EVOL, V13, P537, DOI 10.1093/oxfordjournals.molbev.a025614; Bock R, 2012, GENOMICS CHLOROPLAST; Bolger A, 2014, NAT GENET, V46, P1034, DOI 10.1038/ng.3046; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chang SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056502; Chang SX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-497; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Chen JM, 2005, HUM MUTAT, V25, P207, DOI 10.1002/humu.20133; Cho KS, 2016, PLANT CELL REP, V35, P2113, DOI 10.1007/s00299-016-2022-y; Cho KS, 2016, HORTIC ENVIRON BIOTE, V57, P69, DOI 10.1007/s13580-016-0003-2; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Chung HJ, 2006, PLANT CELL REP, V25, P1369, DOI 10.1007/s00299-006-0196-4; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Daniell H, 2006, THEOR APPL GENET, V112, P1503, DOI 10.1007/s00122-006-0254-x; Darracq A, 2011, GENOME BIOL EVOL, V3, P723, DOI 10.1093/gbe/evr042; Darzentas N, 2010, BIOINFORMATICS, V26, P2620, DOI 10.1093/bioinformatics/btq484; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Downie SR, 2015, SYST BOT, V40, P336, DOI 10.1600/036364415X686620; Gandini CL, 2017, SCI REP-UK, V7, DOI 10.1038/srep43402; Gao CH, 2014, FUNCT INTEGR GENOMIC, V14, P23, DOI 10.1007/s10142-013-0345-0; Goremykin VV, 2012, PLANT J, V71, P615, DOI 10.1111/j.1365-313X.2012.05014.x; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Huang CY, 2005, PLANT PHYSIOL, V138, P1723, DOI 10.1104/pp.105.060327; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Iorizzo M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-61; Jo YD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-561; Kahlau S, 2006, J MOL EVOL, V63, P194, DOI 10.1007/s00239-005-0254-5; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim HT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187318; Kim HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142215; Kim HT, 2014, MOL CELLS, V37, P372, DOI 10.14348/molcells.2014.2296; Kim JS, 2015, PLANT MOL BIOL REP, V33, P1210, DOI 10.1007/s11105-014-0833-y; Kim Seungill, 2014, Nat Genet, V46, P270, DOI 10.1038/ng.2877; Kleine T, 2009, ANNU REV PLANT BIOL, V60, P115, DOI 10.1146/annurev.arplant.043008.092119; Knoop V, 2004, CURR GENET, V46, P123, DOI 10.1007/s00294-004-0522-8; Leister D, 2005, TRENDS GENET, V21, P655, DOI 10.1016/j.tig.2005.09.004; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lichtenstein G, 2016, COMPEND PL GENOME, P111, DOI 10.1007/978-3-662-53389-5_7; Lilly JW, 2001, GENETICS, V159, P317; Liu Y, 2014, MOL BIOL EVOL, V31, P2586, DOI 10.1093/molbev/msu199; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; LONSDALE DM, 1984, NUCLEIC ACIDS RES, V12, P9249, DOI 10.1093/nar/12.24.9249; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma PF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11608; Michalovova M, 2013, HEREDITY, V111, P314, DOI 10.1038/hdy.2013.51; Naito K, 2013, BREEDING SCI, V63, P176, DOI 10.1270/jsbbs.63.176; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Noutsos C, 2005, GENOME RES, V15, P616, DOI 10.1101/gr.3788705; Olmstead RG, 2008, TAXON, V57, P1159, DOI 10.1002/tax.574010; PALMER JD, 1984, NATURE, V307, P437, DOI 10.1038/307437a0; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Renner S.S., 2012, ADV PHOTOSYNTHESIS R, V35, P223; Rice DW, 2013, SCIENCE, V342, P1468, DOI 10.1126/science.1246275; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Richly E, 2004, MOL BIOL EVOL, V21, P1972, DOI 10.1093/molbev/msh210; Rodriguez-Moreno L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-424; Ruhlman TA, 2014, METHODS MOL BIOL, V1132, P3, DOI 10.1007/978-1-62703-995-6_1; Sarkinen T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-214; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shikanai T, 1998, PLANT CELL REP, V17, P832, DOI 10.1007/s002990050493; Sloan DB, 2014, GENOME BIOL EVOL, V6, P3210, DOI 10.1093/gbe/evu253; Sloan DB, 2012, NEW PHYTOL, V196, P1228, DOI 10.1111/j.1469-8137.2012.04340.x; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Smith DR, 2014, NEW PHYTOL, V202, P736, DOI 10.1111/nph.12704; Smith DR, 2011, GENOME BIOL EVOL, V3, P743, DOI [10.1093/gbe/evr001, 10.1093/gbe/evr068]; Sorenson MD, 1998, AUK, V115, P214, DOI 10.2307/4089130; Straub SCK, 2013, GENOME BIOL EVOL, V5, P1872, DOI 10.1093/gbe/evt140; Tanaka Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-352; Van de Paer C, 2016, GENE, V594, P197, DOI 10.1016/j.gene.2016.09.007; VANDERKUYL AC, 1995, J MOL EVOL, V40, P652, DOI 10.1007/BF00160513; Villarreal JC, 2013, AM J BOT, V100, P467, DOI 10.3732/ajb.1200429; Wang D, 2007, MOL BIOL EVOL, V24, P2040, DOI 10.1093/molbev/msm133; Wang XC, 2018, MITOCHONDRIAL DNA A, V29, P635, DOI 10.1080/24701394.2017.1334772; Wang Z, 2015, BMC GENOMICS, V16, DOI [10.1186/s12864-015-1988-0, 10.1186/s12864-015-1216-y]; Weese TL, 2007, SYST BOT, V32, P445, DOI 10.1600/036364407781179671; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Wu ZQ, 2016, MITOCHONDRIAL DNA A, V27, P4155, DOI 10.3109/19401736.2014.1003890; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158	91	12	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202279	10.1371/journal.pone.0202279	http://dx.doi.org/10.1371/journal.pone.0202279			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183712	gold, Green Submitted, Green Published			2022-12-26	WOS:000443789900022
J	Mancuso, JE; Jayaraman, A; Ristenpart, WD				Mancuso, Jordan E.; Jayaraman, Anjana; Ristenpart, William D.			Centrifugation-induced release of ATP from red blood cells	PLOS ONE			English	Article							DEFORMATION-INDUCED RELEASE; VESSELS IN-VIVO; RESISTANCE VESSELS; HUMAN ERYTHROCYTES; SHEAR-STRESS; HEMOLYSIS; MICROCHIP; DYNAMICS; DEFORMABILITY; HYPOXIA	Centrifugation is the primary preparation step for isolating red blood cells (RBCs) from whole blood, including for use in studies focused on transduction of adenosine triphosphate (ATP), an important vasodilatory signaling molecule. Despite the wide use of centrifugation, little work has focused on how the centrifugation itself affects release of ATP from RBCs prior to subsequent experimentation. Here we report that both the centrifugation force and duration have a pronounced impact on the concentration of ATP present in the packed RBCs following centrifugation. Multiple subsequent centrifugations yield extracellular ATP concentrations comparable to the amount released during the initial centrifugation, suggesting this effect is cumulative. Pairwise measurements of hemoglobin and ATP suggest the presence of ATP is primarily due to an increase in centrifugation-induced hemolysis. These results indicate that common centrifugation parameters, within the ranges explored here, can release ATP in quantities comparable to the low end of the range of values measured in typical ATP transduction experiments, potentially complicating experimental interpretation of those results.	[Mancuso, Jordan E.; Jayaraman, Anjana; Ristenpart, William D.] Univ Calif Davis, Dept Chem Engn, Davis, CA 95616 USA	University of California System; University of California Davis	Ristenpart, WD (corresponding author), Univ Calif Davis, Dept Chem Engn, Davis, CA 95616 USA.	wdristenpart@ucdavis.edu	Ristenpart, William/AAG-4462-2021	Jayaraman, Anjana/0000-0001-7372-2352	National Science Foundation [1201245]	National Science Foundation(National Science Foundation (NSF))	Funded by National Science Foundation Grant Numver 1201245. https://www.nsf.gov/awardsearch/showAward?AWD_ID=1201245. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai G, 2012, INT J PHARMACEUT, V423, P264, DOI 10.1016/j.ijpharm.2011.11.044; Barvitenko NN, 2013, MICROCIRCULATION, V20, P484, DOI 10.1111/micc.12052; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; BLACKSHEAR PL, 1965, T AM SOC ART INT ORG, V11, P112; Boehning F, 2014, ARTIF ORGANS, V38, P761, DOI 10.1111/aor.12328; Brunn HF, 2015, GOLDMANS CECIL MED; Carroll J, 2006, MOL BIOSYST, V2, P305, DOI 10.1039/b604362n; Cinar E, 2015, P NATL ACAD SCI USA, V112, P11783, DOI 10.1073/pnas.1507309112; Dietrich HH, 2000, AM J PHYSIOL-HEART C, V278, pH1294, DOI 10.1152/ajpheart.2000.278.4.H1294; DIMITROV DS, 1984, BIOCHIM BIOPHYS ACTA, V779, P437, DOI 10.1016/0304-4157(84)90020-0; Edwards J, 2001, ANALYST, V126, P1257, DOI 10.1039/b100519g; Ellsworth ML, 1995, AM J PHYSIOL-HEART C, V269, pH2155, DOI 10.1152/ajpheart.1995.269.6.H2155; Faris A, 2008, ANALYST, V133, P678, DOI 10.1039/b719990b; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; Fischer DJ, 2003, ANALYST, V128, P1163, DOI 10.1039/b308225n; Forsyth AM, 2011, P NATL ACAD SCI USA, V108, P10986, DOI 10.1073/pnas.1101315108; Kirby BS, 2015, BLOOD, V125, P1844, DOI 10.1182/blood-2014-11-609610; Kiss F, 2016, CLIN HEMORHEOL MICRO, V62, P215, DOI 10.3233/CH-151965; LEVERETT LB, 1972, BIOPHYS J, V12, P257, DOI 10.1016/S0006-3495(72)86085-5; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Moehlenbrock MJ, 2006, ANALYST, V131, P930, DOI 10.1039/b605136g; OFFEMAN RD, 1979, BIOMATER ARTIF CELL, V7, P393, DOI 10.3109/10731197909119387; Price AK, 2006, J CHROMATOGR A, V1111, P220, DOI 10.1016/j.chroma.2005.07.083; Price AK, 2004, ANAL CHEM, V76, P4849, DOI 10.1021/ac0495992; Sikora J, 2014, BLOOD, V124, P2150, DOI 10.1182/blood-2014-05-572024; Simmonds MJ, 2016, BIORHEOLOGY, V53, P237, DOI 10.3233/BIR-16120; Simmonds MJ, 2014, BIORHEOLOGY, V51, P171, DOI 10.3233/BIR-140665; Sprague RS, 2003, AM J PHYSIOL-HEART C, V285, pH693, DOI 10.1152/ajpheart.01026.2002; Sprague RS, 2001, EXP BIOL MED, V226, P434, DOI 10.1177/153537020122600507; Sprague RS, 2001, AM J PHYSIOL-CELL PH, V281, pC1158, DOI 10.1152/ajpcell.2001.281.4.C1158; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Sprague RS, 1996, AM J PHYSIOL-HEART C, V271, pH2717, DOI 10.1152/ajpheart.1996.271.6.H2717; Sprung R, 2002, ANAL CHEM, V74, P2274, DOI 10.1021/ac011144e; Sridharan M, 2010, AM J PHYSIOL-HEART C, V299, pH1146, DOI 10.1152/ajpheart.00301.2010; Subasinghe W, 2008, ANAL CHIM ACTA, V618, P227, DOI 10.1016/j.aca.2008.04.061; Urbina A, 2016, J CHROMATOGR B, V1020, P53, DOI 10.1016/j.jchromb.2016.03.025; Wan JD, 2008, P NATL ACAD SCI USA, V105, P16432, DOI 10.1073/pnas.0805779105; Wang YM, 2014, INTEGR BIOL-UK, V6, P65, DOI 10.1039/c3ib40187a; Wiegmann L, 2017, FRONT PHYSIOL, V8, P11, DOI [10.3389/fphys.2017.00011, DOI 10.3389/FPHYS.2017.00011]	39	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203270	10.1371/journal.pone.0203270	http://dx.doi.org/10.1371/journal.pone.0203270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183749	Green Submitted, Green Published, gold			2022-12-26	WOS:000443789900054
J	Hibbard, TN; Andrade-Diaz, MS; Diaz-Gomez, JM				Nathaniel Hibbard, Thomas; Soledad Andrade-Diaz, Maria; Manuel Diaz-Gomez, Juan			But they move! Vicariance and dispersal in southern South America: Using two methods to reconstruct the biogeography of a clade of lizards endemic to South America	PLOS ONE			English	Article							PHYMATURUS IGUANIA LIOLAEMIDAE; HISTORICAL BIOGEOGRAPHY; DNA-SEQUENCES; PATAGONICUS GROUP; ARGENTINA; PHYLOGENY; DIVERSITY; EVOLUTION; PATTERNS; DIVERSIFICATION	This study aims to identify events that modeled the historical biogeography of Phymaturus, using three methodologies: Spatial Analysis of Vicariance (VIP), Statistical Dispersal-Vicariance Analysis (S-DIVA), and Bayesian Binary Method MCMC (BBM). In order to assign areas for the Dispersal-Vicariance and the BBM analyses, we preferred not to use predefined areas, but to identify areas defined via an endemism analysis of Phymaturus species. The analyses were conducted using the same basic topology, which we obtained by constructing a metatree with two recent phylogenies, both morphology and molecular-based. This topology was also used to obtain time divergence estimates in BEAST, using more out-groups than for the metatree in order to get more accurate estimates. The S-DIVA analysis based on the metatree found 25 vicariance events, 20 dispersals and two extinctions; the SDIVA analysis based on the BEAST tree yielded 30 vicariance events, 42 dispersal events and five extinctions, and the BBM analysis yielded 63 dispersal events, 28 vicariance events and 1 extinction event. According to the metatree analysis, the ancestral area for Phymaturus covers northern Payunia and southern Central Monte. A vicariant event fragmented the ancestral distribution of the genus, resulting in northern Payunia and southern Central Monte as ancestral area for the P. palluma group, and southern Payunia for the P. patagonicus group. The analysis based on the BEAST tree showed a more complex reconstruction, with several dispersal and extinction events in the ancestral node. The Spatial Analysis of Vicariance identified 41 disjunct sister nodes and removed 10 nodes. The barrier that separates the P. palluma group from the P. patagonicus group is roughly congruent with the southern limit of the P. palluma group. The ancestral range for the genus occupies a central position relative to the distribution of the group, which implies that the species must have migrated to the north (P. palluma group) and to the south (P. patagonicus group). To answer questions related to the specific timing of the events, a molecular clock for Phymaturus was obtained, using a Liolaemus fossil for calibration. The present contribution provides a hypothetical framework for the events that modeled the distribution of Phymaturus.	[Nathaniel Hibbard, Thomas; Soledad Andrade-Diaz, Maria; Manuel Diaz-Gomez, Juan] Univ Nacl Salta, Consejo Nacl Invest Cient & Tecn, Inst Bio & Geociencias Noroeste Argentino, Rosario De Lerma, Salta, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Diaz-Gomez, JM (corresponding author), Univ Nacl Salta, Consejo Nacl Invest Cient & Tecn, Inst Bio & Geociencias Noroeste Argentino, Rosario De Lerma, Salta, Argentina.	jmdiaz@unsa.edu.ar		Diaz Gomez, Juan Manuel/0000-0002-0493-6215				Aagesen L, 2009, CLADISTICS, V25, P295, DOI 10.1111/j.1096-0031.2009.00248.x; Abdala Cristian Simón, 2010, Cuad. herpetol., V24, P93; Abdala CS, 2014, CUAD HERPETOL, V28; Albino AM, 2008, AMEGHINIANA, V45, P775; Arias JS, 2011, CLADISTICS, V27, P617, DOI 10.1111/j.1096-0031.2011.00353.x; Bush M.B., 2007, TROPICAL RAINFOREST, P59, DOI DOI 10.1007/978-3-540-48842-2; Cei J.M., 1986, REPTILES CTR CTR OES; Cruz FB, 2011, J COMP PHYSIOL B, V181, P373, DOI 10.1007/s00360-010-0524-4; Cruz FB, 2009, ZOOLOGY, V112, P425, DOI 10.1016/j.zool.2009.03.004; de Berg M., 2008, COMPUTATIONAL GEOMET, V3rd, DOI 10.1007/978-3-540-77974-2_1; Gomez JMD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026412; Diaz Gomez Juan Manuel, 2007, South American Journal of Herpetology, V2, P59; Gomez JMD, 2009, ZOOL SCR, V38, P1, DOI 10.1111/j.1463-6409.2008.00357.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Espinoza RE, 2004, P NATL ACAD SCI USA, V101, P16819, DOI 10.1073/pnas.0401226101; Etheridge R., 1995, AM MUSEUM NAT HIST; Breitman MF, 2011, MOL PHYLOGENET EVOL, V59, P364, DOI 10.1016/j.ympev.2011.02.008; Fontanella FM, 2012, ZOOL J LINN SOC-LOND, V164, P825, DOI 10.1111/j.1096-3642.2011.00786.x; Marin AG, 2016, ZOOTAXA, V4121, P412, DOI 10.11646/zootaxa.4121.4.3; Harris AJ, 2009, TAXON, V58, P108, DOI 10.1002/tax.581012; Hartley AJ, 2003, J GEOL SOC LONDON, V160, P7, DOI 10.1144/0016-764902-083; Hedges SB, 2004, TRENDS GENET, V20, P242, DOI 10.1016/j.tig.2004.03.004; Hovenkamp P, 1997, CLADISTICS, V13, P67, DOI 10.1111/j.1096-0031.1997.tb00241.x; Hovenkamp P, 2001, CLADISTICS, V17, P260, DOI 10.1111/j.1096-0031.2001.tb00122.x; Ibarguengoytia NR, 2008, J ARID ENVIRON, V72, P1620, DOI 10.1016/j.jaridenv.2008.03.018; Ibarguengoytia NR, 2005, J ARID ENVIRON, V62, P435, DOI 10.1016/j.jaridenv.2005.01.008; Ibarguengoytia NR, 2004, J HERPETOL, V38, P73, DOI 10.1670/47-02A; Llambías Eduardo J, 2010, Rev. Asoc. Geol. Argent., V67, P278; Lobo Fernando, 2015, Cuad. herpetol., V29, P5; Lobo F, 2016, ZOOL J LINN SOC-LOND, V176, P648, DOI 10.1111/zoj.12335; Abdala Cristian Simón, 2012, Cuad. herpetol., V26, P215; Lobo F, 2013, ZOOTAXA, V3683, P117, DOI 10.11646/zootaxa.3683.2.2; Lobo F, 2012, ZOOTAXA, P1; Morando M, 2013, MOL PHYLOGENET EVOL, V66, P694, DOI 10.1016/j.ympev.2012.10.019; Pereyra, 1992, PROPUESTA MODELO DIS; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Rambaut A, 2008, FIG TREE TREEFIGURED; Rambaut A., 2014, TRACER V1 6; Riddle BR, 1996, TRENDS ECOL EVOL, V11, P207, DOI 10.1016/0169-5347(96)10032-X; Roig-Junent S, 2006, J ARID ENVIRON, V66, P404, DOI 10.1016/j.jaridenv.2006.01.005; Ronquist F, 2001, EVOLUTION, V55, P2503; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Santos Charles Morphy D., 2007, Pap. Avulsos Zool. (São Paulo), V47, P63, DOI 10.1590/S0031-10492007000400001; Scolaro J.A., 1982, REV U NAC RIO CUARTO, V2, P257; Scolaro Jose A., 2003, FACENA, V19, P157; Quinteros AS, 2011, ZOOTAXA, P35, DOI 10.11646/zootaxa.2789.1.2; Sersic AN, 2011, BIOL J LINN SOC, V103, P475, DOI 10.1111/j.1095-8312.2011.01656.x; Andrade-Diaz MS, 2017, S AM J HERPETOL, V12, P61, DOI 10.2994/SAJH-D-16-00038.1; Speziale KL, 2012, FLORA, V207, P141, DOI 10.1016/j.flora.2011.09.002; Szumik CA, 2004, SYST BIOL, V53, P968, DOI 10.1080/10635150490888859; Xiang QY, 1998, MOL PHYLOGENET EVOL, V10, P178, DOI 10.1006/mpev.1998.0524; Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zheng YC, 2016, MOL PHYLOGENET EVOL, V94, P537, DOI 10.1016/j.ympev.2015.10.009; Zink RM, 2000, P ROY SOC B-BIOL SCI, V267, P497, DOI 10.1098/rspb.2000.1028	56	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202339	10.1371/journal.pone.0202339	http://dx.doi.org/10.1371/journal.pone.0202339			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183727	Green Published, Green Submitted, gold			2022-12-26	WOS:000443789900023
J	Shi, LW; Lai, YQ; Chen, SY; Fu, LR; Lin, Q				Shi, Liwan; Lai, Youqun; Chen, Shanyu; Fu, Lirong; Lin, Qin			Dosimetric superiority of IMRT with jaw tracking technique for whole esophagus and T-shaped field radiotherapy in advanced esophageal cancer	PLOS ONE			English	Article							3D CONFORMAL RADIOTHERAPY; RADIATION PNEUMONITIS; RANDOMIZED-TRIAL; CHEMORADIOTHERAPY; VMAT; VALIDATION; LUNG	Purpose For whole esophagus and T-shaped field radiotherapy using intensity modulated radiotherapy (IMRT) technique in advanced esophageal cancer, lower absorbed doses to lung and heart remains a challenge. The aim of this study was to investigate the dosimetric superiority in IMRT plans with jaw tracking technique for whole esophagus radiotherapy. Methods and materials Thirty-two patients with esophageal cancer were subjected to IMRT treatment plans using Eclipse treatment planning system. For every patient, four different plans were generated with six gantry angles: six large fields IMRT plans with fixed jaw (6F-IMRT), six large fields IMRT plans with jaw tracking technique (6F-IMRT-T), twelve small fields IMRT plans with fixed jaw (12F-IMRT), and twelve small fields IMRT plans with jaw tracking technique (12F-IMRT-T). Dosimetric evaluation was assessed for all plans. Results For every technique, there were no differences in planning target volume (PTV) coverage and conformity. 6F-IMRT-T plans could significantly reduce lung irradiation with 7.9% (P<0.001) reduction in V5(lung) and 2.5% (P<0.001) reduction in V20(lung) respectively compared to 6F-IMRT plans. 12F-IMRT-T plans resulted in superior plans compared to 12-IMRT plans with a reduction of 2.9% (P<0.001) in V5(lung) and 0.9% (P<0.001) in V20(lung), respectively. For heart irradiation, 6F-IMRT-T and 12F-IMRT-T plans were slightly superior to 6F-IMRT and 12-IMRT plans respectively with a reduction of 1.1 Gy and 0.5 Gy in the respective mean doses. Conclusions By the use of jaw tracking technique, the IMRT plans resulted in further lung and heart sparing compared to fixed jaw plans for radiotherapy in esophageal cancer.	[Shi, Liwan; Lai, Youqun; Chen, Shanyu; Fu, Lirong; Lin, Qin] Xiamen Univ, Affiliated Hosp 1, Xiamen Canc Hosp, Dept Radiat Oncol, Xiamen, Peoples R China	Xiamen University	Lai, YQ; Lin, Q (corresponding author), Xiamen Univ, Affiliated Hosp 1, Xiamen Canc Hosp, Dept Radiat Oncol, Xiamen, Peoples R China.	laiyq520@qq.com; linqin05@163.com						Cadman P, 2005, J APPL CLIN MED PHYS, V6, P74, DOI 10.1120/jacmp.2024.25341; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; Feng ZS, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0329-4; Fenkell L, 2008, RADIOTHER ONCOL, V89, P287, DOI 10.1016/j.radonc.2008.08.008; Fogliata A, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0530-5; Harder EM, 2016, PRACT RADIAT ONCOL, V6, pE353, DOI 10.1016/j.prro.2016.01.015; Joy S, 2012, J APPL CLIN MED PHYS, V13, P136, DOI 10.1120/jacmp.v13i2.3707; Kim JI, 2014, J APPL CLIN MED PHYS, V15, P160, DOI 10.1120/jacmp.v15i2.4625; Kumar S, 2007, RADIOTHER ONCOL, V83, P139, DOI 10.1016/j.radonc.2007.03.013; Kuo YC, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-76; Marks LB, 2010, INT J RADIAT ONCOL, V76, pS70, DOI 10.1016/j.ijrobp.2009.06.091; Mayo CS, 2008, INT J RADIAT ONCOL, V71, P1408, DOI 10.1016/j.ijrobp.2007.12.008; Mohan R, 2008, J MED PHYS, V33, P114, DOI 10.4103/0971-6203.42757; Munch S, 2016, STRAHLENTHER ONKOL, V192, P722, DOI 10.1007/s00066-016-1020-x; Nicolini G, 2012, INT J RADIAT ONCOL, V84, P553, DOI 10.1016/j.ijrobp.2011.12.041; Ortholan C, 2010, CANCER RADIOTHER, V14, P312, DOI 10.1016/j.canrad.2010.02.009; Smyth EC, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.48; Sung K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196664; Vuong TNT, 2010, DIS ESOPHAGUS, V23, P324, DOI 10.1111/j.1442-2050.2009.01016.x; Wu H, 2016, J APPL CLIN MED PHYS, V17, P133, DOI 10.1120/jacmp.v17i5.6252; Yao B, 2016, NIGER J CLIN PRACT, V19, P25, DOI 10.4103/1119-3077.173709; Zhang Q, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140362	22	4	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202628	10.1371/journal.pone.0202628	http://dx.doi.org/10.1371/journal.pone.0202628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183753	Green Published, gold, Green Submitted			2022-12-26	WOS:000443789900032
J	Xu, BH; Lu, YQ; Ye, ZW; Zheng, QW; Wei, T; Lin, JF; Guo, LQ				Xu, Ben-Hong; Lu, Ya-Qin; Ye, Zhi-Wei; Zheng, Qian-Wang; Wei, Tao; Lin, Jun-Fang; Guo, Li-Qiong			Genomics-guided discovery and structure identification of cyclic lipopeptides from the Bacillus siamensis JFL15	PLOS ONE			English	Article							ANTIFUNGAL ACTIVITY; BACILLOMYCIN-D; SUBTILIS SPB1; AMYLOLIQUEFACIENS; PURIFICATION; SURFACTIN; FENGYCIN; ITURIN; GENES; BIOSYNTHESIS	In this research, a strain with broad-spectrum antimicrobial activities was isolated from the gastrointestinal tract of hairtail (Trichiurus haumela) and identified as Bacillus siamensis JFL15 through morphological, 16S rRNA, and average nucleotide identity analyses. The genome of B. siamensis JFL15 was sequenced, and three gene clusters involved in the biosynthesis of surfactin (srf), bacillibactin (dhb), and fengycin (fen) were predicted through antiSMASH analysis. The combined genomics-metabolics profiling of the strain revealed 20 active compounds, which belong to four main types of cyclic lipopeptides produced by Bacillus species: bacillibactin, iturin, fengycin, and surfactin. Among these lipopeptides, two highpurity antifungal components, namely, components b and c, were successfully identified as iturin A and bacillomycin F. The minimum inhibitory concentrations (MICs) of iturin A for Magnapothe grisea, Rhizoctorzia solani, and Colletotrichum gloeosporioides were 125.00, 62.50, and 125.00 mu g/ml, respectively, whereas the MICs of bacillomycin F for these three organisms were 62.50, 31.25, and 62.50 mu g/ml, respectively. The mechanism of bacillomycin F and iturin A against M. grisea was also investigated. Scanning electron microscopy (SEM) indicated that the surface of the hypha treated with iturin A or bacillomycin F became sunk, lumpy, and wrinkled. The diversity of the identified and predicted compounds from B. siamensis JFL15 suggested that this strain might be a promising biocontrol agent for an effective and environmentally friendly control of pathogenic microorganisms. To the best of our knowledge, this study is the first to describe cyclic lipopeptides purified and identified from B. siamensis.	[Xu, Ben-Hong; Lu, Ya-Qin; Ye, Zhi-Wei; Zheng, Qian-Wang; Wei, Tao; Lin, Jun-Fang; Guo, Li-Qiong] South China Agr Univ, Coll Food Sci, Guangzhou, Guangdong, Peoples R China; [Xu, Ben-Hong; Lu, Ya-Qin; Ye, Zhi-Wei; Zheng, Qian-Wang; Wei, Tao; Lin, Jun-Fang; Guo, Li-Qiong] South China Agr Univ, Inst Food Biotechnol, Guangzhou, Guangdong, Peoples R China; [Xu, Ben-Hong; Lu, Ya-Qin; Ye, Zhi-Wei; Zheng, Qian-Wang; Wei, Tao; Lin, Jun-Fang; Guo, Li-Qiong] Res Ctr Microecol Agent Engn & Technol Guangdong, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Lin, JF; Guo, LQ (corresponding author), South China Agr Univ, Coll Food Sci, Guangzhou, Guangdong, Peoples R China.; Lin, JF; Guo, LQ (corresponding author), South China Agr Univ, Inst Food Biotechnol, Guangzhou, Guangdong, Peoples R China.; Lin, JF; Guo, LQ (corresponding author), Res Ctr Microecol Agent Engn & Technol Guangdong, Guangzhou, Guangdong, Peoples R China.	linjf@scau.edu.cn; guolq@scau.edu.cn	tao, wei/GXN-4445-2022	Lin, Jun-Fang/0000-0002-2981-5188; Ye, Zhi-Wei/0000-0001-7537-2739	National Natural Science Foundation of China [31372116]; Projects of Science and Technology of Guangdong Province [2015A020209121, 2014B050505018]; Project of Science and Technology of Guangzhou City [201607010197]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of Science and Technology of Guangdong Province; Project of Science and Technology of Guangzhou City	This work was supported by the National Natural Science Foundation of China (Grant Number 31372116)(LQG), the Projects of Science and Technology of Guangdong Province (Grant Numbers 2015A020209121 and 2014B050505018)(JFL), the Project of Science and Technology of Guangzhou City (Grant Number 201607010197)(JFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltz RH, 2017, J IND MICROBIOL BIOT, V44, P573, DOI 10.1007/s10295-016-1815-x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; [陈倩倩 Chen Qianqian], 2016, [农业生物技术学报, Journol of Agricultural Biotechnology], V24, P261; Chiou AL, 2003, J PHYTOPATHOL, V151, P13, DOI 10.1046/j.1439-0434.2003.00669.x; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dunlap CA, 2015, INT J SYST EVOL MICR, V65, P3507, DOI 10.1099/ijsem.0.000444; Falardeau J, 2013, J CHEM ECOL, V39, P869, DOI 10.1007/s10886-013-0319-7; Galica T, 2017, J PHYCOL, V53, P985, DOI 10.1111/jpy.12555; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gong AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116871; Gong QW, 2014, FOOD CONTROL, V36, P8, DOI 10.1016/j.foodcont.2013.07.034; Jasim B, 2016, MICROB ECOL, V72, P106, DOI 10.1007/s00248-016-0753-5; Jeong H, 2012, J BACTERIOL, V194, P4148, DOI 10.1128/JB.00805-12; Kamysz E, 2015, INT J PEPT RES THER, V21, P39, DOI 10.1007/s10989-014-9423-y; Kim YO, 2014, J KOREAN SOC APPL BI, V57, P605, DOI 10.1007/s13765-014-4174-1; Kreutzer MF, 2012, ORG BIOMOL CHEM, V10, P9338, DOI 10.1039/c2ob26296g; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee H, 2008, J APPL MICROBIOL, V105, P663, DOI 10.1111/j.1365-2672.2008.03797.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mnif I, 2016, ENVIRON SCI POLLUT R, V23, P6690, DOI 10.1007/s11356-015-5826-3; Mnif I, 2015, ENVIRON SCI POLLUT R, V22, P18137, DOI 10.1007/s11356-015-5005-6; Moyne AL, 2001, J APPL MICROBIOL, V90, P622, DOI 10.1046/j.1365-2672.2001.01290.x; Naughton LM, 2017, FRONT MICROBIOL, V8, P1, DOI [10.3389/fmicb.2017.00001, DOI 10.3389/FMICB.2017.00001]; Niazi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104651; Paulus C, 2017, SCI REP-UK, V7, DOI 10.1038/srep42382; Ramarathnam R, 2007, CAN J MICROBIOL, V53, P901, DOI 10.1139/W07-049; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roongsawang N, 2002, EXTREMOPHILES, V6, P499, DOI 10.1007/s00792-002-0287-2; Sharma SCD, 2013, J MICROB BIOTEC FOOD, V2, P2293; Shrestha BK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146764; Singh RK, 2014, PLANT GROWTH REGUL, V73, P91, DOI 10.1007/s10725-013-9870-z; Song B, 2013, APPL MICROBIOL BIOT, V97, P7141, DOI 10.1007/s00253-013-5000-0; Tani H, 2005, J NAT PROD, V68, P1768, DOI 10.1021/np0503855; Wang NN, 2015, GENET MOL RES, V14, P15488, DOI 10.4238/2015.November.30.27; Xu Benhong, 2018, Fisheries Science (Liaoning), V37, P193; Xu ZH, 2013, APPL ENVIRON MICROB, V79, P808, DOI 10.1128/AEM.02645-12; Yang H, 2015, ANAL BIOANAL CHEM, V407, P2529, DOI 10.1007/s00216-015-8486-8; Zhang B, 2013, APPL BIOCHEM BIOTECH, V171, P2262, DOI 10.1007/s12010-013-0424-7; Zhang B, 2013, BBA-BIOMEMBRANES, V1828, P2230, DOI 10.1016/j.bbamem.2013.05.033; Zhao JF, 2014, INT J MOL SCI, V15, P19847, DOI 10.3390/ijms151119847; Zhao JF, 2012, J IND MICROBIOL BIOT, V39, P889, DOI 10.1007/s10295-012-1098-9	41	20	24	6	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0202893	10.1371/journal.pone.0202893	http://dx.doi.org/10.1371/journal.pone.0202893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169540	Green Published, Green Submitted, gold			2022-12-26	WOS:000443374400016
J	Arnold, WK; Savage, CR; Lethbridge, KG; Smith, TC; Brissette, CA; Seshu, J; Stevenson, B				Arnold, William K.; Savage, Christina R.; Lethbridge, Kathryn G.; Smith, Trever C.; Brissette, Catherine A.; Seshu, Janakiram; Stevenson, Brian			Transcriptomic insights on the virulence-controlling CsrA, BadR, RpoN, and RpoS regulatory networks in the Lyme disease spirochete	PLOS ONE			English	Article							BORRELIA-BURGDORFERI OSPC; DECORIN-BINDING-PROTEIN; CARBON STORAGE REGULATOR; GENE-EXPRESSION; CARBOHYDRATE UTILIZATION; PLASMID CONTENT; SMALL RNA; INFECTION; SEQUENCE; DISSECTION	Borrelia burgdorferi, the causative agent of Lyme disease, survives in nature through a cycle that alternates between ticks and vertebrates. To facilitate this defined lifestyle, B. burgdorferi has evolved a gene regulatory network that ensures transmission between those hosts, along with specific adaptations to niches within each host. Several regulatory proteins are known to be essential for the bacterium to complete these critical tasks, but interactions between regulators had not previously been investigated in detail, due to experimental uses of different strain backgrounds and growth conditions. To address that deficit in knowledge, the transcriptomic impacts of four critical regulatory proteins were examined in a uniform strain background. Pairs of mutants and their wild-type parent were grown simultaneously under a single, specific culture condition, permitting direct comparisons between the mutant strains. Transcriptomic analyses were strand-specific, and assayed both coding and noncoding RNAs. Intersection analyses identified regulatory overlaps between regu-Ions, including transcripts involved in carbohydrate and polyamine metabolism. In addition, it was found that transcriptional units such as ospC and dbpBA, which were previously observed to be affected by alternative sigma factors, are transcribed by RNA polymerase using the housekeeping sigma factor, RpoD.	[Arnold, William K.; Savage, Christina R.; Lethbridge, Kathryn G.; Stevenson, Brian] Univ Kentucky, Sch Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA; [Smith, Trever C.; Seshu, Janakiram] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Brissette, Catherine A.] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND USA; [Stevenson, Brian] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA; [Arnold, William K.] Addgene, Cambridge, MA USA; [Smith, Trever C.] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	University of Kentucky; University of Texas System; University of Texas at San Antonio (UTSA); University of North Dakota Grand Forks; University of Kentucky; Tufts University	Stevenson, B (corresponding author), Univ Kentucky, Sch Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA.; Stevenson, B (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	brian.stevenson@uky.edu		Lethbridge, Kathryn/0000-0002-7160-7358; Brissette, Catherine/0000-0003-0792-1403; Arnold, Will/0000-0003-2447-3489; Smith II, Trever/0000-0002-1651-313X	National Institutes of Health [R03 AI113648]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, R03 AI113648 (BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PP, 2017, NUCLEIC ACIDS RES, V45, P775, DOI 10.1093/nar/gkw1180; Arnold WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164165; Babb K, 2001, INFECT IMMUN, V69, P4146, DOI 10.1128/IAI.69.6.4146-4153.2001; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bontemps-Gallo S, 2018, MOL MICROBIOL, V108, P350, DOI 10.1111/mmi.13940; Bontemps-Gallo S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005791; Brissette CA, 2008, INT J MED MICROBIOL, V298, P257, DOI 10.1016/j.ijmm.2007.09.004; Bunikis I, 2011, J MICROBIOL METH, V86, P243, DOI 10.1016/j.mimet.2011.05.004; Burke TP, 2016, MBIO, V7, DOI 10.1128/mBio.00240-16; Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x; Bykowski T, 2006, J BACTERIOL, V188, P4879, DOI 10.1128/JB.00229-06; Caimano MJ, 2005, J BACTERIOL, V187, P7845, DOI 10.1128/JB.187.22.7845-7852.2005; Caimano MJ, 2004, INFECT IMMUN, V72, P6433, DOI 10.1128/IAI.72.11.6433-6445.2004; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Casjens S, 1997, J BACTERIOL, V179, P217, DOI 10.1128/jb.179.1.217-227.1997; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Crother TR, 2004, INFECT IMMUN, V72, P5063, DOI 10.1128/IAI.72.9.5063-5072.2004; Drecktrah D, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00231; Drecktrah D, 2015, PLOS PATHOG, V11, DOI [10.1371/journal.ppat.1005160, 10.1371/journal.ppat.1005242]; Drecktrah D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068799; Dulebohn DP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01734; Eggers CH, 2004, J BACTERIOL, V186, P7390, DOI 10.1128/JB.186.21.7390-7402.2004; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Esquerre A T, 2016, SCI REP, V6, P250; Esteve-Gassent MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136707; Feng SL, 1998, INFECT IMMUN, V66, P2827, DOI 10.1128/IAI.66.6.2827-2835.1998; Fikrig E, 2004, J CLIN MICROBIOL, V42, P1243, DOI 10.1128/JCM.42.3.1243-1246.2004; Fischer JR, 2006, INFECT IMMUN, V74, P435, DOI 10.1128/IAI.74.1.435-441.2006; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Garcia BL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005404; Grove AP, 2017, MBIO, V8, DOI [10.1128/mbio.01204-17, 10.1128/mBio.01204-17]; Hagman KE, 1998, INFECT IMMUN, V66, P2674, DOI 10.1128/IAI.66.6.2674-2683.1998; He M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002133; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Hyde JA, 2009, MOL MICROBIOL, V74, P1344, DOI 10.1111/j.1365-2958.2009.06951.x; Imai D, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-100; Indest KJ, 1997, INFECT IMMUN, V65, P1165, DOI 10.1128/IAI.65.4.1165-1171.1997; Iyer Radha, 2016, Microarrays (Basel), V5, DOI 10.3390/microarrays5020009; Jain S, 2015, INFECT IMMUN, V83, P2224, DOI 10.1128/IAI.02859-14; Jewett MW, 2009, J BACTERIOL, V191, P6231, DOI 10.1128/JB.00450-09; Jutras BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066683; Jutras BL, 2013, J BIOL CHEM, V288, P26220, DOI 10.1074/jbc.M113.491357; Jutras BL, 2013, J BACTERIOL, V195, P757, DOI 10.1128/JB.01956-12; Jutras BL, 2012, J BACTERIOL, V194, P778, DOI 10.1128/JB.06394-11; Karna SLR, 2013, INFECT IMMUN, V81, P2972, DOI 10.1128/IAI.00494-13; Karna SLR, 2011, INFECT IMMUN, V79, P732, DOI 10.1128/IAI.00882-10; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P1409, DOI 10.1128/IAI.69.3.1409-1419.2001; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin YH, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00684-16, 10.1128/iai.00684-16]; Liu MY, 1997, J BACTERIOL, V179, P4639, DOI 10.1128/jb.179.14.4639-4642.1997; Livny J, 2014, NUCLEIC ACIDS RES, V42, P12212, DOI 10.1093/nar/gku891; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Lybecker MC, 2010, MOL MICROBIOL, V78, P622, DOI 10.1111/j.1365-2958.2010.07374.x; Miller CL, 2013, MOL MICROBIOL, V88, P105, DOI 10.1111/mmi.12171; Miller JC, 2005, CURRENT PROTOCOLS D, V1D, P3; Ouyang ZM, 2015, MOL MICROBIOL, V98, P1147, DOI 10.1111/mmi.13206; Ouyang ZM, 2014, INFECT IMMUN, V82, P1511, DOI 10.1128/IAI.01555-13; Ouyang ZM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001272; Ouyang ZM, 2009, MOL MICROBIOL, V74, P1331, DOI 10.1111/j.1365-2958.2009.06945.x; Pappas CJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002102; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Popitsch N, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3398-3; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Sanjuan E, 2009, INFECT IMMUN, V77, P5149, DOI 10.1128/IAI.00673-09; Savage CR, 2018, J BACTERIOL, V200, DOI [10.1128/JB.00033-18, 10.1128/jb.00033-18]; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Shi YL, 2008, INFECT IMMUN, V76, P1239, DOI 10.1128/IAI.00897-07; Shishkin AA, 2015, NAT METHODS, V12, P323, DOI [10.1038/NMETH.3313, 10.1038/nmeth.3313]; Smith AH, 2007, J BACTERIOL, V189, P2139, DOI 10.1128/JB.01653-06; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Stevenson B, 2001, SPIROCHETES: MOLECULAR AND CELLULAR BIOLOGY, P87; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Stevenson B, 2018, SPIROCHETE BIOL POST; Stevenson B, 2006, WIEN KLIN WOCHENSCHR, V118, P643, DOI 10.1007/s00508-006-0690-2; Stewart PE, 2006, INFECT IMMUN, V74, P3547, DOI 10.1128/IAI.00158-06; Strother KO, 2005, VECTOR-BORNE ZOONOT, V5, P237, DOI 10.1089/vbz.2005.5.237; Sze CW, 2011, MOL MICROBIOL, V82, P851, DOI 10.1111/j.1365-2958.2011.07853.x; Sze CW, 2011, INFECT IMMUN, V79, P1270, DOI 10.1128/IAI.00871-10; Tilly K, 2004, VECTOR-BORNE ZOONOT, V4, P159, DOI 10.1089/1530366041210738; Tilly K, 1997, MOL MICROBIOL, V25, P361, DOI 10.1046/j.1365-2958.1997.4711838.x; Tilly K, 2001, J BACTERIOL, V183, P5544, DOI 10.1128/JB.183.19.5544-5553.2001; Tilly K, 2007, INFECT IMMUN, V75, P1517, DOI 10.1128/IAI.01725-06; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Troy EB, 2016, MOL MICROBIOL, V101, P1003, DOI 10.1111/mmi.13437; Vakulskas CA, 2015, MICROBIOL MOL BIOL R, V79, P193, DOI 10.1128/MMBR.00052-14; von Lackum K, 2005, FEMS MICROBIOL LETT, V243, P173, DOI 10.1016/j.femsle.2004.12.002; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001104; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x; Xu QL, 2008, MICROB PATHOGENESIS, V45, P70, DOI 10.1016/j.micpath.2008.03.002; Yang XF, 2000, MOL MICROBIOL, V37, P1470, DOI 10.1046/j.1365-2958.2000.02104.x; Yang XFF, 2005, J BACTERIOL, V187, P4822, DOI 10.1128/JB.187.14.4822-4829.2005; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8; Zhiming OY, 2008, MICROBIOL-SGM, V154, P2641, DOI 10.1099/mic.0.2008/019992-0; Zuckert Wolfram R, 2007, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12c01s4	105	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203286	10.1371/journal.pone.0203286	http://dx.doi.org/10.1371/journal.pone.0203286			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161198	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900102
J	Sonnweber, T; Nairz, M; Theurl, I; Petzer, V; Tymoszuk, P; Haschka, D; Rieger, E; Kaessmann, B; Deri, M; Watzinger, K; Steringer-Mascherbauer, R; Tancevski, I; Weiss, G; Loffler-Ragg, J				Sonnweber, Thomas; Nairz, Manfred; Theurl, Igor; Petzer, Verena; Tymoszuk, Piotr; Haschka, David; Rieger, Eva; Kaessmann, Birgit; Deri, Miriam; Watzinger, Kathrin; Steringer-Mascherbauer, Regina; Tancevski, Ivan; Weiss, Guenter; Loeffler-Ragg, Judith			The crucial impact of iron deficiency definition for the course of precapillary pulmonary hypertension	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; ARTERIAL-HYPERTENSION; CHRONIC DISEASE; FERRIC CARBOXYMALTOSE; HEPCIDIN EXPRESSION; THERAPEUTIC TARGET; ANEMIA; HOMEOSTASIS; METABOLISM; HYPOXIA	Imbalances of iron homeostasis are associated with an adverse clinical outcome of pulmonary hypertension (PH). Herein, we aimed to analyze the impact of iron deficiency (ID) in a real-life PH patient cohort according to different currently used ID definitions. In a retrospective study including 153 precapillary PH patients followed over a mean period of five years, iron deficiency was assessed according to five clinical definitions used in previous trials. The impact of ID on clinical, hematological and hemodynamic parameters was investigated. Depending on the different cutoff levels for serum ferritin and transferrin saturation, currently used ID definitions indicated a prevalence of either true or functional ID in 11 to 75 percent of PH patients. A good diagnostic accuracy was achieved by using the sTFRF/log ferritin (sTFRF) index, which identified 33 to 42 percent of PH patients as being iron deficient. The sTFRF index had the best prediction for the association between ID and clinical outcome. Iron deficient patients with precapillary PH had a significantly higher mortality as compared to non-iron deficiency subjects, which was true for both, PH patients with and without anemia. Although levels of the iron hormone hepcidin were rather affected by ID than by inflammation, they were not associated with the clinical course or mortality of PH subjects. To conclude, ID had a significant impact on the clinical course of precapillary PH patients. The appropriate use of robust biomarkers to define ID is a prerequisite to further evaluate the role of ID and the potential benefit of iron supplementation in precapillary PH patients.	[Sonnweber, Thomas; Nairz, Manfred; Theurl, Igor; Petzer, Verena; Tymoszuk, Piotr; Haschka, David; Rieger, Eva; Kaessmann, Birgit; Deri, Miriam; Watzinger, Kathrin; Tancevski, Ivan; Weiss, Guenter; Loeffler-Ragg, Judith] Med Univ Innsbruck, Dept Internal Med 2, Innsbruck, Austria; [Steringer-Mascherbauer, Regina] Elisabethinen Hosp, Dept Internal Med 2, Linz, Austria; [Weiss, Guenter] Med Univ Innsbruck, Christian Doppler Lab Iron Metab & Anemia Res, Innsbruck, Austria	Medical University of Innsbruck; Ordensklinikum Linz Elisabethinen; Medical University of Innsbruck	Weiss, G; Loffler-Ragg, J (corresponding author), Med Univ Innsbruck, Dept Internal Med 2, Innsbruck, Austria.; Weiss, G (corresponding author), Med Univ Innsbruck, Christian Doppler Lab Iron Metab & Anemia Res, Innsbruck, Austria.	guenter.weiss@i-med.ac.at; judith.loeffler@i-med.ac.at	Tancevski, Ivan/AID-5169-2022; Loeffler-Ragg, Judith/ABG-3407-2020	Tancevski, Ivan/0000-0001-5116-8960; Tymoszuk, Piotr/0000-0002-0398-6034; Petzer, Verena/0000-0002-9205-1440; Theurl, Igor/0000-0003-3180-4784; Loeffler-Ragg, Judith/0000-0003-0873-7501	Austrian National bank Fund [17271]; Verein zur Forderung von Forschung und Weiterbildung in Infektiologie und Immunologie, Innsbruck; Christian Doppler Society, Austria	Austrian National bank Fund; Verein zur Forderung von Forschung und Weiterbildung in Infektiologie und Immunologie, Innsbruck; Christian Doppler Society, Austria	This work was supported by the Austrian National bank Fund (Project 17271, J.LR.), the "Verein zur Forderung von Forschung und Weiterbildung in Infektiologie und Immunologie, Innsbruck" (G.W.) and the Christian Doppler Society, Austria (G.W.).	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021; Brugnara C, 2013, CLIN CHEM, V59, P740, DOI 10.1373/clinchem.2012.182071; Camaschella C, 2015, NEW ENGL J MED, V373, P485, DOI 10.1056/NEJMc1507104; Filippatos G, 2013, EUR J HEART FAIL, V15, P1267, DOI 10.1093/eurjhf/hft099; Frise MC, 2016, J CLIN INVEST, V126, P2139, DOI 10.1172/JCI85715; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Ghosh MC, 2013, CELL METAB, V17, P271, DOI 10.1016/j.cmet.2012.12.016; Girelli D, 2016, BLOOD, V127, P2809, DOI 10.1182/blood-2015-12-639112; Hickey MM, 2010, J CLIN INVEST, V120, P827, DOI 10.1172/JCI36362; Krasuski RA, 2011, INT J CARDIOL, V150, P291, DOI 10.1016/j.ijcard.2010.04.038; Lasocki S, 2010, INTENS CARE MED, V36, P1044, DOI 10.1007/s00134-010-1794-8; Levi S, 2009, BBA-GEN SUBJECTS, V1790, P629, DOI 10.1016/j.bbagen.2008.09.008; Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877; Loreal O, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00128; Mleczko-Sanecka K, 2017, HAEMATOLOGICA, V102, P1173, DOI 10.3324/haematol.2016.162917; Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034; Nairz M, 2017, PFLUG ARCH EUR J PHY, V469, P397, DOI 10.1007/s00424-017-1944-8; Nairz M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00152; Oexle H, 1999, BBA-BIOENERGETICS, V1413, P99, DOI 10.1016/S0005-2728(99)00088-2; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pietrangelo A, 2016, LIVER INT, V36, P116, DOI 10.1111/liv.13020; Rhodes CJ, 2011, EUR RESPIR J, V38, P1453, DOI 10.1183/09031936.00037711; Rhodes CJ, 2011, J AM COLL CARDIOL, V58, P300, DOI 10.1016/j.jacc.2011.02.057; Ruiter G, 2011, EUR RESPIR J, V37, P1386, DOI 10.1183/09031936.00100510; Ruiter G, 2014, RHEUMATOLOGY, V53, P285, DOI 10.1093/rheumatology/ket331; Sitbon O, 2015, EUR RESPIR J, V46, P152, DOI 10.1183/09031936.00004414; Skikne BS, 2011, AM J HEMATOL, V86, P923, DOI 10.1002/ajh.22108; Sonnweber T, 2014, GUT, V63, P1951, DOI 10.1136/gutjnl-2013-305317; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Sutendra G, 2015, CIRC RES, V116, P1636, DOI 10.1161/CIRCRESAHA.115.306440; Sutendra G, 2014, CELL METAB, V19, P558, DOI 10.1016/j.cmet.2014.01.004; Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019; Theurl I, 2011, HAEMATOL-HEMATOL J, V96, P1761, DOI 10.3324/haematol.2011.048926; Theurl I, 2009, BLOOD, V113, P5277, DOI 10.1182/blood-2008-12-195651; Tuder RM, 2009, J AM COLL CARDIOL, V54, pS3, DOI 10.1016/j.jacc.2009.04.009; van Veldhuisen DJ, 2017, CIRCULATION, V136, P1374, DOI 10.1161/CIRCULATIONAHA.117.027497; WEISS G, 1993, EMBO J, V12, P3651, DOI 10.1002/j.1460-2075.1993.tb06039.x; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Weiss G, 2015, SEMIN HEMATOL, V52, P313, DOI 10.1053/j.seminhematol.2015.07.004	43	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203396	10.1371/journal.pone.0203396	http://dx.doi.org/10.1371/journal.pone.0203396			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161261	Green Submitted, Green Published, gold			2022-12-26	WOS:000443388900119
J	van Schadewijk, R; van den Berg, TE; Gupta, KBSS; Ronen, I; de Groot, HJM; Alia, A				van Schadewijk, Remco; van den Berg, Tomas E.; Gupta, Karthick B. Sai Sankar; Ronen, Itamer; de Groot, Huub J. M.; Alia, A.			Non-invasive magnetic resonance imaging of oils in Botryococcus braunii green algae: Chemical shift selective and diffusion-weighted imaging	PLOS ONE			English	Article							RACE B; HYDROCARBON PRODUCTION; CULTURE; BIOSYNTHESIS; ACCUMULATION; SPECTROSCOPY; BIODIESEL; STRAIN; GROWTH; MEDIA	Botryococcus braunii is an oleaginous green algae with the distinctive property of accumulating high quantities of hydrocarbons per dry weight in its colonies. Large variation in colony structure exists, yet its implications and influence of oil distribution and diffusion dynamics are not known and could not be answered due to lack of suitable in vivo methods. This publication seeks to further the understanding on oil dynamics, by investigating naturally relevant large (700-1500 mu m) and extra-large (1500-2500 mu m) sized colonies of Botryococcus braunii (race B, strain Showa) in vivo, using a comprehensive approach of chemical shift selective imaging, chemical shift imaging and spin echo diffusion measurements at high magnetic field (17.6T). Hydrocarbon distribution in large colonies was found to be localised in two concentric oil layers with different thickness and concentration. Extra-large colonies were highly unstructured and oil was spread throughout colonies, but with large local variations. Interestingly, fluid channels were observed in extra-large colonies. Diffusion-weighted MRI revealed a strong correlation between colony heterogeneity, oil distribution, and diffusion dynamics in different parts of Botryococcus colonies. Differences between large and extra-large colonies were characterised by using T-2 weighted MRI along with relaxation measurements. Our result, therefore, provides first non-invasive MRI means to obtain spatial information on oil distribution and diffusion dynamics in Botryococcus braunii colonies.	[van Schadewijk, Remco; Gupta, Karthick B. Sai Sankar; de Groot, Huub J. M.; Alia, A.] Leiden Univ, Leiden Inst Chem, Leiden, Netherlands; [van den Berg, Tomas E.] Vrije Univ Amsterdam, Dept Phys & Astron, Biophys Photosynth, Amsterdam, Netherlands; [Ronen, Itamer] Leiden Univ, Med Ctr, Radiol Dept, Leiden, Netherlands; [Alia, A.] Univ Leipzig, Inst Med Phys & Biophys, Leipzig, Germany	Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leipzig University	Alia, A (corresponding author), Leiden Univ, Leiden Inst Chem, Leiden, Netherlands.; Alia, A (corresponding author), Univ Leipzig, Inst Med Phys & Biophys, Leipzig, Germany.	a.alia@chem.leidenuniv.nl	de Groot, Huub J. M./J-4741-2012; de Groot, Huub/GXV-7380-2022	de Groot, Huub J. M./0000-0002-8796-1212; van den Berg, Tomas/0000-0002-7202-4699; van Schadewijk, Remco/0000-0002-7821-3853; Ronen, Itamar/0000-0002-6872-4895	Foundation for Fundamental Research on Matter (FOM) within BioSolar Cells program [10TBSC23]; BioSolar Cell [C2.2, U2.3]	Foundation for Fundamental Research on Matter (FOM) within BioSolar Cells program; BioSolar Cell	This work was funded by the Foundation for Fundamental Research on Matter (FOM) within BioSolar Cells program (grant no. 10TBSC23) and grants from BioSolar Cell (C2.2 &U2.3).	BROWN TR, 1992, NMR BIOMED, V5, P238, DOI 10.1002/nbm.1940050508; BROWNSTEIN KR, 1979, PHYS REV A, V19, P2446, DOI 10.1103/PhysRevA.19.2446; Chiang IZ, 2004, J PHYCOL, V40, P474, DOI 10.1111/j.1529-8817.2004.03096.x; Chu SP, 1942, J ECOL, V30, P284, DOI 10.2307/2256574; Demirbas A, 2011, ENERG CONVERS MANAGE, V52, P163, DOI 10.1016/j.enconman.2010.06.055; Bayona KCD, 2014, J APPL PHYCOL, V26, P2087, DOI 10.1007/s10811-014-0242-5; DUBREUIL C, 1989, ORG GEOCHEM, V14, P543, DOI 10.1016/0146-6380(89)90034-X; Eroglu E, 2011, J APPL PHYCOL, V23, P763, DOI 10.1007/s10811-010-9577-8; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Furuhashi K, 2016, ALGAL RES, V16, P160, DOI 10.1016/j.algal.2016.02.021; GLIKSON M, 1989, ORG GEOCHEM, V14, P595, DOI 10.1016/0146-6380(89)90039-9; Guy-Ohlson D, 1998, PALAEOGEOGR PALAEOCL, V140, P347, DOI 10.1016/S0031-0182(98)00019-4; HAASE A, 1985, PHYS MED BIOL, V30, P341, DOI 10.1088/0031-9155/30/4/008; HILLEN LW, 1982, BIOTECHNOL BIOENG, V24, P193, DOI 10.1002/bit.260240116; Hirose M, 2013, EUKARYOT CELL, V12, P1132, DOI 10.1128/EC.00088-13; Hoh D, 2016, CHEM ENG J, V287, P466, DOI 10.1016/j.cej.2015.11.062; HUANG Z, 1989, PHYTOCHEMISTRY, V28, P3043, DOI 10.1016/0031-9422(89)80276-6; Jin J, 2016, PROCESS BIOCHEM, V51, P1866, DOI 10.1016/j.procbio.2015.11.026; Kaufmann I, 2008, J MAGN RESON, V192, P139, DOI 10.1016/j.jmr.2008.02.008; Khatri W, 2014, BIOTECHNOL BIOENG, V111, P493, DOI 10.1002/bit.25126; Kumar M, 2017, PALYNOLOGY, V41, P462, DOI 10.1080/01916122.2016.1259667; LARGEAU C, 1980, PHYTOCHEMISTRY, V19, P1081, DOI 10.1016/0031-9422(80)83060-3; Metzger P, 2007, ORG GEOCHEM, V38, P566, DOI 10.1016/j.orggeochem.2006.12.003; Meyer L, 2014, CLIMATE CHANGE 2014; Nonomura A., 1988, JPN J PHYCOL, V36, P285; Rivas MO, 2010, MICROB ECOL, V60, P628, DOI 10.1007/s00248-010-9686-6; Ruhl ID, 2011, ORG GEOCHEM, V42, P1, DOI 10.1016/j.orggeochem.2010.09.004; Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8; Shen Y, 2015, BIOPROC BIOSYST ENG, V38, P481, DOI 10.1007/s00449-014-1287-1; Simpson AJ, 2003, PHYTOCHEMISTRY, V62, P783, DOI 10.1016/S0031-9422(02)00628-3; Suzuki R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081626; Tanoi T, 2014, J APPL PHYCOL, V26, P1, DOI 10.1007/s10811-013-0026-3; Uno Y, 2015, ALGAL RES, V8, P214, DOI 10.1016/j.algal.2015.02.015; WAKE LV, 1980, BIOTECHNOL BIOENG, V22, P1637, DOI 10.1002/bit.260220808; WAKE LV, 1983, AUST J BOT, V31, P605, DOI 10.1071/BT9830605; Weiss TL, 2012, EUKARYOT CELL, V11, P1424, DOI 10.1128/EC.00184-12; Weiss TL, 2010, J BIOL CHEM, V285, P32458, DOI 10.1074/jbc.M110.157230; Wijihastuti RS, 2017, J APPL PHYCOL, V29, P1123, DOI 10.1007/s10811-016-1032-z; WOLF FR, 1985, J PHYCOL, V21, P388; Yoshimura T, 2013, BIORESOURCE TECHNOL, V133, P232, DOI 10.1016/j.biortech.2013.01.095	40	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203217	10.1371/journal.pone.0203217	http://dx.doi.org/10.1371/journal.pone.0203217			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161202	gold, Green Published			2022-12-26	WOS:000443388900092
J	Liu, Y; Long, YH; Wang, SQ; Zhang, YY; Li, YF; Mi, JS; Yu, CH; Li, DY; Zhang, JH; Zhang, XJ				Liu, Yan; Long, Yue-Hong; Wang, Shu-Qing; Zhang, Yuan-Yue; Li, Yu-Feng; Mi, Jiang-Sheng; Yu, Cheng-Hua; Li, De-Yan; Zhang, Jing-Hua; Zhang, Xiao-Jun			JMJD6 regulates histone H2A.X phosphorylation and promotes autophagy in triple-negative breast cancer cells via a novel tyrosine kinase activity	ONCOGENE			English	Article							IN-VIVO; PROTEIN; INHIBITOR; TRANSCRIPTION; COMPLEXES; ACTIVATOR; RECEPTOR; BINDING; DAMAGE	Overexpression of Jumonji domain-containing 6 (JMJD6) has been reported to be associated with more aggressive breast cancer characteristics. However, the precise role of JMJD6 in breast cancer development remains unclear. Here, we demonstrate that JMJD6 has intrinsic tyrosine kinase activity and can utilize ATP and GTP as phosphate donors to phosphorylate Y39 of histone H2A.X (H2A.X-Y39ph). High JMJD6 levels promoted autophagy in triple negative breast cancer (TNBC) cells by regulating the expression of autophagy-related genes. The JMJD6-H2A.X-Y39ph axis promoted TNBC cell growth via the autophagy pathway. We show that combined inhibition of JMJD6 kinase activity and autophagy efficiently decreases TNBC growth. Together, these findings suggest an effective strategy for TNBC treatment.	[Liu, Yan; Long, Yue-Hong; Zhang, Yuan-Yue] North China Univ Sci & Technol, Coll Life Sci, Tangshan, Peoples R China; [Liu, Yan; Zhang, Yuan-Yue; Li, Yu-Feng; Zhang, Jing-Hua] Tangshan Peoples Hosp, Inst Canc, Tangshan, Peoples R China; [Wang, Shu-Qing] Hosp North China Univ Sci & Technol, Tangshan, Peoples R China; [Mi, Jiang-Sheng; Yu, Cheng-Hua; Li, De-Yan; Zhang, Xiao-Jun] Peoples Hosp Zunhua, Zunhua, Peoples R China	North China University of Science & Technology	Zhang, JH (corresponding author), Tangshan Peoples Hosp, Inst Canc, Tangshan, Peoples R China.; Wang, SQ (corresponding author), Hosp North China Univ Sci & Technol, Tangshan, Peoples R China.; Zhang, XJ (corresponding author), Peoples Hosp Zunhua, Zunhua, Peoples R China.	044a141211@ncst.edu.cn; jhzhang_te@163.com; tech_ol@foxmail.com	Li, yu/HHZ-5236-2022; zhang, jin/GXV-9154-2022		National Natural Science Foundation of China [81772834, 81302324, 81301779]; Science Fund for Distinguished Young Scholars of North China University of Science and Technology [JQ201704]; Scientific Research Matching Funds of North China University of Science and Technology; scientific research funds of Tangshan People's Hospital; Doctoral Research Project of North China University of Science and Technology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Distinguished Young Scholars of North China University of Science and Technology; Scientific Research Matching Funds of North China University of Science and Technology; scientific research funds of Tangshan People's Hospital; Doctoral Research Project of North China University of Science and Technology	This work was primarily supported by the National Natural Science Foundation of China (grant numbers 81772834, 81302324, 81301779). Other support include: Science Fund for Distinguished Young Scholars of North China University of Science and Technology (JQ201704); Doctoral Research Project of North China University of Science and Technology. This work was also supported by the Scientific Research Matching Funds of North China University of Science and Technology and scientific research funds of Tangshan People's Hospital.	Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200; Aprelikova O, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0205-6; BELLARD M, 1989, METHOD ENZYMOL, V170, P317; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Chittaranjan S, 2014, CLIN CANCER RES, V20, P3159, DOI 10.1158/1078-0432.CCR-13-2060; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Dragowska WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076503; Druzinec D, 2013, ADV BIOCHEM ENG BIOT, V136, P65, DOI 10.1007/10_2013_205; Hahn P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-293; HATHAWAY GM, 1983, METHOD ENZYMOL, V99, P317, DOI 10.1016/0076-6879(83)99067-5; Kung Hsing-Jien, 2011, Hormones & Cancer, V2, P38, DOI 10.1007/s12672-010-0053-3; Lee YF, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3200; Lefort S, 2014, AUTOPHAGY, V10, P2122, DOI 10.4161/15548627.2014.981788; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liang DH, 2016, CANCER LETT, V376, P249, DOI 10.1016/j.canlet.2016.04.002; Liu X, 2010, J BIOL CHEM, V285, P9729, DOI 10.1074/jbc.M109.073452; Liu Y, 2016, FEBS J, V283, P4462, DOI 10.1111/febs.13951; Liu Y, 2012, J BIOL CHEM, V287, P41469, DOI 10.1074/jbc.M112.367847; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Miller TE, 2017, NATURE, V547, P355, DOI 10.1038/nature23000; Mohammed H, 2015, NATURE, V523, P313, DOI 10.1038/nature14583; Pattingre S, 2004, METHOD ENZYMOL, V390, P17; Poulard C, 2016, ONCOTARGET, V7, P67532, DOI 10.18632/oncotarget.11376; Poulard C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126181; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Rao R, 2012, MOL CANCER THER, V11, P973, DOI 10.1158/1535-7163.MCT-11-0979; Rio DC., 2013, COLD SPRING HARB PRO, V2013; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Steger DJ, 1998, P NATL ACAD SCI USA, V95, P12924, DOI 10.1073/pnas.95.22.12924; Thomas S, 2012, CANCER LETT, V325, P63, DOI 10.1016/j.canlet.2012.05.030; Tsai A, 2006, NAT PROTOC, V1, P2820, DOI 10.1038/nprot.2006.371; Vangimalla SS, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7020041; Wang F, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001819; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Wolf A, 2013, BIOCHEM J, V453, P357, DOI 10.1042/BJ20130529; Wu T, 2014, CELL STEM CELL, V15, P281, DOI 10.1016/j.stem.2014.06.004; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	46	36	37	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 14	2019	38	7					980	997		10.1038/s41388-018-0466-y	http://dx.doi.org/10.1038/s41388-018-0466-y			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HL3OH	30185813				2022-12-26	WOS:000458624900005
J	Liu, T; Liu, LM; Liu, MN; Du, R; Dang, YJ; Bai, M; Zhang, L; Ma, F; Yang, XX; Ning, XX; Sun, SR				Liu, Ting; Liu, Limin; Liu, Minna; Du, Rui; Dang, Yangjie; Bai, Ming; Zhang, Lei; Ma, Feng; Yang, Xiaoxia; Ning, Xiaoxuan; Sun, Shiren			MicroRNA-493 targets STMN-1 and promotes hypoxia-induced epithelial cell cycle arrest in G(2)/M and renal fibrosis	FASEB JOURNAL			English	Article						hypoxia; chronic kidney injury; tubular cell; HIF-1 alpha	TO-MESENCHYMAL TRANSITION; DOWN-REGULATION; GROWTH ARREST; CANCER-CELLS; STATHMIN; EXPRESSION; MYOFIBROBLASTS; IDENTIFICATION; PROLIFERATION; PROGRESSION	Hypoxia plays an important role in the development of renal fibrosis. G(2)/M arrest in renal tubular cells is an important pathway in the development of chronic kidney disease. It is unknown whether hypoxia leads to renal fibrosis via the regulation of G(2)/M arrest in renal tubular epithelial cells. For the first time, to our knowledge, we showed that hypoxia induces G(2)/M arrest in renal tubular cells leading to renal fibrosis, and microRNAs are involved in this regulation. We compared microRNA expression between hypoxia and normoxia in HK2 cells and found microRNA (miR)-493 to be highly expressed at 24 and 48 h after hypoxia. The overexpression of miR-493 reduced the expression of the cell cycle regulator, Stathmin (STMN)-1, and increased the percentage of G(2)/M phase cells and profibrotic factors in HK2 cells. Targeting STMN-1 with short hairpin RNA produced an effect similar to that of miR-493 overexpression. On contrast, the miR-493 inhibitor reversed these effects in vitro. Consistent with these results, miR-493 sponge adeno-associated virus reduced the expression of profibrotic factors and increased STMN-1 in vivo. In summary, these results suggest that the miR-493-STMN-1 pathway contributes to hypoxia-induced tubular epithelial cell G(2)/M arrest and renal fibrosis. Abrogating G(2)/M arrest and blocking the miR-493-STMN-1 pathway will provide further insight for the development of antifibrosis therapy.Liu, T., Liu, L., Liu, M., Du, R., Dang, Y., Bai, M., Zhang, L., Ma, F., Yang, X., Ning, X., Sun, S. MicroRNA-493 targets STMN-1 and promotes hypoxia-induced epithelial cell cycle arrest In G(2)/M and renal fibrosis.	[Liu, Ting; Liu, Limin; Liu, Minna; Bai, Ming; Zhang, Lei; Ma, Feng; Yang, Xiaoxia; Sun, Shiren] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian, Shaanxi, Peoples R China; [Liu, Ting; Liu, Limin; Liu, Minna; Bai, Ming; Zhang, Lei; Ning, Xiaoxuan; Sun, Shiren] Fourth Mil Med Univ, State Key Lab Canc Biol, Xijing Hosp, Xian, Shaanxi, Peoples R China; [Ning, Xiaoxuan] Fourth Mil Med Univ, Dept Geriatr, Xijing Hosp, Xian, Shaanxi, Peoples R China; [Liu, Ting] Xi An Jiao Tong Univ, Dept Nephrol, Guangren Hosp, Xian, Shaanxi, Peoples R China; [Du, Rui] Navy Gen Hosp, Dept Radiat Oncol, Beijing, Peoples R China; [Dang, Yangjie] Children Hosp Xian, Dept Anesthesiol, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Xi'an Jiaotong University; Sixth Medical Center of Chinese PLA General Hospital	Ning, XX (corresponding author), Fourth Mil Med Univ, Dept Geriatr, State Key Lab Canc Biol, Xijing Hosp, 127 Chang Le West Rd, Xian 710032, Shaanxi, Peoples R China.; Sun, SR (corresponding author), Fourth Mil Med Univ, Dept Nephrol, State Key Lab Canc Biol, Xijing Hosp, 127 Chang Le West Rd, Xian 710032, Shaanxi, Peoples R China.	ningxx01@fmmu.edu.cn; sunshiren@medmail.com.cn	Liu, Minna/AAV-1609-2020; liu, li/HGC-0900-2022	liu, limin/0000-0003-2527-7201	National Natural Science Foundation of China [81370789, 81670655, 81400699]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Gang Wang and Dr. Di Wang from the Department of Nephrology, Xijing Hospital, who provided kidney biopsies and pathological technical support. This work was supported by The National Natural Science Foundation of China (81370789, 81670655, and 81400699). The authors declare no conflicts of interest.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Barone S, 2005, AM J PHYSIOL-CELL PH, V289, pC826, DOI 10.1152/ajpcell.00629.2004; Boni V, 2010, MOL CANCER THER, V9, P2265, DOI 10.1158/1535-7163.MCT-10-0061; Canaud G, 2015, NEPHROL DIAL TRANSPL, V30, P575, DOI 10.1093/ndt/gfu230; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Du R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030771; Eddy AA, 2014, KIDNEY INT SUPPL, V4, P2, DOI 10.1038/kisup.2014.2; Fine LG, 2000, KIDNEY INT, V57, pS22, DOI 10.1046/j.1523-1755.2000.07512.x; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gu YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102602; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Jayle C, 2007, AM J PHYSIOL-RENAL, V292, pP1082, DOI 10.1152/ajprenal.00338.2006; Jenkins RH, 2014, AM J PATHOL, V184, P996, DOI 10.1016/j.ajpath.2013.12.028; Johnsen JI, 2000, INT J CANCER, V88, P685, DOI 10.1002/1097-0215(20001201)88:5<685::AID-IJC1>3.0.CO;2-Z; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Liu XL, 2015, INT J CLIN EXP MED, V8, P6502; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Loscalzo J, 2010, J CLIN INVEST, V120, P3815, DOI 10.1172/JCI45105; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lv LL, 2013, AM J PHYSIOL-RENAL, V305, pF1220, DOI 10.1152/ajprenal.00148.2013; Mack M, 2015, KIDNEY INT, V87, P297, DOI 10.1038/ki.2014.287; Molitoris BA, 2009, J AM SOC NEPHROL, V20, P1754, DOI 10.1681/ASN.2008111204; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Okamoto K, 2012, EMBO J, V31, P1752, DOI 10.1038/emboj.2012.25; Pichiorri F, 2016, CANCER CELL, V30, P349, DOI 10.1016/j.ccell.2016.07.007; Polager S, 2003, J BIOL CHEM, V278, P1443, DOI 10.1074/jbc.M210327200; Price PM, 2009, KIDNEY INT, V76, P604, DOI 10.1038/ki.2009.224; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Sole C, 2015, NEPHROL DIAL TRANSPL, V30, P1488, DOI 10.1093/ndt/gfv128; Sonneville F, 2015, AM J PATHOL, V185, P897, DOI 10.1016/j.ajpath.2014.12.022; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Tambe M, 2016, ONCOTARGET, V7, P12267, DOI 10.18632/oncotarget.7860; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tian FJ, 2015, AM J PATHOL, V185, P2709, DOI 10.1016/j.ajpath.2015.06.010; Wang G, 2012, AM J NEPHROL, V36, P412, DOI 10.1159/000343452; Whitehouse A, 2015, ONCOTARGET, V6, P32289, DOI 10.18632/oncotarget.5961; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yoon S, 2010, FEBS LETT, V584, P4048, DOI 10.1016/j.febslet.2010.08.025; Zagorska A, 2004, ACTA BIOCHIM POL, V51, P563, DOI 10.18388/abp.2004_3545; Zahedi K, 2006, AM J PHYSIOL-RENAL, V290, pF1559, DOI 10.1152/ajprenal.00424.2005; Zahedi K, 2004, AM J PHYSIOL-CELL PH, V286, pC1203, DOI 10.1152/ajpcell.00432.2003; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	47	18	22	2	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1565	1577		10.1096/fj.201701355RR	http://dx.doi.org/10.1096/fj.201701355RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30183377	Bronze			2022-12-26	WOS:000457296600006
J	Parisi, G; Montemiglio, LC; Giuffre, A; Macone, A; Scaglione, A; Cerutti, G; Exertier, C; Savino, C; Vallone, B				Parisi, Giacomo; Montemiglio, Linda Celeste; Giuffre, Alessandro; Macone, Alberto; Scaglione, Antonella; Cerutti, Gabriele; Exertier, Cecile; Savino, Carmelinda; Vallone, Beatrice			Substrate-induced conformational change in cytochrome P450 OleP	FASEB JOURNAL			English	Article						X-ray crystallography; multistep binding kinetics; 6DEB; structural transition; spectroscopic intermediate	STREPTOMYCES-ANTIBIOTICUS; 2-DIMENSIONAL NMR; STRUCTURAL BASIS; BIOSYNTHESIS; OLEANDOMYCIN; BINDING; DYNAMICS; KINETICS; OXIDATION; ENZYMES	The regulation of cytochrome P450 activity is often achieved by structural transitions induced by substrate binding. We describe the conformational transition experienced upon binding by the P450 OleP, an epoxygenase involved in oleandomycin biosynthesis. OleP bound to the substrate analog 6DEB crystallized in 2 forms: one with an ensemble of open and closed conformations in the asymmetric unit and another with only the closed conformation. Characterization of OleP-6DEB binding kinetics, also using the P450 inhibitor clotrimazole, unveiled a complex binding mechanism that involves slow conformational rearrangement with the accumulation of a spectroscopically detectable intermediate where 6DEB is bound to open OleP. Data reported herein provide structural snapshots of key precatalytic steps in the OleP reaction and explain how structural rearrangements induced by substrate binding regulate activity.Parisi, G., Montemiglio, L. C., Giuffre, A., Macone, A., Scaglione, A., Cerutti, G., Exertier, C., Savino, C., Vallone, B. Substrate-induced conformational change in cytochrome P450 OleP.	[Parisi, Giacomo; Montemiglio, Linda Celeste; Scaglione, Antonella; Vallone, Beatrice] Sapienza Univ Roma, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Parisi, Giacomo; Montemiglio, Linda Celeste; Macone, Alberto; Scaglione, Antonella; Cerutti, Gabriele; Exertier, Cecile; Vallone, Beatrice] Sapienza Univ Roma, Dipartimento Sci Biochim A Rossi Fanelli, Ple A Moro 5, I-00185 Rome, Italy; [Montemiglio, Linda Celeste; Giuffre, Alessandro; Savino, Carmelinda; Vallone, Beatrice] CNR, Inst Mol Biol & Pathol, Ple A Moro 5, I-00185 Rome, Italy; [Parisi, Giacomo] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Scaglione, Antonella] CUNY, Adv Sci Res Ctr, New York, NY 10021 USA	Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Columbia University; City University of New York (CUNY) System	Vallone, B (corresponding author), Sapienza Univ Roma, Dipartimento Sci Biochim A Rossi Fanelli, Ple A Moro 5, I-00185 Rome, Italy.; Savino, C (corresponding author), CNR, Inst Mol Biol & Pathol, Ple A Moro 5, I-00185 Rome, Italy.	linda.savino@uniroma1.it; beatrice.vallone@uniroma1.it	Macone, Alberto/AAB-2570-2019; Scaglione, Antonella/W-4691-2019; Giuffrè, Alessandro/K-4341-2015	Macone, Alberto/0000-0003-0455-1400; Giuffrè, Alessandro/0000-0001-5301-0681; Cerutti, Gabriele/0000-0002-9081-7561; PARISI, GIACOMO/0000-0002-3064-0928	Sapienza Awards Grant [C26H154L5A]; Sapienza Avvio alla Ricerca 2016 grant; Progetto Premiale 2012: Avanzati Sistemi Biosensoristici per la Diagnosi e il Follow-Up della Malattia Celiaca (Advanced Biosensor Systems for the Diagnosis and Follow-Up of Celiac Disease) from the National Research Council; H2CU-Honors Center of Italian Universities; European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie Grant [637295]	Sapienza Awards Grant; Sapienza Avvio alla Ricerca 2016 grant; Progetto Premiale 2012: Avanzati Sistemi Biosensoristici per la Diagnosi e il Follow-Up della Malattia Celiaca (Advanced Biosensor Systems for the Diagnosis and Follow-Up of Celiac Disease) from the National Research Council; H2CU-Honors Center of Italian Universities; European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie Grant	The authors thank Barrie Wilkinson and Rachel Lill (Biotica Technology, Cambridge, United Kingdom) for the kind gift of 6DEB; Ida Freda (University of Rome Sapienza, Rome, Italy) for assistance during protein purification; Prof. Stefano Gianni (University of Rome Sapienza) for carefully reading the manuscript and for insightful comments; and the staff at the European Synchrotron Radiation Facility (Beamlines ID14-01; Grenoble, France) and the synchrotron, Berlin Electron Storage Ring Society for Synchrotron Radiation (BESSY, Hemholtz-Zentrum Berlin, Berlin Germany; Beamline ID-14-02). This work was supported by Sapienza Awards Grant C26H154L5A (to B.V.), Sapienza Avvio alla Ricerca 2016 grant (to L.C.M.), the Progetto Premiale 2012: Avanzati Sistemi Biosensoristici per la Diagnosi e il Follow-Up della Malattia Celiaca (Advanced Biosensor Systems for the Diagnosis and Follow-Up of Celiac Disease) from the National Research Council (to C.S), and H2CU-Honors Center of Italian Universities (to B.V.). This project has received funding from the European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie Grant Agreement 637295. The atomic coordinates and the structure factors were deposited under Codes 5MNV (structural and functional characterization of OleP in complex with 6DEB in PEG) and 5MNS (structural and functional characterization of OleP in complex with 6DEB in sodium formate) in the Protein Data Bank Research Collaboratory for Structural Bioinformatics at Rutgers University (New Brunswick, NJ, USA; http://www.rcsb.org).The authors declare no conflicts of interest.	Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balding PR, 2008, J PHYS CHEM A, V112, P12911, DOI 10.1021/jp802087w; Basudhar D, 2015, J BIOL CHEM, V290, P10000, DOI 10.1074/jbc.M114.627935; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Colthart AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22035; Correia M. A., 2015, CYTOCHROME P450 STRU, V4th, P177, DOI [10.1007/978-3-319-12108-6_5, DOI 10.1007/978-3-319-12108-6_5]; CuppVickery JR, 1996, NAT STRUCT BIOL, V3, P632, DOI 10.1038/nsb0796-632; CUPPVICKERY JR, 1994, PROTEINS, V20, P197, DOI 10.1002/prot.340200210; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Domanski TL, 2001, BIOCHEMISTRY-US, V40, P10150, DOI 10.1021/bi010758a; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gaisser S, 2002, MOL MICROBIOL, V44, P771, DOI 10.1046/j.1365-2958.2002.02910.x; Gianni S, 2014, BIOPHYS CHEM, V189, P33, DOI 10.1016/j.bpc.2014.03.003; HANIU M, 1982, BIOCHEM BIOPH RES CO, V105, P889, DOI 10.1016/0006-291X(82)91053-1; Hays AMA, 2004, J MOL BIOL, V344, P455, DOI 10.1016/j.jmb.2004.09.046; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Korzekwa KR, 1998, BIOCHEMISTRY-US, V37, P4137, DOI 10.1021/bi9715627; Kuznetsov VY, 2006, BIOCHEMISTRY-US, V45, P11934, DOI 10.1021/bi0611154; Lampe JN, 2010, J BIOL CHEM, V285, P9594, DOI 10.1074/jbc.M109.087593; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee YT, 2010, BIOCHEMISTRY-US, V49, P3412, DOI 10.1021/bi100183g; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Montemiglio LC, 2016, BBA-GEN SUBJECTS, V1860, P465, DOI 10.1016/j.bbagen.2015.10.009; Montemiglio LC, 2013, BIOCHEMISTRY-US, V52, P3678, DOI 10.1021/bi400223j; Montemiglio LC, 2010, BIOCHEMISTRY-US, V49, P9199, DOI 10.1021/bi101062v; Ogura H, 2004, BIOCHEMISTRY-US, V43, P14712, DOI 10.1021/bi048980d; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Pochapsky TC, 2010, ANTIOXID REDOX SIGN, V13, P1273, DOI 10.1089/ars.2010.3109; Podust LM, 2012, NAT PROD REP, V29, P1251, DOI 10.1039/c2np20020a; Poulos T. L., 2015, CYTOCHROME P450 STRU, V4th, P3, DOI DOI 10.1007/978-3-319-12108-6_1; QUIROS LM, 1995, J BIOL CHEM, V270, P18234, DOI 10.1074/jbc.270.31.18234; RODRIGUEZ AM, 1995, FEMS MICROBIOL LETT, V127, P117; Savino C, 2009, J BIOL CHEM, V284, P29170, DOI 10.1074/jbc.M109.003590; Shah S, 2000, J ANTIBIOT, V53, P502, DOI 10.7164/antibiotics.53.502; Sherman DH, 2006, J BIOL CHEM, V281, P26289, DOI 10.1074/jbc.M605478200; SHOU M, 1994, BIOCHEMISTRY-US, V33, P6450, DOI 10.1021/bi00187a009; TATSUTA K, 1990, J ANTIBIOT, V43, P909, DOI 10.7164/antibiotics.43.909; Tietz DR, 2017, BIOCHEMISTRY-US, V56, P2701, DOI 10.1021/acs.biochem.7b00291; Vagin A, 1998, ACTA CRYSTALLOGR D, V54, P400, DOI 10.1107/S0907444997014923	47	9	9	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1787	1800		10.1096/fj.201800450RR	http://dx.doi.org/10.1096/fj.201800450RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30207799	Green Submitted, Bronze			2022-12-26	WOS:000457296600022
J	Furniss, RCD; Low, WW; Mavridou, DAI; Dagley, LF; Webb, AI; Tate, EW; Clements, A				Furniss, R. Christopher D.; Low, Wen Wen; Mavridou, Despoina A. I.; Dagley, Laura F.; Webb, Andrew I.; Tate, Edward W.; Clements, Abigail			Plasma membrane profiling during enterohemorrhagic E-coli infection reveals that the metalloprotease StcE cleaves CD55 from host epithelial surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteomics; cell surface; host-pathogen interaction; infection; neutrophil; metalloprotease; CD55; EHEC; EPHA2; StcE	DECAY-ACCELERATING FACTOR; COMPUTATIONAL PLATFORM; FACTOR DAF; EXPRESSION; COMPLEMENT; INHIBITION; O157-H7; CELLS; PROTEASE; TRANSPORTERS	Enterohemorrhagic Escherichia coli (EHEC) is one of several E. coli pathotypes that infect the intestinal tract and cause disease. Formation of the characteristic attaching and effacing lesion on the surface of infected cells causes significant remodeling of the host cell surface; however, limited information is available about changes at the protein level. Here we employed plasma membrane profiling, a quantitative cell-surface proteomics technique, to identify host proteins whose cell-surface levels are altered during infection. Using this method, we quantified more than 1100 proteins, 280 of which showed altered cell-surface levels after exposure to EHEC. 22 host proteins were significantly reduced on the surface of infected epithelial cells. These included both known and unknown targets of EHEC infection. The complement decay-accelerating factor cluster of differentiation 55 (CD55) exhibited the greatest reduction in cell-surface levels during infection. We showed by flow cytometry and Western blot analysis that CD55 is cleaved from the cell surface by the EHEC-specific protease StcE and found that StcE-mediated CD55 cleavage results in increased neutrophil adhesion to the apical surface of intestinal epithelial cells. This suggests that StcE alters host epithelial surfaces to depress neutrophil transepithelial migration during infection. This work is the first report of the global manipulation of the epithelial cell surface by a bacterial pathogen and illustrates the power of quantitative cell-surface proteomics in uncovering critical aspects of bacterial infection biology.	[Furniss, R. Christopher D.; Low, Wen Wen; Mavridou, Despoina A. I.; Clements, Abigail] Imperial Coll London, Dept Life Sci, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Dagley, Laura F.; Webb, Andrew I.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Dagley, Laura F.; Webb, Andrew I.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3050, Australia; [Tate, Edward W.] Imperial Coll London, Dept Chem, London SW7 2AZ, England	Imperial College London; Walter & Eliza Hall Institute; University of Melbourne; Imperial College London	Clements, A (corresponding author), Imperial Coll London, Dept Life Sci, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England.	a.clements@imperial.ac.uk	Furniss, Chris/AAG-7373-2020; Mavridou, Despoina/ABG-5940-2020	Furniss, Chris/0000-0002-5806-5099; Mavridou, Despoina/0000-0002-7449-1151; Clements, Abigail/0000-0003-2285-777X; Low, Wen Wen/0000-0003-4004-7244; Tate, Edward/0000-0003-2213-5814	Medical Research Council (MRC) Centre for Molecular Bacteriology and Infection (CMBI) PhD scholarship as part of the CMBI Centre Award [MR/J006874/1]; Medical Research Council (MRC) Career Development Award [MR/M009505/1]; MRC [MR/M009505/1, MR/J006874/1] Funding Source: UKRI	Medical Research Council (MRC) Centre for Molecular Bacteriology and Infection (CMBI) PhD scholarship as part of the CMBI Centre Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council (MRC) Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Recipient of a Medical Research Council (MRC) Centre for Molecular Bacteriology and Infection (CMBI) PhD scholarship as part of the CMBI Centre Award MR/J006874/1.; Funded by a Medical Research Council (MRC) Career Development Award MR/M009505/1.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Berger CN, 2017, CELL METAB, V26, P738, DOI 10.1016/j.cmet.2017.09.003; Bingle LEH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080160; Borthakur A, 2006, AM J PHYSIOL-GASTR L, V290, pG30, DOI 10.1152/ajpgi.00302.2005; Brandt-Bohne U, 2007, BIOCHEM J, V401, P447, DOI 10.1042/BJ20060691; Brazil JC, 2016, IMMUNOL REV, V273, P94, DOI 10.1111/imr.12446; Broer A, 2016, J BIOL CHEM, V291, P13194, DOI 10.1074/jbc.M115.700534; Broughton SE, 2012, CURR OPIN STRUC BIOL, V22, P350, DOI 10.1016/j.sbi.2012.03.015; Burland V, 1998, NUCLEIC ACIDS RES, V26, P4196, DOI 10.1093/nar/26.18.4196; CLEARY TG, 1988, PEDIATR CLIN N AM, V35, P485; Clements A, 2014, CELL MICROBIOL, V16, P1693, DOI 10.1111/cmi.12319; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Dziva F, 2007, FEMS MICROBIOL LETT, V271, P258, DOI 10.1111/j.1574-6968.2007.00724.x; Furniss R. C. D., 2017, J BACTERIOL, V200, DOI [10.1128/JB.0033617, DOI 10.1128/JB.0033617]; Furniss RCD, 2016, J MOL BIOL, V428, P3399, DOI 10.1016/j.jmb.2016.05.023; Geiger T, 2011, NAT PROTOC, V6, P147, DOI 10.1038/nprot.2010.192; Giepmans BNG, 2009, BBA-BIOMEMBRANES, V1788, P820, DOI 10.1016/j.bbamem.2008.07.015; Gill RK, 2007, J CLIN INVEST, V117, P428, DOI 10.1172/JCI29625; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Hews CL, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12717; Hong JY, 2016, CLIN SCI, V130, P1993, DOI 10.1042/CS20160360; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Lathem WW, 2004, J EXP MED, V199, P1077, DOI 10.1084/jem.20030255; Lathem WW, 2002, MOL MICROBIOL, V45, P277, DOI 10.1046/j.1365-2958.2002.02997.x; Lawrence DW, 2003, J EXP MED, V198, P999, DOI 10.1084/jem.20030380; LEBIVIC A, 1990, J CELL BIOL, V111, P1351, DOI 10.1083/jcb.111.4.1351; Lim JY, 2010, J MICROBIOL BIOTECHN, V20, P5, DOI 10.4014/jmb.0908.08007; Long J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01086; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Matheson NJ, 2015, CELL HOST MICROBE, V18, P409, DOI 10.1016/j.chom.2015.09.003; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; MEDOF ME, 1984, J EXP MED, V160, P1558, DOI 10.1084/jem.160.5.1558; MEDOF ME, 1987, J EXP MED, V165, P848, DOI 10.1084/jem.165.3.848; Mitchell EK, 2004, EUR J IMMUNOL, V34, P2559, DOI 10.1002/eji.200425314; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; Muller WA, 2016, IMMUNOL REV, V273, P61, DOI 10.1111/imr.12443; Ozen A, 2017, NEW ENGL J MED, V377, P52, DOI 10.1056/NEJMoa1615887; Paul NR, 2015, CURR BIOL, V25, pR1092, DOI 10.1016/j.cub.2015.09.049; Pillai L, 2006, INFECT IMMUN, V74, P3742, DOI 10.1128/IAI.00402-06; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; REDDY P, 1989, J BIOL CHEM, V264, P17329; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Sandow JJ, 2017, PROTEOM CLIN APPL, V11, DOI 10.1002/prca.201700013; Scholz R, 2015, MOL CELL PROTEOMICS, V14, P1927, DOI 10.1074/mcp.M114.046847; Schweigel-Rontgen M, 2014, CURR TOP MEMBR, V73, P321, DOI 10.1016/B978-0-12-800223-0.00009-8; Spehlmann ME, 2009, J IMMUNOL, V183, P3332, DOI 10.4049/jimmunol.0900600; Szabady RL, 2011, MICROBIOL-SGM, V157, P516, DOI 10.1099/mic.0.044529-0; Szabady RL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000320; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Weekes MP, 2014, CELL, V157, P1460, DOI 10.1016/j.cell.2014.04.028; Weekes MP, 2012, J PROTEOME RES, V11, P1475, DOI 10.1021/pr201135e; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Zeng L, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00272; Zeng Y, 2009, NAT METHODS, V6, P207, DOI [10.1038/NMETH.1305, 10.1038/nmeth.1305]; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	59	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17188	17199		10.1074/jbc.RA118.005114	http://dx.doi.org/10.1074/jbc.RA118.005114			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30190327	Green Published, hybrid			2022-12-26	WOS:000449466500018
J	Lee, JZ; Everroad, RC; Karaoz, U; Detweiler, AM; Pett-Ridge, J; Weber, PK; Prufert-Bebout, L; Bebout, BM				Lee, Jackson Z.; Everroad, R. Craig; Karaoz, Ulas; Detweiler, Angela M.; Pett-Ridge, Jennifer; Weber, Peter K.; Prufert-Bebout, Leslie; Bebout, Brad M.			Metagenomics reveals niche partitioning within the phototrophic zone of a microbial mat	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; CYANOBACTERIAL MAT; NITROGEN-FIXATION; GEN-NOV; IDENTIFICATION; SULFUR; REDUCTION; DIVERSITY; OXYGEN; SEQUENCE	Hypersaline photosynthetic microbial mats are stratified microbial communities known for their taxonomic and metabolic diversity and strong light-driven day-night environmental gradients. In this study of the upper photosynthetic zone of hypersaline microbial mats of Elkhorn Slough, California (USA), we show how metagenome sequencing can be used to meaningfully assess microbial ecology and genetic partitioning in these complex microbial systems. Mapping of metagenome reads to the dominant Cyanobacteria observed in the system, Coleofasciculus (Microcoleus) chthonoplastes, was used to examine strain variants within these metagenomes. Highly conserved gene subsystems indicated a core genome for the species, and a number of variant genes and subsystems suggested strain level differentiation, especially for nutrient utilization and stress response. Metagenome sequence coverage binning was used to assess ecosystem partitioning of remaining microbes to both reconstruct the model organisms in silico and identify their ecosystem functions as well as to identify novel clades and propose their role in the biogeochemical cycling of mats. Functional gene annotation of these bins (primarily of Proteobacteria, Bacteroidetes, and Cyanobacteria) recapitulated the known biogeochemical functions in microbial mats using a genetic basis, and revealed significant diversity in the Bacteroidetes, presumably in heterotrophic cycling. This analysis also revealed evidence of putative phototrophs within the Gemmatimonadetes and Gammaproteobacteria residing in microbial mats. This study shows that metagenomic analysis can produce insights into the systems biology of microbial ecosystems from a genetic perspective and to suggest further studies of novel microbes.	[Lee, Jackson Z.; Everroad, R. Craig; Detweiler, Angela M.; Prufert-Bebout, Leslie; Bebout, Brad M.] NASA, Ames Res Ctr, Exobiol Branch, Moffett Field, CA 94035 USA; [Lee, Jackson Z.; Detweiler, Angela M.] Bay Area Environm Res Inst, Petaluma, CA 94952 USA; [Karaoz, Ulas] Lawrence Berkeley Natl Lab, Earth & Environm Sci, Berkeley, CA USA; [Pett-Ridge, Jennifer; Weber, Peter K.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Lee, JZ (corresponding author), NASA, Ames Res Ctr, Exobiol Branch, Moffett Field, CA 94035 USA.; Lee, JZ (corresponding author), Bay Area Environm Res Inst, Petaluma, CA 94952 USA.	jzlee2002@gmail.com	Karaoz, Ulas/J-7093-2014; , Jennifer Pett RIdge/AFF-7780-2022; , Jennifer Pett RIdge/AAE-9934-2022; Weber, Peter Kilian/AAP-9517-2020	Karaoz, Ulas/0000-0002-8238-6757; Weber, Peter Kilian/0000-0001-6022-6050; Pett-Ridge, Jennifer/0000-0002-4439-2398; Detweiler, Angela/0000-0001-7026-5467	Department of Energy through the Genome Sciences Program [SCW1039]; LLNL [DE-AC52-07NA27344]; National Energy Research Scientific Computing Center (NERSC) [701]; DOE Joint Genome Institute (JGI) [701]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; NASA Postodoctoral Fellowship	Department of Energy through the Genome Sciences Program(United States Department of Energy (DOE)); LLNL; National Energy Research Scientific Computing Center (NERSC); DOE Joint Genome Institute (JGI)(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NASA Postodoctoral Fellowship	This project is funded by the Department of Energy through the Genome Sciences Program (http://genomicscience.energy.gov) under contract SCW1039 to the Lawrence Livermore National Laboratory (LLNL) Biofuels Scientific Focus Area and performed under the auspices of LLNL under Contract DE-AC52-07NA27344. This research used resources of the National Energy Research Scientific Computing Center (NERSC) (https://www.nersc.gov) and the DOE Joint Genome Institute (JGI) (https://jgi.doe.gov) Community Sequencing Program award #701; both DOE Office of Science User Facilities are supported by the Office of Science of the U.S. Department of Energy (https://science.energy.gov) under Contract No. DE-AC02-05CH11231. RCE acknowledges the support of a NASA Postodoctoral Fellowship (https://npp.usra.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Awramik SM, 1984, ANCIENT STROMATOLITE; Baumgartner LK, 2006, SEDIMENT GEOL, V185, P131, DOI 10.1016/j.sedgeo.2005.12.008; BEBOUT BM, 1993, APPL ENVIRON MICROB, V59, P1495, DOI 10.1128/AEM.59.5.1495-1503.1993; Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bowman JP, 1998, MICROBIOL-UK, V144, P1601, DOI 10.1099/00221287-144-6-1601; Brown CT, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-30; Burow LC, 2014, GEOBIOLOGY, V12, P221, DOI 10.1111/gbi.12080; Burow LC, 2013, ISME J, V7, P817, DOI 10.1038/ismej.2012.150; Burow LC, 2012, ISME J, V6, P863, DOI 10.1038/ismej.2011.142; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3971, DOI 10.1016/0016-7037(93)90347-Y; CANFIELD DE, 1991, SCIENCE, V251, P1471, DOI 10.1126/science.11538266; Pereira IAC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00069; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; D'haeseleer P, 2017, STAND GENOMIC SCI, V12, DOI 10.1186/s40793-017-0279-6; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Dolla A, 2006, J BIOTECHNOL, V126, P87, DOI 10.1016/j.jbiotec.2006.03.041; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; Everroad RC, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-016-0174-6; Fike DA, 2008, ISME J, V2, P749, DOI 10.1038/ismej.2008.39; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; GarciaPichel F, 1996, APPL ENVIRON MICROB, V62, P3284, DOI 10.1128/AEM.62.9.3284-3291.1996; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hanke A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00231; Harris JK, 2013, ISME J, V7, P50, DOI 10.1038/ismej.2012.79; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; JORGENSEN BB, 1994, FEMS MICROBIOL ECOL, V13, P303, DOI 10.1016/0168-6496(94)90068-X; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Khodadad CLM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038229; Lamarche-Gagnon G, 2012, AEROBIC HYDROCARBON; Lee JZ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00061; Lehmann Y, 1996, J BACTERIOL, V178, P7152, DOI 10.1128/jb.178.24.7152-7158.1996; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Oren A., 2010, MICROBIAL MATS, P387, DOI [10.1007/978-90-481-3799-2_20, DOI 10.1007/978-90-481-3799-2_]; OVERMANN J, 1992, ARCH MICROBIOL, V157, P329, DOI 10.1007/BF00248677; Pagani I, 2011, STAND GENOMIC SCI, V4, P154, DOI 10.4056/sigs.1623941; Podell S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061692; Pudlo NA, 2015, MBIO, V6, DOI 10.1128/mBio.01282-15; Rogers TE, 2013, MOL MICROBIOL, V88, P876, DOI 10.1111/mmi.12228; Romling U, 2002, RES MICROBIOL, V153, P205, DOI 10.1016/S0923-2508(02)01316-5; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; Ruvindy R, 2016, ISME J, V10, P183, DOI 10.1038/ismej.2015.87; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Sekiguchi Y, 2015, PEERJ, V3, DOI 10.7717/peerj.740; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Sigalevich P, 2000, APPL ENVIRON MICROB, V66, P5005, DOI 10.1128/AEM.66.11.5005-5012.2000; Spring S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-117; Stuart RK, 2016, ISME J, V10, P1240, DOI 10.1038/ismej.2015.180; Teske A, 1998, APPL ENVIRON MICROB, V64, P2943; Varin T, 2012, APPL ENVIRON MICROB, V78, P549, DOI 10.1128/AEM.06354-11; VISSCHER PT, 1992, FEMS MICROBIOL ECOL, V86, P283, DOI 10.1016/0378-1097(92)90792-M; Woebken D, 2012, ISME J, V6, P1427, DOI 10.1038/ismej.2011.200; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; YURKOV V, 1994, INT J SYST BACTERIOL, V44, P427, DOI 10.1099/00207713-44-3-427; ZEHR JP, 1995, APPL ENVIRON MICROB, V61, P2527, DOI 10.1128/AEM.61.7.2527-2532.1995; Zeng YH, 2014, P NATL ACAD SCI USA, V111, P7795, DOI 10.1073/pnas.1400295111	65	1	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0202792	10.1371/journal.pone.0202792	http://dx.doi.org/10.1371/journal.pone.0202792			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204767	Green Published, Green Submitted, gold			2022-12-26	WOS:000444355500009
J	Burns, W; Peloquin, K; Rondeau, E; Drouin, S; Bertout, L; Lacoste-Julien, A; Krajinovic, M; Laverdiere, C; Sinnett, D; Sultan, S				Burns, Willow; Peloquin, Katherine; Rondeau, Emilie; Drouin, Simon; Bertout, Laurence; Lacoste-Julien, Ariane; Krajinovic, Maja; Laverdiere, Caroline; Sinnett, Daniel; Sultan, Serge			Cancer-related effects on relationships, long-term psychological status and relationship satisfaction in couples whose child was treated for leukemia: A PETALE study	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; QUALITY-OF-LIFE; DYADIC ADJUSTMENT; PROSTATE-CANCER; ADULT SURVIVORS; MARITAL RELATIONSHIPS; EMOTIONAL DISTRESS; SOCIAL SUPPORT; BREAST-CANCER; PARENTS	Objectives Follow-up studies suggest that the psychosocial impact of pediatric cancer on parents often extends beyond the end of their child's cancer treatments, and parents can continue to experience both individual and relationship effects. In a long-term study of parents of children who were treated for acute lymphoblastic leukemia (ALL), we aimed to: 1) describe parents' adjustment (psychological distress, relationship satisfaction; 2) describe the perceived impact of cancer on couples' relationship, and; 3) identify to what extent the perceived impact of cancer on the couple is related to both parents' long-term adjustment. Methods Parents of childhood ALL survivors (n = 103 couples) were surveyed as part of a cohort recall (PETALE cohort). Both parents completed questionnaires exploring adjustment (Brief Symptom Inventory-18, Dyadic Adjustment Scale) and perceived impact of cancer on the relationship (Impact of Cancer on the Couple). Mothers' and fathers' scores were compared using MANOVAs. We also examined the degree to which a parent's perceived changes in relationship dynamics following their child's cancer were associated with their own current adjustment (actor effects), and their partner's current adjustment (partner effects) using the Actor-Partner Interdependence Model (APIM). Results Frequencies of current distress were normative in parents (mothers/fathers): general distress (6.8/7.8%), anxiety (5.8/6.8%), depression (2.9/6.8%), somatization (13.6/9.7%), and relationship distress (21.4/20.4%). Mothers and fathers typically agreed on their reported relationship satisfaction, and the perceived nature of relationship changes following the illness. Dyadic analyses indicated that whereas mothers' adjustment was related to their own perceived relationship changes, fathers' adjustment was primarily related to their partner's perceptions. Conclusion In long-term stable couples, mothers may act as an influential bridge connecting the illness experiences of survivors and fathers. This could explain why mothers' perceptions of relationship changes were related to their partners' long-term adjustment, which was not the case for fathers.	[Burns, Willow; Peloquin, Katherine; Sultan, Serge] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Burns, Willow; Rondeau, Emilie; Drouin, Simon; Bertout, Laurence; Lacoste-Julien, Ariane; Krajinovic, Maja; Laverdiere, Caroline; Sinnett, Daniel; Sultan, Serge] St Justine Univ Hlth Ctr, Montreal, PQ, Canada; [Krajinovic, Maja; Laverdiere, Caroline; Sinnett, Daniel; Sultan, Serge] Univ Montreal, Dept Pediat, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Sultan, S (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.; Sultan, S (corresponding author), St Justine Univ Hlth Ctr, Montreal, PQ, Canada.; Sultan, S (corresponding author), Univ Montreal, Dept Pediat, Montreal, PQ, Canada.	serge.sultan@umontreal.ca	Peloquin, Katherine/AAM-8997-2020; sinnett, daniel/S-4589-2017; Peloquin, Katherine/AGB-3662-2022	sinnett, daniel/0000-0003-3625-6676; 	Institute of Cancer Research (ICR) of the Canadian Institutes of Health Research (CIHR); C17 Council; Canadian Cancer Society (CCS); Cancer Research Society (CRS); Garron Family Cancer Centre at the Hospital for Sick Children; Ontario Institute for Cancer Research (OICR); Fonds de Recherche du Quebec - Sante Cancer Grant; Pediatric Oncology Group of Ontario (POGO) [TCF 118694]; Cole Foundation (Montreal, Canada); CHU Sainte-Justine Foundation	Institute of Cancer Research (ICR) of the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); C17 Council; Canadian Cancer Society (CCS)(Canadian Cancer Society (CCS)); Cancer Research Society (CRS); Garron Family Cancer Centre at the Hospital for Sick Children; Ontario Institute for Cancer Research (OICR); Fonds de Recherche du Quebec - Sante Cancer Grant; Pediatric Oncology Group of Ontario (POGO); Cole Foundation (Montreal, Canada); CHU Sainte-Justine Foundation	This work was supported by the Institute of Cancer Research (ICR) of the Canadian Institutes of Health Research (CIHR), in collaboration with C17 Council, Canadian Cancer Society (CCS), Cancer Research Society (CRS), Garron Family Cancer Centre at the Hospital for Sick hildren, Ontario Institute for Cancer Research (OICR), Fonds de Recherche du Quebec - Sante Cancer Grant, and Pediatric Oncology Group of Ontario (POGO) (grant number: TCF 118694). WB is a recipient of a doctoral scholarship from the Cole Foundation (Montreal, Canada) and support from the CHU Sainte-Justine Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts L, 2015, J SEX MED, V12, P198, DOI 10.1111/jsm.12764; Arden-Close E, 2010, BRIT J HEALTH PSYCH, V15, P543, DOI 10.1348/135910709X476972; Badr H, 2005, J FAM PSYCHOL, V19, P465, DOI 10.1037/0893-3200.19.3.465; Blome C, 2015, VALUE HEALTH, V18, P110, DOI 10.1016/j.jval.2014.10.007; Boinon D, 2014, PSYCHO-ONCOLOGY, V23, P291, DOI 10.1002/pon.3420; Boman K, 2003, ACTA ONCOL, V42, P137, DOI 10.1080/02841860310004995; Brassard A, 2009, FAM RELAT, V58, P634, DOI 10.1111/j.1741-3729.2009.00580.x; Burns W, 2017, PSYCHO-ONCOLOGY, V26, P1660, DOI 10.1002/pon.4189; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Clarke NE, 2009, PSYCHO-ONCOLOGY, V18, P907, DOI 10.1002/pon.1515; Cochrane BB, 2011, ONCOL NURS FORUM, V38, P207, DOI 10.1188/11.ONF.207-214; Compas BE, 2015, HEALTH PSYCHOL, V34, P783, DOI 10.1037/hea0000202; da Silva FM, 2010, J NURS SCHOLARSHIP, V42, P250, DOI 10.1111/j.1547-5069.2010.01360.x; Dahlquist LM, 1996, J PEDIATR PSYCHOL, V21, P541, DOI 10.1093/jpepsy/21.4.541; Derogatis L.R, 1993, BRIEF SYMPTOM INVENT; Gianinazzi ME, 2013, PSYCHO-ONCOLOGY, V22, P2051, DOI 10.1002/pon.3249; Gotze H, 2017, SUPPORT CARE CANCER, V25, P255, DOI 10.1007/s00520-016-3411-z; Goldbeck L, 2001, PSYCHO-ONCOL, V10, P325, DOI 10.1002/pon.530; Green HJ, 2011, EUR J CANCER CARE, V20, P237, DOI 10.1111/j.1365-2354.2010.01225.x; Hall J. A., 2010, CONNECTIONS, V30, P41; Hall JA, 2010, J PSYCHOSOC ONCOL, V28, P511, DOI 10.1080/07347332.2010.498461; Hamilton LD, 2016, PSYCHO-ONCOLOGY, V25, P823, DOI 10.1002/pon.3930; Hardy KK, 2008, J PEDIAT HEMATOL ONC, V30, P153, DOI 10.1097/MPH.0b013e31815814d9; Hensler MA, 2013, J PEDIATR ONCOL NURS, V30, P161, DOI 10.1177/1043454213487435; Kenny D. A., 2006, DYADIC DATA ANAL; Kinahan KE, 2008, J PEDIAT HEMATOL ONC, V30, P651, DOI 10.1097/MPH.0b013e31817e4a6a; Klassen A, 2007, SUPPORT CARE CANCER, V15, P807, DOI 10.1007/s00520-007-0243-x; Lavee Y, 2005, FAM SOC, V86, P112, DOI 10.1606/1044-3894.1883; Lavee Y, 2003, HEALTH SOC WORK, V28, P255, DOI 10.1093/hsw/28.4.255; Lazarus R.S., 1984, EMOTION ADAPTATION; Leclair T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159773; Leventhal-Belfer Laurie, 1993, Journal of Psychosocial Oncology, V11, P19, DOI 10.1300/J077V11N02_02; Ljungman L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103340; Malpert AV, 2015, PSYCHO-ONCOLOGY, V24, P1116, DOI 10.1002/pon.3732; Marcoux S, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26361; Martin J, 2014, PSYCHO-ONCOLOGIE, V8, P222, DOI 10.1007/s11839-014-0488-9; Martin J, 2016, INT J QUAL STUD HEAL, V11, DOI 10.3402/qhw.v11.32423; Maurice-Stam H, 2008, PSYCHO-ONCOLOGY, V17, P448, DOI 10.1002/pon.1260; McLean LM, 2011, SUPPORT CARE CANCER, V19, P1539, DOI 10.1007/s00520-010-0981-z; Muskat B, 2017, J PEDIATR ONCOL NURS, V34, P358, DOI 10.1177/1043454217703594; Ozono S, 2010, PSYCHO-ONCOLOGY, V19, P545, DOI 10.1002/pon.1606; Park CL, 2010, PSYCHOL BULL, V136, P257, DOI 10.1037/a0018301; Peloquin K, 2013, IMPACT CANC COUPLE; Peloquin K, 2010, J PERS ASSESS, V92, P146, DOI 10.1080/00223890903510399; Recklitis CJ, 2006, PSYCHOL ASSESSMENT, V18, P22, DOI 10.1037/1040-3590.18.1.22; Sabourin S, 2005, PSYCHOL ASSESSMENT, V17, P15, DOI 10.1037/1040-3590.17.1.15; Silva-Rodrigues FM, 2016, EUR J ONCOL NURS, V23, P34, DOI 10.1016/j.ejon.2016.03.002; Sultan S, 2016, EUR J CANCER CARE, V25, P616, DOI 10.1111/ecc.12361; Van Schoors M, 2017, PSYCHO-ONCOLOGY, V26, P608, DOI 10.1002/pon.4204; Walker LM, 2017, PSYCHO-ONCOLOGY, V26, P1336, DOI 10.1002/pon.4147; Wiener L, 2017, PSYCHO-ONCOLOGY, V26, P2109, DOI 10.1002/pon.4313; Wikman A, 2017, ACTA ONCOL, V56, P1698, DOI 10.1080/0284186X.2017.1355562; Wilson AE, 2003, MEMORY, V11, P137, DOI 10.1080/741938210	53	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203435	10.1371/journal.pone.0203435	http://dx.doi.org/10.1371/journal.pone.0203435			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT0BU	30192798	gold, Green Published, Green Submitted			2022-12-26	WOS:000444093600074
J	Chang, CH; Hu, CC; Chang, YH; Hsieh, PH; Shih, HN; Ueng, SWN				Chang, Chih-Hsiang; Hu, Chih-Chien; Chang, Yuhan; Hsieh, Pang-Hsin; Shih, Hsin-Nung; Ueng, Steve Wen-Neng			Two-stage revision arthroplasty for Mycobacterium Tuberculosis periprosthetic joint infection: An outcome analysis	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; TOTAL KNEE ARTHROPLASTY; LOADED BONE-CEMENT; REPLACEMENT; SURVIVORSHIP; ARTHRITIS; HISTORY	Background Mycobacterium tuberculosis periprosthetic joint infection (TBPJI) is a rare complication of hip/knee joint arthroplasty. The outcomes of hip/knee TBPJI treatment are still unreported. The objective of this study was to investigate the outcomes of hip/knee TBPJI following treatment with two-stage exchange arthroplasty. Materials and methods From 2003 to 2013, 11 patients with TBPJI (six hips and five knees) were treated with two-stage exchange arthroplasty at our institution. We collected and analyzed variables including demographic data, comorbidities, microbiological data, duration of symptoms, and types of antibiotic used in bone cement. Results At the most recent follow-up, the success rate of two-stage exchange arthroplasty was 63.3% (7 of 11). All five knee treatments resulted in infection eradication and successful prosthesis reimplantation. However, only two hip TBPJI treatments resulted in successful outcomes; two patients died and two experienced chronic infection. Overall, secondary bacterial infections were common in patients with TBPJI (5 of 11 cases, 45.5%). Streptomycin in bone cement increased the success rate (83.33% vs. 40%). Conclusion More than one third of the patients treated with two-stage exchange arthroplasty for TBPJI showed infection relapse or uncontrolled infection. Streptomycin-loaded interim cement spacers appeared to help ensure successful treatment. Routine M. tuberculosis culture is recommended when treating TBPJI in areas of high tuberculosis prevalence.	[Chang, Chih-Hsiang; Hu, Chih-Chien; Chang, Yuhan; Hsieh, Pang-Hsin; Shih, Hsin-Nung; Ueng, Steve Wen-Neng] Chang Gung Mem Hosp, Bone & Joint Res Ctr, Linkou, Taiwan; [Chang, Chih-Hsiang; Hu, Chih-Chien; Chang, Yuhan; Hsieh, Pang-Hsin; Shih, Hsin-Nung; Ueng, Steve Wen-Neng] Chang Gung Mem Hosp, Dept Orthoped Surg, Linkou, Taiwan; [Chang, Chih-Hsiang] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Hu, Chih-Chien; Chang, Yuhan; Hsieh, Pang-Hsin; Shih, Hsin-Nung; Ueng, Steve Wen-Neng] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Ueng, SWN (corresponding author), Chang Gung Mem Hosp, Bone & Joint Res Ctr, Linkou, Taiwan.; Ueng, SWN (corresponding author), Chang Gung Mem Hosp, Dept Orthoped Surg, Linkou, Taiwan.; Ueng, SWN (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	wenneng@adm.cgmh.org.tw	Chang, Chih-Hsiang/G-8238-2016		Chang Gung Memorial Hospital Grant [CORPG3G0531]	Chang Gung Memorial Hospital Grant(Chang Gung Memorial Hospital)	We would like to thank Chang Gung Memorial Hospital Grant (CORPG3G0531 to S.W. N.U.) for financially supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shaikh Raad, 2003, Am J Orthop (Belle Mead NJ), V32, P302; Berbari E F, 1998, Am J Orthop (Belle Mead NJ), V27, P219; BERNEY S, 1972, AM J MED, V53, P36, DOI 10.1016/0002-9343(72)90113-1; Berry DJ, 2002, J BONE JOINT SURG AM, V84A, P171, DOI 10.2106/00004623-200202000-00002; BESSER MIB, 1980, BRIT MED J, V280, P1434, DOI 10.1136/bmj.280.6229.1434; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P45, DOI 10.1007/s11999-009-0945-0; Carrega G, 2013, INT J SURG CASE REP, V4, P178, DOI 10.1016/j.ijscr.2012.11.011; Chen SY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/345475; DANIEL TM, 1987, AM REV RESPIR DIS, V135, P1137; DELRIEU F, 1986, REV RHUM, V53, P113; ELLIS ME, 1993, TUBERCLE LUNG DIS, V74, P399, DOI 10.1016/0962-8479(93)90084-B; Font-Rodriguez DE, 1997, CLIN ORTHOP RELAT R, P79; Han CD, 2013, CLIN ORTHOP RELAT R, V471, P2400, DOI 10.1007/s11999-013-2899-5; Harwin SF, 2013, ORTHOPEDICS, V36, pE1464, DOI 10.3928/01477447-20131021-35; Hsieh PH, 2010, INT J INFECT DIS, V14, pE1054, DOI 10.1016/j.ijid.2010.06.018; Hsieh PH, 2009, CLIN INFECT DIS, V49, P1036, DOI 10.1086/605593; Hsieh PH, 2009, J ANTIMICROB CHEMOTH, V64, P392, DOI 10.1093/jac/dkp177; Hsieh PH, 2004, J BONE JOINT SURG AM, V86A, P1989, DOI 10.2106/00004623-200409000-00018; Huang Tsung-Yu, 2007, Journal of Microbiology Immunology and Infection, V40, P493; Hugate R, 2002, J BONE JOINT SURG AM, V84A, P101, DOI 10.2106/00004623-200201000-00015; Kaya M, 2006, J BONE JOINT SURG BR, V88B, P394, DOI 10.1302/0301-620X.88B3.17006; Khater FJ, 2007, SOUTH MED J, V100, P66, DOI 10.1097/01.smj.0000232972.50186.4c; Klein Gregg R, 2012, J Arthroplasty, V27, DOI 10.1016/j.arth.2011.09.020; Kreder HJ, 1996, J ARTHROPLASTY, V11, P111, DOI 10.1016/S0883-5403(96)80169-0; Kumar M, 2010, INT J TUBERC LUNG D, V14, P847; Lee CL, 2009, KNEE, V16, P87, DOI 10.1016/j.knee.2008.09.006; LEVIN W, 1950, AM J PUBLIC HEALTH, V40, P1305; Marculescu CE, 2006, CLIN ORTHOP RELAT R, P64, DOI 10.1097/01.blo.0000229337.21653.f2; Marmor M, 2004, J ARTHROPLASTY, V19, P397, DOI 10.1016/j.arth.2003.10.015; MASRI BA, 1995, CAN J SURG, V38, P64; Mittal Y, 2007, J BONE JOINT SURG AM, V89A, P1227, DOI 10.2106/JBJS.E.01192; Neogi DS, 2010, CLIN ORTHOP RELAT R, V468, P605, DOI 10.1007/s11999-009-0957-9; Neogi DS, 2009, ACTA ORTHOP BELG, V75, P136; Osmon DR, 2013, CLIN INFECT DIS, V56, DOI [10.1093/cid/cis803, 10.1093/cid/cis966]; Ozturkmen Y, 2014, KNEE SURG SPORT TR A, V22, P1076, DOI 10.1007/s00167-013-2473-4; Parish A, 1999, MOL BIOTECHNOL, V13, P191, DOI 10.1385/MB:13:3:191; Parvizi J, 2011, CLIN ORTHOP RELAT R, V469, P3022, DOI 10.1007/s11999-011-1971-2; Parvizi J, 2010, J ARTHROPLASTY, V25, P103, DOI 10.1016/j.arth.2010.04.011; PATEL S, 1995, ANN RHEUM DIS, V54, P174, DOI 10.1136/ard.54.3.174; Peterson C., 1976, J BONE JOINT SURG AM, V54, P174; Shanbhag V, 2007, ACTA ORTHOP BELG, V73, P268; Spinner RJ, 1996, J ARTHROPLASTY, V11, P217, DOI 10.1016/S0883-5403(05)80023-3; TOKUMOTO JIN, 1995, CLIN INFECT DIS, V21, P134, DOI 10.1093/clinids/21.1.134; Tsukayama DT, 1996, J BONE JOINT SURG AM, V78A, P512, DOI 10.2106/00004623-199604000-00005; UENG WN, 1995, INT ORTHOP, V19, P55; WOLFGANG GL, 1985, CLIN ORTHOP RELAT R, P162; World Health Organization, 2015, GLOB TUB REP 2015; WRAY CC, 1987, ACTA ORTHOP SCAND, V58, P296, DOI 10.3109/17453678709146492	48	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203585	10.1371/journal.pone.0203585	http://dx.doi.org/10.1371/journal.pone.0203585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192830	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600110
J	Hagiwara, S; Kaushal, E; Paruthiyil, S; Pasricha, PJ; Hasdemir, B; Bhargava, A				Hagiwara, Shin-ichiro; Kaushal, Esha; Paruthiyil, Sreenivasan; Pasricha, Pankaj J.; Hasdemir, Burcu; Bhargava, Aditi			Gastric corticotropin-releasing factor influences mast cell infiltration in a rat model of functional dyspepsia	PLOS ONE			English	Article							WATER-AVOIDANCE STRESS; RECEPTOR-LIKE RECEPTOR; ANXIETY-LIKE BEHAVIOR; GASTROINTESTINAL DISORDERS; UROCORTIN-II; GASTRODUODENAL DISORDERS; BRAIN INTERACTION; CRF RECEPTORS; IMMUNE-SYSTEM; GI DISORDERS	Functional gastrointestinal disorders (FGIDs) are characterized by dysregulated gut-brain interactions. Emerging evidence shows that low-grade mucosal inflammation and immune activation contribute to FGIDs, including functional dyspepsia (FD). Stress plays an important role in the onset of FD symptoms. In human subjects with FD, presence of gastric mast cells has been reported, but factors that influence mast cell infiltration remain uncharacterized. Corticotropin-releasing factor (CRF) initiates the body's stress response and is known to degranulate mast cells. In this study, we delineated the role of the CRF system in the pathogenesis of FD in a rat model. Gastric irritation in neonate rat pups with iodoacetamide (IA) was used to induce FD-like symptoms. RNA interference (RNAi) was used to silence gastric CRF expression. Mast cell infiltrate in the stomach increased by 54% in IA-treated rats compared to controls and CRF-RNAi tended to decrease gastric mast cell infiltrate. Sucrose intake decreased in IA-treated rats and mast cell numbers showed a negative association with sucrose intake. IA treatment and transient silencing of gastric CRF increased hypothalamic CRF levels. In IA-treated rats, gastric levels of CRF receptor 2 (CRF2) decreased by similar to 76%, whereas hypothalamic CRF receptor 1 (CRF1) levels increased. Plasma levels of TNF-alpha showed a positive correlation with plasma CRF levels. Levels of phosphorylated p38 and ERK1/2 in the stomach showed a positive correlation with gastric CRF levels. Thus, CRF may contribute to low grade inflammation via modulating mast cell infiltration, cytokine levels, MAPK signaling, and the gut-brain axis.	[Hagiwara, Shin-ichiro; Kaushal, Esha; Paruthiyil, Sreenivasan; Hasdemir, Burcu; Bhargava, Aditi] Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA; [Pasricha, Pankaj J.] Johns Hopkins Sch Med, Div Gastroenterol & Hepatol, Baltimore, MD USA; [Bhargava, Aditi] Univ Calif San Francisco, Dept OBGYN, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California San Francisco	Bhargava, A (corresponding author), Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA.; Bhargava, A (corresponding author), Univ Calif San Francisco, Dept OBGYN, San Francisco, CA 94143 USA.	Aditi.bhargava@ucsf.edu		Bhargava, Aditi/0000-0003-1334-0517	National Institute of Diabetes and Digestive and Kidney Diseases grant [DK097518]; Uehara Memorial Foundation, Tokyo, Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK098722, R01DK097518] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases grant; Uehara Memorial Foundation, Tokyo, Japan(Uehara Memorial Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases grant DK097518 to PJP and AB (Multi-PI) and donor funds to AB. S-I.H was also a recipient of a fellowship from the Uehara Memorial Foundation, Tokyo, Japan.	Alander T, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-8; Aro P, 2015, GASTROENTEROLOGY, V148, P928, DOI 10.1053/j.gastro.2015.01.039; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Barbara G, 2016, GASTROENTEROLOGY, V150, P1305, DOI 10.1053/j.gastro.2016.02.028; Bhargava A, 2004, BRAIN RES PROTOC, V13, P115, DOI 10.1016/j.brainresprot.2004.03.003; Bhargava A, 2013, P NATL ACAD SCI USA, V110, P731, DOI 10.1073/pnas.1219733110; Campbell J, 2004, J IMMUNOL, V173, P6928, DOI 10.4049/jimmunol.173.11.6928; Chang J, 2007, PEPTIDES, V28, P1453, DOI 10.1016/j.peptides.2007.05.008; Chang J, 2011, AM J PHYSIOL-GASTR L, V300, pG884, DOI 10.1152/ajpgi.00319.2010; Chikahisa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078434; Clifton MS, 2007, AM J PHYSIOL-GASTR L, V293, pG36, DOI 10.1152/ajpgi.00464.2006; Cong BH, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-43; Czimmer J, 2006, AM J PHYSIOL-GASTR L, V290, pG511, DOI 10.1152/ajpgi.00289.2005; Drossman DA, 1999, GUT, V45, P25; Drossman DA, 2018, GASTROENTEROLOGY, V154, P1140, DOI 10.1053/j.gastro.2017.11.279; Drossman DA, 2016, GASTROENTEROLOGY, V150, P1257, DOI 10.1053/j.gastro.2016.03.035; Du L, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13304; Fernandez-Majada V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12508; Ford AC, 2015, GUT, V64, P1049, DOI 10.1136/gutjnl-2014-307843; Gourcerol G, 2011, GASTROENTEROLOGY, V140, P1586, DOI 10.1053/j.gastro.2011.01.039; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hall W, 2003, CLIN GASTROENTEROL H, V1, P363, DOI 10.1053/S1542-3565(03)00184-8; Harrell CS, 2013, BEHAV BRAIN RES, V248, P57, DOI 10.1016/j.bbr.2013.04.003; Hasdemir B, 2017, MOL BIOL CELL, V28, P2386, DOI 10.1091/mbc.E16-11-0778; Hasdemir B, 2016, AM J PHYSIOL-REG I, V310, pR1244, DOI 10.1152/ajpregu.00445.2015; Hiroi R, 2006, BEHAV BRAIN RES, V166, P93, DOI 10.1016/j.bbr.2005.07.021; Hussain Z, 2017, YONSEI MED J, V58, P872, DOI 10.3349/ymj.2017.58.4.872; Im E, 2010, GASTROENTEROLOGY, V138, P2457, DOI 10.1053/j.gastro.2010.02.055; Kindt S, 2009, NEUROGASTROENT MOTIL, V21, P832, DOI 10.1111/j.1365-2982.2009.01299.x; Koduru P, 2018, CLIN GASTROENTEROL H, V16, P467, DOI 10.1016/j.cgh.2017.09.002; la Fleur SE, 2005, P NATL ACAD SCI USA, V102, P7647, DOI 10.1073/pnas.0408531102; Larsen JK, 1997, AM J PHYSIOL-LUNG C, V273, pL930, DOI 10.1152/ajplung.1997.273.5.L930; Liu LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019498; Liu S, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13170; Liu S, 2016, NEUROGASTROENT MOTIL, V28, P281, DOI 10.1111/nmo.12725; Mahajan S, 2014, PEPTIDES, V54, P58, DOI 10.1016/j.peptides.2014.01.007; Martinez V, 2002, J PHARMACOL EXP THER, V301, P611, DOI 10.1124/jpet.301.2.611; Million M, 2002, AM J PHYSIOL-GASTR L, V282, pG34, DOI 10.1152/ajpgi.00283.2001; Moon TC, 2010, MUCOSAL IMMUNOL, V3, P111, DOI 10.1038/mi.2009.136; Nautiyal KM, 2008, P NATL ACAD SCI USA, V105, P18053, DOI 10.1073/pnas.0809479105; Nosek K, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-23; Nozu T, 2014, J GASTROENTEROL, V49, P799, DOI 10.1007/s00535-013-0828-8; Overman EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039935; Pajala M, 2005, ALIMENT PHARM THERAP, V21, P277, DOI 10.1111/j.1365-2036.2005.02296.x; PARE WP, 1994, PHYSIOL BEHAV, V55, P433, DOI 10.1016/0031-9384(94)90097-3; Powell N, 2017, NAT REV GASTRO HEPAT, V14, P143, DOI 10.1038/nrgastro.2016.191; Rutz C, 2006, J BIOL CHEM, V281, P24910, DOI 10.1074/jbc.M601554200; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/nmeth.2935, 10.1038/NMETH.2935]; Stanghellini V, 2016, GASTROENTEROLOGY, V150, P1380, DOI 10.1053/j.gastro.2016.02.011; Stengel A, 2010, EXP BIOL MED, V235, P1168, DOI 10.1258/ebm.2010.009347; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Talley NJ, 2015, NEW ENGL J MED, V373, P1853, DOI 10.1056/NEJMra1501505; Teichmann A, 2014, J BIOL CHEM, V289, P24250, DOI 10.1074/jbc.M114.553644; Vanheel H, 2014, GUT, V63, P262, DOI 10.1136/gutjnl-2012-303857; Vanuytsel T, 2014, GUT, V63, P1293, DOI 10.1136/gutjnl-2013-305690; WILLIAMS CL, 1987, AM J PHYSIOL, V253, pG582, DOI 10.1152/ajpgi.1987.253.4.G582; Winston JH, 2016, AM J PHYSIOL-GASTR L, V311, pG32, DOI 10.1152/ajpgi.00067.2016; Wouters MM, 2016, EXPERT REV GASTROENT, V10, P5, DOI 10.1586/17474124.2016.1109446; Wouters MM, 2016, GUT, V65, P155, DOI 10.1136/gutjnl-2015-309151; Yeom JS, 2013, CEPHALALGIA, V33, P323, DOI 10.1177/0333102412472070; Yuan PQ, 2016, AM J PHYSIOL-GASTR L, V310, pG387, DOI 10.1152/ajpgi.00337.2015	61	16	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203704	10.1371/journal.pone.0203704	http://dx.doi.org/10.1371/journal.pone.0203704			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192883	Green Published, gold			2022-12-26	WOS:000444093600135
J	Kuo, KC; Yeh, YC; Huang, YH; Chen, IL; Lee, CH				Kuo, Kuang-Che; Yeh, Yi-Chun; Huang, Ying-Hsien; Chen, I-Ling; Lee, Chen-Hsiang			Understanding physician antibiotic prescribing behavior for children with enterovirus infection	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CLINICAL-FEATURES; VIRAL-INFECTIONS; HOSPITALIZATION; EXPOSURE; TAIWAN; ASTHMA	Background Our previous study demonstrated that pediatricians prescribe antibiotics without proper clinical justification to patients with enterovirus infection, although antibiotics are not effective in treating the infections caused by these viruses. To improve the quality of healthcare, we aim to evaluate the association of clinical and demographic characteristics of patients and further to identify the determining factors for prescribing antibiotics to children experiencing enterovirus infection. Methods We retrospectively reviewed the medical records of children who were hospitalized between January 2008 and December 2016 with a diagnosis of herpangina or hand-foot-mouth disease (HFMD). We identified those children who were prescribed antibiotics for at least 24 hours during admission. We conducted a retrospective descriptive study to analyze data in order to determine the factors associated with pediatrician antibiotics prescribing for enterovirus infection. Results In the nine years of study period, the rate of antibiotics use was about 13% in these patients. A total of 3659 patients were enrolled during 2008 similar to 2012 and analyzed in detail. Elevated levels of C-reactive protein (CRP) and presence of leukocytosis in blood (WBC) were both significantly associated with pediatrician antibiotic prescribing for enterovirus infection (p< 0.001). Between different specialistic devisions, there was significantly different proportion of antibiotics utilization for patients. In further analysis of antibiotics prescribing by Receiver operating characteristic (ROC) curve method, the level of CRP significantly had more the area under curve (0.708) compared with the count of WBC (p< 0.05). Conclusions The present study indicates that higher serum level of CRP is strongly associated with pediatricians prescribing antibiotics for children experiencing herpangina or HFMD. Antibiotic prescribing is a complex process. Pediatricians should be more judicious in decision-making time by their specialistics. Our findings would shed new light on process and allay the concern about inappropriate antibiotics.	[Kuo, Kuang-Che; Huang, Ying-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Kuo, Kuang-Che; Huang, Ying-Hsien; Chen, I-Ling; Lee, Chen-Hsiang] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Yeh, Yi-Chun] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Grad Inst Med, Dept Psychiat,Fac Med,Coll Med, Kaohsiung, Taiwan; [Chen, I-Ling] Kaohsiung Chang Gung Mem Hosp, Dept Pharm, Kaohsiung, Taiwan; [Lee, Chen-Hsiang] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Lee, CH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Lee, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan.	lee900@cgmh.org.tw		Kuo, Kuang-Che/0000-0002-3350-6724	Chang Gung Memorial Hospital, Taiwan [CMRPG8E0481]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This study was partly supported by grants (CMRPG8E0481) from Chang Gung Memorial Hospital, Taiwan. There was no additional external funding received for this study.	Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 2004, PEDIATR INFECT DIS J, V23, P327, DOI 10.1097/00006454-200404000-00010; Chen SP, 2010, J MICROBIOL IMMUNOL, V43, P99, DOI 10.1016/S1684-1182(10)60016-3; Dooling KL, 2014, ANTIBIOTICS-BASEL, V3, P233, DOI 10.3390/antibiotics3020233; Frazee RC, 2015, J AM COLL SURGEONS, V220, P652, DOI 10.1016/j.jamcollsurg.2014.12.036; Hoskin-Parr L, 2013, PEDIAT ALLERG IMM-UK, V24, P762, DOI 10.1111/pai.12153; Huang YC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-33; Huizing KMN, 2011, PEDIATR INFECT DIS J, V30, P1107, DOI 10.1097/INF.0b013e31822cca1f; King RL, 2007, PEDIATRICS, V120, P489, DOI 10.1542/peds.2007-0252; Kuo KC, 2014, INT J INFECT DIS, V25, P100, DOI 10.1016/j.ijid.2014.04.010; Le Uyenphuong, 2014, Pediatrics, V134 Suppl 3, pS135, DOI 10.1542/peds.2014-1817E; Lee CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087391; Lo SH, 2011, J MICROBIOL IMMUNOL, V44, P252, DOI 10.1016/j.jmii.2011.01.031; Lopez CA, 2014, CELL HOST MICROBE, V16, P156, DOI 10.1016/j.chom.2014.07.009; Marra F, 2006, CHEST, V129, P610, DOI 10.1378/chest.129.3.610; PELTOLA HO, 1982, LANCET, V1, P980; Peltola V, 2006, J PEDIATR-US, V149, P721, DOI 10.1016/j.jpeds.2006.08.051; Pichichero ME, 2000, PEDIATRICS, V105, P753, DOI 10.1542/peds.105.4.753; Pitter G, 2016, EUR J EPIDEMIOL, V31, P85, DOI 10.1007/s10654-015-0038-1; Quidley AM, 2015, ORTHOPEDICS, V38, P281, DOI 10.3928/01477447-20150504-02; Rodrigues AT, 2016, CURR MED RES OPIN, V32, P949, DOI 10.1185/03007995.2016.1154520; Rodrigues AT, 2013, INT J ANTIMICROB AG, V41, P203, DOI 10.1016/j.ijantimicag.2012.09.003; SALONEN E, 1981, J MED VIROL, V8, P161, DOI 10.1002/jmv.1890080302; Sedman AB, 2004, PEDIATRICS, V114, P965, DOI 10.1542/peds.2004-0650; Sniffen JC, 2015, CLIN INFECT DIS, V60, pS65, DOI 10.1093/cid/civ176; Thomopoulos N, 2015, NECTAR SER TRANSP, P1; Yang Tsou-Tong, 2005, Journal of Microbiology Immunology and Infection, V38, P417	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202316	10.1371/journal.pone.0202316	http://dx.doi.org/10.1371/journal.pone.0202316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192893	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600024
J	Lai, CY; Chiang, JH; Lin, JG; Yen, HR; Tu, CH; Chen, YH				Lai, Ching-Yuan; Chiang, Jen-Huan; Lin, Jaung-Geng; Yen, Hung-Rong; Tu, Cheng-Hao; Chen, Yi-Hung			Chinese herbal medicine reduced the risk of stroke in patients with Parkinson's disease: A population-based retrospective cohort study from Taiwan	PLOS ONE			English	Article							WESTERN MEDICINE; PEOPLE; ONSET	Parkinson's disease (PD) is associated with a significantly increased risk of stroke. Traditional Chinese medicine (TCM) has long been used in Asia to treat stroke, but there are no large-scale clinical data to confirm its efficacy in protecting PD patients against stroke. Herein, we analyzed a cohort of 1,000,000 records from Taiwan's National Health Insurance Research Database for the period 1997-2011, and identified 1,882 patients with new-onset PD. We matched 290 patients who received Chinese herbal medicine (CHM) by age, sex, year of CHM prescription, and year of PD diagnosis with 290 patients who did not use CHM as control. Both cohorts were followed until the end of 2013 for the incidence of new-onset stroke. In a multivariable Cox proportional hazard model adjusted for potential comorbidities, the incidence of stroke was lower among PD patients using CHM compared with non-CHM users (11.10 per 100 person-years vs 23.15 per 100 person-years; Hazard ratio: 0.56; 95% confidence interval: 0.44 to 0.72). The probability curve generated from our follow-up data showed that PD patients receiving CHM treatment had a decreased risk of stroke compared with those not receiving CHM treatment (P < 0.001). The analysis on the prescription pattern of CHM revealed that Danshen is the most common single herb and Ma Zi Ren Wan is the most common herbal formula. Although the analysis are limited by a lack of analytic information regarding lifestyle patterns, biochemical profiles, and levels of PD severity in database, this population-based study suggest that CHM may be an complementary therapy to reduce the risk of stroke in PD patients.	[Lai, Ching-Yuan; Lin, Jaung-Geng; Yen, Hung-Rong] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Lai, Ching-Yuan] China Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Chiang, Jen-Huan] China Med Univ Hosp, Hlth Data Management Off, Taichung, Taiwan; [Chiang, Jen-Huan] China Med Univ, Sch Med, Taichung, Taiwan; [Lin, Jaung-Geng] China Med Univ Hosp, Dept Med Res, Res Ctr Tradit Chinese Med, Taichung, Taiwan; [Yen, Hung-Rong] China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan; [Yen, Hung-Rong; Tu, Cheng-Hao; Chen, Yi-Hung] China Med Univ, Chinese Med Res Ctr, Taichung, Taiwan; [Tu, Cheng-Hao; Chen, Yi-Hung] China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan; [Chen, Yi-Hung] Asia Univ, Dept Photon & Commun Engn, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Tu, CH; Chen, YH (corresponding author), China Med Univ, Chinese Med Res Ctr, Taichung, Taiwan.; Tu, CH; Chen, YH (corresponding author), China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan.; Chen, YH (corresponding author), Asia Univ, Dept Photon & Commun Engn, Taichung, Taiwan.	lordowen@mail.cmu.edu.tw; yihungchen@mail.cmu.edu.tw	Tu, Cheng-Hao/GOE-4336-2022; Yen, Hung-Rong/M-1373-2013	Tu, Cheng-Hao/0000-0002-7695-5570; Yen, Hung-Rong/0000-0002-0131-1658	Ministry of Health and Welfare, Taiwan [MOHW107-TDU-B-212-123004]; China Medical University Hospital [DMR-107-192]; Stroke Biosignature Project, Academia Sinica, Taiwan [BM10701010021]; Clinical Trial Consortium for Stroke, Ministry of Science and Technology, Taiwan [MOST 106-2321-B-039-005]; Ministry of Science and Technology, Taiwan [MOST 106-2321-B-039-019]; "Chinese Medicine Research Center, China Medical University" from the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education, Taiwan; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Ministry of Health and Welfare, Taiwan; China Medical University Hospital; Stroke Biosignature Project, Academia Sinica, Taiwan; Clinical Trial Consortium for Stroke, Ministry of Science and Technology, Taiwan; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); "Chinese Medicine Research Center, China Medical University" from the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education, Taiwan; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This work was supported by grants from the Ministry of Health and Welfare, Taiwan (MOHW107-TDU-B-212-123004); China Medical University Hospital (DMR-107-192); Stroke Biosignature Project, Academia Sinica, Taiwan (BM10701010021); Clinical Trial Consortium for Stroke, Ministry of Science and Technology, Taiwan (MOST 106-2321-B-039-005); Ministry of Science and Technology, Taiwan (MOST 106-2321-B-039-019); "Chinese Medicine Research Center, China Medical University" from the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education, Taiwan; Tseng-Lien Lin Foundation, Taichung, Taiwan; and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2009, MAYO CLIN PROC, V84, P43, DOI 10.1016/S0025-6196(11)60807-0; Adams-Carr KL, 2016, J NEUROL NEUROSUR PS, V87, P710, DOI 10.1136/jnnp-2015-311680; Au-Yeung SSY, 2009, NEUROREHAB NEURAL RE, V23, P515, DOI 10.1177/1545968308326425; Becker C, 2010, PARKINSONISM RELAT D, V16, P31, DOI 10.1016/j.parkreldis.2009.06.005; Cereda E, 2012, NEUROLOGY, V78, P1507, DOI 10.1212/WNL.0b013e3182553cc9; Chang CC, 2016, J ETHNOPHARMACOL, V186, P311, DOI 10.1016/j.jep.2016.04.018; Chen KY, 2018, J ETHNOPHARMACOL, V226, P168, DOI 10.1016/j.jep.2018.08.021; Chen Liang-Wei, 2007, CNS & Neurological Disorders-Drug Targets, V6, P273; Chen Y, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/7067691; Cheng TM, 2015, HEALTH AFFAIR, V34, P502, DOI 10.1377/hlthaff.2014.1332; Chou PC, 2009, J ALTERN COMPLEM MED, V15, P1067, DOI 10.1089/acm.2008.0579; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; HU HH, 1993, NEUROEPIDEMIOLOGY, V12, P106, DOI 10.1159/000110308; Huang SK, 2016, J ALTERN COMPLEM MED, V22, P832, DOI 10.1089/acm.2015.0080; Huang YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068314; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Lai CY, 2017, EUR J NEUROL, V24, P1166, DOI 10.1111/ene.13361; Lin Tsai-Hui, 2010, Chin Med, V5, P22, DOI 10.1186/1749-8546-5-22; Liu CQ, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00469; Qiu CX, 2011, HYPERTENSION, V57, P1094, DOI 10.1161/HYPERTENSIONAHA.111.171249; Registration DoH, 2016, POP AG SEX MAR STAT; Shih CC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/262039; Shih CC, 2009, CHINESE MED J-PEKING, V122, P1544, DOI 10.3760/cma.j.issn.0366-6999.2009.13.013; Statistics Do, 2016, ABR LIF TABL REP CHI; Swallow DMA, 2016, J NEUROL NEUROSUR PS, V87, P1183, DOI 10.1136/jnnp-2016-313642; Tsai KS, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/543517; Varanese S, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/480260; Williams-Gray CH, 2013, J NEUROL NEUROSUR PS, V84, P1258, DOI 10.1136/jnnp-2013-305277; Woo KS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/132912; Zhang WM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008973; Zhong LDD, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-366	31	10	10	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203473	10.1371/journal.pone.0203473	http://dx.doi.org/10.1371/journal.pone.0203473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192890	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600082
J	Nakatochi, M; Lin, YS; Ito, H; Hara, K; Kinoshita, F; Kobayashi, Y; Ishii, H; Ozaka, M; Sasaki, T; Sasahira, N; Morimoto, M; Kobayashi, S; Ueno, M; Ohkawa, S; Egawa, N; Kuruma, S; Mori, M; Nakao, H; Wang, CC; Nishiyama, T; Kawaguchi, T; Takahashi, M; Matsuda, F; Kikuchi, S; Matsuo, K				Nakatochi, Masahiro; Lin, Yingsong; Ito, Hidemi; Hara, Kazuo; Kinoshita, Fumie; Kobayashi, Yumiko; Ishii, Hiroshi; Ozaka, Masato; Sasaki, Takashi; Sasahira, Naoki; Morimoto, Manabu; Kobayashi, Satoshi; Ueno, Makoto; Ohkawa, Shinichi; Egawa, Naoto; Kuruma, Sawako; Mori, Mitsuru; Nakao, Haruhisa; Wang, Chaochen; Nishiyama, Takeshi; Kawaguchi, Takahisa; Takahashi, Meiko; Matsuda, Fumihiko; Kikuchi, Shogo; Matsuo, Keitaro			Prediction model for pancreatic cancer risk in the general Japanese population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON GENETIC-VARIANTS; SUSCEPTIBILITY LOCI; POLYGENIC RISK; BREAST; DISEASE	Genome-wide association studies (GWASs) have identified many single nucleotide polymorphisms (SNPs) that are significantly associated with pancreatic cancer susceptibility. We sought to replicate the associations of 61 GWAS-identified SNPs at 42 loci with pancreatic cancer in Japanese and to develop a risk model for the identification of individuals at high risk for pancreatic cancer development in the general Japanese population. The model was based on data including directly determined or imputed SNP genotypes for 664 pancreatic cancer case and 664 age-and sex-matched control subjects. Stepwise logistic regression uncovered five GWAS-identified SNPs at five loci that also showed significant associations in our case-control cohort. These five SNPs were included in the risk model and also applied to calculation of the polygenic risk score (PRS). The area under the curve determined with the leave-one-out cross-validation method was 0.63 (95% confidence interval, 0.60-0.66) or 0.61 (0.58-0.64) for versions of the model that did or did not include cigarette smoking and family history of pancreatic cancer in addition to the five SNPs, respectively. Individuals in the lowest and highest quintiles for the PRS had odds ratios of 0.62 (0.42-0.91) and 1.98 (1.42-2.76), respectively, for pancreatic cancer development compared with those in the middle quintile. We have thus developed a risk model for pancreatic cancer that showed moderately good discriminatory ability with regard to differentiation of pancreatic cancer patients from control individuals. Our findings suggest the potential utility of a risk model that incorporates replicated GWAS-identified SNPs and established demographic or environmental factors for the identification of individuals at increased risk for pancreatic cancer development.	[Nakatochi, Masahiro; Kinoshita, Fumie; Kobayashi, Yumiko] Nagoya Univ Hosp, Dept Adv Med, Data Coordinating Ctr, Div Data Sci, Nagoya, Aichi, Japan; [Lin, Yingsong; Wang, Chaochen; Kikuchi, Shogo] Aichi Med Univ, Sch Med, Dept Publ Hlth, Nagakute, Aichi, Japan; [Ito, Hidemi] Aichi Canc Ctr Res Inst, Div Canc Informat & Control, Nagoya, Aichi, Japan; [Hara, Kazuo] Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Ishii, Hiroshi] Natl Hosp Org Shikoku Canc Ctr, Clin Res Ctr, Matsuyama, Ehime, Japan; [Ozaka, Masato; Sasaki, Takashi; Sasahira, Naoki] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Hepatobiliary Pancreat Med, Tokyo, Japan; [Morimoto, Manabu; Kobayashi, Satoshi; Ueno, Makoto; Ohkawa, Shinichi] Kanagawa Canc Ctr Hosp, Hepatobiliary & Pancreat Med Oncol Div, Yokohama, Kanagawa, Japan; [Egawa, Naoto] Tokyo Metropolitan Hiroo Gen Hosp, Tokyo, Japan; [Kuruma, Sawako] Tokyo Metropolitan Komagome Hosp, Dept Internal Med, Tokyo, Japan; [Mori, Mitsuru] Hokkaido Chitose Coll Rehabil, Chitose, Hokkaido, Japan; [Nakao, Haruhisa] Aichi Med Univ, Sch Med, Div Hepatol & Pancreatol, Nagakute, Aichi, Japan; [Nishiyama, Takeshi] Nagoya City Univ, Grad Sch Med, Dept Publ Hlth, Nagoya, Aichi, Japan; [Kawaguchi, Takahisa; Takahashi, Meiko; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Matsuo, Keitaro] Aichi Canc Ctr Res Inst, Div Canc Epidemiol & Prevent, Nagoya, Aichi, Japan	Nagoya University; Aichi Medical University; Aichi Cancer Center; Aichi Cancer Center; Japanese Foundation for Cancer Research; Kanagawa Prefectural Cancer Center; Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Aichi Medical University; Nagoya City University; Kyoto University; Aichi Cancer Center	Lin, YS (corresponding author), Aichi Med Univ, Sch Med, Dept Publ Hlth, Nagakute, Aichi, Japan.	linys@aichi-med-u.ac.jp	Wang, ChaoChen/D-8327-2014; Matsuo, Keitaro/H-6758-2019; Nakatochi, Masahiro/Q-1247-2015	Wang, ChaoChen/0000-0001-5533-1497; Matsuo, Keitaro/0000-0003-1761-6314; Nakatochi, Masahiro/0000-0002-1838-4837; Takahashi, Meiko/0000-0002-8344-5472	Ministry of Health, Labor, and Welfare of Japan [H21-11-1]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [16H06277, 17K09095, 26253041, 17015018]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by The Ministry of Health, Labor, and Welfare of Japan (http://www.mhlw.go.jp/english/): H21-11-1; The Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://www.mext.go.jp/en/): 16H06277, 17K09095, 26253041, and 17015018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2017, J CANCER RES CLIN, V143, P2481, DOI 10.1007/s00432-017-2505-4; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Campa D, 2013, CANCER EPIDEM BIOMAR, V22, P320, DOI 10.1158/1055-9965.EPI-12-1182; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chatterjee N, 2016, NAT REV GENET, V17, P392, DOI 10.1038/nrg.2016.27; Childs EJ, 2015, NAT GENET, V47, P911, DOI 10.1038/ng.3341; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Freedman AN, 2005, JNCI-J NATL CANCER I, V97, P715, DOI 10.1093/jnci/dji128; Gail MH, 2008, J NATL CANCER I, V100, P1037, DOI 10.1093/jnci/djn180; Inoue M, 1997, J CLIN EPIDEMIOL, V50, P69, DOI 10.1016/S0895-4356(96)00297-1; Klein AP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02942-5; Klein AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072311; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lin YS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-337; Low SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011824; Lu Y, 2014, HUM MOL GENET, V23, P6112, DOI 10.1093/hmg/ddu312; Lucas AL, 2016, CLIN GASTROENTEROL H, V14, P1452, DOI 10.1016/j.cgh.2016.05.034; Machiela MJ, 2011, GENET EPIDEMIOL, V35, P506, DOI 10.1002/gepi.20600; Matsuo K, 2011, JPN J CLIN ONCOL, V41, P1292, DOI 10.1093/jjco/hyr141; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Risch HA, 2015, AM J EPIDEMIOL, V182, P26, DOI 10.1093/aje/kwv026; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sueta A, 2012, BREAST CANCER RES TR, V132, P711, DOI 10.1007/s10549-011-1904-5; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wen WQ, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0786-1; Wolpin BM, 2014, NAT GENET, V46, P994, DOI 10.1038/ng.3052; Wu C, 2012, NAT GENET, V44, P62, DOI 10.1038/ng.1020; Yu A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146473; Zhang MF, 2016, ONCOTARGET, V7, P66328, DOI 10.18632/oncotarget.11041	35	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203386	10.1371/journal.pone.0203386	http://dx.doi.org/10.1371/journal.pone.0203386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192808	Green Submitted, Green Published, gold			2022-12-26	WOS:000444093600067
J	Porter, TM; Hajibabaei, M				Porter, Teresita M.; Hajibabaei, Mehrdad			Over 2.5 million COI sequences in GenBank and growing	PLOS ONE			English	Article							DATABASE; IDENTIFICATION; DIVERSITY; 16S; GENERATION; PARADIGM; ECOLOGY; FUTURE; FUNGI	The increasing popularity of cytochrome c oxidase subunit 1 (COI) DNA metabarcoding warrants a careful look at the underlying reference databases used to make high-throughput taxonomic assignments. The objectives of this study are to document trends and assess the future usability of COI records for metabarcode identification. The number of COI records deposited to the NCBI nucleotide database has increased by a geometric average of 51% per year, from 8,137 records deposited in 2003 to a cumulative total of similar to 2.5 million by the end of 2017. About half of these records are fully identified to the species rank, 92% are at least 500 bp in length, 74% have a country annotation, and 51% have latitude-longitude annotations. To ensure the future usability of COI records in GenBank we suggest: 1) Improving the geographic representation of COI records, 2) Improving the cross-referencing of COI records in the Barcode of Life Data System and GenBank to facilitate consolidation and incorporation into existing bioinformatic pipelines, 3) Adherence to the minimum information about a marker gene sequence guidelines, and 4) Integrating metabarcodes from eDNA and mixed community studies with existing reference sequences. The growth of COI reference records over the past 15 years has been substantial and is likely to be a resource across many fields for years to come.	[Porter, Teresita M.; Hajibabaei, Mehrdad] Univ Guelph, Ctr Biodivers Genom, Guelph, ON, Canada; [Porter, Teresita M.; Hajibabaei, Mehrdad] Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada; [Porter, Teresita M.] Nat Resources Canada, Great Lakes Forestry Ctr, Sault Ste Marie, ON, Canada	University of Guelph; University of Guelph; Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre	Porter, TM (corresponding author), Univ Guelph, Ctr Biodivers Genom, Guelph, ON, Canada.; Porter, TM (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada.; Porter, TM (corresponding author), Nat Resources Canada, Great Lakes Forestry Ctr, Sault Ste Marie, ON, Canada.	porter01@uoguelph.ca	Porter, Teresita M/H-4072-2011	Porter, Teresita/0000-0002-0227-6874	Canadian government through the Genomics Research and Development Initiative (GRDI) interdepartmental EcoBiomics project	Canadian government through the Genomics Research and Development Initiative (GRDI) interdepartmental EcoBiomics project	The authors would like to acknowledge funding from the Canadian government through the Genomics Research and Development Initiative (GRDI) interdepartmental EcoBiomics project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baird DJ, 2012, MOL ECOL, V21, P2039, DOI 10.1111/j.1365-294X.2012.05519.x; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Bengtsson-Palme J, BIOINFORMATICS; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Cai YS, 2011, CHINESE SCI BULL, V56, P164, DOI 10.1007/s11434-010-4302-1; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Creer S, 2016, METHODS ECOL EVOL, V7, P1008, DOI 10.1111/2041-210X.12574; Curry CJ, 2018, FRESHW SCI, V37, P178, DOI 10.1086/696613; Deiner K, 2017, MOL ECOL, V26, P5872, DOI 10.1111/mec.14350; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar R.C., 2016, BIORXIV, V081257, DOI 10.1101/081257; Edgar RC, 2018, BIOINFORMATICS, DOI [10.1093/bioinformatics/bty113, DOI 10.1093/BIOINFORMATICS/BTY113]; Elbrecht V, 2017, FRONT ENV SCI-SWITZ, V5, DOI 10.3389/fenvs.2017.00011; Emilson CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13157-x; Erdozain M, ADV STREAM MACROINVE; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Glassman SI, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00148-18; Hajibabaei M, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-28; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hibbett D, 2011, NEW PHYTOL, V191, P592, DOI 10.1111/j.1469-8137.2011.03819.x; Hibbett DS, 2009, NEW PHYTOL, V184, P279, DOI 10.1111/j.1469-8137.2009.03042.x; Horton TR, 2001, MOL ECOL, V10, P1855, DOI 10.1046/j.0962-1083.2001.01333.x; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Leray M, 2018, BIOINFORMATICS, V34, P3753, DOI 10.1093/bioinformatics/bty454; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Lobo J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15823-6; Luo AR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-84; Macher JN, 2016, ECOL INDIC, V61, P159, DOI 10.1016/j.ecolind.2015.08.024; Macher Jan-Niklas, 2017, Metabarcoding and Metagenomics, V1, pe22262, DOI 10.3897/mbmg.1.22262; Machida RJ, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.27; Mahe F, 2014, PEERJ, V2, DOI 10.7717/peerj.593; Nagy LG, 2011, NEW PHYTOL, V191, P789, DOI 10.1111/j.1469-8137.2011.03707.x; Nearing JT, 2018, PEERJ, V6, DOI 10.7717/peerj.5364; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Nilsson RH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-178; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pawlowski J, 2018, SCI TOTAL ENVIRON, V637, P1295, DOI 10.1016/j.scitotenv.2018.05.002; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Porter TM, 2018, MOL ECOL, V27, P313, DOI 10.1111/mec.14478; Porter TM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22505-4; Porter TM, 2014, MOL ECOL RESOUR, V14, P929, DOI 10.1111/1755-0998.12240; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R Core Team, 2021, R LANGUAGE ENV STAT; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Robeson MS, 2018, ECOL EVOL, V8, P185, DOI 10.1002/ece3.3638; Ryberg M, 2009, NEW PHYTOL, V181, P471, DOI 10.1111/j.1469-8137.2008.02667.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yarza P, 2013, SYST APPL MICROBIOL, V36, P69, DOI 10.1016/j.syapm.2012.12.006; Yarza P, 2010, SYST APPL MICROBIOL, V33, P291, DOI 10.1016/j.syapm.2010.08.001; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823; Zizka VMA, 2018, DNA METABARCODING SA, DOI [10.1101/287276, DOI 10.1101/287276]	62	65	66	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0200177	10.1371/journal.pone.0200177	http://dx.doi.org/10.1371/journal.pone.0200177			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192752	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600004
J	Lee, YJ; Lee, IH; Kim, YJ; Chung, YS; Lee, JY; Nam, EJ; Kim, S; Kim, SW; Kim, YT				Lee, Yong Jae; Lee, In Ha; Kim, Yun-Ji; Chung, Young Shin; Lee, Jung-Yun; Nam, Eun Ji; Kim, Sunghoon; Kim, Sang Wun; Kim, Young Tae			Evaluation of various kinetic parameters of CA-125 in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy	PLOS ONE			English	Article							PREDICT OPTIMAL CYTOREDUCTION; INTERVAL DEBULKING SURGERY; RESIDUAL DISEASE; FALLOPIAN-TUBE; SURVIVAL; REGRESSION; REDUCTION; TRIAL	Various kinetic parameters of serum CA-125 have been reported to have better correlation with outcomes for patients treated with neoadjuvant chemotherapy (NAC). This study aimed to compare the available kinetic parameters of serum CA-125 in an external cohort of advanced-stage ovarian cancer. Using the cancer registry databases from the Yonsei Cancer Hospital, we retrospectively reviewed 210 patients with advanced-stage ovarian cancer, treated with NAC followed by interval debulking surgery. We compared area under the receiver-operating characteristics curves (AUCs), false negative rate, and negative predictive value (NPV) using 10 different models for optimal cytoreduction and platinum resistance. In addition, we compared incremental AUC for progression-free survival (PFS) and overall survival (OS). No gross residual tumor was observed in 37.0% and residual tumors <1 cm in 82.2% of patients. No model using CA-125 kinetic parameters had an AUC higher than >0.6 for predicting optimal cytoreduction. After adjusting for age, BMI, disease stage, and histologic subtypes, all models had an AUC >0.70 for predicting platinum resistance. However, no model had a high enough NPV (highest value = 82.0%) to avoid chemotherapy futility. For survival outcomes, no model had an incremental AUC >0.70 for predicting either PFS or OS. None of the proposed serum CA-125 kinetic parameters showed high accuracy in predicting optimal cytoreduction, platinum resistance, or survival in patients receiving NAC. For advanced-stage ovarian cancer treated with NAC, there is a need to discover reliable biomarkers to better stratify patient response groups for optimal treatment decision making.	[Lee, Yong Jae; Lee, In Ha; Kim, Yun-Ji; Chung, Young Shin; Lee, Jung-Yun; Nam, Eun Ji; Kim, Sunghoon; Kim, Sang Wun; Kim, Young Tae] Yonsei Univ, Inst Womens Med Life Sci, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System	Lee, JY (corresponding author), Yonsei Univ, Inst Womens Med Life Sci, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea.	jungyunlee@yuhs.ac	Lee, Yong Jae/GLR-4153-2022	Kim, Sang Wun/0000-0002-8342-8701; Lee, Yong Jae/0000-0003-0297-3116; Lee, Jung-Yun/0000-0001-7948-1350; Nam, Eun Ji/0000-0003-0189-3560; kim, sunghoon/0000-0002-1570-3230; Lee, Inha/0000-0003-4869-6281; Kim, Young Tae/0000-0002-7347-1052; Kim, Sunghoon/0000-0002-1645-7473	National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [2017M3A9E8029714]	National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (2017M3A9E8029714).; This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (2017M3A9E8029714).	Bohm S, 2015, J CLIN ONCOL, V33, P2457, DOI 10.1200/JCO.2014.60.5212; Chan YM, 2003, GYNECOL ONCOL, V88, P9, DOI 10.1006/gyno.2002.6849; Fagotti A, 2016, EUR J CANCER, V59, P22, DOI 10.1016/j.ejca.2016.01.017; Furukawa N, 2013, J GYNECOL ONCOL, V24, P141, DOI 10.3802/jgo.2013.24.2.141; Hou JY, 2007, GYNECOL ONCOL, V105, P211, DOI 10.1016/j.ygyno.2006.11.025; Jung KW, 2017, CANCER RES TREAT, V49, P292, DOI 10.4143/crt.2017.118; Kehoe S, 2015, LANCET, V386, P249, DOI 10.1016/S0140-6736(14)62223-6; Le T, 2008, J OBSTET GYNAECOL CA, V30, P665, DOI 10.1016/S1701-2163(16)32914-0; Ledermann JA, 2013, ANN ONCOL, V24, P24, DOI 10.1093/annonc/mdt333; Lee JY, 2017, J GYNECOL ONCOL, V28, DOI 10.3802/jgo.2017.28.e73; Lee JY, 2014, J GYNECOL ONCOL, V25, P174, DOI 10.3802/jgo.2014.25.3.174; Luo YL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004797; Mahdi H, 2015, INT J GYNECOL CANCER, V25, P823, DOI 10.1097/IGC.0000000000000434; Morimoto A, 2016, JPN J CLIN ONCOL, V46, P517, DOI 10.1093/jjco/hyw029; Onda T, 2008, JPN J CLIN ONCOL, V38, P74, DOI 10.1093/jjco/hym145; Pelissier A, 2016, ANTICANCER RES, V36, P1865; Pelissier A, 2014, GYNECOL ONCOL, V135, P542, DOI 10.1016/j.ygyno.2014.09.005; Rodriguez N, 2012, GYNECOL ONCOL, V125, P362, DOI 10.1016/j.ygyno.2012.02.006; Saha A, 2012, INT J GYNECOL CANCER, V22, P566, DOI 10.1097/IGC.0b013e318247727f; Tate S, 2005, GYNECOL ONCOL, V96, P143, DOI 10.1016/j.ygyno.2004.09.020; Vasudev NS, 2011, ARCH GYNECOL OBSTET, V284, P221, DOI 10.1007/s00404-010-1655-2; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Zeng J, 2016, J CANCER, V7, P2327, DOI 10.7150/jca.16761	23	4	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203366	10.1371/journal.pone.0203366	http://dx.doi.org/10.1371/journal.pone.0203366			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188915	Green Published, gold, Green Submitted			2022-12-26	WOS:000444228700028
J	Bruederle, A; Hodler, R				Bruederle, Anna; Hodler, Roland			Nighttime lights as a proxy for human development at the local level	PLOS ONE			English	Article							SATELLITE IMAGERY; ECONOMIC STATISTICS; AFRICA; INSTITUTIONS; CONFLICT; GROWTH; VALUES; TRADE	Nighttime lights, calculated from weather satellite recordings, are increasingly used by social scientists as a proxy for economic activity or economic development in subnational regions of developing countries where disaggregated data from statistical offices are not available. However, so far, our understanding of what nighttime lights capture in these countries is limited. We use geo-referenced Demographic and Health Surveys (DHS) from 29 African countries to construct indicators of household wealth, education and health for DHS cluster locations as well as for grid cells of roughly 50 x 50 km. We show that nighttime lights are positively associated with these location-specific indicators of human development, and that the variation in nighttime lights can explain a substantial share in the variation in these indicators. We conclude that nighttime lights are a good proxy for human development at the local level.	[Hodler, Roland] Univ St Gallen, Dept Econ, St Gallen, Switzerland; Univ St Gallen, SIAW HSG, St Gallen, Switzerland	University of St Gallen; University of St Gallen	Hodler, R (corresponding author), Univ St Gallen, Dept Econ, St Gallen, Switzerland.	roland.hodler@unisg.ch		Bruederle, Anna/0000-0002-4813-2083; Hodler, Roland/0000-0001-8402-8243	Basic research grant, University of St.Gallen	Basic research grant, University of St.Gallen	This work was supported by Basic research grant, University of St.Gallen, https://www.unisg.ch/en/forschung/foerderung/projekte/gffprojektfoerderung.	Alesina A, 2016, J POLIT ECON, V124, P428, DOI 10.1086/685300; Baugh K., 2010, P ASIA PACIFIC ADV N, V30, P114, DOI DOI 10.7125/APAN.30.17; Besley T, 2014, AM POLIT SCI REV, V108, P319, DOI 10.1017/S0003055414000161; Brown M, 2016, REV FINANC, V20, P907, DOI 10.1093/rof/rfv026; BURBIDGE JB, 1988, J AM STAT ASSOC, V83, P123, DOI 10.2307/2288929; Center for International Earth Science Information Network-CIESIN-Columbia University, 2016, GRIDD POP WORLD VERS; Chen X., 2015, SPAT DEMOGR, V3, P27, DOI [DOI 10.1007/S40980-015-0009-X, 10.1007/s40980-015-0009-x]; Chen X, 2011, P NATL ACAD SCI USA, V108, P8589, DOI 10.1073/pnas.1017031108; De Luca G, 2018, J DEV ECON, V132, P115, DOI 10.1016/j.jdeveco.2017.12.006; Doll CNH, 2006, ECOL ECON, V57, P75, DOI 10.1016/j.ecolecon.2005.03.007; Elvidge C, 2011, URBAN REMOTE SENSING, P211, DOI DOI 10.1002/9780470979563.CH15; Elvidge CD, 2009, COMPUT GEOSCI-UK, V35, P1652, DOI 10.1016/j.cageo.2009.01.009; Ghosh T, 2009, REMOTE SENS-BASEL, V1, P418, DOI 10.3390/rs1030418; Henderson JV, 2018, Q J ECON, V133, P357, DOI 10.1093/qje/qjx030; Henderson JV, 2012, AM ECON REV, V102, P994, DOI 10.1257/aer.102.2.994; Hodler R, 2014, ECON LETT, V124, P530, DOI 10.1016/j.econlet.2014.07.027; Hodler R, 2014, Q J ECON, V129, P995, DOI 10.1093/qje/qju004; ICF International, 1992, DEM HLTH SURV VAR DA; Jean N, 2016, SCIENCE, V353, P790, DOI 10.1126/science.aaf7894; Mamo N, 2017, INTENSIVE EXTENSIVE; Marshall MG., 2016, POLITY 4 PROJECT POL; Mellander C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139779; Michalopoulos S, 2014, Q J ECON, V129, P151, DOI 10.1093/qje/qjt029; Michalopoulos S, 2013, ECONOMETRICA, V81, P113, DOI 10.3982/ECTA9613; Min B, 2013, INT J REMOTE SENS, V34, P8118, DOI 10.1080/01431161.2013.833358; National Oceanic and Atmospheric Administration, VERS 4 DMSP OLS NIGH; Noor Abdisalan M, 2008, Popul Health Metr, V6, P5, DOI 10.1186/1478-7954-6-5; Nordhaus W, 2015, J ECON GEOGR, V15, P217, DOI 10.1093/jeg/lbu010; Rutstein S. O., 2004, DHS COMP REPORTS; Sen Amartya, 2010, MISMEASURING OUR LIV; Storeygard A, 2016, REV ECON STUD, V83, P1263, DOI 10.1093/restud/rdw020; Sutton P, 2001, INT J REMOTE SENS, V22, P3061, DOI 10.1080/01431160010007015; Sutton P., 2007, INT J ECOL EC STAT, V8, P5; Sutton PC, 2003, REMOTE SENS ENVIRON, V86, P353, DOI 10.1016/S0034-4257(03)00078-6; Sutton PC, 2002, ECOL ECON, V41, P509, DOI 10.1016/S0921-8009(02)00097-6; Tollefsen AF, 2012, J PEACE RES, V49, P363, DOI 10.1177/0022343311431287; Weidmann NB, 2017, J PEACE RES, V54, P125, DOI 10.1177/0022343316630359; World Bank, 2016, WORLD DEV IND 2016	38	61	61	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202231	10.1371/journal.pone.0202231	http://dx.doi.org/10.1371/journal.pone.0202231			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS6HC	30183707	Green Submitted, gold, Green Published			2022-12-26	WOS:000443789900021
J	Mehr, SA; Scannell, DA; Winner, E				Mehr, Samuel A.; Scannell, Daniel A.; Winner, Ellen			Sight-over-sound judgments of music performances are replicable effects with limited interpretability	PLOS ONE			English	Article								Virtuosi impress audiences with their musical expressivity and with their theatrical flair. How do listeners use this auditory and visual information to judge performance quality? Both musicians and laypeople report a belief that sound should trump sight in the judgment of music performance, but surprisingly, their actual judgments reflect the opposite pattern. In a recent study, when presented with 6-second videos of music competition performers, listeners accurately guessed the winners only when the videos were muted. Here, we successfully replicate this finding in a highly-powered sample but then demonstrate that the sightover-sound effect holds only under limited conditions. When using different videos from comparable performances, in a forced-choice task, listeners' judgments were at or below chance. And when differences in performance quality were made clearer, listeners' judgments were most accurate when they could hear the music-without audio, performance was at chance. Sight therefore does not necessarily trump sound in the judgment of music performance.	[Mehr, Samuel A.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Mehr, Samuel A.] Harvard Univ, Data Sci Initiat, Cambridge, MA 02138 USA; [Scannell, Daniel A.; Winner, Ellen] Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA	Harvard University; Harvard University; Boston College	Mehr, SA (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.; Mehr, SA (corresponding author), Harvard Univ, Data Sci Initiat, Cambridge, MA 02138 USA.	sam@wjh.harvard.edu		Mehr, Samuel/0000-0002-9400-7718				Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Simonsohn U, 2015, PSYCHOL SCI, V26, P559, DOI 10.1177/0956797614567341; Tsay CJ, 2014, ORGAN BEHAV HUM DEC, V124, P24, DOI 10.1016/j.obhdp.2013.10.003; Tsay CJ, 2013, P NATL ACAD SCI USA, V110, P14580, DOI 10.1073/pnas.1221454110; Wallentin M, 2010, LEARN INDIVID DIFFER, V20, P188, DOI 10.1016/j.lindif.2010.02.004	7	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202075	10.1371/journal.pone.0202075	http://dx.doi.org/10.1371/journal.pone.0202075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS6HC	30183719	Green Submitted, Green Published, gold			2022-12-26	WOS:000443789900014
J	Xie, TL; Gu, WR; Zhang, LG; Li, LJ; Qu, DY; Li, CF; Meng, Y; Li, J; Wei, S; Li, WH				Xie, Tenglong; Gu, Wanrong; Zhang, Liguo; Li, Lijie; Qu, Danyang; Li, Caifeng; Meng, Yao; Li, Jing; Wei, Shi; Li, Wenhua			Modulating the antioxidant system by exogenous 2-(3,4-dichlorophenoxy) triethylamine in maize seedlings exposed to polyethylene glycol-simulated drought stress	PLOS ONE			English	Article							GLUTATHIONE-REDUCTASE; SUPEROXIDE-DISMUTASE; MONODEHYDROASCORBATE REDUCTASE; DEHYDROASCORBATE REDUCTASE; ASCORBATE PEROXIDASE; ENHANCED TOLERANCE; CHILLING STRESS; DEFENSE SYSTEM; ZEA-MAYS; METABOLISM	Maize (Zea mays L.), an important agricultural crop, suffers from drought stress frequently during its growth period, thus leading to a decline in yield. 2-(3,4-Dichlorophenoxy) triethylamine (DCPTA) regulates many aspects of plant development; however, its effects on crop stress tolerance are poorly understood. We pre-treated maize seedlings by adding DCPTA to a hydroponic solution and then subjected the seedlings to a drought condition [15% poly-ethylene glycol (PEG)-6000 treatment]. The activities of superoxide dismutase (SOD), peroxidase (POD), ascorbate peroxidase (APX), and glutathione reductase (GR) were enhanced under drought stress and further enhanced by the DCPTA application. The activities of monodehydroascorbate reductase (MDHAR), dehydroascorbate reductase (DHAR) and catalase (CAT) declined continuously under drought stress; however, the activities partially recovered with DCPTA application. Up-regulation of the activities and transcript levels of APX, GR, MDHAR and DHAR in the DCPTA treatments contributed to the increases in ascorbate (AsA) and glutathione (GSH) levels and inhibited the increased generation rate of superoxide anion radicals (O-2(center dot-)), the contents of hydrogen peroxide (H2O2) and malondialdehyde (MDA), and the electrolyte leakage (EL) induced by drought. These results suggest that the enhanced antioxidant capacity induced by DCPTA application may represent an efficient mechanism for increasing the drought stress tolerance of maize seedlings.	[Xie, Tenglong; Gu, Wanrong; Li, Lijie; Qu, Danyang; Li, Caifeng; Li, Jing; Wei, Shi] Northeast Agr Univ, Coll Agr, Harbin, Heilongjiang, Peoples R China; [Zhang, Liguo; Li, Wenhua] Heilongjiang Acad Agr Sci, Maize Res Inst, Harbin, Heilongjiang, Peoples R China; [Meng, Yao] Heilongjiang Acad Land Reclamat Sci, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China; Heilongjiang Academy of Agricultural Sciences	Wei, S (corresponding author), Northeast Agr Univ, Coll Agr, Harbin, Heilongjiang, Peoples R China.	weishi5608@126.com	li, li/HII-4157-2022; Li, Li/AEM-3636-2022		National Key Research and Development Program of China [2016YFD0300103, 2017YFD0300506]; "Academic Backbone" Project of Northeast Agricultural University [17XG23]	National Key Research and Development Program of China; "Academic Backbone" Project of Northeast Agricultural University	This study was supported by the National Key Research and Development Program of China (2016YFD0300103), the National Key Research and Development Program of China (2017YFD0300506), the "Academic Backbone" Project of Northeast Agricultural University (17XG23).	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Alonso-Blazquez N, 2015, ECOTOXICOLOGY, V24, P279, DOI 10.1007/s10646-014-1376-6; Anjum NA, 2010, ASCORBATE-GLUTATHIONE PATHWAY AND STRESS TOLERANCE IN PLANTS, P1, DOI 10.1007/978-90-481-9404-9; BENEDICT CR, 1985, PLANT SCI, V41, P169, DOI 10.1016/0168-9452(85)90084-6; Bose J, 2014, J EXP BOT, V65, P1241, DOI 10.1093/jxb/ert430; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candan N, 2003, PLANT SCI, V165, P769, DOI 10.1016/S0168-9452(03)00269-3; Caverzan A, 2014, PLANT SCI, V214, P74, DOI 10.1016/j.plantsci.2013.10.001; Chen F, 2010, PLANT PHYSIOL BIOCH, V48, P663, DOI 10.1016/j.plaphy.2010.05.001; Djanaguiraman M, 2010, PLANT PHYSIOL BIOCH, V48, P999, DOI 10.1016/j.plaphy.2010.09.009; Duan M, 2012, J PLANT PHYSIOL, V169, P867, DOI 10.1016/j.jplph.2012.02.012; Dwivedi SK, 2018, PHOTOSYNTHETICA, V56, P478, DOI 10.1007/s11099-017-0695-2; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; Eltayeb AE, 2006, PHYSIOL PLANTARUM, V127, P57, DOI 10.1111/j.1399-3054.2006.00624.x; Eltayeb AE, 2007, PLANTA, V225, P1255, DOI 10.1007/s00425-006-0417-7; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; FOYER CH, 1995, PLANT PHYSIOL, V109, P1047, DOI 10.1104/pp.109.3.1047; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; GAUSMAN HW, 1985, BIO-TECHNOL, V3, P255, DOI 10.1038/nbt0385-255; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gill SS, 2015, ENVIRON SCI POLLUT R, V22, P10375, DOI 10.1007/s11356-015-4532-5; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Hasanuzzaman M., 2017, FRONT PLANT SCI, V8; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hodges DM, 1997, J EXP BOT, V48, P1105, DOI 10.1093/jxb/48.5.1105; Hong CY, 2009, J PLANT PHYSIOL, V166, P1598, DOI 10.1016/j.jplph.2009.04.001; HSU WJ, 1992, J AGR FOOD CHEM, V40, P924, DOI 10.1021/jf00017a046; JANA S, 1982, AQUAT BOT, V12, P345, DOI 10.1016/0304-3770(82)90026-2; Kadioglu A, 2011, PLANT GROWTH REGUL, V64, P27, DOI 10.1007/s10725-010-9532-3; Karkonen A, 2015, PHYTOCHEMISTRY, V112, P22, DOI 10.1016/j.phytochem.2014.09.016; Kaur G, 2015, B ENVIRON CONTAM TOX, V95, P246, DOI 10.1007/s00128-015-1564-y; KEITHLY JH, 1990, PLANT SCI, V68, P57, DOI 10.1016/0168-9452(90)90152-E; KEITHLY JH, 1990, PLANT GROWTH REGUL, V9, P127, DOI 10.1007/BF00027440; Kim YS, 2013, PLANTA, V237, P1613, DOI 10.1007/s00425-013-1862-8; KINGSBURY RW, 1984, PLANT PHYSIOL, V74, P417, DOI 10.1104/pp.74.2.417; Li F, 2012, PHOTOSYNTHETICA, V50, P120, DOI 10.1007/s11099-012-0021-y; Li Z, 2015, PLANT GROWTH REGUL, V76, P71, DOI 10.1007/s10725-014-9978-9; Liu YJ, 2012, J PLANT PHYSIOL, V169, P183, DOI 10.1016/j.jplph.2011.08.018; Lutts S, 1995, J EXP BOT, V46, P1843, DOI 10.1093/jxb/46.12.1843; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Noctor G, 2014, PLANT PHYSIOL, V164, P1636, DOI 10.1104/pp.113.233478; Palma JM, 2015, ANN BOT-LONDON, V116, P627, DOI 10.1093/aob/mcv121; Pandey P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00723; Pyngrope S, 2013, PROTOPLASMA, V250, P585, DOI 10.1007/s00709-012-0444-0; Sanahuja G, 2013, BIOTECHNOL J, V8, P1221, DOI 10.1002/biot.201300064; Selote DS, 2010, PROTOPLASMA, V245, P153, DOI 10.1007/s00709-010-0169-x; Sharma P, 2005, PLANT GROWTH REGUL, V46, P209, DOI 10.1007/s10725-005-0002-2; Singh R, 2016, FRONT PLANT SCI, V7, P1, DOI 10.3389/fpls.2016.01299; Sofo A, 2015, INT J MOL SCI, V16, P13561, DOI 10.3390/ijms160613561; Sultana S, 2012, J PLANT PHYSIOL, V169, P311, DOI 10.1016/j.jplph.2011.09.004; Terzi R, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1792-0; den Berg L, 2006, S AFR J BOT, V72, P284, DOI 10.1016/j.sajb.2005.07.006; Wang W, 2016, BIOCHEMISTRY-MOSCOW+, V81, P465, DOI 10.1134/S0006297916050047; Wang WB, 2009, PLANT PHYSIOL BIOCH, V47, P570, DOI 10.1016/j.plaphy.2009.02.009; Wu ZC, 2017, ENVIRON EXP BOT, V133, P1, DOI 10.1016/j.envexpbot.2016.09.005; Xia XJ, 2015, J EXP BOT, V66, P2839, DOI 10.1093/jxb/erv089; Xie TL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12977-1; Yin LN, 2010, PLANTA, V231, P609, DOI 10.1007/s00425-009-1075-3; You J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01092; ZHANG JX, 1994, PLANT CELL PHYSIOL, V35, P785, DOI 10.1093/oxfordjournals.pcp.a078658; Zhang X, 2016, PLANT PHYSIOL BIOCH, V108, P222, DOI 10.1016/j.plaphy.2016.07.012; ZHENG X, 1992, PLANT SCI, V81, P47, DOI 10.1016/0168-9452(92)90023-F; Ziyomo C, 2013, CROP SCI, V53, P1269, DOI 10.2135/cropsci2012.11.0651	64	10	10	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203626	10.1371/journal.pone.0203626	http://dx.doi.org/10.1371/journal.pone.0203626			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183770	Green Published, gold, Green Submitted			2022-12-26	WOS:000443789900078
J	Nakamura, K; Sakaguchi, M; Matsubara, H; Akagi, S; Sarashina, T; Ejiri, K; Akazawa, K; Kondo, M; Nakagawa, K; Yoshida, M; Miyoshi, T; Ogo, T; Oto, T; Toyooka, S; Higashimoto, Y; Fukami, K; Ito, H				Nakamura, Kazufumi; Sakaguchi, Masakiyo; Matsubara, Hiromi; Akagi, Satoshi; Sarashina, Toshihiro; Ejiri, Kentaro; Akazawa, Kaoru; Kondo, Megumi; Nakagawa, Koji; Yoshida, Masashi; Miyoshi, Toru; Ogo, Takeshi; Oto, Takahiro; Toyooka, Shinichi; Higashimoto, Yuichiro; Fukami, Kei; Ito, Hiroshi			Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INHIBITS PROLIFERATION; RECEPTOR	Background Pulmonary vascular remodeling of pulmonary arterial hypertension (PAH) is characterized by an inappropriate increase of vascular cells. The receptor for advanced glycation end products (RAGE) is a type I single-pass transmembrane protein belonging to the immunoglobulin superfamily and is involved in a broad range of hyperproliferative diseases. RAGE is also implicated in the etiology of PAH and is overexpressed in pulmonary artery smooth muscle cells (PASMCs) in patients with PAH. We examined the role of RAGE in the inappropriate increase of PASMCs in patients with PAH. Methods and results PASMCs were obtained from 12 patients with PAH including 9 patients with idiopathic PAH (IPAH) and 3 patients with heritable PAH (HPAH) (2 patients with BMPR2 mutation and one patient with SMAD9 mutation) who underwent lung transplantation. Western blot analysis and immunofluorescence staining revealed that RAGE and S100A8 and A9, ligands of RAGE, were overexpressed in IPAH and HPAH-PASMCs in the absence of any external growth stimulus. PDGF-BB (10 ng/mL) up-regulated the expression of RAGE in IPAH and HPAH-PASMCs. PAH-PASMCs are hyperplastic in the absence of any external growth stimulus as assessed by 3H-thymidine incorporation. This result indicates overgrowth characterized by continued growth under a condition of no growth stimulation in PAH-PASMCs. PDGF-BB stimulation caused a higher growth rate of PAH-PASMCs than that of non-PAH-PASMCs. AS-1, an inhibitor of TIR domain-mediated RAGE signaling, significantly inhibited overgrowth characterized by continued growth under a condition of no growth stimulation in IPAH and HPAH-PASMCs (P<0.0001). Furthermore, AS-1 significantly inhibited PDGF-stimulated proliferation of IPAH and HPAH-PASMCs (P<0.0001). Conclusions RAGE plays a crucial role in the inappropriate increase of PAH-PASMCs. Inhibition of RAGE signaling may be a new therapeutic strategy for PAH.	[Nakamura, Kazufumi; Akagi, Satoshi; Sarashina, Toshihiro; Ejiri, Kentaro; Akazawa, Kaoru; Kondo, Megumi; Nakagawa, Koji; Yoshida, Masashi; Miyoshi, Toru; Ito, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan; [Sakaguchi, Masakiyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Kita Ku, Okayama, Japan; [Matsubara, Hiromi] Natl Hosp Org Okayama Med Ctr, Div Cardiol, Okayama, Japan; [Ogo, Takeshi] Natl Cerebral & Cardiovasc Ctr, Div Adv Med Pulm Hypertens, Div Pulm Circulat, Dept Cardiovasc Med, Osaka, Japan; [Oto, Takahiro; Toyooka, Shinichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Thorac Surg, Okayama, Japan; [Oto, Takahiro; Toyooka, Shinichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Breast & Endocrinol Surg, Okayama, Japan; [Higashimoto, Yuichiro] Kurume Univ, Sch Med, Dept Med Biochem, Kurume, Fukuoka, Japan; [Fukami, Kei] Kurume Univ, Sch Med, Dept Med, Div Nephrol, Kurume, Fukuoka, Japan	Okayama University; Okayama University; National Cerebral & Cardiovascular Center - Japan; Okayama University; Okayama University; Kurume University; Kurume University	Nakamura, K (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan.	ichibun@cc.okayama-u.ac.jp	Ejiri, Kentaro/AAQ-8589-2020	Higashimoto, Yuichiro/0000-0003-1382-8598	Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan [15K09158, 18K08037]	Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan (to K. Nakamura) (15K09158) and (18K08037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi S, 2016, J CARDIOVASC PHARM, V67, P290, DOI 10.1097/FJC.0000000000000352; Archer S, 2000, CIRCULATION, V102, P2781, DOI 10.1161/01.CIR.102.22.2781; Fujio H, 2006, J CARDIOVASC PHARM, V47, P250, DOI 10.1097/01.fjc.0000201359.58174.c8; Greenway S, 2004, AM J PATHOL, V164, P253, DOI 10.1016/S0002-9440(10)63115-X; Higashimoto Y, 2007, MICROVASC RES, V74, P65, DOI 10.1016/j.mvr.2007.04.001; Hoeper MM, 2013, CIRCULATION, V127, P1128, DOI 10.1161/CIRCULATIONAHA.112.000765; Ikeda T, 2010, J CARDIOVASC PHARM, V55, P39, DOI 10.1097/FJC.0b013e3181c0419c; Matsui T, 2017, DIABETES, V66, P1683, DOI 10.2337/db16-1281; Meloche J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005157; Miura A, 2010, CIRCULATION, V121, P2151, DOI 10.1161/CIR.0b013e3181e037c1; Moser B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106440; Nakamura K, 2012, INT J CARDIOL, V159, P100, DOI 10.1016/j.ijcard.2011.02.024; Nakamura K, 2010, INT J CARDIOL, V140, P102, DOI 10.1016/j.ijcard.2008.11.022; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Oczypok EA, 2015, J ALLERGY CLIN IMMUN, V136, P747, DOI 10.1016/j.jaci.2015.03.011; Ogawa A, 2005, CIRCULATION, V112, P1806, DOI 10.1161/CIRCULATIONAHA.105.536169; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Sakaguchi M, 2014, J BIOL CHEM, V289, P23389, DOI 10.1074/jbc.M114.573071; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; Suzuki S, 2016, INT HEART J, V57, P234, DOI 10.1536/ihj.15-188; Taguchi K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21176-5; Zhu Y, 2011, BASIC RES CARDIOL, V106, P787, DOI 10.1007/s00395-011-0182-z	22	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0203046	10.1371/journal.pone.0203046	http://dx.doi.org/10.1371/journal.pone.0203046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180189	Green Published, gold, Green Submitted			2022-12-26	WOS:000444222400025
J	Deng, JY; Jhandey, A; Zhu, X; Yang, ZB; Yik, KFP; Zuo, Z; Lam, TN				Deng, Jianyuan; Jhandey, Anika; Zhu, Xiao; Yang, Zhibo; Yik, Kin Fu Patrick; Zuo, Zhong; Lam, Tai Ning			In silico drug absorption tract: An agent-based biomimetic model for human oral drug absorption	PLOS ONE			English	Article							TRANSPORT; METABOLISM; PHARMACOKINETICS; BIOAVAILABILITY; BIOEQUIVALENCE; DISPOSITION; SIMULATION; MIDAZOLAM; DEVICE	Background An agent-based modeling approach has been suggested as an alternative to traditional, equation-based modeling methods for describing oral drug absorption. It enables researchers to gain a better understanding of the pharmacokinetic (PK) mechanisms of a drug. This project demonstrates that a biomimetic agent-based model can adequately describe the absorption and disposition kinetics both of midazolam and clonazepam. Methods An agent-based biomimetic model, in silico drug absorption tract (ISDAT), was built to mimic oral drug absorption in humans. The model consisted of distinct spaces, membranes, and metabolic enzymes, and it was altogether representative of human physiology relating to oral drug absorption. Simulated experiments were run with the model, and the results were compared to the referent data from clinical equivalence trials. Acceptable similarity was verified by pre-specified criteria, which included 1) qualitative visual matching between the clinical and simulated concentration-time profiles, 2) quantitative similarity indices, namely, weighted root mean squared error (RMSE), and weighted mean absolute percentage error (MAPE) and 3) descriptive similarity which requires less than 25% difference between key PK parameters calculated by the clinical and the simulated concentration-time profiles. The model and its parameters were iteratively refined until all similarity criteria were met. Furthermore, simulated PK experiments were conducted to predict bioavailability (F). For better visualization, a graphical user interface for the model was developed and a video is available in Supporting Information. Results Simulation results satisfied all three levels of similarity criteria for both drugs. The weighted RMSE was 0.51 and 0.92, and the weighted MAPE was 5.99% and 8.43% for midazolam and clonazepam, respectively. Calculated PK parameter values, including area under the curve (AUC), peak plasma drug concentration (C-max), time to reach C-max (T-max), terminal elimination rate constant (Kel), terminal elimination half life (T-1/2), apparent oral clearance (CL/F), and apparent volume of distribution (V/F), were reasonable compared to the referent values. The predicted absolute oral bioavailability (F) was 44% for midazolam (literature reported value, 31-72%) and 93% (literature reported value, >= 90%) for clonazepam. Conclusion The ISDAT met all the pre-specified similarity criteria for both midazolam and clonazepam, and demonstrated its ability to describe absorption kinetics of both drugs. Therefore, the validated ISDAT can be a promising platform for further research into the use of similar in silico models for drug absorption kinetics.	[Deng, Jianyuan; Jhandey, Anika; Zhu, Xiao; Yik, Kin Fu Patrick; Zuo, Zhong; Lam, Tai Ning] Chinese Univ Hong Kong, Sch Pharm, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Jhandey, Anika] Univ Nottingham, Sch Pharm, Nottingham, England; [Yang, Zhibo] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA; [Lam, Tai Ning] Chinese Univ Hong Kong, Sch Pharm, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; University of Nottingham; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese University of Hong Kong	Lam, TN (corresponding author), Chinese Univ Hong Kong, Sch Pharm, Fac Med, Hong Kong, Hong Kong, Peoples R China.; Lam, TN (corresponding author), Chinese Univ Hong Kong, Sch Pharm, Shatin, Hong Kong, Peoples R China.	teddylam@cuhk.edu.hk	Deng, Jianyuan/ABE-5454-2021; Deng, Jianyuan/ABE-5456-2021; Lam, Teddy/C-6180-2016; Zuo, Zhong/B-6884-2008	Deng, Jianyuan/0000-0003-0647-1287; Lam, Tai Ning/0000-0002-7259-4050; Zhu, Xiao/0000-0003-3295-619X; Zuo, Zhong/0000-0002-6976-6157	Hong Kong University Grants Committee Research Grants Council Early Career Scheme [CUHK489813]	Hong Kong University Grants Committee Research Grants Council Early Career Scheme	This project is partially supported by research grants from the Hong Kong University Grants Committee Research Grants Council Early Career Scheme (https://www.ugc.edu.hk/eng/rgc/funding_opport/early_career.html), Grant number CUHK489813 (TNL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An G, 2007, J CRIT CARE, V22, P169, DOI 10.1016/j.jcrc.2006.12.011; An G, 2009, WIRES SYST BIOL MED, V1, P159, DOI 10.1002/wsbm.45; An G, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-11; Cavedal LE, 2007, J MASS SPECTROM, V42, P81, DOI 10.1002/jms.1141; Chen ML, 2001, CLIN PHARMACOKINET, V40, P701, DOI 10.2165/00003088-200140100-00001; Cosgrove J, 2015, CPT-PHARMACOMET SYST, V4, P615, DOI 10.1002/psp4.12018; Crevoisier C, 2003, EUR NEUROL, V49, P173, DOI 10.1159/000069089; El-Kattan A, 2012, TOPICS ON DRUG METABOLISM, P1; Engelberg JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002030; Garmire LX, 2007, PHARM RES-DORDR, V24, P2171, DOI 10.1007/s11095-007-9391-4; HEIZMANN P, 1983, BRIT J CLIN PHARMACO, V16, pS43, DOI 10.1111/j.1365-2125.1983.tb02270.x; Hunt CA, 2013, WIRES SYST BIOL MED, V5, P461, DOI 10.1002/wsbm.1222; Hunt CA, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-35; Hunt CA, 2009, PHARM RES-DORDR, V26, P2369, DOI 10.1007/s11095-009-9958-3; Jaki T, 2011, PHARM STAT, V10, P284, DOI 10.1002/pst.449; Kadono K, 2010, DRUG METAB DISPOS, V38, P1230, DOI 10.1124/dmd.109.029322; Kim SHJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-122; Lalonde RL, 2007, CLIN PHARMACOL THER, V82, P21, DOI 10.1038/sj.clpt.6100235; Lam TN, 2010, J PHARMACOL EXP THER, V332, P398, DOI 10.1124/jpet.109.160739; Lam TN, 2008, IEEE ENG MED BIO, P5462, DOI 10.1109/IEMBS.2008.4650450; Lam TN, 2009, DRUG METAB DISPOS, V37, P237, DOI 10.1124/dmd.108.023820; Landersdorfer CB, 2008, CLIN PHARMACOKINET, V47, P417, DOI 10.2165/00003088-200847070-00001; Liu Y, 2006, PHARM RES-DORDR, V23, P493, DOI 10.1007/s11095-006-9505-4; Liu Y, 2005, BIOSYSTEMS, V82, P154, DOI 10.1016/j.biosystems.2005.06.008; Luke S, 2005, SIMUL-T SOC MOD SIM, V81, P517, DOI 10.1177/0037549705058073; Marino S, 2010, J THEOR BIOL, V265, P586, DOI 10.1016/j.jtbi.2010.05.012; Park S, 2010, J PHARMACOL EXP THER, V334, P124, DOI 10.1124/jpet.110.168526; Sakuda S, 2006, XENOBIOTICA, V36, P331, DOI 10.1080/00498250600571749; Seal JB, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-33; Sheiner LB, 2000, ANNU REV PHARMACOL, V40, P67, DOI 10.1146/annurev.pharmtox.40.1.67; Spector P, 2008, USE R, P1; Tang J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000681; Wang ZH, 2015, J PHARMACOKINET PHAR, V42, P179, DOI 10.1007/s10928-015-9403-7; Wang ZH, 2012, MATH MED BIOL, V29, P95, DOI 10.1093/imammb/dqq023; Wening K, 2011, INT J PHARMACEUT, V404, P1, DOI 10.1016/j.ijpharm.2010.11.001; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yan L, 2008, PHARM RES, V25, P1023, DOI 10.1007/s11095-007-9494-y; Zhou HH, 2003, J CLIN PHARMACOL, V43, P211, DOI 10.1177/0091270002250613; Zhu X, 2016, AAPS J, V18, P1475, DOI 10.1208/s12248-016-9955-5	39	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203361	10.1371/journal.pone.0203361	http://dx.doi.org/10.1371/journal.pone.0203361			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169515	Green Published, Green Submitted, gold			2022-12-26	WOS:000443374400037
J	Jimenez-Lopez, D; Munoz-Belman, F; Gonzalez-Prieto, JM; Aguilar-Hernandez, V; Guzman, P				Jimenez-Lopez, Domingo; Munoz-Belman, Francisco; Manuel Gonzalez-Prieto, Juan; Aguilar-Hernandez, Victor; Guzman, Plinio			Repertoire of plant RING E3 ubiquitin ligases revisited: New groups counting gene families and single genes	PLOS ONE			English	Article							CONFERS DROUGHT TOLERANCE; ARABIDOPSIS-THALIANA; FINGER PROTEIN; EXPRESSION ANALYSIS; NEGATIVE REGULATOR; SEED-GERMINATION; ROOT DEVELOPMENT; DNA METHYLATION; ATL FAMILY; STRESS	E3 ubiquitin ligases of the ubiquitin proteasome system (UPS) mediate recognition of substrates and later transfer the ubiquitin (Ub). They are the most expanded components of the system. The Really Interesting New Gene (RING) domain contains 40-60 residues that are highly represented among E3 ubiquitin ligases. The Arabidopsis thaliana E3 ubiquitin ligases with a RING finger primarily contain RING-HC or RING-H2 type domains or less frequently RING-v, RING-C2, RING-D, RING-S/T and RING-G type domains. Our previous work on three E3 ubiquitin ligase families with a RING-H2 type domain, ATL, BTL, and CTL, suggested that a phylogenetic distribution based on the RING domain allowed for the creation a catalog of known domains or unknown conserved motifs. This work provided a useful and comprehensive view of particular families of RING E3 ubiquitin ligases. We updated the annotation of A. thaliana RING proteins and surveyed RING proteins from 30 species across eukaryotes. Based on domain architecture profile of the A. thaliana proteins, we catalogued 4711 RING finger proteins into 107 groups, including 66 previously described gene families or single genes and 36 novel families or undescribed genes. Forty-four groups were specific to a plant lineage while 41 groups consisted of proteins found in all eukaryotic species. Our present study updates the current classification of plant RING finger proteins and reiterates the importance of these proteins in plant growth and adaptation.	[Jimenez-Lopez, Domingo; Munoz-Belman, Francisco; Guzman, Plinio] IPN, Ctr Invest & Estudios Avanzados, Dept Ingn Genet, Unidad Irapuato, Irapuato, Gto, Mexico; [Jimenez-Lopez, Domingo; Manuel Gonzalez-Prieto, Juan] Inst Politecn Nacl, Biotecnol Vegetal, Ctr Biotecnol Genom, Reynosa, Tamaulipas, Mexico; [Aguilar-Hernandez, Victor] CONACYT, Unidad Bioquim & Biol Mol Plantas, Ctr Invest Cient Yucatan, Merida, Yucatan, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Centro de Investigacion Cientifica de Yucatan	Guzman, P (corresponding author), IPN, Ctr Invest & Estudios Avanzados, Dept Ingn Genet, Unidad Irapuato, Irapuato, Gto, Mexico.; Aguilar-Hernandez, V (corresponding author), CONACYT, Unidad Bioquim & Biol Mol Plantas, Ctr Invest Cient Yucatan, Merida, Yucatan, Mexico.	victor.aguilar@cicy.mx; plinio.guzman@cinvestav.mx	Aguilar-Hernández, Victor/Q-9860-2019	Aguilar-Hernández, Victor/0000-0001-7308-4047; Guzman, Plinio/0000-0001-7905-5693	Fronteras de la Ciencia 20 from Consejo Nacional de Ciencia y Tecnologia de Mexico	Fronteras de la Ciencia 20 from Consejo Nacional de Ciencia y Tecnologia de Mexico	This work was funded by grant Fronteras de la Ciencia 20 from Consejo Nacional de Ciencia y Tecnologia de Mexico. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar RC, 2003, CURR OPIN CELL BIOL, V15, P184, DOI 10.1016/S0955-0674(03)00010-3; Aguilar-Henonin L, 2006, CURR GENET, V50, P257, DOI 10.1007/s00294-006-0093-y; Aguilar-Hernandez V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072729; Aguilar-Hernandez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023934; Alam I, 2017, SCI REP-UK, V7, DOI 10.1038/srep40690; Ariani P, 2016, SCI REP-UK, V6, DOI 10.1038/srep38260; Azevedo J, 2008, P NATL ACAD SCI USA, V105, P9123, DOI 10.1073/pnas.0800909105; Bao Y, 2014, NEW PHYTOL, V202, P174, DOI 10.1111/nph.12644; Baylis T, 2013, NEW PHYTOL, V197, P737, DOI 10.1111/nph.12084; Belda-Palazon B, 2016, PLANT CELL, V28, P2291, DOI 10.1105/tpc.16.00178; Berrocal-Lobo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014426; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Bourbousse C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002825; Burkhart SE, 2014, PLANT PHYSIOL, V166, P1329, DOI 10.1104/pp.114.247148; Chen IP, 2008, PLANT PHYSIOL, V146, P1786, DOI 10.1104/pp.108.116806; Chen MJ, 2006, PLANT J, V46, P823, DOI 10.1111/j.1365-313X.2006.02740.x; Cho SK, 2011, PLANT PHYSIOL, V157, P2240, DOI 10.1104/pp.111.185595; Dong CH, 2006, P NATL ACAD SCI USA, V103, P8281, DOI 10.1073/pnas.0602874103; Dong H, 2017, GENE DEV, V31, P197, DOI 10.1101/gad.292235.116; Duong S, 2017, J EXP BOT, V68, P1555, DOI 10.1093/jxb/erx046; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Figueroa P, 2005, PLANT CELL, V17, P1180, DOI 10.1105/tpc.105.031989; FREEMONT PS, 1993, ANN NY ACAD SCI, V684, P174, DOI 10.1111/j.1749-6632.1993.tb32280.x; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Gao Y, 2016, MAR GENOM, V26, P51, DOI 10.1016/j.margen.2015.12.008; Greve K, 2003, BIOCHEM J, V371, P97, DOI 10.1042/BJ20021123; Guerra DD, 2013, FEBS LETT, V587, P3400, DOI 10.1016/j.febslet.2013.08.045; Guo L, 2016, PLANT J, V86, P161, DOI 10.1111/tpj.13158; Guzman P, 2014, PLANT SCI, V215, P69, DOI 10.1016/j.plantsci.2013.10.017; Guzman P, 2012, PLANT SIGNAL BEHAV, V7, P1014, DOI 10.4161/psb.20851; Hershko A, 1998, ANN REV; Hindt MN, 2017, METALLOMICS, V9, P876, DOI 10.1039/c7mt00152e; Hsia MM, 2010, J BIOL CHEM, V285, P37070, DOI 10.1074/jbc.M110.168021; Huang YD, 2010, PLANT PHYSIOL, V152, P1889, DOI 10.1104/pp.109.150573; Jimenez-Lopez D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190969; Katoh S, 2005, J BIOL CHEM, V280, P41015, DOI 10.1074/jbc.M411127200; Kawasaki T, 2005, PLANT J, V44, P258, DOI 10.1111/j.1365-313X.2005.02525.x; Kim SJ, 2013, FEBS LETT, V587, P2584, DOI 10.1016/j.febslet.2013.06.038; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Koiwai H, 2007, PLANT J, V51, P92, DOI 10.1111/j.1365-313X.2007.03120.x; Kosarev P, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-4-research0016; Kraft E, 2008, PLANT J, V56, P704, DOI 10.1111/j.1365-313X.2008.03631.x; Lazaro A, 2015, PLANT CELL, V27, P2437, DOI 10.1105/tpc.15.00529; Lee HK, 2009, PLANT CELL, V21, P622, DOI 10.1105/tpc.108.061994; Li HM, 2011, PLANT PHYSIOL, V156, P550, DOI 10.1104/pp.111.176214; Li J, 2015, PLANT CELL, V27, P908, DOI 10.1105/tpc.114.135095; Li JQ, 2017, INT J PARASITOL-PAR, V6, P8, DOI 10.1016/j.ijppaw.2016.12.003; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Li XW, 2017, PLANT BIOTECHNOL-NAR, V34, P71, DOI 10.5511/plantbiotechnology.17.0306a; Li YZ, 2011, MOL GENET GENOMICS, V286, P81, DOI 10.1007/s00438-011-0625-0; Lim SD, 2014, PLANT CELL ENVIRON, V37, P1097, DOI 10.1111/pce.12219; Lim SD, 2013, J EXP BOT, V64, P2899, DOI 10.1093/jxb/ert143; Lim SD, 2010, PLANT MOL BIOL, V72, P369, DOI 10.1007/s11103-009-9576-9; Lin SS, 2008, PLANT J, V56, P550, DOI 10.1111/j.1365-313X.2008.03625.x; Liu HX, 2010, PLANT CELL, V22, P2630, DOI 10.1105/tpc.110.076075; Liu H, 2016, MOL PLANT, V9, P1634, DOI 10.1016/j.molp.2016.10.010; Liu JJ, 2008, PLANT CELL, V20, P1538, DOI 10.1105/tpc.108.059741; Luo G, 2012, J INTEGR PLANT BIOL, V54, P814, DOI 10.1111/j.1744-7909.2012.01152.x; Luo HL, 2010, PLANT PHYSIOL, V154, P1766, DOI 10.1104/pp.110.163915; Lyzenga WJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00502; Lyzenga WJ, 2012, PLANT J, V71, P23, DOI 10.1111/j.1365-313X.2012.04965.x; Lyzenga WJ, 2012, J EXP BOT, V63, P599, DOI 10.1093/jxb/err310; MartinezGarcia M, 1996, MOL GEN GENET, V252, P587, DOI 10.1007/s004380050266; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Miura A, 2009, EMBO J, V28, P1078, DOI 10.1038/emboj.2009.59; Mladek C, 2003, PLANT PHYSIOL, V131, P27, DOI 10.1104/pp.012781; Molnar G, 2002, PLANTA, V215, P127, DOI 10.1007/s00425-001-0723-z; Moschou PN, 2016, DEV CELL, V37, P350, DOI 10.1016/j.devcel.2016.04.015; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Nodzon LA, 2004, PLANT J, V40, P996, DOI 10.1111/j.1365-313X.2004.02266.x; Occhialini A, INT J MOL SCI; Oh TR, 2017, PLANT PHYSIOL, V174, P2515, DOI 10.1104/pp.17.00467; Pan RH, 2016, P NATL ACAD SCI USA, V113, pE7307, DOI 10.1073/pnas.1613530113; Patharkar OR, 2006, PLANTA, V225, P57, DOI 10.1007/s00425-006-0330-0; Peng MS, 2007, PLANT J, V50, P320, DOI 10.1111/j.1365-313X.2007.03050.x; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Ranjan A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-178; Roig-Villanova I, 2006, PLANT PHYSIOL, V141, P85, DOI 10.1104/pp.105.076331; Ruzicka K, 2017, NEW PHYTOL, V215, P157, DOI 10.1111/nph.14586; Sakai T, 2012, PLANT J, V70, P303, DOI 10.1111/j.1365-313X.2011.04870.x; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Serrano M, 2006, J MOL EVOL, V62, P434, DOI 10.1007/s00239-005-0038-y; Serrano M, 2004, GENETICS, V167, P919, DOI 10.1534/genetics.104.028043; Shin LJ, 2013, PLANT CELL, V25, P3039, DOI 10.1105/tpc.113.115212; Son O, 2009, PLANT CELL REP, V28, P561, DOI 10.1007/s00299-009-0680-8; Sonoda Y, 2007, PLANT J, V50, P586, DOI 10.1111/j.1365-313X.2007.03062.x; Sparkes IA, 2005, PLANT PHYSIOL, V139, P690, DOI 10.1104/pp.105.065094; Spratt DE, 2014, BIOCHEM J, V458, P421, DOI 10.1042/BJ20140006; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Su W, 2011, P NATL ACAD SCI USA, V108, P870, DOI 10.1073/pnas.1013251108; Tan XY, 2017, BIOCHEM BIOPH RES CO, V491, P794, DOI 10.1016/j.bbrc.2017.07.059; Trapp O, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00019; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Voiniciuc C, 2013, PLANT CELL, V25, P944, DOI 10.1105/tpc.112.107888; Vonarx EJ, 2006, PLANT J, V46, P512, DOI 10.1111/j.1365-313X.2006.02705.x; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wenzel DM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-24; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wu Q, 2016, PLANT CELL, V28, P2178, DOI 10.1105/tpc.16.00364; Wywial E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-157; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Xu DQ, 2014, PLANT CELL, V26, P1981, DOI 10.1105/tpc.114.124024; Yaeno T, 2008, PLANT PHYSIOL, V148, P1032, DOI 10.1104/pp.108.124529; Yang L, 2016, J INTEGR PLANT BIOL, V58, P67, DOI 10.1111/jipb.12364; Yasuda S, 2014, J BIOL CHEM, V289, P15179, DOI 10.1074/jbc.M113.533133; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zang DD, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01272; Zhang HW, 2015, PLANT CELL, V27, P214, DOI 10.1105/tpc.114.134163; Zhang J., 2016, IEEE T IND ELECTRON, V1-1, P1, DOI DOI 10.1007/S00253-016-7741-Z; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; Zhao HY, 2014, PLANT PHYSIOL, V165, P1255, DOI 10.1104/pp.114.239699; Zhao YS, 2014, PLANT CELL, V26, P2660, DOI 10.1105/tpc.114.126730; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691	116	14	14	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203442	10.1371/journal.pone.0203442	http://dx.doi.org/10.1371/journal.pone.0203442			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169501	Green Published, Green Submitted, gold			2022-12-26	WOS:000443374400041
J	Jose, V; Fumagalli, D; Rothe, F; Majjaj, S; Loi, S; Michiels, S; Sotiriou, C				Jose, Vinu; Fumagalli, Debora; Rothe, Francoise; Majjaj, Samira; Loi, Sherene; Michiels, Stefan; Sotiriou, Christos			Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays	PLOS ONE			English	Article							BREAST-CANCER; NORMALIZATION; MICROARRAYS; BIOLOGY	The reliability of differential gene expression analysis on formalin-fixed, paraffin-embedded (FFPE) expression profiles generated using Affymetrix arrays is questionable, due to the high range of percent-present values reported in studies which profiled FFPE samples using this technology. Moreover, the validity of gene-modules derived from external datasets in FFPE microarray expression profiles is unknown. By generating matched gene expression profiles using RNAs derived from fresh-frozen (FF) and FFPE preserved breast tumors with Affymetrix arrays and FF/FFPE RNA specific amplification-and-labeling kits, the reliability of differential expression analysis and the validity of gene modules derived from external datasets were investigated. Specifically, the reliability of differential expression analysis was investigated by developing de-novo ER/HER2 pathway gene-modules from the matched datasets and validating them on external FF/FFPE gene expression datasets using ROC analysis. Spearman's rank correlation coefficient of module scores between matched FFPE/frozen datasets was used to measure the reliability of gene-modules derived from external datasets in FFPE expression profiles. Independent of the array/amplification-kit/sample preservation method used, de-novo ER/HER2 gene-modules derived from all matched datasets showed similar prediction performance in the independent validation (AUC range in FFPE dataset; ER: 0.93-0.95, HER2: 0.85-0.91), except for the de-novo ER/HER2 gene-module derived from the FFPE dataset using the 3'IVT kit (AUC range in FFPE dataset; ER: 0.79-0.81, HER2: 0.78). Among the external gene modules considered, roughly similar to 50% gene modules showed high concordance between expression profiles derived from matching FF and FFPE RNA. The remaining discordant gene modules between FF and FFPE expression profiles showed high concordance within matching FF datasets and within matching FFPE datasets independently, implying that microarrays still require improved amplification-and-sample-preparation protocols for deriving 100% concordant expression profiles from matching FF and FFPE RNA.	[Jose, Vinu; Rothe, Francoise; Majjaj, Samira; Sotiriou, Christos] Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab, Brussels, Belgium; [Fumagalli, Debora] Univ Libre Bruxelles, Inst Jules Bordet, Breast Int Grp, Brussels, Belgium; [Loi, Sherene] Univ Melbourne, Div Res & Canc Med, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Michiels, Stefan] Univ Paris Saclay, Univ Paris Sud, Fac Med, Serv Biostat & Epidemiol,Gustave Roussy,CESP,U101, Villejuif, France; [Sotiriou, Christos] Univ Libre Bruxelles, Inst Jules Bordet, Dept Med, Med Oncol Clin, Brussels, Belgium	Institut Jules Bordet; Universite Libre de Bruxelles; Breast International Group; Institut Jules Bordet; Universite Libre de Bruxelles; Peter Maccallum Cancer Center; University of Melbourne; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut Jules Bordet; Universite Libre de Bruxelles	Sotiriou, C (corresponding author), Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab, Brussels, Belgium.; Sotiriou, C (corresponding author), Univ Libre Bruxelles, Inst Jules Bordet, Dept Med, Med Oncol Clin, Brussels, Belgium.	christos.sotiriou@bordet.be	Loi, Sherene/H-1979-2016; Michiels, Stefan/L-1516-2013	Loi, Sherene/0000-0001-6137-9171; Michiels, Stefan/0000-0002-6963-2968; Jose, Vinu/0000-0002-0562-8337	F.R.S-FNRS "Fonds de la Recherche Scientifique" - Televie (Belgium)	F.R.S-FNRS "Fonds de la Recherche Scientifique" - Televie (Belgium)(Fonds de la Recherche Scientifique - FNRS)	VJ received funding from a grant F.R.S-FNRS "Fonds de la Recherche Scientifique" - Televie (Belgium), for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF INC, 2002, GENECHIP EXPR AN DAT; [Anonymous], 2021, LANG ENV STAT COMP; Auguie B., 2015, GRIDEXTRA MISCELLANE; Azim HA, 2014, ENDOCR-RELAT CANCER, V21, P545, DOI 10.1530/ERC-14-0111; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Budczies J, 2011, J HISTOCHEM CYTOCHEM, V59, P146, DOI 10.1369/jhc.2010.956607; Callari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086511; Chen YA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-101; Clement-Ziza M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-246; Culhane AC, 2012, NUCLEIC ACIDS RES, V40, pD1060, DOI 10.1093/nar/gkr901; Dedeurwaerder S, 2011, EMBO MOL MED, V3, P726, DOI 10.1002/emmm.201100801; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Dezso Z, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-49; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hackstadt AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-11; Hollander M., 1973, NONPARAMETRIC STAT M; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacobson TAS, 2011, INT J ONCOL, V38, P1075, DOI 10.3892/ijo.2011.936; Kucho KI, 2004, GENES GENET SYST, V79, P189, DOI 10.1266/ggs.79.189; Lassmann S, 2009, J MOL MED, V87, P211, DOI 10.1007/s00109-008-0419-y; Li J, 2018, JCO PRECIS ONCOL, DOI [10.1200/PO.17.00091, DOI 10.1200/PO.17.00091]; Linton KM, 2009, BIOTECHNIQUES, V47, P587, DOI 10.2144/000113169; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Lu J, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr241; NanoString Technologies Inc, 2011, NCOUNTER EXPR CODESE; Neuwirth E, RCOLORBREWER PROVIDE; Roberts L, 2009, GENOMICS, V94, P341, DOI 10.1016/j.ygeno.2009.07.007; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sachs MC, 2016, PLOTROC GENERATE USE; Sanchez G., 2013, COLORTOOLS R PACKAGE; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Thomas Marlene, 2013, J Clin Bioinforma, V3, P10, DOI 10.1186/2043-9113-3-10; Tukey JW, 1977, EXPLORATORY DATA ANA; Viale Agnes, 2007, J Biomol Tech, V18, P150; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; Williams PM, 2010, J MOL DIAGN, V12, P680, DOI 10.2353/jmoldx.2010.090164; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124	45	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203346	10.1371/journal.pone.0203346	http://dx.doi.org/10.1371/journal.pone.0203346			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169535	Green Published, gold			2022-12-26	WOS:000443374400035
J	Birnbaum, MD; Zhao, N; Moorthy, BT; Patel, DM; Kryvenko, ON; Heidman, L; Kumar, A; Morgan, WM; Ban, YG; Reis, IM; Chen, X; Gonzalgo, ML; Jorda, M; Burnstein, KL; Zhang, FL				Birnbaum, Michael D.; Zhao, Ning; Moorthy, Balaji T.; Patel, Devang M.; Kryvenko, Oleksandr N.; Heidman, Laine; Kumar, Akhilesh; Morgan, William M.; Ban, Yuguang; Reis, Isildinha M.; Chen, Xi; Gonzalgo, Mark L.; Jorda, Merce; Burnstein, Kerry L.; Zhang, Fangliang			Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis	ONCOGENE			English	Article							RNA-PROTEIN TRANSFERASE; END RULE PATHWAY; ARGINYLATION; TUMOR; INVASION; ASSAY; BETA	Most prostate cancer cases remain indolent for long periods of time, but metastatic progression quickly worsens the prognosis and leads to mortality. However, little is known about what promotes the metastasis of prostate cancer and there is a lack of effective prognostic indicators, making it immensely difficult to manage options for treatment or surveillance. Arginyltransferase 1 (Ate1) is the enzyme mediating post-translational protein arginylation, which has recently been identified as a master regulator affecting many cancer-relevant pathways including stress response, cell cycle checkpoints, and cell migration/adhesion. However, the precise role of Ate1 in cancer remains unknown. In this study, we found the occurrence of metastasis of prostate cancer is inversely correlated with the levels of Ate1 protein and mRNA in the primary tumor. We also found that metastatic prostate cancer cell lines have a reduced level of Ate1 protein compared to non-metastatic cell lines, and that a depletion of Ate1 drives prostate cancer cells towards more aggressive pro-metastatic phenotypes without affecting proliferation rates. Furthermore, we demonstrated that a reduction of Ate1 can result from chronic stress, and that shRNA-reduced Ate1 increases cellular resistance to stress, and drives spontaneous and stress-induced genomic mutations. Finally, by using a prostate orthotropic xenograft mouse model, we found that a reduction of Ate1 was sufficient to enhance the metastatic phenotypes of prostate cancer cell line PC-3 in vivo. Our study revealed a novel role of Ate1 in suppressing prostate cancer metastasis, which has a profound significance for establishing metastatic indicators for prostate cancer, and for finding potential treatments to prevent its metastasis.	[Birnbaum, Michael D.; Zhao, Ning; Moorthy, Balaji T.; Patel, Devang M.; Heidman, Laine; Kumar, Akhilesh; Morgan, William M.; Burnstein, Kerry L.; Zhang, Fangliang] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Kryvenko, Oleksandr N.; Reis, Isildinha M.; Chen, Xi; Gonzalgo, Mark L.; Jorda, Merce; Burnstein, Kerry L.; Zhang, Fangliang] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Kryvenko, Oleksandr N.; Jorda, Merce] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Kryvenko, Oleksandr N.; Gonzalgo, Mark L.] Univ Miami, Miller Sch Med, Dept Urol, Miami, FL 33136 USA; [Ban, Yuguang; Reis, Isildinha M.; Chen, Xi] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Kumar, Akhilesh] Banaras Hindu Univ, Dept Bot, Varanasi 221005, Uttar Pradesh, India	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; Banaras Hindu University (BHU)	Zhang, FL (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.; Zhang, FL (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.	fzhang2@miami.edu	Patel, Devang/P-9537-2017; Moorthy, Balaji Thas/I-9254-2019	Patel, Devang/0000-0002-0375-2318; Moorthy, Balaji Thas/0000-0002-2196-0209; Zhao, Ning/0000-0001-6514-234X	DoD (CDMRP), Idea Award [PC140622]; DoD (CDMRP), Exploratory grant [PC141013]; NIGMS (NIH) [R01GM107333]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107333] Funding Source: NIH RePORTER	DoD (CDMRP), Idea Award; DoD (CDMRP), Exploratory grant; NIGMS (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Cell sorting was performed in the core facility of Sylvester Comprehensive Cancer Center. Ex vivo imaging was performed in the small animal imaging facility at the University of Miami Miller School of medicine. Gamma irradiation was performed in the Radiation Control core facility at the University of Miami Miller School of medicine. Immunostaining of tumor array samples was performed in the histology core facility in the Hussman Institute for Human Genomics at the University of Miami Miller School of medicine. Dr. Priyamvada Rai (University of Miami) provided critical reading for the manuscript. Dr. Yuanfang Guan (University of Michigan) provided technical consultations for the analysis related to Ate1 mRNA levels. The research presented in this article is funded in part by these grants: DoD (CDMRP), Idea Award, PC140622; DoD (CDMRP), Exploratory grant, PC141013; and NIGMS (NIH), R01GM107333.	Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; BALZI E, 1990, J BIOL CHEM, V265, P7464; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Decca MB, 2006, NEUROCHEM RES, V31, P401, DOI 10.1007/s11064-005-9037-z; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eisenach PA, 2014, J BIOL CHEM, V289, P35376, DOI 10.1074/jbc.M114.578674; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; FIDLER IJ, 1978, CANCER RES, V38, P2651; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Humphrey PA, 2004, MODERN PATHOL, V17, P292, DOI 10.1038/modpathol.3800054; Jiang WG, 2015, SEMIN CANCER BIOL, V35, pS244, DOI 10.1016/j.semcancer.2015.03.008; Klein CA, 2013, NATURE, V501, P365, DOI 10.1038/nature12628; KLEMPERER NS, 1989, J BIOL CHEM, V264, P19245; Kumar A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.284; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Kuroiwa K, 2009, J CLIN PATHOL, V62, P260, DOI 10.1136/jcp.2008.060632; Kurosaka S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000878; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Rai R, 2016, ONCOGENE, V35, P4058, DOI 10.1038/onc.2015.473; Rai R, 2006, EMBO REP, V7, P800, DOI 10.1038/sj.embor.7400747; Rice MA, 2016, ONCOGENE, V35, P4752, DOI 10.1038/onc.2016.6; Rusthoven CG, 2014, UROL ONCOL-SEMIN ORI, V32, P707, DOI 10.1016/j.urolonc.2014.01.004; Sherman MY, 2015, ONCOGENE, V34, P4153, DOI 10.1038/onc.2014.349; Suzuki F, 1983, METHODS CELL SCI, V8, P109, DOI DOI 10.1007/BF01842703; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; WANG M, 1991, DIFFERENTIATION, V48, P115, DOI 10.1111/j.1432-0436.1991.tb00250.x; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wong CCL, 2007, PLOS BIOL, V5, P2231, DOI 10.1371/journal.pbio.0050258; Zhang FL, 2012, J CELL BIOL, V197, P819, DOI 10.1083/jcb.201112129; Zhang FL, 2010, SCIENCE, V329, P1534, DOI 10.1126/science.1191701; Zhang N, 1998, NEUROCHEM RES, V23, P1411, DOI 10.1023/A:1020706924509	39	12	12	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 7	2019	38	6					838	851		10.1038/s41388-018-0462-2	http://dx.doi.org/10.1038/s41388-018-0462-2			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HK5LC	30177837	Green Accepted			2022-12-26	WOS:000458006300006
J	Guntuku, L; Gangasani, JK; Thummuri, D; Borkar, RM; Manavathi, B; Ragampeta, S; Vaidya, JR; Sistla, R; Vegi, NGM				Guntuku, Lalita; Gangasani, Jagadeesh Kumar; Thummuri, Dinesh; Borkar, Roshan M.; Manavathi, Bramanandam; Ragampeta, Srinivas; Vaidya, Jayathirtha Rao; Sistla, Ramakrishna; Vegi, Naidu G. M.			IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo	ONCOGENE			English	Article							ENDOPLASMIC-RETICULUM; APOPTOSIS; DERIVATIVES; LYSOSOMES; PATHWAY; TARGETS; CELLS	Autophagy is a homeostatic process that recycles damaged organelles and long-lived proteins by delivering them in double-membrane vesicles to lysosomes for degradation. Autophagy has a prominent role in survival, proliferation, and resistance of tumors in metabolic and chemotherapeutic stress conditions. Clinical trials with chloroquine-a known autophagy inhibitor -were unable to achieve complete autophagy inhibition in vivo, warranting the search for more potent autophagy inhibitors. In a process of exploring the mechanism of action of previously identified cytotoxic s-triazine analogs, we discovered that both IITZ-01 and IITZ-02 act as potent autophagy inhibitors. Treatment with these compounds resulted in the vacuolated appearance of cells due to their specific accumulation in lysosomes. In addition, these basic compounds also deacidify lysosomes as evidenced by the decrease in lysotracker red staining and inhibit maturation of lysosomal enzymes leading to lysosomal dysfunction. IITZ-01 and IITZ-02 enhance autophagosome accumulation but inhibit autophagosomal degradation by impairing lysosomal function, finally resulting in the inhibition of autophagy. Interestingly, compound IITZ-01 exhibited more than 10-fold potent autophagy inhibition along with 12- to 20-fold better cytotoxic action than CQ. IITZ-01 and IITZ-02 also abolished mitochondrial membrane potential and triggered apoptosis through the mitochondria-mediated pathway. Furthermore, IITZ-01 and IITZ-02 displayed potent antitumor action in vivo through autophagy inhibition and apoptosis induction in MDA-MB-231 breast cancer xenograft model with IITZ-01 exhibiting superior anticancer efficacy. Overall, these data demonstrate that IITZ-01 is potent autophagy inhibitor with single-agent anticancer activity and awaits further preclinical development as potential anticancer therapeutic.	[Guntuku, Lalita; Thummuri, Dinesh; Vegi, Naidu G. M.] Natl Inst Pharmaceut Educ & Res, Dept Pharmacol & Toxicol, Hyderabad, TS, India; [Gangasani, Jagadeesh Kumar; Vaidya, Jayathirtha Rao] CSIR Indian Inst Chem Technol, Crop Protect Chem Div, Hyderabad, TS, India; [Gangasani, Jagadeesh Kumar; Vaidya, Jayathirtha Rao] AcSIR, Training & Dev Complex,CSIR Campus,CSIR Rd, Chennai, TN, India; [Borkar, Roshan M.; Ragampeta, Srinivas] CSIR Indian Inst Chem Technol, Natl Ctr Mass Spectrometry, Hyderabad, TS, India; [Manavathi, Bramanandam] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad, TS, India; [Sistla, Ramakrishna] CSIR Indian Inst Chem Technol IICT, Med Chem & Pharmacol Div, Hyderabad, TS, India; [Vegi, Naidu G. M.] Natl Inst Pharmaceut Educ & Res, Dept Pharmacol & Toxicol, Gauhati, Assam, India	National Institute of Pharmaceutical Education & Research, Hyderabad; National Institute of Pharmaceutical Education & Research (NIPER); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); University of Hyderabad; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); National Institute of Pharmaceutical Education & Research (NIPER)	Vegi, NGM (corresponding author), Natl Inst Pharmaceut Educ & Res, Dept Pharmacol & Toxicol, Hyderabad, TS, India.; Vegi, NGM (corresponding author), Natl Inst Pharmaceut Educ & Res, Dept Pharmacol & Toxicol, Gauhati, Assam, India.	vgmnaidu@gmail.com	Thummuri, Dinesh/Q-2252-2019; BORKAR, ROSHAN M/J-6995-2019; VAIDYA, JAYATHIRTHA RAO/AET-5302-2022	BORKAR, ROSHAN M/0000-0003-1963-7688; VAIDYA, JAYATHIRTHA RAO/0000-0002-6173-3617; Manavathi, Bramanandam/0000-0002-1797-398X	NIPER-Hyderabad; NIPER-Guwahati; Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India	NIPER-Hyderabad; NIPER-Guwahati; Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India	GL and DT are thankful to Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, and Director of NIPER-Hyderabad and NIPER-Guwahati, for providing fellowship and research activity to the authors. We also acknowledge Dr M Lakshman, Sri Venkateshwara University College of Veterinary Sciences, for his help in processing and acquisition of transmission electron microscopy images. We thank Jaya Lakshmi, Veera Bhadra Swami, and Vasu Penugurti for their technical guidance and support.	Alam MM, 2016, APOPTOSIS, V21, P1191, DOI 10.1007/s10495-016-1277-7; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Ashoor R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082481; Ben-Zvi I, 2012, CLIN REV ALLERG IMMU, V42, P145, DOI 10.1007/s12016-010-8243-x; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Cascioferro S, 2017, EUR J MED CHEM, V142, P523, DOI 10.1016/j.ejmech.2017.09.035; Chen C, 2017, MOLECULES, V22, DOI 10.3390/molecules22060891; Chen SN, 2010, BBA-REV CANCER, V1806, P220, DOI 10.1016/j.bbcan.2010.07.003; Chude CI, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061279; Collignon J, 2016, BREAST CANCER-TARGET, V8, P93, DOI 10.2147/BCTT.S69488; de Castro MAG, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.12; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Endo S, 2017, GASTROENTEROLOGY, V152, P1492, DOI 10.1053/j.gastro.2017.01.010; Farrow JM, 2014, NAT REV UROL, V11, P508, DOI 10.1038/nrurol.2014.196; Fu D, 2014, NAT CHEM, V6, P615, DOI [10.1038/nchem.1961, 10.1038/NCHEM.1961]; Guggilapu SD, 2017, EUR J MED CHEM, V128, P1, DOI 10.1016/j.ejmech.2017.01.026; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028491; Hardwick JM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008722; Hata AN, 2015, CANCER DISCOV, V5, P475, DOI 10.1158/2159-8290.CD-15-0011; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Jain K, 2013, AM J CANCER RES, V3, P251; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kim EL, 2010, NEURO-ONCOLOGY, V12, P389, DOI 10.1093/neuonc/nop046; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Kumar D, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-171; Kumar GJ, 2017, MED CHEM RES, V26, P3072, DOI 10.1007/s00044-017-1978-7; Kumar GJ, 2015, MED CHEM RES, V24, P3991, DOI 10.1007/s00044-015-1430-9; Kumar GJ, 2013, MED CHEM RES, V22, P5973, DOI 10.1007/s00044-013-0584-6; Lefort S, 2014, AUTOPHAGY, V10, P2122, DOI 10.4161/15548627.2014.981788; Liang DH, 2016, CANCER LETT, V376, P249, DOI 10.1016/j.canlet.2016.04.002; Linder S, 2005, DRUG RESIST UPDATE, V8, P199, DOI 10.1016/j.drup.2005.06.004; Liu B., 2015, MED CHEM LOS ANGELES, V5, P255, DOI [DOI 10.4172/2161-0444.1000255, 10.4172/2161-0444.1000255]; Lu YY, 2014, AUTOPHAGY, V10, P1895, DOI 10.4161/auto.32200; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Manic G, 2014, MOL CELL ONCOL, V1, DOI 10.4161/mco.29911; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; McAfee Q, 2012, P NATL ACAD SCI USA, V109, P8253, DOI 10.1073/pnas.1118193109; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Morissette G, 2004, J PHARMACOL EXP THER, V310, P395, DOI 10.1124/jpet.104.066084; Mowers EE, 2017, ONCOGENE, V36, P1619, DOI 10.1038/onc.2016.333; Nadanaciva S, 2011, TOXICOL IN VITRO, V25, P715, DOI 10.1016/j.tiv.2010.12.010; OHKUMA S, 1981, J CELL BIOL, V90, P656, DOI 10.1083/jcb.90.3.656; Pal S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-553; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Peterson EA, 2011, BIOORG MED CHEM LETT, V21, P2064, DOI 10.1016/j.bmcl.2011.02.007; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Ramya PVS, 2018, EUR J MED CHEM, V143, P216, DOI 10.1016/j.ejmech.2017.11.010; Repnik U, 2010, MITOCHONDRION, V10, P662, DOI 10.1016/j.mito.2010.07.008; Rosenfeld MR, 2014, AUTOPHAGY, V10, P1359, DOI 10.4161/auto.28984; Shrivastava S, 2015, EXP MOL PATHOL, V98, P313, DOI 10.1016/j.yexmp.2015.03.031; Shrivastava S, 2014, APOPTOSIS, V19, P1148, DOI 10.1007/s10495-014-0991-2; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Thorburn AM, 2014, MOL PHARM, V114; Wang J, 2014, J BIOL CHEM, V289, P17163, DOI 10.1074/jbc.M114.558288; Welker ME, 2013, BIOORGAN MED CHEM, V21, P4063, DOI 10.1016/j.bmc.2013.04.083; Yaguchi SI, 2006, JNCI-J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; Zhao XJ, 2015, AUTOPHAGY, V11, P1849, DOI 10.1080/15548627.2015.1017185	61	24	24	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 24	2019	38	4					581	595		10.1038/s41388-018-0446-2	http://dx.doi.org/10.1038/s41388-018-0446-2			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HI6UB	30166591				2022-12-26	WOS:000456589800009
J	Hidaka, S; Oizumi, M				Hidaka, Shohei; Oizumi, Masafumi			Fast and exact search for the partition with minimal information loss	PLOS ONE			English	Article							CELL ASSEMBLIES; INTEGRATION	In analysis of multi-component complex systems, such as neural systems, identifying groups of units that share similar functionality will aid understanding of the underlying structures of the system. To find such a grouping, it is useful to evaluate to what extent the units of the system are separable. Separability or inseparability can be evaluated by quantifying how much information would be lost if the system were partitioned into subsystems, and the interactions between the subsystems were hypothetically removed. A system of two independent subsystems are completely separable without any loss of information while a system of strongly interacted subsystems cannot be separated without a large loss of information. Among all the possible partitions of a system, the partition that minimizes the loss of information, called the Minimum Information Partition (MIP), can be considered as the optimal partition for characterizing the underlying structures of the system. Although the MIP would reveal novel characteristics of the neural system, an exhaustive search for the MIP is numerically intractable due to the combinatorial explosion of possible partitions. Here, we propose a computationally efficient search to precisely identify the MIP among all possible partitions by exploiting the submodularity of the measure of information loss, when the measure of information loss is submodular. Submodularity is a mathematical property of set functions which is analogous to convexity in continuous functions. Mutual information is one such submodular information loss function, and is a natural choice for measuring the degree of statistical dependence between paired sets of random variables. By using mutual information as a loss function, we show that the search for MIP can be performed in a practical order of computational time for a reasonably large system (N = 100 similar to 1000). We also demonstrate that MIP search allows for the detection of underlying global structures in a network of nonlinear oscillators.	[Hidaka, Shohei] Japan Adv Inst Sci & Technol, Nomi, Ishikawa, Japan; [Oizumi, Masafumi] Araya Inc, Minato Ku, Tokyo, Japan; [Oizumi, Masafumi] RIKEN, Brain Sci Inst, Wako, Saitama, Japan	Japan Advanced Institute of Science & Technology (JAIST); RIKEN	Hidaka, S (corresponding author), Japan Adv Inst Sci & Technol, Nomi, Ishikawa, Japan.	shhidaka@jaist.ac.jp		Hidaka, Shohei/0000-0002-0583-3736	JSPS KAKENHI [JP 16H01609, JP 15KT0013]; CREST, Japan Science and Technology Agency; Araya Inc.	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Araya Inc.	Shohei Hidaka is supported by the JSPS KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas JP 16H01609 (https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-16H01609/) and for Scientific Research B (Generative Research Fields) JP 15KT0013 (https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15KT0013/). This joint work of the two authors was partially supported by CREST, Japan Science and Technology Agency. Araya Inc. provided support in the form of salaries for author MO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; We thank Ryota Kanai for his comments and discussions on earlier versions of this manuscript. This work was partially supported by CREST, Japan Science and Technology Agency, and by the JSPS KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas JP 16H01609 and for Scientific Research B (Generative Research Fields) JP 15KT0013.	Ay N, 2015, ENTROPY-SWITZ, V17, P2432, DOI 10.3390/e17042432; Balduzzi D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000091; Barrett AB, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001052; Burnham K P, 2003, MODEL SELECT MULTIMO; Carrillo-Reid L, 2016, SCIENCE, V353, P691, DOI 10.1126/science.aaf7560; Cover T. M., 1991, ELEMENTS INFORM THEO; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Humphries MD, 2011, J NEUROSCI, V31, P2321, DOI 10.1523/JNEUROSCI.2853-10.2011; Iwata S, 2008, MATH PROGRAM, V112, P45, DOI 10.1007/s10107-006-0084-2; Kaneko K, 1992, CHAOS, V2, P279, DOI 10.1063/1.165869; Kitazono J, 2018, ENTROPY-SWITZ, V20, DOI 10.3390/e20030173; Lopes-dos-Santos V, 2013, J NEUROSCI METH, V220, P149, DOI 10.1016/j.jneumeth.2013.04.010; Narasimhan M., 2006, ADV NEURAL INFORM PR, P979; Oizumi M, 2016, P NATL ACAD SCI USA, V113, P14817, DOI 10.1073/pnas.1603583113; Oizumi M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004654; Oizumi M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003588; Queyranne M, 1998, MATH PROGRAM, V82, P3, DOI 10.1007/BF01585863; Romano SA, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005526; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731; Tegmark M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005123; Toker D, 2016, ARXIV160501096; Tononi G, 2010, ARCH ITAL BIOL, V148, P299; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42	26	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0201126	10.1371/journal.pone.0201126	http://dx.doi.org/10.1371/journal.pone.0201126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204751	Green Submitted, Green Published, gold			2022-12-26	WOS:000444355500002
J	Yamamoto, Y; Miyazaki, S; Maruyama, K; Kobayashi, R; Le, MNT; Kano, A; Kondow, A; Fujii, S; Ohnuma, K				Yamamoto, Yuta; Miyazaki, Shota; Maruyama, Kenshiro; Kobayashi, Ryo; Minh Nguyen Tuyet Le; Kano, Ayumu; Kondow, Akiko; Fujii, Shuji; Ohnuma, Kiyoshi			Random migration of induced pluripotent stem cell-derived human gastrulation-stage mesendoderm	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CULTURE; DIFFERENTIATION; INDUCTION; CATENIN; GROWTH	Gastrulation is the initial systematic deformation of the embryo to form germ layers, which is characterized by the placement of appropriate cells in their destined locations. Thus, gastrulation, which occurs at the beginning of the second month of pregnancy, is a critical stage in human body formation. Although histological analyses indicate that human gastrulation is similar to that of other amniotes (birds and mammals), much of human gastrulation dynamics remain unresolved due to ethical and technical limitations. We used human induced pluripotent stem cells (hiPSCs) to study the migration of mesendodermal cells through the primitive streak to form discoidal germ layers during gastrulation. Immunostaining results showed that hiPSCs differentiated into mesendodermal cells and that epithelial-mesenchymal transition occurred through the activation of the Activin/Nodal and Wnt/beta-catenin pathways. Single-cell time-lapse imaging of cells adhered to cover glass showed that mesendodermal differentiation resulted in the dissociation of cells and an increase in their migration speed, thus confirming the occurrence of epithelial-mesenchymal transition. These results suggest that mesendodermal cells derived from hiPSCs may be used as a model system for studying migration during human gastrulation in vitro. Using random walk analysis, we found that random migration occurred for both undifferentiated hiPSCs and differentiated mesendodermal cells. Two-dimensional random walk simulation showed that homogeneous dissociation of particles may form a discoidal layer, suggesting that random migration might be suitable to effectively disperse cells homogeneously from the primitive streak to form discoidal germ layers during human gastrulation.	[Yamamoto, Yuta; Miyazaki, Shota; Kobayashi, Ryo; Minh Nguyen Tuyet Le; Kano, Ayumu; Ohnuma, Kiyoshi] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata, Japan; [Maruyama, Kenshiro; Ohnuma, Kiyoshi] Nagaoka Univ Technol, Dept Sci Technol Innovat, Nagaoka, Niigata, Japan; [Kondow, Akiko] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Biomed Polymer Sci, Toyoake, Aichi, Japan; [Fujii, Shuji] Nagaoka Univ Technol, Dept Mat Sci & Technol, Nagaoka, Niigata, Japan; [Fujii, Shuji] Hokkaido Univ, Grad Sch Engn, Div Appl Phys, Sapporo, Hokkaido, Japan	Nagaoka University of Technology; Nagaoka University of Technology; Fujita Health University; Nagaoka University of Technology; Hokkaido University	Ohnuma, K (corresponding author), Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata, Japan.; Ohnuma, K (corresponding author), Nagaoka Univ Technol, Dept Sci Technol Innovat, Nagaoka, Niigata, Japan.	kohnuma@vos.nagaokaut.ac.jp	Fujii, Shuji/H-5341-2013	Fujii, Shuji/0000-0003-1087-5647; Ohnuma, Kiyoshi/0000-0002-2272-3643; Le, Minh Nguyen Tuyet/0000-0002-3056-6019	AMED [JP17bk0104011h0005]; Kakenhi [25650049]; Japanese government scholarship (Ministry of Education, Culture, Sports, Science and Technology)	AMED(Japan Agency for Medical Research and Development (AMED)); Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese government scholarship (Ministry of Education, Culture, Sports, Science and Technology)	This work was supported in part by a grant AMED (JP17bk0104011h0005) and Grants-in-Aid for Scientific Research (Kakenhi: 25650049) to KO, and Japanese government scholarship (Ministry of Education, Culture, Sports, Science and Technology) for foreign students who study in higher education institutions MNTL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Barbaric I, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.006; Belle M, 2017, CELL, V169, DOI 10.1016/j.cell.2017.03.008; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Ferrer-Vaquer A, 2013, WIRES DEV BIOL, V2, P427, DOI 10.1002/wdev.97; Funa NS, 2015, CELL STEM CELL, V16, P639, DOI 10.1016/j.stem.2015.03.008; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Hayashi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014099; HERSH R, 1969, SCI AM, V220, P67; Ichikawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064506; Kakutani S., 1944, P IMP ACAD TOKYO, V20, P706; Kinehara M, 2014, STEM CELLS DEV, V23, P2180, DOI 10.1089/scd.2013.0424; Lee MR, 2010, STEM CELLS, V28, P1550, DOI 10.1002/stem.490; Moore K. L., 2016, DEV HUMAN; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ninomiya H, 2015, IN VITRO CELL DEV-AN, V51, P1, DOI 10.1007/s11626-014-9801-y; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Ohnuma K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04646; Pezeron G, 2008, CURR BIOL, V18, P276, DOI 10.1016/j.cub.2008.01.028; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Suga M, 2016, IN VITRO CELL DEV, V53, P83; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Takagi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002648; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ullmann U, 2007, MOL HUM REPROD, V13, P21, DOI 10.1093/molehr/gal091; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xing JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep10038; Yoshimitsu R, 2014, BIOTECHNOL BIOENG, V111, P937, DOI 10.1002/bit.25150	32	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2018	13	9							e0201960	10.1371/journal.pone.0201960	http://dx.doi.org/10.1371/journal.pone.0201960			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7DK	30199537	Green Published, Green Submitted, gold			2022-12-26	WOS:000444681100004
J	Wang, J; He, ZT; Zheng, GQ; Gao, S; Zhao, KX				Wang, Jun; He, Zhitao; Zheng, Guoqiang; Gao, Song; Zhao, Kaixuan			Development and validation of an ensemble classifier for real-time recognition of cow behavior patterns from accelerometer data and location data	PLOS ONE			English	Article							SYSTEM; ALGORITHM; SENSOR	Behaviors are important indicators for assessing the health and well-being of dairy cows. The aim of this study is to develop and validate an ensemble classifier for automatically measuring and distinguishing several behavior patterns of dairy cows from accelerometer data and location data. The ensemble classifier consists of two parts, our new Multi-BP-Ada-Boost algorithm and a data fusion method based on D-S evidence theory. We identify seven behavior patterns: feeding, lying, standing, lying down, standing up, normal walking, and active walking. Accuracy, sensitivity, and precision were used to validate classification performance. The Multi-BP-AdaBoost algorithm performed well when identifying lying (92% accuracy, 93% sensitivity, 82% precision), lying down (99%, 82%, 86%), standing up (99%, 74%, 85%), normal walking (97%, 92%, 86%), and active walking (99%, 94%, 89%). Its results were poor for feeding (80%, 52%, 55%) and standing (80%, 46%, 58%), which are difficult to differentiate using a leg-mounted sensor. Position data made it possible to differentiate feeding and standing. The D-S evidence fusion method for combining accelerometer data and location data in classification was used to fuse two pieces of basic behavior-related evidence into a single estimation model. With this addition, the sensitivity and precision of the two difficult behaviors increased by approximately 20 percentage points. In conclusion, the classification results indicate that the ensemble classifier effectively recognizes various behavior patterns in dairy cows. However, further work is needed to study the robustness of the feature and model by increasing the number of cows enrolled in the trial.	[Wang, Jun] Henan Univ Sci & Technol, Postdoctoral Res Stn Control Sci & Engn, Luoyang, Henan, Peoples R China; [Wang, Jun; He, Zhitao; Gao, Song; Zhao, Kaixuan] Henan Univ Sci & Technol, Coll Agr Equipment Engn, Luoyang, Henan, Peoples R China; [Zheng, Guoqiang] Henan Univ Sci & Technol, Coll Informat Engn, Luoyang, Henan, Peoples R China	Henan University of Science & Technology; Henan University of Science & Technology; Henan University of Science & Technology	Wang, J (corresponding author), Henan Univ Sci & Technol, Postdoctoral Res Stn Control Sci & Engn, Luoyang, Henan, Peoples R China.; Wang, J (corresponding author), Henan Univ Sci & Technol, Coll Agr Equipment Engn, Luoyang, Henan, Peoples R China.	wangjun_haust@163.com	Wang, Jun/AFU-3920-2022	Zheng, Guoqiang/0000-0002-4682-4190	National Natural Science Foundation of China [61771184]; Key Research Project of Education Bureau of Henan Province, China [17A416002]; Key Scientific and Technological Project of Henan Province, China [172102210040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Project of Education Bureau of Henan Province, China; Key Scientific and Technological Project of Henan Province, China	This study was supported by the National Natural Science Foundation of China (Grant No. 61771184, http://www.nsfc.gov.cn/), Key Research Project of Education Bureau of Henan Province, China (Grant No. 17A416002, http://www.haedu.gov.cn/2016/07/05/1467700050775.html) and Key Scientific and Technological Project of Henan Province, China (Grant No. 172102210040, http://www.hnkjt.gov.cn/2016/09/09/1473417379451.html). All of the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaaod M, 2015, J DAIRY SCI, V98, P6236, DOI 10.3168/jds.2015-9657; Arcidiacono C, 2017, COMPUT ELECTRON AGR, V134, P124, DOI 10.1016/j.compag.2017.01.021; Arcidiacono C, 2017, BIOSYST ENG, V153, P99, DOI 10.1016/j.biosystemseng.2016.11.003; Borchers MR, 2016, J DAIRY SCI, V99, P7458, DOI 10.3168/jds.2015-10843; DEMPSTER AP, 1967, ANN MATH STAT, V38, P325, DOI 10.1214/aoms/1177698950; Diosdado J. A. V., 2015, ANIM BIOTELEM, V3, P1, DOI 10.1186/S40317-015-0045-8; Freund Y., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P148; Gaber T, 2016, COMPUT ELECTRON AGR, V122, P55, DOI 10.1016/j.compag.2015.12.022; Huhtala A, 2007, BIOSYST ENG, V96, P399, DOI 10.1016/j.biosystemseng.2006.11.013; [吕雁飞 Lv Yanfei], 2015, [高技术通讯, Chinese High Technology Letters], V25, P437; Mardini W, 2016, PEER PEER NETW APPL, V9, P991, DOI 10.1007/s12083-015-0370-y; Martiskainen P, 2009, APPL ANIM BEHAV SCI, V119, P32, DOI 10.1016/j.applanim.2009.03.005; Mathanker SK, 2011, COMPUT ELECTRON AGR, V77, P60, DOI 10.1016/j.compag.2011.03.008; Moreau M, 2009, APPL ANIM BEHAV SCI, V119, P158, DOI 10.1016/j.applanim.2009.04.008; Muller R, 2003, APPL ANIM BEHAV SCI, V83, P247, DOI 10.1016/S0168-1591(03)00141-2; Noor MHM, 2016, KNOWL-BASED SYST, V114, P47, DOI 10.1016/j.knosys.2016.09.028; O'DriScoll K, 2008, APPL ANIM BEHAV SCI, V111, P195, DOI 10.1016/j.applanim.2007.05.014; Palmer MA, 2012, APPL ANIM BEHAV SCI, V140, P121, DOI 10.1016/j.applanim.2012.06.005; Parker M, 2017, J VET BEHAV, V21, P13, DOI 10.1016/j.jveb.2017.06.003; Porto SMC, 2014, COMPUT ELECTRON AGR, V108, P221, DOI 10.1016/j.compag.2014.08.001; Robert B, 2009, COMPUT ELECTRON AGR, V67, P80, DOI 10.1016/j.compag.2009.03.002; SEIDEL SY, 1992, IEEE T ANTENN PROPAG, V40, P207, DOI 10.1109/8.127405; Shafer G.A., 1976, MATH THEORY EVIDENCE; Shafer G, 2016, INT J APPROX REASON, V79, P26, DOI 10.1016/j.ijar.2015.12.009; Shahriar MS, 2016, COMPUT ELECTRON AGR, V128, P20, DOI 10.1016/j.compag.2016.08.009; Song MX, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016673291; Yuan KJ, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010113; Zehner N, 2017, COMPUT ELECTRON AGR, V136, P31, DOI 10.1016/j.compag.2017.02.021; Zhu J, 2009, STAT INTERFACE, V2, P349; Zhu S, 2000, IEEE T IMAGE PROCESS, V9, P287, DOI 10.1109/83.821744	30	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203546	10.1371/journal.pone.0203546	http://dx.doi.org/10.1371/journal.pone.0203546			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192834	Green Submitted, Green Published, gold			2022-12-26	WOS:000444093600099
J	Meyer, HJ; Purz, S; Sabri, O; Surov, A				Meyer, Hans-Jonas; Purz, Sandra; Sabri, Osama; Surov, Alexey			Relationships between histogram analysis of ADC values and complex 18F-FDG-PET parameters in head and neck squamous cell carcinoma	PLOS ONE			English	Article							APPARENT DIFFUSION-COEFFICIENT; MRI; ASSOCIATIONS; PET/CT	Purpose Histogram analysis is an emergent imaging technique to further analyze radiological images and to obtain imaging biomarker. In head and neck cancer, MRI and PET are routinely used in clinical practice. The aim of this study was to analyze associations between histogram based ADC parameters and complex FDG-PET derived parameters in head and neck squamous cell carcinoma (HNSCC). Methods 34 patients (26% female, mean age, 56.7 +/- 10.2 years) with primary HNSCC were prospectively included into the study. ADC histogram parameters were calculated by inhouse made matlab software using a whole lesion measurement. For each tumor, maximum and mean standardized uptake values (SUVmax, SUVmean), Total Lesion Glycolysis (TLG) and Metabolic Tumor Volume (MTV) were determined on PET-images. Spearman's correlation coefficient (rho) was used to analyze associations between investigated parameters. Benjamini-Hochberg correction was used to adjust for multiple testing. Mann-Whitney test was used for group discrimination. P-values < 0.05 were taken to indicate statistical significance. Results The correlation analysis in the whole tumor group revealed a statistically significant correlation between entropy and MTV as well as TLG (rho = 0.67, P < 0.0001 and rho = 0.61, P = 0.0002 respectively). There were statistically significant differences between T1/2 and T3/4 tumors in the following parameters: entropy (2.07 +/- 0.36 vs 2.61 +/- 0.43, P = 0.007), SUVmax (10.79 +/- 4.13 vs 17.93 +/- 5.89, P = 0.007), SUVmean (6.39 +/- 2.48 vs 9.81 +/- 4.49, P = 0.01), SUVmin (4.09 +/- 1.57 vs 6.34 +/- 2.59, P = 0.03), MTV (9.50 +/- 7.92 vs 20.36 +/- 13.30, P = 0.02), TGU (55.97 +/- 39.09 vs 212.3 +/- 186.3, P = 0.002). Conclusion This study showed that entropy derived from ADC maps is strongly associated with MTV and TLG in HNSCC. Entropy, SUVmax, SUVmean, TLG and MTV were statistically significant higher in T3/4 tumors in comparison to T1/2 carcinomas.	[Meyer, Hans-Jonas; Surov, Alexey] Univ Leipzig, Dept Diagnost & Intervent Radiol, Leipzig, Germany; [Purz, Sandra; Sabri, Osama] Univ Leizig, Dept Nucl Med, Leipzig, Germany	Leipzig University	Meyer, HJ (corresponding author), Univ Leipzig, Dept Diagnost & Intervent Radiol, Leipzig, Germany.	Hans-jonas.meyer@medizin.uni-leipzig.de		Sabri, Osama/0000-0002-6425-3504				Choi SH, 2011, J NUCL MED, V52, P1056, DOI 10.2967/jnumed.111.089334; Covello M, 2015, EUR J RADIOL, V84, P1269, DOI 10.1016/j.ejrad.2015.04.010; Fruehwald-Pallamar J, 2011, EUR J NUCL MED MOL I, V38, P1009, DOI 10.1007/s00259-010-1718-4; Galgano SJ, 2018, MAGN RESON IMAGING C, V26, P167, DOI 10.1016/j.mric.2017.08.010; Gawlitza M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134749; Guan Y, 2016, ACAD RADIOL, V23, P1559, DOI 10.1016/j.acra.2016.08.010; Guizard AVN, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007285; Han M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002141; Hoshikawa H, 2017, ANN NUCL MED, V31, P63, DOI 10.1007/s12149-016-1131-6; Just N, 2014, BRIT J CANCER, V111, P2205, DOI 10.1038/bjc.2014.512; Kaida H, 2016, EUR J RADIOL, V85, P1804, DOI 10.1016/j.ejrad.2016.08.007; Leifels L, 2017, CONTRAST MEDIA MOL I, DOI 10.1155/2017/5369625; Li QF, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008084; Liu LH, 2017, J MAGN RESON IMAGING, V45, P1798, DOI 10.1002/jmri.25460; Liu S, 2018, J MAGN RESON IMAGING, V47, P168, DOI 10.1002/jmri.25752; Meyer HJ, 2018, MAGN RESON IMAGING, V45, P72, DOI 10.1016/j.mri.2017.09.015; Nakajo M, 2012, CLIN NUCL MED, V37, P475, DOI 10.1097/RLU.0b013e318248524a; Preda L, 2016, EUR RADIOL, V26, P4432, DOI 10.1007/s00330-016-4284-8; Schob S, 2017, MOL IMAGING BIOL, V19, P953, DOI 10.1007/s11307-017-1073-y; Shen GH, 2017, NUCL MED COMMUN, V38, P1076, DOI 10.1097/MNM.0000000000000746; Shindo T, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002574; Surov A, 2017, ONCOTARGET, V8, P75434, DOI 10.18632/oncotarget.20406; Surov A, 2017, ONCOTARGET, V8, P59492, DOI 10.18632/oncotarget.17752; Surov A, 2016, ORAL ONCOL, V58, P14, DOI 10.1016/j.oraloncology.2016.04.009; van der Hoorn A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177986; Varoquaux A, 2013, EUR J NUCL MED MOL I, V40, P842, DOI 10.1007/s00259-013-2351-9	26	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0202897	10.1371/journal.pone.0202897	http://dx.doi.org/10.1371/journal.pone.0202897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188926	Green Published, gold, Green Submitted			2022-12-26	WOS:000444228700014
J	Dibao-Dina, C; Angoulvant, D; Lebeau, JP; Peurois, JE; El Hirtsi, KA; Lehr-Drylewicz, AM				Dibao-Dina, Clarisse; Angoulvant, Denis; Lebeau, Jean-Pierre; Peurois, Jean-Eudes; El Hirtsi, Karim Abdallah; Lehr-Drylewicz, Anne-Marie			Patients' adherence to optimal therapeutic, lifestyle and risk factors recommendations after myocardial infarction: Six years follow-up in primary care	PLOS ONE			English	Article							FRENCH FAST-MI; MORTALITY; GUIDELINES; DISEASE	Background The 20% observed mortality within 5 years among survivors of myocardial infarction may be explained in part by non-adherence to the recommended treatment over the long term. Main objective To investigate post-myocardial infarction patients' adherence to the therapeutic, lifestyle and risk factor control recommendations of the French health authority over 6 years. Materials and methods A cohort of survivors of myocardial infarction established in Tours in 2009 was followed over 6 years. The general practitioner of the patients included in the first 1-year follow-up study was contacted to collect data on treatments, cardiovascular risk factors and lifestyle between January and June 2015. Data were described and compared with the recommendations and predictors of achieving all the recommended targets were determined. Results A total of 97 patients (52%) among the 185 patients who underwent a coronary angioplasty for MI were included at baseline. Treatment was adapted by the general practitioner on the advice on the cardiologist for 75% (73/97) patients, by both of them for 12% (12/97) and by the general practitioner alone for 7% (7/97) patients. Among the 97 initial patients, 62 were included in the final analysis at 6 years. Fatal events rate was 5% (5/97) at 1 year and 12% (11/91) at 6 years. Non-fatal events rate was 44% (43/97) at 6 months, 19% (17/91) at 1 year and 29% (18/62) at 6 years. Six years after the myocardial infarction, 6 (10%) patients achieved the recommended targets in terms of prescriptions of treatment, risk factors and lifestyle targets. Exposure to a cardiac rehabilitation program after a myocardial infarction was associated with long-term achievement of optimal therapeutic objectives (OR = 7.31 [95% CI 1.74; 44.88], p<0.002). Conclusion Our data show suboptimal long-term adherence to secondary prevention treatment in this high-risk population of survivors of myocardial infarction, which seems to be improved in patients exposed to a cardiac rehabilitation program.	[Dibao-Dina, Clarisse] Univ Tours, Gen Practice Dept, Tours, France; [Dibao-Dina, Clarisse] Univ Tours, INSERM SPHERE U1246, Tours, France; [Angoulvant, Denis] Univ Tours, Tours Univ Hosp, Cardiol Dept, Tours, France; [Angoulvant, Denis] Univ Tours, Tours Univ Hosp, EA4245, Tours, France; [Lebeau, Jean-Pierre; Peurois, Jean-Eudes; El Hirtsi, Karim Abdallah; Lehr-Drylewicz, Anne-Marie] Univ Tours, Gen Practice Dept, Tours, France; [Lebeau, Jean-Pierre; Peurois, Jean-Eudes; El Hirtsi, Karim Abdallah; Lehr-Drylewicz, Anne-Marie] Univ Tours, EA EES, Tours, France; [Dibao-Dina, Clarisse; Lebeau, Jean-Pierre; Peurois, Jean-Eudes; El Hirtsi, Karim Abdallah; Lehr-Drylewicz, Anne-Marie] Gen Practicice Dept, Tours, France; [Angoulvant, Denis] Cardiol Dept, Tours, France	Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Universite de Tours; CHU Tours; Universite de Tours; Universite de Tours; Universite de Tours	Dibao-Dina, C (corresponding author), Univ Tours, Gen Practice Dept, Tours, France.; Dibao-Dina, C (corresponding author), Univ Tours, INSERM SPHERE U1246, Tours, France.; Dibao-Dina, C (corresponding author), Gen Practicice Dept, Tours, France.	clarisse.dibao-dina@univ-tours.fr	Lebeau, Jean-Pierre/N-3497-2019; Angoulvant, Denis/Q-9743-2019	Lebeau, Jean-Pierre/0000-0002-6847-999X; Angoulvant, Denis/0000-0003-0788-8092; dibao-dina, clarisse/0000-0002-1750-2846				Amann U, 2018, EUR J INTERN MED, V47, P62, DOI 10.1016/j.ejim.2017.08.011; Aronson J., 2015, BMJ, V351, DOI [10.1136/bmj.h3521, DOI 10.1136/BMJ.H4672, DOI 10.1136/BMJ.H3521]; Ayanian JZ, 2002, NEW ENGL J MED, V347, P1678, DOI 10.1056/NEJMsa020080; Ergatoudes C, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0400-6; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Fox KAA, 2010, EUR HEART J, V31, P2755, DOI 10.1093/eurheartj/ehq326; Goss F, 2017, VASC HEALTH RISK MAN, V13, P127, DOI 10.2147/VHRM.S119490; Haute Autorite A de Sante, 2016, PROGR 2007 2010 ENS; Ibanez B, 2017, EUR HEART J, V2018, P119, DOI DOI 10.1093/EURHEARTJ/EHX393; Johnston N, 2016, AM HEART J, V178, P85, DOI 10.1016/j.ahj.2016.05.005; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Nunes S, 2016, ASIAN NURS RES, V10, P150, DOI 10.1016/j.anr.2016.03.005; Pouche M, 2016, ARCH CARDIOVASC DIS, V109, P178, DOI 10.1016/j.acvd.2015.09.009; Puymirat E, 2014, INT J CARDIOL, V177, P281, DOI 10.1016/j.ijcard.2014.09.023; Radzimanowski M, 2018, INT J CARDIOL, V251, P1, DOI 10.1016/j.ijcard.2017.10.048; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Tuppin P, 2010, ARCH CARDIOVASC DIS, V103, P363, DOI 10.1016/j.acvd.2010.05.003	17	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0202986	10.1371/journal.pone.0202986	http://dx.doi.org/10.1371/journal.pone.0202986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180180	gold, Green Published, Green Submitted			2022-12-26	WOS:000444222400022
J	Mathew, S; Al Thani, AA; Yassine, HM				Mathew, Shilu; Al Thani, Asmaa A.; Yassine, Hadi M.			Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors	PLOS ONE			English	Article							AROMATIC-AROMATIC INTERACTIONS; EPIGALLOCATECHIN-3-GALLATE EGCG; FLAVONOID QUERCETIN; IN-VITRO; VIRUS; ANTIBODY; DELIVERY; NANOPARTICLES; VIVO; STRATEGIES	Background With the emergence of new influenza virus strains that are resistant to current inhibitors such as oseltamivir (anti-neuraminidase (NA)) and amantadine (anti-M2 proton channel), influenza A viruses continue to be a serious threat to the public health worldwide. With this in view, there is a persistent need for the development of broader and more effective vaccines and therapeutics. Identification of broadly neutralizing antibodies (bNAbs) that recognize relatively invariant structures on influenza haemagglutinin (HA) stem has invigorated efforts to develop universal influenza vaccines. Aim The current computational study is designed to identify potential flavonoid inhibitors that bind to the contact epitopes of HA stem that are targeted by broadly neutralizing antibodies (bNAb). Method In this study, we utilized the three-dimensional crystallographic structure of different HA sub-types (H1, H2, H5, H3, and H7) in complex with bNAb to screen for potential broadly reactive influenza inhibitors. We performed Quantitative Structure-Activity and Relationship (QSAR) for 100 natural compounds known for their antiviral activity and performed molecular docking using AutoDock 4.2 suite. Furthermore, we conducted virtual screening of 1413 bioassay hit compounds by using virtual lab bench CLC Drug Discovery. Results The results showed 18 lead flavonoids with strong binding abilities to bNAb epitopes of various HA subtypes. These 18 broadly reactive compounds exhibited significant interactions with an average of seven Hbonds, docking energy of -22.43 kcal.mol(-1), and minimum interaction energy of -4.65 kcal.mol(-1), with functional contact residues. Procyanidin depicted strong interactions with group 1 HAs, whereas both sorbitol and procyanidin exhibited significant interactions with group 2 HAs. Conclusion Using in silico docking analysis, we identified 18 bioactive flavonoids with potential strong binding cababilities to influenza HA-stems of various subtypes, which are the target for bNAb. The virtual screened bioassay hit compounds depicted a high number of Hbonds but low interaction and docking values compared to antiviral flavonoids. Using structure-based design and nanotechnology-based approaches, identified molecules could be modified to generate next generation anti-influenza drugs.	[Mathew, Shilu; Al Thani, Asmaa A.; Yassine, Hadi M.] Qatar Univ, Biomed Res Ctr, Doha, Qatar; [Al Thani, Asmaa A.; Yassine, Hadi M.] Qatar Univ, Coll Hlth Sci, Doha, Qatar	Qatar University; Qatar University	Yassine, HM (corresponding author), Qatar Univ, Biomed Res Ctr, Doha, Qatar.; Yassine, HM (corresponding author), Qatar Univ, Coll Hlth Sci, Doha, Qatar.	hyassine@qu.edu.qa	YASSINE, HADI M./AAW-6475-2020	YASSINE, HADI M./0000-0001-7592-2788				Adebayo AA, 1998, BIOLOGICALS, V26, P309, DOI 10.1006/biol.1998.0157; Air GM, 2015, CURR OPIN VIROL, V11, P113, DOI 10.1016/j.coviro.2015.03.006; Anderson AC, 2003, CHEM BIOL, V10, P787, DOI 10.1016/j.chembiol.2003.09.002; [Anonymous], 2015, ACD STRUCT EL VERS 1; Atta-ur-Rahman, 2014, STUDIES NATURAL PROD; Balentine DA, 2015, AM J CLIN NUTR, V101, P1113, DOI 10.3945/ajcn.113.071274; Bang S, 2017, NAT PROD RES, V15, P1; Chen YS, 2015, ACS APPL MATER INTER, V7, P534, DOI 10.1021/am5066893; Cleves AE, 2017, J COMPUT AID MOL DES, V31, P419, DOI 10.1007/s10822-017-0015-8; Corbeil CR, 2012, J COMPUT AID MOL DES, V26, P775, DOI 10.1007/s10822-012-9570-1; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743; Derksen A, 2016, J ETHNOPHARMACOL, V188, P144, DOI 10.1016/j.jep.2016.05.016; Derksen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110089; do Nascimento TG, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1517-3; Dreyfus C, 2013, J VIROL, V87, P7149, DOI 10.1128/JVI.02975-12; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Duopeng An JL, 2017, VIROLOGY MYCOLOGY, V6; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Ertl P, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-1; Espinoza-Fonseca LM, 2008, BIOCHEM BIOPH RES CO, V370, P547, DOI 10.1016/j.bbrc.2008.03.053; Fatma S, 2016, DRUG DELIV, V23, P500, DOI 10.3109/10717544.2014.923956; Ferry DR, 1996, CLIN CANCER RES, V2, P659; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Gauto DF, 2011, CARBOHYD RES, V346, P939, DOI 10.1016/j.carres.2011.02.016; Ghamali M, 2016, J TAIBAH UNIV SCI, V10, P534, DOI 10.1016/j.jtusci.2015.09.006; Ghosh S, 2011, FREE RADICAL BIO MED, V51, P1893, DOI 10.1016/j.freeradbiomed.2011.08.019; Graham AC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00238; Gunasekaran Thirumurugan, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS1, DOI 10.12980/APJTB.4.2014C980; Halgren TA, 1998, J COMPUT CHEM, V17, P553; Hussain M, 2017, INFECT DRUG RESIST, V10, P121, DOI 10.2147/IDR.S105473; Hussain MS, 2012, J PHARM BIOALLIED SC, V4, P10, DOI 10.4103/0975-7406.92725; Kimmel EM, 2011, ANTIVIR RES, V90, P80, DOI 10.1016/j.antiviral.2011.02.011; Lani R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11421; Lanzarotti E, 2011, J CHEM INF MODEL, V51, P1623, DOI 10.1021/ci200062e; Leonarduzzi G, 2010, CURR MED CHEM, V17, P74, DOI 10.2174/092986710789957760; Macedo AS, 2014, PHARM DEV TECHNOL, V19, P677, DOI 10.3109/10837450.2013.823989; Madaan K, 2016, DRUG DELIV, V23, P254, DOI 10.3109/10717544.2014.910564; Malosh RE, 2017, CLIN INFECT DIS OFFI; Mercader AG, 2010, EUR J MED CHEM, V45, P1724, DOI 10.1016/j.ejmech.2010.01.005; Mereles D, 2011, INT J MOL SCI, V12, P5592, DOI 10.3390/ijms12095592; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nakamura G, 2013, CELL HOST MICROBE, V14, P93, DOI 10.1016/j.chom.2013.06.004; Orhan DD, 2010, MICROBIOL RES, V165, P496, DOI 10.1016/j.micres.2009.09.002; Panche AN, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.41; Ramezanpour B, 2016, DISRUPTIVE INNOVATIO; SANTOS E, 1989, FASEB J, V3, P2151, DOI 10.1096/fasebj.3.10.2666231; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Scorza FB, 2016, VACCINE, V34, P2926, DOI 10.1016/j.vaccine.2016.03.085; Sesso HD, 2003, J NUTR, V133, P2336, DOI 10.1093/jn/133.7.2336; Shahat AA, 1998, PHYTOMEDICINE, V5, P133, DOI 10.1016/S0944-7113(98)80010-X; Shriver Z, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00315; Shtyrya YA, 2009, ACTA NATURAE, V1, P26, DOI 10.32607/20758251-2009-1-2-26-32; Song RJ, 2015, J CHROMATOGR B, V995, P8, DOI 10.1016/j.jchromb.2015.05.019; Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thakur N, 2012, NUCLEIC ACIDS RES, V40, pW199, DOI 10.1093/nar/gks450; Vainio MJ, 2007, J CHEM INF MODEL, V47, P2462, DOI 10.1021/ci6005646; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Webster RG, 2014, ANN NY ACAD SCI, V1323, P115, DOI 10.1111/nyas.12462; Whitley R, 2015, ANTIVIR THER, V20, P709, DOI 10.3851/IMP2874; Wu WJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010006; Wu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8708; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927; Yen HL, 2016, CURR OPIN VIROL, V18, P126, DOI 10.1016/j.coviro.2016.05.004	67	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0203148	10.1371/journal.pone.0203148	http://dx.doi.org/10.1371/journal.pone.0203148			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180218	gold, Green Published, Green Submitted			2022-12-26	WOS:000444222400029
J	Shi, CH; Ulke-Lemee, A; Deng, JT; Batulan, Z; O'Brien, ER				Shi, Chunhua; Ulke-Lemee, Annegret; Deng, Jingti; Batulan, Zarah; O'Brien, Edward R.			Characterization of heat shock protein 27 in extracellular vesicles: a potential anti-inflammatory therapy	FASEB JOURNAL			English	Article						exosomes; HSP27; inflammation; mass spectrometry; TEM	CELL-DERIVED EXOSOMES; PROTEOMIC APPROACH; HEAT-SHOCK-PROTEIN-27; EXPRESSION; BIOMARKER; PLAQUES; ATHEROSCLEROSIS	Previously, we reported that elevated serum levels of heat shock protein 27 (HSP27) are predictive of a lower risk of having a heart attack, stroke, or death from cardiovascular disease. Moreover, augmenting HSP27 (or the murine ortholog, HSP25) attenuated experimental atherogenesis, reduced inflammation, and lowered cholesterol levels. Recently, we noted that HSP27 activates NF-B via TLR-4, resulting in attenuation of plaque inflammation; however, the precise anti-atherosclerosis mechanisms mediated by extracellular HSP27 are incompletely understood. Our purpose in this study was to investigate the existence of HSP27 in extracellular vesicles (EVs) and whether HSP27 elicited atheroprotective effects on target cells. Here, we provide evidence that HSP27 localizes to EVs derived from THP-1 cells using transmission electron microscopy (TEM) and immunogold labeling, Western blotting, ELISA, and fluorescence-activated cell sorting. TEM imaging indicated that HSP27 is found at the exosomal membrane. Multiple reactor monitor-mass spectrometric analysis of large vesicles, which included microparticles and exosomes, isolated from human plasma, also led to detection of HSP27 using the unique signature peptide, R.LFDQAFGLPR.L. Studies using THP-1 and human embryonic kidney cells show that HSP27-laden exosomes significantly stimulated NF-B activation (P < 0.001) and release of IL-10 (P < 0.0001), suggesting that HSP27 may be important exosomal cargo with beneficial anti-inflammatory effects.Shi, C., Ulke-Lemee, A., Deng, J., Batulan, Z., O'Brien, E. R. Characterization of heat shock protein 27 in extracellular vesicles: a potential anti-inflammatory therapy.	[Shi, Chunhua; Ulke-Lemee, Annegret; Deng, Jingti; Batulan, Zarah; O'Brien, Edward R.] Univ Calgary, Dept Cardiac Sci, Libin Cardiovasc Inst Alberta, Cumming Sch Med, Calgary, AB, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary	O'Brien, ER (corresponding author), Univ Calgary, Dept Cardiac Sci, Libin Cardiovasc Inst Alberta, Hlth Res & Innovat Ctr,Cumming Sch Med, Room GAA16,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	ermobrie@ucalgary.ca			Canadian Vascular Network; Canadian Institutes of Health Research Project [PJT-149015]; Heart and Stroke Foundation of Canada [G-13-0001599]	Canadian Vascular Network; Canadian Institutes of Health Research Project(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	The authors gratefully acknowledge the contributions of Dr. Wei-Xiang Dong (Microscopy and Imaging Facility, University of Calgary, Calgary, AB, Canada) for his technical expertise and assistance involving transmission electron microscopy, Dr. Adijiang Ayinuer (currently at University of Alberta, Edmonton, AB, Canada) for her technical expertise in generating the HSP27 knockdown THP-1 cell line, Dr. Justin McDonald (Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada) for his support and advice related to the MRM-MS method, and Dr. Yong Xiang Chen (Department of Cardiac Sciences, University of Calgary, Calgary, AB, Canada) for helpful discussions. This manuscript was supported by research grants to E.R.O. from the Canadian Vascular Network, a Canadian Institutes of Health Research Project grant (PJT-149015) and a Heart and Stroke Foundation of Canada grant (G-13-0001599). The authors declare no conflicts of interest.	Arrigo AP, 2017, CELL STRESS CHAPERON, V22, P517, DOI 10.1007/s12192-017-0765-1; Batulan Z, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00285; Bavisotto CC, 2017, EXPERT REV MOL DIAGN, V17, P815, DOI 10.1080/14737159.2017.1356230; Boulanger CM, 2017, NAT REV CARDIOL, V14, P259, DOI 10.1038/nrcardio.2017.7; Braga-Lagache S, 2016, MOL CELL PROTEOMICS, V15, P3640, DOI 10.1074/mcp.M116.060491; Charmpilas N, 2017, CELL STRESS CHAPERON, V22, P481, DOI 10.1007/s12192-016-0761-x; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Coumans FAW, 2017, CIRC RES, V120, P1632, DOI 10.1161/CIRCRESAHA.117.309417; Cruz L, 2018, STEM CELL REV REP, V14, P262, DOI 10.1007/s12015-017-9776-7; Cuerrier CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055867; DENG JT, 1988, CLIN CHIM ACTA, V176, P291; Deng JT, 1996, HEPATOLOGY, V23, P445; Gupta S, 2007, AM J PHYSIOL-HEART C, V292, pH3052, DOI 10.1152/ajpheart.01355.2006; Lepedda AJ, 2009, ATHEROSCLEROSIS, V203, P112, DOI 10.1016/j.atherosclerosis.2008.07.001; Liang WZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26231; Lou NJ, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/3918681; Ma XL, 2014, FASEB J, V28, P594, DOI 10.1096/fj.13-230417; Martin-Ventura JL, 2004, CIRCULATION, V110, P2216, DOI 10.1161/01.CIR.0000136814.87170.B1; Merchant ML, 2017, NAT REV NEPHROL, V13, P731, DOI 10.1038/nrneph.2017.148; Miller H, 2005, ARTERIOSCL THROM VAS, V25, pE10, DOI 10.1161/01.ATV.0000156536.89752.8e; Nguyen MA, 2018, ARTERIOSCL THROM VAS, V38, P49, DOI 10.1161/ATVBAHA.117.309795; Park HK, 2006, CIRCULATION, V114, P886, DOI 10.1161/CIRCULATIONAHA.105.541219; Phuyal S, 2014, FEBS J, V281, P2214, DOI 10.1111/febs.12775; Raizman JE, 2013, BBA-MOL CELL BIOL L, V1831, P1721, DOI 10.1016/j.bbalip.2013.07.015; Rayner K, 2009, ARTERIOSCL THROM VAS, V29, P1751, DOI 10.1161/ATVBAHA.109.193656; Salari S, 2013, CELL STRESS CHAPERON, V18, P53, DOI 10.1007/s12192-012-0356-0; Seibert TA, 2013, J AM COLL CARDIOL, V62, P1446, DOI 10.1016/j.jacc.2013.05.041; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Sun AL, 2012, DIABETES VASC DIS RE, V9, P301, DOI 10.1177/1479164111434318; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602; Venu VKP, 2017, FASEB J, V31, P2364, DOI 10.1096/fj.201601188R; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Waldenstrom A, 2014, CIRC RES, V114, P315, DOI 10.1161/CIRCRESAHA.114.300584; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	36	30	30	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1617	1630		10.1096/fj.201800987R	http://dx.doi.org/10.1096/fj.201800987R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30188755				2022-12-26	WOS:000457296600010
J	Garcia-Cazorla, Y; Getino, M; Sanabria-Rios, DJ; Carballeira, NM; de la Cruz, F; Arechaga, I; Cabezon, E				Garcia-Cazorla, Yolanda; Getino, Maria; Sanabria-Rios, David J.; Carballeira, Nestor M.; de la Cruz, Fernando; Arechaga, Ignacio; Cabezon, Elena			Conjugation inhibitors compete with palmitic acid for binding to the conjugative traffic ATPase TrwD, providing a mechanism to inhibit bacterial conjugation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; ATPase; drug design; bacterial conjugation; secretion; antibiotic resistance; ATPase inhibitors; bacterial conjugation; drug design; type IV secretion system	IV SECRETION APPARATUS; FATTY-ACIDS; MOLECULAR MOTORS; PLASMID R388; VIRB11; 2-BROMOPALMITATE; PALMITOYLATION; PROTEIN; SYSTEMS; VIRD4	Bacterial conjugation is a key mechanism by which bacteria acquire antibiotic resistance. Therefore, conjugation inhibitors (COINs) are promising compounds in the fight against the spread of antibiotic resistance genes among bacteria. Unsaturated fatty acids (uFAs) and alkynoic fatty acid derivatives, such as 2-hexadecanoic acid (2-HDA), have been reported previously as being effective COINs. The traffic ATPase TrwD, a VirB11 homolog in plasmid R388, is the molecular target of these compounds, which likely affect binding of TrwD to bacterial membranes. In this work, we demonstrate that COINs are abundantly incorporated into Escherichia coli membranes, replacing palmitic acid as the major component of the membrane. We also show that TrwD binds palmitic acid, thus facilitating its interaction with the membrane. Our findings also suggest that COINs bind TrwD at a site that is otherwise occupied by palmitic acid. Accordingly, molecular docking predictions with palmitic acid indicated that it shares the same binding site as uFAs and 2-HDA, although it differs in the contacts involved in this interaction. We also identified 2-bromopalmitic acid, a palmitate analog that inhibits many membrane-associated enzymes, as a compound that effectively reduces TrwD ATPase activity and bacterial conjugation. Moreover, we demonstrate that 2-bromopalmitic and palmitic acids both compete for the same binding site in TrwD. Altogether, these detailed findings open up a new avenue in the search for effective synthetic inhibitors of bacterial conjugation, which may be pivotal for combating multidrug-resistant bacteria.	[Garcia-Cazorla, Yolanda; Getino, Maria; de la Cruz, Fernando; Arechaga, Ignacio; Cabezon, Elena] Univ Cantabria, CSIC, Dept Biol Mol, Santander 39011, Spain; [Garcia-Cazorla, Yolanda; Getino, Maria; de la Cruz, Fernando; Arechaga, Ignacio; Cabezon, Elena] Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria, Santander 39011, Spain; [Sanabria-Rios, David J.] Interamer Univ Puerto Rico, Fac Sci & Technol, Metropolitan Campus, San Juan, PR 00919 USA; [Carballeira, Nestor M.] Univ Puerto Rico, Dept Chem, Rio Piedras Campus, San Juan, PR 00925 USA; [Getino, Maria] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Inter American University of Puerto Rico-San German; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Surrey	Arechaga, I; Cabezon, E (corresponding author), Univ Cantabria, CSIC, Dept Biol Mol, Santander 39011, Spain.; Arechaga, I; Cabezon, E (corresponding author), Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria, Santander 39011, Spain.	arechagai@unican.es; cabezone@unican.es	Cabezon, Elena/K-5874-2014; Getino, Maria/L-8541-2019; de la Cruz, Fernando/L-2812-2014	Getino, Maria/0000-0002-2937-3420; de la Cruz, Fernando/0000-0003-4758-6857; Cabezon, Elena/0000-0002-6177-5016; Carballeira, Nestor/0000-0001-7404-0505	NIGMS NIH HHS [P20 GM103475] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103475] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguilar J, 2011, MBIO, V2, DOI 10.1128/mBio.00218-11; Arndt Claudia, 2012, Methods Mol Biol, V869, P49, DOI 10.1007/978-1-61779-821-4_5; Atmakuri K, 2004, MOL MICROBIOL, V54, P1199, DOI 10.1111/j.1365-2958.2004.04345.x; Cabezon E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02329; Cabezon E, 2015, FEMS MICROBIOL REV, V39, P81, DOI 10.1111/1574-6976.12085; Carballeira NM, 2006, LIPIDS, V41, P507, DOI 10.1007/s11745-006-5124-4; Christie PJ, 2014, BBA-MOL CELL RES, V1843, P1578, DOI 10.1016/j.bbamcr.2013.12.019; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; COLEMAN RA, 1992, BIOCHIM BIOPHYS ACTA, V1125, P203, DOI 10.1016/0005-2760(92)90046-X; Das A, 2014, MICROBIOLOGYOPEN, V3, P793, DOI 10.1002/mbo3.208; Davda D, 2013, ACS CHEM BIOL, V8, P1912, DOI 10.1021/cb400380s; Fernandez-Lopez R, 2005, MICROBIOL-SGM, V151, P3517, DOI 10.1099/mic.0.28216-0; Getino M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148098; Getino M, 2015, MBIO, V6, DOI 10.1128/mBio.01032-15; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Hare S, 2006, J MOL BIOL, V360, P56, DOI 10.1016/j.jmb.2006.04.060; Hwang DH, 2016, EUR J PHARMACOL, V785, P24, DOI 10.1016/j.ejphar.2016.04.024; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Judd PK, 2005, P NATL ACAD SCI USA, V102, P11498, DOI 10.1073/pnas.0505290102; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Machon C, 2002, J BACTERIOL, V184, P1661, DOI 10.1128/JB.184.6.1661-1668.2002; Mazel D, 1999, CELL MOL LIFE SCI, V56, P742, DOI 10.1007/s000180050021; Moncalian G, 1997, J MOL BIOL, V270, P188, DOI 10.1006/jmbi.1997.1082; Pena A, 2013, J MOL MICROB BIOTECH, V23, P357, DOI 10.1159/000351360; Planet PJ, 2001, P NATL ACAD SCI USA, V98, P2503, DOI 10.1073/pnas.051436598; Quevillon-Cheruel S, 2009, J BIOL CHEM, V284, P3552, DOI 10.1074/jbc.M808334200; Ripoll-Rozada J, 2016, MOL MICROBIOL, V100, P912, DOI 10.1111/mmi.13359; Ripoll-Rozada J, 2013, J BACTERIOL, V195, P4195, DOI 10.1128/JB.00437-13; Ripoll-Rozada J, 2012, J BIOL CHEM, V287, P17408, DOI 10.1074/jbc.M112.357905; Savvides SN, 2003, EMBO J, V22, P1969, DOI 10.1093/emboj/cdg223; Yeo HJ, 2000, MOL CELL, V6, P1461, DOI 10.1016/S1097-2765(00)00142-8	32	15	17	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16923	16930		10.1074/jbc.RA118.004716	http://dx.doi.org/10.1074/jbc.RA118.004716			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30201608	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000448515100031
J	Su, WM; Han, GS; Dey, P; Carman, GM				Su, Wen-Min; Han, Gil-Soo; Dey, Prabuddha; Carman, George M.			Protein kinase A phosphorylates the Nem1-Spo7 protein phosphatase complex that regulates the phosphorylation state of the phosphatidate phosphatase Pah1 in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phospholipid; diacylglycerol; triacylglycerol; protein phosphatase; yeast metabolism; Saccharomyces cerevisiae; protein kinase A (PKA); lipid metabolism; Nem1-Spo7 protein phosphatase; PA phosphatase	NUCLEAR-MEMBRANE GROWTH; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; LIPID-SYNTHESIS; CTP SYNTHETASE; PHOSPHATIDYLSERINE SYNTHASE; MULTISITE PHOSPHORYLATION; ORTHOLOGUE PAH1P; ACID PHOSPHATASE; SHUTTLE VECTORS	The Nem1-Spo7 protein phosphatase plays a role in lipid synthesis by controlling the membrane localization of Pah1, the diacylglycerol-producing phosphatidate (PA) phosphatase that is crucial for the synthesis of triacylglycerol in the yeast Saccharomyces cerevisiae. By dephosphorylating Pah1, Nem1-Spo7 facilitates its translocation to the nuclear/endoplasmic reticulum membrane for catalytic activity. Like its substrate Pah1, Nem1-Spo7 is phosphorylated in the cell, but the specific protein kinases involved remain to be identified. In this study, we demonstrate that the Nem1-Spo7 complex is phosphorylated by protein kinase A (PKA), which is associated with active cell growth, metabolic activity, and membrane phospholipid synthesis. In vitro phosphorylation of purified Nem1-Spo7 and of their synthetic peptides revealed that both subunits of the phosphatase complex are PKA substrates. Using phosphoamino acid and phosphopeptide-mapping analyses coupled with site-directed mutagenesis, we identified Ser-140 and Ser-210 of Nem1 and Ser-28 of Spo7 as PKA-targeted phosphorylation sites. Immunodetection of the phosphatase complex from the cell with anti-PKA substrate antibody confirmed the in vivo phosphorylations of Nem1 and Spo7 on the serine residues. Lipid-labeling analysis of cells bearing phosphorylation-deficient alleles of NEM1 and SPO7 indicated that the PKA phosphorylation of the phosphatase complex stimulates phospholipid synthesis and attenuates the synthesis of triacylglycerol. This work advances the understanding of how PKA-mediated posttranslational modifications of Nem1 and Spo7 regulate lipid synthesis in yeast.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, 61 Dudley Rd, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 61 Dudley Rd, New Brunswick, NJ 08901 USA.	gcarman@rutgers.edu		Carman, George/0000-0003-4951-8233; Su, Wen-Min/0000-0002-1861-6335	National Institutes of Health [NS046593]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The MS data were obtained from an Orbitrap mass spectrometer funded in part by National Institutes of Health Grant NS046593, for the support of the Rutgers Mass Spectrometry Center for Integrative Neuroscience Research.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Barbosa AD, 2015, MOL BIOL CELL, V26, P3641, DOI 10.1091/mbc.E15-03-0173; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boroda S, 2017, J BIOL CHEM, V292, P20481, DOI 10.1074/jbc.M117.786574; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broach J R, 1990, Adv Cancer Res, V54, P79, DOI 10.1016/S0065-230X(08)60809-X; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Chang HJ, 2004, GENETICS, V168, P1899, DOI 10.1534/genetics.104.032961; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Dubots E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104194; Eaton JM, 2013, J BIOL CHEM, V288, P9933, DOI 10.1074/jbc.M112.441493; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2017, J BIOL CHEM, V292, P13230, DOI 10.1074/jbc.M117.801720; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; Harlow E., 1988, ANTIBODIES LAB MANUA; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; Hsieh LS, 2016, J BIOL CHEM, V291, P9974, DOI 10.1074/jbc.M116.726588; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; Ingrell CR, 2007, BIOINFORMATICS, V23, P895, DOI 10.1093/bioinformatics/btm020; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kim KH, 1999, J BIOL CHEM, V274, P9531, DOI 10.1074/jbc.274.14.9531; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN YP, 1989, J BIOL CHEM, V264, P8641; Lussier M, 1997, GENETICS, V147, P435; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Orij R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r80; Park TS, 1999, BIOCHEMISTRY-US, V38, P8839, DOI 10.1021/bi990784x; Park Y, 2015, J BIOL CHEM, V290, P25382, DOI 10.1074/jbc.M115.680314; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Rahman MA, 2018, FEBS J, V285, P1840, DOI 10.1111/febs.14448; Rose MD., 1990, METHODS YEAST GENETI; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Ruiz C, 1999, YEAST, V15, P1001; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Sherr GL, 2017, BIOCHEM BIOPH RES CO, V491, P693, DOI 10.1016/j.bbrc.2017.07.127; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 2000, J BIOL CHEM, V275, P19352, DOI 10.1074/jbc.M001314200; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; SMITH SW, 1957, J BIOL CHEM, V228, P915; Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007; Sreenivas A, 2003, J BIOL CHEM, V278, P20673, DOI 10.1074/jbc.M300132200; Stuart SA, 2015, MOL CELL PROTEOMICS, V14, P1599, DOI 10.1074/mcp.M114.047233; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Wu R, 2011, BIOCHEMISTRY-US, V50, P3045, DOI 10.1021/bi200336b; Xu XY, 2018, BIOCHEM BIOPH RES CO, V496, P51, DOI 10.1016/j.bbrc.2017.12.163; Yang WL, 1996, J BIOL CHEM, V271, P28777, DOI 10.1074/jbc.271.46.28777; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983; Zhang PX, 2017, BBA-BIOMEMBRANES, V1859, P1583, DOI 10.1016/j.bbamem.2017.04.007	89	9	10	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15801	15814		10.1074/jbc.RA118.005348	http://dx.doi.org/10.1074/jbc.RA118.005348			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30201607	hybrid, Green Published			2022-12-26	WOS:000447256000005
J	Lhuillier, C; Barjon, C; Balochel, V; Niki, T; Gelin, A; Mustapha, R; Claer, L; Hoos, S; Chiba, Y; Ueno, M; Hirashima, M; Wei, M; Morales, O; Raynal, B; Delhem, N; Dellis, O; Busson, P				Lhuillier, Claire; Barjon, Clement; Balochel, Valentin; Niki, Toshiro; Gelin, Aurore; Mustapha, Rami; Claer, Laetitia; Hoos, Sylviane; Chiba, Yoichi; Ueno, Masaki; Hirashima, Mitsuomi; Wei, Ming; Morales, Olivier; Raynal, Bertrand; Delhem, Nadira; Dellis, Olivier; Busson, Pierre			Characterization of neutralizing antibodies reacting with the 213-224 amino-acid segment of human galectin-9	PLOS ONE			English	Article							REGULATORY T-CELLS; CARCINOMA; IMMUNITY; SURVIVAL; EXPRESSION; PROMOTES; CANCER; INFLAMMATION; SUPPRESSES; ACTIVATION	Extra-cellular galectin-9 (gal-9) is an immuno-modulatory protein with predominant immuno-suppressive effects. Inappropriate production of gal-9 has been reported in several human malignancies and viral diseases like nasopharyngeal, pancreatic and renal carcinomas, metastatic melanomas and chronic active viral hepatitis. Therefore therapeutic antibodies neutralizing extra-cellular gal-9 are expected to contribute to immune restoration in these pathological conditions. Two novel monoclonal antibodies targeting gal-9 -Gal-Nab 1 and 2-have been produced and characterized in this study. We report a protective effect of Gal-Nab1 and Gal-Nab2 on the apoptotic cell death induced by gal-9 in primary T cells. In addition, they inhibit late phenotypic changes observed in peripheral T cells that survive gal9-induced apoptosis. Gal-Nab1 and Gal-Nab2 bind nearly identical, overlapping linear epitopes contained in the 213-224 amino-acid segments of gal-9. Nevertheless, they have some distinct functional characteristics suggesting that their three-dimensional epitopes are distinct. These differences are best demonstrated when gal-9 is applied on Jurkat cells where Gal-Nab1 is less efficient than Gal-Nab2 in the prevention of apoptotic cell death. In addition, Gal-Nab1 stimulates non-lethal phosphatidylserine translocation at the plasma membrane and calcium mobilization triggered by gal-9 in these cells. Both Gal-Nab1 and 2 cross-react with murine gal-9. They bind its natural as well as its recombinant form. This cross-species recognition will be an advantage for their assessment in pre-clinical tumor models.	[Lhuillier, Claire; Barjon, Clement; Balochel, Valentin; Gelin, Aurore; Busson, Pierre] CNRS, UMR 8126, Villejuif, France; [Lhuillier, Claire; Barjon, Clement; Balochel, Valentin; Gelin, Aurore; Busson, Pierre] Univ Paris Saclay, Gustave Roussy, Villejuif, France; [Lhuillier, Claire; Barjon, Clement; Balochel, Valentin; Gelin, Aurore; Busson, Pierre] Univ Paris Sud, Univ Paris Saclay, Le Kremlin Bicetre, France; [Lhuillier, Claire; Barjon, Clement; Wei, Ming] Cellvax, Romainville, France; [Niki, Toshiro] Kagawa Univ, Fac Med, Dept Immunol, Takamatsu, Kagawa, Japan; [Niki, Toshiro; Hirashima, Mitsuomi] GalPharma Co Ltd, Takamatsu, Kagawa, Japan; [Mustapha, Rami; Morales, Olivier; Delhem, Nadira] CNRS, UMR 8161, IRCV Grp, Inst Biol Lille, Lille, France; [Claer, Laetitia] H Immune Therapeut, Paris, France; [Hoos, Sylviane; Raynal, Bertrand] Inst Pasteur, Plate Forme Biophys Mol, Paris, France; [Chiba, Yoichi; Ueno, Masaki] Kagawa Univ, Fac Med, Dept Pathol & Host Def, Takamatsu, Kagawa, Japan; [Hirashima, Mitsuomi] Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, Takamatsu, Kagawa, Japan; [Dellis, Olivier] Univ Paris Sud, Univ Paris Saclay, UMR S 1174, INSERM, Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Kagawa University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Kagawa University; Kagawa University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Busson, P (corresponding author), CNRS, UMR 8126, Villejuif, France.; Busson, P (corresponding author), Univ Paris Saclay, Gustave Roussy, Villejuif, France.; Busson, P (corresponding author), Univ Paris Sud, Univ Paris Saclay, Le Kremlin Bicetre, France.	pierre.busson@gustaveroussy.fr	MORALES, Olivier/AAR-5337-2020; Dellis, Olivier/E-8501-2011; Mustapha, Rami/GQP-2833-2022	Dellis, Olivier/0000-0003-0377-9163; Baloche, Valentin/0000-0001-9471-0043; Chiba, Yoichi/0000-0003-1417-8689; raynal, Bertrand/0000-0001-5634-0408; CLAER, Laetitia/0000-0002-1955-7664; MORALES, Olivier/0000-0002-2135-3265	Idex Saclay Satt Saclay, Prematuration Grant 2015; BMS Foundation for Immuno-Oncology-Grant 2016-2017; Idex Saclay; Bristol-Myers-Squibb foundation	Idex Saclay Satt Saclay, Prematuration Grant 2015; BMS Foundation for Immuno-Oncology-Grant 2016-2017; Idex Saclay; Bristol-Myers-Squibb foundation(Bristol-Myers Squibb)	This work was supported by Idex Saclay Satt Saclay, Prematuration Grant 2015, https://www.satt-paris-saclay.fr/; BMS Foundation for Immuno-Oncology-Grant 2016-2017, http://fondation-bms.fr/. Several authors were employed by commercial companies: Cellvax (CL, CB, MW), GalPharma Co, Ltd (TN), H-Immune Therapeutics (LC). These companies provided support in the form of salaries for authors [CL, CB, MW, TN, LC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by a pre-maturation contract from the Idex Saclay (2015-2016-PB coordinator) and by a grant from the Bristol-Myers-Squibb foundation (2016-2017-PB coordinator).	Bacigalupo ML, 2013, WORLD J GASTROENTERO, V19, P8831, DOI 10.3748/wjg.v19.i47.8831; Barjon C, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-16; Bi SG, 2011, P NATL ACAD SCI USA, V108, P10650, DOI 10.1073/pnas.1017954108; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Butt AQ, 2014, ONCOGENE, V33, P4623, DOI 10.1038/onc.2013.432; Daley D, 2017, NAT MED, V23, P556, DOI 10.1038/nm.4314; Denavit V, 2018, TRENDS GLYCOSCI GLYC, V30, pSE21, DOI 10.4052/tigg.1729.1SE; Djillani A, 2014, BBA-MOL CELL RES, V1843, P2341, DOI 10.1016/j.bbamcr.2014.03.012; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Enninga EAL, 2016, MELANOMA RES, V26, P429, DOI 10.1097/CMR.0000000000000281; Fu HC, 2015, TUMOR BIOL, V36, P5791, DOI 10.1007/s13277-015-3248-y; Golden-Mason L, 2017, HEPATOLOGY, V66, P271, DOI 10.1002/hep.29106; Gooden MJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065616; Heusschen R, 2013, BBA-REV CANCER, V1836, P177, DOI 10.1016/j.bbcan.2013.04.006; Hirofumi A, 2002, J IMMUNOL, V169, P5912, DOI 10.4049/jimmunol.169.10.5912; Hoja-Lukowicz D, 2017, BBA-GEN SUBJECTS, V1861, P3237, DOI 10.1016/j.bbagen.2016.08.007; Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486; Kared H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003422; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; Keryer-Bibens C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-283; Kikushige Y, 2015, CELL STEM CELL, V17, P341, DOI 10.1016/j.stem.2015.07.011; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Koenecke C, 2012, J IMMUNOL, V189, P2890, DOI 10.4049/jimmunol.1200413; Lhuillier C, 2015, J BIOL CHEM, V290, P16797, DOI 10.1074/jbc.M115.661272; Liu ZJ, 2016, ONCOL LETT, V11, P1829, DOI 10.3892/ol.2016.4142; Lu LH, 2007, J BIOCHEM, V141, P157, DOI 10.1093/jb/mvm019; Lv K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048379; Madireddi S, 2017, J IMMUNOL, DOI [10.4236/oji.2017.71001, DOI 10.4236/OJI.2017.71001]; Madireddi S, 2017, J IMMUNOL, V199, P2721, DOI 10.4049/jimmunol.1700575; Mengshol JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009504; Mrizak D, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju363; Nebbia G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047648; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Nonaka Y, 2013, J BIOCHEM, V153, P463, DOI 10.1093/jb/mvt009; Ohue Y, 2016, CANCER IMMUNOL RES, V4, P1049, DOI 10.1158/2326-6066.CIR-15-0266; Oomizu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048574; Oomizu S, 2012, CLIN IMMUNOL, V143, P51, DOI 10.1016/j.clim.2012.01.004; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Steelman AJ, 2013, J BIOL CHEM, V288, P23776, DOI 10.1074/jbc.M113.451658; Stock P, 2004, NAT IMMUNOL, V5, P1149, DOI 10.1038/ni1122; Stowell SR, 2009, MOL BIOL CELL, V20, P1408, DOI 10.1091/mbc.E08-07-0786; Strebe N, 2010, ANTIBODY ENGINEERING, VOL 1, SECOND EDITION, P3, DOI 10.1007/978-3-642-01144-3_1; Vanpouille-Box C, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1373237; Wang F, 2007, CELL IMMUNOL, V250, P68, DOI 10.1016/j.cellimm.2008.01.006; Wdowiak K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010210; Wu C, 2014, IMMUNITY, V41, P270, DOI 10.1016/j.immuni.2014.06.011; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	49	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0202512	10.1371/journal.pone.0202512	http://dx.doi.org/10.1371/journal.pone.0202512			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204750	Green Submitted, Green Published, gold			2022-12-26	WOS:000444355500007
J	Barszcz, M; Taciak, M; Tusnio, A; Swiech, E; Bachanek, I; Kowalczyk, P; Borkowski, A; Skomial, J				Barszcz, Marcin; Taciak, Marcin; Tusnio, Anna; Swiech, Ewa; Bachanek, Ilona; Kowalczyk, Pawel; Borkowski, Andrzej; Skomial, Jacek			The effect of dietary level of two inulin types differing in chain length on biogenic amine concentration, oxidant-antioxidant balance and DNA repair in the colon of piglets	PLOS ONE			English	Article							GROWING PIGS; WEANED PIGLETS; CHICORY INULIN; GASTROINTESTINAL-TRACT; LARGE-INTESTINE; TRIGGER CHANGES; YOUNG-PIGS; PROTEIN; SUPPLEMENTATION; MICROBIOTA	The effect of dietary level of two types of inulin on amine concentration, redox status and DNA glycosylase activity in the colon of piglets was investigated. Seven groups of piglets were fed diets without inulin addition (control) or with 1%, 2% or 3% inulin with an average degree of polymerisation of 10 (IN10) or 23 (IN23) for 40 days. The 2% and 3% IN10 diets increased tryptamine concentration in the proximal colon, while methylamine concentration in the distal colon was increased by the 1% and 3% IN10 diets. The 1% and 2% IN23 diets increased phenylethylamine and methylamine concentration in the proximal colon, respectively, while 1,7-diaminoheptane content was increased by both diets. Its concentration in the middle and distal colon was increased by the 1% and 2% IN23 diet, respectively. There was no improvement in the oxidant-antioxidant balance in colonic digesta of piglets fed IN10 and IN23 diets. Piglets fed IN10 diets had lower 1, N-6 -etheno-2'-deoxyadenosine excision activity in each colon segment, as compared with the control group. It was also reduced by the 2% and 3% IN23 diets in the proximal colon, while in the middle and distal colon by all IN23 diets. Feeding all IN10 and IN23 diets reduced 3, N-4 -etheno-2'-deoxycytidine and 8-oxo- deoxyguanosine excision activities in each colon segment. Feeding IN10 and IN23 diets neither decreased amine concentrations nor improved the oxidant-antioxidant balance in colonic digesta of piglets. However, both types of inulin efficiently reduced the activity of DNA repair enzymes.	[Barszcz, Marcin; Taciak, Marcin; Tusnio, Anna; Swiech, Ewa; Bachanek, Ilona; Kowalczyk, Pawel; Skomial, Jacek] Polish Acad Sci, Kielanowski Inst Anim Physiol & Nutr, Dept Anim Nutr, Jablonna, Poland; [Borkowski, Andrzej] Univ Warsaw, Fac Geol, Geomicrobiol Lab, Warsaw, Poland	Polish Academy of Sciences; Kielanowski Institute of Animal Physiology & Nutrition of the Polish Academy of Sciences; University of Warsaw	Barszcz, M (corresponding author), Polish Acad Sci, Kielanowski Inst Anim Physiol & Nutr, Dept Anim Nutr, Jablonna, Poland.	m.barszcz@ifzz.pl	Tuśnio, Anna/AAI-1430-2019; Barszcz, Marcin/AAL-4761-2021; Taciak, Marcin/H-3751-2017	Barszcz, Marcin/0000-0002-3428-9805; Taciak, Marcin/0000-0002-8963-9745; Kowalczyk, Pawel/0000-0003-4025-3750; Swiech, Ewa/0000-0002-8752-1161; Tusnio, Anna/0000-0001-7480-3592; Skomial, Jacek/0000-0002-9026-0812; Borkowski, Andrzej/0000-0001-6762-4350	National Centre for Research and Development of Poland [NR 12 0067 10]; Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences	National Centre for Research and Development of Poland(National Centre for Research & Development, Poland); Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences	The work was supported by the National Centre for Research and Development of Poland (http://www.ncbr.gov.pl/en/; grant number NR 12 0067 10) and the statutory funds of The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC. Official methods of analysis of AOAC International, 2005, CURR REV 4 2011; Apolinario AC, 2014, CARBOHYD POLYM, V101, P368, DOI 10.1016/j.carbpol.2013.09.081; Barszcz M, 2018, ANIM PROD SCI, V58, P1109, DOI 10.1071/AN16014; Barszcz M, 2011, J ANIM FEED SCI, V20, P3, DOI 10.22358/jafs/66152/2011; Barszcz M, 2016, ARCH ANIM NUTR, V70, P278, DOI 10.1080/1745039X.2016.1184368; Bernstein C, 2015, WORLD J GASTRO ONCOL, V7, P30, DOI 10.4251/wjgo.v7.i5.30; Blachier F, 2007, AMINO ACIDS, V33, P547, DOI 10.1007/s00726-006-0477-9; Drohat AC, 2016, CHEM REV, V116, P12711, DOI 10.1021/acs.chemrev.6b00191; Flickinger EA, 2003, J ANIM SCI, V81, P2008; Guarino MPL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169481; Halas D, 2010, ANIM FEED SCI TECH, V160, P137, DOI 10.1016/j.anifeedsci.2010.07.001; Herosimczyk A, 2015, POL J VET SCI, V18, P541, DOI 10.1515/pjvs-2015-0070; Herosimczyk A, 2017, LIVEST SCI, V203, P54, DOI 10.1016/j.livsci.2017.07.004; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Jedinak A, 2011, ANTICANCER RES, V31, P379; Jha R, 2016, ANIM FEED SCI TECH, V212, P18, DOI 10.1016/j.anifeedsci.2015.12.002; Koliakos G., 2009, United States Patent Application Publication, Patent No. [US 2009/0123956 A1, 20090123956]; Larque E, 2007, NUTRITION, V23, P87, DOI 10.1016/j.nut.2006.09.006; Lepczynski A, 2017, J ANIM PHYSIOL AN N, V101, pe225, DOI 10.1111/jpn.12595; Lepczynski A, 2016, J ANIM FEED SCI, V25, P343, DOI 10.22358/jafs/67471/2016; Linhart K, 2014, REDOX BIOL, V3, P56, DOI 10.1016/j.redox.2014.08.009; Loh G, 2006, J NUTR, V136, P1198, DOI 10.1093/jn/136.5.1198; Niness KR, 1999, J NUTR, V129, p1402S, DOI 10.1093/jn/129.7.1402S; Oberreuther-Moschner DL, 2005, TOXICOL LETT, V159, P212, DOI 10.1016/j.toxlet.2005.05.008; Pasqualetti V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098031; Passlack N, 2012, LIVEST SCI, V149, P128, DOI 10.1016/j.livsci.2012.07.005; Pieper R, 2014, ARCH ANIM NUTR, V68, P263, DOI 10.1080/1745039X.2014.932962; Roberfroid MB, 1998, J NUTR, V128, P11, DOI 10.1093/jn/128.1.11; Roberfroid MB, 2005, BRIT J NUTR, V93, pS13, DOI 10.1079/BJN20041350; Sanders LM, 2004, CANCER LETT, V208, P155, DOI 10.1016/j.canlet.2003.12.007; Saparbaev M, 1998, P NATL ACAD SCI USA, V95, P8508, DOI 10.1073/pnas.95.15.8508; Speina E, 2003, CANCER RES, V63, P4351; Taciak M, 2015, J ANIM FEED SCI, V24, P235, DOI 10.22358/jafs/65629/2015; Taciak M, 2017, ARCH ANIM NUTR, V71, P192, DOI [10.1080/1745039X.2017.1291202, 10.1080/1745039x.2017.1291202]; Yin J, 2014, J ANIM SCI, V92, P612, DOI 10.2527/jas.2013-6986; Yin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122893; Zheng P, 2013, BRIT J NUTR, V109, P2253, DOI 10.1017/S0007114512004321	37	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202799	10.1371/journal.pone.0202799	http://dx.doi.org/10.1371/journal.pone.0202799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192784	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600036
J	Moiroud, L; Gerard, CL; Peyre, H; Bucci, MP				Moiroud, Lionel; Gerard, Christophe Loic; Peyre, Hugo; Bucci, Maria Pia			Developmental Eye Movement test and dyslexic children: A pilot study with eye movement recordings	PLOS ONE			English	Article							ATTENTION	The goal of this study is to explore eye movement recordings during the Developmental Eye Movement (DEM) test in dyslexic and non-dyslexic children. Thirteen children with dyslexia, 13 non-dyslexic chronological age-and IQ-matched children and 13 non-dyslexic reading age-and IQ-matched children were examined. Test C of the DEM test was performed with and without eye movement recordings (eye tracker by SuriCog). The results of the three groups were compared. Children with dyslexia and non-dyslexic children of equivalent reading age have significant longer fixation time and take longer to read Test C of the DEM test than non-dyslexic children of similar chronological age. A significant correlation was also found between the fixation time and the number of words read in one minute with the total time to read Test C of the DEM test. DEM test is a useful test for exploring the oculomotor behavior of dyslexic children during reading. The maturation of cortical structures controlling fixation capability appears to play a crucial role in reading skills.	[Moiroud, Lionel; Bucci, Maria Pia] Univ Paris Diderot, Robert Debre Hosp, UMR Inserm 1141, Paris, France; [Gerard, Christophe Loic; Peyre, Hugo] Robert Debre Hosp, Child & Adolescent Psychiat Dept, Paris, France; [Peyre, Hugo] Univ Paris Diderot, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Bucci, MP (corresponding author), Univ Paris Diderot, Robert Debre Hosp, UMR Inserm 1141, Paris, France.	maria-pia.bucci@inserm.fr		bucci, maria pia/0000-0001-6673-2026				Ayton LN, 2009, OPTOMETRY VISION SCI, V86, P722, DOI 10.1097/OPX.0b013e3181a6a4b3; Berlin R., 1887, BESONDERE ART WORTBL; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; Bucci MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033458; Chevrie-Muller C, 1997, BATTERIE LANGAGE ORA; De Luca M, 1999, NEUROPSYCHOLOGIA, V37, P1407, DOI 10.1016/S0028-3932(99)00038-X; Ding Y, 2016, DYSLEXIA, V22, P362, DOI 10.1002/dys.1541; DuPaul G. J, 1998, ADHD RATINGSCALE 4 C; EDEN GF, 1994, VISION RES, V34, P1345, DOI 10.1016/0042-6989(94)90209-7; FernandezVelazquez FJ, 1995, OPTOMETRY VISION SCI, V72, P902, DOI 10.1097/00006324-199512000-00009; Garzia R P, 1990, J Am Optom Assoc, V61, P124; Goswami U, 2003, TRENDS COGN SCI, V7, P534, DOI 10.1016/j.tics.2003.10.003; Hatzidaki A, 2011, DYSLEXIA, V17, P85, DOI 10.1002/dys.416; Kulp MT, 1997, OPTOMETRY VISION SCI, V74, P37, DOI 10.1097/00006324-199701000-00018; Li XH, 2009, CHINESE MED J-PEKING, V122, P267, DOI 10.3760/cma.j.issn.0366-6999.2009.03.006; Lions C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083972; Lukasova K, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00987; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; Medland C, 2010, OPHTHAL PHYSL OPT, V30, P740, DOI 10.1111/j.1475-1313.2010.00779.x; Northway N., 2013, OPHTHAL PHYSL OPT, V23, P457; Palomo-Alvarez C, 2009, GRAEF ARCH CLIN EXP, V247, P1243, DOI 10.1007/s00417-009-1076-8; PAVLIDIS GT, 1981, NEUROPSYCHOLOGIA, V19, P57, DOI 10.1016/0028-3932(81)90044-0; Powers Maureen, 2008, Optometry, V79, P228, DOI 10.1016/j.optm.2007.07.014; Rayner K, 1985, DEV NEUROPSYCHOL, V1, P3, DOI 10.1080/87565648509540294; Seassau M, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00085; Seassau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070261; Tiadi A, 2016, FRONT HUM NEUROSCI, V10, DOI [10.3389/fnhurn.2010.00058, 10.3389/fnhum.2016.00058]; Trauzettel-Klosinski S, 2010, ACTA OPHTHALMOL, V88, P681, DOI 10.1111/j.1755-3768.2009.01523.x; Vagge A, 2015, ANN DYSLEXIA, V65, P24, DOI 10.1007/s11881-015-0098-7; Webber A, 2011, OPTOMETRY VISION SCI, V88, P295, DOI 10.1097/OPX.0b013e31820846c0	30	13	14	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0200907	10.1371/journal.pone.0200907	http://dx.doi.org/10.1371/journal.pone.0200907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT0BU	30192750	gold, Green Published, Green Submitted			2022-12-26	WOS:000444093600008
J	Bettella, F; Brown, AA; Smeland, OB; Wang, YP; Witoelar, A; Demur, AAB; Thompson, WK; Zuber, V; Dale, AM; Djurovic, S; Andreassen, OA				Bettella, Francesco; Brown, Andrew A.; Smeland, Olav B.; Wang, Yunpeng; Witoelar, Aree; Demur, Alfonso A. Buil; Thompson, Wesley K.; Zuber, Verena; Dale, Anders M.; Djurovic, Srdjan; Andreassen, Ole A.			Cross-tissue eQTL enrichment of associations in schizophrenia	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; HUMAN BRAIN; REGULATORY VARIATION; COMPLEX DISEASE; INSIGHTS; TRAITS; ATLAS; TRANSCRIPTOME	The genome-wide association study of the Psychiatric Genomics Consortium identified over one hundred schizophrenia susceptibility loci. The number of non-coding variants discovered suggests that gene regulation could mediate the effect of these variants on disease. Expression quantitative trait loci (eQTLs) contribute to variation in levels of mRNA. Given the co-occurrence of schizophrenia and several traits not involving the central nervous system (CNS), we investigated the enrichment of schizophrenia associations among eQTLs for four non-CNS tissues: adipose tissue, epidermal tissue, lymphoblastoid cells and blood. Significant enrichment was seen in eQTLs of all tissues: adipose (beta = 0.18, p = 8.8 x 10(-06)), epidermal (beta = 0.12, p = 3.1 x 10(-04)), lymphoblastoid (beta = 0.19, p = 6.2 x 10(-08)) and blood (beta = 0.19, p = 6.4 x 10(-06)). For comparison, we looked for enrichment of association with traits of known relevance to one or more of these tissues (body mass index, height, rheumatoid arthritis, systolic blood pressure and type-II diabetes) and found that schizophrenia enrichment was of similar scale to that observed when studying diseases in the context of a more likely causal tissue. To further investigate tissue specificity, we looked for differential enrichment of eQTLs with relevant Roadmap affiliation (enhancers and promoters) and varying distance from the transcription start site. Neither factor significantly contributed to the enrichment, suggesting that this is equally distributed in tissue-specific and cross-tissue regulatory elements. Our analyses suggest that functional correlates of schizophrenia risk are prevalent in non-CNS tissues. This could be because of pleiotropy or the effectiveness of variants affecting expression in different contexts. This suggests the utility of large, single-tissue eQTL experiments to increase eQTL discovery power in the study of schizophrenia, in addition to smaller, multiple-tissue approaches. Our results conform to the notion that schizophrenia is a systemic disorder involving many tissues.	[Bettella, Francesco; Smeland, Olav B.; Wang, Yunpeng; Witoelar, Aree; Djurovic, Srdjan; Andreassen, Ole A.] Univ Oslo, KG Jebsen Ctr Psychosis Res, NORMENT, N-0424 Oslo, Norway; [Bettella, Francesco; Smeland, Olav B.; Wang, Yunpeng; Witoelar, Aree; Djurovic, Srdjan; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Brown, Andrew A.] Univ Geneva, Dept Genet Med & Dev CMU, Rue Michel Servet 1, CH-1211 Geneva, Switzerland; [Smeland, Olav B.; Thompson, Wesley K.; Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA; [Demur, Alfonso A. Buil; Thompson, Wesley K.] Psykiatrisk Ctr Sct Hans, Inst Biol Psykiatrisk, Boserupvej 2, DK-4000 Roskilde, Denmark; [Zuber, Verena] Cambridge Inst Publ Hlth, MRC Biostat Unit, Robinson Way, Cambridge CB2 0SR, England	University of Oslo; University of Oslo; University of Geneva; University of California System; University of California San Diego; MRC Biostatistics Unit; University of Cambridge	Bettella, F (corresponding author), Univ Oslo, KG Jebsen Ctr Psychosis Res, NORMENT, N-0424 Oslo, Norway.; Bettella, F (corresponding author), Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway.	francesco.bettella@medisin.uio.no	Smeland, Olav/ADE-5677-2022; Wang, Yunpeng/W-8871-2018; Andreassen, Ole A./AAY-7531-2020; Smeland, Olav Bjerkehagen/AAM-5284-2020	Wang, Yunpeng/0000-0001-9831-1090; Smeland, Olav Bjerkehagen/0000-0002-3761-5215; Witoelar, Aree/0000-0003-0971-6868; Brown, Andrew/0000-0002-8087-3033; Thompson, Wesley/0000-0002-1148-1976; Buil, Alfonso/0000-0002-3097-1014; Djurovic, Srdjan/0000-0002-8140-8061; Zuber, Verena/0000-0001-9827-1877	Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013); Medical Research Council; National Institute for Health Research (NIHR); Clinical Research Facility and Biomedical Research Centre; Guy's and St Thomas' NHS Foundation Trust; King's College London	Wellcome Trust(Wellcome Trust); European Community's Seventh Framework Programme (FP7/2007-2013)(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Clinical Research Facility and Biomedical Research Centre; Guy's and St Thomas' NHS Foundation Trust; King's College London(General Electric)	The TwinsUK study was funded by the Wellcome Trust, European Community's Seventh Framework Programme (FP7/2007-2013) and the Medical Research Council. The study also received support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre, based at Guy's and St Thomas' NHS Foundation Trust, in partnership with King's College London. SNP genotyping was performed by The Wellcome Trust Sanger Institute and National Eye Institute via NIH-CIDR.	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Andreassen O. A, 2014, MOL PSYCHIAT; Andreassen OA, 2013, AM J HUM GENET, V92, P197, DOI 10.1016/j.ajhg.2013.01.001; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bacanu SA, 2014, MOL PSYCHIATR, V19, P276, DOI 10.1038/mp.2013.33; Bacanu SA, 2013, SCHIZOPHR RES, V151, P226, DOI 10.1016/j.schres.2013.10.016; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bhalala OG, 2016, BIORXIV; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Buil A, 2016, BIORXIV; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; De Hert M, 2009, WORLD PSYCHIATRY, V8, P15; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Finucane H, 2017, BIORXIV; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Gejman PV, 2010, PSYCHIAT CLIN N AM, V33, P35, DOI 10.1016/j.psc.2009.12.003; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Goulart LF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1513-5; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; HEATH RG, 1967, ARCH GEN PSYCHIAT, V16, P1; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Holland D, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00015; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kirkpatrick B., 2009, SCHIZOPHRENIA B; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lowe WL, 2015, GENOME RES, V25, P1432, DOI 10.1101/gr.190603.115; Malavia TA, 2017, NPJ SCHIZOPHR, V3, DOI 10.1038/s41537-017-0010-z; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Muller N, 2000, ANN NY ACAD SCI, V917, P456; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Richards AL, 2012, MOL PSYCHIATR, V17, P193, DOI 10.1038/mp.2011.11; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Robinson D., 2015, QVALUE Q VALUE ESTIM; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Shen EH, 2012, TRENDS NEUROSCI, V35, P711, DOI 10.1016/j.tins.2012.09.005; SPECTOR TD, 1987, BRIT J RHEUMATOL, V26, P307, DOI 10.1093/rheumatology/26.4.307; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Srinivasan S, 2015, BIOL PSYCHIAT, P1; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097	54	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0202812	10.1371/journal.pone.0202812	http://dx.doi.org/10.1371/journal.pone.0202812			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188921	Green Published, gold, Green Submitted			2022-12-26	WOS:000444228700012
J	Ma, CX; He, RC; Zhang, W				Ma, Changxi; He, Ruichun; Zhang, Wei			Path optimization of taxi carpooling	PLOS ONE			English	Article								The problem that passengers are hard to take taxis while empty driving rate is high widely exists under the traditional taxi operation mode. The implementation of taxi carpooling mode can alleviate the problem in a certain extent. The objective of this study is to optimize the taxi carpooling path. Firstly, the taxi carpooling path optimization model with single objective and its extended model with multiple objectives are built respectively. Then, the single objective path optimization model of taxi carpooling is solved based on the improved single objective genetic algorithm, and the multiple-objective path optimization model of taxi carpooling is solved based on the improved multiple-objective genetic algorithm. Finally, a case study is carried out based on a road network with 24 nodes. The case study results show the path optimization models and algorithms of taxi carpooling proposed in the paper can quickly get the taxi carpooling path, and can increase the income of taxi driver while reduce the cost for passengers.	[Ma, Changxi; He, Ruichun; Zhang, Wei] Lanzhou Jiaotong Univ, Sch Traff & Transportat, Lanzhou, Gansu, Peoples R China	Lanzhou Jiaotong University	Ma, CX (corresponding author), Lanzhou Jiaotong Univ, Sch Traff & Transportat, Lanzhou, Gansu, Peoples R China.	machangxi@mail.lzjtu.cn	Ma, Changxi/AAM-5322-2020					Ardekani SA, 1986, TRANSPORT RES REC, V1103, P33; Chen Y. T., 2013, INT J SOCIAL SCI HUM, V3, P87, DOI DOI 10.7763/IJSSH.2013.V3.201; Cheng J., 2013, J WUHAN UNIV TECHNOL, V37, P187; d'Orey P. M., 2012, 2012 12th International Conference on ITS Telecommunications (ITST 2012), P319, DOI 10.1109/ITST.2012.6425191; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Galland S, 2014, TRANSPORT RES C-EMER, V45, P83, DOI 10.1016/j.trc.2013.12.012; Guo RJ, 2011, J DALIAN JIAOTONG U, V32, P28; He ZB, 2017, COMPUT-AIDED CIV INF, V32, P252, DOI 10.1111/mice.12251; He ZB, 2013, TRANSPORT RES C-EMER, V32, P89, DOI 10.1016/j.trc.2013.04.005; Kammerdiener T, 2011, J COMPUTING SCI COLL, V26, P95; Ma XL, 2013, TRANSPORT RES C-EMER, V36, P1, DOI 10.1016/j.trc.2013.07.010; Manzini R., 2012, J TRANSPORTATION TEC, DOI [10.4236/jtts.2012.22011, DOI 10.4236/JTTS.2012.22011]; Morisugi H., 1997, J E ASIA SOC TRANSPO, V2, P1547; Tang JJ, 2018, PHYSICA A, V506, P566, DOI 10.1016/j.physa.2018.04.073; Tang JJ, 2018, PHYSICA A, V493, P430, DOI 10.1016/j.physa.2017.11.114; Tang-Hsien Chang, 2004, 2004 IEEE International Conference on Networking, Sensing and Control (IEEE Cat. No.04EX761), P1335; Wang L., 2012, THESIS; Wang Y, 2017, APPL SOFT COMPUT, V56, P143, DOI 10.1016/j.asoc.2017.02.025; Wang Y, 2017, J CLEAN PROD, V144, P203, DOI 10.1016/j.jclepro.2017.01.001; Yan SY, 2012, TRANSPORTATION, V39, P723, DOI 10.1007/s11116-011-9354-9; Yang X, 2019, TRANSPORTMETRICA B, V7, P386, DOI 10.1080/21680566.2017.1421109; Zhou Heping, 2011, J CHANGSHA U SCI TEC, V08, P20; Zou X. D., 2002, J HIGHWAY TRANSPORTA, V19, P82	23	94	99	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203221	10.1371/journal.pone.0203221	http://dx.doi.org/10.1371/journal.pone.0203221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161199	Green Submitted, Green Published, gold			2022-12-26	WOS:000443388900093
J	Namwongsa, S; Puntumetakul, R; Neubert, MS; Chaiklieng, S; Boucaut, R				Namwongsa, Suwalee; Puntumetakul, Rungthip; Neubert, Manida Swangnetr; Chaiklieng, Sunisa; Boucaut, Rose			Ergonomic risk assessment of smartphone users using the Rapid Upper Limb Assessment (RULA) tool	PLOS ONE			English	Article							MUSCLE-ACTIVITY; NECK-SHOULDER; WORK; PAIN; POSTURE; DISCOMFORT; SYMPTOMS; CHILDREN; SCHOOL	The number of smartphone users globally is rapidly increasing. This study aimed to assess the level of ergonomic risk to smartphone users, and to evaluate the correlation between any selfreported musculoskeletal disorders and the level of ergonomic risk. Thirty participants completed a questionnaire, tailored specifically for smartphone users, to determine any musculoskeletal disorders. Participants were given a seated smartphone texting task and their postures were video recorded during the task. The video scenarios were evaluated by three independent researchers to determine the level of ergonomic risk using the Rapid Upper Limb Assessment (RULA) tool. RULA is an observation-based screening tool which has been widely used to assess the postural risk of IT device users. However, it has not yet been specifically utilized with smartphone users. The RULA tool scores identified ergonomics risks from using smartphones to text. Most smartphone users had a total RULA Grand Score of 6 for both sides (left side: 80.00%, right side: 90.00%), indicating the need for further investigation and changes (Action Level 3). Notably, no participants had acceptable RULA Grand Scores of 1 or 2. The correlation between musculoskeletal disorders and the ergonomic risk among smartphone users was determined using the Chi-Square test and Fisher's exact test; p<0.05 was considered statistically significant. There was a significant correlation between right RULA Grand Score and neck musculoskeletal disorder (chi(2) = 9.424 at p value = 0.009) and right RULA Grand Score and upper back musculoskeletal disorder (chi(2) = 31.717 at p value <0.001). RULA Score B (combination of neck, trunk and leg postures) and RULA Score D (combination of Score B, muscle use and force scores for group B) were also significantly correlated with neck musculoskeletal disorders (chi(2) = 19.286 at pvalue<0.001 and chi(2) = 9.310 at p value = 0.002 respectively). The RULA results identified the high ergonomics risk of smartphone users, this resulted from two key risk factors: posture and muscle use. The neck, trunk and leg postures had a combined effect on neck musculoskeletal disorders. Future investigations should consider these factors when designing ergonomic interventions for smartphone users.	[Namwongsa, Suwalee; Puntumetakul, Rungthip; Neubert, Manida Swangnetr; Chaiklieng, Sunisa] Khon Kaen Univ, Res Ctr Back Neck Other Joint Pain & Human Perfor, Khon Kaen, Thailand; [Namwongsa, Suwalee; Puntumetakul, Rungthip] Khon Kaen Univ, Fac Associated Med Sci, Sch Phys Therapy, Khon Kaen, Thailand; [Neubert, Manida Swangnetr] Khon Kaen Univ, Fac Technol, Program Prod Technol, Khon Kaen, Thailand; [Chaiklieng, Sunisa] Khon Kaen Univ, Fac Publ Hlth, Dept Environm Hlth Sci, Khon Kaen, Thailand; [Boucaut, Rose] Univ South Australia, iCAHE Int Ctr Allied Hlth Evidence, Sch Hlth Sci Physiotherapy, Adelaide, SA, Australia	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; University of South Australia	Puntumetakul, R (corresponding author), Khon Kaen Univ, Res Ctr Back Neck Other Joint Pain & Human Perfor, Khon Kaen, Thailand.; Puntumetakul, R (corresponding author), Khon Kaen Univ, Fac Associated Med Sci, Sch Phys Therapy, Khon Kaen, Thailand.	rungthiprt@gmail.com	Chaiklieng, Sunisa/AAO-9644-2020	Chaiklieng, Sunisa/0000-0003-4190-4930; Boucaut, Rose/0000-0002-1832-077X	Research Center in Back, Neck, Other Joint Pain and Human Performance (BNOJPH), Khon Kaen University, Khon Kaen, Thailand	Research Center in Back, Neck, Other Joint Pain and Human Performance (BNOJPH), Khon Kaen University, Khon Kaen, Thailand	The work was supported by Research Center in Back, Neck, Other Joint Pain and Human Performance (BNOJPH), Khon Kaen University, Khon Kaen, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JH, 2003, OCCUP ENVIRON MED, V60, P649, DOI 10.1136/oem.60.9.649; Ariens GAM, 2002, SCAND J WORK ENV HEA, V28, P222, DOI 10.5271/sjweh.669; Breen R, 2007, ERGONOMICS, V50, P1582, DOI 10.1080/00140130701584944; Briggs A, 2004, ERGONOMICS, V47, P790, DOI 10.1080/00140130410001663569; Chaiklieng S, 2016, SRINAGARIND MED J, V31, P202; Chen JD, 2014, APPL ERGON, V45, P398, DOI 10.1016/j.apergo.2013.05.004; da Costa BR, 2010, AM J IND MED, V53, P285, DOI 10.1002/ajim.20750; Danuta RL, 2017, RISK FACTORS MUSCULO; David GC, 2005, OCCUP MED-OXFORD, V55, P190, DOI 10.1093/occmed/kqi082; Dennerlein JT, 2015, WORK, V52, P269, DOI 10.3233/WOR-152159; 엄수현, 2013, [Journal of Korea Safety Management & Science, 대한안전경영과학회지], V15, P113, DOI 10.12812/ksms.2013.15.2.113; eMarketer, 2014, 2 BILL CONS WORLDW G; Ericsson, 2015, ER MOB REP NOV 2015; Feveile H, 2002, INT ARCH OCC ENV HEA, V75, P243, DOI 10.1007/s00420-001-0298-9; Gustafsson E, 2010, J ELECTROMYOGR KINES, V20, P127, DOI 10.1016/j.jelekin.2008.11.010; Han Yi, 2012, Journal of Shanghai Jiaotong University (Science), V17, P39, DOI 10.1007/s12204-012-1227-7; Harrison DD, 1999, J MANIP PHYSIOL THER, V22, P594, DOI 10.1016/S0161-4754(99)70020-5; Hulley SB, 2015, DELINEANDO PESQUISA, V4; Johnston V, 2008, APPL ERGON, V39, P171, DOI 10.1016/j.apergo.2007.05.011; Kang JH, 2012, ANN REHABIL MED-ARM, V36, P98, DOI 10.5535/arm.2012.36.1.98; Karukunchit U, 2015, THESIS; Kelly G, 2009, WORK, V32, P321, DOI 10.3233/WOR-2009-0830; Kim GY, 2012, J PHYS THER SCI, V24, P1255, DOI 10.1589/jpts.24.1255; Kim HJ, 2015, J PHYS THER SCI, V27, P575, DOI 10.1589/jpts.27.575; Kim MS, 2015, J PHYS THER SCI, V27, P15, DOI 10.1589/jpts.27.15; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Laeser K. L., 1998, Journal of Research on Computing in Education, V31, P173; Lee J, 2014, J PHYS THER SCI, V26, P595, DOI 10.1589/jpts.26.595; Lee S, 2015, ERGONOMICS, V58, P220, DOI 10.1080/00140139.2014.967311; Maslen B, 2009, WORK, V32, P311, DOI 10.3233/WOR-2009-0829; MCATAMNEY L, 1993, APPL ERGON, V24, P91, DOI 10.1016/0003-6870(93)90080-S; Namwongsa S, 2015, DARE DESIRE; Namwongsa S, 2017, DARE DESIRE; Namwongsa S, 2018, WORK, V61, P367, DOI 10.3233/WOR-182819; Oates S., 1998, Computers in the Schools, V14, P55, DOI 10.1300/J025v14n03_06; Occupational Health and Safety Council of Ontario (OHSCO), 2007, RES MAN MSD PREV G 2; OSHA U.D.L, 2000, ERGONOMICS STUDY WOR; Rodjanapanurat N, 2014, THESIS; Saetan O, 2007, THESIS; Smedley J, 2003, OCCUP ENVIRON MED, V60, P864, DOI 10.1136/oem.60.11.864; Straker Leon, 2002, Work, V18, P239; Straker LM, 1997, APPL ERGON, V28, P263, DOI 10.1016/S0003-6870(96)00073-7; Toh SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181220; Viikari-Juntura E, 2001, OCCUP ENVIRON MED, V58, P345, DOI 10.1136/oem.58.5.345; Xie YF, 2016, ERGONOMICS, V59, P61, DOI 10.1080/00140139.2015.1056237; 김양곤, 2013, [Physical Therapy Korea, 한국전문물리치료학회지], V20, P10, DOI 10.12674/ptk.2013.20.1.010	46	14	14	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203394	10.1371/journal.pone.0203394	http://dx.doi.org/10.1371/journal.pone.0203394			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161266	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000443388900118
J	Arcidiacono, MV; Rimondi, E; Maietti, E; Melloni, E; Tisato, V; Gallo, S; Valdivielso, JM; Fernandez, E; Betriu, A; Voltan, R; Zauli, G; Volpato, S; Secchiero, P				Arcidiacono, Maria Vittoria; Rimondi, Erika; Maietti, Elisa; Melloni, Elisabetta; Tisato, Veronica; Gallo, Stefania; Manuel Valdivielso, Jose; Fernandez, Elvira; Betriu, Angels; Voltan, Rebecca; Zauli, Giorgio; Volpato, Stefano; Secchiero, Paola			Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease	PLOS ONE			English	Article							SUBCLINICAL ATHEROMATOSIS; ENDOTHELIAL FUNCTION; SOLUBLE TRAIL; LIGAND TRAIL; APOPTOSIS; RISK; EXPRESSION; MIGRATION; CYTOKINES; CHILDREN	Background Chronic kidney disease (CKD) patients experience a high risk of cardiovascular disease (CV); however, the factors involved in CV-related morbidity and mortality in these patients have not been fully defined. Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) is a cytokine, which exhibits pleiotropic activities on endothelial, vascular smooth muscle and inflammatory cells, with relevant effects on atheromatous plaque formation. On this basis, the present study aims to investigate the role of TRAIL in atheromatosis progression in CKD patients. Methods Circulating TRAIL levels were measured in 378 CKD patients belonging to the Spanish National Observatory of Atherosclerosis in Nephrology (NEFRONA) study. All patients were free of previous CV events. Carotid and femoral B-mode ultrasound was performed to detect the presence of plaque at baseline and after 24 months of follow-up. Results The lowest levels of TRAIL at baseline were significantly (p<0.05) associated with the appearance, after 24 months of follow-up, of at least two new atheromatous plaques in all territories and of one new plaque in the carotid artery, even after adjusting for CV risk factors. In addition, the patients with low levels of TRAIL at baseline were characterized by the presence of at least one hypoechoic plaque in the carotid artery. This association was significant (p<0.05) even after adjusting for CKD stage. Conclusions Overall, the results of our study suggest TRAIL as an assertable independent prognostic biomarker for atheromatosis plaque formation in CKD patients. This observation further supports the potential role of TRAIL for the prevention/treatment of CV disease.	[Arcidiacono, Maria Vittoria] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via Istria, Trieste, Italy; [Arcidiacono, Maria Vittoria; Rimondi, Erika; Melloni, Elisabetta; Tisato, Veronica; Gallo, Stefania; Voltan, Rebecca; Zauli, Giorgio; Secchiero, Paola] Univ Ferrara, Dept Morphol Surg & Expt Med, Via Fossato di Mortara 70, Ferrara, Italy; [Arcidiacono, Maria Vittoria; Rimondi, Erika; Melloni, Elisabetta; Tisato, Veronica; Gallo, Stefania; Voltan, Rebecca; Zauli, Giorgio; Secchiero, Paola] Univ Ferrara, LTTA Ctr, Via Fossato di Mortara 70, Ferrara, Italy; [Maietti, Elisa; Volpato, Stefano] Univ Ferrara, Dept Med Sci, Via Fossato di Mortara 64-B, Ferrara, Italy; [Manuel Valdivielso, Jose; Fernandez, Elvira; Betriu, Angels] Inst Invest Biomed Lleida IRBLleida, Grp Invest Translac Vasc & Renal, Lleida, Spain; [Manuel Valdivielso, Jose; Fernandez, Elvira; Betriu, Angels] Inst Invest Biomed Lleida IRBLleida, RedinRen RETIC, ISCIII, Lleida, Spain	IRCCS Burlo Garofolo; University of Ferrara; University of Ferrara; University of Ferrara; Instituto de Salud Carlos III	Arcidiacono, MV (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via Istria, Trieste, Italy.; Arcidiacono, MV (corresponding author), Univ Ferrara, Dept Morphol Surg & Expt Med, Via Fossato di Mortara 70, Ferrara, Italy.; Arcidiacono, MV (corresponding author), Univ Ferrara, LTTA Ctr, Via Fossato di Mortara 70, Ferrara, Italy.	arcivicki@hotmail.com	Rimondi, Erika/AAB-8237-2022; Melloni, Elisabetta/AAW-7880-2021; Melloni, Elisabetta/AAB-3890-2019; RIMONDI, Erika/AAB-6206-2022; Zauli, Giorgio/ABE-8001-2020; Tisato, Veronica/K-4525-2016; Valdivielso, Jose M/B-5673-2009	Melloni, Elisabetta/0000-0002-7829-0824; RIMONDI, Erika/0000-0002-8241-2513; Valdivielso, Jose M/0000-0003-1343-0184; Tisato, Veronica/0000-0001-8448-066X	Abbvie; Spanish government RETIC [RD16/0009/0011, FIS PI16/01354]; Italian Ministry of Health [GR-2013-02358192]; Associazione Italiana per la Ricerca sul Cancro, AIRC [18055]	Abbvie(AbbVie); Spanish government RETIC; Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro, AIRC(Fondazione AIRC per la ricerca sul cancro)	The NEFRONA study was funded by a research grant from Abbvie and the Spanish government RETIC (RD16/0009/0011) and FIS PI16/01354. MVA is the recipient of the Italian Ministry of Health grant No. GR-2013-02358192. SG is the recipient of the "Associazione Italiana per la Ricerca sul Cancro, AIRC" fellowship, No. 18055. Moreover, the authors would like to thank Fondazione Dott. Carlo Fornasini (Poggio Renatico, Ferrara, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinis C, 2012, HUM REPROD, V27, P2941, DOI 10.1093/humrep/des289; Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; [Anonymous], 2013, Kidney Int Suppl (2011), V3, P263; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Bernardi S, 2018, CLIN SCI, V132, P69, DOI 10.1042/CS20171221; Betriu A, 2014, NEPHROL DIAL TRANSPL, V29, P1415, DOI 10.1093/ndt/gfu038; Bossi F, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/680749; Brombo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058225; Caprio M, 2012, ARCH MED SCI, V8, P4, DOI 10.5114/aoms.2012.27271; Cartland SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092952; Chasseraud M, 2011, THER APHER DIAL, V15, P140, DOI 10.1111/j.1744-9987.2010.00886.x; Di Bartolo BA, 2011, DIABETOLOGIA, V54, P3157, DOI 10.1007/s00125-011-2308-0; Di Bartolo BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074211; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gokce N, 2002, CIRCULATION, V105, P1567, DOI 10.1161/01.CIR.0000012543.55874.47; Gracia M, 2016, CLIN J AM SOC NEPHRO, V11, P287, DOI 10.2215/CJN.01240215; Junyent M, 2010, NEFROLOGIA, V30, P119, DOI 10.3265/Nefrologia.pre2010.Jan.10216; Junyent M, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-14; Kavurma MM, 2008, BIOCHEM PHARMACOL, V75, P1441, DOI 10.1016/j.bcp.2007.10.020; Li JH, 2003, J IMMUNOL, V171, P1526, DOI 10.4049/jimmunol.171.3.1526; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P2596, DOI 10.1093/ndt/gfq042; Michowitz Y, 2005, J AM COLL CARDIOL, V45, P1018, DOI 10.1016/j.jacc.2004.12.065; Niessner A, 2009, EUR HEART J, V30, P789, DOI 10.1093/eurheartj/ehp004; Osmancik P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053860; Perri P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/424019; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Sato K, 2010, ATHEROSCLEROSIS, V213, P33, DOI 10.1016/j.atherosclerosis.2010.03.034; Secchiero P, 2005, BLOOD, V105, P3413, DOI 10.1182/blood-2004-10-4111; Secchiero P, 2004, CELL MOL LIFE SCI, V61, P1965, DOI 10.1007/s00018-004-4197-6; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Secchiero P, 2010, ATHEROSCLEROSIS, V210, P274, DOI 10.1016/j.atherosclerosis.2009.11.005; Secchiero P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004442; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; SORENSEN KE, 1994, J CLIN INVEST, V93, P50, DOI 10.1172/JCI116983; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Tornese G, 2015, ACTA DIABETOL, V52, P1003, DOI 10.1007/s00592-015-0731-2; Tornese G, 2014, ACTA DIABETOL, V51, P239, DOI 10.1007/s00592-013-0507-5; Touboul PJ, 2004, CEREBROVASC DIS, V18, P346, DOI 10.1159/000081812; Arcidiacono MV, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3795142; Volpato S, 2011, ATHEROSCLEROSIS, V215, P452, DOI 10.1016/j.atherosclerosis.2010.11.004; Voltanl R, 2016, INT J BIOCHEM CELL B, V81, P364, DOI 10.1016/j.biocel.2016.09.019; Watt V, 2011, ATHEROSCLEROSIS, V215, P348, DOI 10.1016/j.atherosclerosis.2011.01.010; Zauli G, 2006, CYTOKINE GROWTH F R, V17, P245, DOI 10.1016/j.cytogfr.2006.04.002; Zauli G, 2010, DIABETES, V59, P1261, DOI 10.2337/db09-1771	44	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203716	10.1371/journal.pone.0203716	http://dx.doi.org/10.1371/journal.pone.0203716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204795	Green Published, gold, Green Submitted			2022-12-26	WOS:000444355500041
J	Nykanen, M; Jessopp, M; Doyle, TK; Harman, LA; Canadas, A; Breen, P; Hunt, W; Mackey, M; Cadhla, OO; Reid, D; Rogan, E				Nykanen, Milaja; Jessopp, Mark; Doyle, Thomas K.; Harman, Luke A.; Canadas, Ana; Breen, Patricia; Hunt, William; Mackey, Mick; Cadhla, Oliver O.; Reid, David; Rogan, Emer			Using tagging data and aerial surveys to incorporate availability bias in the abundance estimation of blue sharks (Prionace glauca)	PLOS ONE			English	Article							EUROPEAN CONTINENTAL-SHELF; NORTHEAST ATLANTIC; BASKING SHARKS; PELAGIC SHARKS; OCEAN; CONSERVATION; POPULATION; FISHERIES; SOUTHWEST; BEHAVIOR	There is worldwide concern about the status of elasmobranchs, primarily as a result of over-fishing and bycatch with subsequent ecosystem effects following the removal of top predators. Whilst abundant and wide-ranging, blue sharks (Prionace glauca) are the most heavily exploited shark species having suffered marked declines over the past decades, and there is a call for robust abundance estimates. In this study, we utilized depth data collected from two blue sharks using pop-up satellite archival tags, and modelled the proportion of time the sharks were swimming in the top 1-meter layer and could therefore be detected by observers conducting aerial surveys. The availability models indicated that the tagged sharks preferred surface waters whilst swimming over the continental shelf and during daytime, with a model-predicted average proportion of time spent at the surface of 0.633 (SD = 0.094) for on-shelf, and 0.136 (SD = 0.075) for off-shelf. These predicted values were then used to account for availability bias in abundance estimates for the species over a large area in the Northeast Atlantic, derived through distance sampling using aerial survey data collected in 2015 and 2016 and modelled with density surface models. Further, we compared abundance estimates corrected with model-predicted availability to uncorrected estimates and to estimates that incorporated the average time the sharks were available for detection. The mean abundance (number of individuals) corrected with modelled availability was 15,320 (CV = 0.28) in 2015 and 11,001 (CV = 0.27) in 2016. Depending on the year, these estimates were -7 times higher compared to estimates without the bias correction, and similar to 3 times higher compared to the abundances corrected with average availability. When the survey area contains habitat heterogeneity that may affect surfacing patterns of animals, modelling animals' availability provides a robust alternative to correcting for availability bias and highlights the need for caution when applying "average" correction factors.	[Nykanen, Milaja; Jessopp, Mark; Doyle, Thomas K.; Harman, Luke A.; Breen, Patricia; Hunt, William; Mackey, Mick; Rogan, Emer] Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland; [Nykanen, Milaja; Doyle, Thomas K.; Harman, Luke A.; Hunt, William; Mackey, Mick; Rogan, Emer] Univ Coll Cork, Aquaculture & Fisheries Dev Ctr, Cork, Ireland; [Jessopp, Mark] Univ Coll Cork, MaREI Ctr, Environm Res Inst, Cork, Ireland; [Canadas, Ana] ALNILAM Res & Conservat Ltd, Madrid, Spain; [Breen, Patricia] Natl Univ Ireland, Sch Geog, Galway, Ireland; [Cadhla, Oliver O.] Natl Pk & Wildlife Serv, Dept Culture Heritage & Gaeltacht, Galway, Ireland; [Reid, David] Marine Inst, Galway, Ireland	University College Cork; University College Cork; University College Cork; Ollscoil na Gaillimhe-University of Galway; Marine Institute Ireland	Nykanen, M; Rogan, E (corresponding author), Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland.; Nykanen, M; Rogan, E (corresponding author), Univ Coll Cork, Aquaculture & Fisheries Dev Ctr, Cork, Ireland.	m.nykanen@ucc.ie; e.rogan@ucc.ie	Canadas, Ana/AAA-5761-2019; Reid, David/ABC-5916-2021; Jessopp, Mark/AAI-4786-2020	Jessopp, Mark/0000-0002-2692-3730; Breen, Patricia/0000-0002-5556-5426; Nykanen, Milaja/0000-0002-5489-7162; Breen, Paul/0000-0002-8860-2086; Doyle, Thomas/0000-0003-1616-5590	Ireland's Department of Communication, Climate Action and Environment; Department of Culture, Heritage and the Gaeltacht, under Ireland's ObSERVE Programme; UCC Strategic Research Fund 2013; Department of Agriculture, Food and the Marine's Competitive Research Funding programmes; ALNILAM Research; Conservation Ltd	Ireland's Department of Communication, Climate Action and Environment; Department of Culture, Heritage and the Gaeltacht, under Ireland's ObSERVE Programme; UCC Strategic Research Fund 2013; Department of Agriculture, Food and the Marine's Competitive Research Funding programmes; ALNILAM Research; Conservation Ltd	The funding for the aerial surveys in this project were provided by Ireland's Department of Communication, Climate Action and Environment and the Department of Culture, Heritage and the Gaeltacht, under Ireland's ObSERVE Programme established in 2014. Blue shark tagging was supported by UCC Strategic Research Fund 2013. MN was supported by Project FishKosm that is funded by the Department of Agriculture, Food and the Marine's Competitive Research Funding programmes. ALNILAM Research and Conservation Ltd provided support in the form of salaries for author AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Some of the offshore designs for the aerial surveys in this project were provided by Ireland's Department of Communication, Climate Action and Environment and the Department of Culture, Heritage and the Gaeltacht, under Ireland's ObSERVE Programme established in 2014. We are grateful for the support and assistance of both Departments in undertaking this work. We would like to thank the Aerosotravia pilots Romain Fert, Paul Rameau, Laurent Pellicer and Aurelien Bidot, the plane's engineer Noel Bar and the observers Nick Richardson, Ashley Bennison, Ailbhe Kavanagh, Nicole Janinhoff, Steve Geelhoed and Hans Verdaat for their contribution to the study and Enrico Pirotta for the statistical advice.	Aires-da-Silva Alexandre, 2008, Fish and Aquatic Resources Series, V13, P230; Baines M, 2017, DEEP-SEA RES PT II, V141, P168, DOI 10.1016/j.dsr2.2017.03.007; Barker MJ, 2005, AQUAT CONSERV, V15, P325, DOI 10.1002/aqc.660; Bauer RK, 2015, MAR ECOL PROG SER, V534, P221, DOI 10.3354/meps11392; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Breen P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02103-6; Buckland S. T., 2001, INTRODUCTION TO DIST; Burns RJ, 2008, NEW ZEAL J MAR FRESH, V42, P23, DOI 10.1080/00288330809509933; Campana SE, 2006, CAN J FISH AQUAT SCI, V63, P670, DOI 10.1139/f05-251; Canadas A., 2008, Endangered Species Research, V4, P309, DOI 10.3354/esr00073; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; Carvalho F, 2015, ICES J MAR SCI, V72, P1715, DOI 10.1093/icesjms/fsv026; Carvalho FC, 2011, ICES J MAR SCI, V68, P890, DOI 10.1093/icesjms/fsr047; Carvalho FC, 2010, AQUAT LIVING RESOUR, V23, P373, DOI 10.1051/alr/2011005; Cortes E., 2015, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V71, P2637; Cramer H, 1928, SKAND AKTUARIETIDSKR, V11, P13; di Sciara GN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141189; Doyle Thomas K., 2008, Endangered Species Research, V4, P23, DOI 10.3354/esr00076; Doyle TK, 2015, ANIM BIOTELEM, V3, P46; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Fitzmaurice P., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P1171; Fox J., 2002, AN R AND S PLUS COMP; Gelman A., 2004, BAYESIAN DATA ANALYS; Gibson C, 2008, THE CONSERVATION OF, P76; Hastie T., 1986, STAT SCI, V1, P297; Heide-Jorgensen MP, 2015, SURFACING TIME AVAIL, V9; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Henderson AC, 2001, J FISH BIOL, V58, P1347, DOI 10.1111/j.1095-8649.2001.tb02291.x; HOLLIGAN PM, 1981, PHILOS T R SOC A, V302, P547, DOI 10.1098/rsta.1981.0182; Holt J, 2008, CONT SHELF RES, V28, P887, DOI 10.1016/j.csr.2008.01.012; Ibaibarriaga L, 2007, FISH OCEANOGR, V16, P284, DOI 10.1111/j.1365-2419.2007.00430.x; Kessel ST, 2013, J MAR BIOL, V2013, P1, DOI DOI 10.1155/2013/597383; Liu F, 2015, R J, V7, P34; Miller D. L, 2017, PACKAGE DISTANCE; Miller DL, 2017, PACKAGE DSM; Mises R., 1972, WAHRSCHEINLICHKEIT S, DOI [10.1007/978-3-7091-8287-1, DOI 10.1007/978-3-7091-8287-1]; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nakamura I, 2015, J ANIM ECOL, V84, P590, DOI 10.1111/1365-2656.12346; Nakano H., 2008, SHARKS OPEN OCEAN BI, P140, DOI DOI 10.1002/9781444302516; Pante E., 2015, MAKING USING BATHYME, P1; Queiroz N, 2005, J MAR BIOL ASSOC UK, V85, P1107, DOI 10.1017/S0025315405012154; Queiroz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032374; Queiroz N, 2010, MAR ECOL PROG SER, V406, P265, DOI 10.3354/meps08500; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Rogan E, 2007, FISH RES, V86, P6, DOI 10.1016/j.fishres.2007.02.013; Rowat D, 2009, J EXP MAR BIOL ECOL, V368, P1, DOI 10.1016/j.jembe.2008.09.001; Seminoff JA, 2014, ENDANGER SPECIES RES, V24, P207, DOI 10.3354/esr00601; Sharples J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040683; Sims DW, 2005, J ANIM ECOL, V74, P755, DOI 10.1111/j.1365-2656.2005.00971.x; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Stevens J, 2009, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2009-2.RLTS.T39381A10222811.en, DOI 10.2305/IUCN.UK.2009-2.RLTS.T39381A10222811.EN]; STEVENS JD, 1973, J MAR BIOL ASSOC UK, V53, P357, DOI 10.1017/S0025315400022323; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thomson JA, 2012, METHODS ECOL EVOL, V3, P378, DOI 10.1111/j.2041-210X.2011.00163.x; Thums M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0477; Vandeperre F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103538; Vandeperre F, 2014, FISH RES, V153, P89, DOI 10.1016/j.fishres.2014.01.006; Westgate AJ, 2014, ENDANGER SPECIES RES, V23, P177, DOI 10.3354/esr00567; Wogerbauer Ciara, 2016, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V72, P1150; Wood S., 2015, R PACKAGE VERSION	62	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203122	10.1371/journal.pone.0203122	http://dx.doi.org/10.1371/journal.pone.0203122			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204764	Green Published, Green Submitted, gold			2022-12-26	WOS:000444355500018
J	Zielonka, M; Breuer, M; Okun, JG; Carl, M; Hoffmann, GF; Kolker, S				Zielonka, Matthias; Breuer, Maximilian; Okun, Juergen Guenther; Carl, Matthias; Hoffmann, Georg Friedrich; Koelker, Stefan			Pharmacologic rescue of hyperammonemia-induced toxicity in zebrafish by inhibition of ornithine aminotransferase	PLOS ONE			English	Article							UREA-CYCLE DISORDERS; ACUTE LIVER-FAILURE; MITOCHONDRIAL PERMEABILITY TRANSITION; GLUTAMATE TRANSPORTER; NMDA RECEPTORS; AMINO-ACIDS; TRANSCARBAMYLASE DEFICIENCY; CONGENITAL HYPERAMMONEMIA; HEPATIC-ENCEPHALOPATHY; MONOSODIUM GLUTAMATE	Hyperammonemia is the common biochemical hallmark of urea cycle disorders, activating neurotoxic pathways. If untreated, affected individuals have a high risk of irreversible brain damage and mortality. Here we show that acute hyperammonemia strongly enhances transamination-dependent formation of osmolytic glutamine and excitatory glutamate, thereby inducing neurotoxicity and death in ammoniotelic zebrafish larvae via synergistically acting overactivation of NMDA receptors and bioenergetic impairment induced by depletion of 2-oxoglutarate. Intriguingly, specific and irreversible inhibition of ornithine aminotransferase (OAT) by 5-fluoromethylornithine rescues zebrafish from lethal concentrations of ammonium acetate and corrects hyperammonemia-induced biochemical alterations. Thus, OAT inhibition is a promising and effective therapeutic approach for preventing neurotoxicity and mortality in acute hyperammonemia.	[Zielonka, Matthias; Breuer, Maximilian; Okun, Juergen Guenther; Hoffmann, Georg Friedrich; Koelker, Stefan] Univ Hosp Heidelberg, Ctr Child & Adolescent Med, Div Pediat Neurol & Metab Med, Heidelberg, Germany; [Zielonka, Matthias] HRCMM, Heidelberg, Germany; [Carl, Matthias] Heidelberg Univ, Med Fac Mannheim, Dept Cell & Mol Biol, Mannheim, Germany; [Carl, Matthias] Univ Trento, Ctr Integrat Biol CIBIO, Lab Translat Neu rogenet, Trento, Italy	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Trento	Zielonka, M (corresponding author), Univ Hosp Heidelberg, Ctr Child & Adolescent Med, Div Pediat Neurol & Metab Med, Heidelberg, Germany.; Zielonka, M (corresponding author), HRCMM, Heidelberg, Germany.	matthias.zielonka@med.uni-heidelberg.de		Carl, Matthias/0000-0002-9936-5813	Physician-Scientist Program at Ruprecht-Karls-University Heidelberg Faculty of Medicine; Heidelberg Research Center for Molecular Medicine (HRCMM) of Excellence Initiative II of the German Research Foundation	Physician-Scientist Program at Ruprecht-Karls-University Heidelberg Faculty of Medicine; Heidelberg Research Center for Molecular Medicine (HRCMM) of Excellence Initiative II of the German Research Foundation	Matthias Zielonka was supported by the Physician-Scientist Program at Ruprecht-Karls-University Heidelberg Faculty of Medicine and a Career Development Fellowship provided by the Heidelberg Research Center for Molecular Medicine (HRCMM) in the framework of Excellence Initiative II of the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah Mew N, 2013, J PEDIAT, V162, DOI [10.1016/j.jpeds.2012.06, DOI 10.1016/J.JPEDS.2012.06]; Alvarez VM, 2011, J NEUROSCI RES, V89, P2028, DOI 10.1002/jnr.22708; Ambrosi G, 2014, J NEURAL TRANSM, V121, P849, DOI 10.1007/s00702-013-1149-z; Andre VM, 2010, CNS NEUROSCI THER, V16, P163, DOI 10.1111/j.1755-5949.2010.00134.x; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bachmann C, 2004, MOL GENET METAB, V81, pS52, DOI 10.1016/j.ymgme.2003.10.014; Bachmann C, 2003, EUR J PEDIATR, V162, P410, DOI 10.1007/s00431-003-1188-9; Bai G, 2001, J NEUROSCI RES, V66, P981, DOI 10.1002/jnr.10056; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Benuck M, 1975, Int Rev Neurobiol, V17, P85, DOI 10.1016/S0074-7742(08)60208-1; BESSMAN SP, 1955, J CLIN INVEST, V34, P622, DOI 10.1172/JCI103111; Blasco H, 2014, CURR MED CHEM, V21, P3551, DOI 10.2174/0929867321666140916120118; Bouzier-Sore AK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00179; Braissant O, 2010, MOL GENET METAB, V100, pS3, DOI 10.1016/j.ymgme.2010.02.010; Braun MH, 2009, AM J PHYSIOL-RENAL, V296, pF994, DOI 10.1152/ajprenal.90656.2008; Burgard P, 2016, J INHERIT METAB DIS, V39, P219, DOI 10.1007/s10545-015-9901-1; Cagnon L, 2007, BRAIN RES REV, V56, P183, DOI 10.1016/j.brainresrev.2007.06.026; Camacho A, 2006, ARCH MED RES, V37, P11, DOI 10.1016/j.arcmed.2005.05.014; Chan H, 2000, NEUROCHEM INT, V37, P243, DOI 10.1016/S0197-0186(00)00026-7; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CONNELLY A, 1993, PEDIATR RES, V33, P77, DOI 10.1203/00006450-199301000-00016; Corbo CP, 2012, MICROSC RES TECHNIQ, V75, P325, DOI 10.1002/jemt.21061; Coulter DA, 2012, GLIA, V60, P1215, DOI 10.1002/glia.22341; Cox JA, 2005, DEV DYNAM, V234, P756, DOI 10.1002/dvdy.20532; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Dallerac G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00159; Dam G, 2013, HEPATOLOGY, V57, P258, DOI 10.1002/hep.25995; DAUNE G, 1988, BIOCHEM J, V253, P481, DOI 10.1042/bj2530481; DEKNEGT RJ, 1994, J HEPATOL, V20, P19, DOI 10.1016/S0168-8278(05)80462-3; Dhanasiri AKS, 2012, COMP BIOCHEM PHYS B, V163, P274, DOI 10.1016/j.cbpb.2012.06.003; Dingledine R, 1999, PHARMACOL REV, V51, P7; Enns GM, 2007, NEW ENGL J MED, V356, P2282, DOI 10.1056/NEJMoa066596; Feldman B, 2014, MOL GENET METAB, V113, P142, DOI 10.1016/j.ymgme.2014.07.001; Fontana ACK, 2015, J NEUROCHEM, V134, P982, DOI 10.1111/jnc.13200; Furukawa F, 2015, INT J BIOL SCI, V11, P712, DOI 10.7150/ijbs.11827; GREENAMYRE JT, 1994, NEUROLOGY, V44, P7; Grupp L, 2010, J COMP NEUROL, V518, P4277, DOI 10.1002/cne.22481; Haberle J, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-32; Hakvoort TBM, 2017, HEPATOLOGY, V65, P281, DOI 10.1002/hep.28852; HELENIUS A, 1972, J BIOL CHEM, V247, P3656; Husson MC, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0513-0; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; INOUE I, 1987, BIOCHEM MED METAB B, V38, P378, DOI 10.1016/0885-4505(87)90102-2; Johnston MV, 2005, BRAIN PATHOL, V15, P234; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klejman A, 2005, NEUROCHEM INT, V47, P51, DOI 10.1016/j.neuint.2005.04.006; Kolker S, 2015, J INHERIT METAB DIS, V38, P1041, DOI 10.1007/s10545-015-9839-3; LeMoine CMR, 2013, AM J PHYSIOL-REG I, V304, pR991, DOI 10.1152/ajpregu.00411.2012; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marini AM, 2006, CURR GENET, V49, P364, DOI 10.1007/s00294-006-0062-5; McBride KL, 2004, PEDIATRICS, V114, pE523, DOI 10.1542/peds.2004-0198; McKeown KA, 2012, DEV BIOL, V362, P162, DOI 10.1016/j.ydbio.2011.11.001; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Meredith GE, 2009, EXP NEUROL, V219, P334, DOI 10.1016/j.expneurol.2009.06.005; Mew NA, 2013, J PEDIATR-US, V162, P324, DOI 10.1016/j.jpeds.2012.06.065; Michalak A, 1996, HEPATOLOGY, V24, P908, DOI 10.1002/hep.510240425; Mirando AC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13160; Morioka D, 2005, LIVER TRANSPLANT, V11, P1332, DOI 10.1002/lt.20587; MORONI F, 1983, J NEUROCHEM, V40, P850, DOI 10.1111/j.1471-4159.1983.tb08057.x; Nettesheim S, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0661-x; OLNEY JW, 1969, SCIENCE, V166, P386, DOI 10.1126/science.166.3903.386; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; Perez-Mato M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.507; Posset R, 2016, J INHERIT METAB DIS, V39, P661, DOI 10.1007/s10545-016-9938-9; RAO VLR, 1991, NEUROSCI LETT, V130, P251; Ratnakumari L, 1996, NEUROSCI LETT, V215, P153, DOI 10.1016/0304-3940(96)12975-X; RATNAKUMARI L, 1995, METAB BRAIN DIS, V10, P249, DOI 10.1007/BF02081030; RATNAKUMARI L, 1992, BIOCHEM BIOPH RES CO, V184, P746, DOI 10.1016/0006-291X(92)90653-3; Rodrigo R, 2009, NEUROCHEM INT, V55, P113, DOI 10.1016/j.neuint.2009.01.007; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; SIMELL O, 1973, LANCET, V1, P1031; Singh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095855; Skarpetas A, 1997, BIOCHEM MOL BIOL INT, V43, P133; Steinke D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-20; Strauss GI, 2003, LIVER TRANSPLANT, V9, P1244, DOI 10.1016/j.lts.2003.09.020; Summar ML, 2008, ACTA PAEDIATR, V97, P1420, DOI 10.1111/j.1651-2227.2008.00952.x; Summar ML, 2013, MOL GENET METAB, V110, P179, DOI 10.1016/j.ymgme.2013.07.008; Takahashi K, 2015, CELL MOL LIFE SCI, V72, P3489, DOI 10.1007/s00018-015-1937-8; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Unsinn C, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0493-0; van Karnebeek CD, 2014, AM J HUM GENET, V94, P453, DOI 10.1016/j.ajhg.2014.01.006; Wood Chris M., 1993, P379; ZIMMERMAN HJ, 1964, GASTROENTEROLOGY, V46, P613; Zwingmann C, 2003, HEPATOLOGY, V37, P420, DOI 10.1053/jhep.2003.50052	87	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2018	13	9							e0203707	10.1371/journal.pone.0203707	http://dx.doi.org/10.1371/journal.pone.0203707			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7DK	30199544	gold, Green Submitted, Green Published			2022-12-26	WOS:000444681100020
J	Hammack, PL; Meyer, IH; Krueger, EA; Lightfoot, M; Frost, DM				Hammack, Phillip L.; Meyer, Ilan H.; Krueger, Evan A.; Lightfoot, Marguerita; Frost, David M.			HIV testing and pre-exposure prophylaxis (PrEP) use, familiarity, and attitudes among gay and bisexual men in the United States: A national probability sample of three birth cohorts	PLOS ONE			English	Article							TRANSGENDER WOMEN; YOUNG MEN; SEX; AWARENESS; STIGMA; PREVENTION; WILLINGNESS; BAREBACKING; STRAIGHT; HEALTH	This study examined HIV testing and use, familiarity, and attitudes toward pre-exposure prophylaxis (PrEP) among HIV-negative gay and bisexual men in the United States. A national probability sample (N = 470) of three age cohorts (18 +/- 25, 34 +/- 41, and 52 +/- 59 years) completed a survey between March, 2016 and March, 2017. Most men did not meet CDC recommendations for HIV testing, and 25.2% of men in the younger cohort had never tested. Only 4.1% used PrEP across cohorts. Visiting an LGBT clinic and searching for LGBT resources online were associated with PrEP use. Men in the middle cohort were more familiar with PrEP (79%) than men in the younger (52%) and older (57%) cohorts. Bisexual and non-urban men were less familiar with PrEP. Attitudes were positive among most men (68.4%) familiar with PrEP. Findings suggest that most men potentially at risk for HIV do not meet CDC guidelines for testing, and PrEP use continues to be minimal. Efforts to educate gay and bisexual men about HIV risk and prevention need to be reinvigorated and expanded to include non-gay-identified and non-urban men.	[Hammack, Phillip L.] Univ Calif Santa Cruz, Dept Psychol, Santa Cruz, CA 95064 USA; [Meyer, Ilan H.; Krueger, Evan A.] UCLA, Sch Law, Williams Inst, Los Angeles, CA 90024 USA; [Lightfoot, Marguerita] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Frost, David M.] UCL, Dept Social Sci, London, England	University of California System; University of California Santa Cruz; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; University of London; University College London	Hammack, PL (corresponding author), Univ Calif Santa Cruz, Dept Psychol, Santa Cruz, CA 95064 USA.	hammack@ucsc.edu	Meyer, Ilan H/A-2142-2009	Frost, David/0000-0001-9284-5219; Hammack, Phillip/0000-0003-2203-858X	National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health [R01HD078526]; Center for Advanced Study in the Behavioral Sciences, Stanford University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD078526] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Center for Advanced Study in the Behavioral Sciences, Stanford University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research reported in this article is part of the Generations Study, supported by the National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health under award number R01HD078526. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Generations investigators are: Ilan H. Meyer, Ph.D. (Principal Investigator), David M. Frost, Ph.D., Phillip L. Hammack, Ph.D., Marguerita Lightfoot, Ph.D., Stephen T. Russell, Ph.D., and Bianca D.M. Wilson, Ph.D. (Co-Investigators, listed alphabetically). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Hammack work was also funded by the Center for Advanced Study in the Behavioral Sciences, Stanford University.	Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173; Bradley H, 2014, MMWR-MORBID MORTAL W, V63, P1113; Cahill S, 2017, AIDS CARE, V29, P1351, DOI 10.1080/09540121.2017.1300633; Carballo-Dieguez A, 2004, J HOMOSEXUAL, V47, P1, DOI 10.1300/J082v47n01_01; Carrillo H, 2018, SEXUALITIES, V21, P90, DOI 10.1177/1363460716678561; Carrillo H, 2016, GLOB PUBLIC HEALTH, V11, P923, DOI 10.1080/17441692.2015.1134272; Centers for Disease Control and Prevention, 2018, US PUBL HLTH SERV PR; Centers for Disease Control and Prevention (CDC), 2016, HIV SURV REP 2015; Centers for Disease Control and Prevention (CDC), 2018, HIV AFR AM GAY BIS M; DiNenno EA, 2017, MMWR-MORBID MORTAL W, V66, P830, DOI 10.15585/mmwr.mm6631a3; Eaton LA, 2017, PREV SCI, V18, P505, DOI 10.1007/s11121-017-0756-6; Eaton LA, 2017, AIDS BEHAV, V21, P1236, DOI 10.1007/s10461-017-1690-0; Fallon SA, 2017, AIDS BEHAV, V21, P1268, DOI 10.1007/s10461-016-1619-z; Febo-Vazquez Isaedmarie, 2018, Natl Health Stat Report, P1; Forstein M, 2013, J GAY LESBIAN MENT H, V17, P40, DOI 10.1080/19359705.2013.740212; Frost D. M., QUALITATIVE PSYCHOL, DOI [10.1037/qup0000064, DOI 10.1037/QUP0000064]; Frost DM, 2012, J SEX RES, V49, P36, DOI 10.1080/00224499.2011.565427; Goedel WC, 2016, AIDS BEHAV, V20, P1435, DOI 10.1007/s10461-016-1353-6; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P621, DOI 10.1089/apc.2013.0245; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Halkitis P.N., 2014, AIDS GENERATION STOR; Halkitis PN, 2003, ARCH SEX BEHAV, V32, P351, DOI 10.1023/A:1024095016181; Hall HI, 2012, AIDS BEHAV, V16, P36, DOI 10.1007/s10461-011-9944-8; Hammack PL, 2018, ARCH SEX BEHAV, V47, P59, DOI 10.1007/s10508-017-0990-9; Herek GM, 2009, J COUNS PSYCHOL, V56, P32, DOI 10.1037/a0014672; Klevens R. M., 2014, AIDS BEHAV; Kubicek K, 2015, ARCH SEX BEHAV, V44, P487, DOI 10.1007/s10508-014-0398-8; Kuhns LM, 2017, AIDS BEHAV, V21, P1376, DOI 10.1007/s10461-017-1739-0; Kwakwa HA, 2016, AIDS BEHAV, V20, P1443, DOI 10.1007/s10461-016-1407-9; Lachowsky NJ, 2016, AIDS BEHAV, V20, P1408, DOI 10.1007/s10461-016-1319-8; Merchant RC, 2016, J GAY LESBIAN MENT H, V20, P21, DOI 10.1080/19359705.2015.1105115; Mohr JJ, 2011, J COUNS PSYCHOL, V58, P234, DOI 10.1037/a0022858; Oldenburg CE, 2016, AIDS BEHAV, V20, P1451, DOI 10.1007/s10461-015-1226-4; Parsons JT, 2017, JAIDS-J ACQ IMM DEF, V74, P285, DOI 10.1097/QAI.0000000000001251; Pottie K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006859; Rendina HJ, 2017, SOC SCI MED, V172, P115, DOI 10.1016/j.socscimed.2016.10.030; Schwarcz S, 2011, AIDS CARE, V23, P892, DOI 10.1080/09540121.2010.534436; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4	38	54	54	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202806	10.1371/journal.pone.0202806	http://dx.doi.org/10.1371/journal.pone.0202806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT0BU	30192791	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600037
J	Tu, AG; Xie, SH; Yu, ZB; Li, Y; Nie, XF				Tu, Anguo; Xie, Songhua; Yu, Zhongbo; Li, Ying; Nie, Xiaofei			Long-term effect of soil and water conservation measures on runoff, sediment and their relationship in an orchard on sloping red soil of southern China	PLOS ONE			English	Article							YELLOW-RIVER; DISCHARGE; MANAGEMENT; EROSION; IMPACTS; REGION; STREAMFLOW; TRANSPORT; PATTERNS; PLATEAU	The effect of soil and water conservation measures (SWCMs) is usually dependent on time. Thus the trend in reducing runoff and sediment over time is a very important theoretical problem for evaluating the effectiveness of SWCMs. Moreover, there is still a lack of comprehensive assessment of water erosion dynamics following implementing SWCMs despite their ecological significance. Therefore, the long-term impact of SWCMs on runoff and sediment and their relationships was assessed for an orchard on sloping red soil in southern China. Overland flow and erosion sediment were continuously observed for 15 years on citrus experimental plots under one of four treatments: grass strips, strip inter-cropping, level terrace and clean-tillage. By means of Mann-Kendall trend tests and double cumulative curves, the time series of runoff and sediment under the different treatments were analyzed. Furthermore, we linked the effect of soil conservation and the relationship between runoff and sediment variation to determine the mechanism of conservation measures on sediment reduction. The results showed that the first 4 years was the key period to prevent soil erosion for this orchard, and then the intensity of soil erosion decreased below 500 t.km(-2).a(-1). Considering economic costs and ecological effect, grass strips were the best protective measure for this test situation. The fitted curves of the effect of SWCMs on sediment reduction over time showed an 'L' form, but on runoff there was an approximately horizontal line. The SWCMs did not change the rainfall-runoff relationship, but did change the runoff-sediment erosion relationship. The erosion reduction mechanism of SWCMs in the early phase was a joint function of reducing runoff and changing the runoff-sediment relationship, and in the post-stable phase it worked mainly by reducing runoff. The results provide the basis for rational allocation of SWCMs considering location and time.	[Tu, Anguo; Yu, Zhongbo] Hohai Univ, Coll Hydrol & Water Resources, Nanjing, Jiangsu, Peoples R China; [Tu, Anguo; Xie, Songhua; Li, Ying; Nie, Xiaofei] Jiangxi Prov Key Lab Soil Eros & Prevent, Nanchang, Jiangxi, Peoples R China	Hohai University	Yu, ZB (corresponding author), Hohai Univ, Coll Hydrol & Water Resources, Nanjing, Jiangsu, Peoples R China.	zyu@hhu.edu.cn			National Natural Science Foundation of China [41461060]; Jiangxi Provincial Science and Technology Development Funds [20161BBI90041]; Jiangxi Provincial Natural Science Funds for Distinguished Young Scholar [20162BC23055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi Provincial Science and Technology Development Funds; Jiangxi Provincial Natural Science Funds for Distinguished Young Scholar	This work was funded by the National Natural Science Foundation of China (No. 41461060), Jiangxi Provincial Science and Technology Development Funds (No.20161BBI90041), and Jiangxi Provincial Natural Science Funds for Distinguished Young Scholar (No.20162BC23055).	Adgo E, 2013, AGR WATER MANAGE, V117, P55, DOI 10.1016/j.agwat.2012.10.026; Bastia F, 2016, GLOBAL PLANET CHANGE, V144, P51, DOI 10.1016/j.gloplacha.2016.07.004; BRADFORD JM, 1987, SOIL SCI SOC AM J, V51, P1566, DOI 10.2136/sssaj1987.03615995005100060029x; Cao YB, 2017, ECOL ENG, V102, P270, DOI 10.1016/j.ecoleng.2017.02.043; Cerda A, 2010, EARTH SURF PROCESSES, V34, P1822; Cerda A, 2017, ECOL ENG, V108, P162, DOI 10.1016/j.ecoleng.2017.08.028; Chu ZX, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039513; Clarke RT, 2002, HYDROL EARTH SYST SC, V6, P17, DOI 10.5194/hess-6-17-2002; Darboux F, 2005, SOIL SCI SOC AM J, V69, P748, DOI 10.2136/sssaj2003.0311; Garbrecht JD, 2009, ECOHYDROLOGY, V2, P313, DOI 10.1002/eco.55; Hernandez AJ, 2005, AGR WATER MANAGE, V77, P232, DOI 10.1016/j.agwat.2004.09.030; [胡春宏 Hu Chunhong], 2010, [水科学进展, Advances in Water Science], V21, P524; Huang L, 2012, ECOL ENG, V44, P53, DOI 10.1016/j.ecoleng.2012.03.007; Jiang C, 2017, ECOL ENG, V102, P240, DOI 10.1016/j.ecoleng.2017.01.029; Jiang C, 2015, WATER-SUI, V7, P5849, DOI 10.3390/w7105849; Keesstra S, 2018, SCI TOTAL ENVIRON, V610, P997, DOI 10.1016/j.scitotenv.2017.08.077; Keesstra S, 2016, SCI TOTAL ENVIRON, V551, P357, DOI 10.1016/j.scitotenv.2016.01.182; Li ZW, 2016, J HYDROL, V542, P836, DOI 10.1016/j.jhydrol.2016.09.049; Liang Y, 2010, J MT SCI-ENGL, V7, P92, DOI 10.1007/s11629-010-1052-0; Madejon E, 2009, SOIL TILL RES, V105, P55, DOI 10.1016/j.still.2009.05.007; Maetens W, 2012, EARTH-SCI REV, V115, P21, DOI 10.1016/j.earscirev.2012.08.003; Meade RH, 2010, HYDROL PROCESS, V24, P35, DOI 10.1002/hyp.7477; Oeurng C, 2010, EARTH SURF PROC LAND, V35, P1289, DOI 10.1002/esp.1971; Ouyang Y, 2013, ECOL ENG, V61, P394, DOI 10.1016/j.ecoleng.2013.09.057; Palese AM, 2014, SOIL TILL RES, V144, P96, DOI 10.1016/j.still.2014.07.010; Panagos P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04282-8; Panda DK, 2011, GLOBAL PLANET CHANGE, V75, P108, DOI 10.1016/j.gloplacha.2010.10.012; Ran LS, 2013, GLOBAL PLANET CHANGE, V100, P308, DOI 10.1016/j.gloplacha.2012.11.001; Rusinamhodzi L, 2011, AGRON SUSTAIN DEV, V31, P657, DOI 10.1007/s13593-011-0040-2; Saiz G, 2016, GEODERMA, V274, P1, DOI 10.1016/j.geoderma.2016.03.022; Shui JG, 2008, PEDOSPHERE, V18, P214, DOI 10.1016/S1002-0160(08)60009-0; [孙鹏 Sun Peng], 2010, [地理学报, Acta Geographica Sinica], V65, P828; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Tabari H, 2011, GLOBAL PLANET CHANGE, V79, P1, DOI 10.1016/j.gloplacha.2011.07.008; Tan CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17592; Tang QH, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050834; Vaighan AA, 2017, ENVIRON EARTH SCI, V76, DOI 10.1007/s12665-017-6880-6; Walling DE, 2003, GLOBAL PLANET CHANGE, V39, P111, DOI 10.1016/S0921-8181(03)00020-1; Wang SA, 2016, NAT GEOSCI, V9, P38, DOI [10.1038/ngeo2602, 10.1038/NGEO2602]; Wang S, 2017, SCI TOTAL ENVIRON, V576, P453, DOI 10.1016/j.scitotenv.2016.10.124; [王英俊 Wang Yingjun], 2013, [草地学报, Acta Agrestia Sinica], V21, P485; Wei YH, 2016, CATENA, V140, P105, DOI 10.1016/j.catena.2016.01.016; Xie Y, 2016, J HYDROL, V535, P547, DOI 10.1016/j.jhydrol.2016.02.020; [许炯心 XU Jiongxin], 2006, [水科学进展, Advances in Water Science], V17, P610; Yang Xiaozhu, 2016, Horticultural Plant Journal, V2, P331, DOI 10.1016/j.hpj.2016.11.005; Zhang HD, 2014, CATENA, V123, P106, DOI 10.1016/j.catena.2014.07.013; Zhang JC, 2017, NAT PROD RES, V31, P2745, DOI 10.1080/14786419.2017.1295235; Zhang W, 2012, CONT SHELF RES, V38, P35, DOI 10.1016/j.csr.2012.02.017; Zhang XP, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006711; Zhao GJ, 2010, WATER RESOUR MANAG, V24, P689, DOI 10.1007/s11269-009-9465-7; Zheng FL, 2005, AGR ECOSYST ENVIRON, V108, P85, DOI 10.1016/j.agee.2004.12.009; Zheng H, 2010, SCI SOIL WATER CONSE, V8, P36	52	18	19	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203669	10.1371/journal.pone.0203669	http://dx.doi.org/10.1371/journal.pone.0203669			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192881	Green Submitted, Green Published, gold			2022-12-26	WOS:000444093600130
J	Mao, L; He, J; Gao, X; Guo, H; Wang, K; Zhang, XH; Yang, WW; Zhang, JY; Li, SG; Hu, YH; Mu, L; Van, YZ; Ma, JL; Ding, YS; Zhang, M; Liu, JM; Ma, RL; Guo, SX				Mao, Lei; He, Jia; Gao, Xiang; Guo, Heng; Wang, Kui; Zhang, Xianghui; Yang, Wenwen; Zhang, Jingyu; Li, Shugang; Hu, Yunhua; Mu, Lati; Van, Yizhong; Ma, Jiaolong; Ding, Yusong; Zhang, Mei; Liu, Jiaming; Ma, Rulin; Guo, Shuxia			Metabolic syndrome in Xinjiang Kazakhs and construction of a risk prediction model for cardiovascular disease risk	PLOS ONE			English	Article							BILIRUBIN; CHINESE; EVENTS; ADULTS; MEN	Background The high prevalence of metabolic syndrome (MetS) and cardiovascular diseases (CVD) is observed among Kazakhs in Xinjiang. Because MetS may significantly predict the occurrence of CVD, the inclusion of CVD-related indicators in metabolic network may improve the predictive ability for a CVD-risk model for Kazakhs in Xinjiang. Methods The study included 2,644 subjects who were followed for 5 years or longer. CVD cases were identified via medical records of the local hospitals from April 2016 to August 2017. Factor analysis was performed in 706 subjects (267 men and 439 women) with MetS to extract CVD-related potential factors from 18 biomarkers tested in a routine health check-up, served as a synthetic predictor (SP). We evaluated the predictive ability of the CVD-risk model using age and SP, logistic regression discrimination for internal validation (n = 384; men = 164, women = 220) and external validation (n = 219; men = 89, women = 130), calculated the probability of CVD for each participant, and receiver operating characteristic curves. Results According to the diagnostic criteria of JIS, the prevalence of MetS in Kazakh was 30.9%. Seven potential factors with a similar pattern were obtained from men and women and comprised the CVD predictors. When predicting CVD in the internal validation, the area under the curve (AUC) were 0.857 (95% CI 0.807-0.898) for men and 0.852 (95% CI 0.809-0.889) for women, respectively. In the external validation, the AUC to predict CVD were 0.914 (95% CI 0.832-0.963) for men and 0.848 (95% CI 0.774-0.905) for women. It is suggested that SP might serve as a useful tool in identifying CVD with in Kazakhs, especially for Kazakhs men. Conclusions Among 7 potential factors were extracted from 18 biomarkrs in Kazakhs with MetS, and SP may be used for CVD risk assessment.	[Mao, Lei; He, Jia; Gao, Xiang; Guo, Heng; Wang, Kui; Zhang, Xianghui; Yang, Wenwen; Zhang, Jingyu; Li, Shugang; Hu, Yunhua; Mu, Lati; Van, Yizhong; Ma, Jiaolong; Ding, Yusong; Zhang, Mei; Liu, Jiaming; Ma, Rulin; Guo, Shuxia] Shihezi Univ, Dept Publ Hlth, Sch Med, Shihezi, Xinjiang, Peoples R China; [Gao, Xiang] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Guo, Shuxia] Shihezi Univ, Sch Med, Minist Educ, Dept Pathol, Shihezi, Xinjiang, Peoples R China; [Guo, Shuxia] Shihezi Univ, Sch Med, Minist Educ, Key Lab Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China	Shihezi University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Shihezi University; Shihezi University	Ma, RL; Guo, SX (corresponding author), Shihezi Univ, Dept Publ Hlth, Sch Med, Shihezi, Xinjiang, Peoples R China.; Guo, SX (corresponding author), Shihezi Univ, Sch Med, Minist Educ, Dept Pathol, Shihezi, Xinjiang, Peoples R China.; Guo, SX (corresponding author), Shihezi Univ, Sch Med, Minist Educ, Key Lab Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China.	marulin@126.com; gsxshzu@sina.com		zhong, yan/0000-0003-1957-5421; Zhang, XiangHui/0000-0002-1829-1681	National Natural Science Foundation of China [81560551]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We sincerely thank those who participated in the study. We would also like to thank the clinical laboratory of First Affliated Hospital of Shihezi University School of Medicine for their test work. This research was supported by the National Natural Science Foundation of China (No. 81560551).	Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; Alberti G, 2006, IDF CONS WORLDW DEF; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Chen Jin-Hong, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1311; Chen Jin-hong, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1166; Chen MJ, 2011, ADV CARDIOVASCULAR D, V32, P104; Chen S, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020223; Chen W.W., 2017, CHINA J CIRCULATION, V32, P521, DOI [10.3969/j.issn.1000-3614.2017.06.001, DOI 10.3969/J.ISSN.1000-3614.2017.06.001]; Choi SH, 2013, NUTR METAB CARDIOVAS, V23, P31, DOI 10.1016/j.numecd.2011.03.001; Cuifang Y, 2017, COHORT STUDY RISK PR; Dada AS, 2016, MEDICINES, V3, P15, DOI DOI 10.3390/MEDICINES302001510; de la Iglesia B, 2011, HEART, V97, P491, DOI 10.1136/hrt.2010.203364; Dong-Feng GU, 2005, CHINESE J DIABETES, V13, P181; Fan HQ, 2007, MED RECAPITULATE, V13, P71; Fang W, 2017, CHINESE GEN PRACTICE, V20, P3498; Ghosh A, 2005, DIABETES-METAB RES, V21, P58, DOI 10.1002/dmrr.481; Gong M, 2011, GUIDE CHINA MED, V09, P14; Guo SX, 2008, J SHIHEZI U; He Jia, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P1164; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hou XH, 2011, J GASTROEN HEPATOL, V26, P722, DOI 10.1111/j.1440-1746.2010.06509.x; Isohwg WHO, 1999, DIABETIC MED, V15, P539; Jee SH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005025; Jing Yuling, 2006, JAMA-J AM MED ASSOC, P67; Kahn R, 2005, DIABETOLOGIA, V48, P1684, DOI 10.1007/s00125-005-1876-2; Li J., 2017, J SHANDONG U HLTH SC, V55, P56, DOI [10.6040/j.issn.1671-7554.0.2017.356, DOI 10.6040/J.ISSN.1671-7554.0.2017.356]; [李杰 Li Jie], 2016, [中华糖尿病杂志, Chinese Journal of Diabetes Mellitus], V8, P278; Lin LY, 2009, ATHEROSCLEROSIS, V203, P563, DOI 10.1016/j.atherosclerosis.2008.07.021; Liu XD, 2013, HEPATO-GASTROENTEROL, V60, P343, DOI 10.5754/hge11216; [马儒林 Ma Rulin], 2012, [中国公共卫生, China Public Health], V28, P1009; Nejatinamini S, 2015, J DIAB METAB DISORDE, V14, P1; Novo S, 2012, ATHEROSCLEROSIS, V223, P468, DOI 10.1016/j.atherosclerosis.2012.05.018; [孙凤 Sun Feng], 2010, [中国糖尿病杂志, Chinese Journal of Diabetes], V18, P818; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; TUNSTALLPEDOE H, 1991, BRIT MED J, V303, P744, DOI 10.1136/bmj.303.6805.744; Voss R, 2002, INT J EPIDEMIOL, V31, P1253, DOI 10.1093/ije/31.6.1253; Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499; Xiao Y, 2011, J BAOTOU MEDL COLL, V27, P47; XIaohong Z, 2014, STUDY RISK FACTORS C; Xu HW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2257-5; Yan Sun-jie, 2010, Zhonghua Yi Xue Za Zhi, V90, P1678; [俞黎黎 Yu Lili], 2012, [中国全科医学, Chinese General Practice], V15, P241; Zhang W, 2016, METABOLIC SYNDROME P; Zhang W, 2013, CLIN MED ENG, V20, P1169; [张向辉 Zhang Xianghui], 2017, [中华高血压杂志, Chinese Journal of Hypertension], V25, P55; Zhu ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084204	46	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0202665	10.1371/journal.pone.0202665	http://dx.doi.org/10.1371/journal.pone.0202665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188929	Green Submitted, Green Published, gold			2022-12-26	WOS:000444228700009
J	Perlbarg, V; Lambert, J; Butler, B; Felfli, M; Valabregue, R; Privet, AL; Lehericy, S; Petiet, A				Perlbarg, Vincent; Lambert, Justine; Butler, Benjamin; Felfli, Mehdi; Valabregue, Romain; Privet, Anne-Laure; Lehericy, Stephane; Petiet, Alexandra			Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; SUBSTANTIA-NIGRA; DOPAMINERGIC INNERVATION; STRIATAL CONNECTIVITY; MOTOR CORTEX; BRAIN; DEGENERATION; METAANALYSIS; DISORDERS; NEURONS	Parkinson's disease is characterized by neurodegeneration of the dopaminergic neurons in the substantia nigra pars compacta. The 6-hydroxydopamine (6-OHDA) rat model has been used to study neurodegeneration in the nigro-striatal dopaminergic system. The goal of this study was to evaluate the reliability of diffusion MRI and resting-state functional MRI bio-markers in monitoring neurodegeneration in the 6-OHDA rat model assessed by quantitative histology. We performed a unilateral injection of 6-OHDA in the striatum of Sprague Dawley rats to produce retrograde degeneration of the dopamine neurons in the substantia nigra pars compacta. We carried out a longitudinal study with a multi-modal approach combining structural and functional MRI together with quantitative histological validation to follow the effects of the lesion. Functional and structural connectivity were assessed in the brain of 6-OHDA rats and sham rats (NaCI injection) at 3 and 6 weeks post-lesioning using resting state functional MRI and diffusion-weighted. Our results showed (i) increased functional connectivity in ipsi- and contra-lesioned regions of the cortico-basal ganglia network pathway including the motor cortex, the globus pallidus, and the striatum regions at 3 weeks; (ii) increased fractional anisotropy (FA) in the ipsi- and contralateral striatum of the 6-OHDA group at 3 weeks, and increased axial diffusivity (AD) and mean diffusivity in the ipsilateral striatum at 6 weeks; (iii) a trend for increased FA in both substantia nigra of the 6-OHDA group at 3 weeks. Optical density measurements of tyrosine-hydroxylase (TH) staining of the striatum showed good correlations with the FA and AD measurements in the striatum. No correlations were found between the number of TH-stained dopaminergic neurons and MRI measurements in the substantia nigra. This study suggested that (i) FA and AD were reliable biomarkers to evaluate neurodegeneration in the cortico-basal ganglia network of the 6-OHDA model, (ii) diffusion MRI and resting-state functional MRI (rsfMRl) were not sensitive enough to detect changes in the substantia nigra in this model.	[Perlbarg, Vincent; Valabregue, Romain; Privet, Anne-Laure; Lehericy, Stephane; Petiet, Alexandra] Brain & Spine Inst, UPMC INSERM UMR975, Paris, France; [Perlbarg, Vincent] Brain & Spine Inst, Bioinformat & Biostat Core Facil, Paris, France; [Lambert, Justine; Butler, Benjamin; Felfli, Mehdi; Valabregue, Romain; Lehericy, Stephane; Petiet, Alexandra] Brain & Spine Inst, Ctr Neuroimaging Res, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Petiet, A (corresponding author), Brain & Spine Inst, UPMC INSERM UMR975, Paris, France.; Petiet, A (corresponding author), Brain & Spine Inst, Ctr Neuroimaging Res, Paris, France.	alexandra.petiet@icm-institute.org	valabregue, romain/GWQ-7484-2022	valabregue, romain/0000-0002-1814-9570	France Parkinson Association; program "Institut des Neurosciences Translationnelles" [ANR-10-IAIHU-06]; program "Infrastructure d'Avenir en Biologie Sante" [ANR-11-INBS-0006]	France Parkinson Association; program "Institut des Neurosciences Translationnelles"; program "Infrastructure d'Avenir en Biologie Sante"	The research leading to these results received funding from the France Parkinson Association, and from the programs "Institut des Neurosciences Translationnelles" ANR-10-IAIHU-06 and "Infrastructure d'Avenir en Biologie Sante" ANR-11-INBS-0006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson-Clement C, 2017, NEUROIMAGE-CLIN, V16, P98, DOI 10.1016/j.nicl.2017.07.011; Baudrexel S, 2011, NEUROIMAGE, V55, P1728, DOI 10.1016/j.neuroimage.2011.01.017; Bensaid M, 2016, EXP NEUROL, V275, P209, DOI 10.1016/j.expneurol.2015.11.004; BERGER B, 1991, TRENDS NEUROSCI, V14, P21, DOI 10.1016/0166-2236(91)90179-X; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bezard E, 2013, MOVEMENT DISORD, V28, P61, DOI 10.1002/mds.25108; Brazhnik E, 2012, J NEUROSCI, V32, P7869, DOI 10.1523/JNEUROSCI.0943-12.2012; Cochrane CJ, 2013, NEUROLOGY, V80, P857, DOI 10.1212/WNL.0b013e318284070c; Debeir T, 2005, EXP NEUROL, V193, P444, DOI 10.1016/j.expneurol.2005.01.007; Douaud G, 2009, NEUROIMAGE, V46, P958, DOI 10.1016/j.neuroimage.2009.03.044; Esposito F, 2013, BRAIN, V136, P710, DOI 10.1093/brain/awt007; Goveas J, 2015, MAGN RESON IMAGING, V33, P853, DOI 10.1016/j.mri.2015.04.006; Gozzi A, 2016, NEUROIMAGE, V127, P496, DOI 10.1016/j.neuroimage.2015.12.017; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; Helmich RC, 2010, CEREB CORTEX, V20, P1175, DOI 10.1093/cercor/bhp178; Hepp DH, 2017, RADIOLOGY, V285, P896, DOI 10.1148/radiol.2017170438; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Karachi C, 2010, J CLIN INVEST, V120, P2745, DOI 10.1172/JCI42642; Lehericy S, 2017, MOVEMENT DISORD, V32, P510, DOI 10.1002/mds.26968; Lehericy S, 2012, MOVEMENT DISORD, V27, P822, DOI 10.1002/mds.25015; Menke RA, 2010, NEUROIMAGE, V52, P1175, DOI 10.1016/j.neuroimage.2010.05.086; Moran RJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002124; Ofori E, 2017, MOVEMENT DISORD, V32, P1457, DOI 10.1002/mds.27100; Papp EA, 2014, NEUROIMAGE, V97, P374, DOI 10.1016/j.neuroimage.2014.04.001; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; PRZEDBORSKI S, 1995, NEUROSCIENCE, V67, P631, DOI 10.1016/0306-4522(95)00066-R; Schwarz ST, 2013, NEUROIMAGE-CLIN, V3, P481, DOI 10.1016/j.nicl.2013.10.006; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; Sharman M, 2013, MOVEMENT DISORD, V28, P447, DOI 10.1002/mds.25255; Shimohama S, 2003, TRENDS MOL MED, V9, P360, DOI 10.1016/S1471-4914(03)00117-5; Sierakowiak A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120345; Thibes RB, 2017, BRAIN CONNECT, V7, P643, DOI 10.1089/brain.2017.0534; Vilas D, 2016, MOVEMENT DISORD, V31, P1820, DOI 10.1002/mds.26799; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Westphal R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172394; Zhang Y, 2015, MOVEMENT DISORD, V30, P1229, DOI 10.1002/mds.26251; Zhao FQ, 2008, NEUROIMAGE, V39, P248, DOI 10.1016/j.neuroimage.2007.07.063; Zoons E, 2011, NEUROIMAGE, V56, P1011, DOI 10.1016/j.neuroimage.2011.02.045	40	23	24	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0202597	10.1371/journal.pone.0202597	http://dx.doi.org/10.1371/journal.pone.0202597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188909	gold, Green Published, Green Submitted			2022-12-26	WOS:000444228700008
J	Francis, ML; Plummer, KE; Lythgoe, BA; Macallan, C; Currie, TE; Blount, JD				Francis, Megan L.; Plummer, Kate E.; Lythgoe, Bethany A.; Macallan, Catriona; Currie, Thomas E.; Blount, Jonathan D.			Effects of supplementary feeding on interspecific dominance hierarchies in garden birds	PLOS ONE			English	Article							SOCIAL RANK; BODY-SIZE; COMPETITION; FOOD; HABITATS; SUCCESS; COSTS; DEER; MASS; ENCOUNTERS	Individuals often differ in competitive ability, which can lead to the formation of a dominance hierarchy that governs differential access to resources. Previous studies of dominance have predominently focussed on within-species interactions, while the drivers of between-species competitive hierarchies are poorly understood. The increasing prevalence of predictable anthropogenic food subsidies, such as that provided by garden bird feeders, is likely to intensify between-species competition. However, the consequences for resource acquisition await detailed study, and in particular, whether competitive interactions are influenced by food quality is not known. Here, we examine competitive interactions amongst ten passerine species of birds utilising supplementary food sources of differing quality. We show that dominance rank is strongly predicted by body mass across species. Socially dominant, heavier species monopolised access to a food that had a relatively short handling time (sunflower hearts), spent longer on supplementary feeders, and pecked at lower rates. In contrast subordinate, lighter species were constrained to feed on a food that had a relatively long handling time (sunflower seeds with the hull intact). Our findings suggest that differences in body mass may result in between-species dominance hierarchies that place the heaviest species in the greatest control of supplementary feeding sites, gaining superior access to higher value foods. This may have important implications for the use of supplementary feeding as a conservation tool.	[Francis, Megan L.; Plummer, Kate E.; Lythgoe, Bethany A.; Macallan, Catriona; Currie, Thomas E.; Blount, Jonathan D.] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn Campus, Penryn, Cornwall, England; [Plummer, Kate E.] The Nunnery, British Trust Ornithol, Thetford, Norfolk, England	University of Exeter; British Trust for Ornithology	Plummer, KE; Blount, JD (corresponding author), Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn Campus, Penryn, Cornwall, England.; Plummer, KE (corresponding author), The Nunnery, British Trust Ornithol, Thetford, Norfolk, England.	kate.plummer@bto.org; j.d.blount@exeter.ac.uk	Blount, Jonathan/K-7695-2012	Blount, Jonathan/0000-0002-0016-0130	Natural Environment Research Council [NE/F007922/1]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a studentship from the Natural Environment Research Council (grant number: NE/F007922/1).	ALATALO RV, 1987, ECOLOGY, V68, P1773, DOI 10.2307/1939868; Albers PCH, 2001, ANIM BEHAV, V61, P489, DOI 10.1006/anbe.2000.1571; Archie EA, 2006, ANIM BEHAV, V71, P117, DOI 10.1016/j.anbehav.2005.03.023; Bergman DA, 2003, BIOL BULL-US, V205, P26, DOI 10.2307/1543442; Bonanni R, 2007, ANIM BEHAV, V74, P1369, DOI 10.1016/j.anbehav.2007.02.029; Brown CR, 1995, P ROY SOC B-BIOL SCI, V262, P313, DOI 10.1098/rspb.1995.0211; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; Carrete M, 2010, ANIM CONSERV, V13, P390, DOI 10.1111/j.1469-1795.2010.00352.x; CLUTTONBROCK TH, 1979, ANIM BEHAV, V27, P211, DOI 10.1016/0003-3472(79)90141-6; COWIE RJ, 1988, BIRD STUDY, V35, P163, DOI 10.1080/00063658809476985; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; DeCarvalho TN, 2004, ANIM BEHAV, V68, P473, DOI 10.1016/j.anbehav.2003.08.033; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; Farine DR, 2017, R PACKAGE VERSION 0; Galbraith JA, 2017, FRONTIERS ECOLOGY EV, V5; Galbraith JA, 2015, P NATL ACAD SCI USA, V112, pE2648, DOI 10.1073/pnas.1501489112; Griggio M, 2010, BEHAV PROCESS, V84, P739, DOI 10.1016/j.beproc.2010.05.003; Gros-Louis J, 2003, PRIMATES, V44, P341, DOI 10.1007/s10329-003-0050-z; HALEY MP, 1994, ANIM BEHAV, V48, P1249, DOI 10.1006/anbe.1994.1361; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Holand O, 2004, J ZOOL, V263, P365, DOI 10.1017/S0952836904005382; Husak JF, 2004, BEHAV ECOL SOCIOBIOL, V55, P602, DOI 10.1007/s00265-003-0748-3; Jones DN, 2008, J AVIAN BIOL, V39, P265, DOI 10.1111/j.0908-8857.2008.04271.x; Krams I, 1998, J AVIAN BIOL, V29, P55, DOI 10.2307/3677341; Martinson TJ, 2003, WILDLIFE SOC B, V31, P510; McElligott AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P266, DOI 10.1007/s002650000293; MCNAB B K, 1974, Ohio Journal of Science, V74, P370; Miller ET, 2017, BEHAV ECOL, V28, P1454, DOI 10.1093/beheco/arx108; Neat FC, 1998, ANIM BEHAV, V55, P875, DOI 10.1006/anbe.1997.0668; Neumann C, 2011, ANIM BEHAV, V82, P911, DOI 10.1016/j.anbehav.2011.07.016; Newton I., 1998, POPULATION LIMITATIO; Olsson O, 2000, P ROY SOC B-BIOL SCI, V267, P1457, DOI 10.1098/rspb.2000.1164; POPP JW, 1990, ANIM BEHAV, V39, P980, DOI 10.1016/S0003-3472(05)80964-9; RIECHERT SE, 1988, AM ZOOL, V28, P877; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Robinson RA, 2016, 407 BTO RES; Sanchez-Tojar A, 2018, J ANIM ECOL, V87, P594, DOI 10.1111/1365-2656.12776; Schmidt R, 2007, J ANIM ECOL, V76, P168, DOI 10.1111/j.1365-2656.2006.01182.x; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Shochat E, 2010, BIOSCIENCE, V60, P199, DOI 10.1525/bio.2010.60.3.6; SMITH JM, 1974, J THEOR BIOL, V47, P209, DOI 10.1016/0022-5193(74)90110-6; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Taillon J, 2006, ANIM BEHAV, V72, P1103, DOI 10.1016/j.anbehav.2006.03.016; Van der Meij MAA, 2004, ANIM BIOL, V54, P195, DOI 10.1163/1570756041445164; van Noordwijk MA, 1999, PRIMATES, V40, P105, DOI 10.1007/BF02557705; Vehrencamp SL, 2001, P ROY SOC B-BIOL SCI, V268, P1637, DOI 10.1098/rspb.2001.1714; Wittig RM, 2003, INT J PRIMATOL, V24, P847, DOI 10.1023/A:1024632923180; WOODREY MS, 1990, CONDOR, V92, P621, DOI 10.2307/1368682; Zeng XH, 2009, ECOL RES, V24, P607, DOI 10.1007/s11284-008-0530-0; Zucker N, 1996, ETHOLOGY, V102, P812	50	20	20	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202152	10.1371/journal.pone.0202152	http://dx.doi.org/10.1371/journal.pone.0202152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183709	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000443789900017
J	Tallmadge, RL; Wang, MH; Sun, Q; Felippe, MJB				Tallmadge, Rebecca L.; Wang, Minghui; Sun, Qi; Felippe, Maria Julia B.			Transcriptome analysis of immune genes in peripheral blood mononuclear cells of young foals and adult horses	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NATURAL-KILLER; T-CELLS; DIFFERENTIAL EXPRESSION; MOLECULAR-MECHANISMS; INTERFERON-GAMMA; NEONATAL FOALS; LIGHT-CHAINS; CD40 LIGAND; CORD-BLOOD	During the neonatal period, the ability to generate immune effector and memory responses to vaccines or pathogens is often questioned. This study was undertaken to obtain a global view of the natural differences in the expression of immune genes early in life. Our hypothesis was that transcriptome analyses of peripheral blood mononuclear cells (PBMCs) of foals (on day 1 and day 42 after birth) and adult horses would show differential gene expression profiles that characterize natural immune processes. Gene ontology enrichment analysis provided assessment of biological processes affected by age, and a list of 897 genes with >= 2 fold higher (p<0.01) expression in day 42 when compared to day 1 foal samples. Up-regulated genes included B cell and T cell receptor diversity genes; DNA replication enzymes; natural killer cell receptors; granzyme B and perforin; complement receptors; immunomodulatory receptors; cell adhesion molecules; and cytokines/chemokines and their receptors. The list of 1,383 genes that had higher (p<0.01) expression on day 1 when compared to day 42 foal samples was populated by genes with roles in innate immunity such as antimicrobial proteins; pathogen recognition receptors; cytokines/chemokines and their receptors; cell adhesion molecules; co-stimulatory molecules; and T cell receptor delta chain. Within the 742 genes with increased expression between day 42 foal and adult samples, B cell immunity was the main biological process (p = 2.4E-04). Novel data on markedly low (p<0.0001) TLR3 gene expression, and high (p <= 0.01) expression of IL27, IL13RA1, IREM-1, SIRL-1, and SIRPa on day 1 compared to day 42 foal samples point out potential mechanisms of increased susceptibility to pathogens in early life. The results portray a progression from innate immune gene expression predominance early in life to adaptive immune gene expression increasing with age with a putative overlay of immune suppressing genes in the neonatal phase. These results provide insight to the unique attributes of the equine neonatal and young immune system, and offer many avenues of future investigation.	[Tallmadge, Rebecca L.; Felippe, Maria Julia B.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Equine Immunol Lab, Ithaca, NY 14853 USA; [Wang, Minghui; Sun, Qi] Cornell Univ, Cornell Bioinformat Facil, Ithaca, NY USA	Cornell University; Cornell University	Felippe, MJB (corresponding author), Cornell Univ, Coll Vet Med, Dept Clin Sci, Equine Immunol Lab, Ithaca, NY 14853 USA.	mbf6@cornell.edu		Felippe, Maria Julia B./0000-0002-6440-5272; Tallmadge, Rebecca/0000-0002-7466-5449	United States Department of Agriculture National Institute of Food and Agriculture [2011-02923]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This study was funded by the United States Department of Agriculture National Institute of Food and Agriculture, grant number 2011-02923 (MJBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2013, IMMUNOL RES, V57, P246, DOI 10.1007/s12026-013-8439-2; Adkins Becky, 2007, Current Immunology Reviews, V3, P151; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Arun SS, 1996, J VET MED A, V43, P573, DOI 10.1111/j.1439-0442.1996.tb00489.x; Avanzini MA, 2010, INT J IMMUNOPATH PH, V23, P247, DOI 10.1177/039463201002300122; Basha S, 2014, EXPERT REV CLIN IMMU, V10, P1171, DOI 10.1586/1744666X.2014.942288; BECK R, 1994, IMMUNOL CELL BIOL, V72, P440, DOI 10.1038/icb.1994.65; Black A, 2012, EUR J IMMUNOL, V42, P311, DOI 10.1002/eji.201141847; Boller S, 2014, IMMUNOL REV, V261, P102, DOI 10.1111/imr.12206; Breathnach CC, 2006, VET IMMUNOL IMMUNOP, V112, P199, DOI 10.1016/j.vetimm.2006.02.010; Brugnoni D, 1996, IMMUNOL LETT, V49, P27, DOI 10.1016/0165-2478(95)02468-9; Burt TD, 2013, AM J REPROD IMMUNOL, V69, P346, DOI 10.1111/aji.12083; Call ME, 2004, MOL IMMUNOL, V40, P1295, DOI 10.1016/j.molimm.2003.11.017; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chen ZG, 2014, FRONT MED-PRC, V8, P201, DOI 10.1007/s11684-014-0324-4; Choi YS, 2008, J EXP MED, V205, P3053, DOI 10.1084/jem.20080979; Chuang TH, 2001, BBA-GENE STRUCT EXPR, V1518, P157, DOI 10.1016/S0167-4781(00)00289-X; Conley ME, 2009, ANNU REV IMMUNOL, V27, P199, DOI 10.1146/annurev.immunol.021908.132649; Croft M, 2009, IMMUNOL REV, V229, P173, DOI 10.1111/j.1600-065X.2009.00766.x; Dakic A, 2004, J IMMUNOL, V172, P1018, DOI 10.4049/jimmunol.172.2.1018; Dasari P, 2011, PEDIAT ALLERG IMM-UK, V22, P221, DOI 10.1111/j.1399-3038.2010.01091.x; De Wit D, 2004, BLOOD, V103, P1030, DOI 10.1182/blood-2003-04-1216; Dowling DJ, 2014, TRENDS IMMUNOL, V35, P299, DOI 10.1016/j.it.2014.04.007; DURANDY A, 1995, J IMMUNOL, V154, P1560; Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; Elhmouzi-Younes J, 2009, VET RES, V40, DOI 10.1051/vetres/2009037; Flach H, 2010, IMMUNITY, V33, P723, DOI 10.1016/j.immuni.2010.11.013; Flaminio M Julia B F, 2007, J Immune Based Ther Vaccines, V5, P1, DOI 10.1186/1476-8518-5-1; Flaminio MJBF, 2009, CLIN VACCINE IMMUNOL, V16, P176, DOI 10.1128/CVI.00336-08; Flaminio MJBF, 1999, J VET INTERN MED, V13, P206, DOI 10.1892/0891-6640(1999)013&lt;0206:PBLSAI&gt;2.3.CO;2; Flaminio MJBF, 2000, VET IMMUNOL IMMUNOP, V73, P267, DOI 10.1016/S0165-2427(00)00149-5; FULEIHAN R, 1994, EUR J IMMUNOL, V24, P1925, DOI 10.1002/eji.1830240832; Gaddy J, 1997, CELL IMMUNOL, V180, P132, DOI 10.1006/cimm.1997.1175; GIBSON D, 1974, BIOCHEMISTRY-US, V13, P2776, DOI 10.1021/bi00710a018; Gilfillan S, 1995, IMMUNOL REV, V148, P201, DOI 10.1111/j.1600-065X.1995.tb00099.x; dos Santos ABG, 2013, ANN ANAT, V195, P596, DOI 10.1016/j.aanat.2013.05.003; Goriely S, 2004, J EXP MED, V199, P1011, DOI 10.1084/jem.20031272; Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x; GRIFFIOEN AW, 1993, CLIN IMMUNOL IMMUNOP, V69, P1, DOI 10.1006/clin.1993.1142; GRIFFIOEN AW, 1992, CELL IMMUNOL, V143, P11, DOI 10.1016/0008-8749(92)90002-7; Guilmot A, 2011, J INNATE IMMUN, V3, P280, DOI 10.1159/000323934; Hamza E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120661; Hara S, 2012, VET IMMUNOL IMMUNOP, V145, P50, DOI 10.1016/j.vetimm.2011.10.006; Harris SP, 2011, VET IMMUNOL IMMUNOP, V141, P312, DOI 10.1016/j.vetimm.2011.03.015; Hedges JF, 2016, VET IMMUNOL IMMUNOP, V181, P33, DOI 10.1016/j.vetimm.2016.03.010; Hermann E, 2002, BLOOD, V100, P2153, DOI 10.1182/blood.V100.6.2153.h81802002153_2153_2158; Hestand MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124375; Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154; Holznagel DL, 2003, EQUINE VET J, V35, P620, DOI 10.2746/042516403775467153; Huang GH, 2009, CYTOKINE, V48, P161, DOI 10.1016/j.cyto.2009.08.002; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jones CA, 2002, J REPROD IMMUNOL, V56, P45, DOI 10.1016/S0165-0378(02)00022-0; Kachroo P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062879; Kiros TG, 2010, IMMUNOTHERAPY-UK, V2, P25, DOI 10.2217/IMT.09.80; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kollmann TR, 2007, J IMMUNOL, V178, P3695, DOI 10.4049/jimmunol.178.6.3695; Kollmann TR, 2017, IMMUNITY, V46, P350, DOI 10.1016/j.immuni.2017.03.009; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Kraft JD, 2013, IMMUNOLOGY, V139, P484, DOI 10.1111/imm.12095; Krumbiegel D, 2007, HUM IMMUNOL, V68, P813, DOI 10.1016/j.humimm.2007.08.001; Lee HH, 2008, J EXP MED, V205, P2269, DOI 10.1084/jem.20071371; Lee YC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/427696; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Li LQ, 2001, J IMMUNOL, V167, P2585, DOI 10.4049/jimmunol.167.5.2585; Liu M, 2011, CYTOKINE, V56, P356, DOI 10.1016/j.cyto.2011.07.017; Liu T, 2009, VACCINE, V27, P674, DOI 10.1016/j.vaccine.2008.11.040; Mansour TA, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3451-2; Marchant A, 1999, J IMMUNOL, V163, P2249; Mbawuike IN, 2001, J INFECT DIS, V183, P687, DOI 10.1086/318815; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Merant C, 2009, VET IMMUNOL IMMUNOP, V131, P1, DOI 10.1016/j.vetimm.2009.03.002; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Middleman AB, 2014, PEDIATRICS, V133, pE1500, DOI 10.1542/peds.2013-2940; Moreton J, 2014, PEERJ, V2, DOI 10.7717/peerj.382; Morris MC, 2016, NEONATOLOGY, V109, P161, DOI 10.1159/000442460; Musto P, 2011, EXPERT OPIN BIOL TH, V11, P551, DOI 10.1517/14712598.2011.567262; Noronha LE, 2012, VET IMMUNOL IMMUNOP, V147, P60, DOI 10.1016/j.vetimm.2012.04.003; Pacholewska A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3390-y; Pacholewska A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122011; Pasman Y, 2017, DEV COMP IMMUNOL, V67, P495, DOI 10.1016/j.dci.2016.08.020; Piatosa B, 2010, CYTOM PART B-CLIN CY, V78B, P372, DOI 10.1002/cyto.b.20536; Porras A, 2008, MOL IMMUNOL, V46, P27, DOI 10.1016/j.molimm.2008.06.030; Post M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00535; Prabhu SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162242; Prieto JMB, 2017, VET IMMUNOL IMMUNOP, V183, P60, DOI 10.1016/j.vetimm.2016.12.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenbaum M, 2014, GENE DEV, V28, P1165, DOI 10.1101/gad.240762.114; Ryan C, 2010, CLIN VACCINE IMMUNOL, V17, P1896, DOI 10.1128/CVI.00328-10; Sanz M, 2013, VET MICROBIOL, V167, P623, DOI 10.1016/j.vetmic.2013.09.018; Schillie SF, 2013, VACCINE, V31, P2506, DOI 10.1016/j.vaccine.2012.12.012; Sheoran AS, 2000, AM J VET RES, V61, P1099, DOI 10.2460/ajvr.2000.61.1099; Slavica L, 2013, J LEUKOCYTE BIOL, V94, P1003, DOI 10.1189/jlb.1212617; Sturgill TL, 2014, VACCINE, V32, P1362, DOI 10.1016/j.vaccine.2014.01.032; Sun Y, 2010, DEV COMP IMMUNOL, V34, P1009, DOI 10.1016/j.dci.2010.05.003; Sundstrom Y, 2007, SCAND J IMMUNOL, V66, P335, DOI 10.1111/j.1365-3083.2007.01980.x; Tallmadge RL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177831; Tallmadge RL, 2015, CLIN IMMUNOL, V160, P261, DOI 10.1016/j.clim.2015.05.005; Tallmadge RL, 2014, DEV COMP IMMUNOL, V46, P171, DOI 10.1016/j.dci.2014.04.001; Tallmadge RL, 2013, DEV COMP IMMUNOL, V41, P33, DOI 10.1016/j.dci.2013.03.020; Tallmadge RL, 2009, DEV COMP IMMUNOL, V33, P1027, DOI 10.1016/j.dci.2009.05.002; Tarlinton Rachael E, 2016, BMC Res Notes, V9, P353, DOI 10.1186/s13104-016-2161-9; TERRY LA, 1990, TISSUE ANTIGENS, V35, P82, DOI 10.1111/j.1399-0039.1990.tb01761.x; Thompson N, 2016, RHEUMATOLOGY, V55, P1548, DOI 10.1093/rheumatology/kev420; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Upham JW, 2006, INFECT IMMUN, V74, P1106, DOI 10.1128/IAI.74.2.1106-1112.2006; van Gent R, 2009, CLIN IMMUNOL, V133, P95, DOI 10.1016/j.clim.2009.05.020; Vendrig JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066897; Viveiros MM, 1999, DEV COMP IMMUNOL, V23, P521, DOI 10.1016/S0145-305X(99)00030-0; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wagner B, 2006, VET IMMUNOL IMMUNOP, V110, P269, DOI 10.1016/j.vetimm.2005.10.007; Wagner B, 2006, DEV COMP IMMUNOL, V30, P155, DOI 10.1016/j.dci.2005.06.008; Wagner B, 2004, J IMMUNOL, V173, P3230, DOI 10.4049/jimmunol.173.5.3230; Walk J, 2012, CLIN EXP IMMUNOL, V169, P164, DOI 10.1111/j.1365-2249.2012.04599.x; Wang C, 2015, CURR OPIN IMMUNOL, V37, P6, DOI 10.1016/j.coi.2015.08.001; Wang GH, 2010, J IMMUNOL, V185, P71, DOI 10.4049/jimmunol.0903806; Willems F, 2009, EUR J IMMUNOL, V39, P26, DOI 10.1002/eji.200838391; Wilson RA, 1996, VET IMMUNOL IMMUNOP, V53, P49, DOI 10.1016/0165-2427(95)05543-6; Yan SR, 2004, INFECT IMMUN, V72, P1223, DOI 10.1128/IAI.72.3.1223-1229.2004; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002	126	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202646	10.1371/journal.pone.0202646	http://dx.doi.org/10.1371/journal.pone.0202646			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183726	Green Submitted, gold, Green Published			2022-12-26	WOS:000443789900034
J	Bannister, CA; Halcox, JP; Currie, CJ; Preece, A; Spasic, I				Bannister, Christian A.; Halcox, Julian P.; Currie, Craig J.; Preece, Alun; Spasic, Irena			A genetic programming approach to development of clinical prediction models: A case study in symptomatic cardiovascular disease	PLOS ONE			English	Article							LOGISTIC-REGRESSION; SURVIVAL ANALYSIS; PROPORTIONAL HAZARDS; MEDICAL LITERATURE; USERS GUIDES; RISK; VALIDATION; ALGORITHMS; PRINCIPLES	Background Genetic programming (GP) is an evolutionary computing methodology capable of identifying complex, non-linear patterns in large data sets. Despite the potential advantages of GP over more typical, frequentist statistical approach methods, its applications to survival analyses are rare, at best. The aim of this study was to determine the utility of GP for the automatic development of clinical prediction models. Methods We compared GP against the commonly used Cox regression technique in terms of the development and performance of a cardiovascular risk score using data from the SMART study, a prospective cohort study of patients with symptomatic cardiovascular disease. The composite endpoint was cardiovascular death, non-fatal stroke, and myocardial infarction. A total of 3,873 patients aged 19-82 years were enrolled in the study 1996-2006. The cohort was split 70:30 into derivation and validation sets. The derivation set was used for development of both GP and Cox regression models. These models were then used to predict the discrete hazards at t = 1, 3, and 5 years. The predictive ability of both models was evaluated in terms of their risk discrimination and calibration using the validation set. Results The discrimination of both models was comparable. At time points t = 1, 3, and 5 years the C-index was 0.59, 0.69, 0.64 and 0.66, 0.70, 0.70 for the GP and Cox regression models respectively. At the same time points, the calibration of both models, which was assessed using calibration plots and the generalization of the Hosmer-Lemeshow test statistic, was also comparable, but with the Cox model being better calibrated to the validation data. Conclusion Using empirical data, we demonstrated that a prediction model developed automatically by GP has predictive ability comparable to that of manually tuned Cox regression. The GP model was more complex, but it was developed in a fully automated way and comprised fewer covariates. Furthermore, it did not require the expertise normally needed for its derivation, thereby alleviating the knowledge elicitation bottleneck. Overall, GP demonstrated considerable potential as a method for the automated development of clinical prediction models for diagnostic and prognostic purposes.	[Bannister, Christian A.; Preece, Alun; Spasic, Irena] Cardiff Univ, Sch Comp Sci & Informat, Cardiff, S Glam, Wales; [Bannister, Christian A.; Currie, Craig J.] Cardiff Univ, Sch Med, Cochrane Inst Primary Care & Publ Hlth, Cardiff, S Glam, Wales; [Halcox, Julian P.] Swansea Univ, Med Sch, Dept Cardiol, Swansea, W Glam, Wales	Cardiff University; Cardiff University; Swansea University	Spasic, I (corresponding author), Cardiff Univ, Sch Comp Sci & Informat, Cardiff, S Glam, Wales.	spasici@cardiff.ac.uk		Spasic, Irena/0000-0002-8132-3885	Cardiff School of Computer Science Informatics; Medical Research Council	Cardiff School of Computer Science Informatics; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded through a joint PhD studentship from the Cardiff School of Computer Science & Informatics and the Medical Research Council. We have no other conflicts of interest to declare.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Banzhaf W., 1998, GENETIC PROGRAMMING; Biesheuvel CJ, 2004, J CLIN EPIDEMIOL, V57, P551, DOI 10.1016/j.jclinepi.2003.10.011; Bradburn MJ, 2003, BRIT J CANCER, V89, P431, DOI 10.1038/sj.bjc.6601119; Brownlee Jason, 2012, CLEVER ALGORITHMS NA; Clark TG, 2003, BRIT J CANCER, V89, P781, DOI 10.1038/sj.bjc.6601117; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Coulter A, 1997, J Health Serv Res Policy, V2, P112; COX DR, 1972, J R STAT SOC B, V34, P187; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2004, HANDB STAT, V23, P1; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Efron B., 1994, INTRO BOOTSTRAP; FORREST S, 1993, SCIENCE, V261, P872, DOI 10.1126/science.8346439; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrell FE, 2001, REGRESSION MODELING; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Holland J. H., 1992, ADAPTATION NATURAL A; Janssen KJM, 2012, J CLIN EPIDEMIOL, V65, P404, DOI 10.1016/j.jclinepi.2011.08.011; Janssen KJM, 2009, CLIN CHEM, V55, P994, DOI 10.1373/clinchem.2008.115345; Jerez JM, 2005, BREAST CANCER RES TR, V94, P265, DOI 10.1007/s10549-005-9013-y; Kattan MW, 2003, J UROLOGY, V170, pS6, DOI 10.1097/01.ju.0000094764.56269.2d; Kleinbaum D.G.D., 2011, SURVIVAL ANAL SELF L, V3rd ed.; KNOTTNERUS JA, 1992, MED DECIS MAKING, V12, P93, DOI 10.1177/0272989X9201200202; Koza JR, 1992, GENETIC PROGRAMMING; LAUPACIS A, 1994, JAMA-J AM MED ASSOC, V272, P234, DOI 10.1001/jama.272.3.234; Luke S., 2013, ESSENTIALS METAHEURI; Moore JH, 2001, LECT NOTES ARTIF INT, P372; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; OhnoMachado L, 1997, COMPUT BIOL MED, V27, P55, DOI 10.1016/S0010-4825(96)00036-4; Oxford Center for Evidence-Based Medicine, 1995, GLOSS TERMS EV BAS M; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Podbregar M, 2003, RESUSCITATION, V57, P153, DOI 10.1016/S0300-9572(03)00030-3; Poli R., 2008, FIELD GUIDE GENETIC; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAYDIN PM, 1992, BREAST CANCER RES TR, V21, P47, DOI 10.1007/BF01811963; Ross PL, 2001, J UROLOGY, V165, P1562, DOI 10.1016/S0022-5347(05)66349-5; Schwarzer G, 2000, STAT MED, V19, P541, DOI 10.1002/(SICI)1097-0258(20000229)19:4<541::AID-SIM355>3.0.CO;2-V; Setzkorn C, 2007, BIOSYSTEMS, V87, P31, DOI 10.1016/j.biosystems.2006.03.002; Simons PCG, 1999, EUR J EPIDEMIOL, V15, P773, DOI 10.1023/A:1007621514757; Sipper M., 2011, EVOLVED TO WIN; Steyerberg E., 2009, CLIN PREDICTION MODE; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Taktak A, 2007, COMPUT BIOL MED, V37, P1108, DOI 10.1016/j.compbiomed.2006.10.001; Tsakonas A, 2004, ARTIF INTELL MED, V32, P195, DOI 10.1016/j.artmed.2004.02.007; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Vanneschi L, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-12; Vittinghoff E, 2012, REGRESSION METHODS B	54	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0202685	10.1371/journal.pone.0202685	http://dx.doi.org/10.1371/journal.pone.0202685			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180175	Green Published, gold, Green Accepted			2022-12-26	WOS:000444222400015
J	Nemchinov, LG; Francois, S; Roumagnac, P; Ogliastro, M; Hammond, RW; Mollov, DS; Filloux, D				Nemchinov, Lev G.; Francois, Sarah; Roumagnac, Phillipe; Ogliastro, Mylene; Hammond, Rosemarie W.; Mollov, Dimitre S.; Filloux, Denis			Characterization of alfalfa virus F, a new member of the genus Marafivirus	PLOS ONE			English	Article							GENOME; SEQUENCE; PLANTS	Viral infections of alfalfa are widespread in major cultivation areas and their impact on alfalfa production may be underestimated. A new viral species, provisionally named alfalfa virus F (AVF), was identified using a virion-associated nucleic acid (VANA) metagenomics-based approach in alfalfa (Medicago sativa L.) samples collected in Southern France. The nucleotide sequence of the viral genome was determined by de-novo assembly of VANA reads and by 5'/3' RACE with viral RNA extracted from enriched viral particles or with total RNA, respectively. The virus shares the greatest degree of overall sequence identity (similar to 78%) with Medicago sativa marafivirus 1 (MsMV1) recently deduced from alfalfa transcriptomic data. The tentative nucleotide sequence of the AVF coat protein shares similar to 83% identity with the corresponding region of MsMV1. A sequence search of the predicted single large ORF encoding a polyprotein of 235kDa in the Pfam database resulted in identification of five domains, characteristic of the genus Marafivirus, family Tymoviridae. The AVF genome also contains a conserved "marafibox" , a 16-nt consensus sequence present in all known marafi-viruses. Phylogenetic analysis of the complete nucleotide sequences of AVF and other viruses of the family Tymoviridae grouped AVF in the same cluster with MsMV1. In addition to 5' and 3' terminal extensions, the identity of the virus was confirmed by RT-PCRs with primers derived from VANA-contigs, transmission electron microscopy with virus-infected tissues and transient expression of the viral coat protein gene using a heterologous virus-based vector. Based on the criteria demarcating species in the genus Marafivirus that include overall sequence identity less than 80% and coat protein identity less than 90%, we propose that AVF represents a distinct viral species in the genus Marafivirus, family Tymoviridae.	[Nemchinov, Lev G.; Hammond, Rosemarie W.] USDA ARS, Mol Plant Pathol Lab, Beltsville, MD 20705 USA; [Francois, Sarah; Ogliastro, Mylene] INRA, UMR DGIMI, Montpellier, France; [Roumagnac, Phillipe; Filloux, Denis] CIRAD, UMR BGPI, Montpellier, France; [Roumagnac, Phillipe; Filloux, Denis] Univ Montpellier, BGPI, CIRAD, INRA,Montpellier SupAgro, Montpellier, France; [Mollov, Dimitre S.] USDA ARS, Natl Germplasm Recourses Lab, Beltsville, MD USA	United States Department of Agriculture (USDA); INRAE; Universite de Montpellier; CIRAD; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; United States Department of Agriculture (USDA)	Nemchinov, LG (corresponding author), USDA ARS, Mol Plant Pathol Lab, Beltsville, MD 20705 USA.	lev.nemchinov@ars.usda.gov	François, Sarah/M-7878-2019	François, Sarah/0000-0002-1138-8800; Roumagnac, Philippe/0000-0001-5002-6039; Mollov, Dimitre/0000-0002-4750-6194; Ogliastro, Mylene/0000-0003-4841-7043	United States Department of Agriculture, Agricultural Research Service; CIRAD-INRA-SupAgro, UMR BGPI, Montpellier, France	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); CIRAD-INRA-SupAgro, UMR BGPI, Montpellier, France	This work was supported by the United States Department of Agriculture, Agricultural Research Service and by CIRAD-INRA-SupAgro, UMR BGPI, 34398, Montpellier, France.	Bao YM, 2014, ARCH VIROL, V159, P3293, DOI 10.1007/s00705-014-2197-x; Bejerman N, 2011, PLANT DIS, V95, P771, DOI 10.1094/PDIS-10-10-0764; Bejerman N, 2016, ARCH VIROL, V161, P2029, DOI 10.1007/s00705-016-2854-3; CHAPMAN S, 1992, PLANT J, V2, P549; Dreher T. W., 2012, VIRUS TAXONOMY, P913; Edwards MC, 2014, VIROLOGY, V450, P290, DOI 10.1016/j.virol.2013.12.018; Francois S, 2018, METHODS MOL BIOL, V1746, P77, DOI 10.1007/978-1-4939-7683-6_7; Gamez R., 1980, DESCRIPTIONS PLANT V; Hammond RW, 2010, VIRUS RES, V147, P208, DOI 10.1016/j.virusres.2009.11.002; Hammond RW, 2001, VIROLOGY, V282, P338, DOI 10.1006/viro.2001.0859; Kim H, 2018, GENE, V638, P7, DOI 10.1016/j.gene.2017.09.069; LESEMANN DE, 1983, PHYTOPATHOL Z, V107, P250; Li XH, 2012, AGRONOMY-BASEL, V2, P40, DOI 10.3390/agronomy2010040; Martelli GP, 2002, ARCH VIROL, V147, P1837, DOI 10.1007/s007050200045; Monteros MJ, 2009, P W ALF AG C DEC 2 4; Nemchinov LG, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00531-17, 10.1128/genomea.00531-17]; Nemchinov LG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178222; Roumagnac P, 2015, J VIROL, V89, P9683, DOI 10.1128/JVI.00453-15; Zhang SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122170	19	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0203477	10.1371/journal.pone.0203477	http://dx.doi.org/10.1371/journal.pone.0203477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180217	Green Submitted, Green Published, gold			2022-12-26	WOS:000444222400046
J	Borst, ACW; Verberk, WCEP; Angelini, C; Schotanus, J; Wolters, JW; Christianen, MJA; van der Zee, EM; Derksen-Hooijberg, M; van der Heide, T				Borst, Annieke C. W.; Verberk, Wilco C. E. P.; Angelini, Christine; Schotanus, Jildou; Wolters, Jan-Willem; Christianen, Marjolijn J. A.; van der Zee, Els M.; Derksen-Hooijberg, Marlous; van der Heide, Tjisse			Foundation species enhance food web complexity through non-trophic facilitation	PLOS ONE			English	Article							ECOLOGICAL NETWORKS; HABITAT STRUCTURE; BIODIVERSITY; STABILITY; CONSEQUENCES; ORGANIZATION; COMMUNITIES; DIVERSITY; INCREASES; CASCADE	Food webs are an integral part of every ecosystem on the planet, yet understanding the mechanisms shaping these complex networks remains a major challenge. Recently, several studies suggested that non-trophic species interactions such as habitat modification and mutual isms can be important determinants of food web structure. However, it remains unclear whether these findings generalize across ecosystems, and whether non-trophic interactions affect food webs randomly, or affect specific trophic levels or functional groups. Here, we combine analyses of 58 food webs from seven terrestrial, freshwater and coastal systems to test (1) the general hypothesis that non-trophic facilitation by habitat-forming foundation species enhances food web complexity, and (2) whether these enhancements have either random or targeted effects on particular trophic levels, functional groups, and linkages throughout the food web. Our empirical results demonstrate that foundation species consistently enhance food web complexity in all seven ecosystems. Further analyses reveal that 15 out of 19 food web properties can be well-approximated by assuming that foundation species randomly facilitate species throughout the trophic network. However, basal species are less strongly, and carnivores are more strongly facilitated in foundation species' food webs than predicted based on random facilitation, resulting in a higher mean trophic level and a longer average chain length. Overall, we conclude that foundation species strongly enhance food web complexity through non-trophic facilitation of species across the entire trophic network. We therefore suggest that the structure and stability of food webs often depends critically on non-trophic facilitation by foundation species.	[Borst, Annieke C. W.; Verberk, Wilco C. E. P.; Derksen-Hooijberg, Marlous; van der Heide, Tjisse] Radboud Univ Nijmegen, Inst Water & Wetland Res, Nijmegen, Netherlands; [Angelini, Christine] Univ Florida, Dept Environm Engn Sci, Gainesville, FL 32611 USA; [Schotanus, Jildou] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Microbiol & Biogeochem, Ctr Estuarine & Marine Ecol, Yerseke, Netherlands; [Schotanus, Jildou] HZ Univ Appl Sci, Vlissingen, Netherlands; [Wolters, Jan-Willem] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Christianen, Marjolijn J. A.] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, Wageningen, Netherlands; [van der Zee, Els M.] Altenburg & Wymenga Ecol Res, Feanwalden, Netherlands; [van der Heide, Tjisse] NIOZ Royal Netherlands Inst Sea Res, Dept Coastal Syst, Den Burg, Texel, Netherlands; [van der Heide, Tjisse] Univ Utrecht, Den Burg, Texel, Netherlands; [van der Heide, Tjisse] Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Groningen, Netherlands	Radboud University Nijmegen; State University System of Florida; University of Florida; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Antwerp; Wageningen University & Research; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; University of Groningen	Borst, ACW (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Nijmegen, Netherlands.	Anniekeborst@outlook.com	van der Heide, Tjisse/M-3000-2013; Christianen, Marjolijn J. A./AAD-3865-2021; Verberk, Wilco/E-6337-2011	Christianen, Marjolijn J. A./0000-0001-5839-2981; Verberk, Wilco/0000-0002-0691-583X; Borst, Annieke/0000-0001-7362-5990	Biology Department of the University of Antwerp	Biology Department of the University of Antwerp	Jan-Willem Wolters would like to thank the Biology Department of the University of Antwerp for providing a doctoral grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Altieri AH, 2007, AM NAT, V169, P195, DOI 10.1086/510603; Angelini C, 2014, ECOLOGY, V95, P185, DOI 10.1890/13-0496.1; Angelini C, 2011, BIOSCIENCE, V61, P782, DOI 10.1525/bio.2011.61.10.8; [Anonymous], 1972, P C CONSERVATION PRO; Avin C, 2015, THEOR COMPUT SCI, V584, P91, DOI 10.1016/j.tcs.2014.11.036; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bertness MD, 1999, ECOLOGY, V80, P2711, DOI 10.1890/0012-9658(1999)080[2711:TTRCOP]2.0.CO;2; Bologna PAX, 1999, J EXP MAR BIOL ECOL, V242, P21, DOI 10.1016/S0022-0981(99)00092-1; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bulleri F, 2016, FUNCT ECOL, V30, P70, DOI 10.1111/1365-2435.12528; Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042; Christianen MJA, 2017, BIOL CONSERV, V213, P317, DOI 10.1016/j.biocon.2016.09.028; Donadi S, 2013, ECOLOGY, V94, P489, DOI 10.1890/12-0048.1; Donker JJA, 2013, J SEA RES, V82, P54, DOI 10.1016/j.seares.2012.08.010; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Elton C.S., 1927, ANIMAL ECOLOGY, P1, DOI 10.5962/bhl.title.7435; Filazzola A, 2017, BASIC APPL ECOL, V20, P51, DOI 10.1016/j.baae.2017.01.002; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Gilad E, 2007, J THEOR BIOL, V244, P680, DOI 10.1016/j.jtbi.2006.08.006; Gilad E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098105; Govenar B, 2010, TOP GEOBIOL, V33, P403, DOI 10.1007/978-90-481-9572-5_13; Grutters BMC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124455; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Jaschinski S, 2011, AQUAT SCI, V73, P91, DOI 10.1007/s00027-010-0163-6; Jeppesen E., 1992, STRUCTURING ROLE SUB; Jones CG, 2010, OIKOS, V119, P1862, DOI 10.1111/j.1600-0706.2010.18782.x; Kefi S, 2015, ECOLOGY, V96, P291, DOI 10.1890/13-1424.1; Kefi S, 2012, ECOL LETT, V15, P291, DOI 10.1111/j.1461-0248.2011.01732.x; Klecka J, 2014, OECOLOGIA, V176, P183, DOI 10.1007/s00442-014-3007-6; Kovalenko KE, 2012, HYDROBIOLOGIA, V685, P1, DOI 10.1007/s10750-011-0974-z; Kuiper JJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8727; LODGE DM, 1991, AQUAT BOT, V41, P195, DOI 10.1016/0304-3770(91)90044-6; MEA, 2005, MILL ASS EC HUM WELL; Miller RJ, 2015, OECOLOGIA, V179, P1199, DOI 10.1007/s00442-015-3441-0; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Mulder C, 2012, ADV ECOL RES, V46, P1, DOI 10.1016/B978-0-12-396992-7.00001-0; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Olff H, 2009, PHILOS T R SOC B, V364, P1755, DOI 10.1098/rstb.2008.0222; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Pilosof S, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0101; PIMM SL, 1979, THEOR POPUL BIOL, V16, P144, DOI 10.1016/0040-5809(79)90010-8; Reid AM, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00106.1; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Saint-Beat B, 2015, ECOL INDIC, V52, P458, DOI 10.1016/j.ecolind.2014.12.017; Sanders D, 2014, OIKOS, V123, P513, DOI 10.1111/j.1600-0706.2013.01011.x; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; van der Zee EM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2326; van der Zee EM, 2015, J EXP MAR BIOL ECOL, V465, P41, DOI 10.1016/j.jembe.2015.01.001; Verdonschot RCM, 2012, LIMNOLOGICA, V42, P31, DOI 10.1016/j.limno.2011.07.004; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wright JT, 2017, ECOLOGY, V98, P2425, DOI 10.1002/ecy.1932; Wright JT, 2014, ECOLOGY, V95, P2699, DOI 10.1890/14-0127.1; Zhao QH, 2016, FRESHWATER BIOL, V61, P693, DOI 10.1111/fwb.12739	60	26	26	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0199152	10.1371/journal.pone.0199152	http://dx.doi.org/10.1371/journal.pone.0199152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169517	Green Published, Green Submitted, gold			2022-12-26	WOS:000443374400002
J	Huang, HM; Zhao, YL; Xu, ZG; Ding, Y; Zhang, W; Wu, L				Huang, Huimin; Zhao, Yunlin; Xu, Zhenggang; Ding, Yi; Zhang, Wan; Wu, Liang			Biosorption characteristics of a highly Mn(II)-resistant Ralstonia pickettii strain isolated from Mn ore	PLOS ONE			English	Article							HEAVY-METAL POLLUTION; AQUEOUS-SOLUTION; LEAD; BACTERIA; CADMIUM; REMOVAL; COPPER; BIOREMEDIATION; EQUILIBRIUM; ADSORPTION	Microorganisms play an important role in immobilizing and detoxifying excessive Mn; however, there is so far a lack of sufficient information concerning highly Mn(II)-tolerant bacteria. The present study was conducted to analyze the bio-sorption characteristics of a strain (HM8) isolated from manganese ore wastes. Analytical data from the 16S rDNA sequence determination showed that the species, HM8, had a 99% similarity to Ralstonia pickettii. Results from the designed physiological, biochemical and isothermal adsorption tests indicated that HM8 did not only grow well at a Mn(II) concentration level of 10,000 mg/L but also removed 1,002.83 mg/L of Mn(II) from the bulk solution of the culture, showing that the isolated strain possessed strong capabilities to tolerate and remove Mn(II). In the isothermal bio-sorption experiments performed to investigate the effects of relevant factors on Mn(II) sorption, the highest Mn(II) removal rate was obtained at the contact time 72 h, temperature 40 degrees C, and pH 6.0, while the differences in both strain growth and Mn(II) removal rate between different inoculated HM8 doses were found to be insignificant within the tested range. Scanning electron microscopy showed that, under Mn(II) stress, HM8 cells appeared irregular and cracked, with apparent wrinkles on the surface. The peaks in the Fourier transform infrared spectra showed that hydroxyl and carboxyl groups were the main functional groups for Mn(II) adsorption. The experimental data supported the practical application of HM8 as a biological adsorbent for remediation of heavily Mn contaminated sites.	[Huang, Huimin; Zhao, Yunlin] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China; [Huang, Huimin; Zhao, Yunlin; Xu, Zhenggang; Ding, Yi; Zhang, Wan; Wu, Liang] Cent South Univ Forestry & Technol, Hunan Res Ctr Engn Technol Utilizat Environm & Re, Changsha, Hunan, Peoples R China; [Xu, Zhenggang] Hunan City Univ, Sch Mat & Chem Engn, Yiyang, Hunan, Peoples R China	Hunan Agricultural University; Central South University of Forestry & Technology; Hunan City University	Xu, ZG (corresponding author), Cent South Univ Forestry & Technol, Hunan Res Ctr Engn Technol Utilizat Environm & Re, Changsha, Hunan, Peoples R China.; Xu, ZG (corresponding author), Hunan City Univ, Sch Mat & Chem Engn, Yiyang, Hunan, Peoples R China.	rssq198677@163.com	Zhenggang, Xu/ABE-9095-2020	Zhenggang, Xu/0000-0002-7401-5163	Forestry science and technology project of Hunan Province [XLK201825, XKL201731]; Key Technology R&D Program of Hunan Province [2016TP2007, 2016TP1014, 2016TP1022]	Forestry science and technology project of Hunan Province; Key Technology R&D Program of Hunan Province	This work was supported by Forestry science and technology project of Hunan Province (XLK201825, XKL201731), Yunlin Zhao, Key Technology R&D Program of Hunan Province (2016TP2007, 2016TP1014, 2016TP1022), Zhenggang Xu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Hasan H, 2016, J IND ENG CHEM, V37, P295, DOI 10.1016/j.jiec.2016.03.038; Acosta JA, 2011, J GEOCHEM EXPLOR, V109, P8, DOI 10.1016/j.gexplo.2011.01.004; AIKING H, 1985, APPL ENVIRON MICROB, V50, P1262, DOI 10.1128/AEM.50.5.1262-1267.1985; [Anonymous], 1990, BIOSORPTION HEAVY ME; BROWN MJ, 1982, WATER RES, V16, P1539, DOI 10.1016/0043-1354(82)90206-8; Burger MS, 2008, WATER RES, V42, P4733, DOI 10.1016/j.watres.2008.08.024; CHANMUGATHAS P, 1987, SOIL SCI SOC AM J, V51, P1184, DOI 10.2136/sssaj1987.03615995005100050017x; Chen BY, 2000, INT BIODETER BIODEGR, V46, P11, DOI 10.1016/S0964-8305(00)00054-8; Chen HM, 1999, AMBIO, V28, P130; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Deng PY, 2013, INT J ENVIRON SCI TE, V10, P559, DOI 10.1007/s13762-013-0186-3; Divekar M., 2010, ISOLATION CHARACTERI; Dong J, 2011, ENVIRON EARTH SCI, V64, P1317, DOI 10.1007/s12665-011-0992-1; El Aafi N, 2012, INT J PHYTOREMEDIAT, V14, P261, DOI 10.1080/15226514.2011.604693; Facchinelli A, 2001, ENVIRON POLLUT, V114, P313, DOI 10.1016/S0269-7491(00)00243-8; Fan T, 2008, J HAZARD MATER, V160, P655, DOI 10.1016/j.jhazmat.2008.03.038; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Figueira MM, 1999, ENVIRON SCI TECHNOL, V33, P1840, DOI 10.1021/es981111p; Forstner U, 1990, SEDIMENT CRITERIA DE, DOI [10.1016/j.scitotenv.2013.08.090, DOI 10.1016/J.SCITOTENV.2013.08.090]; Glick BR, 2010, BIOTECHNOL ADV, V28, P367, DOI 10.1016/j.biotechadv.2010.02.001; Govarthanan M, 2013, CHEMOSPHERE, V90, P2267, DOI 10.1016/j.chemosphere.2012.10.038; Han RP, 2005, J HAZARD MATER, V125, P266, DOI 10.1016/j.jhazmat.2005.05.031; Hasan Hassimi Abu, 2012, J Environ Manage, V111, P34, DOI 10.1016/j.jenvman.2012.06.027; Holt John G., 1994, BERGEYS MANUAL DETER, P520; Hynes RK, 2008, CAN J MICROBIOL, V54, P248, DOI [10.1139/W08-008, 10.1139/w08-008]; Iqbal M, 2009, J HAZARD MATER, V164, P161, DOI 10.1016/j.jhazmat.2008.07.141; Jebeli MA, 2017, CHEMOSPHERE, V169, P636, DOI 10.1016/j.chemosphere.2016.11.129; [金羽 Jin Yu], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P2248; Kang CH, 2015, ECOL ENG, V74, P402, DOI 10.1016/j.ecoleng.2014.10.009; Khalilnezhad R, 2014, APPL BIOCHEM BIOTECH, V174, P1919, DOI 10.1007/s12010-014-1076-y; Khani MH, 2008, J HAZARD MATER, V150, P612, DOI 10.1016/j.jhazmat.2007.05.010; Klein R, 2014, ADV BIOCHEM ENG BIOT, V141, P109, DOI 10.1007/10_2013_265; Kuffner M, 2010, J APPL MICROBIOL, V108, P1471, DOI 10.1111/j.1365-2672.2010.04670.x; Learman DR, 2011, GEOCHIM COSMOCHIM AC, V75, P6048, DOI 10.1016/j.gca.2011.07.026; Li DD, 2017, J ENVIRON MANAGE, V196, P8, DOI 10.1016/j.jenvman.2017.02.076; Li FT, 2007, CHINESE CHEM LETT, V18, P325, DOI 10.1016/j.cclet.2007.01.034; [李会东 Li Huidong], 2014, [环境工程学报, Chinese Journal of Environmental Engineering], V8, P5022; Li XA, 2010, STAT RES; Li ZY, 2014, SCI TOTAL ENVIRON, V468, P843, DOI 10.1016/j.scitotenv.2013.08.090; [凌薇薇 LING Weiwei], 2011, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V31, P152; Lu WB, 2006, J HAZARD MATER, V134, P80, DOI 10.1016/j.jhazmat.2005.10.036; Mijnendonckx K, 2013, MICROB ECOL, V65, P347, DOI 10.1007/s00248-012-0139-2; Narayani M, 2013, CRIT REV ENV SCI TEC, V43, P955, DOI 10.1080/10643389.2011.627022; Nelson YM, 2002, ENVIRON SCI TECHNOL, V36, P421, DOI 10.1021/es010907c; Ouyang LN, 2016, CHINA ENV SCI; Oves M, 2013, SAUDI J BIOL SCI, V20, P121, DOI 10.1016/j.sjbs.2012.11.006; Oyetibo GO, 2014, INT BIODETER BIODEGR, V91, P37, DOI 10.1016/j.ibiod.2014.03.004; Pardo R, 2003, ANAL BIOANAL CHEM, V376, P26, DOI 10.1007/s00216-003-1843-z; Paul Dipak, 2017, Annals of Agrarian Science, V15, P278, DOI 10.1016/j.aasci.2017.04.001; Peres TV, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0099-0; POPP JL, 1990, BIOCHEMISTRY-US, V29, P10475, DOI 10.1021/bi00498a008; Rai UN, 2008, ENVIRON MONIT ASSESS, V144, P469, DOI 10.1007/s10661-007-0010-y; Rajkumar M, 2010, TRENDS BIOTECHNOL, V28, P142, DOI 10.1016/j.tibtech.2009.12.002; [任立民 Ren Limin], 2007, [生态学报, Acta Ecologica Sinica], V27, P357; Ryan MP, 2013, J MED MICROBIOL, V62, P1025, DOI 10.1099/jmm.0.054759-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sana Ehsan, 2013, Ecoterra, P37; Saygideger S, 2005, J HAZARD MATER, V126, P96, DOI 10.1016/j.jhazmat.2005.06.012; Sen SK, 2014, J HAZARD MATER, V265, P47, DOI 10.1016/j.jhazmat.2013.11.036; Shiller AM, 2005, GEOMICROBIOL J, V22, P117, DOI 10.1080/01490450590945924; Silva AM, 2012, J CLEAN PROD, V29-30, P11, DOI 10.1016/j.jclepro.2012.01.032; Sun ZhongXing, 2011, Journal of Environmental & Occupational Medicine, V28, P379; Tang WW, 2016, CHEMOSPHERE, V165, P277, DOI 10.1016/j.chemosphere.2016.08.134; Tani Y, 2004, J ENVIRON SCI HEAL A, V39, P2641, DOI [10.1081/ESE-200027021, 10.1081/LESA-200027021]; Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002; Wang L, 2018, J HAZARD MATER, V341, P1, DOI 10.1016/j.jhazmat.2017.07.036; Wang PF, 2015, POL J ENVIRON STUD, V24, P339; Wang T, 2017, ENV SCI POLLUTION RE, V1, P1; Weyens N, 2009, CURR OPIN BIOTECH, V20, P248, DOI 10.1016/j.copbio.2009.02.012; Xie XH, 2010, AFR J BIOTECHNOL, V9, P4056; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897, DOI 10.1111/j.1348-0421.1995.tb03275.x; Yang F, 2010, ENVIRON TECHNOL, V31, P1045, DOI 10.1080/09593330.2010.487290; Zeng Xian-Cai, 2016, China Environmental Science, V36, P293; Zhang P, 2014, CHINA RURAL WATER HY, P35; ZHAO Han XW-j, 2016, ENV HLTH, P303; Zhongxing S., 2017, SHANGHAI J PREV MED, V29, P288; Zouboulis AI, 2004, PROCESS BIOCHEM, V39, P909, DOI 10.1016/S0032-9592(03)00200-0	77	24	26	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203285	10.1371/journal.pone.0203285	http://dx.doi.org/10.1371/journal.pone.0203285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169522	Green Published, gold, Green Submitted			2022-12-26	WOS:000443374400032
J	Liang, H; Estes, MK; Zhang, HL; Du, GW; Zhou, Y				Liang, Hong; Estes, Mary K.; Zhang, Huiling; Du, Guangwei; Zhou, Yong			Bile acids target proteolipid nano-assemblies of EGFR and phosphatidic acid in the plasma membrane for stimulation of MAPK signaling	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; LIGAND-INDEPENDENT ACTIVATION; MODEL MEMBRANES; CHOLESTEROL; KINASE; DOMAIN; HEPATOCYTES; INHIBITION; ENTEROIDS; DYNAMICS	Bile acids are critical biological detergents in the gastrointestinal tract and also act as messengers to regulate a multitude of intracellular signaling events, including mitogenic signaling, lipid metabolism and endo/exocytosis. In particular, bile acids stimulate many receptors and ion channels on the cell surface, the mechanisms of which are still poorly understood. Membrane-associating proteins depend on the local spatial distribution of lipids in the plasma membrane (PM) for their function. Here, we report that the highly amphipathic secondary bile acid deoxycholic acid (DCA), a major constituent in the human bile, at doses <1 mu M enhances the nanoclustering and the PM localization of phosphatidic acid (PA) but disrupts the local segregation of phosphatidylserine in the basolateral PM of the human colorectal adenocarcinoma Caco-2 cells. PA is a key structural component of the signaling nano-domains of epidermal growth factor receptor (EGFR) on the cell surface. We show that DCA promotes the co-localization between PA and EGFR, the PA-driven EGFR dimerization/oligomerization and EGFR signaling. Depletion of PA abolishes the stimulatory effects of DCA on the EGFR oligomerization and signaling. This effect occurs in the cultured Caco-2 cells and the ex vivo human intestinal enteroids. We propose a novel mechanism, where the amphiphilic DCA monomers alter the nano-assemblies of anionic phospholipids and in turn change the dynamic structural integrity of the lipid-driven oligomerization of cell surface receptors and their signal transduction.	[Liang, Hong; Du, Guangwei; Zhou, Yong] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Estes, Mary K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Zhang, Huiling] Soochow Univ, Coll Pharmaceut Sci, Suzhou, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Soochow University - China	Zhou, Y (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	yong.zhou@uth.tmc.edu	zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022	Du, Guangwei/0000-0003-4193-6975; Zhou, Yong/0000-0002-0214-8151	National Institute of Diabetes and Digestive and Kidney Diseases grant [DK056338]; National Institute of Aging [A157788]; National Institute of Heart, Lung and Blood Institute [HL119478]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases grant; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by The National Institute of Diabetes and Digestive and Kidney Diseases grant no. DK056338 to MKE and YZ, The National Institute of Aging grant no. A157788 to MKE, and The National Institute of Heart, Lung and Blood Institute grant no. HL119478 to GD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Halim KB, 2015, BBA-GEN SUBJECTS, V1850, P1017, DOI 10.1016/j.bbagen.2014.09.006; Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164; Ariotti N, 2010, MOL CELL BIOL, V30, P3795, DOI 10.1128/MCB.01615-09; Chen X, 2002, J BIOL CHEM, V277, P49631, DOI 10.1074/jbc.M208327200; Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952; Esteves M, 2015, LANGMUIR, V31, P8901, DOI 10.1021/acs.langmuir.5b01702; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Fuentes NR, 2018, CANCER RES, V78, P3899, DOI 10.1158/0008-5472.CAN-18-0324; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; GARRY FB, 1994, J VET INTERN MED, V8, P432, DOI 10.1111/j.1939-1676.1994.tb03263.x; Hofmann AF, 2014, J LIPID RES, V55, P1553, DOI 10.1194/jlr.R049437; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Jean-Louis S, 2006, J BIOL CHEM, V281, P14948, DOI 10.1074/jbc.M506710200; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Lieu T, 2014, GASTROENTEROLOGY, V147, P1417, DOI 10.1053/j.gastro.2014.08.042; Lu CF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414391; Maekawa M, 2015, J CELL SCI, V128, P1422, DOI 10.1242/jcs.164715; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; Mello-Vieira J, 2013, BBA-BIOMEMBRANES, V1828, P2152, DOI 10.1016/j.bbamem.2013.05.021; Miao BC, 2010, P NATL ACAD SCI USA, V107, P20126, DOI 10.1073/pnas.1004522107; Nagathihalli NS, 2014, CANCER RES, V74, P2062, DOI 10.1158/0008-5472.CAN-13-2329; Natalini B, 2014, J PHARMACEUT BIOMED, V87, P62, DOI 10.1016/j.jpba.2013.06.029; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Qiao L, 2001, MOL BIOL CELL, V12, P2629, DOI 10.1091/mbc.12.9.2629; Rao YP, 2002, HEPATOLOGY, V35, P307, DOI 10.1053/jhep.2002.31104; Saxena K, 2016, J VIROL, V90, P43, DOI 10.1128/JVI.01930-15; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Taberner FJ, 2015, BBA-BIOMEMBRANES, V1848, P1818, DOI 10.1016/j.bbamem.2015.03.022; Wilken JA, 2011, CANCER-AM CANCER SOC, V117, P2358, DOI 10.1002/cncr.25805; Wilson SR, 2013, J NEUROSCI, V33, P9283, DOI 10.1523/JNEUROSCI.5318-12.2013; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhang F, 2014, MOL CELL BIOL, V34, P84, DOI 10.1128/MCB.00987-13; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zhou HP, 2014, STEROIDS, V86, P62, DOI 10.1016/j.steroids.2014.04.016; Zhou Y, 2017, CELL, V168, P239, DOI 10.1016/j.cell.2016.11.059; Zhou Y, 2015, SCIENCE, V349, P873, DOI 10.1126/science.aaa5619; Zhou Y, 2013, J BIOL CHEM, V288, P35660, DOI 10.1074/jbc.M113.519116; Zou WY, 2019, METHODS MOL BIOL, V1576, P229, DOI 10.1007/7651_2017_1	39	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0198983	10.1371/journal.pone.0198983	http://dx.doi.org/10.1371/journal.pone.0198983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169511	gold, Green Published, Green Submitted			2022-12-26	WOS:000443374400001
J	Naidoo, N; Zuma, N; Khosa, NS; Marincowitz, G; Railton, J; Matlakala, N; Jobson, GA; Igumbor, JO; McIntyre, JA; Struthers, HE; Peters, RPH				Naidoo, Nireshni; Zuma, Nkosinathi; Khosa, N. Sellina; Marincowitz, Gert; Railton, Jean; Matlakala, Nthabiseng; Jobson, Geoffrey A.; Igumbor, Jude O.; McIntyre, James A.; Struthers, Helen E.; Peters, Remco P. H.			Qualitative assessment of facilitators and barriers to HIV programme implementation by community health workers in Mopani district, South Africa	PLOS ONE			English	Article							MODEL; CARE	South Africa has implemented a community-based HIV programme (CBHP) in its primary healthcare (PHC) re-engineering strategy that aims to improve public healthcare delivery. This CBHP is delivered by ward-based outreach teams (WBOTs); provision of community HIV services comprises an important component of this programme. We conducted an exploratory study to determine the facilitators and barriers to successful implementation of this CBHP in rural Mopani District, South Africa. Focus group discussions were conducted with the community health workers (CHWs) and PHC nurses; participant interviews were conducted with community members who access these health services, community leaders, and social workers. We conducted a thematic content analysis and based on the key themes reported, we identified the Consolidated Framework for Implementation Research, consisting of five domains, as the most appropriate model to interpret our findings. First, in terms of intervention characteristics, community members generally valued the HIV services provided, but the variable needs impacted on programme implementation. Outer setting challenges include inability to meet the need of patients as a result of stigma, nondisclosure of HIV status and social factors. In terms of the inner setting, CHWs were grateful for the equipment and training received but expressed the need for better support of management and the provision of additional resources. With regard to characteristics of the implementers, the CHWs expressed the desire for further training despite reporting having sufficient knowledge to conduct their HIV work. Finally, in terms of the implementation process, the importance of relationship building between CHWs and community members was emphasised. In conclusion, these data underline the positive receipt and potential of the CBHP in this rural district and identify areas to further strengthen the programme. The success and sustainability of the CBHP requires ongoing commitment of resources, training, supervision, and organisational support in order to operate effectively and efficiently.	[Naidoo, Nireshni; Zuma, Nkosinathi; Khosa, N. Sellina; Railton, Jean; Matlakala, Nthabiseng; Jobson, Geoffrey A.; McIntyre, James A.; Struthers, Helen E.; Peters, Remco P. H.] Anova Hlth Inst, Johannesburg, South Africa; [Naidoo, Nireshni; Igumbor, Jude O.; Peters, Remco P. H.] Univ Witwatersrand, Div Epidemiol & Biostat, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Marincowitz, Gert] Mopani DCST, Dept Hlth, Giyani, Limpopo Provinc, South Africa; [McIntyre, James A.] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Struthers, Helen E.] Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, Cape Town, South Africa; [Peters, Remco P. H.] MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands	University of Witwatersrand; University of Cape Town; University of Cape Town; Maastricht University	Peters, RPH (corresponding author), Anova Hlth Inst, Johannesburg, South Africa.; Peters, RPH (corresponding author), Univ Witwatersrand, Div Epidemiol & Biostat, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa.; Peters, RPH (corresponding author), MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands.	peters@anovahealth.co.za	Igumbor, Jude Ofuzinim/AAJ-2802-2020	Igumbor, Jude Ofuzinim/0000-0002-3324-7654; Peters, Remco Petrus Hendricus/0000-0003-2124-7275	US President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) [674-A-12-00015]; Fogarty and NIAID, The UNC-Wits AIDS Implementation Science and Cohort Analyses Training Grant [5D43TW009774-02]; FOGARTY INTERNATIONAL CENTER [D43TW009774] Funding Source: NIH RePORTER	US President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Fogarty and NIAID, The UNC-Wits AIDS Implementation Science and Cohort Analyses Training Grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study is made possible by the generous support of the American people through the US President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) under Cooperative Agreement number 674-A-12-00015 to the Anova Health Institute. The contents are the responsibility of Anova Health Institute and do not necessarily reflect the views of USAID or the United States Government. The funding body did not play a role in the design of the study, data collection, analysis, interpretation of data, or in writing the manuscript. This research project was supported by a postgraduate training scholarship from the Fogarty and NIAID, The UNC-Wits AIDS Implementation Science and Cohort Analyses Training Grant (Grant number: 5D43TW009774-02 to N.N.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Fogarty or NIAID.	[Anonymous], NVIVO QUAL DAT AN SO; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Condo J, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-71; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; De Neve JW, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002374; Feldstein AC, 2008, JT COMM J QUAL PATIE, V34, P228, DOI 10.1016/S1553-7250(08)34030-6; Geldsetzer P, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0236-x; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Gustafson DH, 2003, HEALTH SERV RES, V38, P751, DOI 10.1111/1475-6773.00143; Javanparast S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-291; Johnson CD, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-25; Klein KJ, 2005, CURR DIR PSYCHOL SCI, V14, P243, DOI 10.1111/j.0963-7214.2005.00373.x; Liu A, 2011, MT SINAI J MED, V78, P419, DOI 10.1002/msj.20260; Macinko J, 2015, NEW ENGL J MED, V372, P2177, DOI 10.1056/NEJMp1501140; Marincowitz G, 2016, COMMUNICATION; Mendel P, 2008, ADM POLICY MENT HLTH, V35, P21, DOI 10.1007/s10488-007-0144-9; Naledi TBP, 2011, PRIMARY HLTH CARE SA; National Department of Health, 2011, PROV GUID IMPL 3 STR; Pettigrew AM, 2001, ACAD MANAGE J, V44, P697, DOI 10.2307/3069411; Pillay Y., 2011, IMPLEMENTATION PHC R; Pronovost P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1714; Rachlis B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149412; Saint S, 2009, JT COMM J QUAL PATIE, V35, P239, DOI 10.1016/S1553-7250(09)35032-1; Schneider H, 2016, HEALTH SYST REFORM, V2, P112, DOI 10.1080/23288604.2016.1166307; Wajid A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075476	26	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203081	10.1371/journal.pone.0203081	http://dx.doi.org/10.1371/journal.pone.0203081			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161208	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900079
J	Lin, YP; Wu, JI; Tseng, CW; Chen, HJ; Wang, LH				Lin, Yi-Pei; Wu, Jun-I; Tseng, Chien-Wei; Chen, Huei-Jane; Wang, Lu-Hai			Gjb4 serves as a novel biomarker for lung cancer and promotes metastasis and chemoresistance via Src activation	ONCOGENE			English	Article							PROTEIN-KINASE-C; SIGNALING PATHWAYS; CELL-MIGRATION; ANGIOTENSIN-II; GAP-JUNCTIONS; EXPRESSION; INVASION; CONNEXIN-43; GROWTH; RECEPTOR	Most lung cancer patients are diagnosed late with metastasis, which is the major cause of cancer-related death and recurrent tumors that often exhibit chemoresistance. In the present study, we initially identified gap junction beta-4 protein (Gjb4) to be overexpressed in highly metastatic cancer cells selected by their enhanced binding to serum components. Overexpression or knockdown of Gjb4 increased or decreased lung metastasis of syngeneic mice, respectively. We found that Gjb4 expression was higher in lung tumors than normal tissues (p = 0.0026), and Gjb4 levels in blood buffy coat samples showed significant performance in diagnosing stage I-III (p = 0.002814) and stage IV (p < 0.0001) lung cancer. Moreover, high Gjb4 expression levels were correlated with poor prognosis (p = 1.4e-4) and recurrence (p = 1.9e-12). Using syngeneic mouse model, we observed that Gjb4 was able to promote tumor growth. High molecular weight serum fraction containing the major growth factor component IGF1 was able to induce Gjb4 via PKC pathway. Gjb4 activated Src signaling via MET, and overexpression of Gjb4 enhanced sphere-forming ability and anchorage-independent growth, which were reversed by inhibition of Src. In addition, we demonstrated that Gjb4-mediated Src activation enhanced chemoresistance of cancer cells toward gemcitabine and etoposide. The combination of Gjb4 knockdown, gemcitabine, and dasatinib further enhanced the inhibition of cancer cell viability. Together, our study has identified Gjb4 as a potential novel diagnostic and prognostic biomarker for lung cancer. Targeting Gjb4 may be exploited as a modality for improving lung cancer therapy.	[Lin, Yi-Pei; Wu, Jun-I; Tseng, Chien-Wei; Chen, Huei-Jane; Wang, Lu-Hai] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Lin, Yi-Pei; Wang, Lu-Hai] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei, Taiwan; [Wu, Jun-I; Wang, Lu-Hai] Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan; [Tseng, Chien-Wei] China Med Univ, Chinese Med Res Ctr, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Taiwan University; National Central University; China Medical University Taiwan	Wang, LH (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan.; Wang, LH (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei, Taiwan.; Wang, LH (corresponding author), Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan.; Wang, LH (corresponding author), China Med Univ, Chinese Med Res Ctr, Taichung, Taiwan.	lu-hai.wang@nhri.org.tw			National Health Research Institutes, Taiwan [06A1-MGPP09-014]; Ministry of Education, Taiwan [CMRC-CHM-7]; Ministry of Science and Technology, Taiwan [MOST 104-2320-B-039-055-MY3, MOST 104-2320-B-039-054-MY3, MOST 106-2320-B-039-059-]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Health Research Institutes, Taiwan (06A1-MGPP09-014), the Ministry of Education, Taiwan (CMRC-CHM-7), and the Ministry of Science and Technology, Taiwan (MOST 104-2320-B-039-055-MY3, MOST 104-2320-B-039-054-MY3 and MOST 106-2320-B-039-059-). We thank Core Laboratory of Microarray, Cell Sorting, Pathology, Confocal Microscopy as well as Proteomics and chemistry of National Health Research Institutes (NHRI) for experiments involving exon array analysis, cell sorting, H&E staining, Immunohistochemistry, confocal microscopy and mass spectrometry, respectively. We thank Dr. Yi Rong Chen of IMGM, NHRI, Taiwan for the gift of H1650 human lung cancer cell line. We also thank Dr. Chin Fu Hsiao of Division of Biostatistics and Bioinformatics of NHRI, Taiwan for the clinical samples from lung cancer tissue bank. We thank Dr. Sheng-Chieh Lin for the assistance of manuscript preparation.	Aasen T, 2016, NAT REV CANCER, V16, P775, DOI 10.1038/nrc.2016.105; Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Banerjee Debarshi, 2016, Int J Cell Biol, V2016, P9025905, DOI 10.1155/2016/9025905; Bausch-Fluck D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121314; Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; Celia-Terrassa T, 2016, GENE DEV, V30, P892, DOI 10.1101/gad.277681.116; Chu CH, 2008, J ENDOCRINOL, V197, P381, DOI 10.1677/JOE-07-0619; Common JEA, 2005, J INVEST DERMATOL, V125, P920, DOI 10.1111/j.0022-202X.2005.23919.x; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; Duggan MA, 2016, AM J SURG PATHOL, V40, pE94, DOI 10.1097/PAS.0000000000000749; Elzarrad MK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-20; Ezumi K, 2008, CLIN CANCER RES, V14, P677, DOI 10.1158/1078-0432.CCR-07-1184; Feliciano P., 2012, NAT GENET, V44, P840; Ganapathy V, 2015, J CONTROL RELEASE, V219, P215, DOI 10.1016/j.jconrel.2015.09.042; Gavalas NG, 2013, INT J MOL SCI, V14, P15885, DOI 10.3390/ijms140815885; Geimonen E, 1996, J BIOL CHEM, V271, P23667, DOI 10.1074/jbc.271.39.23667; George TJ, 2014, ONCOLOGIST, V19, P211, DOI 10.1634/theoncologist.2013-0410; Gielen PR, 2013, NEUROPHARMACOLOGY, V75, P539, DOI 10.1016/j.neuropharm.2013.05.002; Giuffrida ML, 2010, REV NEUROSCIENCE, V21, P83; Gonzalez-Sanchez A, 2016, ONCOTARGET, V7, P49819, DOI 10.18632/oncotarget.10454; Guan PP, 2015, ONCOTARGET, V6, P9140, DOI 10.18632/oncotarget.3274; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Han YH, 2009, ONCOL REP, V22, P215, DOI 10.3892/or_00000427; Hedberg KK, 2000, EXP CELL RES, V257, P67, DOI 10.1006/excr.2000.4873; Huang GY, 2015, CELL MOL LIFE SCI, V72, P1741, DOI 10.1007/s00018-015-1833-2; Huang LM, 2014, ONCOTARGETS THER, V7, DOI 10.2147/OTT.S67251; Jaraiz-Rodriguez M, 2017, STEM CELL REP, V9, P451, DOI 10.1016/j.stemcr.2017.06.007; Jia GH, 2007, J SURG RES, V142, P137, DOI 10.1016/j.jss.2006.11.007; Kalemkerian GP, 2016, LANCET ONCOL, V17, P1033, DOI 10.1016/S1470-2045(16)30160-7; Kloverpris S, 2013, BIOCHEM J, V449, P209, DOI 10.1042/BJ20120801; Kotini M, 2015, DEV BIOL, V401, P143, DOI 10.1016/j.ydbio.2014.12.023; Kyo N, 2008, ONCOL REP, V19, P627; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Leto SM, 2014, J MOL MED, V92, P709, DOI 10.1007/s00109-014-1161-2; Li X, 2012, NEOPLASMA, V59, P500, DOI 10.4149/neo_2012_064; Li YZ, 2015, P NATL ACAD SCI USA, V112, P1839, DOI 10.1073/pnas.1424171112; Lin JHC, 2002, J NEUROSCI, V22, P4302, DOI 10.1523/JNEUROSCI.22-11-04302.2002; Lin KT, 2012, CANCER RES, V72, P3000, DOI 10.1158/0008-5472.CAN-11-2502; Lin R, 2001, J CELL BIOL, V154, P815, DOI 10.1083/jcb.200102027; LONGATI P, 1994, ONCOGENE, V9, P49; Lopez-Bigas N, 2002, HUM MUTAT, V19, DOI 10.1002/humu.9023; Losa D, 2011, EXPERT OPIN THER TAR, V15, P989, DOI 10.1517/14728222.2011.584875; Manegold Christian, 2004, Expert Rev Anticancer Ther, V4, P345, DOI 10.1586/14737140.4.3.345; Matta C, 2014, CELL SIGNAL, V26, P979, DOI 10.1016/j.cellsig.2014.01.011; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Miyata T, 2015, PERS MED U, V4, P40, DOI [10.1016/j.pmu.2015.03.007, DOI 10.1016/J.PMU.2015.03.007]; Montuenga Luis M, 2009, Eur J Cancer, V45 Suppl 1, P377, DOI 10.1016/S0959-8049(09)70055-3; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Munoz JL, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.111; Murphy SF, 2016, CANCER RES, V76, P139, DOI 10.1158/0008-5472.CAN-15-1286; Naoi Y, 2007, BREAST CANCER RES TR, V106, P11, DOI 10.1007/s10549-006-9465-8; Novello S, 2016, ANN ONCOL, V27, pv1, DOI 10.1093/annonc/mdw326; Popper HH, 2016, CANCER METAST REV, V35, P75, DOI 10.1007/s10555-016-9618-0; Reck M, 2005, LUNG CANCER-J IASLC, V48, P409, DOI 10.1016/j.lungcan.2004.11.013; Roskoski R, 2015, PHARMACOL RES, V94, P9, DOI 10.1016/j.phrs.2015.01.003; Shigyo M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12055; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Spray DC, 1998, CIRC RES, V83, P679, DOI 10.1161/01.RES.83.6.679; Steinberg M, 2007, CLIN THER, V29, P2289, DOI 10.1016/j.clinthera.2007.11.005; Steinman RA, 2003, ONCOGENE, V22, P3608, DOI 10.1038/sj.onc.1206523; TAPPER H, 1995, J CELL PHYSIOL, V163, P137, DOI 10.1002/jcp.1041630116; Teleki I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112541; Thakur R, 2015, SCI REP-UK, V5, DOI 10.1038/srep10194; Touyz RM, 2000, PHARMACOL REV, V52, P639; Tung SL, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.25; Uramoto H, 2014, TRANSL LUNG CANCER R, V3, P242, DOI 10.3978/j.issn.2218-6751.2013.12.05; van Oosterwijk JG, 2013, BRIT J CANCER, V109, P1214, DOI 10.1038/bjc.2013.451; Wan YT, 2017, EXP THER MED, V13, P3067, DOI 10.3892/etm.2017.4356; Wang SY, 2009, METHODS MOL BIOL, V568, P151, DOI 10.1007/978-1-59745-280-9_9; Yeh YM, 2013, INT J CANCER, V133, P867, DOI 10.1002/ijc.28086; Zaghloul M., 2015, TROP MED SURG, V3, pe122, DOI [10.4172/2329-9088.1000 e122, DOI 10.4172/2329-9088.1000E122]; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002; Zhang W, 2003, J NEUROSURG, V99, P1039, DOI 10.3171/jns.2003.99.6.1039; Zhao JH, 2016, PHARMACOL THERAPEUT, V160, P145, DOI 10.1016/j.pharmthera.2016.02.008	74	13	13	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 7	2019	38	6					822	837		10.1038/s41388-018-0471-1	http://dx.doi.org/10.1038/s41388-018-0471-1			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HK5LC	30177841				2022-12-26	WOS:000458006300005
J	Miyazaki, T; Haraguchi, S; Kim-Kaneyama, JR; Miyazaki, A				Miyazaki, Takuro; Haraguchi, Shogo; Kim-Kaneyama, Joo-Ri; Miyazaki, Akira			Endothelial calpain systems orchestrate myofibroblast differentiation during wound healing	FASEB JOURNAL			English	Article						PDGFR-beta fibroblasts; angiogenesis; calpastatin; extracellular matrix	KAPPA-B-ALPHA; PROTEOLYTIC SYSTEMS; CA2+ TRANSIENTS; CELL; ANGIOGENESIS; BETA; PROLIFERATION; DYSFUNCTION; INHIBITION; MODULATION	The transformation of fibroblasts to myofibroblasts plays a major role in fibrogenic responses during dermal wound healing. We show a contribution of calpain systems (intracellular regulatory protease systems) in vascular endothelial cells (ECs) to myofibroblast differentiation in wound sites. Dermal wound healing experiments in mice found that calpastatin (an endogenous inhibitor of calpains) is enriched in preexisting vessels but not in newly formed capillaries. Transgenic overexpression of calpastatin in ECs delayed wound healing in mice as well as reducing the keratinocyte layer, extracellular matrix deposition, and myofibroblast accumulation in wound sites. EC and leukocyte markers, however, remain unchanged. Calpastatin overexpression reduced the expression of genes encoding platelet-derived growth factor-B and PDGF receptor- (PDGFR-). Topical application of platelet-derived growth factor-BB-containing ointment to wounds accelerated healing in control mice, but calpastatin overexpression prevented this acceleration. In cultured human dermal fibroblasts, -smooth muscle actin and PDGFR- were up-regulated by coculturing with ECs, but this action was inhibited by suppression of EC calpain activity. EC-driven transformation of mouse dermal fibroblasts was also suppressed by calpastatin overexpression in ECs. These results suggest that endothelial calpain systems influence PDGFR- signaling in fibroblasts, EC-driven myofibroblast differentiation, and subsequent fibrogenic responses in wounds.Miyazaki, T., Haraguchi, S., Kim-Kaneyama, J.-R., Miyazaki, A. Endothelial calpain systems orchestrate myofibroblast differentiation during wound healing.	[Miyazaki, Takuro; Haraguchi, Shogo; Kim-Kaneyama, Joo-Ri; Miyazaki, Akira] Showa Univ, Sch Med, Dept Biochem, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan	Showa University	Miyazaki, T (corresponding author), Showa Univ, Sch Med, Dept Biochem, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	taku@pharm.showa-u.ac.jp		Miyazaki, Takuro/0000-0003-3354-0292; Haraguchi, Shogo/0000-0002-8731-3311	Japan Society for the Promotion of Science (KAKENHI) [17K09869, 15K09418]; Takeda Science Foundation; Senshin Medical Research Foundation; Kanae Foundation for the Promotion of Medical Science	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Senshin Medical Research Foundation(SENSHIN Medical Research Foundation); Kanae Foundation for the Promotion of Medical Science	The authors thank Nicholas Rufaut (Edanz Group, Fukuoka, Japan; https://www.edanzediting.com/ac), for editing a draft of the manuscript. This work was supported, in part, by Japan Society for the Promotion of Science (KAKENHI; Grant 17K09869 to A.M. and 15K09418 to T.M.), and research grants from Takeda Science Foundation, Senshin Medical Research Foundation, and The Kanae Foundation for the Promotion of Medical Science (all to T.M.). The authors declare no conflicts of interest.	Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Darby IA, 2016, CELL MOL LIFE SCI, V73, P1145, DOI 10.1007/s00018-015-2110-0; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; DiPietro LA, 2016, J LEUKOCYTE BIOL, V100, P979, DOI 10.1189/jlb.4MR0316-102R; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Gao ZY, 2005, J BIOL CHEM, V280, P9375, DOI 10.1074/jbc.M413081200; Greaves NS, 2013, J DERMATOL SCI, V72, P206, DOI 10.1016/j.jdermsci.2013.07.008; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Hoang MV, 2011, BBA-MOL BASIS DIS, V1812, P549, DOI 10.1016/j.bbadis.2010.08.008; Kanegae Y, 1996, GENE, V181, P207, DOI 10.1016/S0378-1119(96)00516-1; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kwon YB, 2006, J VET SCI, V7, P105, DOI 10.4142/jvs.2006.7.2.105; Lambers C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19294-1; LIN YC, 1995, P NATL ACAD SCI USA, V92, P552, DOI 10.1073/pnas.92.2.552; Martin P, 2015, BRIT J DERMATOL, V173, P370, DOI 10.1111/bjd.13954; Milligan SA, 1996, ARCH BIOCHEM BIOPHYS, V335, P388, DOI 10.1006/abbi.1996.9998; Miyazaki T, 2001, BIOCHEM BIOPH RES CO, V281, P172, DOI 10.1006/bbrc.2001.4331; Miyazaki T, 2007, LIFE SCI, V81, P1421, DOI 10.1016/j.lfs.2007.08.041; Miyazaki T, 2018, J ATHEROSCLER THROMB, V25, P1, DOI 10.5551/jat.RV17008; Miyazaki T, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00079; Miyazaki T, 2017, CELL MOL LIFE SCI, V74, P3011, DOI 10.1007/s00018-017-2528-7; Miyazaki T, 2016, J CLIN INVEST, V126, P3417, DOI 10.1172/JCI85880; Miyazaki T, 2015, CIRC RES, V116, P1170, DOI 10.1161/CIRCRESAHA.116.305363; Miyazaki T, 2013, J ATHEROSCLER THROMB, V20, P228, DOI 10.5551/jat.14787; Miyazaki T, 2010, CARDIOVASC RES, V85, P530, DOI 10.1093/cvr/cvp311; Nassar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037084; Nissen NN, 1998, AM J PATHOL, V152, P1445; Oberringer M, 2008, J MOL HISTOL, V39, P37, DOI 10.1007/s10735-007-9124-3; Oberringer M, 2007, BIOL CELL, V99, P197, DOI 10.1042/BC20060116; Roman CD, 2002, J SURG RES, V105, P43, DOI 10.1006/jsre.2002.6444; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Scalia R, 2007, DIABETES, V56, P1842, DOI 10.2337/db06-1198; Singh V, 2014, EXP EYE RES, V120, P152, DOI 10.1016/j.exer.2014.01.003; Stalker TJ, 2003, FASEB J, V17, P1511, DOI 10.1096/fj.02-1213fje; Zhang YX, 2017, BBA-MOL BASIS DIS, V1863, P1326, DOI 10.1016/j.bbadis.2017.03.021	35	7	7	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2037	2046		10.1096/fj.201800588RR	http://dx.doi.org/10.1096/fj.201800588RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30199285	Bronze			2022-12-26	WOS:000457296600041
J	Ochoa-Lizarralde, B; Gao, YG; Popov, AN; Samygina, VR; Zhai, XH; Mishra, SK; Boldyrev, IA; Molotkovsky, JG; Simanshu, DK; Patel, DJ; Brown, RE; Malinina, L				Ochoa-Lizarralde, Borja; Gao, Yong-Guang; Popov, Alexander N.; Samygina, Valeria R.; Zhai, Xiuhong; Mishra, Shrawan K.; Boldyrev, Ivan A.; Molotkovsky, Julian G.; Simanshu, Dhirendra K.; Patel, Dinshaw J.; Brown, Rhoderick E.; Malinina, Lucy			Structural analyses of 4-phosphate adaptor protein 2 yield mechanistic insights into sphingolipid recognition by the glycolipid transfer protein family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid-protein interaction; sphingolipid; transport; X-ray crystallography; protein complex; protein structure; 4-phosphate-adaptor-protein-2; FAPP2; nonvesicular lipid transport; protein family	MEMBRANE INTERACTION; LIPID-BILAYERS; BOVINE BRAIN; GLTP-FOLD; PIG BRAIN; PURIFICATION; FLUORESCENCE; SPECIFICITY; REFINEMENT; PROBES	The glycolipid transfer protein (GLTP) fold defines a superfamily of eukaryotic proteins that selectively transport sphingolipids (SLs) between membranes. However, the mechanisms determining the protein selectivity for specific glycosphingolipids (GSLs) are unclear. Here, we report the crystal structure of the GLTP homology (GLTPH) domain of human 4-phosphate adaptor protein 2 (FAPP2) bound with N-oleoyl-galactosylceramide. Using this domain, FAPP2 transports glucosylceramide from its cis-Golgi synthesis site to the trans-Golgi for conversion into complex GSLs. The FAPP2-GLTPH structure revealed an element, termed the ID loop, that controls specificity in the GLTP family. We found that, in accordance with FAPP2 preference for simple GSLs, the ID loop protrudes from behind the SL headgroup-recognition center to mitigate binding by complex GSLs. Mutational analyses including GLTP and FAPP2 chimeras with swapped ID loops supported the proposed restrictive role of the FAPP2 ID loop in GSL selectivity. Comparative analysis revealed distinctly designed ID loops in each GLTP family member. This analysis also disclosed a conserved H-bond triplet that clasps both ID-loop ends together to promote structural autonomy and rigidity. The findings indicated that various ID loops work in concert with conserved recognition centers to create different specificities among family members. We also observed four bulky, conserved hydrophobic residues involved in sensor-like interactions with lipid chains in protein hydrophobic pockets and FF motifs in GLTP and FAPP2, well-positioned to provide acyl chain-dependent SL selectivity for the hydrophobic pockets. In summary, our study provides mechanistic insights into sphingolipid recognition by the GLTP fold and uncovers the elements involved in this recognition.	[Ochoa-Lizarralde, Borja; Samygina, Valeria R.; Malinina, Lucy] CIC BioGUNE, Struct Biol Unit, Technol Pk Bizkaia, Derio 48160, Spain; [Gao, Yong-Guang; Zhai, Xiuhong; Mishra, Shrawan K.; Brown, Rhoderick E.; Malinina, Lucy] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Popov, Alexander N.] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Samygina, Valeria R.] RAS, Shubnikov Inst Crystallog, FSRC Crystallog & Photon, Moscow 119333, Russia; [Boldyrev, Ivan A.; Molotkovsky, Julian G.] RAS, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Simanshu, Dhirendra K.; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA	CIC bioGUNE; University of Minnesota System; European Synchrotron Radiation Facility (ESRF); Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Memorial Sloan Kettering Cancer Center	Brown, RE; Malinina, L (corresponding author), Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	reb@umn.edu; lucy@hi.umn.edu	Gao, Yongguang/B-8546-2012; Samygina, Valeriya R/A-9069-2014	Gao, Yongguang/0000-0002-9359-4252; Simanshu, Dhirendra/0000-0002-9717-4618; Malinina, Lucy/0000-0001-7973-1831; Samygina, Valeriya/0000-0002-1528-5972; Brown, Rhoderick/0000-0002-7337-3604	NIGMS [GM45928]; NCI [CA121493]; NHLBI [HL125353]; Ministerio de Ciencia e Innovacion Grant [BFU2010-17711]; Russian Foundation for Basic Research Grant [14-04-01671]; CIC bioGUNE funds; Abby Rockefeller Mauze Trust; Maloris Foundation; Hormel Foundation; Federal Agency of Scientific Organizations; NATIONAL CANCER INSTITUTE [R01CA121493] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045928] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ministerio de Ciencia e Innovacion Grant(Spanish Government); Russian Foundation for Basic Research Grant(Russian Foundation for Basic Research (RFBR)); CIC bioGUNE funds; Abby Rockefeller Mauze Trust; Maloris Foundation; Hormel Foundation; Federal Agency of Scientific Organizations; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or part by National Institutes of Health Grants GM45928 from NIGMS, CA121493 from NCI, and HL125353 from NHLBI; Ministerio de Ciencia e Innovacion Grant BFU2010-17711; Russian Foundation for Basic Research Grant 14-04-01671; CIC bioGUNE funds; the Abby Rockefeller Mauze Trust; the Maloris and Hormel Foundations; and the Federal Agency of Scientific Organizations. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABE A, 1982, BIOCHEM BIOPH RES CO, V104, P1386, DOI 10.1016/0006-291X(82)91403-6; ABE A, 1985, J BIOL CHEM, V260, P1231; Boldyrev IA, 2007, J LIPID RES, V48, P1518, DOI 10.1194/jlr.M600459-JLR200; BROWN RE, 1990, BIOCHIM BIOPHYS ACTA, V1044, P77, DOI 10.1016/0005-2760(90)90221-I; BROWN RE, 1985, CHEM PHYS LIPIDS, V38, P79, DOI 10.1016/0009-3084(85)90059-3; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Carton I, 2010, BIOPHYS J, V99, P2947, DOI 10.1016/j.bpj.2010.09.016; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamlekar RK, 2013, BBA-MOL CELL BIOL L, V1831, P417, DOI 10.1016/j.bbalip.2012.10.010; Kenoth R, 2010, J BIOL CHEM, V285, P13066, DOI 10.1074/jbc.M109.093203; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Malinina L, 2006, PLOS BIOL, V4, P1996, DOI 10.1371/journal.pbio.0040362; Malinina L, 2017, ANNU REV BIOCHEM, V86, P609, DOI 10.1146/annurev-biochem-061516-044445; Malinina L, 2015, Q REV BIOPHYS, V48, P281, DOI 10.1017/S003358351400016X; Mattjus P, 1999, ANAL BIOCHEM, V268, P297, DOI 10.1006/abio.1998.3065; Mattjus P, 2016, CHEM PHYS LIPIDS, V194, P72, DOI 10.1016/j.chemphyslip.2015.07.018; Mattjus P, 2009, BBA-BIOMEMBRANES, V1788, P267, DOI 10.1016/j.bbamem.2008.10.003; METZ RJ, 1982, J BIOL CHEM, V257, P2901; Mikitova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030455; MOLOTKOVSKY JG, 1991, CHEM PHYS LIPIDS, V58, P199, DOI 10.1016/0009-3084(91)90093-Q; MOLOTKOVSKY JG, 1982, BIOORG KHIM+, V8, P1256; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohvo-Rekila H, 2011, BBA-BIOMEMBRANES, V1808, P47, DOI 10.1016/j.bbamem.2010.08.018; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Samygina VR, 2013, ACTA CRYSTALLOGR D, V69, P603, DOI 10.1107/S0907444913000024; Samygina VR, 2011, STRUCTURE, V19, P1644, DOI 10.1016/j.str.2011.09.011; Simanshu DK, 2014, CELL REP, V6, P388, DOI 10.1016/j.celrep.2013.12.023; Simanshu DK, 2013, NATURE, V500, P463, DOI 10.1038/nature12332; Sugiki T, 2010, ANAL BIOCHEM, V399, P162, DOI 10.1016/j.ab.2009.12.031; Tuuf J, 2009, BIOCHEM BIOPH RES CO, V388, P395, DOI 10.1016/j.bbrc.2009.08.023; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Zhai XH, 2017, J BIOL CHEM, V292, P2531, DOI 10.1074/jbc.M116.760256	36	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16709	16723		10.1074/jbc.RA117.000733	http://dx.doi.org/10.1074/jbc.RA117.000733			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30206120	Green Published, hybrid			2022-12-26	WOS:000448515100014
J	Turek, I; Tischer, N; Lassig, R; Trujillo, M				Turek, Ilona; Tischer, Nadine; Lassig, Roman; Trujillo, Marco			Multi-tiered pairing selectivity between E2 ubiquitin-conjugating enzymes and E3 ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; ubiquitin-conjugating enzyme (E2 enzyme); E3 ubiquitin ligase; innate immunity; cell signaling	U-BOX; NEGATIVE REGULATION; ARABIDOPSIS COP10; FLAGELLIN PERCEPTION; POLYUBIQUITIN CHAINS; INNATE IMMUNITY; DOWN-REGULATION; PLANT IMMUNITY; DROUGHT STRESS; PROTEIN-KINASE	Ubiquitination is a prevalent post-translational modification involved in all aspects of cell physiology. It is mediated by an enzymatic cascade and the E2 ubiquitin-conjugating enzymes (UBCs) lie at its heart. Even though E3 ubiquitin ligases determine the specificity of the reaction, E2s catalyze the attachment of ubiquitin and have emerged as key mediators of chain assembly. They are largely responsible for the type of linkage between ubiquitin moieties and thus, the fate endowed onto the modified substrate. However, in vivo E2-E3 pairing remains largely unexplored. We therefore interrogated the interaction selectivity between 37 Arabidopsis E2s and PUB22, a U-box type E3 ubiquitin ligase that is involved in the dampening of immune signaling. We show that whereas the U-box domain, which mediates E2 docking, is able to interact with 18 of 37 tested E2s, the substrate interacting armadillo (ARM) repeats impose a second layer of specificity, allowing the interaction with 11 E2s. In vitro activity assayed by autoubiquitination only partially recapitulated the in vivo selectivity. Moreover, in vivo pairing was modulated during the immune response; pairing with group VI UBC30 was inhibited, whereas interaction with the K63 chain-building UBC35 was increased. Functional analysis of ubc35 ubc36 mutants shows that they partially mimic pub22 pub23 pub24 enhanced activation of immune responses. Together, our work provides a framework to interrogate in vivo E2-E3 pairing and reveals a multi-tiered and dynamic E2-E3 network.	[Turek, Ilona; Tischer, Nadine; Lassig, Roman; Trujillo, Marco] Leibniz Inst Plant Biochem, Independent Jr Res Grp, D-06120 Halle, Saale, Germany; [Trujillo, Marco] Albert Ludwigs Univ Freiburg, Fac Biol, Inst Biol 2, Cell Biol, Schanzlestr 1, D-79104 Freiburg, Germany	Leibniz Institut fur Pflanzenbiochemie; University of Freiburg	Trujillo, M (corresponding author), Albert Ludwigs Univ Freiburg, Cell Biol, Inst Biol 2, Schanzlestr 1, D-79104 Freiburg, Germany.	marco.trujillo@bio.uni-freiburg.de	Trujillo, Marco/M-7900-2017	Trujillo, Marco/0000-0002-5470-7277; Turek, Ilona/0000-0001-6457-7456	Deutsche Forschungsgemeinschaft (DFG); Leibniz Gemeinschaft	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Leibniz Gemeinschaft	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) and the Leibniz Gemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bednarek P, 2010, CURR OPIN PLANT BIOL, V13, P378, DOI 10.1016/j.pbi.2010.05.002; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Chen YC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05584; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Cho SK, 2008, PLANT CELL, V20, P1899, DOI 10.1105/tpc.108.060699; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Couto D, 2016, NAT REV IMMUNOL, V16, P537, DOI 10.1038/nri.2016.77; Cui F, 2012, PLANT CELL, V24, P233, DOI 10.1105/tpc.111.093062; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Ehlert A, 2006, PLANT J, V46, P890, DOI 10.1111/j.1365-313X.2006.02731.x; Eletr ZM, 2007, J MOL BIOL, V369, P419, DOI 10.1016/j.jmb.2007.03.026; Engler C, 2014, METHODS MOL BIOL, V1116, P119, DOI 10.1007/978-1-62703-764-8_9; Fletcher AJ, 2015, EMBO J, V34, P2078, DOI 10.15252/embj.201490361; Furlan G, 2017, PLANT CELL, V29, P726, DOI 10.1105/tpc.16.00654; Gimenez-Ibanez S, 2009, PLANT SIGNAL BEHAV, V4, P539, DOI 10.4161/psb.4.6.8697; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Jacobs S, 2011, PLANT PHYSIOL, V156, P726, DOI 10.1104/pp.111.176446; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Katsiarimpa A, 2014, PLANT CELL PHYSIOL, V55, P727, DOI 10.1093/pcp/pcu019; Katsiarimpa A, 2011, PLANT CELL, V23, P3026, DOI 10.1105/tpc.111.087254; Kim DY, 2013, PLANT CELL, V25, P1523, DOI 10.1105/tpc.112.108613; Kinoshita A, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1028707; Kinoshita A, 2015, DEVELOPMENT, V142, P444, DOI 10.1242/dev.113167; Kong LY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9630; Kowarschik K, 2018, NEW PHYTOL, V217, P1749, DOI 10.1111/nph.14900; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Lau OS, 2009, BIOCHEM J, V418, P683, DOI 10.1042/BJ20081943; Lee HG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12525; Li W, 2012, PLANT PHYSIOL, V159, P239, DOI 10.1104/pp.111.192617; Li WF, 2010, PLANT J, V62, P330, DOI 10.1111/j.1365-313X.2010.04150.x; Liao DH, 2017, NEW PHYTOL, V214, P1646, DOI 10.1111/nph.14472; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Marino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2479; Ntoukakis V, 2009, SCIENCE, V324, P784, DOI 10.1126/science.1169430; Ohi MD, 2005, MOL CELL BIOL, V25, P451, DOI 10.1128/MCB.25.1.451-460.2005; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Romero-Barrios N, 2018, NEW PHYTOL, V217, P995, DOI 10.1111/nph.14915; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Scaglione KM, 2013, J BIOL CHEM, V288, P18784, DOI 10.1074/jbc.C113.477596; Seo DH, 2016, PLANT CELL, V28, P2952, DOI 10.1105/tpc.16.00347; Seo DH, 2012, PLANT PHYSIOL, V160, P556, DOI 10.1104/pp.112.202143; Soss SE, 2013, BIOCHEMISTRY-US, V52, P2991, DOI 10.1021/bi3015949; Soss SE, 2011, J BIOL CHEM, V286, P21277, DOI 10.1074/jbc.M111.224006; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Stegmann M, 2012, PLANT CELL, V24, P4703, DOI 10.1105/tpc.112.104463; Stewart MD, 2016, CELL RES, V26, P423, DOI 10.1038/cr.2016.35; Suzuki G, 2002, GENE DEV, V16, P554, DOI 10.1101/gad.964602; Tatham MH, 2013, BIOCHEM J, V453, P137, DOI 10.1042/BJ20130244; Teh O.-k., 2018, PHOSPHORYLATION EXOC, DOI [10.1101/266171., DOI 10.1101/266171]; Trujillo M, 2008, CURR BIOL, V18, P1396, DOI 10.1016/j.cub.2008.07.085; Trujillo M, 2018, J EXP BOT, V69, P371, DOI 10.1093/jxb/erx411; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wang JL, 2018, MOL CELL, V69, P493, DOI 10.1016/j.molcel.2017.12.026; Wang YP, 2017, PLANT PHYSIOL, V173, P1235, DOI 10.1104/pp.16.00816; Wiborg J, 2008, BIOCHEM J, V413, P447, DOI 10.1042/BJ20071568; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338; Woodson JD, 2015, SCIENCE, V350, P450, DOI 10.1126/science.aac7444; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Yanagawa Y, 2004, GENE DEV, V18, P2172, DOI 10.1101/gad.1229504; Yin XJ, 2007, PLANT CELL, V19, P1898, DOI 10.1105/tpc.107.052035; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhou JG, 2018, P NATL ACAD SCI USA, V115, pE1906, DOI 10.1073/pnas.1712251115; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	70	26	28	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16324	16336		10.1074/jbc.RA118.004226	http://dx.doi.org/10.1074/jbc.RA118.004226			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30185618	Green Published, hybrid			2022-12-26	WOS:000447833600017
J	McCowan, C; Crameri, S; Kocak, A; Shan, SH; Fegan, M; Forshaw, D; Rubbenstroth, D; Chen, HL; Holmes, C; Harper, J; Dearnley, M; Batovska, J; Bergfeld, J; Walker, C; Wang, JN				McCowan, Christina; Crameri, Sandra; Kocak, Ayfer; Shan, Songhua; Fegan, Mark; Forshaw, David; Rubbenstroth, Dennis; Chen, Honglei; Holmes, Clare; Harper, Jenni; Dearnley, Megan; Batovska, Jana; Bergfeld, Jemma; Walker, Colin; Wang, Jianning			A novel group A rotavirus associated with acute illness and hepatic necrosis in pigeons (Columba livia), in Australia	PLOS ONE			English	Article							AVIAN ROTAVIRUS; EXPERIMENTAL-INFECTION; TURKEY FLOCKS; MOLECULAR CHARACTERIZATION; MAMMALIAN ROTAVIRUSES; VIRAL-INFECTIONS; BROILER-CHICKENS; ENTERIC VIRUSES; CHILDREN; DIARRHEA	Cases of vomiting and diarrhoea were reported in racing pigeons in Western Australia in May, 2016. Morbidity and mortality rates were high. Similar clinical disease was seen in Victoria in December and by early 2017 had been reported in all states except the Northern Territory, in different classes of domestic pigeon-racing, fancy and meat bird-and in a flock of feral pigeons. Autopsy findings were frequently unremarkable; histological examination demonstrated significant hepatic necrosis as the major and consistent lesion, often with minimal inflammatory infiltration. Negative contrast tissue suspension and thin section transmission electron microscopy of liver demonstrated virus particles consistent with a member of the Reoviridae. Inoculation of trypsin-treated Vero, MDBK and MA-104 cell lines resulted in cytopathic changes at two days after infection. Next generation sequencing was undertaken using fresh liver samples and a previously undescribed group A rotavirus (genotype G18P [17]) of avian origin was identified and the virus was isolated in several cell lines. A q-RTPCR assay was developed and used to screen a wider range of samples, including recovered birds. Episodes of disease have continued to occur and to reoccur in previously recovered lofts, with variable virulence reported. This is the first report of a rotavirus associated with hepatic necrosis in any avian species.	[McCowan, Christina; Kocak, Ayfer; Fegan, Mark; Batovska, Jana] Agr Victoria, Bundoora, Vic, Australia; [Crameri, Sandra; Shan, Songhua; Chen, Honglei; Holmes, Clare; Harper, Jenni; Dearnley, Megan; Bergfeld, Jemma; Wang, Jianning] Australian Anim Hlth Lab, Geelong, Vic, Australia; [Forshaw, David] Dept Primary Ind & Reg Dev, Albany, WA, Australia; [Rubbenstroth, Dennis] Univ Freiburg, Med Ctr, Inst Virol, Freiburg, Germany; [Rubbenstroth, Dennis] FLI, Inst Diagnost Virol, Greifswald, Germany; [Batovska, Jana] La Trobe Univ, Sch Appl Syst Biol, Bundoora, Vic, Australia; [Walker, Colin] Melbourne Bird Vet Clin, Melbourne, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Freiburg; Friedrich Loeffler Institute; La Trobe University	McCowan, C (corresponding author), Agr Victoria, Bundoora, Vic, Australia.	christina.mccowan@ecodev.vic.gov.au	shan, songhua/H-8650-2013; Batovska, Jana/N-4926-2015	Batovska, Jana/0000-0002-0919-568X; McCowan, Christina/0000-0002-2513-3235; Bergfeld, Jemma/0000-0003-1401-0982; Crameri, Sandra/0000-0003-3284-3355				Asano KM, 2011, AVIAN DIS, V55, P697, DOI 10.1637/9765-041911-ResNote.1; BABIUK LA, 1977, J CLIN MICROBIOL, V6, P610; Blutt SE, 2007, CURR OPIN GASTROEN, V23, P39, DOI 10.1097/MOG.0b013e328011829d; Blutt SE, 2007, PLOS MED, V4, P660, DOI 10.1371/journal.pmed.0040121; BRUSSOW H, 1992, J CLIN MICROBIOL, V30, P67; Busi C, 2017, EMERG INFECT DIS, V23, P1535, DOI 10.3201/eid2309.170158; Candy DCA, 2007, PLOS MED, V4, P614, DOI 10.1371/journal.pmed.0040117; Chitambar SD, 2008, J MED VIROL, V80, P2169, DOI 10.1002/jmv.21338; Crawford SE, 2006, J VIROL, V80, P4820, DOI 10.1128/JVI.80.10.4820-4832.2006; Crawford SE, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.83; Dhama K, 2015, VET QUART, V35, P142, DOI 10.1080/01652176.2015.1046014; Dickey M, 2009, PEDIATR INFECT DIS J, V28, P318, DOI 10.1097/INF.0b013e31818ddbe9; Domanska-Blicharz K, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1013-8; Falcone E, 2015, AVIAN PATHOL, V44, P509, DOI 10.1080/03079457.2015.1096011; GILGER MA, 1992, J PEDIATR-US, V120, P912, DOI 10.1016/S0022-3476(05)81959-6; GOUGH RE, 1985, VET REC, V116, P295, DOI 10.1136/vr.116.11.295; GOUGH RE, 1992, VET REC, V130, P273, DOI 10.1136/vr.130.13.273; Grech V, 2001, ANN TROP PAEDIATR, V21, P147, DOI 10.1080/02724930120058214; Halaihel N, 2000, J VIROL, V74, P9464, DOI 10.1128/JVI.74.20.9464-9470.2000; Hayashi M, 2016, CAN J VET RES, V80, P189; Ito H, 2001, VIRUS RES, V75, P123, DOI 10.1016/S0168-1702(01)00234-9; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li H., 2013, QUANT BIOL; Lobani AM, 2016, POULTRY SCI, V95, P1257, DOI 10.3382/ps/pew054; Lorrot M, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-31; Marlier D, 2006, VET J, V172, P40, DOI 10.1016/j.tvjl.2005.02.026; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MCDANIELS AE, 1983, WATER RES, V17, P1349, DOI 10.1016/0043-1354(83)90263-4; MCNULTY MS, 1983, AVIAN PATHOL, V12, P45, DOI 10.1080/03079458308436148; MCNULTY MS, 1979, ARCH VIROL, V61, P13, DOI 10.1007/BF01320587; MCNULTY MS, 1984, ARCH VIROL, V81, P113, DOI 10.1007/BF01309301; MEULEMANS G, 1985, BRIT VET J, V141, P69, DOI 10.1016/0007-1935(85)90128-9; MINAMOTO N, 1988, EPIDEMIOL INFECT, V100, P481, DOI 10.1017/S0950268800067212; Mori Y, 2002, J VIROL, V76, P5829, DOI 10.1128/JVI.76.11.5829-5834.2002; Mori Y, 2001, VIROLOGY, V288, P63, DOI 10.1006/viro.2001.1051; Morrison C, 2001, HUM PATHOL, V32, P216, DOI 10.1053/hupa.2001.21565; Moura-Alvarez J, 2014, TROP ANIM HEALTH PRO, V46, P1051, DOI 10.1007/s11250-014-0612-7; Nakano I, 2011, J CLIN MICROBIOL, V49, P4382, DOI 10.1128/JCM.01303-11; Pantin-Jackwood MJ, 2008, AVIAN DIS, V52, P235, DOI 10.1637/8174-111507-Reg.1; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Pauly M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0778-5; Ramig RF, 2004, J VIROL, V78, P10213, DOI 10.1128/JVI.78.19.10213-10220.2004; Ramig RF, 1997, ANNU REV MICROBIOL, V51, P225, DOI 10.1146/annurev.micro.51.1.225; ROHWEDDER A, 1995, VIROLOGY, V210, P231, DOI 10.1006/viro.1995.1338; Romig RF, 2007, EXPERT REV ANTI-INFE, V5, P591, DOI 10.1586/14787210.5.4.591; SALMI TT, 1978, SCAND J INFECT DIS, V10, P29, DOI 10.3109/inf.1978.10.issue-1.06; SANTOSHAM M, 1983, J PEDIATR-US, V103, P583, DOI 10.1016/S0022-3476(83)80591-5; SATTAR SA, 1986, J HYG-CAMBRIDGE, V96, P277, DOI 10.1017/S0022172400066055; Schumann T, 2009, VIROLOGY, V386, P334, DOI 10.1016/j.virol.2009.01.040; Stenzel T, 2017, VET QUART, V37, P166, DOI 10.1080/01652176.2017.1325972; Stenzel T, 2014, POULTRY SCI, V93, P3009, DOI 10.3382/ps.2014-04219; Tafazoli F, 2001, J VIROL, V75, P1540, DOI 10.1128/JVI.75.3.1540-1546.2001; Teitelbaum JE, 2007, DIGEST DIS SCI, V52, P3396, DOI 10.1007/s10620-007-9743-2; TODD D, 1986, AVIAN PATHOL, V15, P149, DOI 10.1080/03079458608436274; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; UHNOO I, 1990, J VIROL, V64, P361, DOI 10.1128/JVI.64.1.361-368.1990; Ursu K, 2011, AVIAN DIS, V55, P123, DOI 10.1637/9428-061610-RESNOTE.1; Wani SA, 2003, VET MICROBIOL, V94, P13, DOI 10.1016/S0378-1135(03)00079-8; WOODS LW, 1994, J VET DIAGN INVEST, V6, P156, DOI 10.1177/104063879400600205; Xiong XS, 2017, VIRUS GENES, V53, P179, DOI 10.1007/s11262-016-1419-6; YASON CV, 1986, AVIAN DIS, V30, P551, DOI 10.2307/1590420; ZHAORI GT, 1991, CHINESE MED J-PEKING, V104, P830	63	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203853	10.1371/journal.pone.0203853	http://dx.doi.org/10.1371/journal.pone.0203853			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204797	Green Published, gold			2022-12-26	WOS:000444355500051
J	Moses-Fynn, E; Tang, W; Beyene, D; Apprey, V; Copeland, R; Kanaan, Y; Kwabi-Addo, B				Moses-Fynn, Emmanuel; Tang, Wei; Beyene, Desta; Apprey, Victor; Copeland, Robert; Kanaan, Yasmine; Kwabi-Addo, Bernard			Correlating blood-based DNA methylation markers and prostate cancer risk in African-American men	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; RACIAL-DIFFERENCES; TUMOR VOLUME; SERUM DNA; HYPOMETHYLATION; TISSUES; GENES; WHITE; IDENTIFICATION; EPIGENETICS	The objective of this work was to investigate the clinical significance of promoter gene DNA methylation changes in whole blood from African-American (AA) men with prostate cancer (PCa). We used high throughput pyrosequencing analysis to quantify percentage DNA methylation levels in a panel of 8 genes (RAR beta 2, TIMP3, SPARC, CDH13, HIN1, LINE1, CYB5R2 and DRD2) in blood DNA obtained from PCa and non-cancerous controls cases. Correlations of methylation status and various clinicopathological features were evaluated. Six genes tested achieved significant difference in DNA methylation levels between the PCa compared to control cases (P < 0.05). The TIMP3 loci demonstrated significant correlation of DNA methylation with age for all cases analyzed (p < 0.05). We observed an inverse correlation between CDH13 methylation (p = 0.045; r = -0.21) and serum vitamin D level whereas TIMP3 methylation (p = 0.021; r = -0.24) and DRD2 methylation (p = 0.056; r = -0.201) showed inverse correlation with supplementary vitamin D in the cancer cases. We also observed a direct correlation between methylation of RAR beta 2 (p = 0.0036; r = 0.293) and SPARC (p = 0.0134; r = 0.20) loci with PSA level in the controls but not the cancer cases. In addition, alcohol cases significantly correlated with higher RAR beta 2 methylation (p = 0.0314) in comparison with non-alcohol cases. Furthermore, we observed an inverse correlation of DRD2 methylation (p = 0.0349; r = -0.343) and Gleason score. Our data suggests that promoter methylation occurred more frequently in the blood of AA PCa and is associated with various clinicopathological features in AA men with PCa.	[Moses-Fynn, Emmanuel] Univ Maine, Dept Biomed Sci, Orono, ME USA; [Tang, Wei] NCI, Lab Human Carcinogenesis, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Beyene, Desta; Apprey, Victor; Kanaan, Yasmine] Howard Univ, Dept Microbiol, Washington, DC 20059 USA; [Copeland, Robert] Howard Univ, Dept Pharmacol, Washington, DC 20059 USA; [Kwabi-Addo, Bernard] Howard Univ, Dept Biochem & Mol Biol, Washington, DC 20059 USA	University of Maine System; University of Maine Orono; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard University; Howard University; Howard University	Kwabi-Addo, B (corresponding author), Howard Univ, Dept Biochem & Mol Biol, Washington, DC 20059 USA.	bkwabi-addo@howard.edu	Copeland, Robert L/AAD-3650-2022; Kwabi-Addo, Bernard/A-6993-2016	Kwabi-Addo, Bernard/0000-0003-3692-6350	Howard University Research Center in Minority Institution (RCMI); US Army Medical Research and Materiel Command (USAMRMC) [DAMD17-03-1-0069]	Howard University Research Center in Minority Institution (RCMI); US Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work is supported by the Howard University Research Center in Minority Institution (RCMI) and the US Army Medical Research and Materiel Command (USAMRMC; DAMD17-03-1-0069).	Alegra-Torres JA, 2011, EPIGENOMICS-UK, V3, P267, DOI [10.2217/EPI.11.22, 10.2217/epi.11.22]; Bastian PJ, 2005, CLIN CANCER RES, V11, P4037, DOI 10.1158/1078-0432.CCR-04-2446; Beyene D, 2014, IN VIVO, V28, P1181; Bonilla C, 2013, CANCER EPIDEM BIOMAR, V22, P597, DOI 10.1158/1055-9965.EPI-12-1248; Brennan K, 2012, CANCER PREV RES, V5, P1345, DOI 10.1158/1940-6207.CAPR-12-0316; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Chao C, 2013, CANCER CAUSE CONTROL, V24, P1615, DOI 10.1007/s10552-013-0249-2; CHIOU HC, 1994, NUCLEIC ACIDS RES, V22, P5439, DOI 10.1093/nar/22.24.5439; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Colli JL, 2006, UROL ONCOL-SEMIN ORI, V24, P184, DOI 10.1016/j.urolonc.2005.05.023; Devaney JM, 2015, EPIGENETICS-US, V10, P319, DOI 10.1080/15592294.2015.1022019; Devaney JM, 2013, PROSTATE CANCER P D, V16, P292, DOI 10.1038/pcan.2013.21; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Freedland SJ, 2005, PROSTATE, V62, P243, DOI 10.1002/pros.20052; Gans KM, 2003, J AM DIET ASSOC, V103, P699, DOI 10.1053/jada.2003.50135; George AK, 2007, MOL CELL BIOCHEM, V304, P181, DOI 10.1007/s11010-007-9498-2; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hsing AW, 2000, INT J CANCER, V85, P60, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;60::AID-IJC11&gt;3.0.CO;2-B; Hu YC, 2002, ONCOGENE, V21, P7289, DOI 10.1038/sj.onc.1205805; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kanaan YM, 2012, OPEN PROSTATE CANC J, V5, P8; Kwabi-Addo B, 2010, CLIN CANCER RES, V16, P3539, DOI 10.1158/1078-0432.CCR-09-3342; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Magi-Galluzzi C, 2011, PROSTATE, V71, P489, DOI 10.1002/pros.21265; Mahon KL, 2014, BRIT J CANCER, V111, P1802, DOI 10.1038/bjc.2014.463; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; Moritz R, 2013, ANTICANCER RES, V33, P5249; Morton LM, 2006, PHARMACOGENET GENOM, V16, P901, DOI 10.1097/01.fpc.0000230417.20468.d0; Moul JW, 1999, J UROLOGY, V162, P394, DOI 10.1016/S0022-5347(05)68568-0; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Nelson WG, 2007, FRONT BIOSCI-LANDMRK, V12, P4254, DOI 10.2741/2385; Papa NP, 2017, PROSTATE CANCER P D, V20, P305, DOI 10.1038/pcan.2017.12; Petrovics G, 2005, ONCOGENE, V24, P3847, DOI 10.1038/sj.onc.1208518; Powell IJ, 2007, J UROLOGY, V177, P444, DOI 10.1016/j.juro.2006.09.024; Rebbeck TR, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/560857; Rodriguez C, 2006, CANCER EPIDEM BIOMAR, V15, P211, DOI 10.1158/1055-9965.EPI-05-0614; Rodriguez-Miguel C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138980; Sanchez-Ortiz RF, 2006, CANCER-AM CANCER SOC, V107, P75, DOI 10.1002/cncr.21954; Schenk JM, 2014, CANCER EPIDEM BIOMAR, V23, P1484, DOI 10.1158/1055-9965.EPI-13-1340; Shan M, 2016, ONCOTARGET, V7, P18485, DOI 10.18632/oncotarget.7608; Shu JM, 2006, CANCER RES, V66, P5077, DOI 10.1158/0008-5472.CAN-05-2629; Slieker RC, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1053-6; Stickel F, 2000, ALCOHOL CLIN EXP RES, V24, P259, DOI 10.1111/j.1530-0277.2000.tb04606.x; Tseng M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-191; Valenzuela CF, 1997, ALCOHOL HEALTH RES W, V21, P144; van Engeland M, 2003, CANCER RES, V63, P3133; Wallace TJ, 2014, J CANCER, V5, P3, DOI 10.7150/jca.7709; Wang SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037928; Yegnasubramanian S, 2008, CANCER RES, V68, P8954, DOI 10.1158/0008-5472.CAN-07-6088	52	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203322	10.1371/journal.pone.0203322	http://dx.doi.org/10.1371/journal.pone.0203322			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204798	Green Submitted, Green Published, gold			2022-12-26	WOS:000444355500022
J	Chatting, M; Smyth, D; Al-Maslamani, I; Obbard, J; Al-Ansi, M; Hamza, S; Al-Mohanady, SF; Al-Kuwari, AJ; Marshall, CD				Chatting, Mark; Smyth, David; Al-Maslamani, Ibrahim; Obbard, Jeffrey; Al-Ansi, Mehsin; Hamza, Shafeeq; Al-Mohanady, Salman Fahad; Al-Kuwari, Ali Jassim; Marshall, Christopher D.			Nesting ecology of hawksbill turtles, Eretmochelys imbricata, in an extreme environmental setting	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; LOGGERHEAD TURTLES; ARABIAN REGION; PERSIAN-GULF; SEA-TURTLES; WEST-INDIES; ISLAND; TEMPERATURE; POPULATION	Relatively few details of hawksbill turtle (Eretmochelys imbricata) nesting ecology exist within the Arabian Gulf. Moreover, little is known about how their nesting dynamics compare to nesting populations throughout the rest of the world. Due to the extreme environmental setting, nesting ecology of hawksbills in the Arabian Gulf is of significant interest to researchers and conservationists. The current research reports on a long-term tagging and monitoring program undertaken at Fuwairit beach, Qatar. To investigate nesting behavior, site surveys and tagging were employed from 2010 to 2016. Presence of nests and clutch sizes were confirmed by excavation. Over the entire study period, nesting hawksbills had a mean curved carapace length of 70.8 cm (SD +/- 2.8). A total 187 nests were confirmed, which contained a mean 78.9 eggs per clutch (SD +/- 17.1), over an annual nesting season that lasted an average of 52.2 days (SD +/- 6.3) from the start of April to the start of June. Meta-analysis with other global regions showed these characteristics to be significantly reduced when compared to nesting hawksbills from other populations. Meteorological data analysis showed air temperatures in the Arabian Gulf to increase on average 13.2 degrees C (SD +/- 0.26) from start to the end of nesting annually, which is significantly greater than other global nesting regions. Their smaller body size and reduced fecundity coupled with the extreme change in ambient air temperatures support the hypothesis that hawksbills in the region are more at risk than the already critically endangered hawksbill populations elsewhere in the world.	[Chatting, Mark; Smyth, David; Al-Maslamani, Ibrahim; Obbard, Jeffrey; Hamza, Shafeeq] Qatar Univ, Ctr Environm Sci, Doha, Qatar; [Al-Ansi, Mehsin] Qatar Univ, Coll Arts & Sci, Doha, Qatar; [Al-Mohanady, Salman Fahad] Ras Laffan Ind City, Doha, Qatar; [Al-Kuwari, Ali Jassim] Minist Municipal & Environm, Doha, Qatar; [Marshall, Christopher D.] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Smyth, David] Queens Univ, Sch Nat & Built Environm, Belfast, Antrim, North Ireland	Qatar University; Qatar University; Qatargas; Texas A&M University System; Queens University Belfast	Chatting, M (corresponding author), Qatar Univ, Ctr Environm Sci, Doha, Qatar.	mchatting@qu.edu.qa	Marshall, Christopher/AAF-9097-2019	Chatting, Mark/0000-0002-7916-7107	Qatar National Research Fund [5-642-1-110]; Ras Laffan Industrial City	Qatar National Research Fund(Qatar National Research Fund (QNRF)); Ras Laffan Industrial City	The funder, Qatar Petroleum, approved the publishing of this work, but had no role in study design, data collection and analysis or preparation of the manuscript. We have the following interests to declare: This study was funded and the work was approved for publication by Qatar Petroleum. Author Christopher D Marshall was supported by grant number 5-642-1-110 from the Qatar National Research Fund. Author Salman Fahad Al-Mohanady (SFM) is employed by Ras Laffan Industrial City (which is administrated by Qatar Petroleum). Ras Laffan Industrial City provided support in the form of salary for author SFM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghais SM, 2009, ZOOL MIDDLE EAST, V48, P43, DOI 10.1080/09397140.2009.10638365; Bagher Nabavi S.M., 2012, J LIFE SCI, V6, P74; Santos AJB, 2016, CHELONIAN CONSERV BI, V15, P109, DOI 10.2744/CCB-1136.1; Beggs Jennifer A., 2007, Endangered Species Research, V3, P159, DOI 10.3354/esr003159; Boll A, 2015, PALAEOGEOGR PALAEOCL, V426, P10, DOI 10.1016/j.palaeo.2015.02.036; Chan Eng-Heng, 1999, Chelonian Conservation and Biology, V3, P326; Diamond A., 1976, BIOL CONSERV, V8, P199; Feary DA, 2013, MAR POLLUT BULL, V72, P406, DOI 10.1016/j.marpolbul.2013.02.038; Godley BJ, 2001, J EXP MAR BIOL ECOL, V263, P45, DOI 10.1016/S0022-0981(01)00269-6; Hatase H, 2004, MAR BIOL, V144, P807, DOI 10.1007/s00227-003-1232-3; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; Hays GC, 2003, GLOBAL CHANGE BIOL, V9, P642, DOI 10.1046/j.1365-2486.2003.00606.x; Hesni MA, 2016, J MAR BIOL ASSOC UK, V96, P1373, DOI 10.1017/S0025315415001125; Hitchins PM, 2004, J ZOOL, V264, P371, DOI 10.1017/s0952836904005850; HOFMANN GE, 1995, J EXP BIOL, V198, P1509; Hume B, 2013, MAR POLLUT BULL, V72, P313, DOI 10.1016/j.marpolbul.2012.11.032; JOHN VC, 1990, OCEANOL ACTA, V13, P273; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kamel SJ, 2009, J HERPETOL, V43, P367, DOI 10.1670/07-231R2.1; Liles Michael J., 2011, Endangered Species Research, V14, P23, DOI 10.3354/esr00338; Limpus C., 2009, BIOL REV AUSTR MARIN; LIMPUS CJ, 1980, HERPETOLOGICA, V36, P265; LOOP KA, 1995, WILDLIFE RES, V22, P241, DOI 10.1071/WR9950241; Marcovaldi MA, 2007, CHELONIAN CONSERV BI, V6, P223, DOI 10.2744/1071-8443(2007)6[223:FYOHST]2.0.CO;2; Marcovaldi Maria Angela, 1999, Chelonian Conservation and Biology, V3, P301; Matsuzawa Y, 2002, MAR BIOL, V140, P639, DOI 10.1007/s00227-001-0724-2; MESHAL AH, 1986, ARAB GULF J SCI RES, V4, P649; Moncada Felix, 1999, Chelonian Conservation and Biology, V3, P257; Mortimer Jeanne A., 1999, Chelonian Conservation and Biology, V3, P318; Naser H.A., 2014, BIODIVERSITY DYNAMIC; Pal JS, 2016, NAT CLIM CHANGE, V6, P197, DOI [10.1038/NCLIMATE2833, 10.1038/nclimate2833]; Pazira A, 2016, REG STUD MAR SCI, V3, P216, DOI 10.1016/j.rsma.2015.11.001; Pilcher NJ, 2014, J EXP MAR BIOL ECOL, V460, P89, DOI 10.1016/j.jembe.2014.06.009; Pilcher NJ, 2014, J EXP MAR BIOL ECOL, V457, P190, DOI 10.1016/j.jembe.2014.04.002; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; PRICE ARG, 1993, MAR POLLUT BULL, V27, P9, DOI 10.1016/0025-326X(93)90004-4; PRICE ARG, 1982, J NAT HIST, V16, P519, DOI 10.1080/00222938200770421; Reina RD, 2002, COPEIA, P653; Reising M, 2015, ENDANGER SPECIES RES, V29, P179, DOI 10.3354/esr00708; Richardson James I., 1999, Chelonian Conservation and Biology, V3, P244; Riegl B.M., 2012, CORAL REEFS GULF, V3, DOI [10.1007/978-94-007-3008-3_1, DOI 10.1007/978-94-007-3008-3_1]; Ross J, 1985, BIOL CONSERV SEA TUR, P373; ROSS JP, 1981, BIOL CONSERV, V19, P99, DOI 10.1016/0006-3207(81)90045-8; Sheppard C, 2010, MAR POLLUT BULL, V60, P13, DOI 10.1016/j.marpolbul.2009.10.017; Tomas J, 2010, BIODIVERS CONSERV, V19, P2699, DOI 10.1007/s10531-010-9868-z; van Dam RP, 1998, B MAR SCI, V62, P145; Vasquez M, 2008, SEA TURTLE RES CONSE; Walton MEM, 2014, MAR ECOL PROG SER, V507, P125, DOI 10.3354/meps10827; Xavier R, 2006, AMPHIBIA-REPTILIA, V27, P539, DOI 10.1163/156853806778877077; Zare R, 2012, CHELONIAN CONSERV BI, V11, P229, DOI 10.2744/CCB-1003.1	50	9	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203257	10.1371/journal.pone.0203257	http://dx.doi.org/10.1371/journal.pone.0203257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192801	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600051
J	Lammert, AC; Shadle, CH; Narayanan, SS; Quatieri, TF				Lammert, Adam C.; Shadle, Christine H.; Narayanan, Shrikanth S.; Quatieri, Thomas F.			Speed-accuracy tradeoffs in human speech production	PLOS ONE			English	Article							DISCRETE MOTOR-RESPONSES; REAL-TIME MRI; VOCAL-TRACT; FITTS LAW; INFORMATION CAPACITY; HARD PALATE; MOVEMENTS; VARIABILITY; MORPHOLOGY; CHALLENGE	Speech motor actions are performed quickly, while simultaneously maintaining a high degree of accuracy. Are speed and accuracy in conflict during speech production? Speed-accuracy tradeoffs have been shown in many domains of human motor action, but have not been directly examined in the domain of speech production. The present work seeks evidence for Fitts' law, a rigorous formulation of this fundamental tradeoff, in speech articulation kinematics by analyzing USC-TIMIT, a real-time magnetic resonance imaging data set of speech production. A theoretical framework for considering Fitts' law with respect to models of speech motor control is elucidated. Methodological challenges in seeking relationships consistent with Fitts' law are addressed, including the operational definitions and measurement of key variables in real-time MRI data. Results suggest the presence of speed-accuracy tradeoffs for certain types of speech production actions, with wide variability across syllable position, and substantial variability also across subjects. Coda consonant targets immediately following the syllabic nucleus show the strongest evidence of this tradeoff, with correlations as high as 0.72 between speed and accuracy. A discussion is provided concerning the potentially limited applicability of Fitts' law in the context of speech production, as well as the theoretical context for interpreting the results.	[Lammert, Adam C.; Quatieri, Thomas F.] MIT, Lincoln Lab, 244 Wood St, Lexington, MA 02173 USA; [Shadle, Christine H.] Haskins Labs Inc, New Haven, CT USA; [Narayanan, Shrikanth S.] Signal Anal & Interpretat Lab, Los Angeles, CA USA	Lincoln Laboratory; Massachusetts Institute of Technology (MIT); Yale University; Haskins Laboratories	Lammert, AC (corresponding author), MIT, Lincoln Lab, 244 Wood St, Lexington, MA 02173 USA.	adam.lammert@LL.mit.edu	Narayanan, Shrikanth S/D-5676-2012		National Science Foundation (US) [1514544]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007124] Funding Source: NIH RePORTER	National Science Foundation (US)(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by the National Science Foundation (US), in Grant #1514544. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, LECT FITTS LAW; Beamish D, 2006, J R SOC INTERFACE, V3, P649, DOI 10.1098/rsif.2006.0123; Bresch E, 2006, J ACOUST SOC AM, V120, P1791, DOI 10.1121/1.2335423; Browman C.P., 1995, PRODUCING SPEECH CON, P19; BROWMAN CP, 1992, PHONETICA, V49, P155, DOI 10.1159/000261913; Brunner J, 2009, J ACOUST SOC AM, V125, P3936, DOI 10.1121/1.3125313; BULLOCK D, 1988, PSYCHOL REV, V95, P49, DOI 10.1037/0033-295X.95.1.49; Byrd D, 2009, J PHONETICS, V37, P97, DOI 10.1016/j.wocn.2008.10.002; CARD SK, 1978, ERGONOMICS, V21, P601, DOI 10.1080/00140137808931762; Carpenter RHS, 1988, MOVEMENTS EYES; Chin S. B., 1997, ALCOHOL AND SPEECH; Chitoran I, 2002, PHONOL PHONET, V4-1, P419; CROSSMAN ERFW, 1983, Q J EXP PSYCHOL-A, V35, P251, DOI 10.1080/14640748308402133; Dart S. N., 1991, ARTICULATORY ACOUSTI, V79; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; DRURY CG, 1975, HUM FACTORS, V17, P368, DOI 10.1177/001872087501700408; Duarte M, 2005, MOTOR CONTROL, V9, P180, DOI 10.1123/mcj.9.2.180; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; FITTS PM, 1964, J EXP PSYCHOL, V67, P103, DOI 10.1037/h0045689; FITTS PM, 1966, J EXP PSYCHOL, V71, P475, DOI 10.1037/h0022970; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Fuchs S., 2008, 8 INT SEM SPEECH PRO, P333; Guenther FH, 1998, PSYCHOL REV, V105, P611, DOI 10.1037/0033-295X.105.4.611-633; Hardcastle W.J., 1976, PHYSL SPEECH PRODUCT; Houde JF, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00082; Kato T, 2009, INT CONF ACOUST SPEE, P4493, DOI 10.1109/ICASSP.2009.4960628; Katsamanis A., 2011, P WORKSH NEW TOOLS M; Kleinow J, 2001, J SPEECH LANG HEAR R, V44, P1041, DOI 10.1044/1092-4388(2001/082); Krakow RA, 1999, J PHONETICS, V27, P23, DOI 10.1006/jpho.1999.0089; Krause JC, 2002, J ACOUST SOC AM, V112, P2165, DOI 10.1121/1.1509432; Kuwabara H., 1996, ICSLP 96, V4; Lammert Adam, 2013, Journal of the Acoustical Society of America, V134, DOI 10.1121/1.4831436; Lammert A, 2013, INTERSPEECH, P959; Lammert A, 2014, PHONETICA, V71, P229, DOI 10.1159/000371820; Lammert A, 2013, J SPEECH LANG HEAR R, V56, pS1924, DOI 10.1044/1092-4388(2013/12-0211); Lammert A, 2013, J SPEECH LANG HEAR R, V56, P521, DOI 10.1044/1092-4388(2012/12-0059); Lammert AC, 2016, INTERSPEECH, P460, DOI 10.21437/Interspeech.2016-157; Lammert AC, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 3 AND 4, P1572; LANGOLF GD, 1976, J MOTOR BEHAV, V8, P113, DOI 10.1080/00222895.1976.10735061; Lehiste I., 1970, SUPRASEGMENTALS; Lingala SG, 2016, J MAGN RESON IMAGING, V43, P28, DOI 10.1002/jmri.24997; Lingala SG, 2016, MAGNETIC RESONANCE M; Lofqvist A, 1997, J SPEECH LANG HEAR R, V40, P877, DOI 10.1044/jslhr.4004.877; MacKenzie I. S., 1992, Human-Computer Interaction, V7, P91, DOI 10.1207/s15327051hci0701_3; MacNeilage PF, 1972, SPEECH PHYSL; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; Narayanan S, 2014, J ACOUST SOC AM, V136, P1307, DOI 10.1121/1.4890284; Perrier P, 2008, J NEUROPHYSIOL, V100, P1171, DOI 10.1152/jn.01116.2007; Ramanarayanan V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104168; Ramanarayanan V, 2013, J ACOUST SOC AM, V134, P510, DOI 10.1121/1.4807639; SALTZMAN E, 1987, PSYCHOL REV, V94, P84, DOI 10.1037/0033-295X.94.1.84; Saltzman E., 1989, ECOL PSYCHOL, V1, P333, DOI [10.1207/s15326969eco0104_2, DOI 10.1207/S15326969EC00104_]; Schuller B, 2014, COMPUT SPEECH LANG, V28, P346, DOI 10.1016/j.csl.2012.12.002; Shannon C.E., 1949, MATH THEORY INFORM; Sibert L. E., 2000, CHI 2000 Conference Proceedings. Conference on Human Factors in Computing Systems. CHI 2000. The Future is Here, P281, DOI 10.1145/332040.332445; Sleimen-Malkoun R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041190; Templin M.C., 1957, CERTAIN LANGUAGE SKI, DOI DOI 10.5749/J.CTTTV2ST; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; Vorperian HK, 2005, J ACOUST SOC AM, V117, P338, DOI 10.1121/1.1835958; Vorperian HK, 2007, J SPEECH LANG HEAR R, V50, P1510, DOI 10.1044/1092-4388(2007/104); Vorperian HK, 2011, J SPEECH LANG HEAR R, V54, P995, DOI 10.1044/1092-4388(2010/10-0097); Vorperian HK, 2009, J ACOUST SOC AM, V125, P1666, DOI 10.1121/1.3075589; Ware Colin, 1987, ACM SIGCHI B, P183, DOI [10.1145/29933.275627, DOI 10.1145/29933.275627]; Welford A.T., 1968, FUNDAMENTALS SKILL; Williamson J. R., 2015, 16 ANN C INT SPEECH; Yunusova Y, 2008, J SPEECH LANG HEAR R, V51, P596, DOI 10.1044/1092-4388(2008/043); Zsiga EC, 2000, J PHONETICS, V28, P69, DOI 10.1006/jpho.2000.0109	67	7	7	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0202180	10.1371/journal.pone.0202180	http://dx.doi.org/10.1371/journal.pone.0202180			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT0BU	30192767	Green Submitted, Green Published, gold			2022-12-26	WOS:000444093600020
J	Lepesqueur, C; Scherrer, S; Vieira, MC; Almeida-Neto, M; Salcido, DM; Dyer, LA; Diniz, IR				Lepesqueur, Cintia; Scherrer, Scheila; Vieira, Marcos C.; Almeida-Neto, Mario; Salcido, Danielle M.; Dyer, Lee A.; Diniz, Ivone R.			Changing interactions among persistent species as the major driver of seasonal turnover in plant-caterpillar interactions	PLOS ONE			English	Article							MEYRICK LEPIDOPTERA; BETA DIVERSITY; CLIMATE-CHANGE; ABUNDANCE; CERRADO; EVOLUTIONARY; ELACHISTIDAE; INSECTS; FOOD	beta diversity of herbivorous insects in the tropics is usually very high, and there is often strong dissimilarity in herbivore species composition across different spatial scales and different abiotic gradients. Similarly, turnover is high for trophic interactions between herbivorous insects and their host plants. Two factors have been proposed to explain temporal or spatial differences in trophic interactions: changes in species composition and temporal changes in the behavior of shared species. The goal of this study was to evaluate determinants of high beta diversity of trophic interactions between lepidopteran caterpillars and their host plants across dry and rainy seasons and their transitions. Over the course of a year, interaction diversity data were collected from 275 temporary plots in Cerrado vegetation, comprising 257 species of caterpillars, 137 species of host plants and 503 different trophic interactions. All these diversity parameters varied across seasons. Species assemblages of caterpillars and plants were different among the four seasons, and there was a high turnover of interactions between the seasons. The high temporal beta diversity of trophic interactions was mostly due to interaction rewiring between co-occurring species, as opposed to changes in species composition over time.	[Lepesqueur, Cintia; Diniz, Ivone R.] Univ Brasilia, Inst Ciencias Biol, Dept Zool, Brasilia, DF, Brazil; [Scherrer, Scheila] Univ Brasilia, Inst Ciencias Biol, Programa Posgrad Ecol, Brasilia, DF, Brazil; [Scherrer, Scheila] Colegio Mil Brasilia, Sistema Colegio Mil Brasil, Brasilia, DF, Brazil; [Vieira, Marcos C.; Almeida-Neto, Mario] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil; [Salcido, Danielle M.; Dyer, Lee A.] Univ Nevada, Dept Biol, Reno, NV 89557 USA	Universidade de Brasilia; Universidade de Brasilia; Universidade Federal de Goias; Nevada System of Higher Education (NSHE); University of Nevada Reno	Dyer, LA (corresponding author), Univ Nevada, Dept Biol, Reno, NV 89557 USA.	ldyer@unr.edu	Almeida-Neto, M./A-6389-2009; Scherrer, Scheila/AAY-8105-2020	Almeida-Neto, M./0000-0002-2161-2968; Scherrer, Scheila/0000-0001-5554-920X	Fundacao de Apoio a Pesquisa do Distrito Federal [193001435/2016]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [59606/2013-6]; National Science Foundation [DEB-1442103]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/PRONEX); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/PVE)	Fundacao de Apoio a Pesquisa do Distrito Federal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Science Foundation(National Science Foundation (NSF)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/PRONEX)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/PVE)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The research was supported by the Fundacao de Apoio a Pesquisa do Distrito Federal (http://www.fap.df.gov.br/) to IRD (no grant number) and CL (grant number 193001435/2016), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br/) to MAN, LAD, IRD (CNPq/PRONEX and CNPq/PVE, no grant number) and CL (grant number 59606/2013-6), and the National Science Foundation (www.nsf.gov) to LAD (grant number DEB-1442103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes NB, 1999, PESQUI AGROPECU BRAS, V34, P517; Bendicho-Lopez A, 2006, NEOTROP ENTOMOL, V35, P182, DOI 10.1590/S1519-566X2006000200005; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; Diniz IR, 1997, BIODIVERS CONSERV, V6, P817, DOI 10.1023/B:BIOC.0000010404.17467.6c; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Dyer LA, 2010, BIOTROPICA, V42, P281, DOI 10.1111/j.1744-7429.2009.00624.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Klemola T, 2008, J ANIM ECOL, V77, P597, DOI 10.1111/j.1365-2656.2008.01369.x; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Lenza Eddie, 2006, Braz. J. Bot., V29, P627, DOI 10.1590/S0100-84042006000400013; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Marquis Robert J., 2002, P306; Morais HC, 1999, REV BIOL TROP, V47, P1025; Morais HC, 2005, REV BRAS ZOOL, V22, P633, DOI 10.1590/S0101-81752005000300016; Morais HC, 2007, NEOTROP ENTOMOL, V36, P843, DOI 10.1590/S1519-566X2007000600004; Morais HC, 2011, BIOTROPICA, V43, P467, DOI 10.1111/j.1744-7429.2010.00736.x; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Novotny V, 2009, INSECT CONSERV DIVER, V2, P5, DOI 10.1111/j.1752-4598.2008.00035.x; Pardikes NA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193822; Poisot T, 2012, ECOL LETT, V15, P1353, DOI 10.1111/ele.12002; Scherrer S, 2010, BRAZ J BIOL, V70, P103, DOI 10.1590/S1519-69842010000100014; Scherrer S, 2016, BIOTROPICA, V48, P491, DOI 10.1111/btp.12325; WOLDA H, 1978, J ANIM ECOL, V47, P369, DOI 10.2307/3789; WOLDA H, 1988, ANNU REV ECOL SYST, V19, P1, DOI 10.1146/annurev.es.19.110188.000245	24	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203164	10.1371/journal.pone.0203164	http://dx.doi.org/10.1371/journal.pone.0203164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188923	Green Submitted, gold, Green Published			2022-12-26	WOS:000444228700023
J	Strathmann, EA; Peters, M; Hosseinibarkooie, S; Rigo, FW; Bennett, CF; Zaworski, PG; Chen, KS; Nothnagel, M; Wirth, B				Strathmann, Eike A.; Peters, Miriam; Hosseinibarkooie, Seyyedmohsen; Rigo, Frank W.; Bennett, C. Frank; Zaworski, Phillip G.; Chen, Karen S.; Nothnagel, Michael; Wirth, Brunhilde			Evaluation of potential effects of Plastin 3 overexpression and low-dose SMN-antisense oligonucleotides on putative biomarkers in spinal muscular atrophy mice	PLOS ONE			English	Article							OLIGOMERIC MATRIX PROTEIN; MOTOR-NEURON PROTEIN; MOUSE MODEL; SERUM FETUIN; CARTILAGE; SURVIVAL; BONE; OSTEOPONTIN; TETRANECTIN; EXPRESSION	Objectives Spinal muscular atrophy (SMA) is a devastating motor neuron disorder caused by homozygous loss of the survival motor neuron 1 (SMN1) gene and insufficient functional SMN protein produced by the SMN2 copy gene. Additional genetic protective modifiers such as Plastin 3 (PLS3) can counteract SMA pathology despite insufficient SMN protein. Recently, Spinraza, an SMN antisense oligonucleotide (ASO) that restores full-length SMN2 transcripts, has been FDA- and EMA-approved for SMA therapy. Hence, the availability of biomarkers allowing a reliable monitoring of disease and therapy progression would be of great importance. Our objectives were (i) to analyse the feasibility of SMN and of six SMA biomarkers identified by the BforSMA study in the Taiwanese SMA mouse model, (ii) to analyse the effect of PLS3 overexpression on these biomarkers, and (iii) to assess the impact of low dose SMN-ASO therapy on the level of SMN and the six biomarkers. Methods At P10 and P21, the level of SMN and six putative biomarkers were compared among SMA, heterozygous and wild type mice, with or without PLS3 overexpression, and with or without presymptomatic low-dose SMN-ASO subcutaneous injection. SMN levels were measured in whole blood by ECL immunoassay and of six SMA putative biomarkers, namely Cartilage Oligomeric Matrix Protein (COMP), Dipeptidyl Peptidase 4 (DPP4), Tetranectin (C-type Lectin Family 3 Member B, CLEC3B), Osteopontin (Secreted Phosphoprotein 1, SPP1), Vitronectin (VTN) and Fetuin A (Alpha 2-HS Glycoprotein, AHSG) in plasma. Results SMN levels were significantly discernible between SMA, heterozygous and wild type mice. However, no significant differences were measured upon low-dose SMN-ASO treatment compared to untreated animals. Of the six biomarkers, only COMP and DPP4 showed high and SPP1 moderate correlation with the SMA phenotype. PLS3 overexpression neither influenced the SMN level nor the six biomarkers, supporting the hypothesis that PLS3 acts as an independent protective modifier.	[Strathmann, Eike A.; Peters, Miriam; Hosseinibarkooie, Seyyedmohsen; Wirth, Brunhilde] Univ Cologne, Inst Human Genet, Cologne, Germany; [Strathmann, Eike A.; Peters, Miriam; Hosseinibarkooie, Seyyedmohsen; Wirth, Brunhilde] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany; [Peters, Miriam] Univ Munich, Endocrine Res Unit, Med Clin & Outpatient Clin 4, Munich, Germany; [Rigo, Frank W.; Bennett, C. Frank] IONIS Pharmaceut, Carlsbad, CA USA; [Zaworski, Phillip G.] PharmOptima, Portage, MI USA; [Chen, Karen S.] SMA Fdn, New York, NY USA; [Nothnagel, Michael] Univ Cologne, Cologne Ctr Genom, Dept Stat Genet & Bioinformat, Cologne, Germany; [Wirth, Brunhilde] Univ Cologne, Inst Genet, Cologne, Germany; [Wirth, Brunhilde] Univ Hosp Cologne, Ctr Rare Dis, Cologne, Germany	University of Cologne; University of Cologne; University of Munich; Ionis Pharmaceuticals, Inc.; University of Cologne; University of Cologne; University of Cologne	Wirth, B (corresponding author), Univ Cologne, Inst Human Genet, Cologne, Germany.; Wirth, B (corresponding author), Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany.; Wirth, B (corresponding author), Univ Cologne, Inst Genet, Cologne, Germany.; Wirth, B (corresponding author), Univ Hosp Cologne, Ctr Rare Dis, Cologne, Germany.	brunhilde.wirth@uk-koeln.de	Nothnagel, Michael/L-7187-2019; Nothnagel, Michael/G-6545-2014; Wirth, Brunhilde/H-3192-2019	Nothnagel, Michael/0000-0001-8305-7114; Wirth, Brunhilde/0000-0003-4051-5191; Hosseini-Barkooie, Seyyedmohsen/0000-0001-6121-8562	European Community [2012-305121]; Deutsche Forschungsgemeinschaft [Wi-945/14-1, Wi-945/16-1, Wi-945/17-1]; CMMC; PharmOptima; SMA Foundation; IONIS Pharmaceuticals	European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CMMC; PharmOptima; SMA Foundation; IONIS Pharmaceuticals	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 2012-305121 "Integrated European - omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases (NEUROMICS)", Deutsche Forschungsgemeinschaft Wi-945/14-1, Wi-945/16-1, Wi-945/17-1 and CMMC (C16) to (BW). FWR and CFB are employee of IONIS Pharmaceuticals, Carlsbad (USA) and PGZ of PharmOptima, Portage (USA); PharmOptima (PGZ) and SMA Foundation (KSC) funded the biomarker analysis; IONIS Pharmaceuticals (FWR and CFB) funded the production of the SMN-ASOs. Further specific roles of these authors (FWR, CFB, PGZ and KSC) are articulated in the "author contributors" section.P	Ackermann B, 2013, HUM MOL GENET, V22, P1328, DOI 10.1093/hmg/dds540; Agarwal P, 2012, J BIOL CHEM, V287, P22549, DOI 10.1074/jbc.M111.335935; Alrafiah A, 2018, MOL THER-METH CLIN D, V9, P81, DOI 10.1016/j.omtm.2018.01.007; Arellano-Garcia ME, 2010, INT J MOL SCI, V11, P3106, DOI 10.3390/ijms11093106; Arnold WD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167077; Arnold WD, 2014, ANN CLIN TRANSL NEUR, V1, P34, DOI 10.1002/acn3.23; Azukizawa M, 2019, CARTILAGE, V10, P451, DOI 10.1177/1947603518767998; Bonati U, 2017, ANN CLIN TRANSL NEUR, V4, P292, DOI 10.1002/acn3.406; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Brylka LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187030; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chen H, 2017, J CANCER, V8, P3623, DOI 10.7150/jca.19438; Chen HY, 2013, EUR J CLIN INVEST, V43, P387, DOI 10.1111/eci.12057; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Crawford TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033572; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Czech C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139950; Delanote V, 2005, TRAFFIC, V6, P335, DOI 10.1111/j.1600-0854.2005.00276.x; Dimitriadi M, 2016, P NATL ACAD SCI USA, V113, pE4377, DOI 10.1073/pnas.1600015113; Dimitriadi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001172; DUNN OJ, 1958, ANN MATH STAT, V29, P1095, DOI 10.1214/aoms/1177706443; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; El Defrawy AO, 2016, Z RHEUMATOL, V75, P917, DOI 10.1007/s00393-015-1647-5; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752; Finkel RS, 2018, NEUROMUSCULAR DISORD, V28, P197, DOI 10.1016/j.nmd.2017.11.004; Finkel RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035462; Geary RS, 1997, ANTI-CANCER DRUG DES, V12, P383; Geary RS, 2003, DRUG METAB DISPOS, V31, P1419, DOI 10.1124/dmd.31.11.1419; Gerdhem P, 2015, EUR SPINE J, V24, P256, DOI 10.1007/s00586-014-3691-2; Hao CC, 2017, INT J MOL MED, V39, P1327, DOI 10.3892/ijmm.2017.2964; Hao LT, 2012, J NEUROSCI, V32, P5074, DOI 10.1523/JNEUROSCI.5808-11.2012; Haylock DN, 2006, BRIT J HAEMATOL, V134, P467, DOI 10.1111/j.1365-2141.2006.06218.x; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; Heesen L, 2016, CELL MOL LIFE SCI, V73, P2089, DOI 10.1007/s00018-015-2084-y; Helmken C, 2003, HUM GENET, V114, P11, DOI 10.1007/s00439-003-1025-2; HOLM S, 1979, SCAND J STAT, V6, P65; Hosseinibarkooie S, 2016, AM J HUM GENET, V99, P647, DOI 10.1016/j.ajhg.2016.07.014; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Iyer Chitra, 2017, J Neuromuscul Dis, V4, P59, DOI 10.3233/JND-170209; Janzen E, 2018, BRAIN, V141, P2343, DOI 10.1093/brain/awy167; Jiao Q, 2016, BIOMARKERS, V21, P146, DOI 10.3109/1354750X.2015.1118547; Kaifer KA, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89970; Karampela I, 2017, J CRIT CARE, V41, P78, DOI 10.1016/j.jcrc.2017.05.004; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Khatri Ismail A, 2008, J Clin Neuromuscul Dis, V10, P11, DOI 10.1097/CND.0b013e318183e0fa; Kitamura Y, 2017, NEUROL RES, V39, P231, DOI 10.1080/01616412.2017.1281195; Kluzek S, 2015, BIOMARKERS, V20, P557, DOI 10.3109/1354750X.2015.1105498; Kobayashi DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060113; Kolb SJ, 2016, ANN CLIN TRANSL NEUR, V3, P132, DOI 10.1002/acn3.283; Kuraoka M, 2016, AM J PATHOL, V186, P1302, DOI 10.1016/j.ajpath.2016.01.002; Lebensztejn DM, 2014, ADV MED SCI-POLAND, V59, P81, DOI 10.1016/j.advms.2013.08.003; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LIN CS, 1993, J BIOL CHEM, V268, P2781; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; Main M, 2003, EUR J PAEDIATR NEURO, V7, P155, DOI 10.1016/S1090-3798(03)00060-6; MANSSON B, 1995, J CLIN INVEST, V95, P1071, DOI 10.1172/JCI117753; McGovern VL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132364; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Mercuri E, 2018, NEUROMUSCULAR DISORD, V28, P103, DOI 10.1016/j.nmd.2017.11.005; Muller G, 1998, CONNECT TISSUE RES, V39, P233, DOI 10.3109/03008209809021499; NEWTON G, 1994, GENOMICS, V24, P435, DOI 10.1006/geno.1994.1649; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Riessland M, 2017, AM J HUM GENET, V100, P297, DOI 10.1016/j.ajhg.2017.01.005; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; Rigo F, 2014, J PHARMACOL EXP THER, V350, P46, DOI 10.1124/jpet.113.212407; Scoto M, 2017, GENE THER, V24, P514, DOI 10.1038/gt.2017.45; Shanmugarajan S, 2009, J PATHOL, V219, P52, DOI 10.1002/path.2566; Sleigh JN, 2011, DIS MODEL MECH, V4, P457, DOI 10.1242/dmm.007245; SRINIVAS PR, 1993, MOL ENDOCRINOL, V7, P1445, DOI 10.1210/me.7.11.1445; Stenvinkel P, 2005, KIDNEY INT, V67, P2383, DOI 10.1111/j.1523-1755.2005.00345.x; Sumner CJ, 2006, NEUROLOGY, V66, P1067, DOI 10.1212/01.wnl.0000201929.56928.13; Szunyogova E, 2016, SCI REP-UK, V6, DOI 10.1038/srep34635; Tiziano FD, 2010, EUR J HUM GENET, V18, P52, DOI 10.1038/ejhg.2009.116; Tukey JW, 1977, EXPLORATORY DATA ANA; Ueland T, 2017, EUR J PREV CARDIOL, V24, P1161, DOI 10.1177/2047487317703826; van der Leeuw J, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003048; Viswambharan V, 2017, BIOMARK MED, V11, P151, DOI 10.2217/bmm-2016-0242; Wadman RI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167087; Wang L, 2010, CIRC RES, V106, P514, DOI 10.1161/CIRCRESAHA.109.202762; Wang TJ, 2011, CIRCULATION, V123, P551, DOI 10.1161/CIRCULATIONAHA.109.912568; Wasserman HM, 2017, NEUROMUSCULAR DISORD, V27, P331, DOI 10.1016/j.nmd.2017.01.019; WEWER UM, 1994, J CELL BIOL, V127, P1767, DOI 10.1083/jcb.127.6.1767; Wirth B, 2006, HUM GENET, V119, P422, DOI 10.1007/s00439-006-0156-7; Wirth B, 2013, CURR OPIN GENET DEV, V23, P330, DOI 10.1016/j.gde.2013.03.003; Zachou K, 2017, EUR J INTERN MED, V43, pE48, DOI 10.1016/j.ejim.2017.05.003; Zaworski P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150640; Zheng TP, 2017, METABOLISM, V73, P125, DOI 10.1016/j.metabol.2017.04.012	93	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203398	10.1371/journal.pone.0203398	http://dx.doi.org/10.1371/journal.pone.0203398			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188931	Green Published, Green Submitted, gold			2022-12-26	WOS:000444228700031
J	Capo, A; Pennacchio, A; Varriale, A; D'Auria, S; Staiano, M				Capo, Alessandro; Pennacchio, Angela; Varriale, Antonio; D'Auria, Sabato; Staiano, Maria			The porcine odorant-binding protein as molecular probe for benzene detection	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; WEB SERVER; STABILITY; DOCKING; FAMILY; SPECTROSCOPY; BIOSENSORS; MECHANISM; TOLUENE; AIR	In recent years, air pollution has been a subject of great scientific and public interests for the strong impact on human health. Air pollution is due to the presence in the atmosphere of polluting substances, such as carbon monoxide, sulfur and nitrogen oxides, particulates and volatile organic compounds (VOCs), derived predominantly from various combustion processes. Benzene is a VOC belonging to group-I carcinogens with a toxicity widely demonstrated. The emission limit values and the daily exposure time to benzene (TLV-TWA) are 5 mu g/m(3) (0.00157 ppm) and 1.6mg/m(3) (0.5 ppm), respectively. Currently, expensive and time-consuming analytical methods are used for detection of benzene. These methods require to perform a few preliminary steps such as sampling, and matrices pre- treatments. In addition, it is also needed the support of specialized personnel. Recently, single-walled carbon nanotube (SWNTs) gas sensors with a limit detection (LOD) of 20 ppm were developed for benzene detection. Other innovative bioassay, called bio-report systems, were proposed. They use a whole cell (Pseudomona putida or Escherichia coli) as molecular recognition element and exhibit a LOD of about 10 mu M. Here, we report on the design of a highly sensitive fluorescence assay for monitoring atmospheric level of benzene. For this purpose, we used as molecular recognition element the porcine odorant-binding protein (pOBP). 1-Aminoanthracene was selected as extrinsic fluorescence probe for designing a competitive fluorescence resonance energy transfer (FRET) assay for benzene detection. The detection limit of our assay wa s 3.9 mu g/m(3), a value lower than the actual emission limit value of benzene as regulated by European law.	[Capo, Alessandro; Pennacchio, Angela; Varriale, Antonio; D'Auria, Sabato; Staiano, Maria] CNR, Inst Food Sci, Avellino, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Staiano, M (corresponding author), CNR, Inst Food Sci, Avellino, Italy.	maria.staiano@isa.cnr.it	STAIANO, MARIA/B-9584-2015; Varriale, Antonio/AAL-1439-2020	STAIANO, MARIA/0000-0003-0223-1825; Capo, Alessandro/0000-0002-5566-2867	 [INAIL-BRIC15-ID 06]		This project was funded by INAIL-BRIC15-ID 06 Sviluppo di nuovi collanti a base organica e inorganica come sostitutivi delle resine contenenti formaldeide nei prodotti legnosi usati nell'edilizia e negli arredi +/- FREEFORES. There was no additional external funding received for this study.	Ahmadi SK, 2015, J BIOMOL STRUCT DYN, V33, P1880, DOI 10.1080/07391102.2014.977351; Albani JR, 2007, PRINCIPLES AND APPLICATIONS OF FLUORESCENCE SPECTROSCOPY, P1, DOI 10.1002/9780470692059; [Anonymous], 2008, CRC HDB CHEM PHYS; Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Barrefors G, 1996, SCI TOTAL ENVIRON, V189, P287, DOI 10.1016/0048-9697(96)05221-7; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BROWN RH, 1981, AM IND HYG ASSOC J, V42, P865, DOI 10.1080/15298668191420828; BURLAGE RS, 1994, ANNU REV MICROBIOL, V48, P291, DOI 10.1146/annurev.micro.48.1.291; Burova TV, 1999, BIOCHEMISTRY-US, V38, P15043, DOI 10.1021/bi990769s; Camagni SS P., 1984, OPTICAL REMOTE SENSI; Chang DTH, 2005, NUCLEIC ACIDS RES, V33, pW233, DOI 10.1093/nar/gki586; Cruz LP., 2017, J ENV PROT, V8, P12, DOI DOI 10.4236/JEP.2017.81002; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; David LB, 1998, EPA600P97001F NAT CT; EEA, 2016, 282016 EEA; EPA U, 2012, TRI EXPL 2014 NAT AN; FLOWER DR, 1995, J MOL RECOGNIT, V8, P185, DOI 10.1002/jmr.300080304; Flower DR, 1996, BIOCHEM J, V318, P1; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Hernandez-Sanchez V, 2016, MICROB BIOTECHNOL, V9, P858, DOI 10.1111/1751-7915.12394; Hosainzadeh A, 2012, J BIOMOL STRUCT DYN, V29, P1013, DOI 10.1080/073911012010525029; IARC, 2009, IARC MONOGRAPHS EVAL; Johansson JS, 2005, FEBS J, V272, P573, DOI 10.1111/j.1742-4658.2004.04500.x; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Kmiecik D, 2010, J FLUORESC, V20, P973, DOI 10.1007/s10895-010-0643-z; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Li J, 2003, NANO LETT, V3, P929, DOI 10.1021/nl034220x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lobel D, 2001, CHEM SENSES, V26, P673, DOI 10.1093/chemse/26.6.673; Makhathini Thobeka P., 2017, South African Journal of Chemical Engineering, V23, P71, DOI 10.1016/j.sajce.2017.03.001; Mikhailopulo KI, 2008, J APPL SPECTROSC+, V75, P857, DOI 10.1007/s10812-009-9120-3; Moghaddam MM, 2014, LUMINESCENCE, V29, P314, DOI 10.1002/bio.2546; Moosavi-Movahedi AA, 2003, J PROTEIN CHEM, V22, P23, DOI 10.1023/A:1023011609931; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mukherjee AK, 2016, J ENVIRON SCI HEAL A, V51, P135, DOI 10.1080/10934529.2015.1087740; Nagnan-Le Meillour P, 2009, BBA-PROTEINS PROTEOM, V1794, P1142, DOI 10.1016/j.bbapap.2009.04.012; Nespoulous C, 2004, CHEM SENSES, V29, P189, DOI 10.1093/chemse/bjh017; Nespoulous C, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-62; Parisi M, 2003, BBA-PROTEINS PROTEOM, V1652, P115, DOI 10.1016/j.bbapap.2003.08.009; Pelosi P, 1996, J NEUROBIOL, V30, P3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prati MV, 2015, J AIR WASTE MANAGE, V65, P970, DOI 10.1080/10962247.2015.1050129; Ramoni R, 2002, BIOCHEM J, V365, P739, DOI 10.1042/BJ20011631; Spinelli S, 1998, BIOCHEMISTRY-US, V37, P7913, DOI 10.1021/bi980179e; Staiano M, 2007, BIOCHEMISTRY-US, V46, P11120, DOI 10.1021/bi7008129; Stepanenko OV, 2008, PROTEINS, V71, P35, DOI 10.1002/prot.21658; Vincent F, 2004, EUR J BIOCHEM, V271, P3832, DOI 10.1111/j.1432-1033.2004.04315.x; Vincent F, 2000, J MOL BIOL, V300, P127, DOI 10.1006/jmbi.2000.3820; Wang JC, 2012, NUCLEIC ACIDS RES, V40, pW393, DOI 10.1093/nar/gks496; WHO, 2000, AIR QUAL GUID; WHO, 2013, TECHNICAL REPORT; WHO, 2014, BURD DIS AMB HOUS AI; World Health Organization, 2005, WHO REGIONAL OFFICE; Xu ZH, 2003, BIOTECHNOL PROGR, V19, P1812, DOI 10.1021/bp0341794; Yu Q, 2011, ANAL BIOANAL CHEM, V401, P2891, DOI 10.1007/s00216-011-5411-7	59	8	9	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202630	10.1371/journal.pone.0202630	http://dx.doi.org/10.1371/journal.pone.0202630			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183769	Green Published, Green Submitted, gold			2022-12-26	WOS:000443789900033
J	Hall, WC; Smith, SR; Sutter, EJ; DeWindt, LA; Dye, TDV				Hall, Wyatte C.; Smith, Scott R.; Sutter, Erika J.; DeWindt, Lori A.; Dye, Timothy D. V.			Considering parental hearing status as a social determinant of deaf population health: Insights from experiences of the "dinner table syndrome"	PLOS ONE			English	Article							LANGUAGE-DEVELOPMENT; OF-HEARING; CHILDREN; IMPLANTATION; DEPRIVATION; ACQUISITION; PERFORMANCE; AGE	The influence of early language and communication experiences on lifelong health outcomes is receiving increased public health attention. Most deaf children have non-signing hearing parents, and are at risk for not experiencing fully accessible language environments, a possible factor underlying known deaf population health disparities. Childhood indirect family communication-such as spontaneous conversations and listening in the routine family environment (e.g. family meals, recreation, car rides)-is an important source of health-related contextual learning opportunities. The goal of this study was to assess the influence of parental hearing status on deaf people's recalled access to childhood indirect family communication. We analyzed data from the Rochester Deaf Health Survey-2013 (n = 211 deaf adults) for associations between sociodemographic factors including parental hearing status, and recalled access to childhood indirect family communication. Parental hearing status predicted deaf adults' recalled access to childhood indirect family communication (chi(2) = 31.939, p < .001). The likelihood of deaf adults reporting "sometimes to never" for recalled comprehension of childhood family indirect communication increased by 17.6 times for those with hearing parents. No other sociodemographic or deaf-specific factors in this study predicted deaf adults' access to childhood indirect family communication. This study finds that deaf people who have hearing parents were more likely to report limited access to contextual learning opportunities during childhood. Parental hearing status and early childhood language experiences, therefore, require further investigation as possible social determinants of health to develop interventions that improve lifelong health and social outcomes of the underserved deaf population.	[Hall, Wyatte C.; Dye, Timothy D. V.] Univ Rochester, Med Ctr, Obstet & Gynecol, Rochester, NY 14642 USA; [Hall, Wyatte C.; Dye, Timothy D. V.] Univ Rochester, Med Ctr, Clin & Translat Sci Inst, Rochester, NY 14642 USA; [Smith, Scott R.] Rochester Inst Technol, Off Associate Dean Res, Natl Tech Inst Deaf, Rochester, NY 14623 USA; [Sutter, Erika J.; DeWindt, Lori A.] Univ Rochester, Med Ctr, Natl Ctr Deaf Hlth Res, Rochester, NY 14642 USA; [DeWindt, Lori A.] Univ Rochester, Med Ctr, Deaf Wellness Ctr, Rochester, NY 14642 USA; [Dye, Timothy D. V.] Univ Rochester, Med Ctr, Pediat & Publ Hlth Sci, Rochester, NY 14642 USA	University of Rochester; University of Rochester; Rochester Institute of Technology; University of Rochester; University of Rochester; University of Rochester	Hall, WC (corresponding author), Univ Rochester, Med Ctr, Obstet & Gynecol, Rochester, NY 14642 USA.; Hall, WC (corresponding author), Univ Rochester, Med Ctr, Clin & Translat Sci Inst, Rochester, NY 14642 USA.	wyatte_hall@urmc.rochester.edu	Dye, Timothy/HHY-9965-2022	Hall, Wyatte/0000-0002-7974-973X	CDC Prevention Research Centers Program [U48 DP000031, U48 DP001910, U48 DP005026]; CDC Community Transformation Grant [U58 DP003599]; National Institute for General Medical Sciences of the National Institutes of Health [K12 GM106997]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002001] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP005026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM106997] Funding Source: NIH RePORTER	CDC Prevention Research Centers Program(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); CDC Community Transformation Grant; National Institute for General Medical Sciences of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the CDC Prevention Research Centers Program (U48 DP000031, U48 DP001910, and U48 DP005026), a CDC Community Transformation Grant (U58 DP003599), and K12 GM106997 from the National Institute for General Medical Sciences of the National Institutes of Health. The funders did not have a direct role in study design, data collection, data analysis and interpretation, or manuscript writing. The findings and conclusions in this article are those of the authors and do not necessarily reflect the official position of the funders.	Anderson Melissa L, 2016, J Child Adolesc Trauma, V9, P353, DOI 10.1007/s40653-016-0111-2; Anderson ML, 2011, VIOLENCE AGAINST WOM, V17, P822, DOI 10.1177/1077801211412544; Barnett S, 2011, AM J PUBLIC HEALTH, V101, P2235, DOI 10.2105/AJPH.2011.300247; Barnett SL, 2017, AM J PREV MED, V52, pS250, DOI 10.1016/j.amepre.2016.10.011; BRADEN JP, 1987, AM ANN DEAF, V132, P263, DOI 10.1353/aad.2012.0723; Buckley KA, 2011, EAR HEARING, V32, P2, DOI 10.1097/AUD.0b013e3181fa41bb; Davidson K, 2014, J DEAF STUD DEAF EDU, V19, P238, DOI 10.1093/deafed/ent045; Davidson Lisa S, 2011, Ear Hear, V32, p19S, DOI 10.1097/AUD.0b013e3181ffdb8b; Fellinger J, 2012, LANCET, V379, P1037, DOI 10.1016/S0140-6736(11)61143-4; Fink Nancy E, 2007, Cochlear Implants Int, V8, P92, DOI 10.1002/cii.333; Gallaudet Research Institute, 2011, REG NAT SUMM REP DAT; Geers A, 2003, EAR HEARING, V24, p24S, DOI 10.1097/01.AUD.0000051687.99218.0F; Greenwood CR, 2017, CLIN CHILD FAM PSYCH, V20, P3, DOI 10.1007/s10567-017-0223-8; Hall ML, 2017, J DEAF STUD DEAF EDU, V22, P9, DOI 10.1093/deafed/enw054; Hall WC, 2017, SOC PSYCH PSYCH EPID, V52, P761, DOI 10.1007/s00127-017-1351-7; Hall WC, 2017, MATERN CHILD HLTH J, V21, P961, DOI 10.1007/s10995-017-2287-y; Hassanzadeh S, 2012, J LARYNGOL OTOL, V126, P989, DOI 10.1017/S0022215112001909; Hauser PC, 2010, AM ANN DEAF, V154, P486, DOI 10.1353/aad.0.0120; Henner J, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01982; Humphries T, 2012, HARM REDUCT J, V9, DOI 10.1186/1477-7517-9-16; Kral A, 2016, LANCET NEUROL, V15, P610, DOI 10.1016/S1474-4422(16)00034-X; Kushalnagar P, 2011, J DEAF STUD DEAF EDU, V16, P512, DOI 10.1093/deafed/enr015; Margellos-Anast H, 2006, PREV MED, V42, P235, DOI 10.1016/j.ypmed.2005.12.012; Marshall C, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00527; Mayberry RI, 2011, BRAIN LANG, V119, P16, DOI 10.1016/j.bandl.2011.05.007; McKee MM, 2015, DISABIL HEALTH J, V8, P573, DOI 10.1016/j.dhjo.2015.05.004; Mitchell R. E., 2004, SIGN LANG STUD, V4, P138, DOI DOI 10.1353/SLS.2004.0005; Mitchell RE, 2005, SIGN LANG STUD, V5, P231, DOI 10.1353/sls.2005.0004; Niparko JK, 2010, JAMA-J AM MED ASSOC, V303, P1498, DOI 10.1001/jama.2010.451; Penicaud S, 2013, NEUROIMAGE, V66, P42, DOI 10.1016/j.neuroimage.2012.09.076; Schick B, 2007, CHILD DEV, V78, P376, DOI 10.1111/j.1467-8624.2007.01004.x; Skotara N, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-44; Smith SR, 2016, J HEALTH COMMUN, V21, P141, DOI 10.1080/10810730.2016.1179368; Smith SR, 2015, J DEAF STUD DEAF EDU, V20, P408, DOI 10.1093/deafed/env021; Tobey EA, 2013, INT J AUDIOL, V52, P219, DOI 10.3109/14992027.2012.759666; Watkins S, 1998, AM ANN DEAF, V143, P29, DOI 10.1353/aad.2012.0098	36	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202169	10.1371/journal.pone.0202169	http://dx.doi.org/10.1371/journal.pone.0202169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS6HC	30183711	gold, Green Submitted, Green Published			2022-12-26	WOS:000443789900018
J	Snell, KRS; Stokke, BG; Moksnes, A; Thorup, K; Fossoy, F				Snell, Katherine R. S.; Stokke, Bard G.; Moksnes, Arne; Thorup, Kasper; Fossoy, Frode			From Svalbard to Siberia: Passerines breeding in the High Arctic also endure the extreme cold of the Western Steppe	PLOS ONE			English	Article							MIGRATION; TRACKING; EXERCISE; WEATHER; CLIMATE; BIRDS	Few species are adapted to high latitudes, and many over-winter in milder climates with migrations involving extensive barrier crossings. By escaping extreme conditions for the majority of the year, physiological and behavioural adaptations presumably need to be less pronounced. The snow bunting Plectrophenax nivalis is the most northerly breeding passerine. We tracked the Svalbard population using geolocators to reveal that these individuals not only breed in environmental extremes, but also spend the winters in the severe cold and highly stochastic weather conditions of the Siberian steppe. Migratory strategies appeared to be flexible between individuals and years. However, common wintering grounds in the Asian Western Steppe were identified, where birds could utilise vast crop-and grasslands while enduring low ambient temperatures. The timing of significant long distance movements was consistent among individuals, and the autumn routing of the >1000 km open water flight to Novaya Zemlya incurred favourable wind assistance and lower risk of precipitation, compared to the shorter route between Svalbard and Norway used in spring. Presumably, Svalbard snow buntings are physiologically well-adapted to extreme conditions and their migration, rather being a retreat from physiologically demanding conditions, allows utilisation of an abundance of resources in the Asian Steppe.	[Snell, Katherine R. S.; Thorup, Kasper] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Nat Hist Museum Denmark, Univ Pk 15, Copenhagen, Denmark; [Stokke, Bard G.; Moksnes, Arne; Fossoy, Frode] Norwegian Univ Sci & Technol NTNU, Dept Biol, Hgsk Ringen 5, Trondheim, Norway; [Stokke, Bard G.; Fossoy, Frode] Norwegian Inst Nat Res NINA, Trondheim, Norway	University of Copenhagen; Norwegian University of Science & Technology (NTNU); Norwegian Institute Nature Research	Snell, KRS (corresponding author), Univ Copenhagen, Ctr Macroecol Evolut & Climate, Nat Hist Museum Denmark, Univ Pk 15, Copenhagen, Denmark.	katherine.snell@snm.ku.dk	Snell, Katherine R S/B-9085-2015; Thorup, Kasper/A-4835-2013	Snell, Katherine R S/0000-0003-3720-4579; Thorup, Kasper/0000-0002-0320-0601	Svalbard Environmental Protection Fund [14/63]; Danish Council for Independent Research [1323-00048B]; Danish National Research Foundation [DNRF96]	Svalbard Environmental Protection Fund; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond)	This study was funded by The Svalbard Environmental Protection Fund (grant 14/63 to F. F.). The Danish Council for Independent Research supported the MATCH project (1323-00048B) and Danish National Research Foundation supported Centre for Macroecology, Evolution and Climate (DNRF96; K.S. and K.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; ALESTAM T, 1990, OPTIMAL BIRD MIGRATI, P331; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2003, MIGRATION WINTER RAN; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Aye R., 2012, BIRDS CENTRAL ASIA K; BAKKON V, 2006, NORWEGIAN BIRD RINGI, VII; Bayly NJ, 2013, IBIS, V155, P271, DOI 10.1111/ibi.12029; Berthold P, 2001, AUK, V2nd; Berthold P, 1996, CONTROL BIRD MIGRATI; Bird Life International, 2017, SPEC FACTSH PLECTR N; Brewer AD, 2000, ATLAS CANADIAN BIRD, V1; Buler JJ, 2011, J ORNITHOL, V152, P101, DOI 10.1007/s10336-010-0640-7; BUTLER PJ, 1991, J EXP BIOL, V160, P233; Byers C, 1995, BUNTINGS SPARROWS GU; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cooper SJ, 2002, PHYSIOL BIOCHEM ZOOL, V75, P386, DOI 10.1086/342256; Coppack T, 2009, INTEGR COMP BIOL, V49, P493, DOI 10.1093/icb/icp029; Cramp S., 1994, HDB BIRDS EUROPE MID, V9; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Dawson WR., 1989, PHYSL COLD ADAPTATIO, P83; Delingat J, 2008, BEHAV ECOL SOCIOBIOL, V62, P1069, DOI 10.1007/s00265-007-0534-8; DeLuca WV, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.1045; Deppe JL, 2015, P NATL ACAD SCI USA, V112, pE6331, DOI 10.1073/pnas.1503381112; Divoky GJ, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0275; Eppley Z.A., 2008, ANIMALS TEMPERATURE, P313, DOI [10.1017/CBO9780511721854.014, DOI 10.1017/CBO9780511721854.014]; Espmark Y, 2016, T R NOR SOC SCI LETT, V1-2016, P1; Formozov AN, 1963, SNOW COVER INTEGRAL; Fossoy F, 2015, POLAR BIOL, V38, P393, DOI 10.1007/s00300-014-1595-6; Fransson T., 2008, SVENSK RINGMARKNINGS; Fraser KC, 2012, P ROY SOC B-BIOL SCI, V279, P4901, DOI 10.1098/rspb.2012.2207; Friedl M., 2010, ISLSCP 2 MODIS COLLE, V10, DOI 10.3334/ORNLDAAC/968; Gavrilov E., 2005, BIRDS KAZAKHSTAN; Gill JA, 2015, J ANIM ECOL, V84, P1141, DOI 10.1111/1365-2656.12412; Hahn TP, 2015, STURKIE'S AVIAN PHYSIOLOGY, 6TH EDITION, P847; HART J. S., 1962, PHYSIOL ZOOL, V35, P224; Kamp J, 2011, BIOL CONSERV, V144, P2607, DOI 10.1016/j.biocon.2011.07.010; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; Kemp MU, 2012, METHODS ECOL EVOL, V3, P65, DOI 10.1111/j.2041-210X.2011.00138.x; Lebedeva NV, 2016, P ALL RUSS SCI C INT; Lerche-Jorgensen M, 2017, MOV ECOL, V5, DOI 10.1186/s40462-017-0109-x; Lisovski S, 2012, METHODS ECOL EVOL, V3, P1055, DOI 10.1111/j.2041-210X.2012.00248.x; Macdonald C. A., 2013, Animal Migration, V1, P23, DOI 10.2478/ami-2012-0003; Macdonald CA, 2016, J AVIAN BIOL, V47, P7, DOI 10.1111/jav.00689; McKechnie AE, 2002, CONDOR, V104, P705, DOI 10.1650/0010-5422(2002)104[0705:AFHRAR]2.0.CO;2; McKinnon EA, 2016, J ORNITHOL, V157, P681, DOI 10.1007/s10336-016-1333-7; Meltofte H., 1983, Polar Research, V1, P185; NASA, NASA WORLDV; National Centers for Environmental Prediction/National Weather Service/NOAA/U.S. Department of Commerce, 2000, NCEP FNL OP MOD GLOB; Newton I, 1996, J ANIM ECOL, V65, P137, DOI 10.2307/5716; Newton I, 2010, MIGRATION ECOLOGY BI; Normann D., 2002, MIGRATION ATLAS MOVE, P637; ORNL DAAC, 2017, SPAT DAT ACC TOOL SD; POHL H, 1973, COMP BIOCHEM PHYSIOL, V45, P851, DOI 10.1016/0300-9629(73)90088-1; Rakhimberdiev E, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0062-5; Sandberg R, 1998, J EXP BIOL, V201, P1859; Sauter A, 2010, IBIS, V152, P600, DOI 10.1111/j.1474-919X.2010.01028.x; Schmaljohann H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22421-7; SCHOLANDER PF, 1950, BIOL BULL, V99, P259, DOI 10.2307/1538742; Sherry Thomas W., 1995, P85; Smith RD, 1994, SNOW BUNTINGS PLECTR; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Swanson DL, 2010, CURR ORNITHOL, V17, P75, DOI 10.1007/978-1-4419-6421-2_3; Thorup K, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601360; Tottrup AP, 2017, J AVIAN BIOL, V48, P149, DOI 10.1111/jav.01352; Visser ME, 2012, J ORNITHOL, V153, pS75, DOI 10.1007/s10336-011-0770-6; Walker BG, 2015, J EXP ZOOL PART A, V323, P266, DOI 10.1002/jez.1923; Willemoes M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083515; Wingfield JC, 2002, COMP BIOCHEM PHYS B, V132, P275, DOI 10.1016/S1096-4959(01)00540-1; Wingfield JC, 2011, CURR ZOOL, V57, P363, DOI 10.1093/czoolo/57.3.363; Wingfield JC, 2011, J ORNITHOL, V152, P279, DOI 10.1007/s10336-011-0668-3	71	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202114	10.1371/journal.pone.0202114	http://dx.doi.org/10.1371/journal.pone.0202114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183717	gold, Green Submitted, Green Published			2022-12-26	WOS:000443789900015
J	Tamayo, LI; Vidaurre, T; Vasquez, JN; Casavilca, S; Palomino, JIA; Calderon, M; Abugattas, JE; Gomez, HL; Castaneda, CA; Song, SK; Cherry, D; Rauscher, GH; Fejerman, L				Tamayo, Lizeth I.; Vidaurre, Tatiana; Vasquez, Jeannie Navarro; Casavilca, Sandro; Palomino, Jessica I. Aramburu; Calderon, Monica; Abugattas, Julio E.; Gomez, Henry L.; Castaneda, Carlos A.; Song, Sikai; Cherry, Daniel; Rauscher, Garth H.; Fejerman, Laura			Breast cancer subtype and survival among Indigenous American women in Peru	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; GENETIC ANCESTRY; HISPANIC WOMEN; RISK; PREVALENCE; ETHNICITY; HISTORY; DISEASE; OBESITY	Latina women in the U.S. have relatively low breast cancer incidence compared to Non-Latina White (NLW) or African American women but are more likely to be diagnosed with the more aggressive "triple negative" breast cancer (TNBC). Latinos in the U.S. are a heterogeneous group originating from different countries with different cultural and ancestral backgrounds. Little is known about the distribution of tumor subtypes in Latin American regions. Clinical records of 303 female Peruvian patients, from the Peruvian National Cancer Institute, were analyzed. Participants were diagnosed with invasive breast cancer between 2010 and 2015 and were identified as residing in either the Selva or Sierra region. We used Fisher's exact test for proportions and multivariable Cox Proportional Hazards Models to compare overall survival between regions. Women from the Selva region were more likely to be diagnosed with TNBC than women from the Sierra region (31% vs. 14%, p = 0.01). In the unadjusted Cox model, the hazard of mortality was 1.7 times higher in women from the Selva than the Sierra (p = 0.025); this survival difference appeared to be largely explained by differences in the prevalence of TNBC. Our results suggest that the distribution of breast cancer subtypes differs between highly Indigenous American women from two regions of Peru. Disentangling the factors that contribute to this difference will add valuable information to better target prevention and treatment efforts in Peru and improve our understanding of TNBC among all women. This study demonstrates the need for larger datasets of Latin American patients to address differences between Latino subpopulations and optimize targeted prevention and treatment.	[Tamayo, Lizeth I.; Rauscher, Garth H.] Univ Illinois, Div Epidemiol & Biostat, Chicago, IL USA; [Vidaurre, Tatiana; Vasquez, Jeannie Navarro; Casavilca, Sandro; Palomino, Jessica I. Aramburu; Calderon, Monica; Abugattas, Julio E.; Gomez, Henry L.; Castaneda, Carlos A.] Inst Nacl Enfermedades Neoplas, Lima, Peru; [Song, Sikai; Fejerman, Laura] Univ Calif San Francisco, Dept Med, San Francisco, CA 94117 USA; [Cherry, Daniel] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Instituto Nacional de Enfermedades Neoplasicas; University of California System; University of California San Francisco; University of California System; University of California San Diego	Fejerman, L (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94117 USA.	laura.fejerman@ucsf.edu	Casavilca-Zambrano, Sandro/AAI-7390-2020	Castaneda, Carlos/0000-0001-6200-0856; Casavilca Zambrano, Sandro/0000-0001-8406-739X; Fejerman, Laura/0000-0003-3179-1151; Tamayo, Lizeth I/0000-0002-2417-3331; Cherry, Daniel/0000-0002-6441-9172	National Cancer Institute [R01 CA204797]; Susan G. Komen Foundation [KG111385]; NATIONAL CANCER INSTITUTE [R01CA204797] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R01 CA204797 from the National Cancer Institute was allotted to Dr. Laura Fejerman. KG111385 from the Susan G. Komen Foundation was allotted to Lizeth Tamayo in the form of a fellowship, under which Dr. Garth Rauscher is a mentor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern J, 2009, AM J EPIDEMIOL, V169, P1140, DOI 10.1093/aje/kwp015; Anderson BO, 2008, WORLD J SURG, V32, P2578, DOI 10.1007/s00268-007-9454-z; Banegas MP, 2014, BREAST CANCER RES TR, V144, P625, DOI 10.1007/s10549-014-2882-1; Banegas MP, 2012, BREAST CANCER RES TR, V134, P1297, DOI 10.1007/s10549-012-2142-1; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Carrillo-Larco RM, 2016, INT J OBESITY, V40, P181, DOI 10.1038/ijo.2015.140; Cartin-Brenes M, 2014, BREAST CANC, V2014; Chlebowski RT, 2005, JNCI-J NATL CANCER I, V97, P439, DOI 10.1093/jnci/dji064; Claudia DeMacedo Andrade A, 2011, MOL BREAST CANC SUBT; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Fejerman L, 2008, CANCER RES, V68, P9723, DOI 10.1158/0008-5472.CAN-08-2039; Goldstein J, 2005, PREV MED, V41, P800, DOI 10.1016/j.ypmed.2005.06.001; Gonzalez-Angulo AM, 2011, CLIN CANCER RES, V17, P1082, DOI 10.1158/1078-0432.CCR-10-2560; Haas JS, 2004, ANN INTERN MED, V140, P184, DOI 10.7326/0003-4819-140-3-200402030-00009; John EM, 2005, CANCER EPIDEM BIOMAR, V14, P2905, DOI 10.1158/1055-9965.EPI-05-0483; Serrano-Gomez SJ, 2016, CARCINOGENESIS, V37, P669, DOI 10.1093/carcin/bgw043; Jung S, 2013, JNCI-J NATL CANCER I, V105, P219, DOI 10.1093/jnci/djs635; Li CI, 2013, BREAST CANCER RES TR, V137, P579, DOI 10.1007/s10549-012-2365-1; Masterson R, 2010, REV PANAM SALUD PUBL, V28, P1; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Miranda JJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000610; Moreno Gomez H, 2014, DESCRIPTION EVOLUTIO; Newman LA, 2006, J CLIN ONCOL, V24, P1342, DOI 10.1200/JCO.2005.03.3472; Newman LA, 2002, CANCER-AM CANCER SOC, V94, P2844, DOI 10.1002/cncr.10575; Ooi SL, 2011, BREAST CANCER RES TR, V127, P729, DOI 10.1007/s10549-010-1191-6; Parise CA, 2009, BREAST J, V15, P593, DOI 10.1111/j.1524-4741.2009.00822.x; Phipps AI, 2011, JNCI-J NATL CANCER I, V103, P470, DOI 10.1093/jnci/djr030; Pike MC, 2002, CANCER EPIDEM BIOMAR, V11, P795; Rauscher GH, 2016, AM J EPIDEMIOL, V183, P884, DOI 10.1093/aje/kwv226; Sandoval JR, 2013, J HUM GENET, V58, P627, DOI 10.1038/jhg.2013.73; Sans M, 2000, HUM BIOL, V72, P155; Serrano-Gomez SJ, 2018, CANCER EPIDEM BIOMAR, V27, P3, DOI 10.1158/1055-9965.EPI-17-0420; Srur-Rivero N, 2014, BREAST CANCER-BASIC, V8, P103, DOI 10.4137/BCBCR.S15854; Stern Mariana C, 2016, Curr Epidemiol Rep, V3, P181, DOI 10.1007/s40471-016-0083-7; Unger-Saldana K, 2014, WORLD J CLIN ONCOL, V5, P465, DOI 10.5306/wjco.v5.i3.465; Vidaurre T., 2015, PLAN ESPERANZA MODEL; Vidaurre T, 2017, LANCET ONCOL, V18, pE595, DOI 10.1016/S1470-2045(17)30598-3; Villarreal-Garza C, 2015, BREAST CANCER RES TR, V150, P389, DOI 10.1007/s10549-015-3312-8; Vona-Davis L, 2008, CANCER EPIDEM BIOMAR, V17, P3319, DOI 10.1158/1055-9965.EPI-08-0544; Wu YL, 2013, BREAST CANCER RES TR, V137, P869, DOI 10.1007/s10549-012-2396-7; Zambrana RE, 1999, PREV MED, V29, P466, DOI 10.1006/pmed.1999.0566; Zhang XH, 2012, AM J CLIN NUTR, V95, P713, DOI 10.3945/ajcn.111.014415; Ziv E, 2006, CANCER EPIDEM BIOMAR, V15, P1878, DOI 10.1158/1055-9965.EPI-06-0092	43	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0201287	10.1371/journal.pone.0201287	http://dx.doi.org/10.1371/journal.pone.0201287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183706	gold, Green Published, Green Submitted			2022-12-26	WOS:000443789900004
J	Chowdhury, S; Dai, BW; Memoli, F				Chowdhury, Samir; Dai, Bowen; Memoli, Facundo			The importance of forgetting: Limiting memory improves recovery of topological characteristics from neural data	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DENTATE GYRUS; HIPPOCAMPUS; CELLS; PERSISTENCE; DEPRESSION; ENGRAM; RAT	We develop of a line of work initiated by Curto and Itskov towards understanding the amount of information contained in the spike trains of hippocampal place cells via topology considerations. Previously, it was established that simply knowing which groups of place cells fire together in an animal's hippocampus is sufficient to extract the global topology of the animal's physical environment. We model a system where collections of place cells group and ungroup according to short-term plasticity rules. In particular, we obtain the surprising result that in experiments with spurious firing, the accuracy of the extracted topological information decreases with the persistence (beyond a certain regime) of the cell groups. This suggests that synaptic transience, or forgetting, is a mechanism by which the brain counteracts the effects of spurious place cell activity.	[Chowdhury, Samir; Memoli, Facundo] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA; [Dai, Bowen] Dartmouth Coll, Dept Comp Sci, Hanover, NH USA; [Memoli, Facundo] Ohio State Univ, Dept Comp Sci & Engn, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Dartmouth College; University System of Ohio; Ohio State University	Memoli, F (corresponding author), Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA.; Memoli, F (corresponding author), Ohio State Univ, Dept Comp Sci & Engn, Columbus, OH 43210 USA.	memoli@math.osu.edu	Dai, Bowen/ABB-6070-2021		National Science Foundation [IIS-1422400]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation award number IIS-1422400 (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1422400&HistoricalAwards=false). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babichev A, 2017, ARXIV171002623; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bjorner A., 1995, HDB COMBINATORICS, V1, P1819; Brown EN, 1998, J NEUROSCI, V18, P7411; Carlsson G, 2010, FOUND COMPUT MATH, V10, P367, DOI 10.1007/s10208-010-9066-0; Carlsson G, 2009, PROCEEDINGS OF THE TWENTY-FIFTH ANNUAL SYMPOSIUM ON COMPUTATIONAL GEOMETRY (SCG'09), P247, DOI 10.1145/1542362.1542408; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Chen Z, 2014, NEURAL COMPUT, V26, P1, DOI 10.1162/NECO_a_00538; Chowdhury S, 2017, COSYNE ABSTRACTS 201, V2017; Chowdhury S, J APPL COMPUTATIONAL; Curto C, 2017, B AM MATH SOC, V54, P63, DOI 10.1090/bull/1554; Curto C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000205; Dabaghian Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002581; Dabaghian Y, 2009, FRONT SYST NEUROSCI; DAYAN P, 1991, BIOL CYBERN, V65, P253, DOI 10.1007/BF00206223; Dayan P., 2001, THEORETICAL NEUROSCI, V10; Dong ZF, 2015, J CLIN INVEST, V125, P234, DOI 10.1172/JCI77888; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Edelsbrunner H., 2014, PERSISTENT HOMOLOGY; Edelsbrunner H, 2008, CONTEMP MATH, V453, P257; Edelsbrunner Herbert, 2010, COMPUTATIONAL TOPOLO; Friedman J., 2001, SPRINGER SERIES STAT, V1; FROSINI P, 1992, P SOC PHOTO-OPT INS, V1607, P122, DOI 10.1117/12.57059; Ghrist R, 2008, B AM MATH SOC, V45, P61, DOI 10.1090/s0273-0979-07-01191-3; Giusti C, 2015, P NATL ACAD SCI USA, V112, P13455, DOI 10.1073/pnas.1506407112; Jardine N., 1971, WILEY SERIES PROBABI; Josselyn SA, 2015, NAT REV NEUROSCI, V16, P521, DOI 10.1038/nrn4000; Kemp A, 2007, TRENDS NEUROSCI, V30, P111, DOI 10.1016/j.tins.2007.01.002; LeCun Y., 1990, ADV NEURAL INFORM PR, V2; Liu YL, 2016, CURR BIOL, V26, P2351, DOI 10.1016/j.cub.2016.06.056; McAvoy KM, 2016, NEURON, V91, P1356, DOI 10.1016/j.neuron.2016.08.009; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Richards BA, 2017, NEURON, V94, P1071, DOI 10.1016/j.neuron.2017.04.037; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Shuai YC, 2010, CELL, V140, P579, DOI 10.1016/j.cell.2009.12.044; Sinai Y.G., 1970, USPEHI MAT NAUK, V25, P141, DOI 10.1070/RM1970v025n02ABEH003794; Spreemann G., 2015, ARXIV151006629; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Tonegawa S, 2015, NEURON, V87, P918, DOI 10.1016/j.neuron.2015.08.002; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908	42	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0202561	10.1371/journal.pone.0202561	http://dx.doi.org/10.1371/journal.pone.0202561			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180172	gold, Green Published, Green Submitted			2022-12-26	WOS:000444222400010
J	Li, JX; Xia, XF; Xu, SJ; Wu, JY; Peng, LL; Zhao, LC				Li, Jianxia; Xia, Xiaofei; Xu, Shenjian; Wu, Jiayue; Peng, Linlin; Zhao, Liangcheng			Development, structure and evolutionary significance of seed appendages in Salix matsudana (Salicaceae)	PLOS ONE			English	Article							POPULUS; COLORADO; FOLIAGE; EOCENE; FRUITS; UTAH	The seeds of Salix and Populus (Salicaceae) are characterized by having numerous long hairs which loosely accompanying the seeds and a small annular appendage which surrounding the base of the seed along with tufted hairs. In this study, the complete development and detailed structure of the hairs and annular appendage in Salix matsudana were investigated using standard techniques for plant anatomy and histochemistry. The results show that the hairs originate successively from the single epidermal cells of the placenta (in megaspore mother cell phase) and funiculus (in eight-nucleate phase), and that their development consists of a progressive increase in cell size and an absence of cell division. The annular appendage is initiated from four to five rows of cells at the distal end of the funiculus in octant proembryo phase and its development is characterized by reactivated meristematic activity and a size increase of these cells. The initiation and development of the hairs are irrelevant to ovule development but fertilization and a developed embryo is necessary for the annular appendage to occur. Considering the reliable fossils, we inferred that the feature of seeds surrounded by long hairs is an ancestral character, and that the detachment of hairs from the funiculus and the occurrence of an annular appendage with tufts of hairs may be the more derived states for seed dispersal in Salix and Populus.	[Li, Jianxia; Xu, Shenjian; Wu, Jiayue; Peng, Linlin; Zhao, Liangcheng] Beijing Forestry Univ, Lab Systemat Evolut & Biogeog Woody Plants, Coll Nat Conservat, Beijing, Peoples R China; [Xia, Xiaofei] Beijing Museum Nat Hist, Beijing, Peoples R China	Beijing Forestry University	Zhao, LC (corresponding author), Beijing Forestry Univ, Lab Systemat Evolut & Biogeog Woody Plants, Coll Nat Conservat, Beijing, Peoples R China.	lczhao@bjfu.edu.cn			Beijing Natural Science Foundation [5133036]; National Natural Science Foundation of China [31370213]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Beijing Natural Science Foundation (http://www.bjkw.gov.cn/jjb/) (5133036) to LCZ and National Natural Science Foundation of China (http://www.nsfc.gov.cn/)(31370213) to LCZ. None of the authors is employed or contracted by the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argus, 1986, SYST BOT MONOGR, V9, P1, DOI [10.2307/25027618, DOI 10.2307/25027618]; Argus G. W., 1997, SYST BOT MONOGR, V52, P1, DOI DOI 10.2307/25096638; Argus GW, 1995, J ARIZONA NEVADA ACA, V29, P39; BOES TK, 1994, AM J BOT, V81, P562, DOI 10.2307/2445730; Boucher LD, 2003, AM J BOT, V90, P1389, DOI 10.3732/ajb.90.9.1389; Chase Mark W., 2002, Kew Bulletin, V57, P141, DOI 10.2307/4110825; COLLINSON ME, 1992, P ROY SOC EDINB B, V98, P155, DOI 10.1017/S0269727000007521; Corner E. J. H., 1976, SEEDS DICOTYLEDONS; Coskuncelebi K, 2017, PHYTOTAXA, V331, P169, DOI 10.11646/phytotaxa.331.2.2; Fang Z., 1999, FLORA CHINA, V4; FECHNER GH, 1972, CAN J BOT, V50, P2503, DOI 10.1139/b72-321; FLINT EA, 1950, BIOL REV, V25, P414, DOI 10.1111/j.1469-185X.1950.tb00767.x; Hu YQ, 2008, GRANA, V47, P241, DOI 10.1080/00173130802237681; Jacobs M., 1955, SALICACEAE FLORA M 1, V5; JOHRI BM, 1954, PHYTOMORPHOLOGY, V4, P230; Johri BM, 1992, COMP EMBRYOLOGY ANGI, V1; Jordaan M, 2005, BOTHALIA, V35, P7, DOI 10.4102/abc.v35i1.364; KAPIL R N, 1980, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V101, P555; Keoleian GA, 2005, CRIT REV PLANT SCI, V24, P385, DOI 10.1080/07352680500316334; KUMAR P, 1990, Phytomorphology, V40, P179; Liu X, 2016, BIOCHEM SYST ECOL, V68, P210, DOI 10.1016/j.bse.2016.07.016; Manchester SR, 2006, INT J PLANT SCI, V167, P897, DOI 10.1086/503918; NAGARAJ M, 1952, BOT GAZ, V114, P222, DOI 10.1086/335763; O'Brien TP, 1981, STUDY PLANT STRUCTUR, DOI DOI 10.2307/2259948; PEARSON NL, 1948, AM J BOT, V35, P27, DOI 10.2307/2437976; Puff C, 1998, PLANT SYST EVOL, V210, P147, DOI 10.1007/BF00985665; Soltis D, 2005, PHYLOGENY EVOLUTION; Steyn EMA, 2004, BOTHALIA, V34, P53, DOI 10.4102/abc.v34i1.413; Takeda H., 1936, BOT MAG TOKYO, V50, P283; Takhtajan A., 2009, FLOWERING PLANTS, DOI 10.1007/978-1-4020-9609-9; Van der Pijl L, 1982, PRINCIPLES DISPERSAL, V214; WERKER E, 1997, SEED ANATOMY; YEUNG EC, 1984, CELL CULTURE SOMATIC	33	1	2	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0203061	10.1371/journal.pone.0203061	http://dx.doi.org/10.1371/journal.pone.0203061			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180181	Green Published, Green Submitted, gold			2022-12-26	WOS:000444222400026
J	Gu, W; Christian, JK; Woodson, CB				Gu, Wen; Christian, Jason K.; Woodson, C. Brock			A novel coupled fluid-behavior model for simulating dynamic huddle formation	PLOS ONE			English	Article							SMOOTHED PARTICLE HYDRODYNAMICS; FINITE-VOLUME METHOD; EMPEROR PENGUINS; INCOMPRESSIBLE FLOWS; AGGREGATION	A coupled numerical model is developed to examine aggregative behavior in instances where the behavior not only responds to the environment, but the environment responds to the behavior such as fish schooling and penguin huddling. In the coupled model, the full Navier-Stokes equations are solved for the wind field using a finite difference method (FDM), and coupled to a smoothed particle hydrodynamics (SPH) model adapted to simulate animal behavior (penguins are individual particles in the SPH). We use the model to examine the dynamics of penguin huddling as a purely individual fitness maximizing behavior. SPH is a mesh-free Lagrangian method driven by local interactions between neighboring fluid particles and their environment allowing particles to act as free ranging 'animals' unconstrained by a computational grid that implicitly interact with one another (a critical element of aggregative behavior). The coupled model is recomputed simultaneously as the huddle evolves over time to update individual particle positions, redefine the properties of the developing huddle (i.e., shape and density), and adjust the wind field flowing through and around the dynamic huddle. This study shows the ability of a coupled model to predict the dynamic properties of penguin huddling, to quantify biometrics of individual particle "penguins", and to confirm communal penguin huddling behavior as an individualistic behavior.	[Gu, Wen; Christian, Jason K.; Woodson, C. Brock] Univ Georgia, Coll Engn, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Woodson, CB (corresponding author), Univ Georgia, Coll Engn, Athens, GA 30602 USA.	bwoodson@uga.edu		Woodson, C. Brock/0000-0003-1325-3667				Ancel A, 2015, ANIM BEHAV, V110, P91, DOI 10.1016/j.anbehav.2015.09.019; Bluestein M, 2002, ENCY ATMOSPHERIC SCI; Canals M, 2011, COMPLEXITY, V17, P35, DOI 10.1002/cplx.20370; Chen FZ, 2015, COMPUT CHEM ENG, V77, P135, DOI 10.1016/j.compchemeng.2015.04.002; Duarte M, 2014, ALIFE 2014: THE FOURTEENTH INTERNATIONAL CONFERENCE ON THE SYNTHESIS AND SIMULATION OF LIVING SYSTEMS, P785, DOI 10.7551/978-0-262-32621-6-ch127; Ellero M, 2007, J COMPUT PHYS, V226, P1731, DOI 10.1016/j.jcp.2007.06.019; Gerum RC, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/12/125022; Gilbert C, 2008, J EXP BIOL, V211, P1, DOI 10.1242/jeb.005785; Gilbert C, 2008, POLAR BIOL, V31, P163, DOI 10.1007/s00300-007-0343-6; Gilbert C, 2006, PHYSIOL BEHAV, V88, P479, DOI 10.1016/j.physbeh.2006.04.024; Gilbert C, 2010, BIOL REV, V85, P545, DOI 10.1111/j.1469-185X.2009.00115.x; GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375, DOI 10.1093/mnras/181.3.375; Glancy J, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160553; Griffin TM, 2000, NATURE, V408, P929, DOI 10.1038/35050167; Ianniello S, 2010, J COMPUT PHYS, V229, P1353, DOI 10.1016/j.jcp.2009.10.034; Inada Y, 2002, J THEOR BIOL, V214, P371, DOI 10.1006/jtbi.2001.2449; KRAUSE J, 1994, ANIM BEHAV, V48, P353, DOI 10.1006/anbe.1994.1248; LUCY LB, 1977, ASTRON J, V82, P1013, DOI 10.1086/112164; LunaJorquera G, 1997, POLAR BIOL, V17, P69, DOI 10.1007/s003000050106; Marrone S, 2016, J COMPUT PHYS, V310, P161, DOI 10.1016/j.jcp.2015.11.059; Morrell LJ, 2008, BEHAV ECOL, V19, P193, DOI 10.1093/beheco/arm122; MORTON TL, 1994, J THEOR BIOL, V167, P73, DOI 10.1006/jtbi.1994.1051; Napoli E, 2016, COMPUT METHOD APPL M, V310, P674, DOI 10.1016/j.cma.2016.07.034; Seibold B., 2008, COMPACT FAST MATLAB; Waters A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050277; Wilson SP, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005378	27	0	0	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203231	10.1371/journal.pone.0203231	http://dx.doi.org/10.1371/journal.pone.0203231			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169532	Green Published, gold, Green Submitted			2022-12-26	WOS:000443374400027
J	Hou, JH; Li, JJ; Huang, JJ; Lu, CH; Zhou, J; Liu, Y; Wu, SL; Wei, F; Wang, LH; Chen, HY; Yu, HB; Wang, Z; Jiang, AL				Hou, Jinhong; Li, Junjuan; Huang, Jinjie; Lu, Chunhong; Zhou, Jing; Liu, Yang; Wu, Shouling; Wei, Fang; Wang, Lihua; Chen, Haiyan; Yu, Haibo; Wang, Zhe; Jiang, Aili			Relationship between the exposure to cumulative cardiovascular health behaviors and factors and chronic kidney disease-The Kailuan study	PLOS ONE			English	Article							BLOOD-PRESSURE; HYPERTENSION; RISK; ASSOCIATION; PATHOPHYSIOLOGY; METAANALYSIS; PREVALENCE; MANAGEMENT; MORTALITY	It is unclear whether ideal cardiovascular health (CVH) behaviors and factors, particularly cumulative exposure to ideal CVH (cumCVH), is associated with chronic kidney disease (CKD). The aim of the study was to examine the effect of cumCVH on CKD using the data from the Kailuan study. The study included the 27,970 (21,199 males) of the Kailuan community (China). The participants were 19 to 98 years of age. They were followed in 2008-2009, 2010-2011, and 2012-2013 by the same medical staff that did the initial physical examinations in 2006-2007. Participants were censored on the visit reporting CKD. A CVH score was created based on the seven AHA health metrics. The cumCVH score was CVH(1)xtime(v1-v2)+CVH(2)xtime(v2-v3)+CVH(3)xtime(v3-v4). In the fully adjusted model, compared with the lowest quintile of cumCVH, individuals in the highest quintile had a 75% lower risk of CKD (95% confidence interval (CI): 66-82%). Every additional year lived with a 1-unit increase in ideal CVH was associated with an 11% (95% CI: 9-13%) reduction in the incidence of CKD. Furthermore, when we excluded each of the six metrics from the cumCVH score in turn, the association was unaffected after the exclusion of individual risk factors. Ideal CVH is associated with a reduced incidence of CKD. Measurements of cumCVH are more likely to reflect the lifetime risk of CKD and possibly of other health outcomes.	[Hou, Jinhong; Wei, Fang; Wang, Lihua; Chen, Haiyan; Yu, Haibo; Wang, Zhe; Jiang, Aili] Tianjin Med Univ, Hosp 2, Kidney Dis & Blood Purificat Dept, Tianjin, Peoples R China; [Hou, Jinhong; Li, Junjuan; Huang, Jinjie; Lu, Chunhong; Zhou, Jing; Liu, Yang] Kailuan Gen Hosp, Dept Nephrol, Tangshan, Peoples R China; [Wu, Shouling] Kailuan Gen Hosp, Dept Cardiol, Tangshan, Peoples R China	Tianjin Medical University	Jiang, AL (corresponding author), Tianjin Med Univ, Hosp 2, Kidney Dis & Blood Purificat Dept, Tianjin, Peoples R China.; Wu, SL (corresponding author), Kailuan Gen Hosp, Dept Cardiol, Tangshan, Peoples R China.	drwusl@163.com; carlos_j@126.com	Chen, Haiyan/HGB-6216-2022		National Key Research and Development Program [2016YFC1305401]	National Key Research and Development Program	This study was funded by the National Key Research and Development Program (2016YFC1305401).	Agarwal R, 2005, CARDIOL CLIN, V23, P237, DOI 10.1016/j.ccl.2005.03.003; Campese VM, 2014, SEMIN NEPHROL, V34, P571, DOI 10.1016/j.semnephrol.2014.08.011; Dorresteijn JAN, 2012, HYPERTENSION, V59, P14, DOI 10.1161/HYPERTENSIONAHA.111.179143; Halperin RO, 2006, HYPERTENSION, V47, P45, DOI 10.1161/01.HYP.0000196306.42418.0e; Hamrahian SM, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0739-9; Han QL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012486; Huai PC, 2013, HYPERTENSION, V62, P1021, DOI 10.1161/HYPERTENSIONAHA.113.01965; Huang QF, 2016, CURR HYPERTENS REV, V12, P181, DOI 10.2174/1573402113666161122114854; Huffman MD, 2012, CIRCULATION, V125, P2595, DOI 10.1161/CIRCULATIONAHA.111.070722; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Johansen MY, 2017, JAMA-J AM MED ASSOC, V318, P637, DOI 10.1001/jama.2017.10169; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liu F, 2016, CARDIOL PLUS, V1, P33; Liu XX, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004132; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Michishita R, 2017, CLIN EXP HYPERTENS, V39, P645, DOI 10.1080/10641963.2017.1306541; Navar-Boggan AM, 2015, CIRCULATION, V131, P451, DOI 10.1161/CIRCULATIONAHA.114.012477; Qi CC, 2013, CHIN J HYPERTENSION, V21, P765; Sullivan CA, 2015, HYPERTENSION, V66, P134, DOI 10.1161/HYPERTENSIONAHA.114.04990; Townsend RR, 2015, NAT REV NEPHROL, V11, P555, DOI 10.1038/nrneph.2015.114; Yamamoto-Kabasawa K, 2015, CLIN EXP NEPHROL, V19, P1079, DOI 10.1007/s10157-015-1103-5; Yan N, 2016, J STROKE CEREBROVASC, V25, P41, DOI 10.1016/j.jstrokecerebrovasdis.2015.08.031; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang XM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19673; Yu JX, 2017, J STROKE CEREBROVASC, V26, P2501, DOI 10.1016/j.jstrokecerebrovasdis.2017.05.037; Zemaitis P, 2014, CLIN J AM SOC NEPHRO, V9, P1922, DOI 10.2215/CJN.02450314; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhao HY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005415; Zheng XM, 2017, ATHEROSCLEROSIS, V260, P56, DOI 10.1016/j.atherosclerosis.2017.03.018	29	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203171	10.1371/journal.pone.0203171	http://dx.doi.org/10.1371/journal.pone.0203171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169509	Green Published, gold, Green Submitted			2022-12-26	WOS:000443374400024
J	Penzias, G; Singanamalli, A; Elliott, R; Gollamudi, J; Shih, N; Feldman, M; Stricker, PD; Delprado, W; Tiwari, S; Bohm, M; Haynes, AM; Ponsky, L; Fu, PF; Tiwari, P; Viswanath, S; Madabhushi, A				Penzias, Gregory; Singanamalli, Asha; Elliott, Robin; Gollamudi, Jay; Shih, Natalie; Feldman, Michael; Stricker, Phillip D.; Delprado, Warick; Tiwari, Sarita; Bohm, Maret; Haynes, Anne-Maree; Ponsky, Lee; Fu, Pingfu; Tiwari, Pallavi; Viswanath, Satish; Madabhushi, Anant			Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findings	PLOS ONE			English	Article							WHOLE HISTOLOGICAL SECTIONS; TEXTURE ANALYSIS; TISSUE COMPOSITION; CENTRAL GLAND; IMAGES; ADENOCARCINOMA; HISTOPATHOLOGY; CLASSIFICATION; SEGMENTATION; MODELS	Translation of radiomics into the clinic may require a more comprehensive understanding of the underlying morphologic tissue characteristics they reflect. In the context of prostate cancer (PCa), some studies have correlated gross histological measurements of gland lumen, epithelium, and nuclei with disease appearance on MRI. Quantitative histomorphometry (QH), like radiomics for radiologic images, is the computer based extraction of features for describing tumor morphology on digitized tissue images. In this work, we attempt to establish the histomorphometric basis for radiomic features for prostate cancer by (1) identifying the radiomic features from T2w MRI most discriminating of low vs. intermediate/high Gleason score, (2) identifying QH features correlated with the most discriminating radiomic features previously identified, and (3) evaluating the discriminative ability of QH features found to be correlated with spatially co-localized radiomic features. On a cohort of 36 patients (23 for training, 13 for validation), Gabor texture features were identified as being most predictive of Gleason grade on MRI (AUC of 0.69) and gland lumen shape features were identified as the most predictive QH features (AUC = 0.75). Our results suggest that the PCa grade discriminability of Gabor features is a consequence of variations in gland shape and morphology at the tissue level.	[Penzias, Gregory; Singanamalli, Asha; Tiwari, Pallavi; Viswanath, Satish; Madabhushi, Anant] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Elliott, Robin; Gollamudi, Jay; Ponsky, Lee] Univ Hosp, Cleveland, OH USA; [Shih, Natalie; Feldman, Michael] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Stricker, Phillip D.] St Vincents Prostate Canc Clin, Darlinghurst, NSW, Australia; [Delprado, Warick] Douglass Hanly Moir Pathol, Macquarie Pk, NSW, Australia; [Tiwari, Sarita; Bohm, Maret; Haynes, Anne-Maree] Kinghorn Canc Ctr, Garvan Inst Med Res, Darlinghurst, NSW, Australia; [Fu, Pingfu] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland; University of Pennsylvania; Garvan Institute of Medical Research; Case Western Reserve University	Penzias, G; Madabhushi, A (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	gregory.penzias@case.edu; anant.madabhushi@case.edu	Madabhushi, Anant/AAG-2908-2019; Fu, Pingfu/O-5415-2019	Madabhushi, Anant/0000-0002-5741-0399; Fu, Pingfu/0000-0002-2334-5218; Viswanath, Satish/0000-0003-4550-8337; Stricker, Phillip/0000-0002-0934-0656	National Cancer Institute of the National Institutes of Health [1U24CA199374-01, R01CA202752-01A1, R01CA208236-01M, R01 CA216579-01A1, R01 CA220581-01A1, R21CA179327-01]; National Institute of Diabetes and Digestive and Kidney Diseases [R21CM 95152-01, R01DK098503-02]; National Center for Research Resources [1 C06 RR12463-01]; DOD Prostate Cancer Synergistic Idea Development Award [PC120857]; DOD Lung Cancer Idea Development New Investigator Award [LC130463]; DOD Prostate Cancer Idea Development Award; DOD career development award [W81XWH-16-1-0329]; Ohio Third Frontier Technology Validation Fund; Case Comprehensive Cancer Center Pilot Grant VelaSano Grant from the Cleveland Clinic the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering; Clinical and Translational Science Award Program (CTSA) at Case Western Reserve University; NIH [RO1]; NATIONAL CANCER INSTITUTE [R01CA202752, R01CA208236, U24CA199374, R01CA216579, R21CA195152, R01CA220581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098503] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOD Prostate Cancer Synergistic Idea Development Award; DOD Lung Cancer Idea Development New Investigator Award; DOD Prostate Cancer Idea Development Award; DOD career development award; Ohio Third Frontier Technology Validation Fund; Case Comprehensive Cancer Center Pilot Grant VelaSano Grant from the Cleveland Clinic the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering; Clinical and Translational Science Award Program (CTSA) at Case Western Reserve University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers 1U24CA199374-01, R01CA202752-01A1, R01CA208236-01M, R01 CA216579-01A1, R01 CA220581-01A1, R21CA179327-01; R21CM 95152-01 the National Institute of Diabetes and Digestive and Kidney Diseases under award number R01DK098503-02, National Center for Research Resources under award number 1 C06 RR12463-01 the DOD Prostate Cancer Synergistic Idea Development Award (PC120857); the DOD Lung Cancer Idea Development New Investigator Award (LC130463), the DOD Prostate Cancer Idea Development Award; the DOD career development award W81XWH-16-1-0329; the Ohio Third Frontier Technology Validation Fund, the Case Comprehensive Cancer Center Pilot Grant VelaSano Grant from the Cleveland Clinic the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering and the Clinical and Translational Science Award Program (CTSA) at Case Western Reserve University. Case Urology Translational Research Training Program (CUTRTP), the I-Corps Ohio Program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health nor the Department of Defense. Author Anant Madabhushi is a co-founder and stake holder in Ibris Inc., a cancer diagnostics company. Additionally he is also an equity holder in Elucid Bioimaging and in Inspirata. He is also a scientific advisory consultant for Inspirata, and holds a joint NIH RO1 grant with them. Author Satish Viswanath is a scientific advisory board member and equity holder in Virbio, Inc. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2016, JAMA ONCOL, V2, P1636, DOI 10.1001/jamaoncol.2016.2631; Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; Ali S, 2015, COMPUT MED IMAG GRAP, V41, P3, DOI 10.1016/j.compmedimag.2014.11.001; Ali Sahirzeeshan, 2013, Med Image Comput Comput Assist Interv, V16, P412; Allsbrook WC, 2001, HUM PATHOL, V32, P81, DOI 10.1053/hupa.2001.21135; Antunes J, 2016, TRANSL ONCOL, V9, P155, DOI 10.1016/j.tranon.2016.01.008; Basavanhally AN, 2010, IEEE T BIO-MED ENG, V57, P642, DOI 10.1109/TBME.2009.2035305; Bhargava R, 2016, ANNU REV BIOMED ENG, V18, P387, DOI 10.1146/annurev-bioeng-112415-114722; Bhatnagar G, 2016, ABDOM RADIOL, V41, P1261, DOI 10.1007/s00261-016-0657-3; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; BOVIK AC, 1990, IEEE T PATTERN ANAL, V12, P55, DOI 10.1109/34.41384; Bunyak F, 2015, IEEE INT C BIOINFORM, P450, DOI 10.1109/BIBM.2015.7359726; Bunyak F, 2011, ADV EXP MED BIOL, V696, P413, DOI 10.1007/978-1-4419-7046-6_41; Chappelow J, 2011, COMPUT MED IMAG GRAP, V35, P557, DOI 10.1016/j.compmedimag.2011.01.010; Chatterjee A, 2015, RADIOLOGY, V277, P751, DOI 10.1148/radiol.2015142414; Coroller TP, 2015, RADIOTHER ONCOL, V114, P345, DOI 10.1016/j.radonc.2015.02.015; Depeursinge A, 2015, MED PHYS, V42, P2054, DOI 10.1118/1.4916088; Doyle S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-282; Doyle S, 2008, I S BIOMED IMAGING, P496, DOI 10.1109/ISBI.2008.4541041; Epstein JI, 2010, J UROLOGY, V183, P433, DOI 10.1016/j.juro.2009.10.046; Fehr D, 2015, P NATL ACAD SCI USA, V112, pE6265, DOI 10.1073/pnas.1505935112; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Ganeshan B, 2013, RADIOLOGY, V266, P326, DOI 10.1148/radiol.12112428; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Ginsburg SB, 2015, J MAGN RESON IMAGING, V41, P1383, DOI 10.1002/jmri.24676; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Gnep K, 2017, J MAGN RESON IMAGING, V45, P103, DOI 10.1002/jmri.25335; Gunduz-Demir C, 2010, MED IMAGE ANAL, V14, P1, DOI 10.1016/j.media.2009.09.001; Hafiane A, 2008, LECT NOTES COMPUT SC, V5259, P903, DOI 10.1007/978-3-540-88458-3_82; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Huang YQ, 2016, J CLIN ONCOL, V34, P2157, DOI 10.1200/JCO.2015.65.9128; Janowczyk Andrew, 2016, J Pathol Inform, V7, P29, DOI 10.4103/2153-3539.186902; Khalvati F, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0069-9; Kickingereder P, 2016, RADIOLOGY, V280, P880, DOI 10.1148/radiol.2016160845; Kien Nguyen, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P1497, DOI 10.1109/ICPR.2010.370; Kobus T, 2016, RADIOLOGY, V278, P801, DOI 10.1148/radiol.2015142889; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Langer DL, 2010, RADIOLOGY, V255, P485, DOI 10.1148/radiol.10091343; Laws KI., 1980, TEXTURED IMAGE SEGME, V940, P188; Lee G, 2015, IEEE T MED IMAGING, V34, P284, DOI 10.1109/TMI.2014.2355175; Lee G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097954; Leo P, 2016, J MED IMAGING, V3, DOI 10.1117/1.JMI.3.4.047502; Li H, 2016, RADIOLOGY, V281, P382, DOI 10.1148/radiol.2016152110; Liang CS, 2016, ONCOTARGET, V7, P31401, DOI 10.18632/oncotarget.8919; Litjens GJS, 2016, RADIOLOGY, V278, P135, DOI 10.1148/radiol.2015142856; Madabhushi A, 2010, CLIN CHEM LAB MED, V48, P989, DOI 10.1515/CCLM.2010.193; Mattonen SA, 2014, MED PHYS, V41, DOI 10.1118/1.4866219; Miles KA, 2014, J NUCL MED, V55, P386, DOI 10.2967/jnumed.113.120485; Monaco JP, 2010, MED IMAGE ANAL, V14, P617, DOI 10.1016/j.media.2010.04.007; Naik S, 2008, I S BIOMED IMAGING, P284, DOI 10.1109/ISBI.2008.4540988; Nyul LG, 2000, IEEE T MED IMAGING, V19, P143, DOI 10.1109/42.836373; Pallavi T, 2014, INT SOC OPTICAL ENG, V9035; Parmar C, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00272; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13087; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11044; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Penzias G, 2016, SCI REP-UK, V6, DOI 10.1038/srep29906; Prasath VS, 2012, 1 IEEE HEALTHC TECHN, P40; Rahbar H, 2016, ACAD RADIOL, V23, P768, DOI 10.1016/j.acra.2016.02.008; Singanamalli A, 2016, J MAGN RESON IMAGING, V43, P149, DOI 10.1002/jmri.24975; Sirinukunwattana K, 2015, IEEE T MED IMAGING, V34, P2366, DOI 10.1109/TMI.2015.2433900; Sparks R, 2013, COMPUT VIS IMAGE UND, V117, P1138, DOI 10.1016/j.cviu.2012.11.011; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tiwari P, 2013, MED IMAGE ANAL, V17, P219, DOI 10.1016/j.media.2012.10.004; Toth Robert J, 2014, J Pathol Inform, V5, P8, DOI 10.4103/2153-3539.129441; Veta M, 2014, IEEE T BIO-MED ENG, V61, P1400, DOI 10.1109/TBME.2014.2303852; Vignati A, 2015, PHYS MED BIOL, V60, P2685, DOI 10.1088/0031-9155/60/7/2685; Viswanath SE, 2012, J MAGN RESON IMAGING, V36, P213, DOI 10.1002/jmri.23618; Wang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143308; Wibmer A, 2015, EUR RADIOL, V25, P2840, DOI 10.1007/s00330-015-3701-8; Wu WM, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00071	73	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0200730	10.1371/journal.pone.0200730	http://dx.doi.org/10.1371/journal.pone.0200730			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169514	Green Published, gold, Green Submitted			2022-12-26	WOS:000443374400004
J	Bernfeld, E; Menon, D; Vaghela, V; Zerin, I; Faruque, P; Frias, MA; Foster, DA				Bernfeld, Elyssa; Menon, Deepak; Vaghela, Vishaldeep; Zerin, Ismat; Faruque, Promie; Frias, Maria A.; Foster, David A.			Phospholipase D-dependent mTOR complex 1 (mTORC1) activation by glutamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mTOR complex (mTORC); phospholipase D; phosphatidic acid; glutamine; Rag GTPase; RHEB (Ras homolog expressed in brain); -ketoglutarate; Arf1; RalA	CANCER-CELLS; SURVIVAL; ARF; GROWTH; RAPTOR; RALA; RHEB; RAS	Glutamine is a key nutrient required for sustaining cell proliferation, contributing to nucleotide, protein, and lipid synthesis. The mTOR complex 1 (mTORC1) is a highly conserved protein complex that acts as a sensor of nutrients, relaying signals for the shift from catabolic to anabolic metabolism. Although glutamine plays an important role in mTORC1 activation, the mechanism is not clear. Here we describe a leucine- and Rag-independent mechanism of mTORC1 activation by glutamine that depends on phospholipase D and the production of phosphatidic acid, which is required for the stability and activity of mTORC1. The phospholipase D-dependent activation of mTORC1 by glutamine depended on the GTPases ADP ribosylation factor 1 (Arf1), RalA, and Rheb. Glutamine deprivation could be rescued by -ketoglutarate, a downstream metabolite of glutamine. This mechanism represents a distinct nutrient input to mTORC1 that is independent of Rag GTPases and leucine.	[Bernfeld, Elyssa; Menon, Deepak; Vaghela, Vishaldeep; Faruque, Promie; Frias, Maria A.; Foster, David A.] CUNY Hunter Coll, Dept Biol Sci, 413 E 69th St, New York, NY 10065 USA; [Zerin, Ismat] CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA; [Bernfeld, Elyssa; Menon, Deepak; Foster, David A.] CUNY, Grad Ctr, Biochem Program, New York, NY 10016 USA; [Vaghela, Vishaldeep; Foster, David A.] CUNY, Grad Ctr, Biol Program, New York, NY 10016 USA; [Foster, David A.] Weill Cornell Med, Dept Pharmacol, New York, NY 10021 USA; [Bernfeld, Elyssa] Pfizer Worldwide Res & Dev, Oncol R&D Grp, 401 N Middletown Rd, Pearl River, NY 10965 USA; [Menon, Deepak] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Cornell University; Pfizer; University System of Maryland; University of Maryland Baltimore	Foster, DA (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 413 E 69th St, New York, NY 10065 USA.	foster@genectr.hunter.cuny.edu	Menon, Deepak/S-7899-2019	Menon, Deepak/0000-0002-6529-7859; Lehman, Elyssa/0000-0002-9869-1588; Frias, Maria A/0000-0001-7753-6290	National Institutes of Health [R01-CA046677, R01-CA179542]; Research Centers in Minority Institutions from the National Center for Research Resources of the National Institutes of Health [RP-03037]; NATIONAL CANCER INSTITUTE [R01CA179542, R01CA046677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Centers in Minority Institutions from the National Center for Research Resources of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health Grants R01-CA046677 and R01-CA179542 (to D. A. F.) and a pilot project award from the Research Centers in Minority Institutions (RP-03037) from the National Center for Research Resources of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Byun JK, 2017, CELL REP, V20, P586, DOI 10.1016/j.celrep.2017.06.066; Duran RV, 2013, ONCOGENE, V32, P4549, DOI 10.1038/onc.2012.465; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Frohman MA, 2015, TRENDS PHARMACOL SCI, V36, P137, DOI 10.1016/j.tips.2015.01.001; Gentry LR, 2014, BBA-MOL CELL RES, V1843, P2976, DOI 10.1016/j.bbamcr.2014.09.004; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hamanaka RB, 2012, J EXP MED, V209, P211, DOI 10.1084/jem.20120162; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Houghton PJ, 2010, CLIN CANCER RES, V16, P1368, DOI 10.1158/1078-0432.CCR-09-1314; Jackson CL, 2014, J CELL SCI, V127, P4103, DOI 10.1242/jcs.144899; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Kim JH, 1998, FEBS LETT, V430, P231, DOI 10.1016/S0014-5793(98)00661-9; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Luo JQ, 1997, BIOCHEM BIOPH RES CO, V235, P854, DOI 10.1006/bbrc.1997.6793; Luo JQ, 1998, P NATL ACAD SCI USA, V95, P3632, DOI 10.1073/pnas.95.7.3632; Ma WN, 2010, EXP MOL MED, V42, P456, DOI 10.3858/emm.2010.42.6.047; Menon D, 2017, J BIOL CHEM, V292, P6303, DOI 10.1074/jbc.M116.772988; Mukhopadhyay Suman, 2015, Oncoscience, V2, P807; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Patel D, 2016, J BIOL CHEM, V291, P9322, DOI 10.1074/jbc.M115.710145; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Saqcena M, 2015, ONCOGENE, V34, P2672, DOI 10.1038/onc.2014.207; Shi M, 2007, CANCER LETT, V258, P268, DOI 10.1016/j.canlet.2007.09.003; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105; Toda K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081632; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Utter M, 2018, CANCER LETT, V423, P28, DOI 10.1016/j.canlet.2018.03.006; Voss M, 1999, J BIOL CHEM, V274, P34691, DOI 10.1074/jbc.274.49.34691; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631; Yoon MS, 2015, MOL CELL, V58, P549, DOI 10.1016/j.molcel.2015.03.028; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	40	23	23	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16390	16401		10.1074/jbc.RA118.004972	http://dx.doi.org/10.1074/jbc.RA118.004972			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30194281	hybrid, Green Published			2022-12-26	WOS:000447833600022
J	Harnos, J; Rynes, J; Viskova, P; Foldynova-Trantirkova, S; Bajard-Esner, L; Trantirek, L; Bryja, V				Harnos, Jakub; Rynes, Jan; Viskova, Pavlina; Foldynova-Trantirkova, Silvie; Bajard-Esner, Lola; Trantirek, Lukas; Bryja, Vitezslav			Analysis of binding interfaces of the human scaffold protein AXIN1 by peptide microarrays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peptide array; scaffold protein; axin; serine; threonine protein kinase; p53; Myc (c-Myc); casein kinase 1E; dishevelled; intrinsically disordered region; Wnt pathway	CASEIN KINASE-I; BETA-CATENIN; STRUCTURAL BASIS; TRANSCRIPTIONAL REGULATION; CRYSTAL-STRUCTURE; COMPLEX; WNT; ACTIVATION; PHOSPHORYLATION; DEGRADATION	Intrinsically disordered regions (IDRs) are protein regions that lack persistent secondary or tertiary structure under native conditions. IDRs represent >40% of the eukaryotic proteome and play a crucial role in protein-protein interactions. The classical approach for identification of these interaction interfaces is based on mutagenesis combined with biochemical techniques such as coimmunoprecipitation or yeast two-hybrid screening. This approach either provides information of low resolution (large deletions) or very laboriously tries to precisely define the binding epitope via single amino acid substitutions. Here, we report the use of a peptide microarray based on the human scaffold protein AXIN1 for high-throughput and -resolution mapping of binding sites for several AXIN1 interaction partners in vitro. For each of the AXIN1-binding partners tested, i.e. casein kinase 1 E (CK1E); c-Myc; peptidyl-prolyl cis/trans isomerase, NIMA-interacting 1 (Pin1); and p53, we found at least three different epitopes, predominantly in the central IDR of AXIN1. We functionally validated the specific AXIN1-CK1E interaction identified here with epitope-mimicking peptides and with AXIN1 variants having deletions of short binding epitopes. On the basis of these results, we propose a model in which AXIN1 competes with dishevelled (DVL) for CK1E and regulates CK1E-induced phosphorylation of DVL and activation of Wnt/-catenin signaling.	[Harnos, Jakub; Bryja, Vitezslav] Masaryk Univ, Fac Sci, Inst Expt Biol, Kamenice 5, Brno 62500, Czech Republic; [Rynes, Jan; Viskova, Pavlina; Foldynova-Trantirkova, Silvie; Bajard-Esner, Lola; Trantirek, Lukas] Masaryk Univ, Cent European Inst Technol, Kamenice 753-5, Brno 62500, Czech Republic; [Bajard-Esner, Lola] Masaryk Univ, Fac Sci, Chem Sect, Res Ctr Tox Cpds Environm RECETOX, Kamenice 5, Brno 62500, Czech Republic; [Rynes, Jan; Foldynova-Trantirkova, Silvie; Bryja, Vitezslav] Acad Sci Czech Republ, Inst Biophys, Vvi, Kralovopolska 135, CS-61265 Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Bryja, V (corresponding author), Masaryk Univ, Fac Sci, Inst Expt Biol, Kamenice 5, Brno 62500, Czech Republic.	bryja@sci.muni.cz	Bryja, Vítězslav/P-4217-2019; Trantirek, Lukas/F-9923-2014; Harnos, Jakub/AAE-7855-2021	Bryja, Vítězslav/0000-0002-9136-5085; Rynes, Jan/0000-0003-2091-390X; Harnos, Jakub/0000-0002-0752-9260; bajard, Lola/0000-0001-9002-7095; Foldynova-Trantirkova, Silvie/0000-0001-8863-083X	Czech Science Foundation [18-17658S, 17-12075S, 15-34405A, 15-22380Y]; Grant Agency of Masaryk University [MUNI/G/1100/2016, MUNI/A/1145/2017]; "Netherlands Organization for Scientific Research" VIDI [700.59.426]; European Regional Development Fund [CZ.02.1.01/0.0/0.0/15_003/0000477]; Neuron-Fund for the Support of Science; Ministry of Education, Youth, and Sports (MEYS) of the Czech Republic [LQ1601]; MEYS CR; National Programme for Sustainability II	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Masaryk University; "Netherlands Organization for Scientific Research" VIDI(Netherlands Organization for Scientific Research (NWO)); European Regional Development Fund(European Commission); Neuron-Fund for the Support of Science; Ministry of Education, Youth, and Sports (MEYS) of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); MEYS CR; National Programme for Sustainability II	This work was supported by the Czech Science Foundation (Projects 18-17658S, 17-12075S, 15-34405A, and 15-22380Y), Grant Agency of Masaryk University (Grants MUNI/G/1100/2016 and MUNI/A/1145/2017), "Netherlands Organization for Scientific Research" VIDI (Project 700.59.426), European Regional Development Fund (Grant CZ.02.1.01/0.0/0.0/15_003/0000477), and Neuron-Fund for the Support of Science (to V. B.). This work was also supported by the Ministry of Education, Youth, and Sports (MEYS) of the Czech Republic (Grant LQ1601) with financial contribution from the MEYS CR and National Programme for Sustainability II. The authors declare that they have no conflicts of interest with the contents of this article.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Arnold HK, 2009, EMBO J, V28, P500, DOI 10.1038/emboj.2008.279; Bernatik O, 2014, J BIOL CHEM, V289, P23520, DOI 10.1074/jbc.M114.590638; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bryja V, 2004, CELL MOL LIFE SCI, V61, P1384, DOI 10.1007/s00018-004-4081-4; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; de Groot REA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004985; Dunker A Keith, 2013, Intrinsically Disord Proteins, V1, pe24157, DOI 10.4161/idp.24157; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Espejo A, 2002, BIOCHEM J, V367, P697, DOI 10.1042/BJ20020860; Fiedler M, 2011, P NATL ACAD SCI USA, V108, P1937, DOI 10.1073/pnas.1017063108; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Kishida M, 2001, J BIOL CHEM, V276, P33147, DOI 10.1074/jbc.M103555200; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Noutsou M, 2011, J MOL BIOL, V405, P773, DOI 10.1016/j.jmb.2010.11.013; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Reinhardt J, 2007, PROTEIN EXPRES PURIF, V54, P101, DOI 10.1016/j.pep.2007.02.020; Rubinfeld B, 2001, J BIOL CHEM, V276, P39037, DOI 10.1074/jbc.M105148200; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zhang Y, 2002, J BIOL CHEM, V277, P17706, DOI 10.1074/jbc.M111982200	33	7	7	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16337	16347		10.1074/jbc.RA118.005127	http://dx.doi.org/10.1074/jbc.RA118.005127			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30166345	hybrid, Green Published			2022-12-26	WOS:000447833600018
J	Moloughney, JG; Vega-Cotto, NM; Liu, SR; Patel, C; Kim, PK; Wu, CC; Albaciete, D; Magaway, C; Chang, A; Rajput, S; Su, XY; Werlen, G; Jacinto, E				Moloughney, Joseph G.; Vega-Cotto, Nicole M.; Liu, Sharon; Patel, Chadni; Kim, Peter K.; Wu, Chang-chih; Albaciete, Danielle; Magaway, Cedric; Chang, Austin; Rajput, Swati; Su, Xiaoyang; Werlen, Guy; Jacinto, Estela			mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mTOR complex (mTORC); glutamine; cell metabolism; protein phosphorylation; Akt PKB; glutaminolysis; hexosamine biosynthesis; metabolism; mTOR; nutrients; hexosamine biosynthetic pathway	HUMAN GLUTAMINE-FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE; PROTEIN-KINASE-C; BIOSYNTHETIC-PATHWAY; MOTIF PHOSPHORYLATION; GLUCOSE-METABOLISM; HIGH EXPRESSION; CANCER-CELLS; COMPLEX; GLUTAMINE; AKT	The mechanistic target of rapamycin (mTOR) controls metabolic pathways in response to nutrients. Recently, we have shown that mTOR complex 2 (mTORC2) modulates the hexosamine biosynthetic pathway (HBP) by promoting the expression of the key enzyme of the HBP, glutamine:fructose-6-phosphate aminotransferase 1 (GFAT1). Here, we found that GFAT1 Ser-243 phosphorylation is also modulated in an mTORC2-dependent manner. In response to glutamine limitation, active mTORC2 prolongs the duration of Ser-243 phosphorylation, albeit at lower amplitude. Blocking glycolysis using 2-deoxyglucose robustly enhances Ser-243 phosphorylation, correlating with heightened mTORC2 activation, increased AMPK activity, and O-GlcNAcylation. However, when 2-deoxyglucose is combined with glutamine deprivation, GFAT1 Ser-243 phosphorylation and mTORC2 activation remain elevated, whereas AMPK activation and O-GlcNAcylation diminish. Phosphorylation at Ser-243 promotes GFAT1 expression and production of GFAT1-generated metabolites including ample production of the HBP end-product, UDP-GlcNAc, despite nutrient starvation. Hence, we propose that the mTORC2-mediated increase in GFAT1 Ser-243 phosphorylation promotes flux through the HBP to maintain production of UDP-GlcNAc when nutrients are limiting. Our findings provide insights on how the HBP is reprogrammed via mTORC2 in nutrient-addicted cancer cells.	[Moloughney, Joseph G.; Vega-Cotto, Nicole M.; Liu, Sharon; Patel, Chadni; Kim, Peter K.; Wu, Chang-chih; Albaciete, Danielle; Magaway, Cedric; Chang, Austin; Rajput, Swati; Werlen, Guy; Jacinto, Estela] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Su, Xiaoyang] Rutgers State Univ, Dept Med, Div Endocrinol, Child Hlth Inst New Jersey, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Jacinto, E (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.	jacintes@rwjms.rutgers.edu		Rajput, Swati/0000-0001-8794-4300; Patel, Chadni/0000-0003-2302-0453; Su, Xiaoyang/0000-0001-8081-1396	National Institutes of Health [GM079176, CA154674]; New Jersey Commission for Cancer Research Grant; Research Supplement to promote diversity in health-related research [CA154674-04S1]; NCI, National Institutes of Health [P30 CA072720]; NATIONAL CANCER INSTITUTE [R01CA154674, P30CA072720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission for Cancer Research Grant; Research Supplement to promote diversity in health-related research; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM079176 and CA154674 (to E. J.), a New Jersey Commission for Cancer Research Grant (to J. G. M.), and a Research Supplement to promote diversity in health-related research CA154674-04S1 (to N. M. V-C.). This work was also supported by Grant P30 CA072720 from the NCI, National Institutes of Health to The Rutgers Cancer Institute of New Jersey (to X. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Chang Q, 2000, J BIOL CHEM, V275, P21981, DOI 10.1074/jbc.M001049200; Chaveroux C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27278; Chen CY, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00338; Dai N, 2013, GENE DEV, V27, P301, DOI 10.1101/gad.209130.112; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Denzel MS, 2014, CELL, V156, P1167, DOI 10.1016/j.cell.2014.01.061; Duan FF, 2016, ONCOTARGET, V7, P38427, DOI 10.18632/oncotarget.9538; Durand P, 2008, ARCH BIOCHEM BIOPHYS, V474, P302, DOI 10.1016/j.abb.2008.01.026; Eguchi S, 2009, GENES CELLS, V14, P179, DOI 10.1111/j.1365-2443.2008.01260.x; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gelinas R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02795-4; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim SJ, 2012, MOL CELL, V48, P875, DOI 10.1016/j.molcel.2012.09.029; Leskoske KL, 2017, GENETICS, V207, P179, DOI 10.1534/genetics.117.1124; Li LL, 2017, ONCOTARGET, V8, P19205, DOI 10.18632/oncotarget.15164; Li X, 2014, EMBO REP, V15, P191, DOI 10.1002/embr.201338119; Li Y, 2007, BIOCHEMISTRY-US, V46, P13163, DOI 10.1021/bi700694c; Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460; Moloughney JG, 2016, MOL CELL, V63, P811, DOI 10.1016/j.molcel.2016.07.015; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pusapati RV, 2016, CANCER CELL, V29, P548, DOI 10.1016/j.ccell.2016.02.018; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Tobias IS, 2016, BIOCHEM J, V473, P509, DOI 10.1042/BJ20151013; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Vasconcelos-dos-Santos A, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.2; Vasseur S, 2015, SEMIN CANCER BIOL, V33, P34, DOI 10.1016/j.semcancer.2015.04.001; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Xie XJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002207; Yang CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep39044; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zibrova D, 2017, BIOCHEM J, V474, P983, DOI 10.1042/BCJ20160980	45	23	23	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16464	16478		10.1074/jbc.RA118.003991	http://dx.doi.org/10.1074/jbc.RA118.003991			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30201609	hybrid, Green Published			2022-12-26	WOS:000447833600028
J	Luong, B; Schwenk, R; Brautigam, J; Muller, R; Menche, D; Bischoff, I; Furst, R				Luong, Betty; Schwenk, Rebecca; Braeutigam, Jacqueline; Mueller, Rolf; Menche, Dirk; Bischoff, Iris; Fuerst, Robert			The vacuolar-type ATPase inhibitor archazolid increases tumor cell adhesion to endothelial cells by accumulating extracellular collagen	PLOS ONE			English	Article							BREAST-CANCER CELLS; V-ATPASE; CATHEPSIN-B; IN-VITRO; H+-ATPASES; INTEGRIN RECEPTORS; MATRIX PROTEINS; TUBE FORMATION; PROTON PUMPS; DEGRADATION	The vacuolar-type H+-ATPase (v-ATPase) is the major proton pump that acidifies intracellular compartments of eukaryotic cells. Since the inhibition of v-ATPase resulted in anti-tumor and anti-metastatic effects in different tumor models, this enzyme has emerged as promising strategy against cancer. Here, we used the well-established v-ATPase inhibitor archazolid, a natural product first isolated from the myxobacterium Archangium gephyra, to study the consequences of v-ATPase inhibition in endothelial cells (ECs), in particular on the interaction between ECs and cancer cells, which has been neglected so far. Human endothelial cells treated with archazolid showed an increased adhesion of tumor cells, whereas the transendothelial migration of tumor cells was reduced. The adhesion process was independent from the EC adhesion molecules ICAM-1, VCAM-1, E-selectin and N-cadherin. Instead, the adhesion was mediated by beta 1-integrins expressed on tumor cells, as blocking of the integrin beta 1 subunit reversed this process. Tumor cells preferentially adhered to the beta 1-integrin ligand collagen and archazolid led to an increase in the amount of collagen on the surface of ECs. The accumulation of collagen was accompanied by a strong decrease of the expression and activity of the protease cathepsin B. Overexpression of cathepsin B in ECs prevented the capability of archazolid to increase the adhesion of tumor cells onto ECs. Our study demonstrates that the inhibition of v-ATPase by archazolid induces a pro-adhesive phenotype in endothelial cells that promotes their interaction with cancer cells, whereas the transmigration of tumor cells was reduced. These findings further support archazolid as a promising anti-metastatic compound.	[Luong, Betty; Schwenk, Rebecca; Braeutigam, Jacqueline; Bischoff, Iris; Fuerst, Robert] Goethe Univ Frankfurt, Inst Pharmaceut Biol, Frankfurt, Germany; [Mueller, Rolf] Saarland Univ, Helmholtz Inst Pharmaceut Res Saarland, Dept Microbial Nat Prod, Saarbrucken, Germany; [Menche, Dirk] Univ Bonn, Kekule Inst Organ Chem & Biochem, Bonn, Germany	Goethe University Frankfurt; Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; University of Bonn	Furst, R (corresponding author), Goethe Univ Frankfurt, Inst Pharmaceut Biol, Frankfurt, Germany.	fuerst@em.uni-frankfurt.de	Müller, Rolf/B-1559-2008	Müller, Rolf/0000-0002-1042-5665; Furst, Robert/0000-0002-9926-7578	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [FU 691/9-2 FOR 1406]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	This project was supported by a grant (FU 691/9-2 FOR 1406) to R.F. from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG; http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel K, 2017, ONCOTARGET, V8, P9476, DOI 10.18632/oncotarget.14339; Bockelmann S, 2010, J BIOL CHEM, V285, P38304, DOI 10.1074/jbc.M110.137539; BUCK MR, 1992, BIOCHEM J, V282, P273, DOI 10.1042/bj2820273; BURLEIGH MC, 1974, BIOCHEM J, V137, P387, DOI 10.1042/bj1370387; Cavallo-Medved D, 2009, EXP CELL RES, V315, P1234, DOI 10.1016/j.yexcr.2009.01.021; Cotter K, 2015, J BIOL CHEM, V290, P3680, DOI 10.1074/jbc.M114.611210; ELICES MJ, 1991, J CELL BIOL, V112, P169, DOI 10.1083/jcb.112.1.169; EVERTS V, 1992, J CELL PHYSIOL, V150, P221, DOI 10.1002/jcp.1041500202; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Goel Ashish, 1997, Indian Journal of Experimental Biology, V35, P553; GUI GPH, 1995, BRIT J SURG, V82, P1192, DOI 10.1002/bjs.1800820914; Haidari M, 2012, J BIOL CHEM, V287, P32981, DOI 10.1074/jbc.M112.395905; Harada M, 1997, LIVER, V17, P244; HEMLER ME, 1990, CELL DIFFER DEV, V32, P229, DOI 10.1016/0922-3371(90)90035-U; Heyder C, 2005, CLIN EXP METASTAS, V22, P99, DOI 10.1007/s10585-005-4335-z; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Huss Markus, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-13; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kubisch R, 2014, INT J CANCER, V134, P2478, DOI 10.1002/ijc.28562; LAH TT, 1989, CLIN EXP METASTAS, V7, P461, DOI 10.1007/BF01753666; Lopes-Bastos BM, 2016, ANTICANCER RES, V36, P1119; Lundstrom A, 1998, BIOCHEM BIOPH RES CO, V250, P735, DOI 10.1006/bbrc.1998.9389; Madge LA, 2001, EXP MOL PATHOL, V70, P317, DOI 10.1006/exmp.2001.2368; Maxson ME, 2014, J CELL SCI, V127, P4987, DOI 10.1242/jcs.158550; Menche D, 2007, J AM CHEM SOC, V129, P6100, DOI 10.1021/ja071461o; Michel V, 2013, INT J CANCER, V132, pE1, DOI 10.1002/ijc.27811; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Mograbi B, 1999, EUR CYTOKINE NETW, V10, P79; Mort JS, 1997, INT J BIOCHEM CELL B, V29, P715, DOI 10.1016/S1357-2725(96)00152-5; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; Perez-Sayans M, 2009, CANCER TREAT REV, V35, P707, DOI 10.1016/j.ctrv.2009.08.003; Premzl A, 2006, J CELL BIOCHEM, V97, P1230, DOI 10.1002/jcb.20720; Price EA, 1996, BRIT J CANCER, V74, P1762, DOI 10.1038/bjc.1996.627; Rath S, 2014, ANGIOGENESIS, V17, P587, DOI 10.1007/s10456-013-9408-z; Robinson DG, 2004, PROTOPLASMA, V224, P255, DOI 10.1007/s00709-004-0070-6; Roethle PA, 2007, J AM CHEM SOC, V129, P8960, DOI 10.1021/ja0733033; Rojas JD, 2006, AM J PHYSIOL-HEART C, V291, pH1147, DOI 10.1152/ajpheart.00166.2006; Rojas JD, 2004, BIOCHEM BIOPH RES CO, V320, P1123, DOI 10.1016/j.bbrc.2004.06.068; Sasse F, 2003, J ANTIBIOT, V56, P520, DOI 10.7164/antibiotics.56.520; Spugnini EP, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-44; Staton CA, 2004, INT J EXP PATHOL, V85, P233, DOI 10.1111/j.0959-9673.2004.00396.x; Strell Carina, 2008, Cell Commun Signal, V6, P10, DOI 10.1186/1478-811X-6-10; Sun-Wada GH, 2015, BBA-BIOENERGETICS, V1847, P1166, DOI 10.1016/j.bbabio.2015.06.010; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Thomas L, 2017, BIOCHEM PHARMACOL, V130, P71, DOI 10.1016/j.bcp.2017.02.004; Uhlman A, 2017, CANCER MICROENVIRON, V10, P49, DOI 10.1007/s12307-017-0196-7; Victor BC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3058; von Schwarzenberg K, 2013, J BIOL CHEM, V288, P1385, DOI 10.1074/jbc.M112.412007; Wiedmann RM, 2012, CANCER RES, V72, P5976, DOI 10.1158/0008-5472.CAN-12-1772; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219	51	4	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203053	10.1371/journal.pone.0203053	http://dx.doi.org/10.1371/journal.pone.0203053			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204757	Green Published, Green Submitted, gold			2022-12-26	WOS:000444355500017
J	Aliyu, G; El-Kamary, SS; Abimiku, A; Blattner, W; Charurat, M				Aliyu, Gambo; El-Kamary, Samer S.; Abimiku, Alash'le; Blattner, William; Charurat, Manhattan			Demography and the dual epidemics of tuberculosis and HIV: Analysis of cross-sectional data from Sub-Saharan Africa	PLOS ONE			English	Article							SEX-DIFFERENCES; HOMOSEXUAL-MEN; TRANSMISSION; AGE; INFECTION; PREVALENCE; CHILDREN; GENDER; LYMPHADENOPATHY; HOUSEHOLD	Background Convergence of tuberculosis (TB) and HIV epidemics is associated with higher morbidity and mortality risks and understanding their distribution across key demographic factors is essential for prevention and control. This analysis examines the prevalence of TB, HIV and TB-HIV coinfection across age and gender in patients with presumptive TB seeking care at the National TB and Leprosy Training Center in Nigeria. Methods Samples from 1603 presumptive pulmonary TB cases who provided informed consent were evaluated with a sequential testing algorithm that included a smear microscopy, cultures in liquid and broth media and then genotyping by Hain line probe assays. HIV was serially tested with two HIV rapid assays and retested with a third assay in non-conclusive samples. Results Twenty-three percent (375/1603) had confirmed pulmonary TB infection, 23.6% (378/1603) were positive for HIV infection and 26.9% (101/375) of the confirmed TB cases were HIV coinfected. Males had a higher prevalence of TB: 27.6% vs. 18.0%, p <.0001; and a lower prevalence of HIV: 19.0% vs. 29.6%, p <.0001. In the age range of 25 +/- 29 years, males were twice as likely to have TB (OR = 2.2; 95% confidence interval [CI]: 1.3 +/- 3.9, p = 0.0032) while females were five times more likely to have HIV (OR = 4.8; 95% CI: 2.6 +/- 8.9, p <.0001). Persons with TB-HIV coinfection were more likely to be young, female and less likely to be married. Conclusion Younger females with a high burden of HIV may be under-diagnosed and under-reported for TB in Nigeria. Community programs for intensified and early detection of TB and HIV targeting younger females are needed in this setting.	[Aliyu, Gambo; Abimiku, Alash'le; Blattner, William; Charurat, Manhattan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [El-Kamary, Samer S.; Blattner, William] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Aliyu, G (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	galiyu@ihv.umaryland.edu			Fogarty AIDS International Training and Research Program [D43TW001041]	Fogarty AIDS International Training and Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the Fogarty AIDS International Training and Research Program (Grant no: D43TW001041) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS DI, 1984, ANN INTERN MED, V100, P801, DOI 10.7326/0003-4819-100-6-801; Aliyu Gambo, 2013, Tuberc Res Treat, V2013, P650561, DOI 10.1155/2013/650561; Aliyu G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063170; Aliyu GG, 2011, ACCOUNT RES, V18, P289, DOI 10.1080/08989621.2011.584766; ANDERSON RM, 1985, J HYG-CAMBRIDGE, V94, P365, DOI 10.1017/S002217240006160X; Bemelmans M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20751; Beyers N, 1997, INT J TUBERC LUNG D, V1, P38; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; CASSELS A, 1982, TUBERCLE, V63, P175, DOI 10.1016/S0041-3879(82)80028-7; CHAISSON RE, 1987, AM J PUBLIC HEALTH, V77, P169, DOI 10.2105/AJPH.77.2.169; CHAN WC, 1985, ARCH PATHOL LAB MED, V109, P133; CLONINGER CR, 1975, BRIT J PSYCHIAT, V127, P11, DOI 10.1192/bjp.127.1.11; Connolly Maire, 1996, World Health Statistics Quarterly, V49, P115; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; DESJARLAIS DC, 1988, J ACQ IMMUN DEF SYND, V1, P267; DESJARLAIS DC, 1988, REV INFECT DIS, V10, P151; Dodd PJ, 2016, AM J EPIDEMIOL, V183, P156, DOI 10.1093/aje/kwv160; Fochsen G, 2006, QUAL HEALTH RES, V16, P1236, DOI 10.1177/1049732306293776; Fowler MG, 1997, OBSTET GYN CLIN N AM, V24, P705, DOI 10.1016/S0889-8545(05)70340-5; Getahun H, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21002; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; JARLAIS DCD, 1987, AIDS, V1, P67; Kakietek J, 2013, AIDS CARE, V25, pS78, DOI 10.1080/09540121.2012.740158; Kivihya-Ndugga LEA, 2005, INT J TUBERC LUNG D, V9, P294; Kumar AMV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156487; LANGE M, 1984, ANN NY ACAD SCI, V437, P350, DOI 10.1111/j.1749-6632.1984.tb37155.x; Modiano D, 1998, AM J TROP MED HYG, V59, P539, DOI 10.4269/ajtmh.1998.59.539; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nguyen PH, 2009, HEALTH POLICY, V90, P8, DOI 10.1016/j.healthpol.2008.08.006; Oxlade O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047533; Paxton Keisha C, 2013, J AIDS Clin Res, V4, P221; Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30; Richardson ET, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19035; Rosenberg M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125510; Salim MAH, 2004, INT J TUBERC LUNG D, V8, P952; Sanou A, 2004, INT J TUBERC LUNG D, V8, P1479; Singh M, 2005, ARCH DIS CHILD, V90, P624, DOI 10.1136/adc.2003.044255; UNAIDS, WOM AIDS EXTR AIDS E; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; YAMAMOTO Y, 1990, AM REV RESPIR DIS, V142, P430, DOI 10.1164/ajrccm/142.2.430	41	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0191387	10.1371/journal.pone.0191387	http://dx.doi.org/10.1371/journal.pone.0191387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT0BU	30192746	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600001
J	Kishi, RNI; Stach-Machado, D; Singulani, JD; dos Santos, CT; Fusco-Almeida, AM; Cilli, EM; Freitas-Astua, J; Picchi, SC; Machado, MA				Inui Kishi, Rosangela Naomi; Stach-Machado, Dagmar; Singulani, Junya de lacorte; dos Santos, Claudia Tavares; Fusco-Almeida, Ana Marisa; Cilli, Eduardo Maffud; Freitas-Astua, Juliana; Picchi, Simone Cristina; Machado, Marcos Antonio			Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus	PLOS ONE			English	Article							IN-VIVO MODEL; GALLERIA-MELLONELLA; ALAMAR BLUE; HYPSIBOAS-ALBOPUNCTATUS; BIOLOGICAL-ACTIVITY; CYTOLYTIC PEPTIDE; CTX-HA; TOXICITY; MEMBRANES; CANKER	Antimicrobial peptides (AMPs) can be found in various organisms, and could be considered an alternative for pesticides used to control plant pathogens, including those affecting citrus. Brazil is the largest producer and exporter of frozen concentrated orange juice in the world. However, the citrus industry has been affected by several diseases such as citrus canker and huanglongbing (HLB), caused by the bacteria Xanthomonas citri subsp. citri (X. citri) and Candidatus Liberibacter asiaticus (CaLas), respectively. In order to control these pathogens, putative AMPs were prospected in databases containing citrus sequences. Furthermore, AMPs already reported in the literature were also used for in vitro and in vivo assays against X. citri. Since CaLas cannot be cultivated in vitro, surrogates as Sinorhizobium meliloti and Agrobacterium tumefaciens were used. This study reports the evaluation of six AMPs obtained from different sources, two of them from Citrus spp. (citrus-amp1 and citrus-amp2), three from amphibians (Hylin-a1, K-0-W-6-Hy-a1 and Ocellatin 4-analogue) and one from porcine (Tritrpticin). Peptides K-0-W-6-Hy-a1, Ocellatin 4-analogue, and citrus-amp1 showed bactericidal activity against X. citri and S. meliloti and bacteriostatic effect on A. tumefaciens. These results were confirmed for X. citri in planta. In addition cytotoxicity evaluations of these molecules were performed. The AMPs that showed the lowest hemolytic activities were Triptrpticin, citrus-amp1 and citrus-amp2. Citrus-amp1 and citrus-amp2 not presented toxicity in experiments using in vivo model, G. mellonella and U87 MG cells. To verify the interaction of these AMPs with bacteria and erythrocyte cell membranes, vesicles mimicking these cells were built. Citrus-amp1 and Tritrpticin exhibited higher affinity to bacterial membranes, while Ocellatin 4-analogue and Hylin-a1 showed higher affinity to erythrocyte membranes; exclude their use in citrus. This work demonstrates an essential alternative, trough AMPs obtained from Citrus spp., which can be feasibly used to control bacterial pathogens.	[Inui Kishi, Rosangela Naomi; Picchi, Simone Cristina; Machado, Marcos Antonio] Inst Agron, Ctr Citricultura Sylvio Moreira, Sao Paulo, Brazil; [Inui Kishi, Rosangela Naomi; Stach-Machado, Dagmar] Univ Estadual Campinas, Inst Biol, Sao Paulo, Brazil; [Singulani, Junya de lacorte; dos Santos, Claudia Tavares; Fusco-Almeida, Ana Marisa] Univ Estadual Paulista, Fac Ciencias Farmaceut, Sao Paulo, Brazil; [Cilli, Eduardo Maffud] Univ Estadual Paulista, Inst Quim Araraquara, Dept Bioquim & Tecnol Quim, Sao Paulo, Brazil; [Freitas-Astua, Juliana] Embrapa Cassava & Fruits, Cruz Das Almas, BA, Brazil; [Inui Kishi, Rosangela Naomi] Fundo Def Citricultura, FUNDECITRUS, Sao Paulo, Brazil	Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade Estadual Paulista; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Fundo de Defesa da Citricultura	Kishi, RNI (corresponding author), Inst Agron, Ctr Citricultura Sylvio Moreira, Sao Paulo, Brazil.; Kishi, RNI (corresponding author), Univ Estadual Campinas, Inst Biol, Sao Paulo, Brazil.; Kishi, RNI (corresponding author), Fundo Def Citricultura, FUNDECITRUS, Sao Paulo, Brazil.	rosangela.inui@gmail.com	Cilli, Eduardo Maffud/B-9130-2012; Cilli, Eduardo Maffud/K-1857-2019; Singulani, Junya de Lacorte/P-6955-2016; Freitas-Astua, Juliana/C-5833-2013; Machado, Marcos Antonio/G-3582-2012; Inui Kishi, Rosangela/N-5946-2014	Cilli, Eduardo Maffud/0000-0002-4767-0904; Cilli, Eduardo Maffud/0000-0002-4767-0904; Freitas-Astua, Juliana/0000-0002-0506-6880; Machado, Marcos Antonio/0000-0001-9780-3990; Picchi, Simone Cristina/0000-0001-5619-9889; Inui Kishi, Rosangela/0000-0002-7313-6756	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2010/11072-4, 2012/15346-7, 2008/52691-9]; Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/11072-4, 2012/15346-7, 2008/52691-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: 2010/11072-4 for the scholarship and resource (RNIK); 2012/15346-7 for resource (EMC) and 2008/52691-9 for resource (MAM).; We are grateful to Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) for financial support (proc. 2010/11072-4, 2012/15346-7 and 2008/52691-9); and to Drs. Carlos Bloch Jr. and Guilherme Dotto Brand, Embrapa Recursos Geneticos e Biotecnologia, for the assistance with the Kamal Software.	Agarraberes FA, 2001, BBA-BIOMEMBRANES, V1513, P1, DOI 10.1016/S0304-4157(01)00005-3; Almeida RA, 2015, J BRAZIL CHEM SOC, V26, P2290, DOI 10.5935/0103-5053.20150219; Amaral AM, 2005, FITOPATOL BRAS, V30, P1995, DOI [10.1590/S0100-, DOI 10.1590/S0100-]; [Anonymous], 1970, MANUAL PRACTICAL STU; Araujo WL, 2002, APPL ENVIRON MICROB, V68, P4906, DOI 10.1128/AEM.68.10.4906-4914.2002; BESSALLE R, 1990, FEBS LETT, V274, P151, DOI 10.1016/0014-5793(90)81351-N; Bradshaw JP, 2003, BIODRUGS, V17, P233, DOI 10.2165/00063030-200317040-00002; Brand GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045848; Brender JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00195; Castro MS, 2006, CURR PROTEIN PEPT SC, V7, P473, DOI 10.2174/138920306779025648; Castro MS, 2009, PEPTIDES, V30, P291, DOI 10.1016/j.peptides.2008.11.003; Cespedes GF, 2012, PROTEIN PEPTIDE LETT, V19, P596; Crusca E, 2011, BIOPOLYMERS, V96, P41, DOI 10.1002/bip.21454; Desbois AP, 2012, ADV APPL MICROBIOL, V78, P25, DOI 10.1016/B978-0-12-394805-2.00002-6; Dolan N, 2016, BIOORG MED CHEM LETT, V26, P630, DOI 10.1016/j.bmcl.2015.11.058; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Furman N, 2013, J BIOTECHNOL, V167, P412, DOI 10.1016/j.jbiotec.2013.07.019; Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200; Guell I, 2011, APPL ENVIRON MICROB, V77, P2667, DOI 10.1128/AEM.02759-10; Guimaraes AB, 2015, THESIS; Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012; Hancock REW, 2005, LANCET INFECT DIS, V5, P209, DOI 10.1016/S1473-3099(05)70051-7; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hao GX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186810; Hao GX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01078; Kobayashi AK, 2017, EUR J PLANT PATHOL, V149, P865, DOI 10.1007/s10658-017-1234-5; Le CF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09761; Lee AG, 1998, BBA-REV BIOMEMBRANES, V1376, P381, DOI 10.1016/S0304-4157(98)00010-0; Lorenzon EN, 2013, AMINO ACIDS, V44, P1521, DOI 10.1007/s00726-013-1475-3; Lorenzon EN, 2012, ANTIMICROB AGENTS CH, V56, P3004, DOI 10.1128/AAC.06262-11; Lorenzon EN, 2014, AMINO ACIDS, V46, P2627, DOI 10.1007/s00726-014-1832-x; Maguire R, 2016, CELL BIOL TOXICOL, V32, P209, DOI 10.1007/s10565-016-9329-x; Makovitzki A, 2007, APPL ENVIRON MICROB, V73, P6629, DOI 10.1128/AEM.01334-07; McManus PS, 2002, ANNU REV PHYTOPATHOL, V40, P443, DOI 10.1146/annurev.phyto.40.120301.093927; Megaw J, 2015, CHEMOSPHERE, V139, P197, DOI 10.1016/j.chemosphere.2015.06.026; Na DH, 2007, PHARM RES-DORDR, V24, P1544, DOI 10.1007/s11095-007-9274-8; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Nascimento A, 2007, TOXICON, V50, P1095, DOI 10.1016/j.toxicon.2007.07.014; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Onuma Y, 1999, TOXICON, V37, P55, DOI 10.1016/S0041-0101(98)00133-0; Paulsen VS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053326; Reis MS, 2007, GENET MOL BIOL, V30, P1024, DOI 10.1590/S1415-47572007000500031; Rigano LA, 2007, MOL PLANT MICROBE IN, V20, P1222, DOI 10.1094/mpmi-20-10-1222; Romeiro R, 2001, METODOS BACTERIOLOGI, DOI [10.1128/AEM.01334-07, DOI 10.1128/AEM.01334-07]; Santos e Silva F. de A., 2016, African Journal of Agricultural Research, V11, P3733; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Singulani JD, 2016, INT J ANTIMICROB AG, V48, P292, DOI 10.1016/j.ijantimicag.2016.05.012; Stover E, 2013, J AM SOC HORTIC SCI, V138, P142, DOI 10.21273/JASHS.138.2.142; Tahara H, 2017, J PHARMACOL TOX MET, V88, P92, DOI 10.1016/j.vascn.2017.08.003; Valente V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062200; Vicente EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060818; Yang ST, 2002, BIOCHEM BIOPH RES CO, V296, P1044, DOI 10.1016/S0006-291X(02)02048-X; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zetezetsky I, 2006, BIOCHIM BIOPHYS ACTA, V1758, P1436, DOI [10.1016/j.bbamem.2006.03.021, DOI 10.1016/J.BBAMEM.2006.03.021]; Zhu WL, 2007, J PEPT SCI, V13, P529, DOI 10.1002/psc.882	55	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203451	10.1371/journal.pone.0203451	http://dx.doi.org/10.1371/journal.pone.0203451			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192822	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600076
J	Loughran, ST; Power, PA; Maguire, PT; McQuaid, SL; Buchanan, PJ; Jonsdottir, I; Newman, RW; Harvey, R; Johnson, PA				Loughran, Sinead T.; Power, Patrick A.; Maguire, Paula T.; McQuaid, Samantha L.; Buchanan, Paul J.; Jonsdottir, Ingileif; Newman, Robert W.; Harvey, Ruth; Johnson, Patricia A.			Influenza infection directly alters innate IL-23 and IL-12p70 and subsequent IL-17A and IFN-gamma responses to pneumococcus in vitro in human monocytes	PLOS ONE			English	Article							MIXED LEUKOCYTE REACTION; T-HELPER-CELLS; DENDRITIC CELLS; BACTERIAL PNEUMONIA; VIRUS HEMAGGLUTININ; INTERFERON-GAMMA; EXPRESSION; LUNG; DIFFERENTIATION; NEURAMINIDASE	It is well accepted that influenza A virus predisposes individuals to often more severe super-infections with Streptococcus pneumonia. However, the mechanisms that lead to this synergy are not clearly understood. Recent data suggests that competent Th17 immunity is crucial to clearance and protection from invasive pneumococcal disease of the lung. We demonstrate that early influenza infection significantly reduced levels of pneumococcus driven IL-12p70, IL-23 and IL-27 in human monocytes with significant impairment of IL-17A and IFN-. in HKSP-treated allogeneic mixed lymphocyte cultures. We also provide evidence to suggest that the hemagglutinin component of the virus is at least partially responsible for this downward pressure on IL-17 responses but surprisingly this suppression occurs despite robust IL-23 levels in hemagglutinin-treated monocyte cultures. This study demonstrates that influenza can directly affect the immunological pathways that promote appropriate responses to Streptococcus pneumonia in human immune cells. Importance Influenza virus is highly contagious and poses substantial public health problems due to its strong association with morbidity and mortality. Approximately 250,000-500,000 deaths are caused by seasonal influenza virus annually, and this figure increases during periods of pandemic infections. Most of these deaths are due to secondary bacterial pneumonia. Influenza-bacterial superinfection can result in hospitalisation and/or death of both patients with pre-existing lung disease or previously healthy individuals. The importance of our research is in determining that influenza and its component haemagglutinin has a direct effect on the classic pneumococcus induced pathways to IL-17A in our human ex vivo model. Our understanding of the mechanism which leaves people exposed to influenza infection during superinfection remain unresolved. This paper demonstrates that early infection of monocytes inhibits an arm of immunity crucial to bacterial clearance. Understanding this mechanism may provide alternative interventions in the case of superinfection with antimicrobial resistant strains of bacteria.	[Loughran, Sinead T.; Power, Patrick A.; Maguire, Paula T.; McQuaid, Samantha L.; Johnson, Patricia A.] Dublin City Univ, Sch Nursing & Human Sci, Viral Immunol Lab, Dublin, Ireland; [Buchanan, Paul J.] Dublin City Univ, Sch Nursing & Human Sci, Translat Canc Physiol Lab, Dublin, Ireland; [Jonsdottir, Ingileif] Natl Univ Hosp Iceland, Landspitali, Dept Immunol, Reykjavik, Iceland; [Newman, Robert W.; Harvey, Ruth] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England; [Loughran, Sinead T.] Dundalk Inst Technol, Dept Appl Sci, Dundalk, Louth, Ireland; [Power, Patrick A.] Dublin Inst Technol, Dublin, Ireland; [McQuaid, Samantha L.] Mason Technol Ltd, Dublin, Ireland	Dublin City University; Dublin City University; Landspitali National University Hospital; National Institute for Biological Standards & Control; Dundalk Institute of Technology; Technological University Dublin	Johnson, PA (corresponding author), Dublin City Univ, Sch Nursing & Human Sci, Viral Immunol Lab, Dublin, Ireland.	patricia.johnson@dcu.ie	Johnson, Patricia/AAQ-1870-2020	Loughran, Sinead/0000-0001-5929-7118; Buchanan, Paul/0000-0002-9055-2794; , Paula/0000-0002-5392-3322; Johnson, Patricia/0000-0002-2891-7940	Wellcome Trust [WT086509MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust, WT086509MA (https://wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2001, PEDIATR INFECT DIS J, V20, P718, DOI 10.1097/00006454-200107000-00018; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Cai Li, 2006, Kobe Journal of Medical Sciences, V52, P97; Cao J, 2014, EMBO MOL MED, V6, P120, DOI 10.1002/emmm.201302890; Chertow DS, 2013, JAMA-J AM MED ASSOC, V309, P275, DOI 10.1001/jama.2012.194139; Damjanovic D, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.5; Damjanovic D, 2013, AM J PATHOL, V183, P868, DOI 10.1016/j.ajpath.2013.05.016; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Diavatopoulos DA, 2010, FASEB J, V24, P1789, DOI 10.1096/fj.09-146779; Donninelli G, 2018, IMMUNOBIOLOGY, V223, P342, DOI 10.1016/j.imbio.2017.10.049; Fan Y, 2018, SLAS DISCOV, V23, P742, DOI 10.1177/2472555218775409; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Ghoneim HE, 2013, J IMMUNOL, V191, P1250, DOI 10.4049/jimmunol.1300014; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Houser K, 2015, CELL HOST MICROBE, V17, P295, DOI 10.1016/j.chom.2015.02.012; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Huber VC, 2010, J VIROL, V84, P4105, DOI 10.1128/JVI.02621-09; Kamiya S, 2004, J IMMUNOL, V173, P3871, DOI 10.4049/jimmunol.173.6.3871; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; LeMessurier KS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003727; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Levitsky J, 2010, NIH PUBLIC ACCESS, V88, P1303, DOI [10.1097/TP.0b013e3181bbee98, DOI 10.1097/TP.0B013E3181BBEE98]; Lorenzo MMG, 2013, CHEST, V143, P502, DOI 10.1378/chest.12-1711; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Matikainen S, 2000, VIROLOGY, V276, P138, DOI 10.1006/viro.2000.0542; McCullers JA, 2014, NAT REV MICROBIOL, V12, P252, DOI 10.1038/nrmicro3231; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Metersky ML, 2012, INT J INFECT DIS, V16, pE321, DOI 10.1016/j.ijid.2012.01.003; Metzger DW, 2013, J IMMUNOL, V191, P2047, DOI 10.4049/jimmunol.1301152; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; Munster DJ, 2004, INT IMMUNOL, V16, P33, DOI 10.1093/intimm/dxh004; Noone C, 2007, J LEUKOCYTE BIOL, V81, P952, DOI 10.1189/jlb.1006615; Noone CM, 2005, J GEN VIROL, V86, P1885, DOI 10.1099/vir.0.80891-0; Palese P, 2006, EMERG INFECT DIS, V12, P61, DOI 10.3201/eid1201.051043; Parker D, 2011, MBIO, V2, DOI 10.1128/mBio.00016-11; Peltola VT, 2005, J INFECT DIS, V192, P249, DOI 10.1086/430954; Peters A, 2015, J IMMUNOL, V195, P4144, DOI 10.4049/jimmunol.1302246; Ren JQ, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1400-3; Rijneveld AW, 2002, J INFECT DIS, V185, P91, DOI 10.1086/338122; Robinson KM, 2015, RESP RES, P1, DOI [10.1186/s12931-014-0139-5, DOI 10.1186/S12931-014-0139-5]; Rudd JM, 2016, J INFECT PULM DIS, V2, P973, DOI [10.1016/S2215-0366(16)30284-X, DOI 10.1016/S2215-0366(16)30284-X]; Rynda-Apple A, 2015, INFECT IMMUN, V83, P3764, DOI 10.1128/IAI.00298-15; Shah NS, 2016, J CLIN VIROL, V80, P12, DOI 10.1016/j.jcv.2016.04.008; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; STEINMAN RM, 1983, J EXP MED, V157, P613, DOI 10.1084/jem.157.2.613; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sun J, 2012, ARTHRITIS RHEUM-US, V64, P2158, DOI 10.1002/art.34372; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Sun K, 2007, INFECT IMMUN, V75, P1196, DOI 10.1128/IAI.01403-06; Tao YZ, 2014, J IMMUNOL, V192, P5610, DOI 10.4049/jimmunol.1302580; van der Sluijs KF, 2006, J INFECT DIS, V193, P214, DOI 10.1086/498911; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; Villarino AV, 2005, J IMMUNOL, V174, P7684, DOI 10.4049/jimmunol.174.12.7684; Wagner R, 2000, J VIROL, V74, P6316, DOI 10.1128/JVI.74.14.6316-6323.2000; WANG XJ, 2011, J TRANSPLANT, DOI DOI 10.1155/2011/; WEIGENT DA, 1986, MICROB PATHOGENESIS, V1, P399, DOI 10.1016/0882-4010(86)90071-9; Wong KK, 2013, PEDIATRICS, V132, P796, DOI 10.1542/peds.2013-1493; Wong SS, 2013, CLIN MICROBIOL REV, V26, P476, DOI 10.1128/CMR.00097-12; Yamada M, 2011, AM J RESP CRIT CARE, V183, P1391, DOI 10.1164/rccm.201004-0592OC; Yoshimoto T, 2007, J IMMUNOL, V179, P4415, DOI 10.4049/jimmunol.179.7.4415; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731	65	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203521	10.1371/journal.pone.0203521	http://dx.doi.org/10.1371/journal.pone.0203521			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192848	Green Published, gold, Green Submitted			2022-12-26	WOS:000444093600091
J	Rahmani, M; Rahman, MH				Rahmani, Mehran; Rahman, Mohammad Habibur			Novel robust control of a 7-DOF exoskeleton robot	PLOS ONE			English	Article							UPPER-LIMB EXOSKELETON; SLIDING MODE CONTROL; ADAPTIVE-CONTROL; UPPER EXTREMITY; NEURAL-NETWORK; ARM	This paper proposes a novel robust control method for the control of a 7-DOF exoskeleton robot. The external disturbances and unknown dynamics in the form of friction forces, different upper-limb's mass, backlash, and input saturation make robot unstable, which prevents the robot from correctly following the defined path. A new fractional sliding mode controller (NFSMC) is designed, which is robust against unknown dynamic and external disturbances. Fractional PID controller (FPID) has high trajectory tracking, but it is not robust against external disturbances. Therefore, by combining NFSMC and FPID controllers, a new compound fractional PID sliding mode controller (NCFPIDSMC) is proposed, which benefits high trajectory tracking of FPID and robustness of NFSMC. The stability of the proposed control method is verified by Lyapunov theory. A random noise is applied in order to confirm the robustness of the proposed control method.	[Rahmani, Mehran; Rahman, Mohammad Habibur] Univ Wisconsin, Dept Mech Engn, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Rahmani, M (corresponding author), Univ Wisconsin, Dept Mech Engn, Milwaukee, WI 53201 USA.	mrahmani@uwm.edu		Rahmani, Mehran/0000-0002-6541-8606				Babaiasl M, 2015, RSI INT CONF ROBOT M, P694, DOI 10.1109/ICRoM.2015.7367867; Brahim Brahmi, 2017, 2017 IEEE Great Lakes Biomedical Conference (GLBC), DOI 10.1109/GLBC.2017.7928879; Brahmi B, 2018, IEEE ASME T MECHATRO; Brahmi B, 2018, EUROPEAN J CONTROL; Brahmi B, 2017, INT C REHAB ROBOT, P1369, DOI 10.1109/ICORR.2017.8009439; Craig J.J., 2005, INTRO ROBOTICS MECH, V3, P48; Freeman CT, 2009, CONTROL ENG PRACT, V17, P368, DOI 10.1016/j.conengprac.2008.08.003; Guo Y, 2017, IEEE INT CONF SOFTW, P1, DOI 10.1109/ICST.2017.8; Hunt KJ, 2001, CONTROL ENG PRACT, V9, P313, DOI 10.1016/S0967-0661(00)00126-X; Jarrasse N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00947; Kang HB, 2013, ISA T, V52, P844, DOI 10.1016/j.isatra.2013.05.003; Kawasaki H, 2007, INT C REHAB ROBOT, P234, DOI 10.1109/ICORR.2007.4428432; Luna CO, 2016, ROBOTICA, V34, P1587, DOI 10.1017/S026357471400246X; Luna CO, 2015, INT J ADV ROBOT SYST, V12, DOI 10.5772/60784; Maciejasz P, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-3; Madani T, 2017, IEEE T CONTR SYST T, V25, P1133, DOI 10.1109/TCST.2016.2579603; Munih M, 1997, IEEE Trans Rehabil Eng, V5, P341, DOI 10.1109/86.650288; Munoz-Vazquez AJ, 2017, INT J SYST SCI, V48, P2901, DOI 10.1080/00207721.2017.1348564; Mushage BO, 2017, NONLINEAR DYNAM, V87, P2021, DOI 10.1007/s11071-016-3173-7; Podlubny I, 1997, IEEE DECIS CONTR P, P4985, DOI 10.1109/CDC.1997.649841; Rahman MH, 2015, ROBOTICA, V33, P19, DOI 10.1017/S0263574714000034; Rahman MH, 2013, INT J CONTROL AUTOM, V11, P92, DOI 10.1007/s12555-011-0135-1; Rahman MH, 2014, INT J MODEL IDENTIF, V21, P390, DOI 10.1504/IJMIC.2014.062026; Rahman MH, 2012, APPL BIONICS BIOMECH, V9, P275, DOI 10.1155/2012/956310; Rahmani M, 2016, J VIB CONTROL, DOI [10.1177/1077546314568696, DOI 10.1177/1077546314568696]; Rahmani M, 2018, ISA T, V72, P37, DOI 10.1016/j.isatra.2017.11.009; Rahmani M, 2016, MECH SYST SIGNAL PR, V80, P117, DOI 10.1016/j.ymssp.2016.04.004; Rahmani M, 2016, EXPERT SYST APPL, V56, P164, DOI 10.1016/j.eswa.2016.03.006; Razzaghian A, 2015, SECOND INTERNATIONAL CONGRESS ON TECHNOLOGY, COMMUNICATION AND KNOWLEDGE (ICTCK 2015), P25, DOI 10.1109/ICTCK.2015.7582642; Riani A, 2017, 2017 18TH INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS (ICAR), P131, DOI 10.1109/ICAR.2017.8023507; Shah P, 2016, MECHATRONICS, V38, P29, DOI 10.1016/j.mechatronics.2016.06.005; Wu QC, 2015, IEEE INT SYM MED MEA, P451, DOI 10.1109/MeMeA.2015.7145246; Yu W, 2010, IEEE DECIS CONTR P, P3548, DOI 10.1109/CDC.2010.5716985; Zhang D, 2017, INT J ADV ROBOT SYST, V14, DOI 10.1177/1729881417694290	34	28	28	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203440	10.1371/journal.pone.0203440	http://dx.doi.org/10.1371/journal.pone.0203440			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192815	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600075
J	Tyulmankov, D; Tass, PA; Bokil, H				Tyulmankov, Danil; Tass, Peter A.; Bokil, Hemant			Periodic flashing coordinated reset stimulation paradigm reduces sensitivity to ON and OFF period durations	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; SUBTHALAMIC NUCLEUS STIMULATION; ADVANCED PARKINSON DISEASE; NEURAL SUBPOPULATIONS; MOTOR FLUCTUATIONS; BASAL GANGLIA; MODEL; SYNCHRONIZATION; OSCILLATORS; MODULATION	Pathological synchronization in the basal ganglia network has been considered an important component of Parkinson's disease pathophysiology. An established treatment for some patients with Parkinson's disease is deep brain stimulation, in which a tonic high-frequency pulse train is delivered to target regions of the brain. In recent years, a novel neuromodulation paradigm called coordinated reset stimulation has been proposed, which aims to reverse the pathological synchrony by sequentially delivering short high-frequency bursts to distinct sub-regions of the pathologically synchronized network, with an average intra-burst interval for each sub-region corresponding to period of the pathological oscillation. It has further been proposed that the resultant desynchronization can be enhanced when stimulation is interrupted periodically, and that it is particularly beneficial to precisely tune the stimulation ON and OFF time-windows to the underlying pathological frequency. Pre-clinical and clinical studies of coordinated reset stimulation have relied on these proposals for their stimulation protocols. In this study, we present a modified ON-OFF coordinated reset stimulation paradigm called periodic flashing and study its behavior through computational modeling using the Kuramoto coupled phase oscillator model. We demonstrate that in contrast to conventional coordinated reset stimulation, the periodic flashing variation does not exhibit a need for precise turning of the ON-OFF periods to the pathological frequency, and demonstrates desynchronization for a wide range of ON and OFF periods. We provide a mechanistic explanation for the previously observed sensitivities and demonstrate that they are an artifact of the specific ON-OFF cycling paradigm used. As a practical consequence, the periodic flashing paradigm simplifies the tuning of optimal stimulation parameters by decreasing the dimension of the search space. It also suggests new, more flexible ways of delivering coordinated reset stimulation.	[Tyulmankov, Danil; Bokil, Hemant] Boston Sci Neuromodulat, Valencia, CA 91355 USA; [Tass, Peter A.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA USA	Stanford University	Bokil, H (corresponding author), Boston Sci Neuromodulat, Valencia, CA 91355 USA.	hemant.bokil@bsci.com			Boston Scientific Corporation	Boston Scientific Corporation(Boston Scientific)	DT was employed by Boston Scientific Corporation when this work was performed. PAT's contribution was part of consultancy work for Boston Scientific Corporation. HB is employed by and owns stock in Boston Scientific Corporation. The funder, Boston Scientific Corporation, provided support in the form of salaries for DT and HB, and consulting compensation for PAT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Adamchic I, 2014, MOVEMENT DISORD, V29, P1679, DOI 10.1002/mds.25923; Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; BEST EN, 1979, BIOPHYS J, V27, P87, DOI 10.1016/S0006-3495(79)85204-2; Beudel M, 2016, PARKINSONISM RELAT D, V22, pS123, DOI 10.1016/j.parkreldis.2015.09.028; DAIDO H, 1992, PROG THEOR PHYS, V88, P1213, DOI 10.1143/PTP.88.1213; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Fraix V, 2006, J NEUROL NEUROSUR PS, V77, P443, DOI 10.1136/jnnp.2005.077677; Graupe D, 2010, NEUROL RES, V32, P899, DOI 10.1179/016164110X12767786356354; GUTTMAN R, 1980, J PHYSIOL-LONDON, V305, P377, DOI 10.1113/jphysiol.1980.sp013370; Harrison TR, 2010, HARRISONS NEUROLOGY; Hauptmann C, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016004; Hauptmann C, 2007, BIOSYSTEMS, V89, P173, DOI 10.1016/j.biosystems.2006.04.015; Hauptmann C, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056008; Horstink M, 2006, EUR J NEUROL, V13, P1170, DOI 10.1111/j.1468-1331.2006.01547.x; Humphries MD, 2006, J NEUROSCI, V26, P12921, DOI 10.1523/JNEUROSCI.3486-06.2006; Kuhn AA, 2008, J NEUROSCI, V28, P6165, DOI 10.1523/JNEUROSCI.0282-08.2008; Kuhn AA, 2017, MOVEMENT DISORD, V32, P11, DOI 10.1002/mds.26703; Kuramoto Y., 2003, CHEM OSCILLATIONS WA; Leblois A, 2006, J NEUROSCI, V26, P3567, DOI 10.1523/JNEUROSCI.5050-05.2006; LIMOUSIN P, 1995, LANCET, V345, P91, DOI 10.1016/S0140-6736(95)90062-4; Little S, 2013, ANN NEUROL, V74, P449, DOI 10.1002/ana.23951; Lysyansky B, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036019; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Obeso JA, 1997, J NEUROL NEUROSUR PS, V62, P2, DOI 10.1136/jnnp.62.1.2; Pahwa R, 2006, NEUROLOGY, V66, P983, DOI 10.1212/01.wnl.0000215250.82576.87; Pliss VA., 1964, IZV AKAD NAUK SSSR, V28, P1297; Potter-Nerger M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00436; Popovych OV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117205; Quinn EJ, 2015, MOVEMENT DISORD, V30, P1750, DOI 10.1002/mds.26376; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Richardson KA, 2003, EPILEPSIA, V44, P768, DOI 10.1046/j.1528-1157.2003.35402.x; Rosa M, 2015, MOVEMENT DISORD, V30, P1003, DOI 10.1002/mds.26241; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Syrkin-Nikolau J, 2017, NEUROBIOL DIS, V108, P288, DOI 10.1016/j.nbd.2017.09.002; Tass P., 2007, PHASE RESETTING MED; Tass PA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011902; Tass PA, 2006, BIOL CYBERN, V94, P58, DOI 10.1007/s00422-005-0028-6; Tass PA, 2003, PROG THEOR PHYS SUPP, P281, DOI 10.1143/PTPS.150.281; Tass PA, 2003, BIOL CYBERN, V89, P81, DOI [10.1007/s00422-003-0425-7, 10.1007/S00422-003-0425-7]; Tass PA, 2007, INT J PSYCHOPHYSIOL, V64, P53, DOI 10.1016/j.ijpsycho.2006.07.013; Tass PA, 2012, ANN NEUROL, V72, P816, DOI 10.1002/ana.23663; Wang J, 2016, BRAIN STIMUL, V9, P611, DOI 10.1016/j.brs.2016.03.014; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Yamamoto T, 2013, NEUROMODULATION, V16, P230, DOI 10.1111/j.1525-1403.2012.00521.x; Zeitler M, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00049	48	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203782	10.1371/journal.pone.0203782	http://dx.doi.org/10.1371/journal.pone.0203782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192855	Green Submitted, Green Published, gold			2022-12-26	WOS:000444093600142
J	Wang, QJ; Li, JJ; Dang, C; Chang, XF; Fang, Q; Stanley, D; Ye, GY				Wang, Qianjin; Li, Jingjing; Dang, Cong; Chang, Xuefei; Fang, Qi; Stanley, David; Ye, Gongyin			Rice dwarf virus infection alters green rice leafhopper host preference and feeding behavior	PLOS ONE			English	Article							MYZUS-PERSICAE HOMOPTERA; INSECT VECTORS; MOSAIC-VIRUS; PLANTS; MANIPULATION; DISEASE; PROTEIN; APHID; EPIDEMIOLOGY; RESPONSES	Host plants, pathogens and their herbivore vectors systems have complex relationships via direct and indirect interactions. Although there are substantial gaps in understanding these systems, the dynamics of the relationships may influence the processes of virus transmission and plant disease epidemics. Rice dwarf virus (RDV) is mainly vectored by green rice leafhoppers (GRLHs), Nephotettix cincticeps (Uhler) (Hemiptera: Cicadellidae) in a persistently circulative manner. In this study, host plant selection preferences of non-viruliferous and viruliferous (carrying RDV) GRLHs between RDV-free and RDV-infected plants were tested. Non-viruliferous GRLHs preferred RDV-infected rice plants over RDV-free rice plants, and viruliferous GRLHs preferred RDV-free rice plants over RDV-infected rice plants. In odor selection preference bioassay using a four-field olfactometer, non-viruliferous GRLHs preferred odors of RDV-infected rice plants over healthy rice and viruliferous GRLHs preferred odors of RDV-free rice plants over RDV-infected ones. In 6 h plant penetration behavior bioassay using electrical penetration graphs, non-viruliferous GRLHs spent shorter time in non-penetration and much longer time in xylem feeding on RDV-infected, compared to RDV-free rice plants. Viruliferous GRLHs exhibited more salivation and stylet movement on RDV-free rice plants than on RDV-infected rice plants. We infer from these findings that RDV influences these vector behaviors by altering host plant physiology to promote viral transmission.	[Wang, Qianjin; Li, Jingjing; Dang, Cong; Chang, Xuefei; Fang, Qi; Ye, Gongyin] Zhejiang Univ, Inst Insect Sci, Key Lab Mol Biol Crop Pathogens & Insects, State Key Lab Rice Biol,Minist Agr, Hangzhou, Zhejiang, Peoples R China; [Stanley, David] USDA ARS, Biol Control Insects Res Lab, Columbia, MO 65205 USA	Ministry of Agriculture & Rural Affairs; Zhejiang University; United States Department of Agriculture (USDA)	Ye, GY (corresponding author), Zhejiang Univ, Inst Insect Sci, Key Lab Mol Biol Crop Pathogens & Insects, State Key Lab Rice Biol,Minist Agr, Hangzhou, Zhejiang, Peoples R China.	chu@zju.edu.cn	Li, Jing/GYU-5036-2022	Ye, Gongyin/0000-0003-4937-8867	National Program on Key Basic Research Projects (973 Program) [2014CB138404]; Special Research Projects for Developing Transgenic Plants, China [2016ZX08011-001]	National Program on Key Basic Research Projects (973 Program)(National Basic Research Program of China); Special Research Projects for Developing Transgenic Plants, China	This work was supported by the National Program on Key Basic Research Projects (973 Program, 2014CB138404) and the Special Research Projects for Developing Transgenic Plants, China (2016ZX08011-001).	Alvarez AE, 2007, ENTOMOL EXP APPL, V125, P135, DOI 10.1111/j.1570-7458.2007.00607.x; Ashourloo D, 2014, REMOTE SENS-BASEL, V6, P5107, DOI 10.3390/rs6065107; Bak A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14493; Casteel CL, 2014, PLANT J, V77, P653, DOI 10.1111/tpj.12417; Castle SJ, 1998, ANN ENTOMOL SOC AM, V91, P661, DOI 10.1093/aesa/91.5.661; Chen HY, 2011, VIRUS RES, V160, P389, DOI 10.1016/j.virusres.2011.04.028; Chen Q, 2015, J GEN VIROL, V96, P933, DOI 10.1099/jgv.0.000022; Colvin J, 2006, ADV VIRUS RES, V67, P419, DOI 10.1016/S0065-3527(06)67011-5; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; He YP, 2011, J ECON ENTOMOL, V104, P1877, DOI 10.1603/EC11180; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Honda K, 2007, PHYTOPATHOLOGY, V97, P712, DOI 10.1094/PHYTO-97-6-0712; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Ingwell LL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00578; Jeger MJ, 1998, IMA J MATH APPL MED, V15, P1; Jeger MJ, 2004, PHYSIOL ENTOMOL, V29, P291, DOI 10.1111/j.0307-6962.2004.00394.x; Lacroix R, 2005, PLOS BIOL, V3, P1590, DOI 10.1371/journal.pbio.0030298; Lei WB, 2016, SCI REP-UK, V6, DOI 10.1038/srep30240; Li P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165014; Li W, 1995, CHINESE J VIROL, V1, P56; Liu BM, 2013, J VIROL, V87, P4929, DOI 10.1128/JVI.03571-12; Malmstrom CM, 2011, VIRUS RES, V159, P84, DOI 10.1016/j.virusres.2011.05.010; Maris PC, 2004, PHYTOPATHOLOGY, V94, P706, DOI 10.1094/PHYTO.2004.94.7.706; Mauck K, 2012, FUNCT ECOL, V26, P1162, DOI 10.1111/j.1365-2435.2012.02026.x; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; MONTLLOR CB, 1986, ENTOMOL EXP APPL, V42, P63, DOI 10.1007/BF00186159; Moreno-Delafuente A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061543; Nakagawa A, 2003, STRUCTURE, V11, P1227, DOI 10.1016/j.str.2003.08.012; Rajabaskar D, 2014, VIRUS RES, V186, P32, DOI 10.1016/j.virusres.2013.11.005; Roossinck MJ, 2015, VIROLOGY, V479, P271, DOI 10.1016/j.virol.2015.03.041; SPSS, 2007, SPSS WIND US GUID RE; Stafford CA, 2011, P NATL ACAD SCI USA, V108, P9350, DOI 10.1073/pnas.1100773108; Tan XL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01597; Thomas F, 2005, BEHAV PROCESS, V68, P185, DOI 10.1016/j.beproc.2004.06.010; TJALLINGII WF, 1993, PHYSIOL ENTOMOL, V18, P317, DOI 10.1111/j.1365-3032.1993.tb00604.x; TJALLINGII WF, 1978, ENTOMOL EXP APPL, V24, P721, DOI 10.1007/BF02385128; Trebicki P, 2012, ARTHROPOD-PLANT INTE, V6, P405, DOI 10.1007/s11829-012-9192-5; Tungadi T, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0754-0; Wang H, 2014, PHYTOPATHOLOGY, V104, P196, DOI 10.1094/PHYTO-08-13-0227-R; Wang QJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181258; Wei TY, 2016, ANNU REV PHYTOPATHOL, V54, P99, DOI 10.1146/annurev-phyto-080615-095900; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Williams CT, 1995, B ENTOMOL RES, V85, P557, DOI 10.1017/S000748530003306X; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Youn Young Nam, 1998, Journal of Asia-Pacific Entomology, V1, P147; Zheng HH, 2000, J VIROL, V74, P9808, DOI 10.1128/JVI.74.20.9808-9810.2000	49	12	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203364	10.1371/journal.pone.0203364	http://dx.doi.org/10.1371/journal.pone.0203364			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192810	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600063
J	Weerasooriya, DK; Bean, SR; Nugusu, Y; Ioerger, BP; Tesso, TT				Weerasooriya, Dilooshi K.; Bean, Scott R.; Nugusu, Yohannes; Ioerger, Brian P.; Tesso, Tesfaye T.			The effect of genotype and traditional food processing methods on in-vitro protein digestibility and micronutrient profile of sorghum cooked products	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; TRYPSIN-INHIBITOR; PHYTIC ACID; STARCH DIGESTIBILITY; IRON-ABSORPTION; GRAIN-SORGHUM; CHYMOTRYPSIN INHIBITORS; ENDOSPERM TEXTURE; GLYCEMIC INDEX; MAIZE	Sorghum (Sorghum bicolor (L.) Moench) is one of the principal staple for millions of people in sub-Saharan Africa serving as the main sources of protein. However, protein digestibility is low in sorghum and this may be affected by processing methods. In this study 15 sorghum cultivars and one variety each of maize (Zea maize) and tef (Eragrostis tef) all of Ethiopian origin were investigated for in-vitro protein digestibility (IVPD), activity and concentration of anti-nutritional factors and micro nutrient profile in raw flour and various cooked food samples. Kafirin composition content and composition was also determined from raw flour samples of the sorghum cultivars. IVPD was significantly different between genotypes with both maize and tef superior to sorghum both in cooked and uncooked state except for the high lysine genotype Wetet Be-gunchie. Cooking significantly reduced IVPD in all crops but had only minor effect in maize. Results revealed a highly significant interaction between genotype and food processing methods where, occasionally, genotypes with highest IVPD under one processing method ended up to be the lowest under another. Trypsin inhibitor levels had a significant and negative correlation with IVPD (r(2) = 0.1), while changes in phytic acid concentration and intrinsic phytase levels during processing followed opposite trends to each other. Processing increased mineral levels by 20-44% for iron and 4- 29% for zinc perhaps due to degradation of phytic acid. Results demonstrated that protein digestibility and the concentration of anti-nutritional factors varied widely depending on the food type. Identification of specific genotypes for a specific food product may help improve the nutritional quality of sorghum based foods.	[Weerasooriya, Dilooshi K.; Tesso, Tesfaye T.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Bean, Scott R.; Ioerger, Brian P.] USDA ARS, Manhattan, KS USA; [Nugusu, Yohannes] Ethiopian Inst Agr Res, Addis Ababa, Ethiopia	Kansas State University; United States Department of Agriculture (USDA); Ethiopian Institute of Agricultural Research (EIAR)	Tesso, TT (corresponding author), Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA.	ttesso@ksu.edu	Bean, Scott R./AAE-9327-2019	Bean, Scott R./0000-0001-8678-8094; Gorfineh, Yohannes/0000-0002-1194-1127	American People through the United States Agency for International Development (USAID) Feed the Future Innovation Lab for Collaborative Research on Sorghum and Millet (SMIL) [AID-OAA-A-13-00047]	American People through the United States Agency for International Development (USAID) Feed the Future Innovation Lab for Collaborative Research on Sorghum and Millet (SMIL)(United States Agency for International Development (USAID))	This research was supported by the American People through the United States Agency for International Development (USAID) Feed the Future Innovation Lab for Collaborative Research on Sorghum and Millet (SMIL) under Cooperative Agreement No. AID-OAA-A-13-00047. The contents are the sole responsibility of the authors and do not reflect the views of USAID or the United States Government.	Afify AEMR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031154; Ali N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068161; ASIEDU M, 1993, FOOD CHEM, V46, P351, DOI 10.1016/0308-8146(93)90003-X; Awika JM, 2004, PHYTOCHEMISTRY, V65, P1199, DOI 10.1016/j.phytochem.2004.04.001; Axtell J. D., 1982, Sorghum in the eighties: proceedings of the international symposium on sorghum, 2-7 November 1981, ICRISAT Center, Patancheru, A.P., India., P589; AXTELL JD, 1981, P NATL ACAD SCI-BIOL, V78, P1333, DOI 10.1073/pnas.78.3.1333; Bean SR, 2011, J AGR FOOD CHEM, V59, P85, DOI 10.1021/jf1036195; Benmoussa M, 2015, PLANT SCI, V241, P70, DOI 10.1016/j.plantsci.2015.08.025; CHAVAN UD, 1988, J FOOD SCI, V53, P1574, DOI 10.1111/j.1365-2621.1988.tb09329.x; CHERYAN M, 1980, CRC CR REV FOOD SCI, V13, P297, DOI 10.1080/10408398009527293; Correia I, 2010, J CEREAL SCI, V51, P146, DOI 10.1016/j.jcs.2009.11.005; Cremer JE, 2014, CEREAL CHEM, V91, P218, DOI 10.1094/CCHEM-04-13-0068-R; da Silva LS, 2011, J CEREAL SCI, V54, P160, DOI 10.1016/j.jcs.2011.04.009; de Mesa-Stonestreet NJ, 2012, J FOOD ENG, V108, P365, DOI 10.1016/j.jfoodeng.2011.07.024; Duodu KG, 2001, J CEREAL SCI, V33, P261, DOI 10.1006/jcrs.2000.0352; Duodu KG, 2003, J CEREAL SCI, V38, P117, DOI 10.1016/S0733-5210(03)00016-X; Duodu KG, 2002, J CEREAL SCI, V35, P161, DOI 10.1006/jcrs.2001.0411; Duodu KG, 2003, AFRIPRO; Ejeta G, 1987, P NATL ACAD SCI USA, P84; Ezeogu LI, 2005, J CEREAL SCI, V42, P33, DOI 10.1016/j.jcs.2005.02.002; FAPOJUWO OO, 1987, J FOOD SCI, V52, P218, DOI 10.1111/j.1365-2621.1987.tb14010.x; FEENEY RE, 1969, J BIOL CHEM, V244, P1957; FILHO JX, 1974, J FOOD SCI, V39, P422, DOI 10.1111/j.1365-2621.1974.tb02911.x; Gebrekidan B, 1979, ETHIOPIAN J AGR SCI; Gieseking JE, 1935, IND ENG CHEM, V7, P0185, DOI 10.1021/ac50095a021; GRAF E, 1990, FREE RADICAL BIO MED, V8, P61, DOI 10.1016/0891-5849(90)90146-A; GRAHAM GG, 1986, J NUTR, V116, P978, DOI 10.1093/jn/116.6.978; Greiner R, 2003, J AGR FOOD CHEM, V51, P847, DOI 10.1021/jf0204405; Greiner R, 1999, J FOOD PROCESS PRES, V23, P249, DOI 10.1111/j.1745-4549.1999.tb00383.x; Grootboom AW, 2014, PLANT CELL REP, V33, P521, DOI 10.1007/s00299-013-1556-5; Guillamon E, 2008, FOOD CHEM, V107, P68, DOI 10.1016/j.foodchem.2007.07.029; HAMAKER BR, 1986, J AGR FOOD CHEM, V34, P647, DOI 10.1021/jf00070a014; HAMAKER BR, 1994, CEREAL CHEM, V71, P515; Hamaker BR, 1987, P NATL ACAD SCI USA, P84; HAYNES R, 1967, J BIOL CHEM, V242, P5378; HISAYASU S, 1992, J NUTR, V122, P1190, DOI 10.1093/jn/122.5.1190; Hunt JR, 2003, AM J CLIN NUTR, V78, p633S, DOI 10.1093/ajcn/78.3.633S; Hurrell RF, 2003, AM J CLIN NUTR, V77, P1213, DOI 10.1093/ajcn/77.5.1213; Hurrell R, 2010, AM J CLIN NUTR, V91, p1461S, DOI 10.3945/ajcn.2010.28674F; Ibrahim FS, 2005, FOOD CHEM, P92; International AACC, 1999, APPR METH AN; Kakade ML, 1969, CEREAL CHEM; Kasim AB, 1998, J SCI FOOD AGR, V76, P1, DOI 10.1002/(SICI)1097-0010(199801)76:1&lt;1::AID-JSFA922&gt;3.0.CO;2-9; Kayode APP, 2007, J SCI FOOD AGR, V87, P832, DOI 10.1002/jsfa.2782; KUMAR PMH, 1978, INT J PEPT PROT RES, V12, P185; Kuo HT, 2013, J FOOD PROCESS PRES, V37, P419, DOI 10.1111/j.1745-4549.2011.00666.x; Lemlioglu-Austin D, 2012, MOLECULES, V17, P11124, DOI 10.3390/molecules170911124; Lestienne I, 2005, J AGR FOOD CHEM, V53, P8342, DOI 10.1021/jf050741p; Lonnerdal B, 2000, J NUTR, V130, p1378S, DOI 10.1093/jn/130.5.1378S; MACLEAN WC, 1983, J NUTR, V113, P2071, DOI 10.1093/jn/113.10.2071; Makokha A. O., 2002, African Journal of Food, Agriculture, Nutrition and Development, V2, P59; MARFO EK, 1990, J AGR FOOD CHEM, V38, P1580, DOI 10.1021/jf00097a032; MELVILLE JC, 1972, BIOCHEM GENET, V7, P15, DOI 10.1007/BF00487006; Mertz ET, 1984, P NATL ACAD SCI USA, P81; MIKOLA J, 1972, ACTA CHEM SCAND, V26, P787, DOI 10.3891/acta.chem.scand.26-0787; MIKOLA J, 1969, EUR J BIOCHEM, V9, P555, DOI 10.1111/j.1432-1033.1969.tb00645.x; Mikola M, 1999, J CEREAL SCI, V30, P227, DOI 10.1006/jcrs.1999.0280; Mkandawire NL, 2015, LWT-FOOD SCI TECHNOL, V62, P662, DOI 10.1016/j.lwt.2014.12.051; MUKURU SZ, 1992, J AGR FOOD CHEM, V40, P1172, DOI 10.1021/jf00019a017; ODANI S, 1983, J BIOL CHEM, V258, P7998; ODELL BL, 1960, P SOC EXP BIOL MED, V103, P304, DOI 10.3181/00379727-103-25498; Oom A, 2008, J CEREAL SCI, V47, P109, DOI 10.1016/j.jcs.2007.02.005; Oria MP, 2000, P NATL ACAD SCI USA, V97, P5065, DOI 10.1073/pnas.080076297; ORIA MP, 1995, J AGR FOOD CHEM, V43, P2148, DOI 10.1021/jf00056a036; Osman MA, 2004, FOOD CHEM, V88, P129, DOI 10.1016/j.foodchem.2003.12.038; Parker ML, 1999, J CEREAL SCI, V30, P209, DOI 10.1006/jcrs.1999.0281; Perlas LA, 2002, J SCI FOOD AGR, V82, P1115, DOI 10.1002/jsfa.1156; PRICE ML, 1978, J AGR FOOD CHEM, V26, P1214, DOI 10.1021/jf60219a031; Raihanatu MB, 2011, BIOKEMISTRI, V23; Reddy MB, 1996, AM J CLIN NUTR, V63, P203, DOI 10.1093/ajcn/63.2.203; ROONEY LW, 1986, J ANIM SCI, V63, P1607, DOI 10.2527/jas1986.6351607x; Sandberg AS, 2002, BRIT J NUTR, V88, pS281, DOI 10.1079/BJN/2002718; Saravanabavan SN, 2013, J FOOD SCI TECH MYS, V50, P387, DOI 10.1007/s13197-011-0336-x; SAVELKOUL FHMG, 1992, PLANT FOOD HUM NUTR, V42, P71, DOI 10.1007/BF02196074; Schlemmer U., 2009, MOL NUTR FOOD RES, V53; SMITH C, 1980, J SCI FOOD AGR, V31, P341, DOI 10.1002/jsfa.2740310403; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; TAN CGL, 1971, EUR J BIOCHEM, V18, P503, DOI 10.1111/j.1432-1033.1971.tb01270.x; Tanksley TD, ILEAL DIGESTIBILITIE; TASHIRO M, 1978, AGR BIOL CHEM TOKYO, V42, P1119, DOI 10.1080/00021369.1978.10863122; Taylor J, 2002, INT J FOOD SCI TECH, V37, P129, DOI 10.1046/j.1365-2621.2002.00549.x; Taylor J, 2011, J AGR FOOD CHEM, V59, P2386, DOI 10.1021/jf104006v; Taylor JR, 2005, P AUSTR POULTR SCI S, V17, P16; TAYLOR JRN, 1984, CEREAL CHEM, V61, P69; Team RC, 2016, R LANG ENV STAT COMP; Tesso T, 2008, PLANT BREEDING, V127, P579, DOI 10.1111/j.1439-0523.2008.01523.x; Wang X, 2011, CHINESE SCI BULL, V56, P2351, DOI 10.1007/s11434-011-4568-y; Weaver CA, 1998, CEREAL CHEM, V75, P665, DOI 10.1094/CCHEM.1998.75.5.665; WEN L, 1992, PLANT MOL BIOL, V18, P813, DOI 10.1007/BF00020026; Wong JH, 2009, J CEREAL SCI, V49, P73, DOI 10.1016/j.jcs.2008.07.013	90	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0203005	10.1371/journal.pone.0203005	http://dx.doi.org/10.1371/journal.pone.0203005			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192773	Green Submitted, Green Published, gold			2022-12-26	WOS:000444093600042
J	Manresa, JB; Andersen, OK; Mouraux, A; van den Broeke, EN				Manresa, Jose Biurrun; Andersen, Ole Kaeseler; Mouraux, Andre; van den Broeke, Emanuel N.			High frequency electrical stimulation induces a long-lasting enhancement of event-related potentials but does not change the perception elicited by intra-epidermal electrical stimuli delivered to the area of increased mechanical pinprick sensitivity	PLOS ONE			English	Article							NEUROGENIC HYPERALGESIA; SECONDARY HYPERALGESIA; CAPSAICIN INJECTION; HEAT HYPERALGESIA; TERM POTENTIATION; HAIRY SKIN; HUMANS; RESPONSES; PAIN; AFFERENTS	High frequency electrical stimulation (HFS) of the skin induces increased pinprick sensitivity in the surrounding unconditioned skin. The aim of the present study was to investigate the contribution of A-fiber nociceptors to this increased pinprick sensitivity. For this we assessed if the perception and brain responses elicited by low-intensity intra-epidermal electrical stimulation (IES), a method preferentially activating A delta-fiber nociceptors, are increased in the area of HFS-induced increased pinprick sensitivity. HFS was delivered to one of the two forearms of seventeen healthy volunteers. Mechanical pinprick stimulation and IES were delivered at both arms before HFS (TO), 20 minutes after HFS (T1) and 45 minutes after HFS (T2). In all participants, HFS induced an increase in pinprick perception at the HFS-treated arm, adjacent to the site of HFS. This increase was significant at both T1 and T2. HFS did not affect the percept elicited by IES, but did enhance the magnitude of the N2 wave of IES-evoked brain potentials, both at T1 and at T2. Our results show that HFS induces a long-lasting enhancement of the N2 wave elicited by IES in the area of secondary hyperalgesia, indicating that HFS enhances the responsiveness of the central nervous system to nociceptive A-fiber input. However, we found no evidence that HFS affects the perception elicited by IES, which may suggest that the population of nociceptors that mediate the perception elicited by IES do not contribute to HFS-induced increased pinprick sensitivity.	[Manresa, Jose Biurrun; Andersen, Ole Kaeseler] Aalborg Univ, Fac Med, Ctr Neu roplastic & Pain, Dept Hlth Sci & Technol, Aalborg, Denmark; [Manresa, Jose Biurrun] CONICET UNER, Inst Invest & Desarrollo Bioingn & Bioinformat, Entre Rios, Argentina; [Mouraux, Andre; van den Broeke, Emanuel N.] Catholic Univ Louvain, Inst Neurosci, Div Cognit & Syst, Brussels, Belgium	Aalborg University; Universite Catholique Louvain	van den Broeke, EN (corresponding author), Catholic Univ Louvain, Inst Neurosci, Div Cognit & Syst, Brussels, Belgium.	Emanuel.vandenbroeke@uclouvain.be	Andersen, Ole Kæseler/J-7825-2013; Manresa, José A Biurrun/Q-4801-2017; Manresa, José A Biurrun/B-2190-2012; Mouraux, Andre/F-3724-2012	Andersen, Ole Kæseler/0000-0001-6307-8786; Manresa, José A Biurrun/0000-0003-4060-9665; Mouraux, Andre/0000-0003-1056-5980	European Research Council (ERC) [PROBING PAIN 336130]; Danish National Research Foundation [DNRF121]	European Research Council (ERC)(European Research Council (ERC)); Danish National Research Foundation(Danmarks Grundforskningsfond)	ENvdB and AM are supported by the European Research Council (ERC) "StartingGrant" (PROBING PAIN 336130). OKA and JBM are supported by the Danish National Research Foundation (DNRF121).	Ali Z, 1996, PAIN, V68, P401, DOI 10.1016/S0304-3959(96)03199-5; Geber C, 2007, J PAIN, V8, P503, DOI 10.1016/j.jpain.2007.01.008; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; HARDY JD, 1950, J CLIN INVEST, V29, P115, DOI 10.1172/JCI102227; Henrich F, 2015, BRAIN, V138, P2505, DOI 10.1093/brain/awv108; Inui K, 2002, PAIN, V96, P247, DOI 10.1016/S0304-3959(01)00453-5; Klein T, 2004, J NEUROSCI, V24, P964, DOI 10.1523/JNEUROSCI.1222-03.2004; LAMOTTE RH, 1991, J NEUROPHYSIOL, V66, P190, DOI 10.1152/jn.1991.66.1.190; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Liang M, 2016, J NEUROPHYSIOL, V116, P286, DOI 10.1152/jn.00013.2016; MEYER RA, 1981, BRAIN RES, V224, P149, DOI 10.1016/0006-8993(81)91124-0; Mouraux A, 2010, PAIN, V150, P199, DOI 10.1016/j.pain.2010.04.026; Nicholls MER, 2013, CORTEX, V49, P2914, DOI 10.1016/j.cortex.2013.02.002; Pfau DB, 2011, PAIN, V152, P1532, DOI 10.1016/j.pain.2011.02.037; Serra J, 1998, J NEUROPHYSIOL, V80, P2801, DOI 10.1152/jn.1998.80.6.2801; SIMONE DA, 1991, J NEUROPHYSIOL, V66, P228, DOI 10.1152/jn.1991.66.1.228; Sumikura H, 2005, SOMATOSENS MOT RES, V22, P233, DOI 10.1080/08990220500262778; Torta DME, 2017, PAIN, V158, P691, DOI 10.1097/j.pain.0000000000000816; Treede RD, 1998, J NEUROPHYSIOL, V80, P1082, DOI 10.1152/jn.1998.80.3.1082; van den Broeke EN, 2017, CLIN NEUROPHYSIOL, V128, P1445, DOI 10.1016/j.clinph.2017.05.006; van den Broeke EN, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00531; van den Broeke EN, 2016, J PHYSIOL-LONDON, V594, P6767, DOI 10.1113/JP272599; van den Broeke EN, 2014, J NEUROPHYSIOL, V111, P1564, DOI 10.1152/jn.00651.2013; Wooten M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5122	24	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2018	13	9							e0203365	10.1371/journal.pone.0203365	http://dx.doi.org/10.1371/journal.pone.0203365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1KN	30188910	Green Published, gold, Green Submitted			2022-12-26	WOS:000444228700027
J	Abu Bakar, A; Adamson, EAS; Juliana, LH; Mohd, SAN; Wei-Jen, C; Man, A; Md, DN				Abu Bakar, Adibah; Adamson, Eleanor A. S.; Juliana, Lia Halim; Mohd, Siti Azizah Nor; Wei-Jen, Chen; Man, Alias; Md, Darlina Naim			DNA barcoding of Malaysian commercial snapper reveals an unrecognized species of the yellow-lined Lutjanus (Pisces: Lutjanidae)	PLOS ONE			English	Article							COMPARATIVE PHYLOGEOGRAPHY; RECENT INVASION; ATLANTIC	Management of wild fisheries resources requires accurate knowledge on which species are being routinely exploited, but it can be hard to identify fishes to species level, especially in speciose fish groups where colour patterns vary with age. Snappers of the genus Lutjanus represent one such group, where fishes can be hard to identify and as a result fisheries statistics fail to capture species-level taxonomic information. This study employs traditional morphological and DNA barcoding approaches to identify adult and juvenile Lutjanus species harvested in Malaysian waters. Our results reveal a suite of species that differs markedly from those that have previously been considered important in the Malaysian wild-capture fishery and show that official fisheries statistics do not relate to exploitation at the species level. Furthermore, DNA barcoding uncovered two divergent groups of bigeye snapper ('Lutjanus lutjanus') distributed on either side of the Malay Peninsula, displaying a bio-geographical pattern similar to distributions observed for many co-occurring reef-distributed fish groups. One of these bigeye snapper groups almost certainly represents an unrecognized species in need of taxonomic description. The study demonstrates the utility of DNA barcoding in uncovering overlooked diversity and for assessing species catch composition in a complicated but economically important taxonomic group.	[Abu Bakar, Adibah; Adamson, Eleanor A. S.; Juliana, Lia Halim; Mohd, Siti Azizah Nor; Md, Darlina Naim] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Abu Bakar, Adibah] UPSI, Fac Sci & Math, Tanjong Malim, Perak, Malaysia; [Mohd, Siti Azizah Nor] Univ Malaysia Terengganu, Inst Bioteknol Marin, Kuala Terengganu, Terengganu, Malaysia; [Wei-Jen, Chen] Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan; [Man, Alias] FRI, Batu Maung, Pulau Pinang, Malaysia	Universiti Sains Malaysia; Universiti Malaysia Terengganu; National Taiwan University	Abu Bakar, A (corresponding author), Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia.; Abu Bakar, A (corresponding author), UPSI, Fac Sci & Math, Tanjong Malim, Perak, Malaysia.	adibahabubakar85@gmail.com	CHEN, Wei-Jen/A-2605-2008	CHEN, Wei-Jen/0000-0003-4751-7632	Delivering Excellence Grant from the Universiti Sains Malaysia [1002/PBIOLOGI/910317, 1001/PBiology/815087]; Skim Latihan Akademik Bumiputera (SLAB) from Universiti Pendidikan Sultan Idris (UPSI); Ministry of Education, Malaysia; DRMREEF Korean Grant	Delivering Excellence Grant from the Universiti Sains Malaysia(Universiti Sains Malaysia); Skim Latihan Akademik Bumiputera (SLAB) from Universiti Pendidikan Sultan Idris (UPSI); Ministry of Education, Malaysia(Ministry of Education, Malaysia); DRMREEF Korean Grant	This work was supported by Delivering Excellence Grant from the Universiti Sains Malaysia 1002/PBIOLOGI/910317: DNA Barcoding and Genomics-Ensuring Sustainable Fisheries Malaysia and Research University Grant (1001/PBiology/815087). This work forms a part of Adibah A.B.'s doctoral research. She was funded by the Skim Latihan Akademik Bumiputera (SLAB) from Universiti Pendidikan Sultan Idris (UPSI) and Ministry of Education, Malaysia. The study was also funded by the DRMREEF Korean Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Talib A., 2000, SUSTAINABLE MANAGEME, P25; Adibah AB, 2015, BIOCHEM SYST ECOL, V60, P204, DOI 10.1016/j.bse.2015.04.026; Allen G. R., 1985, FAO SPECIES CATALOGU, V6; Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Allen Gerald R., 2013, Journal of the Ocean Science Foundation, V6, P33; [Anonymous], 1993, FAO SPECIES IDENTIFI; Barber PH, 2006, EVOLUTION, V60, P1825; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bowen BW, 2006, MAR BIOL, V149, P899, DOI 10.1007/s00227-006-0252-1; Bowen BW, 2006, J HERED, V97, P1, DOI 10.1093/jhered/esj006; Carr CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022232; Cervigon F., 1993, PECES MARINHOS VENEZ, VII; Chong VC, 2010, J FISH BIOL, V76, P2009, DOI 10.1111/j.1095-8649.2010.02685.x; Costa L. D. F, 2007, ADV PHYS, V56, P78; DoFM-Department of Fisheries Malaysia, 2014, ANN FISH STAT 2014; Eschmeyer WN, CATALOG FISHES GENER; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Iwatsuki Y., 2015, LUTJANUS XANTHOPINNI; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knittweis L., 2008, THESIS; Kochzius M., 2008, MOL ECOLOGY; Lamendin R, 2015, FOOD CONTROL, V47, P436, DOI 10.1016/j.foodcont.2014.07.039; Lourie SA, 2005, MOL ECOL, V14, P1073, DOI 10.1111/j.1365-294X.2005.02464.x; Matos-Caraballo D, 2000, PUERTO RICO NMFS INT; Mendoza J. J, 1996, ICLARM C P, V48, P266; Nelson JS, 2006, FISHES WORLD; Packer L, 2009, MOL ECOL RESOUR, V9, P42, DOI 10.1111/j.1755-0998.2009.02631.x; Prescod S, 1991, SNAPPER FISHERY BARB; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rocha LA, 2005, MOL ECOL, V14, P3921, DOI 10.1111/j.1365-294X.2005.02698.x; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Strauss R.E., 1990, P109; Sugama K, 2002, AQUACULTURE, V205, P37, DOI 10.1016/S0044-8486(01)00662-7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716	38	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202945	10.1371/journal.pone.0202945	http://dx.doi.org/10.1371/journal.pone.0202945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183729	gold, Green Published, Green Submitted			2022-12-26	WOS:000443789900041
J	Zhang, R; Li, SS; Li, C; Zhao, DD; Guo, LQ; Qu, PF; Liu, DM; Dang, SN; Yan, H				Zhang, Ruo; Li, Shanshan; Li, Chao; Zhao, Doudou; Guo, Leqian; Qu, Pengfei; Liu, Danmeng; Dang, Shaonong; Yan, Hong			Socioeconomic inequalities and determinants of maternal health services in Shaanxi Province, Western China	PLOS ONE			English	Article							CESAREAN-SECTION; CARE; INTERVENTIONS; COUNTRIES; TRENDS	Prenatal health care interventions are effective ways to improve maternal and neonatal health. There have been few large investigations conducted on the inequalities in maternal health services utilization in Shaanxi Province of west China since the health care reform in 2009. This study examined the inequalities and determinants of maternal health services utilization in Shaanxi Province. A household survey was conducted from August to November in 2013. By using a multistage sampling method, local women aged 15-49 who had given birth in the preceding three years were recruited. Information including social-demographic characteristics and maternal health services utilization was collected through a face-to-face interview. A concentration index approach was used to measure inequalities in maternal health services utilization. A logistic regression model was employed to investigate the determinants of maternal health services utilization. There were 8,488 women from urban areas and 18,724 women from rural areas enrolled in this study. The concentration index for all the indicators of maternal health services utilization showed significance in these two areas. In urban areas, the concentration index of having 5 or more prenatal visits, receiving the first prenatal visit within 12 weeks, delivering at secondary-or higher-level health facilities and delivering by C-section were 0.0356, 0.0166, 0.0177 and 0.0591, respectively, while in rural areas, the corresponding figures were 0.0385, 0.0183, 0.0334 and 0.0566, respectively. The determinants related to maternal health services utilization were women's age at delivery, educational level, employment status, parity, health problems during pregnancy and household income. Inequalities in maternal health services utilization still exist in Shaanxi Province. Providing maternal health services for younger, less educated, unemployed, high parity and poorer women, especially in rural areas, is expected to reduce the inequalities in maternal health services utilization.	[Zhang, Ruo; Li, Shanshan; Li, Chao; Zhao, Doudou; Guo, Leqian; Qu, Pengfei; Liu, Danmeng; Dang, Shaonong; Yan, Hong] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian, Shaanxi, Peoples R China; [Yan, Hong] Nutr & Food Safety Engn Res Ctr Shaanxi Prov, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Dang, SN; Yan, H (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian, Shaanxi, Peoples R China.; Yan, H (corresponding author), Nutr & Food Safety Engn Res Ctr Shaanxi Prov, Xian, Shaanxi, Peoples R China.	tjdshn@mail.xjtu.edu.cn; xjtu_yh.paper@aliyun.com	Shaonong, Dang/J-7421-2019	Shaonong, Dang/0000-0002-6980-8169	National Natural Science Foundation of China [81230016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China provided grant no. 81230016 and had no role in the design, analysis or writing of this article.	Amano A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-105; Azami-Aghdash S, 2014, IRAN J PUBLIC HEALTH, V43, P545; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; CAI JL, 2017, INT J EQUITY HEALTH, V16, P46204, DOI DOI 10.1186/S12939-017-0624-9; Darling Rosa D, 2012, Policy Polit Nurs Pract, V13, P17, DOI 10.1177/1527154412442391; Doctor HV, 2011, HEALTH PLACE, V17, P480, DOI 10.1016/j.healthplace.2010.12.003; Fan XJ, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4601-4; Feng Xing Lin, 2012, J Glob Health, V2, P010405, DOI 10.7189/jogh.02.010405; Feyissa TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097194; Friberg IK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000295; Garg Pankaj, 2015, Asia Pac Fam Med, V14, P7, DOI 10.1186/s12930-015-0024-5; Harrison MS, 2017, ACTA OBSTET GYN SCAN, V96, P410, DOI 10.1111/aogs.13098; Joshi C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-94; Kebede A, 2016, INT J WOMENS HEALTH, V8, P463, DOI 10.2147/IJWH.S109498; Kifle D, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-016-0270-5; Lassi ZS, 2015, EBIOMEDICINE, V2, P985, DOI 10.1016/j.ebiom.2015.05.023; Li C, 2015, PUBLIC HEALTH, V129, P1251, DOI 10.1016/j.puhe.2015.07.002; Liu XN, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-102; Liu Ying-hui, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P1029; Long Q, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0686-x; Manzi A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-290; Matsumura M, 2001, WOMENS STATUS HOUSEH; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Muhwava LS, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0807-1; Murray KD, 2007, PAEDIATR PERINAT EP, V21, P274, DOI 10.1111/j.1365-3016.2007.00800.x; Mustafa MH, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1128-1; National Bureau of Statistics of the People's Republic of China, 2015, B 6 NAT CENS SHAANX; Pei LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139452; Pulok MH, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0970-4; Rahman A, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-016-0078-5; Rajabi Abdolhalim, 2015, Med J Islam Repub Iran, V29, P294; Sagna ML, 2012, HEALTH PLACE, V18, P415, DOI 10.1016/j.healthplace.2011.12.006; Shen Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-155; Sprague DA, 2016, EMERG THEMES EPIDEMI, V13, DOI 10.1186/s12982-016-0049-8; Wado YD, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-36; Wagstaff A., 1989, OXFORD REV EC, V5, P89, DOI DOI 10.1093/oxrep/5.1.89; Wang C, 2013, CHEST, V143, P524, DOI 10.1378/chest.12-1839; Wang YP, 2016, LANCET, V387, P273, DOI 10.1016/S0140-6736(15)00554-1; WHO, 2018, MAT MORT; Xiao SB, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-695; Yang W, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-20; Yuan BB, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19542; Zhao Q, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1012; Zhou Y, 2012, J REPROD MED, V57, P441	44	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0202129	10.1371/journal.pone.0202129	http://dx.doi.org/10.1371/journal.pone.0202129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183720	Green Published, gold, Green Submitted			2022-12-26	WOS:000443789900016
J	Clark, L; Leatherby, D; Krilich, E; Ropelewski, AJ; Perozich, J				Clark, Louis; Leatherby, Danielle; Krilich, Elizabeth; Ropelewski, Alexander J.; Perozich, John			In silico analysis of class I adenylate-forming enzymes reveals family and group-specific conservations	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASE; FATTY ACYL-COENZYME; SITE-DIRECTED MUTAGENESIS; AMINO-ACID-RESIDUES; FIREFLY LUCIFERASE; ALCOHOL DEHYDROGENASES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; COA SYNTHETASE; A SYNTHETASE	Luciferases, aryl-and fatty-acyl CoA synthetases, and non-ribosomal peptide synthetase proteins belong to the class I adenylate-forming enzyme superfamily. The reaction catalyzed by the adenylate-forming enzymes is categorized by a two-step process of adenylation and thioesterification. Although all of these proteins perform a similar two-step process, each family may perform the process to yield completely different results. For example, luciferase proteins perform adenylation and oxidation to produce the green fluorescent light found in fireflies, while fatty-acyl CoA synthetases perform adenylation and thioesterification with coenzyme A to assist in metabolic processes involving fatty acids. This study aligned a total of 374 sequences belonging to the adenylate-forming superfamily. Analysis of the sequences revealed five fully conserved residues throughout all sequences, as well as 78 more residues conserved in at least 60% of sequences aligned. Conserved positions are involved in magnesium and AMP binding and maintaining enzyme structure. Also, ten conserved sequence motifs that included most of the conserved residues were identified. A phylogenetic tree was used to assign sequences into nine different groups. Finally, group entropy analysis identified novel conservations unique to each enzyme group. Common group-specific positions identified in multiple groups include positions critical to coordinating AMP and the CoA-bound product, a position that governs active site shape, and positions that help to maintain enzyme structure through hydrogen bonds and hydrophobic interactions. These positions could serve as excellent targets for future research.	[Clark, Louis; Leatherby, Danielle; Krilich, Elizabeth; Perozich, John] Franciscan Univ Steubenville, Dept Biol, Steubenville, OH 43952 USA; [Ropelewski, Alexander J.] Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA	Franciscan University of Steubenville; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Perozich, J (corresponding author), Franciscan Univ Steubenville, Dept Biol, Steubenville, OH 43952 USA.	jperozich@franciscan.edu			U.S. National Institutes of Health, National Institute of General Medical Sciences [T36-GM-008789, T36-GM-095335]; NSF Award [ACI-1445606]; National Science Foundation [OCI-1053575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T36GM095335, T36GM008789] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF Award(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The computing resources used were provided through the Pittsburgh Supercomputing Center. Specifically, BioU which was supported by U.S. National Institutes of Health, National Institute of General Medical Sciences Minority Access to Research Careers Grants (T36-GM-008789, T36-GM-095335) and Bridges acquired through NSF Award ACI-1445606 and made available through the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by the National Science Foundation grant OCI-1053575. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ST, 2016, ANGEW CHEM INT EDIT, V55, P4943, DOI 10.1002/anie.201511350; Airas RK, 2007, BIOPHYS CHEM, V131, P29, DOI 10.1016/j.bpc.2007.08.006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Banchio C, 2002, APPL ENVIRON MICROB, V68, P4240, DOI 10.1128/AEM.68.9.4240-4246.2002; Black PN, 1997, J BIOL CHEM, V272, P4896, DOI 10.1074/jbc.272.8.4896; Branchini BR, 2017, PHOTOCHEM PHOTOBIOL, V93, P479, DOI 10.1111/php.12671; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Chang KH, 1997, BIOCHEMISTRY-US, V36, P15650, DOI 10.1021/bi971262p; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Crosby HA, 2012, APPL ENVIRON MICROB, V78, P6619, DOI 10.1128/AEM.01733-12; Dieckmann R, 2001, FEBS LETT, V498, P42, DOI 10.1016/S0014-5793(01)02471-1; Drake EJ, 2006, CHEM BIOL, V13, P409, DOI 10.1016/j.chembiol.2006.02.005; Drake EJ, 2010, BIOCHEMISTRY-US, V49, P9292, DOI 10.1021/bi101226n; Dunphy KY, 2010, J INFECT DIS, V201, P1232, DOI 10.1086/651452; Felsenstein J., 1990, PHYLIP MANUAL VERSIO; Feng SX, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00072; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; Ford TJ, 2015, PEERJ, V3, DOI 10.7717/peerj.1040; Freas N, 2016, FEBS OPEN BIO, V6, P77, DOI 10.1002/2211-5463.12022; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; GOCHT M, 1994, J BACTERIOL, V176, P2654, DOI 10.1128/JB.176.9.2654-2662.1994; Gonzalez O, 2017, MICROB ECOL, V73, P616, DOI 10.1007/s00248-016-0896-4; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Han JW, 2012, BIOTECHNOL LETT, V34, P1327, DOI 10.1007/s10529-012-0913-8; Harwood KR, 2011, CHEM BIOL, V18, P1649, DOI 10.1016/j.chembiol.2011.09.019; HASTINGS JW, 1983, J MOL EVOL, V19, P309, DOI 10.1007/BF02101634; Hempel J, 2003, CHEM-BIOL INTERACT, V143, P23, DOI 10.1016/S0009-2797(02)00165-5; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Hughes AJ, 2011, CHEM BIOL, V18, P165, DOI 10.1016/j.chembiol.2010.12.014; Ilinkin I, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-71; Innis CA, 2000, PROTEIN ENG, V13, P839, DOI 10.1093/protein/13.12.839; Inouye S, 2010, CELL MOL LIFE SCI, V67, P387, DOI 10.1007/s00018-009-0170-8; Irvin J, 2017, FEBS OPEN BIO, V7, P1480, DOI 10.1002/2211-5463.12275; JORNVALL H, 1977, EUR J BIOCHEM, V72, P443, DOI 10.1111/j.1432-1033.1977.tb11268.x; Khare G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008387; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; Koksharov MI, 2013, PHOTOCH PHOTOBIO SCI, V12, P2016, DOI 10.1039/c3pp50242b; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li ZN, 2001, J GEN VIROL, V82, P1085, DOI 10.1099/0022-1317-82-5-1085; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Liu Z, 2013, J BIOL CHEM, V288, P18473, DOI 10.1074/jbc.M113.466912; Lucas RL, 2000, J BACTERIOL, V182, P1872, DOI 10.1128/JB.182.7.1872-1882.2000; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Modestova Y, 2014, BBA-PROTEINS PROTEOM, V1844, P1463, DOI 10.1016/j.bbapap.2014.04.021; Murakami K, 2001, BIOCHEM J, V353, P231, DOI 10.1042/0264-6021:3530231; Nakamura M, 2005, BIOCHEM BIOPH RES CO, V331, P471, DOI 10.1016/j.bbrc.2005.03.202; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Nelson D.L., 2017, LEHNINGER PRINCIPLES; Le NH, 2016, J BIOL CHEM, V291, P22793, DOI 10.1074/jbc.M116.748053; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Nishiguchi T, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.10.101205; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oba Y, 2003, FEBS LETT, V540, P251, DOI 10.1016/S0014-5793(03)00272-2; Oba Y, 2009, FEBS LETT, V583, P2004, DOI 10.1016/j.febslet.2009.05.018; Perozich J, 1998, BBA-PROTEIN STRUCT M, V1382, P23, DOI 10.1016/S0167-4838(97)00131-3; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prlic A, 2010, BIOINFORMATICS, V26, P2983, DOI 10.1093/bioinformatics/btq572; Ray S, 2011, INFECT IMMUN, V79, P258, DOI 10.1128/IAI.00663-10; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Ropelewski AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013999; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schmelz S, 2009, CURR OPIN STRUC BIOL, V19, P666, DOI 10.1016/j.sbi.2009.09.004; Stevens BW, 2006, BIOCHEMISTRY-US, V45, P15495, DOI 10.1021/bi061788m; Strieker M, 2010, CURR OPIN STRUC BIOL, V20, P234, DOI 10.1016/j.sbi.2010.01.009; Tejima K, 2018, CURR GENET, V64, P429, DOI 10.1007/s00294-017-0751-2; Weimar JD, 2002, J BIOL CHEM, V277, P29369, DOI 10.1074/jbc.M107022200; Widder EA, 2010, SCIENCE, V328, P704, DOI 10.1126/science.1174269; Wu R, 2008, BIOCHEMISTRY-US, V47, P8026, DOI 10.1021/bi800698m; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200; Youn B, 2006, ORG BIOMOL CHEM, V4, P1687, DOI 10.1039/b601672c; Zhang ZN, 2011, J MOL BIOL, V406, P313, DOI 10.1016/j.jmb.2010.12.011	82	9	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2018	13	9							e0203218	10.1371/journal.pone.0203218	http://dx.doi.org/10.1371/journal.pone.0203218			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1IK	30180199	Green Published, gold, Green Submitted			2022-12-26	WOS:000444222400031
J	Dzhonova, D; Olariu, R; Leckenby, J; Dhayani, A; Vemula, PK; Prost, JC; Banz, Y; Taddeo, A; Rieben, R				Dzhonova, Dzhuliya; Olariu, Radu; Leckenby, Jonathan; Dhayani, Ashish; Vemula, Praveen Kumar; Prost, Jean-Christophe; Banz, Yara; Taddeo, Adriano; Rieben, Robert			Local release of tacrolimus from hydrogel-based drug delivery system is controlled by inflammatory enzymes in vivo and can be monitored non-invasively using in vivo imaging	PLOS ONE			English	Article							REJECTION	Background Local drug delivery systems that adjust the release of immunosuppressive drug in response to the nature and intensity of inflammation represent a promising approach to reduce systemic immunosuppression and its side effects in allotransplantation. Here we aimed to demonstrate that release of tacrolimus from triglycerol monostearate hydrogel is inflammationdependent in vivo. We further report that by loading the hydrogel with a near-infrared dye, it is possible to monitor drug release non-invasively in an in vivo model of vascularized composite allotransplantation. Materials and methods Inflammation was induced by local challenge with lipopolysaccharides in naive rats 7 days after injection of tacrolimus-loaded hydrogel in the hind limb. Tacrolimus levels in blood and tissues were measured at selected time points. A near-infrared dye was encapsulated in the hydrogel together with tacrolimus in order to monitor hydrogel deposits and drug release in vitro and in vivo in a model of vascularized composite allotransplantation. Results Injection of lipopolysaccharides led to increased blood and skin tacrolimus levels (p = 0.0076, day 7 vs. day 12 in blood, and p = 0.0007 in treated limbs, 48 h after injection compared to controls). Moreover, lipopolysaccharides-injected animals had higher tacrolimus levels in treated limbs compared to contralateral limbs (p = 0.0003 for skin and p = 0.0053 for muscle). Imaging of hydrogel deposits and tacrolimus release was achieved by encapsu-lating near-infrared dye in the hydrogel for 160 days. The correlation of tacrolimus and near infrared dye release from hydrogel was R-2 = 0.6297 and R-2 = 0.5619 in blood and grafts of transplanted animals respectively and R-2 = 0.6066 in vitro. Conclusions Here we demonstrate the inflammation-responsiveness of a tacrolimus-loaded hydrogel in vivo. Moreover, we show that encapsulating a near-infrared dye in the hydrogel provides a reliable correlation of tacrolimus and dye release from the hydrogel, and an accessible noninvasive method for monitoring drug release from hydrogel deposits.	[Dzhonova, Dzhuliya; Taddeo, Adriano; Rieben, Robert] Univ Bern, Dept BioMed Res DBMR, Bern, Switzerland; [Dzhonova, Dzhuliya] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Olariu, Radu; Leckenby, Jonathan; Taddeo, Adriano] Bern Univ Hosp, Inselspital, Dept Plast & Hand Surg, Bern, Switzerland; [Dhayani, Ashish; Vemula, Praveen Kumar] Inst Stem Cell Biol & Regenerat Med, Bangalore, Karnataka, India; [Dhayani, Ashish] SASTRA Univ, Sch Chem & Biotechnol, Thanjavur, Tamil Nadu, India; [Prost, Jean-Christophe] Univ Hosp, Univ Inst Clin Chem, Ctr Lab Med, Bern, Switzerland; [Banz, Yara] Univ Bern, Inst Pathol, Bern, Switzerland	University of Bern; University of Bern; University of Bern; University Hospital of Bern; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Shanmugha Arts, Science, Technology & Research Academy (SASTRA); University of Bern; University Hospital of Bern; University of Bern	Taddeo, A; Rieben, R (corresponding author), Univ Bern, Dept BioMed Res DBMR, Bern, Switzerland.; Taddeo, A (corresponding author), Bern Univ Hosp, Inselspital, Dept Plast & Hand Surg, Bern, Switzerland.	adriano.taddeo@dbmr.unibe.ch; robert.rieben@dbmr.unibe.ch	Taddeo, Adriano/AAW-3861-2021; Rieben, Robert/D-7044-2017	Taddeo, Adriano/0000-0003-3281-1548; Bovet, Cedric/0000-0002-1600-3818; Dzhonova, Dzhuliya/0000-0001-5196-5417; Rieben, Robert/0000-0003-4179-8891; Prost, Jean-Christophe/0000-0002-8820-706X; Dhayani, Ashish/0000-0002-5488-8952; Olariu, Radu/0000-0002-0204-4432	Indo-Swiss Joint Research Program of the Swiss National Science Foundation (SNF) [156773]; Department of Science and Technology, Govt. of India [INT/SWISS/SNSFP-51/2015]; University Grant Commission	Indo-Swiss Joint Research Program of the Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); University Grant Commission(University Grants Commission, India)	This work was supported by Indo-Swiss Joint Research Program of the Swiss National Science Foundation (SNF, grant 156773) and the Department of Science and Technology, Govt. of India (grant INT/SWISS/SNSFP-51/2015) to R.R. and P.V. respectively. A.D. thanks the University Grant Commission for the senior research fellowship.	Asai D, 2012, BIOMATERIALS, V33, P5451, DOI 10.1016/j.biomaterials.2012.03.083; Bloch S, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2070148; Capron A, 2012, TRANSPL INT, V25, P41, DOI 10.1111/j.1432-2277.2011.01365.x; Dzhonova DV, 2018, TRANSPLANTATION, P1; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gajanayake T, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008778; Gharb BB, 2013, TRANSPLANTATION, V95, P1197, DOI 10.1097/TP.0b013e31828bca61; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Mieog JSD, 2011, ANN SURG ONCOL, V18, P2483, DOI 10.1245/s10434-011-1566-x; Olariu R, 2017, J SURG RES, V218, P49, DOI 10.1016/j.jss.2017.05.046; Petrou P, 2018, CULT HEALTH SEX, V20, P640, DOI 10.1080/13691058.2017.1368710; Petruzzo P, 2017, CURRENT TRANSPLANTAT, P1; Selvam S, 2011, BIOMATERIALS, V32, P7785, DOI 10.1016/j.biomaterials.2011.07.020; Solari MG, 2009, PLAST RECONSTR SURG, V123, p17S, DOI 10.1097/PRS.0b013e318191bcbd; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Taddeo A, 2018, CURRENT OPINION ORGA, V1; Unadkat JV, 2017, PLAST RECONSTR SURG, V139, p403E, DOI 10.1097/PRS.0000000000002951; Wang T, 2010, AM J TRANSPLANT, V10, P1524, DOI 10.1111/j.1600-6143.2010.03066.x	18	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203409	10.1371/journal.pone.0203409	http://dx.doi.org/10.1371/journal.pone.0203409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161258	gold, Green Published, Green Submitted			2022-12-26	WOS:000443388900123
J	Na'ara, S; Amit, M; Gil, Z				Na'ara, Shorook; Amit, Moran; Gil, Ziv			L1CAM induces perineural invasion of pancreas cancer cells by upregulation of metalloproteinase expression	ONCOGENE			English	Article							PRESENILIN/GAMMA-SECRETASE; DUCTAL ADENOCARCINOMA; MOLECULE L1; ADHESION; ACTIVATION; CARCINOMA; NERVE; DISSEMINATION; CONTRIBUTES; MIGRATION	Pancreas cancer cells have a tendency to invade along nerves. Such cancerous nerve invasion (CNI) is associated with poor outcome; however, the exact mechanism that drives cancer cells to disseminate along nerves is unknown. Immunohistochemical analysis of human pancreatic ductal adenocarcinoma (PDAC) specimens showed overexpression of the L1 cell adhesion molecule (L1CAM) in cancer cells and in adjacent Schwann cells (SC) in invaded nerves. By modeling the neural microenvironment, we found that L1CAM secreted from SCs acts as a strong chemoattractant to cancer cells, through activation of MAP kinase signaling. L1CAM also upregulated expression of metalloproteinase-2 (MMP-2) and MMP-9 by PDAC cells, through STAT3 activation. Using a transgenic Pdx-1-Cre/KrasG12D /p53R172H (KPC) mouse model, we show that treatment with anti-L1CAM Ab significantly reduces CNI in vivo. We provide evidence of a paracrine response between SCs and cancer cells in the neural niche, which promotes cancer invasion via L1CAM secretion.	[Na'ara, Shorook; Amit, Moran; Gil, Ziv] Rambam Healthcare Campus, Lab Appl Canc Res, Head & Neck Ctr, Dept Otolaryngol Head & Neck Surg,Clin Res Inst, Haifa, Israel; [Gil, Ziv] Technion Israel Inst Technol, Rappaport Inst Med & Res, Technion Integrated Canc Ctr, Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Gil, Z (corresponding author), Rambam Healthcare Campus, Lab Appl Canc Res, Head & Neck Ctr, Dept Otolaryngol Head & Neck Surg,Clin Res Inst, Haifa, Israel.; Gil, Z (corresponding author), Technion Israel Inst Technol, Rappaport Inst Med & Res, Technion Integrated Canc Ctr, Haifa, Israel.	ziv@baseofskull.org			Israeli Science Foundation; Binational US-Israel Science Foundation; ICRF grant (Jacki and Bruce Barron cancer research scholars' program); ICRF grant (Barbara S Goodman research grant); Israel Cancer Association	Israeli Science Foundation(Israel Science Foundation); Binational US-Israel Science Foundation(US-Israel Binational Science Foundation); ICRF grant (Jacki and Bruce Barron cancer research scholars' program); ICRF grant (Barbara S Goodman research grant); Israel Cancer Association	Cindy Cohen is thanked for her editorial assistance. Nofar Rada is thanked for her artistic work. This study was supported by grants from the Israeli Science Foundation, Binational US-Israel Science Foundation, ICRF grant (Jacki and Bruce Barron cancer research scholars' program and Barbara S Goodman research grant) and Israel Cancer Association.	Abiatari I, 2009, INT J ONCOL, V35, P1111, DOI 10.3892/ijo_00000426; Amit M, 2017, ONCOGENE, V36, P3232, DOI 10.1038/onc.2016.483; Amit M, 2016, NAT REV CANCER, V16, P399, DOI 10.1038/nrc.2016.38; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Bapat AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165586; Ben QW, 2010, ANN SURG ONCOL, V17, P2213, DOI 10.1245/s10434-010-0955-x; Bergmann F, 2010, ONCOL REP, V24, P909, DOI 10.3892/or_00000936; BOCKMAN DE, 1994, GASTROENTEROLOGY, V107, P219, DOI 10.1016/0016-5085(94)90080-9; Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; CARTER RL, 1983, J CLIN PATHOL, V36, P269, DOI 10.1136/jcp.36.3.269; Cavel O, 2012, CANCER RES, V72, P5733, DOI 10.1158/0008-5472.CAN-12-0764; Ceyhan GO, 2006, ANN SURG, V244, P274, DOI 10.1097/01.sla.0000217642.68697.55; Colombo F, 2014, P NATL ACAD SCI USA, V111, P16943, DOI 10.1073/pnas.1406097111; Dai H, 2007, HUM PATHOL, V38, P299, DOI 10.1016/j.humpath.2006.08.002; Deborde S, 2016, J CLIN INVEST, V126, P1538, DOI 10.1172/JCI82658; Demir IE, 2014, J NATL CANC I, V106; Demir IE, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00097; Demir Ihsan Ekin, 2010, Cancers (Basel), V2, P1513, DOI 10.3390/cancers2031513; Gavert N, 2008, EXPERT OPIN BIOL TH, V8, P1749, DOI 10.1517/14712598.8.11.1749 ; Geismann C, 2009, CANCER RES, V69, P4517, DOI 10.1158/0008-5472.CAN-08-3493; Gil Z, 2010, J NATL CANCER I, V102, P107, DOI 10.1093/jnci/djp456; Guo K, 2013, MOL CANCER THER, V12, P264, DOI 10.1158/1535-7163.MCT-12-0809; Hauser S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018989; He SB, 2014, P NATL ACAD SCI USA, V111, pE2008, DOI 10.1073/pnas.1402944111; Huang XH, 2013, BRAIN RES, V1530, P13, DOI 10.1016/j.brainres.2013.07.043; Kaifi JT, 2006, WORLD J GASTROENTERO, V12, P94, DOI 10.3748/wjg.v12.i1.94; Lahoud MJ, 2016, WORLD J GASTRO ONCOL, V8, P599, DOI 10.4251/wjgo.v8.i8.599; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Maru N, 2001, HUM PATHOL, V32, P828, DOI 10.1053/hupa.2001.26456; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Na'ara S, 2016, JOVE-J VIS EXP, DOI 10.3791/52990; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Roh J, 2015, ORAL ONCOL, V51, P16, DOI 10.1016/j.oraloncology.2014.10.004; Saloman JL, 2016, P NATL ACAD SCI USA, V113, P3078, DOI 10.1073/pnas.1512603113; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Silletti S, 2004, J BIOL CHEM, V279, P28880, DOI 10.1074/jbc.M404075200; Stopczynski RE, 2014, CANCER RES, V74, P1718, DOI 10.1158/0008-5472.CAN-13-2050; Swanson BJ, 2007, CANCER RES, V67, P10222, DOI 10.1158/0008-5472.CAN-06-2483; Takahashi T, 1997, J SURG ONCOL, V65, P164, DOI 10.1002/(SICI)1096-9098(199707)65:3<164::AID-JSO4>3.0.CO;2-4; Torres MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080580; Webber C, 2010, EXP NEUROL, V223, P51, DOI 10.1016/j.expneurol.2009.05.037; Weinspach D, 2014, CLIN EXP METASTAS, V31, P87, DOI 10.1007/s10585-013-9613-6	42	39	39	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 24	2019	38	4					596	608		10.1038/s41388-018-0458-y	http://dx.doi.org/10.1038/s41388-018-0458-y			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HI6UB	30171263				2022-12-26	WOS:000456589800010
J	Tian, B; Widen, SG; Yang, J; Wood, TG; Kudlicki, A; Zhao, YX; Brasier, AR				Tian, Bing; Widen, Steven G.; Yang, Jun; Wood, Thomas G.; Kudlicki, Andrzej; Zhao, Yingxin; Brasier, Allan R.			The NF kappa B subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NF-B; epithelial-mesenchymal transition (EMT); gene regulation; transforming growth factor (TGF-); transcription regulation; lung disease; mucosal injury; RELA proto-oncogene; Wnt; ZEB	TGF-BETA; PULMONARY-FIBROSIS; SIGNALING PATHWAY; UP-REGULATION; EXPRESSION; INFLAMMATION; MECHANISMS; MODEL; PHOSPHORYLATION; ELONGATION	The epithelial-mesenchymal transition (EMT) is a multistep dedifferentiation program important in tissue repair. Here, we examined the role of the transcriptional regulator NF-B in EMT of primary human small airway epithelial cells (hSAECs). Surprisingly, transforming growth factor (TGF) activated NF-B/RELA proto-oncogene, NF-B subunit (RELA) translocation within 1 day of stimulation, yet induction of its downstream gene regulatory network occurred only after 3 days. A time course of TGF-induced EMT transition was analyzed by RNA-Seq in the absence or presence of inducible shRNA-mediated silencing of RELA. In WT cells, TGF stimulation significantly affected the expression of 2,441 genes. Gene set enrichment analysis identified WNT, cadherin, and NF-B signaling as the most prominent TGF-inducible pathways. By comparison, RELA controlled expression of 3,138 overlapping genes mapping to WNT, cadherin, and chemokine signaling pathways. Conducting upstream regulator analysis, we found that RELA controls six clusters of upstream transcription factors, many of which overlapped with a transcription factor topology map of EMT developed earlier. RELA triggered expression of three key EMT pathways: 1) the WNT/-catenin morphogen pathway, 2) the JUN transcription factor, and 3) the Snail family transcriptional repressor 1 (SNAI1). RELA binding to target genes was confirmed by ChIP. Experiments independently validating WNT dependence on RELA were performed by silencing RELA via genome editing and indicated that TGF-induced WNT5B expression and downstream activation of the WNT target AXIN2 are RELA-dependent. We conclude that RELA is a master transcriptional regulator of EMT upstream of WNT morphogen, JUN, SNAI1-ZEB1, and interleukin-6 autocrine loops.	[Tian, Bing; Yang, Jun; Zhao, Yingxin] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Widen, Steven G.; Wood, Thomas G.; Kudlicki, Andrzej] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Tian, Bing; Widen, Steven G.; Yang, Jun; Wood, Thomas G.; Kudlicki, Andrzej; Zhao, Yingxin] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Kudlicki, Andrzej; Zhao, Yingxin] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Brasier, Allan R.] Univ Wisconsin, Sch Med & Publ Hlth, Inst Clin & Translat Res, Madison, WI 53705 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Wisconsin System; University of Wisconsin Madison	Brasier, AR (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Hlth Sci Learning Ctr 4246, Madison, WI 53705 USA.	abrasier@wisc.edu	Wood, Thomas/GWZ-2481-2022; Kudlicki, Andrzej/AAG-8537-2019	Wood, Thomas/0000-0001-8962-8571; Kudlicki, Andrzej/0000-0001-8158-9600; Brasier, Allan/0000-0002-5012-4090	NIAID, National Institutes of Health Grant [AI062885]; National Center for Advancing Translational Sciences, National Institutes of Health Grant [ULTR00002373]; National Science Foundation [DMS-1361411]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER	NIAID, National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Advancing Translational Sciences, National Institutes of Health Grant; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grant AI062885; National Center for Advancing Translational Sciences, National Institutes of Health Grant ULTR00002373; and National Science Foundation Grant DMS-1361411. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bao J, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003028; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Brasier AR, 2011, J VIROL, V85, P11752, DOI 10.1128/JVI.05360-11; Brasier AR, 2009, CELLULAR SIGNALING AND INNATE IMMUNE RESPONSES TO RNA VIRUS INFECTIONS, P119; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Chang HY, 2016, NUCLEIC ACIDS RES, V44, P2514, DOI 10.1093/nar/gkw126; Cieslik M, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-28; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Forbus J, 2006, PROTEOMICS, V6, P2656, DOI 10.1002/pmic.200500652; Gould J., GENE E MATRIX VISUAL; Harris WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070196; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoot KE, 2010, J CLIN INVEST, V120, P3606, DOI 10.1172/JCI43304; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Ijaz T, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-13; Jamaluddin M, 2007, CELL SIGNAL, V19, P1419, DOI 10.1016/j.cellsig.2007.01.020; Jamaluddin M, 2009, J VIROL, V83, P10605, DOI 10.1128/JVI.01090-09; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jordan NV, 2011, CELL CYCLE, V10, P2865, DOI 10.4161/cc.10.17.17188; Kalita M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/505864; Kalita MK, 2011, J BIOL CHEM, V286, P37741, DOI 10.1074/jbc.M111.280925; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanazawa A, 2005, BIOCHEM BIOPH RES CO, V330, P505, DOI 10.1016/j.bbrc.2005.03.007; Kanzawa M, 2013, PATHOBIOLOGY, V80, P235, DOI 10.1159/000346843; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim MK, 2013, INT J CLIN EXP PATHO, V6, P1747; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Komiya Yuko, 2008, Organogenesis, V4, P68; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu M, 2013, P NATL ACAD SCI USA, V110, P18144, DOI 10.1073/pnas.1318192110; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tian B, 2018, CELL REP, V23, P1138, DOI 10.1016/j.celrep.2018.03.106; Tian B, 2018, J VIROL, V92, DOI 10.1128/JVI.00441-18; Tian B, 2017, AM J RESP CELL MOL, V56, P506, DOI 10.1165/rcmb.2016-0259OC; Tian B, 2016, AM J PHYSIOL-LUNG C, V311, pL1183, DOI 10.1152/ajplung.00224.2016; Tian B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1707-x; Tian B, 2013, J VIROL, V87, P7075, DOI 10.1128/JVI.03399-12; Tian B, 2012, METHODS MOL BIOL, V809, P105, DOI 10.1007/978-1-61779-376-9_7; Vaughan MB, 2006, DIFFERENTIATION, V74, P141, DOI 10.1111/j.1432-0436.2006.00069.x; Vogelmeier CF, 2017, EUR RESPIR J, V49, DOI [10.1183/13993003.00214-2017, 10.1016/j.arbres.2017.02.001, 10.1111/resp.13012, 10.1164/rccm.201701-0218PP]; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Zhang JY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005304; Zhao YX, 2016, J PROTEOMICS, V148, P126, DOI 10.1016/j.jprot.2016.07.014	70	26	28	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16528	16545		10.1074/jbc.RA118.003662	http://dx.doi.org/10.1074/jbc.RA118.003662			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30166344	Green Published, hybrid			2022-12-26	WOS:000447833600033
J	Wegelius, A; Li, X; Turco, F; Stensjo, K				Wegelius, Adam; Li, Xin; Turco, Federico; Stensjo, Karin			Design and characterization of a synthetic minimal promoter for heterocyst-specific expression in filamentous cyanobacteria	PLOS ONE			English	Article							GENE-EXPRESSION; DIFFERENTIATION; SELECTION; VECTORS; BIOLOGY	Short and well defined promoters are essential for advancing cyanobacterial biotechnology. The heterocyst of Nostoc sp. is suggested as a microbial cell factory for oxygen sensitive catalysts, such as hydrogenases for hydrogen production, due to its microoxic environment. We identified and predicted promoter elements of possible significance through a consensus strategy using a pool of heterocyst-induced DIF+ promoters known from Anabaena sp. PCC 7120. To test if these conserved promoter elements were crucial for heterocyst-specific expression, promoter-yfp reporter constructs were designed. The characterization was accomplished by replacing, -35 and -10 regions and the upstream element, with well described elements from the trc promoter of Escherichia coli, which is also functional in Nostoc sp. From the in vivo spatial fluorescence of the different promoter-yfp reporters in Nostoc punctiforme ATCC 29133, we concluded that both the consensus -35 and extended -10 regions were important for heterocyst-specific expression. Further that the promoter strength could be improved by the addition of an upstream element. We designed a short synthetic promoter of 48 nucleotides, P-synDIF, including a consensus DIF1 sequence, a 17 base pair stretch of random nucleotides and an extended consensus -10 region, and thus generated the shortest promoter for heterocyst-specific expression to date.	[Wegelius, Adam; Li, Xin; Turco, Federico; Stensjo, Karin] Uppsala Univ, Dept Chem, Angstrom Lab, Uppsala, Sweden; [Turco, Federico] Univ Nottingham, Ctr Biomol Sci, Univ Pk, Nottingham, England	Uppsala University; University of Nottingham	Stensjo, K (corresponding author), Uppsala Univ, Dept Chem, Angstrom Lab, Uppsala, Sweden.	karin.stensjo@kemi.uu.se	Stensjo, Karin/E-3801-2017	Stensjo, Karin/0000-0001-6993-8476	NordForsk, NCoE program "NordAqua" [82845]; Swedish Energy Agency [11674-5]	NordForsk, NCoE program "NordAqua"; Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC))	This work was supported by NordForsk (https://www.nordforsk.org/en), NCoE program "NordAqua" (project # 82845), and the Swedish Energy Agency (https://www.energimyndigheten.se/en/), (project # 11674-5) to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agervald A, 2008, BMC MICROBIOL, V8, P1, DOI [10.1186/1471-2180-8-1, DOI 10.1186/1471-2180-8-1]; Aldea MR, 2007, J BACTERIOL, V189, P8392, DOI 10.1128/JB.00821-07; Argueta C, 2004, J MICROBIOL METH, V59, P181, DOI 10.1016/j.mimet.2004.06.009; Avilan L, 2018, APPL MICROBIOL BIOT, V102, P5775, DOI 10.1007/s00253-018-8989-2; Bell N, 2017, MOL MICROBIOL, V104, P179, DOI 10.1111/mmi.13620; BERNARD P, 1994, GENE, V148, P71, DOI 10.1016/0378-1119(94)90235-6; BUIKEMA WJ, 1991, GENE DEV, V5, P321, DOI 10.1101/gad.5.2.321; Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Ehira Shigeki, 2015, Life-Basel, V5, P587, DOI 10.3390/life5010587; Ekman M, 2011, J PROTEOME RES, V10, P1772, DOI 10.1021/pr101055v; Elhai J, 2018, MOL MICROBIOL, V110, P931, DOI 10.1111/mmi.14003; Flores E, 2018, BIOCH BIOPHYS ACTA D, DOI [10.1016/j.bbagrm.2018.07.005, DOI 10.1016/J.BBAGRM.2018.07.005]; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; Gartner K, 2012, APPL ENVIRON MICROB, V78, P8579, DOI 10.1128/AEM.01959-12; Golden JW, 2003, CURR OPIN MICROBIOL, V6, P557, DOI 10.1016/j.mib.2003.10.004; Heidorn T, 2011, METHOD ENZYMOL, V497, P539, DOI 10.1016/B978-0-12-385075-1.00024-X; HOLMES MJ, 2009, BMC MICROBIOL, V9, P69786, DOI DOI 10.1186/1471-2180-9-1; Huang HH, 2010, NUCLEIC ACIDS RES, V38, P2577, DOI 10.1093/nar/gkq164; Huang X, 2004, P NATL ACAD SCI USA, V101, P4848, DOI 10.1073/pnas.0400429101; Ihara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071581; Ionescu D, 2010, J MOL BIOL, V398, P177, DOI 10.1016/j.jmb.2010.03.010; Knight T., 2003, IDEMPOTENT VECTOR DE, P1; Li X, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mariscal V, 2007, MOL MICROBIOL, V65, P1139, DOI 10.1111/j.1365-2958.2007.05856.x; McWhinnie RL, 2014, APPL ENVIRON MICROB, V80, P226, DOI 10.1128/AEM.02793-13; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P20130, DOI 10.1073/pnas.1112724108; Muro-Pastor AM, 2017, ENV MICROBIOL REP, V9, P449, DOI 10.1111/1758-2229.12555; Muro-Pastor AM, 2014, MBIO, V5, DOI 10.1128/mBio.01079-14; Muro-Pastor AM, 2012, TRENDS MICROBIOL, V20, P548, DOI 10.1016/j.tim.2012.07.005; Ow SY, 2008, J PROTEOME RES, V7, P1615, DOI 10.1021/pr700604v; Rangel-Chavez C, 2017, MOL BIOSYST, V13, P665, DOI 10.1039/c6mb00789a; Redden H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8810; Sabel J, 2011, PRIMETIME QPCR APPL, V63; Sandh G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1064; Stensjo K, 2018, PHYSIOL PLANTARUM, V162, P148, DOI 10.1111/ppl.12606; Videau P, 2014, J BACTERIOL, V196, P1113, DOI 10.1128/JB.01372-13	38	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2018	13	9							e0203898	10.1371/journal.pone.0203898	http://dx.doi.org/10.1371/journal.pone.0203898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT2UM	30204806	Green Submitted, Green Published, gold			2022-12-26	WOS:000444355500056
J	Wang, Y; Wen, L; Zhou, S; Zhang, Y; Wang, XH; He, YY; Davie, A; Broadbent, S				Wang, Yun; Wen, Li; Zhou, Shi; Zhang, Yong; Wang, Xin-Hao; He, You-Yu; Davie, Allan; Broadbent, Suzanne			Effects of four weeks intermittent hypoxia intervention on glucose homeostasis, insulin sensitivity, GLUT4 translocation, insulin receptor phosphorylation, and Akt activity in skeletal muscle of obese mice with type 2 diabetes	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; NORMOBARIC HYPOXIA; WEIGHT-LOSS; PHOSPHATIDYLINOSITOL 3-KINASE; MITOCHONDRIAL DYSFUNCTION; GENOMIC CONSEQUENCES; SIGNALING PATHWAYS; RESISTANCE; EXERCISE; TRANSPORT	Aims The aims of this study were to determine the effects of four weeks of intermittent exposure to a moderate hypoxia environment (15% oxygen), and compare with the effects of exercise in normoxia or hypoxia, on glucose homeostasis, insulin sensitivity, GLUT4 translocation, insulin receptor phosphorylation, Akt-dependent GSK3 phosphorylation and Akt activity in skeletal muscle of obese mice with type 2 diabetes. Methods C57BL/6J mice that developed type 2 diabetes with a high-fat-diet (55% fat) (fasting blood glucose, FBG = 13.9 +/- 0.69 (SD) mmol/L) were randomly allocated into diabetic control (DC), rest in hypoxia (DH), exercise in normoxia (DE), and exercise in hypoxia (DHE) groups (n = 7, each), together with a normal-diet (4% fat) control group (NC, FBG = 9.1 +/- 1.11 (SD) mmol/L). The exercise groups ran on a treadmill at intensities of 75-90% VO(2)max. The interventions were applied one hour per day, six days per week for four weeks. Venous blood samples were analysed for FBG, insulin (FBI) and insulin sensitivity (QUICKI) pre and post the intervention period. The quadriceps muscle samples were collected 72 hours post the last intervention session for analysis of GLUT4 translocation, insulin receptor phosphorylation, Akt expression and phosphorylated GSK3 fusion protein by western blot. Akt activity was determined by the ratio of the phosphorylated GSK3 fusion protein to the total Akt protein. Results The FBG of the DH, DE and DHE groups returned to normal level (FBG = 9.4 +/- 1.50, 8.86 +/- 0.94 and 9.0 +/- 1.13 (SD) mmol/L for DH, DE and DHE respectively, P < 0.05), with improved insulin sensitivity compared to DC (P < 0.05), after the four weeks treatment, while the NC and DC showed no significant changes, as analysed by general linear model with repeated measures. All three interventions resulted in a significant increase of GLUT4 translocation to cell membrane compared to the DC group (P < 0.05). The DE and DH showed a similar level of insulin receptor phosphorylation compared with NC that was significantly lower than the DC (P < 0.05) post intervention. The DH and DHE groups showed a significantly higher Akt activity compared to the DE, DC and NC (P < 0.05) post intervention, as analysed by one-way ANOVA. Conclusions This study produced new evidence that intermittent exposure to mild hypoxia (0.15 FiO(2)) for four weeks resulted in normalisation of FBG, improvement in whole body insulin sensitivity, and a significant increase of GLUT4 translocation in the skeletal muscle, that were similar to the effects of exercise intervention during the same time period, in mice with diet-induced type 2 diabetes. However, exercise in hypoxia for four weeks did not have additive effects on these responses. The outcomes of the research may contribute to the development of effective, alternative and complementary interventions for management of hyperglycaemia and type 2 diabetes, particularly for individuals with limitations in participation of physical activity.	[Wang, Yun; Zhou, Shi; Davie, Allan; Broadbent, Suzanne] Southern Cross Univ, Sch Hlth & Human Sci, Lismore, NSW, Australia; [Wen, Li; Zhang, Yong] Tianjin Univ Sport, Key Lab Exercise Physiol & Sports Med, Tianjin, Peoples R China; [Wang, Xin-Hao; He, You-Yu] Tianjin Univ Sport, Dept Hlth & Exercise Sci, Tianjin, Peoples R China; [Broadbent, Suzanne] Univ Sunshine Coast, Sch Hlth & Sports Sci, Maroochydore, Australia	Southern Cross University; Tianjin University of Sport; Tianjin University of Sport; University of the Sunshine Coast	Zhou, S (corresponding author), Southern Cross Univ, Sch Hlth & Human Sci, Lismore, NSW, Australia.; Wen, L (corresponding author), Tianjin Univ Sport, Key Lab Exercise Physiol & Sports Med, Tianjin, Peoples R China.	wenli34@hotmail.com; shi.zhou@scu.edu.au	Zhou, Shi/B-8884-2009; Broadbent, Suzanne/AAI-7298-2020	Zhou, Shi/0000-0001-9038-5984; 	National Natural Science Foundation of China [NSFC 31271275]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NSFC 31271275). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasland KE, 2010, LAB ANIM-UK, V44, P25, DOI 10.1258/la.2009.009017; Abdul-Ghani MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/476279; Abdul-Ghani MA, 2008, CURR DIABETES REP, V8, P173, DOI 10.1007/s11892-008-0030-1; Assari S, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-3; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Chandel NS, 2000, J APPL PHYSIOL, V88, P1880, DOI 10.1152/jappl.2000.88.5.1880; Chen JX, 2007, AM J PHYSIOL-HEART C, V292, pH1664, DOI 10.1152/ajpheart.01138.2006; Chen YC, 2011, HIGH ALT MED BIOL, V12, P371, DOI 10.1089/ham.2010.1088; Clanton TL, 2001, J APPL PHYSIOL, V90, P2476, DOI 10.1152/jappl.2001.90.6.2476; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Colberg SR, 2010, DIABETES CARE, V33, P2692, DOI [10.2337/dc10-1548, 10.2337/dc10-9990]; Connett RJ, 1999, J APPL PHYSIOL, V68, P833; Costalat G, 2018, SLEEP BREATH, V22, P267, DOI 10.1007/s11325-017-1459-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Dela F, 2004, AM J PHYSIOL-ENDOC M, V287, pE1024, DOI 10.1152/ajpendo.00056.2004; Dokken BB, 2005, AM J PHYSIOL-ENDOC M, V288, pE1188, DOI 10.1152/ajpendo.00547.2004; Duennwald T, 2013, DIABETES CARE, V36, P2183, DOI 10.2337/dc12-2113; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Frosig C, 2007, DIABETES, V56, P2093, DOI 10.2337/db06-1698; Gnaiger E., 2003, OXYGEN CONFORMANCE C, P39; Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311; Gregg EW, 2002, DIABETES CARE, V25, P61, DOI 10.2337/diacare.25.1.61; Henriksen EJ, 2002, J APPL PHYSIOL, V93, P788, DOI 10.1152/japplphysiol.01219.2001; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hoshi M, 1996, P NATL ACAD SCI USA, V93, P2719, DOI 10.1073/pnas.93.7.2719; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; Itani SI, 2003, DIABETES, V52, P1635, DOI 10.2337/diabetes.52.7.1635; KANETY H, 1994, P NATL ACAD SCI USA, V91, P1853, DOI 10.1073/pnas.91.5.1853; Katz A, 2007, J APPL PHYSIOL, V102, P1671, DOI 10.1152/japplphysiol.01066.2006; KLIP A, 1987, FEBS LETT, V224, P224, DOI 10.1016/0014-5793(87)80452-0; Kong ZW, 2014, SLEEP BREATH, V18, P591, DOI 10.1007/s11325-013-0922-4; Krisan AD, 2004, J APPL PHYSIOL, V96, P1691, DOI 10.1152/japplphysiol.01054.2003; Krook A, 1997, DIABETES, V46, P2110, DOI 10.2337/diabetes.46.12.2110; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lee JS, 2007, DIABETES RES CLIN PR, V77, pS49, DOI 10.1016/j.diabres.2007.01.033; Levine BD, 2002, HIGH ALT MED BIOL, V3, P177, DOI 10.1089/15270290260131911; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; Liu M, 2010, J ETHNOPHARMACOL, V127, P32, DOI 10.1016/j.jep.2009.09.055; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Lyamina NP, 2011, J HYPERTENS, V29, P2265, DOI 10.1097/HJH.0b013e32834b5846; Mackenzie R, 2012, J CLIN ENDOCR METAB, V97, pE546, DOI 10.1210/jc.2011-2829; Mackenzie RWA, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/6934937; Mackenzie R, 2011, DIABETES-METAB RES, V27, P94, DOI 10.1002/dmrr.1156; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marcaletti Stefan, 2011, Curr Protoc Mouse Biol, V1, P141, DOI 10.1002/9780470942390.mo100160; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Netzer NC, 2008, SLEEP BREATH, V12, P129, DOI 10.1007/s11325-007-0149-3; Neubauer JA, 2001, J APPL PHYSIOL, V90, P1593, DOI 10.1152/jappl.2001.90.4.1593; Oakes ND, 1997, DIABETES, V46, P1768, DOI 10.2337/diabetes.46.11.1768; Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/h06-071; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reinke C, 2011, J APPL PHYSIOL, V111, P881, DOI 10.1152/japplphysiol.00492.2011; Reuter T.Y., 2007, DRUG DISCOV, V4, P3, DOI [10.1016/j.ddmod.2007.09.004, DOI 10.1016/J.DDMOD.2007.09.004]; Rhodes CJ, 2002, EUR J CLIN INVEST, V32, P3, DOI 10.1046/j.1365-2362.32.s3.2.x; Richardson RS, 2006, J PHYSIOL-LONDON, V571, P415, DOI 10.1113/jphysiol.2005.102327; Richardson RS, 1999, AM J PHYSIOL-HEART C, V277, pH2247, DOI 10.1152/ajpheart.1999.277.6.H2247; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; */* S  81, 2014, DIABETES CARE S1, V37, pS8, DOI DOI 10.2337/DC14-S081; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schreuder THA, 2014, HIGH ALT MED BIOL, V15, P349, DOI 10.1089/ham.2013.1144; Seifalian AM, 2001, FASEB J, V15, P2642, DOI 10.1096/fj.01-0308com; Serebrovska TV, 2017, EXP BIOL MED, V242, P1542, DOI 10.1177/1535370217723578; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Toledo FGS, 2007, DIABETES, V56, P2142, DOI 10.2337/db07-0141; Tremblay F, 2001, DIABETES, V50, P1901, DOI 10.2337/diabetes.50.8.1901; Urdampilleta A, 2012, J PHYSL BIOCH, P1; Valle MD, 2006, J NUCL CARDIOL, V13, P69, DOI 10.1016/j.nuclcard.2005.11.008; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Weisbrod CJ, 2004, DIABETES, V53, P2073, DOI 10.2337/diabetes.53.8.2073; Wiesner S, 2010, OBESITY, V18, P116, DOI 10.1038/oby.2009.193; Wood IS, 2003, BRIT J NUTR, V89, P3, DOI 10.1079/BJN2002763; Wu MC, 2013, EUR J SPORT SCI, V13, P221, DOI 10.1080/17461391.2011.606839; Xia RH, 2003, AM J PHYSIOL-CELL PH, V285, pC215, DOI 10.1152/ajpcell.00034.2002; Zuo L, 2005, AM J PHYSIOL-CELL PH, V289, pC207, DOI 10.1152/ajpcell.00449.2004	86	11	12	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2018	13	9							e0203551	10.1371/journal.pone.0203551	http://dx.doi.org/10.1371/journal.pone.0203551			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT7DK	30199540	Green Published, gold, Green Submitted			2022-12-26	WOS:000444681100015
J	Maksimenko, VA; Runnova, AE; Zhuravlev, MO; Protasov, P; Kulanin, R; Khramova, MV; Pisarchik, AN; Hramov, AE				Maksimenko, Vladimir A.; Runnova, Anastasia E.; Zhuravlev, Maksim O.; Protasov, Pavel; Kulanin, Roman; Khramova, Marina V.; Pisarchik, Alexander N.; Hramov, Alexander E.			Human personality reflects spatio-temporal and time-frequency EEG structure	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; AUTISM SPECTRUM DISORDERS; MENTAL PROCESSES; TASK-DIFFICULTY; SPEED; INTELLIGENCE; INFORMATION; PERFORMANCE; BRAIN; ALPHA	The reliable and objective assessment of intelligence and personality has been a topic of increasing interest of contemporary neuroscience and psychology. It is known that intelligence can be measured by estimating the mental speed or velocity of information processing. This is usually measured as a reaction time during elementary cognitive task processing, while personality is often assessed by means of questionnaires. On the other hand, human personality affects the way a subject accomplishes elementary cognitive tasks and, therefore, some personality features can define intelligence. It is expected that these features, as well as mental abilities in performing cognitive tasks are associated with the brain's electrical neural activity. Although several studies reported correlation between event-related potentials, mental ability and intelligence, there is a lack of information about time-frequency and spatio-temporal structures of neural activity which characterize this relation. In the present work, we analyzed human electroencephalograms (EEG) recorded during the performance of elementary cognitive tasks using the Schulte test, which is a paper-pencil based instrument for assessing elementary cognitive ability or mental speed. According to particular features found of the EEG structure, we divided the subjects into three groups. For subjects in each group, we applied the Sixteen Personality Factor Questionnaire (16PF) to assess the their personality traits. We demonstrated that each group exhibited a different score on the personality scale, such as warmth, reasoning, emotional stability and dominance. Summing up, we found a link between EEG features, mental abilities and personality traits. The obtained results can be of great interest for testing human personality to create automatized intelligent programs which combine simple tests and EEG measurements for real estimation of human personality traits and mental abilities.	[Maksimenko, Vladimir A.; Runnova, Anastasia E.; Zhuravlev, Maksim O.; Protasov, Pavel; Kulanin, Roman; Pisarchik, Alexander N.; Hramov, Alexander E.] Res & Educ Ctr Artificial Intelligence Syst & Neu, Politehnicheskaya Str 77, Saratov 410054, Russia; [Khramova, Marina V.] Saratov NG Chernyshevskii State Univ, Astrakhanskaya Str 83, Saratov 410012, Russia; [Pisarchik, Alexander N.] Tech Univ Madrid, Ctr Biomed Technol, Campus Montegancedo, Madrid 28223, Spain	Saratov State University; Universidad Politecnica de Madrid	Pisarchik, AN (corresponding author), Res & Educ Ctr Artificial Intelligence Syst & Neu, Politehnicheskaya Str 77, Saratov 410054, Russia.; Pisarchik, AN (corresponding author), Tech Univ Madrid, Ctr Biomed Technol, Campus Montegancedo, Madrid 28223, Spain.	alexander.pisarchik@ctb.upm.es	PROTASOV, PAVEL/AAH-6429-2019; Pisarchik, Alexander N./K-9704-2019; Khramova, Marina/AAS-1633-2020; Zhuravlev, Maxim MO/B-2068-2015; Hramov, Alexander/C-5600-2008; Maksimenko, Vladimir/K-1549-2019; Runnova, Anastasiya/M-2363-2016; Pisarchik, Alexander N./E-7545-2011	Pisarchik, Alexander N./0000-0003-2471-2507; Zhuravlev, Maxim MO/0000-0002-8620-1609; Hramov, Alexander/0000-0003-2787-2530; Maksimenko, Vladimir/0000-0002-4632-6896; Runnova, Anastasiya/0000-0002-2102-164X; Pisarchik, Alexander N./0000-0003-2471-2507	Ministry of Education and Science of Russian Federation of the Russian Federal Target Programme [RFMEFI57717X0282]	Ministry of Education and Science of Russian Federation of the Russian Federal Target Programme	This work has been supported by the Ministry of Education and Science of Russian Federation (Project RFMEFI57717X0282 of the Russian Federal Target Programme).	[Anonymous], J STAT SOFTWARE; Archer RP, 2016, EUROPEAN SCI J ESJ, V12, P147; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P171, DOI 10.1016/S1388-2457(02)00362-0; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P184, DOI 10.1016/S1388-2457(02)00363-2; Basar E, 2012, INT J PSYCHOPHYSIOL, V86, P25, DOI 10.1016/j.ijpsycho.2012.07.001; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; CATTELL RB, 1995, EDUC PSYCHOL MEAS, V55, P926, DOI 10.1177/0013164495055006002; Conn S.R., 1994, 16PF 5 EDITION TECHN; Demsar J, 2013, J MACH LEARN RES, V14, P2349; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; EDWARDS AL, 1973, ANNU REV PSYCHOL, V24, P241, DOI 10.1146/annurev.ps.24.020173.001325; Euler MJ, 2017, INTELLIGENCE, V65, P1, DOI 10.1016/j.intell.2017.08.003; Eysenck H. J, 2017, BIOL BASIS PERSONALI; Gomathi B, 2014, INT J ADV RES COMPUT, V5; Grigorenko E. L., 2009, MULTICULTURAL PSYCHO; GRIGORENKO EL, 1992, ACTA GENET MED GEMEL, V41, P65, DOI 10.1017/S000156600000252X; Handel RW, 2016, J CLIN PSYCHOL MED S, V23, P361, DOI 10.1007/s10880-016-9475-6; Harmony T, 1996, INT J PSYCHOPHYSIOL, V24, P161, DOI 10.1016/S0167-8760(96)00053-0; Harmony T, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00083; Herrington JD, 2010, PSYCHOPHYSIOLOGY, V47, P442, DOI 10.1111/j.1469-8986.2009.00958.x; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Houlihan M, 1998, INTELLIGENCE, V26, P9, DOI 10.1016/S0160-2896(99)80049-X; Hramov AE, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00674; Jager AO., 1997, TEST BERLINER INTELL; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; KEIRN ZA, 1990, IEEE T BIO-MED ENG, V37, P1209, DOI 10.1109/10.64464; Kleinhans NM, 2008, BRAIN RES, V1221, P115, DOI 10.1016/j.brainres.2008.04.080; Klimesch W, 1999, INTELLIGENCE, V27, P347, DOI 10.1016/S0160-2896(99)00027-6; Kuznetsova Julia, 2007, P 2 C GEN APPR LANG, P224; Langner R, 2010, ACTA PSYCHOL, V133, P64, DOI 10.1016/j.actpsy.2009.10.001; Lerche V, 2017, PSYCHOL RES-PSYCH FO, V81, P629, DOI 10.1007/s00426-016-0770-5; Lerche V, 2017, BEHAV RES METHODS, V49, P513, DOI 10.3758/s13428-016-0740-2; Luschekina E. A., 2017, Human Physiology, V43, P265, DOI 10.1134/S0362119717030112; Lutsyuk NV, 2006, NEUROPHYSIOLOGY+, V38, P209, DOI 10.1007/s11062-006-0048-4; Maksimenko VA, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.012316; Matthews G, 2002, EMOTION, V2, P315, DOI 10.1037//1528-3542.2.4.315; Milali MP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198245; Miller J, 2013, PSYCHON B REV, V20, P819, DOI 10.3758/s13423-013-0404-5; Neubauer AC, 1996, INTELLIGENCE, V22, P23, DOI 10.1016/S0160-2896(96)90019-7; Neubauer AC, 1998, INTELLIGENCE, V26, P123, DOI 10.1016/S0160-2896(99)80058-0; Niedermeyer E., 2014, ELECTROENCEPHALOGRAP; OSAKA M, 1984, PSYCHOPHYSIOLOGY, V21, P101, DOI 10.1111/j.1469-8986.1984.tb02325.x; Oswald WD., 1987, ZAHLEN VERBINDUNGS T; Palaniappan R, 2006, IEEE T NEUR SYS REH, V14, P299, DOI 10.1109/TNSRE.2006.881539; Pavlenko VB, 2004, NEUROPHYSIOLOGY+, V36, P276, DOI 10.1007/s11062-005-0019-1; Pavlenko VB, 2009, NEUROPHYSIOLOGY+, V41, P337, DOI 10.1007/s11062-010-9111-2; Pavlov AN, 2012, PHYS-USP+, V55, P845, DOI 10.3367/UFNe.0182.201209a.0905; POSNER MI, 1967, PSYCHOL REV, V74, P392, DOI 10.1037/h0024913; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Rogers LJ, 2004, P ROY SOC B-BIOL SCI, V271, pS420, DOI 10.1098/rsbl.2004.0200; Roslan NS, 2017, PERS INDIV DIFFER, V119, P323, DOI 10.1016/j.paid.2017.07.040; Santarnecchi E, 2015, HUM BRAIN MAPP, V36, P3586, DOI 10.1002/hbm.22864; Schubert AL, 2015, INTELLIGENCE, V51, P28, DOI 10.1016/j.intell.2015.05.002; Sheppard LD, 2008, PERS INDIV DIFFER, V44, P535, DOI 10.1016/j.paid.2007.09.015; Shmelev AG, 1989, WORKSH PSYCH SPEC PS; So WKY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174949; Socan G, 1998, PERS INDIV DIFFER, V25, P35; Steinbach M., 2000, P KDD WORKSH TEXT MI, V400, P525; Steinborn MB, 2018, PSYCHOL ASSESSMENT, V30, P339, DOI 10.1037/pas0000482; Steinborn MB, 2016, APPL COGNITIVE PSYCH, V30, P795, DOI 10.1002/acp.3255; Sternberg R.J., 1994, PERSONALITY INTELLIG; Sternberg RJ, 2008, ABILITY TESTING ACRO; STERNBERG S, 1969, AM SCI, V57, P421; VINGIANO W, 1989, INT J NEUROSCI, V44, P263, DOI 10.3109/00207458908986206; Zhang L, 2010, J MED SYST, V34, P51, DOI 10.1007/s10916-008-9215-z	67	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2018	13	9							e0197642	10.1371/journal.pone.0197642	http://dx.doi.org/10.1371/journal.pone.0197642			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT0BU	30192756	Green Published, Green Submitted, gold			2022-12-26	WOS:000444093600002
J	Lu, XL; Lu, XN; Liao, YC				Lu, Xingli; Lu, Xingneng; Liao, Yuncheng			Conservation tillage increases carbon sequestration of winter wheat-summer maize farmland on Loess Plateau in China	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; SYSTEMS; CORN; AGROECOSYSTEM; ECOSYSTEMS; BALANCE; YIELD; CYCLE; FIELD; FLUX	The idea of mitigating anthropogenic CO2 emissions by increasing soil organic carbon (SOC) is notable. However, the estimation of the net ecosystem carbon balance after conversion from conventional tillage to conservational tillage has been poorly quantified for the Loess Plateau in China. A 2-year field experiment was conducted to estimate the agroeco-system carbon balance of a winter wheat-summer maize rotation system using a full carbon cycle analysis. The results showed that a positive net ecosystem carbon balance value in the cases of rotary tillage with straw incorporation, chisel plow tillage with straw incorporation, and no tillage with straw mulching treatments. Note that a negative value was detected for the conventional moldboard plowing tillage without crop straw treatment. The conversion from conventional tillage to conservational tillage substantially enhanced the carbon sink potential from 0.84 t C ha(-1) yr(-1) to 2.69 t C ha(-1) yr(-1) in both years. Our findings suggest that the expansion of conservational tillage could enhance the potential carbon sink of the rain-fed land in China.	[Lu, Xingli] Ningxia Univ, Coll Agron, Ningxia, Peoples R China; [Lu, Xingneng] Peoples Bank China, Yinchuan Prov Subbranch, Ningxia, Peoples R China; [Liao, Yuncheng] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China	Ningxia University; People's Bank of China; Northwest A&F University - China	Liao, YC (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.	liaoyuncheng1969@163.com			National Natural Science Foundation of China [3157162]; Yinchuan Provincial Sub-branch, The People's Bank of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yinchuan Provincial Sub-branch, The People's Bank of China	This study was supported in part by the National Natural Science Foundation of China (Grant Nos. 3157162). In addition, Yinchuan Provincial Sub-branch, The People's Bank of China, gave support in the form of salaries for author Xingneng Lu but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bao S.D, 2008, AGROCHEMICAL ANAL SO; Blanco-Canqui H, 2007, GEODERMA, V141, P355, DOI 10.1016/j.geoderma.2007.06.012; Boomsma CR, 2010, SOIL TILL RES, V106, P227, DOI 10.1016/j.still.2009.12.006; Chen ZD, 2015, J CLEAN PROD, V103, P70, DOI 10.1016/j.jclepro.2014.05.014; Gao ChengDa, 2008, Journal of Beijing Forestry University, V30, P102; Grace J, 2004, J ECOL, V92, P189, DOI 10.1111/j.0022-0477.2004.00874.x; Graham RL, 2007, AGRON J, V99, P1, DOI 10.2134/agronj2005.0222; Gregory PJ, 2006, EUR J SOIL SCI, V57, P2, DOI 10.1111/j.1365-2389.2005.00778.x; Han Bin, 2010, Yingyong Shengtai Xuebao, V21, P91; Han X, 2018, BIOGEOSCIENCES, V15, P1933, DOI 10.5194/bg-15-1933-2018; Kimura M, 2004, SOIL BIOL BIOCHEM, V36, P1399, DOI 10.1016/j.soilbio.2004.03.006; Li J, 2006, SCI CHINA D S, V36, P210; [李琳 LI Lin], 2008, [农业环境科学学报, Journal of Agro-Environment Science], V27, P248; Li X, 2016, SCI TOTAL ENVIRON, V554, P293, DOI 10.1016/j.scitotenv.2016.02.151; Li XD, 2010, SOIL BIOL BIOCHEM, V42, P337, DOI 10.1016/j.soilbio.2009.11.013; [李玉宁 Li Yuning], 2002, [地学前缘, Earth science frontiers], V9, P351; [林慧龙 Lin Huilong], 2005, [草业科学, Pratacultural Science], V22, P59; Liu Dan, 2018, Yingyong Shengtai Xuebao, V29, P573, DOI 10.13287/j.1001-9332.201802.023; Lu XL, 2017, J CLEAN PROD, V162, P1617, DOI 10.1016/j.jclepro.2016.09.044; [罗友进 LUO Youjin], 2007, [水土保持学报, Journal of Soil and Water Conservation], V21, P55; Metz ORDB, 2007, CLIMATE CHANGE 2007; Nguyen C, 2003, AGRONOMIE, V23, P375, DOI 10.1051/agro:2003011; Norton JB, 2012, SOIL SCI SOC AM J, V76, P505, DOI 10.2136/sssaj2011.0284; [彭小瑜 Peng Xiaoyu], 2015, [农业环境科学学报, Journal of Agro-Environment Science], V34, P809; Pietola LM, 2005, SOIL TILL RES, V80, P103, DOI 10.1016/j.still.2004.03.001; Qin RJ, 2004, AGRON J, V96, P1523, DOI 10.2134/agronj2004.1523; Roldan A, 2005, APPL SOIL ECOL, V30, P11, DOI 10.1016/j.apsoil.2005.01.004; [芮雯奕 RUI Wenyi], 2006, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V15, P207; Smith P, 2010, AGR ECOSYST ENVIRON, V139, P302, DOI 10.1016/j.agee.2010.04.004; Snyder CS, 2009, AGR ECOSYST ENVIRON, V133, P247, DOI 10.1016/j.agee.2009.04.021; Tian Y.B., 2005, J YANGTZE U NAT SCI, V2, P1, DOI DOI 10.3969/J.ISSN.1673-1409-C.2005.02.001; Tubiello FN, 2015, GLOBAL CHANGE BIOL, V21, P2655, DOI 10.1111/gcb.12865; Van den Putte A, 2010, EUR J AGRON, V33, P231, DOI 10.1016/j.eja.2010.05.008; [王成己 WANG Cheng-ji], 2009, [农业环境科学学报, Journal of Agro-Environment Science], V28, P2464; Wang QJ, 2014, SOIL TILL RES, V137, P43, DOI 10.1016/j.still.2013.11.006; Wang Y, 2011, ENVIRON POLLUT, V159, P1427, DOI 10.1016/j.envpol.2010.12.031; Wei H, 2007, CHINESE J ECOAGRICUL, V15, P43; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; West TO, 2002, ENVIRON POLLUT, V116, P439, DOI 10.1016/S0269-7491(01)00221-4; Wienhold BJ, 2013, BIOENERG RES, V6, P786, DOI 10.1007/s12155-013-9301-z; Xu Di, 1999, Transactions of the Chinese Society of Agricultural Engineering, V15, P101; Zha T. G., 2008, SCI SOIL WATER CONSE, V6, p112 119; Zhang MY, 2013, J CLEAN PROD, V54, P101, DOI 10.1016/j.jclepro.2013.04.033; Zhao RongQin, 2010, Journal of Henan Agricultural Sciences, P40	44	13	13	9	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0199846	10.1371/journal.pone.0199846	http://dx.doi.org/10.1371/journal.pone.0199846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183708	Green Published, gold, Green Submitted			2022-12-26	WOS:000443789900085
J	Tufon, KA; Anong, DN; Meriki, HD; Georges, TD; Maurice, M; Kouanou, YS; Bolimo, AF; Tony, NJ; Kwenti, TE; Wung, NH; Nkuo-Akenji, T				Tufon, Kukwah Anthony; Anong, Damian Nota; Meriki, Henry Dilonga; Georges, Teuwafeu Denis; Maurice, Mouladje; Kouanou, Youmbi Sylvain; Bolimo, Ayah Flora; Tony, Nyeke James; Kwenti, Tebit Emmanuel; Wung, Ndze Henry; Nkuo-Akenji, Theresa			Characterization and assessment of HBV chronically infected patients: Identification of those eligible for treatment in the South West region of Cameroon	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; NATURAL-HISTORY; VIRUS INFECTION; GENDER DISPARITY; LIVER FIBROSIS; PREDICT; DISEASE; INDEX	Background The management of patients with chronic hepatitis B infection is quite complex because it requires an in-depth knowledge of the natural history of the disease. This study was aimed at characterizing HBV infected patients in order to determine the phase of the infection and identify the proportion eligible for treatment using 3 different guidelines. Methods HBV chronically infected patients (negative for HIV and HCV) were enrolled and the following tests were done for them: ALT, AST, HBV viral load, HBV serologic panel and Full blood count. APRI score was calculated for all patients. These patients were classified into immunotolerant, immune clearance, immune control and immune escape phases of the infection. The WHO and the 2018 AASLD criteria was also used to identify those who need treatment. Patients were clinically examined for signs and symptoms. Questionnaire was administered to all participants to ascertain their treatment status. Statistical analysis was done using SPSS version 21. Results A total of 283 participants (101 females and 182 males) with a mean age of 31.3 +/- 8.5 were enrolled. Fifty-two (18.4%) were eligible for treatment (Immune clearance and immune escape phases) and they recorded a significantly higher mean APRI score (0.71 +/- 0.51) as compared to those in the immune control and immune tolerant phase (0.43 +/- 0.20). Based on WHO and AASLD criteria, 12(4.2%) and 15 (5.3%) were eligible for treatment respectively and these were all subsets of the 52 cases mentioned above. Six (2.1%) and 29 (10.2%) of those identified under the immune control phase were on tenofovir and traditional medication respectively. Conclusion Considering treatment for patients in the immune clearance and immune escape phases of the infection can be a reliable strategy to implement in our setting as this may probably tie with considerations from other treatment guidelines. Fifty-two (18.4%) patients were eligible for treatment and none of them were among the 2.1% of patients put on Tenofovir based treatment. This calls for the need for more trained health experts to periodically assess patients, implement an adequate treatment guideline and place the right patients on treatment in Cameroon.	[Tufon, Kukwah Anthony; Meriki, Henry Dilonga; Tony, Nyeke James; Kwenti, Tebit Emmanuel] Univ Buea, Fac Sci, Dept Microbiol & Parasitol, Buea, South West Regi, Cameroon; [Tufon, Kukwah Anthony; Meriki, Henry Dilonga; Georges, Teuwafeu Denis; Maurice, Mouladje; Kouanou, Youmbi Sylvain; Bolimo, Ayah Flora; Kwenti, Tebit Emmanuel] Buea Reg Hosp, Buea, South West Regi, Cameroon; [Anong, Damian Nota; Nkuo-Akenji, Theresa] Univ Bamenda, Fac Sci, Dept Biol Sci, Bamenda, North West Regi, Cameroon; [Meriki, Henry Dilonga; Kwenti, Tebit Emmanuel] Univ Buea, Fac Hlth Sci, Dept Publ Hlth & Hyg, Buea, South West Regi, Cameroon; [Meriki, Henry Dilonga] BioCollect Worldwide Inc, Miami, FL USA; [Georges, Teuwafeu Denis] Univ Buea, Dept Internal Med, Fac Hlth Sci, Buea, South West Regi, Cameroon; [Kwenti, Tebit Emmanuel] Univ Buea, Fac Hlth Sci, Dept Med Lab Sci, Buea, South West Regi, Cameroon; [Wung, Ndze Henry] Univ Buea, Fac Sci, Dept Biochem & Mol Biol, Buea, South West Regi, Cameroon		Tufon, KA (corresponding author), Univ Buea, Fac Sci, Dept Microbiol & Parasitol, Buea, South West Regi, Cameroon.; Tufon, KA (corresponding author), Buea Reg Hosp, Buea, South West Regi, Cameroon.	drkapt@yahoo.com	Meriki, Henry Dilonga/V-4634-2019; Kwenti, Tebit E./P-8688-2018	Meriki, Henry Dilonga/0000-0002-9148-0171; Kwenti, Tebit E./0000-0001-5526-9179; Tufon, Kukwah/0000-0002-5643-0515; James Tony, Nyeke/0000-0003-1191-3502				Baig S, 2009, JCPSP-J COLL PHYSICI, V19, P598, DOI 09.2009/JCPSP.598600; Bertoletti A, 2015, CELL MOL IMMUNOL, V12, P258, DOI 10.1038/cmi.2014.79; Bigna JJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015298; Chang TT, 2008, HEPATOL INT, V2, pS19, DOI 10.1007/s12072-008-9059-0; Crawford D, 2014, ALL YOU WANTED KNOW, P63; Croagh CMN, 2014, WORLD J GASTROENTERO, V20, P10395, DOI 10.3748/wjg.v20.i30.10395; Dixit V, 2007, INDIAN J, P6; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Hosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180; Huang Y, 2017, LIVER INT, V37, P121, DOI 10.1111/liv.13116; Izzo I., 2011, OPEN INFECT DIS J, V5, P1, DOI [10.2174/1874279301105010001, DOI 10.2174/1874279301105010001]; Lemoine M, 2016, LANCET GLOB HEALTH, V4, pE559, DOI 10.1016/S2214-109X(16)30130-9; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Liaw YF, 2013, HEPATOLOGY, V58, P1856, DOI 10.1002/hep.26358; Liu WC, 2014, WORLD J GASTROENTERO, V20, P6252, DOI 10.3748/wjg.v20.i20.6252; Livingston SE, 2007, GASTROENTEROLOGY, V133, P1452, DOI 10.1053/j.gastro.2007.08.010; Ivon CFM, 2017, CURR THER RES CLIN E, V85, P15, DOI 10.1016/j.curtheres.2017.04.007; McGoogan KE, 2010, J PEDIATR GASTR NUTR, V50, P344, DOI 10.1097/MPG.0b013e3181aed725; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Moraleda G, 1997, J VIROL, V71, P9392, DOI 10.1128/JVI.71.12.9392-9399.1997; Nwokediuko SC, 2011, HEPAT MON, V11, P786, DOI 10.5812/kowsar.1735143X.757; Organization WH, 2015, GUID PREV CAR TREATM; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Pang J, 2014, ALL YOU WANTED KNOW, P43; Pita Inês, 2014, GE Port J Gastroenterol, V21, P241, DOI 10.1016/j.jpge.2014.08.003; Roos RAN, 2015, J VIRAL HEPATITIS, V22, P53, DOI 10.1111/jvh.64_12425; Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Stroffolini T, 2015, J MED VIROL, V87, P1899, DOI 10.1002/jmv.24243; Stuver S O, 1997, IARC Sci Publ, P319; Sun J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175482; SWINSCOW TDV, 1976, BRIT MED J, V1, P1262, DOI 10.1136/bmj.1.6020.1262; Szpakowski JL, 2013, HEPATOLOGY, V58, P21, DOI 10.1002/hep.26110; Terrault Norah A, 2018, Clin Liver Dis (Hoboken), V12, P33, DOI 10.1002/cld.728; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; World Health Organization, 2017, GUID HEP B C TEST; Wu JF, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0199-y; Yang F, 2010, J PROTEOME RES, V9, P134, DOI 10.1021/pr900593r; You H, 2016, SCI REP-UK, V6, DOI 10.1038/srep37498	40	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2018	13	9							e0203312	10.1371/journal.pone.0203312	http://dx.doi.org/10.1371/journal.pone.0203312			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6HC	30183765	gold, Green Published, Green Submitted			2022-12-26	WOS:000443789900056
J	Correa-Rocha, R; Lopez-Abente, J; Gutierrez, C; Perez-Fernandez, VA; Prieto-Sanchez, A; Moreno-Guillen, S; Munoz-Fernandez, MA; Pion, M				Correa-Rocha, Rafael; Lopez-Abente, Jacobo; Gutierrez, Carolina; Astrid Perez-Fernandez, Veronica; Prieto-Sanchez, Adrian; Moreno-Guillen, Santiago; Munoz-Fernandez, Maria-Angeles; Pion, Marjorie			CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1(+) viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion	PLOS ONE			English	Article							LYMPHOCYTE SEMAPHORIN; CD100-CD72 INTERACTION; DENDRITIC CELLS; IMMUNE-SYSTEM; HIV-INFECTION; REGULATORY T; CD72; SURFACE; PD-1; SEMA4D/CD100	In our work, we analyzed the role of the CD100/CD72 and PD-1/PD-L1 axes in immune response dysfunction in human immunodeficiency virus (HIV)-1 infection in which high expressions of PD-1 and PD-L1 were associated with an immunosuppressive state via limitation of the HIV-1-specific T-cell responses. CD100 was demonstrated to play a relevant role in immune responses in various pathological processes and may be responsible for immune dysregulation during HIV-1 infection. We investigated the function of CD72/CD100, and PD-1/PDL-1 axes on T and B cells in HIV-infected individuals and in healthy individuals. We analyzed the frequencies and fluorescence intensities of these four markers on CD4(+), CD8(+) T and B cells. Marker expressions were increased during active HIV-1 infection. CD100 frequency on T cells was positively associated with the expression of PD-1 and PDL1 on T cells from HIV-infected treatment-naive individuals. In addition, the frequency of CD72-expressing T cells was associated with interferon gamma (IFN-gamma) production in HIV-infected treatment-naive individuals. Our data suggest that the CD72/CD100 and PD-1/PDL1 axes may jointly participate in dysregulation of immunity during HIV-1 infection and could partially explain the immune systems' hyper-activation and exhaustion.	[Correa-Rocha, Rafael; Lopez-Abente, Jacobo; Astrid Perez-Fernandez, Veronica; Prieto-Sanchez, Adrian; Pion, Marjorie] Gregorio Maranon Univ Gen Hosp, Gregorio Maranon Hlth Res Inst IiSGM, Immuno Regulat Lab, Madrid, Spain; [Gutierrez, Carolina; Moreno-Guillen, Santiago] Alcala de Henares Univ, Hosp Ramon y Cajal, IRYCIS, Dept Infect Dis, Madrid, Spain; [Munoz-Fernandez, Maria-Angeles; Pion, Marjorie] Gregorio Maranon Univ, Immuno Biol Mol Lab, Gregorio Maranon Hlth Res Inst IiSGM, Gen Hosp,Spanish HIV HGM BioBank, Madrid, Spain; [Munoz-Fernandez, Maria-Angeles] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain	General University Gregorio Maranon Hospital; Hospital Universitario Ramon y Cajal; Universidad de Alcala; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Pion, M (corresponding author), Gregorio Maranon Univ Gen Hosp, Gregorio Maranon Hlth Res Inst IiSGM, Immuno Regulat Lab, Madrid, Spain.; Pion, M (corresponding author), Gregorio Maranon Univ, Immuno Biol Mol Lab, Gregorio Maranon Hlth Res Inst IiSGM, Gen Hosp,Spanish HIV HGM BioBank, Madrid, Spain.	marjorie.pion@iisgm.com	Pion, Marjorie/AAB-5812-2022; Correa-Rocha, Rafael/C-8213-2011; Pion, Marjorie/D-8139-2012; Pion, Marjorie/D-8139-2012	Correa-Rocha, Rafael/0000-0003-3456-9986; Pion, Marjorie/0000-0003-1828-4745; Lopez-Abente, Jacobo/0000-0003-3640-4077; Pion, Marjorie/0000-0002-6406-747X; Munoz-Fernandez/0000-0002-0813-4500	Ministry of Economy and Competitiveness ISCIII-FIS [PI12/01763, PI12/00934, PI15/00923]; ERDF (FEDER) Funds from the European Commission; IiSGM; Youth Employment Program; Madrid community; FEDER Founds; Spanish AIDS Research Network; "Miguel Servet" program [CPII13/00033]; Spanish MICINN through the Ramon y Cajal [RYC-2009-05486]	Ministry of Economy and Competitiveness ISCIII-FIS; ERDF (FEDER) Funds from the European Commission; IiSGM; Youth Employment Program; Madrid community; FEDER Founds(European Commission); Spanish AIDS Research Network; "Miguel Servet" program; Spanish MICINN through the Ramon y Cajal	This work was partially supported by the Ministry of Economy and Competitiveness ISCIII-FIS grants PI12/01763, PI12/00934 and PI15/00923, co-financed by ERDF (FEDER) Funds from the European Commission, "A way of making Europe". JL-A was supported by a grant from IiSGM. AP-S and VP-F were supported by the Youth Employment Program co-financed by the Madrid community and FEDER Founds. CG was supported by the Spanish AIDS Research Network. RC-R was supported by "Miguel Servet" program (CPII13/00033), and MP by the Spanish MICINN through the Ramon y Cajal (RYC-2009-05486).; We acknowledge Dr. Laura Doaz from Cytometry Unit of IiSGM for samples analysis, Dr. Maribel Clemente from Cell Culture Unit of IiSGM and Jose-Maria Bellon from the Unit of Methodology and Biostatistics of IiSGM. This work was partially supported by the Ministry of Economy and Competitiveness ISCIII-FIS grants PI12/01763, PI12/00934 and PI15/00923, co-financed by ERDF (FEDER) Funds from the European Commission, "A way of making Europe". J.L-A. was supported by a Grant from IiSGM. A.P-S and V.A. P-F were supported by the Youth Employment Program co-financed by the Madrid community and FEDER Founds. C.G. was supported by the Spanish AIDS Research Network. R.C-R was supported by "Miguel Servet" program (CPII13/00033), and M.P by the Spanish MICINN through the Ramon y Cajal (RYC-2009-05486). All this work was performed in the Laboratorio de Inmuno-Biologia Molecular, Department of Immunology (HGUG and IiSGM) lead by M-A.M-F.	Adachi T, 2000, J IMMUNOL, V164, P1223, DOI 10.4049/jimmunol.164.3.1223; Ahmad F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00338; Barathan M, 2016, EUR J CLIN INVEST, V46, P170, DOI 10.1111/eci.12581; Bardhan K, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00550; Besliu A, 2011, AUTOIMMUNITY, V44, P427, DOI 10.3109/08916934.2010.541171; Chaudhry A, 2013, J CLIN INVEST, V123, P939, DOI 10.1172/JCI57175; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deaglio S, 2005, BLOOD, V105, P3042, DOI 10.1182/blood-2004-10-3873; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Ellegard R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00899; Eriksson EM, 2012, BLOOD, V119, P745, DOI 10.1182/blood-2010-12-324848; Granziero L, 2003, BLOOD, V101, P1962, DOI 10.1182/blood-2002-05-1339; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; He Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113338; Ishida I, 2003, INT IMMUNOL, V15, P1027, DOI 10.1093/intimm/dxg098; Jiang XJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00765; Kuklina EM, 2017, B EXP BIOL MED; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2001, TRENDS IMMUNOL, V22, P670, DOI 10.1016/S1471-4906(01)02087-7; Larsson M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-31; Li BJ, 2017, J INT MED RES, V45, P89, DOI 10.1177/0300060516676136; Li T, 2018, MOL IMMUNOL, V94, P98, DOI 10.1016/j.molimm.2017.12.020; Liu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073958; Lopez-Abente J, 2017, CELL MOL IMMUNOL; Maleki KT, 2016, CLIN IMMUNOL, V163, P52, DOI 10.1016/j.clim.2015.12.012; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Meier A, 2008, AIDS, V22, P655, DOI 10.1097/QAD.0b013e3282f4de23; Mizrahi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000818; Moir S, 2014, CURR OPIN HIV AIDS, V9, P472, DOI 10.1097/COH.0000000000000092; Peretz Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002840; Rosignoli G, 2009, CLIN EXP IMMUNOL, V157, P90, DOI 10.1111/j.1365-2249.2009.03960.x; Rothstein TL, 2013, ANN NY ACAD SCI, V1285, P97, DOI 10.1111/nyas.12137; Saeidi A, 2015, CELL IMMUNOL, V297, P19, DOI 10.1016/j.cellimm.2015.05.005; Saeidi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124659; Schweneker M, 2008, J IMMUNOL, V180, P6490, DOI 10.4049/jimmunol.180.10.6490; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Suzuki K, 2003, CYTOKINE GROWTH F R, V14, P17, DOI 10.1016/S1359-6101(02)00073-4; Thibult ML, 2013, INT IMMUNOL, V25, P129, DOI 10.1093/intimm/dxs098; Trabattoni D, 2003, BLOOD, V101, P2514, DOI 10.1182/blood-2002-10-3065; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Vadasz Z, 2018, CLIN IMMUNOL, V191, P88, DOI 10.1016/j.clim.2017.09.010; Wang L, 2015, DIGEST DIS SCI, V60, P405, DOI 10.1007/s10620-014-3372-3; Wu HJ, 2002, IMMUNOL RES, V25, P155, DOI 10.1385/IR:25:2:155; Yamamoto T, 2011, BLOOD, V117, P4805, DOI 10.1182/blood-2010-11-317297; Zhang JY, 2007, BLOOD, V109, P4671, DOI 10.1182/blood-2006-09-044826; Zheng MK, 2014, IMMUNOL INVEST, V43, P705, DOI 10.3109/08820139.2014.917096	46	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203419	10.1371/journal.pone.0203419	http://dx.doi.org/10.1371/journal.pone.0203419			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161254	Green Published, gold, Green Submitted			2022-12-26	WOS:000443388900124
